PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	McLelland, D; Paulsen, O				McLelland, Douglas; Paulsen, Ole			Cortical songs revisited: A lesson in statistics	NEURON			English	Editorial Material							ELECTRODES; PATTERNS; ORDER	Recordings from single neurons in the cortex have revealed precisely repeating patterns of synaptic events. These repeats are known as cortical "motifs" and have been suggested to reflect the precise replay of spatiotemporal firing sequences ("synfire" chains). In this issue of Neuron, Mokeichev et al. use compelling statistical analysis to show that, rather than being evidence of deterministic synfire chains, such cortical motifs are bound to appear by chance due to the natural dynamics of voltage fluctuations in neurons.	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Paulsen, O (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, S Parks Rd, Oxford OX1 3PT, England.	ole.paulsen@dpag.ox.ac.uk	Paulsen, Ole/ABB-4843-2020	Paulsen, Ole/0000-0002-2258-5455; McLelland, Douglas/0000-0002-5892-9854				Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Gautrais J, 1998, BIOSYSTEMS, V48, P57, DOI 10.1016/S0303-2647(98)00050-1; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; HEBB DO, 1949, ORG BEHV; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Lee AK, 2004, J NEUROPHYSIOL, V92, P2555, DOI 10.1152/jn.01030.2003; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Mokeichev A, 2007, NEURON, V53, P413, DOI 10.1016/j.neuron.2007.01.017; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021	12	8	8	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					319	321		10.1016/j.neuron.2007.01.020	http://dx.doi.org/10.1016/j.neuron.2007.01.020			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270729	Bronze			2022-12-28	WOS:000245126800003
J	Sobczyk, A; Svoboda, K				Sobczyk, Aleksander; Svoboda, Karel			Activity-dependent plasticity of the NMDA-receptor fractional Ca2+ current	NEURON			English	Article							LONG-TERM POTENTIATION; SINGLE DENDRITIC SPINES; SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; CALCIUM-CHANNELS; VISUAL-CORTEX; CA1; HIPPOCAMPUS; EXPRESSION; AMPA	Ca2+, influx through NMDA receptors (NIVIDARs) triggers synaptic plasticity, gene transcription, and cytotoxicity, but little is known about the regulation of NMDA-Rs themselves. We used two-photon glutamate uncaging to activate NMDA-Rs on individual dendritic spines in rat CA1 neurons while we measured NMDAR currents at the soma and [Ca 2,] changes in spines. Low-frequency uncaging trains induced Ca 2, -dependent long-term depression of NMDA-R-mediated synaptic currents. Additionally, uncaging trains caused a reduction in the Ca2+ accumulation per unit of NMDA-R current in spines due to a reduction in the fraction of the NMDA-R current carried by Ca2+. Induction of depression of NMDA-R-mediated Ca2+ influx required activation of NR2B-containing receptors. Receptors in single spines depressed rapidly in an all-or-none manner. These adaptive changes in NMDA-R function likely play a critical role in metaplasticity and in stabilizing activity levels in neuronal networks with Hebbian synapses.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, POB 100, Cold Spring Harbor, NY 11724 USA.	svobodak@janelia.hhmi.org						Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Garaschuk O, 1996, J PHYSIOL-LONDON, V491, P757, DOI 10.1113/jphysiol.1996.sp021255; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Kullmann DM, 2003, PHILOS T R SOC B, V358, P727, DOI 10.1098/rstb.2002.1229; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Montgomery JM, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-48; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; MORISHITA W, 2006, IN PRESS NEUROPHARMA; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Racca C, 2000, J NEUROSCI, V20, P2512; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; SCHNEGGENBURGER R, 1993, NEURON, V11, P133, DOI 10.1016/0896-6273(93)90277-X; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Skeberdis VA, 2006, NAT NEUROSCI, V9, P501, DOI 10.1038/nn1664; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YASUDA R, 2004, SCI STKE, pPL5; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	55	77	85	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					17	24		10.1016/j.neuron.2006.11.016	http://dx.doi.org/10.1016/j.neuron.2006.11.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196527	Green Accepted, Bronze			2022-12-28	WOS:000245126500005
J	Santamaria, F; Wils, S; De Schutter, E; Augustine, GJ				Santamaria, Fidel; Wils, Stefan; De Schutter, Erik; Augustine, George J.			Anomalous diffusion in Purkinje cell dendrites caused by spines	NEURON			English	Article							CALCIUM DYNAMICS; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; NMDA RECEPTORS; CHANNELS; MECHANISMS; PLASTICITY; KINETICS; SYNAPSE; AXON	We combined local photolysis of caged compounds with fluorescence imaging to visualize molecular diffusion within dendrites of cerebellar Purkinje cells. Diffusion of a volume marker, fluorescein dextran, within spiny dendrites was remarkably slow in comparison to its diffusion in smooth dendrites. Computer simulations indicate that this retardation is due to a transient trapping of molecules within dendritic spines, yielding anomalous diffusion. We considered the influence of spine trapping on the diffusion of calcium ions (Ca2+) and inositol-1, 4,5-triphospate (IP3) two synaptic second messengers. Diffusion Of IP3 was strongly influenced by the presence of dendritic spines, while Ca2+ was removed so rapidly that it could not diffuse far enough to be trapped. We conclude that an important function of dendritic spines may be to trap chemical signals and thereby create slowed anomalous diffusion within dendrites.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium	Duke University; University of Antwerp	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, POB 3209, Durham, NC 27710 USA.	georgea@neuro.duke-edu	Santamaria, Fidel/I-2544-2012; De Schutter, Erik/G-8460-2011; Santamaria, Fidel/H-4721-2019; Augustine, George James/J-9228-2013	Santamaria, Fidel/0000-0001-8750-2932; De Schutter, Erik/0000-0001-8618-5138; Santamaria, Fidel/0000-0001-8750-2932; 	NIGMS NIH HHS [GM65473, R24 GM065473] Funding Source: Medline; NINDS NIH HHS [NS-34045, R01 NS034045] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM065473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034045] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; ben-Avraham D., 2005, DIFFUSION REACTIONS; Bird GS, 2004, CURR MOL MED, V4, P291, DOI 10.2174/1566524043360681; Bormann Guy, 2001, P189; Bower J. M., 1995, BOOK GENESIS; Crank J., 1975, MATH DIFFUSION; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; Edgerton JR, 2003, J PHYSIOL-LONDON, V548, P53, DOI 10.1113/jphysiol.2002.027854; Ellis-Davies GCR, 1998, TETRAHEDRON LETT, V39, P953, DOI 10.1016/S0040-4039(97)10668-2; Fiala J.C., 1999, DENDRITES, P1, DOI DOI 10.1093/ACPROF:OSO/9780198566564.003.0001; Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; FRITZSCH B, 1993, J NEUROSCI METH, V50, P95, DOI 10.1016/0165-0270(93)90060-5; Fukano T, 2004, J STRUCT BIOL, V147, P12, DOI 10.1016/j.jsb.2003.11.002; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Goldberg JH, 2005, TRENDS NEUROSCI, V28, P158, DOI 10.1016/j.tins.2005.01.005; Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Hartmann J, 2005, CELL CALCIUM, V37, P459, DOI 10.1016/j.ceca.2005.01.014; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holthoff K, 2002, NEURON, V33, P425, DOI 10.1016/S0896-6273(02)00576-7; Khodakhah K, 1997, BIOPHYS J, V73, P3349, DOI 10.1016/S0006-3495(97)78359-0; Klafter J, 2005, PHYS WORLD, V18, P29; Korkotian E, 2006, CELL CALCIUM, V40, P441, DOI 10.1016/j.ceca.2006.08.008; LAFARGA M, 1991, J NEUROCYTOL, V20, P533, DOI 10.1007/BF01215262; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; MARTONE ME, 1993, J NEUROSCI, V13, P4636; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Michailova A, 2002, BIOPHYS J, V83, P3134, DOI 10.1016/S0006-3495(02)75317-4; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; PALAY SL, 1974, CEREBELLAX CORTEX; Pattni K, 2004, CELL SIGNAL, V16, P643, DOI 10.1016/j.cellsig.2003.10.009; POO MM, 1990, J NEUROBIOL, V21, P157, DOI 10.1002/neu.480210111; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; SAXTON MJ, 1994, BIOPHYS J, V66, P394, DOI 10.1016/S0006-3495(94)80789-1; Schmidt H, 2005, P NATL ACAD SCI USA, V102, P5850, DOI 10.1073/pnas.0407855102; Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824; Schnell S, 2004, PROG BIOPHYS MOL BIO, V85, P235, DOI 10.1016/j.pbiomolbio.2004.01.012; Schutter E. D. E., 1998, METHODS NEURONAL MOD, P211; Sepulveda MR, 2004, EUR J NEUROSCI, V19, P542, DOI 10.1111/j.0953-816X.2003.03156.x; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Stiles JR, 2001, METH NE FRO NEUROSCI, P87; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; WALKER JW, 1989, BIOCHEMISTRY-US, V28, P3272, DOI 10.1021/bi00434a023; Wang HB, 2003, MOL PHARMACOL, V63, P463, DOI 10.1124/mol.63.3.463; WANG SSH, 1995, NEURON, V15, P755, DOI 10.1016/0896-6273(95)90167-1; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004; Yuste R, 1999, J NEUROSCI, V19, P1976; ZADOR A, 1994, J NEUROSCI, V14, P4705; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	67	206	209	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					635	648		10.1016/j.neuron.2006.10.025	http://dx.doi.org/10.1016/j.neuron.2006.10.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114048	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000242413100011
J	Sharma, S; Black, DL				Sharma, Shalini; Black, Douglas L.			Maps, codes, and sequence elements: Can we predict the protein output from an alternatively spliced locus?	NEURON			English	Editorial Material								Alternative splicing choices are governed by splicing regulatory protein interactions with splicing silencer and enhancer elements present in the pre-mRNA. However, the prediction of these choices from genomic sequence is difficult, in part because the regulators can act as either enhancers or silencers. A recent study describes how for a particular neuronal splicing regulatory protein, Nova, the location of its binding sites is highly predictive of the protein's effect on an exon's splicing.	Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Sharma, S (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.							Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; House AE, 2006, NAT STRUCT MOL BIOL, V13, P937, DOI 10.1038/nsmb1149; Hui JY, 2005, EMBO J, V24, P1988, DOI 10.1038/sj.emboj.7600677; IBRAHIM, 2005, P NATL ACAD SCI US, V102, P5002; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jin Y, 2003, EMBO J, V22, P905, DOI 10.1093/emboj/cdg089; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Sharma S, 2005, MOL CELL, V19, P485, DOI 10.1016/j.molcel.2005.07.014; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; ULE J, 2006, IN PRESS NATURE; Will CL, 2006, COLD SPRING HARB MON, V43, P369; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74	13	5	7	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					574	576		10.1016/j.neuron.2006.11.005	http://dx.doi.org/10.1016/j.neuron.2006.11.005			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114042	Bronze			2022-12-28	WOS:000242413100005
J	Yu, X; Yoganarasimha, D; Knierim, JJ				Yu, Xintian; Yoganarasimha, D.; Knierim, James J.			Backward shift of head direction tuning curves of the anterior thalamus: Comparison with CA1 place fields	NEURON			English	Article							TIMING-DEPENDENT PLASTICITY; LATERAL MAMMILLARY NUCLEUS; FREELY MOVING RATS; PATH-INTEGRATION; CELL-ACTIVITY; THALAMOCORTICAL CIRCUIT; HIPPOCAMPAL SUBFIELDS; ENTORHINAL CORTEX; DISTAL LANDMARKS; RECEPTIVE-FIELDS	The head direction cell system is composed of multiple regions associated with the hippocampal formation. The dynamics of head direction tuning curves (HDTCs) were compared with those of hippocampal place fields. In both familiar and cue-altered environments, as a rat ran an increasing number of laps on a track, the center of mass (COM) of the HDTC tended to shift backward, similar to shifting observed in place cells. However, important differences existed between these cells in terms of the shift patterns relative to the cue-altered conditions, the proportion of backward versus forward shifts, and the time course of shift resetting. The demonstration of backward COM shifts in head direction cells and place cells suggests that similar plasticity mechanisms (such as temporally asymmetric LTP induction or spike timing-dependent plasticity) may be at work in both brain systems, and these processes may reflect a general mechanism for storing learned sequences of neural activity patterns.	Univ Texas, Sch Med, Dept Neurobiol & Anat, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77225 USA	University of Texas System	Knierim, JJ (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, WM Keck Ctr Neurobiol Learning & Memory, Houston, TX 77225 USA.	james.j.knierim@uth.tmc.edu		Knierim, James/0000-0002-1796-2930; Doreswamy, Yoganarasimha/0000-0001-7122-6953	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH063297] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039456] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH063297, K02 MH63297] Funding Source: Medline; NINDS NIH HHS [R01 NS39456, R01 NS039456] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		August DA, 1999, J COMPUT NEUROSCI, V6, P71, DOI 10.1023/A:1008861001091; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blair HT, 1998, NEURON, V21, P1387, DOI 10.1016/S0896-6273(00)80657-1; BLAIR HT, 1995, J NEUROSCI, V15, P6260; Blair HT, 1996, ADV NEUR IN, V8, P152; Blair HT, 1999, J NEUROSCI, V19, P6673; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2002, J NEUROSCI, V22, P3817; Frohardt RJ, 2006, BEHAV NEUROSCI, V120, P135, DOI 10.1037/0735-7044.120.1.135; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Goodridge JP, 2000, J NEUROPHYSIOL, V83, P3402, DOI 10.1152/jn.2000.83.6.3402; Goodridge JP, 1997, J NEUROSCI, V17, P9315; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Khan AM, 2000, J COMP NEUROL, V428, P428; Knierim JJ, 1998, J NEUROPHYSIOL, V80, P425, DOI 10.1152/jn.1998.80.1.425; Knierim JJ, 2000, NEURON, V25, P504, DOI 10.1016/S0896-6273(00)81053-3; KNIERIM JJ, 1995, J NEUROSCI, V15, P1648, DOI 10.1523/JNEUROSCI.15-03-01648.1995; Knierim JJ, 2002, J NEUROSCI, V22, P6254; Knierim JJ, 2005, HEAD DIRECTION CELLS, P163; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lee I, 2006, NEURON, V51, P639, DOI 10.1016/j.neuron.2006.06.033; Leutgeb S, 2000, NEUROSCIENCE, V100, P11, DOI 10.1016/S0306-4522(00)00258-X; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Ma TG, 1997, BRAIN RES, V760, P187, DOI 10.1016/S0006-8993(97)00279-5; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1991, J COGNITIVE NEUROSCI, V3, P192, DOI 10.1162/jocn.1991.3.2.190; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; McNaughton BL, 1996, J EXP BIOL, V199, P173; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Mehta MR, 2000, NEUROCOMPUTING, V32, P905, DOI 10.1016/S0925-2312(00)00259-9; Muir GM, 2004, BEHAV BRAIN RES, V153, P249, DOI 10.1016/j.bbr.2003.12.007; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Muller RU, 1996, CURR OPIN NEUROBIOL, V6, P196, DOI 10.1016/S0959-4388(96)80073-0; O'Keefe J, 2005, HIPPOCAMPUS, V15, P853, DOI 10.1002/hipo.20115; Ranck J.B., 1985, ELECT ACTIVITY ARCHI, P217; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Shapiro ML, 1997, HIPPOCAMPUS, V7, P624, DOI 10.1002/(SICI)1098-1063(1997)7:6<624::AID-HIPO5>3.0.CO;2-E; Sharp PE, 2001, TRENDS NEUROSCI, V24, P289, DOI 10.1016/S0166-2236(00)01797-5; Shen JM, 1997, J NEUROSCI, V17, P6769; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Song PC, 2005, J NEUROSCI, V25, P1002, DOI 10.1523/JNEUROSCI.4172-04.2005; Stackman RW, 1998, J NEUROSCI, V18, P9020; Taube JS, 1998, HIPPOCAMPUS, V8, P87, DOI 10.1002/(SICI)1098-1063(1998)8:2<87::AID-HIPO1>3.0.CO;2-4; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; TAUBE JS, 1990, J NEUROSCI, V10, P436; Wang XJ, 1999, J NEUROSCI, V19, P9587; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yoganarasimha D, 2006, J NEUROSCI, V26, P622, DOI 10.1523/JNEUROSCI.3885-05.2006; Yoganarasimha D, 2005, EXP BRAIN RES, V160, P344, DOI 10.1007/s00221-004-2016-9; Yu X, 2006, NEUROCOMPUTING, V69, P1253, DOI 10.1016/j.neucom.2005.12.087; Zhang K, 1996, J NEUROSCI, V16, P2112; Zugaro MB, 2003, J NEUROSCI, V23, P3478	68	18	18	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					717	729		10.1016/j.neuron.2006.10.003	http://dx.doi.org/10.1016/j.neuron.2006.10.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114054	Bronze, Green Accepted			2022-12-28	WOS:000242413100017
J	Nagy, A; Kruse, W; Rottmann, S; Dannenberg, S; Hoffmann, KP				Nagy, Attila; Kruse, Wolfgang; Rottmann, Silke; Dannenberg, Sabine; Hoffmann, Klaus-Peter			Somatosensory-motor neuronal activity in the superior colliculus of the primate	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; UNDERLYING RETICULAR-FORMATION; MOVEMENT-RELATED NEURONS; GAZE SHIFTS; HEAD MOVEMENTS; ARM MOVEMENTS; SENSORIMOTOR INTEGRATION; ELECTRICAL-STIMULATION; SEQUENTIAL MOVEMENTS; ASSOCIATION CORTEX	The superior colliculus (SC) in primates plays an important role in orienting gaze and arms toward novel stimuli. Here we ask whether neurons in the intermediate and deep layers of the SC are also involved in the interaction with objects. In two trained monkeys we found a large number of SC units that were specifically activated when the monkeys contacted and pushed a target that had been reached with either hand. These neurons, however, were silent when the monkeys simply looked at or reached for the target but did not touch it. The activity related to interacting with objects was spatially tuned and increased with push strength. Neurons in the SC with this type of activity may be involved in a somatosensory-motor feedback loop that monitors the force of the active muscles together with the spatial position of the limb required for proper interaction with an object.	Ruhr Univ Bochum, Dept Zool & Neurobiol, D-44780 Bochum, Germany	Ruhr University Bochum	Hoffmann, KP (corresponding author), Ruhr Univ Bochum, Dept Zool & Neurobiol, ND 7-67, D-44780 Bochum, Germany.	kph@neurobiologie.rub.de						ABRAHAMS VC, 1975, J PHYSIOL-LONDON, V247, P117, DOI 10.1113/jphysiol.1975.sp010923; Arts MPM, 2000, BEHAV BRAIN RES, V108, P73, DOI 10.1016/S0166-4328(99)00133-3; Battaglia-Mayer A, 2003, CEREB CORTEX, V13, P1009, DOI 10.1093/cercor/13.10.1009; Battaglia-Mayer A, 2002, BRAIN, V125, P225, DOI 10.1093/brain/awf034; Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Birznieks I, 2001, J NEUROSCI, V21, P8222, DOI 10.1523/JNEUROSCI.21-20-08222.2001; Breveglieri R, 2006, J NEUROSCI, V26, P3679, DOI 10.1523/JNEUROSCI.4637-05.2006; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Choi WY, 2006, NEURON, V50, P491, DOI 10.1016/j.neuron.2006.03.032; CLEMO HR, 1991, J COMP NEUROL, V314, P534, DOI 10.1002/cne.903140310; Courjon JH, 2004, J PHYSIOL-LONDON, V556, P675, DOI 10.1113/jphysiol.2004.061713; COWIE RJ, 1994, J NEUROPHYSIOL, V72, P2648, DOI 10.1152/jn.1994.72.6.2648; Debowy DJ, 2001, EXP BRAIN RES, V137, P269, DOI 10.1007/s002210000660; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P2978, DOI 10.1152/jn.00958.2002; Fattori P, 2004, EUR J NEUROSCI, V20, P2457, DOI 10.1111/j.1460-9568.2004.03697.x; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; Ferraina S, 1997, EUR J NEUROSCI, V9, P1090, DOI 10.1111/j.1460-9568.1997.tb01460.x; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; FRIES W, 1984, J COMP NEUROL, V230, P55, DOI 10.1002/cne.902300106; Gardner EP, 1999, EXP BRAIN RES, V127, P329, DOI 10.1007/s002210050803; GEORGOPOULOS AP, 1984, EXP BRAIN RES, V54, P446; Glickstein Mitchell, 2003, Adv Neurol, V93, P43; GRANTYN A, 1985, EXP BRAIN RES, V57, P417; Guitton D, 2003, PROG BRAIN RES, V142, P55; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; HOUK J, 1967, J NEUROPHYSIOL, V30, P466, DOI 10.1152/jn.1967.30.3.466; Hunt CC, 1974, HDB SENSORY PHYSL, VIII/2, P191; Jackson SR, 2005, CURR BIOL, V15, P42, DOI 10.1016/S0960-9822(04)01046-2; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KALASKA JF, 1985, EXP BRAIN RES, V59, P197; Lock TM, 2003, EXP BRAIN RES, V151, P455, DOI 10.1007/s00221-003-1500-y; Lunenburger L, 2000, EUR J NEUROSCI, V12, P4107, DOI 10.1046/j.1460-9568.2000.00298.x; Lunenburger L, 2001, PROG BRAIN RES, V134, P109; MARTIN JH, 1993, EXP BRAIN RES, V94, P418; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; Pare M, 1997, J NEUROPHYSIOL, V78, P3493, DOI 10.1152/jn.1997.78.6.3493; PARE M, 1994, EXP BRAIN RES, V101, P123; Ro JY, 2000, EXP BRAIN RES, V135, P1, DOI 10.1007/s002210000496; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Shima K, 1996, J NEUROPHYSIOL, V76, P2115, DOI 10.1152/jn.1996.76.3.2115; Snyder LH, 1998, J NEUROPHYSIOL, V79, P2814, DOI 10.1152/jn.1998.79.5.2814; Snyder LH, 2000, J NEUROPHYSIOL, V83, P1099, DOI 10.1152/jn.2000.83.2.1099; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sparks D L, 1989, Rev Oculomot Res, V3, P213; Stein BE, 2001, PROG BRAIN RES, V134, P143; Stuphorn V, 2000, J NEUROPHYSIOL, V83, P1283, DOI 10.1152/jn.2000.83.3.1283; Stuphorn V, 1999, J NEUROPHYSIOL, V81, P1978, DOI 10.1152/jn.1999.81.4.1978; TAIRA M, 1990, EXP BRAIN RES, V83, P29; UPDYKE BV, 1977, J COMP NEUROL, V173, P81, DOI 10.1002/cne.901730106; Wallace MT, 1996, PROG BRAIN RES, V112, P301; Werner W, 1997, EXP BRAIN RES, V115, P191, DOI 10.1007/PL00005690; Werner W, 1997, EXP BRAIN RES, V115, P206, DOI 10.1007/PL00005691; WERNER W, 1993, EUR J NEUROSCI, V5, P335, DOI 10.1111/j.1460-9568.1993.tb00501.x; WIBERG M, 1987, J COMP NEUROL, V264, P92, DOI 10.1002/cne.902640108; WURTZ RH, 1980, ANNU REV NEUROSCI, V3, P189, DOI 10.1146/annurev.ne.03.030180.001201	63	25	25	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					525	534		10.1016/j.neuron.2006.08.010	http://dx.doi.org/10.1016/j.neuron.2006.08.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088217	Bronze			2022-12-28	WOS:000242269700014
J	Plath, N; Ohana, O; Dammermann, B; Errington, ML; Schmitz, D; Gross, C; Mao, XS; Engelsberg, A; Mahlke, C; Welzl, H; Kobaz, U; Stawrakakis, A; Fernandez, E; Waltereit, R; Bick-Sander, A; Therstappen, E; Cooke, SF; Blanquet, V; Wurst, W; Salmen, B; Boesl, MR; Lipp, HP; Grant, SGN; Bliss, TVP; Wolfer, DP; Kuhl, D				Plath, Niels; Ohana, Ora; Dammermann, Bjoern; Errington, Mick L.; Schmitz, Dietmar; Gross, Christina; Mao, Xiaosong; Engelsberg, Arne; Mahlke, Claudia; Welzl, Hans; Kobaz, Ursula; Stawrakakis, Anastasia; Fernandez, Esperanza; Waltereit, Robert; Bick-Sander, Anika; Therstappen, Eric; Cooke, Sam F.; Blanquet, Veronique; Wurst, Wolfgang; Salmen, Benedikt; Boesl, Michael R.; Lipp, Hans-Peter; Grant, Seth G. N.; Bliss, Tim V. P.; Wolfer, David P.; Kuhl, Dietmar			Arc/Arg3.1 is essential for the consolidation of synaptic plasticity and memories	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; CYTOSKELETON-ASSOCIATED PROTEIN; MESSENGER-RNA; SPATIAL MEMORY; RECEPTOR TRAFFICKING; INCREASED EXPRESSION; NEURONAL ENSEMBLES; C-FOS; ARC	Arc/Arg3.1 is robustly induced by plasticity-producing stimulation and specifically targeted to stimulated synaptic areas. To investigate the role of Arc/Arg3.1 in synaptic plasticity and learning and memory, we generated Arc/Arg3.1 knockout mice. These animals fail to form long-lasting memories for implicit and explicit learning tasks, despite intact short-term memory. Moreover, they exhibit a biphasic alteration of hippocampal long-term potentiation in the dentate gyrus and area CA1 with an enhanced early and absent late phase. In addition, long-term depression is significantly impaired. Together, these results demonstrate a critical role for Arc/Arg3.1 in the consolidation of enduring synaptic plasticity and memory storage.	Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany; Ctr Mol Neurobiol, D-20251 Hamburg, Germany; Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; Natl Inst Med Res, London NW7 1AA, England; Univ Zurich, Div Neuroanat & Behav, CH-8057 Zurich, Switzerland; Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; GSF Res Ctr, D-85764 Oberschleissheim, Germany; Neurosci Res Ctr Charite, D-10117 Berlin, Germany	Free University of Berlin; University of Zurich; MRC National Institute for Medical Research; University of Zurich; Wellcome Trust Sanger Institute; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kuhl, D (corresponding author), Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany.	kuhl@neuroscience.fu-berlin.de	Kuhl, Dietmar/A-4689-2009; Wolfer, David P/B-3293-2016	Kuhl, Dietmar/0000-0002-4772-6701; Wolfer, David P/0000-0002-5957-1401; Grant, Seth/0000-0001-8732-8735; Schmitz, Dietmar/0000-0003-2741-5241; Wurst, Wolfgang/0000-0003-4422-7410; cooke, samuel/0000-0002-4876-6502	MRC [MC_U117512674] Funding Source: UKRI; Medical Research Council [MC_U117512674] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bock J, 2005, NEUROSCIENCE, V133, P625, DOI 10.1016/j.neuroscience.2005.02.048; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Gusev PA, 2005, J NEUROSCI, V25, P9384, DOI 10.1523/JNEUROSCI.0832-05.2005; Guthrie K, 2000, NEUROREPORT, V11, P1809, DOI 10.1097/00001756-200006260-00003; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; Liu D, 2000, MECH DEVELOP, V92, P207, DOI 10.1016/S0925-4773(99)00340-8; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mahlke C, 2004, HEARING RES, V195, P17, DOI 10.1016/j.heares.2004.03.005; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Montag-Sallaz M, 1999, J NEUROBIOL, V38, P234, DOI 10.1002/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Pocklington AJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100041; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	41	612	627	3	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					437	444		10.1016/j.neuron.2006.08.024	http://dx.doi.org/10.1016/j.neuron.2006.08.024			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088210	Bronze			2022-12-28	WOS:000242269700007
J	Cole, GM; Frautschy, SA				Cole, Greg M.; Frautschy, Sally A.			Cat and mouse	NEURON			English	Editorial Material							ALZHEIMERS-DISEASE; CATHEPSIN-B; PEPTIDE		Greater Los Angeles Healthcare Syst, Vet Adm Med Ctr, Geriatr Res Educ Clin Ctr, North Hills, CA 91343 USA; Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cole, GM (corresponding author), Greater Los Angeles Healthcare Syst, Vet Adm Med Ctr, Geriatr Res Educ Clin Ctr, North Hills, CA 91343 USA.			Frautschy, Sally A./0000-0003-0194-0363	NATIONAL INSTITUTE ON AGING [R01AG013741, P50AG016570] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG013741, P50 AG016570] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Kingham PJ, 2001, J NEUROCHEM, V76, P1475, DOI 10.1046/j.1471-4159.2001.00146.x; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Nixon RA, 2006, J ALZHEIMERS DIS, V9, P277; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200	11	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					671	672		10.1016/j.neuron.2006.09.005	http://dx.doi.org/10.1016/j.neuron.2006.09.005			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982408	Bronze			2022-12-28	WOS:000240997900001
J	Stetson, C; Xu, C; Montague, PR; Eagleman, DM				Stetson, Chess; Xu Cui; Montague, P. Read; Eagleman, David M.			Motor-sensory recalibration leads to an illusory reversal of action and sensation	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; TIME PERCEPTION; CONFLICT; FMRI; PERFORMANCE; ADAPTATION; INTENTION; ATTENTION; AWARENESS; SELECTION	To judge causality, organisms must determine the temporal order of their actions and sensations. However, this judgment may be confounded by changing delays in sensory pathways, suggesting the need for dynamic temporal recalibration. To test for such a mechanism, we artificially injected a fixed delay between participants' actions (keypresses) and subsequent sensations (flashes). After participants adapted to this delay, flashes at unexpectedly short delays after the keypress were often perceived as occurring before the keypress, demonstrating a recalibration of motor-sensory temporal order judgments. When participants experienced illusory reversals, fMRI BOLD signals increased in anterior cingulate cortex/medial frontal cortex (ACC/MFC), a brain region previously implicated in conflict monitoring. This illusion-specific activation suggests that the brain maintains not only a recalibrated representation of timing, but also a less-plastic representation against which to compare it.	Univ Texas, Sch Med, Dept Neurobiol & Anat, Houston, TX 77030 USA; Baylor Coll Med, Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA; Univ Texas, Dept Biomed Engn, Austin, TX 77003 USA; Univ Texas, Dept Psychol, Austin, TX 77003 USA; Rice Univ, Dept Psychol, Houston, TX 77005 USA	University of Texas System; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Rice University	Eagleman, DM (corresponding author), Univ Texas, Sch Med, Dept Neurobiol & Anat, 6431 Fannin St,Suite 7046, Houston, TX 77030 USA.	david@eaglemanlab.net			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER; NIDA NIH HHS [R01 DA 11723] Funding Source: Medline; NINDS NIH HHS [NS 045790] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Bushara KO, 2001, J NEUROSCI, V21, P300, DOI 10.1523/JNEUROSCI.21-01-00300.2001; CAMPBELL WW, 1981, MUSCLE NERVE, V4, P520, DOI 10.1002/mus.880040609; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cosmelli D, 2004, NEUROIMAGE, V23, P128, DOI 10.1016/j.neuroimage.2004.05.008; COULT JT, 2004, SCIENCE, P1506; Cunningham DW, 2001, PSYCHOL SCI, V12, P532, DOI 10.1111/1467-9280.d01-17; Eagleman DM, 2000, SCIENCE, V287, P2036, DOI 10.1126/science.287.5460.2036; Eagleman DM, 2004, SCIENCE, V303, P1144, DOI 10.1126/science.1095331; Eagleman DM, 2002, TRENDS COGN SCI, V6, P323, DOI 10.1016/S1364-6613(02)01945-9; EAGLEMAN DM, 2000, SCIENCE, V289, P1107; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fujisaki W, 2004, NAT NEUROSCI, V7, P773, DOI 10.1038/nn1268; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Jech R, 2005, NEUROREPORT, V16, P1467, DOI 10.1097/01.wnr.0000175616.00936.1c; Kao YC, 2005, NAT NEUROSCI, V8, P1776, DOI 10.1038/nn1595; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Lau HC, 2004, SCIENCE, V303, P1208, DOI 10.1126/science.1090973; Leung HC, 2000, CEREB CORTEX, V10, P552, DOI 10.1093/cercor/10.6.552; Lewis PA, 2006, BEHAV PROCESS, V71, P226, DOI 10.1016/j.beproc.2005.12.009; Linden DEJ, 1999, CEREB CORTEX, V9, P815, DOI 10.1093/cercor/9.8.815; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Namba J, 2004, PERCEPTION, V33, P621, DOI 10.1068/p5212; Nenadic I, 2003, EXP BRAIN RES, V148, P238, DOI 10.1007/s00221-002-1188-4; NIJHAWAN R, 1994, NATURE, V370, P256, DOI 10.1038/370256b0; Nobre AC, 2004, TRENDS COGN SCI, V8, P387, DOI 10.1016/j.tics.2004.07.005; PAILLARD J, 1948, CR SOC BIOL, V142, P935; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Pouthas V, 2005, HUM BRAIN MAPP, V25, P433, DOI 10.1002/hbm.20126; PURPURA K, 1990, VISUAL NEUROSCI, V4, P75, DOI 10.1017/S0952523800002789; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Vroomen J, 2004, COGNITIVE BRAIN RES, V22, P32, DOI 10.1016/j.cogbrainres.2004.07.003; Walton ME, 2004, NAT NEUROSCI, V7, P1259, DOI 10.1038/nn1339	45	226	233	0	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					651	659		10.1016/j.neuron.2006.08.006	http://dx.doi.org/10.1016/j.neuron.2006.08.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	085RZ	16950162	Bronze			2022-12-28	WOS:000240623400013
J	Feierstein, CE; Quirk, MC; Uchida, N; Sosulski, DL; Mainen, ZF				Feierstein, Claudia E.; Quirk, Michael C.; Uchida, Naoshige; Sosulski, Dara L.; Mainen, Zachary F.			Representation of spatial goals in rat orbitofrontal cortex	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; POSTERIOR CINGULATE CORTEX; HEAD-DIRECTION CELLS; NEURONAL-ACTIVITY; BASOLATERAL AMYGDALA; OLFACTORY DISCRIMINATION; REWARD EXPECTATION; PARIETAL CORTEX; FRONTAL-CORTEX; MACAQUE	The orbitofrontal cortex (OFC) is thought to participate in making and evaluating goal-directed decisions. In rodents, spatial navigation is a major mode of goal-directed behavior, and anatomical and lesion studies implicate the OFC in spatial processing, but there is little direct evidence for coding of spatial or motor variables. Here, we recorded from ventrolateral and lateral OFC in an odor-cued two-alternative choice task requiring orientation and approach to spatial goal ports. In this context, over half of OFC neurons encoded choice direction or goal port location. A subset of neurons was jointly selective for the trial outcome and port location, information useful for the selection or evaluation of spatial goals. These observations show that the rodent OFC not only encodes information relating to general motivational significance, as shown previously, but also encodes spatiomotor variables needed to define specific behavioral goals and the locomotor actions required to attain them.	Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory	Mainen, ZF (corresponding author), Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	zach@cshl.edu		Feierstein, Claudia/0000-0002-8002-922X; Mainen, Zachary/0000-0001-7913-9109; Uchida, Naoshige/0000-0002-5755-9409	NIDCD NIH HHS [5R01DC006104-02] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Arana FS, 2003, J NEUROSCI, V23, P9632; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; CHEN LL, 1994, EXP BRAIN RES, V101, P24, DOI 10.1007/BF00243213; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; CORWIN JV, 1994, BEHAV BRAIN RES, V61, P79, DOI 10.1016/0166-4328(94)90010-8; DAMASIO AR, 1994, DESCARTES ERROR; Dean HL, 2004, J NEUROPHYSIOL, V92, P3056, DOI 10.1152/jn.00691.2003; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; FERINO F, 1987, EXP BRAIN RES, V65, P421; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Green DM, 1966, SIGNAL DETECTION THE; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Hok V, 2005, P NATL ACAD SCI USA, V102, P4602, DOI 10.1073/pnas.0407332102; Hyman JM, 2005, HIPPOCAMPUS, V15, P739, DOI 10.1002/hipo.20106; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; KING V, 1989, EXP NEUROL, V105, P287, DOI 10.1016/0014-4886(89)90132-5; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Koene RA, 2005, CEREB CORTEX, V15, P1964, DOI 10.1093/cercor/bhi072; KOLB B, 1983, BEHAV NEUROSCI, V97, P13, DOI 10.1037/0735-7044.97.1.13; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Lipton PA, 1999, NEURON, V22, P349, DOI 10.1016/S0896-6273(00)81095-8; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; McDannald MA, 2005, J NEUROSCI, V25, P4626, DOI 10.1523/JNEUROSCI.5301-04.2005; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nitz DA, 2006, NEURON, V49, P747, DOI 10.1016/j.neuron.2006.01.037; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pickens CL, 2003, J NEUROSCI, V23, P11078; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; Reep RL, 1996, EXP BRAIN RES, V111, P215; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Roberts AC, 2006, TRENDS COGN SCI, V10, P83, DOI 10.1016/j.tics.2005.12.002; Roesch MR, 2005, J NEUROPHYSIOL, V94, P1469, DOI 10.1152/jn.00064.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; ROSENKILDE CE, 1981, BRAIN RES, V209, P375, DOI 10.1016/0006-8993(81)90160-8; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 2001, LEARN MEMORY, V8, P134, DOI 10.1101/lm.39901; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Sharp PE, 1999, HIPPOCAMPUS, V9, P432, DOI 10.1002/(SICI)1098-1063(1999)9:4<432::AID-HIPO9>3.3.CO;2-G; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; Vafaei AA, 2004, BEHAV BRAIN RES, V149, P61, DOI 10.1016/S0166-4328(03)00209-2; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x	70	185	185	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					495	507		10.1016/j.neuron.2006.06.032	http://dx.doi.org/10.1016/j.neuron.2006.06.032			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908414	Bronze			2022-12-28	WOS:000240504700012
J	Li, W; Piech, V; Gilbert, CD				Li, Wu; Piech, Valentin; Gilbert, Charles D.			Contour saliency in primary visual cortex	NEURON			English	Article							CONTEXTUAL INTERACTIONS; INTRINSIC CONNECTIONS; FEEDBACK CONNECTIONS; NEURONAL RESPONSES; RECEPTIVE-FIELDS; STRIATE CORTEX; AREA V1; INTEGRATION; CAT; ATTENTION	Contour integration is an important intermediate stage of object recognition, in which line segments belonging to an object boundary are perceptually linked and segmented from complex backgrounds. Contextual influences observed in primary visual cortex (V1) suggest the involvement of V1 in contour integration. Here, we provide direct evidence that, in monkeys performing a contour detection task, there was a close correlation between the responses of V1 neurons and the perceptual saliency of contours. Receiver operating characteristic analysis showed that single neuronal responses encode the presence or absence of a contour as reliably as the animal's behavioral responses. We also show that the same visual contours elicited significantly weaker neuronal responses when they were not detected in the detection task, or when they were unattended. Our results demonstrate that contextual interactions in V1 play a pivotal role in contour integration and saliency.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rockefeller.edu	Li, Wu/G-9415-2011; Li, Wu/AHA-4320-2022	Li, Wu/0000-0002-2175-4579; 	NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER; NEI NIH HHS [EY07968] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adini Y, 1997, P NATL ACAD SCI USA, V94, P10426, DOI 10.1073/pnas.94.19.10426; Bair W, 2003, J NEUROSCI, V23, P7690; Bauer R, 2002, EXP BRAIN RES, V147, P145, DOI 10.1007/s00221-002-1178-6; BISHOP PO, 1973, J PHYSIOL-LONDON, V231, P31, DOI 10.1113/jphysiol.1973.sp010218; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DRESP B, 1993, SPATIAL VISION, V7, P213, DOI 10.1163/156856893X00379; Effron B, 1993, INTRO BOOTSTRAP; Ernst UA, 2004, NEUROCOMPUTING, V58, P971, DOI 10.1016/j.neucom.2004.01.154; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P229, DOI 10.1152/jn.1965.28.2.229; Hupe JM, 2001, J NEUROPHYSIOL, V85, P146, DOI 10.1152/jn.2001.85.1.146; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kinoshita M, 2001, J NEUROPHYSIOL, V86, P2559, DOI 10.1152/jn.2001.86.5.2559; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lee TS, 2002, NAT NEUROSCI, V5, P589, DOI 10.1038/nn860; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Li W, 2000, J NEUROPHYSIOL, V83, P941, DOI 10.1152/jn.2000.83.2.941; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Li W, 2001, EXP BRAIN RES, V139, P359, DOI 10.1007/s002210100757; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Polat U, 2000, SPATIAL VISION, V13, P393, DOI 10.1163/156856800741270; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; ROCKLAND KS, 1982, J COMP NEUROL, V209, P41, DOI 10.1002/cne.902090105; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treue S, 2001, TRENDS NEUROSCI, V24, P295, DOI 10.1016/S0166-2236(00)01814-2; ULLMAN S, 1992, PHILOS T ROY SOC B, V337, P371, DOI 10.1098/rstb.1992.0115; VanRullen R, 2001, NEUROCOMPUTING, V38, P1003, DOI 10.1016/S0925-2312(01)00445-3; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; WANG QQ, 1994, PERCEPT PSYCHOPHYS, V56, P495, DOI 10.3758/BF03206946; Wertheimer M, 1923, PSYCHOL FORSCH, V4, P301, DOI 10.1007/BF00410640; Yen SC, 1998, VISION RES, V38, P719, DOI 10.1016/S0042-6989(97)00197-1; Zipser K, 1996, J NEUROSCI, V16, P7376	62	173	175	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					951	962		10.1016/j.neuron.2006.04.035	http://dx.doi.org/10.1016/j.neuron.2006.04.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772175	Bronze			2022-12-28	WOS:000238589500014
J	Wagner, S; Gresser, AL; Torello, AT; Dulac, C				Wagner, Shlomo; Gresser, Amy L.; Torello, A. Thomas; Dulac, Catherine			Multireceptor genetic approach uncovers an ordered integration of VNO sensory inputs in the accessory olfactory bulb	NEURON			English	Article							AXONAL PROJECTIONS; VOMERONASAL SYSTEM; RECEPTOR GENES; ANTENNAL LOBE; MUTANT MICE; PHEROMONE; EXPRESSION; NEURONS; MOUSE; MAP	Pheromone detection by the vomeronasal organ (VNO) is thought to rely on activation of specific receptors from the V1R and V2R gene families, but the central representation of pheromone receptor activation remains poorly understood. We generated transgenic mouse lines in which projections from multiple populations of VNO neurons, each expressing a distinct V1R, are differentially labeled with fluorescent proteins. This approach revealed that inputs from neurons expressing closely related V1Rs intermingle within shared, spatially conserved domains of the accessory olfactory bulb (AOB). Mitral cell-glomerular connectivity was examined by injecting intracellular dyes into AOB mitral cells and monitoring dendritic contacts with genetically labeled glomeruli. We show that individual mitral cells extend dendrites to glomeruli associated with different, but likely closely related, V1Rs. This organization differs from the labeled line of OR signaling in the main olfactory system and suggests that integration of information may already occur at the level of the AOB.	Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Hebrew University of Jerusalem; Harvard University; Howard Hughes Medical Institute	Wagner, S (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel.	shlomo@lobster.ls.huji.ac.il; dulac@fas.harvard.edu		Wagner, Shlomo/0000-0002-7618-0752; Dulac, Catherine/0000-0001-5024-5418	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003903] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003903] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Boehm U, 2005, CELL, V123, P683, DOI 10.1016/j.cell.2005.09.027; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Conzelmann S, 2001, EUR J NEUROSCI, V14, P1623, DOI 10.1046/j.0953-816x.2001.01788.x; DA LY, 2005, NATURE, V434, P470; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Dulac Catherine, 2005, Novartis Foundation Symposium, V268, P100; GANGRADE BK, 1984, BIOL REPROD, V31, P89, DOI 10.1095/biolreprod31.1.89; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; KABA H, 1989, NEUROSCIENCE, V32, P657, DOI 10.1016/0306-4522(89)90287-X; KANZAKI R, 1989, J COMP PHYSIOL A, V165, P427, DOI 10.1007/BF00611233; KUMAR A, 1993, PHYSIOL BEHAV, V54, P1169, DOI 10.1016/0031-9384(93)90343-E; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Mandiyan VS, 2005, NAT NEUROSCI, V8, P1660, DOI 10.1038/nn1589; Mombaerts P, 1996, CURR OPIN NEUROBIOL, V6, P481, DOI 10.1016/S0959-4388(96)80053-5; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rodriguez I, 2002, NAT NEUROSCI, V5, P134, DOI 10.1038/nn795; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sadek MM, 2002, J EXP BIOL, V205, P1363; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Sorensen PW, 1998, CURR OPIN NEUROBIOL, V8, P458, DOI 10.1016/S0959-4388(98)80032-9; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Strotmann J, 1999, GENE, V236, P281, DOI 10.1016/S0378-1119(99)00275-9; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; TAKAMI S, 1990, BRAIN RES, V510, P339, DOI 10.1016/0006-8993(90)91387-V; Tsuboi A, 1999, J NEUROSCI, V19, P8409; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vickers NJ, 2003, CHEM SENSES, V28, P325, DOI 10.1093/chemse/28.4.325; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	45	90	90	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					697	709		10.1016/j.neuron.2006.04.033	http://dx.doi.org/10.1016/j.neuron.2006.04.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731509	Bronze			2022-12-28	WOS:000238165000006
J	Adcock, RA; Thangavel, A; Whitfield-Gabrieli, S; Knutson, B; Gabrieli, JDE				Adcock, R. Alison; Thangavel, Arul; Whitfield-Gabrieli, Susan; Knutson, Brian; Gabrieli, John D. E.			Reward-motivated learning: Mesolimbic activation precedes memory formation	NEURON			English	Article							NUCLEUS-ACCUMBENS; PARAHIPPOCAMPAL CORTEX; PREFRONTAL CORTEX; HIPPOCAMPAL CA1; BRAIN ACTIVITY; DOPAMINE; FMRI; RAT; ANTICIPATION; POTENTIATION	We examined anticipatory mechanisms of reward-motivated memory formation using event-related FMRI. In a monetary incentive encoding task, cues signaled high- or low-value reward for memorizing an upcoming scene. When tested 24 hr postscan, subjects were significantly more likely to remember scenes that followed cues for high-value rather than low-value reward. A monetary incentive delay task independently localized regions responsive to reward anticipation. In the encoding task, high-reward cues preceding remembered but not forgotten scenes activated the ventral tegmental area, nucleus accumbens, and hippocampus. Across subjects, greater activation in these regions predicted superior memory performance. Within subject, increased correlation between the hippocampus and ventral tegmental area was associated with enhanced long-term memory for the subsequent scene. These findings demonstrate that brain activation preceding stimulus encoding can predict declarative memory formation. The findings are consistent with the hypothesis that reward motivation promotes memory formation via dopamine release in the hippocampus prior to learning.	Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Stanford University	Adcock, RA (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.	alison.adcock@ucsf.edu	Gabrieli, John/AAJ-2869-2020; Adcock, R Alison/AAX-6649-2020	Adcock, R Alison/0000-0002-7859-5484; Knutson, Brian/0000-0002-7669-426X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059940, R25MH060482] Funding Source: NIH RePORTER; NIMH NIH HHS [MH59940] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKIL M, 1994, NEUROSCIENCE, V60, P857, DOI 10.1016/0306-4522(94)90268-2; AKIL M, 1993, CEREB CORTEX, V3, P533, DOI 10.1093/cercor/3.6.533; AMARAL DG, 1980, J COMP NEUROL, V189, P573, DOI 10.1002/cne.901890402; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Floresco SB, 2001, J NEUROSCI, V21, P4915, DOI 10.1523/JNEUROSCI.21-13-04915.2001; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; GARRIS PA, 1994, J NEUROSCI, V14, P442; Gasbarri A, 1996, NEUROSCIENCE, V74, P1037, DOI 10.1016/0306-4522(96)00202-3; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; GOLDSMITH SK, 1994, HIPPOCAMPUS, V4, P354, DOI 10.1002/hipo.450040318; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Hommer DW, 2003, ANN NY ACAD SCI, V985, P476; HUANG YY, 1995, P NATL ACAD SCI USA, V92, P2446, DOI 10.1073/pnas.92.7.2446; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; JORK R, 1982, PHARMACOL BIOCHEM BE, V17, P11, DOI 10.1016/0091-3057(82)90254-4; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Liu Z, 2004, P NATL ACAD SCI USA, V101, P12336, DOI 10.1073/pnas.0403639101; Lodge DJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1356, DOI 10.1038/sj.npp.1300963; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Otmakhova NA, 1996, J NEUROSCI, V16, P7478; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; PENNARTZ CMA, 1991, J NEUROSCI, V11, P2838; Pennartz CMA, 2004, J NEUROSCI, V24, P6446, DOI 10.1523/JNEUROSCI.0575-04.2004; Pruessner JC, 2002, CEREB CORTEX, V12, P1342, DOI 10.1093/cercor/12.12.1342; SAMSON Y, 1990, J COMP NEUROL, V298, P250, DOI 10.1002/cne.902980209; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Sharot T, 2004, NAT NEUROSCI, V7, P1376, DOI 10.1038/nn1353; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tabuchi ET, 2000, HIPPOCAMPUS, V10, P717, DOI 10.1002/1098-1063(2000)10:6<717::AID-HIPO1009>3.0.CO;2-3; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weiss T, 2003, EUR J NEUROSCI, V18, P2573, DOI 10.1046/j.1460-9568.2003.02970.x; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010	49	648	655	8	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					507	517		10.1016/j.neuron.2006.03.036	http://dx.doi.org/10.1016/j.neuron.2006.03.036			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675403	Bronze			2022-12-28	WOS:000237726800018
J	Martin, A				Martin, A			Shades of Dejerine - Forging a causal link between the visual word form area and reading	NEURON			English	Editorial Material							RECOGNITION; TOPOGRAPHY; BRAIN	In 1892, the French neurologist Jules Dejerine suggested that pure alexia resulted from an occipital lesion that selectively disconnected visual input from a region of the brain that housed "optical images of words." In this issue of Neuron, Gaillard and colleagues offer evidence consistent with Dejerine's proposal and provide new insights to the functional role of the "visual word form area."							NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002588, Z01MH002588] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BAY E, 1953, BRAIN, V76, P515, DOI 10.1093/brain/76.4.515; BINDER JR, 1992, BRAIN, V115, P1807, DOI 10.1093/brain/115.6.1807; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; DEJERINE J., 1892, MEMOIRES SOC BIOL, V4, P61; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Martin A, 2001, CURR OPIN NEUROBIOL, V11, P194, DOI 10.1016/S0959-4388(00)00196-3; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Polk TA, 1998, P NATL ACAD SCI USA, V95, P847, DOI 10.1073/pnas.95.3.847; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Price CJ, 2004, NEUROIMAGE, V22, P477, DOI 10.1016/j.neuroimage.2004.01.018; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	13	23	23	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					173	175		10.1016/j.neuron.2006.04.004	http://dx.doi.org/10.1016/j.neuron.2006.04.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630825	Bronze			2022-12-28	WOS:000237176700001
J	Mu, Y; Poo, MM				Mu, Y; Poo, MM			Spike timing-dependent LTP/LTD mediates visual experience-dependent plasticity in a developing retinotectal system	NEURON			English	Article							LONG-TERM POTENTIATION; NITRIC-OXIDE; SYNAPTIC PLASTICITY; NMDA RECEPTOR; IN-VIVO; DIRECTION SELECTIVITY; HIPPOCAMPAL-NEURONS; SUPERIOR COLLICULUS; NEUROTROPHIC FACTOR; OCULAR DOMINANCE	Sensory experience plays an instructive role in the development of the nervous system. Here we showed that visual experience can induce persistent modification of developing retinotectal circuits via spike timing-dependent plasticity (STDP). Pairing light stimuli with spiking of the tectal cell induced persistent enhancement or reduction of light-evoked responses, with a dependence on the relative timing between light stimulus and postsynaptic spiking similar to that for STDP. Using precisely timed sequential three-bar stimulation to mimic a moving bar, we showed that spike timing-dependent LTP/LTD can account for the asymmetric modification of the tectal cell receptive field induced by moving bar. Furthermore, selective inhibition of signaling mediated by brain-derived neurotrophic factor and nitric oxide, which are respectively required for light-induced LTP and LTD, interfered with moving bar-induced temporally specific changes in the tectal cell responses. Together, these findings suggest that STDP can mediate sensory experience-dependent circuit refinement in the developing nervous system.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu			NEI NIH HHS [EY014979] Funding Source: Medline; NINDS NIH HHS [NS 36999] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; ALEINIKOVA T V, 1981, Fiziologicheskii Zhurnal SSSR Imeni I M Sechenova, V67, P542; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x; Buchs NJ, 2002, J COMPUT NEUROSCI, V13, P167, DOI 10.1023/A:1020210230751; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; Chance FS, 1998, J NEUROSCI, V18, P4785; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; Cohen-Cory S, 2002, SCIENCE, V298, P770, DOI 10.1126/science.1075510; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Ernst AF, 1998, PROG BRAIN RES, V118, P115; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FREGNAC Y, 1994, J NEUROPHYSIOL, V71, P1403, DOI 10.1152/jn.1994.71.4.1403; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; GOODHILL GJ, 1993, BIOL CYBERN, V69, P109, DOI 10.1007/BF00226194; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HEEGER DJ, 1993, J NEUROPHYSIOL, V70, P1885, DOI 10.1152/jn.1993.70.5.1885; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCILWAIN JT, 1972, ANNU REV PHYSIOL, V34, P291, DOI 10.1146/annurev.ph.34.030172.001451; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mize RR, 1998, PROG BRAIN RES, V118, P133; Mize RR, 2000, BRAIN RES, V886, P15, DOI 10.1016/S0006-8993(00)02750-5; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPOU; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rao RPN, 2001, NOVART FDN SYMP, V239, P208; Renteria RC, 1996, J NEUROBIOL, V29, P415; Renteria RC, 1999, J NEUROSCI, V19, P7066, DOI 10.1523/JNEUROSCI.19-16-07066.1999; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Shon AP, 2004, NETWORK-COMP NEURAL, V15, P179, DOI 10.1088/0954-898X/15/3/002; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Wenisch OG, 2005, BIOL CYBERN, V93, P239, DOI 10.1007/s00422-005-0006-z; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	65	116	116	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					115	125		10.1016/j.neuron.2006.03.009	http://dx.doi.org/10.1016/j.neuron.2006.03.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600860	Bronze			2022-12-28	WOS:000236811300015
J	Poskanzer, KE; Fetter, RD; Davis, GW				Poskanzer, KE; Fetter, RD; Davis, GW			Discrete residues in the C2B domain of synaptotagmin I independently specify endocytic rate and synaptic vesicle size	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; TRANSMITTER RELEASE; MUTATIONAL ANALYSIS; CA2+ BINDING; MEMBRANE; TRANSMISSION; KINETICS; MUTANTS; FUSION; OLIGOMERIZATION	It has been demonstrated that synapses lacking functional synaptotagmin I (Syt I) have a decreased rate of synaptic vesicle endocytosis. Beyond this, the function of Syt I during endocytosis remains undefined. Here, we demonstrate that a decreased rate of endocytosis in syt(null) mutants correlates with a stimulus-dependent perturbation of membrane internalization, assayed ultrastructurally. We then separate the mechanisms that control endocytic rate and vesicle size by mapping these processes to discrete residues in the Syt I C2B domain. Mutation of a poly-lysine motif alters vesicle size but not endocytic rate, whereas the mutation of calcium-coordinating aspartate residues (syt-D3,4N) alters endocytic rate but not vesicle size. Finally, slowed endocytic rate in the syt-D3,4N animals, but not syt(null) animals, can be rescued by elevating extracellular calcium concentration, supporting the conclusion that calcium coordination within the C2B domain contributes to the control of endocytic rate.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Rock Hall,1550 4th St,Box 2822, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu			NINDS NIH HHS [NS39313] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039313] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; Fernandez I, 2001, NEURON, V32, P1057, DOI 10.1016/S0896-6273(01)00548-7; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 2000, FEBS LETT, V482, P269, DOI 10.1016/S0014-5793(00)02064-0; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gaietta G, 2002, SCIENCE, V296, P503, DOI 10.1126/science.1068793; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Haucke V, 2000, EMBO J, V19, P6011, DOI 10.1093/emboj/19.22.6011; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kee Y, 1996, J NEUROSCI, V16, P1975; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Llinas RR, 2004, P NATL ACAD SCI USA, V101, P17855, DOI 10.1073/pnas.0408200101; Mackiewicz P, 2001, GENOME BIOL, V2; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marek KW, 2002, NEURON, V36, P805, DOI 10.1016/S0896-6273(02)01068-1; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; PERIN MS, 1991, J BIOL CHEM, V266, P623; Phillips AM, 2000, J NEUROSCI, V20, P8254, DOI 10.1523/JNEUROSCI.20-22-08254.2000; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Poskanzer KE, 2004, NEUROPHARMACOLOGY, V47, P714, DOI 10.1016/j.neuropharm.2004.07.026; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; Reist NE, 1998, J NEUROSCI, V18, P7662; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Stevens CF, 2003, NEURON, V39, P299, DOI 10.1016/S0896-6273(03)00432-X; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WHITNEY JA, 1995, CELL, V83, P703; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	59	66	68	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					49	62		10.1016/j.neuron.2006.02.021	http://dx.doi.org/10.1016/j.neuron.2006.02.021			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600855	Bronze			2022-12-28	WOS:000236811300010
J	Jacobson, C; Schnapp, B; Banker, GA				Jacobson, C; Schnapp, B; Banker, GA			A change in the selective translocation of the Kinesin-1 motor domain marks the initial specification of the axon	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; TAU-PROTEIN; POLARITY; PHOSPHORYLATION; ESTABLISHMENT; MICROTUBULES; MOLECULES; TRANSPORT; TUBULIN; COMPLEX	We used the accumulation of constitutively active kinesin motor domains as a measure of where kinesins translocate in developing neurons. Throughout development, truncated Kinesin-3 accumulates at the tips of all neurites. In contrast, Kinesin-1 selectively accumulates in only a subset of neurites. Before neurons become polarized, truncated Kinesin-1 accumulates transiently in a single neurite. Coincident with axon specification, truncated Kinesin-1 accumulates only in the emerging axon and no longer appears in any other neurite. The translocation of Kinesin-1 along a biochemically distinct track leading to the nascent axon could ensure the selective delivery of Kinesin-1 cargoes to the axon and hence contribute to its molecular specification. Imaging YFP-tagged truncated Kinesin-1 provides the most precise definition to date of when neuronal polarity first emerges and allows visualization of the molecular differentiation of the axon in real time.	Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Banker, GA (corresponding author), Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA.	bankerg@ohsu.edu			NIMH NIH HHS [MH66179] Funding Source: Medline; NINDS NIH HHS [NS17112, NS488655] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017112] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; BOUCHER D, 1994, BIOCHEMISTRY-US, V33, P12471, DOI 10.1021/bi00207a014; BOYNE LJ, 1995, J NEUROSCI RES, V40, P439, DOI 10.1002/jnr.490400403; Bradke F, 1997, NEURON, V19, P1175, DOI 10.1016/S0896-6273(00)80410-9; Burack MA, 2000, NEURON, V26, P465, DOI 10.1016/S0896-6273(00)81178-2; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Esch T, 1999, J NEUROSCI, V19, P6417; Friedman DS, 1999, NAT CELL BIOL, V1, P293, DOI 10.1038/13008; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Goslin K., 1998, CULTURING NERVE CELL, P339; HOLLENBECK PJ, 1993, J NEUROCHEM, V60, P2265, DOI 10.1111/j.1471-4159.1993.tb03513.x; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Jiang H, 2005, NAT NEUROSCI, V8, P544, DOI 10.1038/nn0505-544; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Lee JR, 2004, EMBO J, V23, P1506, DOI 10.1038/sj.emboj.7600164; Mallik R, 2004, CURR BIOL, V14, pR971, DOI 10.1016/j.cub.2004.10.046; Mandell JW, 1996, J NEUROSCI, V16, P5727; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Reynolds CH, 1997, J NEUROCHEM, V68, P1736; Samsonov A, 2004, J CELL SCI, V117, P6129, DOI 10.1242/jcs.01531; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Seitz A, 2002, EMBO J, V21, P4896, DOI 10.1093/emboj/cdf503; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Stepanova T, 2003, J NEUROSCI, V23, P2655; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007	32	194	196	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					797	804		10.1016/j.neuron.2006.02.005	http://dx.doi.org/10.1016/j.neuron.2006.02.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543128	Bronze			2022-12-28	WOS:000236227500008
J	Ince-Dunn, G; Hall, BJ; Hu, SC; Ripley, B; Huganir, RL; Olson, JM; Tapscott, SJ; Ghosh, A				Ince-Dunn, G; Hall, BJ; Hu, SC; Ripley, B; Huganir, RL; Olson, JM; Tapscott, SJ; Ghosh, A			Regulation of thalamocortical patterning and synaptic maturation by NeuroD2	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; MOUSE CEREBRAL-CORTEX; BARREL CORTEX; CRITICAL PERIOD; MOLECULAR MECHANISMS; SOMATOSENSORY CORTEX; CALCIUM REGULATION; GENE-EXPRESSION; NERVOUS-SYSTEM; VISUAL-CORTEX	During cortical development, both activity-dependent and genetically determined mechanisms are required to establish proper neuronal connectivity. While activity-dependent transcription may link the two processes, specific transcription factors that mediate such a process have not been identified. We identified the basic helix-loop-helix (bHLH) transcription factor Neurogenic Differentiation 2 (NeuroD2) in a screen for calcium-regulated transcription factors and report that it is required for the proper development of thalamocortical connections. In neuroD2 null mice, thalamocortical axon terminals fail to segregate in the somatosensory cortex, and the postsynaptic barrel organization is disrupted. Additionally, synaptic transmission is defective at thalamocortical synapses in neuroD2 null mice. Total excitatory synaptic currents are reduced in layer IV in the knockouts, and the relative contribution of AMPA and NMDA receptor-mediated currents to evoked responses is decreased. These observations indicate that NeuroD2 plays a critical role in regulating synaptic maturation and the patterning of thalamocortical connections.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Human Biol Div, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; University of California System; University of California San Diego; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	aghosh@ucsd.edu		Ince Dunn, Gulayse/0000-0003-1352-990X; Tapscott, Stephen/0000-0002-0319-0968; ripley, beth/0000-0001-7723-169X	NIMH NIH HHS [MH68830, MH68578] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH068578] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; AGMON A, 1992, J NEUROSCI, V12, P319; Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fox K, 2002, NEUROSCIENCE, V111, P799, DOI 10.1016/S0306-4522(02)00027-1; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Land PW, 2003, CEREB CORTEX, V13, P921, DOI 10.1093/cercor/13.9.921; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lein ES, 2000, J NEUROSCI, V20, P1470; Lin CH, 2004, DEV BIOL, V265, P234, DOI 10.1016/j.ydbio.2003.08.027; Lober S, 1999, BIOORG MED CHEM LETT, V9, P97, DOI 10.1016/S0960-894X(98)00692-1; Lu HC, 2003, NAT NEUROSCI, V6, P939, DOI 10.1038/nn1106; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; MARTIN KJ, 1990, NATURE, V346, P147, DOI 10.1038/346147a0; McCormick MB, 1996, MOL CELL BIOL, V16, P5792; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207; ROSEN KM, 1992, P NATL ACAD SCI USA, V89, P5437, DOI 10.1073/pnas.89.12.5437; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Senft SL, 1991, CEREB CORTEX, V1, P308, DOI 10.1093/cercor/1.4.308; Shen YP, 2002, J NEUROSCI, V22, P239, DOI 10.1523/JNEUROSCI.22-01-00239.2002; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; WALLACE MN, 1987, BRAIN RES, V418, P178, DOI 10.1016/0006-8993(87)90977-2; WELKER C, 1976, J COMP NEUROL, V166, P173, DOI 10.1002/cne.901660205; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X	39	89	93	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					683	695		10.1016/j.neuron.2006.01.031	http://dx.doi.org/10.1016/j.neuron.2006.01.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504944	Bronze			2022-12-28	WOS:000236070600010
J	Piazza, M; Pinel, P; Le Bihan, D; Dehaene, S				Piazza, Manuela; Pinel, Philippe; Le Bihan, Denis; Dehaene, Stanislas			A magnitude code common to numerosities and number symbols in human intraparietal cortex	NEURON			English	Article							HEMISPHERIC-SPECIALIZATION; NUMERICAL MAGNITUDE; HUMAN BRAIN; REPRESENTATION; SYSTEMS; DISSOCIATION; KNOWLEDGE; FMRI; SPECIFICITY; LATERALITY	Activation of the horizontal segment of the intraparietal sulcus (hIPS) has been observed in various number-processing tasks, whether numbers were conveyed by symbolic numerals (digits, number words) or by nonsymbolic displays (dot patterns). This suggests an abstract coding of numerical magnitude. Here, we critically tested this hypothesis using fMRI adaptation to demonstrate notation-independent coding of numerical quantity in the hIPS. Once subjects were adapted either to dot patterns or to Arabic digits, activation in the hIPS and in frontal regions recovered in a distance-dependent fashion whenever a new number was presented, irrespective of notation changes. This remained unchanged when analyzing the hIPS peaks from an independent localizer scan of mental calculation. These results suggest an abstract coding of approximate number common to dots, digits, and number words. They support the idea that symbols acquire meaning by linking neural populations coding symbol shapes to those holding nonsymbolic representations of quantities.	Univ Trent, Ctr Mind Brain Sci, Funct NeuroImaging Lab, I-38068 Rovereto, TN, Italy; Serv Hosp Frederic Joliot, DSV, DRM, CEA, F-91406 Orsay, France; Coll France, F-75005 Paris, France; Serv Hosp Frederic Joliot, Cognit Neuroimaging Unit, INSERM, F-91401 Orsay, France	University of Trento; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Piazza, M (corresponding author), Univ Trent, Ctr Mind Brain Sci, Funct NeuroImaging Lab, Via Tartarotti 7, I-38068 Rovereto, TN, Italy.	manuela.piazza@unitn.it	Piazza, Manuela/D-2028-2010; pinel, philippe/AAJ-3768-2020	Piazza, Manuela/0000-0003-2557-9701; pinel, philippe/0000-0001-6945-1369				Andres M, 2005, COGNITIVE BRAIN RES, V25, P283, DOI 10.1016/j.cogbrainres.2005.06.002; Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Brannon EM, 2006, CURR OPIN NEUROBIOL, V16, P222, DOI 10.1016/j.conb.2006.03.002; BUCKLEY PB, 1974, J EXP PSYCHOL, V103, P1131, DOI 10.1037/h0037361; Butterworth B, 2001, NAT NEUROSCI, V4, P784, DOI 10.1038/90484; Butterworth B., 1999, MATH BRAIN; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Caramazza A, 1998, J COGNITIVE NEUROSCI, V10, P1, DOI 10.1162/089892998563752; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; CIPOLOTTI L, 1991, BRAIN, V114, P2619, DOI 10.1093/brain/114.6.2619; Cohen L, 1996, NEUROCASE, V2, P155, DOI 10.1093/neucas/2.3.155; Dehaene S, 1997, CORTEX, V33, P219, DOI 10.1016/S0010-9452(08)70002-9; DEHAENE S, 1991, NEUROPSYCHOLOGIA, V29, P1045, DOI 10.1016/0028-3932(91)90076-K; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; DEHAENE S, 1990, J EXP PSYCHOL HUMAN, V16, P626, DOI 10.1037/0096-1523.16.3.626; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1997, NUMBER SENSE; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Halpern CH, 2004, NEUROLOGY, V62, P1163, DOI 10.1212/01.WNL.0000118209.95423.96; HARNAD S, 1990, PHYSICA D, V42, P335, DOI 10.1016/0167-2789(90)90087-6; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; KIMURA D, 1966, NEUROPSYCHOLOGIA, V4, P275, DOI 10.1016/0028-3932(66)90033-9; Koechlin E, 1999, J EXP PSYCHOL HUMAN, V25, P1882, DOI 10.1037/0096-1523.25.6.1882; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; Maess B, 2002, J COGNITIVE NEUROSCI, V14, P455, DOI 10.1162/089892902317361967; MCGLONE J, 1973, NEUROPSYCHOLOGIA, V11, P105, DOI 10.1016/0028-3932(73)90070-5; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; Pasini M, 2001, PSYCHOL RES-PSYCH FO, V65, P57, DOI 10.1007/s004260000036; Perani D, 1999, NEUROPSYCHOLOGIA, V37, P293, DOI 10.1016/S0028-3932(98)00073-6; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P865; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Reynvoet B, 2002, Q J EXP PSYCHOL-A, V55, P1127, DOI 10.1080/02724980244000116; Rickard TC, 2000, NEUROPSYCHOLOGIA, V38, P325, DOI 10.1016/S0028-3932(99)00068-8; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; SHEPARD RN, 1975, COGNITIVE PSYCHOL, V7, P82, DOI 10.1016/0010-0285(75)90006-7; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Thioux M, 1998, NEUROCASE, V4, P371, DOI 10.1080/13554799808410633; Thioux M, 2001, NEUROIMAGE, V13, pS617; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; WARRINGTON EK, 1967, J NEUROL NEUROSUR PS, V30, P468, DOI 10.1136/jnnp.30.5.468; YOUNG AW, 1979, NEUROPSYCHOLOGIA, V17, P99, DOI 10.1016/0028-3932(79)90028-9; Zamarian L, 2006, NEUROPSYCHOLOGIA, V44, P1708, DOI 10.1016/j.neuropsychologia.2006.03.032	53	566	571	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					293	305		10.1016/j.neuron.2006.11.022	http://dx.doi.org/10.1016/j.neuron.2006.11.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224409	Bronze			2022-12-28	WOS:000245126600013
J	Jakubs, K; Nanobashvili, A; Bonde, S; Ekdahl, CT; Kokaia, Z; Kokaia, M; Lindvall, O				Jakubs, Katherine; Nanobashvili, Avtandil; Bonde, Sara; Ekdahl, Christine T.; Kokaia, Zaal; Kokaia, Merab; Lindvall, Olle			Environment matters: Synaptic properties of neurons born in the epileptic adult brain develop to reduce excitability	NEURON			English	Article							TEMPORAL-LOBE EPILEPSY; GENERATED GRANULE CELLS; LONG-TERM POTENTIATION; PRESYNAPTIC GABA(B) AUTORECEPTORS; PAIRED-PULSE DEPRESSION; RAT DENTATE GYRUS; PERFORANT PATH; FUNCTIONAL IMPLICATIONS; TRANSMITTER RELEASE; HIPPOCAMPAL SYNAPSE	Neural progenitors in the adult dentate gyrus continuously produce new functional granule cells. Here we used whole-cell patch-clamp recordings to explore whether a pathological environment influences synaptic properties of new granule cells labeled with a GFP-retroviral vector. Rats were exposed to a physiological stimulus, i.e., running, or a brain insult, i.e., status epilepticus, which gave rise to neuronal death, inflammation, and chronic seizures. Granule cells formed after these stimuli exhibited similar intrinsic membrane properties. However, the new neurons born into the pathological environment differed with respect to synaptic drive and short-term plasticity of both excitatory and inhibitory afferents. The new granule cells formed in the epileptic brain exhibited functional connectivity consistent with reduced excitability. We demonstrate a high degree of plasticity in synaptic inputs to adult-born new neurons, which could act to mitigate pathological brain function.	Univ Lund Hosp, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden; Univ Lund Hosp, Expt Epilepsy Grp, Sect Restorat Neurol, Wallenberg Neurosci Ctr, SE-22184 Lund, Sweden; Univ Lund Hosp, Lab Neural Stem Cell Biol, Sect Restorat Neurol, Stem Cell Inst, SE-22184 Lund, Sweden; Lund Strat Res Ctr Stem Cell Biol & Cell Therapy, Biomed Ctr, SE-22184 Lund, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Lindvall, O (corresponding author), Univ Lund Hosp, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden.	olle.lindvall@med.lu.se	Kokaia, Zaal/AAL-6009-2020; Kokaia, Merab/A-2133-2010	Kokaia, Zaal/0000-0003-2296-2449; 				Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Ambrogini P, 2004, BRAIN RES, V1017, P21, DOI 10.1016/j.brainres.2004.05.039; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Behr J, 1998, J NEUROPHYSIOL, V79, P1726, DOI 10.1152/jn.1998.79.4.1726; Belluzzi O, 2003, J NEUROSCI, V23, P10411; Berninger B, 1999, LEARN MEMORY, V6, P232; Bonde S, 2006, EUR J NEUROSCI, V23, P965, DOI 10.1111/j.1460-9568.2006.04635.x; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Cohen AS, 2003, EUR J NEUROSCI, V17, P1607, DOI 10.1046/j.1460-9568.2003.02597.x; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; Crespel A, 2005, NEUROBIOL DIS, V19, P436, DOI 10.1016/j.nbd.2005.01.020; DAVIES CH, 1990, J PHYSIOL-LONDON, V424, P513, DOI 10.1113/jphysiol.1990.sp018080; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gibbs JW, 1997, J NEUROPHYSIOL, V77, P1924, DOI 10.1152/jn.1997.77.4.1924; Gloveli T, 2003, NEUROBIOL DIS, V13, P203, DOI 10.1016/S0969-9961(03)00039-1; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Ivanova SY, 2004, SYNAPSE, V53, P122, DOI 10.1002/syn.20040; Klapstein GJ, 1999, NEUROPHARMACOLOGY, V38, P927, DOI 10.1016/S0028-3908(99)00016-7; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Kokaia M, 1998, J NEUROSCI, V18, P8730; Leinekugel X, 1999, Adv Neurol, V79, P189; LOTHMAN EW, 1989, EPILEPSY RES, V3, P107, DOI 10.1016/0920-1211(89)90038-7; Markakis EA, 1999, J COMP NEUROL, V406, P449; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; Mohapel P, 2004, NEUROBIOL DIS, V15, P196, DOI 10.1016/j.nbd.2003.11.010; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Naylor AS, 2005, J NEUROPHYSIOL, V93, P2406, DOI 10.1152/jn.01085.2004; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; OTIS TS, 1993, J PHYSIOL-LONDON, V463, P391, DOI 10.1113/jphysiol.1993.sp019600; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickering M, 2005, EXP PHYSIOL, V90, P663, DOI 10.1113/expphysiol.2005.030734; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scharfman H, 2005, GROWTH FACTORS AND EPILEPSY, P1; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Scharfman HE, 2002, NEUROSCIENCE, V111, P71, DOI 10.1016/S0306-4522(01)00599-1; SCHARFMAN HE, 1992, EPILEPSY RES, P93; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Scimemi A, 2006, J NEUROPHYSIOL, V95, P1213, DOI 10.1152/jn.00680.2005; Shao LR, 2005, J NEUROPHYSIOL, V94, P952, DOI 10.1152/jn.01342.2004; Simmons ML, 1997, J NEUROPHYSIOL, V78, P1860, DOI 10.1152/jn.1997.78.4.1860; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; SUTULA T, 1986, BRAIN RES, V385, P291, DOI 10.1016/0006-8993(86)91075-9; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; VANBOHLEN, 2005, IN PRESS BIOL PSYCHI; Wierenga CJ, 1999, J NEUROPHYSIOL, V82, P1352, DOI 10.1152/jn.1999.82.3.1352; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Wong M, 2005, EPILEPSY BEHAV, V7, P569, DOI 10.1016/j.yebeh.2005.08.007; Wu CP, 1997, J NEUROSCI, V17, P9261; Wuarin JP, 2001, J NEUROPHYSIOL, V85, P1067, DOI 10.1152/jn.2001.85.3.1067; Zha XM, 2005, MOL CELL NEUROSCI, V29, P494, DOI 10.1016/j.mcn.2005.04.007; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; ZUCKER RS, 1983, J NEUROSCI, V3, P1263	73	196	206	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1047	1059		10.1016/j.neuron.2006.11.004	http://dx.doi.org/10.1016/j.neuron.2006.11.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178407	Bronze			2022-12-28	WOS:000243115100012
J	Li, W; Luxenberg, E; Parrish, T; Gottfried, JA				Li, Wen; Luxenberg, Erin; Parrish, Todd; Gottfried, Jay A.			Learning to smell the roses: Experience-dependent neural plasticity in human piriform and orbitofrontal cortices	NEURON			English	Article							RAT OLFACTORY-BULB; PERCEIVED ODOR INTENSITY; ENHANCED SENSITIVITY; PREFRONTAL CORTEX; CROSS-ADAPTATION; DISCRIMINATION; PERCEPTION; RECOGNITION; ACTIVATION; MEMORY	It is widely presumed that odor quality is a direct outcome of odorant structure, but human studies indicate that molecular knowledge of an odorant is not always sufficient to predict odor quality. Indeed, the same olfactory input may generate different odor percepts depending on prior learning and experience. Combining functional magnetic resonance imaging with an olfactory paradigm of perceptual learning, we examined how sensory experience modifies odor perception and odor quality coding in the human brain. Prolonged exposure to a target odorant enhanced perceptual differentiation for odorants related in odor quality or functional group, an effect that was paralleled by learning-induced response increases in piriform cortex and orbitofrontal cortex (OFC). Critically, the magnitude of OFC activation predicted subsequent improvement in behavioral differentiation. Our findings suggest that neural representations of odor quality can be rapidly updated through mere perceptual experience, a mechanism that may underlie the development of odor perception.	Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Radiol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Li, W (corresponding author), Northwestern Univ, Feinberg Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA.	wenli@northwestern.edu		Parrish, Todd/0000-0002-1184-1572	NIDCD NIH HHS [1 K08 DC007653-01A1, K08 DC007653] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC007653] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AMOORE JE, 1969, OLFACTION TASTE, V2; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Arctander S, 1994, PERFUME FLAVOR CHEM; BEDFORD FL, 1995, COGNITION, V54, P253, DOI 10.1016/0010-0277(94)00637-Z; BERGLUND B, 1978, SENS PROCESS, V2, P191; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CAIN WS, 1974, PERCEPT PSYCHOPHYS, V5, P271; Case TI, 2004, PERCEPTION, V33, P113, DOI 10.1068/p5044; Cleland TA, 2002, BEHAV NEUROSCI, V116, P222, DOI 10.1037//0735-7044.116.2.222; Dade LA, 2002, BRAIN, V125, P86, DOI 10.1093/brain/awf003; Dalton P, 2002, NAT NEUROSCI, V5, P199, DOI 10.1038/nn803; de Araujo IE, 2005, NEURON, V46, P671, DOI 10.1016/j.neuron.2005.04.021; EKMAN G, 1967, SCAND J PSYCHOL, V8, P177, DOI 10.1111/j.1467-9450.1967.tb01392.x; ESTES WK, 1986, COGNITIVE PSYCHOL, V18, P500, DOI 10.1016/0010-0285(86)90008-3; Fahle M, 2002, PERCEPTUAL LEARNING; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gibson E. J., 1991, ODYSSEY LEARNING PER; GIBSON EJ, 1956, J COMP PHYSIOL PSYCH, V49, P239, DOI 10.1037/h0048274; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Gottfried JA, 2006, NEURON, V49, P467, DOI 10.1016/j.neuron.2006.01.007; Gottfried JA, 2005, BRAIN RES REV, V50, P287, DOI 10.1016/j.brainresrev.2005.08.004; Gottfried JA, 2002, J NEUROSCI, V22, P10819; Gottfried JA, 2003, NEURON, V39, P375, DOI 10.1016/S0896-6273(03)00392-1; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Green BG, 1996, CHEM SENSES, V21, P323, DOI 10.1093/chemse/21.3.323; Haberly L. B., 1998, OLFACTORY CORTEX; Hahn U, 2005, MEM COGNITION, V33, P289, DOI 10.3758/BF03195318; Hall G., 1991, PERCEPTUAL ASS LEARN; Hawkey DJC, 2004, NAT NEUROSCI, V7, P1055, DOI 10.1038/nn1315; Herz RS, 2003, J EXP PSYCHOL GEN, V132, P595, DOI 10.1037/0096-3445.132.4.595; Herz RS, 2001, PERCEPTION, V30, P381, DOI 10.1068/p3179; JEHL C, 1995, PERCEPT PSYCHOPHYS, V57, P1002, DOI 10.3758/BF03205459; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; JONES PD, 1975, J EXP PSYCHOL HUMAN, V1, P323, DOI 10.1037/0096-1523.1.4.323; KOSSUT M, 1988, ACTA NEUROBIOL EXP, V48, P83; Linster C, 2001, J NEUROSCI, V21, P9837, DOI 10.1523/JNEUROSCI.21-24-09837.2001; Livingston KR, 1998, J EXP PSYCHOL LEARN, V24, P732, DOI 10.1037/0278-7393.24.3.732; Mai J.K., 1997, ATLAS HUMAN BRAIN; Mainland JD, 2002, NATURE, V419, P802, DOI 10.1038/419802a; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Meister M, 2001, J NEUROSCI, V21, P1351; NOSOFSKY RM, 1988, J EXP PSYCHOL LEARN, V14, P700, DOI 10.1037/0278-7393.14.4.700; Ongur D, 2003, J COMP NEUROL, V460, P425, DOI 10.1002/cne.10609; OWEN DH, 1979, PERCEPTION, V8, P199, DOI 10.1068/p080199; PERON RM, 1988, J GEN PSYCHOL, V115, P403, DOI 10.1080/00221309.1988.9710577; Pierce JD, 1996, CHEM SENSES, V21, P223, DOI 10.1093/chemse/21.2.223; Poellinger A, 2001, NEUROIMAGE, V13, P547, DOI 10.1006/nimg.2000.0713; Pothos EM, 2005, Q J EXP PSYCHOL-A, V58, P733, DOI 10.1080/02724980443000322; RABIN MD, 1988, PERCEPT PSYCHOPHYS, V44, P532, DOI 10.3758/BF03207487; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Savic I, 2000, NEURON, V26, P735, DOI 10.1016/S0896-6273(00)81209-X; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Shepherd GM, 2004, PLOS BIOL, V2, P572, DOI 10.1371/journal.pbio.0020146; Sigman M, 2005, NEURON, V46, P823, DOI 10.1016/j.neuron.2005.05.014; Sobel N, 2000, J NEUROPHYSIOL, V83, P537, DOI 10.1152/jn.2000.83.1.537; STEVENS DA, 1995, CHEM SENSES, V20, P413, DOI 10.1093/chemse/20.4.413; Stevenson RJ, 2001, Q J EXP PSYCHOL-A, V54, P561, DOI 10.1080/02724980042000246; WADE NJ, 1994, PERCEPTION, V23, P1111, DOI 10.1068/p231111; Wilson DA, 2003, J NEUROPHYSIOL, V90, P65, DOI 10.1152/jn.00133.2003; Wilson DA, 2003, TRENDS NEUROSCI, V26, P243, DOI 10.1016/S0166-2236(03)00076-6; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; WILSON DA, 2003, SENSORY PHYSL CTR OL; WYSOCKI CJ, 1989, P NATL ACAD SCI USA, V86, P7976, DOI 10.1073/pnas.86.20.7976; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; ZATORRE RJ, 1991, BRAIN, V114, P71; Zelano C, 2005, NAT NEUROSCI, V8, P114, DOI 10.1038/nn1368; ZELLNER DA, 1990, J EXP PSYCHOL HUMAN, V16, P391, DOI 10.1037/0096-1523.16.2.391	76	123	125	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1097	1108		10.1016/j.neuron.2006.10.026	http://dx.doi.org/10.1016/j.neuron.2006.10.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	120VS	17178411	Green Accepted, Bronze			2022-12-28	WOS:000243115100016
J	Frank, E				Frank, Eric			Axon guidance in the spinal cord: Choosin' by exclusion	NEURON			English	Editorial Material							SENSORY AXONS; AFFERENTS	A critical step in the formation of correct patterns of sensory inputs to the spinal cord is the guidance of specific subsets of sensory axons to their appropriate target regions. Yoshida et al. demonstrate in this issue of Neuron that a repulsive interaction between plexinA1 and sema6C/6D prevents the growth of proprioceptive sensory axons into the superficial laminae of the dorsal horn where cutaneous sensory axons terminate.	Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Frank, E (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.							FITZGERALD M, 1993, DEVELOPMENT, V117, P1377; GENC B, 2004, PLOS BIOL, V2; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Lentz SI, 1999, J NEUROSCI, V19, P1038; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Ozaki S, 1997, J COMP NEUROL, V380, P215; Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Ringstedt T, 1997, DEVELOPMENT, V124, P2603; Sharma K, 1998, DEVELOPMENT, V125, P635; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032	12	4	4	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					745	746		10.1016/j.neuron.2006.11.013	http://dx.doi.org/10.1016/j.neuron.2006.11.013			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145495	Bronze			2022-12-28	WOS:000242856400002
J	Halpain, S				Halpain, Shelley			They're plastic, but they recycle	NEURON			English	Editorial Material							SYNAPTIC PLASTICITY; SYNAPSES	Dendritic spines form and grow during hippocampal long-term potentiation (LTP). In this issue of Neuron, a new study by Park et al. uses both serial reconstruction electron microscopy and time-lapse imaging to show that plasma membrane for such spine expansion is trafficked from recycling endosomes that reside locally at the spines themselves.	Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Halpain, S (corresponding author), Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH050861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037311] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH050861] Funding Source: Medline; NINDS NIH HHS [R01 NS037311] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Calabrese B, 2006, PHYSIOLOGY, V21, P38, DOI 10.1152/physiol.00042.2005; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; MATSUZAKI M, 2006, IN PRESS NEUROSCI RE; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	10	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					746	748		10.1016/j.neuron.2006.11.018	http://dx.doi.org/10.1016/j.neuron.2006.11.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145496	Bronze			2022-12-28	WOS:000242856400003
J	Elias, GM; Funke, L; Stein, V; Grant, SG; Bredt, DS; Nicoll, RA				Elias, Guillermo M.; Funke, Lars; Stein, Valentin; Grant, Seth G.; Bredt, David S.; Nicoll, Roger A.			Synapse-specific and developmentally regulated targeting of AMPA receptors by a family of MAGUK scaffolding proteins	NEURON			English	Article							LONG-TERM POTENTIATION; PSD-95; PLASTICITY; NEUROLIGINS; TRANSMISSION; MEMBRANE; NEURONS; MICE	Trafficking of AMPA receptors (AMPA-Rs) to and from synapses controls the strength of excitatory synaptic transmission. However, proteins that cluster AMPA-Rs at synapses remain poorly understood. Here we show that PSD-95-like membrane-associated guanylate kinases (PSD-MAGUKs) mediate this synaptic targeting, and we uncover a remarkable functional redundancy within this protein family. By manipulating endogenous neuronal PSD-MAGUK levels, we find that both PSD-95 and PSD-93 independently mediate AMPA-R targeting at mature synapses. We also reveal unanticipated synapse heterogeneity as loss of either PSD-95 or PSD-93 silences largely nonoverlapping populations of excitatory synapses. In adult PSD-95 and PSD-93 double knockout animals, SAP-102 is upregulated and compensates for the loss of synaptic AMPA-Rs. At immature synapses, PSD-95 and PSD-93 play little role in synaptic AMPA-R clustering; instead, SAP-102 dominates. These studies establish a PSD-MAGUK-specific regulation of AMPA-R synaptic expression that establishes and maintains glutamatergic synaptic transmission in the mammalian central nervous system.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Free Univ Berlin, D-14195 Berlin, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wellcome Trust Sanger Institute; Free University of Berlin	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu	Stein, Valentin/A-8025-2008	Stein, Valentin/0000-0003-1222-4928; Grant, Seth/0000-0001-8732-8735				AEL DE, 2002, CELL, V108, P849; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Firestein BL, 1999, NEURON, V24, P659, DOI 10.1016/S0896-6273(00)81120-4; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Rao A, 1998, J NEUROSCI, V18, P1217; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Stein V, 2003, J NEUROSCI, V23, P5503; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Wyszynski M, 2002, NEURON, V34, P39, DOI 10.1016/S0896-6273(02)00640-2; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	31	297	310	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					307	320		10.1016/j.neuron.2006.09.012	http://dx.doi.org/10.1016/j.neuron.2006.09.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046693	Bronze			2022-12-28	WOS:000241799900011
J	Kesari, S; Stiles, CD				Kesari, Santosh; Stiles, Charles D.			The bad seed: PDGF receptors link adult neural progenitors to glioma stem cells	NEURON			English	Editorial Material							TUMORS; BRAIN; OLIG2		Harvard Univ, Dana Farber Canc Ctr, Program Neuro Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Kesari, S (corresponding author), Harvard Univ, Dana Farber Canc Ctr, Program Neuro Oncol, Boston, MA 02115 USA.		Kesari, Santosh/E-8461-2013					Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fredriksson L, 2004, CYTOKINE GROWTH F R, V15, P197, DOI 10.1016/j.cytogfr.2004.03.007; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Lokker NA, 2002, CANCER RES, V62, P3729; Rowitch DH, 2004, NAT REV NEUROSCI, V5, P409, DOI 10.1038/nrn1389; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	12	22	23	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					151	153		10.1016/j.neuron.2006.07.001	http://dx.doi.org/10.1016/j.neuron.2006.07.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846849	Bronze			2022-12-28	WOS:000239535100002
J	Alvania, RS; Chen, X; Ginty, DD				Alvania, Rebecca S.; Chen, Xi; Ginty, David D.			Calcium signals control wnt-dependent dendrite growth	NEURON			English	Editorial Material							TRANSCRIPTION; ACTIVATION	Activity-dependent dendritic growth is dependent upon intracellular calcium signaling. Yet the specific mechanisms by which calcium signals lead to morphologic changes in dendrites are not well understood. A paper in this issue of Neuron by Wayman et al. describes a novel calcium-dependent signaling cascade linking neuronal activity and calcium influx to expression of Wnt-2, a member of a family of proteins that controls elaboration of dendrites.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Alvania, RS (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Neurosci, Baltimore, MD 21205 USA.			Alvania, Rebecca/0000-0002-3846-0702				Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132	11	8	9	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					813	815		10.1016/j.neuron.2006.06.001	http://dx.doi.org/10.1016/j.neuron.2006.06.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772162	Bronze			2022-12-28	WOS:000238589500001
J	Ferezou, I; Bolea, S; Petersen, CCH				Ferezou, Isabelle; Bolea, Sonia; Petersen, Carl C. H.			Visualizing the cortical representation of whisker touch: Voltage-sensitive dye imaging in freely moving mice	NEURON			English	Article							RAT BARREL CORTEX; SOMATOSENSORY CORTEX; ELECTRICAL-ACTIVITY; IN-VIVO; SPATIOTEMPORAL DYNAMICS; SENSORY RESPONSES; THALAMOCORTICAL SYNAPSES; SYNAPTIC RESPONSES; VIBRISSA MOVEMENT; RECEPTIVE-FIELDS	Voltage-sensitive dye imaging resolves the spatiotemporal dynamics of supragranular subthreshold cortical activity with millisecond temporal resolution and subcolumnar spatial resolution. We used a flexible fiber optic image bundle to visualize voltage-sensitive dye dynamics in the barrel cortex of freely moving mice while simultaneously filming whisker-related behavior to generate two movies matched frame-by-frame with a temporal resolution of up to 2 ms. Sensory responses evoked by passive whisker stimulation lasted longer and spread further across the barrel cortex in awake mice compared to anesthetized mice. Passively evoked sensory responses were large during behaviorally quiet periods and small during active whisking. However, as an exploring mouse approached an object while whisking, large-amplitude, propagating cortical sensory activity was evoked by active whisker-touch. These experiments demonstrate that fiber optics can be used to image cortical sensory activity with high resolution in freely moving animals. The results demonstrate differential processing of sensory input depending upon behavior.	Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, SV BMI,LSENS, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Petersen, CCH (corresponding author), Ecole Polytech Fed Lausanne, Lab Sensory Proc, Brain Mind Inst, SV BMI,LSENS, AAB 105,Stn 15, CH-1015 Lausanne, Switzerland.	carl.petersen@epfl.ch	Petersen, Carl/M-5123-2017; Ferezou, Isabelle/B-4454-2012	Petersen, Carl/0000-0003-3344-4495; Ferezou, Isabelle/0000-0001-7602-1295				Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0; Castro-Alamancos MA, 2002, J PHYSIOL-LONDON, V541, P319, DOI 10.1113/jphysiol.2002.016857; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; CHAPIN JK, 1984, J COMP NEUROL, V229, P199, DOI 10.1002/cne.902290206; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Derdikman D, 2003, J NEUROSCI, V23, P3100; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; GRINVALD A, 1984, NATURE, V308, P848, DOI 10.1038/308848a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; HENTSCHKE H, 2005, IN PRESS CEREB  1012; Higley MJ, 2005, J NEUROPHYSIOL, V93, P1920, DOI 10.1152/jn.00917.2004; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Keller A, 1999, J COMP NEUROL, V412, P83, DOI 10.1002/(SICI)1096-9861(19990913)412:1<83::AID-CNE6>3.0.CO;2-7; Kelly MK, 1999, J NEUROSCI, V19, P9117, DOI 10.1523/JNEUROSCI.19-20-09117.1999; Kleinfeld D, 1996, J COMP NEUROL, V375, P89, DOI 10.1002/(SICI)1096-9861(19961104)375:1<89::AID-CNE6>3.0.CO;2-K; Krupa DJ, 2004, SCIENCE, V304, P1989, DOI 10.1126/science.1093318; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; ORBACH HS, 1985, J NEUROSCI, V5, P1886; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Petersen RS, 2001, NEURON, V32, P503, DOI 10.1016/S0896-6273(01)00481-0; Polley DB, 2004, NATURE, V429, P67, DOI 10.1038/nature02469; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x; Seidemann E, 2002, SCIENCE, V295, P862, DOI 10.1126/science.1066641; Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2; Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; Slovin H, 2002, J NEUROPHYSIOL, V88, P3421, DOI 10.1152/jn.00194.2002; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	44	341	347	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					617	629		10.1016/j.neuron.2006.03.043	http://dx.doi.org/10.1016/j.neuron.2006.03.043			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701211	Green Submitted, Bronze			2022-12-28	WOS:000237875200012
J	Wojcik, SM; Katsurabayashi, S; Guillemin, I; Friauf, E; Rosenmund, C; Brose, N; Rhee, JS				Wojcik, Sonja M.; Katsurabayashi, Shutaro; Guillemin, Isabelle; Friauf, Eckhard; Rosenmund, Christian; Brose, Nils; Rhee, Jeong-Seop			A shared vesicular carrier allows synaptic corelease of GABA and glycine	NEURON			English	Article							GLUTAMIC-ACID DECARBOXYLASE; GAMMA-AMINOBUTYRIC-ACID; MOUSE HIPPOCAMPAL-NEURONS; AUDITORY BRAIN-STEM; DEVELOPMENTAL SWITCH; EXCITATORY ACTIONS; SPINAL NEURONS; CLEFT-PALATE; RAT; VESICLES	The type of vesicular transporter expressed by a neuron is thought to determine its neurotransmitter phenotype. We show that inactivation of the vesicular inhibitory amino acid transporter (Viaat, VGAT) leads to embryonic lethality, an abdominal defect known as omphalocele, and a cleft palate. Loss of Viaat causes a drastic reduction of neurotransmitter release in both GABAergic and glycinergic neurons, indicating that glycinergic neurons do not express a separate vesicular glycine transporter. This loss of GABAergic and glycinergic synaptic transmission does not impair the development of inhibitory synapses or the expression of KCC2, the K+-Cl- cotransporter known to be essential for the establishment of inhibitory neurotransmission. In the absence of Viaat, GABA-synthesizing enzymes are partially lost from presynaptic terminals. Since GABA and glycine compete for vesicular uptake, these data point to a close association of Viaat with GABA-synthesizing enzymes as a key factor in specifying GABAergic neuronal phenotypes.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ Kaiserslautern, Dept Anim Physiol, D-67653 Kaiserslautern, Germany	Max Planck Society; Baylor College of Medicine; Baylor College of Medicine; University of Kaiserslautern	Wojcik, SM (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	wojcik@em.mpg.de; rhee@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Jansen, Heiko T./A-5770-2008; Friauf, Eckhard/D-7529-2012	Rosenmund, Christian/0000-0002-3905-2444; Jansen, Heiko T./0000-0003-0178-396X; Friauf, Eckhard/0000-0002-1833-1698				Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496; Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Bedet C, 2000, J NEUROCHEM, V75, P1654, DOI 10.1046/j.1471-4159.2000.0751654.x; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; CHEN G, 1995, J NEUROPHYSIOL, V74, P1473, DOI 10.1152/jn.1995.74.4.1473; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; CHRISTENSEN H, 1991, NEUROSCI LETT, V129, P217, DOI 10.1016/0304-3940(91)90465-6; CHRISTENSEN H, 1991, EUR J PHARM-MOLEC PH, V207, P73, DOI 10.1016/S0922-4106(05)80040-9; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Colin I, 1998, J COMP NEUROL, V398, P359; Condie BG, 1997, P NATL ACAD SCI USA, V94, P11451, DOI 10.1073/pnas.94.21.11451; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Demarque M, 2002, NEURON, V36, P1051, DOI 10.1016/S0896-6273(02)01053-X; Ebihara S, 2003, MOL BRAIN RES, V110, P126, DOI 10.1016/S0169-328X(02)00648-4; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Gao BX, 2001, J NEUROPHYSIOL, V86, P492, DOI 10.1152/jn.2001.86.1.492; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hubner CA, 2004, GENE EXPR PATTERNS, V5, P219, DOI 10.1016/j.modgep.2004.08.002; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5; Jin H, 2003, P NATL ACAD SCI USA, V100, P4293, DOI 10.1073/pnas.0730698100; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Kalloniatis M, 1996, J NEUROSCI, V16, P6807; Kanaani J, 2002, J CELL BIOL, V158, P1229, DOI 10.1083/jcb.200205053; Katz LA, 2004, AM J MED GENET A, V130A, P277, DOI 10.1002/ajmg.a.30329; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882; Leitch E, 2005, J NEUROSCI, V25, P4801, DOI 10.1523/JNEUROSCI.0172-05.2005; Lim R, 2000, J PHYSIOL-LONDON, V525, P447, DOI 10.1111/j.1469-7793.2000.t01-1-00447.x; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Nabekura J, 2004, NAT NEUROSCI, V7, P17, DOI 10.1038/nn1170; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Pyott SJ, 2002, J PHYSIOL-LONDON, V539, P523, DOI 10.1113/jphysiol.2001.013277; REICHLING DB, 1994, J PHYSIOL-LONDON, V476, P411, DOI 10.1113/jphysiol.1994.sp020142; Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; Sagne C, 1997, FEBS LETT, V417, P177, DOI 10.1016/S0014-5793(97)01279-9; SEILER N, 1980, PHYSIOL CHEM PHYS M, V12, P411; SOLIMENA M, 1993, P NATL ACAD SCI USA, V90, P3073, DOI 10.1073/pnas.90.7.3073; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Titz S, 2003, J PHYSIOL-LONDON, V550, P719, DOI 10.1113/jphysiol.2003.041863; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; WALTON MK, 1993, J NEUROSCI, V13, P2068; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S	58	258	269	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					575	587		10.1016/j.neuron.2006.04.016	http://dx.doi.org/10.1016/j.neuron.2006.04.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701208	Bronze			2022-12-28	WOS:000237875200009
J	Goldberg, II; Harel, M; Malach, R				Goldberg, II; Harel, M; Malach, R			When the brain loses its self: Prefrontal inactivation during sensorimotor processing	NEURON			English	Article							HUMAN VISUAL-CORTEX; HUMAN OBJECT AREAS; CONSCIOUS EXPERIENCE; DEFAULT MODE; FMRI; MIND; RECOGNITION; ORGANIZATION; FRAMEWORK; EMOTION	A common theme in theories of subjective awareness poses a self-related "observer" function, or a homunculus, as a critical element without which awareness can not emerge. Here, we examined this question using fMRI. In our study, we compared brain activity patterns produced by a demanding sensory categorization paradigm to those engaged during self-reflective introspection, using similar sensory stimuli. Our results show a complete segregation between the two patterns of activity. Furthermore, regions that showed enhanced activity during introspection underwent a robust inhibition during the demanding perceptual task. The results support the notion that self-related processes are not necessarily engaged during sensory perception and can be actually suppressed.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Malach, R (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	rafi.malach@weizmann.ac.il						AMASIO A, 1999, FEELING WHAT HAPPENS; Baars BJ, 2003, TRENDS NEUROSCI, V26, P671, DOI 10.1016/j.tins.2003.09.015; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Damasio A.R., 2005, DESCARTES ERROR EMOT; DAMASIO H, 1994, SCIENCE, V264, P1102, DOI 10.1126/science.8178168; Formisano E, 2003, NEURON, V40, P859, DOI 10.1016/S0896-6273(03)00669-X; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, J CEREBR BLOOD F MET, V15, P361, DOI 10.1038/jcbfm.1995.45; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Hannula DE, 2005, NAT REV NEUROSCI, V6, P247, DOI 10.1038/nrn1630; Hasson U, 2003, NEURON, V37, P1027, DOI 10.1016/S0896-6273(03)00144-2; Iacoboni M, 2004, NEUROIMAGE, V21, P1167, DOI 10.1016/j.neuroimage.2003.11.013; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Keenan JP, 2000, TRENDS COGN SCI, V4, P338, DOI 10.1016/S1364-6613(00)01521-7; Keenan JP, 2001, NATURE, V409, P305, DOI 10.1038/35053167; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; KOLB BWI, 1990, FUNAMENTALS HUMAN NE; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Lang P. J., 2005, A6 U FLOR, DOI DOI 10.1027/0269-8803/A000147; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Luria AR., 1973, WORKING BRAIN; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Morin A, 2002, CONSCIOUS COGN, V11, P396, DOI 10.1016/S1053-8100(02)00009-0; Phan KL, 2004, NEUROIMAGE, V21, P768, DOI 10.1016/j.neuroimage.2003.09.072; RACZKOWSKI D, 1974, NEUROPSYCHOLOGIA, V12, P43, DOI 10.1016/0028-3932(74)90025-6; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rotshtein P, 2001, NEURON, V32, P747, DOI 10.1016/S0896-6273(01)00513-X; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Stuss D.T., 1986, FRONTAL LOBES; Stuss DT, 2004, BRAIN COGNITION, V55, P69, DOI 10.1016/s0278-2626(03)00271-9; Suzuki D. T., 1927, INTRO ZEN BUDDHISM; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; Turk DJ, 2003, ANN NY ACAD SCI, V1001, P65, DOI 10.1196/annals.1279.005; Turk DJ, 2002, NAT NEUROSCI, V5, P841, DOI 10.1038/nn907; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2003, TRENDS COGN SCI, V7, P38, DOI 10.1016/S1364-6613(02)00003-7; Wolf E, 1988, TREATING SELF	47	393	401	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					329	339		10.1016/j.neuron.2006.03.015	http://dx.doi.org/10.1016/j.neuron.2006.03.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630842	Bronze			2022-12-28	WOS:000237176700018
J	Constantine-Paton, M				Constantine-Paton, M			Shining light on spike timing-dependent plasticity	NEURON			English	Editorial Material							NEURONS	Although spike timing-dependent plasticity has been well-characterized in vitro, it is less clear to what degree spike timing-dependent plasticity contributes to shaping visual system properties in vivo. In this issue of Neuron, two papers by Vislay-Meltzer et al. and Mu and Poo provide evidence that STDP contributes to the effects of sensory stimuli in refinement of the retinotectal system in Xenopus.	Massachusetts Inst Technol, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Constantine-Paton, M (corresponding author), Massachusetts Inst Technol, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Fregnac Y, 1999, J NEUROBIOL, V41, P69; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3	14	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					5	7		10.1016/j.neuron.2006.03.024	http://dx.doi.org/10.1016/j.neuron.2006.03.024			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600848	Bronze			2022-12-28	WOS:000236811300003
J	Ishibashi, T; Dakin, KA; Stevens, B; Lee, PR; Kozlov, SV; Stewart, CL; Fields, RD				Ishibashi, T; Dakin, KA; Stevens, B; Lee, PR; Kozlov, SV; Stewart, CL; Fields, RD			Astrocytes promote myelination in response to electrical impulses	NEURON			English	Article							LEUKEMIA INHIBITORY FACTOR; CILIARY NEUROTROPHIC FACTOR; WHITE-MATTER ARCHITECTURE; ACTION-POTENTIALS; ALEXANDER-DISEASE; NEURAL IMPULSES; EXPRESSION; CNS; OLIGODENDROCYTES; MATURATION	Myelin, the insulating layers of membrane wrapped around axons by oligodendrocytes, is essential for normal impulse conduction. It forms during late stages of fetal development but continues into early adult life. Myelination correlates with cognitive development and can be regulated by impulse activity through unknown molecular mechanisms. Astrocytes do not form myelin, but these nonneuronal cells can promote myelination in ways that are not understood. Here, we identify a link between myelination, astrocytes, and electrical impulse activity in axons that is mediated by the cytokine leukemia inhibitory factor (LIF). These findings show that LIF is released by astrocytes in response to ATP liberated from axons firing action potentials, and LIF promotes myelination by mature oligodendrocytes. This activity-dependent mechanism promoting myelination could regulate myelination according to functional activity or environmental experience and may offer new approaches to treating demyelinating diseases.	NICHHD, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA; NCI, Lab Canc & Dev Biol, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Fields, RD (corresponding author), NICHHD, Nervous Syst Dev & Plast Sect, Bethesda, MD 20892 USA.	fieldsd@mail.nih.gov			Intramural NIH HHS Funding Source: Medline; NICHD NIH HHS [Z01 HD000713-11] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000713] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [Z01BC010376] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BANNER LR, 1994, P NATL ACAD SCI USA, V91, P7109, DOI 10.1073/pnas.91.15.7109; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Burnstock G, 2004, CURR TOP MED CHEM, V4, P793, DOI 10.2174/1568026043451014; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Dupree JL, 2004, NEURON GLIA BIOL, V1, P179, DOI 10.1017/S1740925X04000304; Dziewulska D, 1999, FOLIA NEUROPATHOL, V37, P81; Fields R. Douglas, 1992, P67; Fields RD, 2004, SCI AM, V290, P54, DOI 10.1038/scientificamerican0404-54; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fields RD, 2000, TRENDS NEUROSCI, V23, P625, DOI 10.1016/S0166-2236(00)01674-X; FIELDS RD, 2006, PURINERGIC SIGNALING, V276; GARD AL, 1989, DEVELOPMENT, V106, P119; Giedd JN, 2004, ANN NY ACAD SCI, V1021, P77, DOI 10.1196/annals.1308.009; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; Johnson AB, 2002, INT J DEV NEUROSCI, V20, P391, DOI 10.1016/S0736-5748(02)00045-X; Lee PR, 2004, NEURON GLIA BIOL, V1, P135, DOI 10.1017/S1740925X04000274; Li R, 2002, INT J DEV NEUROSCI, V20, P259, DOI 10.1016/S0736-5748(02)00019-9; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Markham JA, 2004, NEURON GLIA BIOL, V1, P351, DOI 10.1017/S1740925X05000219; MAYER M, 1994, DEVELOPMENT, V120, P143; Mey J, 2002, CELL TISSUE RES, V310, P155, DOI 10.1007/s00441-002-0624-x; Meyer-Franke A, 1999, MOL CELL NEUROSCI, V14, P385, DOI 10.1006/mcne.1999.0788; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Schmithorst VJ, 2005, HUM BRAIN MAPP, V26, P139, DOI 10.1002/hbm.20149; SCOLDING NJ, 1989, J NEUROIMMUNOL, V22, P169, DOI 10.1016/0165-5728(89)90014-3; Stankoff B, 2002, J NEUROSCI, V22, P9221; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Stevens B, 1998, J NEUROSCI, V18, P9303; Stevens B, 2000, SCIENCE, V287, P2267, DOI 10.1126/science.287.5461.2267; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3; Yamakuni H, 2002, J NEUROIMMUNOL, V129, P43, DOI 10.1016/S0165-5728(02)00179-0; Zalc B, 2000, NEUROSCIENTIST, V6, P5, DOI 10.1177/107385840000600109	36	480	513	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					823	832		10.1016/j.neuron.2006.02.006	http://dx.doi.org/10.1016/j.neuron.2006.02.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543131	Green Accepted, Bronze			2022-12-28	WOS:000236227500011
J	Grinband, J; Hirsch, J; Ferrera, VP				Grinband, J; Hirsch, J; Ferrera, VP			A neural representation of categorization uncertainty in the human brain	NEURON			English	Article							PERCEPTUAL DECISION-MAKING; HUMAN ORBITOFRONTAL CORTEX; OLD-WORLD MONKEY; PREFRONTAL CORTEX; PARIETAL CORTEX; REWARD; FMRI; ACTIVATION; ANTICIPATION; EXPERIENCE	The ability to classify visual objects into discrete categories ("friend" versus "foe"; "edible" versus "poisonous") is essential for survival and is a fundamental cognitive function. The cortical substrates that mediate this function, however, have not been identified in humans. To identify brain regions involved in stimulus categorization, we developed a task in which subjects classified stimuli according to a variable categorical boundary. Psychophysical functions were used to define a decision variable, categorization uncertainty, which was systematically manipulated. Using eevent-related functional MRI, we discovered that activity in a fronto-striatal-thalamic network, consisting of the medial frontal gyrus, anterior insula, ventral striatum, and dorsomedial thalamus, was modulated by categorization uncertainty. We found this network to be distinct from the frontoparietal attention network, consisting of the frontal and parietal eye fields, where activity was not correlated with categorization uncertainty.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, FMRI Res Ctr, New York, NY 10032 USA; Columbia Univ, David Mahoney Ctr Brain & Behav Res, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Grinband, J (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	jg2269@columbia.edu	Grinband, Jack/AAX-7675-2020	Grinband, Jack/0000-0001-7658-6755; Ferrera, Vincent/0000-0002-6599-7740; Hirsch, Joy/0000-0002-1418-6489	NATIONAL EYE INSTITUTE [T32EY013933, R24EY015634] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059244, T32MH015174] Funding Source: NIH RePORTER; NEI NIH HHS [R24 EY015634-01, R24 EY015634-04, T32EY013933, R24 EY015634, R24 EY015634-02, R24 EY015634-03] Funding Source: Medline; NIMH NIH HHS [T32MH015174, R01MH59244] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Heekeren HR, 2004, NATURE, V431, P859, DOI 10.1038/nature02966; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Kringelbach ML, 2003, CEREB CORTEX, V13, P1064, DOI 10.1093/cercor/13.10.1064; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Miller EK, 2003, CURR OPIN NEUROBIOL, V13, P198, DOI 10.1016/S0959-4388(03)00037-0; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; QUICK RF, 1974, KYBERNETIK, V16, P65, DOI 10.1007/BF00271628; Ratcliff R, 2003, J NEUROPHYSIOL, V90, P1392, DOI 10.1152/jn.01049.2002; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Usher M, 2001, PSYCHOL REV, V108, P550, DOI 10.1037//0033-295X.108.3.550; Volz KG, 2004, NEUROIMAGE, V21, P848, DOI 10.1016/j.neuroimage.2003.10.028; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0	35	248	249	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					757	763		10.1016/j.neuron.2006.01.032	http://dx.doi.org/10.1016/j.neuron.2006.01.032			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504950	Bronze			2022-12-28	WOS:000236070600016
J	Hoeffer, CA; Klann, E				Hoeffer, Charles A.; Klann, Eric			Switching gears: Translational mastery of transcription during memory formation	NEURON			English	Editorial Material							TERM SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; CREB; CONSOLIDATION; STRESS; CELLS; MICE	A critical molecular requirement underlying many forms of long-lasting synaptic plasticity and memory is the de novo synthesis of mRNAs and proteins. In a recent paper in Cell, Costa-Mattioli et al. present data from a pharmacogenetic study that places a key regulatory event in the "neural decision" to undergo these persistent neuronal changes under translational control mediated by eIF2 alpha.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Klann, E (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	eklann@cns.nyu.edu						Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Govindarajan A, 2006, NAT REV NEUROSCI, V7, P575, DOI 10.1038/nrn1937; Gu YH, 2002, J NEUROSCI, V22, P2753, DOI 10.1523/JNEUROSCI.22-07-02753.2002; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Sanyal S, 2002, NATURE, V416, P870, DOI 10.1038/416870a; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; Wagatsuma A, 2006, J NEUROSCI RES, V84, P954, DOI 10.1002/jnr.21012	15	2	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					186	189		10.1016/j.neuron.2007.04.003	http://dx.doi.org/10.1016/j.neuron.2007.04.003			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442240	Bronze			2022-12-28	WOS:000246190600004
J	Shimizu, H; Watanabe, E; Hiyama, TY; Nagakura, A; Fujikawa, A; Okado, H; Yanagawa, Y; Obata, K; Noda, M				Shimizu, Hidetada; Watanabe, Eiji; Hiyama, Takeshi Y.; Nagakura, Ayano; Fujikawa, Akihiro; Okado, Haruo; Yanagawa, Yuchio; Obata, Kunihiko; Noda, Masaharu			Glial Na-x channels control lactate signaling to neurons for brain [Na+] sensing	NEURON			English	Article							SENSORY CIRCUMVENTRICULAR ORGANS; NA+,K+-ATPASE ALPHA-SUBUNIT; SENSITIVE SODIUM-CHANNEL; SUBFORNICAL ORGAN; FIRING PATTERNS; GLUCOSE-UPTAKE; NA,K-ATPASE; METABOLISM; TRANSPORT; SINGLE	Sodium (Na) homeostasis is crucial for life, and Na levels in body fluids are constantly monitored in the brain. The subfornical organ (SFO) is the center of the sensing responsible for the control of salt-intake behavior, where Na-x channels are expressed in specific glial cells as the Na-level sensor. Here, we show direct interaction between Na-x channels and alpha subunits of Na+/K+-ATPase, which brings about Na-dependent activation of the metabolic state of the glial cells. The metabolic enhancement leading to extensive lactate production was observed in the SFO of wild-type mice, but not of the Na-x-knockout mice. Furthermore, lactate, as well as Na, stimulated the activity of GABAergic neurons in the SFO. These results suggest that the information on a physiological increase of the Na level in body fluids sensed by Na-x in glial cells is transmitted to neurons by lactate as a mediator to regulate neural activities of the SFO.	Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; Natl Inst Basic Biol, Lab Neurophysiol, Okazaki, Aichi 4448787, Japan; Grad Univ Adv Studies, Sch Life Sci, Okazaki, Aichi 4448787, Japan; Tokyo Metropolitan Inst Neurosci, Dept Mol Physiol, Fuchu, Tokyo 1838526, Japan; Gunma Univ, Dept Genet & Behav Neurosci, Grad Sch Med, Maebashi, Gunma 3718511, Japan; RIKEN, Neuronal Circuit Mechanisms Res Grp, Brain Sci Inst, Wako, Saitama 3510198, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Gunma University; RIKEN	Noda, M (corresponding author), Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan.	madon@nibb.ac.jp	Fujikawa, Akihiro/K-9805-2015; Hiyama, Takeshi/X-4134-2018; Noda, Masaharu/D-7146-2016	Fujikawa, Akihiro/0000-0002-3950-0550; Hiyama, Takeshi/0000-0001-8612-8707; Noda, Masaharu/0000-0002-3796-524X; Watanabe, Eiji/0000-0001-9089-8122				ANDERSSON B, 1978, PHYSIOL REV, V58, P582, DOI 10.1152/physrev.1978.58.3.582; Chih CP, 2001, TRENDS NEUROSCI, V24, P573, DOI 10.1016/S0166-2236(00)01920-2; COX PS, 1987, AM J PHYSIOL, V252, pR1, DOI 10.1152/ajpregu.1987.252.1.R1; Denton DA, 1996, P NATL ACAD SCI USA, V93, P7397, DOI 10.1073/pnas.93.14.7397; Feschenko MS, 2003, J NEUROSCI, V23, P2161; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; GAUTRON S, 1992, P NATL ACAD SCI USA, V89, P7272, DOI 10.1073/pnas.89.15.7272; Gladden LB, 2004, J PHYSIOL-LONDON, V558, P5, DOI 10.1113/jphysiol.2003.058701; Goldberg JA, 2005, J NEUROSCI, V25, P10230, DOI 10.1523/JNEUROSCI.2734-05.2005; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hertz L, 2005, J NEUROSCI RES, V79, P11, DOI 10.1002/jnr.20294; Hiyama TY, 2004, J NEUROSCI, V24, P9276, DOI 10.1523/JNEUROSCI.2795-04.2004; Hiyama TY, 2002, NAT NEUROSCI, V5, P511, DOI 10.1038/nn856; Hu YB, 1997, J NEUROCHEM, V69, P1484; Hyder F, 2006, J CEREBR BLOOD F MET, V26, P865, DOI 10.1038/sj.jcbfm.9600263; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Jung JH, 2002, J BIOL CHEM, V277, P48931, DOI 10.1074/jbc.M208806200; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kondo S, 1998, J PHYSIOL-LONDON, V509, P233, DOI 10.1111/j.1469-7793.1998.233bo.x; Krivoi II, 2006, PFLUG ARCH EUR J PHY, V452, P756, DOI 10.1007/s00424-006-0081-6; Magistretti PJ, 2000, BRAIN RES, V886, P108, DOI 10.1016/S0006-8993(00)02945-0; MCGRAIL KM, 1991, J NEUROSCI, V11, P381, DOI 10.1523/jneurosci.11-02-00381.1991; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Noda M, 2005, CHEM SENSES, V30, pI44, DOI 10.1093/chemse/bjh105; NOSE H, 1992, J APPL PHYSIOL, V73, P1419, DOI 10.1152/jappl.1992.73.4.1419; PARK R, 1989, BRAIN RES, V493, P123, DOI 10.1016/0006-8993(89)91006-8; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; ROSENTHAL M, 1992, CAN J PHYSIOL PHARM, V70, pS165, DOI 10.1139/y92-258; SERPERSU EH, 1984, J BIOL CHEM, V259, P7155; SHAMRAJ OI, 1994, P NATL ACAD SCI USA, V91, P12952, DOI 10.1073/pnas.91.26.12952; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; WAKERLEY JB, 1978, BRAIN RES, V148, P425, DOI 10.1016/0006-8993(78)90730-8; Wang XQ, 2005, J NEUROCHEM, V93, P1515, DOI 10.1111/j.1471-4159.2005.03147.x; Waniewski RA, 2004, NEUROCHEM RES, V29, P209, DOI 10.1023/B:NERE.0000010450.21586.a6; Washburn DLS, 2000, J PHYSIOL-LONDON, V529, P359, DOI 10.1111/j.1469-7793.2000.00359.x; Watanabe E, 2006, AM J PHYSIOL-REG I, V290, pR568, DOI 10.1152/ajpregu.00618.2005; Watanabe E, 2000, J NEUROSCI, V20, P7743; WATTS AG, 1991, P NATL ACAD SCI USA, V88, P7425, DOI 10.1073/pnas.88.16.7425; WEISINGER RS, 1979, NATURE, V280, P490, DOI 10.1038/280490a0; Yamada K, 2000, J BIOL CHEM, V275, P22278, DOI 10.1074/jbc.M908048199; Yoshioka K, 1996, BBA-GEN SUBJECTS, V1289, P5, DOI 10.1016/0304-4165(95)00153-0; Zouzoulas A, 2006, J BIOL CHEM, V281, P8539, DOI 10.1074/jbc.M512700200	45	148	152	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					59	72		10.1016/j.neuron.2007.03.014	http://dx.doi.org/10.1016/j.neuron.2007.03.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408578	Bronze, Green Submitted			2022-12-28	WOS:000245848400010
J	Katagiri, H; Fagiolini, M; Hensch, TK				Katagiri, Hiroyuki; Fagiolini, Michela; Hensch, Takao K.			Optimization of somatic inhibition at critical period onset in mouse visual cortex	NEURON			English	Article							SYNAPTIC GABA(A) RECEPTORS; GAMMA-AMINOBUTYRIC-ACID; HIPPOCAMPAL PYRAMIDAL CELLS; POSTNATAL-DEVELOPMENT; BENZODIAZEPINE-RECEPTOR; GABAERGIC INNERVATION; PLASTICITY; NUMBER; SYNAPSES; CIRCUITS	Local GABAergic circuits trigger visual cortical plasticity in early postnatal life. How these diverse connections contribute to critical period onset was investigated by nonstationary fluctuation analysis following laser photo-uncaging of GABA onto discrete sites upon individual pyramidal cells in slices of mouse visual cortex. The GABA(A) receptor number decreased on the soma-proximal dendrite (SPD), but not at the axon initial segment, with age and sensory deprivation. Benzodiazepine sensitivity was also higher on the immature SPD. Too many or too few SPID receptors in immature or dark-reared mice, respectively, were adjusted to critical period levels by benzodiazepine treatment in vivo, which engages ocular dominance plasticity in these animal models. Combining GAD65 deletion with dark rearing from birth confirmed that an intermediate number of SPD receptors enable plasticity. Site-specific optimization of perisomatic GABA response may thus trigger experience-dependent development in visual cortex.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Osaka 5600082, Japan	RIKEN; Japan Science & Technology Agency (JST)	Hensch, TK (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	hensch@mcb.harvard.edu	Hensch, Takao/L-4182-2019	fagiolini, michela/0000-0003-2807-803X				Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; BENEVENTO LA, 1992, BRAIN RES, V572, P198, DOI 10.1016/0006-8993(92)90470-T; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Bogdanov Y, 2006, EMBO J, V25, P4381, DOI 10.1038/sj.emboj.7601309; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; CHATTOPADHYAYA B, 2006, CSHL GABA WORKSH, P7; Chen L, 2001, MOL BRAIN RES, V88, P135, DOI 10.1016/S0169-328X(01)00042-0; Cherubini E, 2001, TRENDS NEUROSCI, V24, P155, DOI 10.1016/S0166-2236(00)01724-0; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; DAW N, 1995, VISUAL DEV; DeLorey TM, 1998, J NEUROSCI, V18, P8505; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Fritschy JM, 1998, J COMP NEUROL, V390, P194; Heinen K, 2004, NEUROSCIENCE, V124, P161, DOI 10.1016/j.neuroscience.2003.11.004; Henneberger C, 2005, NEUROSCIENCE, V135, P749, DOI 10.1016/j.neuroscience.2005.06.044; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hutcheon B, 2004, EUR J NEUROSCI, V19, P2475, DOI 10.1111/j.0953-816X.2004.03349.x; Iwai Y, 2003, J NEUROSCI, V23, P6695; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; KOMATSU Y, 1991, BRAIN RES, V540, P14, DOI 10.1016/0006-8993(91)90487-G; Kunig G, 2000, ANN NEUROL, V47, P644; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Morales B, 2002, J NEUROSCI, V22, P8084; Morrow AL, 2001, BRAIN RES REV, V37, P98, DOI 10.1016/S0165-0173(01)00127-8; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; MOWER GD, 1988, J COMP NEUROL, V272, P293, DOI 10.1002/cne.902720211; NICOLL RA, 1994, NATURE, V368, P808, DOI 10.1038/368808a0; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1996, P NATL ACAD SCI USA, V93, P11939, DOI 10.1073/pnas.93.21.11939; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nutt DJ, 2001, BRIT J PSYCHIAT, V179, P390, DOI 10.1192/bjp.179.5.390; Pettit DL, 2000, J NEUROPHYSIOL, V84, P28, DOI 10.1152/jn.2000.84.1.28; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Prusky GT, 2003, EUR J NEUROSCI, V17, P167, DOI 10.1046/j.1460-9568.2003.02420.x; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sanna E, 2002, EUR J PHARMACOL, V451, P103, DOI 10.1016/S0014-2999(02)02191-X; Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X; TANAKA K, 1987, EXP BRAIN RES, V65, P673; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327	54	99	103	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 15	2007	53	6					805	812		10.1016/j.neuron.2007.02.026	http://dx.doi.org/10.1016/j.neuron.2007.02.026			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359916	Bronze			2022-12-28	WOS:000245292800006
J	Papaleo, F; Kitchener, P; Contarino, A				Papaleo, Francesco; Kitchener, Pierre; Contarino, Angelo			Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal	NEURON			English	Article							CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-LIKE BEHAVIOR; NEUROPEPTIDE MESSENGER-RNA; GENE-EXPRESSION; PRECIPITATED WITHDRAWAL; REDUCED ANXIETY; BRAIN-REGIONS; MICE LACKING; DELTA-FOSB; ANTAGONIST	Escape from the extremely stressful opiate withdrawal syndrome may motivate opiate seeking and taking. The corticotropin-releasing factor receptor-1 (CRF1) pathway mediates behavioral and endocrine responses to stress. Here, we report that genetic inactivation (CRF1-/-) as well as pharmacological antagonism of the CRF/ CRF1 receptor pathway increased and prolonged the somatic expression of opiate withdrawal. Opiate-withdrawn CRF1-/- mice also showed aberrant CRF and dynorphin expression in the paraventricular nucleus of the hypothalamus (PVN) and the striatum, indicating profound impairments in stress-responsive brain circuitry. Intake of nonstressful amounts of corticosterone effectively reduced the exaggerated somatic reactions of CRF1-/- mice to opiate withdrawal. Exogenous corticosterone also restored "wild-type-like" patterns of CRF and dynorphin gene expression in the PVN and the striatum of opiate-withdrawn CRF1-/- mice, respectively. The present findings unravel a key role for the hypothalamus-pituitary-adrenal (HPA) system and brainextra- hypothalamic CRF/CRF1 receptor circuitry in somatic, molecular, and endocrine alterations induced by opiate withdrawal.	Univ Victor Segalen Bordeaux 2, EA 3666, Lab Homeostasie Allostasie Pathol, F-33076 Bordeaux, France; INSERM Unite 588, F-33076 Bordeaux, France; Dipartimento Farmacol & Anestesiol, I-35131 Padua, Italy	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm)	Contarino, A (corresponding author), Univ Victor Segalen Bordeaux 2, EA 3666, Lab Homeostasie Allostasie Pathol, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	angelo.contarino@nppda.u-bordeaux2.fr	Contarino, Angelo/C-9429-2014; Papaleo, Francesco/AAD-1844-2019	Papaleo, Francesco/0000-0002-6326-0657; Contarino, Angelo/0000-0002-7286-6941				ALMEIDA OF, 1909, BRAIN RES, V571, P189; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; Carrera MRA, 1999, PSYCHOPHARMACOLOGY, V144, P111, DOI 10.1007/s002130050983; Contarino A, 2005, P NATL ACAD SCI USA, V102, P18649, DOI 10.1073/pnas.0506999102; Contarino A, 2002, NEUROPEPTIDES, V36, P103, DOI 10.1054/npep.2002.0899; Contarino A, 1999, BRAIN RES, V835, P1, DOI 10.1016/S0006-8993(98)01158-5; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Deak T, 1999, ENDOCRINOLOGY, V140, P79, DOI 10.1210/en.140.1.79; FACCHINETTI F, 1985, DRUG ALCOHOL DEPEN, V15, P361, DOI 10.1016/0376-8716(85)90014-6; FALLON JH, 1990, HDB CHEM NEUROANATOM, P1; Fukunaga Y, 2000, JPN J PHARMACOL, V82, P175, DOI 10.1254/jjp.82.175; Georges F, 1999, EUR J NEUROSCI, V11, P481, DOI 10.1046/j.1460-9568.1999.00462.x; Hauger RL, 2003, PHARMACOL REV, V55, P21, DOI 10.1124/pr.55.1.3; HEINRICHS SC, 1994, NEUROPSYCHOPHARMACOL, V11, P179, DOI 10.1038/sj.npp.1380104; HEINRICHS SC, 1995, BEHAV PHARMACOL, V6, P74; Houshyar H, 2004, J NEUROSCI, V24, P9414, DOI 10.1523/JNEUROSCI.1641-04.2004; Iredale PA, 2000, J NEUROCHEM, V74, P199, DOI 10.1046/j.1471-4159.2000.0740199.x; JABER M, 1995, NEUROSCIENCE, V65, P1041, DOI 10.1016/0306-4522(94)00537-F; Jutkiewicz EM, 2005, PSYCHOPHARMACOLOGY, V180, P215, DOI 10.1007/s00213-005-2164-z; Kenny PJ, 2006, J NEUROSCI, V26, P5894, DOI 10.1523/JNEUROSCI.0740-06.2006; Koob GF, 2001, NEUROPSYCHOPHARMACOL, V24, P97, DOI 10.1016/S0893-133X(00)00195-0; Koob GF, 1999, BRAIN RES, V848, P141, DOI 10.1016/S0006-8993(99)01991-5; Kreek MJ, 1998, DRUG ALCOHOL DEPEN, V51, P23, DOI 10.1016/S0376-8716(98)00064-7; LIGHTMAN SL, 1998, J PHYSL, V403, P511; Limbird, 1996, GOODMAN GILMANS PHAR, P557; LINSEMAN MA, 1977, PSYCHOPHARMACOLOGY, V54, P159, DOI 10.1007/BF00426773; Lu L, 2005, PSYCHOPHARMACOLOGY, V181, P90, DOI 10.1007/s00213-005-2207-5; Lu L, 2000, EUR J NEUROSCI, V12, P4398; Lucas LR, 1998, J NEUROCHEM, V71, P833; McClung CA, 2004, MOL BRAIN RES, V132, P146, DOI 10.1016/j.molbrainres.2004.05.014; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; MUCHA RF, 1987, BRAIN RES, V418, P214, DOI 10.1016/0006-8993(87)90088-6; Muller DL, 2005, J PHARMACOL EXP THER, V314, P148, DOI 10.1124/jpet.105.083410; NABESHIMA T, 1992, LIFE SCI, V51, P211, DOI 10.1016/0024-3205(92)90077-3; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; *NIDA, 2005, MON FUT NAT RES AD D; Papaleo F, 2006, BEHAV BRAIN RES, V170, P110, DOI 10.1016/j.bbr.2006.02.009; Paxinos G., 2001, MOUSE BRAIN STEREOTA; RATTAN AK, 1992, BRAIN RES, V584, P207, DOI 10.1016/0006-8993(92)90896-H; Reyes BAS, 2005, EUR J NEUROSCI, V22, P93, DOI 10.1111/j.1460-9568.2005.04197.x; RIVIER C, 1983, NATURE, V305, P325, DOI 10.1038/305325a0; SARNYAI Z, 1995, BRAIN RES, V675, P89, DOI 10.1016/0006-8993(95)00043-P; SAWCHENKO PE, 1993, CIBA F SYMP, V172, P5; SAWCHENKO PE, 1987, J NEUROSCI, V7, P1093; Schulteis G, 1996, NEUROCHEM RES, V21, P1437, DOI 10.1007/BF02532385; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1998, PSYCHOPHARMACOLOGY, V137, P184, DOI 10.1007/s002130050608; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Smith GW, 1998, NEURON, V20, P1093, DOI 10.1016/S0896-6273(00)80491-2; Stinus L, 2005, NEUROPSYCHOPHARMACOL, V30, P90, DOI 10.1038/sj.npp.1300487; STORNETTA RL, 1993, BRAIN RES, V624, P19, DOI 10.1016/0006-8993(93)90055-R; Tanimura SM, 1998, ENDOCRINOLOGY, V139, P3830, DOI 10.1210/en.139.9.3830; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Tjon GHK, 1997, NEUROSCIENCE, V76, P167; Valdez GR, 2002, ALCOHOL CLIN EXP RES, V26, P1494, DOI 10.1097/01.ALC.0000033120.51856.F0; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; Wong ML, 1999, LIFE SCI, V65, pPL53, DOI 10.1016/S0024-3205(99)00268-4; Zachariou V, 2006, NAT NEUROSCI, V9, P205, DOI 10.1038/nn1636; Zorrilla EP, 2002, BRAIN RES, V952, P188, DOI 10.1016/S0006-8993(02)03189-X	59	42	42	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					577	589		10.1016/j.neuron.2007.01.022	http://dx.doi.org/10.1016/j.neuron.2007.01.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296558	Bronze			2022-12-28	WOS:000245126900015
J	Lynch, DR; Gleichman, AJ				Lynch, David R.; Gleichman, Amy J.			Picking up the pieces: The roles of functional remnants of calpain-mediated proteolysis	NEURON			English	Editorial Material							ADHESION; CLEAVAGE; SUBUNIT; KINASE	Calpain-mediated cleavage of neuronal targets has long been associated with excitotoxicity and synaptic plasticity. In this issue of Neuron, two papers by Xu et al. and Abe and Takeichi explore the respective roles of mGIuR1 alpha cleavage in excitotoxicity and beta-catenin cleavage in transcriptional control. Together, these papers show the functional importance of fragments of calpain-mediated cleavage.	Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Lynch, DR (corresponding author), Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA.	lynch@pharm.med.upenn.edu		Gleichman, Amy/0000-0003-1029-4471				Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Kordasiewicz HB, 2006, HUM MOL GENET, V15, P1587, DOI 10.1093/hmg/ddl080; Sawhney RS, 2006, J BIOL CHEM, V281, P8497, DOI 10.1074/jbc.M600787200; Shumway SD, 1999, J BIOL CHEM, V274, P30874, DOI 10.1074/jbc.274.43.30874; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Wu HV, 2006, MOL NEUROBIOL, V33, P215, DOI 10.1385/MN:33:3:215; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020	12	12	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					317	319		10.1016/j.neuron.2007.01.014	http://dx.doi.org/10.1016/j.neuron.2007.01.014			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270728	Bronze			2022-12-28	WOS:000245126800002
J	Isomura, Y; Sirota, A; Ozen, S; Montgomery, S; Mizuseki, K; Henze, DA; Buzsaki, G				Isomura, Yoshikazu; Sirota, Anton; Ozen, Simal; Montgomery, Sean; Mizuseki, Kenji; Henze, Darrell A.; Buzsaki, Gyoergy			Integration and segregation of activity in entorhinal-hippocampal subregions by neocortical slow oscillations	NEURON			English	Article							LESS-THAN-1 HZ OSCILLATION; LOCAL-FIELD POTENTIALS; THALAMOCORTICAL NEURONS; NETWORK MECHANISMS; CEREBRAL-CORTEX; GUINEA-PIG; SLEEP; FREQUENCY; CELLS; BRAIN	Brain systems communicate by means of neuronal oscillations at multiple temporal and spatial scales. In anesthetized rats, we find that neocortical "slow" oscillation engages neurons in prefrontal, somatosensory, entorhinal, and subicular cortices into synchronous transitions between UP and DOWN states, with a corresponding bimodal distribution of their membrane potential. The membrane potential of hippocampal granule cells and CA3 and CA1 pyramidal cells lacked bimodality, yet it was influenced by the slow oscillation in a region-specific manner. Furthermore, in both anesthetized and naturally sleeping rats, the cortical UP states resulted in increased activity of dentate and most CA1 neurons, as well as the highest probability of ripple events. Yet, the CA3-CA1 network could self-organize into gamma bursts and occasional ripples during the DOWN state. Thus, neo/paleocortical and hippocampal networks periodically reset, self-organize, and temporally coordinate their cell assemblies via the slow oscillation.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; RIKEN Brain Sci Inst, Neural Circuit Theory, Wako, Saitama 3510198, Japan; Tokyo Metropolitan Inst Neurosci, Fuchu, Tokyo 1838526, Japan; Merck Res Labs, Neurosci Drug Discovery, West Point, PA 19486 USA	Rutgers State University Newark; Rutgers State University New Brunswick; RIKEN; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Merck & Company	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Mizuseki, Kenji/A-9214-2011; Sirota, Anton/G-1395-2011	Mizuseki, Kenji/0000-0002-1456-2149; , sukru/0000-0002-5538-6786; Montgomery, Sean/0000-0001-7370-0938; Buzsaki, Gyorgy/0000-0002-3100-4800	NIMH NIH HHS [MH54671] Funding Source: Medline; NINDS NIH HHS [NS034994, NS043157] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043157, R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; AMZICA F, 1995, J NEUROSCI, V15, P4658; Bartho P, 2004, J NEUROPHYSIOL, V92, P600, DOI 10.1152/jn.01170.2003; Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Biesold, 1990, BRAIN CHOLINERGIC SY, P3; BRAGIN A, 1995, J NEUROSCI, V15, P47; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; CHARPAK S, 1995, EUR J NEUROSCI, V7, P1548, DOI 10.1111/j.1460-9568.1995.tb01150.x; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; COWAN RL, 1994, J NEUROPHYSIOL, V71, P17, DOI 10.1152/jn.1994.71.1.17; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 2003, J NEUROPHYSIOL, V90, P1314, DOI 10.1152/jn.00116.2003; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Cunningham MO, 2006, P NATL ACAD SCI USA, V103, P5597, DOI 10.1073/pnas.0600604103; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Detari L, 1997, BRAIN RES, V759, P112, DOI 10.1016/S0006-8993(97)00252-7; Dickson CT, 2003, J NEUROPHYSIOL, V90, P39, DOI 10.1152/jn.01063.2002; Duque A, 2000, J NEUROPHYSIOL, V84, P1627, DOI 10.1152/jn.2000.84.3.1627; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fisher NI, 1995, STAT ANAL CIRCULAR D; FREEMAN JA, 1975, J NEUROPHYSIOL, V38, P369, DOI 10.1152/jn.1975.38.2.369; Friston KJ, 2000, PHILOS T R SOC B, V355, P215, DOI 10.1098/rstb.2000.0560; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2; KLOOSTERMAN F, 2003, THESIS U AMSTERDAM; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Lestienne R, 1997, J PHYSIOLOGY-PARIS, V91, P273, DOI 10.1016/S0928-4257(97)82407-2; LUCZAK A, 2006, IN PRESS P NATL ACAD; MacLean P, 1990, TRIUNE BRAIN EVOLUTI; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; MUKOVSKI M, 2006, IN PRESS CEREB CORTE; Pelletier JG, 2004, J NEUROPHYSIOL, V91, P2079, DOI 10.1152/jn.01197.2003; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sirota A, 2003, P NATL ACAD SCI USA, V100, P2065, DOI 10.1073/pnas.0437938100; Sporns O, 2000, NEURAL NETWORKS, V13, P909, DOI 10.1016/S0893-6080(00)00053-8; STERIADE M, 1993, J NEUROSCI, V13, P3284; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Timofeev I, 2001, P NATL ACAD SCI USA, V98, P1924, DOI 10.1073/pnas.041430398; TIRNOFEEV I, 2000, J PHYSIOL-PARIS, V94, P343; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Wilson CJ, 1996, J NEUROSCI, V16, P2397; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; YLINEN A, 1995, J NEUROSCI, V15, P30	66	323	328	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					871	882		10.1016/j.neuron.2006.10.023	http://dx.doi.org/10.1016/j.neuron.2006.10.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145507	Bronze			2022-12-28	WOS:000242856400014
J	Hirzel, K; Muller, U; Latal, AT; Huelsmann, S; Grudzinska, J; Seeliger, MW; Betz, H; Laube, B				Hirzel, Klaus; Mueller, Ulrike; Latal, A. Tobias; Huelsmann, Swen; Grudzinska, Joanna; Seeliger, Mathias W.; Betz, Heinrich; Laube, Bodo			Hyperekplexia phenotype of glycine receptor alpha 1 subunit mutant mice identifies Zn2+ as an essential endogenous modulator of glycinergic neurotransmission	NEURON			English	Article							ZINC-ENRICHED TERMINALS; SPINAL-CORD; SYNAPTIC ZINC; ZEN TERMINALS; RECEPTOR; POTENTIATION; RAT; BRAIN; IONS; IMMUNOHISTOCHEMISTRY	Zn2+ is thought to modulate neurotransmission by affecting currents mediated by ligand-gated ion channels and transmitter reuptake by Na+-dependent transporter systems. Here, we examined the in vivo relevance of Zn2+ neuromodulation by producing knockin mice carrying the mutation D80A in the glycine receptor (GlyR) alpha 1 subunit gene (Glra1). This substitution selectively eliminates the potentiating effect of Zn2+ on GlyR currents. Mice homozygous for Glra1(D80A) develop a severe neuromotor phenotype postnatally that resembles forms of human hyperekplexia (startle disease) caused by mutations in GlyR genes. In spinal neurons and brainstem slices from Glra1(D80A) mice, GlyR expression, synaptic localization, and basal glycinergic transmission were normal; however, potentiation of spontaneous glycinergic currents by Zn2+ was significantly impaired. Thus, the hyperekplexia phenotype of Glra1(D80A) mice is due to the loss of Zn2+ potentiation of alpha 1 subunit containing GlyRs, indicating that synaptic Zn2+ is essential for proper in vivo functioning of glycinergic neurotransmission.	Max Planck Inst Hirnforsch, Neurochem Abt, D-60528 Frankfurt, Germany; Zentrum Physiol, Abt Neurosinnesphysiol, D-37073 Gottingen, Germany; Zentrum Physiol, DFG Forschungszentrum Mol Physiol Gehirns, D-37073 Gottingen, Germany; Univ Tubingen, Retinal Electrodiagnost Res Grp, Dept Pathophysiol Vis & Neuroophthamol, D-72076 Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen	Betz, H (corresponding author), Max Planck Inst Hirnforsch, Neurochem Abt, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpih-frankfurt.mpg.de	Hülsmann, Swen/F-7169-2010	Hülsmann, Swen/0000-0001-5042-8724				ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; Baranano DE, 2001, TRENDS NEUROSCI, V24, P99, DOI 10.1016/S0166-2236(00)01716-1; BECKER CM, 1992, NEURON, V8, P283, DOI 10.1016/0896-6273(92)90295-O; BECKER CM, 1988, EMBO J, V7, P3717, DOI 10.1002/j.1460-2075.1988.tb03255.x; Becker L, 2002, J NEUROSCI, V22, P2505, DOI 10.1523/JNEUROSCI.22-07-02505.2002; Betz H, 2006, J NEUROCHEM, V97, P1600, DOI 10.1111/j.1471-4159.2006.03908.x; BLOOMENTHAL AB, 1994, MOL PHARMACOL, V46, P1156; Chandra T, 2005, NEUROSCIENCE, V134, P145, DOI 10.1016/j.neuroscience.2005.02.049; Chen CJ, 2003, NEUROCHEM INT, V42, P471, DOI 10.1016/S0197-0186(02)00154-7; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Danscher G, 2001, NEUROSCIENCE, V105, P941, DOI 10.1016/S0306-4522(01)00243-3; Doraiswamy PM, 2004, LANCET NEUROL, V3, P431, DOI 10.1016/S1474-4422(04)00809-9; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Graham BA, 2006, J NEUROSCI, V26, P4880, DOI 10.1523/JNEUROSCI.3991-05.2006; Harvey RJ, 1999, J PHYSIOL-LONDON, V520, P53, DOI 10.1111/j.1469-7793.1999.00053.x; Haverkamp S, 2004, J COMP NEUROL, V477, P399, DOI 10.1002/cne.20267; Jo SM, 2000, BRAIN RES, V870, P163, DOI 10.1016/S0006-8993(00)02418-5; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kay AR, 2006, TRENDS NEUROSCI, V29, P200, DOI 10.1016/j.tins.2006.02.004; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Laube B, 2002, EUR J NEUROSCI, V16, P1025, DOI 10.1046/j.1460-9568.2002.02170.x; Laube B, 2000, J PHYSIOL-LONDON, V522, P215, DOI 10.1111/j.1469-7793.2000.t01-1-00215.x; LAUBE B, 1995, J PHYSIOL-LONDON, V483, P613, DOI 10.1113/jphysiol.1995.sp020610; Laube B, 2002, TRENDS PHARMACOL SCI, V23, P519, DOI 10.1016/S0165-6147(02)02138-7; Lee JY, 2000, J NEUROSCI, V20; Li Y, 2001, J NEUROPHYSIOL, V86, P2597, DOI 10.1152/jn.2001.86.5.2597; Li Y.V., 2003, SCI STKE, V182, P19; Liguz-Lecznar M, 2005, BRAIN RES BULL, V66, P106, DOI 10.1016/j.brainresbull.2005.03.019; Lu YM, 2000, SYNAPSE, V38, P187, DOI 10.1002/1098-2396(200011)38:2<187::AID-SYN10>3.0.CO;2-R; Luo DG, 2002, BRAIN RES BULL, V58, P461, DOI 10.1016/S0361-9230(02)00818-3; Lynch JW, 1998, J NEUROCHEM, V71, P2159; Lynch JW, 2004, PHYSIOL REV, V84, P1051, DOI 10.1152/physrev.00042.2003; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Paoletti P, 1997, J NEUROSCI, V17, P5711; Plappert CF, 2001, BEHAV BRAIN RES, V125, P183, DOI 10.1016/S0166-4328(01)00299-6; Qian J, 2005, J PHYSIOL-LONDON, V566, P747, DOI 10.1113/jphysiol.2005.089276; Schofield PR, 2002, ADV NEUROL, V89, P263; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Suwa H, 2001, J NEUROPHYSIOL, V85, P912, DOI 10.1152/jn.2001.85.2.912; Ugarte M, 2001, PROG NEUROBIOL, V64, P219, DOI 10.1016/S0301-0082(00)00057-5; Velazquez RA, 1999, J NEUROSCI, V19, P2288; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Wang ZY, 2002, NEUROSCI LETT, V321, P37, DOI 10.1016/S0304-3940(01)02560-5; Wang ZY, 2001, BRAIN RES, V921, P165, DOI 10.1016/S0006-8993(01)03114-6	47	104	108	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					679	690		10.1016/j.neuron.2006.09.035	http://dx.doi.org/10.1016/j.neuron.2006.09.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114051	hybrid			2022-12-28	WOS:000242413100014
J	Fonseca, R; Vabulas, RM; Hartl, FU; Bonhoeffer, T; Nagerl, UV				Fonseca, Rosalina; Vabulas, Ramunas M.; Hartl, F. Ulrich; Bonhoeffer, Tobias; Naegerl, U. Valentin			A balance of protein synthesis and proteasome-dependent degradation determines the maintenance of LTP	NEURON			English	Article							LONG-TERM POTENTIATION; UBIQUITIN SYSTEM; LATE-PHASE; MEMORY; FACILITATION; PROTEOLYSIS; ACTIVATION; MECHANISMS; INHIBITORS; TURNOVER	Long-lasting changes in synaptic strength are thought to play a pivotal role in activity-dependent plasticity and memory. There is ample evidence indicating that in hippocampal long-term potentiation (LTP) the synthesis of new proteins is crucial for enduring changes. However, whether protein degradation also plays a role in this process has only recently begun to receive attention. Here, we examine the effects of blocking protein degradation on LTP. We show that pharmacological inhibition of proteasome-dependent protein degradation, just like inhibition of protein synthesis, disrupts expression of late (L-)LTP. However, when protein degradation and protein synthesis are inhibited at the same time, LTP is restored to control levels, calling into question the commonly held hypothesis that synthesis of new proteins is indispensable for L-LTP. Instead, these findings point to a more facetted model, in which L-LTP is determined by the combined action of synthesis and degradation of plasticity proteins.	Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Munich, Germany; Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Munich, Germany	Max Planck Society; Max Planck Society	Bonhoeffer, T (corresponding author), Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, Klopferspitz 18, D-82152 Munich, Germany.	tobias.bonhoeffer@neuro.mpg.de; naegerl@neuro.mpg.de	Nägerl, Valentin/AAD-2575-2022; Vabulas, R. Martin/D-3506-2011; Bonhoeffer, Tobias/B-9481-2009; Fonseca, Rosalina/I-1715-2012; Hartl, F. Ulrich/Y-8206-2019; Fonseca, Rosalina/AAS-1117-2020	Nägerl, Valentin/0000-0001-6831-9008; Bonhoeffer, Tobias/0000-0001-7897-6634; Fonseca, Rosalina/0000-0003-0884-6441				Ageta H, 2001, J BIOL CHEM, V276, P15893, DOI 10.1074/jbc.M011097200; Ageta H, 2001, MOL BRAIN RES, V97, P186, DOI 10.1016/S0169-328X(01)00303-5; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bradshaw KD, 2003, EUR J NEUROSCI, V18, P3150, DOI 10.1111/j.1460-9568.2003.03054.x; Calixto E, 2003, J NEUROSCI, V23, P4842; Cammalleri M, 2003, P NATL ACAD SCI USA, V100, P14368, DOI 10.1073/pnas.2336098100; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; CHAIN DG, 1995, J NEUROSCI, V15, P7592; Chain DG, 1999, NEURON, V22, P147, DOI 10.1016/S0896-6273(00)80686-8; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; DiAntonio A, 2004, ANNU REV NEUROSCI, V27, P223, DOI 10.1146/annurev.neuro.27.070203.144317; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dick LR, 1996, J BIOL CHEM, V271, P7273, DOI 10.1074/jbc.271.13.7273; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Hegde AN, 1997, CELL, V89, P115, DOI 10.1016/S0092-8674(00)80188-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hershko A, 2005, CELL DEATH DIFFER, V12, P1191, DOI 10.1038/sj.cdd.4401702; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Patrick GN, 2006, CURR OPIN NEUROBIOL, V16, P90, DOI 10.1016/j.conb.2006.01.007; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; STANTON PK, 1984, J NEUROSCI, V4, P3080; Yi JJ, 2005, NEURON, V47, P629, DOI 10.1016/j.neuron.2005.07.008; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	35	225	227	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					239	245		10.1016/j.neuron.2006.08.015	http://dx.doi.org/10.1016/j.neuron.2006.08.015			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046687	Bronze			2022-12-28	WOS:000241799900005
J	Pinheiro, EM; Gertler, FB				Pinheiro, Elaine Maria; Gertler, Frank B.			Nervous Rac: DOCK7 regulation of axon formation	NEURON			English	Editorial Material							MICROTUBULES; POLARITY; PROTEINS; GEFS		MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Pinheiro, EM (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; FERREIRA A, 1989, DEV BRAIN RES, V49, P215, DOI 10.1016/0165-3806(89)90023-0; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Watabe-Uchida M, 2006, NEURON, V51, P727, DOI 10.1016/j.neuron.2006.07.020; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; YU WQ, 1994, J NEUROSCI, V14, P2818	12	8	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					674	676		10.1016/j.neuron.2006.08.020	http://dx.doi.org/10.1016/j.neuron.2006.08.020			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982410	Bronze, Green Published			2022-12-28	WOS:000240997900003
J	Miwa, JM; Stevens, TR; King, SL; Caldarone, BJ; Ibanez-Tallon, I; Cheng, X; Fitzsimonds, RM; Pavildes, C; Lester, HA; Picciotto, MR; Heintz, N				Miwa, Julie M.; Stevens, Tanya R.; King, Sarah L.; Caldarone, Barbara J.; Ibanez-Tallon, Ines; Cheng Xiao; Fitzsimonds, Reiko Maki; Pavildes, Constantine; Lester, Henry A.; Picciotto, Marina R.; Heintz, Nathaniel			The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo	NEURON			English	Article							MIDBRAIN DOPAMINE AREAS; FRONTAL-LOBE EPILEPSY; BRAIN REWARD AREAS; INDUCED SEIZURES; INCREASED SENSITIVITY; CA2+ PERMEABILITY; MICE; CALCIUM; DESENSITIZATION; DISEASE	Nicotinic acetylcholine receptors (nAChRs) affect a wide array of biological processes, including learning and memory, attention, and addiction. lynx1, the founding member of a family of mammalian prototoxins, modulates nAChR function in vitro by altering agonist sensitivity and desensitization kinetics. Here we demonstrate, through the generation of lynx1 null mutant mice, that lynx1 modulates nAChR signaling in vivo. Its loss decreases the EC50 for nicotine by similar to 10-fold, decreases receptor desensitization, elevates intracellular calcium levels in response to nicotine, and enhances synaptic efficacy. lynx1 null mutant mice exhibit enhanced performance in specific tests of learning and memory. Consistent with reports that mutations resulting in hyperactivation of nAChRs can lead to neurodegeneration, aging lynx1 null mutant mice exhibit a vacuolating degeneration that is exacerbated by nicotine and ameliorated by null mutations in nAChRs. We conclude that lynx1 functions as an allosteric modulator of nAChR function in vivo, balancing neuronal activity and survival in the CNS.	Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA; Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; Rockefeller Univ, Dept Neuroendocrinol, New York, NY 10021 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Howard Hughes Medical Institute; Rockefeller University; Yale University; Yale University; Rockefeller University; California Institute of Technology	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10021 USA.	heintz@mail.rockefeller.edu	Xiao, Cheng/O-5696-2015; Picciotto, Marina/F-8747-2012	Xiao, Cheng/0000-0001-9649-7450; Picciotto, Marina/0000-0002-4404-1280; Miwa, Julie/0000-0002-4418-3756; Fitzsimonds, Reiko/0000-0002-0576-9885; King, Sarah/0000-0002-7412-9558	NCI NIH HHS [CA 09673] Funding Source: Medline; NIAAA NIH HHS [AA 15632] Funding Source: Medline; NIDA NIH HHS [DA 15241, DA 00436, DA 17279] Funding Source: Medline; NINDS NIH HHS [R21 NS 047751] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS047751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA015632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017279] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abrous DN, 2002, J NEUROSCI, V22, P3656; Berg DK, 2002, J NEUROBIOL, V53, P512, DOI 10.1002/neu.10116; Bertrand S, 1998, BRIT J PHARMACOL, V125, P751, DOI 10.1038/sj.bjp.0702154; Broide RS, 2002, MOL PHARMACOL, V61, P695, DOI 10.1124/mol.61.3.695; Buisson B, 2001, J NEUROSCI, V21, P1819, DOI 10.1523/JNEUROSCI.21-06-01819.2001; Chimienti F, 2003, HUM MOL GENET, V12, P3017, DOI 10.1093/hmg/ddg320; Chorvat R J, 1998, Expert Opin Investig Drugs, V7, P499, DOI 10.1517/13543784.7.4.499; Chou JH, 2001, GENETICS, V157, P211; Clarke G, 2005, BRAIN RES BULL, V65, P59, DOI 10.1016/j.brainresbull.2004.11.009; CLARKE PBS, 1983, BRIT J PHARMACOL, V78, P329, DOI 10.1111/j.1476-5381.1983.tb09398.x; Crawley Jacqueline N., 2007, WHATS WRONG MY MOUSE; Dajas-Bailador FA, 2000, NEUROPHARMACOLOGY, V39, P2799, DOI 10.1016/S0028-3908(00)00127-1; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; Dani JA, 2000, EUR J PHARMACOL, V393, P31, DOI 10.1016/S0014-2999(00)00003-0; Dani JA, 2001, BIOL PSYCHIAT, V49, P166, DOI 10.1016/S0006-3223(00)01011-8; Dittman JS, 2000, J NEUROSCI, V20, P1374; Fonck C, 2005, J NEUROSCI, V25, P11396, DOI 10.1523/JNEUROSCI.3597-05.2005; Fonck C, 2003, J NEUROSCI, V23, P2582; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Gould TJ, 1999, BEHAV BRAIN RES, V102, P31, DOI 10.1016/S0166-4328(98)00157-0; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; Kaneko WM, 1998, DEV BRAIN RES, V105, P141, DOI 10.1016/S0165-3806(97)00160-0; Kelton MC, 2000, BRAIN COGNITION, V43, P274; King SL, 2004, NEUROPHARMACOLOGY, V47, P132, DOI 10.1016/j.neuropharm.2004.06.024; Klein RC, 2005, J PHYSIOL-LONDON, V568, P881, DOI 10.1113/jphysiol.2005.096081; Kuryatov A, 1997, J NEUROSCI, V17, P9035; Labarca C, 2001, P NATL ACAD SCI USA, V98, P2786, DOI 10.1073/pnas.041582598; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Maelicke A, 2000, BEHAV BRAIN RES, V113, P199, DOI 10.1016/S0166-4328(00)00214-X; Maggi L, 2004, J PHYSIOL-LONDON, V559, P863, DOI 10.1113/jphysiol.2004.067041; Mann EO, 2003, J PHYSIOL-LONDON, V551, P539, DOI 10.1113/jphysiol.2003.045492; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; MARKS MJ, 1992, J NEUROSCI, V12, P2765; MARKS MJ, 1994, J NEUROCHEM, V63, P2125, DOI 10.1046/j.1471-4159.1994.63062125.x; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; McLeod JR, 1998, J NEUROPHYSIOL, V80, P2688, DOI 10.1152/jn.1998.80.5.2688; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Orb S, 2004, PHYSIOL GENOMICS, V18, P299, DOI 10.1152/physiolgenomics.00012.2004; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; Pereira EFR, 2002, J NEUROBIOL, V53, P479, DOI 10.1002/neu.10146; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Picciotto MR, 2000, NEUROPSYCHOPHARMACOL, V22, P451, DOI 10.1016/S0893-133X(99)00146-3; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; Quick MW, 2002, J NEUROBIOL, V53, P457, DOI 10.1002/neu.10109; RATHOUZ MM, 1994, J NEUROSCI, V14, P6935; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; Schafe GE, 2001, TRENDS NEUROSCI, V24, P540, DOI 10.1016/S0166-2236(00)01969-X; Sekhon HS, 2005, CELL TISSUE RES, V320, P287, DOI 10.1007/s00441-005-1077-9; Sharma G, 2003, NEURON, V38, P929, DOI 10.1016/S0896-6273(03)00322-2; Sheffield EB, 2000, NEUROPHARMACOLOGY, V39, P2591, DOI 10.1016/S0028-3908(00)00138-6; Shinnick-Gallagher P, 2003, ANN NY ACAD SCI, V985, P135; Stevens TR, 2003, J NEUROSCI, V23, P10093; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Trinh NH, 2003, JAMA-J AM MED ASSOC, V289, P210, DOI 10.1001/jama.289.2.210; Truong A, 2001, MOL BRAIN RES, V96, P68, DOI 10.1016/S0169-328X(01)00268-6; Tsuneki H, 2000, EUR J NEUROSCI, V12, P2475, DOI 10.1046/j.1460-9568.2000.00138.x; *US DEP HHS, 1988, HLTH CONS SMOK NIC A; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Whiteaker P, 1998, MOL PHARMACOL, V53, P950; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597; Zoli M, 1999, EMBO J, V18, P1235, DOI 10.1093/emboj/18.5.1235	65	127	133	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					587	600		10.1016/j.neuron.2006.07.025	http://dx.doi.org/10.1016/j.neuron.2006.07.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950157	Bronze			2022-12-28	WOS:000240623400008
J	Jack, AI; Shulman, GL; Snyder, AZ; McAvoy, M; Corbetta, M				Jack, Anthony I.; Shulman, Gordon L.; Snyder, Abraham Z.; McAvoy, Mark; Corbetta, Maurizio			Separate modulations of human V1 associated with spatial attention and task structure	NEURON			English	Article							STRIATE CORTEX; FRONTAL-CORTEX; VISUAL-CORTEX; PERFORMANCE; INTEGRATION; RESPONSES; SOFTWARE; SYSTEM; AREAS	Functional magnetic resonance imaging (fMRI) was used while normal human volunteers engaged in simple detection and discrimination tasks, revealing separable modulations of early visual cortex associated with spatial attention and task structure. Both modulations occur even when there is no change in sensory stimulation. The modulation due to spatial attention is present throughout the early visual areas V1, V2, V3, and VP, and varies with the attended location. The task structure activations are strongest in V1 and are greater in regions that represent more peripheral parts of the visual field. Control experiments demonstrate that the task structure activations cannot be attributed to visual, auditory, or somatosensory processing, the motor response for the detection/discrimination judgment, or oculomotor responses such as blinks or saccades. These findings demonstrate that early visual areas are modulated by at least two types of endogenous signals, each with distinct cortical distributions.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020; Jack, Anthony Ian/AAJ-7153-2021; Jack, Anthony/A-8929-2008	Jack, Anthony Ian/0000-0001-9613-3964; Jack, Anthony/0000-0001-9613-3964; CORBETTA, MAURIZIO/0000-0001-8295-3304	NATIONAL EYE INSTITUTE [T32EY013360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER; NEI NIH HHS [5-T32-EY13360-04] Funding Source: Medline; NIMH NIH HHS [R01 MH71920-06] Funding Source: Medline; NINDS NIH HHS [R01 NS48013] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Clavagnier S, 2004, COGN AFFECT BEHAV NE, V4, P117, DOI 10.3758/CABN.4.2.117; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; DOTY RW, 1983, J COMP NEUROL, V218, P159, DOI 10.1002/cne.902180204; Falchier A, 2002, J NEUROSCI, V22, P5749; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Fujii N, 2005, P NATL ACAD SCI USA, V102, P9032, DOI 10.1073/pnas.0503541102; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GRAHAM J, 1982, EXP BRAIN RES, V47, P1; Grossberg S, 1999, CONSCIOUS COGN, V8, P1, DOI 10.1006/ccog.1998.0372; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAdams CJ, 2005, J NEUROSCI, V25, P11023, DOI 10.1523/JNEUROSCI.2904-05.2005; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Neisser U., 1967, COGNITIVE PSYCHOL; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PETERS A, 1994, CEREB CORTEX, V4, P215, DOI 10.1093/cercor/4.3.215; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sadato N, 1998, BRAIN, V121, P1213, DOI 10.1093/brain/121.7.1213; Sarter M, 2005, BRAIN RES REV, V48, P98, DOI 10.1016/j.brainresrev.2004.08.006; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Shulman GL, 2003, J NEUROPHYSIOL, V90, P3384, DOI 10.1152/jn.00343.2003; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Van Essen DC, 2005, NEUROIMAGE, V28, P635, DOI 10.1016/j.neuroimage.2005.06.058; Van Essen DC, 2001, J AM MED INFORM ASSN, V8, P443, DOI 10.1136/jamia.2001.0080443; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828	37	89	89	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					135	147		10.1016/j.neuron.2006.06.003	http://dx.doi.org/10.1016/j.neuron.2006.06.003			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815338	Bronze			2022-12-28	WOS:000239037700016
J	Dulac, C				Dulac, Catherine			Sparse encoding of natural scents	NEURON			English	Editorial Material							COMPLEX STIMULI; MAP	Natural scents are mixtures of tens to hundreds of individual chemical compounds. While previous studies have investigated how the olfactory bulb responds to simple odorants, how the nose and the brain respond to and interpret complex mixtures is less clear. In a paper in this issue of Neuron, Lin et al. combined gas chromatography and intrinsic signal imaging to examine the responses of individual olfactory bulb glomeruli in the mouse to natural odors and their component parts.	Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Dulac, C (corresponding author), Harvard Univ, Howard Hughes Med Inst, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.			Dulac, Catherine/0000-0001-5024-5418				Kayser C, 2004, CURR OPIN NEUROBIOL, V14, P468, DOI 10.1016/j.conb.2004.06.002; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo MM, 2004, CURR OPIN NEUROBIOL, V14, P428, DOI 10.1016/j.conb.2004.07.001; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McGee H, 2004, FLAVORING PLANTS HER; Meister M, 2001, J NEUROSCI, V21, P1351; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Nelken I, 2004, CURR OPIN NEUROBIOL, V14, P474, DOI 10.1016/j.conb.2004.06.005; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Rust NC, 2005, NAT NEUROSCI, V8, P1647, DOI 10.1038/nn1606; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wrangham R, 2003, COMP BIOCHEM PHYS A, V136, P35, DOI 10.1016/S1095-6433(03)00020-5	14	8	8	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					816	818		10.1016/j.neuron.2006.06.002	http://dx.doi.org/10.1016/j.neuron.2006.06.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772164	Bronze			2022-12-28	WOS:000238589500003
J	Suzuki, WA				Suzuki, WA			Encoding new episodes and making them stick	NEURON			English	Review							HIPPOCAMPAL-NEURONS; MEMORY; COMPRESSION; SEQUENCES; REPLAY	How do we encode, store, and retrieve new episodic memories, and what are the computations performed by the hippocampus during this process? One system that has been used to model the brain basis of episodic memory in humans is the study of spatial navigation by path integration in rodents. Here I discuss three exciting new findings focused on encoding or replay of spatial sequences in the rat hippocampus. These findings not only provide important new insight into the computations associated with encoding and consolidation of spatial trajectories, but may also have implications for understanding key aspects of human episodic memory.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Suzuki, WA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	wendy@cns.nyu.edu						Bayley PJ, 2005, NEURON, V46, P799, DOI 10.1016/j.neuron.2005.04.034; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; Shapiro ML, 2006, P NATL ACAD SCI USA, V103, P4287, DOI 10.1073/pnas.0508688103; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Squire LR, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P691; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605	21	27	27	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					19	21		10.1016/j.neuron.2006.03.029	http://dx.doi.org/10.1016/j.neuron.2006.03.029			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600852	Bronze			2022-12-28	WOS:000236811300007
J	Summerfield, JJ; Lepsien, J; Gitelman, DR; Mesulam, MM; Nobre, AC				Summerfield, JJ; Lepsien, J; Gitelman, DR; Mesulam, MM; Nobre, AC			Orienting attention based on long-term memory experience	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; SPATIAL ATTENTION; SCENE PERCEPTION; EPISODIC MEMORY; NATURAL SCENES; PARAHIPPOCAMPAL CORTICES; VISUAL REPRESENTATIONS; MENTAL REPRESENTATIONS; HUMAN HIPPOCAMPUS; NEURAL SYSTEMS	Attentional Orienting and memory are intrinsically bound, but their interaction has rarely been investigated. Here we introduce an experimental paradigm using naturalistic scenes to investigate how long-term memory can guide spatial attention and thereby enhance identification of events in the perceptual domain. In the task, stable memories of objects embedded within complex scenes guide spatial orienting. We compared the behavioral effects and neural systems of memory-guided orienting with those in a more traditional attention-orienting task in which transient spatial cues guide attention. Memory-guided attention operated within surprisingly short intervals and conferred reliable and sizeable advantages for detection of objects embedded in scenes. Event-related functional magnetic resonance imaging showed that memory-guided attention involves the interaction between brain areas participating in retrieval of memories for spatial context with the parietal-frontal network for visual spatial orienting. Activity in the hippocampus was specifically engaged in memory-guided spatial attention and correlated with the ensuing behavioral advantage.	Univ Oxford, Dept Expt Psychol, Brain & Cognit Lab, Oxford OX1 3UD, England; Northwestern Univ, Sch Med, Cognit Neurol & Alzheimers Dis Ctr, Chicago, IL 60611 USA	University of Oxford; Northwestern University	Nobre, AC (corresponding author), Univ Oxford, Dept Expt Psychol, Brain & Cognit Lab, S Parks Rd, Oxford OX1 3UD, England.	kia.nobre@psy.ox.ac.uk	Gitelman, Darren R/B-8292-2013	Gitelman, Darren R/0000-0001-6057-5605; Nobre, Anna Christina/0000-0001-5762-2802				Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Bar M, 2003, NEURON, V38, P347, DOI 10.1016/S0896-6273(03)00167-3; Bar M, 2004, NAT REV NEUROSCI, V5, P617, DOI 10.1038/nrn1476; Becker MW, 2002, PSYCHON B REV, V9, P744, DOI 10.3758/BF03196330; BIEDERMAN I, 1982, COGNITIVE PSYCHOL, V14, P143, DOI 10.1016/0010-0285(82)90007-X; BIEDERMAN I, 1972, J EXP PSYCHOL, V93, P219, DOI 10.1037/h0032511; Bohbot VD, 2004, NEUROPSYCHOLOGY, V18, P418, DOI 10.1037/0894-4105.18.3.418; Bohbot VD, 1998, NEUROPSYCHOLOGIA, V36, P1217, DOI 10.1016/S0028-3932(97)00161-9; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 2000, BRAIN, V123, P620, DOI 10.1093/brain/123.3.620; Burgess N, 2001, NEUROIMAGE, V14, P439, DOI 10.1006/nimg.2001.0806; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Chun MM, 1998, COGNITIVE PSYCHOL, V36, P28, DOI 10.1006/cogp.1998.0681; Chun MM, 2003, J EXP PSYCHOL LEARN, V29, P224, DOI 10.1037/0278-7393.29.2.224; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Coull JT, 1998, J NEUROSCI, V18, P7426; Duzel E, 2003, J NEUROSCI, V23, P9439; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; GAFFAN D, 1994, EXP BRAIN RES, V99, P411; Gaffan D, 1998, EXP BRAIN RES, V123, P201, DOI 10.1007/s002210050562; Giesbrecht B, 2003, NEUROIMAGE, V19, P496, DOI 10.1016/S1053-8119(03)00162-9; Giesbrecht Barry, 2005, P63, DOI 10.1016/B978-012375731-9/50015-X; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Gitelman DR, 2002, BEHAV RES METH INS C, V34, P605, DOI 10.3758/BF03195488; Hayes SM, 2004, BEHAV NEUROSCI, V118, P885, DOI 10.1037/0735-7044.118.5.885; Henderson JM, 1999, ANNU REV PSYCHOL, V50, P243, DOI 10.1146/annurev.psych.50.1.243; Hollingworth A, 2004, J EXP PSYCHOL HUMAN, V30, P519, DOI 10.1037/0096-1523.30.3.519; Hollingworth A, 2001, PSYCHON B REV, V8, P761, DOI 10.3758/BF03196215; Irwin DE, 2002, PERCEPT PSYCHOPHYS, V64, P882, DOI 10.3758/BF03196793; Janzen G, 2004, NAT NEUROSCI, V7, P673, DOI 10.1038/nn1257; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kohler S, 2002, HIPPOCAMPUS, V12, P718, DOI 10.1002/hipo.10077; Lee ACH, 2005, NEUROPSYCHOLOGIA, V43, P1, DOI 10.1016/j.neuropsychologia.2004.07.017; Lepsien J, 2005, NEUROIMAGE, V26, P733, DOI 10.1016/j.neuroimage.2005.02.026; Maguire EA, 1998, J COGNITIVE NEUROSCI, V10, P61, DOI 10.1162/089892998563789; Maguire EA, 2001, REV NEUROL-FRANCE, V157, P791; Maguire EA, 2001, SCAND J PSYCHOL, V42, P225, DOI 10.1111/1467-9450.00233; Manns JR, 2001, HIPPOCAMPUS, V11, P776, DOI 10.1002/hipo.1093; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MILNER AD, 1993, PROG BRAIN RES, V95, P317, DOI 10.1016/S0079-6123(08)60379-9; Mishkin M, 1998, HIPPOCAMPUS, V8, P212; Moores E, 2003, NAT NEUROSCI, V6, P182, DOI 10.1038/nn996; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Nobre AC, 2004, J COGNITIVE NEUROSCI, V16, P363, DOI 10.1162/089892904322926700; Nobre AC, 2001, NEUROSCI BIOBEHAV R, V25, P477, DOI 10.1016/S0149-7634(01)00028-8; Nobre AC, 2004, COGNITIVE NEUROSCIEN, P157; O'Regan JK, 2001, BEHAV BRAIN SCI, V24, P939, DOI 10.1017/S0140525X01000115; PALMER RD, 1975, J CLIN PSYCHOL, V31, P437, DOI 10.1002/1097-4679(197507)31:3<437::AID-JCLP2270310313>3.0.CO;2-F; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rensink RA, 2002, ANNU REV PSYCHOL, V53, P245, DOI 10.1146/annurev.psych.53.100901.135125; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rolls ET, 2003, J NEUROSCI, V23, P339; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; Rosenbaum RS, 2000, NAT NEUROSCI, V3, P1044, DOI 10.1038/79867; Spiers HJ, 2004, NAT NEUROSCI, V7, P572, DOI 10.1038/nn0604-572; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1994, NEUROREPORT, V5, P2525, DOI 10.1097/00001756-199412000-00030; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; VANHOESEN GW, 1981, J COMP NEUROL, V199, P205, DOI 10.1002/cne.901990205; Wolfe JM, 1999, NATURE, V400, P813, DOI 10.1038/23579; Yantis S, 2002, NAT NEUROSCI, V5, P995, DOI 10.1038/nn921	72	176	178	2	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					905	916		10.1016/j.neuron.2006.01.021	http://dx.doi.org/10.1016/j.neuron.2006.01.021			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	024WQ	16543137	Bronze			2022-12-28	WOS:000236227500017
J	Simard, AR; Soulet, D; Gowing, G; Julien, JP; Rivest, S				Simard, AR; Soulet, D; Gowing, G; Julien, JP; Rivest, S			Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease	NEURON			English	Article							APPSW TRANSGENIC MICE; AMYLOID-BETA-PEPTIDE; CELLS; BRAIN; ORIGIN; ALPHA; NEUROPROTECTION; GLUCOCORTICOIDS; PHAGOCYTOSIS; PROGENITORS	Microglia are the immune cells of the brain. Here we show a massive infiltration of highly ramified and elongated microglia within the core of amyloid plaques in transgenic mouse models of Alzheimer's disease (AD). Many of these cells originate from the bone marrow, and the beta-amyloid-40 and -42 isoforms are able to trigger this chemoattraction. These newly recruited cells also exhibit a specific immune reaction to both exogenous and enclogenous beta-amyloid in the brain. Creation of a new AD transgenic mouse that expresses the thymidine kinase protein under the control of the CD11b promoter allowed us to show that blood-derived microglia and not their resident counterparts have the ability to eliminate amyloid deposits by a cell-specific phagocytic mechanism. These bone marrow-derived microglia are thus very efficient in restricting amyloid deposits. Therapeutic strategies aiming to improve their recruitment could potentially lead to a new powerful tool for the elimination of toxic senile plaques.	CHU Laval, Ctr Rech, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Dept Anat & Physiol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University	Rivest, S (corresponding author), CHU Laval, Ctr Rech, 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	serge.rivest@crchul.ulaval.ca	Simard, Alain/E-1493-2013; Soulet, Denis/P-4940-2019; Soulet, Denis/E-8677-2011	Simard, Alain/0000-0002-3499-6235; Rivest, Serge/0000-0002-6082-770X; Soulet, Denis/0000-0002-0937-7061				Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Anthony JC, 2000, NEUROLOGY, V54, P2066, DOI 10.1212/WNL.54.11.2066; Arnett HA, 2001, NAT NEUROSCI, V4, P1116, DOI 10.1038/nn738; BRINSTER RL, 1981, SCIENCE, V211, P396, DOI 10.1126/science.7194505; DICKSON DW, 1988, AM J PATHOL, V132, P86; Frautschy SA, 1998, AM J PATHOL, V152, P307; Giulian D, 1996, J NEUROSCI, V16, P6021; Gowing G, 2006, GLIA, V53, P331, DOI 10.1002/glia.20288; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Heppner FL, 2005, NAT MED, V11, P146, DOI 10.1038/nm1177; Hess DC, 2004, EXP NEUROL, V186, P134, DOI 10.1016/j.expneurol.2003.11.005; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; ITAGAKI S, 1989, J NEUROIMMUNOL, V24, P173, DOI 10.1016/0165-5728(89)90115-X; Kaur C, 2001, MICROSC RES TECHNIQ, V54, P2, DOI 10.1002/jemt.1114; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kukar T, 2005, NAT MED, V11, P545, DOI 10.1038/nm1235; Laflamme N, 2003, EUR J IMMUNOL, V33, P1127, DOI 10.1002/eji.200323821; Laflamme N, 1999, J NEUROCHEM, V73, P309, DOI 10.1046/j.1471-4159.1999.0730309.x; Liu Y, 2005, BRAIN, V128, P1778, DOI 10.1093/brain/awh531; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Nadeau S, 2003, J NEUROSCI, V23, P5536, DOI 10.1523/jneurosci.23-13-05536.2003; Nadeau S, 2002, J IMMUNOL, V169, P3370, DOI 10.4049/jimmunol.169.6.3370; Nguyen MD, 2002, NAT REV NEUROSCI, V3, P216, DOI 10.1038/nrn752; Nussbaum RL, 2003, NEW ENGL J MED, V348, P1356, DOI 10.1056/NEJM2003ra020003; PERLMUTTER LS, 1992, J NEUROSCI RES, V33, P549, DOI 10.1002/jnr.490330407; Priller J, 2001, NAT MED, V7, P1356, DOI 10.1038/nm1201-1356; Rogers J, 2002, GLIA, V40, P260, DOI 10.1002/glia.10153; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Sheng JG, 1997, ACTA NEUROPATHOL, V94, P1, DOI 10.1007/s004010050664; Simard AR, 2004, FASEB J, V18, P998, DOI 10.1096/fj.04-1517fje; Simard AR, 2004, NEUROREPORT, V15, P2305, DOI 10.1097/00001756-200410250-00001; Stewart WF, 1997, NEUROLOGY, V48, P626, DOI 10.1212/WNL.48.3.626; Turrin NP, 2006, J NEUROSCI, V26, P143, DOI 10.1523/JNEUROSCI.4032-05.2006; Tzeng SF, 1999, NEUROREPORT, V10, P2287, DOI 10.1097/00001756-199908020-00012; Walker DG, 2005, J NEUROSCI RES, V81, P412, DOI 10.1002/jnr.20484; Wegiel J, 2004, BRAIN RES, V1022, P19, DOI 10.1016/j.brainres.2004.06.058; Wegiel J, 2003, ACTA NEUROPATHOL, V105, P393, DOI 10.1007/s00401-002-0660-3; Wegiel J, 2001, NEUROBIOL AGING, V22, P49, DOI 10.1016/S0197-4580(00)00181-0; Yip Agustin G, 2005, BMC Geriatr, V5, P2, DOI 10.1186/1471-2318-5-2	40	945	993	0	73	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					489	502		10.1016/j.neuron.2006.01.022	http://dx.doi.org/10.1016/j.neuron.2006.01.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476660	Bronze			2022-12-28	WOS:000235643800004
J	Cheer, JF; Aragona, BJ; Heien, MLAV; Seipel, AT; Carelli, RM; Wightman, RM				Cheer, Joseph F.; Aragona, Brandon J.; Heien, Michael L. A. V.; Seipel, Andrew T.; Carelli, Regina M.; Wightman, R. Mark			Coordinated accumbal dopamine release and neural activity drive goal-directed behavior	NEURON			English	Article							MEDIAL FOREBRAIN-BUNDLE; INTRACRANIAL SELF-STIMULATION; COCAINE-SEEKING BEHAVIOR; NUCLEUS-ACCUMBENS; NEOSTRIATAL NEURONS; PREFRONTAL CORTEX; DRUG-ADDICTION; D1 RECEPTORS; REWARD; RAT	Intracranial self-stimulation (ICSS) activates the neural pathways that mediate reward, including dopaminergic terminal areas such as the nucleus accumbens (NAc). However, a direct role of dopamine in ICSS-mediated reward has been questioned. Here, simultaneous voltammetric and electrophysiological recordings from the same electrode reveal that, at certain sites, the onset of anticipatory dopamine surges and changes in neuronal firing patterns during ICSS are coincident, whereas sites lacking dopamine changes also lack patterned firing. Intrashell microinfusion of a D1, but not a D2 receptor antagonist, blocks ICSS. An iontophoresis approach was implemented to explore the effect of dopamine antagonists on firing patterns without altering behavior. Similar to the microinfusion experiments, ICSS-related firing is selectively attenuated following D1 receptor blockade. This work establishes a temporal link between anticipatory rises of dopamine and firing patterns in the NAc shell during ICSS and suggests that they may play a similar role with natural rewards and during drug self-ad ministration.	Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Psychol, Chapel Hill, NC 27599 USA; Univ N Carolina, Neurobiol Curriculum, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Wightman, RM (corresponding author), Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA.	rmw@unc.edu	Heien, Michael/A-4731-2009; Cheer, Joseph F/J-6102-2014	Heien, Michael/0000-0001-5164-9596; Cheer, Joseph F/0000-0001-5086-7559	NIDA NIH HHS [DA 10900, DA 017318] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017318, R01DA010900] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Arbuthnott GW, 2007, TRENDS NEUROSCI, V30, P62, DOI 10.1016/j.tins.2006.12.003; ARMSTRONGJAMES M, 1980, NATURE, V288, P181, DOI 10.1038/288181a0; Bassareo V, 2007, PSYCHOPHARMACOLOGY, V191, P689, DOI 10.1007/s00213-006-0560-7; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BIELAJEW C, 1986, J NEUROSCI, V6, P919; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; Carelli RM, 2000, J NEUROSCI, V20, P4255; Cheer JF, 2005, P NATL ACAD SCI USA, V102, P19150, DOI 10.1073/pnas.0509607102; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Di Chiara G, 2007, CURR OPIN PHARMACOL, V7, P69, DOI 10.1016/j.coph.2006.11.003; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Fenu S, 2001, J NEUROSCI, V21, P6897, DOI 10.1523/JNEUROSCI.21-17-06897.2001; Gardner EL, 2005, PHARMACOL BIOCHEM BE, V81, P263, DOI 10.1016/j.pbb.2005.01.032; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Heien MLAV, 2005, P NATL ACAD SCI USA, V102, P10023, DOI 10.1073/pnas.0504657102; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Hernandez G, 2006, BEHAV NEUROSCI, V120, P888, DOI 10.1037/0735-7044.120.4.888; Ito R, 2004, NAT NEUROSCI, V7, P389, DOI 10.1038/nn1217; Ito R, 2000, J NEUROSCI, V20, P7489; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; MOGENSON GJ, 1987, BRAIN RES, V404, P221, DOI 10.1016/0006-8993(87)91373-4; Montague PR, 2004, J NEUROSCI, V24, P1754, DOI 10.1523/JNEUROSCI.4279-03.2004; MURRAY B, 1994, BEHAV BRAIN RES, V63, P47, DOI 10.1016/0166-4328(94)90050-7; Nicola SM, 2005, NEUROSCIENCE, V135, P1025, DOI 10.1016/j.neuroscience.2005.06.088; PachecoCano MT, 1996, EXP BRAIN RES, V110, P205; Pecina S, 2006, NEUROSCIENTIST, V12, P500, DOI 10.1177/1073858406293154; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; Reynolds SM, 2001, J NEUROSCI, V21, P3261, DOI 10.1523/JNEUROSCI.21-09-03261.2001; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SESACK SR, 1990, BRAIN RES, V527, P266, DOI 10.1016/0006-8993(90)91146-8; Singh J, 1997, BEHAV BRAIN RES, V86, P171, DOI 10.1016/S0166-4328(96)02263-2; STELLAR JR, 1989, BRAIN RES, V477, P126, DOI 10.1016/0006-8993(89)91400-5; SURMEIER DJ, 1995, NEURON, V14, P385, DOI 10.1016/0896-6273(95)90294-5; Taha SA, 2006, J NEUROSCI, V26, P217, DOI 10.1523/JNEUROSCI.3227-05.2006; Tran AH, 2005, P NATL ACAD SCI USA, V102, P2117, DOI 10.1073/pnas.0409726102; Tran AH, 2002, P NATL ACAD SCI USA, V99, P8986, DOI 10.1073/pnas.132284599; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; Wightman RM, 2006, SCIENCE, V311, P1570, DOI 10.1126/science.1120027; WILLIAMS GV, 1990, NEUROSCIENCE, V39, P1, DOI 10.1016/0306-4522(90)90217-R; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zahm DS, 2000, NEUROSCI BIOBEHAV R, V24, P85, DOI 10.1016/S0149-7634(99)00065-2	49	150	151	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					237	244		10.1016/j.neuron.2007.03.021	http://dx.doi.org/10.1016/j.neuron.2007.03.021			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442245	Bronze, Green Submitted			2022-12-28	WOS:000246190600009
J	Dymecki, SM; Kim, JC				Dymecki, Susan M.; Kim, Jun Chul			Molecular neuroanatomy's "three Gs": A primer	NEURON			English	Review							SITE-SPECIFIC RECOMBINATION; BACTERIAL ARTIFICIAL CHROMOSOMES; CONDITIONAL CELL ABLATION; TAMOXIFEN-INDUCIBLE FORM; NEURAL STEM-CELLS; MOUSE ES CELLS; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO; CRE RECOMBINASE	New genetic technologies are transforming nervous system studies in mice, impacting fields from neural development to the neurobiology of disease. Alongside these methodological advances, new concepts are taking shape with respect to both vocabulary and form. Here we review aspects of both burgeoning areas. Presented are technologies which, by co-opting site-specific recombinase systems, enable select genes to be turned on or off in specific brain cells of otherwise undisturbed mouse embryos or adults. Manipulated genes can be endogenous loci or inserted transgenes encoding reporter, sensor, or effector molecules, making it now possible to assess not only gene function, but also cell function, origin, fate, connectivity, and behavioral output. From these methodological advances, a new form of molecular neuroscience is emerging that may be said to lean on the concepts of genetic access, genetic lineage, and genetic anatomy-the three "Gs"-much like a general education rests on the basics of reading, 'riting, and 'rithmetic.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK061802, R01DK067826] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD036379-060006, P01 HD036379, R01 HD051936] Funding Source: Medline; NIDDK NIH HHS [R21 DK061802-02, R21 DK061802-02S1, R01 DK067826, R21 DK618021, R01 DK067826-01, R21 DK061802-03, R21 DK061802-01, R01 DK067826-03, R21 DK061802, R01 DK067826-04, R01 DK067826-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Andreas S, 2002, NUCLEIC ACIDS RES, V30, P2299, DOI 10.1093/nar/30.11.2299; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; Awatramani R, 2001, NAT GENET, V29, P257, DOI 10.1038/ng1101-257; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; Belteki G, 2003, NAT BIOTECHNOL, V21, P321, DOI 10.1038/nbt787; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; BREITMAN ML, 1990, MOL CELL BIOL, V10, P474, DOI 10.1128/MCB.10.2.474; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P4256, DOI 10.1093/nar/24.21.4256; Buchholz F, 1998, NAT BIOTECHNOL, V16, P657, DOI 10.1038/nbt0798-657; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; CEPKO CL, 1990, COLD SH Q B, V55, P265; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chen YT, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh158; Chizhikov VV, 2006, DEVELOPMENT, V133, P2793, DOI 10.1242/dev.02441; Clark AJ, 1997, GENE THER, V4, P101, DOI 10.1038/sj.gt.3300367; Coen L, 1997, P NATL ACAD SCI USA, V94, P9400, DOI 10.1073/pnas.94.17.9400; DANG DT, 1992, DEV GENET, V13, P367, DOI 10.1002/dvg.1020130507; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; DANIELIAN PS, 1993, MOL ENDOCRINOL, V7, P232, DOI 10.1210/me.7.2.232; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; DYMECKI SM, 2000, GENE TARGETING PRACT, P37; DYMECKI SM, 2002, EMBRYONI STEM CELLS; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; GALILEO DS, 1990, P NATL ACAD SCI USA, V87, P458, DOI 10.1073/pnas.87.1.458; Garcia-Otin AL, 2006, FRONT BIOSCI-LANDMRK, V11, P1108, DOI 10.2741/1867; Giepmans BNG, 2006, SCIENCE, V312, P217, DOI 10.1126/science.1124618; Golden JA, 1996, DEVELOPMENT, V122, P65; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Guo QX, 2003, DEV BIOL, V264, P166, DOI 10.1016/j.ydbio.2003.08.012; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hasan MT, 2001, GENESIS, V29, P116, DOI 10.1002/gene.1014; HASTY P, 2000, GENE TARGETING PRACT, P1; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; HOESS RH, 1982, P NATL ACAD SCI-BIOL, V79, P3398, DOI 10.1073/pnas.79.11.3398; HOESS RH, 1986, NUCLEIC ACIDS RES, V14, P2287, DOI 10.1093/nar/14.5.2287; Horowitz LF, 1999, P NATL ACAD SCI USA, V96, P3194, DOI 10.1073/pnas.96.6.3194; Hunter NL, 2005, GENESIS, V41, P99, DOI 10.1002/gene.20101; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Isles AR, 2001, J NEUROBIOL, V47, P183, DOI 10.1002/neu.1026; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Johns DC, 1999, J NEUROSCI, V19, P1691; Joyner AL, 2006, DEV DYNAM, V235, P2376, DOI 10.1002/dvdy.20884; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; Kimmel RA, 2000, GENE DEV, V14, P1377; Kissa K, 2002, MOL CELL NEUROSCI, V20, P627, DOI 10.1006/mcne.2002.1141; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KOBAYASHI K, 1995, P NATL ACAD SCI USA, V92, P1132, DOI 10.1073/pnas.92.4.1132; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Le Douarin N.M., 1982, NEURAL CREST; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leuchtenberger S, 2001, NUCLEIC ACIDS RES, V29, part. no., DOI 10.1093/nar/29.16.e76; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Lindeberg J, 2002, J NEUROSCI RES, V68, P248, DOI 10.1002/jnr.10213; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; LOGIE C, 1995, P NATL ACAD SCI USA, V92, P5940, DOI 10.1073/pnas.92.13.5940; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Mallet VO, 2002, NAT BIOTECHNOL, V20, P1234, DOI 10.1038/nbt762; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; Matise MP, 2000, GENE TARGETING PRACT, P101; MCLEOD M, 1986, MOL CELL BIOL, V6, P3357, DOI 10.1128/MCB.6.10.3357; Metzger D, 2001, METHODS, V24, P71, DOI 10.1006/meth.2001.1159; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Miyawaki A, 2003, CURR OPIN NEUROBIOL, V13, P591, DOI 10.1016/j.conb.2003.09.005; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Muyrers JPP, 2001, TRENDS BIOCHEM SCI, V26, P325, DOI 10.1016/S0968-0004(00)01757-6; Muyrers JPP, 1999, NUCLEIC ACIDS RES, V27, P1555, DOI 10.1093/nar/27.6.1555; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; ORBAN PC, 1992, P NATL ACAD SCI USA, V89, P6861, DOI 10.1073/pnas.89.15.6861; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; PALMITER RD, 1991, P NATL ACAD SCI USA, V88, P478, DOI 10.1073/pnas.88.2.478; Park JY, 2004, BIOTECHNIQUES, V36, P390, DOI 10.2144/04363BM03; Pearse RV, 2006, NATURE, V439, P404, DOI 10.1038/439404a; Raymond CS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000162; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Sauer B, 2004, NUCLEIC ACIDS RES, V32, P6086, DOI 10.1093/nar/gkh941; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Schonig Kai, 2003, Methods Mol Biol, V209, P69; Schwenk F, 1998, NUCLEIC ACIDS RES, V26, P1427, DOI 10.1093/nar/26.6.1427; Scott MM, 2005, P NATL ACAD SCI USA, V102, P16472, DOI 10.1073/pnas.0504510102; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; SGALER SK, 2005, NEURON, V45, P27; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Slimko EM, 2002, J NEUROSCI, V22, P7373; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STARK WM, 1992, TRENDS GENET, V8, P432, DOI 10.1016/0168-9525(92)90176-5; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; WALSH C, 1988, SCIENCE, V241, P1342, DOI 10.1126/science.3137660; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Wingate R, 2005, NEURON, V48, P1, DOI 10.1016/j.neuron.2005.09.012; Wulff P, 2005, TRENDS NEUROSCI, V28, P44, DOI 10.1016/j.tins.2004.11.004; XU T, 1993, DEVELOPMENT, V117, P1223; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Yoshihara Y, 2002, NEUROSCI RES, V44, P133, DOI 10.1016/S0168-0102(02)00130-X; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Yu HMI, 2005, P NATL ACAD SCI USA, V102, P8615, DOI 10.1073/pnas.0500124102; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6; Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	151	82	86	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					17	34		10.1016/j.neuron.2007.03.009	http://dx.doi.org/10.1016/j.neuron.2007.03.009			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408575	Bronze, Green Accepted			2022-12-28	WOS:000245848400007
J	Ligon, KL; Huillard, E; Mehta, S; Kesari, S; Liu, HY; Alberta, JA; Bachoo, RM; Kane, M; Louis, DN; DePinho, RA; Anderson, DJ; Stiles, CD; Rowitch, DH				Ligon, Keith L.; Huillard, Emmanuelle; Mehta, Shwetal; Kesari, Santosh; Liu, Hongye; Alberta, John A.; Bachoo, Robert M.; Kane, Michael; Louis, David N.; DePinho, Ronald A.; Anderson, David J.; Stiles, Charles D.; Rowitch, David H.			Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma	NEURON			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; FACTOR-BINDING SITES; HUMAN BRAIN-TUMORS; PROGENITOR CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GLIOBLASTOMA-MULTIFORME; SUBVENTRICULAR ZONE	Recent studies have identified stem cells in brain cancer. However, their relationship to normal CNS progenitors, including dependence on common lineage-restricted pathways, is unclear. We observe expression of the CNS-restricted transcription factor, OLIG2, in human glioma stem and progenitor cells reminiscent of type C transit-amplifying cells in germinal zones of the adult brain. Olig2 function is required for proliferation of neural progenitors and for glioma formation in a genetically relevant murine model. Moreover, we show p21(WAF1/CIP1), a tumor suppressor and inhibitor of stem cell proliferation, is directly repressed by OLIG2 in neural progenitors and gliomas. Our findings identify an Olig2-regulated lineage-restricted pathway critical for proliferation of normal and tumorigenic CNS stem cells.	Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Childrens Hosp, Informat Program, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02129 USA; Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02129 USA; CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; Childrens Hosp, Div Neonatol, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Ctr Appl Canc Sci, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; California Institute of Technology; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stiles, CD (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, 4 Binney St, Boston, MA 02115 USA.	charles_stiles@dfci.harvard.edu; rowitchd@peds.ucsf.edu	Kesari, Santosh/E-8461-2013	Rowitch, David/0000-0002-0079-0060; DePinho, Ronald/0000-0002-5625-577X	NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS047213, P01NS047572, F32NS055631, R01NS040511] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA095616, P01 CA95616] Funding Source: Medline; NINDS NIH HHS [K08NS047213, NS05563, F32 NS055631, R01NS40511, P01NS047572, R01 NS040511, P01 NS047572, K08 NS047213] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams PD, 1998, CURR OPIN CELL BIOL, V10, P791, DOI 10.1016/S0955-0674(98)80123-3; Agrawal D, 1996, MOL CELL BIOL, V16, P4327; Anderson DJ, 2001, NEURON, V30, P19, DOI 10.1016/S0896-6273(01)00260-4; Anderson RC, 2002, CLIN IMMUNOL, V102, P84, DOI 10.1006/clim.2001.5152; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; Azzarelli B, 2004, J NEUROPATH EXP NEUR, V63, P170, DOI 10.1093/jnen/63.2.170; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barber TD, 2004, NEW ENGL J MED, V351, P2883, DOI 10.1056/NEJM200412303512724; Barker FG, 1997, J NEURO-ONCOL, V31, P17, DOI 10.1023/A:1005768910871; Besson A, 2001, J NEURO-ONCOL, V51, P245, DOI 10.1023/A:1010657030494; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Bouvier C, 2003, J NEUROSURG, V99, P344, DOI 10.3171/jns.2003.99.2.0344; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Du JY, 2004, CANCER CELL, V6, P565, DOI 10.1016/j.ccr.2004.10.014; Duerr EM, 1998, ONCOGENE, V16, P2259, DOI 10.1038/sj.onc.1201756; Ferrando AA, 2004, LANCET, V363, P535, DOI 10.1016/S0140-6736(04)15542-6; Furusho M, 2006, DEV BIOL, V293, P348, DOI 10.1016/j.ydbio.2006.01.031; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Garraway LA, 2006, NAT REV CANCER, V6, P593, DOI 10.1038/nrc1947; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hengst L, 1996, SCIENCE, V271, P1861, DOI 10.1126/science.271.5257.1861; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kamiya M, 2002, J NEURO-ONCOL, V59, P143, DOI 10.1023/A:1019633910603; Kesari S, 2006, NEURON, V51, P151, DOI 10.1016/j.neuron.2006.07.001; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kho AT, 2004, GENE DEV, V18, P629, DOI 10.1101/gad.1182504; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Korshunov A, 2002, J NEURO-ONCOL, V58, P237, DOI 10.1023/A:1016270101321; Kraus JA, 2001, J NEURO-ONCOL, V52, P263, DOI 10.1023/A:1010684203704; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Laywell Eric D, 2002, Methods Mol Biol, V198, P15; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Livesey FJ, 2004, P NATL ACAD SCI USA, V101, P1374, DOI 10.1073/pnas.0307014101; Louis DN, 2002, CANCER CELL, V1, P125, DOI 10.1016/S1535-6108(02)00040-5; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, NAT NEUROSCI, V4, P973, DOI 10.1038/nn718; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Marie Y, 2001, LANCET, V358, P298, DOI 10.1016/S0140-6736(01)05499-X; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Miettinen HE, 2001, J NEURO-ONCOL, V55, P29, DOI 10.1023/A:1012961918848; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ohnishi A, 2003, J NEUROPATH EXP NEUR, V62, P1052, DOI 10.1093/jnen/62.10.1052; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rasheed B K, 1999, Curr Opin Oncol, V11, P162; Rasheed BKA, 1997, CANCER RES, V57, P4187; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Setoguchi T, 2004, J CELL BIOL, V166, P963, DOI 10.1083/jcb.200404104; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STECK PA, 1988, CANCER RES, V48, P5433; Sun T, 2003, J NEUROSCI, V23, P9547; Tabu K, 2006, J CELL SCI, V119, P1433, DOI 10.1242/jcs.02854; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	83	372	383	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					503	517		10.1016/j.neuron.2007.01.009	http://dx.doi.org/10.1016/j.neuron.2007.01.009			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296553	Green Accepted, Bronze			2022-12-28	WOS:000245126900010
J	Spencer, B; Crews, L; Masliah, E				Spencer, Brian; Crews, Leslie; Masliah, Eliezer			Climbing the scaffolds of Parkinson's disease pathogenesis	NEURON			English	Editorial Material							SEPTIN GENE	Several neurodegenerative disorders, including Parkinson's and Alzheimer's diseases, are characterized neuropathologically by accumulation of misfolded proteins such as alpha-synuclein that disrupts scaffold molecules in the caveolae. A new study by Ihara et al. in this issue of Neuron shows that a novel scaffold protein, Sept4, may be an important player in modulating the pathological alterations of alpha-synuclein in models of Parkinson's disease, suggesting that gene therapies targeting scaffold proteins might be effective in the treatment of neurodegenerative disorders.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Crews, Leslie/B-7584-2014	Crews, Leslie/0000-0003-0704-0067	NIA NIH HHS [AG18440, AG10435, AG022074] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG018440, R37AG018440, P01AG010435, P01AG022074] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Hall PA, 2004, J PATHOL, V204, P489, DOI 10.1002/path.1654; Hashimoto M, 2004, GENE THER, V11, P1713, DOI 10.1038/sj.gt.3302349; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Kartmann B, 2001, J CELL SCI, V114, P839; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; KREUZIGER LM, 2007, IN PRESS LEUK R 0122; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Russell SEH, 2000, CANCER RES, V60, P4729; Smart EJ, 1999, MOL CELL BIOL, V19, P7289; Takehashi M, 2003, GENE EXPRESSION, V11, P263, DOI 10.3727/000000003783992243	11	7	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					469	470		10.1016/j.neuron.2007.02.002	http://dx.doi.org/10.1016/j.neuron.2007.02.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296545	Bronze			2022-12-28	WOS:000245126900002
J	Sindreu, CB; Scheiner, ZS; Storm, DR				Sindreu, Carlos Balet; Scheiner, Zachary S.; Storm, Daniel R.			Ca2+-Stimulated adenylyl cyclases regulate ERK-dependent activation of MSK1 during fear conditioning	NEURON			English	Article							LONG-TERM-MEMORY; CAMP-RESPONSIVE ELEMENT; PROTEIN-KINASE-A; SYNAPTIC PLASTICITY; MUTANT MICE; MAP KINASE; NEURONAL PLASTICITY; DORSAL HIPPOCAMPUS; BINDING PROTEIN; SPATIAL MEMORY	The cAMP and ERK/MAP kinase (MAPK) signal transduction pathways are critical for hippocampus-dependent memory, a process that depends on CREB-mediated transcription. However, the extent of crosstalk between these pathways and the downstream CREB kinase activated during memory formation has not been elucidated. Here we report that PKA, MAPK, and MSK1, a CREB kinase, are coactivated in a subset of hippocampal CA1 pyramidal neurons following contextual fear conditioning. Activation of PKA, MAPK, MSK1, and CREB is absolutely dependent on Ca2+ -stimulated adenylyl cyclase activity. We conclude that adenylyl cyclase activity supports the activation of MAPK, and that MSK1 is the major CREB kinase activated during training for contextual memory.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Storm, DR (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	dstorm@u.washington.edu	sindreu, carlos/D-3901-2014	sindreu, carlos/0000-0001-6730-8278	NIGMS NIH HHS [T32 GM007108, T32 GM07108] Funding Source: Medline; NIMH NIH HHS [MH 073601, R01 MH073601] Funding Source: Medline; NINDS NIH HHS [NS 20498, R01 NS020498] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020498] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Blum S, 1999, J NEUROSCI, V19, P3535; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Maas JW, 2005, J NEUROSCI, V25, P4118, DOI 10.1523/JNEUROSCI.4273-04.2005; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mazzucchelli C, 2000, CELL MOL LIFE SCI, V57, P604, DOI 10.1007/PL00000722; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061; Vanhoose AM, 2006, J NEUROSCI, V26, P1138, DOI 10.1523/JNEUROSCI.3572-05.2006; Villacres EC, 1998, J NEUROSCI, V18, P3186; Villalba M, 1997, J NEUROSCI, V17, P83, DOI 10.1523/JNEUROSCI.17-01-00083.1997; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	36	159	159	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					79	89		10.1016/j.neuron.2006.11.024	http://dx.doi.org/10.1016/j.neuron.2006.11.024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196532	Bronze, Green Accepted			2022-12-28	WOS:000245126500010
J	Takahashi, H; Shin, Y; Cho, SJ; Zago, WM; Nakamura, T; Gu, ZZ; Ma, YL; Furukawa, H; Liddington, R; Zhang, DX; Tong, G; Chen, HSV; Lipton, SA				Takahashi, Hiroto; Shin, Yeonsook; Cho, Seung-Je; Zago, Wagner M.; Nakamura, Tomohiro; Gu, Zezong; Ma, Yuliang; Furukawa, Hiroyasu; Liddington, Robert; Zhang, Dongxian; Tong, Gary; Chen, Huei-Sheng Vincent; Lipton, Stuart A.			Hypoxia enhances S-nitrosylation-mediated NMDA receptor inhibition via a thiol oxygen sensor motif	NEURON			English	Article							D-ASPARTATE RECEPTOR; REDOX MODULATORY SITE; CALCIUM-RELEASE CHANNEL; ZINC-SULFUR CLUSTERS; NEURONS IN-VITRO; NITRIC-OXIDE; PYRROLOQUINOLINE QUINONE; PHOSPHORYLATION SITE; OXIDIZED GLUTATHIONE; CRYSTAL-STRUCTURES	Under ambient air conditions, NO inhibits NMDAR activity by reacting with the NR2A subunit C399 along with two additional cysteine pairs if their disulfide bonds are reduced to free thiol groups [NR1(C744,C798); NR2(C87, C320)]. Here we demonstrate that relative hypoxia enhances S-nitrosylation of NMDARs by a unique mechanism involving an "NO-reactive oxygen sensor motif" whose determinants include C744 and C798 of the NR1 subunit. Redox reactions involving these two thiol groups sensitize other NMDAR sites to S-nitrosylation and consequent receptor inhibition, while their own nitrosylation has little effect on NIVIDAR activity. The crystal structure of the ligand-binding domain of NR1 reveals a flexible disulfide bond (C744-C798), which may account for its susceptibility to reduction and subsequent reaction with NO that is observed with biochemical techniques. These thiols may be nitrosylated preferentially during increasing hypoxia or stroke conditions, thus preventing excessive activity associated with cytotoxicity while avoiding blockade of physiologically active NMDARs.	Burnham Inst Med Res, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; Burnham Inst Med Res, Proteom Facil, La Jolla, CA 92037 USA; Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92037 USA; Univ Calif San Diego, Div Cardiol, La Jolla, CA 92037 USA; Kanazawa Univ, Grad Sch Med Sci, Dept Mol Pharmacol, Kanazawa, Ishikawa 9208640, Japan	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Columbia University; University of California System; University of California San Diego; University of California System; University of California San Diego; Kanazawa University	Lipton, SA (corresponding author), Burnham Inst Med Res, Ctr Neurosci & Aging, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	slipton@burnham.org	Tong, Gary/AAC-9426-2022	Lipton, Stuart/0000-0002-3490-1259	NEI NIH HHS [R01 EY009024, R01 EY05477, R01 EY005477, R01 EY09024] Funding Source: Medline; NICHD NIH HHS [P01 HD29587, P01 HD029587] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD029587] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009024, R01EY005477] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AIZENMAN E, 1995, NEUROSCI LETT, V189, P57, DOI 10.1016/0304-3940(95)11442-Y; AIZENMAN E, 1992, J NEUROSCI, V12, P2362; AIZENMAN E, 1990, NEURON, V5, P841, DOI 10.1016/0896-6273(90)90343-E; AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Aravindakumar CT, 1999, BIOCHEM J, V344, P253, DOI 10.1042/0264-6021:3440253; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Choi YB, 2000, NAT NEUROSCI, V3, P15, DOI 10.1038/71090; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Eu JP, 2000, CELL, V102, P499, DOI 10.1016/S0092-8674(00)00054-4; Furukawa H, 2003, EMBO J, V22, P2873, DOI 10.1093/emboj/cdg303; GILBERT KR, 1991, NEUROSCI LETT, V133, P11, DOI 10.1016/0304-3940(91)90045-U; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Heras B, 2004, P NATL ACAD SCI USA, V101, P8876, DOI 10.1073/pnas.0402769101; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kim WK, 1999, NEURON, V24, P461, DOI 10.1016/S0896-6273(00)80859-4; KOHR G, 1994, NEURON, V12, P1031, DOI 10.1016/0896-6273(94)90311-5; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kroncke KD, 2000, FASEB J, V14, P166; KRONCKE KD, 1994, BIOCHEM BIOPH RES CO, V200, P1105, DOI 10.1006/bbrc.1994.1564; LEI SZ, 1992, NEURON, V8, P1087, DOI 10.1016/0896-6273(92)90130-6; Lipton SA, 2004, NATURE, V428, P473, DOI 10.1038/428473a; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lipton SA, 2004, CELL DEATH DIFFER, V11, P18, DOI 10.1038/sj.cdd.4401344; Lipton SA, 2002, TRENDS NEUROSCI, V25, P474, DOI 10.1016/S0166-2236(02)02245-2; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Lipton SA, 1996, TRENDS PHARMACOL SCI, V17, P186, DOI 10.1016/0165-6147(96)20028-8; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; MANZONI O, 1992, NEURON, V8, P653, DOI 10.1016/0896-6273(92)90087-T; Misra RR, 1996, CHEM RES TOXICOL, V9, P326, DOI 10.1021/tx950109y; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pearce LL, 2000, P NATL ACAD SCI USA, V97, P477, DOI 10.1073/pnas.97.1.477; Scanlon JM, 1997, EUR J PHARMACOL, V326, P67, DOI 10.1016/S0014-2999(97)00137-4; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Stamler JS, 1997, SCIENCE, V276, P2034, DOI 10.1126/science.276.5321.2034; Sucher NJ, 1996, TRENDS PHARMACOL SCI, V17, P348, DOI 10.1016/S0165-6147(96)10046-8; SUCHER NJ, 1991, J NEUROSCI RES, V30, P582, DOI 10.1002/jnr.490300316; SULLIVAN JM, 1994, NEURON, V13, P929, DOI 10.1016/0896-6273(94)90258-5; TANG LH, 1993, MOL PHARMACOL, V44, P473; TANG LH, 1993, NEURON, V11, P857, DOI 10.1016/0896-6273(93)90115-8; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xu L, 1998, SCIENCE, V279, P234, DOI 10.1126/science.279.5348.234; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101	55	88	91	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					53	64		10.1016/j.neuron.2006.11.023	http://dx.doi.org/10.1016/j.neuron.2006.11.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196530	Green Accepted, Bronze			2022-12-28	WOS:000245126500008
J	Barbee, SA; Estes, PS; Cziko, AM; Hillebrand, J; Luedeman, RA; Coller, JM; Johnson, N; Howlett, IC; Geng, CY; Ueda, R; Brand, AH; Newbury, SF; Wilhelm, JE; Levine, RB; Nakamura, A; Parker, R; Ramaswamil, M				Barbee, Scott A.; Estes, Patricia S.; Cziko, Anne-Marie; Hillebrand, Jens; Luedeman, Rene A.; Coller, Jeff M.; Johnson, Nick; Howlett, Iris C.; Geng, Cuiyun; Ueda, Ryu; Brand, Andrea H.; Newbury, Sarah F.; Wilhelm, James E.; Levine, Richard B.; Nakamura, Akira; Parker, Roy; Ramaswami, Mani			Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies	NEURON			English	Article							OSKAR MESSENGER-RNA; CONTAINING RIBONUCLEOPROTEIN-PARTICLES; PHYSIOLOGICAL GERMLINE APOPTOSIS; BINDING-PROTEIN; TRANSLATIONAL REPRESSION; PROCESSING BODIES; LOCALIZATION; GRANULES; MICRORNA; COMPLEX	Local control of mRNA translation modulates neuronal development, synaptic plasticity, and memory formation. A poorly understood aspect of this control is the role and composition of ribonucleoprotein (RNP) particles that mediate transport and translation of neuronal RNAs. Here, we show that staufen- and FMRP-containing RNPs in Drosophila neurons contain proteins also present in somatic "P bodies," including the RNA-degradative enzymes Dcp1p and Xrn1p/Pacman and crucial components of miRNA (argonaute), NMD (Upf1p), and general translational repression (Dhh1p/Me31B) pathways. Drosophila Me31B is shown to participate (1) with an FMRP-associated, P body protein (Scd6p/trailer hitch) in FMRP-driven, argonaute-dependent translational repression in developing eye imaginal discs; (2) in dendritic elaboration of larval sensory neurons; and (3) in bantam miRNA-mediated translational repression in wing imaginal discs. These results argue for a conserved mechanism of translational control critical to neuronal function and open up new experimental avenues for understanding the regulation of mRNA function within neurons.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA; Univ Dublin Trinity Coll, Smurfit Inst Genet & TCIN, Dublin 2, Ireland; Univ Texas, Inst Mol & Cellular Biol, Sect Mol Cell & Dev Biol, Austin, TX 78712 USA; Univ Cambridge, Dept Genet, Cambridge CB2 1QR, England; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA; RIKEN, Ctr Dev Biol, Lab Germline Dev, Chuo Ku, Kobe, Hyogo 6500047, Japan; Natl Inst Genet, Invertebrate Genet Lab, Genet Strains Res Ctr, Mishima, Shizuoka 4118540, Japan	University of Arizona; University of Arizona; Howard Hughes Medical Institute; University of Arizona; Trinity College Dublin; University of Texas System; University of Texas Austin; University of Cambridge; University of Cambridge; Newcastle University - UK; University of California System; University of California San Diego; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu; mani@u.arizona.edu	Brand, Andrea H/F-8220-2014; Nakamura, Akira/V-6869-2019	Brand, Andrea H/0000-0002-2089-6954; Nakamura, Akira/0000-0001-6506-9146; Coller, Jeff/0000-0001-5662-8110; Ramaswami, Mani/0000-0001-7631-0468	Biotechnology and Biological Sciences Research Council [BB/C005163/1] Funding Source: Medline; Medical Research Council [G0300072] Funding Source: Medline; NIDA NIH HHS [DA15495, K02 DA017749, DA17749, R01 DA015495] Funding Source: Medline; NIGMS NIH HHS [R37 GM045443, R01 GM054409, GM54409] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054409, R37GM045443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015495, K02DA017749] Funding Source: NIH RePORTER; MRC [G0300072] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andrei MA, 2005, RNA, V11, P717, DOI 10.1261/rna.2340405; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Audhya A, 2005, J CELL BIOL, V171, P267, DOI 10.1083/jcb.200506124; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boag PR, 2005, DEVELOPMENT, V132, P4975, DOI 10.1242/dev.02060; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; Forbes A, 1998, DEVELOPMENT, V125, P679; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Johnstone O, 2001, ANNU REV GENET, V35, P365, DOI 10.1146/annurev.genet.35.102401.090756; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kosik KS, 2005, NEURON, V47, P779, DOI 10.1016/j.neuron.2005.08.019; Kraft R, 1998, J NEUROSCI, V18, P8886; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Ladomery M, 1997, NUCLEIC ACIDS RES, V25, P965, DOI 10.1093/nar/25.5.965; LaGrandeur TE, 1998, EMBO J, V17, P1487, DOI 10.1093/emboj/17.5.1487; Lall S, 2005, MOL BIOL CELL, V16, P5880, DOI 10.1091/mbc.E05-07-0622; Lasko P, 2005, BIOCHEM SOC T, V33, P1544, DOI 10.1042/BST0331544; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Macchi P, 2003, J NEUROSCI, V23, P5778; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Mansfield JH, 2002, DEVELOPMENT, V129, P197; Martin KC, 2004, CURR OPIN NEUROBIOL, V14, P305, DOI 10.1016/j.conb.2004.05.009; Muhlrad D, 1999, MOL BIOL CELL, V10, P3971, DOI 10.1091/mbc.10.11.3971; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Nakamura A, 2001, DEVELOPMENT, V128, P3233; Navarro RE, 2001, DEVELOPMENT, V128, P3221; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Richter JD, 2002, CURR OPIN NEUROBIOL, V12, P300, DOI 10.1016/S0959-4388(02)00318-5; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Sheth U, 2006, CELL, V125, P1095, DOI 10.1016/j.cell.2006.04.037; Shiina N, 2005, J NEUROSCI, V25, P4420, DOI 10.1523/JNEUROSCI.0382-05.2005; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WANG C, 1994, DEV DYNAM, V199, P103, DOI 10.1002/aja.1001990204; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wilhelm JE, 2003, J CELL BIOL, V163, P1197, DOI 10.1083/jcb.200309088; Yang WH, 2006, RNA, V12, P547, DOI 10.1261/rna.2302706; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	73	275	277	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					997	1009		10.1016/j.neuron.2006.10.028	http://dx.doi.org/10.1016/j.neuron.2006.10.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178403	Bronze, Green Accepted			2022-12-28	WOS:000243115100008
J	Frank, CA; Kennedy, MJ; Goold, CP; Marek, KW; Davis, GW				Frank, C. Andrew; Kennedy, Matthew J.; Goold, Carleton P.; Marek, Kurt W.; Davis, Graeme W.			Mechanisms underlying the rapid induction and sustained expression of synaptic homeostasis	NEURON			English	Article							SENSITIVE PARALYTIC MUTANT; CHANNEL ALPHA-1 SUBUNIT; CALCIUM-CHANNEL; RETROGRADE SIGNAL; GENETIC-ANALYSIS; QUANTAL CONTENT; END-PLATES; CA2+ ENTRY; DROSOPHILA; RELEASE	Homeostatic signaling systems are thought to interface with the mechanisms of neural plasticity to achieve stable yet flexible neural circuitry. However, the time course, molecular design, and implementation of homeostatic signaling remain poorly defined. Here we demonstrate that a homeostatic increase in presynaptic neurotransmitter release can be induced within minutes following postsynaptic glutamate receptor blockade. The rapid induction of synaptic homeostasis is independent of new protein synthesis and does not require evoked neurotransmission, indicating that a change in the efficacy of spontaneous quantal release events is sufficient to trigger the induction of synaptic homeostasis. Finally, both the rapid induction and the sustained expression of synaptic homeostasis are blocked by mutations that disrupt the pore-forming subunit of the presynaptic Ca(v)2.1 calcium channel encoded by cacophony. These data confirm the presynaptic expression of synaptic homeostasis and implicate presynaptic Ca(v)2.1 in a homeostatic retrograde signaling system.	Univ Calif San Francisco, Dept Biochem & Biophys, Neurosci Program, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Neurosci Program, 1550 4th St,Rock Hall 4th Floor N, San Francisco, CA 94158 USA.	gdavis@biochem.ucsf.edu		Frank, C. Andrew/0000-0001-9599-421X	NINDS NIH HHS [F32 NS049694-02, NS39313, F32 NS049694, R01 NS039313-07, NS049694, F32 NS049694-03, R01 NS039313, F32 NS049694-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS049694, R01NS039313] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Barrett CF, 2005, J BIOL CHEM, V280, P24064, DOI 10.1074/jbc.M502223200; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Brooks IM, 2003, GENETICS, V164, P163; Cao YQ, 2005, P NATL ACAD SCI USA, V102, P2590, DOI 10.1073/pnas.0409896102; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Dellinger B, 2000, GENETICS, V155, P203; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DiAntonio A, 1999, J NEUROSCI, V19, P3023; ELDEFRAWI AT, 1988, P NATL ACAD SCI USA, V85, P4910, DOI 10.1073/pnas.85.13.4910; Evans RM, 2006, TRENDS NEUROSCI, V29, P617, DOI 10.1016/j.tins.2006.08.006; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; KARST H, 1991, COMP BIOCHEM PHYS C, V98, P479, DOI 10.1016/0742-8413(91)90237-N; Kawasaki F, 2002, J NEUROSCI, V22, P5856; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Kawasaki F, 2000, J NEUROSCI, V20, P4885; Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42; Macleod GT, 2006, EUR J NEUROSCI, V23, P3230, DOI 10.1111/j.1460-9568.2006.04873.x; Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185; Marrus SB, 2005, J NEUROBIOL, V63, P62, DOI 10.1002/neu.20120; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; MURPHY TH, 1994, SCIENCE, V263, P529, DOI 10.1126/science.7904774; MURPHY TH, 1994, J NEUROSCI, V14, P1320, DOI 10.1523/JNEUROSCI.14-03-01320.1994; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Plomp J J, 2001, Curr Opin Investig Drugs, V2, P1250; PLOMP JJ, 1994, J PHYSIOL-LONDON, V478, P125, DOI 10.1113/jphysiol.1994.sp020236; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Rieckhof GE, 2003, J BIOL CHEM, V278, P41099, DOI 10.1074/jbc.M306417200; Smith LA, 1998, GENETICS, V149, P1407; Smith LA, 1996, J NEUROSCI, V16, P7868; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2005, J NEUROBIOL, V64, P116, DOI 10.1002/neu.20152; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Xing B, 2005, SYNAPSE, V57, P132, DOI 10.1002/syn.20165	52	259	260	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					663	677		10.1016/j.neuron.2006.09.029	http://dx.doi.org/10.1016/j.neuron.2006.09.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114050	Green Accepted, Bronze			2022-12-28	WOS:000242413100013
J	Costa, RM; Lin, SC; Sotnikova, TD; Cyr, M; Gainetdinov, RR; Caron, MG; Nicolelis, MAL				Costa, Rui M.; Lin, Shih-Chieh; Sotnikova, Tatyana D.; Cyr, Michel; Gainetdinov, Raul R.; Caron, Marc G.; Nicolelis, Miguel A. L.			Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction	NEURON			English	Article							LOCAL-FIELD POTENTIALS; PARKINSONS-DISEASE; GLOBUS-PALLIDUS; SUBTHALAMIC NUCLEUS; BASAL GANGLIA; IN-VIVO; CORTEX STIMULATION; PROJECTION NEURONS; GABA INTERNEURONS; SUBSTANTIA-NIGRA	Dopaminergic dysregulation can cause motor dysfunction, but the mechanisms underlying dopamine-related motor disorders remain under debate. We used an inducible and reversible pharmacogenetic approach in dopamine transporter knockout mice to investigate the simultaneous activity of neuronal ensembles in the dorsolateral striatum and primary motor cortex during hyperdopaminergia (similar to 500% of controls) with hyperkinesia, and after rapid and profound dopamine depletion (< 0.2%) with akinesia in the same animal. Surprisingly, although most cortical and striatal neurons (similar to 70%) changed firing rate during the transition between dopamine-related hyperkinesia and akinesia, the overall cortical firing rate remained unchanged. Conversely, neuronal oscillations and ensemble activity coordination within and between cortex and striatum did change rapidly between these periods. During hyperkinesia, corticostriatal activity became largely asynchronous, while during dopamine-depletion the synchronicity increased. Thus, dopamine-related disorders like Parkinson's disease may not stem from changes in the overall levels of cortical activity, but from dysfunctional activity coordination in corticostriatal circuits.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychol & Brain Sci, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Neuroengn, Durham, NC 27710 USA; NIAAA, Sect Vivo Neural Funct, Lab Integrat Neurosci, NIH, Rockville, MD 20852 USA	Duke University; Duke University; Duke University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Costa, RM (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	costarui@mail.nih.gov	Sotnikova, Tatyana D/T-9992-2017; Gainetdinov, Raul R/G-5875-2011	Gainetdinov, Raul R/0000-0003-2951-6038; Lin, Shih-Chieh/0000-0003-3693-5476; Costa, Rui M./0000-0003-0495-8374	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000416, ZIAAA000416] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bar-Gad I, 2004, J NEUROSCI, V24, P7410, DOI 10.1523/JNEUROSCI.1691-04.2004; Bar-Gad I, 2003, J NEUROSCI, V23, P4012; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; CARLSSON A, 1972, ACTA NEUROL SCAND, V48, P11; Cassidy M, 2002, BRAIN, V125, P1235, DOI 10.1093/brain/awf135; CORDINGLEY GE, 1986, BRIT J PHARMACOL, V88, P847, DOI 10.1111/j.1476-5381.1986.tb16258.x; Costa RM, 2004, CURR BIOL, V14, P1124, DOI 10.1016/j.cub.2004.06.053; DASILVA FL, 1991, ELECTROEN CLIN NEURO, V79, P81, DOI 10.1016/0013-4694(91)90044-5; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DEUTCH AY, 1991, SCHIZOPHR RES, V4, P121, DOI 10.1016/0920-9964(91)90030-U; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; FILION M, 1991, BRAIN RES, V547, P142; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Gainetdinov RR, 2003, ANNU REV PHARMACOL, V43, P261, DOI 10.1146/annurev.pharmtox.43.050802.112309; GERFEN CR, 1992, J NEURAL TRANSM-GEN, P43; Gervasoni D, 2004, J NEUROSCI, V24, P11137, DOI 10.1523/JNEUROSCI.3524-04.2004; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goldberg JA, 2004, J NEUROSCI, V24, P6003, DOI 10.1523/JNEUROSCI.4848-03.2004; Goldberg JA, 2002, J NEUROSCI, V22, P4639, DOI 10.1523/JNEUROSCI.22-11-04639.2002; Goldberg JA, 2003, J NEUROSCI, V23, P10058; Gray JA, 1998, SCHIZOPHRENIA BULL, V24, P249, DOI 10.1093/oxfordjournals.schbul.a033324; Hof PR., 2000, COMP CYTOARCHITECTON; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kaneda K, 2005, EUR J NEUROSCI, V22, P3241, DOI 10.1111/j.1460-9568.2005.04488.x; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kuhn AA, 2005, EXP NEUROL, V194, P212, DOI 10.1016/j.expneurol.2005.02.010; LAMPL I, 1993, J NEUROPHYSIOL, V70, P2181, DOI 10.1152/jn.1993.70.5.2181; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Levesque M, 2003, J CHEM NEUROANAT, V26, P271, DOI 10.1016/j.jchemneu.2003.07.001; Levy R, 2002, BRAIN, V125, P1196, DOI 10.1093/brain/awf128; Liu XG, 2002, MOVEMENT DISORD, V17, P346, DOI 10.1002/mds.10038; LLOYD KG, 1975, J PHARMACOL EXP THER, V195, P453; Magill PJ, 2004, J NEUROPHYSIOL, V92, P700, DOI 10.1152/jn.00134.2004; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Mallet N, 2005, J NEUROSCI, V25, P3857, DOI 10.1523/JNEUROSCI.5027-04.2005; Masimore B, 2005, NEUROREPORT, V16, P2021, DOI 10.1097/00001756-200512190-00010; Masimore B, 2004, J NEUROSCI METH, V138, P97, DOI 10.1016/j.jneumeth.2004.03.014; MISGELD U, 1979, EXP BRAIN RES, V34, P575; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Parr-Brownlie LC, 2005, J NEUROSCI, V25, P5700, DOI 10.1523/JNEUROSCI.0523-05.2005; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Plenz D, 1999, NATURE, V400, P677, DOI 10.1038/23281; Rager G, 1998, EUR J NEUROSCI, V10, P1856, DOI 10.1046/j.1460-9568.1998.00197.x; Raz A, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-03-j0006.2001; Reynolds JNJ, 2000, NEUROSCIENCE, V99, P199, DOI 10.1016/S0306-4522(00)00273-6; Reynolds JNJ, 2001, NATURE, V413, P67, DOI 10.1038/35092560; RYAN LJ, 1986, BRAIN RES BULL, V17, P751, DOI 10.1016/0361-9230(86)90086-9; Silberstein P, 2005, BRAIN, V128, P1277, DOI 10.1093/brain/awh480; Silberstein P, 2003, BRAIN, V126, P2597, DOI 10.1093/brain/awg267; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sotnikova TD, 2005, PLOS BIOL, V3, P1488, DOI 10.1371/journal.pbio.0030271; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Williams D, 2002, BRAIN, V125, P1558, DOI 10.1093/brain/awf156; Yin HH, 2006, P NATL ACAD SCI USA, V103, P8251, DOI 10.1073/pnas.0510797103	60	218	223	1	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					359	369		10.1016/j.neuron.2006.07.030	http://dx.doi.org/10.1016/j.neuron.2006.07.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046697	Bronze			2022-12-28	WOS:000241799900015
J	Marsh, JL; Thompson, LM				Marsh, J. Lawrence; Thompson, Leslie Michels			Drosophila in the study of neurodegenerative disease	NEURON			English	Review							BLOOD-BRAIN-BARRIER; AXONAL-TRANSPORT; DEPENDENT NEURODEGENERATION; MEDIATES NEURODEGENERATION; POLYGLUTAMINE AGGREGATION; MITOCHONDRIAL PATHOLOGY; PARKINSONS-DISEASE; REDUCES TOXICITY; GENE-EXPRESSION; NERVOUS-SYSTEM	As populations benefit from increasing lifespans, neurodegenerative diseases have emerged as a critical health concern. How can the fruit fly, Drosophila melanogaster, contribute to curing human diseases of the nervous system? A growing number of neurodegenerative diseases, as well as other human diseases, are being modeled in Drosophila and used as a platform to identify and validate cellular pathways that contribute to neurodegeneration and to identify promising therapeutic targets by using a variety of approaches from screens to target validation. The unique properties and tools available in the Drosophila system, coupled with the fact that testing in vivo has proven highly productive, have accelerated the progress of testing therapeutic strategies in mice and, ultimately, humans. This review highlights selected recent applications to illustrate the use of Drosophila in studying neurodegenerative diseases.	Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Thompson, LM (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Gillespie 2121, Irvine, CA 92697 USA.	lmthomps@uci.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045283] Funding Source: NIH RePORTER; NICHD NIH HHS [HD36081] Funding Source: Medline; NINDS NIH HHS [NS045283] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agrawal N, 2005, P NATL ACAD SCI USA, V102, P3777, DOI 10.1073/pnas.0500055102; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Auluck PK, 2002, NAT MED, V8, P1185, DOI 10.1038/nm1102-1185; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Benn CL, 2005, HUM MOL GENET, V14, P3065, DOI 10.1093/hmg/ddi340; Bhandari P, 2001, ONCOGENE, V20, P6871, DOI 10.1038/sj.onc.1204849; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; Daneman R, 2005, CELL, V123, P9, DOI 10.1016/j.cell.2005.09.017; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fergestad T, 2006, GENETICS, V172, P1031, DOI 10.1534/genetics.105.050625; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Finelli A, 2004, MOL CELL NEUROSCI, V26, P365, DOI 10.1016/j.mcn.2004.03.001; Furutani T, 2005, J PHARMACOL EXP THER, V315, P545, DOI 10.1124/jpet.105.087643; Greene JC, 2003, P NATL ACAD SCI USA, V100, P4078, DOI 10.1073/pnas.0737556100; Greeve I, 2004, J NEUROSCI, V24, P3899, DOI 10.1523/JNEUROSCI.0283-04.2004; Grens A, 1995, DEVELOPMENT, V121, P4027; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Gunawardena S, 2003, NEURON, V40, P25, DOI 10.1016/S0896-6273(03)00594-4; Haywood AFM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-14; Hidalgo A, 2006, BRAIN BEHAV EVOLUT, V68, P173, DOI 10.1159/000094086; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404; HOTTA Y, 1970, P NATL ACAD SCI USA, V67, P1156, DOI 10.1073/pnas.67.3.1156; Hughes RE, 2001, P NATL ACAD SCI USA, V98, P13201, DOI 10.1073/pnas.191498198; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Karsten SL, 2006, NEURON, V51, P549, DOI 10.1016/j.neuron.2006.07.019; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; LANE NJ, 1978, DEV BIOL, V62, P415, DOI 10.1016/0012-1606(78)90225-7; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lin YJ, 1998, SCIENCE, V282, P943, DOI 10.1126/science.282.5390.943; Lush MJ, 1998, BIOCHEM J, V332, P1; MARSH JL, 1986, GENETICS, V112, P249; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; McCampbell A, 2001, P NATL ACAD SCI USA, V98, P15179, DOI 10.1073/pnas.261400698; MCGINNIS N, 1990, CELL, V63, P969, DOI 10.1016/0092-8674(90)90500-E; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Muchowski PJ, 2005, NAT REV NEUROSCI, V6, P11, DOI 10.1038/nrn1587; Mudher A, 2004, MOL PSYCHIATR, V9, P522, DOI 10.1038/sj.mp.4001483; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Reiter LT, 2001, GENOME RES, V11, P1114, DOI 10.1101/gr.169101; Rival T, 2004, CURR BIOL, V14, P599, DOI 10.1016/j.cub.2004.03.039; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; ROTHBACHER U, 1995, DEV BIOL, V170, P717, DOI 10.1006/dbio.1995.1249; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Seidner GA, 2006, CURR BIOL, V16, P1026, DOI 10.1016/j.cub.2006.04.004; Shulman JM, 2003, GENETICS, V165, P1233; Slepko N, 2006, P NATL ACAD SCI USA, V103, P14367, DOI 10.1073/pnas.0602348103; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Thoreen CC, 2004, NAT GENET, V36, P553, DOI 10.1038/ng0604-553; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Wang DF, 2006, P NATL ACAD SCI USA, V103, P13244, DOI 10.1073/pnas.0605551103; Warrick JM, 2005, MOL CELL, V18, P37, DOI 10.1016/j.molcel.2005.02.030; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Waza M, 2006, J MOL MED, V84, P635, DOI 10.1007/s00109-006-0066-0; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Yang YF, 2003, NEURON, V37, P911, DOI 10.1016/S0896-6273(03)00143-0; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	85	141	146	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					169	178		10.1016/j.neuron.2006.09.025	http://dx.doi.org/10.1016/j.neuron.2006.09.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015234	Green Submitted, Bronze			2022-12-28	WOS:000241408100012
J	Castren, E; Tanila, H				Castren, Eero; Tanila, Heikki			Neurotrophins and dementia - Keeping in touch	NEURON			English	Editorial Material							TRANSGENIC MICE; ALZHEIMERS-DISEASE; GROWTH-FACTOR; FULL-LENGTH; TRANSPORT	Down's syndrome patients develop dementia similar to Alzheimer's disease and show elevated levels of amyloid precursor protein in brain. Two papers in this issue of Neuron show that reduced retrograde transport or signaling of the neurotrophins NGF or BDNF, respectively, may account for the neuronal pathology in mouse models of Down's syndrome.	Univ Helsinki, Neurosci Ctr, Sigrid Juselius Lab Mol Neurosci, Helsinki 00014, Finland; Univ Kuopio, AI Virtanen Inst, Dept Neurobiol, Kuopio 70211, Finland	Sigrid Juselius Foundation; University of Helsinki; University of Eastern Finland	Castren, E (corresponding author), Univ Helsinki, Neurosci Ctr, Sigrid Juselius Lab Mol Neurosci, Helsinki 00014, Finland.		Castrén, Eero/A-4618-2010	Castren, Eero/0000-0002-1402-2791				Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Dorsey SG, 2002, J NEUROSCI, V22, P2571, DOI 10.1523/JNEUROSCI.22-07-02571.2002; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Koponen E, 2004, MOL CELL NEUROSCI, V26, P166, DOI 10.1016/j.mcn.2004.01.006; Saarelainen T, 2000, SYNAPSE, V38, P102, DOI 10.1002/1098-2396(200010)38:1<102::AID-SYN11>3.0.CO;2-K; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SCOTT SA, 1995, J NEUROSCI, V15, P6213; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681	11	14	16	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 6	2006	51	1					1	3		10.1016/j.neuron.2006.06.019	http://dx.doi.org/10.1016/j.neuron.2006.06.019			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815323	Bronze			2022-12-28	WOS:000239037700001
J	Schluter, OM; Xu, WF; Malenka, RC				Schlueter, Oliver M.; Xu, Weifeng; Malenka, Robert C.			Alternative N-terminal domains of PSD-95 and SAP97 govern activity-dependent regulation of synaptic AMPA receptor function	NEURON			English	Article							TUMOR-SUPPRESSOR PROTEIN; OUT MICE REVEAL; EXCITATORY SYNAPSES; DISTINCT MECHANISMS; PLASTICITY; POTENTIATION; TRAFFICKING; CHANNEL; GENE; MULTIMERIZATION	PSD-95 and SAP97 are scaffolding proteins that have been implicated in regulating AMPA receptor incorporation and function at synapses. Gain- and loss-of-function approaches, however, have generated conflicting results. To minimize adaptations during development and potential dominant-negative effects of overexpression, we have combined silencing of endogenous PSD-95 in mature neurons with heterologous expression of specific SAP97 or PSD-95 isoforms. We find that both PSD-95 and SAP97 contain alternative N termini expressing either double cysteines that normally are palmitoylated (alpha-isoforms) or an L27 domain (beta-isoforms). Whereas alpha-isoforms of PSD-95 and SAP97 influence AMPA receptor-mediated synaptic strength independent of activity, the effects of beta-isoforms are regulated by activity in a CaMKII-dependent manner. Importantly, the synaptic effects of the beta-isoforms are masked by the endogenous alpha-isoform of PSD-95. These results demonstrate that the different N termini of the predominant endogenous forms of PSD-95 (alpha-isoform) and SAP97 (beta-isoform) govern their role in regulating synaptic function.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA	Stanford University	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.	malenka@stanford.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH063394, R01MH063394, F32MH075220] Funding Source: NIH RePORTER; NIMH NIH HHS [MH063394, MH075220] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Caruana G, 2001, MOL CELL BIOL, V21, P1475, DOI 10.1128/MCB.21.5.1475-1483.2001; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Gardoni F, 2003, J BIOL CHEM, V278, P44745, DOI 10.1074/jbc.M303576200; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Klocker N, 2002, EUR J NEUROSCI, V16, P1517, DOI 10.1046/j.1460-9568.2002.02228.x; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Lee S, 2002, MOL CELL BIOL, V22, P1778, DOI 10.1128/MCB.22.6.1778-1791.2002; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin ZX, 1997, NEURON, V18, P153, DOI 10.1016/S0896-6273(01)80054-4; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mauceri D, 2004, J BIOL CHEM, V279, P23813, DOI 10.1074/jbc.M402796200; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; McLaughlin M, 2002, J BIOL CHEM, V277, P6406, DOI 10.1074/jbc.M108724200; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Parker MJ, 2004, J NEUROSCI, V24, P378, DOI 10.1523/JNEUROSCI.3865-03.2004; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Sans N, 2001, J NEUROSCI, V21, P7506, DOI 10.1523/JNEUROSCI.21-19-07506.2001; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schluter OM, 1999, J NEUROSCI, V19, P5834, DOI 10.1523/JNEUROSCI.19-14-05834.1999; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; Wu HJ, 2000, EMBO J, V19, P5740, DOI 10.1093/emboj/19.21.5740; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0	53	187	188	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 6	2006	51	1					99	111		10.1016/j.neuron.2006.05.016	http://dx.doi.org/10.1016/j.neuron.2006.05.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815335	Bronze			2022-12-28	WOS:000239037700013
J	Burdakov, D; Jensen, LT; Alexopoulos, H; Williams, RH; Fearon, IM; O'Kelly, I; Gerasimenko, O; Fugger, L; Verkhratsky, A				Burdakov, Denis; Jensen, Lise T.; Alexopoulos, Haris; Williams, Rhiannan H.; Fearon, Ian M.; O'Kelly, Ita; Gerasimenko, Oleg; Fugger, Lars; Verkhratsky, Alexei			Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose	NEURON			English	Article							POTASSIUM CHANNELS; HYPOTHALAMIC NEURONS; SYNAPTIC PLASTICITY; HYPOCRETIN NEURONS; SENSING NEURONS; PLASMA-MEMBRANE; TASK-1 KCNK3; RAT; NARCOLEPSY; EXPRESSION	Glucose-inhibited neurons orchestrate behavior and metabolism according to body energy levels, but how glucose inhibits these cells is unknown. We studied glucose inhibition of orexin/hypocretin neurons, which promote wakefulness (their loss causes narcolepsy) and also regulate metabolism and reward. Here we demonstrate that their inhibition by glucose is mediated by ion channels not previously implicated in central or peripheral glucose sensing: tandem-pore K+ (K-2P) channels. Importantly, we show that this electrical mechanism is sufficiently sensitive to encode variations in glucose levels reflecting those occurring physiologically between normal meals. Moreover, we provide evidence that glucose acts at an extracellular site on orexin neurons, and this information is transmitted to the channels by an intracellular intermediary that is not ATP, Ca2+, or glucose itself. These results reveal an unexpected energy-sensing pathway in neurons that regulate states of consciousness and energy balance.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Aarhus Univ Hosp, Dept Clin Immunol, Skejby, Denmark; Univ Oxford, Univ Lab Physiol, Oxford, England; Univ Liverpool, Physiol Lab, Liverpool, Merseyside, England; Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford, England; Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Weatherall Inst Mol Med, Oxford, England	University of Manchester; Aarhus University; University of Oxford; University of Liverpool; University of Oxford; University of Oxford	Burdakov, D (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	dib22@cam.ac.uk	Verkhratsky, Alexei/J-4527-2013; Gerasimenko, Oleg/A-6622-2010	Verkhratsky, Alexei/0000-0003-2592-9898; Gerasimenko, Oleg/0000-0003-2573-8258; Alexopoulos, Harry/0000-0002-8672-7619; Burdakov, Denis/0000-0002-9134-9165	Medical Research Council [MC_U137881016, G0401222] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0401222, MC_U137881016] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; ANAND BK, 1964, AM J PHYSIOL, V207, P1146, DOI 10.1152/ajplegacy.1964.207.5.1146; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Berg AP, 2004, J NEUROSCI, V24, P6693, DOI 10.1523/JNEUROSCI.1408-04.2004; Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Burdakov D, 2004, EUR J NEUROSCI, V20, P3281, DOI 10.1111/j.1460-9568.2004.03815.x; Burdakov D, 2003, J NEUROSCI, V23, P4951; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; DODT HU, 2002, INFRARED GUIDED LASE; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Gribkoff VK, 2001, NEUROSCIENTIST, V7, P166, DOI 10.1177/107385840100700211; Han J, 2003, J PHYSIOL-LONDON, V546, P625, DOI 10.1113/jphysiol.2002.032094; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hopwood SE, 2005, J PHYSIOL-LONDON, V568, P145, DOI 10.1113/jphysiol.2005.093070; Kang DW, 2004, J PHYSIOL-LONDON, V554, P64, DOI 10.1113/jphysiol.2003.054387; Kindler CH, 2000, MOL BRAIN RES, V80, P99, DOI 10.1016/S0169-328X(00)00136-4; Kintner DB, 2000, NEUROCHEM RES, V25, P1385, DOI 10.1023/A:1007664700661; Leonoudakis D, 1998, J NEUROSCI, V18, P868; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Li Y, 2002, NEURON, V36, P1169, DOI 10.1016/S0896-6273(02)01132-7; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Medhurst AD, 2001, MOL BRAIN RES, V86, P101, DOI 10.1016/S0169-328X(00)00263-1; Meuth SG, 2003, J NEUROSCI, V23, P6460; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Mogami H, 1998, EMBO J, V17, P435, DOI 10.1093/emboj/17.2.435; O'Connell AD, 2002, BBA-BIOMEMBRANES, V1566, P152, DOI 10.1016/S0005-2736(02)00597-7; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; OOMURA Y, 1974, NATURE, V247, P284, DOI 10.1038/247284a0; Patel AJ, 2001, TRENDS NEUROSCI, V24, P339, DOI 10.1016/S0166-2236(00)01810-5; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; PELLERIN L, 1994, NEUROSCIENTIST, V56, P297; PETERSEN OH, 1994, ANNU REV PHYSIOL, V56, P297, DOI 10.1146/annurev.ph.56.030194.001501; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; PHILLIPSON EA, 1986, HDB PHYSL 3, V2, P649; PHILPOTT HG, 1979, NATURE, V281, P684, DOI 10.1038/281684a0; Rajan S, 2005, CELL, V121, P37, DOI 10.1016/j.cell.2005.01.019; Rajan S, 2000, J BIOL CHEM, V275, P16650, DOI 10.1074/jbc.M000030200; Routh VH, 2002, PHYSIOL BEHAV, V76, P403, DOI 10.1016/S0031-9384(02)00761-8; Rusznak Z, 2004, CELL MOL LIFE SCI, V61, P1532, DOI 10.1007/s00018-004-4082-3; Sakurai T, 1999, J BIOL CHEM, V274, P17771, DOI 10.1074/jbc.274.25.17771; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Selbach O, 2004, NEUROSCIENCE, V127, P519, DOI 10.1016/j.neuroscience.2004.05.012; SILVER IA, 1994, J NEUROSCI, V14, P5068; Smith Nicola P, 2002, Paediatr Respir Rev, V3, P339, DOI 10.1016/S1526-0542(02)00262-2; Talley EM, 2001, J NEUROSCI, V21, P7491, DOI 10.1523/JNEUROSCI.21-19-07491.2001; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Talley EM, 2002, J BIOL CHEM, V277, P17733, DOI 10.1074/jbc.M200502200; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; Verheugen JAH, 1999, J NEUROSCI, V19, P2546; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yamamoto Y, 2003, HISTOCHEM CELL BIOL, V120, P335, DOI 10.1007/s00418-003-0577-5; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3	72	222	224	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					711	722		10.1016/j.neuron.2006.04.032	http://dx.doi.org/10.1016/j.neuron.2006.04.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731510	Bronze			2022-12-28	WOS:000238165000007
J	Mitchell, JP; Macrae, CN; Banaji, MR				Mitchell, JP; Macrae, CN; Banaji, MR			Dissociable medial prefrontal contributions to judgments of similar and dissimilar others	NEURON			English	Article							TEMPORO-PARIETAL JUNCTION; IMPLICIT ASSOCIATION TEST; EVENT-RELATED FMRI; SOCIAL COGNITION; EMOTIONAL STATE; MIND; SELF; CORTEX; SIMULATION; MEMORY	Human social interaction requires the recognition that other people are governed by the same types of mental states-beliefs, desires, intentions-that guide one's own behavior. We used functional neurolmaging to examine how perceivers; make mental state inferences when such self-other overlap can be assumed (when the other is similar to oneself) and when it cannot (when the other is dissimilar from oneself). We observed a double dissociation such that mentalizing about a similar other engaged a region of ventral mPFC linked to self-referential thought, whereas mentalizing about a dissimilar other engaged a more dorsal subregion of mPFC. The overlap between judgments of self and similar others suggests the plausibility of "simulation" accounts of social cognition, which posit that perceivers can use knowledge about themselves to infer the mental states of others.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; Univ Aberdeen, Sch Psychol, Aberdeen AB24 2UB, Scotland	Harvard University; University of Aberdeen	Mitchell, JP (corresponding author), Harvard Univ, Dept Psychol, William James Hall,33 Kirkland St, Cambridge, MA 02138 USA.	mitchell@wjh.harvard.edu	Macrae, Neil/C-4761-2008		NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NCRR NIH HHS [P41RR14075] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Ames DR, 2004, J PERS SOC PSYCHOL, V87, P340, DOI 10.1037/0022-3514.87.3.340; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.3.CO;2-N; Davies M., 1995, FOLK PSYCHOL THEORY; Davies M., 1995, FOLK PSYCHOL; DEMOULIN S, 2004, EUROPEAN REV SOCIAL, P259; DENNETT DC, 1987, INT STANCE; Fazio R.H., 1990, RES METHODS PERSONAL, V11, P74; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher HL, 2002, NEUROIMAGE, V16, P814, DOI 10.1006/nimg.2002.1117; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; GOEL V, 1995, NEUROREPORT, V6, P1741, DOI 10.1097/00001756-199509000-00009; GORDON RM, 1992, MIND LANG, V1, P158, DOI DOI 10.1111/J.1468-0017.1986.TB00324.X; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gregory C, 2002, BRAIN, V125, P752, DOI 10.1093/brain/awf079; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Heal J, 1986, LANGUAGE MIND LOGIC, P135; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; McCabe K, 2001, P NATL ACAD SCI USA, V98, P11832, DOI 10.1073/pnas.211415698; Meltzoff A. N., 2001, INTENTIONS INTENTION, P171; Mitchell JP, 2005, J COGNITIVE NEUROSCI, V17, P1306, DOI 10.1162/0898929055002418; Mitchell JP, 2005, TRENDS COGN SCI, V9, P363, DOI 10.1016/j.tics.2005.06.010; Mitchell JP, 2005, NEUROIMAGE, V26, P251, DOI 10.1016/j.neuroimage.2005.01.031; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Monin B, 2003, J PERS SOC PSYCHOL, V85, P1035, DOI 10.1037/0022-3514.85.6.1035; MORAN JM, 2006, IN PRESS J COGN NEUR; Nickerson RS, 1999, PSYCHOL BULL, V125, P737, DOI 10.1037/0033-2909.125.6.737; Niedenthal PM, 2001, COGNITION EMOTION, V15, P853, DOI 10.1080/02699930143000194; Niedenthal PM, 2000, EUR J SOC PSYCHOL, V30, P211, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<211::AID-EJSP988>3.0.CO;2-3; NORTHOFF G, 2006, IN PRESS NEUROI 0205; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; RUFFMAN T, 1996, MIND LANG, V11, P387; Saxe R, 2005, TRENDS COGN SCI, V9, P174, DOI 10.1016/j.tics.2005.01.012; Saxe R, 2003, NEUROIMAGE, V19, P1835, DOI 10.1016/S1053-8119(03)00230-1; Saxe R, 2005, NEUROPSYCHOLOGIA, V43, P1391, DOI 10.1016/j.neuropsychologia.2005.02.013; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tomasello Michael, 1999, CULTURAL ORIGINS HUM; Vaes J, 2003, J PERS SOC PSYCHOL, V85, P1016, DOI 10.1037/0022-3514.85.6.1016; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008	52	718	734	1	72	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 18	2006	50	4					655	663		10.1016/j.neuron.2006.03.040	http://dx.doi.org/10.1016/j.neuron.2006.03.040			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701214	Bronze			2022-12-28	WOS:000237875200015
J	Wagh, DA; Rasse, TM; Asan, E; Hofbauer, A; Schwenkert, I; Durrbeck, H; Buchner, S; Dabauvalle, MC; Schmidt, M; Olin, G; Wichmann, C; Kittel, R; Sigrist, SJ; Buchner, E				Wagh, DA; Rasse, TM; Asan, E; Hofbauer, A; Schwenkert, I; Durrbeck, H; Buchner, S; Dabauvalle, MC; Schmidt, M; Olin, G; Wichmann, C; Kittel, R; Sigrist, SJ; Buchner, E			Bruchpilot, a protein with homology to ELKS/CAST, is required for structural integrity and function of synaptic active zones in Drosophila	NEURON			English	Article							RIM-BINDING PROTEINS; GLUTAMATE-RECEPTOR; NEUROMUSCULAR-JUNCTIONS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC CYTOMATRIX; MUTANT DROSOPHILA; WILD-TYPE; ULTRASTRUCTURE; MELANOGASTER; CAST	Neurotransmitters are released at presynaptic active zones (AZs). In the fly Drosophila, monoclonal antibody (MAB) nc82 specifically labels AZs. We employ nc82 to identify Bruchpilot protein (BRP) as a previously unknown AZ component. BRP shows homology to human AZ protein ELKS/CAST/ERC, which binds RIM1 in a complex with Bassoon and Munc13-1. The C terminus of BRP displays structural similarities to multifunctional cytoskeletal proteins. During development, transcription of the bruchpilot locus (brp) coincides with neuronal differentiation. Panneural reduction of BRP expression by RNAi constructs permits a first functional characterization of this large AZ protein: larvae show reduced evoked but normal spontaneous transmission at neuromuscular junctions. In adults, we observe loss of T bars at active zones, absence of synaptic components in electroretinogram, locomotor inactivity, and unstable flight (hence "bruchpilot"-crash pilot). We propose that BRP is critical for intact AZ structure and normal-evoked neurotransmitter release at chemical synapses of Drosophila.	Theodor Boveri Inst Biowissen, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany; European Neurosci Inst Gottingen, D-37077 Gottingen, Germany; Inst Anat & Zellbiol, D-97070 Wurzburg, Germany; Inst Zool, Lehrstuhl Entwicklungsbiol, D-93047 Regensburg, Germany; Theodor Boveri Inst Biowissenschaft, Lehrstuhl Zell & Entwicklungsbiol, D-97074 Wurzburg, Germany	University of Wurzburg	Buchner, E (corresponding author), Theodor Boveri Inst Biowissen, Lehrstuhl Genet & Neurobiol, D-97074 Wurzburg, Germany.	buchner@biozentrum.uni-wuerzburg.de	Kittel, Robert J/G-6404-2015	Kittel, Robert J/0000-0002-9199-4826; Schmidt, Manuela/0000-0003-1972-3519				Albin SD, 2004, J NEUROSCI, V24, P6871, DOI 10.1523/JNEUROSCI.1538-04.2004; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Atwood HL, 1996, J NEUROSCI METH, V69, P51, DOI 10.1016/S0165-0270(96)00020-9; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; BOSCHEK CB, 1971, Z ZELLFORSCH MIK ANA, V118, P369; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1993, J NEUROSCI, V13, P144; BUCHNER E, 1986, CELL TISSUE RES, V246, P57; BUCHNER E, 1988, CELL TISSUE RES, V253, P357, DOI 10.1007/BF00222292; BURG MG, 1993, EMBO J, V12, P911, DOI 10.1002/j.1460-2075.1993.tb05732.x; Deguchi-Tawarada M, 2004, GENES CELLS, V9, P15, DOI 10.1111/j.1356-9597.2004.00697.x; Deken SL, 2005, J NEUROSCI, V25, P5975, DOI 10.1523/JNEUROSCI.0804-05.2005; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2001, CELL MOL LIFE SCI, V58, P94, DOI 10.1007/PL00000781; Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Harden N, 1996, MOL CELL BIOL, V16, P1896; HEISENBERG M, 1971, J EXP BIOL, V55, P85; HOFBAUER A, 1991, THESIS U WURZBURG WU; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Kawasaki F, 2004, J NEUROSCI, V24, P282, DOI 10.1523/JNEUROSCI.3553-03.2004; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Laissue PP, 1999, J COMP NEUROL, V405, P543; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; MEINERTZHAGEN IA, 1993, PROG RETIN RES, V12, P13, DOI 10.1016/0278-4327(93)90003-C; Meinertzhagen IA, 1996, J NEUROSCI METH, V69, P59, DOI 10.1016/S0165-0270(96)00021-0; Ohara-Imaizumi M, 2005, MOL BIOL CELL, V16, P3289, DOI 10.1091/mbc.E04-09-0816; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Rein K, 1999, CURR BIOL, V9, P93, DOI 10.1016/S0960-9822(99)80021-9; Rheuben MB, 1999, INT REV NEUROBIOL, V43, P69, DOI 10.1016/S0074-7742(08)60541-3; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Rosenmund C, 2003, CURR OPIN NEUROBIOL, V13, P509, DOI 10.1016/j.conb.2003.09.011; Samson ML, 2003, MECH DEVELOP, V120, P373, DOI 10.1016/S0925-4773(02)00444-6; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Shayan AJ, 2000, J NEUROBIOL, V43, P89, DOI 10.1002/(SICI)1097-4695(200004)43:1<89::AID-NEU8>3.0.CO;2-L; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004	47	617	624	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					833	844		10.1016/j.neuron.2006.02.008	http://dx.doi.org/10.1016/j.neuron.2006.02.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543132	Bronze			2022-12-28	WOS:000236227500012
J	Wise, RA				Wise, RA			A new peptide input to learning and addiction	NEURON			English	Editorial Material							CORTICOTROPIN-RELEASING-FACTOR; STRESS-INDUCED RELAPSE; COCAINE-SEEKING; DOPAMINE; NEURONS; HEROIN	In this issue of Neuron, Borgland et al. report that the arousal-associated peptide orexin enhances LTP-like changes in glutamatergic excitability of ventral tegmental dopamine neurons. This parallels a similar effect of corticotropin-releasing factor and suggests a form of neuroadaptation that increases the likelihood of addiction relapse.	NIDA, Intramural Res Program, US Dept HHS, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Wise, RA (corresponding author), NIDA, Intramural Res Program, US Dept HHS, NIH, 5500 Nathan Shock Dr, Baltimore, MD 21224 USA.		Wise, Roy A/A-6465-2012		NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000471, Z01DA000471] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016; Boutrel B, 2005, P NATL ACAD SCI USA, V102, P19168, DOI 10.1073/pnas.0507480102; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Narita M, 2006, J NEUROSCI, V26, P398, DOI 10.1523/JNEUROSCI.2761-05.2006; Shaham Y, 1997, J NEUROSCI, V17, P2605; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Ungless MA, 2003, NEURON, V39, P401, DOI 10.1016/S0896-6273(03)00461-6; Wang B, 2005, J NEUROSCI, V25, P5389, DOI 10.1523/JNEUROSCI.0955-05.2005	9	3	3	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 16	2006	49	4					483	484		10.1016/j.neuron.2006.01.028	http://dx.doi.org/10.1016/j.neuron.2006.01.028			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476658	Bronze			2022-12-28	WOS:000235643800002
J	Suto, F; Tsuboi, M; Kamiya, H; Mizuno, H; Kiyama, Y; Komai, S; Shimizu, M; Sanbo, M; Yagi, T; Hiromi, Y; Chedotal, A; Mitchell, KJ; Manabe, T; Fujisawa, H				Suto, Fumikazu; Tsuboi, Miu; Kamiya, Haruyuki; Mizuno, Hidenobu; Kiyama, Yuji; Komai, Shoji; Shimizu, Masayuki; Sanbo, Makoto; Yagi, Takeshi; Hiromi, Yasushi; Chedotal, Alain; Mitchell, Kevin J.; Manabe, Toshiya; Fujisawa, Hajime			Interactions between plexin-A2, plexin-A4, and semaphorin 6A control lamina-restricted projection of hippocampal mossy fibers	NEURON			English	Article							LONG-TERM POTENTIATION; SECRETED SEMAPHORINS; DENTATE GYRUS; GUIDANCE; RECEPTORS; NEURONS; MICE; NEUROPILIN-2; GROWTH; TRANSMISSION	Hippocampal mossy fibers project preferentially to the stratum lucidum, the proximal-most lamina of the suprapyramidal region of CA3. The molecular mechanisms that govern this lamina-restricted projection are still unknown. We examined the projection pattern of mossy fibers in mutant mice for semaphorin receptors plexin-A2 and plexin-A4, and their ligand, the transmembrane semaphorin Sema6A. We found that plexin-A2 deficiency causes a shift of mossy fibers from the suprapyramidal region to the infra- and intrapyramidal regions, while plexin-A4 deficiency induces inappropriate spreading of mossy fibers within CA3. We also report that the plexin-A2 loss-of-function phenotype is genetically suppressed by Sema-6A loss of function. Based on these results, we propose a model for the lamina-restricted projection of mossy fibers: the expression of plexinA4 on mossy fibers prevents them from entering the Sema6A-expressing suprapyramidal region of CA3 and restricts them to the proximal-most part, where Sema6A repulsive activity is attenuated by plexin-A2.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century COE Program, Nagoya, Aichi 4648602, Japan; Natl Inst Genet, Div Dev Genet, Mishima, Shizuoka 4118540, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Grp Dev Neurobiol, Nagoya, Aichi 4648602, Japan; Hokkaido Univ, Grad Sch Med, Dept Mol Neuroanat, Sapporo, Hokkaido 0608637, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Neuronal Network, Tokyo 1088639, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Kumamoto Univ, Div Cellular Interact, Inst Embryol & Genet, Kumamoto 8600811, Japan; Natl Inst Physiol Sci, Lab Neurobiol & Behav Genet, Okazaki, Aichi 4448585, Japan; Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; Univ Paris 06, CNRS, UMR 7102, F-75005 Paris, France; Trinity Coll Dublin, Smufit Inst Genet, Dublin 2, Ireland	Nagoya University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Japan Science & Technology Agency (JST); Nagoya University; Hokkaido University; University of Tokyo; Nara Institute of Science & Technology; Kumamoto University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University; Graduate University for Advanced Studies - Japan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Trinity College Dublin	Fujisawa, H (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, 21st Century COE Program, Nagoya, Aichi 4648602, Japan.	fujisawa@bio.nagoya-u.ac.jp	Komai, Shoji/L-9273-2018; Chedotal, Alain/F-2750-2017; Kamiya, Haruyuki/E-7199-2010	Komai, Shoji/0000-0002-8474-7800; Chedotal, Alain/0000-0001-7577-3794; Kamiya, Haruyuki/0000-0002-2618-3146; Mitchell, Kevin/0000-0002-3433-4530				Amaral David G., 1995, P443; Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Brinks H, 2004, J NEUROSCI, V24, P3862, DOI 10.1523/JNEUROSCI.5296-03.2004; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Forster E, 2006, NAT REV NEUROSCI, V7, P259, DOI 10.1038/nrn1882; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goslin K., 1998, CULTURING NERVE CELL, P339; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Mizuhashi S, 2001, J NEUROSCI, V21, P6181, DOI 10.1523/JNEUROSCI.21-16-06181.2001; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pozas E, 2001, MOL CELL NEUROSCI, V18, P26, DOI 10.1006/mcne.2001.0999; Sahay A, 2003, J NEUROSCI, V23, P6671; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Skutella T, 2001, TRENDS NEUROSCI, V24, P107, DOI 10.1016/S0166-2236(00)01717-3; Stein E, 1999, J NEUROSCI, V19, P8885, DOI 10.1523/JNEUROSCI.19-20-08885.1999; Steup A, 1999, EUR J NEUROSCI, V11, P729, DOI 10.1046/j.1460-9568.1999.00517.x; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039; Zhao ST, 2003, J NEUROSCI, V23, P7351; Zimmer M, 2003, NAT CELL BIOL, V5, P869, DOI 10.1038/ncb1045	40	148	157	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					535	547		10.1016/j.neuron.2007.01.028	http://dx.doi.org/10.1016/j.neuron.2007.01.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296555	Bronze			2022-12-28	WOS:000245126900012
J	Mumm, JS; Williams, PR; Godinho, L; Koerber, A; Pittman, AJ; Roeser, T; Chien, CB; Baier, H; Wong, ROL				Mumm, Jeff S.; Williams, Philip R.; Godinho, Leanne; Koerber, Amy; Pittman, Andrew J.; Roeser, Tobias; Chien, Chi-Bin; Baier, Herwig; Wong, Rachel O. L.			In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells	NEURON			English	Article							GROWTH CONE; DIFFERENTIATION; STRATIFICATION; PATHWAYS; DYNAMICS; AXONS; SPECIFICITY; MATURATION; RESPONSES; CIRCUITS	Targeting of axons and dendrites to particular synaptic laminae is an important mechanism by which precise patterns of neuronal connectivity are established. Although axons target specific laminae during development, dendritic lamination has been thought to occur largely by pruning of inappropriately placed arbors. We discovered by in vivo time-lapse imaging that retinal ganglion cell (RGC) dendrites in zebrafish show growth patterns implicating dendritic targeting as a mechanism for contacting appropriate synaptic partners. Populations of RGCs labeled in transgenic animals establish distinct dendritic strata sequentially, predominantly from the inner to outer retina. Imaging individual cells over successive days confirmed that multistratified RGCs generate strata sequentially, each arbor elaborating within a specific lamina. Simultaneous imaging of RGCs and subpopulations of presynaptic amacrine interneurons revealed that RGC dendrites appear to target amacrine plexuses that had already laminated. Dendritic targeting of prepatterned afferents may thus be a novel mechanism for establishing proper synaptic connectivity.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Inst Brain, Salt Lake City, UT 84112 USA; Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Physiol, Dept Genet & Dev Biol, San Francisco, CA 94158 USA	Washington University (WUSTL); Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Mumm, JS (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.	jeff@luminomics.com; wongr2@u.washington.edu	Mumm, Jeff S/F-3125-2013	Mumm, Jeff/0000-0002-2575-287X	NEI NIH HHS [EY14358, R01 EY014358, EY12873, EY13855, R01 EY012873, F32 EY014084, EY12406, R01 EY013855, R01 EY012406] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012873, R01EY014358, F32EY014084, R01EY013855, R01EY012406] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Bansal A, 2000, J NEUROSCI, V20, P7672; Bodnarenko SR, 1999, NEUROREPORT, V10, P2955, DOI 10.1097/00001756-199909290-00015; BODNARENKO SR, 1995, J NEUROSCI, V15, P7037; BURRILL JD, 1995, J NEUROSCI, V15, P2935; Chalupa LM, 2004, PROG RETIN EYE RES, V23, P31, DOI 10.1016/j.preteyeres.2003.10.001; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; DANN JF, 1988, J NEUROSCI, V8, P1485; Easter SS, 1996, DEV BIOL, V180, P646; Easter SS, 1997, DEV PSYCHOBIOL, V31, P267, DOI 10.1002/(SICI)1098-2302(199712)31:4<267::AID-DEV4>3.0.CO;2-P; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Godinho L, 2005, DEVELOPMENT, V132, P5069, DOI 10.1242/dev.02075; Goldberg JL, 2002, SCIENCE, V296, P1860, DOI 10.1126/science.1068428; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LETTVIN JY, 1959, P IRE, V47, P1940, DOI 10.1109/JRPROC.1959.287207; Lin JW, 2004, DEV BIOL, V274, P490, DOI 10.1016/j.ydbio.2004.07.002; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; LOHMANN C, 2005, IMAGING NEUROSCIENCE, P171; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Mangrum WI, 2002, VISUAL NEUROSCI, V19, P767, DOI 10.1017/S0952523802196076; MASLIM J, 1986, J COMP NEUROL, V254, P382, DOI 10.1002/cne.902540310; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Miller B, 2001, J COMP NEUROL, V436, P17; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P271, DOI 10.1007/BF00522528; Mumm JS, 2005, PROG BRAIN RES, V147, P155, DOI 10.1016/S0079-6123(04)47012-5; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191; Ozaki S, 1997, J COMP NEUROL, V380, P215; Peterson RE, 2001, J COMP NEUROL, V429, P530, DOI 10.1002/1096-9861(20010122)429:4<530::AID-CNE2>3.0.CO;2-C; Rajan I, 1998, J NEUROSCI, V18, P7836; RAMOA AS, 1988, J NEUROSCI, V8, P4239; Ramon y Cajal S, 1972, STRUCTURE RETINA; Reese BE, 2001, VISUAL NEUROSCI, V18, P559, DOI 10.1017/S0952523801184063; Ren JQ, 2002, VISION RES, V42, P293, DOI 10.1016/S0042-6989(01)00284-X; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Sernagor E, 2001, PROG RETIN EYE RES, V20, P139, DOI 10.1016/S1350-9462(00)00024-0; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Stacy RC, 2005, J NEUROSCI, V25, P9347, DOI 10.1523/JNEUROSCI.1800-05.2005; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; VAUGHN JE, 1988, SYNAPSE, V2, P69, DOI 10.1002/syn.890020110; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1999, J NEUROSCI, V19, P4472; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Xu HP, 2004, NEUROSCIENTIST, V10, P337, DOI 10.1177/1073858404265254; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8	62	121	124	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					609	621		10.1016/j.neuron.2006.10.004	http://dx.doi.org/10.1016/j.neuron.2006.10.004			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114046	Bronze, Green Accepted			2022-12-28	WOS:000242413100009
J	Huberman, AD; Speer, CM; Chapman, B				Huberman, Andrew D.; Speer, Colenso M.; Chapman, Barbara			Spontaneous retinal activity mediates development of ocular dominance columns and binocular receptive fields in V1	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; EYE-SPECIFIC SEGREGATION; SUBPLATE NEURONS; EPHRIN-AS; CORTICAL COLUMNS; CRITICAL PERIOD; STRIATE CORTEX; IN-VIVO; FERRET	The mechanisms that give rise to ocular dominance columns (ODCs) during development are controversial. Early experiments indicated a key role for retinal activity in ODC formation. However, later studies showed that in those early experiments, the retinal activity perturbation was initiated afterODCs had already formed. Moreover, recent studies concluded that early eye removals do not impact ODC segregation. Here we blocked spontaneous retinal activity during the very early stages of ODC development. This permanently disrupted the anatomical organization of ODCs and led to a dramatic increase in receptive field size for binocular cells in primary visual cortex. Our data suggest that early spontaneous retinal activity conveys crucial information about whether thalamocortical axons represent one or the other eye and that this activity mediates binocular competition important for shaping receptive fields in primary visual cortex.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chapman, B (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	bxchapman@ucdavis.edu		Speer, Colenso/0000-0002-3076-7072	NEI NIH HHS [R01 EY011369-11, R01 EY011369] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011369] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adams DL, 2006, J NEUROPHYSIOL, V96, P2253, DOI 10.1152/jn.00131.2006; Adams DL, 2003, NAT NEUROSCI, V6, P113, DOI 10.1038/nn1004; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Feller MB, 2005, CURR OPIN NEUROBIOL, V15, P94, DOI 10.1016/j.conb.2005.01.012; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GRUBB MS, 2003, NEURON, V30, P1151; GUILLERY RW, 1985, DEV BRAIN RES, V20, P221, DOI 10.1016/0165-3806(85)90109-9; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Huberman AD, 2002, J NEUROSCI, V22, P9419; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; LAW MI, 1988, J COMP NEUROL, V278, P157, DOI 10.1002/cne.902780202; LEVAY S, 1985, J NEUROSCI, V5, P486; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; LOWEL S, 1994, J NEUROSCI, V14, P7451; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 1999, J COMP NEUROL, V407, P151; STRYKER MP, 1986, J NEUROSCI, V6, P2117; Usrey WM, 2003, J NEUROPHYSIOL, V89, P1003, DOI 10.1152/jn.00749.2002; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; White LE, 1999, J NEUROSCI, V19, P7089, DOI 10.1523/JNEUROSCI.19-16-07089.1999; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; ZAHS KR, 1988, J NEUROPHYSIOL, V59, P1410, DOI 10.1152/jn.1988.59.5.1410	43	92	94	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					247	254		10.1016/j.neuron.2006.07.028	http://dx.doi.org/10.1016/j.neuron.2006.07.028			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046688	Green Accepted, Bronze			2022-12-28	WOS:000241799900006
J	Wang, XQ; Deriy, LV; Foss, S; Huang, P; Lamb, FS; Kaetzel, MA; Bindokas, V; Marks, JD; Nelson, DJ				Wang, Xue Qing; Deriy, Ludmila V.; Foss, Sarah; Huang, Ping; Lamb, Fred S.; Kaetzel, Marcia A.; Bindokas, Vytautas; Marks, Jeremy D.; Nelson, Deborah J.			CLC-3 channels modulate excitatory synaptic transmission in hippocampal neurons	NEURON			English	Article							CHLORIDE CHANNEL; COTRANSPORTER KCC2; SK CHANNELS; VESICLES; ANION; IDENTIFICATION; CONDUCTANCE; ACTIVATION; PORES; BLOCK	It is well established that ligand-gated chloride flux across the plasma membrane modulates neuronal excitability. We find that a voltage-dependent Cl- conductance increases neuronal excitability in immature rodents as well, enhancing the time course of NMDA receptor-mediated miniature excitatory postsynaptic potentials (mEPSPs). This Cl- conductance is activated by CaMKII, is electrophysiologically identical to the CaMKII-activated CLC-3 conductance in non-neuronal cells, and is absent in clc-3(-/-) mice. Systematically decreasing [CI-](i) to mimic postnatal [CI-](i) regulation progressively decreases the amplitude and decay time constant of spontaneous mEPSPs. This Cl--dependent change in synaptic strength is absent in clc-3(-/-) mice. Using surface biotinylation, immunohistochemistry, electron microscopy, and coimmuno-precipitation studies, we find that CLC-3 channels are localized on the plasma membrane, at postsynaptic sites, and in association with NMDA receptors. This is the first demonstration that a voltage-dependent chloride conductance modulates neuronal excitability. By increasing postsynaptic potentials in a Cl(-)dependent fashion, CLC-3 channels regulate neuronal excitability postsynaptically in immature neurons.	Univ Chicago, Dept Neurobiol Physiol & Pharmacol, Chicago, IL 60637 USA; Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Univ Cincinnati, Dept Genome Sci, Cincinnati, OH 45267 USA	University of Chicago; University of Chicago; University of Iowa; University System of Ohio; University of Cincinnati	Nelson, DJ (corresponding author), Univ Chicago, Dept Neurobiol Physiol & Pharmacol, Chicago, IL 60637 USA.	nelson@uchicago.edu	Marks, Jeremy/W-2087-2019	Marks, Jeremy/0000-0002-2644-5257; Lamb, Fred/0000-0003-2955-5133	NIDDK NIH HHS [DK57882] Funding Source: Medline; NIGMS NIH HHS [GM36823] Funding Source: Medline; NINDS NIH HHS [R01 NS038547-02, R01 NS038547, R01 NS038547-04, R01 NS038547-05S1, R01 NS38547, R01 NS038547-05, R01 NS038547-03] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038547] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BLATZ AL, 1991, J PHYSIOL-LONDON, V441, P1; CURRIE KPM, 1995, J PHYSIOL-LONDON, V482, P291, DOI 10.1113/jphysiol.1995.sp020518; Davis KE, 1998, J NEUROSCI, V18, P2475; Dickerson LW, 2002, BRAIN RES, V958, P227, DOI 10.1016/S0006-8993(02)03519-9; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; FRANCIOLINI F, 1987, J GEN PHYSIOL, V90, P453, DOI 10.1085/jgp.90.4.453; Huang LQ, 2005, J BIOL CHEM, V280, P36150, DOI 10.1074/jbc.M507706200; Huang P, 2001, J BIOL CHEM, V276, P20093, DOI 10.1074/jbc.M009376200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Lin YW, 1999, J GEN PHYSIOL, V114, P1, DOI 10.1085/jgp.114.1.1; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Ludewig U, 1997, BIOPHYS J, V73, P789, DOI 10.1016/S0006-3495(97)78111-6; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; MADISON DV, 1986, NATURE, V321, P695, DOI 10.1038/321695a0; Marks JD, 2005, J NEUROSCI, V25, P6561, DOI 10.1523/JNEUROSCI.1450-05.2005; MARKS JD, 1988, BRAIN RES DEV BRIAN, V124, P101; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nobile M, 2000, FEBS LETT, V479, P10, DOI 10.1016/S0014-5793(00)01876-7; Pusch M, 2001, J GEN PHYSIOL, V118, P45, DOI 10.1085/jgp.118.1.45; Robinson NC, 2004, J PHYSIOL-LONDON, V556, P353, DOI 10.1113/jphysiol.2003.058032; Sacchi O, 1999, J NEUROPHYSIOL, V82, P1662, DOI 10.1152/jn.1999.82.4.1662; SANCHEZVIVES MV, 1994, J PHYSIOL-LONDON, V475, P391, DOI 10.1113/jphysiol.1994.sp020080; Saviane C, 1999, J GEN PHYSIOL, V113, P457, DOI 10.1085/jgp.113.3.457; STALEY K, 1994, J NEUROPHYSIOL, V72, P273, DOI 10.1152/jn.1994.72.1.273; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Thoidis G, 1998, P NATL ACAD SCI USA, V95, P183, DOI 10.1073/pnas.95.1.183; Wang GX, 2003, AM J PHYSIOL-HEART C, V285, pH1453, DOI 10.1152/ajpheart.00244.2003; WATSON JB, 1994, MOL BRAIN RES, V27, P323, DOI 10.1016/0169-328X(94)90017-5; WHITE MM, 1979, J BIOL CHEM, V254, P161; Yoshikawa M, 2002, GENES CELLS, V7, P597, DOI 10.1046/j.1365-2443.2002.00539.x	35	66	70	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					321	333		10.1016/j.neuron.2006.08.035	http://dx.doi.org/10.1016/j.neuron.2006.08.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046694	Bronze			2022-12-28	WOS:000241799900012
J	Licatalosi, DD; Darnell, RB				Licatalosi, Donny D.; Darnell, Robert B.			Splicing regulation in neurologic disease	NEURON			English	Review							SPINAL MUSCULAR-ATROPHY; PRE-MESSENGER-RNA; DOMINANT RETINITIS-PIGMENTOSA; MYOTONIC-DYSTROPHY; EXON 10; PROTEOMIC ANALYSIS; BINDING PROTEINS; GENE-EXPRESSION; NMDA RECEPTORS; NR1 SUBUNIT	The importance of alternative splicing in the regulation of diverse biological processes is reflected in the growing list of human diseases associated with known or suspected splicing defects. It is becoming evident that alternative splicing plays a particularly important role in neurologic disease, which is perhaps not surprising given the important role splicing plays in generating complexity and function in the brain. This review considers the evidence that defects in regulation of splicing may underlie many types of human neurologic diseases.	Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; Rockefeller Univ, Mol Neurooncol Lab, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Darnell, RB (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	darnelr@rockefeller.edu	Darnell, Robert B/B-9022-2008	Darnell, Robert B/0000-0002-5134-8088	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040955, R01NS034389] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS34389, R01 NS40955] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Ars E, 2000, HUM MOL GENET, V9, P237, DOI 10.1093/hmg/9.2.237; Bao YP, 2002, J BIOL CHEM, V277, P12263, DOI 10.1074/jbc.M109633200; Beroud C, 2004, NEUROMUSCULAR DISORD, V14, P10, DOI 10.1016/S0960-8966(03)00169-X; Bhalla K, 2004, J HUM GENET, V49, P308, DOI 10.1007/s10038-004-0145-4; Black D L, 2003, Prog Mol Subcell Biol, V31, P187; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cartegni L, 2003, NAT STRUCT BIOL, V10, P120, DOI 10.1038/nsb887; Cartegni L, 2006, AM J HUM GENET, V78, P63, DOI 10.1086/498853; Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; Clinton SM, 2003, AM J PSYCHIAT, V160, P1100, DOI 10.1176/appi.ajp.160.6.1100; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Disset A, 2006, HUM MOL GENET, V15, P999, DOI 10.1093/hmg/ddl015; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Glatz DC, 2006, J NEUROCHEM, V96, P635, DOI 10.1111/j.1471-4159.2005.03552.x; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Grabowski PJ, 2001, PROG NEUROBIOL, V65, P289, DOI 10.1016/S0301-0082(01)00007-7; Grover A, 1999, J BIOL CHEM, V274, P15134, DOI 10.1074/jbc.274.21.15134; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Hagerman PJ, 2004, AM J HUM GENET, V74, P805, DOI 10.1086/386296; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Hasegawa M, 1999, FEBS LETT, V443, P93, DOI 10.1016/S0014-5793(98)01696-2; Holmes SE, 2001, NAT GENET, V29, P377, DOI 10.1038/ng760; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Iwahashi CK, 2006, BRAIN, V129, P256, DOI 10.1093/brain/awh650; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Kashima T, 2003, NAT GENET, V34, P460, DOI 10.1038/ng1207; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Koob MD, 1999, NAT GENET, V21, P379, DOI 10.1038/7710; Koushika SP, 2000, MOL CELL BIOL, V20, P1836, DOI 10.1128/MCB.20.5.1836-1845.2000; KRAWCZAK M, 1992, HUM GENET, V90, P41; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leroy O, 2006, BBA-MOL BASIS DIS, V1762, P460, DOI 10.1016/j.bbadis.2005.12.003; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lipscombe D, 2005, CURR OPIN NEUROBIOL, V15, P358, DOI 10.1016/j.conb.2005.04.002; Martins S, 2005, AM J MED GENET B, V139B, P109, DOI 10.1002/ajmg.b.30235; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Monani UR, 2000, HUM MOL GENET, V9, P333, DOI 10.1093/hmg/9.3.333; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Moseley ML, 2006, NAT GENET, V38, P758, DOI 10.1038/ng1827; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Musunuru K, 2001, ANNU REV NEUROSCI, V24, P239, DOI 10.1146/annurev.neuro.24.1.239; Nissim-Rafinia M, 2005, TRENDS GENET, V21, P480, DOI 10.1016/j.tig.2005.07.005; Oostra BA, 2003, HUM MOL GENET, V12, pR249, DOI 10.1093/hmg/ddg298; Pagani F, 2002, NAT GENET, V30, P426, DOI 10.1038/ng858; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pick M, 2004, ANN NY ACAD SCI, V1018, P85, DOI 10.1196/annals.1296.010; Puttaraju M, 1999, NAT BIOTECHNOL, V17, P246, DOI 10.1038/6986; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Ranum LPW, 2004, TRENDS GENET, V20, P506, DOI 10.1016/j.tig.2004.08.004; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902; Roberts WK, 2004, CURR OPIN IMMUNOL, V16, P616, DOI 10.1016/j.coi.2004.07.009; Sergeant N, 2001, HUM MOL GENET, V10, P2143, DOI 10.1093/hmg/10.19.2143; Skordis LA, 2003, P NATL ACAD SCI USA, V100, P4114, DOI 10.1073/pnas.0633863100; Soller M, 2003, GENE DEV, V17, P2526, DOI 10.1101/gad.1106703; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; SULLENGER BA, 1994, NATURE, V371, P619, DOI 10.1038/371619a0; SZABO A, 1991, CELL, V67, P325, DOI 10.1016/0092-8674(91)90184-Z; Taylor JE, 1998, EUR J HUM GENET, V6, P467, DOI 10.1038/sj.ejhg.5200210; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; Tuffery-Giraud S, 2003, HUM MUTAT, V21, P608, DOI 10.1002/humu.10214; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, CURR OPIN NEUROBIOL, V16, P102, DOI 10.1016/j.conb.2006.01.003; ULE J, 2006, IN PRESS NATURE; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Vallano ML, 1999, NEUROREPORT, V10, P3659, DOI 10.1097/00001756-199911260-00036; van Koningsbruggen S, 2004, J MED GENET, V41, DOI 10.1136/jmg 2003.012781; Veltman MWM, 2005, PSYCHIAT GENET, V15, P243, DOI 10.1097/00041444-200512000-00006; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wang ZF, 2004, CELL, V119, P831, DOI 10.1016/j.cell.2004.11.010; Willemsen R, 2003, HUM MOL GENET, V12, P949, DOI 10.1093/hmg/ddg114; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	99	189	211	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 5	2006	52	1					93	101		10.1016/j.neuron.2006.09.017	http://dx.doi.org/10.1016/j.neuron.2006.09.017			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015229	Bronze			2022-12-28	WOS:000241408100007
J	Granseth, B; Odermatt, B; Royle, SJ; Lagnado, L				Granseth, Bjorn; Odermatt, Benjamin; Royle, Stephen J.; Lagnado, Leon			Clathrin-mediated endocytosis is the dominant mechanism of vesicle retrieval at hippocampal synapses	NEURON			English	Article							RETINAL BIPOLAR CELLS; KISS-AND-RUN; SINGLE SYNAPTIC VESICLES; READILY RELEASABLE POOL; CENTRAL-NERVOUS-SYSTEM; NEUROTRANSMITTER RELEASE; QUANTAL ANALYSIS; EXOCYTOSIS; MEMBRANE; KINETICS	The maintenance of synaptic transmission requires that vesicles be recycled after releasing neurotransmitter. Several modes of retrieval have been proposed to operate at small synaptic terminals of central neurons, including a fast "kiss-and-run" mechanism that releases neurotransmitter through a fusion pore. Using an improved fluorescent reporter comprising pHluorin fused to synaptophysin, we find that only a slow mode of endocytosis (tau = 15 s) operates at hippocampal synapses when vesicle fusion is triggered by a single nerve impulse or short burst. This retrieval mechanism is blocked by overexpression of the C-terminal fragment of AP180 or by knockdown of clathrin using RNAi, and it is associated with the movement of clathrin and vesicle proteins out of the synapse. These results indicate that clathrin-mediated endocytosis is the major, if not exclusive, mechanism of vesicle retrieval after physiological stimuli.	MRC, Lab Mol Biol, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Lab Mol Biol, Hills Rd, Cambridge CB2 2QH, England.	ll1@mrc-lmb.cam.ac.uk	Granseth, Björn/AAG-2142-2020	Granseth, Bjorn/0000-0001-7526-923X; Royle, Stephen/0000-0001-8927-6967	MRC [MC_U105178794] Funding Source: UKRI; Medical Research Council [MC_U105178794] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aravanis AM, 2003, NEUROPHARMACOLOGY, V45, P797, DOI 10.1016/S0028-3908(03)00310-1; Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bekkers John M., 1994, Current Opinion in Neurobiology, V4, P360, DOI 10.1016/0959-4388(94)90097-3; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Biro AA, 2005, J NEUROSCI, V25, P223, DOI 10.1523/JNEUROSCI.3688-04.2005; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Fernandez-Alfonso T, 2006, NEURON, V51, P179, DOI 10.1016/j.neuron.2006.06.008; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Franks KM, 2003, J NEUROSCI, V23, P3186; Frerking M, 2005, J NEUROPHYSIOL, V94, P1528, DOI 10.1152/jn.00108.2005; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Heidelberger R, 2002, J NEUROPHYSIOL, V88, P2509, DOI 10.1152/jn.00267.2002; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Hull C, 2004, NEURON, V44, P469, DOI 10.1016/j.neuron.2004.10.010; Jockusch WJ, 2005, NEURON, V46, P869, DOI 10.1016/j.neuron.2005.05.004; Katz B., 1969, RELEASE NEURAL TRANS; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Klyachko VA, 2002, NATURE, V418, P89, DOI 10.1038/nature00852; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; Llobet A, 2003, NEURON, V40, P1075, DOI 10.1016/S0896-6273(03)00765-7; Marte B, 2002, NAT CELL BIOL, V4, pE123, DOI 10.1038/ncb0502-e123; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mueller VJ, 2004, J NEUROSCI, V24, P2004, DOI 10.1523/JNEUROSCI.4080-03.2004; Mundigl O, 1998, J NEUROSCI, V18, P93; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2005, J CELL BIOL, V168, P929, DOI 10.1083/jcb.200407148; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2003, NATURE, V423, P591, DOI 10.1038/423591a; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Royle SJ, 2003, J PHYSIOL-LONDON, V553, P345, DOI 10.1113/jphysiol.2003.049221; Royle SJ, 2005, NATURE, V434, P1152, DOI 10.1038/nature03502; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; Sun JY, 2002, NATURE, V417, P555, DOI 10.1038/417555a; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tyler WJ, 2004, CURR BIOL, V14, pR294, DOI 10.1016/j.cub.2004.03.046; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012; van Santen RA, 1995, CHEM KINETICS CATALY; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Wienisch M, 2006, NAT NEUROSCI, V9, P1019, DOI 10.1038/nn1739; Yamashita T, 2005, SCIENCE, V307, P124, DOI 10.1126/science.1103631; Yao PJ, 2003, NEUROSCIENCE, V121, P25, DOI 10.1016/S0306-4522(03)00431-7; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	61	461	471	0	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					773	786		10.1016/j.neuron.2006.08.029	http://dx.doi.org/10.1016/j.neuron.2006.08.029			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982422	Bronze			2022-12-28	WOS:000240997900015
J	Sasaki, Y; Rajimehr, R; Kim, BW; Ekstrom, LB; Vanduffel, W; Tootell, RBH				Sasaki, Yuka; Rajimehr, Reza; Kim, Byoung Woo; Ekstrom, Leeland B.; Vanduffel, Wim; Tootell, Roger B. H.			The radial bias: A different slant on visual orientation sensitivity in human and nonhuman primates	NEURON			English	Article							SURFACE-BASED ANALYSIS; STRIATE CORTEX; PERIPHERAL-VISION; SPATIAL-FREQUENCY; RECEPTIVE-FIELDS; CONTRAST AGENT; GANGLION-CELLS; FUNCTIONAL MRI; DORSAL V4; AREAS	It is generally assumed that sensitivity to different stimulus orientations is mapped in a globally equivalent fashion across primate visual cortex, at a spatial scale larger than that of orientation columns. However, some evidence predicts instead that radial orientations should produce higher activity than other orientations, throughout visual cortex. Here, this radial orientation bias was robustly confirmed using (1) human psychophysics, plus fMRI in (2) humans and (3) behaving monkeys. In visual cortex, fMRI activity was at least 20% higher in the retinotopic representations of polar angle which corresponded to the radial stimulus orientations (relative to tangential). In a global demonstration of this, we activated complementary retinotopic quadrants of visual cortex by simply changing stimulus orientation, without changing stimulus location in the visual field. This evidence reveals a neural link between orientation sensitivity and the cortical retinotopy, which have previously been considered independent.	Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martios Ctr Biomed Imaging, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; CALTECH, ERATO Shimojo Implicit Brain Funct Project, Pasadena, CA 91125 USA; MIT, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; California Institute of Technology; Massachusetts Institute of Technology (MIT)	Sasaki, Y (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martios Ctr Biomed Imaging, 149 13th St, Charlestown, MA 02129 USA.	yuka@nmr.mgh.harvard.edu		Sasaki, Yuka/0000-0002-0061-0250	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067529] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR 14075] Funding Source: Medline; NEI NIH HHS [R01 EY017081] Funding Source: Medline; NIBIB NIH HHS [EB 00790] Funding Source: Medline; NIMH NIH HHS [MH 67529] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBRECHT DG, 1980, SCIENCE, V207, P88, DOI 10.1126/science.6765993; Alexander DM, 2004, VISION RES, V44, P857, DOI 10.1016/j.visres.2003.11.009; BENNETT PJ, 1991, VISION RES, V31, P1759, DOI 10.1016/0042-6989(91)90025-Z; BERARDI N, 1991, VISION RES, V31, P1831, DOI 10.1016/0042-6989(91)90030-9; BERKLEY MA, 1975, VISION RES, V15, P239, DOI 10.1016/0042-6989(75)90213-8; Cox RW, 1999, MAGNET RESON MED, V42, P1014, DOI 10.1002/(SICI)1522-2594(199912)42:6<1014::AID-MRM4>3.0.CO;2-F; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Durand JB, 2002, J NEUROPHYSIOL, V88, P2874, DOI 10.1152/jn.00291.2002; DURAND JB, 2004, 34 ANN M SOC NEUR SA; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FAHLE M, 1986, EXP BRAIN RES, V63, P113; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fize D, 2003, J NEUROSCI, V23, P7395; FRISEN L, 1975, INVEST OPHTH VISUAL, V14, P528; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; GREVE DN, 2003, HUM BRAIN MAPP NY NY; Haynes JD, 2005, NAT NEUROSCI, V8, P686, DOI 10.1038/nn1445; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kim DS, 2004, NEUROIMAGE, V21, P876, DOI 10.1016/j.neuroimage.2003.10.018; Leite FP, 2002, NEUROIMAGE, V16, P283, DOI 10.1006/nimg.2002.1110; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P476, DOI 10.1002/cne.902200409; LEVICK WR, 1982, J PHYSIOL-LONDON, V329, P243, DOI 10.1113/jphysiol.1982.sp014301; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MANSFIELD RJ, 1974, SCIENCE, V186, P1133, DOI 10.1126/science.186.4169.1133; McGraw PV, 1999, EXP BRAIN RES, V125, P122, DOI 10.1007/s002210050667; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; ORBAN GA, 1984, VISION RES, V24, P121, DOI 10.1016/0042-6989(84)90097-X; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; RODIECK RW, 1985, J COMP NEUROL, V233, P115, DOI 10.1002/cne.902330107; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; Sasaki Y, 2001, P NATL ACAD SCI USA, V98, P2077, DOI 10.1073/pnas.98.4.2077; SCHALL JD, 1986, BRAIN RES, V368, P18, DOI 10.1016/0006-8993(86)91037-1; SCHALL JD, 1987, J COMP NEUROL, V257, P149, DOI 10.1002/cne.902570202; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCOBEY RP, 1991, VISION RES, V31, P99, DOI 10.1016/0042-6989(91)90077-I; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Shmuel A, 1996, J NEUROSCI, V16, P6945; SHOU T, 1989, J NEUROSCI, V9, P4287; TEMME LA, 1985, AM J OPTOM PHYS OPT, V62, P545; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1988, J NEUROSCI, V8, P1610; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Tsao DY, 2003, NEURON, V39, P555, DOI 10.1016/S0896-6273(03)00459-8; Tsao DY, 2003, NAT NEUROSCI, V6, P989, DOI 10.1038/nn1111; Vanduffel W, 2002, CEREB CORTEX, V12, P647, DOI 10.1093/cercor/12.6.647; Vanduffel W, 2001, NEURON, V32, P565, DOI 10.1016/S0896-6273(01)00502-5; Westheimer G, 2005, SPATIAL VISION, V18, P159, DOI 10.1163/1568568053320611; Westheimer G, 2003, VISION RES, V43, P53, DOI 10.1016/S0042-6989(02)00398-X; YAP YL, 1987, J OPT SOC AM A, V4, P1562, DOI 10.1364/JOSAA.4.001562	54	144	147	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					661	670		10.1016/j.neuron.2006.07.021	http://dx.doi.org/10.1016/j.neuron.2006.07.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950163	Bronze			2022-12-28	WOS:000240623400014
J	Knutson, B; Cooper, JC				Knutson, Brian; Cooper, Jeffrey C.			The lure of the unknown	NEURON			English	Editorial Material							LONG-TERM-MEMORY; BRAIN ACTIVITY; FMRI; ACTIVATION; SIGNAL; VTA	Using event-related fMRI, Bunzeck and Duzel show that midbrain regions putatively housing dopamine cell bodies activate more for novel pictures than for negative pictures, pictures requiring a motor response, or repeated pictures. These findings indicate that midbrain regions preferentially respond to novelty and suggest that novelty can serve as its own reward.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Knutson, B (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.			Knutson, Brian/0000-0002-7669-426X				Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; BERRIDGE KC, 1993, BRAIN RES BRAIN RES, V18, P247; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Bunzeck N, 2006, NEURON, V51, P369, DOI 10.1016/j.neuron.2006.06.021; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Dayan P, 2002, TRENDS COGN SCI, V6, P105, DOI 10.1016/S1364-6613(00)01851-9; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Knutson B, 2005, NEURON, V45, P331, DOI 10.1016/j.neuron.2005.01.020; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845; Pankseep J., 1998, AFFECTIVE NEUROSCIEN; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010	18	11	11	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					280	282		10.1016/j.neuron.2006.07.017	http://dx.doi.org/10.1016/j.neuron.2006.07.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880122	Bronze			2022-12-28	WOS:000239908800003
J	Fainzilber, M; Twiss, JL				Fainzilber, Mike; Twiss, Jeffery L.			Tracking in the WId(s) - The hunting of the SIRT and the luring of the draper	NEURON			English	Review							WALLERIAN DEGENERATION; IN-VITRO; AXON DEGENERATION; SENSORY NEURONS; WILD-TYPE; WLD(S); PROTEINS; REGENERATION; INJURY; NERVE	Wallerian degeneration of distal axons after nerve injury is significantly delayed in the Wids mutant mouse. The Wids protein is a fusion of nicotinamide mononucleotide adenyltransferase-1 (Nmnat1), an essential enzyme in the biosynthesis pathway of nicotinamide adenine dinuclecitide (NAD), with the N-terminal 70 amino acids of the Ube4b ubiquitination assembly factor. The mechanism of Wld(s) action is still enigmatic, although recent efforts suggest that it is indirect and requires sequences flanking or linking the two fused open reading frames. Three papers in this issue of Neuron now show that Wids action is conserved in Drosophila and that a critical role of Wids may be the suppression of axonal self-destruct signals that induce Draper-mediated clearance of damaged axons by glial cells.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Alfred I DuPont Hosp Children, Nemours Biomed Res, Wilmington, DE 19899 USA	Weizmann Institute of Science; Nemours Alfred I. duPont Hospital for Children	Fainzilber, M (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	mike.fainzilber@weizmann.ac.il; twiss@medsci.udel.edu		Fainzilber, Mike/0000-0001-8173-8557	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041596, R21NS045880] Funding Source: NIH RePORTER; NCRR NIH HHS [RR020173] Funding Source: Medline; NINDS NIH HHS [NS045880, NS041596] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bedi SS, 2001, J NEUROSCI, V21, P9667, DOI 10.1523/JNEUROSCI.21-24-09667.2001; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; BITTNER GD, 1991, TRENDS NEUROSCI, V14, P188, DOI 10.1016/0166-2236(91)90104-3; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; CONFORTI L, 2006, CELL DEATH DIFFER; Dormeyer W, 2005, MOL CELL PROTEOMICS, V4, P1226, DOI 10.1074/mcp.M500047-MCP200; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Fang C, 2005, NEUROSCIENCE, V135, P1107, DOI 10.1016/j.neuroscience.2005.06.078; Gillingwater TH, 2006, HUM MOL GENET, V15, P625, DOI 10.1093/hmg/ddi478; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Laser H, 2006, MOL BIOL CELL, V17, P1075, DOI 10.1091/mbc.E05-04-0375; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; MacInnis BL, 2005, MOL CELL NEUROSCI, V28, P430, DOI 10.1016/j.mcn.2004.10.003; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zheng JQ, 2001, J NEUROSCI, V21, P9291, DOI 10.1523/JNEUROSCI.21-23-09291.2001	27	20	21	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 15	2006	50	6					819	821		10.1016/j.neuron.2006.05.023	http://dx.doi.org/10.1016/j.neuron.2006.05.023			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772165	Bronze			2022-12-28	WOS:000238589500004
J	Mushiake, H; Saito, N; Sakamoto, K; Itoyama, Y; Tanji, J				Mushiake, Hajime; Saito, Naohiro; Sakamoto, Kazuhiro; Itoyama, Yasuto; Tanji, Jun			Activity in the lateral prefrontal cortex reflects multiple steps of future events in action plans	NEURON			English	Article							PRECENTRAL MOTOR CORTEX; PRIMATE FRONTAL-CORTEX; NEURONAL-ACTIVITY; WORKING-MEMORY; CUE LOCATION; REPRESENTATION; MOVEMENTS; TASK; MACAQUE; INFORMATION	To achieve a behavioral goal in a complex environment, we must plan multiple steps of motor behavior. On planning a series of actions, we anticipate future events that will occur as a result of each action and mentally organize the temporal sequence of events. To investigate the involvement of the lateral prefrontal cortex (PFC) in such multistep planning, we examined neuronal activity in the PFC of monkeys performing a maze task that required the planning of stepwise cursor movements to reach a goal. During the preparatory period, PFC neurons reflected each of all forthcoming cursor movements, rather than arm movements. In contrast, in the primary motor cortex, most neuronal activity reflected arm movements but little of cursor movements during the preparatory period, as well as during movement execution. Our data suggest that the PFC is involved primarily in planning multiple future events that occur as a consequence of behavioral actions.	Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Res Inst Elect Commun, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Dept Neurol, Sch Med, Sendai, Miyagi 9808575, Japan; Tamagawa Univ, Brain Sci Res Inst, Res Inst, Tokyo 1948610, Japan	Tohoku University; Tohoku University; Tohoku University	Mushiake, H (corresponding author), Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 9808575, Japan.	hmushiak@mail.tains.tohoku.ac.jp		Mushiake, Hajime/0000-0002-5130-4720				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Fukushima T, 2004, J NEUROPHYSIOL, V91, P1367, DOI 10.1152/jn.00306.2003; Fuster J., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Hasegawa RP, 2000, SCIENCE, V290, P1786, DOI 10.1126/science.290.5497.1786; Hoshi E, 1998, J NEUROPHYSIOL, V80, P3392, DOI 10.1152/jn.1998.80.6.3392; Hoshi E, 2004, J NEUROPHYSIOL, V91, P2707, DOI 10.1152/jn.00904.2003; Hoshi E, 2000, J NEUROPHYSIOL, V83, P2355, DOI 10.1152/jn.2000.83.4.2355; Jenkins IH, 2000, BRAIN, V123, P1216, DOI 10.1093/brain/123.6.1216; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kitazawa S, 1998, NATURE, V392, P494, DOI 10.1038/33141; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; MUSHIAKE H, 1991, J NEUROPHYSIOL, V66, P705, DOI 10.1152/jn.1991.66.3.705; Mushiake H, 2001, COGNITIVE BRAIN RES, V11, P165, DOI 10.1016/S0926-6410(00)00067-7; Nieder A, 2002, SCIENCE, V297, P1708, DOI 10.1126/science.1072493; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; Ninokura Y, 2003, J NEUROPHYSIOL, V89, P2868, DOI 10.1152/jn.00647.2002; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; SATO KC, 1989, J NEUROPHYSIOL, V62, P959, DOI 10.1152/jn.1989.62.4.959; Takeda K, 2002, J NEUROPHYSIOL, V87, P567, DOI 10.1152/jn.00249.2001; Tanji J, 2001, CURR OPIN NEUROBIOL, V11, P164, DOI 10.1016/S0959-4388(00)00192-6; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; White IM, 1999, EXP BRAIN RES, V126, P315, DOI 10.1007/s002210050740; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	40	170	173	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					631	641		10.1016/j.neuron.2006.03.045	http://dx.doi.org/10.1016/j.neuron.2006.03.045			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701212	Bronze			2022-12-28	WOS:000237875200013
J	Wilson, CJ				Wilson, Charles J.			Striatal D2 receptors and LTD: Yes, but not where you thought they were	NEURON			English	Editorial Material							SPINY NEURONS; DOPAMINE-RECEPTORS; EXCITABILITY; MODULATION	D1 and D2 dopamine receptors are expressed in disjoint subsets of striatal projection neurons, the direct and indirect pathways, respectively. This differential distribution of receptors forms the basis for explanations of many aspects of basal ganglia function and dysfunction, but it seems incompatible with some other important properties of striatal neurons. In this issue of Neuron, Wang et al. discover the mechanism of D2 sensitivity of long term depression at synapses on the striatal projection neuron. They show that D2 dependence of LTD does not depend on dopamine receptors of on the projection cell but is mediated by dopamine-induced changes in release of acetylcholine by interneurons that contact projection cells of both types.	Univ Texas, Dept Biol, San Antonio, TX 78249 USA	University of Texas System	Wilson, CJ (corresponding author), Univ Texas, Dept Biol, 6900 N Loop 1604 W, San Antonio, TX 78249 USA.		Wilson, Charles/D-2529-2011	Wilson, Charles/0000-0002-9004-2145				Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Centonze D, 2003, J NEUROSCI, V23, P8506, DOI 10.1523/jneurosci.23-24-08506.2003; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; Kerr JND, 2001, J NEUROPHYSIOL, V85, P117, DOI 10.1152/jn.2001.85.1.117; Onn SP, 2003, J PHARMACOL EXP THER, V306, P870, DOI 10.1124/jpet.103.050062; SURMEIER DJ, 1993, TRENDS NEUROSCI, V16, P299, DOI 10.1016/0166-2236(93)90103-S; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010	11	14	17	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					347	348		10.1016/j.neuron.2006.04.023	http://dx.doi.org/10.1016/j.neuron.2006.04.023			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675388	Bronze			2022-12-28	WOS:000237726800003
J	Kumar, V; Ramaswami, M				Kumar, V; Ramaswami, M			Kissing and pinching: Synaptotagmin and calcium do more between bilayers	NEURON			English	Editorial Material							CA2+ SENSOR; ENDOCYTOSIS; EXOCYTOSIS; TERMINALS	Building on recent findings that synaptotagmin (Syt) participates in synaptic vesicle endocytosis, Poskanzer et al., in this issue of Neuron, show distinct mechanisms by which Syt functions in this process. Most significantly, they show (1) that calcium binding to Syt determines the rate but not fidelity of vesicle recycling and (2) that mutations in a different Syt domain affect the shape but not rate of formation of recycled synaptic vesicles.	Trinity Coll Dublin, Smurfit Inst Genet, Dublin 2, Ireland; Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL Div Neurobiol, Tucson, AZ 85721 USA	Trinity College Dublin; University of Arizona; University of Arizona	Kumar, V (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Lloyd Bldg, Dublin 2, Ireland.			Ramaswami, Mani/0000-0001-7631-0468				Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Koh TW, 2003, TRENDS NEUROSCI, V26, P413, DOI 10.1016/S0166-2236(03)00195-4; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Poskanzer KE, 2003, NATURE, V426, P559, DOI 10.1038/nature02184; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Wenk MR, 2004, P NATL ACAD SCI USA, V101, P8262, DOI 10.1073/pnas.0401874101	10	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					3	5		10.1016/j.neuron.2006.03.028	http://dx.doi.org/10.1016/j.neuron.2006.03.028			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600847	Bronze			2022-12-28	WOS:000236811300002
J	Kaczmarek, LK				Kaczmarek, LK			Policing the ball: A new potassium channel subunit determines inactivation rate	NEURON			English	Editorial Material							BETA-SUBUNIT	Inactivation of potassium currents during maintained firing results in a progressive increase in action potential width and neuronal excitability. In Kv1.1 channels, inactivation has attributed to a beta subunit that blocks the pore of the channel shortly after channel opening. In this issue of Neuron, Shulte and colleagues have identified a novel channel subunit whose interaction with Kv1.1 and the P subunit prevents such inactivation. Mutations in this subunit lead to temporal lobe epilepsy.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University; Yale University	Kaczmarek, LK (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA.							ALDRICH RW, 1979, J PHYSIOL-LONDON, V291, P531, DOI 10.1113/jphysiol.1979.sp012829; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; LEVITAN IB, 2006, IN PRESS NAT NEUROSC; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Pongs O, 1999, ANN NY ACAD SCI, V868, P344, DOI 10.1111/j.1749-6632.1999.tb11296.x; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Schulte U, 2006, NEURON, V49, P697, DOI 10.1016/j.neuron.2006.01.033; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; TEMPEL BL, 1988, NATURE, V332, P837, DOI 10.1038/332837a0; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	11	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					642	644		10.1016/j.neuron.2006.02.011	http://dx.doi.org/10.1016/j.neuron.2006.02.011			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504937	Bronze			2022-12-28	WOS:000236070600002
J	Snyder, SH				Snyder, SH			Dopamine receptor excess and mouse madness	NEURON			English	Editorial Material							SCHIZOPHRENIA	The dopamine hypothesis of schizophrenia is based on evidence that the major antipsychotic drugs act by blocking dopamine D2 receptors and that dopamine-releasing drugs worsen symptoms. In this issue of Neuron, Kellendonk et al. report an elegant conditional transgenic mouse overexpressing dopamine D2 receptors selectively in the striatum. Strikingly, these animals display selective cognitive impairment typically associated with frontal cortical defects and abnormal dopamine markers in the prefrontal cortex, suggesting that striatal dopamine receptors can influence cortical dopamine function.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.							Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; SNYDER SH, 1976, AM J PSYCHIAT, V133, P197; Winterer G, 2004, TRENDS NEUROSCI, V27, P683, DOI 10.1016/j.tins.2004.08.002	6	27	27	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 16	2006	49	4					484	485		10.1016/j.neuron.2006.02.002	http://dx.doi.org/10.1016/j.neuron.2006.02.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476659	Bronze			2022-12-28	WOS:000235643800003
J	Gleeson, P; Steuber, V; Silver, RA				Gleeson, Padraig; Steuber, Volker; Silver, R. Angus			neuroConstruct: A tool for modeling networks of neurons in 3D space	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; DENDRITIC MORPHOLOGY; HIPPOCAMPAL-NEURONS; SPIKE INITIATION; SYSTEMS BIOLOGY; NITRIC-OXIDE; IN-VIVO; CELL; SIMULATION; CORTEX	Conductance-based neuronal network models can help us understand how synaptic and cellular mechanisms underlie brain function. However, these complex models are difficult to develop and are inaccessible to most neuroscientists. Moreover, even the most biologically realistic network models disregard many 3D anatomical features of the brain. Here, we describe a new software application, neuroConstruct, that facilitates the creation, visualization, and analysis of networks of multicompartmental neurons in 3D space. A graphical user interface allows model generation and modification without programming. Models within neuroConstruct are based on new simulator-in dependent NeuroML standards, allowing automatic generation of code for NEURON or GENESIS simulators. neuroConstruct was tested by reproducing published models and its simulator independence verified by comparing the same model on two simulators. We show how more anatomically realistic network models can be created and their properties compared with experimental measurements by extending a published 1D cerebellar granule cell layer model to 3D.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk	Gleeson, Padraig/A-7549-2012	Gleeson, Padraig/0000-0001-5963-8576; Steuber, Volker/0000-0003-0186-3580; Silver, Robin/0000-0002-5480-6638	MRC [G0400598, G90/100] Funding Source: UKRI; Medical Research Council [G90/100, G0400598] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Ascoli GA, 2001, PHILOS T R SOC B, V356, P1131, DOI 10.1098/rstb.2001.0905; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Bednar JA, 2004, NEUROCOMPUTING, V58, P1129, DOI 10.1016/j.neucom.2004.01.177; Berends M, 2004, NEUROCOMPUTING, V58, P587, DOI 10.1016/j.neucom.2004.01.099; BLOMFIELD S, 1974, BRAIN RES, V69, P115, DOI 10.1016/0006-8993(74)90375-8; Bower J, 1997, BOOK GENESIS EXPLORI; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Bush PC, 1999, J NEUROPHYSIOL, V82, P1748, DOI 10.1152/jn.1999.82.4.1748; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cannon RC, 1998, J NEUROSCI METH, V84, P49, DOI 10.1016/S0165-0270(98)00091-0; CANNON RC, 2007, IN PRESS NEUROINFORM; Cornelis H, 2003, NEUROCOMPUTING, V52-4, P227, DOI [10.1016/S0925-2312(02)00750-6, 10.1016/SO925-2312(02)00750-6]; CROOK S, 2007, IN PRESS NEUROINFORM; Davison AP, 2003, J NEUROPHYSIOL, V90, P1921, DOI 10.1152/jn.00623.2002; De Schutter E, 2005, TRENDS NEUROSCI, V28, P562, DOI 10.1016/j.tins.2005.08.002; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Diesmann M., 2002, NEST ENV NEURAL SYST, V58, P43; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Eberhard JP, 2006, NEUROCOMPUTING, V70, P327, DOI 10.1016/j.neucom.2006.01.028; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; Finkelstein A, 2004, COMPUTER, V37, P26, DOI 10.1109/MC.2004.1297236; Goddard NH, 2001, PHILOS T ROY SOC B, V356, P1209, DOI 10.1098/rstb.2001.0910; Hanson JE, 2004, J NEUROSCI, V24, P329, DOI 10.1523/JNEUROSCI.3937-03.2004; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hines ML, 2000, NEURAL COMPUT, V12, P995, DOI 10.1162/089976600300015475; Hines ML, 2004, J COMPUT NEUROSCI, V17, P7, DOI 10.1023/B:JCNS.0000023869.22017.2e; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Howell FW, 2000, NEUROCOMPUTING, V32, P1041, DOI 10.1016/S0925-2312(00)00277-0; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Ito M, 1984, CEREBELLUM NEURAL CO; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; Kunec S, 2005, J NEUROPHYSIOL, V94, P70, DOI 10.1152/jn.00731.2004; Lloyd CM, 2004, PROG BIOPHYS MOL BIO, V85, P433, DOI 10.1016/j.pbiomolbio.2004.01.004; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Mainen ZF, 1996, NATURE, V382, P363, DOI 10.1038/382363a0; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Migliore M, 2006, J COMPUT NEUROSCI, V21, P119, DOI 10.1007/s10827-006-7949-5; MIGLIORE M, 1995, J NEUROPHYSIOL, V73, P1157, DOI 10.1152/jn.1995.73.3.1157; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Nicolelis MAL, 2002, CURR OPIN NEUROBIOL, V12, P602, DOI 10.1016/S0959-4388(02)00374-4; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; Schweighofer N, 2000, P NATL ACAD SCI USA, V97, P10661, DOI 10.1073/pnas.97.19.10661; Segev I, 2000, SCIENCE, V290, P744, DOI 10.1126/science.290.5492.744; Shepherd G. M., 1998, SYNAPTIC ORG BRAIN; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sultan F, 1998, J COMP NEUROL, V393, P353; Traub RD, 2005, J NEUROPHYSIOL, V93, P2194, DOI 10.1152/jn.00983.2004; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Vos BP, 1999, J NEUROSCI, V19; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilson RI, 2002, SCIENCE, V296, P678, DOI 10.1126/science.1063545; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	72	124	124	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					219	235		10.1016/j.neuron.2007.03.025	http://dx.doi.org/10.1016/j.neuron.2007.03.025			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442244	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000246190600008
J	Finn, IM; Priebe, NJ; Ferster, D				Finn, Ian M.; Priebe, Nicholas J.; Ferster, David			The emergence of contrast-invariant orientation tuning in simple cells of cat visual cortex	NEURON			English	Article							CORTICAL SIMPLE CELLS; STRIATE CORTEX; RECEPTIVE-FIELDS; DIRECTION SELECTIVITY; SPATIOTEMPORAL ORGANIZATION; RESPONSE VARIABILITY; SYNAPTIC POTENTIALS; SPATIAL SUMMATION; SPIKE THRESHOLD; THALAMIC INPUT	Simple cells in primary visual cortex exhibit contrast-invariant orientation tuning, in seeming contradiction to feed-forward models that rely on lateral geniculate nucleus (LGN) input alone. Contrast invariance has therefore been thought to depend on the presence of intracortical lateral inhibition. In vivo intracellular recordings instead suggest that contrast invariance can be explained by three properties of the excitatory pathway. (1) Depolarizations evoked by orthogonal stimuli are determined by the amount of excitation a cell receives from the LGN, relative to the excitation it receives from other cortical cells. (2) Depolarizations evoked by preferred stimuli saturate at lower contrasts than the spike output of LGN relay cells. (3) Visual stimuli evoke contrast-dependent changes in trial-to-trial variability, which lead to contrast-dependent changes in the relationship between membrane potential and spike rate. Thus, high-contrast, orthogonally oriented stimuli that evoke significant depolarizations evoke few spikes. Together these mechanisms, without lateral inhibition, can account for contrast-invariant stimulus selectivity.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Ferster, D (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2205 Tech Dr, Evanston, IL 60208 USA.	ferster@northwestern.edu			NEI NIH HHS [R01 EY04726, R01 EY004726, R01 EY004726-23] Funding Source: Medline; NIMH NIH HHS [P20 MH066239-01A10003, P20 MH066239] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH066239] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Bannister NJ, 2002, PHILOS T R SOC B, V357, P1793, DOI 10.1098/rstb.2002.1160; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 2002, J NEUROSCI, V22, P10053; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Freeman TCB, 2002, NEURON, V35, P759, DOI 10.1016/S0896-6273(02)00819-X; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; HARTLINE HK, 1949, FED PROC, V8, P69; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Hirsch JA, 2003, NAT NEUROSCI, V6, P1300, DOI 10.1038/nn1152; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; Lampl I, 2001, NEURON, V30, P263, DOI 10.1016/S0896-6273(01)00278-1; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; Li BW, 2006, J NEUROPHYSIOL, V96, P1755, DOI 10.1152/jn.00425.2006; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; Martinez LM, 2005, NAT NEUROSCI, V8, P372, DOI 10.1038/nn1404; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; McLaughlin D, 2003, J PHYSIOL-PARIS, V97, P237, DOI 10.1016/j.jphysparis.2003.09.019; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Priebe NJ, 2005, NEURON, V45, P133, DOI 10.1016/j.neuron.2004.12.024; Priebe NJ, 2006, NAT NEUROSCI, V9, P552, DOI 10.1038/nn1660; Priebe NJ, 2004, NAT NEUROSCI, V7, P1113, DOI 10.1038/nn1310; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SOMPOLINSKY H, 1990, P NATL ACAD SCI USA, V87, P7200, DOI 10.1073/pnas.87.18.7200; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Tao L, 2004, P NATL ACAD SCI USA, V101, P366, DOI 10.1073/pnas.2036460100; Tolhurst DJ, 1997, VISUAL NEUROSCI, V14, P293, DOI 10.1017/S0952523800011433; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x	60	172	173	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					137	152		10.1016/j.neuron.2007.02.029	http://dx.doi.org/10.1016/j.neuron.2007.02.029			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408583	Bronze, Green Accepted			2022-12-28	WOS:000245848400015
J	Johnston, K; Levin, HM; Koval, MJ; Everling, S				Johnston, Kevin; Levin, Helen M.; Koval, Michael J.; Everling, Stefan			Top-down control-signal dynamics in anterior cingulate and prefrontal cortex neurons following task switching	NEURON			English	Article							ANTI-SACCADES; CONFLICT; PERFORMANCE; LESIONS; MONKEY; ATTENTION; RESPONSES; CELLS; MODEL; RULE	The prefrontal cortex (PFC) and anterior cingulate cortex (ACC) have both been implicated in cognitive control, but their relative roles remain unclear. Here we recorded the activity of single neurons in both areas while monkeys performed a task that required them to switch between trials in which they had to look toward a flashed stimulus (prosaccades) and trials in which they had to look away from the stimulus (antisaccades). We found that ACC neurons had a higher level of task selectivity than PFC neurons during the preparatory period on trials immediately following a task switch. In ACC neurons, task selectivity was strongest after the task switch and declined throughout the task block, whereas task selectivity remained constant in the PFC. These results demonstrate that the ACC is recruited when cognitive demands increase and suggest a role for both areas in task maintenance and the implementation of top-down control.	John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; Univ Western Ontario, Grad Program Neurosci, London, ON N6G 2V4, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Everling, S (corresponding author), John P Robarts Res Inst, POB 5015, London, ON N6A 5K8, Canada.	severlin@uwo.ca	Everling, Stefan/K-5208-2013; Everling, Stefan/AAR-8687-2020	Everling, Stefan/0000-0001-9714-9757; Johnston, Kevin/0000-0001-9481-6251				ALLPORT A, 1994, SHIFTING INT SET EXP, P421; Amador N, 2004, J NEUROPHYSIOL, V91, P1672, DOI 10.1152/jn.00138.2003; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Condy C, 2007, CEREB CORTEX, V17, P221, DOI 10.1093/cercor/bhj140; DeSouza JFX, 2004, J NEUROPHYSIOL, V91, P855, DOI 10.1152/jn.00273.2003; Dias R, 1996, BEHAV NEUROSCI, V110, P872, DOI 10.1037/0735-7044.110.5.872; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 2005, J COGNITIVE NEUROSCI, V17, P1483, DOI 10.1162/0898929054985455; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Gaymard B, 2003, ANN NEUROL, V53, P542, DOI 10.1002/ana.10560; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Ito S, 2003, SCIENCE, V302, P120, DOI 10.1126/science.1087847; Johnston K, 2006, J NEUROSCI, V26, P12471, DOI 10.1523/JNEUROSCI.4101-06.2006; Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; LEICHNETZ GR, 1981, NEUROSCIENCE, V6, P1023, DOI 10.1016/0306-4522(81)90068-3; Liston C, 2006, NEURON, V50, P643, DOI 10.1016/j.neuron.2006.04.015; Luks TL, 2004, NEUROIMAGE, V22, P1515, DOI 10.1016/j.neuroimage.2004.04.008; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Paus T, 2001, EUR J NEUROSCI, V14, P1405, DOI 10.1046/j.0953-816x.2001.01757.x; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; Sohn MH, 2001, J EXP PSYCHOL GEN, V130, P764, DOI 10.1037//0096-3445.130.4.764; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wang Y, 2004, NEUROREPORT, V15, P1559, DOI 10.1097/01.wnr.0000133300.62031.9b; Wiese H, 2004, NEUROSCI LETT, V371, P220, DOI 10.1016/j.neulet.2004.08.078; Woodward TS, 2006, BRAIN RES, V1068, P161, DOI 10.1016/j.brainres.2005.10.094; Wylie GR, 2004, HUM BRAIN MAPP, V21, P279, DOI 10.1002/hbm.20003; Yeung N, 2003, J EXP PSYCHOL HUMAN, V29, P455, DOI 10.1037/0096-1523.29.2.455	49	204	206	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					453	462		10.1016/j.neuron.2006.12.023	http://dx.doi.org/10.1016/j.neuron.2006.12.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270740	Bronze			2022-12-28	WOS:000245126800014
J	Xu, W; Wong, TP; Chery, N; Gaertner, T; Wang, YT; Baudry, M				Xu, Wei; Wong, Tak Pan; Chery, Nadege; Gaertner, Tara; Wang, Yu Tian; Baudry, Michel			Calpain-mediated mGluR1 alpha truncation: A key step in excitotoxicity	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; OXIDATIVE STRESS; NEURONAL APOPTOSIS; CELL-DEATH; ACTIVATION; PROTEINS; INJURY; GLUTAMATE-RECEPTOR-1; NEUROPROTECTION; INHIBITION	Excitotoxicity mediated by glutamate receptors plays crucial roles in ischemia and other neurodegenerative diseases. Whereas overactivation of ionotropic glutamate receptors is neurotoxic, the role of metabotropic glutamate receptors (mGluRs), and especially mGluR1, remains equivocal. Here we report that activation of NMDA receptors results in calpain-mediated truncation of the C-terminal domain of mGluR1 alpha at Ser(936). The truncated mGluR1 alpha maintains its ability to increase cytosolic calcium while it no longer activates the neuroprotective PI3K-Akt signaling pathways. Full-length and truncated forms of mGluR1 alpha play distinct roles in excitotoxic neuronal degeneration in cultured neurons. A fusion peptide derived from the calpain cleavage site of mGluR1 alpha efficiently blocks NMDA-incluced truncation of mGluR1 alpha in primary neuronal cultures and exhibits neuroprotection against excitotoxicity both in vitro and in vivo. These findings shed light on the relationship between NMDA and mGluR1 a and indicate the existence of a positive feedback regulation in excitotoxicity involving calpain and mGluR1 alpha.	Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada	University of Southern California; University of British Columbia	Baudry, M (corresponding author), Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA.	baudry@usc.edu	Wang, Yu Tian/J-8255-2015	Wong, Tak Pan/0000-0001-8611-4911; xu, wei/0000-0003-0987-2481	NINDS NIH HHS [NS048521-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048521] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allen JW, 1999, NEUROPHARMACOLOGY, V38, P1243, DOI 10.1016/S0028-3908(99)00044-1; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Baskys A, 2005, NEUROPHARMACOLOGY, V49, P146, DOI 10.1016/j.neuropharm.2005.04.029; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Bi XN, 1998, BRAIN RES, V790, P245, DOI 10.1016/S0006-8993(98)00067-5; Blaabjerg M, 2003, EXP NEUROL, V183, P573, DOI 10.1016/S0014-4886(03)00204-8; BRUNO V, 1995, NEUROPHARMACOLOGY, V34, P1089, DOI 10.1016/0028-3908(95)00077-J; Calo L, 2005, J NEUROSCI, V25, P2245, DOI 10.1523/JNEUROSCI.4956-04.2005; Chong ZZ, 2006, CURR NEUROVASC RES, V3, P107, DOI 10.2174/156720206776875830; Fagni Laurent, 2002, Sci STKE, V2002, pre8, DOI 10.1126/stke.2002.137.re8; Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gomeza J, 1996, J BIOL CHEM, V271, P2199, DOI 10.1074/jbc.271.4.2199; Herrero I, 1998, J BIOL CHEM, V273, P1951, DOI 10.1074/jbc.273.4.1951; Higuchi M, 2005, J BIOL CHEM, V280, P15229, DOI 10.1074/jbc.M500939200; Holcik M, 2000, P NATL ACAD SCI USA, V97, P2286, DOI 10.1073/pnas.040469797; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Ishikawa K, 1999, GENES CELLS, V4, P381, DOI 10.1046/j.1365-2443.1999.00269.x; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kitano J, 2003, J BIOL CHEM, V278, P25101, DOI 10.1074/jbc.M303266200; KOH JY, 1991, P NATL ACAD SCI USA, V88, P9431, DOI 10.1073/pnas.88.21.9431; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Moroni F, 1998, EUR J PHARMACOL, V347, P189, DOI 10.1016/S0014-2999(98)00124-1; Newcomb JK, 2000, METH MOL B, V144, P219; Pellegrini-Giampietro DE, 2003, TRENDS PHARMACOL SCI, V24, P461, DOI 10.1016/S0165-6147(03)00231-1; Rong R, 2003, NAT NEUROSCI, V6, P1153, DOI 10.1038/nn1134; Sagara Y, 1998, J NEUROSCI, V18, P6662; Saugstad JA, 1996, J NEUROSCI, V16, P5979; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Scholzke MN, 2003, EUR J NEUROSCI, V18, P3305, DOI 10.1111/j.1460-9568.2003.03079.x; Schroder UH, 1999, NEUROPHARMACOLOGY, V38, P209, DOI 10.1016/S0028-3908(98)00180-4; SILIPRANDI R, 1992, EUR J PHARMACOL, V219, P173, DOI 10.1016/0014-2999(92)90598-X; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Stowell JN, 1999, NEURON, V22, P525, DOI 10.1016/S0896-6273(00)80707-2; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Vincent AM, 2000, EXP NEUROL, V166, P65, DOI 10.1006/exnr.2000.7487; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Zhu PM, 2004, J NEUROSCI RES, V77, P525, DOI 10.1002/jnr.20175	42	131	135	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					399	412		10.1016/j.neuron.2006.12.020	http://dx.doi.org/10.1016/j.neuron.2006.12.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270736	Bronze			2022-12-28	WOS:000245126800010
J	Zolles, G; Klocker, N; Wenzel, D; Weisser-Thomas, J; Fleischmann, BK; Roeper, J; Fakler, B				Zolles, Gerd; Kloecker, Nikolaj; Wenzel, Daniela; Weisser-Thomas, Jutta; Fleischmann, Bernd K.; Roeper, Jochen; Fakler, Bernd			Pacemaking by HCN channels requires interaction with phosphoinositides	NEURON			English	Article							HYPERPOLARIZATION-ACTIVATED CHANNELS; RABBIT SINOATRIAL NODE; RECTIFIER K+ CHANNELS; VENTRICULAR MYOCYTES; CATION CHANNELS; DENDRITIC I(H); ATP CHANNELS; CELLS; MODULATION; NEURONS	Hyperpolarization-activated, cyclic-nucleotide-gated (HCN) channels mediate the depolarizing cation current (termed I-h or If) that initiates spontaneous rhythmic activity in heart and brain. This function critically depends on the reliable opening of HCN channels in the subthreshold voltage-range. Here we show that activation of HCN channels at physiologically relevant voltages requires interaction with phosphoinositides such as phosphatidylinositol-4,5-bisphosphate (PIP2). PIP2 acts as a ligand that allosterically opens HCN channels by shifting voltage-dependent channel activation similar to 20 mV toward depolarized potentials. Allosteric gating by PIP2 occurs in all HCN subtypes and is independent of the action of cyclic nucleotides. In CNS neurons and cardiomyocytes, enzymatic degradation of phospholipids results in reduced channel activation and slowing of the spontaneous firing rate. These results demonstrate that gating by phospholipids is essential for the pacemaking activity of HCN channels in cardiac and neuronal rhythmogenesis.	Univ Marburg, Inst Physiol, Div Neurophysiol, D-35037 Marburg, Germany; Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Univ Bonn, Inst Physiol, Life & Brain Ctr, D-53105 Bonn, Germany	Philipps University Marburg; University of Freiburg; University of Bonn	Roeper, J (corresponding author), Univ Marburg, Inst Physiol, Div Neurophysiol, Deutschhausstr 1-2, D-35037 Marburg, Germany.	roeper@mailer.uni-marburg.de; bernd.fakler@physiologie.uni-freiburg.de	Wenzel, Daniela/B-7613-2014	Wenzel, Daniela/0000-0003-1100-6363; Roeper, Jochen/0000-0003-2145-8742				Abi-Gerges N, 2000, J PHYSIOL-LONDON, V523, P377, DOI 10.1111/j.1469-7793.2000.t01-2-00377.x; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Baruscotti M, 2005, PHARMACOL THERAPEUT, V107, P59, DOI 10.1016/j.pharmthera.2005.01.005; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Cerbai E, 1999, CARDIOVASC RES, V42, P416, DOI 10.1016/S0008-6363(99)00037-1; Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491; DIFRANCESCO D, 1986, J PHYSIOL-LONDON, V377, P61, DOI 10.1113/jphysiol.1986.sp016177; DIFRANCESCO D, 1994, J PHYSIOL-LONDON, V474, P473, DOI 10.1113/jphysiol.1994.sp020038; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fleischmann BK, 2004, J CLIN INVEST, V114, P994, DOI 10.1172/JCI200415925; Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kaupp UB, 2001, ANNU REV PHYSIOL, V63, P235, DOI 10.1146/annurev.physiol.63.1.235; Krauss M, 2003, J CELL BIOL, V162, P113, DOI 10.1083/jcb.200301006; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Ludwig J, 2001, P NATL ACAD SCI USA, V98, P4178, DOI 10.1073/pnas.071613498; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Milosevic I, 2005, J NEUROSCI, V25, P2557, DOI 10.1523/JNEUROSCI.3761-04.2005; Neuhoff H, 2002, J NEUROSCI, V22, P1290, DOI 10.1523/JNEUROSCI.22-04-01290.2002; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Pian P, 2006, J GEN PHYSIOL, V128, P593, DOI 10.1085/jgp.200609648; Qu JH, 2001, CIRC RES, V89, pE8, DOI 10.1161/hh1301.094395; Robinson RB, 1997, PFLUG ARCH EUR J PHY, V433, P533, DOI 10.1007/s004240050309; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Rohacs T, 2003, P NATL ACAD SCI USA, V100, P745, DOI 10.1073/pnas.0236364100; Santoro B, 1999, ANN NY ACAD SCI, V868, P741, DOI 10.1111/j.1749-6632.1999.tb11353.x; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Stevens DR, 2001, NATURE, V413, P631, DOI 10.1038/35098087; Ulens C, 2003, NEURON, V40, P959, DOI 10.1016/S0896-6273(03)00753-0; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Woscholski R, 1995, J BIOL CHEM, V270, P31001, DOI 10.1074/jbc.270.52.31001; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	43	122	126	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1027	1036		10.1016/j.neuron.2006.12.005	http://dx.doi.org/10.1016/j.neuron.2006.12.005			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178405	Bronze			2022-12-28	WOS:000243115100010
J	Ward, B; McGuinness, L; Akerman, CJ; Fine, A; Bliss, TVP; Emptage, NJ				Ward, Bonnie; McGuinness, Lindsay; Akerman, Colin J.; Fine, Alan; Bliss, Tim V. P.; Emptage, Nigel J.			State-dependent mechanisms of LTP expression revealed by optical quantal analysis	NEURON			English	Article							LONG-TERM POTENTIATION; SILENT SYNAPSES; NEUROTRANSMITTER RELEASE; AMPA RECEPTORS; POSTSYNAPTIC EXPRESSION; PRESYNAPTIC COMPONENT; NEUROTROPHIC FACTOR; CALCIUM TRANSIENTS; MEMBRANE-PROTEIN; DENDRITIC SPINES	The expression mechanism of long-term potentiation (LTP) remains controversial. Here we combine electrophysiology and Ca2+ imaging to examine the role of silent synapses in LTP expression. Induction of LTP fails to change p(r) at these synapses but instead mediates an unmasking process that is sensitive to the inhibition of postsynaptic membrane fusion. Once unmasked, however, further potentiation of formerly silent synapses leads to an increase in p(r). The state of the synapse thus determines how LTP is expressed.	Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Natl Inst Med Res, MRC, Div Neurophysiol, London NW7 1AA, England; Dalhousie Univ, Fac Med, Dept Physiol & Biophys, Halifax, NS B3H 4H7, Canada	University of Oxford; MRC National Institute for Medical Research; Dalhousie University	Emptage, NJ (corresponding author), Univ Oxford, Dept Pharmacol, Mansfield Rd, Oxford OX1 3QT, England.	nigel.emptage@pharm.ox.ac.uk	Fine, Alan/P-5936-2014	Fine, Alan/0000-0002-4960-6973	Medical Research Council [MC_U117512674, G0501572] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0501572, MC_U117512674] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Arancio O, 1996, J PHYSIOLOGY-PARIS, V90, P321, DOI 10.1016/S0928-4257(97)87907-7; ARCHER BT, 1990, J BIOL CHEM, V265, P17267; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P283; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ELFERINK LA, 1989, J BIOL CHEM, V264, P11061; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Emptage NJ, 2003, NEURON, V38, P797, DOI 10.1016/S0896-6273(03)00325-8; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Isaac JTR, 2003, NEUROPHARMACOLOGY, V45, P450, DOI 10.1016/S0028-3908(03)00229-6; Isaac JTR, 1999, CAN J PHYSIOL PHARM, V77, P735, DOI 10.1139/cjpp-77-9-735; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kauer JS, 1998, CURR BIOL, V8, pR282, DOI 10.1016/S0960-9822(98)70173-3; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kullmann DM, 2003, PHILOS T R SOC B, V358, P727, DOI 10.1098/rstb.2002.1229; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Li YX, 1998, J NEUROSCI, V18, P10231; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINK E, 1992, BIOCHEM BIOPH RES CO, V189, P1017, DOI 10.1016/0006-291X(92)92305-H; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; PORTIS A, 1979, BIOCHEMISTRY-US, V18, P780, DOI 10.1021/bi00572a007; Pothos EN, 1998, J NEUROSCI, V18, P5575; Reid CA, 2004, J NEUROSCI, V24, P3618, DOI 10.1523/JNEUROSCI.3567-03.2004; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Rumpel S, 1998, J NEUROSCI, V18, P8863; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stoop R, 1996, J NEUROSCI, V16, P3256; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang S, 1999, CAN J PHYSIOL PHARM, V77, P651, DOI 10.1139/cjpp-77-9-651; WILLIAMS JH, 1989, NATURE, V341, P739, DOI 10.1038/341739a0; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; YAMAMOTO N, 1989, SCIENCE, V245, P192, DOI 10.1126/science.2749258; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zakharenko SS, 2001, NAT NEUROSCI, V4, P711, DOI 10.1038/89498; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	74	46	47	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					649	661		10.1016/j.neuron.2006.10.007	http://dx.doi.org/10.1016/j.neuron.2006.10.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114049	Bronze			2022-12-28	WOS:000242413100012
J	Yang, L; Bashaw, GJ				Yang, Long; Bashaw, Greg J.			Son of sevenless directly links the robo receptor to Rac activation to control axon repulsion at the midline	NEURON			English	Article							GROWTH CONE GUIDANCE; ROUNDABOUT RECEPTOR; TYROSINE KINASE; RHO GTPASES; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; CNS MIDLINE; R-RAS; SLIT; PROTEIN	Son of sevenless (Sos) is a dual specificity guanine nucleotide exchange factor (GEF) that regulates both Ras and Rho family GTPases and thus is uniquely poised to integrate signals that affect both gene expression and cytoskeletal reorganization. Here, using genetics, biochemistry, and cell biology, we demonstrate that Sos is recruited to the plasma membrane, where it forms a ternary complex with the Roundabout receptor and the SH3-SH2 adaptor protein Dreadlocks (Dock) to regulate Rac-dependent cytoskeletal rearrangement in response to the Slit ligand. Intriguingly, the Ras and Rac-GEF activities of Sos can be uncoupled during Robo-mediated axon repulsion; Sos axon guidance function depends on its Rac-GEF activity, but not its Ras-GEF activity. These results provide in vivo evidence that the Ras and RhoGEF domains of Sos are separable signaling modules and support a model in which Robo recruits Sos to the membrane via Dock to activate Rac during midline repulsion.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 421 Curie Blvd, Philadelphia, PA 19104 USA.	gbashaw@mail.med.upenn.edu			NINDS NIH HHS [NS046333, R01 NS046333] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS046333, R01NS046333] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; BONFINI L, 1992, SCIENCE, V255, P603, DOI 10.1126/science.1736363; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Englund C, 2002, DEVELOPMENT, V129, P4941; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Fritz JL, 2000, DEVELOPMENT, V127, P1991; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; HARIHARAN IK, 1995, EMBO J, V14, P292, DOI 10.1002/j.1460-2075.1995.tb07003.x; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hsouna A, 2003, J NEUROBIOL, V57, P15, DOI 10.1002/neu.10232; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; HU QJ, 1995, MOL CELL BIOL, V15, P1169; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Luschnig S, 2004, GENETICS, V167, P325, DOI 10.1534/genetics.167.1.325; Matsuura R, 2004, EUR J NEUROSCI, V19, P21, DOI 10.1046/j.1460-9568.2003.03084.x; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Oinuma I, 2004, J NEUROSCI, V24, P11473, DOI 10.1523/JNEUROSCI.3257-04.2004; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Okada S, 1996, J BIOL CHEM, V271, P25533, DOI 10.1074/jbc.271.41.25533; Patel BN, 2002, CURR OPIN CELL BIOL, V14, P221, DOI 10.1016/S0955-0674(02)00308-3; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Scita G, 1999, NATURE, V401, P290, DOI 10.1038/45822; Scita G, 2001, J CELL BIOL, V154, P1031, DOI 10.1083/jcb.200103146; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Silver SJ, 2004, GENESIS, V39, P263, DOI 10.1002/gene.20054; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Wills Z, 2002, NEURON, V36, P611, DOI 10.1016/S0896-6273(02)01022-X; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yu TW, 2002, NAT NEUROSCI, V5, P1147, DOI 10.1038/nn956; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895	47	78	80	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					595	607		10.1016/j.neuron.2006.09.039	http://dx.doi.org/10.1016/j.neuron.2006.09.039			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114045	Bronze			2022-12-28	WOS:000242413100008
J	Deinhardt, K; Salinas, S; Verastegui, C; Watson, R; Worth, D; Hanrahan, S; Bucci, C; Schiavo, G				Deinhardt, Katrin; Salinas, Sara; Verastegui, Carole; Watson, Rose; Worth, Daniel; Hanrahan, Sarah; Bucci, Cecilia; Schiavo, Giampietro			Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway	NEURON			English	Article							NERVE GROWTH-FACTOR; P75 NEUROTROPHIN RECEPTOR; TETANUS TOXIN; ANDROGEN RECEPTOR; LATE ENDOSOMES; NEURONS; MOTOR; PROTEIN; INTERNALIZATION; PROGRESSION	Vesicular pathways coupling the neuromuscular junction with the motor neuron soma are essential for neuronal function and survival. To characterize the organelles responsible for this long-distance crosstalk, we developed a purification strategy based on a fragment of tetanus neurotoxin (TeNT H-C) conjugated to paramagnetic beads. This approach enabled us to identify, among other factors, the small GTPase Rab7 as a functional marker of a specific pool of axonal retrograde carriers, which transport neurotrophins and their receptors. Furthermore, Rab5 is essential for an early step in TeNT H-C sorting but is absent from axonally transported vesicles. Our data demonstrate that TeNT H-C uses a retrograde transport pathway shared with p75(NTR), TrkB, and BDNF, which is strictly dependent on the activities of both Rab5 and Rab7. Therefore, Rab7 plays an essential role in axonal retrograde transport by controlling a vesicular compartment implicated in neurotrophin traffic.	Canc Res UK London Res Inst, Mol Neuropathol Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Electron Microscopy Lab, London WC2A 3PX, England; Canc Res UK London Res Inst, Prot Anal Lab, London WC2A 3PX, England; Univ Lecce, Dipartimento Sci & Tecnol Biol Ambientali, I-73100 Lecce, Italy	Cancer Research UK; Cancer Research UK; Cancer Research UK; University of Salento	Schiavo, G (corresponding author), Canc Res UK London Res Inst, Mol Neuropathol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	giampietro.schiavo@cancer.org.uk	Salinas, Sara/O-1856-2013; Bucci, Cecilia/F-6699-2012; Salinas, Sara/O-1150-2019	Salinas, Sara/0000-0003-4492-2093; Bucci, Cecilia/0000-0002-6232-6183; Salinas, Sara/0000-0003-4492-2093; Schiavo, Giampietro/0000-0002-4319-8745; Deinhardt, Katrin/0000-0002-6473-5298	Telethon [GGP05160] Funding Source: Medline	Telethon(Fondazione Telethon)		Adachi H, 2003, J NEUROSCI, V23, P2203; Bohnert S, 2005, J BIOL CHEM, V280, P42336, DOI 10.1074/jbc.M506750200; Bronfman FC, 2003, J NEUROSCI, V23, P3209; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CLAUDE P, 1982, J NEUROSCI, V2, P431; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Devon RS, 2006, P NATL ACAD SCI USA, V103, P9595, DOI 10.1073/pnas.0510197103; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; GROB PM, 1985, J BIOL CHEM, V260, P8044; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Gutierrez MG, 2004, J CELL SCI, V117, P2687, DOI 10.1242/jcs.01114; Guzik BW, 2004, CURR OPIN CELL BIOL, V16, P443, DOI 10.1016/j.ceb.2004.06.002; Hadano S, 2006, HUM MOL GENET, V15, P233, DOI 10.1093/hmg/ddi440; Hafezparast M, 2003, SCIENCE, V300, P808, DOI 10.1126/science.1083129; Harrison RE, 2003, MOL CELL BIOL, V23, P6494, DOI 10.1128/MCB.23.18.6494-6506.2003; Holzbaur ELF, 2004, TRENDS CELL BIOL, V14, P233, DOI 10.1016/j.tcb.2004.03.009; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; JOHNSON EM, 1987, J NEUROSCI, V7, P923; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lalli G, 2002, J CELL BIOL, V156, P233, DOI 10.1083/jcb.200106142; McLauchlan H, 1998, CURR BIOL, V8, P34, DOI 10.1016/S0960-9822(98)70018-1; MECKLER RL, 1990, NEUROSCIENCE, V36, P823, DOI 10.1016/0306-4522(90)90025-Y; Perlson E, 2004, MOL CELL PROTEOMICS, V3, P510, DOI 10.1074/mcp.M400004-MCP200; Pfeffer S, 2003, CELL, V112, P507, DOI 10.1016/S0092-8674(03)00118-1; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Roux S, 2005, MOL CELL NEUROSCI, V30, P79, DOI 10.1016/j.mcn.2005.05.008; Sakisaka T, 2002, EMBO J, V21, P6125, DOI 10.1093/emboj/cdf603; Samuels IS, 2001, J CELL BIOCHEM, V82, P452, DOI 10.1002/jcb.1177; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Schiavo G, 2001, NAT REV MOL CELL BIO, V2, P530, DOI 10.1038/35080089; Snider MD, 2003, MOL CELL, V12, P796, DOI 10.1016/S1097-2765(03)00401-5; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; STOCKEL K, 1975, BRAIN RES, V99, P1, DOI 10.1016/0006-8993(75)90604-6; Tucker BA, 2005, BRAIN RES PROTOC, V16, P50, DOI 10.1016/j.brainresprot.2005.10.004; Ure DR, 1997, J NEUROSCI, V17, P1282; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vidricaire G, 2005, J IMMUNOL, V175, P6517, DOI 10.4049/jimmunol.175.10.6517; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Whitaker HC, 2004, CLIN CANCER RES, V10, P7392, DOI 10.1158/1078-0432.CCR-04-0388; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	52	348	353	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					293	305		10.1016/j.neuron.2006.08.018	http://dx.doi.org/10.1016/j.neuron.2006.08.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046692	Bronze			2022-12-28	WOS:000241799900010
J	Arguello, PA; Gogos, JA				Arguello, P. Alexander; Gogos, Joseph A.			Modeling madness in mice: One piece at a time	NEURON			English	Review							INBRED MOUSE STRAINS; NMDA RECEPTOR HYPOFUNCTION; F-1 HYBRIDS IMPLICATIONS; NEUROTROPHIC FACTOR; WORKING-MEMORY; PREPULSE INHIBITION; ANIMAL-MODELS; VAL66MET POLYMORPHISM; COGNITIVE DEFICITS; PRECLINICAL MODELS	Mouse models that recapitulate the full phenotypic spectrum of a psychiatric disorder, such as schizophrenia, are impossible. However, a more piecemeal recreation of phenotypic components is feasible and promises to harness the power of animal models using approaches that are either off limits or confounded by drug treatment in humans. In that context, animal models will have a central and indispensable role in the process of discovering the causes of psychiatric disorders and generating novel, mechanism-based treatments. Here, we discuss current approaches used to generate animal models of psychiatric disorders, address the different components of these disorders that can be modeled in animals, and describe currently available analytical tools. We also discuss accumulating empirical data and take an in-depth look at what we believe to be the future of animal models made possible by recent advances in psychiatric genetics.	Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Med Ctr, Dept Physiol & Cellular Biophys, New York, NY 10032 USA	Columbia University; Columbia University	Gogos, JA (corresponding author), Columbia Univ, Med Ctr, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu		Arguello, P. Alexander/0000-0002-7709-8697				Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Akbarian S, 2002, J NEUROSCI, V22, P4153, DOI 10.1523/JNEUROSCI.22-10-04153.2002; Aleman A, 1999, AM J PSYCHIAT, V156, P1358; Anholt RRH, 2003, NAT GENET, V35, P180, DOI 10.1038/ng1240; Arnold JS, 2006, HUM MOL GENET, V15, P1629, DOI 10.1093/hmg/ddl084; Babb SJ, 2006, CURR BIOL, V16, P1317, DOI 10.1016/j.cub.2006.05.025; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; Bender HU, 2005, AM J HUM GENET, V76, P409, DOI 10.1086/428142; Birrell JM, 2000, J NEUROSCI, V20, P4320; Brewer WJ, 2005, AM J PSYCHIAT, V162, P71, DOI 10.1176/appi.ajp.162.1.71; Brown VJ, 2002, TRENDS NEUROSCI, V25, P340, DOI 10.1016/S0166-2236(02)02164-1; Cabib S, 2000, SCIENCE, V289, P463, DOI 10.1126/science.289.5478.463; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; CANNON TD, 1994, ARCH GEN PSYCHIAT, V51, P651; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Chourbaji S, 2004, MOL BRAIN RES, V121, P28, DOI 10.1016/j.molbrainres.2003.11.002; Chudasama Y, 2004, PSYCHOPHARMACOLOGY, V174, P86, DOI 10.1007/s00213-004-1805-y; Clayton NS, 2003, NAT REV NEUROSCI, V4, P685, DOI 10.1038/nrn1180; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Costall B., 1995, P401; Coyle JT, 2004, PSYCHOPHARMACOLOGY, V174, P32, DOI 10.1007/s00213-003-1709-2; Crabbe JC, 2004, NAT NEUROSCI, V7, P1175, DOI 10.1038/nn1343; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; Crusio WE, 2004, BIOL PSYCHIAT, V56, P381, DOI 10.1016/j.biopsych.2003.12.026; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; DEUTCH AY, 1992, J NEURAL TRANSM-GEN, P61; Dudchenko PA, 2004, NEUROSCI BIOBEHAV R, V28, P699, DOI 10.1016/j.neubiorev.2004.09.002; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Duman RS, 2002, MOL PSYCHIATR, V7, pS29, DOI 10.1038/sj.mp.4001016; Duncan GE, 2002, BRAIN RES, V951, P166, DOI 10.1016/S0006-8993(02)03156-6; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Ellenbroek BA, 2000, BEHAV PHARMACOL, V11, P223, DOI 10.1097/00008877-200006000-00006; Elvevag B, 2000, CRIT REV NEUROBIOL, V14, P1; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Escobar M, 2002, NEUROSCI BIOBEHAV R, V26, P203, DOI 10.1016/S0149-7634(01)00067-7; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Floresco SB, 2005, SCHIZOPHRENIA BULL, V31, P888, DOI 10.1093/schbul/sbi041; Floresco SB, 1997, J NEUROSCI, V17, P1880; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Freimer N, 2004, NAT GENET, V36, P1045, DOI 10.1038/ng1433; Gainetdinov RR, 1999, SCIENCE, V283, P397, DOI 10.1126/science.283.5400.397; Geller B, 2004, AM J PSYCHIAT, V161, P1698, DOI 10.1176/appi.ajp.161.9.1698; Gerber DJ, 2003, P NATL ACAD SCI USA, V100, P8993, DOI 10.1073/pnas.1432927100; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Geyer MA, 2001, PSYCHOPHARMACOLOGY, V156, P117, DOI 10.1007/s002130100811; Geyer MA, 2002, NEUROPSYCHOPHARMACOL, V27, P689; Geyer Mark A, 2006, Dialogues Clin Neurosci, V8, P9; Glickstein SB, 2002, J NEUROSCI, V22, P5619; Goff DC, 2001, AM J PSYCHIAT, V158, P1367, DOI 10.1176/appi.ajp.158.9.1367; Gogos JA, 2006, TRENDS PHARMACOL SCI, V27, P226, DOI 10.1016/j.tips.2006.02.005; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gray NS, 2005, NEUROSCI BIOBEHAV R, V29, P989, DOI 10.1016/j.neubiorev.2005.01.006; Green EK, 2006, MOL PSYCHIATR, V11, P798, DOI 10.1038/sj.mp.4001853; Green MF, 1999, ARCH GEN PSYCHIAT, V56, P1007, DOI 10.1001/archpsyc.56.11.1007; Green MF, 2005, SCHIZOPHRENIA BULL, V31, P882, DOI 10.1093/schbul/sbi049; Green MF, 2004, SCHIZOPHR RES, V72, P1, DOI 10.1016/j.schres.2004.09.006; Green MF, 2000, SCHIZOPHRENIA BULL, V26, P119, DOI 10.1093/oxfordjournals.schbul.a033430; Grillet N, 2005, MOL CELL BIOL, V25, P4221, DOI 10.1128/MCB.25.10.4221-4228.2005; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Hagan JJ, 2005, SCHIZOPHRENIA BULL, V31, P830, DOI 10.1093/schbul/sbi058; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hall D, 2003, AM J HUM GENET, V73, P370, DOI 10.1086/377003; Hampton RR, 2004, CURR OPIN NEUROBIOL, V14, P192, DOI 10.1016/j.conb.2004.03.006; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Hennah W, 2003, HUM MOL GENET, V12, P3151, DOI 10.1093/hmg/ddg341; Huotari M, 2002, EUR J NEUROSCI, V15, P246, DOI 10.1046/j.0953-816x.2001.01856.x; Huotari M, 2004, PSYCHOPHARMACOLOGY, V172, P1, DOI 10.1007/s00213-003-1627-3; Jablensky A., 2003, SCHIZOPHRENIA, P203; Jacquet H, 2005, MOL PSYCHIATR, V10, P479, DOI 10.1038/sj.mp.4001597; JAVITT DC, 1991, AM J PSYCHIAT, V148, P1301; Javitt DC, 2000, ARCH GEN PSYCHIAT, V57, P1131, DOI 10.1001/archpsyc.57.12.1131; Jentsch JD, 2003, CLIN NEUROSCI RES, V3, P303, DOI 10.1016/j.cnr.2003.10.011; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jentsch JD, 1997, SCIENCE, V277, P953, DOI 10.1126/science.277.5328.953; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Karayiorgou M, 2004, MOL BRAIN RES, V132, P95, DOI 10.1016/j.molbrainres.2004.09.029; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kremen WS, 2000, J ABNORM PSYCHOL, V109, P743, DOI 10.1037/0021-843X.109.4.743; Kuc KA, 2006, GENES BRAIN BEHAV, V5, P355, DOI 10.1111/j.1601-183X.2005.00168.x; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Le Pen G, 2000, BEHAV PHARMACOL, V11, P257, DOI 10.1097/00008877-200006000-00009; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lipska BK, 2000, NEUROPSYCHOPHARMACOL, V23, P223, DOI 10.1016/S0893-133X(00)00137-8; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Liu M, 2000, GENE DEV, V14, P2839, DOI 10.1101/gad.840500; Logue SF, 1997, NEUROSCIENCE, V80, P1075, DOI 10.1016/S0306-4522(97)00164-4; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Lubow RE, 2005, SCHIZOPHRENIA BULL, V31, P139, DOI 10.1093/schbul/sbi005; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Meyer U, 2005, NEUROSCI BIOBEHAV R, V29, P913, DOI 10.1016/j.neubiorev.2004.10.012; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Mirnics K, 2005, J NEUROSCI, V25, P1571, DOI 10.1523/JNEUROSCI.4145-04.2005; Mirnics ZK, 2003, MOL PSYCHIATR, V8, P863, DOI 10.1038/sj.mp.4001389; Miyakawa T, 2003, P NATL ACAD SCI USA, V100, P8987, DOI 10.1073/pnas.1432926100; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Moore H, 2006, BIOL PSYCHIAT, V60, P253, DOI 10.1016/j.biopsych.2006.01.003; Moore JH, 2005, NAT GENET, V37, P13, DOI 10.1038/ng0105-13; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Newton-Cheh C, 2005, MUTAT RES-FUND MOL M, V573, P54, DOI 10.1016/j.mrfmmm.2005.01.006; O'Tuathaigh CM, 2006, NEUROREPORT, V17, P79, DOI 10.1097/01.wnr.0000192738.31029.0a; Owen EH, 1997, NEUROSCIENCE, V80, P1087, DOI 10.1016/S0306-4522(97)00165-6; Palmer BW, 1997, NEUROPSYCHOLOGY, V11, P437, DOI 10.1037/0894-4105.11.3.437; PARK S, 1992, ARCH GEN PSYCHIAT, V49, P975; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Rebbeck TR, 2004, NAT REV GENET, V5, P589, DOI 10.1038/nrg1403; Renick SE, 1999, J NEUROSCI, V19, P21, DOI 10.1523/JNEUROSCI.19-01-00021.1999; Riccio CA, 2002, ARCH CLIN NEUROPSYCH, V17, P235, DOI 10.1016/S0887-6177(01)00111-1; Rimer M, 2005, NEUROREPORT, V16, P271, DOI 10.1097/00001756-200502280-00014; Robbins TW, 1998, BEHAV PHARMACOL, V9, P509, DOI 10.1097/00008877-199811000-00005; ROBBINS TW, 2004, NEUROBIOLOGY MENTAL, P263; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Sarter M, 1999, TRENDS NEUROSCI, V22, P300, DOI 10.1016/S0166-2236(99)01419-8; Sawa A, 2005, SCIENCE, V310, P1128, DOI 10.1126/science.1121114; SAYKIN AJ, 1994, ARCH GEN PSYCHIAT, V51, P124; Schwab SG, 2005, BIOL PSYCHIAT, V58, P446, DOI 10.1016/j.biopsych.2005.05.005; Scolnick EM, 2006, BIOL PSYCHIAT, V59, P1039, DOI 10.1016/j.biopsych.2006.02.022; Shi LM, 2003, J NEUROSCI, V23, P297, DOI 10.1523/jneurosci.23-01-00297.2003; Shu TZ, 2004, NEURON, V44, P263, DOI 10.1016/j.neuron.2004.09.030; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Sklar P, 2002, MOL PSYCHIATR, V7, P579, DOI 10.1038/sj.mp.4001058; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Svenningsson P, 2003, SCIENCE, V302, P1412, DOI 10.1126/science.1089681; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Talamini LM, 2005, ARCH GEN PSYCHIAT, V62, P485, DOI 10.1001/archpsyc.62.5.485; TAYLOR MA, 1992, AM J PSYCHIAT, V149, P22; Tecott LH, 2004, NAT NEUROSCI, V7, P462, DOI 10.1038/nn1225; Vitelli F, 2003, HUM MOL GENET, V12, P2041, DOI 10.1093/hmg/ddg216; Waddington JL, 2005, PSYCHOPHARMACOLOGY, V181, P611, DOI 10.1007/s00213-005-0058-8; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; WEINBERGER DR, 1995, LANCET, V346, P552, DOI 10.1016/S0140-6736(95)91386-6; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	168	255	261	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					179	196		10.1016/j.neuron.2006.09.023	http://dx.doi.org/10.1016/j.neuron.2006.09.023			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015235	Bronze			2022-12-28	WOS:000241408100013
J	Hardy, J				Hardy, John			A hundred years of Alzheimer's disease research	NEURON			English	Editorial Material							AMYLOID-PRECURSOR-PROTEIN; PAIRED HELICAL FILAMENTS; HEREDITARY CEREBRAL-HEMORRHAGE; GAMMA-SECRETASE ACTIVITY; LONG-TERM POTENTIATION; DEMENTED OLD PEOPLE; BETA-PROTEIN; TRANSGENIC MICE; ALPHA-SYNUCLEIN; APOLIPOPROTEIN-E	On the 100(th) anniversary of Alzheimer's lecture describing the clinicopathological entity which bears his eponym, this article reviews the major areas of progress in our understanding of the disease and outlines the many gaps still remaining. The progress toward effective mechanistic therapy is reviewed.	NIA, Neurogenet Lab, Bethesda, MD 20892 USA; UCL, Inst Neurol, Reta Lila Weston Inst, London WC2, England	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London	Hardy, J (corresponding author), NIA, Neurogenet Lab, Porter Neurosci Bldg,35 Convent Dr, Bethesda, MD 20892 USA.	hardyJ@mail.nih.gov	Hardy, John/C-2451-2009; Blossey, Erich C/A-9696-2011	Hardy, John/0000-0002-3122-0423; Blossey, Erich C/0000-0002-8189-766X	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G0701075] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADOLFSSON R, 1979, BRIT J PSYCHIAT, V135, P216, DOI 10.1192/bjp.135.3.216; Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; Atwood CS, 2003, SCIENCE, V299, P1014; Atwood CS, 2002, J NEUROSCI RES, V70, P356, DOI 10.1002/jnr.10388; BARTUS RT, 1979, SCIENCE, V206, P1087, DOI 10.1126/science.227061; BEACH TG, 1987, J HIST MED ALL SCI, V42, P327, DOI 10.1093/jhmas/42.3.327; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bielschowsky M., 1902, NEUROL CENTRALBL, V21, P579; Bird T D, 1989, Prog Clin Biol Res, V317, P229; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; BOWEN DM, 1976, BRAIN, V99, P459, DOI 10.1093/brain/99.3.459; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRION JP, 1985, ARCH BIOL, V96, P229; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHARTIERHARLIN MC, 1994, HUM MOL GENET, V3, P569, DOI 10.1093/hmg/3.4.569; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Citron M, 2004, TRENDS PHARMACOL SCI, V25, P92, DOI 10.1016/j.tips.2003.12.004; CITRON M, 1995, NEURON, V14, P661, DOI 10.1016/0896-6273(95)90323-2; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Crook R, 1998, NAT MED, V4, P452, DOI 10.1038/nm0498-452; DAVIES P, 1976, LANCET, V2, P1403; DAVIS KL, 1978, SCIENCE, V201, P272, DOI 10.1126/science.351807; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; DELABAR JM, 1987, SCIENCE, V235, P1390, DOI 10.1126/science.2950593; Dewachter I, 2002, J NEUROSCI, V22, P3445; DUFF K, 2004, PROTEOMICS, V3, P47; Duyckaerts C, 2004, NEUROBIOL AGING, V25, P735, DOI 10.1016/neurobiolaging.2003.12.014; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Essen-Moller E, 1946, ACTA PSYCH NEUROL, V21, P233, DOI 10.1111/j.1600-0447.1946.tb07276.x; FARRER LA, 1995, ANN NEUROL, V38, P797, DOI 10.1002/ana.410380515; Foster NL, 1997, ANN NEUROL, V41, P706, DOI 10.1002/ana.410410606; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOATE AM, 1989, LANCET, V1, P352; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Graeber MB, 1998, NEUROGENETICS, V1, P223, DOI 10.1007/s100480050033; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; Gustafson L, 1998, HUM GENET, V102, P253, DOI 10.1007/s004390050688; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HANSEN LA, 1993, J NEUROPATH EXP NEUR, V52, P648, DOI 10.1097/00005072-199311000-00012; HARDY J, 1992, NAT GENET, V1, P233, DOI 10.1038/ng0792-233; Hardy J, 1998, NAT NEUROSCI, V1, P355, DOI 10.1038/1565; HARDY J, 1987, NEUROSCI LETT, V73, P77, DOI 10.1016/0304-3940(87)90034-6; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holtzman DM, 2004, J MOL NEUROSCI, V23, P247, DOI 10.1385/JMN:23:3:247; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hooper NM, 2002, CURR MED CHEM, V9, P1107, DOI 10.2174/0929867023370121; Hornykiewicz E, 2002, MOVEMENT DISORD, V17, P501, DOI 10.1002/mds.10115; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATZMAN R, 1976, ARCH NEUROL-CHICAGO, V33, P217, DOI 10.1001/archneur.1976.00500040001001; Khachaturian ZS, 2006, J ALZHEIMERS DIS, V9, P409; KIDD M, 1963, NATURE, V197, P192, DOI 10.1038/197192b0; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; KRAEPELIN E, 1910, LEHRBUCH STUDIERENDE, V1910, P593; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LANTOS PL, 1994, NEUROSCI LETT, V172, P77, DOI 10.1016/0304-3940(94)90666-1; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lleo A, 2006, ANNU REV MED, V57, P513, DOI 10.1146/annurev.med.57.121304.131442; MARTIN JJ, 1991, NEUROLOGY, V41, P62, DOI 10.1212/WNL.41.1.62; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Maurer K, 1997, LANCET, V349, P1546, DOI 10.1016/S0140-6736(96)10203-8; MCGEER PL, 1992, NEUROLOGY, V42, P447, DOI 10.1212/WNL.42.2.447; MIYAKAWA T, 1979, ACTA NEUROPATHOL, V48, P153, DOI 10.1007/BF00691158; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MULLAN M, 1993, NEUROBIOL AGING, V14, P407, DOI 10.1016/0197-4580(93)90099-W; MURRAY JM, 1982, NATURE, V300, P69, DOI 10.1038/300069a0; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NEWTON RD, 1948, J MENT SCI, V94, P225, DOI 10.1192/bjp.94.395.225; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; NUKINA N, 1986, J BIOCHEM-TOKYO, V99, P1541, DOI 10.1093/oxfordjournals.jbchem.a135625; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PERRY EK, 1977, J NEUROL SCI, V34, P247, DOI 10.1016/0022-510X(77)90073-9; PERUSINI G, 1991, PSICHIATRIA ELETTOTE, V4, P193; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; REDLICH F, 1998, JB PSYCHIAT NEUROLOG, P17; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Roses AD, 2006, J ALZHEIMERS DIS, V9, P361; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Scahill RI, 2002, P NATL ACAD SCI USA, V99, P4703, DOI 10.1073/pnas.052587399; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHELLENBERG GD, 1988, SCIENCE, V241, P1507, DOI 10.1126/science.3420406; Schenk D, 2004, NATURE, V431, P398, DOI 10.1038/431398b; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Schottky J, 1932, Z GESAMTE NEUROL PSY, V140, P333, DOI 10.1007/BF02864363; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Spillantini MG, 1998, BRAIN PATHOL, V8, P387; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; STGEORGEHYSLOP P, 1992, NAT GENET, V2, P330, DOI 10.1038/ng1292-330; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; STGEORGEHYSLOP PH, 1987, SCIENCE, V238, P664, DOI 10.1126/science.2890206; STGEORGEHYSLOP PH, 1990, NATURE, V347, P194, DOI 10.1038/347194a0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; SUMMERS WK, 1986, NEW ENGL J MED, V315, P1241, DOI 10.1056/NEJM198611133152001; SUMPTER PQ, 1986, NEUROPATH APPL NEURO, V12, P305, DOI 10.1111/j.1365-2990.1986.tb00142.x; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; TERRY RD, 1964, AM J PATHOL, V44, P269; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; TOMLINSON BE, 1968, J NEUROL SCI, V7, P331, DOI 10.1016/0022-510X(68)90154-8; van Bogaert L, 1940, MON PSYCHIATR NEUROL, V102, P249; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; VAN BROECKHOVEN C, 1990, SCIENCE, V248, P1120, DOI 10.1126/science.1971458; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Webster S, 1997, NEUROBIOL AGING, V18, P415, DOI 10.1016/S0197-4580(97)00042-0; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WENK H, 1980, BRAIN RES REV, V2, P295, DOI 10.1016/0165-0173(80)90011-9; WHITEHOUSE PJ, 1982, SCIENCE, V215, P1237, DOI 10.1126/science.7058341; WILHELMSEN KC, 1994, AM J HUM GENET, V55, P1159; Winblad B, 2003, NEURON, V38, P517, DOI 10.1016/S0896-6273(03)00297-6; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; WOOD JG, 1986, P NATL ACAD SCI USA, V83, P4040, DOI 10.1073/pnas.83.11.4040; Xia XF, 2001, P NATL ACAD SCI USA, V98, P10863, DOI 10.1073/pnas.191284198; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	164	357	377	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					3	13		10.1016/j.neuron.2006.09.016	http://dx.doi.org/10.1016/j.neuron.2006.09.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015223	Bronze			2022-12-28	WOS:000241408100001
J	Hauser, SL; Oksenberg, JR				Hauser, Stephen L.; Oksenberg, Jorge R.			The neurobiology of multiple sclerosis: Genes, inflammation, and neurodegeneration	NEURON			English	Review							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; OLIGODENDROCYTE PROGENITOR CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; SPINAL-CORD; AFRICAN-AMERICANS; AXONAL DAMAGE; CEREBROSPINAL-FLUID	The autoimmune model of multiple sclerosis (MS) pathogenesis provided for many years a useful but incomplete conceptual framework for understanding the complex array of factors that lead to the loss of immune homeostasis, myelin and axonal injury, and progressive neurological symptoms. The availability of novel tools in molecular neurogenetics and increasingly sophisticated neuroimaging technologies, together with the revitalization of MS neuropathology, has created a new paradigm for the multidisciplinary study of this disease. This is reflected by the growing resolution of the MS genomic map, discovery of delicate inflammatory networks that are perturbed in MS, identification of mediators of demyelination, and recognition that cumulative axonal loss and neuronal injury are the histological correlates of neurological disability. Together, these advances have set the stage for the development of therapeutic approaches designed to target the demyelinating and neurodegenerative components of the disease and promote repair.	Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Oksenberg, JR (corresponding author), Univ Calif San Francisco, Dept Neurol, Sch Med, San Francisco, CA 94143 USA.	jorge.oksenberg@ucsf.edu	Hauser, Stephen L/J-2978-2016					Acar G, 2003, J NEUROL, V250, P588, DOI 10.1007/s00415-003-1041-0; Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; ASCHERIO A, 2001, JAMA-J AM MED ASSOC, V386, P3083; Bachelin C, 2005, BRAIN, V128, P540, DOI 10.1093/brain/awh406; Bagnato F, 2003, BRAIN, V126, P1782, DOI 10.1093/brain/awg182; Baranzini SE, 2005, PLOS BIOL, V3, P166, DOI 10.1371/journal.pbio.0030002; Baranzini SE, 1999, J IMMUNOL, V163, P5133; Barcellos LF, 2002, BRAIN, V125, P150; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Barnett MH, 2004, ANN NEUROL, V55, P458, DOI 10.1002/ana.20016; Bechtold DA, 2004, ANN NEUROL, V55, P607, DOI 10.1002/ana.20045; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bezzi P, 2004, NAT NEUROSCI, V7, P613, DOI 10.1038/nn1246; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bieber AJ, 2003, ANN NEUROL, V53, P680, DOI 10.1002/ana.10578; Bitsch A, 2000, BRAIN, V123, P1174, DOI 10.1093/brain/123.6.1174; Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Bozzali M, 2002, AM J NEURORADIOL, V23, P985; Brassat D, 1999, NEUROLOGY, V52, P1632, DOI 10.1212/WNL.52.8.1632; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; BROWNELL B, 1962, J NEUROL NEUROSUR PS, V25, P315, DOI 10.1136/jnnp.25.4.315; Cader S, 2006, BRAIN, V129, P527, DOI 10.1093/brain/awh670; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Cepok S, 2005, J CLIN INVEST, V115, P1352, DOI 10.1172/JCI200523661; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Cid C, 2002, J NEUROL SCI, V193, P103, DOI 10.1016/S0022-510X(01)00650-5; Coles AJ, 2006, J NEUROL, V253, P98, DOI 10.1007/s00415-005-0934-5; Colombo M, 2000, J IMMUNOL, V164, P2782, DOI 10.4049/jimmunol.164.5.2782; COMPSTON A, 2006, MCALPINES MULTIPLE; Confavreux C, 2006, BRAIN, V129, P595, DOI 10.1093/brain/awh714; Confavreux C, 2003, BRAIN, V126, P770, DOI 10.1093/brain/awg081; Corcione A, 2004, P NATL ACAD SCI USA, V101, P11064, DOI 10.1073/pnas.0402455101; Craner MJ, 2004, BRAIN, V127, P294, DOI 10.1093/brain/awh032; Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; Cree BAC, 2004, NEUROLOGY, V63, P2039, DOI 10.1212/01.WNL.0000145762.60562.5D; Cross AH, 2005, IMMUNOL RES, V32, P85, DOI 10.1385/IR:32:1-3:085; CROSS AH, 1994, J CLIN INVEST, V93, P2684, DOI 10.1172/JCI117282; Diemel LT, 2004, GLIA, V45, P278, DOI 10.1002/glia.10335; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Ebers GC, 2000, ANN NEUROL, V48, P927, DOI 10.1002/1531-8249(200012)48:6<927::AID-ANA14>3.3.CO;2-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Farina C, 2005, LANCET NEUROL, V4, P567, DOI 10.1016/S1474-4422(05)70167-8; Feldmann M, 2005, NATURE, V435, P612, DOI 10.1038/nature03727; Ferguson B, 1997, BRAIN, V120, P393, DOI 10.1093/brain/120.3.393; FILIPPI M, 2005, MULTIPLE SCLEROSIS N, P215; Firth D., 1948, CASE AUGUSTUS DESTE; Foote AK, 2005, BRAIN, V128, P528, DOI 10.1093/brain/awh417; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Frost EE, 2003, J NEUROBIOL, V54, P457, DOI 10.1002/neu.10158; Gadea M, 2004, BRAIN, V127, P89, DOI 10.1093/brain/awh002; Garbern JY, 2002, BRAIN, V125, P551, DOI 10.1093/brain/awf043; GENAIN CP, 1994, J CLIN INVEST, V94, P1339, DOI 10.1172/JCI117454; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Ghosh S, 2003, NEW ENGL J MED, V348, P24, DOI 10.1056/NEJMoa020732; Goodin DS, 2006, ANN NEUROL, V59, P597, DOI 10.1002/ana.20832; Goodnow CC, 2005, NATURE, V435, P590, DOI 10.1038/nature03724; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Hafler DA, 2005, IMMUNOL REV, V204, P208, DOI 10.1111/j.0105-2896.2005.00240.x; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; HAUSER SL, 2005, HARRISONS PRINCIPLES, P2461; Hoftberger R, 2004, BRAIN PATHOL, V14, P43; Hohlfeid R, 2004, P NATL ACAD SCI USA, V101, P14599, DOI 10.1073/pnas.0404874101; Hohlfeld R, 2000, J NEUROIMMUNOL, V107, P161, DOI 10.1016/S0165-5728(00)00233-2; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kantarci OH, 2002, J NEUROIMMUNOL, V123, P144, DOI 10.1016/S0165-5728(01)00481-7; Karadottir R, 2005, NATURE, V438, P1162, DOI 10.1038/nature04302; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kornek B, 1999, BRAIN PATHOL, V9, P651; Kornek B, 2000, AM J PATHOL, V157, P267, DOI 10.1016/S0002-9440(10)64537-3; Kotter MR, 2005, NEUROBIOL DIS, V18, P166, DOI 10.1016/j.nbd.2004.09.019; Krumbholz M, 2005, J EXP MED, V201, P195, DOI 10.1084/jem.20041674; KURTZKE JF, 1979, NEUROLOGY, V29, P1228, DOI 10.1212/WNL.29.9_Part_1.1228; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lassmann H, 2003, LANCET, V361, P1317, DOI 10.1016/S0140-6736(03)13088-7; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Leppert D, 1998, BRAIN, V121, P2327, DOI 10.1093/brain/121.12.2327; Leppert D, 1996, ANN NEUROL, V40, P846, DOI 10.1002/ana.410400606; Levin LI, 2005, JAMA-J AM MED ASSOC, V293, P2496, DOI 10.1001/jama.293.20.2496; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; LINDSTROM AB, 1994, J EXPO ANAL ENV EPID, V4, P183; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Lo AC, 2003, J NEUROPHYSIOL, V90, P3566, DOI 10.1152/jn.00434.2003; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; Losseff NA, 1996, BRAIN, V119, P2009, DOI 10.1093/brain/119.6.2009; Lucchinetti CF, 2004, ANN NEUROL, V56, P308, DOI 10.1002/ana.20182; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; MEDAER R, 1979, ACTA NEUROL SCAND, V60, P189; Merkler D, 2006, BRAIN, V129, P1972, DOI 10.1093/brain/awl135; Miller DH, 2002, BRAIN, V125, P1676, DOI 10.1093/brain/awf177; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Mummert SK, 2005, GENE CHROMOSOME CANC, V43, P155, DOI 10.1002/gcc.20176; Neumann H, 2003, CURR OPIN NEUROL, V16, P267, DOI 10.1097/00019052-200306000-00004; Newman TA, 2001, BRAIN, V124, P2203, DOI 10.1093/brain/124.11.2203; Noseworthy JH, 2003, CURR OPIN NEUROL, V16, P289, DOI 10.1097/00019052-200306000-00007; O'Connor KC, 2005, J IMMUNOL, V175, P1974, DOI 10.4049/jimmunol.175.3.1974; O'Connor PW, 2004, NEUROLOGY, V62, P2038, DOI 10.1212/01.WNL.0000128136.79044.D6; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Oksenberg JR, 2005, GENES IMMUN, V6, P375, DOI 10.1038/sj.gene.6364237; Owens GP, 1998, ANN NEUROL, V43, P236, DOI 10.1002/ana.410430214; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Platten M, 2005, SCIENCE, V310, P850, DOI 10.1126/science.1117634; Platten M, 2005, NAT MED, V11, P252, DOI 10.1038/nm0305-252; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; POSER CM, 1994, ANN NEUROL, V36, pS231, DOI 10.1002/ana.410360810; Ransohoff RM, 2005, NAT NEUROSCI, V8, P1275, DOI 10.1038/nn1005-1275; Redford EJ, 1997, BRAIN, V120, P2149, DOI 10.1093/brain/120.12.2149; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; RIDICK RA, 2006, IN PRESS ANN NEUROL; RISCH N, 1990, AM J HUM GENET, V46, P222; Rivers TM, 1935, J EXP MED, V61, P689, DOI 10.1084/jem.61.5.689; Rosati G, 2001, NEUROL SCI, V22, P117, DOI 10.1007/s100720170011; Sadovnick AD, 1996, LANCET, V347, P1728, DOI 10.1016/S0140-6736(96)90807-7; Sahrbacher UC, 1998, EUR J IMMUNOL, V28, P1332, DOI 10.1002/(SICI)1521-4141(199804)28:04<1332::AID-IMMU1332>3.0.CO;2-G; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sawcer S, 2005, AM J HUM GENET, V77, P454; Schneider A, 2004, J BIOL CHEM, V279, P55833, DOI 10.1074/jbc.M409954200; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seifert T, 2002, MULT SCLER, V8, P447, DOI 10.1191/1352458502ms830oa; Seldin MF, 2004, GENOME RES, V14, P1076, DOI 10.1101/gr.2165904; Setzu A, 2006, GLIA, V54, P297, DOI 10.1002/glia.20371; Sheridan C, 2005, NAT BIOTECHNOL, V23, P397, DOI 10.1038/nbt0405-397; Smith KJ, 2001, ANN NEUROL, V49, P470; SMITH KJ, 2005, MULTIPLE SCLEROSIS N, P255; Smith-Jensen T, 2000, NEUROLOGY, V54, P1227, DOI 10.1212/WNL.54.6.1227; Stefano S, 2003, AUTOIMMUNITY, V36, P257, DOI 10.1080/0891693031000151607; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinman L, 2002, ANNU REV NEUROSCI, V25, P491, DOI 10.1146/annurev.neuro.25.112701.142913; Steinman L, 2006, ANN NEUROL, V60, P12, DOI 10.1002/ana.20913; Stern JNH, 2005, P NATL ACAD SCI USA, V102, P1620, DOI 10.1073/pnas.0409022102; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Stuve O, 1996, ANN NEUROL, V40, P853, DOI 10.1002/ana.410400607; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Vollmer T, 2004, LANCET, V363, P1607, DOI 10.1016/S0140-6736(04)16205-3; Wallin MT, 2004, ANN NEUROL, V55, P65, DOI 10.1002/ana.10788; Waxman S, 2005, MULTIPLE SCLEROSIS N; Waxman SG., 2005, MULTIPLE SCLEROSIS N, P165; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Windrem MS, 2004, NAT MED, V10, P93, DOI 10.1038/nm974; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Wucherpfennig KW, 2005, CURR TOP MICROBIOL, V296, P19; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Zhang YP, 2005, J NEUROIMMUNOL, V167, P120, DOI 10.1016/j.jneuroim.2005.05.006; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	158	552	567	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					61	76		10.1016/j.neuron.2006.09.011	http://dx.doi.org/10.1016/j.neuron.2006.09.011			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015227	Bronze			2022-12-28	WOS:000241408100005
J	Ross, CA; Margolis, RL; Reading, SAJ; Pletnikov, M; Coyle, JT				Ross, Christopher A.; Margolis, Russell L.; Reading, Sarah A. J.; Pletnikov, Mikhail; Coyle, Joseph T.			Neurobiology of schizophrenia	NEURON			English	Review							BRAIN-DEVELOPMENT; BIPOLAR DISORDER; GENE-EXPRESSION; SCHIZOAFFECTIVE DISORDER; TRANSCRIPTION FACTOR; ADULT SCHIZOPHRENIA; SUSCEPTIBILITY GENE; COGNITIVE DEFICITS; NEURONAL MIGRATION; NEURITE OUTGROWTH	With its hallucinations, delusions, thought disorder, and cognitive deficits, schizophrenia affects the most basic human processes of perception, emotion, and judgment. Evidence increasingly suggests that schizophrenia is a subtle disorder of brain development and plasticity. Genetic studies are beginning to identify proteins of candidate genetic risk factors for schizophrenia, including dysbindin, neuregulin 1, DAOA, COMT, and DISC1, and neurobiological studies of the normal and variant forms of these genes are now well justified. We suggest that DISC1 may offer especially valuable insights. Mechanistic studies of the properties of these candidate genes and their protein products should clarify the molecular, cellular, and systems-level pathogenesis of schizophrenia. This can help redefine the schizophrenia phenotype and shed light on the relationship between schizophrenia and other major psychiatric disorders. Understanding these basic pathologic processes may yield novel targets for the development of more effective treatments.	Johns Hopkins Univ, Sch Med, Div Neurobiol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Schizophrenia Program, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; Harvard Univ, McLean Hosp, Sch Med, Belmont, MA 02478 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; McLean Hospital	Ross, CA (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurobiol, Baltimore, MD 21287 USA.	caross@jhu.edu	Gur, Ruben/K-1999-2019; Ross, Christopher A/H-8395-2013; Pletnikov, Mikhail V/G-8709-2012; Bernardo, Miquel/P-3049-2015; Arnold, Steven E/J-7546-2012	Gur, Ruben/0000-0002-9657-1996; Pletnikov, Mikhail V/0000-0002-8819-6559; Bernardo, Miquel/0000-0001-8748-6717; 				Abdolmaleky HM, 2005, AM J MED GENET B, V134B, P60, DOI 10.1002/ajmg.b.30140; Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Antonova E, 2004, SCHIZOPHR RES, V70, P117, DOI 10.1016/j.schres.2003.12.002; Arnold SE, 1997, BIOL PSYCHIAT, V42, P639, DOI 10.1016/S0006-3223(97)00142-X; Arnold SE, 2005, PROG BRAIN RES, V147, P319, DOI 10.1016/S0079-6123(04)47023-X; Arnold SE, 1998, ARCH GEN PSYCHIAT, V55, P225, DOI 10.1001/archpsyc.55.3.225; Austin CP, 2003, NEUROREPORT, V14, P951, DOI 10.1097/01.wnr.0000074342.81633.63; Benson MA, 2001, J BIOL CHEM, V276, P24232, DOI 10.1074/jbc.M010418200; Blackwood DHR, 2001, AM J HUM GENET, V69, P428, DOI 10.1086/321969; Bowie CR, 2005, PSYCHIAT CLIN N AM, V28, P613, DOI 10.1016/j.psc.2005.05.004; Bramon E, 2006, EUR PSYCHIAT, V21, P70, DOI 10.1016/j.eurpsy.2005.11.001; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Bray NJ, 2005, HUM MOL GENET, V14, P1947, DOI 10.1093/hmg/ddi199; Brown AS, 2002, MENT RETARD DEV D R, V8, P51, DOI 10.1002/mrdd.10004; Burdick KE, 2006, HUM MOL GENET, V15, P1563, DOI 10.1093/hmg/ddi481; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Cannon M, 2002, AM J PSYCHIAT, V159, P1080, DOI 10.1176/appi.ajp.159.7.1080; Cannon TD, 2005, ARCH GEN PSYCHIAT, V62, P1205, DOI 10.1001/archpsyc.62.11.1205; Cannon TD, 2005, CURR OPIN PSYCHIATR, V18, P135, DOI 10.1097/00001504-200503000-00005; Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925; Chen JS, 2006, BIOL PSYCHIAT, V59, P1180, DOI 10.1016/j.biopsych.2006.02.024; Coyle JT, 2006, CELL MOL NEUROBIOL, V26, P365, DOI 10.1007/s10571-006-9062-8; Craddock N, 2006, MOL PSYCHIATR, V11, P446, DOI 10.1038/sj.mp.4001808; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; D'Arcangelo G, 2006, EPILEPSY BEHAV, V8, P81, DOI 10.1016/j.yebeh.2005.09.005; DeRosse P, 2006, AM J PSYCHIAT, V163, P532, DOI 10.1176/appi.ajp.163.3.532; Detera-Wadleigh SD, 2006, BIOL PSYCHIAT, V60, P106, DOI 10.1016/j.biopsych.2006.01.019; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Ekelund J, 2001, HUM MOL GENET, V10, P1611, DOI 10.1093/hmg/10.15.1611; Erwin RJ, 1998, SCHIZOPHR RES, V33, P157, DOI 10.1016/S0920-9964(98)00075-9; Ettinger U, 2006, AM J PSYCHIAT, V163, P543, DOI 10.1176/appi.ajp.163.3.543; Fallgatter AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2002, DOI 10.1038/sj.npp.1301003; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; Fanous AH, 2005, AM J PSYCHIAT, V162, P1824, DOI 10.1176/appi.ajp.162.10.1824; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Gilmore JH, 1997, SCHIZOPHR RES, V24, P365, DOI 10.1016/S0920-9964(96)00123-5; Gold JM, 2004, SCHIZOPHR RES, V72, P21, DOI 10.1016/j.schres.2004.09.008; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gornick MC, 2005, J AUTISM DEV DISORD, V35, P831, DOI 10.1007/s10803-005-0028-3; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green EK, 2006, MOL PSYCHIATR, V11, P798, DOI 10.1038/sj.mp.4001853; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Hamshere ML, 2005, ARCH GEN PSYCHIAT, V62, P1081, DOI 10.1001/archpsyc.62.10.1081; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Harvey PD, 2003, PSYCHOPHARMACOLOGY, V169, P404, DOI 10.1007/s00213-002-1342-5; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Hennah W, 2006, SCHIZOPHRENIA BULL, V32, P409, DOI 10.1093/schbul/sbj079; Heresco-Levy U, 2002, AM J PSYCHIAT, V159, P480, DOI 10.1176/appi.ajp.159.3.480; Honea R, 2005, AM J PSYCHIAT, V162, P2233, DOI 10.1176/appi.ajp.162.12.2233; Honer WG, 2000, NEUROPATHOLOGY SCHIZ, P105; Hong LE, 2006, ARCH GEN PSYCHIAT, V63, P259, DOI 10.1001/archpsyc.63.3.259; Ishizuka K, 2006, BIOL PSYCHIAT, V59, P1189, DOI 10.1016/j.biopsych.2006.03.065; Kamiya A, 2005, NAT CELL BIOL, V7, P1167, DOI 10.1038/ncb1328; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kato M, 2003, HUM MOL GENET, V12, pR89, DOI 10.1093/hmg/ddg086; Katsel PL, 2005, INT REV NEUROBIOL, V63, P41, DOI 10.1016/S0074-7742(05)63003-6; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kirkpatrick B, 2001, ARCH GEN PSYCHIAT, V58, P165, DOI 10.1001/archpsyc.58.2.165; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kubicki M, 2005, ANN NY ACAD SCI, V1064, P134, DOI 10.1196/annals.1340.024; Kyle UG, 2006, CURR OPIN CLIN NUTR, V9, P388, DOI 10.1097/01.mco.0000232898.74415.42; Lane HY, 2005, ARCH GEN PSYCHIAT, V62, P1196, DOI 10.1001/archpsyc.62.11.1196; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lewis DA, 2000, NEURON, V28, P325, DOI 10.1016/S0896-6273(00)00111-2; Li W, 2003, NAT GENET, V35, P84, DOI 10.1038/ng1229; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lipska BK, 2006, HUM MOL GENET, V15, P1245, DOI 10.1093/hmg/ddl040; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Lymer GKS, 2006, NEUROIMAGE, V33, P275, DOI 10.1016/j.neuroimage.2006.06.031; MARGOLIS RL, 2006, GENETIC INSTABILITIE, P261; McEvoy JP, 2006, AM J PSYCHIAT, V163, P600, DOI 10.1176/appi.ajp.163.4.600; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2003, BIOCHEM BIOPH RES CO, V311, P1019, DOI 10.1016/j.bbrc.2003.10.101; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Morris JA, 2003, HUM MOL GENET, V12, P1591, DOI 10.1093/hmg/ddg162; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Niemi LT, 2003, SCHIZOPHR RES, V60, P239, DOI 10.1016/S0920-9964(02)00234-7; Niznikiewicz MA, 2003, CURR OPIN PSYCHIATR, V16, P123, DOI 10.1097/00001504-200303000-00002; Nuechterlein KH, 2004, SCHIZOPHR RES, V72, P29, DOI 10.1016/j.schres.2004.09.007; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Ogawa F, 2005, BIOCHEM BIOPH RES CO, V338, P771, DOI 10.1016/j.bbrc.2005.10.013; Olson EC, 2002, CURR OPIN GENET DEV, V12, P320, DOI 10.1016/S0959-437X(02)00305-2; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Pantelis C, 2005, SCHIZOPHRENIA BULL, V31, P672, DOI 10.1093/schbul/sbi034; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Patterson PH, 2002, CURR OPIN NEUROBIOL, V12, P115, DOI 10.1016/S0959-4388(02)00299-4; Pickard BS, 2006, MOL PSYCHIATR, V11, P847, DOI 10.1038/sj.mp.4001867; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Porteous DJ, 2006, TRENDS MOL MED, V12, P255, DOI 10.1016/j.molmed.2006.04.009; Porteous DJ, 2006, BIOL PSYCHIAT, V60, P123, DOI 10.1016/j.biopsych.2006.04.008; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Riley B, 2006, EUR J HUM GENET, V14, P669, DOI 10.1038/sj.ejhg.5201571; Ross CA, 1996, TRENDS NEUROSCI, V19, P171, DOI 10.1016/S0166-2236(96)10022-9; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2005, CLIN NEUROSCI RES, V5, P3, DOI 10.1016/j.cnr.2005.07.001; Sachs NA, 2005, MOL PSYCHIATR, V10, P758, DOI 10.1038/sj.mp.4001667; Schurov IL, 2004, MOL PSYCHIATR, V9, P1100, DOI 10.1038/sj.mp.4001574; Selemon LD, 1999, BIOL PSYCHIAT, V45, P17, DOI 10.1016/S0006-3223(98)00281-9; SELEMON LD, 1995, ARCH GEN PSYCHIAT, V52, P805; Singleton A, 2004, HUM MOL GENET, V13, pR123, DOI 10.1093/hmg/ddh093; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Snyder SH, 2006, NEURON, V49, P484, DOI 10.1016/j.neuron.2006.02.002; St Clair D, 2005, JAMA-J AM MED ASSOC, V294, P557, DOI 10.1001/jama.294.5.557; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Straub RE, 2002, AM J HUM GENET, V71, P337, DOI 10.1086/341750; Straub RE, 2006, BIOL PSYCHIAT, V60, P81, DOI 10.1016/j.biopsych.2006.06.002; Talbot K, 2004, J CLIN INVEST, V113, P1353, DOI 10.1172/JCI200420425; Thomson PA, 2005, MOL PSYCHIATR, V10, P657, DOI 10.1038/sj.mp.4001669; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; Tunbridge EM, 2006, BIOL PSYCHIAT, V60, P141, DOI 10.1016/j.biopsych.2005.10.024; Turner JA, 2006, NEUROINFORMATICS, V4, P21, DOI 10.1385/NI:4:1:21; Verdoux Helene, 2004, Curr Psychiatry Rep, V6, P162, DOI 10.1007/s11920-004-0060-6; Yolken RH, 2000, BRAIN RES REV, V31, P193, DOI 10.1016/S0165-0173(99)00037-5	122	503	531	1	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					139	153		10.1016/j.neuron.2006.09.015	http://dx.doi.org/10.1016/j.neuron.2006.09.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	096WS	17015232	Bronze			2022-12-28	WOS:000241408100010
J	Etkin, A; Egner, T; Peraza, DM; Kandel, ER; Hirsch, J				Etkin, Amit; Egner, Tobias; Peraza, Daniel M.; Kandel, Eric R.; Hirsch, Joy			Resolving emotional conflict: A role for the rostral anterior cingulate cortex in modulating activity in the amygdala	NEURON			English	Article							MEDIAL PREFRONTAL CORTEX; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE CONTROL; FRONTAL-CORTEX; SUBCORTICAL PROJECTIONS; FUNCTIONAL-INTEGRATION; BASOLATERAL AMYGDALA; SURPRISED FACES; VISUAL-STIMULI; FEARFUL FACES	Effective mental functioning requires that cognition be protected from emotional conflict due to interference by task-irrelevant emotionally salient stimuli. The neural mechanisms by which the brain detects and resolves emotional conflict are still largely unknown, however. Drawing on the classic Stroop conflict task, we developed a protocol that allowed us to dissociate the generation and monitoring of emotional conflict from its resolution. Using functional magnetic resonance imaging (fMRI), we find that activity in the amygdala and dorsomedial and dorsolateral prefrontal cortices reflects the amount of emotional conflict. By contrast, the resolution of emotional conflict is associated with activation of the rostral anterior cingulate cortex. Activation of the rostral cingulate is predicted by the amount of previous-trial conflict-related neural activity and is accompanied by a simultaneous and correlated reduction of amygdalar activity. These data suggest that emotional conflict is resolved through top-down inhibition of amygdalar activity by the rostral cingulate cortex.	Columbia Univ, Med Ctr, Neurol Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Kavli Inst Brain Sci, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Funct MRI Res Ctr, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Dept Radiol, New York, NY 10032 USA; Columbia Univ, Med Ctr, Neurol Inst, Dept Psychol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Columbia University	Etkin, A (corresponding author), Columbia Univ, Med Ctr, Neurol Inst, Ctr Neurobiol & Behav, Box 108,710 W 168th St, New York, NY 10032 USA.	ae157@columbia.edu; jh2155@columbia.edu	Egner, Tobias/A-5237-2009; Etkin, Amit/ABD-5761-2021; Egner, Tobias/AAD-5864-2022	Egner, Tobias/0000-0001-7956-3241; Egner, Tobias/0000-0001-7956-3241; Hirsch, Joy/0000-0002-1418-6489	NICHD NIH HHS [HD 07430] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Algom D, 2004, J EXP PSYCHOL GEN, V133, P323, DOI 10.1037/0096-3445.133.3.323; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Broadbent D.E., 1958, PERCEPTION COMMUNICA; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Carroll NC, 2005, Q J EXP PSYCHOL-A, V58, P1173, DOI 10.1080/02724980443000539; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Compton RJ, 2003, COGN AFFECT BEHAV NE, V3, P81, DOI 10.3758/CABN.3.2.81; Critchley HD, 2003, BRAIN, V126, P2139, DOI 10.1093/brain/awg216; Davidson RJ, 2002, ANNU REV PSYCHOL, V53, P545, DOI 10.1146/annurev.psych.53.100901.135148; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Egner T, 2005, NEUROIMAGE, V24, P539, DOI 10.1016/j.neuroimage.2004.09.007; Ekman P., 1976, PICTURES FACIAL AFFE; Etkin A, 2004, NEURON, V44, P1043, DOI 10.1016/j.neuron.2004.12.006; Etkin A, 2005, J NEUROPSYCH CLIN N, V17, P145, DOI 10.1176/appi.neuropsych.17.2.145; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Garcia R, 1999, NATURE, V402, P294, DOI 10.1038/46286; GRATTON G, 1992, J EXP PSYCHOL GEN, V121, P480, DOI 10.1037/0096-3445.121.4.480; Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Hull AM, 2002, BRIT J PSYCHIAT, V181, P102; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Kawasaki H, 2005, J COGNITIVE NEUROSCI, V17, P1509, DOI 10.1162/089892905774597182; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kim H, 2003, NEUROREPORT, V14, P2317, DOI 10.1097/00001756-200312190-00006; Kim H, 2004, J COGNITIVE NEUROSCI, V16, P1730, DOI 10.1162/0898929042947865; Krolak-Salmon P, 2004, NEURON, V42, P665, DOI 10.1016/S0896-6273(04)00264-8; Kumari V, 2003, BIOL PSYCHIAT, V54, P777, DOI 10.1016/S0006-3223(02)01785-7; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; MATHEWS A, 1985, BEHAV RES THER, V23, P563, DOI 10.1016/0005-7967(85)90104-4; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Mayr U, 2003, NAT NEUROSCI, V6, P450, DOI 10.1038/nn1051; MCKENNA F P, 1986, Current Psychological Research and Reviews, V5, P3, DOI 10.1007/BF02686591; MUSIL SY, 1988, J COMP NEUROL, V272, P219, DOI 10.1002/cne.902720206; MUSIL SY, 1988, J COMP NEUROL, V272, P203, DOI 10.1002/cne.902720205; Nachev P, 2005, CURR BIOL, V15, P122, DOI 10.1016/j.cub.2005.01.006; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Oya H, 2002, J NEUROSCI, V22, P9502; Paxinos G., 1990, HUMAN NERVOUS SYSTEM; Penny WD, 2004, NEUROIMAGE, V23, pS264, DOI 10.1016/j.neuroimage.2004.07.041; Pessoa L, 2003, J NEUROSCI, V23, P3990; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; Posner MI, 1998, ATTENTIVE BRAIN, P401; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rosenkranz JA, 2002, J NEUROSCI, V22, P324, DOI 10.1523/JNEUROSCI.22-01-00324.2002; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Sheline YI, 2001, BIOL PSYCHIAT, V50, P651, DOI 10.1016/S0006-3223(01)01263-X; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Tipples J, 2000, BRIT J PSYCHOL, V91, P87, DOI 10.1348/000712600161691; Van Hoesen G. W. M., 1993, NEUROBIOLOGY CINGULA, P249, DOI DOI 10.1007/978-1-4899-6704-6_9; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wager TD, 2004, NEUROIMAGE, V22, P1679, DOI 10.1016/j.neuroimage.2004.03.052; Weissman DH, 2004, J NEUROSCI, V24, P10941, DOI 10.1523/JNEUROSCI.3669-04.2004; Whalen PJ, 1998, BIOL PSYCHIAT, V44, P1219, DOI 10.1016/S0006-3223(98)00251-0; Williams JMG, 1996, PSYCHOL BULL, V120, P3, DOI 10.1037/0033-2909.120.1.3; Yang TT, 2002, NEUROREPORT, V13, P1737, DOI 10.1097/00001756-200210070-00009	83	928	955	2	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					871	882		10.1016/j.neuron.2006.07.029	http://dx.doi.org/10.1016/j.neuron.2006.07.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	091AM	16982430	Bronze			2022-12-28	WOS:000240997900023
J	Fulton, S; Pissios, P; Manchon, RP; Stiles, L; Frank, L; Pothos, EN; Maratos-Flier, E; Flier, JS				Fulton, Stephanie; Pissios, Pavlos; Manchon, Ramon Pinol; Stiles, Linsey; Frank, Lauren; Pothos, Emmanuel N.; Maratos-Flier, Eleftheria; Flier, Jeffrey S.			Leptin regulation of the mesoaccumbens dopamine pathway	NEURON			English	Article							BRAIN REWARD CIRCUITRY; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; OB/OB MICE; BODY-WEIGHT; EXTRACELLULAR DOPAMINE; TYROSINE-HYDROXYLASE; PREFRONTAL CORTEX; NEUROPEPTIDE-Y; FOOD REWARD	Leptin is an adipose-derived hormone that acts on hypothalamic leptin receptors to regulate energy balance. Leptin receptors are also expressed in extra-hypothalamic sites including the ventral tegmental area (VTA), critical to brain reward circuitry. We report that leptin targets DA and GABA neurons of the VTA, inducing phosphorylation of signal-transducer-and-activator-of-transcription-3 (STAT3). Retrograde tracing combined with pSTAT3 immunohistochemistry show leptin-responsive VTA neurons projecting to nucleus accumbens (NAc). Assessing leptin function in the VTA, we showed that ob/ob mice had diminished locomotor response to amphetamine and lacked locomotor sensitization to repeated amphetamine injections, both defects reversed by leptin infusion. Electrically stimulated DA release from NAc shell terminals was markedly reduced in ob/ob slice preparations, and NAc DA levels and TH expression were lower. These data define a role for leptin in mesoaccumbens DA signaling and indicate that the mesoaccumbens DA pathway, critical to integrating motivated behavior, responds to this adipose-derived signal.	Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; Beth Israel Deaconess Med Ctr, Div Endocrinol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Tufts Univ, Sch Med, Dept Pharmacol & Expt Therapeut, Boston, MA 02111 USA; Tufts Univ, Sch Med, Program Neurosci, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Tufts University; Tufts University	Maratos-Flier, E (corresponding author), Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA.	emaratos@bidmc.harvard.edu	Jansen, Heiko T./A-5770-2008; Chee, Melissa/G-4150-2014; Flier, jeffrey/AAG-6223-2019	Jansen, Heiko T./0000-0003-0178-396X; Chee, Melissa/0000-0003-3815-9095; Pothos, Emmanuel/0000-0001-8825-7852; Pinol, Ramon/0000-0002-8877-8444; Stiles, Linsey/0000-0002-1514-458X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069983, R01DK065872] Funding Source: NIH RePORTER; NIDDK NIH HHS [1R01DK065872, DK069983] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahn S, 2002, J NEUROSCI, V22, P10958; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bassareo V, 1999, EUR J NEUROSCI, V11, P4389, DOI 10.1046/j.1460-9568.1999.00843.x; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bina KG, 2000, NEUROENDOCRINOLOGY, V71, P68, DOI 10.1159/000054522; CAMPFIELD LA, 1995, SCIENCE, V269, P546, DOI 10.1126/science.7624778; CIOLKOWSKI EL, 1994, ANAL CHEM, V66, P3611, DOI 10.1021/ac00093a013; DAHLSTROM A, 1964, EXPERIENTIA, V20, P398, DOI 10.1007/BF02147990; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; FARNEBO LO, 1971, ACTA PHYSIOL SCAND, P35; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2004, BEHAV BRAIN RES, V155, P319, DOI 10.1016/j.bbr.2004.05.021; Hajnal A, 2004, AM J PHYSIOL-REG I, V286, pR31, DOI 10.1152/ajpregu.00282.2003; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Halaas JL, 1997, P NATL ACAD SCI USA, V94, P8878, DOI 10.1073/pnas.94.16.8878; Hao J, 2004, PHYSIOL BEHAV, V83, P377, DOI 10.1016/j.physbeh.2004.08.007; Harada K, 1996, J NEUROCHEM, V67, P629; Harris RBS, 1998, ENDOCRINOLOGY, V139, P8, DOI 10.1210/en.139.1.8; Hay-Schmidt A, 2001, NEUROENDOCRINOLOGY, V73, P215, DOI 10.1159/000054638; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Heusner CL, 2003, BRAIN RES, V980, P266, DOI 10.1016/S0006-8993(03)02986-X; HOEBEL BG, 1983, PSYCHOPHARMACOLOGY, V81, P158, DOI 10.1007/BF00429012; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jedynak JP, 2002, J NEUROCHEM, V82, P382, DOI 10.1046/j.1471-4159.2002.00982.x; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Martel P, 1996, PHARMACOL BIOCHEM BE, V53, P221, DOI 10.1016/0091-3057(95)00187-5; Niswender KD, 2001, NATURE, V413, P794, DOI 10.1038/35101657; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; PHILLIPSON OT, 1985, NEUROSCIENCE, V16, P275, DOI 10.1016/0306-4522(85)90002-8; POTHOS EN, 1995, J NEUROSCI, V15, P6640; Pothos EN, 1998, APPETITE, V31, P405, DOI 10.1006/appe.1998.0210; Robinson S, 2005, BEHAV NEUROSCI, V119, P5, DOI 10.1037/0735-7044.119.1.5; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; Salamone JD, 2005, CURR OPIN PHARMACOL, V5, P34, DOI 10.1016/j.coph.2004.09.004; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Scislowski PWD, 1999, INT J OBESITY, V23, P425, DOI 10.1038/sj.ijo.0800893; Sesack SR, 2002, PHYSIOL BEHAV, V77, P513, DOI 10.1016/S0031-9384(02)00931-9; Shalev U, 2001, J NEUROSCI, V21; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Zaborszky L, 2001, BEHAV GENET, V31, P47, DOI 10.1023/A:1010257808945; Zhao AZ, 2002, NAT NEUROSCI, V5, P727, DOI 10.1038/nn885	60	490	498	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					811	822		10.1016/j.neuron.2006.09.006	http://dx.doi.org/10.1016/j.neuron.2006.09.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982425	Bronze			2022-12-28	WOS:000240997900018
J	Karsten, SL; Sang, TK; Gehman, LT; Chatterjee, S; Liu, JK; Lawless, GM; Sengupta, S; Berry, RW; Pomakian, J; Oh, HS; Schulz, C; Hui, KS; Wiedau-Pazos, M; Vinters, HV; Binder, LI; Geschwind, DH; Jackson, GR				Karsten, Stanislav L.; Sang, Tzu-Kang; Gehman, Lauren T.; Chatterjee, Shreyasi; Liu, Jiankai; Lawless, George M.; Sengupta, Soma; Berry, Robert W.; Pomakian, Justine; Oh, Hyun S.; Schulz, Cordula; Hui, Koon-Sea; Wiedau-Pazos, Martina; Vinters, Harry V.; Binder, Lester I.; Geschwind, Daniel H.; Jackson, George R.			A genomic screen for modifiers of tauopathy identifies puromycin-sensitive aminopeptidase as an inhibitor of tau-induced neurodegeneration	NEURON			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; PROTEIN-TAU; ABNORMAL PHOSPHORYLATION; NEUROFIBRILLARY TANGLES; POSTTRANSLATIONAL MODIFICATIONS; DROSOPHILA-MELANOGASTER; GENETIC-ANALYSIS; EXPRESSION; BRAIN	Neurofibrillary tangles (NFT) containing tau are a hallmark of neurodegenerative diseases, including Alzheimer's disease (AD). NFT burden correlates with cognitive decline and neurodegeneration in AD. However, little is known about mechanisms that protect against tau-induced neurodegeneration. We used a cross species functional genomic approach to analyze gene expression in multiple brain regions in mouse, in parallel with validation in Drosophila, to identify tau modifiers, including the highly conserved protein puromycin-sensitive aminopeptidase (PSA/Npepps). PSA protected against tau-induced neurodegeneration in vivo, whereas PSA loss of function exacerbated neurodegeneration. We further show that human PSA directly proteolyzes tau in vitro. These data highlight the utility of using both evolutionarily distant species for genetic screening and functional assessment to identify modifiers of neurodegeneration. Further investigation is warranted in defining the role of PSA and other genes identified here as potential therapeutic targets in tauopathy.	Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Ctr Neurobehav Genet, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Kungwon Univ, Dept Appl Stat, Sungnam, South Korea; Cold Spring Harbor Labs, Cold Spring Harbor, NY 11724 USA; NYU, Nathan S Kline Inst Psychiat Res, Sch Med, Orangeburg, NY 10962 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northwestern University; Feinberg School of Medicine; Cold Spring Harbor Laboratory; Nathan Kline Institute for Psychiatric Research; New York University	Geschwind, DH (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Program Neurogenet, Dept Neurol, Los Angeles, CA 90095 USA.	dhg@mednet.ucla.edu; dhg@mednet.ucla.edu	Karsten, Stan/AAI-4076-2021	Sang, Tzu-Kang/0000-0001-7924-9359; Karsten, Stanislav/0000-0001-7387-4874	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026938, R37AG014453, P50AG016570] Funding Source: NIH RePORTER; NIA NIH HHS [AG 14453, AG 016570, AG 026938] Funding Source: Medline; NINDS NIH HHS [R01 NS046489, NS 046489] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amadoro G, 2004, CELL DEATH DIFFER, V11, P217, DOI 10.1038/sj.cdd.4401314; Arai T, 2005, J BIOL CHEM, V280, P5145, DOI 10.1074/jbc.M409234200; Arrasate M, 1999, FEBS LETT, V446, P199, DOI 10.1016/S0014-5793(99)00210-0; BANCHER C, 1991, BRAIN RES, V539, P11, DOI 10.1016/0006-8993(91)90681-K; BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789; Chen E, 2000, EXP CELL RES, V259, P140, DOI 10.1006/excr.2000.4952; Chen F, 2004, CURR DRUG TARGETS, V5, P503, DOI 10.2174/1389450043345236; CONSTAM DB, 1995, J BIOL CHEM, V270, P26931, DOI 10.1074/jbc.270.45.26931; D'Souza I, 2005, BBA-MOL BASIS DIS, V1739, P104, DOI 10.1016/j.bbadis.2004.08.009; Doglio LE, 2006, NEURON, V50, P359, DOI 10.1016/j.neuron.2006.03.038; Duttaroy A, 1998, EXP CELL RES, V238, P168, DOI 10.1006/excr.1997.3819; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; GOEDERT M, 1989, EMBO J, V8, P393, DOI 10.1002/j.1460-2075.1989.tb03390.x; Gong CX, 2005, J NEURAL TRANSM, V112, P813, DOI 10.1007/s00702-004-0221-0; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hui M, 2003, NEUROCHEM RES, V28, P855, DOI 10.1023/A:1023263123911; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Ingram EM, 2002, TRENDS MOL MED, V8, P555, DOI 10.1016/S1471-4914(02)02440-1; IQBAL K, 1991, MOL NEUROBIOL, V5, P399, DOI 10.1007/BF02935561; Ishizawa T, 2003, AM J PATHOL, V163, P1057, DOI 10.1016/S0002-9440(10)63465-7; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Jain N, 2003, BIOINFORMATICS, V19, P1945, DOI 10.1093/bioinformatics/btg264; Kosik KS, 2005, BBA-MOL BASIS DIS, V1739, P298, DOI 10.1016/j.bbadis.2004.10.011; Kosik KS, 2002, J MOL NEUROSCI, V19, P261, DOI 10.1385/JMN:19:3:261; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lewis J, 2000, NAT GENET, V25, P402, DOI 10.1038/78078; Lin WL, 2003, J NEUROCYTOL, V32, P1091, DOI 10.1023/B:NEUR.0000021904.61387.95; Liu F, 2002, FEBS LETT, V512, P101, DOI 10.1016/S0014-5793(02)02228-7; Lobo MK, 2006, NAT NEUROSCI, V9, P443, DOI 10.1038/nn1654; Lomen-Hoerth C, 2004, DEMENT GERIATR COGN, V17, P337, DOI 10.1159/000077167; MCLELLAN S, 1988, J NEUROCHEM, V51, P1552, DOI 10.1111/j.1471-4159.1988.tb01124.x; MERCKEN M, 1995, FEBS LETT, V368, P10, DOI 10.1016/0014-5793(95)00590-6; Minnasch Petra, 2003, Leg Med (Tokyo), V5 Suppl 1, pS285, DOI 10.1016/S1344-6223(02)00151-7; Mirnics K, 2004, NAT NEUROSCI, V7, P434, DOI 10.1038/nn1230; Mirnics K, 2001, NAT REV NEUROSCI, V2, P444, DOI 10.1038/35077587; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SAFAVI A, 1995, J NEUROCHEM, V65, P389; Sang TK, 2005, HUM MOL GENET, V14, P357, DOI 10.1093/hmg/ddi032; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHONLEIN C, 1994, BIOCHEM BIOPH RES CO, V201, P45, DOI 10.1006/bbrc.1994.1667; Schulz C, 2001, DEV GENES EVOL, V211, P581, DOI 10.1007/s00427-001-0194-z; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Shulman JM, 2003, GENETICS, V165, P1233; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; SMITH DE, 1989, J CELL BIOL, V108, P255, DOI 10.1083/jcb.108.2.255; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; THAM A, 1993, J NEURAL TRANSM-PARK, V5, P165, DOI 10.1007/BF02257671; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tobler AR, 1997, J NEUROCHEM, V68, P889; Wang JZ, 1996, NAT MED, V2, P871, DOI 10.1038/nm0896-871; Wilczak N, 2003, LANCET, V361, P1007, DOI 10.1016/S0140-6736(03)12828-0; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200	69	108	112	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					549	560		10.1016/j.neuron.2006.07.019	http://dx.doi.org/10.1016/j.neuron.2006.07.019			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950154	Bronze			2022-12-28	WOS:000240623400005
J	Hou, LF; Antion, MD; Hu, DY; Spencer, CM; Paylor, R; Klann, E				Hou, Lingfei; Antion, Marcia D.; Hu, Daoying; Spencer, Corinne M.; Paylor, Richard; Klann, Eric			Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression	NEURON			English	Article							HIPPOCAMPAL AREA CA1; GLUTAMATE-RECEPTOR ACTIVATION; SYNAPTIC PLASTICITY; MESSENGER-RNAS; MOUSE MODEL; UBIQUITIN; FMR1; DEGRADATION; SYNAPSES; SYSTEM	Genetic deletion of fragile X mental retardation protein (FMRP) has been shown to enhance mGluR-dependent long-term depression (LTD). Herein, we demonstrate that mGIuR-LTD induces a transient, translation-dependent increase in FMRP that is rapidly degraded by the ubiquitin-proteasome pathway. Moreover, proteasome inhibitors abolished mGIuR-LTD, and LTD was absent in mice that overexpress human FMRP. Neither translation nor proteasome inhibitors blocked the augmentation of mGIuR-LTD in FMRP-deficient mice. In addition, mGluR-LTD is associated with rapid increases in the protein levels of FMRP target mRNAs in wild-type mice. Interestingly, the basal levels of these proteins were elevated and their synthesis was improperly regulated during mGIuR-LTD in FMRP-deficient mice. Our findings indicate that hippocampal mGluR-LTD requires the rapid synthesis and degradation of FMRP and that mGIuR-LTD triggers the synthesis of FMRP binding mRNAs. These findings indicate that the translation, ubiquitination, and proteolysis of FMRP functions as a dynamic regulatory system for controlling synaptic plasticity.	Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Klann, E (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl,Rm 809, New York, NY 10003 USA.	eklann@cns.nyu.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034007, R29NS034007, R01NS047384, R37NS034007] Funding Source: NIH RePORTER; NICHD NIH HHS [HD024064] Funding Source: Medline; NINDS NIH HHS [NS047384, NS034007] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BAKKER CE, 1994, CELL, V78, P23; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Banko JL, 2006, J NEUROSCI, V26, P2167, DOI 10.1523/JNEUROSCI.5196-05.2006; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Cline H, 2003, CURR BIOL, V13, pR514, DOI 10.1016/S0960-9822(03)00443-3; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Faas GC, 2002, J NEUROSCI, V22, P6885; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Gabel LA, 2004, J NEUROSCI, V24, P10579, DOI 10.1523/JNEUROSCI.2185-04.2004; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gonzalez-Billault C, 2004, J NEUROBIOL, V58, P48, DOI 10.1002/neu.10283; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hegde AN, 2002, NAT REV NEUROSCI, V3, P854, DOI 10.1038/nrn961; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kooy RF, 2003, TRENDS GENET, V19, P148; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Nosyreva ED, 2006, J NEUROPHYSIOL, V95, P3291, DOI 10.1152/jn.01316.2005; Nosyreva ED, 2005, J NEUROSCI, V25, P2992, DOI 10.1523/JNEUROSCI.3652-04.2005; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Speese SD, 2003, CURR BIOL, V13, P899, DOI 10.1016/S0960-9822(03)00338-5; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Todd PK, 2003, MOL BRAIN RES, V110, P267, DOI 10.1016/S0169-328X(02)00657-5; Turner G, 1996, AM J MED GENET, V64, P196, DOI 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G; Wang HP, 2004, HUM MOL GENET, V13, P79, DOI 10.1093/hmg/ddh009; WARREN ST, 2001, METABOLIC MOL BASES, P1257; Weiler IJ, 2004, P NATL ACAD SCI USA, V101, P17504, DOI 10.1073/pnas.0407533101; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhao YL, 2003, CURR BIOL, V13, P887, DOI 10.1016/S0960-9822(03)00332-4	61	358	364	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					441	454		10.1016/j.neuron.2006.07.005	http://dx.doi.org/10.1016/j.neuron.2006.07.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908410	Bronze			2022-12-28	WOS:000240504700008
J	Monory, K; Massa, F; Egertova, M; Eder, M; Blaudzun, H; Westenbroek, R; Kelsch, W; Jacob, W; Marsch, R; Ekker, M; Long, J; Rubenstein, JL; Goebbels, S; Nave, KA; During, M; Klugmann, M; Wolfel, B; Dodt, HU; Zieglgansberger, W; Wotjak, CT; Mackie, K; Elphick, MR; Marsicano, G; Lutz, B				Monory, Krisztina; Massa, Federico; Egertova, Michaela; Eder, Matthias; Blaudzun, Heike; Westenbroek, Ruth; Kelsch, Wolfgang; Jacob, Wolfgang; Marsch, Rudolf; Ekker, Marc; Long, Jason; Rubenstein, John L.; Goebbels, Sandra; Nave, Klaus-Armin; During, Matthew; Klugmann, Matthias; Woelfel, Barbara; Dodt, Hans-Ulrich; Zieglgaensberger, Walter; Wotjak, Carsten T.; Mackie, Ken; Elphick, Maurice R.; Marsicano, Giovanni; Lutz, Beat			The endocannabinoid system controls key epileptogenic circuits in the hippocampus	NEURON			English	Article							CB1 CANNABINOID RECEPTORS; GLUTAMATERGIC SYNAPTIC-TRANSMISSION; ACID-INDUCED SEIZURE; RAT-BRAIN; IMMUNOHISTOCHEMICAL LOCALIZATION; DOUBLE REPORTER; MESSENGER-RNA; GABA RELEASE; EXPRESSION; FOREBRAIN	Balanced control of neuronal activity is central in maintaining function and viability of neuronal circuits. The endocannabinoid system tightly controls neuronal excitability. Here, we show that endocannabinoids directly target hippocampal glutamatergic neurons to provide protection against acute epileptiform seizures in mice. Functional CB1 cannabinoid receptors are present on glutamatergic terminals of the hippocampal formation, colocalizing with vesicular glutamate transporter 1 (VGluT1). Conditional deletion of the CB1 gene either in cortical glutamatergic neurons or in forebrain GABAergic neurons, as well as virally induced deletion of the CB1 gene in the hippocampus, demonstrate that the presence of CB1 receptors in glutamatergic hippocampal neurons is both necessary and sufficient to provide substantial endogenous protection against kainic acid (KA)-induced seizures. The direct endocannabinoid-mediated control of hippocampal glutamatergic neurotransmission may constitute a promising therapeutic target for the treatment of disorders associated with excessive excitatory neuronal activity.	Johannes Gutenberg Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany; Max Planck Inst Psychiat, D-80804 Munich, Germany; Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Ottawa, Dept Biol, Ctr Adv Res Environm Genom, Ottawa, ON K1N 6N5, Canada; Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Univ Auckland, Sch Med, Dept Mol Med & Pathol, Auckland 92019, New Zealand	Johannes Gutenberg University of Mainz; Max Planck Society; University of London; Queen Mary University London; University of Washington; University of Washington Seattle; University of Ottawa; University of California System; University of California San Francisco; Max Planck Society; University of Auckland	Marsicano, G (corresponding author), INSERM, Inst Francois Magendie, AVENIR, 146 Rue Leo Saignat, F-33077 Bordeaux, France.	giovanni.marsicano@bordeaux.inserm.fr; blutz@uni-mainz.de	During, Matthew/AAC-1388-2020; Lutz, Beat/AFK-6229-2022; Lutz, Beat/AAG-4538-2022; Marsicano, Giovanni/I-9603-2016; Wotjak, Carsten T./S-3200-2019; Massa, Federico/C-5697-2011; Nave, Klaus-Armin/C-8883-2011; Mackie, Ken/E-3715-2013; Mackie, Kenneth P/B-7358-2011	Massa, Federico/0000-0002-9427-3418; Mackie, Ken/0000-0001-8501-6199; Elphick, Maurice/0000-0002-9169-0048; Kelsch, Wolfgang/0000-0002-3470-8125; Eder, Matthias/0000-0002-2579-2628; Marsicano, Giovanni/0000-0003-3804-1951	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R37MH049428, K05MH065670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011322, K02DA000286, P01DA015916] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [S19916] Funding Source: Medline; NIDA NIH HHS [DA00286, DA15916, P01 DA015916, DA11322, R01 DA011322, K02 DA000286] Funding Source: Medline; NIMH NIH HHS [K05 MH065670, R37 MH049428, R01 MH049428, MH065670, MH49428] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alger BE, 2002, PROG NEUROBIOL, V68, P247; Aparicio LC, 2004, J NEUROCHEM, V91, P30, DOI 10.1111/j.1471-4159.2004.02633.x; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Chevaleyre V, 2006, ANNU REV NEUROSCI, V29, P37, DOI 10.1146/annurev.neuro.29.051605.112834; Clark KR, 1999, HUM GENE THER, V10, P1031, DOI 10.1089/10430349950018427; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Marzo V, 2004, NAT REV DRUG DISCOV, V3, P771, DOI 10.1038/nrd1495; Domenici MR, 2006, J NEUROSCI, V26, P5794, DOI 10.1523/JNEUROSCI.0372-06.2006; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Foldy C, 2006, J NEUROSCI, V26, P1465, DOI 10.1523/JNEUROSCI.4587-05.2006; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gerdeman GL, 2003, BRIT J PHARMACOL, V140, P781, DOI 10.1038/sj.bjp.0705466; Ghanem N, 2003, GENOME RES, V13, P533, DOI 10.1101/gr.716103; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hajos N, 2001, NEUROSCIENCE, V106, P1, DOI 10.1016/S0306-4522(01)00287-1; Harkany T, 2003, EUR J NEUROSCI, V18, P1979, DOI 10.1046/j.1460-9568.2003.02898.x; Hoffman AF, 2005, EUR J NEUROSCI, V22, P2387, DOI 10.1111/j.1460-9568.2005.04401.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Johnston D., 2004, SYNAPTIC ORG BRAIN, V5th, P455; Kaneko T, 2002, J COMP NEUROL, V444, P39, DOI 10.1002/cne.10129; Katona I, 1999, J NEUROSCI, V19, P4544; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kleppisch T, 2003, J NEUROSCI, V23, P6005, DOI 10.1523/JNEUROSCI.23-14-06005.2003; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Lee J, 2002, NEUROSCI LETT, V333, P87, DOI 10.1016/S0304-3940(02)00987-4; LI XM, 1994, POTENTIAL ANAL, V3, P339, DOI 10.1007/BF01049807; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Lutz B, 2004, BIOCHEM PHARMACOL, V68, P1691, DOI 10.1016/j.bcp.2004.07.007; Mackie K, 2006, ANNU REV PHARMACOL, V46, P101, DOI 10.1146/annurev.pharmtox.46.120604.141254; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2006, J Endocrinol Invest, V29, P27; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; Mohler H, 2002, J PHARMACOL EXP THER, V300, P2, DOI 10.1124/jpet.300.1.2; Morozov A, 2003, BIOL PSYCHIAT, V54, P1125, DOI 10.1016/S0006-3223(03)00467-0; Nomura M, 2000, NEUROENDOCRINOLOGY, V71, P318, DOI 10.1159/000054552; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ong WY, 1999, NEUROSCIENCE, V92, P1177, DOI 10.1016/S0306-4522(99)00025-1; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Paterna JC, 2000, GENE THER, V7, P1304, DOI 10.1038/sj.gt.3301221; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Schauwecker PE, 1997, P NATL ACAD SCI USA, V94, P4103, DOI 10.1073/pnas.94.8.4103; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takahashi KA, 2006, NEUROSCIENCE, V139, P795, DOI 10.1016/j.neuroscience.2006.01.024; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; van der Stelt M, 2002, MOL NEUROBIOL, V26, P317, DOI 10.1385/MN:26:2-3:317; Wager-Miller J, 2002, CHEM PHYS LIPIDS, V121, P83, DOI 10.1016/S0009-3084(02)00151-2; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	59	533	547	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					455	466		10.1016/j.neuron.2006.07.006	http://dx.doi.org/10.1016/j.neuron.2006.07.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908411	Green Accepted, Bronze			2022-12-28	WOS:000240504700009
J	Pugh, EN				Pugh, Edward N., Jr.			RGS expression level precisely regulates the duration of rod photoresponses	NEURON			English	Editorial Material							ACTIVATION STEPS; PHOTOTRANSDUCTION; KINETICS; RECOVERY; PHASE	Regulators of G protein signaling (FIGS) constitute a family of proteins that bind specifically to the activated alpha subunits of G proteins (G alpha-GTP), acting as GTPase activating proteins, or GAPs, for the rate of GTP hydrolysis. In this issue of Neuron, Krispel et al. resolve a long-standing puzzle in phototransduction, establishing that RGS9 "GAPping" of G(t)alpha-GTP is the molecular mechanism underlying the dominant recovery time constant of mouse rod photoreceptors and that a precise level of expression of RGS9 is required for normal photoresponse timing.	Univ Penn, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania	Pugh, EN (corresponding author), Univ Penn, FM Kirby Ctr Mol Ophthalmol, 422 Curie Blvd, Philadelphia, PA 19104 USA.							Hamer RD, 2000, VISUAL NEUROSCI, V17, P679, DOI 10.1017/S0952523800175030; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Martemyanov KA, 2003, J NEUROSCI, V23, P10175; Matthews HR, 1997, J GEN PHYSIOL, V109, P141, DOI 10.1085/jgp.109.2.141; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rahman Z, 2003, NEURON, V38, P941, DOI 10.1016/S0896-6273(03)00321-0; Shea LD, 2000, LIFE SCI, V68, P647, DOI 10.1016/S0024-3205(00)00977-2	14	13	14	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 17	2006	51	4					391	393		10.1016/j.neuron.2006.08.002	http://dx.doi.org/10.1016/j.neuron.2006.08.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908403	Bronze			2022-12-28	WOS:000240504700001
J	Heisler, LK; Jobst, EE; Sutton, GM; Zhou, LG; Borok, E; Thornton-Jones, Z; Liu, HY; Zigman, JM; Balthasar, N; Kishi, T; Lee, CE; Aschkenasi, CJ; Zhang, CY; Yu, J; Boss, O; Mountjoy, KG; Clifton, PG; Lowell, BB; Friedman, JM; Horvath, T; Butler, AA; Elmquist, JK; Cowley, MA				Heisler, Lora K.; Jobst, Erin E.; Sutton, Gregory M.; Zhou, Ligang; Borok, Erzsebet; Thornton-Jones, Zoe; Liu, Hong Yan; Zigman, Jeffrey M.; Balthasar, Nina; Kishi, Toshiro; Lee, Charlotte E.; Aschkenasi, Carl J.; Zhang, Chen-Yu; Yu, Jia; Boss, Olivier; Mountjoy, Kathleen G.; Clifton, Peter G.; Lowell, Bradford B.; Friedman, Jeffrey M.; Horvath, Tamas; Butler, Andrew A.; Elmquist, Joel K.; Cowley, Michael A.			Serotonin reciprocally regulates melanocortin neurons to modulate food intake	NEURON			English	Article							RECEPTOR MESSENGER-RNA; ARCUATE NUCLEUS; NEUROPEPTIDE-Y; D-FENFLURAMINE; HYPOTHALAMIC CART; AGONIST CP-94,253; 5-HT1B RECEPTORS; KNOCKOUT MICE; POMC NEURONS; LEPTIN	The neural pathways through which central serotonergic systems regulate food intake and body weight remain to be fully elucidated. We report that serotonin, via action at serotonin1B receptors (5-HT(1B)Rs), modulates the endogenous release of both agonists and antagonists of the melanocortin receptors, which are a core component of the central circuitry controlling body weight homeostasis. We also show that serotonin-induced hypophagia requires downstream activation of melanocortin 4, but not melanocortin 3, receptors. These results identify a primary mechanism underlying the serotonergic regulation of energy balance and provide an example of a centrally derived signal that reciprocally regulates melanocortin receptor agonists and antagonists in a similar manner to peripheral adiposity signals.	Harvard Univ, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02215 USA; Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 2QQ, England; Oregon Hlth & Sci Univ, Oregon Natl Primate Res Ctr, Div Neurosci, Beaverton, OR 97006 USA; Pacific Univ, Sch Phys Therapy, Forest Grove, OR 97116 USA; Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Univ Sussex, Dept Psychol, Brighton BN1 9QG, E Sussex, England; Rockefeller Univ, Howard Hughes Med Inst, Mol Genet Lab, New York, NY 10021 USA; Shimane Med Univ, Sch Med, Dept Anat & Morphol Neurosci, Izumo, Shimane 6938501, Japan; Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland 1, New Zealand; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Oregon Health & Science University; Oregon National Primate Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Yale University; Yale University; University of Sussex; Howard Hughes Medical Institute; Rockefeller University; Shimane University; University of Auckland; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Elmquist, JK (corresponding author), Harvard Univ, Sch Med, Div Endocrinol Diabet & Metab, Dept Med, Boston, MA 02215 USA.	lkh30@medschl.cam.ac.uk; joel.elmquist@UTSouthwestern.edu; cowleym@ohsu.edu	Cowley, Michael A/B-9428-2008; Mountjoy, Kathy/L-4473-2019	Cowley, Michael A/0000-0001-7811-134X; Clifton, Pete/0000-0003-1230-133X; Butler, Andrew/0000-0001-7196-0170; Heisler, Lora/0000-0002-7731-1419; Zigman, Jeffrey/0000-0003-3477-1295	NCRR NIH HHS [RR 00163] Funding Source: Medline; NIDDK NIH HHS [DK53301, P01DK056116, DK060711, DK62202, DK065171, DK068330, DK074386, DK56116] Funding Source: Medline; NIMH NIH HHS [MH061583] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062202, P01DK056116, R37DK053301, R01DK074386, R01DK065171, R01DK060711, R01DK053301, R56DK062202, R21DK068330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061583] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ahima RS, 1999, ENDOCRINOLOGY, V140, P4923, DOI 10.1210/en.140.11.4923; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Bonaventure P, 1998, NEUROSCIENCE, V82, P469; Bouwknecht JA, 2001, PHYSIOL BEHAV, V74, P507, DOI 10.1016/S0031-9384(01)00589-3; BREISCH ST, 1976, SCIENCE, V192, P382, DOI 10.1126/science.130678; Broberger C, 1998, J COMP NEUROL, V402, P460; BRUINVELS AT, 1994, NEUROPHARMACOLOGY, V33, P367, DOI 10.1016/0028-3908(94)90067-1; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Chadha A, 2000, BRIT J PHARMACOL, V130, P1927, DOI 10.1038/sj.bjp.0703526; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Elias CF, 1998, NEURON, V21, P1375, DOI 10.1016/S0896-6273(00)80656-X; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fan T, 2000, ENDOCRINOLOGY, V141, P3072; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; FERNSTROM JD, 1972, SCIENCE, V178, P414, DOI 10.1126/science.178.4059.414; GARATTINI S, 1986, APPETITE, V7, P15, DOI 10.1016/S0195-6663(86)80050-2; GOUDIE AJ, 1976, J PHARM PHARMACOL, V28, P318, DOI 10.1111/j.2042-7158.1976.tb04165.x; Grill HJ, 1997, PSYCHOPHARMACOLOGY, V130, P375, DOI 10.1007/s002130050253; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Halford JCG, 1996, PHYSIOL BEHAV, V60, P933, DOI 10.1016/S0031-9384(96)00073-X; Heisler LK, 2002, SCIENCE, V297, P609, DOI 10.1126/science.1072327; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; KOE BK, 1992, DRUG DEVELOP RES, V26, P241, DOI 10.1002/ddr.430260305; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Lambert PD, 1998, SYNAPSE, V29, P293, DOI 10.1002/(SICI)1098-2396(199808)29:4<293::AID-SYN1>3.0.CO;2-0; Lee MD, 2004, PSYCHOPHARMACOLOGY, V176, P39, DOI 10.1007/s00213-004-1864-0; Lee MD, 2002, PSYCHOPHARMACOLOGY, V164, P49, DOI 10.1007/s00213-002-1162-7; Lee MD, 1998, PSYCHOPHARMACOLOGY, V136, P304, DOI 10.1007/s002130050570; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lucas JJ, 1998, J NEUROSCI, V18, P5537, DOI 10.1523/JNEUROSCI.18-14-05537.1998; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Makarenko IG, 2002, NEUROSCI LETT, V328, P155, DOI 10.1016/S0304-3940(02)00345-2; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Roseberry AG, 2004, NEURON, V41, P711, DOI 10.1016/S0896-6273(04)00074-1; SAMANIN R, 1980, PROG NEURO-PSYCHOPHA, V4, P363, DOI 10.1016/0364-7722(80)90006-5; Selkirk JV, 1998, BRIT J PHARMACOL, V125, P202, DOI 10.1038/sj.bjp.0702059; Stanford IM, 1996, J NEUROSCI, V16, P7566; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vickers SP, 1999, PSYCHOPHARMACOLOGY, V143, P309, DOI 10.1007/s002130050952	47	290	299	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2006	51	2					239	249		10.1016/j.neuron.2006.06.004	http://dx.doi.org/10.1016/j.neuron.2006.06.004			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846858	Bronze			2022-12-28	WOS:000239535100011
J	Callaway, EM				Callaway, EM			Should I stay or should I go? Presynaptic boutons in the adult cortex still haven't made up their minds	NEURON			English	Editorial Material							VISUAL-CORTEX; CAT; PLASTICITY; NEOCORTEX; CELLS; VIVO	Previous studies demonstrating turnover of the dendritic spines of cortical neurons have suggested a modest rate of turnover of synaptic connections. Now, two papers in this issue of Neuron address this question from the other side of the synapse, the presynaptic boutons. Both studies use in vivo multiphoton imaging of cortical axons to show that synaptic boutons come and go, just like spines. One of the studies shows remarkable diversity in the lability of boutons depending on the cell type from which they originate, with some boutons displaying nearly complete turnover in just a few months. The other study shows that bouton turnover occurs in primates as well as rodents.	Salk Inst Biol Studies, Syst Neurobiol Lab, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267				Ahmed B, 1997, J COMP NEUROL, V380, P230; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; Davidson BL, 2003, NAT REV NEUROSCI, V4, P353, DOI 10.1038/nrn1104; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; STTTLER DD, 2006, NEURON, V49, P877; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	12	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					780	783		10.1016/j.neuron.2006.03.007	http://dx.doi.org/10.1016/j.neuron.2006.03.007			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543123	Bronze			2022-12-28	WOS:000236227500003
J	Huettel, SA; Stowe, CJ; Gordon, EM; Warner, BT; Platt, ML				Huettel, SA; Stowe, CJ; Gordon, EM; Warner, BT; Platt, ML			Neural signatures of economic preferences for risk and ambiguity	NEURON			English	Article							PREFRONTAL CORTEX; DECISION-MAKING; COGNITIVE CONTROL; RESPONSE SELECTION; ANTERIOR CINGULATE; PARIETAL CORTICES; FRONTAL-CORTEX; UNCERTAINTY; BRAIN; CHOICE	People often prefer the known over the unknown, sometimes sacrificing potential rewards for the sake of surety. Overcoming impulsive preferences for certainty in order to exploit uncertain but potentially lucrative options may require specialized neural mechanisms. Here, we demonstrate by functional magnetic resonance imaging (fMRI) that individuals' preferences for risk (uncertainty with known probabilities) and ambiguity (uncertainty with unknown probabilities) predict brain activation associated with decision making. Activation within the lateral prefrontal cortex was predicted by ambiguity preference and was also negatively correlated with an independent clinical measure of behavioral impulsiveness, suggesting that this region implements contextual analysis and inhibits impulsive responses. In contrast, activation of the posterior parietal cortex was predicted by risk preference. Together, this novel double dissociation indicates that decision making under ambiguity does not represent a special, more complex case of risky decision making; instead, these two forms of uncertainty are supported by distinct mechanisms.	Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA; Duke Univ, Fuqua Sch Business, Res Triangle Pk, NC 27708 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Ctr Neuroecon Studies, Durham, NC 27708 USA	Duke University; Duke University; Duke University; Duke University	Huettel, SA (corresponding author), Duke Univ, Med Ctr, Brain Imaging & Anal Ctr, Durham, NC 27710 USA.	scott.huettel@duke.edu	Gordon, Evan/J-5672-2019	Gordon, Evan/0000-0002-2276-5237	NIMH NIH HHS [MH 70685] Funding Source: Medline; NINDS NIH HHS [NS 41328] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070685] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS041328] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bechara A, 1999, J NEUROSCI, V19, P5473; BECKER SW, 1964, J POLIT ECON, V72, P62, DOI 10.1086/258854; Bernoulli D., 1738, COMMENTARII ACAD SCI; Best M, 2002, P NATL ACAD SCI USA, V99, P8448, DOI 10.1073/pnas.112604099; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2004, J NEUROSCI, V24, P8847, DOI 10.1523/JNEUROSCI.2513-04.2004; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; CAMERER C, 1992, J RISK UNCERTAINTY, V5, P325, DOI 10.1007/BF00122575; Chapman GB, 2001, PSYCHON B REV, V8, P615, DOI 10.3758/BF03196198; CHIPMAN JS, 1960, DECISIONS VALUES GRO, P70; Cools R, 2005, NEUROPSYCHOPHARMACOL, V30, P1362, DOI 10.1038/sj.npp.1300704; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Dickhaut J, 2003, P NATL ACAD SCI USA, V100, P3536, DOI 10.1073/pnas.0530279100; Dorris MC, 2004, NEURON, V44, P365, DOI 10.1016/j.neuron.2004.09.009; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; ELLSBERG D, 1961, Q J ECON, V75, P643, DOI 10.2307/1884324; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Ghirardato P, 2004, J ECON THEORY, V118, P133, DOI 10.1016/j.jet.2003.12.004; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goel V, 2004, COGNITION, V93, pB109, DOI 10.1016/j.cognition.2004.03.001; HEATH C, 1991, J RISK UNCERTAINTY, V4, P177; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2002, NAT NEUROSCI, V5, P485, DOI 10.1038/nn841; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Knight, 1933, RISK UNCERTAINTY PRO; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Lauriola M, 2001, J BEHAV DECIS MAKING, V14, P107, DOI 10.1002/bdm.368; Leland DS, 2005, DRUG ALCOHOL DEPEN, V78, P83, DOI 10.1016/j.drugalcdep.2004.10.001; Luce RD, 2000, UTILITY GAINS LOSSES; McCoy A, 2005, J COMP PHYSIOL A, V191, P201, DOI 10.1007/s00359-004-0565-9; McCoy AN, 2005, NAT NEUROSCI, V8, P1220, DOI 10.1038/nn1523; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Parrott AC, 2000, NEUROPSYCHOBIOLOGY, V42, P17, DOI 10.1159/000026666; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Paulus MP, 2002, NEUROIMAGE, V15, P836, DOI 10.1006/nimg.2001.1031; Paulus MP, 2001, NEUROIMAGE, V13, P91, DOI 10.1006/nimg.2000.0667; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Platt ML, 2002, CURR OPIN NEUROBIOL, V12, P141, DOI 10.1016/S0959-4388(02)00302-1; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Smith K, 2002, MANAGE SCI, V48, P711, DOI 10.1287/mnsc.48.6.711.194; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Walderhaug E, 2002, PSYCHOPHARMACOLOGY, V164, P385, DOI 10.1007/s00213-002-1238-4	51	437	443	2	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					765	775		10.1016/j.neuron.2006.01.024	http://dx.doi.org/10.1016/j.neuron.2006.01.024			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	022QL	16504951	Bronze			2022-12-28	WOS:000236070600017
J	Gray, MA; Critchley, HD				Gray, Marcus A.; Critchley, Hugo D.			Interoceptive basis to craving	NEURON			English	Editorial Material							NEURAL MECHANISMS; ADDICTION; EMOTION	Awareness of one's physiology is an important component of emotion. How might these processes be related to addiction? In a recent issue of Science, Naqvi et al. demonstrated that smoking addiction is disrupted by damage to the insula cortex. This suggests that brain circuits mediating interoception also contribute to craving states.	Univ Sussex, Brighton & Sussex Med Sch, Brighton BN1 6PX, E Sussex, England	University of Brighton; University of Sussex	Gray, MA (corresponding author), Univ Sussex, Brighton & Sussex Med Sch, Falmer Campus, Brighton BN1 6PX, E Sussex, England.	m.a.gray@bsms.ac.uk	Gray, Marcus/F-6521-2013; critchley, hugo d/G-9267-2011	Gray, Marcus/0000-0001-8671-6939; critchley, hugo d/0000-0002-2445-9284	Wellcome Trust [074333] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Craig AD, 2005, TRENDS COGN SCI, V9, P566, DOI 10.1016/j.tics.2005.10.005; Critchley HD, 2005, J COMP NEUROL, V493, P154, DOI 10.1002/cne.20749; Damasio A.R., 2005, DESCARTES ERROR EMOT; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; JAMES W, 1994, PSYCHOL REV, V101, P205, DOI 10.1037/0033-295X.101.2.205; Kilts CD, 2004, AM J PSYCHIAT, V161, P233, DOI 10.1176/appi.ajp.161.2.233; Kilts CD, 2001, ARCH GEN PSYCHIAT, V58, P334, DOI 10.1001/archpsyc.58.4.334; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; NAUTA WJH, 1971, J PSYCHIAT RES, V8, P167, DOI 10.1016/0022-3956(71)90017-3; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Wiens S, 2005, CURR OPIN NEUROL, V18, P442, DOI 10.1097/01.wco.0000168079.92106.99	14	113	115	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					183	186		10.1016/j.neuron.2007.03.024	http://dx.doi.org/10.1016/j.neuron.2007.03.024			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442239	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000246190600003
J	Borst, A				Borst, Alexander			The broader, the better? Drosophila olfactory interneurons are found to respond to a wider range of odorants than their immediate sensory input	NEURON			English	Editorial Material							ANTENNAL LOBE; MAP	The Drosophila antennal lobe represents the first processing stage for olfactory information. In contrast to previous views, Olsen et al. (this issue of Neuron) demonstrate that antennal lobe output neurons show a broadened odor-tuning spectrum as compared to their sensory input. Likely candidates responsible for this broadening of odor tuning are recently identified excitatory local interneurons.	Max Planck Inst Neurobiol, Dept Syst & Computat Neurosci, Martinsried, Germany	Max Planck Society	Borst, A (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurosci, Martinsried, Germany.	borst@neuro.mpg.de						BOECKH J, 1987, J COMP PHYSIOL A, V161, P549, DOI 10.1007/BF00603661; BORST A, 1983, J COMP PHYSIOL, V152, P373, DOI 10.1007/BF00606242; BORST A, 1982, J COMP PHYSIOL, V147, P479, DOI 10.1007/BF00612013; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; DERBY CD, 1984, J NEUROPHYSIOL, V51, P906, DOI 10.1152/jn.1984.51.5.906; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Laissue PP, 1999, J COMP NEUROL, V405, P543; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782	16	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					6	8		10.1016/j.neuron.2007.03.016	http://dx.doi.org/10.1016/j.neuron.2007.03.016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408571	Bronze			2022-12-28	WOS:000245848400003
J	He, BJ; Snyder, AZ; Vincent, JL; Epstein, A; Shulman, GL; Corbetta, M				He, Biyu J.; Snyder, Abraham Z.; Vincent, Justin L.; Epstein, Adrian; Shulman, Gordon L.; Corbetta, Maurizio			Breakdown of functional connectivity in frontoparietal networks underlies behavioral deficits in spatial neglect	NEURON			English	Article							POSTERIOR PARIETAL CORTEX; VISUAL NEGLECT; SUSTAINED ATTENTION; HEMISPATIAL NEGLECT; UNILATERAL NEGLECT; FRONTAL LESIONS; WORKING-MEMORY; HUMAN BRAIN; HUMANS; MECHANISMS	Spatial neglect is a syndrome following stroke manifesting attentional deficits in perceiving and responding to stimuli in the contralesional field. We examined brain network integrity in patients with neglect by measuring coherent fluctuations of fMRI signals (functional connectivity). Connectivity in two largely separate attention networks located in dorsal and ventral frontoparietal areas was assessed at both acute and chronic stages of recovery. Connectivity in the ventral network, part of which directly lesioned, was diffusely disrupted and showed no recovery. In the structurally intact dorsal network, interhemispheric connectivity in posterior parietal cortex was acutely disrupted but fully recovered. This acute disruption, and disrupted connectivity in specific pathways in the ventral network, strongly correlated with impaired attentional processing across subjects. Lastly, disconnection of the white matter tracts connecting frontal and parietal cortices was associated with more severe neglect and more disrupted functional connectivity. These findings support a network view in understanding neglect.	Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Corbetta, M (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	mau@npg.wustl.edu	Vincent, Justin L/B-5033-2012; He, Biyu J/A-7795-2009; Corbetta, Maurizio/AAZ-5219-2020	He, Biyu/0000-0003-1549-1351; CORBETTA, MAURIZIO/0000-0001-8295-3304	NIMH NIH HHS [R01 MH71920-06] Funding Source: Medline; NINDS NIH HHS [R01 NS48013] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048013] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrington CM, 2000, J COGNITIVE NEUROSCI, V12, P106, DOI 10.1162/089892900563975; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Astafiev SV, 2003, J NEUROSCI, V23, P4689; Astafiev SV, 2006, EUR J NEUROSCI, V23, P591, DOI 10.1111/j.1460-9568.2005.04573.x; Bartolomeo P, 2007, CEREB CORTEX, V17, P2479, DOI 10.1093/cercor/bhl181; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, J COGNITIVE NEUROSCI, V14, P508, DOI 10.1162/089892902317362029; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Diller L, 1977, Adv Neurol, V18, P63; Downar J, 2000, NAT NEUROSCI, V3, P277, DOI 10.1038/72991; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; Friedrich FJ, 1998, NEUROPSYCHOLOGY, V12, P193, DOI 10.1037/0894-4105.12.2.193; Gaffan D, 1997, BRAIN, V120, P1647, DOI 10.1093/brain/120.9.1647; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Hampson M, 2006, NEUROIMAGE, V31, P513, DOI 10.1016/j.neuroimage.2005.12.040; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Heilman K.M., 1985, INT J CLIN NEUROPSYC, V2nd, P243; HEILMAN KM, 1980, NEUROLOGY, V30, P327, DOI 10.1212/WNL.30.3.327; Hillis AE, 2006, NEUROSCIENTIST, V12, P153, DOI 10.1177/1073858405284257; Husain M, 1996, J NEUROL, V243, P652, DOI 10.1007/BF00878662; Husain M, 2003, NAT REV NEUROSCI, V4, P26, DOI 10.1038/nrn1005; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; Karnath HO, 2002, BRAIN, V125, P350, DOI 10.1093/brain/awf032; Karnath HO, 2004, CEREB CORTEX, V14, P1164, DOI 10.1093/cercor/bhh076; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Kincade JM, 2005, J NEUROSCI, V25, P4593, DOI 10.1523/JNEUROSCI.0236-05.2005; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Macaluso E, 2002, J COGNITIVE NEUROSCI, V14, P389, DOI 10.1162/089892902317361912; Malhotra P, 2006, CURR OPIN NEUROL, V19, P14, DOI 10.1097/01.wco.0000198101.87670.7e; Malhotra PA, 2006, ANN NEUROL, V59, P186, DOI 10.1002/ana.20701; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Milner AD, 2005, CURR OPIN NEUROL, V18, P748, DOI 10.1097/01.wco.0000191512.60368.ee; MORROW LA, 1988, PSYCHOBIOLOGY, V16, P261; Mort DJ, 2003, BRAIN, V126, P1986, DOI 10.1093/brain/awg200; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; Peers PV, 2005, CEREB CORTEX, V15, P1469, DOI 10.1093/cercor/bhi029; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; POSNER MI, 1984, J NEUROSCI, V4, P1863; Quigley M, 2003, AM J NEURORADIOL, V24, P208; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Robertson IH, 2001, NEUROIMAGE, V14, pS85, DOI 10.1006/nimg.2001.0838; ROBERTSON IH, 1995, J CLIN EXP NEUROPSYC, V17, P416, DOI 10.1080/01688639508405133; Robertson IH, 1998, NATURE, V395, P169, DOI 10.1038/25993; Rueckert L, 1996, NEUROPSYCHOLOGIA, V34, P953, DOI 10.1016/0028-3932(96)00016-4; Schluppeck D, 2005, J NEUROPHYSIOL, V94, P1372, DOI 10.1152/jn.01290.2004; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, DOI DOI 10.1093/ACPROF:OSO/9780195104233.003.0014; Serences JT, 2004, J NEUROPHYSIOL, V92, P3538, DOI 10.1152/jn.00435.2004; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Shapiro K, 2002, CURR BIOL, V12, P1320, DOI 10.1016/S0960-9822(02)01040-0; Shimony JS, 2006, CEREB CORTEX, V16, P1653, DOI 10.1093/cercor/bhj102; Silver MA, 2005, J NEUROPHYSIOL, V94, P1358, DOI 10.1152/jn.01316.2004; Talairach J., 1988, COPLANAR STEREOTAXIC; Thiebaut de Schotten M, 2005, SCIENCE, V309, P2226, DOI 10.1126/science.1116251; Vallar G., 1987, NEUROPHYSIOLOGICAL N, V45, P235; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Whalley HC, 2005, BRAIN, V128, P2097, DOI 10.1093/brain/awh556; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8; Zar J. H., 1996, BIOSTATISTICAL ANAL	69	703	727	2	178	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					905	918		10.1016/j.neuron.2007.02.013	http://dx.doi.org/10.1016/j.neuron.2007.02.013			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359924	Bronze, Green Submitted			2022-12-28	WOS:000245292800014
J	Helmchen, F; Nevian, T				Helmchen, Fritjof; Nevian, Thomas			Little strokes fill big oaks: A simple in vivo stain of brain cells	NEURON			English	Editorial Material							NEURONS; ELECTROPORATION; TRANSFECTION; NETWORKS; DYNAMICS; CNS	High-resolution functional imaging of neural activity in vivo relies on appropriate labeling methods. In this issue of Neuron, Nagayama et al. introduce a simple procedure for staining subsets of neurons with organic calcium indicator dyes via local electroporation. Neuronal populations are sparsely labeled, preserving the ability to resolve calcium signals in dendrites and synaptic structures.	Univ Zurich, Brain Res Inst, Dept Neurophysiol, CH-8057 Zurich, Switzerland; Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland	University of Zurich; University of Bern	Helmchen, F (corresponding author), Univ Zurich, Brain Res Inst, Dept Neurophysiol, CH-8057 Zurich, Switzerland.	helmchen@hifo.unizh.ch	; Helmchen, Fritjof/A-6255-2008	Nevian, Thomas/0000-0001-9804-608X; Helmchen, Fritjof/0000-0002-8867-9569				Bonnot AS, 2005, J NEUROPHYSIOL, V93, P1793, DOI 10.1152/jn.00923.2004; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Knopfel T, 2006, TRENDS NEUROSCI, V29, P160, DOI 10.1016/j.tins.2006.01.004; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Nagayama S, 2007, NEURON, V53, P789, DOI 10.1016/j.neuron.2007.02.018; NEVIAN T, 2007, IN PRESS PFLUGERS AR; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Teruel MN, 1999, J NEUROSCI METH, V93, P37, DOI 10.1016/S0165-0270(99)00112-0; TSIEN RY, 1989, ANNU REV NEUROSCI, V12, P227, DOI 10.1146/annurev.neuro.12.1.227	15	0	0	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 15	2007	53	6					771	773		10.1016/j.neuron.2007.03.001	http://dx.doi.org/10.1016/j.neuron.2007.03.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359911	Bronze			2022-12-28	WOS:000245292800001
J	Peng, CY; Yajima, H; Burns, CE; Zon, LI; Sisodia, SS; Pfaff, SL; Sharma, K				Peng, Chian-Yu; Yajima, Hiroshi; Burns, Caroline Erter; Zon, Leonard I.; Sisodia, Sangram S.; Pfaff, Samuel L.; Sharma, Kamal			Notch and MAML signaling drives scl-dependent interneuron diversity in the spinal cord	NEURON			English	Article							PROGENITOR-CELL IDENTITY; MOTOR-NEURON; TRANSCRIPTION FACTORS; POSITIONAL IDENTITY; SUBTYPE IDENTITY; V2 INTERNEURONS; SONIC HEDGEHOG; FATE; SPECIFICATION; EXPRESSION	The ventral spinal cord generates multiple inhibitory and excitatory interneuron subtypes from four cardinal progenitor domains (p0, p1,, p2, p3). Here we show that cell-cell interactions mediated by the Notch receptor play a critical evolutionarily conserved role in the generation of excitatory v2aIN and inhibitory v2bIN interneurons. Lineage-tracing experiments show that the v2aIN and v2bIN develop from genetically identical p2 progenitors. The p2 daughter cell fate is controlled by Delta4 activation of Notch receptors together with MAML factors. Cells receiving Notch signals activate a transcription factor code that specifies the v2bIN fate, whereas cells deprived of Notch signaling express another code for v2aIN formation. Thus, our study provides insight into the cell-extrinsic signaling that controls combinatorial transcription factor profiles involved in regulating the process of interneuron subtype diversification.	Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Harvard Stem Cell Inst, Boston, MA 02115 USA; Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	University of Chicago; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Salk Institute	Sharma, K (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	ksharma@bsd.uchicago.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045106] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045106, R01 NS045106-04, R01-NS045106] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chen N, 2004, DEV CELL, V6, P183, DOI 10.1016/S1534-5807(04)00021-8; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dorsky RI, 1997, NATURE, V385, P67, DOI 10.1038/385067a0; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1995, INT J DEV BIOL, V39, P809; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017; Goulding M, 2000, CURR BIOL, V10, pR565, DOI 10.1016/S0960-9822(00)00615-1; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jiang YJ, 1996, DEVELOPMENT, V123, P205; Karunaratne A, 2002, DEV BIOL, V249, P30, DOI 10.1006/dbio.2002.0754; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; Li SG, 2005, P NATL ACAD SCI USA, V102, P10688, DOI 10.1073/pnas.0504799102; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Lutolf S, 2002, DEVELOPMENT, V129, P373; Maillard I, 2004, BLOOD, V104, P1696, DOI 10.1182/blood-2004-02-0514; Mizuguchi R, 2006, NAT NEUROSCI, V9, P770, DOI 10.1038/nn1706; Muroyama Y, 2005, NATURE, V438, P360, DOI 10.1038/nature04139; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nardelli J, 1999, DEV BIOL, V210, P305, DOI 10.1006/dbio.1999.9278; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pattyn A, 2004, NAT NEUROSCI, V7, P589, DOI 10.1038/nn1247; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Sapir T, 2004, J NEUROSCI, V24, P1255, DOI 10.1523/JNEUROSCI.3187-03.2004; Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Smith E, 2002, DEV DYNAM, V224, P231, DOI 10.1002/dvdy.10093; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Yang XD, 2006, DEV NEUROSCI-BASEL, V28, P102, DOI 10.1159/000090757; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Yedvobnick B, 2004, GENETICS, V166, P1281, DOI 10.1534/genetics.166.3.1281; Yoo AS, 2004, SCIENCE, V303, P663, DOI 10.1126/science.1091639; Zhou YH, 2000, DEVELOPMENT, V127, P3829	57	119	119	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					813	827		10.1016/j.neuron.2007.02.019	http://dx.doi.org/10.1016/j.neuron.2007.02.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359917	Bronze, Green Accepted			2022-12-28	WOS:000245292800007
J	Price, GD; Trussell, LO				Price, Gareth D.; Trussell, Laurence O.			Good players left on the sidelines: Why some synaptic vesicles don't get in the game	NEURON			English	Editorial Material							TRANSMITTER RELEASE; CALYX	A key question in synaptic physiology is what determines the release probability of a synaptic vesicle. In this issue of Neuron, Wadel et al. shed UV light on this problem, finding that hard-to-release vesicles are too far from Ca2+ channels.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Vollum Inst, Portland, OR 97239 USA	Oregon Health & Science University	Trussell, LO (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Vollum Inst, Portland, OR 97239 USA.	trussell@ohsu.edu						Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Wadel K, 2007, NEURON, V53, P563, DOI 10.1016/j.neuron.2007.01.021	12	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					471	473		10.1016/j.neuron.2007.02.003	http://dx.doi.org/10.1016/j.neuron.2007.02.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296546	Bronze			2022-12-28	WOS:000245126900003
J	Zhang, SJ; Steijaert, MN; Lau, D; Schutz, G; Delucinge-Vivier, C; Descombes, P; Bading, H				Zhang, Sheng-Jia; Steijaert, Marvin N.; Lau, David; Schuetz, Guenther; Delucinge-Vivier, Celine; Descombes, Patrick; Bading, Hilmar			Decoding NMDA receptor signaling: Identification of genomic programs specifying neuronal survival and death	NEURON			English	Article							ACTIVITY-DEPENDENT NEUROPROTECTION; BINDING PROTEIN CREB; CENTER B-CELLS; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; WIDE ANALYSIS; CALCIUM; TRANSCRIPTION; APOPTOSIS	NMDA receptors promote neuronal survival but also cause cell degeneration and neuron loss. The mechanisms underlying these opposite effects on neuronal fate are unknown. Whole-genome expression profiling revealed that NMDA receptor signaling is decoded at the genomic level through activation of two distinct, largely nonoverlapping gene-expression programs. The location of the NMDA receptor activated specifies the transcriptional response: synaptic NMDA receptors induce a coordinate upregulation of newly identified pro-survival genes and downregulation of pro-death genes. Extrasynaptic NMDA receptors fail to activate this neuroprotective program, but instead induce expression of C/ca1, a putative calcium-activated chloride channel that kills neurons. These results help explain the opposing roles of synaptic and extrasynaptic NMDA receptors on neuronal fate. They also demonstrate that the survival function is implemented in neurons through a multicomponent system of functionally related genes, whose coordinate expression is controlled by specific calcium signal initiation sites.	Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Univ Geneva, CH-1211 Geneva, Switzerland	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Geneva	Bading, H (corresponding author), Univ Heidelberg, Dept Neurobiol, Interdisciplinary Ctr Neurosci, D-69120 Heidelberg, Germany.	hilmar.bading@uni-hd.de						Arnold FJL, 2005, J PHYSIOL-LONDON, V564, P3, DOI 10.1113/jphysiol.2004.077446; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1995, NEUROSCIENCE, V64, P653, DOI 10.1016/0306-4522(94)00462-E; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carmel JB, 2004, EXP NEUROL, V185, P81, DOI 10.1016/j.expneurol.2003.09.007; Chawla S, 2003, J NEUROCHEM, V85, P151, DOI 10.1046/j.1471-4159.2003.01648.x; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; Corrente G, 2002, NEUROREPORT, V13, P417, DOI 10.1097/00001756-200203250-00011; Culmsee C, 2005, BIOCHEM BIOPH RES CO, V331, P761, DOI 10.1016/j.bbrc.2005.03.149; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dong ZZ, 2005, MOL THER, V11, P80, DOI 10.1016/j.ymthe.2004.09.007; DREYER EB, 1995, NEUROREPORT, V6, P942, DOI 10.1097/00001756-199504190-00029; el-Ghissassi F, 2002, ONCOGENE, V21, P6772, DOI 10.1038/sj.onc.1205888; Elble RC, 2001, J BIOL CHEM, V276, P40510, DOI 10.1074/jbc.M104821200; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Forch P, 2001, APOPTOSIS, V6, P463, DOI 10.1023/A:1012441824719; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Gibson A, 2005, J BIOL CHEM, V280, P27205, DOI 10.1074/jbc.M504654200; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; IACOPETTI P, 1994, MECH DEVELOP, V47, P127, DOI 10.1016/0925-4773(94)90085-X; Ikonomidou C, 1999, SCIENCE, V283, P70, DOI 10.1126/science.283.5398.70; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Klugmann M, 2005, MOL CELL NEUROSCI, V28, P347, DOI 10.1016/j.mcn.2004.10.002; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; LIM RW, 1987, ONCOGENE, V1, P263; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagomi S, 2003, J NEUROSCI, V23, P5187; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Park S, 2004, MOL CELL BIOL, V24, P10256, DOI 10.1128/MCB.24.23.10256-10262.2004; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Pawlowski K, 2006, PROTEINS, V63, P424, DOI 10.1002/prot.20887; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Prevot D, 2000, J BIOL CHEM, V275, P147, DOI 10.1074/jbc.275.1.147; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang JH, 1995, J BIOL CHEM, V270, P30245, DOI 10.1074/jbc.270.51.30245; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; Xu R, 2001, GENE THER, V8, P1323, DOI 10.1038/sj.gt.3301529; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	74	238	245	2	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					549	562		10.1016/j.neuron.2007.01.025	http://dx.doi.org/10.1016/j.neuron.2007.01.025			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296556	Bronze			2022-12-28	WOS:000245126900013
J	Liu, XY; Chu, XP; Mao, LM; Wang, M; Lan, HX; Li, MH; Zhang, GC; Parelkar, NK; Fibuch, EE; Haines, M; Neve, KA; Liu, F; Xiong, ZG; Wang, JQ				Liu, Xian-Yu; Chu, Xiang-Ping; Mao, Li-Min; Wang, Min; Lan, Hong-Xiang; Li, Ming-Hua; Zhang, Guo-Chi; Parelkar, Nikhil K.; Fibuch, Eugene E.; Haines, Michelle; Neve, Kim A.; Liu, Fang; Xiong, Zhi-Gang; Wang, John Q.			Modulation of D2R-NR2B interactions in response to cocaine	NEURON			English	Article							D-ASPARTATE RECEPTOR; PROTEIN-KINASE-II; NMDA RECEPTOR; BEHAVIORAL SENSITIZATION; NR2B SUBUNIT; TYROSINE PHOSPHORYLATION; DOPAMINE D1; MOLECULAR-MECHANISMS; SURFACE EXPRESSION; GLUTAMATE	Dopamine-glutamate interactions in the neostriatum determine psychostimulant action, but the underlying molecular mechanisms remain elusive. Here we found that dopamine stimulation by cocaine enhances a heteroreceptor complex formation between dopamine D2 receptors (D2R) and NMDA receptor NR2B subunits in the neostriatum in vivo. The D2R-NR2B interaction is direct and occurs in the confined postsynaptic density microdomain of excitatory synapses. The enhanced D2R-NR2B interaction disrupts the association of Ca2+/ calmodulin-dependent protein kinase H (CaMKII) with NR2B, reduces NR2B phosphorylation at a CaMKII-sensitive site (Ser1303), and inhibits NMDA receptor-mediated currents in medium-sized striatal neurons. Furthermore, the regulated D2R-NR2B interaction is critical for constructing behavioral responsiveness to cocaine. Our findings here uncover a direct and dynamic D2R-NR2B interaction in striatal neurons in vivo. This type of dopamine-glutamate integration at the receptor level may be responsible for synergistically inhibiting the D2R-mediated circuits in the basal ganglia and fulfilling the stimulative effect of psychostimulants.	Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA; Univ Missouri, Dept Anesthesiol, Sch Med, Kansas City, MO 64108 USA; Robert S Dow Neurobiol Labs, Portland, OR 97232 USA; Univ Toronto, Dept Neurosci, Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada; Oregon Hlth & Sci Univ, Dept Behav Neurosci, Portland, OR 97239 USA; Vet Affairs Med Ctr, Portland, OR 97239 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Wang, JQ (corresponding author), Univ Missouri, Dept Basic Med Sci, Sch Med, Kansas City, MO 64108 USA.	wangjq@umkc.edu	LIU, XIANYU/B-8111-2014	Liu, Xianyu/0000-0001-6089-8826; Chu, Xiang-Ping/0000-0002-6781-0468	NIDA NIH HHS [DA010355] Funding Source: Medline; NIMH NIH HHS [MH061469] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA010355, R29DA010355] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bibb JA, 2005, CELL, V122, P153, DOI 10.1016/j.cell.2005.07.011; Bofill-Cardona E, 2000, J BIOL CHEM, V275, P32672, DOI 10.1074/jbc.M002780200; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chen YK, 2000, ORG LETT, V2, P743, DOI 10.1021/ol9903887; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Dunah AW, 2004, MOL PHARMACOL, V65, P121, DOI 10.1124/mol.65.1.121; Fiorentini C, 2003, J BIOL CHEM, V278, P20196, DOI 10.1074/jbc.M213140200; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Gardoni F, 1998, J NEUROCHEM, V71, P1733; Gerfen CR, 2000, TRENDS NEUROSCI, V23, pS64, DOI 10.1016/S1471-1931(00)00019-7; GRAYBIEL AM, 1981, NEUROSCIENCE, V6, P377, DOI 10.1016/0306-4522(81)90131-7; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; HERSCH SM, 1995, J NEUROSCI, V15, P5222; Holmes A, 2004, NEUROPHARMACOLOGY, V47, P1117, DOI 10.1016/j.neuropharm.2004.07.034; HURD YL, 1989, SYNAPSE, V3, P48, DOI 10.1002/syn.890030107; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; KALIVAS PW, 1993, J NEUROSCI, V13, P266; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; Koob GF, 1997, J NEUROPSYCH CLIN N, V9, P482; Kotecha SA, 2002, NEURON, V35, P1111, DOI 10.1016/S0896-6273(02)00859-0; Kuppenbender KD, 2000, J COMP NEUROL, V419, P407, DOI 10.1002/(SICI)1096-9861(20000417)419:4<407::AID-CNE1>3.0.CO;2-I; LANDWEHRMEYER GB, 1995, J NEUROSCI, V15, P5297; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee FJS, 2002, CELL, V111, P219, DOI 10.1016/S0092-8674(02)00962-5; Liao GY, 2001, MOL PHARMACOL, V59, P960, DOI 10.1124/mol.59.5.960; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; Mao LM, 2005, J NEUROSCI, V25, P2741, DOI 10.1523/JNEUROSCI.4360-04.2005; Nakazawa T, 2001, J BIOL CHEM, V276, P693, DOI 10.1074/jbc.M008085200; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; Rostas JAP, 1996, P NATL ACAD SCI USA, V93, P10452, DOI 10.1073/pnas.93.19.10452; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Sesack SR, 2003, ANN NY ACAD SCI, V1003, P36, DOI 10.1196/annals.1300.066; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; Standaert DG, 1999, MOL BRAIN RES, V64, P11, DOI 10.1016/S0169-328X(98)00293-9; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Svenningsson P, 2005, AAPS J, V7, DOI 10.1208/aapsj070235; Szumlinski KK, 2004, NEURON, V43, P401, DOI 10.1016/j.neuron.2004.07.019; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Valjent E, 2000, J NEUROSCI, V20, P8701; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wang H, 2002, J COMP NEUROL, V442, P392, DOI 10.1002/cne.10086; Wang JQ, 1999, ADDICT BIOL, V4, P141, DOI 10.1080/13556219971641; WANG LY, 1993, SCIENCE, V259, P1173, DOI 10.1126/science.8382377; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xiong ZG, 1999, J NEUROSCI, V19; Yao WD, 2004, NEURON, V41, P625, DOI 10.1016/S0896-6273(04)00048-0; Yung KKL, 2000, SYNAPSE, V38, P413, DOI 10.1002/1098-2396(20001215)38:4<413::AID-SYN6>3.3.CO;2-M; Zhang L, 2004, J NEUROSCI, V24, P3344, DOI 10.1523/JNEUROSCI.0060-04.2004; Zorumski CF, 1998, PROG BRAIN RES, V118, P173	62	193	198	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					897	909		10.1016/j.neuron.2006.10.011	http://dx.doi.org/10.1016/j.neuron.2006.10.011			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145509	Bronze			2022-12-28	WOS:000242856400016
J	Kay, AR; Neyton, J; Paoletti, P				Kay, Alan R.; Neyton, Jacques; Paoletti, Pierre			A startling role for synaptic zinc	NEURON			English	Editorial Material							RELEASED ZINC; POTENTIATION; RECEPTORS; INHIBITION; PATHWAYS; IONS	It has long been known that the synaptic vesicles of certain glutamatergic terminals, as well as some inhibitory terminals, are richly supplied with zinc ions, yet the functional role of this pool of zinc in synaptic transmission has remained elusive. In this issue of Neuron, Hirzel et al. provide direct in vivo evidence that endogenous zinc is required for proper functioning of neuronal circuitry in the brainstem and spinal cord. They show that knockin mice carrying a point mutation which eliminates zinc potentiation of alpha 1-containing glycine receptors develop severe sensorimotor deficits characteristic of impaired glycinergic neurotransmission.	Univ Iowa, Iowa City, IA 52242 USA; Ecole Normale Super, CNRS, UMR 8544, F-75005 Paris, France	University of Iowa; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Kay, AR (corresponding author), Univ Iowa, Iowa City, IA 52242 USA.		Paoletti, Pierre/L-7358-2013	Paoletti, Pierre/0000-0002-3681-4845				Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; Cole TB, 2000, EPILEPSY RES, V39, P153, DOI 10.1016/S0920-1211(99)00121-7; Danscher G, 2005, J HISTOCHEM CYTOCHEM, V53, P141, DOI 10.1369/jhc.4R6460.2005; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Hirzel K, 2006, NEURON, V52, P679, DOI 10.1016/j.neuron.2006.09.035; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Kay AR, 2006, TRENDS NEUROSCI, V29, P200, DOI 10.1016/j.tins.2006.02.004; Kodirov SA, 2006, P NATL ACAD SCI USA, V103, P15218, DOI 10.1073/pnas.0607131103; Miller PS, 2005, J BIOL CHEM, V280, P37877, DOI 10.1074/jbc.M508303200; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Paoletti P, 1997, J NEUROSCI, V17, P5711; Smart TG, 2004, NEUROSCIENTIST, V10, P432, DOI 10.1177/1073858404263463; Suwa H, 2001, J NEUROPHYSIOL, V85, P912, DOI 10.1152/jn.2001.85.2.912; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6	14	16	18	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					572	574		10.1016/j.neuron.2006.11.007	http://dx.doi.org/10.1016/j.neuron.2006.11.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114041	Bronze, Green Submitted			2022-12-28	WOS:000242413100004
J	Nakamura, K; Hara, N; Kouider, S; Takayama, Y; Hanajima, R; Sakai, K; Ugawa, Y				Nakamura, Kimihiro; Hara, Nobuko; Kouider, Sid; Takayama, Yoshihiro; Hanajima, Ritsuko; Sakai, Katsuyuki; Ugawa, Yoshikazu			Task-guided selection of the dual neural pathways for reading	NEURON			English	Article							VISUAL WORD RECOGNITION; MULTISENSORY INTEGRATION; NEUROIMAGING EVIDENCE; MAGNETIC STIMULATION; FUNCTIONAL-ANATOMY; TEMPORAL CORTEX; BRAIN; CONNECTIVITY; REPETITION; ATTENTION	The visual perception of words is known to activate the auditory representation of their spoken forms automatically. We examined the neural mechanism for this phonological activation using transcranial magnetic stimulation (TMS) with a masked priming paradigm. The stimulation sites (left superior temporal gyrus [L-STG] and inferior parietal lobe [L-IPL]), modality of targets (visual and auditory), and task (pronunciation and lexical decision) were manipulated independently. For both within- and cross-modal conditions, the repetition priming during pronunciation was eliminated when TMS was applied to the L-IPL, but not when applied to the L-STG, whereas the priming during lexical decision was eliminated when the L-STG, but not the L-IPL, was stimulated. The observed double dissociation suggests that the conscious task instruction modulates the stimulus-driven activation of the lateral temporal cortex for lexico-phonological activation and the inferior parietal cortex for spoken word production, and thereby engages a different neural network for generating the appropriate behavioral response.	Univ Tokyo, Grad Sch Med, Dept Speech Physiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Cognit Neurosci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1130033, Japan; ENS, EHESS, CNRS, Lab Sci Cognit & Psycholinguist, F-75005 Paris, France	University of Tokyo; University of Tokyo; University of Tokyo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Nakamura, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Speech Physiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kimihiro@m.u-tokyo.ac.jp	Ugawa, Yoshikazu/AAM-2052-2020	Ugawa, Yoshikazu/0000-0002-8016-152X				Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bitan T, 2005, J NEUROSCI, V25, P5397, DOI 10.1523/JNEUROSCI.0864-05.2005; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Catani M, 2003, BRAIN, V126, P2093, DOI 10.1093/brain/awg203; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fiebach CJ, 2002, J COGNITIVE NEUROSCI, V14, P11, DOI 10.1162/089892902317205285; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Forster K. I., 2003, MASKED PRIMING STATE, P3; FORSTER KI, 1991, J MEM LANG, V30, P1, DOI 10.1016/0749-596X(91)90008-8; Friedman RF, 1993, CLIN NEUROPSYCHOLOGY, P37; Frost R., 2003, MASKED PRIMING STATE, P173; FUSTER JM, 1997, PREFRONTAL CORTEX; Grainger J, 2003, J EXP PSYCHOL LEARN, V29, P1256, DOI 10.1037/0278-7393.29.6.1256; Greenwald M, 2001, HDB NEUROPSYCHOLOGY, P205; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Herbster AN, 1997, HUM BRAIN MAPP, V5, P84, DOI 10.1002/(SICI)1097-0193(1997)5:2<84::AID-HBM2>3.0.CO;2-I; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; HOWARD D, 1992, BRAIN, V115, P1769, DOI 10.1093/brain/115.6.1769; Ilmoniemi RJ, 1997, NEUROREPORT, V8, P3537, DOI 10.1097/00001756-199711100-00024; Kouider S, 2001, COGNITION, V82, pB35, DOI 10.1016/S0010-0277(01)00152-4; Lamme VAF, 2003, TRENDS COGN SCI, V7, P12, DOI 10.1016/S1364-6613(02)00013-X; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Lupker, 2003, MASKED PRIMING STATE, P223; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Paulesu E, 2000, NAT NEUROSCI, V3, P91, DOI 10.1038/71163; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; RAMACHANDRAN VS, 1995, NATURE, V373, P66, DOI 10.1038/373066a0; ROTH BJ, 1991, ELECTROEN CLIN NEURO, V81, P47, DOI 10.1016/0168-5597(91)90103-5; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Shaywitz SE, 1998, P NATL ACAD SCI USA, V95, P2636, DOI 10.1073/pnas.95.5.2636; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; van Turennout M, 2000, NAT NEUROSCI, V3, P1329, DOI 10.1038/81873; Wright TM, 2003, CEREB CORTEX, V13, P1034, DOI 10.1093/cercor/13.10.1034	47	49	49	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					557	564		10.1016/j.neuron.2006.09.030	http://dx.doi.org/10.1016/j.neuron.2006.09.030			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	108WK	17088220	Bronze			2022-12-28	WOS:000242269700017
J	Shepherd, JD; Rumbaugh, G; Wu, J; Chowdhury, S; Plath, N; Kuhl, D; Huganir, RL; Worley, PF				Shepherd, Jason D.; Rumbaugh, Gavin; Wu, Jing; Chowdhury, Shoalb; Plath, Niels; Kuhl, Dietmar; Huganir, Richard L.; Worley, Paul F.			Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors	NEURON			English	Article							LONG-TERM POTENTIATION; ARC MESSENGER-RNA; HIPPOCAMPAL-NEURONS; PROTEIN EXPRESSION; CULTURED NEURONS; TRANSGENIC MICE; VISUAL-CORTEX; PLASTICITY; ACTIVATION; GENE	Homeostatic plasticity may compensate for Hebbian forms of synaptic plasticity, such as long-term potentiation (LTP) and depression (LTD), by scaling neuronal output without changing the relative strength of individual synapses. This delicate balance between neuronal output and distributed synaptic weight may be necessary for maintaining efficient encoding of information across neuronal networks. Here, we demonstrate that Arc/Arg3.1, an immediate-early gene (IEG) that is rapidly induced by neuronal activity associated with information encoding in the brain, mediates homeostatic synaptic scaling of AMPA type glutamate receptors (AMPARs) via its ability to activate a novel and selective AMPAR endocytic pathway. High levels of Arc/Arg3.1 block the homeostatic increases in AMPAR function induced by chronic neuronal inactivity. Conversely, loss of Arc/Arg3.1 results in increased AMPAR function and abolishes homeostatic scaling of AMPARs. These observations, together with evidence that Arc/Arg3.1 is required for memory consolidation, reveal the importance of Arc/Arg3.1's dynamic expression as it exerts continuous and precise control over synaptic strength and cellular excitability.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Free University of Berlin	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Shepherd, Jason/N-8555-2018; Kuhl, Dietmar/A-4689-2009	Shepherd, Jason/0000-0001-7384-8289; Kuhl, Dietmar/0000-0002-4772-6701	NIMH NIH HHS [P50 MH068830, R01 MH053608] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH053608] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; BARIK T, 2002, PCR CLONING PROTOCOL, V192; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Dickey CA, 2003, J NEUROSCI, V23, P5219; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Guzowski JF, 2006, P NATL ACAD SCI USA, V103, P1077, DOI 10.1073/pnas.0505519103; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Marder E, 2006, NAT REV NEUROSCI, V7, P563, DOI 10.1038/nrn1949; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nguyen PV, 1996, J NEUROSCI, V16, P3189; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Watt AJ, 2004, NAT NEUROSCI, V7, P518, DOI 10.1038/nn1220; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yeung LC, 2004, P NATL ACAD SCI USA, V101, P14943, DOI 10.1073/pnas.0405555101; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	49	545	555	1	41	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					475	484		10.1016/j.neuron.2006.08.034	http://dx.doi.org/10.1016/j.neuron.2006.08.034			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088213	Green Accepted, Bronze			2022-12-28	WOS:000242269700010
J	Zhou, ZL; Hong, EJ; Cohen, S; Zhao, WN; Ho, HYH; Schmidt, L; Chen, WG; Lin, YX; Savner, E; Griffith, EC; Hu, L; Steen, JAJ; Weitz, CJ; Greenberg, ME				Zhou, Zhaolan; Hong, Elizabeth J.; Cohen, Sonia; Zhao, Wen-ning; Ho, Hsin-yi Henry; Schmidt, Lauren; Chen, Wen G.; Lin, Yingxi; Savner, Erin; Griffith, Eric C.; Hu, Linda; Steen, Judith A. J.; Weitz, Charles J.; Greenberg, Michael E.			Brain-specific phosphorylation of MeCP2 regulates activity-dependent Bdnf transcription, dendritic growth, and spine maturation	NEURON			English	Article							SEVERE MENTAL-RETARDATION; IMMEDIATE-EARLY GENES; RETT-SYNDROME; DNA METHYLATION; MOUSE MODEL; NEUROLOGICAL SYMPTOMS; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; NEURONS; EXPRESSION	Mutations or duplications in MECP2 cause Rett and Rett-like syndromes, neurodevelopmental disorders characterized by mental retardation, motor dysfunction, and autistic behaviors. MeCP2 is expressed in many mammalian tissues and functions as a global repressor of transcription; however, the molecular mechanisms by which MeCP2 dysfunction leads to the neural-specific phenotypes of RTT remain poorly understood. Here, we show that neuronal activity and subsequent calcium influx trigger the de novo phosphorylation of MeCP2 at serine 421 (S421) by a CaMKII-dependent mechanism. MeCP2 S421 phosphorylation is induced selectively in the brain in response to physiological stimuli. Significantly, we find that S421 phosphorylation controls the ability of MeCP2 to regulate dendritic patterning, spine morphogenesis, and the activity-dependent induction of Bdnf transcription. These findings suggest that, by triggering MeCP2 phosphorylation, neuronal activity regulates a program of gene expression that mediates nervous system maturation and that disruption of this process in individuals with mutations in MeCP2 may underlie the neural-specific pathology of RTT.	Harvard Univ, Sch Med, Childrens Hosp Boston, Neurobiol Program, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Neurobiol Program, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu		Chen, Wen/0000-0003-0853-7526; Griffith, Eric/0000-0003-0428-3215; /0000-0002-7002-1275	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043491, K99NS058391, R01NS048276, R00NS058391] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NINDS NIH HHS [R00 NS058391-04, K99 NS058391-02, R01 NS043491, NS43491, R00 NS058391-03, K99 NS058391, NS048276, R01 NS048276, R00 NS058391-05, K99 NS058391-01, R00 NS058391] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; Asaka Y, 2006, NEUROBIOL DIS, V21, P217, DOI 10.1016/j.nbd.2005.07.005; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878; Chandler SP, 1999, BIOCHEMISTRY-US, V38, P7008, DOI 10.1021/bi990224y; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Dani VS, 2005, P NATL ACAD SCI USA, V102, P12560, DOI 10.1073/pnas.0506071102; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gorski JA, 2003, J NEUROSCI, V23, P6856; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hong EJ, 2005, CURR OPIN NEUROBIOL, V15, P21, DOI 10.1016/j.conb.2005.01.002; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Kornhauser JM, 1996, BEHAV GENET, V26, P221, DOI 10.1007/BF02359382; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kriaucionis S, 2003, HUM MOL GENET, V12, pR221, DOI 10.1093/hmg/ddg286; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lom B, 1999, J NEUROSCI, V19, P9928; Lugtenberg D, 2006, J MED GENET, V43, P362, DOI 10.1136/jmg.2005.036178; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moretti P, 2006, CURR OPIN GENET DEV, V16, P276, DOI 10.1016/j.gde.2006.04.009; Nelson ED, 2006, CURR BIOL, V16, P710, DOI 10.1016/j.cub.2006.02.062; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rett A, 1966, Wien Med Wochenschr, V116, P723; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Wayman GA, 2006, NEURON, V50, P897, DOI 10.1016/j.neuron.2006.05.008; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071	54	634	658	1	58	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					255	269		10.1016/j.neuron.2006.09.037	http://dx.doi.org/10.1016/j.neuron.2006.09.037			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046689	Bronze, Green Accepted			2022-12-28	WOS:000241799900007
J	Mueller-Steiner, S; Zhou, Y; Arai, H; Roberson, ED; Sun, BG; Chen, J; Wang, X; Yu, GQ; Esposito, L; Mucke, L; Gan, L				Mueller-Steiner, Sarah; Zhou, Yungui; Arai, Hideaki; Roberson, Erik D.; Sun, Binggui; Chen, Jennifer; Wang, Xin; Yu, Guiqiu; Esposito, Luke; Mucke, Lennart; Gan, Li			Antiamyloidogenic and neuroprotective functions of cathepsin B: implications for Alzheimer's disease	NEURON			English	Article							AMYLOID-BETA PEPTIDE; REGULATED SECRETORY VESICLES; INSULIN-DEGRADING ENZYME; TRANSGENIC MOUSE MODEL; BRAIN A-BETA; PRECURSOR PROTEIN; EXTRACELLULAR LEVELS; COGNITIVE FUNCTION; CHROMAFFIN CELLS; PLAQUE-FORMATION	Alzheimer's disease (AD) may result from the accumulation of amyloid-beta (A beta) peptides in the brain. The cysteine protease cathepsin B (CatB) is associated with amyloid plaques in AD brains and has been suspected to increase AD production. Here, we demonstrate that CatB actually reduces levels of AD peptides, especially the aggregation-prone species A beta 1-42, through proteolytic cleavage. Genetic inactivation of CatB in mice with neuronal expression of familial AD-mutant human amyloid precursor protein (hAPP) increased the relative abundance of A beta 1-42, worsening plaque deposition and other AD-related pathologies. Lentivirus-mediated expression of CatB in aged hAPP mice reduced preexisting amyloid deposits, even thioflavin S-positive plaques. Under cell-free conditions, CatB effectively cleaved A beta 1-42, generating C-terminally truncated A beta peptides that are less amyloidogenic. Thus, CatB likely fulfills antiamyloidogenic and neuroprotective functions. Insufficient CatB activity might promote AD; increasing CatB activity could counteract the neuropathology of this disease.	Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Tokyo 1538902, Japan	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of Tokyo	Gan, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	Igan@gladstone.ucsf.edu	Sun, Binggui/J-9028-2016; Sun, Binggui/B-2739-2010; Roberson, Erik/A-5718-2009	Sun, Binggui/0000-0002-0386-6569; Roberson, Erik/0000-0002-1810-9763	NIA NIH HHS [R21 AG024447] Funding Source: Medline; NINDS NIH HHS [K08 NS054811-01, K08 NS054811] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS054811] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG024447] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Authier F, 1999, J BIOL CHEM, V274, P33723, DOI 10.1074/jbc.274.47.33723; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BUCK MR, 1992, BIOCHEM J, V282, P273, DOI 10.1042/bj2820273; Cataldo AM, 2004, NEUROBIOL AGING, V25, P1263, DOI 10.1016/j.neurobiolaging.2004.02.027; Cataldo AM, 1997, J NEUROSCI, V17, P6142; CATALDO AM, 1990, P NATL ACAD SCI USA, V87, P3861, DOI 10.1073/pnas.87.10.3861; Chapman HA, 1997, ANNU REV PHYSIOL, V59, P63, DOI 10.1146/annurev.physiol.59.1.63; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Cheng IH, 2004, NAT MED, V10, P1190, DOI 10.1038/nm1123; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Comings DE, 2000, MOL GENET METAB, V71, P19, DOI 10.1006/mgme.2000.3015; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Eckman EA, 2001, J BIOL CHEM, V276, P24540, DOI 10.1074/jbc.M007579200; Esposito L, 2004, J NEUROCHEM, V91, P1260, DOI 10.1111/j.1471-4159.2004.02816.x; Frautschy SA, 1998, J NEUROSCI, V18, P8311; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gouras GK, 1998, J NEUROCHEM, V71, P1920; HAMILTON RL, 1980, J LIPID RES, V21, P981; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hook V, 2005, BIOL CHEM, V386, P931, DOI 10.1515/BC.2005.108; Hook VYH, 2002, J NEUROCHEM, V81, P237; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Iwata N, 2004, J NEUROSCI, V24, P991, DOI 10.1523/JNEUROSCI.4792-03.2004; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; KHOURI HE, 1991, BIOCHEM J, V275, P751, DOI 10.1042/bj2750751; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Mackay EA, 1997, EUR J BIOCHEM, V244, P414, DOI 10.1111/j.1432-1033.1997.00414.x; Marr RA, 2003, J NEUROSCI, V23, P1992; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MUSIL D, 1991, EMBO J, V10, P2321, DOI 10.1002/j.1460-2075.1991.tb07771.x; Nagler DK, 1997, BIOCHEMISTRY-US, V36, P12608, DOI 10.1021/bi971264+; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; TSUJINAKA T, 1995, BIOCHEM BIOPH RES CO, V208, P353, DOI 10.1006/bbrc.1995.1345; Tucker HM, 2000, J NEUROSCI, V20, P3937; Vekrellis K, 2000, J NEUROSCI, V20, P1657; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wyss-Coray T, 2001, NAT MED, V7, P612, DOI 10.1038/87945; Yamin R, 1999, J BIOL CHEM, V274, P18777, DOI 10.1074/jbc.274.26.18777; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhang Y, 2002, J CELL BIOL, V156, P519, DOI 10.1083/jcb.200110119	66	315	328	1	39	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					703	714		10.1016/j.neuron.2006.07.027	http://dx.doi.org/10.1016/j.neuron.2006.07.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982417	Bronze			2022-12-28	WOS:000240997900010
J	Ohshiro, T; Weliky, M				Ohshiro, Tomokazu; Weliky, Michael			Subplate neurons foster inhibition	NEURON			English	Editorial Material							OCULAR DOMINANCE COLUMNS; DEVELOPING VISUAL-CORTEX; LONG-TERM DEPRESSION; STRIATE CORTEX; PLASTICITY; KITTENS; PERIOD; EYE	Previous work demonstrates an essential role of subplate neurons during ocular dominance (OD) column formation in the developing visual cortex. While inhibitory circuitry has also been shown to play an essential role in OD plasticity, the relationship between subplate neurons and the development of inhibitory circuits has been unclear. In this issue of Neuron, Kanold and Shatz provide evidence that maturation of inhibitory circuitry requires subplate neurons in the developing cortex.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Ohshiro, T (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.							Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McAllister AK, 1999, P NATL ACAD SCI USA, V96, P13600, DOI 10.1073/pnas.96.24.13600; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	17	1	1	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					524	526		10.1016/j.neuron.2006.08.022	http://dx.doi.org/10.1016/j.neuron.2006.08.022			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950151	Bronze			2022-12-28	WOS:000240623400002
J	Kirchhoff, BA; Buckner, RL				Kirchhoff, Brenda A.; Buckner, Randy L.			Functional-anatomic correlates of individual differences in memory	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; FREE-RECALL; LEARNING-STRATEGIES; REPORTED MEDIATORS; PREFRONTAL CORTEX; EPISODIC MEMORY; BRAIN ACTIVITY; LONG-TERM; ACTIVATION; RETRIEVAL	Memory abilities differ greatly across individuals. To explore a source of these differences, we characterized the varied strategies people adopt during unconstrained encoding. Participants intentionally encoded object pairs during functional MRI. Principal components analysis applied to a strategy questionnaire revealed that participants variably used four main strategies to aid learning. Individuals' use of verbal elaboration and visual inspection strategies independently correlated with their memory performance. Verbal elaboration correlated with activity in a network of regions that included prefrontal regions associated with controlled verbal processing, while visual inspection correlated with activity in a network of regions that included an extrastriate region associated with object processing. Activity in regions associated with use of these, strategies was also correlated with memory performance. This study reveals functional-anatomic correlates of verbal and perceptual strategies that are variably used by individuals during encoding. These strategies engage distinct brain regions and may separately influence memory performance.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Harvard Univ, Dept Psychol, Ctr Brain Sci, Cambridge, MA 02138 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Martinos Ct, Boston, MA 02129 USA	Washington University (WUSTL); Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Kirchhoff, BA (corresponding author), Washington Univ, Dept Psychol, Campus Box 1125,1 Brookings Dr, St Louis, MO 63130 USA.	bkirchho@artsci.wustl.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057506] Funding Source: NIH RePORTER; NIMH NIH HHS [MH57506] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alkire MT, 1998, P NATL ACAD SCI USA, V95, P14506, DOI 10.1073/pnas.95.24.14506; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; BOLTWOOD CE, 1970, PSYCHON SCI, V20, P339, DOI 10.3758/BF03335678; BORS DA, 1996, MEMORY, P411; Buckner RL, 1999, NAT NEUROSCI, V2, P311, DOI 10.1038/7221; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; CAMP CJ, 1983, AM J PSYCHOL, V96, P503, DOI 10.2307/1422571; Canli T, 1999, PSYCHOBIOLOGY, V27, P441; Casasanto DJ, 2002, BRAIN LANG, V80, P287, DOI 10.1006/brln.2001.2584; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; DEMB JB, 1995, J NEUROSCI, V15, P5870; Denys K, 2004, J NEUROSCI, V24, P2551, DOI 10.1523/JNEUROSCI.3569-03.2004; Dunlosky J, 2001, MEM COGNITION, V29, P247, DOI 10.3758/BF03194918; EAGLE MN, 1967, AM J PSYCHOL, V80, P421, DOI 10.2307/1420376; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; GEISELMAN RE, 1982, J EXP PSYCHOL GEN, V111, P109, DOI 10.1037/0096-3445.111.1.109; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Habib R, 2000, ACTA PSYCHOL, V105, P141, DOI 10.1016/S0001-6918(00)00058-5; HASHER L, 1976, J EXP PSYCHOL-HUM L, V2, P172; Heun R, 2000, EUR PSYCHIAT, V15, P470, DOI 10.1016/S0924-9338(00)00517-4; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; KARIS D, 1984, COGNITIVE PSYCHOL, V16, P177, DOI 10.1016/0010-0285(84)90007-0; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Maccotta L, 2001, NEUROIMAGE, V14, P1105, DOI 10.1006/nimg.2001.0912; Machielsen WCM, 2000, HUM BRAIN MAPP, V9, P156, DOI 10.1002/(SICI)1097-0193(200003)9:3<156::AID-HBM4>3.0.CO;2-Q; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin C. J., 1965, PSYCHONOMIC SCI, V3, P455; MCDANIEL MA, 1984, MEM COGNITION, V12, P361, DOI 10.3758/BF03198296; McDermott KB, 2003, NEUROPSYCHOLOGIA, V41, P293, DOI 10.1016/S0028-3932(02)00162-8; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller MB, 2002, J COGNITIVE NEUROSCI, V14, P1200, DOI 10.1162/089892902760807203; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; PAIVIO A, 1969, J EXP PSYCHOL, V79, P458, DOI 10.1037/h0026929; PALVIO A, 1966, CAN J PSYCHOL, V20, P362; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; PRESSLEY M, 1977, J EXP CHILD PSYCHOL, V24, P431, DOI 10.1016/0022-0965(77)90089-3; Reed HB, 1918, PSYCHOL REV, V25, P128, DOI 10.1037/h0071516; RICHARDSON JTE, 1978, MEM COGNITION, V6, P376, DOI 10.3758/BF03197469; Richardson JTE, 1998, PSYCHON B REV, V5, P597, DOI 10.3758/BF03208837; ROBERTS WA, 1968, AM J PSYCHOL, V81, P433, DOI 10.2307/1420642; Savage CR, 2001, BRAIN, V124, P219, DOI 10.1093/brain/124.1.219; SHAUGHNESSY JJ, 1981, J VERB LEARN VERB BE, V20, P216, DOI 10.1016/S0022-5371(81)90389-3; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; STOFF DM, 1971, J EXP PSYCHOL, V87, P423, DOI 10.1037/h0030541; Talairach J., 1988, COPLANAR STEREOTAXIC; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tulving E, 1999, HIPPOCAMPUS, V9, P71, DOI 10.1002/(SICI)1098-1063(1999)9:1<71::AID-HIPO8>3.0.CO;2-F; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wheeler ME, 2003, J NEUROSCI, V23, P3869; Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001; Wheeler ME, 2000, P NATL ACAD SCI USA, V97, P11125, DOI 10.1073/pnas.97.20.11125; YARMEY AD, 1968, PSYCHOL REC, V18, P191, DOI 10.1007/BF03393760; ZIVIAN MT, 1983, DEV PSYCHOL, V19, P513, DOI 10.1037/0012-1649.19.4.513	56	96	99	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2006	51	2					263	274		10.1016/j.neuron.2006.06.006	http://dx.doi.org/10.1016/j.neuron.2006.06.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	070PK	16846860	Bronze			2022-12-28	WOS:000239535100013
J	Scott, MM; Marcus, JN; Elmquist, JK				Scott, MM; Marcus, JN; Elmquist, JK			Orexin neurons and the TASK of glucosensing	NEURON			English	Editorial Material							GLUCOPRIVATION; NARCOLEPSY; MICE	Relatively little is known about the mechanisms that link changing levels of glucose and neuronal activity. A paper in the current issue of Neuron by Burdakov et al. demonstrates that orexin/hypocretin neurons are inhibited by rising glucose in part due to membrane potential effects mediated by tandem-pore K+ (K-2P) channels. The findings may shed light on the mechanisms that link hypoglycemia and coordinated arousal and autonomic responses.	Univ Texas, SW Med Ctr, Ctr Hypothalam Res, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol,Program Neurosci, Div Endocrinol Diabet & Metab,Beth Israel Deacone, Boston, MA 02215 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Scott, MM (corresponding author), Univ Texas, SW Med Ctr, Ctr Hypothalam Res, Dallas, TX 75390 USA.							Bayliss Douglas A, 2003, Mol Interv, V3, P205, DOI 10.1124/mi.3.4.205; Burdakov D, 2005, J NEUROSCI, V25, P2429, DOI 10.1523/JNEUROSCI.4925-04.2005; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cryer PE, 2005, DIABETES, V54, P3592, DOI 10.2337/diabetes.54.12.3592; DIROCCO RJ, 1979, SCIENCE, V204, P1112, DOI 10.1126/science.451558; Hudson B, 2004, PHYSIOL BEHAV, V82, P241, DOI 10.1016/j.physbeh.2004.03.032; Ibrahim N, 2003, ENDOCRINOLOGY, V144, P1331, DOI 10.1210/en.2002-221033; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Obici S, 2003, NAT MED, V9, P756, DOI 10.1038/nm873; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; SILVER IA, 1994, J NEUROSCI, V14, P5068; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zigman JM, 2003, ENDOCRINOLOGY, V144, P3749, DOI 10.1210/en.2003-0241	14	4	4	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 1	2006	50	5					665	667		10.1016/j.neuron.2006.05.014	http://dx.doi.org/10.1016/j.neuron.2006.05.014			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731504	Bronze			2022-12-28	WOS:000238165000001
J	Kramer, ER; Knott, L; Su, FY; Dessaud, E; Krull, CE; Helmbacher, F; Klein, R				Kramer, ER; Knott, L; Su, FY; Dessaud, E; Krull, CE; Helmbacher, F; Klein, R			Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb	NEURON			English	Article							NEUROTROPHIC FACTOR; TYROSINE KINASE; NERVOUS-SYSTEM; HOMEOBOX GENES; CELL-MIGRATION; RECEPTOR GENE; NEURON POOLS; MICE LACKING; C-RET; EXPRESSION	Establishment of limb innervation by motor neurons involves a series of hierarchical axon guidance decisions by which motor-neuron subtypes evaluate peripheral guidance cues and choose their axonal trajectory. Earlier work indicated that the pathway into the dorsal limb by lateral motor column (LMC[I]) axons requires the EphA4 receptor, which mediates repulsion elicited by ephrinAs expressed in ventral limb mesoderm. Here, we implicate glial-cell-line-derived neurotrophic factor (GDNF) and its receptor, Ret, in the same guidance decision. In Gdnf or Ret mutant mice, LMC(I) axons follow an aberrant ventral trajectory away from dorsal territory enriched in GDNF, showing that the GDNF/Ret system functions as an instructive guidance signal for motor axons. This phenotype is enhanced in mutant mice lacking Ret and EphA4. Thus, Ret and EphA4 signals cooperate to enforce the precision of the same binary choice in motoraxon guidance.	Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Martinsried, Germany; Univ Michigan, Ann Arbor, MI 48109 USA; Inst Biol Dev Marseille Luminy, UMR 623, Inst Natl Sante & Rech Med, F-13288 Marseille 09, France; Inst Biol Dev Marseille, CNRS, UMR 6218, F-13288 Marseille 09, France	Max Planck Society; University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Klein, R (corresponding author), Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Martinsried, Germany.	rklein@neuro.mpg.de	Klein, Ruediger/C-6147-2008; Helmbacher, Francoise/AAM-2318-2021; Kramer, Edgar/A-9288-2012	Klein, Ruediger/0000-0002-3109-0163; Helmbacher, Francoise/0000-0001-6822-1246; Kramer, Edgar/0000-0002-4882-4143; Dessaud, Eric/0000-0001-9723-6658	NIMH NIH HHS [R01 MH59894] Funding Source: Medline; NINDS NIH HHS [R01 NS050142] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059894] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050142] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dottori M, 1998, P NATL ACAD SCI USA, V95, P13248, DOI 10.1073/pnas.95.22.13248; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; Eberhart J, 2000, DEV NEUROSCI-BASEL, V22, P237, DOI 10.1159/000017446; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Golden JP, 1999, EXP NEUROL, V158, P504, DOI 10.1006/exnr.1999.7127; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8; Homma S, 2000, DEV BIOL, V217, P121, DOI 10.1006/dbio.1999.9543; Honma Y, 2002, NEURON, V35, P267, DOI 10.1016/S0896-6273(02)00774-2; Iwamasa H, 1999, DEV GROWTH DIFFER, V41, P685; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Krieglstein K, 2002, J PHYSIOLOGY-PARIS, V96, P25, DOI 10.1016/S0928-4257(01)00077-8; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lallemand Y, 1998, TRANSGENIC RES, V7, P105, DOI 10.1023/A:1008868325009; LANCEJONES C, 1981, PROC R SOC SER B-BIO, V214, P1, DOI 10.1098/rspb.1981.0079; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Ohta K, 1997, MECH DEVELOP, V64, P127, DOI 10.1016/S0925-4773(97)00056-7; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Poliakov A, 2004, DEV CELL, V7, P465, DOI 10.1016/j.devcel.2004.09.006; Pozas E, 2005, NEURON, V45, P701, DOI 10.1016/j.neuron.2005.01.043; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sariola H, 2003, J CELL SCI, V116, P3855, DOI 10.1242/jcs.00786; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soler RM, 1999, J NEUROSCI, V19, P9160; Swartz ME, 2001, DEVELOPMENT, V128, P4669; TANG JC, 1994, NEURON, V13, P405, DOI 10.1016/0896-6273(94)90356-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2	52	156	158	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					35	47		10.1016/j.neuron.2006.02.020	http://dx.doi.org/10.1016/j.neuron.2006.02.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600854	Bronze			2022-12-28	WOS:000236811300009
J	Burgos-Robles, A; Vidal-Gonzalez, I; Santini, E; Quirk, GJ				Burgos-Robles, Anthony; Vidal-Gonzalez, Ivan; Santini, Edwin; Quirk, Gregory J.			Consolidation of fear extinction requires NMDA receptor-dependent bursting in the ventromedial prefrontal cortex	NEURON			English	Article							LONG-TERM POTENTIATION; D-CYCLOSERINE; SYNAPTIC PLASTICITY; CONDITIONED FEAR; HIPPOCAMPAL; MEMORY; AMYGDALA; ANTAGONIST; MECHANISMS; SIGNAL	Extinction of conditioned fear is an active learning process requiring N-methyl-D-aspartate receptors (NMDARs), but the timing, location, and neural mechanisms of NMDAR-mediated processing in extinction are a matter of debate. Here we show that infusion of the NMDAR antagonist CPP into the ventromedial prefrontal cortex (vmPFC) prior to, or immediately after, extinction training impaired 24 hr recall of extinction. These findings indicate that consolidation of extinction requires posttraining activation of NMDARs within the vmPFC. Using multichannel unit recording, we observed that CPP selectively reduced burst firing in vmPFC neurons, suggesting that bursting in vmPFC is necessary for consolidation of extinction. In support of this, we found that the degree of bursting in infralimbic vmPFC neurons shortly after extinction predicted subsequent recall of extinction. We suggest that NMDAR-dependent bursting in the infralimbic vmPFC initiates calcium-dependent molecular cascades that stabilize extinction memory, thereby allowing for successful recall of extinction.	Ponce Sch Med, Dept Physiol, Ponce, PR 00732 USA		Quirk, GJ (corresponding author), Univ Puerto Rico, Sch Med, Dept Psychiat, POB 365067, San Juan, PR 00936 USA.	gjquirk@yahoo.com	anand, amit/A-7222-2009		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058883, R21MH072156, T32MH018882, R37MH058883, R29MH058883] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM008236] Funding Source: Medline; NIMH NIH HHS [MH058883, T32 MH018882, R29 MH058883, MH072156, T32MH018882] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Barrett D, 2003, J NEUROSCI, V23, P5740; Berlau DJ, 2006, NEUROBIOL LEARN MEM, V86, P123, DOI 10.1016/j.nlm.2005.12.008; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; BLANCHARD DC, 1972, J COMP PHYSIOL PSYCH, V81, P281, DOI 10.1037/h0033521; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Buzsaki G, 2002, CEREB CORTEX, V12, P893, DOI 10.1093/cercor/12.9.893; Corcoran KA, 2005, J NEUROSCI, V25, P8978, DOI 10.1523/JNEUROSCI.2246-05.2005; Corcoran KA, 2007, J NEUROSCI, V27, P840, DOI 10.1523/JNEUROSCI.5327-06.2007; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Davis M, 2002, EUR J NEUROSCI, V16, P395, DOI 10.1046/j.1460-9568.2002.02138.x; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; FALLS WA, 1992, J NEUROSCI, V12, P854; Foa EB, 2000, J CLIN PSYCHIAT, V61, P43; GOLD JI, 1994, P NATL ACAD SCI USA, V91, P3941, DOI 10.1073/pnas.91.9.3941; Gureviciene I, 2003, NEUROBIOL LEARN MEM, V79, P72, DOI 10.1016/S1074-7427(02)00012-6; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Herry C, 2006, EUR J NEUROSCI, V24, P261, DOI 10.1111/j.1460-9568.2006.04893.x; Hofmann SG, 2006, ARCH GEN PSYCHIAT, V63, P298, DOI 10.1001/archpsyc.63.3.298; Hughes S, 2006, SYNAPSE, V60, P280, DOI 10.1002/syn.20291; Hugues S, 2004, LEARN MEMORY, V11, P540, DOI 10.1101/lm.77704; Ishikawa A, 2003, J NEUROSCI, V23, P9987; Jackson ME, 2004, P NATL ACAD SCI USA, V101, P8467, DOI 10.1073/pnas.0308455101; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lin CH, 2003, J NEUROSCI, V23, P8310; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MILAD MR, 2006, IN PRESS BIOL PSYCHI; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; ONEILL KA, 1987, BRAIN RES, V435, P371, DOI 10.1016/0006-8993(87)91628-3; Pare D, 2004, J NEUROPHYSIOL, V92, P1, DOI 10.1152/jn.00153.2004; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Quirk GJ, 2002, LEARN MEMORY, V9, P402, DOI 10.1101/lm.49602; Quirk GJ, 2000, J NEUROSCI, V20, P6225, DOI 10.1523/JNEUROSCI.20-16-06225.2000; Ressler KJ, 2004, ARCH GEN PSYCHIAT, V61, P1136, DOI 10.1001/archpsyc.61.11.1136; Richardson R, 2004, LEARN MEMORY, V11, P510, DOI 10.1101/lm.78204; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Shi WX, 2003, J PHARMACOL EXP THER, V305, P680, DOI 10.1124/jpet.102.046359; Sierra-Mercado D, 2006, EUR J NEUROSCI, V24, P1751, DOI 10.1111/j.1460-9568.2006.05014.x; Sotres-Bayon F, 2007, NEUROPSYCHOPHARMACOL, V32, P1929, DOI 10.1038/sj.npp.1301316; Sotres-Bayon F, 2006, BIOL PSYCHIAT, V60, P329, DOI 10.1016/j.biopsych.2005.10.012; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tierney PL, 2004, EUR J NEUROSCI, V20, P514, DOI 10.1111/j.1460-9568.2004.03501.x; Walker DL, 2002, PHARMACOL BIOCHEM BE, V71, P379, DOI 10.1016/S0091-3057(01)00698-0; Wayner MJ, 2000, PHYSIOL BEHAV, V69, P505, DOI 10.1016/S0031-9384(00)00208-0; Zhang XX, 1999, ACTA PHARMACOL SIN, V20, P1125	61	384	393	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					871	880		10.1016/j.neuron.2007.02.021	http://dx.doi.org/10.1016/j.neuron.2007.02.021			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359921	Bronze			2022-12-28	WOS:000245292800011
J	Nagayama, S; Zeng, SQ; Xiong, WH; Fletcher, ML; Masurkar, AV; Davis, DJ; Pieribone, VA; Chen, WR				Nagayama, Shin; Zeng, Shaoqun; Xiong, Wenhui; Fletcher, Max L.; Masurkar, Arjun V.; Davis, Douglas J.; Pieribone, Vincent A.; Chen, Wei R.			In vivo simultaneous tracing and Ca2+ imaging of local neuronal circuits	NEURON			English	Article							DENDRITIC CALCIUM DYNAMICS; OLFACTORY-BULB; ODOR MAPS; CELLS; ELECTROPORATION; LAYER; TRANSMISSION; PROPAGATION; NEOCORTEX; SYSTEM	A central question about the brain is how information is processed by large populations of neurons embedded in intricate local networks. Answering this question requires not only monitoring functional dynamics of many neurons simultaneously, but also interpreting such activity patterns in the context of neuronal circuitry. Here, we introduce a versatile approach for loading Ca2+, indicators in vivo by local electroporation. With this method, Ca2+, imaging can be performed both at neuron population level and with exquisite subcellular resolution down to dendritic spines and axon boutons. This enabled mitral cell odor-evoked ensemble activity to be analyzed simultaneously with revealing their specific connectivity to different glomeruli. Colabeling of Purkinje cell dendrites and intersecting parallel fibers allowed Ca2+, imaging of both presynaptic boutons and postsynaptic dendrites. This approach thus provides an unprecedented capability for in vivo visualizing active cell ensembles and tracing their underlying local neuronal circuits.	Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA; Huazhong Univ Sci & Technol, Minist Educ, Wuhan Natl Lab Optoelect, Key Lab Biomed Photon, Wuhan 430074, Peoples R China; John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Dept Mol & Cellular Physiol, New Haven, CT 06510 USA	Yale University; Huazhong University of Science & Technology; Yale University; The John B Pierce Laboratory, Inc; Yale University	Chen, WR (corresponding author), Yale Univ, Dept Neurobiol, New Haven, CT 06520 USA.	wei.chen@yale.edu		Pieribone, Vincent/0000-0002-5836-5454; Masurkar, Arjun/0000-0002-2498-2059	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH064214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003918] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC003918, DC003918] Funding Source: Medline; NIMH NIH HHS [MH064214, R21 MH064214] Funding Source: Medline; NINDS NIH HHS [T32 NS007224, NS007224] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beierlein M, 2004, J NEUROPHYSIOL, V92, P591, DOI 10.1152/jn.00057.2004; Bonnot AS, 2005, J NEUROPHYSIOL, V93, P1793, DOI 10.1152/jn.00923.2004; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Charpak S, 2001, P NATL ACAD SCI USA, V98, P1230, DOI 10.1073/pnas.021422798; Debarbieux F, 2003, J NEUROSCI, V23, P5553; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Garaschuk O, 2006, PFLUG ARCH EUR J PHY, V453, P385, DOI 10.1007/s00424-006-0150-x; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haugland R.P., 2002, HDB FLUORESCENT PROB; Heim N, 2007, NAT METHODS, V4, P127, DOI 10.1038/nmeth1009; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hirase H, 2004, GLIA, V46, P95, DOI 10.1002/glia.10295; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Lodovichi C, 2003, NEURON, V38, P265, DOI 10.1016/S0896-6273(03)00194-6; MORI K, 1983, J COMP NEUROL, V219, P339, DOI 10.1002/cne.902190308; Mulligan SJ, 2001, NEUROSCIENCE, V104, P137, DOI 10.1016/S0306-4522(01)00057-4; Nagayama S, 2004, J NEUROPHYSIOL, V91, P2532, DOI 10.1152/jn.01266.2003; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tabata H, 2001, NEUROSCIENCE, V103, P865, DOI 10.1016/S0306-4522(01)00016-1; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wilent WB, 2004, J NEUROSCI, V24, P3985, DOI 10.1523/JNEUROSCI.5782-03.2004; Xiong WH, 2002, NEURON, V34, P115, DOI 10.1016/S0896-6273(02)00628-1; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Zeng SQ, 2006, OPT LETT, V31, P1091, DOI 10.1364/OL.31.001091	41	87	94	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					789	803		10.1016/j.neuron.2007.02.018	http://dx.doi.org/10.1016/j.neuron.2007.02.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359915	Green Accepted, Bronze			2022-12-28	WOS:000245292800005
J	Murphy, GJ; Rieke, F				Murphy, Gabe J.; Rieke, Fred			Network variability limits stimulus-evoked spike timing precision in retinal ganglion cells	NEURON			English	Article							TIGER SALAMANDER RETINA; INNER PLEXIFORM LAYER; MAMMALIAN RETINA; FEEDFORWARD INHIBITION; BIPOLAR CELLS; SYNAPTIC CONDUCTANCE; CORTICAL-NEURONS; PYRAMIDAL CELLS; AUDITORY-CORTEX; VISUAL-CORTEX	Visual, auditory, somatosensory, and olfactory stimuli generate temporally precise patterns of action potentials (spikes). It is unclear, however, how the precision of spike generation relates to the pattern and variability of synaptic input elicited by physiological stimuli. We determined how synaptic conductances evoked by light stimuli that activate the rod bipolar pathway control spike generation in three identified types of mouse retinal ganglion cells (RGCs). The relative amplitude, timing, and impact of excitatory and inhibitory input differed dramatically between On and Off RGCs. Spikes evoked by repeated somatic injection of identical light-evoked synaptic conductances were more temporally precise than those evoked by light. However, the precision of spikes evoked by conductances that varied from trial to trial was similar to that of light-evoked spikes. Thus, the rod bipolar pathway modulates different RGCs via unique combinations of synaptic input, and RGC temporal variability reflects variability in the input this circuit provides.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Murphy, GJ (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	gjmurphy@u.washington.edu		Murphy, Gabe/0000-0002-9321-8556	NATIONAL EYE INSTITUTE [R01EY011850] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11850, R01 EY011850] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bacci A, 2006, NEURON, V49, P119, DOI 10.1016/j.neuron.2005.12.014; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Buracas GT, 1999, TRENDS NEUROSCI, V22, P303, DOI 10.1016/S0166-2236(98)01376-9; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; DeWeese MR, 2003, J NEUROSCI, V23, P7940; Dhingra NK, 2004, J NEUROSCI, V24, P2914, DOI 10.1523/JNEUROSCI.5346-03.2004; DIAMOND JS, 1993, NEURON, V11, P725, DOI 10.1016/0896-6273(93)90082-3; DIAMOND JS, 1995, J PHYSIOL-LONDON, V487, P711, DOI 10.1113/jphysiol.1995.sp020912; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Grunert U, 2000, MICROSC RES TECHNIQ, V50, P130; HENSLEY SH, 1993, J NEUROPHYSIOL, V69, P2099, DOI 10.1152/jn.1993.69.6.2099; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Matsui K, 1998, J NEUROSCI, V18, P4500; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Olveczky BP, 2003, NATURE, V423, P401, DOI 10.1038/nature01652; Owczarzak MT, 1999, ANAT RECORD, V255, P363; Pang JJ, 2003, J NEUROSCI, V23, P6063, DOI 10.1523/JNEUROSCI.23-14-06063.2003; Petersen RS, 2002, CURR OPIN NEUROBIOL, V12, P441, DOI 10.1016/S0959-4388(02)00338-0; Pillow JW, 2005, J NEUROSCI, V25, P11003, DOI 10.1523/JNEUROSCI.3305-05.2005; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Protti DA, 1997, J NEUROSCI, V17, P6075; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; RHEE JS, 1994, J NEUROPHYSIOL, V72, P1103, DOI 10.1152/jn.1994.72.3.1103; ROBINSON HPC, 1993, J NEUROSCI METH, V49, P157, DOI 10.1016/0165-0270(93)90119-C; Roska B, 1998, J NEUROSCI, V18, P3451; Roska B, 2006, J NEUROPHYSIOL, V95, P3810, DOI 10.1152/jn.00113.2006; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SHARP AA, 1993, J NEUROPHYSIOL, V69, P992, DOI 10.1152/jn.1993.69.3.992; Shu YS, 2003, J NEUROSCI, V23, P10388; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; Stuart G., 2000, DENDRITES; Trussell LO, 1997, CURR OPIN NEUROBIOL, V7, P487, DOI 10.1016/S0959-4388(97)80027-X; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Volgyi B, 2004, J NEUROSCI, V24, P11182, DOI 10.1523/JNEUROSCI.3096-04.2004; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; White JA, 2000, TRENDS NEUROSCI, V23, P131, DOI 10.1016/S0166-2236(99)01521-0; Zaghloul KA, 2003, J NEUROSCI, V23, P2645; Zsiros V, 2005, J NEUROPHYSIOL, V93, P3248, DOI 10.1152/jn.01027.2004	67	142	142	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					511	524		10.1016/j.neuron.2006.09.014	http://dx.doi.org/10.1016/j.neuron.2006.09.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088216	Green Accepted, Bronze			2022-12-28	WOS:000242269700013
J	Varshney, LR; Sjostrom, PJ; Chklovskii, DB				Varshney, Lav R.; Sjostrom, Per Jesper; Chklovskii, Dmitri B.			Optimal information storage in noisy synapses under resource constraints	NEURON			English	Editorial Material							LONG-TERM POTENTIATION; SYNAPTIC CONNECTIONS; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; CHANNEL CAPACITY; QUANTAL ANALYSIS; ADULT-RAT; PART I; COMMUNICATION; AMPLITUDE	Experimental investigations have revealed that synapses possess interesting and, in some cases, unexpected properties. We propose a theoretical framework that accounts for three of these properties: typical central synapses are noisy, the distribution of synaptic weights among central synapses is wide, and synaptic connectivity between neurons is sparse. We also comment on the possibility that synaptic weights may vary in discrete steps. Our approach is based on maximizing information storage capacity of neural tissue under resource constraints. Based on previous experimental and theoretical work, we use volume as a limited resource and utilize the empirical relationship between volume and synaptic weight. Solutions of our constrained optimization problems are not only consistent with existing experimental measurements but also make nontrivial predictions.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	Cold Spring Harbor Laboratory; Massachusetts Institute of Technology (MIT); University of London; University College London; University of London; University College London	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	mitya@cshl.org	Sjöström, Per Jesper/B-9696-2019	Sjöström, Per Jesper/0000-0001-7085-2223	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069838] Funding Source: NIH RePORTER; NIMH NIH HHS [MH69838] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 2002, J NEUROSCI, V22, P9626; ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; AMIT DJ, 1994, NEURAL COMPUT, V6, P957, DOI 10.1162/neco.1994.6.5.957; ARIMOTO S, 1972, IEEE T INFORM THEORY, V18, P14, DOI 10.1109/TIT.1972.1054753; Balasubramanian V, 2001, NEURAL COMPUT, V13, P799, DOI 10.1162/089976601300014358; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; BLAHUT RE, 1972, IEEE T INFORM THEORY, V18, P460, DOI 10.1109/TIT.1972.1054855; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; Chklovskii DB, 2002, NEURON, V34, P341, DOI 10.1016/S0896-6273(02)00679-7; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Csiszar I., 1997, INFORM THEORY CODING; de Polavieja GG, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.061910; De Polavieja GG, 2002, J THEOR BIOL, V214, P657, DOI 10.1006/jtbi.2001.2498; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; ELDRIDGE DF, 1963, IEEE T ACOUST SPEECH, VAU11, P3, DOI 10.1109/TAU.1963.1161677; Faisal AA, 2005, CURR BIOL, V15, P1143, DOI 10.1016/j.cub.2005.05.056; Fusi S, 2005, NEURON, V45, P599, DOI 10.1016/j.neuron.2005.02.001; GARDNER E, 1987, EUROPHYS LETT, V4, P481, DOI 10.1209/0295-5075/4/4/016; Gastpar M, 2003, IEEE T INFORM THEORY, V49, P1147, DOI 10.1109/TIT.2003.810631; GASTPAR M, 2003, THESIS ECOLE POLYTEC; Goldman MS, 2004, NEURAL COMPUT, V16, P1137, DOI 10.1162/089976604773717568; Gursoy MC, 2005, IEEE T WIREL COMMUN, V4, P2193, DOI 10.1109/TWC.2005.853970; HARRINGTON JV, 1955, IRE T INFORM THEOR, V1, P1, DOI 10.1109/TIT.1955.1055127; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Hsu A, 1998, VISION RES, V38, P2539, DOI 10.1016/S0042-6989(97)00370-2; Huang JY, 2005, IEEE T INFORM THEORY, V51, P2336, DOI 10.1109/TIT.2005.850108; Immink KAS, 1998, IEEE T INFORM THEORY, V44, P2260, DOI 10.1109/18.720539; Isope P, 2002, J NEUROSCI, V22, P9668; JIMBO M, 1979, INFORM CONTROL, V43, P216, DOI 10.1016/S0019-9958(79)90719-8; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; KOCH C, 1999, BIOPHYS COMPUTATION; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Kolmogorov A. N., 1959, USPEKHI MAT NAUK, V14, P3; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Le Be JV, 2006, P NATL ACAD SCI USA, V103, P13214, DOI 10.1073/pnas.0604691103; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Levy WB, 2002, J NEUROSCI, V22, P4746, DOI 10.1523/JNEUROSCI.22-11-04746.2002; Lisman J, 2003, PHILOS T ROY SOC B, V358, P829, DOI 10.1098/rstb.2002.1242; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Manwani A, 2001, NEURAL COMPUT, V13, P1, DOI 10.1162/089976601300014619; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1991, J NEUROSCI, V11, P72; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McEliece R.J., 1977, THEORY INFORM CODING; MCELIECE RJ, 1987, IEEE T INFORM THEORY, V33, P461, DOI 10.1109/TIT.1987.1057328; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; Morris RGM, 2003, PHILOS T ROY SOC B, V358, P643, DOI 10.1098/rstb.2002.1230; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; NEWMAN CM, 1988, NEURAL NETWORKS, V1, P223, DOI 10.1016/0893-6080(88)90028-7; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; PIERCE JP, 1993, J NEUROSCI, V13, P4748; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; RAASTAD M, 1992, EUR J NEUROSCI, V4, P113, DOI 10.1111/j.1460-9568.1992.tb00114.x; Ramon y Cajal S., 1899, TEXTURA SISTEMA NERV; Rieke F., 1997, SPIKES EXPLORING NEU; ROLLS ET, 1998, NEURAL NETOWRKS BRAI; ROOT WL, 1968, IEEE T INFORM THEORY, V14, P361, DOI 10.1109/TIT.1968.1054156; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Sahai A, 2006, IEEE T INFORM THEORY, V52, P3369, DOI 10.1109/TIT.2006.878169; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; SAYER RJ, 1990, J NEUROSCI, V10, P826; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schreiber S, 2002, NEURAL COMPUT, V14, P1323, DOI 10.1162/089976602753712963; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHANNON CE, 1959, IRE NAT CONV REC, V4, P142; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SMITH JG, 1971, INFORM CONTROL, V18, P203, DOI 10.1016/S0019-9958(71)90346-9; SONG S, 2005, PLOS BIOL, V3, DOI DOI 10.1371/JOURNAL.PBIO.0030068; Stepanyants A, 2005, TRENDS NEUROSCI, V28, P387, DOI 10.1016/j.tins.2005.05.006; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; STREICHERT LC, 1989, J COMP NEUROL, V281, P159, DOI 10.1002/cne.902810113; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Tchamkerten A, 2004, IEEE T INFORM THEORY, V50, P2773, DOI 10.1109/TIT.2004.836662; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Verdu S, 2002, IEEE T INFORM THEORY, V48, P1319, DOI 10.1109/TIT.2002.1003824; VERDU S, 1990, IEEE T INFORM THEORY, V36, P1019, DOI 10.1109/18.57201; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wen Q, 2005, PLOS COMPUT BIOL, V1, P617, DOI 10.1371/journal.pcbi.0010078; YEOW MBL, 1991, J COMP NEUROL, V307, P475, DOI 10.1002/cne.903070310; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	103	52	53	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					409	423		10.1016/j.neuron.2006.10.017	http://dx.doi.org/10.1016/j.neuron.2006.10.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088208	Bronze			2022-12-28	WOS:000242269700005
J	Boyden, ES; Katoh, A; Pyle, JL; Chatila, TA; Tsien, RW; Raymond, JL				Boyden, Edward S.; Katoh, Akira; Pyle, Jason L.; Chatila, Tallal A.; Tsien, Richard W.; Raymond, Jennifer L.			Selective engagement of plasticity mechanisms for motor memory storage	NEURON			English	Article							LONG-TERM DEPRESSION; CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; VESTIBULO-OCULAR REFLEX; CEREBELLAR PURKINJE-CELLS; PURSUIT EYE-MOVEMENTS; RAT CEREBELLUM; NITRIC-OXIDE; MUTANT MICE; LATE-PHASE; DYNAMIC CHARACTERISTICS	The number and diversity of plasticity mechanisms in the brain raises a central question: does a neural circuit store all memories by stereotyped application of the available plasticity mechanisms, or can subsets of these mechanisms be selectively engaged for specific memories? The uniform architecture of the cerebellum has inspired the idea that plasticity mechanisms like cerebellar long-term depression (LTD) contribute universally to memory storage. To test this idea, we investigated a set of closely related, cerebellum-dependent motor memories. In mutant mice lacking Ca2+/calmodulin-dependent protein kinase IV (CaMKIV), the maintenance of cerebellar LTD is abolished. Although memory for an increase in the gain of the vestibulo-ocular reflex (VOR) induced with high-frequency stimuli was impaired in these mice, memories for decreases in VOR gain and increases in gain induced with low-frequency stimuli were intact. Thus, a particular plasticity mechanism need not support all cerebellum-dependent memories, but can be engaged selectively according to the parameters of training.	Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; Stanford Univ, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Univ Calif Los Angeles, Dept Pediat, David Geffen Sch Med, Los Angeles, CA USA	Stanford University; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Raymond, JL (corresponding author), Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA.	jenr@stanford.edu	Katoh, Akira/B-2683-2010	Katoh, Akira/0000-0001-7867-2964; Raymond, Jennifer/0000-0002-8145-747X; Chatila, Talal/0000-0001-7439-2762	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS053862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004154, F31DC007006] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004154, R01 DC04154, F31 DC07006] Funding Source: Medline; NINDS NIH HHS [P01 NS053862] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Anderson KA, 2004, J BIOL CHEM, V279, P31708, DOI 10.1074/jbc.M404523200; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Balaban CD, 2000, NEUROSCIENCE, V99, P669, DOI 10.1016/S0306-4522(00)00232-3; BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1; Bernstein HG, 1999, J NEUROCYTOL, V28, P655, DOI 10.1023/A:1007056731551; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; BROCHU G, 1990, J COMP NEUROL, V291, P538, DOI 10.1002/cne.902910405; Caria MA, 2001, NEUROREPORT, V12, P2353, DOI 10.1097/00001756-200108080-00014; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Coesmans M, 2003, ANN NEUROL, V53, P325, DOI 10.1002/ana.10451; Cohen MR, 2004, LEARN MEMORY, V11, P559, DOI 10.1101/lm.82304; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dow ER, 1996, NEUROREPORT, V7, P1305, DOI 10.1097/00001756-199605170-00018; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; ITO M, 1974, P JPN ACAD, V50, P85, DOI 10.2183/pjab1945.50.85; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1972, BRAIN RES, V40, P81, DOI 10.1016/0006-8993(72)90110-2; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; JAGER J, 1981, EXP BRAIN RES, V41, P108; JANDE SS, 1981, NATURE, V294, P765, DOI 10.1038/294765a0; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P4050, DOI 10.1073/pnas.88.9.4050; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; KANO M, 1992, NATURE, V356, P601, DOI 10.1038/356601a0; Kimpo RR, 2005, J NEUROPHYSIOL, V94, P3092, DOI 10.1152/jn.00048.2005; Kimura Y, 2002, EMBO REP, V3, P962, DOI 10.1093/embo-reports/kvf191; Kistler WM, 2002, ANN NY ACAD SCI, V978, P391, DOI 10.1111/j.1749-6632.2002.tb07582.x; Koekkoek Sebastiaan K. E., 1997, Genes and Function, V1, P175; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; Kuki Y, 2004, NEUROREPORT, V15, P1007, DOI 10.1097/00001756-200404290-00015; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LI J, 1995, J NEUROPHYSIOL, V74, P489, DOI 10.1152/jn.1995.74.1.489; LISBERGER SG, 1994, J NEUROPHYSIOL, V72, P954, DOI 10.1152/jn.1994.72.2.954; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P733, DOI 10.1152/jn.1978.41.3.733; LUDDENS H, 1990, NATURE, V346, P648, DOI 10.1038/346648a0; Maffei A, 2003, J NEUROPHYSIOL, V90, P2478, DOI 10.1152/jn.00399.2003; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Means AR, 1997, RECENT PROG HORM RES, V52, P389; MILES FA, 1980, J NEUROPHYSIOL, V43, P1406, DOI 10.1152/jn.1980.43.5.1406; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; MORII E, 1992, DEV BRAIN RES, V65, P123, DOI 10.1016/0165-3806(92)90016-P; MUGNAINI E, 1987, ARCH ITAL BIOL, V126, P41; NAGAO S, 1991, NEUROREPORT, V2, P193, DOI 10.1097/00001756-199104000-00008; NAGAO S, 1983, EXP BRAIN RES, V53, P36; NAKANISHI S, 1991, J NEUROSCI, V11, P2075; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; OBERDICK J, 1988, NEURON, V1, P367, DOI 10.1016/0896-6273(88)90186-9; Pastor AM, 1997, PROG BRAIN RES, V114, P359; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Peters M, 2003, J NEUROSCI, V23, P9752; Piedras-Renteria ES, 2004, P NATL ACAD SCI USA, V101, P3609, DOI 10.1073/pnas.0308188100; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Raymond JL, 1998, J NEUROSCI, V18, P9112; Raymond JL, 1996, J NEUROSCI, V16, P7791; Raymond JL, 1997, LEARN MEMORY, V3, P503, DOI 10.1101/lm.3.6.503; ROBINSON DA, 1976, J NEUROPHYSIOL, V39, P954, DOI 10.1152/jn.1976.39.5.954; Ruigrok TJH, 2000, J COMP NEUROL, V426, P209, DOI 10.1002/1096-9861(20001016)426:2<209::AID-CNE4>3.0.CO;2-0; SAKAGAMI H, 1992, MOL BRAIN RES, V16, P20, DOI 10.1016/0169-328X(92)90189-I; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Smith SL, 2003, J NEUROSCI, V23, P367, DOI 10.1523/JNEUROSCI.23-02-00367.2003; Stahl JS, 2004, J NEUROPHYSIOL, V91, P2066, DOI 10.1152/jn.01068.2003; STONE LS, 1990, J NEUROPHYSIOL, V63, P1241, DOI 10.1152/jn.1990.63.5.1241; TORTE MP, 1994, EXP BRAIN RES, V99, P441; van Alphen AM, 2002, EUR J NEUROSCI, V16, P486, DOI 10.1046/j.1460-9568.2002.02094.x; van Alphen AM, 2001, BRAIN RES, V890, P296, DOI 10.1016/S0006-8993(00)03180-2; Wall MJ, 2003, EUR J NEUROSCI, V18, P869, DOI 10.1046/j.1460-9568.2003.02822.x; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2	82	105	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					823	834		10.1016/j.neuron.2006.08.026	http://dx.doi.org/10.1016/j.neuron.2006.08.026			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982426	Bronze			2022-12-28	WOS:000240997900019
J	Lee, KH; Thompson, RF				Lee, Ka Hung; Thompson, Richard F.			Multiple memory mechanisms in the cerebellum?	NEURON			English	Editorial Material							II MUTANT MICE; MOTOR COORDINATION; PLASTICITY; DEPRESSION; REFLEX		Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA	University of Southern California	Lee, KH (corresponding author), Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA.							Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Chen C, 1995, CELL, V83, P1233, DOI 10.1016/0092-8674(95)90148-5; Christian KM, 2003, LEARN MEMORY, V10, P427, DOI 10.1101/lm.59603; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Smith SL, 2003, J NEUROSCI, V23, P367, DOI 10.1523/JNEUROSCI.23-02-00367.2003; Wei F, 2002, NAT NEUROSCI, V5, P573, DOI 10.1038/nn0602-855	17	4	4	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					680	682		10.1016/j.neuron.2006.09.010	http://dx.doi.org/10.1016/j.neuron.2006.09.010			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982413	Bronze			2022-12-28	WOS:000240997900006
J	LoGiudice, L; Matthews, G				LoGiudice, Lisamarie; Matthews, Gary			The synaptic vesicle cycle: Is kissing overrated?	NEURON			English	Editorial Material							SYNAPSES; KINETICS		SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	LoGiudice, L (corresponding author), SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA.							Atluri PP, 2006, J NEUROSCI, V26, P2313, DOI 10.1523/JNEUROSCI.4425-05.2006; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Matthews G, 2004, NEURON, V44, P223, DOI 10.1016/j.neuron.2004.09.025; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	8	11	11	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					676	677		10.1016/j.neuron.2006.09.004	http://dx.doi.org/10.1016/j.neuron.2006.09.004			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982411	Bronze			2022-12-28	WOS:000240997900004
J	Chechik, G; Anderson, MJ; Bar-Yosef, O; Young, ED; Tishby, N; Nelken, I				Chechik, Gal; Anderson, Michael J.; Bar-Yosef, Omer; Young, Eric D.; Tishby, Naftali; Nelken, Israel			Reduction of information redundancy in the ascending auditory pathway	NEURON			English	Article							SPECTROTEMPORAL RECEPTIVE-FIELDS; POPULATION; SYNERGY; TRANSMISSION; COMPUTATION; EFFICIENCY; LOCATION; CORTEX; CODE	Information processing by a sensory system is reflected in the changes in stimulus representation along its successive processing stages. We measured information content and stimulus-induced redundancy in the neural responses to a set of natural sounds in three successive stations of the auditory path way-inferior colliculus (IC), auditory thalamus (MGB), and primary auditory cortex (A1). Information about stimulus identity was somewhat reduced in single A1 and MGB neurons relative to single IC neurons, when information is measured using spike counts, latency, or temporal spiking patterns. However, most of this difference was due to differences in firing rates. On the other hand, IC neurons were substantially more redundant than A1 and MGB neurons. IC redundancy was largely related to frequency selectivity. Redundancy reduction may be a generic organization principle of neural systems, allowing for easier readout of the identity of complex stimuli in A1 relative to IC.	Hebrew Univ Jerusalem, Interdisciplinary Ctr Neural Computat, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Dept Neurobiol, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Sch Engn & Comp Sci, IL-91904 Jerusalem, Israel; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Johns Hopkins University	Chechik, G (corresponding author), Stanford Univ, Dept Comp Sci, 353 Serra Mall, Stanford, CA 94305 USA.	gal@stanford.edu	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Young, Eric/0000-0003-0334-408X				[Anonymous], 1998, NEURAL NETWORKS BRAI; APNIK VN, 1995, NATURE STAT LEARNING; ASSEDAY JH, 2002, INTEGRATIVE FUNCTION, P238; AT I, 1999, ADV NEURAL INFORMATI; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; BECKER S, 1992, NATURE, V355, P161, DOI 10.1038/355161a0; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Cover TM, 1991, ELEMENTS INFORM THEO; DECHEVEIGNE A, 2001, PHYSL PSYCHOPHYSICAL, P453; Ehret G, 2003, NEUROREPORT, V14, P1365, DOI 10.1097/01.wnr.0000078545.07662.85; Escabi MA, 2003, J NEUROSCI, V23, P11489; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Levy WB, 2002, J NEUROSCI, V22, P4746, DOI 10.1523/JNEUROSCI.22-11-04746.2002; MEDDIS R, 1986, J ACOUST SOC AM, V79, P702, DOI 10.1121/1.393460; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Rieke F, 1997, SPIKES; Schneidman E, 2003, J NEUROSCI, V23, P11539; Schnupp JWH, 2001, NATURE, V414, P200, DOI 10.1038/35102568; Schreiner CE, 1997, NATURE, V388, P383, DOI 10.1038/41106; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197; Studeny M, 1998, NATO ADV SCI I D-BEH, V89, P261; TREVES A, 1995, NEURAL COMPUT, V7, P399, DOI 10.1162/neco.1995.7.2.399; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Victor JD, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051903; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336	45	181	181	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					359	368		10.1016/j.neuron.2006.06.030	http://dx.doi.org/10.1016/j.neuron.2006.06.030			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880130	Bronze			2022-12-28	WOS:000239908800011
J	Curtis, JC; Kleinfeld, D				Curtis, John C.; Kleinfeld, David			Seeing what the mouse sees with its vibrissae: A matter of behavioral state	NEURON			English	Editorial Material							ELECTRICAL-ACTIVITY; CORTEX; INFORMATION; MOVEMENT	The behavioral state of an animal is accompanied by ongoing brain activity that primes neuronal circuitry to sensory inputs. While it should come as no surprise that the pattern of cortical activation is tied to behavioral states, only now has this dependence been imaged. In this issue of Neuron, Ferezou, Bolea, and Petersen show that the level and spatial extent of activation of vibrissa sensory cortex critically depend on behavioral context and mode of stimulation, i.e., passive versus active contact.	Univ Calif San Diego, Grad Program Computat Neurosci, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Phys, La Jolla, CA 92037 USA; Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Curtis, JC (corresponding author), Univ Calif San Diego, Grad Program Computat Neurosci, La Jolla, CA 92037 USA.				NINDS NIH HHS [R01 NS058668-01, R01 NS058668] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058668] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andermann ML, 2006, NAT NEUROSCI, V9, P543, DOI 10.1038/nn1671; Berg RW, 2005, J NEUROPHYSIOL, V94, P699, DOI 10.1152/jn.01125.2004; Castro-Alamancos MA, 2004, NEURON, V41, P455, DOI 10.1016/S0896-6273(03)00853-5; CHAPIN JK, 1982, EXP NEUROL, V78, P654, DOI 10.1016/0014-4886(82)90082-6; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Fee MS, 1997, J NEUROPHYSIOL, V78, P1144, DOI 10.1152/jn.1997.78.2.1144; Ganguly K, 2004, P NATL ACAD SCI USA, V101, P12348, DOI 10.1073/pnas.0308470101; GRINVALD A, 1982, J PHYSIOL-LONDON, V333, P269, DOI 10.1113/jphysiol.1982.sp014453; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Helmchen F, 2002, CURR OPIN NEUROBIOL, V12, P593, DOI 10.1016/S0959-4388(02)00362-8; Lavallee P, 2005, J NEUROSCI, V25, P7489, DOI 10.1523/JNEUROSCI.2301-05.2005; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Neimark MA, 2003, J NEUROSCI, V23, P6499; Nguyen QT, 2005, NEURON, V45, P447, DOI 10.1016/j.neuron.2004.12.042; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Trageser JC, 2004, J NEUROSCI, V24, P8911, DOI 10.1523/JNEUROSCI.3218-04.2004	17	10	11	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					524	526		10.1016/j.neuron.2006.05.004	http://dx.doi.org/10.1016/j.neuron.2006.05.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701202	Green Accepted, Bronze			2022-12-28	WOS:000237875200003
J	Kwon, CH; Luikart, BW; Powell, CM; Zhou, J; Matheny, SA; Zhang, W; Li, YJ; Baker, SJ; Parada, LF				Kwon, Chang-Hyuk; Luikart, Bryan W.; Powell, Craig M.; Zhou, Jing; Matheny, Sharon A.; Zhang, Wei; Li, Yanjiao; Baker, Suzanne J.; Parada, Luis F.			Pten regulates neuronal arborization and social interaction in mice	NEURON			English	Article							TUBEROUS SCLEROSIS COMPLEX; TUMOR-SUPPRESSOR; MOLECULAR-GENETICS; COWDEN-SYNDROME; PROTEIN-KINASE; MOUSE MODEL; SOMA SIZE; AUTISM; PATHWAY; BRAIN	CNS deletion of Pten in the mouse has revealed its roles in controlling cell size and number, thus providing compelling etiology for macrocephaly and Lhermitte-Duclos disease. PTEN mutations in individuals with autism spectrum disorders (ASD) have also been reported, although a causal link between PTEN and ASD remains unclear. In the present study, we deleted Pten in limited differentiated neuronal populations in the cerebral cortex and hippocampus of mice. Resulting mutant mice showed abnormal social interaction and exaggerated responses to sensory stimuli. We observed macrocephaly and neuronal hypertrophy, including hypertrophic and ectopic dendrites and axonal tracts with increased synapses. This abnormal morphology was associated with activation of the Akt/mTor/S6k pathway and inactivation of Gsk3 beta. Thus, our data suggest that abnormal activation of the PI3K/AKT pathway in specific neuronal populations can underlie macrocephaly and behavioral abnormalities reminiscent of certain features of human ASD.	Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Neurosci Res Nerve Gro, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Neurol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; St Jude Children's Research Hospital	Parada, LF (corresponding author), Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Baker, Suzanne J/N-8167-2018; Luikart, Bryan/D-2683-2012; Warfield, Simon/B-3352-2009; Kwon, Chang-hyuk/E-3450-2011; Parada, luis F/B-9400-2014	Warfield, Simon/0000-0002-7659-3880; Powell, Craig/0000-0001-5451-2165	NIMH NIH HHS [R01 MH081164, K08 MH065975-04, MH06597503, K08 MH065975, K08 MH065975-03, K08 MH065975-05] Funding Source: Medline; NINDS NIH HHS [R37 NS033199, R01 NS044172, NS44172, R37NS33199] Funding Source: Medline; Autism Speaks [AS1270] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH065975, R01MH081164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044172, R37NS033199] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Autism Speaks; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali IU, 1999, JNCI-J NATL CANCER I, V91, P1922, DOI 10.1093/jnci/91.22.1922; *AM PSYCH ASS, 2000, TASK FORC DMS 4; AMARAL DG, 1978, J COMP NEUROL, V182, P851, DOI 10.1002/cne.901820508; Andres C, 2002, BRAIN RES BULL, V57, P109, DOI 10.1016/S0361-9230(01)00642-6; Asano E, 2001, NEUROLOGY, V57, P1269, DOI 10.1212/WNL.57.7.1269; Backman SA, 2001, NAT GENET, V29, P396, DOI 10.1038/ng782; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; BlascoIbanez JM, 1997, HIPPOCAMPUS, V7, P307, DOI 10.1002/(SICI)1098-1063(1997)7:3<307::AID-HIPO6>3.0.CO;2-H; Broderick DK, 2004, CANCER RES, V64, P5048, DOI 10.1158/0008-5472.CAN-04-1170; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Cody H, 2002, INT J DEV NEUROSCI, V20, P421, DOI 10.1016/S0736-5748(02)00053-9; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Crawley JN, 2004, MENT RETARD DEV D R, V10, P248, DOI 10.1002/mrdd.20039; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Dakin S, 2005, NEURON, V48, P497, DOI 10.1016/j.neuron.2005.10.018; Danscher G, 2004, J HISTOCHEM CYTOCHEM, V52, P1619, DOI 10.1369/jhc.4A6371.2004; DAWSON GR, 1995, TRENDS PHARMACOL SCI, V16, P33, DOI 10.1016/S0165-6147(00)88973-7; de Vries P, 2005, EUR CHILD ADOLES PSY, V14, P183, DOI 10.1007/s00787-005-0443-1; Dulawa SC, 2000, NEUROPHARMACOLOGY, V39, P2170, DOI 10.1016/S0028-3908(00)00030-7; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fombonne E, 1999, J AUTISM DEV DISORD, V29, P113, DOI 10.1023/A:1023036509476; Fraser MM, 2004, CANCER RES, V64, P7773, DOI 10.1158/0008-5472.CAN-04-2487; Goffin A, 2001, AM J MED GENET, V105, P521, DOI 10.1002/ajmg.1477; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hay N, 2005, CANCER CELL, V8, P179, DOI 10.1016/j.ccr.2005.08.008; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kwon CH, 2006, GENESIS, V44, P130, DOI 10.1002/gene.20197; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2003, P NATL ACAD SCI USA, V100, P12923, DOI 10.1073/pnas.2132711100; Li G, 2002, DEVELOPMENT, V129, P4159; Lijam N, 1997, CELL, V90, P895, DOI 10.1016/S0092-8674(00)80354-2; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2003, BIOCHEM SOC T, V31, P573, DOI 10.1042/BST0310573; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Marui T, 2004, AM J MED GENET B, V131B, P43, DOI 10.1002/ajmg.b.20119; Mbarek O, 1999, AM J MED GENET, V88, P729, DOI 10.1002/(SICI)1096-8628(19991215)88:6<729::AID-AJMG26>3.3.CO;2-H; Moretti P, 2005, HUM MOL GENET, V14, P205, DOI 10.1093/hmg/ddi016; Moy SS, 2004, GENES BRAIN BEHAV, V3, P287, DOI 10.1111/j.1601-1848.2004.00076.x; Muhle R, 2004, PEDIATRICS, V113, pE472, DOI 10.1542/peds.113.5.e472; Murcia CL, 2005, INT J DEV NEUROSCI, V23, P265, DOI 10.1016/j.ijdevneu.2004.07.001; Perandones C, 2004, MOL BRAIN RES, V128, P8, DOI 10.1016/j.molbrainres.2004.05.021; Powell CM, 2004, NEURON, V42, P143, DOI 10.1016/S0896-6273(04)00146-1; Schumann CM, 2004, J NEUROSCI, V24, P6392, DOI 10.1523/JNEUROSCI.1297-04.2004; Shapiro LA, 2005, BRAIN RES REV, V48, P43, DOI 10.1016/j.brainresrev.2004.08.003; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Waite KA, 2002, AM J HUM GENET, V70, P829, DOI 10.1086/340026; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zoghbi HY, 2003, SCIENCE, V302, P826, DOI 10.1126/science.1089071; Zori RT, 1998, AM J MED GENET, V80, P399, DOI 10.1002/(SICI)1096-8628(19981204)80:4<399::AID-AJMG18>3.0.CO;2-O	63	697	712	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					377	388		10.1016/j.neuron.2006.03.023	http://dx.doi.org/10.1016/j.neuron.2006.03.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675393	Green Accepted, Bronze			2022-12-28	WOS:000237726800008
J	Demas, J; Sagdullaev, BT; Green, E; Jaubert-Miazza, L; McCall, MA; Gregg, RG; Wong, ROL; Guido, W				Demas, J; Sagdullaev, BT; Green, E; Jaubert-Miazza, L; McCall, MA; Gregg, RG; Wong, ROL; Guido, W			Failure to maintain eye-specific segregation in nob, a mutant with abnormally patterned retinal activity	NEURON			English	Article							STATIONARY NIGHT BLINDNESS; NICOTINIC ACETYLCHOLINE-RECEPTOR; LATERAL GENICULATE-NUCLEUS; VISUAL-SYSTEM DEVELOPMENT; RETINOGENICULATE PATHWAY; MAMMALIAN RETINA; GANGLION-CELLS; POSTNATAL-DEVELOPMENT; ELECTRICAL-ACTIVITY; BURSTING ACTIVITY	Axon terminals from the two eyes initially overlap in the dorsal-lateral geniculate nucleus (dLGN) but subsequently refine to occupy nonoverlapping territories. Retinal activity is required to establish and maintain this segregation. We show that despite the presence of retinal activity, segregated projections desegregate when the structure of activity is altered. Early in development, spontaneous retinal activity in the no b-wave (nob) mouse is indistinguishable from that of wildtype mice, and eye-specific segregation proceeds normally. But, around eye-opening, spontaneous and visually evoked activity in nob retinas become abnormal, coincident with a failure to preserve precise eye-specific territories. Dark-rearing studies suggest that altered visual experience is not responsible. Transgenic rescue of the mutated protein (nyctalopin) within nob retinal interneurons, without rescuing expression in either retinal projection neurons or their postsynaptic targets in the dLGN, restores spontaneous retinal activity patterns and prevents desegregation. Thus, normally structured spontaneous retinal activity stabilizes newly refined retinogeniculate circuitry.	Louisiana State Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40205 USA; Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40205 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Washington University (WUSTL); University of Louisville; University of Louisville	Guido, W (corresponding author), Louisiana State Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA 70112 USA.	wguido@vcu.edu		McCall, Maureen/0000-0002-9781-315X; Gregg, Ronald/0000-0001-5805-224X; Demas, Jay/0000-0001-7678-1905; Sagdullaev, Botir/0000-0002-0611-1479	NEI NIH HHS [R01 EY012354, R01 EY012354-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012354] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Akerman CJ, 2004, J NEUROSCI, V24, P170, DOI 10.1523/JNEUROSCI.1002-03.2004; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; Allen LE, 2003, BRIT J OPHTHALMOL, V87, P1413, DOI 10.1136/bjo.87.11.1413; Ball SL, 2003, VISUAL NEUROSCI, V20, P267, DOI 10.1017/S0952523803203059; Bansal A, 2000, J NEUROSCI, V20, P7672; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; Candille SI, 1999, INVEST OPHTH VIS SCI, V40, P2748; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Demas J, 2003, J NEUROSCI, V23, P2851; DUBIN MW, 1986, J NEUROSCI, V6, P1021; Eglen SJ, 1999, PHILOS T ROY SOC B, V354, P497, DOI 10.1098/rstb.1999.0400; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Gregg RG, 2003, INVEST OPHTH VIS SCI, V44, P378, DOI 10.1167/iovs.02-0501; GREGG RG, 2005, ARVO ABSTRACTS; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; IHAKA R, 1996, J GRAPHICAL COMPUTAT, V5, P491; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khan NW, 2005, J NEUROPHYSIOL, V93, P481, DOI 10.1152/jn.00365.2004; Lee CW, 2002, J NEUROPHYSIOL, V88, P2311, DOI 10.1152/jn.00372.2002; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MIYAKE Y, 1987, JPN J OPHTHALMOL, V31, P81; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; ODONOVAN MJ, 1987, J NEUROSCI, V7, P3256; OLNEY JW, 1968, NATURE, V218, P281, DOI 10.1038/218281a0; Pardue MT, 1998, INVEST OPHTH VIS SCI, V39, P2443; Personius KE, 2001, NEURON, V31, P395, DOI 10.1016/S0896-6273(01)00369-5; Pesch K, 2003, INVEST OPHTH VIS SCI, V44, P2260, DOI 10.1167/iovs.02-0115; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Ruthazer ES, 2004, J NEUROBIOL, V59, P134, DOI 10.1002/neu.10344; Scholl HPN, 2001, INVEST OPHTH VIS SCI, V42, P2728; Sernagor E, 2000, J NEUROSCI, V20, part. no.; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Stoica P., 1997, SPECTRAL ANAL SIGNAL; Tagawa Y, 1999, J NEUROSCI, V19, P2568; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Torborg CL, 2004, J NEUROSCI METH, V135, P17, DOI 10.1016/j.jneumeth.2003.11.019; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WILLSHAW DJ, 1976, PROC R SOC SER B-BIO, V194, P431, DOI 10.1098/rspb.1976.0087; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; YOUNG RSL, 1991, CLIN VISION SCI, V6, P309; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	63	99	101	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					247	259		10.1016/j.neuron.2006.03.033	http://dx.doi.org/10.1016/j.neuron.2006.03.033			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630836	Bronze			2022-12-28	WOS:000237176700012
J	Flannery, JG; Greenberg, KP				Flannery, JG; Greenberg, KP			Looking within for vision	NEURON			English	Editorial Material							DOMINANT RETINITIS-PIGMENTOSA; TRANSGENIC RAT MODEL; MAMMALIAN RETINA; PHOTORECEPTOR; RESCUE; VIRUS; LIGHT	Channelrhodopsin-2 (ChR2), a directly light-gated cation channel from the green alga Chlamydomonas rein-hardtii has been shown to be a directly light-switched cation-selective ion channel, which employs 11-cis retinal as its chromophore. This is the same chromophore as the mammalian photoreceptor's visual pigment-rhodopsin. Previously, investigators demonstrated that ChR2 can be used to optically control neuronal firing by depolarizing the cell. In this issue of Neuron, Bi et al. apply viral-mediated gene transfer to deliver ChR2 to retinal ganglion cells (RGC) in a rodent model of inherited blindness. In this way, the authors have genetically engineered surviving retinal neurons to take on the lost photoreceptive function. The conversion of light-insensitive retinal interneurons into photosensitive cells introduces an entirely new direction for treatments of blinding retinal degeneration.	Univ Calif Berkeley, Vis Sci & Neurosci Div, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Flannery, JG (corresponding author), Univ Calif Berkeley, Vis Sci & Neurosci Div, Dept Mol & Cell Biol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.			Flannery, John/0000-0002-0720-8897				Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Fisher SK, 2005, PROG RETIN EYE RES, V24, P395, DOI 10.1016/j.preteyeres.2004.10.004; FLANNERY JG, 1989, INVEST OPHTH VIS SCI, V30, P191; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Hauswirth William W, 2005, Retina, V25, pS60, DOI 10.1097/00006982-200512001-00027; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; Lakhanpal Rohit R, 2003, Curr Opin Ophthalmol, V14, P122, DOI 10.1097/00055735-200306000-00002; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; Sanftner LHM, 2001, MOL THER, V4, P622, DOI 10.1006/mthe.2001.0498; Seiler MJ, 2005, EUR J NEUROSCI, V21, P161, DOI 10.1111/j.1460-9568.2004.03851.x	14	11	14	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					1	3		10.1016/j.neuron.2006.03.027	http://dx.doi.org/10.1016/j.neuron.2006.03.027			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600846	Bronze			2022-12-28	WOS:000236811300001
J	Mallucci, GR; White, MD; Farmer, M; Dickinson, A; Khatun, H; Powell, AD; Brandner, S; Jefferys, JGR; Collinge, J				Mallucci, Giovanna R.; White, Melanie D.; Farmer, Michael; Dickinson, Andrew; Khatun, Husna; Powell, Andrew D.; Brandner, Sebastian; Jefferys, John G. R.; Collinge, John			Targeting cellular prion protein reverses early coanitive deficits and neurophysiological dysfunction in prion-infected mice	NEURON			English	Article							EARLY BEHAVIORAL-CHANGES; OBJECT RECOGNITION TASK; LONG-TERM POTENTIATION; TRANSGENIC MICE; ALZHEIMERS-DISEASE; COGNITIVE DEFICITS; PLAQUE-FORMATION; MOUSE MODEL; IN-VIVO; MEMORY	Currently, no treatment can prevent the cognitive and motor decline associated with widespread neurodegeneration in prion disease. However, we previously showed that targeting endogenous neuronal prion protein (PrPc) (the precursor of its disease-associated isoform, PrPsc) in mice with early prion infection reversed spongiform change and prevented clinical symptoms and neuronal loss. We now show that cognitive and behavioral deficits and impaired neurophysiological function accompany early hippocampal spongiform pathology. Remarkably, these behavioral and synaptic impairments recover when neuronal PrPc is depleted, in parallel with reversal of spongiosis. Thus, early functional impairments precede neuronal loss in prion disease and can be rescued. Further, they occur before extensive PrPsc deposits accumulate and recover rapidly after PrPc depletion, supporting the concept that they are caused by a transient neurotoxic species, distinct from aggregated PrPsc. These data suggest that early intervention in human prion disease may lead to recovery of cognitive and behavioral symptoms.	Inst Neurol, MRC, Prion Unit, London WC1N 3BG, England; Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England; Univ Birmingham, Dept Neurophysiol, Div Neurosci, Birmingham B15 2TT, W Midlands, England	University of London; University College London; University of London; University College London; University of Birmingham	Mallucci, GR (corresponding author), Inst Neurol, MRC, Prion Unit, Queen Sq, London WC1N 3BG, England.	g.mallucci@prion.ucl.ac.uk	Brandner, Sebastian/J-4562-2014; White, Melanie/J-5565-2019; Jefferys, John G R/AAF-1164-2021; Powell, Andrew/A-7472-2010; Jefferys, John/E-6132-2012	Brandner, Sebastian/0000-0002-9821-0342; White, Melanie/0000-0002-7399-8348; Jefferys, John G R/0000-0003-0106-4412; Jefferys, John/0000-0003-0106-4412; Mallucci, Giovanna/0000-0001-8504-1191	Medical Research Council [MC_U123160654, MC_U123192748, MC_U132692719] Funding Source: Medline; MRC [MC_U123160654] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Asante EA, 2002, EMBO J, V21, P6358, DOI 10.1093/emboj/cdf653; Betmouni S, 1999, PSYCHOBIOLOGY, V27, P63; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; BRACE HM, 1985, J PHYSIOL-LONDON, V368, P343, DOI 10.1113/jphysiol.1985.sp015861; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Buttini M, 2002, J NEUROSCI, V22, P10539; Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Clark RE, 2000, J NEUROSCI, V20, P8853; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Cunningham C, 2005, NEUROBIOL DIS, V18, P258, DOI 10.1016/j.nbd.2004.08.015; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Deacon RMJ, 2001, NEUROREPORT, V12, P2053, DOI 10.1097/00001756-200107030-00052; Dell'Omo G, 2002, EUR J NEUROSCI, V16, P735, DOI 10.1046/j.1460-9568.2002.02128.x; Dodart JC, 1997, NEUROREPORT, V8, P1173, DOI 10.1097/00001756-199703240-00023; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Frick KM, 2003, BEHAV NEUROSCI, V117, P1283, DOI 10.1037/0735-7044.117.6.1283; Gerlai R, 1999, TRENDS NEUROSCI, V22, P47, DOI 10.1016/S0166-2236(98)01346-0; Giese KP, 1998, LEARN MEMORY, V5, P257; Guenther K, 2001, EUR J NEUROSCI, V14, P401, DOI 10.1046/j.0953-816x.2001.01645.x; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Jamieson E, 2001, NEUROREPORT, V12, P2147, DOI 10.1097/00001756-200107200-00021; Jeffrey M, 1997, NEUROPATH APPL NEURO, V23, P93, DOI 10.1111/j.1365-2990.1997.tb01191.x; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Joiner S, 2002, J NEUROL NEUROSUR PS, V73, P597, DOI 10.1136/jnnp.73.5.597; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, MOL NEUROBIOL, V8, P121, DOI 10.1007/BF02780662; Messier C, 1997, NEUROBIOL LEARN MEM, V67, P172, DOI 10.1006/nlme.1996.3755; Morgan SL, 2001, J NEUROPHYSIOL, V86, P1289, DOI 10.1152/jn.2001.86.3.1289; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mumby DG, 2005, HIPPOCAMPUS, V15, P1050, DOI 10.1002/hipo.20122; Roesler R, 1999, MOL BRAIN RES, V71, P349, DOI 10.1016/S0169-328X(99)00193-X; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SAUER B, 1989, NUCLEIC ACIDS RES, V17, P147, DOI 10.1093/nar/17.1.147; Sik A, 2003, BEHAV BRAIN RES, V147, P49, DOI 10.1016/S0166-4328(03)00117-7; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang HW, 2002, BRAIN RES, V924, P133, DOI 10.1016/S0006-8993(01)03058-X; Winegar BD, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-5; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6	48	192	199	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					325	335		10.1016/j.neuron.2007.01.005	http://dx.doi.org/10.1016/j.neuron.2007.01.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270731	Bronze			2022-12-28	WOS:000245126800005
J	Luan, HJ; Peabody, NC; Vinson, CR; White, BH				Luan, Haojiang; Peabody, Nathan C.; Vinson, Charles R.; White, Benjamin H.			Refined spatial manipulation of neuronal function by combinatorial restriction of transgene expression	NEURON			English	Article							NEURAL CIRCUITRY; GENE-EXPRESSION; DROSOPHILA; SYSTEM; GAL4; PROTEIN; SPECIFICITY; CELLS	Selective genetic manipulation of neuronal function in vivo requires techniques for targeting gene expression to specific cells. Existing systems accomplish this using the promoters of endogenous genes to drive expression of transgenes directly in cells of interest or, in "binary" systems, to drive expression of a transcription factor or recombinase that subsequently activates the expression of other transgenes. All such techniques are constrained by the limited specificity of the available promoters. We introduce here a combinatorial system in which the DNA-binding (DBD) and transcription-activation (AD) domains of a transcription factor are independently targeted using two different promoters. The domains heterodimerize to become transcriptionally competent and thus drive transgene expression only at the intersection of the expression patterns of the two promoters. We use this system to dissect a neuronal network in Drosophila by selectively targeting expression of the cell death gene reaper to subsets of neurons within the network.	NIMH, Mol Biol Lab, Bethesda, MD 20892 USA; NCI, Lab Metab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	White, BH (corresponding author), NIMH, Mol Biol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	benjaminwhite@mail.nih.gov			NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002800] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [Z01 MH002800-03] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; CAHILL MA, 1994, FEBS LETT, V344, P105, DOI 10.1016/0014-5793(94)00320-3; Draizen TA, 1999, J NEUROBIOL, V38, P455, DOI 10.1002/(SICI)1097-4695(199903)38:4<455::AID-NEU2>3.0.CO;2-F; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Ewer J, 1996, J COMP NEUROL, V370, P330; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fassler J, 2002, GENOME RES, V12, P1190, DOI 10.1101/gr.67902; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GINIGER E, 1993, ROUX ARCH DEV BIOL, V202, P112, DOI 10.1007/BF00636536; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Halfon MS, 2002, GENESIS, V34, P135, DOI 10.1002/gene.10136; KEEGAN L, 1986, SCIENCE, V231, P699, DOI 10.1126/science.3080805; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Luan HJ, 2006, J NEUROSCI, V26, P573, DOI 10.1523/JNEUROSCI.3916-05.2006; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MA J, 1987, CELL, V50, P137, DOI 10.1016/0092-8674(87)90670-2; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Mallo M, 2006, FRONT BIOSCI-LANDMRK, V11, P313, DOI 10.2741/1799; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Miesenbock G, 2005, ANNU REV NEUROSCI, V28, P533, DOI 10.1146/annurev.neuro.28.051804.101610; Moll JR, 2001, PROTEIN SCI, V10, P649, DOI 10.1110/ps.39401; Osterwalder T, 2001, P NATL ACAD SCI USA, V98, P12596, DOI 10.1073/pnas.221303298; Park JH, 2003, DEVELOPMENT, V130, P2645, DOI 10.1242/dev.00503; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Suster ML, 2004, GENESIS, V39, P240, DOI 10.1002/gene.20051; Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661; WANG YL, 1994, P NATL ACAD SCI USA, V91, P8180, DOI 10.1073/pnas.91.17.8180; Wei Q, 2000, DEV BIOL, V228, P239, DOI 10.1006/dbio.2000.9938; White B, 2001, CURR BIOL, V11, pR1041, DOI 10.1016/S0960-9822(01)00621-2; Wulff P, 2005, TRENDS NEUROSCI, V28, P44, DOI 10.1016/j.tins.2004.11.004; YAO KM, 1994, J NEUROCHEM, V63, P41	37	254	259	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					425	436		10.1016/j.neuron.2006.08.028	http://dx.doi.org/10.1016/j.neuron.2006.08.028			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088209	Green Accepted, Bronze			2022-12-28	WOS:000242269700006
J	Fitzjohn, SM; Doherty, AJ; Collingridge, GL				Fitzjohn, Stephen M.; Doherty, Andrew J.; Collingridge, Graham L.			Promiscuous interactions between AMPA-Rs and MAGUKs	NEURON			English	Editorial Material							LONG-TERM POTENTIATION; DOMAIN INTERACTION; PSD-95; GLUR1; PROTEIN; SAP97; MICE; LTP	What controls the number of AMPA receptors at excitatory synapses? MAGUKs are known to play a critical role in this process, but which ones are involved and when has been contentious. In this issue of Neuron, Elias et al. have elucidated the roles of three MAGUKs, PSD-95, PSD-93, and SAP-102, in the targeting of AMPA receptors to synapses in hippocampal neurons.	Univ Bristol, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Fitzjohn, SM (corresponding author), Univ Bristol, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.		collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015	Collingridge, Graham L/0000-0002-9572-5359; Fitzjohn, Stephen/0000-0002-3859-7530				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Schluter OM, 2006, NEURON, V51, P99, DOI 10.1016/j.neuron.2006.05.016; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199	10	16	16	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					222	224		10.1016/j.neuron.2006.10.002	http://dx.doi.org/10.1016/j.neuron.2006.10.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046684	Bronze			2022-12-28	WOS:000241799900002
J	Boillee, S; Vande Velde, C; Cleveland, DW				Boillee, Sverine; Vande Velde, Christine; Cleveland, Don W.			ALS: A disease of motor neurons and their nonneuronal neighbors	NEURON			English	Review							AMYOTROPHIC-LATERAL-SCLEROSIS; CU/ZN-SUPEROXIDE-DISMUTASE; TRANSGENIC MOUSE MODEL; GROWTH-FACTOR-I; NEUROFILAMENT HEAVY GENE; MARIE-TOOTH-DISEASE; GLUTAMATE TRANSPORTER GLT1; RESPIRATORY-CHAIN FUNCTION; HYPOXIA-RESPONSE ELEMENT; CENTRAL-NERVOUS-SYSTEM	Amyotrophic lateral sclerosis is a late-onset progressive neurodegenerative disease affecting motor neurons. The etiology of most ALS cases remains unknown, but 2% of instances are due to mutations in Cu/Zn superoxide dismutase (SOD1). Since sporadic and familial ALS affects the same neurons with similar pathology, it is hoped that therapies effective in mutant SOD1 models will translate to sporadic ALS. Mutant SOD1 induces non-cell-autonomous motor neuron killing by an unknown gain of toxicity. Selective vulnerability of motor neurons likely arises from a combination of several mechanisms, including protein misfolding, mitochondrial dysfunction, oxidative damage, defective axonal transport, excitotoxicity, insufficient growth factor signaling, and inflammation. Damage within motor neurons is enhanced by damage incurred by nonneuronal neighboring cells, via an inflammatory response that accelerates disease progression. These findings validate therapeutic approaches aimed at nonneuronal cells.	Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Cleveland, DW (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	dcleveland@ucsd.edu	Cleveland, Don/AAN-9783-2021; Boillee, Severine/J-4027-2017	BOILLEE, Severine/0000-0001-5518-9005; Cleveland, Don/0000-0002-1934-3682	NINDS NIH HHS [R37 NS027036] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS027036] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abalkhail H, 2003, AM J HUM GENET, V73, P383, DOI 10.1086/377156; Ackerley S, 2003, J CELL BIOL, V161, P489, DOI 10.1083/jcb.200303138; Acsadi G, 2002, HUM GENE THER, V13, P1047, DOI 10.1089/104303402753812458; AFIFI AK, 1966, NEUROLOGY, V16, P475, DOI 10.1212/WNL.16.5.475; Al-Chalabi A, 1999, HUM MOL GENET, V8, P157, DOI 10.1093/hmg/8.2.157; Azzouz M, 2000, HUM MOL GENET, V9, P803, DOI 10.1093/hmg/9.5.803; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Basso M, 2006, J BIOL CHEM, V281, P33325, DOI 10.1074/jbc.M603489200; Batulan Z, 2003, J NEUROSCI, V23, P5789; BEERS DR, 2006, IN PRESS P NATL ACAD; Bergemalm D, 2006, J NEUROSCI, V26, P4147, DOI 10.1523/JNEUROSCI.5461-05.2006; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Borasio GD, 1998, NEUROLOGY, V51, P583, DOI 10.1212/WNL.51.2.583; Boston-Howes W, 2006, J BIOL CHEM, V281, P14076, DOI 10.1074/jbc.M600653200; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; Browne SE, 1998, J NEUROCHEM, V71, P281; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Bruening W, 1999, J NEUROCHEM, V72, P693, DOI 10.1046/j.1471-4159.1999.0720693.x; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chance PF, 1998, AM J HUM GENET, V62, P633, DOI 10.1086/301769; Charcot J-M, 1869, ARCH PHYSL NORM PATH, V2, P744; Chen W, 2006, NEUROLOGY, V67, P508, DOI 10.1212/01.wnl.0000227926.42370.04; Chen YZ, 2004, AM J HUM GENET, V74, P1128, DOI 10.1086/421054; Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076; Chung MJ, 2002, ULTRASTRUCT PATHOL, V26, P3, DOI 10.1080/01913120252934260; Cifuentes-Diaz C, 2001, J CELL BIOL, V152, P1107, DOI 10.1083/jcb.152.5.1107; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; Corti S, 2004, BRAIN, V127, P2518, DOI 10.1093/brain/awh273; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Coulpier M, 1996, J NEUROSCI, V16, P5897; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Damiano M, 2006, J NEUROCHEM, V96, P1349, DOI 10.1111/j.1471-4159.2006.03619.x; Darman J, 2004, J NEUROSCI, V24, P7566, DOI 10.1523/JNEUROSCI.2002-04.2004; de Aguilar JLG, 2000, NEUROBIOL DIS, V7, P406, DOI 10.1006/nbdi.2000.0295; de Hemptinne I, 2006, NEUROSCI LETT, V401, P25, DOI 10.1016/j.neulet.2006.02.060; De Jonghe P, 2001, ANN NEUROL, V49, P245, DOI 10.1002/1531-8249(20010201)49:2<245::AID-ANA45>3.0.CO;2-A; Deng HX, 2006, P NATL ACAD SCI USA, V103, P7142, DOI 10.1073/pnas.0602046103; Deshpande DM, 2006, ANN NEUROL, V60, P32, DOI 10.1002/ana.20901; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Drachman DB, 2002, ANN NEUROL, V52, P771, DOI 10.1002/ana.10374; Drory VE, 2001, J NEUROL SCI, V191, P133, DOI 10.1016/S0022-510X(01)00610-4; Dupuis L, 2003, FASEB J, V17, P2091, DOI 10.1096/fj.02-1182fje; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Echaniz-Laguna A, 2002, ANN NEUROL, V52, P623, DOI 10.1002/ana.10357; Ekegren T, 1999, ACTA NEUROL SCAND, V100, P317; Elliott JL, 2001, MOL BRAIN RES, V95, P172, DOI 10.1016/S0169-328X(01)00242-X; ENGELHARDT JI, 1990, ARCH NEUROL-CHICAGO, V47, P1210, DOI 10.1001/archneur.1990.00530110068019; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; FIGLEWICZ DA, 1994, HUM MOL GENET, V3, P1757, DOI 10.1093/hmg/3.10.1757; Fischer LR, 2005, NEUROBIOL DIS, V19, P293, DOI 10.1016/j.nbd.2005.01.008; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fray AE, 1998, EUR J NEUROSCI, V10, P2481, DOI 10.1046/j.1460-9568.1998.00273.x; Frey D, 2000, J NEUROSCI, V20, P2534; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Ganel R, 2006, NEUROBIOL DIS, V21, P556, DOI 10.1016/j.nbd.2005.08.014; Garbuzova-Davis S, 2003, J HEMATOTH STEM CELL, V12, P255, DOI 10.1089/152581603322022990; Garcia ML, 2006, NEUROBIOL DIS, V21, P102, DOI 10.1016/j.nbd.2005.06.016; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Goldknopf IL, 2006, BIOCHEM BIOPH RES CO, V342, P1034, DOI 10.1016/j.bbrc.2006.02.051; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Gordon PH, 2004, NEUROLOGY, V62, P1845, DOI 10.1212/01.WNL.0000125321.92112.7E; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Groeneveld GJ, 2003, ANN NEUROL, V53, P437, DOI 10.1002/ana.10554; Gros-Louis F, 2003, MUSCLE NERVE, V28, P774, DOI 10.1002/mus.10498; Gros-Louis F, 2004, J BIOL CHEM, V279, P45951, DOI 10.1074/jbc.M408139200; Gros-Louis F, 2006, BBA-MOL BASIS DIS, V1762, P956, DOI 10.1016/j.bbadis.2006.01.004; GUREY ME, 1994, SCIENCE, V264, P1772; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hafezparast M, 2003, AMYOTROPH LATERAL SC, V4, P249, DOI 10.1080/14660820310016084; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; Hand CK, 2002, AM J HUM GENET, V70, P251, DOI 10.1086/337945; Harper JM, 2004, P NATL ACAD SCI USA, V101, P7123, DOI 10.1073/pnas.0401103101; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Henkel JS, 2006, MOL CELL NEUROSCI, V31, P427, DOI 10.1016/j.mcn.2005.10.016; Hensley K, 2003, NEUROBIOL DIS, V14, P74, DOI 10.1016/S0969-9961(03)00087-1; Hentati A, 1998, NEUROGENETICS, V2, P55, DOI 10.1007/s100480050052; HENTATI A, 1994, NAT GENET, V7, P425, DOI 10.1038/ng0794-425; Higgins CMJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-16; Higgins CMJ, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-06-j0001.2002; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P461, DOI 10.1097/00005072-198409000-00001; HIRANO A, 1991, ADV NEUROL, V56, P91; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Hosler BA, 2000, JAMA-J AM MED ASSOC, V284, P1664, DOI 10.1001/jama.284.13.1664; Houseweart MK, 1999, J NEUROSCI, V19, P6446; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; HUTTON M, 1998, NATURE, V702, P393; Ince PG, 1998, J NEUROPATH EXP NEUR, V57, P895, DOI 10.1097/00005072-199810000-00002; Jaarsma D, 2000, NEUROBIOL DIS, V7, P623, DOI 10.1006/nbdi.2000.0299; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Jonsson PA, 2006, BRAIN, V129, P451, DOI 10.1093/brain/awh704; Jonsson PA, 2004, BRAIN, V127, P73, DOI 10.1093/brain/awh005; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Jung CW, 2002, J NEUROSCI METH, V114, P165, DOI 10.1016/S0165-0270(01)00524-6; Kabashi E, 2004, J NEUROCHEM, V89, P1325, DOI 10.1111/j.1471-4159.2004.02453.x; Kasarskis EJ, 1999, NEUROLOGY, V52, P1427; Kaspar BK, 2003, SCIENCE, V301, P839, DOI 10.1126/science.1086137; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; KAWAMATA T, 1992, AM J PATHOL, V140, P691; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kirby J, 2005, BRAIN, V128, P1686, DOI 10.1093/brain/awh503; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Kislinger T, 2006, CELL, V125, P173, DOI 10.1016/j.cell.2006.01.044; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Kong JM, 2000, NEUROSCI LETT, V281, P72, DOI 10.1016/S0304-3940(00)00808-9; Kong JM, 1998, J NEUROSCI, V18, P3241; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Kruman II, 1999, EXP NEUROL, V160, P28, DOI 10.1006/exnr.1999.7190; Lai EC, 1997, NEUROLOGY, V49, P1621, DOI 10.1212/WNL.49.6.1621; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Lariviere RC, 2003, NEUROBIOL DIS, V13, P158, DOI 10.1016/S0969-9961(03)00036-6; LEE MK, 1994, NEURON, V13, P975, DOI 10.1016/0896-6273(94)90263-1; Levine JB, 1999, GLIA, V28, P215; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Liu J, 2005, J NEUROCHEM, V93, P875, DOI 10.1111/j.1471-4159.2005.03054.x; Liu ZP, 2006, J COMP NEUROL, V497, P468, DOI 10.1002/cne.21012; Lobsiger CS, 2005, P NATL ACAD SCI USA, V102, P10351, DOI 10.1073/pnas.0503862102; Lotz B, 1996, NEUROLOGY, V46, P1244; Lukas TJ, 2006, MOL CELL PROTEOMICS, V5, P1233, DOI 10.1074/mcp.M500431-MCP200; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Maragakis NJ, 2004, ANN NEUROL, V55, P469, DOI 10.1002/ana.20003; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; MCGEER PL, 1991, CAN J NEUROL SCI, V18, P376, DOI 10.1017/S0317167100032479; Mendonca DMF, 2005, BRAZ J MED BIOL RES, V38, P925, DOI 10.1590/S0100-879X2005000600015; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; Mitsumoto H., 1998, AMYOTROPHIC LATERAL; MIZUSAWA H, 1989, ACTA NEUROPATHOL, V79, P37, DOI 10.1007/BF00308955; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Mu XJ, 1996, ANN NEUROL, V40, P379, DOI 10.1002/ana.410400307; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagano I, 2005, NEUROL RES, V27, P768, DOI 10.1179/016164105X39860; Nagano I, 2005, J NEUROL SCI, V235, P61, DOI 10.1016/j.jns.2005.04.011; Nguyen MD, 2004, J NEUROSCI, V24, P1340, DOI 10.1523/JNEUROSCI.4786-03.2004; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nishimura AL, 2004, J MED GENET, V41, P315, DOI 10.1136/jmg.2003.013029; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Niwa J, 2002, J BIOL CHEM, V277, P36793, DOI 10.1074/jbc.M206559200; Okado-Matsumoto A, 2002, P NATL ACAD SCI USA, V99, P9010, DOI 10.1073/pnas.132260399; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Ostojic J, 2003, NEUROSCI LETT, V340, P245, DOI 10.1016/S0304-3940(03)00126-5; Pardo AC, 2006, EXP NEUROL, V201, P120, DOI 10.1016/j.expneurol.2006.03.028; Pasinelli P, 2000, P NATL ACAD SCI USA, V97, P13901, DOI 10.1073/pnas.240305897; Pasinelli P, 2004, NEURON, V43, P19, DOI 10.1016/j.neuron.2004.06.021; Patel YJK, 2005, MOL BRAIN RES, V134, P256, DOI 10.1016/j.molbrainres.2004.10.028; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; PERRY VH, 1990, EUR J NEUROSCI, V2, P802, DOI 10.1111/j.1460-9568.1990.tb00472.x; Pieri M, 2003, NEUROSCI LETT, V351, P153, DOI 10.1016/j.neulet.2003.07.010; Pinto AC, 1999, J NEUROL SCI, V169, P69, DOI 10.1016/S0022-510X(99)00218-X; Pontieri FE, 2005, NEUROL SCI, V26, P285, DOI 10.1007/s10072-005-0474-x; Pramatarova A, 2001, J NEUROSCI, V21, P3369, DOI 10.1523/JNEUROSCI.21-10-03369.2001; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Puttaparthi K, 2005, EXP NEUROL, V196, P441, DOI 10.1016/j.expneurol.2005.08.027; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2002, NEURON, V35, P1067, DOI 10.1016/S0896-6273(02)00905-4; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Raoul C, 2006, P NATL ACAD SCI USA, V103, P6007, DOI 10.1073/pnas.0508774103; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; Reid E, 2002, AM J HUM GENET, V71, P1189, DOI 10.1086/344210; RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689; Robertson J, 2003, J CELL BIOL, V160, P939, DOI 10.1083/jcb.200205027; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; ROTHSTEIN JD, 1992, NEW ENGL J MED, V326, P1464, DOI 10.1056/NEJM199205283262204; ROTHSTEIN JD, 1995, ANN NEUROL, V38, P73, DOI 10.1002/ana.410380114; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Rothstein JD, 1999, J NEUROCHEM, V72, P422, DOI 10.1046/j.1471-4159.1999.0720422.x; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Ruddy DM, 2003, AM J HUM GENET, V73, P390, DOI 10.1086/377157; Samsam M, 2003, J NEUROSCI, V23, P2833; Sapp PC, 2003, AM J HUM GENET, V73, P397, DOI 10.1086/377158; Sasaki S, 2004, ACTA NEUROPATHOL, V107, P461, DOI 10.1007/s00401-004-0837-z; Sasaki S, 2000, ACTA NEUROPATHOL, V100, P138, DOI 10.1007/s004019900159; Sato T, 2005, NEUROLOGY, V65, P1954, DOI 10.1212/01.wnl.0000188760.53922.05; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Schmitt-John T, 2005, NAT GENET, V37, P1213, DOI 10.1038/ng1661; Shefner JM, 2004, NEUROLOGY, V63, P1656, DOI 10.1212/01.WNL.0000142992.81995.F0; Simpson EP, 2004, NEUROLOGY, V62, P1758, DOI 10.1212/WNL.62.10.1758; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; SOBUE G, 1990, ACTA NEUROPATHOL, V79, P402, DOI 10.1007/BF00308716; Solomon JN, 2006, GLIA, V53, P744, DOI 10.1002/glia.20331; Spalloni A, 2004, NEUROREPORT, V15, P2477, DOI 10.1097/00001756-200411150-00009; Spalloni A, 2004, NEUROBIOL DIS, V15, P340, DOI 10.1016/j.nbd.2003.11.012; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Subramaniam JR, 2002, NAT NEUROSCI, V5, P301, DOI 10.1038/nn823; Takeuchi H, 2002, BRAIN RES, V949, P11, DOI 10.1016/S0006-8993(02)02568-4; Takuma H, 1999, ANN NEUROL, V46, P806, DOI 10.1002/1531-8249(199912)46:6<806::AID-ANA2>3.0.CO;2-S; Terry PD, 2004, J NEUROGENET, V18, P429, DOI 10.1080/01677060490894450; Teuchert M, 2006, EXP NEUROL, V198, P271, DOI 10.1016/j.expneurol.2005.12.005; Tomkins J, 1998, NEUROREPORT, V9, P3967, DOI 10.1097/00001756-199812010-00036; TROOST D, 1993, NEUROPATH APPL NEURO, V19, P390, DOI 10.1111/j.1365-2990.1993.tb00459.x; Tummala H, 2005, J BIOL CHEM, V280, P17725, DOI 10.1074/jbc.M501705200; Turner MR, 2004, NEUROBIOL DIS, V15, P601, DOI 10.1016/j.nbd.2003.12.012; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Van Damme P, 2002, J NEUROPHYSIOL, V88, P1279, DOI 10.1152/jn.2002.88.3.1279; Van Den Bosch L, 2004, NEUROBIOL DIS, V17, P21, DOI 10.1016/j.nbd.2004.06.004; Van Den Bosch L, 2002, NEUROREPORT, V13, P1067, DOI 10.1097/00001756-200206120-00018; Van Vught PWJ, 2005, NEUROLOGY, V65, P1643, DOI 10.1212/01.wnl.0000184514.39853.56; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Velde CV, 2004, NEUROMOL MED, V5, P193, DOI 10.1385/NMM:5:3:193; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vielhaber S, 1999, J NEUROL SCI, V169, P133, DOI 10.1016/S0022-510X(99)00236-1; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Vleminckx V, 2002, J NEUROPATH EXP NEUR, V61, P968, DOI 10.1093/jnen/61.11.968; Vukosavic S, 2000, J NEUROSCI, V20, P9119; Wang J, 2003, HUM MOL GENET, V12, P2753, DOI 10.1093/hmg/ddg312; Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005; Wang LJ, 2002, J NEUROSCI, V22, P6920; Watanabe M, 2001, NEUROBIOL DIS, V8, P933, DOI 10.1006/nbdi.2001.0443; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Wengenack TM, 2004, BRAIN RES, V1027, P73, DOI 10.1016/j.brainres.2004.08.054; West M, 2004, J NEUROCHEM, V91, P133, DOI 10.1111/j.1471-4159.2004.02700.x; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Wiedemann FR, 2002, J NEUROCHEM, V80, P616, DOI 10.1046/j.0022-3042.2001.00731.x; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; Wong NKY, 2000, J NEUROPATH EXP NEUR, V59, P972, DOI 10.1093/jnen/59.11.972; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Xia XG, 2006, NEUROBIOL DIS, V23, P578, DOI 10.1016/j.nbd.2006.04.019; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yamanaka K, 2006, ANN NEUROL, V60, P95, DOI 10.1002/ana.20888; Yan J, 2006, STEM CELLS, V24, P1976, DOI 10.1634/stemcells.2005-0518; Yang Y, 2001, NAT GENET, V29, P160, DOI 10.1038/ng1001-160; Yasojima K, 2001, NEUROLOGY, V57, P952, DOI 10.1212/WNL.57.6.952; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; YOSHIDA S, 1986, Neuroepidemiology, V5, P61, DOI 10.1159/000110815; Yoshihara T, 2002, J NEUROCHEM, V80, P158, DOI 10.1046/j.0022-3042.2001.00683.x; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; Zhao WH, 2004, J NEUROPATH EXP NEUR, V63, P964, DOI 10.1093/jnen/63.9.964; Zheng CY, 2004, ANN NEUROL, V56, P564, DOI 10.1002/ana.20223; Zhu S, 2002, NATURE, V417, P74, DOI 10.1038/417074a	262	1088	1130	2	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					39	59		10.1016/j.neuron.2006.09.018	http://dx.doi.org/10.1016/j.neuron.2006.09.018			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015226	Bronze			2022-12-28	WOS:000241408100004
J	Rinberg, D; Koulakov, A; Gelperin, A				Rinberg, Dmitry; Koulakov, Alexei; Gelperin, Alan			Speed-accuracy tradeoff in olfaction	NEURON			English	Article							RECEPTOR NEURON INPUT; ODOR REPRESENTATIONS; DISCRIMINATION; COMPUTATION; DYNAMICS; TIME; TOPOGRAPHY; STIMULUS; LATENCY; HUMANS	The basic psychophysical principle of speed-accuracy tradeoff (SAT) has been used to understand key aspects of neuronal information processing in vision and audition, but the principle of SAT is still debated in olfaction. In this study we present the direct observation of SAT in olfaction. We developed a behavioral paradigm for mice in which both the duration of odorant sampling and the difficulty of the odor discrimination task were controlled by the experimenter. We observed that the accuracy of odor discrimination increases with the duration of imposed odorant sampling, and that the rate of this increase is slower for harder tasks. We also present a unifying picture of two previous, seemingly disparate experiments on timing of odorant sampling in odor discrimination tasks. The presence of SAT in olfaction provides strong evidence for temporal integration in olfaction and puts a constraint on models of olfactory processing.	Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Monell Chemical Senses Center; Cold Spring Harbor Laboratory	Rinberg, D (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA 20147 USA.	rinbergd@janelia.hhmi.org	Ying, Hua/D-8724-2012					Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Axel R, 2005, ANGEW CHEM INT EDIT, V44, P6110, DOI 10.1002/anie.200501726; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bensafi M, 2003, NAT NEUROSCI, V6, P1142, DOI 10.1038/nn1145; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Brody CD, 2003, NEURON, V37, P843, DOI 10.1016/S0896-6273(03)00120-X; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Buck LB, 2005, ANGEW CHEM INT EDIT, V44, P6128, DOI 10.1002/anie.200501120; Buonviso N, 2003, EUR J NEUROSCI, V17, P1811, DOI 10.1046/j.1460-9568.2003.02619.x; Christensen TA, 2005, CHEM SENSES, V30, pI283, DOI 10.1093/chemse/bjh225; Cleland TA, 2005, CHEM SENSES, V30, P801, DOI 10.1093/chemse/bji072; Fecteau J, 2001, INT J NEUROSCI, V108, P11, DOI 10.3109/00207450108986501; Friedrich RW, 2006, TRENDS NEUROSCI, V29, P40, DOI 10.1016/j.tins.2005.10.004; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Fukushima N, 2002, CHEM SENSES, V27, P1, DOI 10.1093/chemse/27.1.1; Gelperin A, 2006, J NEUROSCI, V26, P1663, DOI 10.1523/JNEUROSCI.3737-05b.2006; Hayar A, 2004, J NEUROSCI, V24, P1190, DOI 10.1523/JNEUROSCI.4714-03.2004; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; Hudson R, 1999, J COMP PHYSIOL A, V185, P297, DOI 10.1007/s003590050390; Jinks A, 1999, COGNITIVE BRAIN RES, V8, P311, DOI 10.1016/S0926-6410(99)00034-8; Kay LM, 2005, P NATL ACAD SCI USA, V102, P3863, DOI 10.1073/pnas.0407920102; Kepecs A, 2006, CHEM SENSES, V31, P167, DOI 10.1093/chemsce/bjj016; Khan RM, 2004, NEURON, V44, P744, DOI 10.1016/j.neuron.2004.11.024; LAING DG, 1986, PHYSIOL BEHAV, V37, P163, DOI 10.1016/0031-9384(86)90400-2; Laurent G, 2001, ANNU REV NEUROSCI, V24, P263, DOI 10.1146/annurev.neuro.24.1.263; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Leon M, 2003, BRAIN RES REV, V42, P23, DOI 10.1016/S0165-0173(03)00142-5; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Lu XCM, 1998, NEUROSCIENCE, V84, P849, DOI 10.1016/S0306-4522(97)00520-4; Luce R. D., 1986, RESPONSE TIMES; MACRIDES F, 1982, J NEUROSCI, V2, P1705; Mainland J, 2006, CHEM SENSES, V31, P181, DOI 10.1093/chemse/bjj012; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Meister M, 2001, J NEUROSCI, V21, P1351; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; PAGER J, 1985, BEHAV BRAIN RES, V16, P81, DOI 10.1016/0166-4328(85)90084-1; Rinberg D, 2006, SEMIN CELL DEV BIOL, V17, P454, DOI 10.1016/j.semcdb.2006.04.009; Rosner B., 1999, FUNDAMENTALS BIOSTAT; Roux SG, 2006, J NEUROSCI METH, V152, P173, DOI 10.1016/j.jneumeth.2005.09.004; Schoenfeld TA, 2006, CHEM SENSES, V31, P131, DOI 10.1093/chemse/bjj015; Scott JW, 2006, CHEM SENSES, V31, P119, DOI 10.1093/chemse/bjj013; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Slotnick B, 2004, J NEUROSCI, V24, P9195, DOI 10.1523/JNEUROSCI.1936-04.2004; Sobel N, 2001, P NATL ACAD SCI USA, V98, P4154, DOI 10.1073/pnas.071061598; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Wachowiak M, 2002, J NEUROPHYSIOL, V87, P1035, DOI 10.1152/jn.00522.2001; Wise PM, 2000, CHEM SENSES, V25, P247, DOI 10.1093/chemse/25.3.247; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Youngentob SL, 2005, CHEM SENSES, V30, P219, DOI 10.1093/chemse/bji017	53	191	191	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					351	358		10.1016/j.neuron.2006.07.013	http://dx.doi.org/10.1016/j.neuron.2006.07.013			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880129	Bronze			2022-12-28	WOS:000239908800010
J	Galimberti, I; Gogolla, N; Alberi, S; Santos, AF; Muller, D; Caroni, P				Galimberti, Ivan; Gogolla, Nadine; Alberi, Stefano; Santos, Alexandre Ferrao; Muller, Dominique; Caroni, Pico			Long-term rearrangements of hippocampal mossy fiber terminal connectivity in the adult regulated by experience	NEURON			English	Article							DENDRITIC SPINES; IN-VIVO; RAT HIPPOCAMPUS; FEEDFORWARD INHIBITION; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; BARN OWLS; SYNAPSES; CA3; BOUTONS	We investigated rearrangements of connectivity between hippocampal mossy fibers and CA3 pyramidal neurons. We found that mossy fibers establish 10-15 local terminal arborization complexes (LMT-Cs) in CA3, which exhibit major differences in size and divergence in adult mice. LMT-Cs exhibited two types of long-term rearrangements in connectivity in the adult: progressive expansion of LMT-C subsets along individual dendrites throughout life, and pronounced increases in LMT-C complexities in response to an enriched environment. In organotypic slice cultures, subsets of LMT-Cs also rearranged extensively and grew over weeks and months, altering the strength of preexisting connectivity, and establishing or dismantling connections with pyramidal neurons. Differences in LMT-C plasticity reflected properties of individual LMT-Cs, not mossy fibers. LMT-C maintenance and growth were regulated by spiking activity, mGluR2-sensitive transmitter release from LMTs, and PKC. Thus, subsets of terminal arborization complexes by mossy fibers rearrange their local connectivities in response to experience and age throughout life.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Geneva, Ctr Med Univ, Geneva, Switzerland	Friedrich Miescher Institute for Biomedical Research; University of Geneva	Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	caroni@fmi.ch						Acsady L, 1998, J NEUROSCI, V18, P3386; CHICUREL ME, 1992, J COMP NEUROL, V325, P169, DOI 10.1002/cne.903250204; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Danzer SC, 2004, J NEUROSCI, V24, P11346, DOI 10.1523/JNEUROSCI.3846-04.2004; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gonzales RB, 2001, J COMP NEUROL, V430, P357, DOI 10.1002/1096-9861(20010212)430:3<357::AID-CNE1036>3.0.CO;2-K; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; Henze DA, 2002, NAT NEUROSCI, V5, P790, DOI 10.1038/nn887; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; ISHIDA M, 1993, BRIT J PHARMACOL, V109, P1169, DOI 10.1111/j.1476-5381.1993.tb13745.x; JOHNSTON D, 1998, HIPPOCAMPUS SYNAPITI, P417; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Pleskacheva MG, 2000, HIPPOCAMPUS, V10, P17, DOI 10.1002/(SICI)1098-1063(2000)10:1<17::AID-HIPO2>3.0.CO;2-O; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Qin LX, 2001, J COMP NEUROL, V440, P284, DOI 10.1002/cne.1386; Ramirez-Amaya V, 2001, J NEUROSCI, V21, P7340; Reid CA, 2001, J NEUROSCI, V21, P2206, DOI 10.1523/JNEUROSCI.21-07-02206.2001; Sandi C, 2003, EUR J NEUROSCI, V17, P2447, DOI 10.1046/j.1460-9568.2003.02675.x; Schopke R, 1991, Hippocampus, V1, P315, DOI 10.1002/hipo.450010322; SCHWEGLER H, 1991, J NEUROSCI, V11, P2102; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	51	112	129	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					749	763		10.1016/j.neuron.2006.04.026	http://dx.doi.org/10.1016/j.neuron.2006.04.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731513	Bronze			2022-12-28	WOS:000238165000010
J	Wang, ZF; Kai, L; Day, M; Ronesi, J; Yin, HH; Ding, J; Tkatch, T; Lovinger, DM; Surmeier, DJ				Wang, Zhongfeng; Kai, Li; Day, Michelle; Ronesi, Jennifer; Yin, Henry H.; Ding, Jun; Tkatch, Tatiana; Lovinger, David M.; Surmeier, D. James			Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons	NEURON			English	Article							RAT STRIATAL NEURONS; CA2+ CURRENTS; ENDOCANNABINOID RELEASE; COORDINATED EXPRESSION; BASAL GANGLIA; N-TYPE; RECEPTOR; MODULATION; CHANNELS; TRANSMISSION	Long-term depression (LTD) of the synapse formed between cortical pyramidal neurons and striatal medium spiny neurons is central to many theories of motor plasticity and associative learning. The induction of LTD at this synapse is thought to depend upon D-2 dopamine receptors localized in the postsynaptic membrane. If this were true, LTD should be inducible in neurons from only one of the two projection systems of the striatum. Using transgenic mice in which neurons that contribute to these two systems are labeled, we show that this is not the case. Rather, in both cell types, the D-2 receptor dependence of LTD induction reflects the need to lower M-1 muscarinic receptor activity-a goal accomplished by D-2 receptors on cholinergic interneurons. In addition to reconciling discordant tracts of the striatal literature, these findings point to cholinergic interneurons as key mediators of dopamine-dependent striatal plasticity and learning.	Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; NIAAA, Lab Integrat Neurosci, Div Intramural Clin & Basic Res, NIH, Rockville, MD 20852 USA	Northwestern University; Feinberg School of Medicine; Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Surmeier, DJ (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA.	j-surmeier@northwestern.edu	Ding, Jun/B-2513-2009	Ding, Jun/0000-0003-0690-1312; Tkatch, Tatiana/0000-0001-6626-7435	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034696, R37NS034696] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000407] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [MH 074866] Funding Source: Medline; NINDS NIH HHS [NS 34696] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizman O, 2000, NAT NEUROSCI, V3, P226, DOI 10.1038/72929; AOSAKI T, 1994, SCIENCE, V265, P412, DOI 10.1126/science.8023166; Bamford NS, 2004, NEURON, V42, P653, DOI 10.1016/S0896-6273(04)00265-X; Bennett BD, 1999, J NEUROSCI, V19, P5586; BERNARD V, 1992, J NEUROSCI, V12, P3591; CALABRESI P, 1994, J NEUROSCI, V14, P4871; CALABRESI P, 1992, J NEUROSCI, V12, P4224; Calabresi P, 1997, J NEUROSCI, V17, P4536; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Centonze D, 2001, EUR J NEUROSCI, V13, P1071, DOI 10.1046/j.0953-816x.2001.01485.x; Cepeda C, 2001, J NEUROPHYSIOL, V85, P659, DOI 10.1152/jn.2001.85.2.659; Choi S, 1997, P NATL ACAD SCI USA, V94, P2665, DOI 10.1073/pnas.94.6.2665; David HN, 2005, BRAIN RES REV, V50, P336, DOI 10.1016/j.brainresrev.2005.09.002; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; DeBoer P, 1996, EUR J PHARMACOL, V317, P257, DOI 10.1016/S0014-2999(96)00761-3; DelleDonne KT, 1997, BRAIN RES, V746, P239, DOI 10.1016/S0006-8993(96)01226-7; DODT HU, 1986, J PHYSIOL-LONDON, V380, P593, DOI 10.1113/jphysiol.1986.sp016304; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Heintz N, 2001, NAT REV NEUROSCI, V2, P861, DOI 10.1038/35104049; Hernandez-Echeagaray E, 1998, NEUROPHARMACOLOGY, V37, P1493, DOI 10.1016/S0028-3908(98)00131-2; Hernandez-Lopez S, 2000, J NEUROSCI, V20, P8987; HERSCH SM, 1994, J NEUROSCI, V14, P3351; HOWE AR, 1995, J NEUROSCI, V15, P458; HSU KS, 1995, NEUROSCI LETT, V197, P141, DOI 10.1016/0304-3940(95)11915-J; KAWAGUCHI Y, 1989, J NEUROPHYSIOL, V62, P1052, DOI 10.1152/jn.1989.62.5.1052; Kreitzer AC, 2005, J NEUROSCI, V25, P10537, DOI 10.1523/JNEUROSCI.2959-05.2005; Lei WL, 2004, J NEUROSCI, V24, P8289, DOI 10.1523/JNEUROSCI.1990-04.2004; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maurice N, 2004, J NEUROSCI, V24, P10289, DOI 10.1523/JNEUROSCI.2155-04.2004; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Olson PA, 2005, J NEUROSCI, V25, P1050, DOI 10.1523/JNEUROSCI.3327-04.2005; PATRIDGE JG, 2002, J NEUROSCI, V22, P2541; Ronesi J, 2005, J PHYSIOL-LONDON, V562, P245, DOI 10.1113/jphysiol.2004.068460; Schmitz Y, 2003, J NEUROCHEM, V87, P273, DOI 10.1046/j.1471-4159.2003.02050.x; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Smith Y, 1998, NEUROSCIENCE, V86, P353; Surmeier DJ, 1996, J NEUROSCI, V16, P6579, DOI 10.1523/jneurosci.16-20-06579.1996; Tkatch T, 2000, J NEUROSCI, V20, P579, DOI 10.1523/JNEUROSCI.20-02-00579.2000; Watanabe K, 1998, J NEUROPHYSIOL, V79, P2568, DOI 10.1152/jn.1998.79.5.2568; Xu WF, 2001, J NEUROSCI, V21, P5944, DOI 10.1523/JNEUROSCI.21-16-05944.2001; Yan Z, 2001, NEUROSCIENCE, V103, P1017, DOI 10.1016/S0306-4522(01)00039-2; Yan Z, 1997, J NEUROPHYSIOL, V77, P1003, DOI 10.1152/jn.1997.77.2.1003; Yin HH, 2005, EUR J NEUROSCI, V22, P513, DOI 10.1111/j.1460-9568.2005.04218.x; Zhang H, 2005, J NEUROSCI, V25, P1037, DOI 10.1523/JNEUROSCI.4554-04.2005	49	381	392	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					443	452		10.1016/j.neuron.2006.04.010	http://dx.doi.org/10.1016/j.neuron.2006.04.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675398	Bronze			2022-12-28	WOS:000237726800013
J	Huberman, AD				Huberman, AD			Nob mice wave goodbye to eye-specific segregation	NEURON			English	Editorial Material							RETINAL WAVES; BETA-2 SUBUNIT; MAPS	Spontaneous retinal activity is necessary to establish and maintain eye-specific projections to the LGN, but whether the spatial and temporal structure of this activity is important remains unclear. A new study by Demas et al. in the current issue of Neuron shows that when the frequency of spontaneous retinal waves is increased and waves abnormally persist past eye opening, eye-specific projections to the LGN desegregate. These results provide important new insight into the mechanisms that drive eye-specific refinement and stabilization.	Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94305 USA	Stanford University	Huberman, AD (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Palo Alto, CA 94305 USA.							Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chapman B, 2000, SCIENCE, V287, P2479, DOI 10.1126/science.287.5462.2479; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Huberman AD, 2003, SCIENCE, V300, P994, DOI 10.1126/science.1080694; Huberman AD, 2005, NAT NEUROSCI, V8, P1013, DOI 10.1038/nn1505; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Stellwagen D, 2002, NEURON, V33, P357, DOI 10.1016/S0896-6273(02)00577-9; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; WILLIAMS RW, 1994, NATURE, V367, P637, DOI 10.1038/367637a0; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29	15	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					175	177		10.1016/j.neuron.2006.04.006	http://dx.doi.org/10.1016/j.neuron.2006.04.006			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630826	Bronze			2022-12-28	WOS:000237176700002
J	Vogels, R				Vogels, Rufin			Representation of response categories in visual cortex	NEURON			English	Editorial Material							ATTENTION; FEATURES	It is known that single neurons in visual area V4 are selective for visual features and that their responses are modulated by selective attention. Surprisingly, a new study by Mirabella et al. in this issue of Neuron found that V4 neurons also signal the behavioral response category of the attended feature.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Sch Med, BE-3000 Louvain, Belgium	KU Leuven	Vogels, R (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Sch Med, Campus Gasthuisberg O&N2,Herestr 49,Bus 1021, BE-3000 Louvain, Belgium.	rufin.vogels@med.kuleuven.be						Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; GALLANT JL, 1993, SCIENCE, V259, P100, DOI 10.1126/science.8418487; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Mirabella G, 2007, NEURON, V54, P303, DOI 10.1016/j.neuron.2007.04.007; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Sakagami M, 1999, NEUROSCI RES, V34, P79, DOI 10.1016/S0168-0102(99)00038-3	12	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					181	183		10.1016/j.neuron.2007.04.008	http://dx.doi.org/10.1016/j.neuron.2007.04.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442238	Bronze			2022-12-28	WOS:000246190600002
J	Ferkey, DM; Hyde, R; Haspel, G; Dionne, HM; Hess, HA; Suzuki, H; Schafer, WR; Koelle, MR; Hart, AC				Ferkey, Denise M.; Hyde, Rhonda; Haspel, Gal; Dionne, Heather M.; Hess, Heather A.; Suzuki, Hiroshi; Schafer, William R.; Koelle, Michael R.; Hart, Anne C.			C-elegans G protein regulator RGS-3 controls sensitivity to sensory stimuli	NEURON			English	Article							HETEROTRIMERIC G-PROTEINS; NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; MECHANOSENSORY RESPONSES; NERVOUS-SYSTEM; ASH NEURONS; GLUTAMATE; CHEMOSENSATION; SEROTONIN; OLFACTION	Signal transduction through heterotrimeric G proteins is critical for sensory response across species. Regulator of G protein signaling (RGS) proteins are negative regulators of signal transduction. Herein we describe a role for C. elegans RGS-3 in the regulation of sensory behaviors. rgs-3 mutant animals fail to respond to intense sensory stimuli but respond normally to low concentrations of specific odorants. We find that loss of RGS-3 leads to aberrantly increased G protein-coupled calcium signaling but decreased synaptic output, ultimately leading to behavioral defects. Thus, rgs-3 responses are restored by decreasing G protein-coupled signal transduction, either genetically or by exogenous dopamine, by expressing a calcium-binding protein to buffer calcium levels in sensory neurons or by enhancing glutamatergic synaptic transmission from sensory neurons. Therefore, while RGS proteins generally act to downregulate signaling, loss of a specific RGS protein in sensory neurons can lead to defective responses to external stimuli.	Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA; Univ Calif San Diego, Div Biol, La Jolla, CA 92093 USA; Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Harvard University; Massachusetts General Hospital; Harvard University; Yale University; University of California System; University of California San Diego; Yale University	Hart, AC (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA.	hart@helix.mgh.harvard.edu	Haspel, Gal/AAH-1269-2019	Haspel, Gal/0000-0001-6701-697X; Dionne, Heather/0000-0001-7700-8885; Schafer, William/0000-0002-6676-8034	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057918, R55GM057918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036918] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016445] Funding Source: NIH RePORTER; MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: Medline; NIDA NIH HHS [R01DA016445-01, R01 DA016445] Funding Source: Medline; NIGMS NIH HHS [R01 GM057918, GM057918] Funding Source: Medline; NIMH NIH HHS [T32 MH018882] Funding Source: Medline; NINDS NIH HHS [NS036918, R01 NS036918] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Barger AJ, 1998, J NEUROSCI, V18, P2871; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1990, COLD SPRING HARB SYM, V55, P529; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Birnby DA, 2000, GENETICS, V155, P85; BRENNER S, 1974, GENETICS, V77, P71; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; Chao MY, 2004, P NATL ACAD SCI USA, V101, P15512, DOI 10.1073/pnas.0403369101; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cuppen E, 2003, COMP FUNCT GENOM, V4, P479, DOI 10.1002/cfg.318; Dong MQ, 2000, GENE DEV, V14, P2003; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hart AC, 1999, J NEUROSCI, V19, P1952; Hess HA, 2004, CELL, V119, P209, DOI 10.1016/j.cell.2004.09.025; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Kahn-Kirby AH, 2004, CELL, V119, P889, DOI 10.1016/j.cell.2004.11.005; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Kuhara A, 2002, NEURON, V33, P751, DOI 10.1016/S0896-6273(02)00607-4; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lans H, 2004, GENETICS, V167, P1677, DOI 10.1534/genetics.103.024786; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lints R, 1999, DEVELOPMENT, V126, P5819; Luo X, 2001, MOL CELL, V7, P651, DOI 10.1016/S1097-2765(01)00211-8; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mellem JE, 2002, NEURON, V36, P933, DOI 10.1016/S0896-6273(02)01088-7; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; Nuttley WM, 2001, LEARN MEMORY, V8, P170, DOI 10.1101/lm.36501; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Rios M, 1999, J NEUROSCI, V19, P3519; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saitoh O, 1997, NATURE, V390, P525, DOI 10.1038/37385; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Taylor CW, 2002, CELL CALCIUM, V32, P321, DOI 10.1016/S0143416002001859; Tobin DM, 2002, NEURON, V35, P307, DOI 10.1016/S0896-6273(02)00757-2; Troemel ER, 1999, BIOESSAYS, V21, P1011, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;1011::AID-BIES5&gt;3.0.CO;2-V; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Vazquez G, 2004, BBA-MOL CELL RES, V1742, P21, DOI 10.1016/j.bbamcr.2004.08.015; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zhu MX, 2005, PFLUG ARCH EUR J PHY, V451, P105, DOI 10.1007/s00424-005-1427-1; Zwaal RR, 1997, GENETICS, V145, P715	70	46	56	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					39	52		10.1016/j.neuron.2006.11.015	http://dx.doi.org/10.1016/j.neuron.2006.11.015			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196529	Green Accepted, Bronze			2022-12-28	WOS:000245126500007
J	Gottlieb, J				Gottlieb, Jacqueline			From thought to action: The parietal cortex as a bridge between perception, action, and cognition	NEURON			English	Review							LATERAL INTRAPARIETAL AREA; SPATIAL ATTENTION; PREFRONTAL CORTEX; NEURONAL-ACTIVITY; TARGET SELECTION; DECISION-MAKING; VISUAL SALIENCE; SINGLE NEURONS; MONKEY; REPRESENTATION	The lateral intraparietal area (LIP) is a subdivision of the inferior parietal lobe that has been implicated in the guidance of spatial attention. In a variety of tasks, LIP provides a "salience representation" of the external world-a topographic visual representation that encodes the locations of salient or behaviorally relevant objects. Recent neurophysiological experiments show that this salience representation incorporates information about multiple behavioral variables-such as a specific motor response, reward, or category membership-associated with the task-relevant object. This integration occurs in a wide variety of tasks, including those requiring eye or limb movements or goaldirected or nontargeting operant responses. Thus, LIP acts as a multifaceted behavioral integrator that binds visuospatial, motor, and cognitive information into a topographically organized signal of behavioral salience. By specifying attentional priority as a synthesis of multiple task demands, LIP operates at the interface of perception, action, and cognition.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University	Gottlieb, J (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.	jg2141@columbia.edu			NEI NIH HHS [R24 EY015634-02, R24 EY015634-03, R24 EY015634-01, R24 EY015634-04, R24 EY015634] Funding Source: Medline; NATIONAL EYE INSTITUTE [R24EY015634] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Balan PF, 2006, J NEUROSCI, V26, P9239, DOI 10.1523/JNEUROSCI.1898-06.2006; Bisley James W, 2003, Adv Neurol, V93, P141; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Ciaramitaro VM, 2001, VISION RES, V41, P57, DOI 10.1016/S0042-6989(00)00203-0; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Gail A, 2006, J NEUROSCI, V26, P9376, DOI 10.1523/JNEUROSCI.1570-06.2006; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Goldberg ME, 2002, ANN NY ACAD SCI, V956, P205, DOI 10.1111/j.1749-6632.2002.tb02820.x; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Ipata AE, 2006, J NEUROSCI, V26, P3656, DOI 10.1523/JNEUROSCI.5074-05.2006; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; JANSSEN P, 1985, NAT NEUROSCI, V8, P234; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Krauzlis RJ, 2004, VISION RES, V44, P1445, DOI 10.1016/j.visres.2004.01.005; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9; Mazurek ME, 2003, CEREB CORTEX, V13, P1257, DOI 10.1093/cercor/bhg097; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Miller EK, 2002, PHILOS T R SOC B, V357, P1123, DOI 10.1098/rstb.2002.1099; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Nelissen K, 2005, SCIENCE, V310, P332, DOI 10.1126/science.1115593; Oristaglio J, 2006, J NEUROSCI, V26, P8310, DOI 10.1523/JNEUROSCI.1779-06.2006; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Rizzolatti G, 2005, CURR OPIN NEUROBIOL, V15, P623, DOI 10.1016/j.conb.2005.10.018; Rizzolatti Giacomo, 2006, Novartis Found Symp, V270, P129; ROBINSON DL, 1995, J NEUROPHYSIOL, V74, P698, DOI 10.1152/jn.1995.74.2.698; Roitman JD, 2002, J NEUROSCI, V22, P9475; Snyder LH, 2000, VISION RES, V40, P1433, DOI 10.1016/S0042-6989(00)00052-3; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Thompson KG, 2005, PROG BRAIN RES, V147, P251, DOI 10.1016/S0079-6123(04)47019-8; Wardak C, 2004, NEURON, V42, P501, DOI 10.1016/S0896-6273(04)00185-0; Wardak C, 2002, J NEUROSCI, V22, P9877; Watanabe M, 2001, EXP BRAIN RES, V140, P511, DOI 10.1007/s002210100856; Wilson M, 2002, PSYCHON B REV, V9, P625, DOI 10.3758/BF03196322; Wise SP, 2000, TRENDS NEUROSCI, V23, P271, DOI 10.1016/S0166-2236(00)01570-8	45	373	379	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					9	16		10.1016/j.neuron.2006.12.009	http://dx.doi.org/10.1016/j.neuron.2006.12.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196526	Bronze			2022-12-28	WOS:000245126500004
J	Leshchyns'ka, I; Sytnyk, V; Richter, M; Andreyeva, A; Puchkov, D; Schachner, M				Leshchyns'ka, Iryna; Sytnyk, Vladimir; Richter, Melanie; Andreyeva, Aksana; Puchkov, Dmytro; Schachner, Melitta			The adhesion molecule CHL1 regulates uncoating of clathrin-coated synaptic vesicles	NEURON			English	Article							CLOSE HOMOLOG; L1 CHL1; MICE DEFICIENT; CALL GENE; NEUROTRANSMITTER EXOCYTOSIS; PRESYNAPTIC TERMINALS; NEURITE OUTGROWTH; NERVE-TERMINALS; IN-VITRO; SCHIZOPHRENIA	In searching for binding partners of the intracellular domain of the immunoglobulin superfamily adhesion molecule CHL1, we identified the clathrin-uncoating ATPase Hsc70. CHL1 gene ablation resulted in reduced targeting of Hsc70 to the synaptic plasma membrane and synaptic vesicles, suggesting CHL1 as a synapse-targeting cue for Hsc70. CHL1 accumulates in presynaptic membranes and, in response to synapse activation, is targeted to synaptic vesicles by endocytosis. CHL1 deficiency or disruption of the CHL1/Hsc70 complex results in accumulation of abnormally high levels of clathrin-coated synaptic vesicles with a reduced ability to release clathrin. Generation of new clathrin-coated synaptic vesicles in an activity-dependent manner is inhibited when the CHL1/Hsc70 complex is disrupted, resulting in impaired uptake and release of FM dyes in synaptic boutons. Abnormalities in clathrin-dependent synaptic vesicle recycling may thus underlie brain malfunctions in humans and mice that carry mutations in the CHL1 gene.	Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; Rutgers State Univ, Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; Rutgers State University New Brunswick	Schachner, M (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol, Martinistr 52, D-20246 Hamburg, Germany.	melitta.schachner@zmnh.uni-hamburg.de	Gimenez, Luis E Diaz/D-9291-2011; Sytnyk, Vladimir/A-3523-2009; Leshchyns'ka, Iryna/A-3579-2009; Sytnyk, Vladimir/A-3878-2010	Puchkov, Dmytro/0000-0001-8341-4847; Leshchyns'ka, Iryna/0000-0002-2025-5831; Richter, Melanie/0000-0003-0575-9625; Sytnyk, Vladimir/0000-0003-1927-2199				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Angeloni D, 1999, PSYCHIATR GENET, V9, P165, DOI 10.1097/00041444-199909000-00011; APPEL F, 1993, J NEUROSCI, V13, P4764; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Buhusi M, 2003, J BIOL CHEM, V278, P25024, DOI 10.1074/jbc.M303084200; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CARTER LL, 1993, J CELL BIOL, V120, P37, DOI 10.1083/jcb.120.1.37; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Chang HC, 2002, J CELL BIOL, V159, P477, DOI 10.1083/jcb.200205086; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Demyanenko GP, 2004, NEURON, V44, P423, DOI 10.1016/j.neuron.2004.10.016; Fatemi SH, 2005, SYNAPSE, V57, P91, DOI 10.1002/syn.20162; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Gerrow K, 2006, FRONT BIOSCI-LANDMRK, V11, P2400, DOI 10.2741/1978; Hannah MJ, 1999, ANNU REV CELL DEV BI, V15, P733, DOI 10.1146/annurev.cellbio.15.1.733; Harata N, 2001, TRENDS NEUROSCI, V24, P637, DOI 10.1016/S0166-2236(00)02030-0; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; Hillenbrand R, 1999, EUR J NEUROSCI, V11, P813, DOI 10.1046/j.1460-9568.1999.00496.x; Irintchev A, 2004, BRAIN RES, V1029, P131, DOI 10.1016/j.brainres.2004.09.042; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; Massol RH, 2006, P NATL ACAD SCI USA, V103, P10265, DOI 10.1073/pnas.0603369103; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Montag-Sallaz M, 2002, MOL CELL BIOL, V22, P7967, DOI 10.1128/MCB.22.22.7967-7981.2002; Morgan JR, 2001, NEURON, V32, P289, DOI 10.1016/S0896-6273(01)00467-6; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; PALLEROS DR, 1993, NATURE, V365, P664, DOI 10.1038/365664a0; Pimm J, 2005, AM J HUM GENET, V76, P902, DOI 10.1086/430095; Pratte M, 2003, BEHAV BRAIN RES, V147, P31, DOI 10.1016/S0166-4328(03)00114-1; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; SCHMID SL, 1991, J CELL BIOL, V114, P869, DOI 10.1083/jcb.114.5.869; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; SMYTHE E, 1989, J CELL BIOL, V108, P843, DOI 10.1083/jcb.108.3.843; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sytnyk V, 2004, J CELL SCI, V117, P381, DOI 10.1242/jcs.00956; Sytnyk V, 2002, J CELL BIOL, V159, P649, DOI 10.1083/jcb.200205098; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tobaben S, 2001, NEURON, V31, P987, DOI 10.1016/S0896-6273(01)00427-5; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Virmani T, 2003, EMBO J, V22, P5347, DOI 10.1093/emboj/cdg514; Yao PJ, 2002, J COMP NEUROL, V447, P152, DOI 10.1002/cne.10217; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	49	71	72	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1011	1025		10.1016/j.neuron.2006.10.020	http://dx.doi.org/10.1016/j.neuron.2006.10.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178404	Bronze			2022-12-28	WOS:000243115100009
J	Chalupa, LM				Chalupa, Leo M.			Developing dendrites demonstrate unexpected specificity	NEURON			English	Editorial Material							RETINA; PATHWAYS	Our knowledge of how developing dendrites attain their mature state is still rudimentary. In this issue of Neuron, Mumm et al. rely on time-lapsed analysis of ingrowing dendrites of retinal ganglion cells in transgenic zebrafish to show that this process is much more specific than has been suspected.	Univ Calif Davis, Sch Med, Coll Biol Sci, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Chalupa, LM (corresponding author), Univ Calif Davis, Sch Med, Coll Biol Sci, Dept Ophthalmol & Vis Sci, Davis, CA 95616 USA.							Bansal A, 2000, J NEUROSCI, V20, P7672; BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0; Bureau I, 2004, NEURON, V42, P789, DOI 10.1016/j.neuron.2004.05.002; Chalupa LM, 2004, PROG RETIN EYE RES, V23, P31, DOI 10.1016/j.preteyeres.2003.10.001; Coombs J, 2006, NEUROSCIENCE, V140, P123, DOI 10.1016/j.neuroscience.2006.02.079; Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004; NELSON R, 2004, VISUAL NEUROSCIENCES, P260; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001	9	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					567	568		10.1016/j.neuron.2006.10.013	http://dx.doi.org/10.1016/j.neuron.2006.10.013			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114038	Bronze			2022-12-28	WOS:000242413100001
J	Clark, E; Vacher, H; Trimmer, JS				Clark, Eliana; Vacher, Helene; Trimmer, James S.			Kv1.1 Takes a deTOR from the Axon to the Dendrite	NEURON			English	Editorial Material							POTASSIUM CHANNELS; SYNAPTIC PLASTICITY; MESSENGER-RNA; LOCALIZATION; MECHANISMS; EXPRESSION; BRAIN	In the October 6th issue of Science, Raab-Graham et al. described two surprising findings. They discovered that local dendritic translation of Kv1.1 occurs in CA1 dendrites of rat hippocampal slices and in cultured neurons. This local translation is inhibited by NMDA receptor-mediated synaptic signaling acting through the mTOR kinase.	Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Clark, E (corresponding author), Univ Calif Davis, Sch Med, Dept Pharmacol, Davis, CA 95616 USA.				NINDS NIH HHS [R37 NS034383-12, R37 NS034383] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034383] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Guan D, 2006, J PHYSIOL-LONDON, V571, P371, DOI 10.1113/jphysiol.2005.097006; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Martin KC, 2006, J NEUROSCI, V26, P7131, DOI 10.1523/JNEUROSCI.1801-06.2006; Misonou H, 2004, NAT NEUROSCI, V7, P711, DOI 10.1038/nn1260; Pirola L, 2003, J BIOL CHEM, V278, P15641, DOI 10.1074/jbc.M208984200; Raab-Graham KF, 2006, SCIENCE, V314, P144, DOI 10.1126/science.1131693; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; WANG H, 1994, J NEUROSCI, V14, P4588; Yuan LL, 2006, PROG NEUROBIOL, V78, P374, DOI 10.1016/j.pneurobio.2006.03.003	13	0	0	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					399	401		10.1016/j.neuron.2006.10.014	http://dx.doi.org/10.1016/j.neuron.2006.10.014			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088206	Bronze			2022-12-28	WOS:000242269700003
J	Krapivinsky, G; Mochida, S; Krapivinsky, L; Cibulsky, SM; Clapham, DE				Krapivinsky, Grigory; Mochida, Sumiko; Krapivinsky, Luba; Cibulsky, Susan M.; Clapham, David E.			The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release	NEURON			English	Article							NEUROTRANSMITTER RELEASE; SYMPATHETIC NEURONS; QUANTAL RELEASE; BINDING PROTEIN; SNAPIN; EXOCYTOSIS; PHOSPHORYLATION; IDENTIFICATION; TRANSMISSION; POTENTIATION	A longstanding hypothesis is that ion channels are present in the membranes of synaptic vesicles and might affect neurotransmitter release. Here we demonstrate that TRPM7, a member of the transient receptor potential (TRP) ion channel family, resides in the membrane of synaptic vesicles of sympathetic neurons, forms molecular complexes with the synaptic vesicle proteins synapsin I and synaptotagmin 1, and directly interacts with synaptic vesicular snapin. In sympathetic neurons, changes in TRPM7 levels and channel activity alter acetylcholine release, as measured by EPSP amplitudes and decay times in postsynaptic neurons. TRPM7 affects EPSP quantal size, an intrinsic property of synaptic vesicle release. Targeted peptide interference of TRPM7's interaction with snapin affects the amplitudes and kinetics of postsynaptic EPSPs. Thus, vesicular TRPM7 channel activity is critical to neurotransmitter release in sympathetic neurons.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Tokyo Med Univ, Dept Physiol, Tokyo 1608402, Japan	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Tokyo Medical University	Clapham, DE (corresponding author), Childrens Hosp, Howard Hughes Med Inst, 1309 Enders Bldg,320 Longwood Ave, Boston, MA 02115 USA.	dclapham@enders.tch.harvard.edu	Clapham, David/S-1123-2019; Clapham, David/R-5974-2019	Clapham, David/0000-0002-4459-9428; 				Bennett M R, 1972, Monogr Physiol Soc, P1; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; BUCKLEY KM, 1983, J NEUROCYTOL, V12, P67, DOI 10.1007/BF01148088; Burgoyne RD, 2002, TRENDS NEUROSCI, V25, P176, DOI 10.1016/S0166-2236(00)02126-3; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chapman ER, 2002, NAT REV MOL CELL BIO, V3, P498, DOI 10.1038/nrm855; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; EHRENSTEIN G, 1991, ANN NY ACAD SCI, V635, P297, DOI 10.1111/j.1749-6632.1991.tb36500.x; FULDNER HH, 1982, EUR J BIOCHEM, V121, P519, DOI 10.1111/j.1432-1033.1982.tb05817.x; Grahammer F, 2001, GASTROENTEROLOGY, V120, P1363, DOI 10.1053/gast.2001.24053; GREENGARD P, 1994, ADV SEC MESS PHOSPH, V29, P31; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Jackson VM, 2001, NEUROCHEM RES, V26, P875, DOI 10.1023/A:1012320130988; Jentsch TJ, 2005, CURR OPIN NEUROBIOL, V15, P319, DOI 10.1016/j.conb.2005.05.002; Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Kelly ML, 1996, BIOPHYS J, V70, P2593, DOI 10.1016/S0006-3495(96)79830-2; LaPlante JM, 2002, FEBS LETT, V532, P183, DOI 10.1016/S0014-5793(02)03670-0; Lockhart ST, 2000, J NEUROBIOL, V42, P460, DOI 10.1002/(SICI)1097-4695(200003)42:4<460::AID-NEU7>3.3.CO;2-R; Micheva KD, 2001, J CELL BIOL, V154, P355, DOI 10.1083/jcb.200102098; MOCHIDA S, 1994, MICROSC RES TECHNIQ, V29, P94, DOI 10.1002/jemt.1070290206; Mochida S, 2003, P NATL ACAD SCI USA, V100, P2813, DOI 10.1073/pnas.262787299; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; MOHANTHAPPA NK, 2002, CULTURING NERVE CELL, P289; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; NANAVATI C, 1993, SCIENCE, V259, P963, DOI 10.1126/science.8438154; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Pawlu C, 2004, NEURON, V42, P607, DOI 10.1016/S0896-6273(04)00269-7; PHELAN P, 1997, NEUROCHEMISTRY PRACT, P27; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Stobrawa SM, 2001, NEURON, V29, P185, DOI 10.1016/S0896-6273(01)00189-1; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Thakur P, 2004, J NEUROSCI, V24, P6476, DOI 10.1523/JNEUROSCI.0590-04.2004; Thevenod F, 2002, AM J PHYSIOL-CELL PH, V283, pC651, DOI 10.1152/ajpcell.00600.2001; UVNAS B, 1989, ACTA PHYSIOL SCAND, V136, P309, DOI 10.1111/j.1748-1716.1989.tb08671.x; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200; YAKIR N, 1995, J PHYSIOL-LONDON, V485, P683, DOI 10.1113/jphysiol.1995.sp020762; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938	50	159	166	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					485	496		10.1016/j.neuron.2006.09.033	http://dx.doi.org/10.1016/j.neuron.2006.09.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088214	Bronze			2022-12-28	WOS:000242269700011
J	Jorntell, H; Hansel, C				Jorntell, Henrik; Hansel, Christian			Synaptic memories upside down: Bidirectional plasticity at cerebellar parallel fiber-Purkinje cell synapses	NEURON			English	Review							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; DOMAIN-CONTAINING PROTEIN; CLIMBING FIBER; ACTION-POTENTIALS; GLUR1 SUBUNIT; NITRIC-OXIDE; KINASE-II; PHOSPHORYLATION; LTD	Information storage in neural circuits depends on activity-dependent alterations in synaptic weights, such as long-term potentiation (LTP) and long-term depression (LTD). Bidirectional synaptic plasticity endows synapses with mechanisms for rapid reversibility, but it remains unclear how it correlates with reversibility in behavioral learning and whether there is a universal synaptic memory mechanism that operates similarly at all types of synapses. A recently discovered postsynaptic form of LTP at cerebellar parallel fiber (PF)-Purkinje cell (PC) synapses provides a reversal mechanism for PF-LTD and enables a fresh look at the implications of bidirectional plasticity in a brain structure that is particularly suitable to correlate cellular to behavioral learning events. Here, we will review recent studies that reveal unique properties of bidirectional cerebellar plasticity and suggest that the induction cascades for cerebellar LTP and LTD provide a mirror image of their counterparts at hippocampal synapses. We will also discuss how PF-LTP helps to explain reversibility observed in cerebellar motor learning.	Erasmus Univ, Ctr Med, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; Lund Univ, Dept Expt Med Sci, Sect Neurosci, SE-22184 Lund, Sweden	Erasmus University Rotterdam; Lund University	Hansel, C (corresponding author), Erasmus Univ, Ctr Med, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.hansel@erasmusmc.nl						AJIMA A, 1995, NEUROREPORT, V6, P297, DOI 10.1097/00001756-199501000-00018; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Apps R, 2005, NAT REV NEUROSCI, V6, P297, DOI 10.1038/nrn1646; BAUDE A, 1994, J NEUROSCI, V14, P2830; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; Bear MF, 2001, SYNAPSES, P455; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Carey MR, 2002, NEURON, V35, P223, DOI 10.1016/S0896-6273(02)00771-7; Chen CF, 1997, J NEUROSCI, V17, P8687; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; CREPEL F, 1982, J PHYSIOL-LONDON, V329, P297, DOI 10.1113/jphysiol.1982.sp014304; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Ekerot CF, 2003, CEREBELLUM, V2, P101, DOI 10.1080/14734220309411; Ekerot CF, 2001, EUR J NEUROSCI, V13, P1303, DOI 10.1046/j.0953-816x.2001.01499.x; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Eto M, 2002, NEURON, V36, P1145, DOI 10.1016/S0896-6273(02)01107-8; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Garwicz M, 1998, J PHYSIOL-LONDON, V512, P277, DOI 10.1111/j.1469-7793.1998.277bf.x; GERRITS NM, 1989, NEUROSCI LETT, V105, P27, DOI 10.1016/0304-3940(89)90006-2; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hansel C, 2006, NEURON, V51, P835, DOI 10.1016/j.neuron.2006.08.013; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hrabetova S, 1996, J NEUROSCI, V16, P5324; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1982, ANNU REV NEUROSCI, V5, P275, DOI 10.1146/annurev.ne.05.030182.001423; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; ITO M, 1982, NEUROSCI LETT, V33, P253, DOI 10.1016/0304-3940(82)90380-9; Ito M, 1984, CEREBELLUM NEURAL CO; Ito M, 2006, PROG NEUROBIOL, V78, P272, DOI 10.1016/j.pneurobio.2006.02.006; Jacoby S, 2001, J PHYSIOL-LONDON, V535, P825, DOI 10.1111/j.1469-7793.2001.t01-1-00825.x; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; Kimura T, 2005, P NATL ACAD SCI USA, V102, P17160, DOI 10.1073/pnas.0508190102; Kishimoto Y, 2001, EUR J NEUROSCI, V14, P1515, DOI 10.1046/j.0953-816x.2001.01772.x; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; Launey T, 2004, P NATL ACAD SCI USA, V101, P676, DOI 10.1073/pnas.0302914101; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 2001, SYNAPSES, P393; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1997, LEARN MEMORY, V4, P130, DOI 10.1101/lm.4.1.130; McCormack SG, 2006, NEURON, V50, P75, DOI 10.1016/j.neuron.2006.02.027; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; Raymond JL, 1998, J NEUROSCI, V18, P9112; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; Schmolesky MT, 2002, ANN NY ACAD SCI, V978, P359, DOI 10.1111/j.1749-6632.2002.tb07581.x; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SIMPSON JI, 1974, BRAIN RES, V82, P302, DOI 10.1016/0006-8993(74)90610-6; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Storm DR, 1998, NEURON, V20, P1199, DOI 10.1016/S0896-6273(00)80500-0; STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X; Thiels E, 1998, NEUROSCIENCE, V86, P1023, DOI 10.1016/S0306-4522(98)00135-3; Thompson RF, 1996, P NATL ACAD SCI USA, V93, P13438, DOI 10.1073/pnas.93.24.13438; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Welsh JP, 2005, P NATL ACAD SCI USA, V102, P17166, DOI 10.1073/pnas.0508191102; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yeo CH, 1998, TRENDS COGN SCI, V2, P322, DOI 10.1016/S1364-6613(98)01219-4	113	259	260	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					227	238		10.1016/j.neuron.2006.09.032	http://dx.doi.org/10.1016/j.neuron.2006.09.032			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046686	Bronze			2022-12-28	WOS:000241799900004
J	Roesch, MR; Taylor, AR; Schoenbaum, G				Roesch, Matthew R.; Taylor, Adam R.; Schoenbaum, Geoffrey			Encoding of time-discounted rewards in orbitofrontal cortex is independent of value representation	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS CORE; BASOLATERAL AMYGDALA; NEURONAL-ACTIVITY; IMPULSIVE CHOICE; FRONTAL-CORTEX; DELAYED REINFORCEMENT; QUANTITATIVE-ANALYSIS; LESIONS; TASK	We monitored single-neuron activity in the orbitofrontal cortex of rats performing a time-discounting task in which the spatial location of the reward predicted whether the delay preceding reward delivery would be short or long. We found that rewards delivered after a short delay elicited a stronger neuronal response than those delivered after a long delay in most neurons. Activity in these neurons was not influenced by reward size when delays were held constant. This was also true for a minority of neurons that exhibited sustained increases in firing in anticipation of delayed reward. Thus, encoding of time-discounted rewards in orbitofrontal cortex is independent of the encoding of absolute reward value. These results are contrary to the proposal that orbitofrontal neurons signal the value of delayed rewards in a common currency and instead suggest alternative proposals for the role this region plays in guiding responses for delayed versus immediate rewards.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Neurosci Program, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Roesch, MR (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, 20 Penn St,HSF-2 S251, Baltimore, MD 21201 USA.	mroes001@umaryland.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER; NIDA NIH HHS [R01-DA015718, R01 DA015718, R01 DA015718-03] Funding Source: Medline; NINDS NIH HHS [T32 NS007375, T32-NS07375] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arana FS, 2003, J NEUROSCI, V23, P9632; Baxter MG, 2000, J NEUROSCI, V20, P4311; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Cardinal RN, 2004, ANN NY ACAD SCI, V1021, P33, DOI 10.1196/annals.1308.004; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-9; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Elster J., 1992, CHOICE TIME, P213; Evenden JL, 1996, PSYCHOPHARMACOLOGY, V128, P161, DOI 10.1007/s002130050121; Goto Y, 2005, NAT NEUROSCI, V8, P805, DOI 10.1038/nn1471; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; GROENEWEGEN HJ, 1987, NEUROSCIENCE, V23, P103, DOI 10.1016/0306-4522(87)90275-2; GROENEWEGEN HJ, 1990, PROG BRAIN RES, V85, P95; HABER SN, 1995, J NEUROSCI, V15, P4851; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Ho MY, 1999, PSYCHOPHARMACOLOGY, V146, P362, DOI 10.1007/PL00005482; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kalenscher T, 2005, CURR BIOL, V15, P594, DOI 10.1016/j.cub.2005.02.052; Katz DB, 2002, CURR OPIN NEUROBIOL, V12, P448, DOI 10.1016/S0959-4388(02)00341-0; Katz DB, 2001, J NEUROSCI, V21, P4478, DOI 10.1523/JNEUROSCI.21-12-04478.2001; Kheramin S, 2002, PSYCHOPHARMACOLOGY, V165, P9, DOI 10.1007/s00213-002-1228-6; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lipton PA, 1999, NEURON, V22, P349, DOI 10.1016/S0896-6273(00)81095-8; MCDONALD AJ, 1991, NEUROSCIENCE, V44, P1, DOI 10.1016/0306-4522(91)90247-L; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, J NEUROSCI, V23, P7931; Pickens CL, 2003, J NEUROSCI, V23, P11078; Roesch MR, 2007, CEREB CORTEX, V17, P643, DOI 10.1093/cercor/bhk009; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Rolls ET, 1996, PHILOS T ROY SOC B, V351, P1433, DOI 10.1098/rstb.1996.0128; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; RUDEBECK PH, 2006, IN PRESS NAT NEUROSC; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schoenbaum G, 2005, CEREB CORTEX, V15, P1162, DOI 10.1093/cercor/bhh216; SCHOENBAUM G, 1995, J NEUROPHYSIOL, V74, P733, DOI 10.1152/jn.1995.74.2.733; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; THALER R, 1981, ECON LETT, V8, P201, DOI 10.1016/0165-1765(81)90067-7; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Wade TR, 2000, PSYCHOPHARMACOLOGY, V150, P90; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	56	227	230	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					509	520		10.1016/j.neuron.2006.06.027	http://dx.doi.org/10.1016/j.neuron.2006.06.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908415	Green Accepted, Bronze			2022-12-28	WOS:000240504700013
J	Elia, LP; Yamamoto, M; Zang, KL; Reichardt, LF				Elia, Lisa P.; Yamamoto, Miya; Zang, Keling; Reichardt, Louis F.			p120 Catenin regulates dendritic spine and synapse development through Rho-family GTPases and cadherins	NEURON			English	Article							BETA-CATENIN; N-CADHERIN; TYROSINE PHOSPHORYLATION; CELL-ADHESION; DELTA-CATENIN; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; CONTACT FORMATION; NERVOUS-SYSTEM; NMDA RECEPTOR	Both the cadherin-catenin complex and Rho-family GTPases have been shown to regulate dendrite development. We show here a role for p120 catenin (p120ctn) in regulating spine and synapse formation in the developing mouse brain. p120catenin gene deletion in hippocampal pyramidal neurons in vivo resulted in reduced spine and synapse densities along dendrites. In addition, p120 catenin loss resulted in reduced cadherin levels and misregulation of Rho-family GTPases, with decreased Rac1 and increased RhoA activity. Analyses in vitro indicate that the reduced spine density reflects aberrant Rho-family GTPase signaling, whereas the effects on spine maturation appear to result from reduced cadherin levels and possibly aberrant Rho-family GTPase signaling. Thus, p120ctn acts as a signal coordinator between cadherins and Rho-family GTPases to regulate cytoskeletal changes required during spine and synapse development.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, 1550 4th St, San Francisco, CA 94143 USA.	lfr@cgl.ucsf.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033-25, P01 NS016033] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Aono S, 1999, J CELL BIOL, V145, P551, DOI 10.1083/jcb.145.3.551; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; Bozdagi O, 2004, MOL CELL NEUROSCI, V27, P509, DOI 10.1016/j.mcn.2004.08.008; Chauvet N, 2003, MOL CELL NEUROSCI, V22, P467, DOI 10.1016/S1044-7431(03)00030-7; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Cozzolino M, 2003, MOL BIOL CELL, V14, P1964, DOI 10.1091/mbc.E02-08-0469; Davis MA, 2006, DEV CELL, V10, P21, DOI 10.1016/j.devcel.2005.12.004; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Elste AM, 2006, J COMP NEUROL, V495, P324, DOI 10.1002/cne.20876; Esser S, 1998, J CELL SCI, V111, P1853; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fiala JC, 2002, BRAIN RES REV, V39, P29, DOI 10.1016/S0165-0173(02)00158-3; Fiala JC, 1998, J NEUROSCI, V18, P8900; Franz CM, 2004, J BIOL CHEM, V279, P6588, DOI 10.1074/jbc.M312812200; Gavard J, 2004, J CELL SCI, V117, P257, DOI 10.1242/jcs.00857; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Gorski JA, 2002, J NEUROSCI, V22, P6309; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Gray NW, 2005, J CELL SCI, V118, P1279, DOI 10.1242/jcs.01711; Grosheva I, 2001, J CELL SCI, V114, P695; Hatzfeld M, 2005, EUR J CELL BIOL, V84, P205, DOI 10.1016/j.ejcb.2004.12.016; Hering H, 2003, J NEUROSCI, V23, P11759; Ho C, 2000, J COMP NEUROL, V420, P261; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081; Keirsebilck A, 1998, GENOMICS, V50, P129, DOI 10.1006/geno.1998.5325; KINCH MS, 1995, J CELL BIOL, V130, P461, DOI 10.1083/jcb.130.2.461; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Konur S, 2004, J NEUROBIOL, V59, P236, DOI 10.1002/neu.10306; Li WJ, 2005, DEV DYNAM, V234, P512, DOI 10.1002/dvdy.20496; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Martinez MC, 2003, J CELL BIOL, V162, P99, DOI 10.1083/jcb.200211025; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Orsulic S, 2000, J CELL SCI, V113, P1793; Ozawa M, 2001, J CELL SCI, V114, P503; Pacquelet A, 2005, J CELL BIOL, V170, P803, DOI 10.1083/jcb.200506131; Park E, 2003, J BIOL CHEM, V278, P19220, DOI 10.1074/jbc.M301052200; Park JI, 2005, DEV CELL, V8, P843, DOI 10.1016/j.devcel.2005.04.010; Perez-Moreno M, 2006, CELL, V124, P631, DOI 10.1016/j.cell.2005.11.043; Prakash S, 2005, NAT NEUROSCI, V8, P443, DOI 10.1038/nn1415; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; SHIBAMOTO S, 1995, J CELL BIOL, V128, P949, DOI 10.1083/jcb.128.5.949; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Singh G, 2003, TRENDS BIOCHEM SCI, V28, P464, DOI 10.1016/S0968-0004(03)00176-2; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Teng JL, 2005, NAT CELL BIOL, V7, P474, DOI 10.1038/ncb1249; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Xia XB, 2003, BIOCHEMISTRY-US, V42, P9195, DOI 10.1021/bi034597h; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Xu G, 2004, J CELL SCI, V117, P3207, DOI 10.1242/jcs.01174; Yanagisawa M, 2004, J BIOL CHEM, V279, P9512, DOI 10.1074/jbc.M310895200; Yap AS, 1998, J CELL BIOL, V141, P779, DOI 10.1083/jcb.141.3.779; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	71	160	163	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					43	56		10.1016/j.neuron.2006.05.018	http://dx.doi.org/10.1016/j.neuron.2006.05.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815331	Bronze, Green Accepted			2022-12-28	WOS:000239037700009
J	Greger, IH; Akamine, P; Khatri, L; Ziff, EB				Greger, Ingo H.; Akamine, Pearl; Khatri, Latika; Ziff, Edward B.			Developmentally regulated, combinatorial RNA processing modulates AMPA receptor biogenesis	NEURON			English	Article							GLUTAMATE-OPERATED CHANNELS; LIGAND-BINDING CORE; AMINO-ACID-RESIDUES; KINETIC-PROPERTIES; ENDOPLASMIC-RETICULUM; RECOMBINANT AMPA; QUALITY-CONTROL; MESSENGER-RNAS; POINT MUTATION; DESENSITIZATION	The subunit composition determines AMPA receptor (AMPA-R) function and trafficking. Mechanisms underlying channel assembly are thus central to the efficacy and plasticity of glutamatergic synapses. We previously showed that RNA editing at the Q/R site of the GluR2 subunit contributes to the assembly of AMPAR heteromers by attenuating formation of GluR2 homotetramers. Here we report that this function of the Q/R site depends on subunit contacts between adjacent ligand binding domains (LBDs). Changes of LBD interface contacts alter GluR2 assembly properties, forward traffic, and expression at synapses. Interestingly, developmentally regulated RNA editing within the LBD (at the R/G site) produces analogous effects. Our data reveal that editing to glycine reduces the self-assembly competence of this critical subunit and slows GluR2 maturation in the endoplasmic reticulum (ER). Therefore, RNA editing sites, located at strategic subunit interfaces, shape AMPA-R assembly and trafficking in a developmentally regulated manner.	MRC, Lab Mol Biol, Neurobiol Div, Cambridge CB2 2QH, England; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	MRC Laboratory Molecular Biology; New York University	Greger, IH (corresponding author), MRC, Lab Mol Biol, Neurobiol Div, Cambridge CB2 2QH, England.	ig@mrc-lmb.cam.ac.uk		Ziff, Edward/0000-0001-7389-8649	MRC [MC_U105174197] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [R37AG013620, R01AG013620] Funding Source: NIH RePORTER; Medical Research Council [MC_U105174197] Funding Source: Medline; NIA NIH HHS [AG13620] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Banke TG, 2001, J NEUROSCI, V21, P3052, DOI 10.1523/JNEUROSCI.21-09-03052.2001; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BASS MF, 2001, ANNU REV BIOCHEM, V71, P817; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BRUSA R, 1995, SCIENCE, V270, P1677, DOI 10.1126/science.270.5242.1677; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Chen GQ, 1998, PROTEIN SCI, V7, P2623, DOI 10.1002/pro.5560071216; DeLano W.L, PYMOL MOL GRAPHICS S; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fleck MW, 2003, J NEUROSCI, V23, P1219; FLOCCO MW, 1995, J MOL BIOL, V254, P96, DOI 10.1006/jmbi.1995.0602; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grosskreutz J, 2003, EUR J NEUROSCI, V17, P1173, DOI 10.1046/j.1460-9568.2003.02531.x; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Gurevich I, 2002, J NEUROSCI, V22, P10529; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Keegan LP, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-209; Krampfl K, 2002, EUR J NEUROSCI, V15, P51, DOI 10.1046/j.0953-816x.2001.01841.x; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Lampinen M, 1998, EMBO J, V17, P4704, DOI 10.1093/emboj/17.16.4704; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; LOMELI H, 1994, SCIENCE, V266, P1709, DOI 10.1126/science.7992055; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Mayer ML, 2005, CURR OPIN NEUROBIOL, V15, P282, DOI 10.1016/j.conb.2005.05.004; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Netzer WJ, 1997, NATURE, V388, P343, DOI 10.1038/41024; Norledge BV, 1996, NAT STRUCT BIOL, V3, P267, DOI 10.1038/nsb0396-267; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Paternain AV, 2003, J NEUROSCI, V23, P8641; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x; Rosenthal JJC, 2002, NEURON, V34, P743, DOI 10.1016/S0896-6273(02)00701-8; Rubio ME, 1997, NEURON, V18, P939, DOI 10.1016/S0896-6273(00)80333-5; Sans N, 2003, J NEUROSCI, V23, P9367; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; Seeburg PH, 2002, NEURON, V35, P17, DOI 10.1016/S0896-6273(02)00760-2; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Singh J., 1992, ATLAS PROTEIN SIDE C; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Valente L, 2005, PROG NUCLEIC ACID RE, V79, P299, DOI 10.1016/S0079-6603(04)79006-6; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004	73	82	85	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					85	97		10.1016/j.neuron.2006.05.020	http://dx.doi.org/10.1016/j.neuron.2006.05.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815334	Bronze			2022-12-28	WOS:000239037700012
J	Frith, CD; Frith, U				Frith, Chris D.; Frith, Uta			The neural basis of mentalizing	NEURON			English	Review							FRONTAL-LOBE; MIND; INTENTIONS; SYSTEMS; CORTEX	Mentalizing refers to our ability to read the mental states of other agents and engages many neural processes. The brain's mirror system allows us to share the emotions of others. Through perspective taking, we can infer what a person currently believes about the world given their point of view. Finally, the human brain has the unique ability to represent the mental states of the self and the other and the relationship between these mental states, making possible the communication of ideas.	UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCL, Inst Cognit Neurosci, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Frith, CD (corresponding author), UCL, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England.	cfirth@fil.ion.ucl.ac.uk	Frith, Chris D/A-2171-2009; Galantucci, Bruno/E-5770-2010; Frith, Uta/C-1757-2008	Frith, Chris D/0000-0002-8665-0690; Frith, Uta/0000-0002-9063-4466	Medical Research Council [G9617036] Funding Source: Medline; MRC [G9617036] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; AICHHORN M, 2005, NEUROIMAGE, V30, P1059, DOI DOI 10.1016/J.NEURONIMAGE; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Bird CM, 2004, BRAIN, V127, P914, DOI 10.1093/brain/awh108; Blanke O, 2005, J NEUROSCI, V25, P550, DOI 10.1523/JNEUROSCI.2612-04.2005; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Damasio H, 2004, COGNITION, V92, P179, DOI 10.1016/j.cognition.2002.07.001; DENNETT CD, 1987, INT STANCE; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Funnell E, 2001, COGNITIVE NEUROPSYCH, V18, P323, DOI 10.1080/02643290042000134; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Grezes J, 2004, J NEUROSCI, V24, P5500, DOI 10.1523/JNEUROSCI.0219-04.2004; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; INGVAR DH, 1985, HUM NEUROBIOL, V4, P127; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Langton SRH, 2000, TRENDS COGN SCI, V4, P50, DOI 10.1016/S1364-6613(99)01436-9; Pelphrey KA, 2004, PSYCHOL SCI, V15, P598, DOI 10.1111/j.0956-7976.2004.00726.x; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.3.CO;2-9; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; SPERBERG D, 1995, RELEVANCE COMMUNICAT; Stuss DT, 2001, BRAIN, V124, P279, DOI 10.1093/brain/124.2.279; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; Walter H, 2004, J COGNITIVE NEUROSCI, V16, P1854, DOI 10.1162/0898929042947838; WIMMER H, 1988, CHILD DEV, V59, P386, DOI 10.1111/j.1467-8624.1988.tb01474.x	29	1076	1087	12	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					531	534		10.1016/j.neuron.2006.05.001	http://dx.doi.org/10.1016/j.neuron.2006.05.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701204	Bronze			2022-12-28	WOS:000237875200005
J	Perez-Garci, E; Gassmann, M; Bettler, B; Larkum, ME				Perez-Garci, E; Gassmann, M; Bettler, B; Larkum, ME			The GABA(B1b) isoform mediates long-lasting inhibition of dendritic Ca2+ spikes in layer 5 somatosensory pyramidal neurons	NEURON			English	Article							RAT VISUAL-CORTEX; GABAERGIC NEURONS; IN-VIVO; SUBCELLULAR-LOCALIZATION; COINCIDENCE DETECTION; RECEPTOR SUBUNITS; ACTION-POTENTIALS; APICAL DENDRITES; CEREBRAL-CORTEX; MESSENGER-RNA	The apical tuft of layer 5 pyramidal neurons is innervated by a large number of inhibitory inputs with unknown functions. Here, we studied the functional consequences and underlying molecular mechanisms of apical inhibition on dendritic spike activity. Extracellular stimulation of layer 1, during blockade of glutamatergic transmission, inhibited the dendritic Ca2+ spike for up to 400 ms. Activation of metabotropic GABA(B) receptors was responsible for a gradual and long-lasting inhibitory effect, whereas GABA(A) receptors mediated a short-lasting (similar to 150 ms) inhibition. Our results suggest that the mechanism underlying the GABAB inhibition of Ca2+ spikes involves direct blockade of dendritic Ca2+ channels. By using knockout mice for the two predominant GABA(B1) isoforms, GABA(B1a). and GABA(B1b), we showed that postsynaptic inhibition of Ca2+ spikes is mediated by GABA(B1b), whereas presynaptic inhibition of GABA release is mediated by GABA(B1a). We conclude that the molecular subtypes of GABA(B) receptors play strategically different physiological roles in neocortical neurons.	Univ Bern, Inst Physiol, CH-3012 Bern, Switzerland; Univ Basel, Pharmazentrum, Dept Clin Biol Sci, Inst Physiol, CH-4056 Basel, Switzerland	University of Bern; University of Basel	Perez-Garci, E (corresponding author), Univ Bern, Inst Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.		bettler, bernhard/AAO-8018-2020	Bettler, Bernhard/0000-0003-0842-8207; Larkum, Matthew/0000-0001-9799-2656; Gassmann, Martin/0000-0001-6201-3032				AMITAI Y, 1993, CEREB CORTEX, V3, P26, DOI 10.1093/cercor/3.1.26; BEAULIEU C, 1990, EUR J NEUROSCI, V2, P296, DOI 10.1111/j.1460-9568.1990.tb00421.x; BENARDO LS, 1994, J PHYSIOL-LONDON, V476, P203, DOI 10.1113/jphysiol.1994.sp020124; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BEULIEU C, 1992, CEREB CORTEX, V2, P295; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Bischoff S, 1999, J COMP NEUROL, V412, P1; Buzsaki G, 1996, P NATL ACAD SCI USA, V93, P9921, DOI 10.1073/pnas.93.18.9921; CAMPBELL V, 1993, J PHYSIOL-LONDON, V470, P1; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cauller LJ, 1998, J COMP NEUROL, V390, P297; Chen HM, 1997, J NEUROPHYSIOL, V78, P3484, DOI 10.1152/jn.1997.78.6.3484; Chu ZG, 2003, J NEUROSCI, V23, P96; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Costa E, 2002, NEUROPHARMACOLOGY, V43, P925, DOI 10.1016/S0028-3908(02)00199-5; DEBLAS AL, 1988, J NEUROSCI, V8, P602; DeFelipe J., 1988, CAJAL CEREBRAL CORTE; DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2; Diamond ME, 1995, CEREBR CORT, V11, P189; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; Fritschy JM, 1998, J COMP NEUROL, V390, P194; GAHWILER BH, 1985, P NATL ACAD SCI USA, V82, P1558, DOI 10.1073/pnas.82.5.1558; Gonchar Y, 1997, CEREB CORTEX, V7, P347, DOI 10.1093/cercor/7.4.347; Gonchar Y, 2003, J NEUROSCI, V23, P10904; Gonchar Y, 1999, J COMP NEUROL, V406, P346, DOI 10.1002/(SICI)1096-9861(19990412)406:3<346::AID-CNE4>3.0.CO;2-E; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; HELMCHEN F, 2005, IMAGING NEUROSCIENCE, P253; Hestrin S, 1996, J NEUROSCI, V16, P5290; HOUSER CR, 1983, J NEUROCYTOL, V12, P617, DOI 10.1007/BF01181527; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; KIM HG, 1995, J NEUROPHYSIOL, V74, P1810, DOI 10.1152/jn.1995.74.4.1810; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Liang FY, 2000, J COMP NEUROL, V416, P475, DOI 10.1002/(SICI)1096-9861(20000124)416:4<475::AID-CNE5>3.0.CO;2-V; Llinas RR, 2002, P NATL ACAD SCI USA, V99, P449, DOI 10.1073/pnas.012604899; Lopez-Bendito G, 2002, EUR J NEUROSCI, V15, P1766, DOI 10.1046/j.1460-9568.2002.02032.x; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Migliore M, 2002, NAT REV NEUROSCI, V3, P362, DOI 10.1038/nrn810; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; NEWBERRY NR, 1984, NATURE, V308, P450, DOI 10.1038/308450a0; Olson IR, 2001, BRAIN, V124, P1417, DOI 10.1093/brain/124.7.1417; Poorkhalkali N, 2000, ANAT EMBRYOL, V201, P1, DOI 10.1007/PL00008224; Princivalle AP, 2001, NEUROREPORT, V12, P591, DOI 10.1097/00001756-200103050-00032; Radnikow G, 2002, J NEUROSCI, V22, P6908; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schiller Y, 2004, J NEUROPHYSIOL, V92, P862, DOI 10.1152/jn.00972.2003; SCHOLZ KP, 1991, J PHYSIOL-LONDON, V444, P669, DOI 10.1113/jphysiol.1991.sp018900; Shao ZW, 1999, J NEUROPHYSIOL, V81, P1014, DOI 10.1152/jn.1999.81.3.1014; Shlosberg D, 2003, EUR J NEUROSCI, V18, P2751, DOI 10.1111/j.1460-9568.2003.03016.x; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Takigawa T, 1999, J PHYSIOL-LONDON, V517, P385, DOI 10.1111/j.1469-7793.1999.0385t.x; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053; Thomson AM, 2003, CEREB CORTEX, V13, P5, DOI 10.1093/cercor/13.1.5; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2005, J NEUROSCI, V25, P5894, DOI 10.1523/JNEUROSCI.0502-05.2005; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; WONG RKS, 1979, SCIENCE, V204, P1228, DOI 10.1126/science.451569; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	74	194	202	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 18	2006	50	4					603	616		10.1016/j.neuron.2006.04.019	http://dx.doi.org/10.1016/j.neuron.2006.04.019			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701210	Bronze			2022-12-28	WOS:000237875200011
J	Turk-Browne, NB; Yi, DJ; Chun, MM				Turk-Browne, NB; Yi, DJ; Chun, MM			Linking implicit and explicit memory: Common encoding factors and shared representations	NEURON			English	Article							PERCEPTUAL FLUENCY; ATTENTIONAL MODULATION; COGNITIVE NEUROSCIENCE; REPETITION SUPPRESSION; RECOGNITION MEMORY; WORKING-MEMORY; DISSOCIATION; SUPPORT; STATE; DEACTIVATIONS	Dissociations between implicit and explicit memory have featured prominently in theories of human memory. However, similarities between the two forms of memory have been less studied. One open question concerns whether implicit and explicit memory share encoding resources. To explore this question, we employed a subsequent memory design in which several novel scenes were repeated once during an fMRI session and explicit memory for the scenes was unexpectedly tested afterward. Subsequently remembered scenes produced more behavioral priming and neural attenuation-two conventional measures of implicit memory-than did subsequently forgotten scenes. Moreover, brain-behavior correlations between these two implicit measures were mediated by subsequent memory. Finally, tonic activity, possibly reflecting the natural time course of attention, was predictive of subsequent memory. These results suggest that implicit and explicit memory are subject to the same encoding factors and can rely on similar perceptual processes and representations.	Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Chun, MM (corresponding author), Yale Univ, Dept Psychol, Box 11A Yale StnPOB 11A, New Haven, CT 06520 USA.	marvin.chun@yale.edu		Chun, Marvin/0000-0003-1070-7993				Badgaiyan RD, 1997, J NEUROSCI, V17, P4904; Baker CI, 2004, PSYCHOL SCI, V15, P460, DOI 10.1111/j.0956-7976.2004.00702.x; Bentin S, 1998, ACTA PSYCHOL, V98, P311, DOI 10.1016/S0001-6918(97)00048-6; BLAXTON TA, 1989, J EXP PSYCHOL LEARN, V15, P657, DOI 10.1037/0278-7393.15.4.657; Brett M., 2002, 8 INT C FUNCT MAPP H, V16, P497; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Buckner RL, 1998, P NATL ACAD SCI USA, V95, P891, DOI 10.1073/pnas.95.3.891; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Conroy MA, 2005, COGN AFFECT BEHAV NE, V5, P14, DOI 10.3758/CABN.5.1.14; Daselaar SM, 2004, NEUROIMAGE, V23, P921, DOI 10.1016/j.neuroimage.2004.07.031; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Eger E, 2004, J NEUROPHYSIOL, V92, P1241, DOI 10.1152/jn.00206.2004; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; GABRIELI JDE, 1995, PSYCHOL SCI, V6, P76, DOI 10.1111/j.1467-9280.1995.tb00310.x; Gonsalves BD, 2005, NEURON, V47, P751, DOI 10.1016/j.neuron.2005.07.013; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P501, DOI 10.1037/0278-7393.11.3.501; Grunwald T, 2003, NEUROIMAGE, V20, pS139, DOI 10.1016/j.neuroimage.2003.09.004; Henson R, 2000, SCIENCE, V287, P1269, DOI 10.1126/science.287.5456.1269; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Henson RNA, 2003, NEUROPSYCHOLOGIA, V41, P263, DOI 10.1016/S0028-3932(02)00159-8; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; Hyder F, 2002, P NATL ACAD SCI USA, V99, P10771, DOI 10.1073/pnas.132272299; Ishai A, 2004, P NATL ACAD SCI USA, V101, P9827, DOI 10.1073/pnas.0403559101; James TW, 2006, HUM BRAIN MAPP, V27, P37, DOI 10.1002/hbm.20165; JERNIGAN TL, 1993, NEUROPSYCHOLOGY, V7, P14, DOI DOI 10.1037/0894-4105.7.1.14; Jiang YH, 2001, Q J EXP PSYCHOL-A, V54, P1105, DOI 10.1080/02724980042000516; Jimenez L, 1999, J EXP PSYCHOL LEARN, V25, P236, DOI 10.1037/0278-7393.25.1.236; JOHNSON MK, 1994, BINDING COMPLEX MEMO, P311; JOHNSTON WA, 1991, J EXP PSYCHOL LEARN, V17, P210, DOI 10.1037/0278-7393.17.2.210; Kinder A, 2003, PSYCHOL REV, V110, P728, DOI 10.1037/0033-295X.110.4.728; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Kohler S, 2005, HIPPOCAMPUS, V15, P763, DOI 10.1002/hipo.20098; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Maccotta L, 2004, J COGNITIVE NEUROSCI, V16, P1625, DOI 10.1162/0898929042568451; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; MOSCOVITCH M, 1993, J EXP PSYCHOL LEARN, V19, P148, DOI 10.1037/0278-7393.19.1.148; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; O'Craven KM, 2000, J COGNITIVE NEUROSCI, V12, P1013, DOI 10.1162/08989290051137549; O'Kane G, 2005, HIPPOCAMPUS, V15, P326, DOI 10.1002/hipo.20053; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, CURR BIOL, V11, P1528, DOI 10.1016/S0960-9822(01)00454-7; Paller KA, 2003, NEURON, V38, P507, DOI 10.1016/S0896-6273(03)00198-3; Poldrack RA, 1996, PSYCHON B REV, V3, P434, DOI 10.3758/BF03214547; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; RATCLIFF R, 1988, PSYCHOL REV, V95, P385, DOI 10.1037/0033-295X.95.3.385; Reynolds JR, 2004, NEUROIMAGE, V21, P1472, DOI 10.1016/j.neuroimage.2003.10.033; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Schacter Daniel, 1994, P1; SCHACTER DL, 1991, J EXP PSYCHOL LEARN, V17, P3, DOI 10.1037/0278-7393.17.1.3; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schott B, 2002, J COGNITIVE NEUROSCI, V14, P578, DOI 10.1162/08989290260045828; Schott BH, 2005, P NATL ACAD SCI USA, V102, P1257, DOI 10.1073/pnas.0409070102; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Squire L. R., 1987, MEMORY BRAIN; TALARACH J, 1988, COPLANAR STEREOTACTI; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; TULVING E, 1990, SCIENCE, V247, P301, DOI 10.1126/science.2296719; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552; TURKBROWNE NB, 2006, IN PRESS CEREB CORTE; Verfaellie M, 1999, NEUROPSYCHOLOGY, V13, P198, DOI 10.1037/0894-4105.13.2.198; Vuilleumier P, 2005, J COGNITIVE NEUROSCI, V17, P1245, DOI 10.1162/0898929055002409; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner AD, 2001, CURR BIOL, V11, pR964, DOI 10.1016/S0960-9822(01)00575-9; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weis S, 2004, CEREB CORTEX, V14, P256, DOI 10.1093/cercor/bhg125; Wig GS, 2005, NAT NEUROSCI, V8, P1228, DOI 10.1038/nn1515; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Yi DJ, 2005, J NEUROSCI, V25, P3593, DOI 10.1523/JNEUROSCI.4677-04.2005; Yi DJ, 2004, NAT NEUROSCI, V7, P992, DOI 10.1038/nn1294; YI DJ, 2006, IN PRESS BRAIN RES	79	164	171	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					917	927		10.1016/j.neuron.2006.01.030	http://dx.doi.org/10.1016/j.neuron.2006.01.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	024WQ	16543138	Bronze			2022-12-28	WOS:000236227500018
J	Becker, EBE; Bonni, A				Becker, EBE; Bonni, A			Pin1 mediates neural-specific activation of the mitochondrial apoptotic machinery	NEURON			English	Article							PROLYL ISOMERASE PIN1; NEURONAL APOPTOSIS; SCAFFOLD PROTEIN; CELL-DEATH; C-JUN; SIGNALING PATHWAY; AXONAL-TRANSPORT; PHOSPHORYLATION; BIM; ISOMERIZATION	Apoptosis of neurons plays fundamental roles in brain development and disease. Although neurons share with other cell types components of the mitochondrial apoptotic machinery, how this machinery is specifically activated in neurons remains poorly understood. Remarkably, phosphorylation of the BH3-only protein BIMEL at Ser65 triggers apoptosis in neurons but suppresses cell death in non-neural cells. Here, we report that the prolyl isomerase Pin1 interacts with Ser65-phosphorylated BIMEL in neurons. Pinl is enriched at the mitochondrial membrane in neurons, where it forms a physical complex with the neuron-specific JNK scaffold protein JIP3. Activation of JNK signaling induces the dissociation of Pin1 from JIP3 and concomitantly promotes Pinl binding to phosphorylated BIMEL. The interaction of Pin1 with phosphorylated BIMEL stabilizes BIMEL and thereby activates neuronal apoptosis. These findings define a neural-specific mechanism of cell death whereby Pinl couples phosphorylation of BH3-only proteins to activation of the mitochondrial apoptotic machinery.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	azad_bonni@hms.harvard.edu		Becker, Esther B E/0000-0002-5238-4902	NINDS NIH HHS [NS41021] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041021] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Becker EBE, 2004, PROG NEUROBIOL, V72, P1, DOI 10.1016/j.pneurobio.2003.12.005; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Bouillet P, 2002, J CELL SCI, V115, P1567; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Byrd DT, 2001, NEURON, V32, P787, DOI 10.1016/S0896-6273(01)00532-3; Cavalli V, 2005, J CELL BIOL, V168, P775, DOI 10.1083/jcb.200410136; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; Ito M, 1999, MOL CELL BIOL, V19, P7539; Kelkar N, 2003, P NATL ACAD SCI USA, V100, P9843, DOI 10.1073/pnas.1733944100; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; Ley R, 2004, J BIOL CHEM, V279, P8837, DOI 10.1074/jbc.M311578200; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 2002, J BIOL CHEM, V277, P2381, DOI 10.1074/jbc.C100228200; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; Meriin AB, 1998, J BIOL CHEM, V273, P6373, DOI 10.1074/jbc.273.11.6373; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Putcha GV, 2003, NEURON, V38, P899, DOI 10.1016/S0896-6273(03)00355-6; Putcha GV, 2001, NEURON, V29, P615, DOI 10.1016/S0896-6273(01)00238-0; Reginato MJ, 2005, MOL CELL BIOL, V25, P4591, DOI 10.1128/MCB.25.11.4591-4601.2005; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Whitmarsh AJ, 2001, GENE DEV, V15, P2421, DOI 10.1101/gad.922801; Wulf G, 2005, NAT CELL BIOL, V7, P435, DOI 10.1038/ncb0505-435; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899	35	67	68	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					655	662		10.1016/j.neuron.2006.01.034	http://dx.doi.org/10.1016/j.neuron.2006.01.034			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504941	Bronze			2022-12-28	WOS:000236070600007
J	Arenkiel, BR; Peca, J; Davison, IG; Feliciano, C; Deisseroth, K; Augustine, GJ; Ehlers, MD; Feng, GP				Arenkiel, Benjamin R.; Peca, Joao; Davison, Ian G.; Feliciano, Catia; Deisseroth, Karl; Augustine, George J.; Ehlers, Michael D.; Feng, Guoping			In vivo light-induced activation of neural circuitry in transgenic mice expressing channelrhodopsin-2	NEURON			English	Article							MAMMALIAN OLFACTORY-BULB; MITRAL CELLS; ODORANT REPRESENTATIONS; CAENORHABDITIS-ELEGANS; BEHAVIORAL-RESPONSES; LATERAL INHIBITION; PIRIFORM CORTEX; REMOTE-CONTROL; SENSORY MAP; NEURONS	Channelrhodopsin-2 (ChR2) is a light-gated, cation-selective ion channel isolated from the green algae Chlamydomonas reinhardtii. Here, we report the generation of transgenic mice that express a ChR2-YFP fusion protein in the CNS for in vivo activation and mapping of neural circuits. Using focal illumination of the cerebral cortex and olfactory bulb, we demonstrate a highly reproducible, light-dependent activation of neurons and precise control of firing frequency in vivo. To test the feasibility of mapping neural circuits, we exploited the circuitry formed between the olfactory bulb and the piriform cortex in anesthetized mice. In the olfactory bulb, individual mitral cells fired action potentials in response to light, and their firing rate was not influenced by costimulated glomeruli. However, in piriform cortex, the activity of target neurons increased as larger areas of the bulb were illuminated to recruit additional glomeruli. These results support a model of olfactory processing that is dependent upon mitral cell convergence and integration onto cortical cells. More broadly, these findings demonstrate a system for precise manipulation of neural activity in the intact mammalian brain with light and illustrate the use of ChR2 mice in exploring functional connectivity of complex neural circuits in vivo.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; Gulbenkian Inst Sci, Gulbenkian PhD Programme Biomed, P-2781901 Oeiras, Portugal; Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Duke University; Howard Hughes Medical Institute; Duke University; Universidade de Coimbra; Stanford University	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Peça, João/K-7900-2013; Feng, Guoping/Y-2827-2019; Augustine, George James/J-9228-2013; Oka, Yoshitaka/C-9670-2010	Peça, João/0000-0003-4989-2129; Oka, Yoshitaka/0000-0002-3482-3051; Feliciano, Catia/0000-0001-7545-6924; Arenkiel, Benjamin/0000-0001-9047-2420	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS064171] Funding Source: NIH RePORTER; NINDS NIH HHS [K99 NS064171] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALLISON AC, 1953, BIOL REV, V28, P195, DOI 10.1111/j.1469-185X.1953.tb01376.x; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bi AD, 2006, NEURON, V50, P23, DOI 10.1016/j.neuron.2006.02.026; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; BUONVISO N, 1991, EUR J NEUROSCI, V3, P493, DOI 10.1111/j.1460-9568.1991.tb00836.x; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Chen BE, 2000, LEARN MEMORY, V7, P433, DOI 10.1101/lm.32700; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; FENG G, 2004, METHODS MOL MED, V9, P255; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; Flusberg BA, 2005, OPT LETT, V30, P2272, DOI 10.1364/OL.30.002272; Franks KM, 2006, NEURON, V49, P357, DOI 10.1016/j.neuron.2005.12.026; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Haberly LB, 2001, CHEM SENSES, V26, P551, DOI 10.1093/chemse/26.5.551; Hamada S, 1998, MOL BRAIN RES, V54, P199, DOI 10.1016/S0169-328X(97)00322-7; Hardy A, 2005, NEUROSCIENCE, V131, P717, DOI 10.1016/j.neuroscience.2004.10.034; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Illig KR, 2003, J COMP NEUROL, V457, P361, DOI 10.1002/cne.10557; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Johnson DMG, 2000, J NEUROSCI, V20, P6974, DOI 10.1523/JNEUROSCI.20-18-06974.2000; Kandel ER., 2000, PRINCIPLES NEUROSCIE, V4; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kobbert C, 2000, PROG NEUROBIOL, V62, P327, DOI 10.1016/S0301-0082(00)00019-8; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Lei HM, 2006, J NEUROSCI, V26, P12023, DOI 10.1523/JNEUROSCI.2598-06.2006; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Lin DY, 2006, NEURON, V50, P937, DOI 10.1016/j.neuron.2006.03.021; Lledo PM, 2005, PHYSIOL REV, V85, P281, DOI 10.1152/physrev.00008.2004; Llinas R.R., 2004, SYNAPTIC ORG BRAIN; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MCLEAN JH, 1995, J COMP NEUROL, V353, P371, DOI 10.1002/cne.903530305; Miesenbock G, 2004, CURR OPIN NEUROBIOL, V14, P395, DOI 10.1016/j.conb.2004.05.004; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Nagel G, 2005, BIOCHEM SOC T, V33, P863, DOI 10.1042/BST0330863; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Nagel G, 2005, CURR BIOL, V15, P2279, DOI 10.1016/j.cub.2005.11.032; OJIMA H, 1984, J COMP NEUROL, V230, P77, DOI 10.1002/cne.902300107; Parrish-Aungst S, 2007, J COMP NEUROL, V501, P825, DOI 10.1002/cne.21205; Piyawattanametha W, 2006, OPT LETT, V31, P2018, DOI 10.1364/OL.31.002018; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, DOI [DOI 10.1093/ACPROF:OSO/9780195159561.001.1, 10.1093/acprof:oso/9780195159561.001.1]; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; WANG H, 2007, IN PRESS P NATL ACAD; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755; Zou ZH, 2005, P NATL ACAD SCI USA, V102, P7724, DOI 10.1073/pnas.0503027102; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	64	536	585	1	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 19	2007	54	2					205	218		10.1016/j.neuron.2007.03.005	http://dx.doi.org/10.1016/j.neuron.2007.03.005			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442243	Green Accepted, Bronze			2022-12-28	WOS:000246190600007
J	Crepel, V; Aronov, D; Jorquera, I; Represa, A; Ben-Ari, Y; Cossart, R				Crepel, Valerie; Aronov, Dmitriy; Jorquera, Isabel; Represa, Alfonso; Ben-Ari, Yehezkel; Cossart, Rosa			A parturition-associated nonsynaptic coherent activity pattern in the developing hippocampus	NEURON			English	Article							GIANT DEPOLARIZING POTENTIALS; DEVELOPING RAT HIPPOCAMPUS; ACTIVATED CATION CURRENT; MOUSE CORTICAL-NEURONS; IN-VITRO; DEVELOPING NEOCORTEX; CALCIUM-CHANNELS; GAP-JUNCTIONS; POSTNATAL-DEVELOPMENT; SUPRAOPTIC NUCLEUS	Correlated neuronal activity is instrumental in the formation of networks, but its emergence during maturation is poorly understood. We have used multibeam two-photon calcium microscopy combined with targeted electrophysiological recordings in order to determine the development of population coherence from embryonic to postnatal stages in the hippocampus. At embryonic stages (E16-E19), synchronized activity is absent, and neurons are intrinsically active and generate L-type channel-mediated calcium spikes. At birth, small cell assemblies coupled by gap junctions spontaneously generate synchronous nonsynaptic calcium plateaus associated to recurrent burst discharges. The emergence of coherent calcium plateaus at birth is controlled by oxytocin, a maternal hormone initiating labour, and progressively shut down a few days later by the synapse-driven giant depolarizing potentials (GDPs) that synchronize the entire network. Therefore, in the developing hippocampus, delivery is an important signal that triggers the first coherent activity pattern, which is silenced by the emergence of synaptic transmission.	Univ Mediterranee, INSERM, INMED, U29, F-13273 Marseille 09, France; MIT, Cambridge, MA 02139 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Massachusetts Institute of Technology (MIT)	Cossart, R (corresponding author), Univ Mediterranee, INSERM, INMED, U29, Parc Sci Luminy,BP 13, F-13273 Marseille 09, France.	cossart@inmed.univ-mrs.fr	Cossart, Rosa/AAT-7934-2020; Represa, Alfonso/M-7383-2016; Crépel, Valérie/E-1870-2016; Cossart, Rosa/E-7674-2014	Cossart, Rosa/0000-0003-2111-6638; Represa, Alfonso/0000-0002-5096-8939; Crépel, Valérie/0000-0003-0408-3766; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				ARGIOLAS A, 1991, NEUROSCI BIOBEHAV R, V15, P217, DOI 10.1016/S0149-7634(05)80002-8; Arumugam H, 2005, NAT NEUROSCI, V8, P1720, DOI 10.1038/nn1588; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bender RA, 2005, EUR J NEUROSCI, V22, P2669, DOI 10.1111/j.1460-9568.2005.04407.x; Bittman K, 1997, J NEUROSCI, V17, P7037; Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Brewster AL, 2007, CEREB CORTEX, V17, P702, DOI 10.1093/cercor/bhk021; Brun ICL, 2004, J PHYSIOL-LONDON, V559, P129, DOI 10.1113/jphysiol.2004.065060; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Corlew R, 2004, J PHYSIOL-LONDON, V560, P377, DOI 10.1113/jphysiol.2004.071621; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Cruikshank SJ, 2004, P NATL ACAD SCI USA, V101, P12364, DOI 10.1073/pnas.0402044101; DI PE, 2001, EUR J NEUROSCI, V13, P1403; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dupont E, 2006, NATURE, V439, P79, DOI 10.1038/nature04264; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gimpl G, 2001, PHYSIOL REV, V81, P629, DOI 10.1152/physrev.2001.81.2.629; Gu XN, 1997, DEV NEUROSCI-BASEL, V19, P33, DOI 10.1159/000111183; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hatton GI, 1996, J NEUROSCI, V16, P123; Jiang M, 2005, NEUROSCIENCE, V135, P839, DOI 10.1016/j.neuroscience.2005.06.073; Kandler K, 2005, TRENDS NEUROSCI, V28, P290, DOI 10.1016/j.tins.2005.04.007; Kandler K, 1998, J NEUROSCI, V18, P1419; Kasyanov AM, 2004, P NATL ACAD SCI USA, V101, P3967, DOI 10.1073/pnas.0305974101; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Khazipov R, 2004, NATURE, V432, P758, DOI 10.1038/nature03132; Khazipov R, 2001, J NEUROSCI, V21, P9770, DOI 10.1523/JNEUROSCI.21-24-09770.2001; Leinekugel X, 1998, J NEUROSCI, V18, P6349; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Leznik E, 2005, J NEUROPHYSIOL, V94, P2447, DOI 10.1152/jn.00353.2005; Liljelund P, 2000, J NEUROSCI, V20, P7394; Loewenstein Y, 2001, P NATL ACAD SCI USA, V98, P8095, DOI 10.1073/pnas.131116898; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; McCabe AK, 2006, J PHYSIOL-LONDON, V577, P155, DOI 10.1113/jphysiol.2006.117523; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Nielsen T, 2001, J MICROSC-OXFORD, V201, P368, DOI 10.1046/j.1365-2818.2001.00852.x; Nita DA, 2003, J PHYSIOL-LONDON, V552, P325, DOI 10.1113/jphysiol.2003.050310; ODONOVAN MJ, 1989, J NEUROSCI, V9, P943; Owens DF, 1998, J NEUROSCI, V18, P5374, DOI 10.1523/JNEUROSCI.18-14-05374.1998; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Peinado A, 2000, J NEUROSCI, V20; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; Raggenbass M, 2001, PROG NEUROBIOL, V64, P307, DOI 10.1016/S0301-0082(00)00064-2; Redmond L, 2005, CELL CALCIUM, V37, P411, DOI 10.1016/j.ceca.2005.01.009; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Rozental R, 2000, BRAIN RES REV, V32, P57, DOI 10.1016/S0165-0173(99)00096-X; Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Syed MM, 2004, J PHYSIOL-LONDON, V560, P533, DOI 10.1113/jphysiol.2004.066597; Theodosis DT, 2006, MOL CELL NEUROSCI, V31, P785, DOI 10.1016/j.mcn.2006.01.006; Tomizawa K, 2003, NAT NEUROSCI, V6, P384, DOI 10.1038/nn1023; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Tyzio R, 2006, SCIENCE, V314, P1788, DOI 10.1126/science.1133212; Vasilyev DV, 2002, J NEUROSCI, V22, P8992; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8	74	142	143	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					105	120		10.1016/j.neuron.2007.03.007	http://dx.doi.org/10.1016/j.neuron.2007.03.007			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408581	Bronze			2022-12-28	WOS:000245848400013
J	Gonzalez-Maeso, J; Weisstaub, NV; Zhou, MM; Chan, P; Ivic, L; Ang, R; Lira, A; Bradley-Moore, M; Ge, YC; Zhou, Q; Sealfon, SC; Gingrich, JA				Gonzalez-Maeso, Javier; Weisstaub, Noelia V.; Zhou, Mingming; Chan, Pokman; Ivic, Lidija; Ang, Rosalind; Lira, Alena; Bradley-Moore, Maria; Ge, Yongchao; Zhou, Qiang; Sealfon, Stuart C.; Gingrich, Jay A.			Hallucinogens recruit specific cortical 5-HT2A receptor-mediated signaling pathways to affect behavior	NEURON			English	Article							LYSERGIC-ACID DIETHYLAMIDE; RAT-BRAIN; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; MULTIPLE CLASSES; KINASE PATHWAY; MESSENGER-RNA; LISURIDE; AGONIST	Hallucinogens, including mescaline, psilocybin, and lysergic acid diethylamide (LSD), profoundly affect perception, cognition, and mood. All known drugs of this class are 5-HT2A receptor (2AR) agonists, yet closely related 2AR agonists such as lisuride lack comparable psychoactive properties. Why only certain 2AR agonists are hallucinogens and which neural circuits mediate their effects are poorly understood. By genetically expressing 2AR only in cortex, we show that 2AR-regulated pathways on cortical neurons are sufficient to mediate the signaling pattern and behavioral response to hallucinogens. Hallucinogenic and nonhallucinogenic 2AR agonists both regulate signaling in the same 2AR-expressing cortical neurons. However, the signaling and behavioral responses to the hallucinogens are distinct. While lisuride and LSD both act at 2AR expressed by cortex neurons to regulate phospholipase C, LSD responses also involve pertussis toxin-sensitive heterotrimeric G(i/o) proteins and Src. These studies identify the long-elusive neural and signaling mechanisms responsible for the unique effects of hallucinogens.	Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; Mt Sinai Sch Med, Ctr Translat Syst Biol, New York, NY 10029 USA; Columbia Univ, Dept Biol Sci, New York, NY 10032 USA; Columbia Univ, Dept Psychiat, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Sackler Inst Labs, New York, NY 10032 USA; New York State Psychiat Inst & Hosp, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; New York State Psychiatry Institute; New York State Psychiatry Institute	Sealfon, SC (corresponding author), Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA.	stuart.sealfon@mssm.edu	Weisstaub, Noelia/ABA-1706-2021; Ge, Yongchao/AAG-9317-2021	Ge, Yongchao/0000-0001-6448-5703; SEALFON, Stuart/0000-0001-5791-1217	NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012923, T32DA007135] Funding Source: NIH RePORTER; NIDA NIH HHS [T32 DA007135, P01 DA12923, T32 DA07135, P01 DA012923] Funding Source: Medline; NIMH NIH HHS [K08 MH01711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADAMS LM, 1985, BEHAV NEUROSCI, V99, P881, DOI 10.1037/0735-7044.99.5.881; ADAMS LM, 1985, PHARMACOL BIOCHEM BE, V23, P461, DOI 10.1016/0091-3057(85)90022-X; Banes A, 1999, J PHARMACOL EXP THER, V291, P1179; BARKAI E, 1994, J NEUROPHYSIOL, V72, P644, DOI 10.1152/jn.1994.72.2.644; Barnes NM, 1999, NEUROPHARMACOLOGY, V38, P1083, DOI 10.1016/S0028-3908(99)00010-6; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; CALLAHAN PM, 1990, PSYCHOPHARMACOLOGY, V100, P13, DOI 10.1007/BF02245782; Chan P, 2005, J COMP NEUROL, V482, P50, DOI 10.1002/cne.20377; CORNE SJ, 1967, PSYCHOPHARMACOLOGIA, V11, P65, DOI 10.1007/BF00401509; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; DARMANI NA, 1990, PHARMACOL BIOCHEM BE, V37, P95, DOI 10.1016/0091-3057(90)90047-L; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Ebersole BJ, 2003, MOL PHARMACOL, V63, P36, DOI 10.1124/mol.63.1.36; Egan CT, 1998, PSYCHOPHARMACOLOGY, V136, P409, DOI 10.1007/s002130050585; FIORELLA D, 1995, PSYCHOPHARMACOLOGY, V121, P364, DOI 10.1007/BF02246076; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; GONALEZMAESO J, 2006, ENDOCRINOLOGY, P177; Gonzalez-Maeso J, 2003, J NEUROSCI, V23, P8836; Gonzalez-Maeso J, 2002, MOL PSYCHIATR, V7, P755, DOI 10.1038/sj.mp.4001067; Gorski JA, 2002, J NEUROSCI, V22, P6309; Gresch PJ, 2002, NEUROSCIENCE, V114, P707, DOI 10.1016/S0306-4522(02)00349-4; Gutkind J. S., 2000, SCI STKE, pre1, DOI DOI 10.1126/STKE.2000.40.RE1; HOROWSKI R, 1976, EUR J PHARMACOL, V36, P373, DOI 10.1016/0014-2999(76)90091-1; HOYER D, 1994, PHARMACOL REV, V46, P157; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; JOHNSON AR, 1982, APPL MULTIVARIATE ST; Kenakin T, 2002, ANNU REV PHARMACOL, V42, P349, DOI 10.1146/annurev.pharmtox.42.091401.113012; Kenakin T, 2003, TRENDS PHARMACOL SCI, V24, P346, DOI 10.1016/S0165-6147(03)00167-6; Kurrasch-Orbaugh DM, 2003, J NEUROCHEM, V86, P980, DOI 10.1046/j.1471-4159.2003.01921.x; Li QH, 2004, J COMP NEUROL, V469, P128, DOI 10.1002/cne.11004; Lopez-Gimenez JF, 2001, J COMP NEUROL, V429, P571, DOI 10.1002/1096-9861(20010122)429:4<571::AID-CNE5>3.0.CO;2-X; LopezGimenez JF, 1997, N-S ARCH PHARMACOL, V356, P446, DOI 10.1007/PL00005075; MAJ J, 1977, J NEURAL TRANSM, V41, P253, DOI 10.1007/BF01252020; Marek GJ, 2001, NEUROSCIENCE, V105, P379, DOI 10.1016/S0306-4522(01)00199-3; Marona-Lewicka D, 2002, PSYCHOPHARMACOLOGY, V164, P93, DOI 10.1007/s00213-002-1141-z; McLoughlin DJ, 2000, J NEUROCHEM, V74, P347, DOI 10.1046/j.1471-4159.2000.0740347.x; MILLAN MJ, 1991, J PHARMACOL EXP THER, V256, P973; Millan MJ, 2002, J PHARMACOL EXP THER, V303, P791, DOI 10.1124/jpet.102.039867; MOKLER DJ, 1984, PHARMACOL BIOCHEM BE, V21, P281, DOI 10.1016/0091-3057(84)90227-2; Nair VD, 2003, J BIOL CHEM, V278, P47053, DOI 10.1074/jbc.M303364200; Newman-Tancredi A, 2002, J PHARMACOL EXP THER, V303, P805, DOI 10.1124/jpet.102.039875; Nichols DE, 2004, PHARMACOL THERAPEUT, V101, P131, DOI 10.1016/j.pharmthera.2003.11.002; NIELSEN EB, 1986, EUR J PHARMACOL, V125, P85, DOI 10.1016/0014-2999(86)90086-5; Nocjar C, 2002, NEUROSCIENCE, V111, P163, DOI 10.1016/S0306-4522(01)00593-0; PAZOS A, 1985, BRAIN RES, V346, P231, DOI 10.1016/0006-8993(85)90857-1; PIERI L, 1978, NATURE, V272, P278, DOI 10.1038/272278a0; Prioleau C, 2002, J BIOL CHEM, V277, P36577, DOI 10.1074/jbc.M206223200; Quinn JC, 2002, J PHARMACOL EXP THER, V303, P746, DOI 10.1124/jpet.102.038083; Raymond JR, 2001, PHARMACOL THERAPEUT, V92, P179, DOI 10.1016/S0163-7258(01)00169-3; Rex A, 1998, PHARMACOL BIOCHEM BE, V59, P677, DOI 10.1016/S0091-3057(97)00461-9; Roth BL, 1998, PHARMACOL THERAPEUT, V79, P231, DOI 10.1016/S0163-7258(98)00019-9; Ruf F, 2004, TRENDS ENDOCRIN MET, V15, P331, DOI 10.1016/j.tem.2004.07.008; SAPIENZA S, 1981, EXP BRAIN RES, V43, P47; Scruggs JL, 2000, J NEUROSCI, V20, P8846; Scruggs JL, 2003, NEUROSCI LETT, V346, P137, DOI 10.1016/S0304-3940(03)00547-0; SILVA MTA, 1975, PSYCHOPHARMACOLOGIA, V42, P163, DOI 10.1007/BF00429548; TRULSON ME, 1984, DEV PSYCHOBIOL, V17, P329, DOI 10.1002/dev.420170402; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; VETULANI J, 1979, POL J PHARMACOL PHAR, V31, P413; Vollenweider FX, 1998, NEUROREPORT, V9, P3897, DOI 10.1097/00001756-199812010-00024; Willins DL, 1997, J PHARMACOL EXP THER, V282, P699	63	510	531	4	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					439	452		10.1016/j.neuron.2007.01.008	http://dx.doi.org/10.1016/j.neuron.2007.01.008			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270739	Bronze			2022-12-28	WOS:000245126800013
J	Shin, JB; Streijger, F; Beynon, A; Peters, T; Gadzala, L; McMillen, D; Bystrom, C; Van der Zee, CEEM; Wallimann, T; Gillespie, PG				Shin, Jung-Bum; Streijger, Femke; Beynon, Andy; Peters, Theo; Gadzala, Laura; McMillen, Debra; Bystrom, Cory; Van der Zee, Catharina E. E. M.; Wallimann, Theo; Gillespie, Peter G.			Hair bundles are specialized for ATP delivery via creatine kinase	NEURON			English	Article							PHOTORECEPTOR OUTER SEGMENTS; PLASMA-MEMBRANE; GLYCOLYTIC-ENZYMES; CELL STEREOCILIA; INNER-EAR; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; MECHANOELECTRICAL-TRANSDUCTION; ADENOSINE TRIPHOSPHATE; SHOTGUN PROTEOMICS; DEAFWADDLER MICE	When stimulated strongly, a hair cell's mechanically sensitive hair bundle may consume ATP too rapidly for replenishment by diffusion. To provide a broad view of the bundle's protein complement, including those proteins participating in energy metabolism, we used shotgun mass spectrometry methods to identify proteins of purified chicken vestibular bundles. In addition to cytoskeletal proteins, proteins involved in Ca2+ regulation, and stress-response proteins, many of the most abundant bundle proteins that were identified by mass spectrometry were involved in ATP synthesis. After beta-actin, the cytosolic brain isoform of creatine kinase was the next most abundant bundle protein; at similar to 0.5 mM, creatine kinase is capable of maintaining high ATP levels despite 1 mM/s ATP consumption by the plasma-membrane Ca2+-ATPase. Consistent with this critical role in hair bundle function, the creatine kinase circuit is essential for high-sensitivity hearing as demonstrated by hearing loss in creatine kinase knockout mice.	Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; Radboud Univ Nijmegen, Med Ctr, Dept Cell Biol, NCMLS, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Oregon Hlth & Sci Univ, Proteom Shared Resource, Portland, OR 97239 USA; ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland	Oregon Health & Science University; Oregon Health & Science University; Radboud University Nijmegen; Radboud University Nijmegen; Oregon Health & Science University; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gillespie, PG (corresponding author), Oregon Hlth & Sci Univ, Oregon Hearing Res Ctr, Portland, OR 97239 USA.	gillespp@ohsu.edu	Van der Zee, Catharina E.E.M./L-4773-2015; Beynon, Andy/D-3476-2009; Peters, T.A./L-4571-2015; Beynon, Andy/L-4198-2015; Wallimann, Theo/C-6047-2008	Beynon, Andy/0000-0002-3191-6113; Peters, T.A./0000-0001-8443-5500; Beynon, Andy/0000-0002-3191-6113; Wallimann, Theo/0000-0003-4957-5836; Barr-Gillespie, Peter/0000-0002-9787-5860	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC005983, R21DC006097, R01DC002368] Funding Source: NIH RePORTER; NIDCD NIH HHS [R21 DC006097, R01 DC002368, P30 DC005983] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ARNOLD H, 1971, EUR J BIOCHEM, V22, P121, DOI 10.1111/j.1432-1033.1971.tb01522.x; BOWEN WJ, 1964, ARCH BIOCHEM BIOPHYS, V107, P30, DOI 10.1016/0003-9861(64)90265-6; BRONSTEIN WW, 1981, CAN J BIOCHEM CELL B, V59, P494, DOI 10.1139/o81-069; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; COREY DP, 1983, J NEUROSCI, V3, P942; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Dzeja PP, 1996, J BIOL CHEM, V271, P12847, DOI 10.1074/jbc.271.22.12847; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; GATTO C, 1993, AM J PHYSIOL, V264, pC1577, DOI 10.1152/ajpcell.1993.264.6.C1577; GILLESPIE PG, 1991, J CELL BIOL, V112, P625, DOI 10.1083/jcb.112.4.625; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; GILLESPIE PG, 1993, P NATL ACAD SCI USA, V90, P2710, DOI 10.1073/pnas.90.7.2710; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Goodyear RJ, 1999, J NEUROCYTOL, V28, P851, DOI 10.1023/A:1007070121751; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; HEMMER W, 1993, J CELL SCI, V106, P671; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hirono M, 2004, NEURON, V44, P309, DOI 10.1016/j.neuron.2004.09.020; Hornemann T, 2000, BBA-PROTEIN STRUCT M, V1480, P365, DOI 10.1016/S0167-4838(00)00098-4; HSU SC, 1994, J BIOL CHEM, V269, P17954; HSU SC, 1990, J BIOL CHEM, V265, P13308; INFANTE AA, 1965, J BIOL CHEM, V240, P3996; JACOBS RA, 1990, COLD SPRING HARB SYM, V55, P547; Jones SM, 1996, J VESTIBUL RES-EQUIL, V6, P71, DOI 10.1016/0957-4271(95)02008-X; Jost CR, 2002, EUR J NEUROSCI, V15, P1692, DOI 10.1046/j.1460-9568.2002.02001.x; Kaldis P, 1996, J CELL SCI, V109, P2079; Kay L, 2000, J BIOL CHEM, V275, P6937, DOI 10.1074/jbc.275.10.6937; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kraft T, 2000, J MUSCLE RES CELL M, V21, P691, DOI 10.1023/A:1005623002979; KRZANOWSKI JJ, 1971, J HISTOCHEM CYTOCHEM, V19, P321, DOI 10.1177/19.5.321; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Liang P, 1997, J CELL SCI, V110, P1431; Lin HW, 2005, CURR OPIN CELL BIOL, V17, P55, DOI 10.1016/j.ceb.2004.12.005; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Lumpkin EA, 1997, P NATL ACAD SCI USA, V94, P10997, DOI 10.1073/pnas.94.20.10997; Lumpkin EA, 1998, J NEUROSCI, V18, P6300; Maul RS, 2003, J CELL BIOL, V160, P399, DOI 10.1083/jcb.200212057; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; MEJEAN C, 1989, BIOCHEM J, V264, P671, DOI 10.1042/bj2640671; MEYER RA, 1984, AM J PHYSIOL, V246, P365; NEELY JG, 1991, HEARING RES, V52, P403, DOI 10.1016/0378-5955(91)90028-8; NEUGEBAUER DC, 1984, J NEUROCYTOL, V13, P797, DOI 10.1007/BF01148494; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Petit C, 2006, TRENDS MOL MED, V12, P57, DOI 10.1016/j.molmed.2005.12.006; Powell DW, 2004, MOL CELL BIOL, V24, P7249, DOI 10.1128/MCB.24.16.7249-7259.2004; Prochasson P, 2005, GENE DEV, V19, P2534, DOI 10.1101/gad.1341105; Rezaul K, 2005, MOL CELL PROTEOMICS, V4, P169, DOI 10.1074/mcp.M400115-MCP200; Ricci AJ, 1998, J PHYSIOL-LONDON, V506, P159, DOI 10.1111/j.1469-7793.1998.159bx.x; ROSSI AM, 1990, J BIOL CHEM, V265, P5258; Schneider ME, 2002, NATURE, V418, P837, DOI 10.1038/418837a; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; SHEPHERD GMG, 1989, P NATL ACAD SCI USA, V86, P4973, DOI 10.1073/pnas.86.13.4973; Shi SR, 2001, J HISTOCHEM CYTOCHEM, V49, P931, DOI 10.1177/002215540104900801; Shi XR, 2005, AM J PHYSIOL-CELL PH, V288, pC1332, DOI 10.1152/ajpcell.00522.2004; SPICER SS, 1992, J HISTOCHEM CYTOCHEM, V40, P185, DOI 10.1177/40.2.1313059; Stauffer EA, 2005, NEURON, V47, P541, DOI 10.1016/j.neuron.2005.07.024; Steeghs K, 1997, CELL, V89, P93, DOI 10.1016/S0092-8674(00)80186-5; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Streijger F, 2005, BEHAV BRAIN RES, V157, P219, DOI 10.1016/j.bbr.2004.07.002; TILNEY MS, 1989, J CELL BIOL, V109, P1711, DOI 10.1083/jcb.109.4.1711; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; WALKER RG, 1993, P NATL ACAD SCI USA, V90, P2807, DOI 10.1073/pnas.90.7.2807; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Yamoah EN, 1998, J NEUROSCI, V18, P610; YOSHIZAKI K, 1987, JPN J PHYSIOL, V37, P923, DOI 10.2170/jjphysiol.37.923	72	94	98	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					371	386		10.1016/j.neuron.2006.12.021	http://dx.doi.org/10.1016/j.neuron.2006.12.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270734	Green Accepted, Bronze			2022-12-28	WOS:000245126800008
J	Yoshida, Y; Han, B; Mendelsohn, M; Jessell, TM				Yoshida, Yutaka; Han, Barbara; Mendelsohn, Monica; Jessell, Thomas M.			PlexinA1 signaling directs the segregation of proprioceptive sensory axons in the developing spinal cord	NEURON			English	Article							DORSAL-ROOT-GANGLIA; PERIPHERAL-NERVE PROJECTION; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SEMAPHORIN-III; MOTOR-NEURONS; NOGO RECEPTOR; NEURAL MAP; RAT; AFFERENTS	As different classes of sensory neurons project into the CNS, their axons segregate and establish distinct trajectories and target zones. One striking instance of axonal segregation is the projection of sensory neurons into the spinal cord, where proprioceptive axons avoid the superficial dorsal horn-the target zone of many cutaneous afferent fibers. PlexinA1 is a proprioceptive sensory axon-specific receptor for sema6C and sema6D, which are expressed in a dynamic pattern in the dorsal horn. The loss of plexinA1 signaling causes the shafts of proprioceptive axons to invade the superficial dorsal horn, disrupting the organization of cutaneous afferents. This disruptive influence appears to involve the intermediary action of oligodendrocytes, which accompany displaced proprioceptive axon shafts into the dorsal horn. Our findings reveal a dedicated program of axonal shaft positioning in the mammalian CNS and establish a role for plexinA1-mediated axonal exclusion in organizing the projection pattern of spinal sensory afferents.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Yoshida, Y (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	yy2032@columbia.edu; tmj1@columbia.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH050733] Funding Source: NIH RePORTER; NIMH NIH HHS [P50 MH050733] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Aurelio O, 2002, SCIENCE, V295, P686, DOI 10.1126/science.1066642; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Blagburn JM, 2004, ANNU REV NEUROSCI, V27, P29, DOI 10.1146/annurev.neuro.27.070203.144143; Brown AG, 1981, ORG SPINAL CORD; Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x; DeBellard ME, 1996, MOL CELL NEUROSCI, V7, P89, DOI 10.1006/mcne.1996.0007; DURNITRIU D, IN PRESS CEREB CORTE; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; FITZGERALD M, 1987, J COMP NEUROL, V261, P98, DOI 10.1002/cne.902610108; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Fu SY, 2000, J NEUROBIOL, V45, P227, DOI 10.1002/1097-4695(200012)45:4<227::AID-NEU4>3.0.CO;2-N; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416; He ZG, 2004, ANNU REV NEUROSCI, V27, P341, DOI 10.1146/annurev.neuro.27.070203.144340; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Hunt D, 2002, MOL CELL NEUROSCI, V20, P537, DOI 10.1006/mcne.2002.1153; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kawasaki T, 2006, DEVELOPMENT, V133, P845, DOI 10.1242/dev.02257; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Koerber HR, 1992, SENSORY NEURONS DIVE, P77; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Lawson SN, 2002, EXP PHYSIOL, V87, P239, DOI 10.1113/eph8702350; Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063; Lefcort F, 1996, J NEUROSCI, V16, P3704; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIKOSHIBA K, 1991, ANNU REV NEUROSCI, V14, P201, DOI 10.1146/annurev.ne.14.030191.001221; MIMICS K, 1995, J COMP NEUROL, V355, P601; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Ozaki S, 1997, J COMP NEUROL, V380, P215; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Perrin FE, 2001, NEURON, V30, P707, DOI 10.1016/S0896-6273(01)00315-4; Pietri T, 2003, DEV BIOL, V259, P176, DOI 10.1016/S0012-1606(03)00175-1; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; REN K, 1993, BRAIN RES BULL, V31, P13, DOI 10.1016/0361-9230(93)90004-U; ROSKIES AL, 1994, SCIENCE, V265, P799, DOI 10.1126/science.8047886; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; SCHOLES JH, 1979, NATURE, V278, P620, DOI 10.1038/278620a0; Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009; SCHWAB ME, 1989, J NEUROCYTOL, V18, P161, DOI 10.1007/BF01206659; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Toyofuku T, 2004, GENE DEV, V18, P435, DOI 10.1101/gad.1167304; Watanabe K, 2006, DEVELOPMENT, V133, P1379, DOI 10.1242/dev.02312; Woodruff RH, 1998, J NEUROCYTOL, V27, P683, DOI 10.1023/A:1006972316697; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Zhong JA, 2006, NEURON, V49, P325, DOI 10.1016/j.neuron.2006.01.013	60	100	101	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					775	788		10.1016/j.neuron.2006.10.032	http://dx.doi.org/10.1016/j.neuron.2006.10.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145500	Green Accepted, Bronze			2022-12-28	WOS:000242856400007
J	Vincent, A; Lang, B; Kleopa, KA				Vincent, Angela; Lang, Bethan; Kleopa, Kleopas A.			Autoimmune channelopathies and related neurological disorders	NEURON			English	Review							EATON-MYASTHENIC-SYNDROME; THYMIC MYOID CELLS; ARTHROGRYPOSIS MULTIPLEX CONGENITA; ACETYLCHOLINE-RECEPTOR TURNOVER; CALCIUM-CHANNEL ANTIBODIES; MORVANS FIBRILLARY CHOREA; CENTRAL-NERVOUS-SYSTEM; IMMUNE-COMPLEXES IGG; END-PLATE POTENTIALS; POTASSIUM CHANNEL	Ion channels are crucial elements in neuronal signaling and synaptic transmission, and defects in their function are known to underlie rare genetic disorders, including some forms of epilepsy. A second class of channelopathies, characterized by autoantibodies against ligand- and voltage-gated ion channels, cause a variety of defects in peripheral neuromuscular and ganglionic transmission. There is also emerging evidence for autoantibody-mediated mechanisms in subgroups of patients with central nervous system disorders, particularly those involving defects in cognition or sleep and often associated with epilepsy. In all autoimmune channelopathies, the relationship between autoantibody specificity and clinical phenotype is complex. But with this new information, autoimmune channelopathies are detected and treated with increasing success, and future research promises new insights into the mechanisms of dysfunction at neuronal synapses and the determinants of clinical phenotype.	John Radcliffe Hosp, Weatherall Inst Med, Dept Clin Neurol, Neurosci Grp, Oxford OX3 9DS, England; Cyprus Inst Neurol & Genet, CY-1683 Nicosia, Cyprus	University of Oxford	Vincent, A (corresponding author), John Radcliffe Hosp, Weatherall Inst Med, Dept Clin Neurol, Neurosci Grp, Oxford OX3 9DS, England.	angela.vincent@imm.ox.ac.uk	Vincent, Angela/AAE-7310-2019	Kleopa, Kleopas/0000-0002-4103-8094	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Antozzi C, 2005, NEUROLOGY, V64, P1290, DOI 10.1212/01.WNL.0000156945.39471.2C; Arimura K, 2005, CLIN NEUROPHYSIOL, V116, P1835, DOI 10.1016/j.clinph.2005.03.023; Arroyo EJ, 2000, HISTOCHEM CELL BIOL, V113, P1, DOI 10.1007/s004180050001; ASHER O, 1993, J IMMUNOL, V151, P6442; Barber PA, 2000, NEUROLOGY, V54, P771, DOI 10.1212/WNL.54.3.771; BARRETTJOLLEY R, 1994, PFLUG ARCH EUR J PHY, V428, P492, DOI 10.1007/BF00374570; Bataller L, 2004, SEMIN NEUROL, V24, P461, DOI 10.1055/s-2004-861540; Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Benveniste O, 2005, J NEUROIMMUNOL, V170, P41, DOI 10.1016/j.jneuroim.2005.08.016; Bien CG, 2005, BRAIN, V128, P454, DOI 10.1093/brain/awh415; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Buchwald B, 2005, MUSCLE NERVE, V31, P487, DOI 10.1002/mus.20269; Buckley C, 2005, NAT CLIN PRACT NEURO, V1, P22, DOI 10.1038/ncpneuro0033; Buckley C, 2001, ANN NEUROL, V50, P73, DOI 10.1002/ana.1097; Bufler J, 1998, ANN NEUROL, V43, P458, DOI 10.1002/ana.410430408; BURGES J, 1990, MUSCLE NERVE, V13, P407, DOI 10.1002/mus.880130507; BURGES J, 1994, MUSCLE NERVE, V17, P1393, DOI 10.1002/mus.880171208; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Chung YH, 2001, BRAIN RES, V895, P173, DOI 10.1016/S0006-8993(01)02068-6; COMPSTON DAS, 1980, BRAIN, V103, P579, DOI 10.1093/brain/103.3.579; CORRETTE BJ, 1991, PFLUG ARCH EUR J PHY, V418, P408, DOI 10.1007/BF00550879; Dalton P, 2003, ANN NEUROL, V53, P533, DOI 10.1002/ana.10557; Dalton P, 2006, NEUROMUSCULAR DISORD, V16, P481, DOI 10.1016/j.nmd.2006.05.015; DeGiorgio LA, 2001, NAT MED, V7, P1189, DOI 10.1038/nm1101-1189; Devaux J, 2003, J NEUROSCI, V23, P4509; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; DRACHMAN DB, 1982, NEW ENGL J MED, V307, P769, DOI 10.1056/NEJM198209233071301; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; EATON LM, 1957, JAMA-J AM MED ASSOC, V163, P1117, DOI 10.1001/jama.1957.02970480021005; ELMQVIST D, 1968, MAYO CLIN PROC, V43, P689; ENGEL AG, 1977, MAYO CLIN PROC, V52, P267; ENGEL AG, 1989, ANN NY ACAD SCI, V560, P278, DOI 10.1111/j.1749-6632.1989.tb24105.x; Eunson LH, 2000, ANN NEUROL, V48, P647; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; Farrugia ME, 2006, BRAIN, V129, P1481, DOI 10.1093/brain/awl095; FUKUNAGA H, 1983, P NATL ACAD SCI-BIOL, V80, P7636, DOI 10.1073/pnas.80.24.7636; FUKUOKA T, 1987, ANN NEUROL, V22, P193, DOI 10.1002/ana.410220203; FUKUOKA T, 1987, ANN NEUROL, V22, P200, DOI 10.1002/ana.410220204; Giovannini F, 2002, BRIT J PHARMACOL, V136, P1135, DOI 10.1038/sj.bjp.0704818; Glass DJ, 2003, NAT CELL BIOL, V5, P87, DOI 10.1038/ncb0203-87; Graus F, 2002, NEUROLOGY, V59, P764, DOI 10.1212/WNL.59.5.764; Guyon T, 1998, J CLIN INVEST, V102, P249, DOI 10.1172/JCI1248; HALBACH M, 1987, J NEUROL, V234, P433, DOI 10.1007/BF00314093; Hart IK, 2002, BRAIN, V125, P1887, DOI 10.1093/brain/awf178; Hart IK, 1997, ANN NEUROL, V41, P238, DOI 10.1002/ana.410410215; Heidenreich F, 1998, NEUROLOGY, V50, P1483, DOI 10.1212/WNL.50.5.1483; HEINEMANN S, 1977, P NATL ACAD SCI USA, V74, P3090, DOI 10.1073/pnas.74.7.3090; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Hoedemaekers A, 1998, J NEUROIMMUNOL, V89, P131, DOI 10.1016/S0165-5728(98)00126-X; Iranzo A, 2006, ANN NEUROL, V59, P178, DOI 10.1002/ana.20693; ISAACS H, 1974, J NEUROL NEUROSUR PS, V37, P1231, DOI 10.1136/jnnp.37.11.1231; ITO Y, 1978, BRAIN, V101, P345, DOI 10.1093/brain/101.2.345; Jacobson L, 1999, J CLIN INVEST, V103, P1031, DOI 10.1172/JCI5943; Jahn K, 2000, NEUROLOGY, V54, P474, DOI 10.1212/WNL.54.2.474; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; Johnston D, 2000, J PHYSIOL-LONDON, V525, P75, DOI 10.1111/j.1469-7793.2000.00075.x; Jun K, 1999, P NATL ACAD SCI USA, V96, P15245, DOI 10.1073/pnas.96.26.15245; Kaminski HJ, 1998, ANN NY ACAD SCI, V841, P309, DOI 10.1111/j.1749-6632.1998.tb10937.x; Kaminski HJ, 2004, EXP NEUROL, V189, P333, DOI 10.1016/j.expneurol.2004.06.005; Kleopa KA, 2002, MUSCLE NERVE, V26, P299, DOI 10.1002/mus.10164; Kleopa KA, 2006, BRAIN, V129, P1570, DOI 10.1093/brain/awl084; Kowal C, 2004, IMMUNITY, V21, P179, DOI 10.1016/j.immuni.2004.07.011; Kurono A, 2006, ACTA NEUROL SCAND, V113, P185, DOI 10.1111/j.1600-0404.2005.00569.x; Kusner LL, 1996, BRAIN RES, V730, P238; LAMBERT EH, 1971, ANN NY ACAD SCI, V183, P183, DOI 10.1111/j.1749-6632.1971.tb30750.x; LANCE JW, 1979, ANN NEUROL, V5, P523, DOI 10.1002/ana.410050605; LANG B, 1987, J PHYSIOL-LONDON, V390, P257, DOI 10.1113/jphysiol.1987.sp016698; Lee EK, 1998, J NEUROL NEUROSUR PS, V65, P857, DOI 10.1136/jnnp.65.6.857; Lennon VA, 2003, J CLIN INVEST, V111, P907, DOI 10.1172/JCI200317429; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; LENNON VA, 1995, NEW ENGL J MED, V332, P1467, DOI 10.1056/NEJM199506013322203; Levite M, 1999, J AUTOIMMUN, V13, P73, DOI 10.1006/jaut.1999.0297; Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; Losen M, 2005, BRAIN, V128, P2327, DOI 10.1093/brain/awh612; LUNDER O, 1993, PROGR UNDERSTANDING, V2, P1249; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MacLennan C, 1997, ANN NEUROL, V41, P423, DOI 10.1002/ana.410410404; Maddison P, 2006, MUSCLE NERVE, V33, P801, DOI 10.1002/mus.20536; Madrid A, 1996, J NEUROL, V243, P350, DOI 10.1007/BF00868410; Manganas LN, 2000, J BIOL CHEM, V275, P29685, DOI 10.1074/jbc.M005010200; Mantegazza R, 2002, J NEUROIMMUNOL, V131, P179, DOI 10.1016/S0165-5728(02)00261-8; Marx A, 1997, VIRCHOWS ARCH, V430, P355, DOI 10.1007/s004280050044; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; McNamara J O, 1999, Adv Neurol, V79, P543; Mesnard-Rouiller L, 2004, J NEUROIMMUNOL, V148, P97, DOI 10.1016/j.jneuroim.2003.11.013; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; MOSSMAN S, 1986, LANCET, V1, P116; MOTOMURA M, 1995, J NEUROL NEUROSUR PS, V58, P85, DOI 10.1136/jnnp.58.1.85; Nagado T, 1999, BRAIN, V122, P2057, DOI 10.1093/brain/122.11.2057; NEWSOMDAVIS J, 1978, NEUROLOGY, V28, P266, DOI 10.1212/WNL.28.3.266; NEWSOMDAVIS J, 1993, BRAIN, V116, P453, DOI 10.1093/brain/116.2.453; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; ONEILL JH, 1988, BRAIN, V111, P577, DOI 10.1093/brain/111.3.577; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; PEERS C, 1990, J PHYSIOL-LONDON, V421, P293, DOI 10.1113/jphysiol.1990.sp017945; PFOMP JJ, 1995, ANN NEUROL, V37, P627; Piddlesden SJ, 1996, J NEUROIMMUNOL, V71, P173, DOI 10.1016/S0165-5728(96)00144-0; Pinto A, 2002, MUSCLE NERVE, V25, P715, DOI 10.1002/mus.10087; Pinto A, 1998, P NATL ACAD SCI USA, V95, P8328, DOI 10.1073/pnas.95.14.8328; Plested CP, 2002, NEUROLOGY, V59, P1682, DOI 10.1212/01.WNL.0000041625.41937.FF; Plomp JJ, 1996, J PHYSIOL-LONDON, V493, P175, DOI 10.1113/jphysiol.1996.sp021373; Poliak S, 2003, J CELL BIOL, V162, P1149, DOI 10.1083/jcb.200305018; Polizzi A, 2000, TERATOLOGY, V62, P332, DOI 10.1002/1096-9926(200011)62:5<332::AID-TERA7>3.3.CO;2-5; Reid G, 1999, J PHYSIOL-LONDON, V518, P681, DOI 10.1111/j.1469-7793.1999.0681p.x; Riemersma S, 1996, J CLIN INVEST, V98, P2358, DOI 10.1172/JCI119048; ROBERTSON JG, 1985, J CELL SCI, P317; ROGERS SW, 1994, SCIENCE, V265, P648, DOI 10.1126/science.8036512; ROPER J, 1989, J PHYSIOL-LONDON, V416, P93; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; Roxanis I, 2002, J NEUROIMMUNOL, V125, P185, DOI 10.1016/S0165-5728(02)00038-3; Ruff RL, 1998, ANN NEUROL, V43, P370, DOI 10.1002/ana.410430315; SAFRONOV BV, 1993, J PHYSIOL-LONDON, V460, P675, DOI 10.1113/jphysiol.1993.sp019493; SAHASHI K, 1978, J NEUROPATH EXP NEUR, V37, P212, DOI 10.1097/00005072-197803000-00008; SAHASHI K, 1980, J NEUROPATH EXP NEUR, V39, P160, DOI 10.1097/00005072-198003000-00005; Salmon AM, 1998, J CLIN INVEST, V101, P2340, DOI 10.1172/JCI1615; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCADDING GK, 1981, NEUROLOGY, V31, P935, DOI 10.1212/WNL.31.8.935; SCHLUEP M, 1987, ANN NEUROL, V22, P212, DOI 10.1002/ana.410220205; Scuderi F, 2002, LAB INVEST, V82, P1139, DOI 10.1097/01.LAB.0000028144.48023.9B; Selcen D, 2004, NEUROLOGY, V62, P1945, DOI 10.1212/01.WNL.0000128048.23930.1D; SERRATRICE G, 1994, REV NEUROL, V150, P257; SHENG J, 1994, PERMIAN STRATIGRAPHY, V1, P14; SHER E, 1989, LANCET, V2, P640; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; SHILLITO P, 1995, ANN NEUROL, V38, P714, DOI 10.1002/ana.410380505; Shiono H, 2003, INT IMMUNOL, V15, P903, DOI 10.1093/intimm/dxg088; Shiraishi H, 2005, ANN NEUROL, V57, P289, DOI 10.1002/ana.20341; SINHA S, 1991, LANCET, V338, P75, DOI 10.1016/0140-6736(91)90073-X; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Sonoda Y, 1996, MUSCLE NERVE, V19, P1439, DOI 10.1002/mus.880191102; Spreadbury I, 2005, J NEUROIMMUNOL, V162, P149, DOI 10.1016/j.jneuroim.2005.01.009; STANLEY EF, 1978, SCIENCE, V200, P1285, DOI 10.1126/science.663610; TAKAMORI M, 1995, J NEUROL SCI, V133, P95, DOI 10.1016/0022-510X(95)00162-U; Takamori M, 2000, AM J MED SCI, V319, P204, DOI 10.1097/00000441-200004000-00002; TAKAMORI M, 1994, ANN NEUROL, V35, P74, DOI 10.1002/ana.410350112; Thieben MJ, 2004, NEUROLOGY, V62, P1177, DOI 10.1212/01.WNL.0000122648.19196.02; Tomimitsu H, 2004, ANN NEUROL, V56, P440, DOI 10.1002/ana.20221; TOYKA KV, 1975, SCIENCE, V190, P397, DOI 10.1126/science.1179220; Traka M, 2003, J CELL BIOL, V162, P1161, DOI 10.1083/jcb.200305078; TZARTOS SJ, 1981, J BIOL CHEM, V256, P8635; Tzartos SJ, 1998, IMMUNOL REV, V163, P89, DOI 10.1111/j.1600-065X.1998.tb01190.x; TZARTOS SJ, 1988, P NATL ACAD SCI USA, V85, P2899, DOI 10.1073/pnas.85.9.2899; Urbano FJ, 2003, P NATL ACAD SCI USA, V100, P3491, DOI 10.1073/pnas.0437991100; VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9; VEH RW, 1995, EUR J NEUROSCI, V7, P2189, DOI 10.1111/j.1460-9568.1995.tb00641.x; Vernino S, 2000, NEW ENGL J MED, V343, P847, DOI 10.1056/NEJM200009213431204; Vernino S, 2004, J NEUROSCI, V24, P7037, DOI 10.1523/JNEUROSCI.1485-04.2004; Verschuuren JJ, 1998, NEUROLOGY, V50, P475, DOI 10.1212/WNL.50.2.475; VINCENT A, 1987, ANN NY ACAD SCI, V505, P106, DOI 10.1111/j.1749-6632.1987.tb51286.x; Vincent A, 2004, BRAIN, V127, P701, DOI 10.1093/brain/awh077; Vincent A, 2002, NAT REV IMMUNOL, V2, P797, DOI 10.1038/nri916; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Waterman SA, 2000, PROG NEUROBIOL, V60, P181, DOI 10.1016/S0301-0082(99)00025-8; Waterman SA, 1997, ANN NEUROL, V42, P147, DOI 10.1002/ana.410420204; Watson R, 2004, NEUROLOGY, V63, P43, DOI 10.1212/01.WNL.0000132651.66689.0F; WEINBERG CB, 1979, P NATL ACAD SCI USA, V76, P504, DOI 10.1073/pnas.76.1.504; WHITING PJ, 1986, NEUROLOGY, V36, P612, DOI 10.1212/WNL.36.5.612; WILSON S, 1983, J NEUROL NEUROSUR PS, V46, P377, DOI 10.1136/jnnp.46.5.377; WILSON S, 1983, J NEUROL NEUROSUR PS, V46, P383, DOI 10.1136/jnnp.46.5.383; Xu W, 1999, P NATL ACAD SCI USA, V96, P5746, DOI 10.1073/pnas.96.10.5746; YAMAMOTO T, 1991, ANN NEUROL, V30, P550, DOI 10.1002/ana.410300407; Yoshikawa H, 2006, J NEUROIMMUNOL, V175, P169, DOI 10.1016/j.jneuroim.2006.02.012	169	81	87	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					123	138		10.1016/j.neuron.2006.09.024	http://dx.doi.org/10.1016/j.neuron.2006.09.024			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015231	Bronze			2022-12-28	WOS:000241408100009
J	Kiebler, MA; Bassell, GJ				Kiebler, Michael A.; Bassell, Gary J.			Neuronal RNA granules: Movers and makers	NEURON			English	Review							MESSENGER-RNAS; HIPPOCAMPAL-NEURONS; PROTEIN-SYNTHESIS; LIVING NEURONS; LOCALIZATION; TRANSPORT; BRAIN; STAUFEN; TRANSLOCATION; TRANSLATION		Univ Vienna, Ctr Brain Res, A-1090 Vienna, Austria; Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	University of Vienna; Emory University	Kiebler, MA (corresponding author), Univ Vienna, Ctr Brain Res, Waehringer Guertel 18, A-1090 Vienna, Austria.	michael.kiebler@meduniwien.ac.at		Kiebler, Michael/0000-0002-8850-6297				AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Cook HA, 2004, CELL, V116, P817, DOI 10.1016/S0092-8674(04)00250-8; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Eom T, 2003, J NEUROSCI, V23, P10433; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Goetze B, 2006, J CELL BIOL, V172, P221, DOI 10.1083/jcb.200509035; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Mallardo M, 2003, P NATL ACAD SCI USA, V100, P2100, DOI 10.1073/pnas.0334355100; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Schmid M, 2006, CURR BIOL, V16, P1538, DOI 10.1016/j.cub.2006.06.025; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; WILHELM JE, 1993, J CELL BIOL, V123, P269, DOI 10.1083/jcb.123.2.269; Willis D, 2005, J NEUROSCI, V25, P778, DOI 10.1523/JNEUROSCI.4235-04.2005; Zalfa F, 2006, CURR OPIN NEUROBIOL, V16, P265, DOI 10.1016/j.conb.2006.05.010; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	32	418	424	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					685	690		10.1016/j.neuron.2006.08.021	http://dx.doi.org/10.1016/j.neuron.2006.08.021			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982415	Bronze			2022-12-28	WOS:000240997900008
J	Scherer, SS				Scherer, Steven S.			Inherited neuropathies: New genes don't fit old models	NEURON			English	Editorial Material							MARIE-TOOTH-DISEASE		Univ Penn, Sch Med, William N Kelley Prof Dept Neurol, Philadelphia, PA 19104 USA	University of Pennsylvania	Scherer, SS (corresponding author), Univ Penn, Sch Med, William N Kelley Prof Dept Neurol, 464 Stemmler Hall, Philadelphia, PA 19104 USA.							Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Thomas PK, 2005, PERIPHERAL NEUROPATH, V2, P1623; WRABETZ L, 2004, MYELIN BIOL DISORDER, P905	8	2	2	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					672	674		10.1016/j.neuron.2006.09.008	http://dx.doi.org/10.1016/j.neuron.2006.09.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982409	Bronze			2022-12-28	WOS:000240997900002
J	Cheah, JH; Kim, SF; Hester, LD; Clancy, KW; Patterson, SE; Papadopoulos, V; Snyder, SH				Cheah, Jaime H.; Kim, Sangwon F.; Hester, Lynda D.; Clancy, Kathleen W.; Patterson, Stanley E., III; Papadopoulos, Vassilios; Snyder, Solomon H.			NMDA receptor-nitric oxide transmission mediates neuronal iron homeostasis via the GTPase Dexras1	NEURON			English	Article							TRANSFERRIN-BOUND IRON; INDEPENDENT ACTIVATORS; S-NITROSYLATION; PROTEIN; SYNTHASE; RAT; BELGRADE; BRAIN; GENE; IDENTIFICATION	Dexras1 is a 30 kDa G protein in the Ras subfamily whose discovery was based on its pronounced inducibility by the glucocorticoid dexamethasone. It binds to neuronal nitric oxide synthase (nNOS) via the adaptor protein CAPON, eliciting S-nitrosylation and activation of Dexras1. We report that Dexras1 binds to the peripheral benzodiazepine receptor-associated protein (PAP7), a protein of unknown function that binds to cyclic AMP-dependent protein kinase and the peripheral benzodiazepine receptor. PAP7 in turn binds to the divalent metal transporter (DIVIT1), an iron import channel. We have identified a signaling cascade in neurons whereby stimulation of NMDA receptors activates nNOS, leading to S-nitrosylation and activation of Dexras1, which, via PAP7 and DMT1, physiologically induces iron uptake. As selective iron chelation prevents NMDA neurotoxicity in cortical cultures, the NMDA-NO-Dexras1-PAP7-DMT1-iron uptake signaling cascade also appears to mediate NMDA neurotoxicity.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; Georgetown Univ, Sch Med, Dept Cell Biol, Washington, DC 20057 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Georgetown University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568	NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH079614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA000074, P50DA000266] Funding Source: NIH RePORTER; NIDA NIH HHS [K05 DA000074, P50 DA000266, DA00074, DA000266] Funding Source: Medline; NIMH NIH HHS [K99 MH079614-01, K99 MH079614] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Blumer JB, 2005, TRENDS PHARMACOL SCI, V26, P470, DOI 10.1016/j.tips.2005.07.003; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1996, J NEUROSCI, V16, P7407; CELLIER M, 1995, P NATL ACAD SCI USA, V92, P10089, DOI 10.1073/pnas.92.22.10089; Cheng HYM, 2004, NEURON, V43, P715, DOI 10.1016/j.neuron.2004.08.021; CHOI DW, 1994, PROG BRAIN RES, V100, P47; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Cismowski MJ, 2001, LIFE SCI, V68, P2301, DOI 10.1016/S0024-3205(01)01019-0; DAWSON VL, 1991, P NATL ACAD SCI USA, V88, P6368, DOI 10.1073/pnas.88.14.6368; Falk JD, 1999, J NEUROSCI RES, V57, P782, DOI 10.1002/(SICI)1097-4547(19990915)57:6<782::AID-JNR3>3.0.CO;2-9; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; FARCICH EA, 1992, AM J HEMATOL, V39, P9, DOI 10.1002/ajh.2830390104; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Fleming MD, 1998, P NATL ACAD SCI USA, V95, P1148, DOI 10.1073/pnas.95.3.1148; Garrick LM, 1999, J CELL PHYSIOL, V178, P349, DOI 10.1002/(SICI)1097-4652(199903)178:3<349::AID-JCP9>3.0.CO;2-R; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Graham TE, 2004, BIOCHEM BIOPH RES CO, V316, P307, DOI 10.1016/j.bbrc.2004.02.049; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; HUANG ZH, 1994, SCIENCE, V265, P1883, DOI 10.1126/science.7522345; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Jaffrey SR, 2002, CHEM BIOL, V9, P1329, DOI 10.1016/S1074-5521(02)00293-4; Jaffrey SR, 1998, NEURON, V20, P115, DOI 10.1016/S0896-6273(00)80439-0; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kim SW, 2002, P NATL ACAD SCI USA, V99, P12214, DOI 10.1073/pnas.192316099; KOH JY, 1988, J NEUROSCI, V8, P2153, DOI 10.1523/jneurosci.08-06-02153.1988; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; Moos T, 1998, J NEUROSCI RES, V54, P486, DOI 10.1002/(SICI)1097-4547(19981115)54:4<486::AID-JNR6>3.0.CO;2-I; Nguyen CH, 2005, BIOCHEM BIOPH RES CO, V332, P913, DOI 10.1016/j.bbrc.2005.05.041; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Ponka P, 2004, ANN NY ACAD SCI, V1012, P267, DOI 10.1196/annals.1306.022; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; Rouault TA, 2001, PEDIATR NEUROL, V25, P130, DOI 10.1016/S0887-8994(01)00260-0; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Shoham S, 2000, CELL MOL BIOL, V46, P743; Sohda M, 2001, J BIOL CHEM, V276, P45298, DOI 10.1074/jbc.M108961200; Takahashi H, 2003, MOL BRAIN RES, V110, P1, DOI 10.1016/S0169-328X(02)00543-0; Vargiu P, 2001, MOL BRAIN RES, V94, P1, DOI 10.1016/S0169-328X(01)00140-1; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Zecca L, 2004, NAT REV NEUROSCI, V5, P863, DOI 10.1038/nrn1537	43	194	209	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					431	440		10.1016/j.neuron.2006.07.011	http://dx.doi.org/10.1016/j.neuron.2006.07.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908409	Bronze, Green Accepted			2022-12-28	WOS:000240504700007
J	Gaffield, MA; Rizzoli, SO; Betz, WJ				Gaffield, Michael A.; Rizzoli, Silvio O.; Betz, William J.			Mobility of synaptic vesicles in different pools in resting and stimulated frog motor nerve terminals	NEURON			English	Article							NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; FLUORESCENCE; DYNAMICS; RECOVERY; BOUTONS; TEMPERATURE; ENDOCYTOSIS; EXOCYTOSIS; PLASTICITY	We used fluorescence recovery after photobleaching (FRAP) to measure the mobility of synaptic vesicles in frog motor nerve terminals. Vesicles belonging to the recycling pool or to the reserve pool were selectively labeled with FM1-43. In resting terminals, vesicles in the reserve pool were immobile, while vesicles in the recycling pool were mobile. Nerve stimulation increased the mobility of reserve pool vesicles. Treatment with latrunculin A, which destroyed actin filaments, had no significant effect on mobility, and reducing the temperature likewise had little effect, suggesting that recycling pool vesicles move by simple diffusion. Application of okadaic acid caused vesicle mobility in both pools to increase to the same level. We could model these and others' results quantitatively by taking into account the relative numbers of mobile and immobile vesicles in each pool, and vesicle packing density, which has a large effect on mobility.	Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA; Univ Colorado, Neurosci Program, Sch Med, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Betz, WJ (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA.	bill.betz@uchsc.edu	Rizzoli, Silvio/ABG-2227-2020	Rizzoli, Silvio/0000-0002-1667-7839				AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; BETZ WJ, 1994, J CELL BIOL, V124, P843, DOI 10.1083/jcb.124.5.843; BETZ WJ, 1993, J PHYSIOL-LONDON, V460, P287, DOI 10.1113/jphysiol.1993.sp019472; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; FUSHIMI K, 1991, J CELL BIOL, V112, P719, DOI 10.1083/jcb.112.4.719; Guatimosim C, 2002, J NEUROCHEM, V82, P1047, DOI 10.1046/j.1471-4159.2002.01029.x; Henkel AW, 1996, J NEUROSCI, V16, P3960; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Hook P, 2000, J MUSCLE RES CELL M, V21, P357, DOI 10.1023/A:1005614212575; Jordan R, 2005, BIOPHYS J, V89, P2091, DOI 10.1529/biophysj.105.061663; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kushmerick C, 2006, J NEUROSCI, V26, P1366, DOI 10.1523/JNEUROSCI.3889-05.2006; Lemke EA, 2005, J NEUROSCI, V25, P11034, DOI 10.1523/JNEUROSCI.2971-05.2005; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; Merrifield CJ, 2004, TRENDS CELL BIOL, V14, P352, DOI 10.1016/j.tcb.2004.05.008; Micheva KD, 2005, J NEUROSCI, V25, P7481, DOI 10.1523/JNEUROSCI.1801-05.2005; Rea R, 2004, NEURON, V41, P755, DOI 10.1016/S0896-6273(04)00088-1; Richards DA, 2004, J PHYSIOL-LONDON, V557, P77, DOI 10.1113/jphysiol.2004.062158; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Shtrahman M, 2005, BIOPHYS J, V89, P3615, DOI 10.1529/biophysj.105.059295; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; Yang XF, 2005, J PHYSIOL-LONDON, V567, P215, DOI 10.1113/jphysiol.2005.088948; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	33	76	79	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					317	325		10.1016/j.neuron.2006.06.031	http://dx.doi.org/10.1016/j.neuron.2006.06.031			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880126	Bronze			2022-12-28	WOS:000239908800007
J	Dorsey, SG; Renn, CL; Carim-Todd, L; Barrick, CA; Bambrick, L; Krueger, BK; Ward, CW; Tessarollo, L				Dorsey, Susan G.; Renn, Cynthia L.; Carim-Todd, Laura; Barrick, Colleen A.; Bambrick, Linda; Krueger, Bruce K.; Ward, Christopher W.; Tessarollo, Lino			In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model	NEURON			English	Article							MEDIATING BDNF MODULATION; NEUROTROPHIN RECEPTORS; HIPPOCAMPAL; SURVIVAL; MICE; EXPRESSION; PHOSPHORYLATION; ASTROCYTES; ROLES	Imbalances in neurotrophins or their high-affinity Trk receptors have long been reported in neurodegenerative diseases. However, a molecular link between these gene products and neuronal cell death has not been established. In the trisomy 16 (Ts16) mouse there is increased apoptosis in the cortex, and hippocampal neurons undergo accelerated cell death that cannot be rescued by administration of brain-derived neurotrophic factor (BDNF). Ts16 neurons have normal levels of the TrkB tyrosine kinase receptor but an upregulation of the TrkB.T1 truncated receptor isoform. Here we show that restoration of the physiological level of the TrkB.T1 receptor by gene targeting rescues Ts16 cortical cell and hippocampal neuronal death. Moreover, it corrects resting Ca2+ levels and restores BDNF-induced intracellular signaling mediated by full-length TrkB in Ts16 hippocampal neurons. These data provide a direct link between neuronal cell death and abnormalities in Trk neurotrophin receptor levels.	NCI, Ctr Canc Res, Mouse Canc Genet Program, Neural Dev Grp, Frederick, MD 21702 USA; Univ Maryland, Sch Med, Sch Nursing, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Anesthesiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Dorsey, SG (corresponding author), NCI, Ctr Canc Res, Mouse Canc Genet Program, Neural Dev Grp, Frederick, MD 21702 USA.	sdorsey@son.umaryland.edu; tessarol@ncifcrf.gov		Renn, Cynthia/0000-0001-6764-9347	NATIONAL CANCER INSTITUTE [Z01BC010390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR002177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [K22NR000174] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIAMS NIH HHS [K01-AR02177] Funding Source: Medline; NINDS NIH HHS [R01NS40492] Funding Source: Medline; NINR NIH HHS [K22NR00174] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		Alcantara S, 1997, J NEUROSCI, V17, P3623; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Alonso M, 2002, CELL MOL NEUROBIOL, V22, P663, DOI 10.1023/A:1021848706159; Bambrick LL, 1997, GLIA, V19, P352, DOI 10.1002/(SICI)1098-1136(199704)19:4<352::AID-GLIA8>3.0.CO;2-Z; BAMBRICK LL, 1995, P NATL ACAD SCI USA, V92, P9692, DOI 10.1073/pnas.92.21.9692; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Blanquet PR, 2000, NEUROSCIENCE, V95, P705; Bonin A, 2000, METH MOL B, V158, P121; Chen KS, 1997, J NEUROSCI, V17, P7288; Chun LG, 2003, AM J PHYSIOL-CELL PH, V285, pC686, DOI 10.1152/ajpcell.00072.2003; Connor B, 1996, MOL BRAIN RES, V42, P1, DOI 10.1016/S0169-328X(96)00040-X; Coyle J T, 1991, Res Publ Assoc Res Nerv Ment Dis, V69, P85; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Dorsey SG, 2002, J NEUROSCI, V22, P2571, DOI 10.1523/JNEUROSCI.22-07-02571.2002; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; GEARHART JD, 1986, BRAIN RES BULL, V16, P789, DOI 10.1016/0361-9230(86)90075-4; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; Haydar TF, 1996, J NEUROSCI, V16, P6175; Haydar TF, 2000, J NEUROSCI, V20, P4156; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jacobowitz D.M, 1998, CHEMOARCHITECTONIC A; JOHNSON EM, 1992, EXP NEUROL, V115, P163, DOI 10.1016/0014-4886(92)90242-I; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kust BM, 2002, EXP NEUROL, V177, P419, DOI 10.1006/exnr.2002.8011; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; Mao R, 2003, GENOMICS, V81, P457, DOI 10.1016/S0888-7543(03)00035-1; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MIRANDA RC, 1993, P NATL ACAD SCI USA, V90, P6439, DOI 10.1073/pnas.90.14.6439; Muller W, 1997, NEUROSCI LETT, V223, P81, DOI 10.1016/S0304-3940(97)13406-1; Mutoh T, 2000, NEUROCHEM RES, V25, P239, DOI 10.1023/A:1007575504321; Ochs G, 2000, AMYOTROPH LATERAL SC, V1, P201, DOI 10.1080/14660820050515197; Ohira K, 1999, DEV BRAIN RES, V112, P21, DOI 10.1016/S0165-3806(98)00151-5; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Schuchmann S, 1998, J NEUROSCI, V18, P7216; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Segal RA, 2003, ANNU REV NEUROSCI, V26, P299, DOI 10.1146/annurev.neuro.26.041002.131421; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Tessarollo L, 2000, METH MOL B, V158, P47; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	49	87	89	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					21	28		10.1016/j.neuron.2006.06.009	http://dx.doi.org/10.1016/j.neuron.2006.06.009			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815329	Bronze			2022-12-28	WOS:000239037700007
J	Mameli-Engvall, M; Evrard, A; Pons, S; Maskos, U; Svensson, TH; Changeux, JP; Faure, P				Mameli-Engvall, Monica; Evrard, Alexis; Pons, Stephanie; Maskos, Uwe; Svensson, Torgny H.; Changeux, Jean-Pierre; Faure, Philippe			Hierarchical control of dopamine neuron-firing patterns by nicotinic receptors	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MEDIAL FOREBRAIN-BUNDLE; ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC MECHANISMS; AFFERENT MODULATION; BURST STIMULATION; PUTATIVE ROLE; RAT	Nicotine elicits dopamine release by stimulating nicotinic acetylcholine receptors (nAChRs) on dopaminergic neurons. However, a modulation of these neurons by endogenous acetylcholine has not been described. We recorded, in vivo, the spontaneous activity of dopaminergic neurons in the VTA of anaesthetized wt and nAChR knockout mice and their response to nicotine injections. Deleting alpha 7 or beta 2 subunits modified the spontaneous firing patterns, demonstrating their direct stimulation by endogenous acetylcholine. Quantitative analysis further revealed four principal modes of firing, each depending on the expression of particular nAChR subunits and presenting unique responses to nicotine. The prominent role of the beta 2 subunit was further confirmed by its selective lentiviral reexpression in the VTA. These data suggest a hierarchical control of dopaminergic neuron firing patterns by nAChRs: activation of beta 2*-nAChR switches cells from a resting to an excited state, whereas activation of alpha 7*-nAChRs finely tunes the latter state but only once beta 2*-nAChRs have been activated.	Inst Pasteur, CNRS, URA 2182, Unite Recepteurs & Cognit, F-75724 Paris 15, France; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Karolinska Institutet	Changeux, JP (corresponding author), Inst Pasteur, CNRS, URA 2182, Unite Recepteurs & Cognit, F-75724 Paris 15, France.	changeux@pasteur.fr; phfaure@pasteur.fr		Faure, Philippe/0000-0003-3573-4971				Bardo MT, 1996, BEHAV BRAIN RES, V77, P23, DOI 10.1016/0166-4328(95)00203-0; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Changeux J-P, 2005, NICOTINIC ACETYLCHOL; CHANGEUX JP, 1989, COGNITION, V33, P63, DOI 10.1016/0010-0277(89)90006-1; Chergui K, 1997, EUR J NEUROSCI, V9, P2370, DOI 10.1111/j.1460-9568.1997.tb01654.x; Chergui K, 1996, NEUROSCIENCE, V72, P141, DOI 10.1016/0306-4522(95)00513-7; CHERGUI K, 1993, EUR J NEUROSCI, V5, P137, DOI 10.1111/j.1460-9568.1993.tb00479.x; CUNNINGHAM MG, 1993, J NEUROSCI METH, V47, P105, DOI 10.1016/0165-0270(93)90026-N; Dehaene S, 1991, CEREB CORTEX, V1, P62, DOI 10.1093/cercor/1.1.62; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Diana M. M., 2001, HDB EXPT PHARM, P1; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1983, NEUROSCIENCE, V10, P317, DOI 10.1016/0306-4522(83)90136-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; GRACE AA, 1989, J NEUROSCI, V9, P3463; Granon S, 2003, P NATL ACAD SCI USA, V100, P9596, DOI 10.1073/pnas.1533498100; GRENHOFF J, 1986, ACTA PHYSIOL SCAND, V128, P351, DOI 10.1111/j.1748-1716.1986.tb07988.x; Gutkin BS, 2006, P NATL ACAD SCI USA, V103, P1106, DOI 10.1073/pnas.0510220103; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Jones IW, 2004, J NEUROSCI, V24, P11244, DOI 10.1523/JNEUROSCI.3009-04.2004; Kitai ST, 1999, CURR OPIN NEUROBIOL, V9, P690, DOI 10.1016/S0959-4388(99)00040-9; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; LACEY MG, 1989, J NEUROSCI, V9, P1233; Lodge DJ, 2006, P NATL ACAD SCI USA, V103, P5167, DOI 10.1073/pnas.0510715103; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; MEREU G, 1987, EUR J PHARMACOL, V141, P395, DOI 10.1016/0014-2999(87)90556-5; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naylor DE, 2005, EPILEPSIA, V46, P142, DOI 10.1111/j.1528-1167.2005.01022.x; NISELL M, 1994, PHARMACOL TOXICOL, V75, P348, DOI 10.1111/j.1600-0773.1994.tb00373.x; ORRURTREGER A, 1995, GENOMICS, V26, P399, DOI 10.1016/0888-7543(95)80228-E; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PICCIOTTO MR, 1995, NATURE, V374, P65, DOI 10.1038/374065a0; SANGHERA MK, 1984, NEUROSCIENCE, V12, P793, DOI 10.1016/0306-4522(84)90171-4; Schilstrom B, 2000, SYNAPSE, V38, P375, DOI 10.1002/1098-2396(20001215)38:4<375::AID-SYN2>3.0.CO;2-Y; Schilstrom B, 1998, NEUROSCIENCE, V85, P1005, DOI 10.1016/S0306-4522(98)00114-6; Schilstrom B, 2003, INT J NEUROPSYCHOPH, V6, P1, DOI 10.1017/S1461145702003188; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Steffensen SC, 1998, J NEUROSCI, V18, P8003; Stolerman IP, 2004, NEUROPHARMACOLOGY, V46, P363, DOI 10.1016/j.neuropharm.2003.10.002; TEAM RDC, 2005, R LANGUAGE ENV STAT; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Wooltorton JRA, 2003, J NEUROSCI, V23, P3176; Zachariou V, 2001, NEUROPSYCHOPHARMACOL, V24, P576, DOI 10.1016/S0893-133X(00)00224-4	50	215	221	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					911	921		10.1016/j.neuron.2006.05.007	http://dx.doi.org/10.1016/j.neuron.2006.05.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772172	Bronze			2022-12-28	WOS:000238589500011
J	Sagdullaev, BT; McCall, MA; Lukasiewicz, PD				Sagdullaev, Botir T.; McCall, Maureen A.; Lukasiewicz, Peter D.			Presynaptic inhibition modulates spillover, creating distinct dynamic response ranges of sensory output	NEURON			English	Article							RETINAL GANGLION-CELLS; EXCITATORY SYNAPTIC-TRANSMISSION; RECEPTOR-MEDIATED INHIBITION; MULTIVESICULAR RELEASE; BIPOLAR CELLS; NMDA RECEPTORS; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; GABA(C) RECEPTORS; TIGER SALAMANDER	Sensory information is thought to be modulated by presynaptic inhibition. Although this form of inhibition is a well-studied phenomenon, it is still unclear what role it plays in shaping sensory signals in intact circuits. By visually stimulating the retinas of transgenic mice lacking GABAc receptor-mediated presynaptic inhibition, we found that this inhibition regulated the dynamic range of ganglion cell (GC) output to the brain. Presynaptic inhibition acted differentially upon two major retinal pathways; its elimination affected GC responses to increments, but not decrements, in light intensity across the visual scene. The GC dynamic response ranges were different because presynaptic inhibition limited glutamate release from ON, but not OFF, bipolar cells, which modulate the extent of glutamate spillover and activation of perisynaptic NMDA receptors at ON GCs. Our results establish a role for presynaptic inhibitory control of spillover in determining sensory output in the CNS.	Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Louisville, Dept Psychol & Brain Sci, Louisville, KY 40292 USA; Univ Louisville, Dept Ophthalmol & Visual Sci, Louisville, KY 40292 USA	Washington University (WUSTL); Washington University (WUSTL); University of Louisville; University of Louisville	Lukasiewicz, PD (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, 660 S Euclid Ave, St Louis, MO 63110 USA.	lukasiewicz@vision.wustl.edu		McCall, Maureen/0000-0002-9781-315X; Sagdullaev, Botir/0000-0002-0611-1479	NEI NIH HHS [P30 EY002687, EY014701, EY08922, EY02687] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY002687, R01EY014701, R01EY008922] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825; Auger C, 1998, J NEUROSCI, V18, P4532; Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Chen S, 2002, J NEUROSCI, V22, P2165, DOI 10.1523/JNEUROSCI.22-06-02165.2002; Chichilnisky EJ, 2002, J NEUROSCI, V22, P2737, DOI 10.1523/JNEUROSCI.22-07-02737.2002; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; CLELAND BG, 1973, J PHYSIOL-LONDON, V228, P649, DOI 10.1113/jphysiol.1973.sp010105; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Cohen ED, 2000, J NEUROPHYSIOL, V83, P3217, DOI 10.1152/jn.2000.83.6.3217; Cook P. B., 1996, Investigative Ophthalmology and Visual Science, V37, pS1153; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DIAMOND JS, 1993, NEURON, V11, P725, DOI 10.1016/0896-6273(93)90082-3; DUDEL J, 1961, J PHYSIOL-LONDON, V155, P543, DOI 10.1113/jphysiol.1961.sp006646; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; Hare WA, 1996, J NEUROPHYSIOL, V76, P2005, DOI 10.1152/jn.1996.76.3.2005; Higgs MH, 1999, J NEUROSCI, V19, P3691; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; LUKASIEWICZ PD, 1995, J NEUROSCI, V15, P4592; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Matsui K, 1998, J NEUROSCI, V18, P4500; Matsui K, 2001, J NEUROPHYSIOL, V86, P2285, DOI 10.1152/jn.2001.86.5.2285; McCall MA, 2002, J NEUROSCI, V22, P4163, DOI 10.1523/JNEUROSCI.22-10-04163.2002; McMahon MJ, 2004, J NEUROSCI, V24, P3736, DOI 10.1523/JNEUROSCI.5252-03.2004; MURAKAMI M, 1975, VISION RES, V15, P456, DOI 10.1016/0042-6989(75)90101-7; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PEICHL L, 1981, PROC R SOC SER B-BIO, V212, P139, DOI 10.1098/rspb.1981.0030; Ragozzino D, 1996, MOL PHARMACOL, V50, P1024; Roska B, 1998, J NEUROSCI, V18, P3451; Rotolo TC, 2003, VISUAL NEUROSCI, V20, P373, DOI 10.1017/S095252380320403X; Sagdullaev BT, 2005, VISUAL NEUROSCI, V22, P649, DOI 10.1017/S0952523805225142; Shields CR, 2000, J NEUROSCI, V20, P2673; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; THIBOS LN, 1978, J PHYSIOL-LONDON, V278, P79, DOI 10.1113/jphysiol.1978.sp012294; TROY JB, 1992, VISUAL NEUROSCI, V9, P535, DOI 10.1017/S0952523800001784; Verweij J, 1996, VISION RES, V36, P3943, DOI 10.1016/S0042-6989(96)00142-3; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WATKINS JC, 1987, TRENDS NEUROSCI, V10, P265, DOI 10.1016/0166-2236(87)90171-8; Zaghloul KA, 2003, J NEUROSCI, V23, P2645; ZHANG J, 1995, J NEUROPHYSIOL, V74, P1583, DOI 10.1152/jn.1995.74.4.1583; Zhang JA, 1997, VISUAL NEUROSCI, V14, P553, DOI 10.1017/S0952523800012219	48	95	97	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					923	935		10.1016/j.neuron.2006.05.015	http://dx.doi.org/10.1016/j.neuron.2006.05.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772173	Bronze			2022-12-28	WOS:000238589500012
J	Jiang, X; Rosen, E; Zeffiro, T; VanMeter, J; Blanz, V; Riesenhuber, M				Jiang, X; Rosen, E; Zeffiro, T; VanMeter, J; Blanz, V; Riesenhuber, M			Evaluation of a shape-based model of human face discrimination using fMRI and behavioral techniques	NEURON			English	Article							NEURAL MECHANISMS; TEMPORAL CORTEX; TASK-DIFFICULTY; PERCEPTION; NEURONS; INVERSION; RESPONSES; AREA; REPRESENTATIONS; SELECTIVITY	Understanding the neural mechanisms underlying object recognition is one of the fundamental challenges of visual neuroscience. While neurophysiology experiments have provided evidence for a "simple-to-complex" processing model based on a hierarchy of increasingly complex image features, behavioral and fMRI studies of face processing have been interpreted as incompatible with this account. We present a neurophysiologically plausible, feature-based model that quantitatively accounts for face discrimination characteristics, including face inversion and "configural" effects. The model predicts that face discrimination is based on a sparse representation of units selective for face shapes, without the need to postulate additional, "face-specific" mechanisms. We derive and test predictions that quantitatively link model FFA face neuron tuning, neural adaptation measured in an fMRI rapid adaptation paradigm, and face discrimination performance. The experimental data are in excellent agreement with the model prediction that discrimination performance should asymptote as faces become dissimilar enough to activate different neuronal populations.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; Georgetown Univ, Med Ctr, Ctr Funct & Mol Imaging, Washington, DC 20007 USA; Max Planck Inst Informat, Saarbrucken, Germany	Georgetown University; Georgetown University; Max Planck Society	Riesenhuber, M (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Res Bldg Room WP-12,3970 Reservoir Rd NW, Washington, DC 20007 USA.	mr287@georgetown.edu	Zeffiro, Thomas/AAE-3441-2019; VanMeter, John W/D-2589-2018	Zeffiro, Thomas/0000-0002-0846-4577; VanMeter, John W/0000-0002-7012-5197; Riesenhuber, Maximilian/0000-0002-5744-0408	NIAID NIH HHS [1P20MH66239-01AI] Funding Source: Medline; NIMH NIH HHS [1R01MH076281-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076281] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barton JJS, 2003, NEUROL CLIN, V21, P521, DOI 10.1016/S0733-8619(02)00106-8; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; BLANZ V, 1999, SIGGRAPH 99 LOS ANG; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; CADIEU C, 2004, SHAPE REPRESENTATION; DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1, DOI 10.1162/jocn.1991.3.1.1; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; FARAH MJ, 1995, J EXP PSYCHOL HUMAN, V21, P628, DOI 10.1037/0096-1523.21.3.628; Freedman DJ, 2003, J NEUROSCI, V23, P5235; FRISTON KJ, 1995, NEUROIMAGE, V2, P157, DOI 10.1006/nimg.1995.1018; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Golby AJ, 2001, NAT NEUROSCI, V4, P845, DOI 10.1038/90565; Grady CL, 1996, HUM BRAIN MAPP, V4, P227, DOI 10.1002/(SICI)1097-0193(1996)4:4<227::AID-HBM1>3.0.CO;2-5; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kiebel SJ, 1999, NEUROIMAGE, V10, P756, DOI 10.1006/nimg.1999.0508; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Lampl I, 2004, J NEUROPHYSIOL, V92, P2704, DOI 10.1152/jn.00060.2004; Loffler G, 2005, NAT NEUROSCI, V8, P1386, DOI 10.1038/nn1538; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; MILLER EK, 1993, J NEUROSCI, V13, P1460; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Riesenhuber M, 1999, NEURON, V24, P87, DOI 10.1016/S0896-6273(00)80824-7; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; ROLLS ET, 1995, EXP BRAIN RES, V103, P409; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Shelton CR, 2000, INT J COMPUT VISION, V38, P75, DOI 10.1023/A:1008170818506; Sunaert S, 2000, NEUROIMAGE, V11, P612, DOI 10.1006/nimg.2000.0587; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wilson HR, 2002, VISION RES, V42, P2909, DOI 10.1016/S0042-6989(02)00362-0; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Yovel G, 2005, CURR BIOL, V15, P2256, DOI 10.1016/j.cub.2005.10.072; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	49	126	128	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					159	172		10.1016/j.neuron.2006.03.012	http://dx.doi.org/10.1016/j.neuron.2006.03.012			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600863	Bronze			2022-12-28	WOS:000236811300018
J	Zou, YM				Zou, YM			Navigating the anterior-posterior axis with Wnts	NEURON			English	Editorial Material							HOX GENE-EXPRESSION; AXON GUIDANCE; COMMISSURAL AXONS; CELL-MIGRATION; SPINAL-CORD; C-ELEGANS; SYSTEM	Recent studies have begun to shed light on the molecular guidance cues controlling anterior-posterior axon guidance. Two recent studies in the current issue of Developmental Cell show that Wnts play critical roles in patterning processes and directing neuronal migration in C. elegans. Together with previous findings in vertebrates and flies, these new results establish conserved function of Wnts in A-P guidance.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	University of Chicago	Zou, YM (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047484] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS047484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bourikas D, 2005, NAT NEUROSCI, V8, P297, DOI 10.1038/nn1396; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dickson BJ, 2005, NAT NEUROSCI, V8, P1130, DOI 10.1038/nn0905-1130; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Harris J, 1996, DEVELOPMENT, V122, P3117; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Imondi R, 2003, SCIENCE, V302, P1903, DOI 10.1126/science.1092976; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Maloof JN, 1999, DEVELOPMENT, V126, P37; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; PRASAD BC, 2006, IN PRESS DEVELOPMENT; Sato M, 2006, NAT NEUROSCI, V9, P67, DOI 10.1038/nn1604; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Schnorrer F, 2004, CURR BIOL, V14, pR19, DOI 10.1016/j.cub.2003.12.016; Stoeckli ET, 2006, CURR OPIN NEUROBIOL, V16, P35, DOI 10.1016/j.conb.2006.01.008; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	18	19	19	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					787	789		10.1016/j.neuron.2006.03.004	http://dx.doi.org/10.1016/j.neuron.2006.03.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543126	Bronze			2022-12-28	WOS:000236227500006
J	Smith, APR; Stephan, KE; Rugg, MD; Dolan, RJ				Smith, APR; Stephan, KE; Rugg, MD; Dolan, RJ			Task and content modulate amygdala-hippocampal connectivity in emotional retrieval	NEURON			English	Article							LOBE MEMORY SYSTEM; EPISODIC MEMORY; RECONSOLIDATION; ORIENTATION; RECOLLECTION; RECOGNITION; ACTIVATION; AROUSAL; FEAR	The ability to remember emotional events is crucial for adapting to biologically and socially significant situations. Little is known, however, about the nature of the neural interactions supporting the integration of mnemonic and emotional information. Using fMRI and dynamic models of effective connectivity, we examined regional neural activity and specific interactions between brain regions during a contextual memory retrieval task. We independently manipulated emotional context and relevance of retrieved emotional information to task demands. We show that retrieval of emotionally valenced contextual information is associated with enhanced connectivity from hippocampus to amygdala, structures crucially involved with encoding of emotional events. When retrieval of emotional information is relevant to current behavior, amygdala-hippocampal connectivity increases bidirectionally, under modulatory influences from orbitofrontal cortex, a region implicated in representation of affective value and behavioral guidance. Our findings demonstrate that both memory content and behavioral context impact upon large scale neuronal dynamics underlying emotional retrieval.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 6BT, England; UCL, Inst Cognit Neurosci, London WC1E 3AR, England; Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA	University of London; University College London; University of London; University College London; University of California System; University of California Irvine; University of California System; University of California Irvine	Smith, APR (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 6BT, England.	adam.smith@ucl.ac.uk	Smith-Collins, Adam/C-6946-2009	Smith-Collins, Adam/0000-0002-5620-6169; Dolan, Ray/0000-0001-9356-761X; Stephan, Klaas Enno/0000-0002-8594-9092	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AMARAL D G, 1992, P1; Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Bechara A, 2004, BRAIN COGNITION, V55, P30, DOI 10.1016/j.bandc.2003.04.001; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Christianson Sven -Ake, 1992, HDB EMOTION MEMORY; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dobbins IG, 2003, NEUROPSYCHOLOGIA, V41, P318, DOI 10.1016/S0028-3932(02)00164-1; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102; Dolcos F, 2004, NEURON, V42, P855, DOI 10.1016/S0896-6273(04)00289-2; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Glascher J, 2003, J NEUROSCI, V23, P10274; Greenberg DL, 2005, NEUROPSYCHOLOGIA, V43, P659, DOI 10.1016/j.neuropsychologia.2004.09.002; Hamann SB, 2002, PSYCHOL SCI, V13, P135, DOI 10.1111/1467-9280.00425; Henson RNA, 1999, J NEUROSCI, V19, P3962; Herron JE, 2003, J COGNITIVE NEUROSCI, V15, P843, DOI 10.1162/089892903322370762; Hornberger M, 2004, J COGNITIVE NEUROSCI, V16, P1196, DOI 10.1162/0898929041920450; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; LANG PJ, 1997, INT AFFECTIVE PICTOR; Laurienti PJ, 2003, J NEUROSCI METH, V131, P41, DOI 10.1016/S0165-0270(03)00238-3; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; Maratos EJ, 2001, NEUROPSYCHOLOGIA, V39, P910, DOI 10.1016/S0028-3932(01)00025-2; Penny WD, 2004, NEUROIMAGE, V22, P1157, DOI 10.1016/j.neuroimage.2004.03.026; Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Richardson MP, 2004, NAT NEUROSCI, V7, P278, DOI 10.1038/nn1190; Smith APR, 2005, LEARN MEMORY, V12, P472, DOI 10.1101/lm.84305; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Smith APR, 2004, J COGNITIVE NEUROSCI, V16, P760, DOI 10.1162/089892904970816; Stephan KE, 2004, J ANAT, V205, P443, DOI 10.1111/j.0021-8782.2004.00359.x; Wang SH, 2005, J NEUROSCI, V25, P830, DOI 10.1523/JNEUROSCI.4716-04.2005	36	184	192	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 16	2006	49	4					631	638		10.1016/j.neuron.2005.12.025	http://dx.doi.org/10.1016/j.neuron.2005.12.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476670	Green Submitted, Bronze			2022-12-28	WOS:000235643800014
J	Bargmann, C; Mason, C				Bargmann, C; Mason, C			In appreciation of Lawrence C. Katz, 1956-2005 - Obituary	NEURON			English	Biographical-Item									Rockefeller Univ, New York, NY 10021 USA; Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA	Rockefeller University; Columbia University	Bargmann, C (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.			Bargmann, Cornelia/0000-0002-8484-0618					0	0	0	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 22	2005	48	6					897	900		10.1016/j.neuron.2005.12.012	http://dx.doi.org/10.1016/j.neuron.2005.12.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	998EP	16450476	Bronze			2022-12-28	WOS:000234301700006
J	Plested, AJR; Mayer, ML				Plested, Andrew J. R.; Mayer, Mark L.			Structure and mechanism of kainate receptor modulation by anions	NEURON			English	Article							LIGAND-BINDING CORE; PARTIAL AGONIST ACTION; AMINO-ACID RECEPTORS; GLUTAMATE-RECEPTOR; CRYSTAL-STRUCTURES; NMDA RECEPTORS; AMPA RECEPTORS; SYNAPTIC PLASTICITY; ALPHA-AMYLASE; BIPOLAR CELLS	L-glutamate, the major excitatory neurotransmitter in the human brain, activates a family of ligand-gated ion channels, the major subtypes of which are named AMPA, kainate, and NMDA receptors. In common with many signal transduction proteins, glutamate receptors are modulated by ions and small molecules, including Ca2+, Mg2+, Zn2+, protons, polyamines, and ste roids. Strikingly, the activation of kainate receptors by glutamate requires the presence of both Na+ and Cl- in the extracellular solution, and in the absence of these ions, receptor activity is abolished. Here, we identify the site and mechanism of action of anions. Surprisingly, we find that Cl- ions are essential structural components of kainate receptors. Cl- ions bind in a cavity formed at the interface between subunits in a dimer pair. In the absence of Cl-, dinner stability is reduced, the rate of desensitization increases, and the fraction of receptors competent for activation by glutamate drops precipitously.	NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mayer, ML (corresponding author), NICHHD, Lab Cellular & Mol Neurophysiol, Porter Neurosci Res Ctr, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	mlm@helix.nih.gov	Mayer, Mark L/H-5500-2013; Mayer, Mark/AAE-7356-2019	Mayer, Mark/0000-0003-4378-8451; Plested, Andrew/0000-0001-6062-0832	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000707] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000707] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; BETTLER B, 1992, NEURON, V8, P257, DOI 10.1016/0896-6273(92)90292-L; Bowie D, 2002, J PHYSIOL-LONDON, V539, P725, DOI 10.1113/jphysiol.2001.013407; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; D'Amico S, 2000, GENE, V253, P95, DOI 10.1016/S0378-1119(00)00229-8; DeLano W.L, PYMOL MOL GRAPHICS S; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; EGEBJERG J, 1991, NATURE, V351, P745, DOI 10.1038/351745a0; Fleck MW, 2003, J NEUROSCI, V23, P1219; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; HEINEMANN SH, 1992, METHOD ENZYMOL, V207, P131; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; JIANG C, 1992, J PHYSIOL-LONDON, V448, P697, DOI 10.1113/jphysiol.1992.sp019065; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jonas P, 2004, TRENDS NEUROSCI, V27, P30, DOI 10.1016/j.tins.2003.10.010; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lobet S, 2006, EMBO J, V25, P24, DOI 10.1038/sj.emboj.7600909; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Masuko T, 1999, MOL PHARMACOL, V55, P957, DOI 10.1124/mol.55.6.957; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; NEHER E, 1992, METHOD ENZYMOL, V207, P123; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Numao S, 2002, BIOCHEMISTRY-US, V41, P215, DOI 10.1021/bi0115636; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paternain AV, 2003, J NEUROSCI, V23, P8641; Perin-Dureau F, 2002, J NEUROSCI, V22, P5955; POWELL DH, 1988, FARADAY DISCUSS, V85, P137, DOI 10.1039/dc9888500137; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Rachline J, 2005, J NEUROSCI, V25, P308, DOI 10.1523/JNEUROSCI.3967-04.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Strobl S, 1998, J MOL BIOL, V278, P617, DOI 10.1006/jmbi.1998.1667; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; WANG ZY, 1993, BIOCHEMISTRY-US, V32, P2125, DOI 10.1021/bi00060a001; Watchorn E, 1935, Biochem J, V29, P2291; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Wong AYC, 2006, J NEUROSCI, V26, P5750, DOI 10.1523/JNEUROSCI.0301-06.2006	54	89	90	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					829	841		10.1016/j.neuron.2007.02.025	http://dx.doi.org/10.1016/j.neuron.2007.02.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359918	Bronze			2022-12-28	WOS:000245292800008
J	Dkhissi-Benyahya, O; Gronfier, C; De Vanssay, W; Flamant, F; Cooper, HM				Dkhissi-Benyahya, Ouria; Gronfier, Claude; De Vanssay, Wena; Flamant, Frederic; Cooper, Howard M.			Modeling the role of mid-wavelength cones in circadian responses to light	NEURON			English	Article							RETINAL GANGLION-CELLS; THYROID-HORMONE RECEPTOR; SPECTRAL SENSITIVITY; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; PHASE-SHIFTS; NON-ROD; MELANOPSIN; PHOTORECEPTORS; MICE	Nonvisual responses to light, such as entrainment of the circadian clock, involve trinsically light-sensitive melanopsin-expressing ganglion cells as well as rod and cone toreceptors. However, previous studies been unable to demonstrate aspecific contribution of cones in the photic control of responses to light. Using a mouse model specifically lacks mid-wavelength (MW) we show that these photoreceptors; icant role in light entrainment and in phase ing of the circadian oscillator. The of MW cones is mainly observed for light sures of short duration and toward the wavelength region of the spectrum, with the known properties of this opsin. Modeling the contributions of the various tors stresses the importance of the particular spectral, temporal, and response domains of the photopigments assessing their role and contribution in than responses to light.	Stem Cell & Brain Res Inst, INSERM U846, Dept Chronobiol, F-69500 Bron, France; Univ Lyon 1, F-69000 Lyon, France; ENS, Biol Cellulaire & Mol Lab, F-69000 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Cooper, HM (corresponding author), Stem Cell & Brain Res Inst, INSERM U846, Dept Chronobiol, F-69500 Bron, France.	cooper@lyon.inserm.fr	Dkhissi-Benyahya, Ouria/M-5665-2014; COOPER, HOWARD/M-7304-2014; Gronfier, Claude/C-1243-2008	Dkhissi-Benyahya, Ouria/0000-0001-9168-3801; Gronfier, Claude/0000-0002-6549-799X				Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955; ARGAMASO SM, 1995, BIOPHYS CHEM, V56, P3, DOI 10.1016/0301-4622(95)00009-M; Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; Bullough JD, 2005, ZOOL SCI, V22, P223, DOI 10.2108/zsj.22.223; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyahya O, 2000, J NEUROSCI, V20, P7790; EBIHARA S, 1980, PHYSIOL BEHAV, V24, P523, DOI 10.1016/0031-9384(80)90246-2; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Forrest D, 1996, EMBO J, V15, P3006, DOI 10.1002/j.1460-2075.1996.tb00664.x; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Gauthier K, 1999, EMBO J, V18, P623, DOI 10.1093/emboj/18.3.623; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Kaiser P.K, 1996, HUMAN COLOR VISION; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; LAMB TD, 1995, VISION RES, V35, P3083, DOI 10.1016/0042-6989(95)00114-F; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Mrosovsky N, 2005, J COMP PHYSIOL A, V191, P1011, DOI 10.1007/s00359-005-0017-1; Mrosovsky N, 2003, J COMP PHYSIOL A, V189, P69, DOI 10.1007/s00359-002-0378-7; Mrosovsky N, 2001, CHRONOBIOL INT, V18, P613, DOI 10.1081/CBI-100106076; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; NEWELL FW, 1977, KLIN MONATSBL AUGENH, V171, P731; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Refinetti R, 2003, CHRONOBIOL INT, V20, P417, DOI 10.1081/CBI-120021443; Roberts SGE, 2005, CURR OPIN GENET DEV, V15, P542, DOI 10.1016/j.gde.2005.08.004; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; Sakamoto K, 2004, J NEUROSCI, V24, P9693, DOI 10.1523/JNEUROSCI.2556-04.2004; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Sevilla-Romero E, 2002, OPHTHALMIC RES, V34, P181, DOI 10.1159/000063885; SHIMOMURA K, 1994, J BIOL RHYTHM, V9, P97, DOI 10.1177/074873049400900201; SZEL A, 1986, EXP EYE RES, V43, P871, DOI 10.1016/0014-4835(86)90066-7; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; Van Gelder RN, 2003, SCIENCE, V299, P222, DOI 10.1126/science.1079536; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Wong KY, 2005, NEURON, V48, P1001, DOI 10.1016/j.neuron.2005.11.016; Yanagi Y, 2002, INVEST OPHTH VIS SCI, V43, P3489; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	51	115	117	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					677	687		10.1016/j.neuron.2007.02.005	http://dx.doi.org/10.1016/j.neuron.2007.02.005			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329208	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000245127100009
J	Navalpakkam, V; Itti, L				Navalpakkam, Vidhya; Itti, Laurent			Search goal tunes visual features optimally	NEURON			English	Article							FEATURE-BASED ATTENTION; NEURAL MECHANISMS; TOP-DOWN; SELECTIVE ATTENTION; SPATIAL ATTENTION; AREA V4; CORTICAL AREAS; CORTEX; COLOR; INTEGRATION	How does a visual search goal modulate the activity of neurons encoding different visual features (e.g., color, direction of motion)? Previous research suggests that goal-driven attention enhances the gain of neurons representing the target's visual features. Here, we present mathematical and behavioral evidence that this strategy is suboptimal and that humans do not deploy it. We formally derive the optimal feature gain modulation theory, which combines information from both the target and distracting clutter to maximize the relative salience of the target. We qualitatively validate the theory against existing electrophysiological and psychophysical literature. A surprising prediction is that it is sometimes optimal to enhance nontarget features. We provide experimental evidence toward this through psychophysics experiments on human subjects, thus suggesting that humans deploy the optimal gain modulation strategy.	CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ So Calif, Dept Comp Sci, Viterbi Sch Engn, Los Angeles, CA 90089 USA	California Institute of Technology; University of Southern California	Navalpakkam, V (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	vidhya@klab.caltech.edu; itti@usc.edu						Bauer B, 1996, VISION RES, V36, P1439, DOI 10.1016/0042-6989(95)00207-3; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bichot NP, 2002, J NEUROSCI, V22, P4675, DOI 10.1523/JNEUROSCI.22-11-04675.2002; Boynton GM, 2005, CURR OPIN NEUROBIOL, V15, P465, DOI 10.1016/j.conb.2005.06.009; Braithwaite JJ, 2003, PERCEPT PSYCHOPHYS, V65, P213, DOI 10.3758/BF03194796; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; Cave KR, 1999, PSYCHOL RES-PSYCH FO, V62, P182, DOI 10.1007/s004260050050; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; DECO G, 2002, COMPUTATIONAL NEUROS; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCAN J, 1989, PERCEPTION, V18, P457, DOI 10.1068/p180457; DZMURA M, 1991, VISION RES, V31, P951, DOI 10.1016/0042-6989(91)90203-H; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Hamker FH, 2004, VISION RES, V44, P501, DOI 10.1016/j.visres.2003.09.033; Hillyard SA, 1998, PHILOS T ROY SOC B, V353, P1257, DOI 10.1098/rstb.1998.0281; Hodsoll J, 2001, PERCEPT PSYCHOPHYS, V63, P918, DOI 10.3758/BF03194447; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Itti L, 2001, J ELECTRON IMAGING, V10, P161, DOI 10.1117/1.1333677; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MALJKOVIC V, 1994, MEM COGNITION, V22, P657, DOI 10.3758/BF03209251; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; NAGY AL, 1990, J OPT SOC AM A, V7, P1209, DOI 10.1364/JOSAA.7.001209; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; Navalpakkam V., 2006, P IEEE C COMP VIS PA, V1, P1; PASHLER H, 1987, PERCEPT PSYCHOPHYS, V41, P285, DOI 10.3758/BF03208228; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SOFTKY WR, 1993, J NEUROSCI, V13, P334; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; TREISMAN A, 1991, J EXP PSYCHOL HUMAN, V17, P652, DOI 10.1037/0096-1523.17.3.652; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; TSOTSOS JK, 1995, ARTIF INTELL, V78, P507, DOI 10.1016/0004-3702(95)00025-9; Vickery TJ, 2005, J VISION, V5, P81, DOI 10.1167/5.1.8; Watanabe T, 1998, J NEUROPHYSIOL, V79, P2218, DOI 10.1152/jn.1998.79.4.2218; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483; Wolfe JM, 2004, VISION RES, V44, P1411, DOI 10.1016/j.visres.2003.11.024; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	54	220	237	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					605	617		10.1016/j.neuron.2007.01.018	http://dx.doi.org/10.1016/j.neuron.2007.01.018			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	149DJ	17296560	Bronze			2022-12-28	WOS:000245126900017
J	Friederici, AD; von Cramon, DY; Kotz, SA				Friederici, Angela D.; von Cramon, D. Yves; Kotz, Sonja A.			Role of the corpus callosum in speech comprehension: Interfacing syntax and prosody	NEURON			English	Article							BRAIN POTENTIALS; RIGHT-HEMISPHERE; SENTENCE COMPREHENSION; LANGUAGE; LATERALIZATION; PERCEPTION; DISTURBANCES; MICROBLEEDS; MORPHOLOGY; RESPONSES	The role of the corpus callosurn (CC) in the interhemispheric interaction of prosodic and syntactic information during speech comprehension was investigated in patients with lesions in the CC, and in healthy controls. The event-related brain potential experiment examined the effect of prosodic phrase structure on the processing of a verb whose argument structure matched or did not match the prior prosody-induced syntactic structure. While controls showed an N400-like effect for prosodically mismatching verb argument structures, thus indicating a stable interplay between prosody and syntax, patients with lesions in the posterior third of the CC did not show this effect. Because these patients displayed a prosody- independent semantic N400 effect, the present data indicate that the posterior third of the CC is the crucial neuroanatomical structure for the interhemispheric interplay of suprasegmental prosodic information and syntactic information.	Univ Leipzig, Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany; Univ Leipzig, Day Care Clin Cognit Neurol, D-04103 Leipzig, Germany	Leipzig University; Max Planck Society; Leipzig University	Friederici, AD (corresponding author), Univ Leipzig, Max Planck Inst Human Cognit & Brain Sci, D-04103 Leipzig, Germany.	angelafr@cbs.mpg.de						BEHRENS SJ, 1985, BRAIN LANG, V26, P332, DOI 10.1016/0093-934X(85)90047-1; Blumstein S. E., 1974, CORTEX, V10, P246; BRADVIK B, 1991, ACTA NEUROL SCAND, V84, P114, DOI 10.1111/j.1600-0404.1991.tb04919.x; BROWN C, 1993, J COGNITIVE NEUROSCI, V5, P34, DOI 10.1162/jocn.1993.5.1.34; BRYAN KL, 1989, APHASIOLOGY, V3, P285, DOI 10.1080/02687038908249000; DELACOSTE MC, 1985, J NEUROPATH EXP NEUR, V44, P578, DOI 10.1097/00005072-198511000-00004; DUARA R, 1991, ARCH NEUROL-CHICAGO, V48, P410, DOI 10.1001/archneur.1991.00530160078018; EMMOREY KD, 1987, BRAIN LANG, V30, P305, DOI 10.1016/0093-934X(87)90105-2; Fabbro F, 2002, NEUROPSYCHOLOGIA, V40, P1541, DOI 10.1016/S0028-3932(02)00026-X; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; Friederici AD, 2004, BRAIN LANG, V89, P267, DOI 10.1016/S0093-934X(03)00351-1; Friederici AD, 1999, BRAIN, V122, P1033, DOI 10.1093/brain/122.6.1033; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; FRIEDERICI AD, 1993, COGNITIVE BRAIN RES, V1, P183, DOI 10.1016/0926-6410(93)90026-2; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gross J, 1998, BRAIN TOPOGR, V10, P273, DOI 10.1023/A:1022223007231; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; HOLCOMB PJ, 1992, DEV NEUROPSYCHOL, V8, P203, DOI 10.1080/87565649209540525; Huang H, 2005, NEUROIMAGE, V26, P195, DOI 10.1016/j.neuroimage.2005.01.019; KIRKBRIDE V, 1994, PEDIATR RES, V36, pA20; KLOUDA GV, 1988, BRAIN LANG, V35, P154, DOI 10.1016/0093-934X(88)90106-X; Kruggel F, 1996, INT CONGR SER, V1124, P323; LEE JH, 1995, MAGN RESON MED, V34, P308, DOI 10.1002/mrm.1910340305; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Meyer M, 2003, J NEUROLINGUIST, V16, P277, DOI 10.1016/S0911-6044(03)00026-5; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; NIJOKIKTJIEN C, 1990, ACTA PAEDOPSYCHIATR, V53, P126; Nosarti C, 2004, BRAIN, V127, P2080, DOI 10.1093/brain/awh230; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; Pell MD, 1997, BRAIN LANG, V57, P195, DOI 10.1006/brln.1997.1736; Pell MD, 1998, NEUROPSYCHOLOGIA, V36, P701, DOI 10.1016/S0028-3932(98)00008-6; Perkins JM, 1996, APHASIOLOGY, V10, P343, DOI 10.1080/02687039608248416; Poeppel D, 2003, SPEECH COMMUN, V41, P245, DOI 10.1016/S0167-6393(02)00107-3; Pollmann S, 2002, NEUROPSYCHOLOGY, V16, P56, DOI 10.1037//0894-4105.16.1.56; Roob G, 1999, NERVENARZT, V70, P1082, DOI 10.1007/s001150050542; Rumsey JM, 1996, BIOL PSYCHIAT, V39, P769, DOI 10.1016/0006-3223(95)00225-1; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; SHAPIRO LP, 1987, COGNITION, V27, P219, DOI 10.1016/S0010-0277(87)80010-0; SHAPIRO LP, 1993, BRAIN LANG, V45, P423, DOI 10.1006/brln.1993.1053; SHARBROUGH F, 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI DOI 10.1097/00004691-199104000-00007; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; STNYER MA, 2005, MED IMAGE COMPUT C 2, V8, P765; SUGISHITA M, 1995, BRAIN, V118, P417, DOI 10.1093/brain/118.2.417; UGURBIL K, 1993, MAGN RESON QUART, V9, P259; VANLANCKER D, 1992, J SPEECH HEAR RES, V35, P963, DOI 10.1044/jshr.3505.963; WEINTRAUB S, 1981, ARCH NEUROL-CHICAGO, V38, P742, DOI 10.1001/archneur.1981.00510120042004	50	69	69	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					135	145		10.1016/j.neuron.2006.11.020	http://dx.doi.org/10.1016/j.neuron.2006.11.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196536	Bronze			2022-12-28	WOS:000245126500014
J	Gu, C; Zhou, W; Puthenveedu, MA; Xu, MX; Jan, YN; Jan, LY				Gu, Chen; Zhou, Wei; Puthenveedu, Manojkumar A.; Xu, Mingxuan; Jan, Yuh Nung; Jan, Lily Yeh			The microtubule plus-end tracking protein EB1 is required for Kv1 voltage-gated K+ channel axonal targeting	NEURON			English	Article							BINDING-PROTEIN; SURFACE EXPRESSION; POTASSIUM CHANNELS; BETA-SUBUNITS; KINESIN; APC; MECHANISMS; TRANSPORT; MOTOR; DETERMINANTS	Axonal Kv1 channels regulate action potential propagation-an evolutionarily conserved function important for the control of motor behavior as evidenced from the linkage of human Kv1 channel mutations to myokymia/episodic ataxia type 1 (EA1) and the Shaker mutant phenotype in Drosophila. To search for the machinery that mediates axonal targeting of Kv1 channels composed of both alpha and beta subunits, we first demonstrate that Kv beta 2 is responsible for targeting Kv1 channels to the axon. Next, we show that Kv beta 2 axonal targeting depends on its ability to associate with the microtubule (MT) plus-end tracking protein (+TIP) EB1. Not only do Kv beta 2 and EB1 move in unison down the axon, Brefeldin A-sensitive Kv1-containing vesicles can also be found at microtubule ends near the cell membrane. In addition, we found that Kv beta 2 associates with KIF3/kinesin II as well. Indeed, Kv1 channels rely on both KIF3/kinesin II and EB1 for their axonal targeting.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; Ohio State Univ, Ctr Mol Neurobiol, Columbus, OH 43210 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Gu, C (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	gu.49@osu.edu; lily.jan@ucsf.edu	Gu, Chen/E-3163-2011; xu, mingxuan/B-9787-2011; Puthenveedu, Manojkumar/A-3795-2016	Jan, Lily/0000-0003-3938-8498; Puthenveedu, Manojkumar/0000-0002-3177-4231; Jan, Yuh Nung/0000-0003-1367-6299	NIDA NIH HHS [DA10154, DA10711] Funding Source: Medline; PHS HHS [R01 65334] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010154, R29DA010711, R37DA010711, R01DA010711] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akhmanova A, 2005, CURR OPIN CELL BIOL, V17, P47, DOI 10.1016/j.ceb.2004.11.001; Baccus SA, 2000, J NEUROPHYSIOL, V83, P1693, DOI 10.1152/jn.2000.83.3.1693; Berezuk MA, 2004, TRAFFIC, V5, P503, DOI 10.1111/j.1398-9219.2004.00197.x; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Browning H, 2005, J BIOL CHEM, V280, P12299, DOI 10.1074/jbc.M413620200; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Busch KE, 2004, DEV CELL, V6, P831, DOI 10.1016/j.devcel.2004.05.008; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Chiu SY, 1999, J NEUROCYTOL, V28, P349, DOI 10.1023/A:1007013731231; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Debanne D, 2004, NAT REV NEUROSCI, V5, P304, DOI 10.1038/nrn1397; Elliott SL, 2005, MOL BIOL CELL, V16, P891, DOI 10.1091/mbc.e04-07-0633; Galjart N, 2005, NAT REV MOL CELL BIO, V6, P487, DOI 10.1038/nrm1664; Grosse G, 2000, J NEUROSCI, V20, P1869; Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998; Gu C, 2001, CURR BIOL, V11, P185, DOI 10.1016/S0960-9822(01)00044-6; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; HEIDEMANN SR, 1981, J CELL BIOL, V91, P661, DOI 10.1083/jcb.91.3.661; Heinemann Stefan H, 2006, Sci STKE, V2006, ppe33, DOI 10.1126/stke.3502006pe33; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Honnappa S, 2005, EMBO J, V24, P261, DOI 10.1038/sj.emboj.7600529; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; Komarova Y, 2005, MOL BIOL CELL, V16, P5334, DOI 10.1091/mbc.E05-07-0614; Lang B, 2003, AUTOIMMUN REV, V2, P94, DOI 10.1016/S1568-9972(02)00146-5; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Nakata T, 2003, J CELL BIOL, V162, P1045, DOI 10.1083/jcb.200302175; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Rouzier R, 2005, P NATL ACAD SCI USA, V102, P8315, DOI 10.1073/pnas.0408974102; Shi GY, 1996, NEURON, V16, P843, DOI 10.1016/S0896-6273(00)80104-X; Slep KC, 2005, J CELL BIOL, V168, P587, DOI 10.1083/jcb.200410114; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Sorkin A, 2000, CURR BIOL, V10, P1395, DOI 10.1016/S0960-9822(00)00785-5; Southan AP, 2000, J NEUROSCI, V20, P114, DOI 10.1523/JNEUROSCI.20-01-00114.2000; Stepanova T, 2003, J NEUROSCI, V23, P2655; SU LK, 1995, CANCER RES, V55, P2972; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; TIMAUER JS, 2000, J CELL BIOL, V149, P761; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Vasquez RJ, 1997, MOL BIOL CELL, V8, P973, DOI 10.1091/mbc.8.6.973; Vaughan KT, 2005, BBA-MOL CELL RES, V1744, P316, DOI 10.1016/j.bbamcr.2005.05.001; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zhou L, 1998, J NEUROSCI, V18, P7200	53	107	107	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					803	816		10.1016/j.neuron.2006.10.022	http://dx.doi.org/10.1016/j.neuron.2006.10.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145502	Bronze			2022-12-28	WOS:000242856400009
J	Dehaene, S; Naccache, L				Dehaene, Stanislas; Naccache, Lionel			Can one suppress subliminal words?	NEURON			English	Editorial Material							ATTENTION; MECHANISMS; NUMBER	Subliminal words cause behavioral priming, yet the depth of their processing remains debated. Using transcranial magnetic stimulation (TMS), Nakamura et al. demonstrate in this issue of Neuron that this subliminal priming effect can be selectively disrupted. Distinct TIVIS sites disrupt priming in lexical decision and pronunciations tasks, suggesting that task set influences subliminal processing.	INSERM, Cognit Neuroimaging Unit, Serv Hosp Frederic Joliot, Orsay, France; Coll France, F-75231 Paris, France; Hop La Pitie Salpetriere, Dept Clin Neurophysiol, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; College de France; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Dehaene, S (corresponding author), INSERM, Cognit Neuroimaging Unit, Serv Hosp Frederic Joliot, Orsay, France.			naccache, lionel/0000-0002-2874-1009				Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; Devlin JT, 2004, P NATL ACAD SCI USA, V101, P14984, DOI 10.1073/pnas.0403766101; Eimer M, 1998, J EXP PSYCHOL HUMAN, V24, P1737, DOI 10.1037/0096-1523.24.6.1737; Greenwald AG, 2003, J EXP PSYCHOL LEARN, V29, P235, DOI 10.1037/0278-7393.29.2.235; Kentridge RW, 1999, P ROY SOC B-BIOL SCI, V266, P1805, DOI 10.1098/rspb.1999.0850; Kiefer M, 2006, J COGNITIVE NEUROSCI, V18, P184, DOI 10.1162/089892906775783688; Kouider S, 2001, COGNITION, V82, pB35, DOI 10.1016/S0010-0277(01)00152-4; Lachter J, 2004, PSYCHOL REV, V111, P880, DOI 10.1037/0033-295x.111.4.880; Naccache L, 2002, PSYCHOL SCI, V13, P416, DOI 10.1111/1467-9280.00474; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nakamura K, 2005, J COGNITIVE NEUROSCI, V17, P954, DOI 10.1162/0898929054021166; Nakamura K, 2006, NEURON, V52, P557, DOI 10.1016/j.neuron.2006.09.030; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297	15	11	11	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					397	399		10.1016/j.neuron.2006.10.018	http://dx.doi.org/10.1016/j.neuron.2006.10.018			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088205	Bronze			2022-12-28	WOS:000242269700002
J	Hooks, BM; Chen, CF				Hooks, Bryan M.; Chen, Chinfei			Distinct roles for spontaneous and visual activity in remodeling of the retinogeniculate synapse	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; EYE-SPECIFIC SEGREGATION; POSTNATAL-DEVELOPMENT; RETINAL ACTIVITY; CLIMBING FIBER; MULTIPLE INNERVATION; CORTICAL CIRCUITS; RECEPTIVE-FIELDS; RAT CEREBELLUM; NMDA RECEPTORS	Sensory experience and spontaneous activity play important roles in development of sensory circuits; however, their relative contributions are unclear. Here, we test the role of different forms of activity on remodeling of the mouse retinogeniculate synapse. We found that the bulk of maturation occurs without patterned sensory activity over 4 days spanning eye opening. During this early developmental period, blockade of spontaneous retinal activity by tetrodotoxin, but not visual deprivation, retarded synaptic strengthening and inhibited pruning of excess retinal afferents. Later in development, synaptic remodeling becomes sensitive to changes in visually evoked activity, but only if there has been previous visual experience. Synaptic strengthening and pruning were disrupted by visual deprivation following 1 week of vision, but not by chronic deprivation from birth. Thus, spontaneous activity is necessary to drive the bulk of synaptic refinement around the time of eye opening, while sensory experience is important for the subsequent maintenance of connections.	Harvard Univ, Sch Med, Dept Neurol, Neurobiol Program,Childrens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Chen, CF (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Neurobiol Program,Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	chinfei.chen@childrens.harvard.edu			NEI NIH HHS [R01 EY013613, R01EY013613] Funding Source: Medline; NICHD NIH HHS [P01HD18655, P30 HD018655] Funding Source: Medline; NINDS NIH HHS [F31 NS048630] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS048630] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 2003, NEURON, V39, P831, DOI 10.1016/S0896-6273(03)00527-0; Akerman CJ, 2002, NEURON, V36, P869, DOI 10.1016/S0896-6273(02)01010-3; BLAKEMORE C, 1986, J PHYSIOL-LONDON, V380, P453, DOI 10.1113/jphysiol.1986.sp016297; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Carrasco MM, 2005, J NEUROPHYSIOL, V94, P1962, DOI 10.1152/jn.00166.2005; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609; CYNADER M, 1976, EXP BRAIN RES, V25, P139; DANIELS JD, 1978, J NEUROPHYSIOL, V41, P1373, DOI 10.1152/jn.1978.41.6.1373; Demas J, 2003, J NEUROSCI, V23, P2851; Demas J, 2006, NEURON, V50, P247, DOI 10.1016/j.neuron.2006.03.033; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; Gandhi SP, 2005, NAT NEUROSCI, V8, P9, DOI 10.1038/nn0105-9; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; Gomperts SN, 2000, J NEUROSCI, V20, P2229; HAHM JO, 1991, NATURE, V351, P568, DOI 10.1038/351568a0; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007; Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; JACKSON H, 1982, J NEUROSCI, V2, P1736; Jaubert-Miazza L, 2005, VISUAL NEUROSCI, V22, P661, DOI 10.1017/S0952523805225154; Kandel E., 2000, PRINCIPLES NEURAL SC; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Lu W, 2004, NEURON, V43, P237, DOI 10.1016/j.neuron.2004.06.031; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MARIANI J, 1981, J NEUROSCI, V1, P696, DOI 10.1523/JNEUROSCI.01-07-00696.1981; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Muir-Robinson G, 2002, J NEUROSCI, V22, P5259; OBRIEN RAD, 1978, J PHYSIOL-LONDON, V282, P571, DOI 10.1113/jphysiol.1978.sp012482; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pfeiffenberger C, 2005, NAT NEUROSCI, V8, P1022, DOI 10.1038/nn1508; Prusky GT, 1999, J NEUROSCI METH, V87, P105, DOI 10.1016/S0165-0270(98)00172-1; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Sugihara I, 2005, J COMP NEUROL, V487, P93, DOI 10.1002/cne.20531; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Tavazoie SF, 2000, NAT NEUROSCI, V3, P608, DOI 10.1038/75786; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Turner JP, 1998, J PHYSIOL-LONDON, V510, P829, DOI 10.1111/j.1469-7793.1998.829bj.x; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212; ZHOU YF, 1995, J NEUROSCI, V15, P689	56	207	211	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					281	291		10.1016/j.neuron.2006.07.007	http://dx.doi.org/10.1016/j.neuron.2006.07.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046691	Bronze			2022-12-28	WOS:000241799900009
J	Mori, S; Zhang, JY				Mori, Susumu; Zhang, Jiangyang			Principles of diffusion tensor imaging and its applications to basic neuroscience research	NEURON			English	Review							ANISOTROPIC WATER DIFFUSION; MAGNETIC-RESONANCE MICROSCOPY; DEVELOPING MOUSE-BRAIN; HUMAN WHITE-MATTER; AXONAL PROJECTIONS; NERVOUS-SYSTEM; FIELD GRADIENT; WEIGHTED MRI; SPIN ECHOES; TRACKING	The brain contains more than 100 billion neurons that communicate with each other via axons for the formation of complex neural networks. The structural mapping of such networks during health and disease states is essential for understanding brain function. However, our understanding of brain structural connectivity is surprisingly limited, due in part to the lack of noninvasive methodologies to study axonal anatomy. Diffusion tensor imaging (DTI) is a recently developed MRI technique that can measure macroscopic axonal organization in nervous system tissues. In this article, the principles of DTI methodologies are explained, and several applications introduced, including visualization of axonal tracts in myelin and axonal injuries as well as human brain and mouse embryonic development. The strengths and limitations of DTI and key areas for future research and development are also discussed.	Johns Hopkins Univ, Sch Med, Div NMR, Dept Radiol, Baltimore, MD 21205 USA; Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD 21205 USA	Johns Hopkins University; Kennedy Krieger Institute	Mori, S (corresponding author), Johns Hopkins Univ, Sch Med, Div NMR, Dept Radiol, 720 Rutland Ave, Baltimore, MD 21205 USA.	susumu@mri.jhu.edu	Kennedy, Kristen M/B-4699-2008	Kennedy, Kristen M/0000-0001-5373-9026; Zhang, Jiangyang/0000-0003-4146-8163; Zhang, Jiangyang/0000-0003-0740-2662	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB003543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020012] Funding Source: NIH RePORTER; NCRR NIH HHS [RR 15241] Funding Source: Medline; NIA NIH HHS [AG 20012] Funding Source: Medline; NIBIB NIH HHS [EB 003543] Funding Source: Medline; NIEHS NIH HHS [ES 012665] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Ahrens ET, 1998, MAGN RESON MED, V40, P119, DOI 10.1002/mrm.1910400117; Baratti C, 1999, RADIOLOGY, V210, P133, DOI 10.1148/radiology.210.1.r99ja09133; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BEAULIEU C, 1994, MAGNET RESON MED, V31, P394, DOI 10.1002/mrm.1910310408; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Behrens TEJ, 2003, NAT NEUROSCI, V6, P750, DOI 10.1038/nn1075; Bock NA, 2003, MAGNET RESON MED, V49, P158, DOI 10.1002/mrm.10326; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; CHENEVERT TL, 1990, RADIOLOGY, V177, P401, DOI 10.1148/radiology.177.2.2217776; Conturo TE, 1999, P NATL ACAD SCI USA, V96, P10422, DOI 10.1073/pnas.96.18.10422; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; HALL SM, 1972, J CELL SCI, V10, P535; Harsan LA, 2006, J NEUROSCI RES, V83, P392, DOI 10.1002/jnr.20742; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Huppi PS, 1998, PEDIATR RES, V44, P584; JACOBS RE, 1994, J NEUROSCI METH, V54, P189, DOI 10.1016/0165-0270(94)90192-9; Johnson GA, 2002, J MAGN RESON IMAGING, V16, P423, DOI 10.1002/jmri.10175; JOHNSON GA, 1993, MAGN RESON QUART, V9, P1; Jones DK, 1999, MAGN RESON MED, V42, P37, DOI 10.1002/(SICI)1522-2594(199907)42:1<37::AID-MRM7>3.0.CO;2-O; Kroenke CD, 2006, MAGN RESON MED, V55, P187, DOI 10.1002/mrm.20728; Lazar M, 2005, NEUROIMAGE, V24, P524, DOI 10.1016/j.neuroimage.2004.08.050; Lazar M, 2003, HUM BRAIN MAPP, V18, P306, DOI 10.1002/hbm.10102; MacKenzie-Graham A, 2004, J ANAT, V204, P93, DOI 10.1111/j.1469-7580.2004.00264.x; Makris N, 1997, ANN NEUROL, V42, P951, DOI 10.1002/ana.410420617; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2001, MAGN RESON MED, V46, P18, DOI 10.1002/mrm.1155; MOSELEY ME, 1990, RADIOLOGY, V176, P439, DOI 10.1148/radiology.176.2.2367658; Mukherjee P, 2002, AM J NEURORADIOL, V23, P1445; Nair G, 2005, NEUROIMAGE, V28, P165, DOI 10.1016/j.neuroimage.2005.05.049; Neil J, 2002, NMR BIOMED, V15, P543, DOI 10.1002/nbm.784; Neil JJ, 1998, RADIOLOGY, V209, P57, DOI 10.1148/radiology.209.1.9769812; Nieman BJ, 2006, PHYSIOL GENOMICS, V24, P154, DOI 10.1152/physiolgenomics.00217.2005; Nolte J, 1998, HUMAN BRAIN INTRO IT; Pagani E, 2005, NEUROIMAGE, V26, P258, DOI 10.1016/j.neuroimage.2005.01.008; Pajevic S, 1999, MAGNET RESON MED, V42, P526, DOI 10.1002/(SICI)1522-2594(199909)42:3<526::AID-MRM15>3.0.CO;2-J; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Poupon C, 2000, NEUROIMAGE, V12, P184, DOI 10.1006/nimg.2000.0607; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Smith BR, 1996, COMPUT MED IMAG GRAP, V20, P483, DOI 10.1016/S0895-6111(96)00046-8; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; STEJSKAL EO, 1965, J CHEM PHYS, V43, P3597, DOI 10.1063/1.1696526; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stieltjes B, 2001, NEUROIMAGE, V14, P723, DOI 10.1006/nimg.2001.0861; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Sun SW, 2005, MAGN RESON MED, V53, P1447, DOI 10.1002/mrm.20488; Thornton JS, 1997, MAGN RESON IMAGING, V15, P433, DOI 10.1016/S0730-725X(96)00378-5; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; TURNER R, 1990, RADIOLOGY, V177, P407, DOI 10.1148/radiology.177.2.2217777; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Zhang JY, 2005, J NEUROSCI, V25, P1881, DOI 10.1523/JNEUROSCI.4129-04.2005; Zhang JY, 2003, NEUROIMAGE, V20, P1639, DOI 10.1016/S1053-8119(03)00410-5	58	1159	1190	4	161	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					527	539		10.1016/j.neuron.2006.08.012	http://dx.doi.org/10.1016/j.neuron.2006.08.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950152	Bronze			2022-12-28	WOS:000240623400003
J	Fog, JU; Khoshbouei, H; Holy, M; Owens, WA; Vaegter, CB; Sen, N; Nikandrova, Y; Bowton, E; McMahon, DG; Colbran, RJ; Daws, LC; Sitte, HH; Javitch, JA; Galli, A; Gether, U				Fog, Jacob U.; Khoshbouei, Habibeh; Holy, Marion; Owens, William A.; Vaegter, Christian Bjerggaard; Sen, Namita; Nikandrova, Yelyzaveta; Bowton, Erica; McMahon, Douglas G.; Colbran, Roger J.; Daws, Lynette C.; Sitte, Harald H.; Javitch, Jonathan A.; Galli, Aurelio; Gether, Ulrik			Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport	NEURON			English	Article							CARRIER-MEDIATED RELEASE; NEUROTRANSMITTER RELEASE; PARA-METHOXYAMPHETAMINE; NA+ SIGNALS; PHOSPHORYLATION; EFFLUX; 3,4-METHYLENEDIOXYMETHAMPHETAMINE; INHIBITION; DENSIN-180; SUBUNIT	Efflux of dopamine through the dopamine transporter (DAT) is critical for the psychostimulatory properties of amphetamines, but the underlying mechanism is unclear. Here we show that Ca2+/calmodulin-dependent protein kinase II (CaMKII) plays a key role in this efflux. CaMKII alpha bound to the distal C terminus of DAT and colocalized with DAT in dopaminergic neurons. CaMKII alpha stimulated dopamine efflux via DAT in response to amphetamine in heterologous cells and in dopaminergic neurons. CaMKII alpha phosphorylated serines in the distal N terminus of DAT in vitro, and mutation of these serines eliminated the stimulatory effects of CaMKII alpha. A mutation of the DAT C terminus impairing CaMKII alpha binding also impaired amphetamine-induced dopamine efflux. An in vivo role for CaMKII was supported by chronoamperometry measurements showing reduced amphetamine-induced dopamine efflux in response to the CaMKII inhibitor KN93. Our data suggest that CaMKII alpha binding to the DAT C terminus facilitates phosphorylation of the DAT N terminus and mediates amphetamine-induced dopamine efflux.	Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark; Univ Copenhagen, Panum Inst, Dept Pharmacol, Ctr Pharmacogenom, DK-2200 Copenhagen, Denmark; H Lundbeck & Co AS, DK-2500 Copenhagen, Denmark; Vanderbilt Univ, Sch Med, Dept Physiol & Mol Biophys, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Dept Biol Sci, Nashville, TN 37232 USA; Med Univ Vienna, Inst Pharmacol, Ctr Biomol Med & Pharmacol, A-1090 Vienna, Austria; Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA; Columbia Univ Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	University of Copenhagen; University of Copenhagen; Lundbeck Corporation; Vanderbilt University; Vanderbilt University; Medical University of Vienna; University of Texas System; University of Texas Health San Antonio; Columbia University; Columbia University; Columbia University	Gether, U (corresponding author), Univ Copenhagen, Panum Inst, Dept Pharmacol, Mol Neuropharmacol Grp, DK-2200 Copenhagen, Denmark.	gether@neuropharm.ku.dk	Sitte, Harald/O-7025-2019; Vægter, Christian Bjerggaard/AFW-0912-2022; Sitte, Harald/N-2681-2013; Colbran, Roger/AAU-7708-2021; Vægter, Christian Bjerggaard/A-7909-2008	Sitte, Harald/0000-0002-1339-7444; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Sitte, Harald/0000-0002-1339-7444; Colbran, Roger/0000-0001-7401-8244; Vægter, Christian Bjerggaard/0000-0001-6573-146X; Gether, Ulrik/0000-0002-0020-3807; Khoshbouei, Habibeh/0000-0002-1533-8771; Javitch, Jonathan/0000-0001-7395-2967	NEI NIH HHS [EY 15815] Funding Source: Medline; NIDA NIH HHS [DA 14684, DA 13975, DA 11495, P01 DA 12408, DA 18992] Funding Source: Medline; NIMH NIH HHS [R01 MH063232, MH 57324, MH 63232, R01 MH063232-06] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY015815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014684, R01DA013975, R56DA013975, R01DA011495, P01DA012408, R21DA018992] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Bjerggaard C, 2004, J NEUROSCI, V24, P7024, DOI 10.1523/JNEUROSCI.1863-04.2004; Callaghan PD, 2005, NEUROCHEM INT, V47, P350, DOI 10.1016/j.neuint.2005.04.026; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chen NH, 2004, PFLUG ARCH EUR J PHY, V447, P519, DOI 10.1007/s00424-003-1064-5; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; Daws LC, 2000, PROG NEURO-PSYCHOPH, V24, P955, DOI 10.1016/S0278-5846(00)00113-5; Falkenburger BH, 2001, SCIENCE, V293, P2465, DOI 10.1126/science.1060645; FISCHER JF, 1979, J PHARMACOL EXP THER, V208, P203; Galli A, 1997, J NEUROSCI, V17, P3401; Gardoni F, 1999, FEBS LETT, V456, P394, DOI 10.1016/S0014-5793(99)00985-0; Gnegy ME, 2004, MOL PHARMACOL, V66, P137, DOI 10.1124/mol.66.1.137; Gnegy ME, 2003, EUR J PHARMACOL, V479, P83, DOI 10.1016/j.ejphar.2003.08.059; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Griffith LC, 2004, J NEUROSCI, V24, P8394, DOI 10.1523/JNEUROSCI.3604-04.2004; Iwata SI, 1997, J PHARMACOL EXP THER, V283, P1445; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Johnson LA, 2005, J BIOL CHEM, V280, P10914, DOI 10.1074/jbc.M413887200; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Kantor L, 1999, J NEUROSCI, V19, P3801; Khoshbouei H, 2004, PLOS BIOL, V2, P387, DOI 10.1371/journal.pbio.0020078; Khoshbouei H, 2003, J BIOL CHEM, V278, P12070, DOI 10.1074/jbc.M212815200; Lieberman JA, 1997, NEUROPSYCHOPHARMACOL, V17, P205, DOI 10.1016/S0893-133X(97)00045-6; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; Loland CJ, 2003, EUR J PHARMACOL, V479, P187, DOI 10.1016/j.ejphar.2003.08.068; Montanez S, 2003, J NEUROCHEM, V86, P210, DOI 10.1046/j.1471-4159.2003.01836.x; Pierce RC, 1997, J NEUROSCI, V17, P3254; Pifl C, 1999, MOL PHARMACOL, V56, P1047, DOI 10.1124/mol.56.5.1047; Rawson RA, 2002, J SUBST ABUSE TREAT, V23, P145, DOI 10.1016/S0740-5472(02)00256-8; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Robison AJ, 2005, J BIOL CHEM, V280, P35329, DOI 10.1074/jbc.M502191200; Rose CR, 2002, NEUROSCIENTIST, V8, P532, DOI 10.1177/1073858402238512; Rose CR, 2001, J NEUROSCI, V21, P4207, DOI 10.1523/JNEUROSCI.21-12-04207.2001; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; SCHOLZE P, 2002, J BIOL CHEM, V276, P40476; Sitte HH, 1998, J NEUROCHEM, V71, P1289; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; Torres GE, 2001, NEURON, V30, P121, DOI 10.1016/S0896-6273(01)00267-7; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; WALL SC, 1995, MOL PHARMACOL, V47, P544	42	167	170	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					417	429		10.1016/j.neuron.2006.06.028	http://dx.doi.org/10.1016/j.neuron.2006.06.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908408	Bronze			2022-12-28	WOS:000240504700006
J	Hoopfer, ED; McLaughlin, T; Watts, RJ; Schuldiner, O; O'Leary, DDM; Luo, LQ				Hoopfer, Eric D.; McLaughlin, Todd; Watts, Ryan J.; Schuldiner, Oren; O'Leary, Dennis D. M.; Luo, Liqun			Wld(S) protection distinguishes axon degeneration following injury from naturally occurring developmental pruning	NEURON			English	Article							CELL CORPSE ENGULFMENT; WALLERIAN DEGENERATION; UBIQUITIN-PROTEASOME; IN-VIVO; DROSOPHILA; GENE; RECEPTOR; MODEL; ELIMINATION; REQUIREMENT	Axon pruning by degeneration remodels exuberant axonal connections and is widely required for the development of proper circuitry in the nervous system from insects to mammals. Developmental axon degeneration morphologically resembles injury-induced Wallerian degeneration, suggesting similar underlying mechanisms. As previously reported for mice, we show that Wld(s) protein substantially delays Wallerian degeneration in files. Surprisingly, Wld(s) has no effect on naturally occurring developmental axon degeneration in flies or mice, although it protects against injury-induced degeneration of the same axons at the same developmental age. By contrast, the ubiquitin-proteasome system is intrinsically required for both developmental and injury-induced axon degeneration. We also show that the glial cell surface receptor Draper is required for efficient clearance of axon fragments during developmental axon degeneration, similar to its function in injury-induced degeneration. Thus, mechanistically, naturally occurring developmental axon pruning by degeneration and injury-induced axon degeneration differ significantly in early steps, but may converge onto a common execution pathway.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Stanford Univ, Dept Biol Sci, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Genentech Inc, San Francisco, CA 94080 USA	Salk Institute; Howard Hughes Medical Institute; Stanford University; Stanford University; Roche Holding; Genentech	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu; lluo@stanford.edu	Schuldiner, Oren/K-1353-2012	Schuldiner, Oren/0000-0002-7350-9380; Luo, Liqun/0000-0001-5467-9264	NEI NIH HHS [R01-EY07025] Funding Source: Medline; NINDS NIH HHS [R37-NS31558, R37-NS041044] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS041044, R37NS031558] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Beirowski B, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-6; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Griffin John W., 1995, P375; INNOCENTI GM, 1983, DEV BRAIN RES, V11, P39, DOI 10.1016/0165-3806(83)90200-6; INNOCENTI GM, 1983, DEV BRAIN RES, V11, P55, DOI 10.1016/0165-3806(83)90201-8; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; Mi WQ, 2005, BRAIN, V128, P405, DOI 10.1093/brain/awh368; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OLEARY DDM, 1990, COLD SH Q B, V55, P453; OLEARY DDM, 1988, NEURON, V1, P901, DOI 10.1016/0896-6273(88)90147-X; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Parson SH, 1997, EUR J NEUROSCI, V9, P1586, DOI 10.1111/j.1460-9568.1997.tb01516.x; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Samsam M, 2003, J NEUROSCI, V23, P2833; Schubiger M, 2003, MECH DEVELOP, V120, P909, DOI 10.1016/S0925-4773(03)00134-5; STOCKER RF, 1990, CELL TISSUE RES, V262, P9, DOI 10.1007/BF00327741; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; WATTS RJ, 2004, IN PRESS CURR BIOL; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	48	199	202	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					883	895		10.1016/j.neuron.2006.05.013	http://dx.doi.org/10.1016/j.neuron.2006.05.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772170	Bronze			2022-12-28	WOS:000238589500009
J	Doglio, LE; Kanwar, R; Jackson, GR; Perez, M; Avila, J; Dingwal, C; Dotti, CG; Fortini, ME; Feiguin, F				Doglio, Laura E.; Kanwar, Ritu; Jackson, George R.; Perez, Mar; Avila, Jesus; Dingwal, Colin; Dotti, Carlos G.; Fortini, Mark E.; Feiguin, Fabian			RETRACTED: gamma-cleavage-independent functions of presenilin, nicastrin, and aph-1 regulate cell-junction organization and prevent tau toxicity in vivo (Retracted article. See vol. 53, pg. 463, 2007)	NEURON			English	Article; Retracted Publication							FAMILIAL ALZHEIMERS-DISEASE; GLYCOGEN-SYNTHASE KINASE-3; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; AMYLOID HYPOTHESIS; WILD-TYPE; A-BETA; DROSOPHILA; NEURODEGENERATION; MUTATIONS	Genetic analysis of familial Alzheimer's disease has revealed that mutations in the gamma-secretase enzyme presenilin promote toxic A beta secretion; however, presenilin mutations might also influence tau hyperphosphorylation and neurodegeneration through gamma-secretase-independent mechanisms. To address this possibility and determine whether other components of the gamma-secretase complex possess similar regulatory functions, we analyzed the roles of presenilin, nicastrin, and aph-1 in a Drosophila model for tau-induced neurodegeneration. Here, we show that presenilin and nicastrin prevent tau toxicity by modulating the PI3K/Akt/GSK3 beta phosphorylation pathway, whereas aph-1 regulates aPKC/PAR-1 activities. Moreover, we found that these transmembrane proteins differentially regulate the intracellular localization of GSK3 beta and aPKC at cell junctions. Inhibition of gamma-secretase activity neither interfered with these kinase pathways nor induced aberrant tau phosphorylation. These results establish new in vivo molecular functions for the three components of the gamma-secretase complex and reveal a different mechanism that might contribute to neuronal degeneration in Alzheimer's disease.	NCI, Canc Res Ctr, Frederick, MD 21702 USA; Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy; Flanders Interuniv Inst Biotechnol VIB, B-3000 Louvain, Belgium; Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; Univ Calif Los Angeles, Dept Neurol, Neurogenet Program, David Geffen Sch Med, Los Angeles, CA 90095 USA; Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain; GlaxoSmithKline, Neurol & GI CEDD, Harlow CM19 5AW, Essex, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Turin; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); GlaxoSmithKline	Fortini, ME (corresponding author), NCI, Canc Res Ctr, Frederick, MD 21702 USA.	carlos.dotti@med.kuleuven.be; fortini@ncifcrf.gov; fabian.feiguin@unito.it	Avila, Jesus/I-2610-2015; Dotti, Carlos G/I-5533-2015	Avila, Jesus/0000-0002-6288-0571; Dotti, Carlos G/0000-0003-4052-1719	Intramural NIH HHS Funding Source: Medline; NIA NIH HHS [AG016570] Funding Source: Medline; NINDS NIH HHS [NS046489] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Baumeister R, 1997, Genes Funct, V1, P149; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Chung HM, 2001, NAT CELL BIOL, V3, P1129, DOI 10.1038/ncb1201-1129; Davis JA, 1998, NEURON, V20, P603, DOI 10.1016/S0896-6273(00)80998-8; De Strooper B, 2003, NEURON, V38, P9, DOI 10.1016/S0896-6273(03)00205-8; Dermaut B, 2004, ANN NEUROL, V55, P617, DOI 10.1002/ana.20083; Feng RB, 2004, P NATL ACAD SCI USA, V101, P8162, DOI 10.1073/pnas.0402733101; Gotz J, 2001, SCIENCE, V293, P1491, DOI 10.1126/science.1062097; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto Y, 2004, J NEUROSCI RES, V75, P417, DOI 10.1002/jnr.10861; Hernandez F, 2003, NEUROBIOL AGING, V24, P1087, DOI 10.1016/j.neurobiolaging.2003.04.002; Hu Y, 2003, J CELL BIOL, V161, P685, DOI 10.1083/jcb.200304014; Hu Y, 2002, DEV CELL, V2, P69, DOI 10.1016/S1534-5807(01)00105-8; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Jackson GR, 2002, NEURON, V34, P509, DOI 10.1016/S0896-6273(02)00706-7; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Levitan D, 1996, P NATL ACAD SCI USA, V93, P14940, DOI 10.1073/pnas.93.25.14940; Lewis J, 2001, SCIENCE, V293, P1487, DOI 10.1126/science.1058189; Lopez-Schier H, 2002, DEV CELL, V2, P79, DOI 10.1016/S1534-5807(01)00109-5; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Lucas JJ, 2001, EMBO J, V20, P27, DOI 10.1093/emboj/20.1.27; LUO LQ, 1990, J NEUROSCI, V10, P3849, DOI 10.1523/JNEUROSCI.10-12-03849.1990; Marjaux E, 2004, NEURON, V42, P189, DOI 10.1016/S0896-6273(04)00218-1; Matsubayashi H, 2004, MOL CELL BIOL, V24, P2012, DOI 10.1128/MCB.24.5.2012-2024.2004; Menendez M, 2004, J ALZHEIMERS DIS, V6, P475; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Nusse R, 1997, CELL, V89, P321, DOI 10.1016/S0092-8674(00)80210-X; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Qian S, 1998, NEURON, V20, P611, DOI 10.1016/S0896-6273(00)80999-X; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SEUBERT P, 1995, J BIOL CHEM, V270, P18917, DOI 10.1074/jbc.270.32.18917; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tysoe C, 1998, AM J HUM GENET, V62, P70, DOI 10.1086/301672; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Ye YH, 1999, J CELL BIOL, V146, P1351, DOI 10.1083/jcb.146.6.1351; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2; Zoghbi HY, 2002, TRENDS GENET, V18, P463, DOI 10.1016/S0168-9525(02)02729-4	53	20	20	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					359	375		10.1016/j.neuron.2006.03.038	http://dx.doi.org/10.1016/j.neuron.2006.03.038			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675392	Bronze			2022-12-28	WOS:000237726800007
J	Harris, DA; True, HL				Harris, DA; True, HL			New insights into prion structure and toxicity	NEURON			English	Review							TRANSGENIC MICE; PROTEIN; SCRAPIE; YEAST; PRP; DISEASE; NEUROTOXICITY; CONFORMATION; CONVERSION; DIVERSITY	Prion diseases in humans and animals are due to conformational conversion of PrPC, a cellular glycoprotein of unknown function, into PrPSc, an isoform that appears to be infectious in the absence of nucleic acids. Proteins that behave as prions are also found in yeast and filamentous fungi. Although there is now strong experimental support for the hypothesis that prions are infectious proteins, two subjects have remained poorly understood: the structure of prions, and the mechanisms by which they kill neurons. In this review, we will highlight recent studies that shed new light on these important issues.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Harris, DA (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.	dharris@wustl.edu	True, Heather/D-2979-2012	Harris, David/0000-0002-6985-5790	NIGMS NIH HHS [R01 GM072778] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072778] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baskakov IV, 2004, J BIOL CHEM, V279, P7671, DOI 10.1074/jbc.M310594200; Behrens A, 2002, TRENDS NEUROSCI, V25, P150, DOI 10.1016/S0166-2236(00)02089-0; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 2001, NEUROBIOL DIS, V8, P743, DOI 10.1006/nbdi.2001.0433; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200; Ma JY, 2002, SCIENCE, V298, P1781, DOI 10.1126/science.1073725; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Wille H, 2000, J STRUCT BIOL, V130, P323, DOI 10.1006/jsbi.2000.4242; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103	31	94	97	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 4	2006	50	3					353	357		10.1016/j.neuron.2006.04.020	http://dx.doi.org/10.1016/j.neuron.2006.04.020			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675391	Bronze			2022-12-28	WOS:000237726800006
J	Steinberg, JP; Takamiya, K; Shen, Y; Xia, J; Rubio, ME; Yu, S; Jin, WY; Thomas, GM; Linden, DJ; Huganir, RL				Steinberg, JP; Takamiya, K; Shen, Y; Xia, J; Rubio, ME; Yu, S; Jin, WY; Thomas, GM; Linden, DJ; Huganir, RL			Targeted in vivo mutations of the AMPA receptor subunit GluR2 and its interacting protein PICK1 eliminate cerebellar long-term depression	NEURON			English	Article							KINASE-C-ALPHA; MOTOR COORDINATION; BINDING-PROTEIN; PHOSPHORYLATION; LTD; EXPRESSION; PLASTICITY; PKC; LOCALIZATION; ORGANIZATION	Cerebellar long-term depression (LTD) is a major form of synaptic plasticity that is thought to be critical for certain types of motor learning. Phosphorylation of the AMPA receptor subunit GluR2 on serine-880 as well as interaction of GluR2 with PICK1 have been suggested to contribute to the endocytic removal of postsynaptic AMPA receptors during LTD. Here, we show that targeted mutation of PICK1, the GluR2 C-terminal PDZ ligand, or the GluR2 PKC phosphorylation site eliminates cerebellar LTD in mice. LTD can be rescued in cerebellar cultures from mice lacking PICK1 by transfection of wild-type PICK1 but not by a PDZ mutant or a BAR domain mutant deficient in lipid binding, indicating the importance of these domains in PICK1 function. These results demonstrate that PICK1-GluR2 PDZ-based interactions and GluR2 phosphorylation are required for LTD expression in the cerebellum.	Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Hong Kong Univ Sci & Technol, Dept Biochem, Kowloon, Hong Kong, Peoples R China; Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Hong Kong University of Science & Technology; University of Connecticut	Huganir, RL (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.	rhuganir@jhmi.edu	Steinberg, Jordan P./AAP-5568-2020; Xia, Jun/C-7234-2009	Steinberg, Jordan P./0000-0001-7930-3394; Xia, Jun/0000-0001-9308-2188; Takamiya, Kogo/0000-0001-7240-6307	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH051106, R29MH051106, R01MH051106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036715] Funding Source: NIH RePORTER; NIMH NIH HHS [MH51106] Funding Source: Medline; NINDS NIH HHS [R01 NS036715, NS 36715] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; BAUDE A, 1994, J NEUROSCI, V14, P2830; Bear MF, 2001, SYNAPSES, P455; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Boyden ES, 2004, ANNU REV NEUROSCI, V27, P581, DOI 10.1146/annurev.neuro.27.070203.144238; Chung HJ, 2000, J NEUROSCI, V20, P7258; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; Dev KK, 1999, NEUROPHARMACOLOGY, V38, P635, DOI 10.1016/S0028-3908(98)00230-5; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; KASHIWABUCHI N, 1995, CELL, V81, P245, DOI 10.1016/0092-8674(95)90334-8; KEMP BE, 1990, TRENDS BIOCHEM SCI, V15, P342, DOI 10.1016/0968-0004(90)90073-K; Kishimoto Y, 2001, EUR J NEUROSCI, V13, P1249, DOI 10.1046/j.0953-816x.2001.01488.x; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 2003, SCIENCE, V301, P1682, DOI 10.1126/science.1090462; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Matsumoto M, 2000, INORG REACT MECH, V2, P19; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rubio ME, 2001, J NEUROSCI, V21, P641, DOI 10.1523/JNEUROSCI.21-02-00641.2001; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3	42	215	222	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					845	860		10.1016/j.neuron.2006.02.025	http://dx.doi.org/10.1016/j.neuron.2006.02.025			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543133	Bronze			2022-12-28	WOS:000236227500013
J	Dudman, JT; Siegelbaum, SA				Dudman, JT; Siegelbaum, SA			Making the grade with models of persistent activity	NEURON			English	Editorial Material							WORKING-MEMORY; NEURONS	Persistent neural activity that outlasts an initial stimulus is thought to provide a mechanism for the transient storage of memory. In this issue of Neuron, Fransen et al. identify important principles for a cell-autonomous mechanism of graded persistent firing using an elegant combination of experimental and computational approaches.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Dudman, JT (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.			Dudman, Joshua/0000-0002-4436-1057				Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Constantinidis C, 2004, NEUROSCIENTIST, V10, P553, DOI 10.1177/1073858404268742; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1990, PROG BRAIN RES, V85, P325; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1	11	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					649	651		10.1016/j.neuron.2006.02.010	http://dx.doi.org/10.1016/j.neuron.2006.02.010			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504940	Bronze			2022-12-28	WOS:000236070600005
J	Jaeger, D				Jaeger, Dieter			Pauses as neural code in the cerebellum	NEURON			English	Editorial Material							PURKINJE-CELL; SIMULATION; NEURONS; SPIKES	Spikes are frequently taken as the basic unit of neural coding. In the presence of constant activity, however, pauses in spiking may be just as meaningful. In this issue of Neuron, Steuber et al propose that pauses of spiking in cerebellar Purkinje neurons carry significant information in pattern recognition tasks.	Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University	Jaeger, D (corresponding author), Emory Univ, Dept Biol, 1510 Clifton Rd, Atlanta, GA 30322 USA.	djaeger@emory.edu		Jaeger, Dieter/0000-0002-5122-1319				Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Gauck V, 2000, J NEUROSCI, V20, P3006; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; JAEGER D, 1994, EXP BRAIN RES, V100, P200; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; Santamaria F, 2005, J NEUROPHYSIOL, V93, P237, DOI 10.1152/jn.00458.2004; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; Steuber V, 2007, NEURON, V54, P121, DOI 10.1016/j.neuron.2007.03.015; Walter JT, 2006, J NEUROSCI, V26, P12861, DOI 10.1523/JNEUROSCI.4507-05.2006; WURTZ RH, 1986, PROG BRAIN RES, V64, P175	13	6	6	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					9	10		10.1016/j.neuron.2007.03.018	http://dx.doi.org/10.1016/j.neuron.2007.03.018			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408572	Bronze			2022-12-28	WOS:000245848400004
J	Howard, RJ; Clark, KA; Holton, JM; Minor, DL				Howard, Rebecca J.; Clark, Kimberly A.; Holton, James M.; Minor, Daniel L., Jr.			Structural Insight into KCNQ (Kv7) Channel Assembly and Channelopathy	NEURON			English	Article							LONG-QT SYNDROME; POTASSIUM CHANNEL; K+ CHANNEL; GENOMIC ORGANIZATION; SURFACE EXPRESSION; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; COILED COILS; MUTATIONS; SUBUNIT	Kv7.x (KCNQ) voltage-gated potassium channels form the cardiac and auditory l(Ks) current and the neuronal M-current. The five Kv7 subtypes have distinct assembly preferences encoded by a C-terminal cytoplasmic assembly domain, the A-domain Tail. Here, we present the high-resolution structure of the Kv7.4 Adomain Tail together with biochemical experiments that show that the domain is a selfassembling, parallel, four-stranded coiled coil. Structural analysis and biochemical studies indicate conservation of the coiled coil in all Kv7 subtypes and that a limited set of interactions encode assembly specificity determinants. Kv7 mutations have prominent roles in arrhythmias, deafness, and epilepsy. The structure together with biochemical data indicate that A-domain Tail arrhythmia mutations cluster on the solvent-accessible surface of the subunit interface at a likely site of action for modulatory proteins. Together, the data provide a framework for understanding Kv7 assembly specificity and the molecular basis of a distinct set of Kv7 channelopathies.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Minor, DL (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA.	daniel.minor@ucsf.edu		Howard, Rebecca/0000-0003-2049-3378	NIDCD NIH HHS [R01 DC007664-03, R01 DC007664] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen S, 2003, CLIN GENET, V63, P273, DOI 10.1034/j.1399-0004.2003.00048.x; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Cooper EC, 2003, ARCH NEUROL-CHICAGO, V60, P496, DOI 10.1001/archneur.60.4.496; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; DeLano W.L, PYMOL MOL GRAPHICS S; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Friedrich T, 2002, BIOPHYS J, V82, p577A; Grunnet M, 2005, HEART RHYTHM, V2, P1238, DOI 10.1016/j.hrthm.2005.07.025; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; HARBURY PB, 1995, P NATL ACAD SCI USA, V92, P8408, DOI 10.1073/pnas.92.18.8408; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Huang LQ, 2001, CARDIOVASC RES, V51, P670, DOI 10.1016/S0008-6363(01)00350-9; Itoh T, 1998, HUM GENET, V103, P290, DOI 10.1007/s004390050819; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; Kissinger CR, 2001, ACTA CRYSTALLOGR D, V57, P1474, DOI 10.1107/S0907444901012458; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Lerche C, 2000, J BIOL CHEM, V275, P22395, DOI 10.1074/jbc.M002378200; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liu J, 2006, J MOL BIOL, V361, P168, DOI 10.1016/j.jmb.2006.05.063; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Neyroud N, 1999, CIRC RES, V84, P290, DOI 10.1161/01.RES.84.3.290; Novotny T, 2006, Vnitr Lek, V52, P116; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Piippo K, 2001, J AM COLL CARDIOL, V37, P562, DOI 10.1016/S0735-1097(00)01124-4; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schroeder BC, 2000, J BIOL CHEM, V275, P24089, DOI 10.1074/jbc.M003245200; Schroeder BC, 1998, NATURE, V396, P687, DOI 10.1038/25367; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Selyanko AA, 2000, J PHYSIOL-LONDON, V522, P349, DOI 10.1111/j.1469-7793.2000.t01-2-00349.x; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Tarbouriech N, 2000, NAT STRUCT BIOL, V7, P777; Tester DJ, 2005, HEART RHYTHM, V2, P507, DOI 10.1016/j.hrthm.2005.01.020; Tsuruda PR, 2006, NEURON, V51, P201, DOI 10.1016/j.neuron.2006.06.023; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yamashita F, 2001, J MOL CELL CARDIOL, V33, P197, DOI 10.1006/jmcc.2000.1300; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100	69	132	138	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					663	675		10.1016/j.neuron.2007.02.010	http://dx.doi.org/10.1016/j.neuron.2007.02.010			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329207	Green Accepted, Bronze			2022-12-28	WOS:000245127100008
J	Brown, DA; Lancaster, B; Shah, MM				Brown, David A.; Lancaster, Barrie; Shah, Mala M.			Hippocalcin: A new solution to an old puzzle	NEURON			English	Editorial Material							CA2+-ACTIVATED K+ CHANNELS; HIPPOCAMPAL-NEURONS; SLOW-AFTERHYPERPOLARIZATION; PHOTOLYTIC MANIPULATION; PROTEIN HIPPOCALCIN; POTASSIUM CHANNELS; PYRAMIDAL NEURONS; SWITCH PROTEIN; ACTIVATION; CELLS	In hippocampal pyramidal neurons, calcium entry following an action potential burst results in a slow afterhyperpolarization (sAHP) that critically regulates subsequent excitability. Although this potassium current was described two decades ago, the mechanism whereby the rise in intracellular calcium generates the sAHP was, until now, not known. In this issue of Neuron, Tzingounis et al. now show that calcium binding to hippocalcin, a member of the NCS family, is one of the necessary steps involved in production of the sAHP.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Brown, DA (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	d.a.brown@ucl.ac.uk	Brown, David A/J-9019-2012	Shah, Mala/0000-0002-8323-4739	Medical Research Council [G0700369] Funding Source: Medline; Wellcome Trust [063247] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALGER BE, 1980, SCIENCE, V210, P1122, DOI 10.1126/science.7444438; Ames JB, 1996, CURR OPIN STRUC BIOL, V6, P432, DOI 10.1016/S0959-440X(96)80106-0; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Disterhoft JF, 2004, AGEING RES REV, V3, P383, DOI 10.1016/j.arr.2004.07.001; Haynes LP, 2006, PROTEOMICS, V6, P1822, DOI 10.1002/pmic.200500489; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; LANCASTER B, 1994, J PHYSIOL-LONDON, V475, P229, DOI 10.1113/jphysiol.1994.sp020064; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; O'Callaghan DW, 2005, BIOCHEM J, V391, P231, DOI 10.1042/BJ20051001; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; Sah P, 1999, J NEUROSCI, V19, P3657; SCHWINDT PC, 1988, J NEUROPHYSIOL, V59, P424, DOI 10.1152/jn.1988.59.2.424; Shah MM, 2006, MOL PHARMACOL, V70, P1494, DOI 10.1124/mol.106.026625; Stocker M, 2004, TOXICON, V43, P933, DOI 10.1016/j.toxicon.2003.12.009; Tzingounis AV, 2007, NEURON, V53, P487, DOI 10.1016/j.neuron.2007.01.011; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	17	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					467	468		10.1016/j.neuron.2007.01.026	http://dx.doi.org/10.1016/j.neuron.2007.01.026			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296544	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000245126900001
J	Abizaid, A; Gao, Q; Horvath, TL				Abizaid, Alfonso; Gao, Qian; Horvath, Tamas L.			Thoughts for food: Brain mechanisms and peripheral energy balance	NEURON			English	Review							MELANIN-CONCENTRATING HORMONE; RECEPTOR MESSENGER-RNA; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; MELANOCYTE-STIMULATING HORMONE; DOPAMINE-DEFICIENT MICE; CENTRAL-NERVOUS-SYSTEM; AGOUTI-RELATED PROTEIN; RAT ARCUATE NUCLEUS; CENTRAL MELANOCORTIN SYSTEM; BODY-WEIGHT REGULATION		Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Horvath, TL (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06520 USA.	tamas.horvath@yale.edu		Abizaid, Alfonso/0000-0001-9303-3511	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074386, R01DK060711] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022880] Funding Source: NIH RePORTER; NIA NIH HHS [AG022880] Funding Source: Medline; NIDDK NIH HHS [DK-074386, DK-060711] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe H, 2001, MOL BRAIN RES, V87, P92, DOI 10.1016/S0169-328X(00)00295-3; ABIZAID A, 2006, IN PRESS J CLIN INVE; ADAN RAH, 1994, MOL PHARMACOL, V46, P1182; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; ANAND BK, 1951, P SOC EXP BIOL MED, V77, P323, DOI 10.3181/00379727-77-18766; Bagnasco M, 2002, ENDOCRINOLOGY, V143, P4409, DOI 10.1210/en.2002-220505; Bailey ART, 2000, J NEUROENDOCRINOL, V12, P191; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Baskin DG, 1999, HORM METAB RES, V31, P345, DOI 10.1055/s-2007-978751; Bates SH, 2003, TRENDS ENDOCRIN MET, V14, P447, DOI 10.1016/j.tem.2003.10.003; Bellinger LL, 2002, PHYSIOL BEHAV, V76, P431, DOI 10.1016/S0031-9384(02)00756-4; Benoit S, 2000, HORM BEHAV, V37, P299, DOI 10.1006/hbeh.2000.1588; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Biebermann H, 2006, CELL METAB, V3, P141, DOI 10.1016/j.cmet.2006.01.007; Boston BA, 1997, SCIENCE, V278, P1641, DOI 10.1126/science.278.5343.1641; BOUALI SM, 1995, BRAIN RES BULL, V36, P131, DOI 10.1016/0361-9230(94)00177-3; Brobeck J R, 1943, Yale J Biol Med, V15, P831; BROBECK JR, 1946, PHYSIOL REV, V26, P541, DOI 10.1152/physrev.1946.26.4.541; Broberger C, 1998, J COMP NEUROL, V402, P460; Broberger C, 1998, P NATL ACAD SCI USA, V95, P15043, DOI 10.1073/pnas.95.25.15043; Buijs RM, 2003, J ENDOCRINOL, V177, P17, DOI 10.1677/joe.0.1770017; Cannon CM, 2003, J NEUROSCI, V23, P10827; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chou TC, 2002, J NEUROSCI, V22, P977, DOI 10.1523/JNEUROSCI.22-03-00977.2002; Chou TC, 2003, J NEUROSCI, V23, P10691; CHRONWALL BM, 1984, NEUROSCI LETT, V52, P213, DOI 10.1016/0304-3940(84)90164-2; CLARK JT, 1984, ENDOCRINOLOGY, V115, P427, DOI 10.1210/endo-115-1-427; Clifton PG, 1998, BEHAV NEUROSCI, V112, P502, DOI 10.1037/0735-7044.112.3.502; COLEMAN DL, 1982, DIABETES, V31, P1; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Couce ME, 1997, NEUROENDOCRINOLOGY, V66, P145, DOI 10.1159/000127232; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Cowley MA, 1999, NEURON, V24, P155, DOI 10.1016/S0896-6273(00)80829-6; Davis AM, 2004, J NEUROBIOL, V60, P424, DOI 10.1002/neu.20030; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Diano S, 2003, ENDOCRINOLOGY, V144, P3774, DOI 10.1210/en.2003-0274; Dickson SL, 1997, ENDOCRINOLOGY, V138, P771, DOI 10.1210/en.138.2.771; Dube MG, 1999, BRAIN RES, V842, P473, DOI 10.1016/S0006-8993(99)01824-7; Edwards CMB, 1999, J ENDOCRINOL, V160, pR7, DOI 10.1677/joe.0.160R007; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Elias CF, 2000, J COMP NEUROL, V423, P261; Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Figlewicz DP, 2003, AM J PHYSIOL-REG I, V284, pR882, DOI 10.1152/ajpregu.00602.2002; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Gao XB, 2001, J PHYSIOL-LONDON, V533, P237, DOI 10.1111/j.1469-7793.2001.0237b.x; GARCIASEGURA LM, 1994, PROG NEUROBIOL, V44, P279, DOI 10.1016/0301-0082(94)90042-6; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Grill HJ, 2001, INT J OBESITY, V25, pS73, DOI 10.1038/sj.ijo.0801917; Grill HJ, 2002, FRONT NEUROENDOCRIN, V23, P2, DOI 10.1006/frne.2001.0224; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Guan JL, 2002, INT J OBESITY, V26, P1523, DOI 10.1038/sj.ijo.0802155; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Hahn TM, 1998, NAT NEUROSCI, V1, P271, DOI 10.1038/1082; Hakansson ML, 1998, J NEUROSCI, V18, P559; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Harrold JA, 1999, DIABETES, V48, P267, DOI 10.2337/diabetes.48.2.267; Hastings M H, 2003, Novartis Found Symp, V253, P203; Hentges ST, 2004, J NEUROSCI, V24, P1578, DOI 10.1523/JNEUROSCI.3952-03.2004; Hetherington AW, 1942, J COMP NEUROL, V76, P475, DOI 10.1002/cne.900760308; Hetherington AW, 1940, ANAT REC, V78, P149, DOI 10.1002/ar.1090780203; Hewson AK, 2000, J NEUROENDOCRINOL, V12, P1047, DOI 10.1046/j.1365-2826.2000.00584.x; Hnasko TS, 2004, BRAIN RES, V1023, P309, DOI 10.1016/j.brainres.2004.07.051; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Horvath TL, 2004, NAT REV NEUROSCI, V5, P662, DOI 10.1038/nrn1479; HORVATH TL, 1992, ENDOCRINOLOGY, V131, P2461, DOI 10.1210/en.131.5.2461; Horvath TL, 1997, BRAIN RES, V756, P283, DOI 10.1016/S0006-8993(97)00184-4; Horvath TL, 1999, J NEUROSCI, V19, P1072; Horvath TL, 2001, ENDOCRINOLOGY, V142, P4163, DOI 10.1210/en.142.10.4163; Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kennedy AR, 2001, ENDOCRINOLOGY, V142, P3265, DOI 10.1210/en.142.7.3265; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; Komori T, 2006, NEUROSCIENCE, V139, P1107, DOI 10.1016/j.neuroscience.2005.12.066; Lee YS, 2006, CELL METAB, V3, P135, DOI 10.1016/j.cmet.2006.01.006; Li YZ, 2004, J NEUROSCI RES, V77, P596, DOI 10.1002/jnr.20192; LopezValpuesta FJ, 1996, P ROY SOC B-BIOL SCI, V263, P881, DOI 10.1098/rspb.1996.0130; Lu XY, 2000, HORM BEHAV, V37, P335, DOI 10.1006/hbeh.2000.1584; Ludwig DS, 1998, AM J PHYSIOL-ENDOC M, V274, pE627, DOI 10.1152/ajpendo.1998.274.4.E627; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Lynn RB, 1996, BIOCHEM BIOPH RES CO, V219, P884, DOI 10.1006/bbrc.1996.0328; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Maywood ES, 2003, J NEUROENDOCRINOL, V15, P329, DOI 10.1046/j.1365-2826.2003.00971.x; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Mitchell V, 2001, J COMP NEUROL, V429, P469, DOI 10.1002/1096-9861(20010115)429:3<469::AID-CNE8>3.0.CO;2-#; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; MORLEY JE, 1987, AM J PHYSIOL, V253, pR516, DOI 10.1152/ajpregu.1987.253.3.R516; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nakagawa T, 2003, INT J OBESITY, V27, P557, DOI 10.1038/sj.ijo.0802265; Nakagawa T, 2002, DIABETES-METAB RES, V18, P185, DOI 10.1002/dmrr.290; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Parducz A, 1996, CELL MOL NEUROBIOL, V16, P259, DOI 10.1007/BF02088180; Parducz A, 2002, EUR J NEUROSCI, V16, P665, DOI 10.1046/j.1460-9568.2002.02127.x; Parker KL, 2002, RECENT PROG HORM RES, V57, P19, DOI 10.1210/rp.57.1.19; Peyron C, 1998, J NEUROSCI, V18, P9996; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Quillan JM, 1998, FEBS LETT, V428, P59, DOI 10.1016/S0014-5793(98)00487-6; Riediger T, 2003, NEUROSCI LETT, V341, P151, DOI 10.1016/S0304-3940(02)01381-2; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Rollins BL, 2001, PHYSIOL BEHAV, V72, P735, DOI 10.1016/S0031-9384(01)00433-4; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; SAHM UG, 1994, FEBS LETT, V350, P29, DOI 10.1016/0014-5793(94)00725-X; Sahu A, 2002, BRAIN RES, V944, P232, DOI 10.1016/S0006-8993(02)02941-4; SAHU A, 1988, BRAIN RES, V457, P376, DOI 10.1016/0006-8993(88)90710-X; SAHU A, 1988, PEPTIDES, V9, P83, DOI 10.1016/0196-9781(88)90013-7; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SANACORA G, 1990, ENDOCRINOLOGY, V127, P730, DOI 10.1210/endo-127-2-730; SAPER CB, 1976, J COMP NEUROL, V169, P409, DOI 10.1002/cne.901690403; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 2004, ANNU REV NUTR, V24, P133, DOI 10.1146/annurev.nutr.24.012003.132428; Segal JP, 2005, J NEUROSCI, V25, P4181, DOI 10.1523/JNEUROSCI.0158-05.2005; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Shioda S, 1998, NEUROSCI LETT, V243, P41, DOI 10.1016/S0304-3940(98)00082-2; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Sotak BN, 2005, BRAIN RES, V1061, P88, DOI 10.1016/j.brainres.2005.08.053; Stein CJ, 2004, J CLIN ENDOCR METAB, V89, P2522, DOI 10.1210/jc.2004-0288; STELLAR E, 1954, PSYCHOL REV, V61, P5, DOI 10.1037/0033-295X.101.2.301; Stern JE, 1998, J NEUROSCI, V18, P841; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Sumova A, 2004, PHYSIOL RES, V53, pS167; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Tejwani G A, 1986, NIDA Res Monogr, V75, P497; TERHORST GJ, 1986, BRAIN RES BULL, V16, P231; Theodosis DT, 2004, NEUROCHEM INT, V45, P491, DOI 10.1016/j.neuint.2003.11.003; Torrealba F, 2003, NEUROSCIENCE, V119, P1033, DOI 10.1016/S0306-4522(03)00238-0; Toshinai K, 2003, ENDOCRINOLOGY, V144, P1506, DOI 10.1210/en.2002-220788; Traebert M, 2002, J NEUROENDOCRINOL, V14, P580, DOI 10.1046/j.1365-2826.2002.00810.x; Tritos NA, 2001, BRAIN RES, V895, P160, DOI 10.1016/S0006-8993(01)02066-2; Tritos NA, 1998, DIABETES, V47, P1687, DOI 10.2337/diabetes.47.11.1687; Tsuchida A, 2002, DIABETES OBES METAB, V4, P262, DOI 10.1046/j.1463-1326.2002.00206.x; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; van den Pol AN, 2003, NEURON, V40, P1059, DOI 10.1016/S0896-6273(03)00809-2; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; WILDING JPH, 1993, ENDOCRINOLOGY, V132, P1939, DOI 10.1210/en.132.5.1939; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wisialowski T, 2000, J CLIN INVEST, V105, P1253, DOI 10.1172/JCI8695; Xiong JJ, 1997, ENDOCRINOLOGY, V138, P1240, DOI 10.1210/en.138.3.1240; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Yamanaka A, 2000, BRAIN RES, V859, P404, DOI 10.1016/S0006-8993(00)02043-6; Yi CX, 2006, ENDOCRINOLOGY, V147, P283, DOI 10.1210/en.2005-1051; ZABORSZKY L, 1979, EXP BRAIN RES, V34, P201; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zsarnovszky A, 2001, J NEUROENDOCRINOL, V13, P22, DOI 10.1046/j.1365-2826.2001.00602.x; ZUCKER TF, 1963, J NUTR, V80, P6, DOI 10.1093/jn/80.1.6	171	87	90	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					691	702		10.1016/j.neuron.2006.08.025	http://dx.doi.org/10.1016/j.neuron.2006.08.025			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982416	Bronze			2022-12-28	WOS:000240997900009
J	Hommel, JD; Trinko, R; Sears, RM; Georgescu, D; Liu, ZW; Gao, XB; Thurmon, JJ; Marinelli, M; DiLeone, RJ				Hommel, Jonathan D.; Trinko, Richard; Sears, Robert M.; Georgescu, Dan; Liu, Zong-Wu; Gao, Xiao-Bing; Thurmon, Jeremy J.; Marinelli, Michela; DiLeone, Ralph J.			Leptin receptor signaling in midbrain dopamine neurons regulates feeding	NEURON			English	Article							VENTRAL TEGMENTAL AREA; MESSENGER-RNA EXPRESSION; NUCLEUS-ACCUMBENS; FOOD-INTAKE; ARCUATE NUCLEUS; BODY-WEIGHT; SYNAPTIC PLASTICITY; PLACE PREFERENCE; BRAIN-STEM; OBESE GENE	The leptin hormone is critical for normal food intake and metabolism. While leptin receptor (Lept) function has been well studied in the hypothalamus, the functional relevance of Lepr expression in the ventral tegmental area (VTA) has not been investigated. The VTA contains dopamine neurons that are important in modulating motivated behavior, addiction, and reward. Here, we show that VTA dopamine neurons express Lepr mRNA and respond to leptin with activation of an intracellular JAK-STAT pathway and a reduction in firing rate. Direct administration of leptin to the VTA caused decreased food intake while long-term RNAi-mediated knockdown of Lepr in the VTA led to increased food intake, locomotor activity, and sensitivity to highly palatable food. These data support a critical role for VTA Lepr in regulating feeding behavior and provide functional evidence for direct action of a peripheral metabolic signal on VTA dopamine neurons.	Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06519 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06519 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Yunyang Med Coll, Dept Neurobiol, Shiyan 442000, Hubei, Peoples R China; Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06520 USA; Rosalind Franklin Univ Med & Sci, Dept Cellular & Mol Pharmacol, N Chicago, IL 60064 USA	Yale University; Yale University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Yale University; Rosalind Franklin University Medical & Science	DiLeone, RJ (corresponding author), Yale Univ, Sch Med, Dept Psychiat, 333 Cedar St, New Haven, CT 06519 USA.	ralph.dileone@yale.edu	Marinelli, Michela/P-7645-2018; Chee, Melissa/G-4150-2014; Gao, Xiao-Bing/C-3121-2011; Liu, Zhong-Wu/C-2794-2011; Jansen, Heiko T./A-5770-2008	Marinelli, Michela/0000-0002-1903-1937; Chee, Melissa/0000-0003-3815-9095; Gao, Xiao-Bing/0000-0002-2035-4936; Jansen, Heiko T./0000-0003-0178-396X; DiLeone, Ralph/0000-0002-4770-2590; Hommel, Jonathan/0000-0001-8305-3746; , robert/0000-0001-5688-1853	NIDDK NIH HHS [DK071205] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK071205] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BADIANI A, 1995, BRAIN RES, V690, P112, DOI 10.1016/0006-8993(95)00607-R; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Banks WA, 2000, AM J PHYSIOL-ENDOC M, V278, pE1158, DOI 10.1152/ajpendo.2000.278.6.E1158; Bassareo V, 1999, NEUROSCIENCE, V89, P637, DOI 10.1016/S0306-4522(98)00583-1; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berhow MT, 1996, J NEUROSCI, V16, P8019; Blendy JA, 2005, PSYCHOPHARMACOLOGY, V180, P306, DOI 10.1007/s00213-005-2167-9; Bolanos CA, 2003, BIOL PSYCHIAT, V54, P1317, DOI 10.1016/S0006-3223(03)00570-5; Carr KD, 2002, PHYSIOL BEHAV, V76, P353, DOI 10.1016/S0031-9384(02)00759-X; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Echo JA, 2002, PHYSIOL BEHAV, V76, P107, DOI 10.1016/S0031-9384(02)00690-X; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2004, BEHAV NEUROSCI, V118, P479, DOI 10.1037/0735-7044.118.3.479; Figlewicz DP, 2003, AM J PHYSIOL-REG I, V284, pR882, DOI 10.1152/ajpregu.00602.2002; Figlewicz DP, 2001, PHYSIOL BEHAV, V73, P229, DOI 10.1016/S0031-9384(01)00486-3; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Grill HJ, 2002, ENDOCRINOLOGY, V143, P239, DOI 10.1210/en.143.1.239; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; HENRY DJ, 1989, J PHARMACOL EXP THER, V251, P833; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hosoi T, 2002, ENDOCRINOLOGY, V143, P3498, DOI 10.1210/en.2002-220077; Huang XF, 1996, NEUROREPORT, V7, P2635, DOI 10.1097/00001756-199611040-00045; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kamohara S, 1997, NATURE, V389, P374, DOI 10.1038/38717; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Krugel U, 2003, EUR J PHARMACOL, V482, P185, DOI 10.1016/j.ejphar.2003.09.047; Levin BE, 2000, BRAIN RES, V874, P158, DOI 10.1016/S0006-8993(00)02573-7; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; Marinelli M, 2000, J NEUROSCI, V20, P8876; MOGENSON GJ, 1991, ADV EXP MED BIOL, V295, P267; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; MUCHA RF, 1986, BRAIN RES, V397, P214, DOI 10.1016/0006-8993(86)90622-0; Naleid AM, 2005, PEPTIDES, V26, P2274, DOI 10.1016/j.peptides.2005.04.025; NOEL MB, 1995, BRAIN RES, V673, P304, DOI 10.1016/0006-8993(94)01442-K; NOEL MB, 1995, SYNAPSE, V21, P110, DOI 10.1002/syn.890210204; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Satoh N, 1997, NEUROSCI LETT, V224, P149, DOI 10.1016/S0304-3940(97)00163-8; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Seeley RJ, 1996, HORM METAB RES, V28, P664, DOI 10.1055/s-2007-979874; Shalev U, 2001, J NEUROSCI, V21; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Vaisse C, 1996, NAT GENET, V14, P95, DOI 10.1038/ng0996-95; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; White FJ, 1996, ANNU REV NEUROSCI, V19, P405, DOI 10.1146/annurev.ne.19.030196.002201; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	61	670	682	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					801	810		10.1016/j.neuron.2006.08.023	http://dx.doi.org/10.1016/j.neuron.2006.08.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982424	Bronze			2022-12-28	WOS:000240997900017
J	Tan, EM; Yamaguchi, Y; Horwitz, GD; Gosgnach, S; Lein, ES; Goulding, M; Albright, TD; Callaway, EM				Tan, Elaine M.; Yamaguchi, Yoshiaki; Horwitz, Gregory D.; Gosgnach, Simon; Lein, Edward S.; Goulding, Martyn; Albright, Thomas D.; Callaway, Edward M.			Reversible inactivation of mammalian neurons in vivo using the Drosophila allatostatin receptor	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; ADENOASSOCIATED VIRUS VECTORS; PRIMARY VISUAL-CORTEX; REMOTE-CONTROL; ION CHANNELS; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; TRANSGENIC MICE; PHOTOSTIMULATION; IDENTIFICATION	Genetic strategies for perturbing activity of selected neurons hold great promise for understanding circuitry and behavior. Several such strategies exist, but there has been no direct demonstration of reversible inactivation of mammalian neurons in vivo. We previously reported quickly reversible inactivation of neurons in vitro using expression of the Drosophila allatostatin receptor (AlstR). Here, adeno-associated viral vectors are used to express AlstR in vivo in cortical and thalamic neurons of rats, ferrets, and monkeys. Application of the receptor's ligand, allatostatin (AL), leads to a dramatic reduction in neural activity, including responses of visual neurons to optimized visual stimuli. Additionally, AL eliminates activity in spinal cords of transgenic mice conditionally expressing AlstR. This reduction occurs selectively in AlstR-expressing neurons. Inactivation can be reversed within minutes upon washout of the ligand and is repeatable, demonstrating that the AlstR/AL system is effective for selective, quick, and reversible silencing of mammalian neurons in vivo.	Salk Inst Biol Studies, Vis Ctr, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Labs, La Jolla, CA 92037 USA; Univ Calif San Diego, Grad Program Neurosci, La Jolla, CA 92093 USA; Allen Inst Brain Sci, Seattle, WA 98103 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; Allen Institute for Brain Science	Callaway, EM (corresponding author), Salk Inst Biol Studies, Vis Ctr, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Yamaguchi, Yoshiaki/K-9418-2013; Callaway, Edward/D-4336-2011	Yamaguchi, Yoshiaki/0000-0003-4126-542X; Callaway, Edward/0000-0002-6366-5267; Tan, Elaine/0000-0002-2302-5222; Horwitz, Gregory/0000-0001-5130-5259				Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Baker GE, 1998, EUR J NEUROSCI, V10, P2657, DOI 10.1046/j.1460-9568.1998.t01-1-00276.x; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Birgul N, 1999, EMBO J, V18, P5892, DOI 10.1093/emboj/18.21.5892; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; Chatterjee S, 2002, NEURON, V35, P1135, DOI 10.1016/S0896-6273(02)00874-7; Coward P, 1998, P NATL ACAD SCI USA, V95, P352, DOI 10.1073/pnas.95.1.352; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; Isles AR, 2001, J NEUROBIOL, V47, P183, DOI 10.1002/neu.1026; Johns DC, 1999, J NEUROSCI, V19, P1691; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; KOBAYASHI K, 1995, P NATL ACAD SCI USA, V92, P1132, DOI 10.1073/pnas.92.4.1132; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Rabinowitz JE, 2002, J VIROL, V76, P791, DOI 10.1128/JVI.76.2.791-801.2002; Slimko EM, 2002, J NEUROSCI, V22, P7373; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; Wiser AK, 1996, J NEUROSCI, V16, P2724; Xiao X, 1998, J VIROL, V72, P2224, DOI 10.1128/JVI.72.3.2224-2232.1998; Xiao X, 1997, EXP NEUROL, V144, P113, DOI 10.1006/exnr.1996.6396; Zemelman BV, 2003, P NATL ACAD SCI USA, V100, P1352, DOI 10.1073/pnas.242738899; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	31	118	122	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					157	170		10.1016/j.neuron.2006.06.018	http://dx.doi.org/10.1016/j.neuron.2006.06.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846851	Bronze			2022-12-28	WOS:000239535100004
J	Shalin, SC; Hernandez, CM; Dougherty, MK; Morrison, DK; Sweatt, JD				Shalin, Sara C.; Hernandez, Caterina M.; Dougherty, Michele K.; Morrison, Deborah K.; Sweatt, J. David			Kinase suppressor of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic plasticity and memory formation	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; DENDRITIC K+ CHANNELS; ERK MAP KINASE; AREA CA1; PRESYNAPTIC PLASTICITY; DORSAL HIPPOCAMPUS; CONTEXTUAL FEAR; ERK/MAP KINASE; NMDA RECEPTOR	The ERK/MAP kinase cascade is important for long-term memory formation and synaptic plasticity, with a myriad of upstream signals converging upon ERK activation. Despite this convergence of signaling, neurons routinely activate appropriate biological responses to different stimuli. Scaffolding proteins represent a mechanism to achieve compartmentalization of signaling and the appropriate targeting of ERK-dependent processes. We report that kinase suppressor of Ras (KSR1) functions biochemically in the hippocampus to scaffold the components of the ERK cascade, specifically regulating the cascade when a membrane fraction of ERK is activated via a PKC-dependent pathway but not via a cAMP/PKA-dependent pathway. Specificity of KSR1-dependent signaling also extends to specific downstream targets of ERK. Behaviorally and physiologically, we found that the absence of KSR1 leads to deficits in associative learning and theta burst stimulation-induced LTP. Our report provides novel insight into the endogenous scaffolding role of KSR1 in controlling kinase activation within the nervous system.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; NCI, Lab Prot Dynam & Signaling, Ft Detrick, MD 21702 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Sweatt, JD (corresponding author), Baylor Coll Med, Dept Neurosci, 1 Baylor Pl, Houston, TX 77030 USA.	dsweatt@nrc.uab.edu		Sweatt, J. David/0000-0003-3567-485X	NATIONAL CANCER INSTITUTE [Z01BC010329, ZIABC010329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057014, F31MH071014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013546, P01NS037444] Funding Source: NIH RePORTER; NIMH NIH HHS [F31MH071014, MH57014] Funding Source: Medline; NINDS NIH HHS [NS37444, NS13546] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Adams JP, 2002, ANNU REV PHARMACOL, V42, P135, DOI 10.1146/annurev.pharmtox.42.082701.145401; Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Apergis-Schoute AM, 2005, J NEUROSCI, V25, P5730, DOI 10.1523/JNEUROSCI.0096-05.2005; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Banko JL, 2004, J NEUROCHEM, V91, P462, DOI 10.1111/j.1471-4159.2004.02734.x; Blum S, 1999, J NEUROSCI, V19, P3535; Cacace AM, 1999, MOL CELL BIOL, V19, P229; Delgado JY, 2005, NEUROPHARMACOLOGY, V48, P936, DOI 10.1016/j.neuropharm.2005.01.008; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dudek SM, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-02-j0002.2001; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Gallagher SM, 2004, J NEUROSCI, V24, P4859, DOI 10.1523/JNEUROSCI.5407-03.2004; Gerdjikov TV, 2004, BEHAV NEUROSCI, V118, P740, DOI 10.1037/0735-7044.118.4.740; Goldin M, 2003, EUR J NEUROSCI, V17, P2529, DOI 10.1046/j.1460-9568.2003.02694.x; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kushner SA, 2005, J NEUROSCI, V25, P9721, DOI 10.1523/JNEUROSCI.2836-05.2005; Mazzucchelli C, 2002, NEURON, V34, P807, DOI 10.1016/S0896-6273(02)00716-X; Miller CA, 2005, NEURON, V47, P873, DOI 10.1016/j.neuron.2005.08.006; Morozov A, 2003, NEURON, V39, P309, DOI 10.1016/S0896-6273(03)00404-5; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Morrison DK, 2001, J CELL SCI, V114, P1609; Muller J, 2000, MOL CELL BIOL, V20, P5529, DOI 10.1128/MCB.20.15.5529-5539.2000; Nguyen A, 2002, MOL CELL BIOL, V22, P3035, DOI 10.1128/MCB.22.9.3035-3045.2002; Ohmachi M, 2002, CURR BIOL, V12, P427, DOI 10.1016/S0960-9822(02)00690-5; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Roberson ED, 1999, J NEUROSCI, V19, P4337; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Schafe GE, 2000, J NEUROSCI, V20, P8177; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Selcher JC, 2003, LEARN MEMORY, V10, P26, DOI 10.1101/lm.51103; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; THERRIEN M, 1995, CELL, V83, P879, DOI 10.1016/0092-8674(95)90204-X; Vomastek T, 2004, P NATL ACAD SCI USA, V101, P6981, DOI 10.1073/pnas.0305894101; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Winder DG, 1999, NEURON, V24, P715, DOI 10.1016/S0896-6273(00)81124-1; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Xing HM, 1997, CURR BIOL, V7, P294, DOI 10.1016/S0960-9822(06)00152-7; Xing HR, 2004, J BIOL CHEM, V279, P26210, DOI 10.1074/jbc.M401323200; Yu W, 1998, CURR BIOL, V8, P56, DOI 10.1016/S0960-9822(98)70020-X; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002	51	74	76	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					765	779		10.1016/j.neuron.2006.04.029	http://dx.doi.org/10.1016/j.neuron.2006.04.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731514	Bronze			2022-12-28	WOS:000238165000011
J	Judkewitz, B; Roth, A; Hausser, M				Judkewitz, B; Roth, A; Hausser, M			Dendritic enlightenment: Using patterned two-photon uncaging to reveal the secrets of the brain's smallest dendrites	NEURON			English	Editorial Material							CA1 PYRAMIDAL NEURONS; BASAL DENDRITES; SPIKES	It has been a longstanding challenge for experimentalists to manipulate precisely the spatial and temporal patterns of synaptic input to the dendritic tree in order to mimic activity occurring in the intact brain and determine their importance for synaptic integration. In this issue of Neuron, Losonczy and Magee have used rapid multisite two-photon uncaging of glutamate to define patterns of synaptic input on a submillisecond and micron scale to investigate the rules for summation of synaptic inputs in the fine oblique dendrites of pyramidal neurons.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Judkewitz, B (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.		Judkewitz, Benjamin/C-3645-2014; Hausser, Michael/AAW-6827-2020	Judkewitz, Benjamin/0000-0002-8570-3869; Hausser, Michael/0000-0002-2673-8957; Roth, Arnd/0000-0003-0325-4287				Ariav G, 2003, J NEUROSCI, V23, P7750; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; KAPLAN JH, 1978, BIOCHEMISTRY-US, V17, P1929, DOI 10.1021/bi00603a020; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Reddy GD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2141504; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Shoham S, 2005, NAT METHODS, V2, P837, DOI 10.1038/nmeth793; Urban NN, 1998, P NATL ACAD SCI USA, V95, P11450, DOI 10.1073/pnas.95.19.11450	17	25	25	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 20	2006	50	2					180	183		10.1016/j.neuron.2006.04.011	http://dx.doi.org/10.1016/j.neuron.2006.04.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630828	Bronze			2022-12-28	WOS:000237176700004
J	Henry, LK; DeFelice, LJ; Blakely, RD				Henry, LK; DeFelice, LJ; Blakely, RD			Getting the message across: A recent transporter structure shows the way	NEURON			English	Review							TRANSMEMBRANE DOMAIN-I; HUMAN SEROTONIN TRANSPORTERS; HIGH-AFFINITY RECOGNITION; NEUROTRANSMITTER TRANSPORTERS; DOPAMINE TRANSPORTER; TRANSMITTER UPTAKE; COCAINE BINDING; SUBSTRATE; CHANNELS; HOMOLOG	Efforts to define the mechanisms governing neurotransmitter uptake and drug action have moved into high gear with the publication of a high-resolution structure of a leucine transporter from Aquifex aeolicus, a bacterial member of the SLC6 transporter family. Solved with the substrate leucine bound, the new structure corroborates extensive biochemical and mutagenesis studies performed with related mammalian neurotransmitter transporters and provides exciting suggestions as to how coupling arises between ions and substrates to permit efficient neurotransmitter clearance.	Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Blakely, RD (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 221 Kirkland Hall, Nashville, TN 37232 USA.	randy.blakely@vanderbilt.edu		De Felice, Louis/0000-0002-4594-3171				Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Adkins EM, 2001, MOL PHARMACOL, V59, P514, DOI 10.1124/mol.59.3.514; Artigas P, 2003, P NATL ACAD SCI USA, V100, P501, DOI 10.1073/pnas.0135849100; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Blakely RD, 2005, PHYSIOLOGY, V20, P225, DOI 10.1152/physiol.00013.2005; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Chen FH, 2005, J NEUROCHEM, V92, P21, DOI 10.1111/j.1471-4159.2004.02835.x; Chen JG, 1997, J BIOL CHEM, V272, P28321, DOI 10.1074/jbc.272.45.28321; DeFelice LJ, 2004, TRENDS NEUROSCI, V27, P352, DOI 10.1016/j.tins.2004.04.007; DeFelice LJ, 1996, BIOPHYS J, V70, P579, DOI 10.1016/S0006-3495(96)79604-2; DeLano W.L, PYMOL MOL GRAPHICS S; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDVARDSEN O, 1994, MOL BRAIN RES, V27, P265, DOI 10.1016/0169-328X(94)90009-4; Gadsby DC, 2004, NATURE, V427, P795, DOI 10.1038/427795a; Hahn MK, 2005, MOL PHARMACOL, V68, P457, DOI 10.1124/mol.105.011270; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; IVERSEN LL, 1971, BRIT J PHARMACOL, V41, P571, DOI 10.1111/j.1476-5381.1971.tb07066.x; IVERSEN LL, 1966, MOL PHARMACOL, V2, P360; Kahlig KM, 2005, P NATL ACAD SCI USA, V102, P3495, DOI 10.1073/pnas.0407737102; Lee SH, 2000, MOL PHARMACOL, V57, P883; Lester HA, 1996, NEURON, V17, P807, DOI 10.1016/S0896-6273(00)80213-5; LESTER HA, 1994, ANNU REV PHARMACOL, V34, P219; MacKinnon R, 2003, FEBS LETT, V555, P62, DOI 10.1016/S0014-5793(03)01104-9; Petersen CI, 1999, NAT NEUROSCI, V2, P605, DOI 10.1038/10158; Pornillos O, 2006, FEBS LETT, V580, P358, DOI 10.1016/j.febslet.2005.12.054; Quick MW, 2003, NEURON, V40, P537, DOI 10.1016/S0896-6273(03)00605-6; Ramamoorthy S, 1999, SCIENCE, V285, P763, DOI 10.1126/science.285.5428.763; Schwartz JW, 2003, J BIOL CHEM, V278, P9768, DOI 10.1074/jbc.M209824200; Sen N, 2005, NEUROPHARMACOLOGY, V49, P780, DOI 10.1016/j.neuropharm.2005.08.014; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sung U, 2005, BIOCHEM BIOPH RES CO, V333, P671, DOI 10.1016/j.bbrc.2005.05.165; Sutcliffe JS, 2005, AM J HUM GENET, V77, P265, DOI 10.1086/432648; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200	40	46	47	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					791	796		10.1016/j.neuron.2006.03.002	http://dx.doi.org/10.1016/j.neuron.2006.03.002			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543127	Bronze			2022-12-28	WOS:000236227500007
J	Peng, PL; Zhong, XF; Tu, WH; Soundarapandian, MM; Molner, P; Zhu, DY; Lau, L; Liu, SH; Liu, F; Lu, YM				Peng, PL; Zhong, XF; Tu, WH; Soundarapandian, MM; Molner, P; Zhu, DY; Lau, L; Liu, SH; Liu, F; Lu, YM			ADAR2-dependent RNA editing of AMPA receptor subunit GluR2 determines vulnerability of neurons in forebrain ischemia	NEURON			English	Article							TRANSIENT CEREBRAL-ISCHEMIA; HIPPOCAMPAL CA1 NEURONS; CELL-DEATH; MESSENGER-RNA; KAINATE RECEPTORS; CA2+ PERMEABILITY; GLUTAMATE RELEASE; TEMPORAL PROFILE; PYRAMIDAL CELLS; RAT HIPPOCAMPUS	ADAR2 is a nuclear enzyme essential for GluR2 pre-mRNA editing at Q/R site-607, which gates Ca2+ entry through AMPA receptor channels. Here, we show that forebrain ischemia in adult rats selectively reduces expression of ADAR2 enzyme and, hence, disrupts RNA Q/R site editing of GluR2 subunit in vulnerable neurons. Recovery of GluR2 Q/R site editing by expression of exogenous ADAR2b gene or a constitutively active CREB, VP16-CREB, which induces expression of endogenous ADAR2, protects vulnerable neurons in the rat hippocampus from forebrain ischemic insult. Generation of a stable ADAR2 gene silencing by delivering small interfering RNA (siRNA) inhibits GluR2 Q/R site editing, leading to degeneration of ischemia-insensitive neurons. Direct introduction of the Q/R site edited GluR2 gene, GluR2(R-607), rescues ADAR2 degeneration. Thus, ADAR2-dependent GluR2 Q/R site editing determines vulnerability of neurons in the rat hippocampus to forebrain ischemia.	Univ Cent Florida, Biomol Sci Ctr, Orlando, FL 32816 USA; Univ Cent Florida, Coll Biomed Sci, Nanotechnol Sci Ctr, Orlando, FL 32816 USA; Nanjing Med Univ, Dept Pharmacol, Nanjing, Peoples R China; Univ Calgary, Fac Med, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada	State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida; Nanjing Medical University; University of Calgary	Lu, YM (corresponding author), Univ Cent Florida, Biomol Sci Ctr, Orlando, FL 32816 USA.	youming@mail.ucf.edu						Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Anzai T, 2003, NEUROSCI RES, V46, P41, DOI 10.1016/S0168-0102(03)00023-3; Barco A, 2002, CELL, V108, P689, DOI 10.1016/S0092-8674(02)00657-8; BENVENISTE H, 1984, J NEUROCHEM, V43, P1369, DOI 10.1111/j.1471-4159.1984.tb05396.x; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Grishin AA, 2004, J NEUROSCI, V24, P350, DOI 10.1523/JNEUROSCI.4933-03.2004; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; HIGUCHI M, 1993, CELL, V75, P1361, DOI 10.1016/0092-8674(93)90622-W; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Iadecola C, 1997, J NEUROSCI, V17, P9157; JIA Z, 1996, NEURON, V17, P9452; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; KAMPHUIS W, 1995, NEUROREPORT, V6, P1133, DOI 10.1097/00001756-199505300-00015; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; Liu D, 2003, J NEUROCHEM, V86, P966, DOI 10.1046/j.1471-4159.2003.01913.x; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SH, 2003, J NEUROSCI, V23, P732; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morris GF, 1999, J NEUROSURG, V91, P737, DOI 10.3171/jns.1999.91.5.0737; Oguro K, 1999, J NEUROSCI, V19, P9218; Paschen W, 1996, J CEREBR BLOOD F MET, V16, P548, DOI 10.1097/00004647-199607000-00004; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; RUETER SM, 1995, SCIENCE, V267, P1491, DOI 10.1126/science.7878468; Rump A, 1996, J CEREBR BLOOD F MET, V16, P1362, DOI 10.1097/00004647-199611000-00034; SCHMIDTKASTNER R, 1991, NEUROSCIENCE, V40, P599, DOI 10.1016/0306-4522(91)90001-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Slavov D, 2002, GENE, V299, P83, DOI 10.1016/S0378-1119(02)01016-8; Soundarapandian MM, 2005, MOL NEUROBIOL, V32, P145, DOI 10.1385/MN:32:2:145; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Tanaka K, 1999, NEUROREPORT, V10, P2245, DOI 10.1097/00001756-199908020-00004; Vissel B, 2001, NEURON, V29, P217, DOI 10.1016/S0896-6273(01)00192-1; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang J, 2003, J NEUROSCI, V23, P826; Watanabe M, 1998, EUR J NEUROSCI, V10, P478, DOI 10.1046/j.1460-9568.1998.00063.x; Weiss JH, 2000, TRENDS NEUROSCI, V23, P365, DOI 10.1016/S0166-2236(00)01610-6; WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; YANG JH, 1995, NATURE, V374, P77, DOI 10.1038/374077a0; Zhu DY, 2004, P NATL ACAD SCI USA, V101, P9453, DOI 10.1073/pnas.0401063101	63	171	184	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					719	733		10.1016/j.neuron.2006.01.025	http://dx.doi.org/10.1016/j.neuron.2006.01.025			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504947	Bronze			2022-12-28	WOS:000236070600013
J	Kellendonk, C; Simpson, EH; Polan, HJ; Malleret, G; Vronskaya, S; Winiger, V; Moore, H; Kandel, ER				Kellendonk, C; Simpson, EH; Polan, HJ; Malleret, G; Vronskaya, S; Winiger, V; Moore, H; Kandel, ER			Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning	NEURON			English	Article							WORKING-MEMORY DEFICITS; DOUBLE-BLIND PET; BASAL GANGLIA; ANTIPSYCHOTIC-DRUGS; SCHIZOPHRENIC SUBJECTS; C957T POLYMORPHISM; DELAYED-RESPONSE; SPATIAL MEMORY; D-2 RECEPTORS; IN-VIVO	Increased activity of D2 receptors (D2Rs) in the striatum has been linked to the pathophysiology of schizophrenia. To determine directly the behavioral and physiological consequences of increased D2R function in the striatum, we generated mice with reversibly increased levels of D2Rs restricted to the striatum. D2 transgenic mice exhibit selective cognitive impairments in working memory tasks and behavioral flexibility without more general cognitive deficits. The deficit in the working memory task persists even after the transgene has been switched off, indicating that it results not from continued overexpression of D2Rs but from excess expression during development. To determine the effects that may mediate the observed cognitive deficits, we analyzed the prefrontal cortex, the brain structure mainly associated with working memory. We found that D2R overexpression in the striatum impacts dopamine levels, rates of dopamine turnover, and activation of D1 receptors in the prefrontal cortex, measures that are critical for working memory.	Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Lieber Ctr Schizophrenia Res, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Cornell University	Simpson, EH (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	es534@columbia.edu; erk5@columbia.edu	Kellendonk, Christoph/O-7229-2018	Kellendonk, Christoph/0000-0003-3302-2188; Simpson, Eleanor/0000-0002-9092-2230	NIMH NIH HHS [P50 MH066171] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH066171] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Akil M, 1999, AM J PSYCHIAT, V156, P1580, DOI 10.1176/ajp.156.10.1580; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BATTIG K, 1960, J COMP PHYSIOL PSYCH, V53, P400, DOI 10.1037/h0047392; Birrell JM, 2000, J NEUROSCI, V20, P4320; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; BUNNEY BS, 1976, BRAIN RES, V117, P423, DOI 10.1016/0006-8993(76)90751-4; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Carpenter WT, 2002, BIOL PSYCHIAT, V51, P969, DOI 10.1016/S0006-3223(02)01399-9; Castner SA, 2000, SCIENCE, V287, P2020, DOI 10.1126/science.287.5460.2020; Colacicco G, 2002, BEHAV BRAIN RES, V132, P95, DOI 10.1016/S0166-4328(01)00391-6; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; DAVIS KL, 1991, AM J PSYCHIAT, V148, P1474; Dias R, 2000, EUR J NEUROSCI, V12, P4457, DOI 10.1046/j.0953-816X.2000.01323.x; DIVAC I, 1972, Acta Neurobiologiae Experimentalis (Warsaw), V32, P461; Floresco SB, 1997, J NEUROSCI, V17, P1880; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Fuster J., 1997, PREFRONTAL CORTEX AN, P66; Glickstein SB, 2002, J NEUROSCI, V22, P5619; Goldman-Rakic PS, 1999, ANN NY ACAD SCI, V868, P13, DOI 10.1111/j.1749-6632.1999.tb11270.x; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Granon S, 2000, J NEUROSCI, V20, P1208, DOI 10.1523/JNEUROSCI.20-03-01208.2000; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Guo NN, 2003, NEUROPSYCHOPHARMACOL, V28, P1703, DOI 10.1038/sj.npp.1300224; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Hirvonen J, 2005, ARCH GEN PSYCHIAT, V62, P371, DOI 10.1001/archpsyc.62.4.371; Hirvonen M, 2004, MOL PSYCHIATR, V9, P1060, DOI 10.1038/sj.mp.4001561; JASKIW GE, 1990, BRAIN RES, V534, P263, DOI 10.1016/0006-8993(90)90138-2; KAHN RS, 1994, SCHIZOPHR RES, V11, P217, DOI 10.1016/0920-9964(94)90015-9; Kapur S, 2000, AM J PSYCHIAT, V157, P514, DOI 10.1176/appi.ajp.157.4.514; Laruelle M, 1998, Q J NUCL MED, V42, P211; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lawford BR, 2005, SCHIZOPHR RES, V73, P31, DOI 10.1016/j.schres.2004.08.020; Lee I, 2003, J NEUROSCI, V23, P1517, DOI 10.1523/JNEUROSCI.23-04-01517.2003; LOUGHLIN SE, 1984, NEUROSCIENCE, V11, P425, DOI 10.1016/0306-4522(84)90034-4; MARKOWITSCH HJ, 1977, PSYCHOL BULL, V84, P817, DOI 10.1037/0033-2909.84.5.817; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Meltzer HY, 2004, CURR OPIN PHARMACOL, V4, P53, DOI 10.1016/j.coph.2003.09.010; Meyer-Lindenberg A, 2002, NAT NEUROSCI, V5, P267, DOI 10.1038/nn804; Miyamoto S, 2005, MOL PSYCHIATR, V10, P79, DOI 10.1038/sj.mp.4001556; NORDSTROM AL, 1993, BIOL PSYCHIAT, V33, P227, DOI 10.1016/0006-3223(93)90288-O; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Ohtani N, 2003, J NEUROSCI, V23, P2840; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; Partiot A, 1996, NEUROPSYCHOLOGIA, V34, P709, DOI 10.1016/0028-3932(95)00143-3; ROBERTS AC, 1994, J NEUROSCI, V14, P2531; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schmitz C, 2000, J CHEM NEUROANAT, V20, P93, DOI 10.1016/S0891-0618(00)00066-1; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 1998, J NEUROSCI, V18, P1613; Seeman P, 2000, P NATL ACAD SCI USA, V97, P7673, DOI 10.1073/pnas.97.14.7673; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Silva AJ, 1997, NEURON, V19, P755, DOI 10.1016/S0896-6273(00)80958-7; Velakoulis D, 1996, AUST NZ J PSYCHIAT, V30, P195, DOI 10.3109/00048679609076095; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zvara A, 2005, DIS MARKERS, V21, P61, DOI 10.1155/2005/275318	66	403	411	0	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					603	615		10.1016/j.neuron.2006.01.023	http://dx.doi.org/10.1016/j.neuron.2006.01.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476668	Bronze			2022-12-28	WOS:000235643800012
J	Petkov, CI; O'Connor, KN; Sutter, ML				Petkov, Christopher I.; O'Connor, Kevin N.; Sutter, Mitchell L.			Encoding of illusory continuity in primary auditory cortex	NEURON			English	Article							CORTICAL DEAFNESS; AMODAL COMPLETION; MACAQUE MONKEYS; GAP DETECTION; NOISE; SOUNDS; CAT; INDUCTION; RESPONSES; NEURONS	When interfering objects occlude a scene, the visual system restores the occluded information. Similarly, when a sound of interest (a "foreground" sound) is interrupted (occluded) by loud noise, the auditory system restores the occluded information. This process, called auditory induction, can be exploited to create a continuity illusion. When a segment of a foreground sound is deleted and loud noise fills the missing portion, listeners incorrectly report hearing the foreground continuing through the noise. Here we reveal the neurophysiological underpinnings of illusory continuity in single-neuron responses from awake macaque monkeys' primary auditory cortex (A1). A1 neurons represented the missing segment of occluded tonal foregrounds by responding to discontinuous foregrounds interrupted by intense noise as if they were responding to the complete foregrounds. By comparison, simulated peripheral responses represented only the noise and not the occluded foreground. The results reveal that many A1 single-neuron responses closely follow the illusory percept.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Sect Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Sutter, ML (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	mlsutter@ucdavis.edu	Petkov, Christopher/O-5318-2015	Petkov, Christopher/0000-0002-4932-7907	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002514, R01DC002514] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002514, DC-02514, R29 DC002514] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; BASHFORD JA, 1988, J ACOUST SOC AM, V84, P1635, DOI 10.1121/1.397178; Bregman A.S., 1990, AUDITORY SCENE ANAL; BREGMAN AS, 1977, CAN J PSYCHOL, V31, P151, DOI 10.1037/h0081658; Brosch M, 1998, NEUROREPORT, V9, P2551, DOI 10.1097/00001756-199808030-00023; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037/0096-1523.27.1.115; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DAY RH, 1983, PERCEPT PSYCHOPHYS, V33, P355, DOI 10.3758/BF03205882; Eggermont JJ, 1999, J NEUROPHYSIOL, V81, P2570, DOI 10.1152/jn.1999.81.5.2570; ERULKER SD, 1956, J HOPKINS HOSP B, V39, P55; Fishbach A, 2001, J NEUROPHYSIOL, V85, P2303, DOI 10.1152/jn.2001.85.6.2303; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Grady CL, 1997, NEUROREPORT, V8, P2511, DOI 10.1097/00001756-199707280-00019; GRAHAM J, 1980, J NEUROL SCI, V48, P35, DOI 10.1016/0022-510X(80)90148-3; Hackett TA, 2001, J COMP NEUROL, V441, P197, DOI 10.1002/cne.1407; HOUTGAST T, 1972, J ACOUST SOC AM, V51, P1885, DOI 10.1121/1.1913048; Husain FT, 2005, J COGNITIVE NEUROSCI, V17, P1275, DOI 10.1162/0898929055002472; KANIZSA G, 1979, ORG VISION ESSAYS GE; KATSUKI Y, 1959, J NEUROPHYSIOL, V22, P343, DOI 10.1152/jn.1959.22.4.343; KLUENDER KR, 1992, PERCEPT PSYCHOPHYS, V51, P231, DOI 10.3758/BF03212249; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Las L, 2005, J NEUROSCI, V25, P1503, DOI 10.1523/JNEUROSCI.4007-04.2005; MEDDIS R, 1990, J ACOUST SOC AM, V87, P1813, DOI 10.1121/1.399379; MEDDIS R, 1986, J ACOUST SOC AM, V79, P702, DOI 10.1121/1.393460; MERZENICH MM, 1973, BRAIN RES, V50, P275, DOI 10.1016/0006-8993(73)90731-2; MICHEL F, 1980, BRAIN LANG, V10, P367, DOI 10.1016/0093-934X(80)90062-0; Micheyl C, 2003, J COGNITIVE NEUROSCI, V15, P747, DOI 10.1162/089892903322307456; Miller CT, 2001, NAT NEUROSCI, V4, P783, DOI 10.1038/90481; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O'Connor KN, 2000, J COMP PHYSIOL A, V186, P903, DOI 10.1007/s003590000145; O'Connor KN, 2005, J NEUROPHYSIOL, V94, P4051, DOI 10.1152/jn.00046.2005; PATTERSON RD, 1992, ADV BIOSCI, V83, P429; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; Paxinos G., 2000, RHESUS MONKEY BRAIN; Pessoa L., 2003, FILLING IN PERCEPTUA; Petkov CI, 2004, NAT NEUROSCI, V7, P658, DOI 10.1038/nn1256; Petkov CI, 2003, J NEUROSCI, V23, P9155; PICKETT JM, 1959, J ACOUST SOC AM, V31, P127, DOI 10.1121/1.1930194; Pressnitzer D, 2001, J NEUROSCI, V21, P6377, DOI 10.1523/JNEUROSCI.21-16-06377.2001; Pugh KR, 1996, NEUROIMAGE, V4, P159, DOI 10.1006/nimg.1996.0067; Rauschecker JP, 2004, J NEUROPHYSIOL, V91, P2578, DOI 10.1152/jn.00834.2003; Recanzone GH, 2000, HEARING RES, V150, P104, DOI 10.1016/S0378-5955(00)00194-5; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; RHODE WS, 1978, J NEUROPHYSIOL, V41, P692, DOI 10.1152/jn.1978.41.3.692; Rossi AF, 1996, VISION RES, V36, P1391, DOI 10.1016/0042-6989(95)00206-5; SCHREINER C, 1980, HEARING RES, V3, P265, DOI 10.1016/0378-5955(80)90022-2; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; SCHREINER CE, 1992, J NEUROPHYSIOL, V68, P1487, DOI 10.1152/jn.1992.68.5.1487; Sivonen P, 2006, NEUROSCI LETT, V408, P220, DOI 10.1016/j.neulet.2006.09.001; Slaney M., 1993, 35 APPL COMP, P1; Slaney M., 1998, 1998010 INT RES CORP, P1; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Sugita Y, 1997, NEUROREPORT, V8, P1155, DOI 10.1097/00001756-199703240-00019; Sutter ML, 2005, INT REV NEUROBIOL, V70, P253, DOI 10.1016/S0074-7742(05)70008-8; Walton JP, 1997, J COMP PHYSIOL A, V181, P161, DOI 10.1007/s003590050103; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WARREN RM, 1988, J ACOUST SOC AM, V84, P1338, DOI 10.1121/1.396632; WARREN RM, 1994, PERCEPT PSYCHOPHYS, V55, P313, DOI 10.3758/BF03207602; WARREN RM, 1972, SCIENCE, V176, P1149, DOI 10.1126/science.176.4039.1149; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WRIGHTSON JM, 1981, J ACOUST SOC AM, V69, pS105	63	84	85	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					153	165		10.1016/j.neuron.2007.02.031	http://dx.doi.org/10.1016/j.neuron.2007.02.031			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408584	Green Accepted, Bronze			2022-12-28	WOS:000245848400016
J	Haushofer, J; Kanwisher, N				Haushofer, Johannes; Kanwisher, Nancy			In the eye of the beholder: Visual experience and categories in the human brain	NEURON			English	Editorial Material							PREFRONTAL CORTEX; DISCRIMINATION; REPRESENTATIONS	How does experience change representations of visual objects in the brain? Do cortical object representations reflect category membership? In this issue of Neuron, Jiang et al. show that category training leads to sharpening of neural responses in high-level visual cortex; in contrast, category boundaries may be represented only in prefrontal cortex.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Haushofer, J (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	haushof@fas.harvard.edu						Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; Fiser J, 2002, P NATL ACAD SCI USA, V99, P15822, DOI 10.1073/pnas.232472899; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; GOLDSTONE R, 1994, J EXP PSYCHOL GEN, V123, P178, DOI 10.1037/0096-3445.123.2.178; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Jiang X, 2007, NEURON, V53, P891, DOI 10.1016/j.neuron.2007.02.015; LIBERMAN AM, 1957, J EXP PSYCHOL, V54, P358, DOI 10.1037/h0044417; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Rosenthal O, 2001, P NATL ACAD SCI USA, V98, P4265, DOI 10.1073/pnas.071525998; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; Turk-Browne NB, 2005, J EXP PSYCHOL GEN, V134, P552, DOI 10.1037/0096-3445.134.4.552	14	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 15	2007	53	6					773	775		10.1016/j.neuron.2007.03.003	http://dx.doi.org/10.1016/j.neuron.2007.03.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359912	Bronze			2022-12-28	WOS:000245292800002
J	Putignano, E; Lonetti, G; Cancedda, L; Ratto, G; Costa, M; Maffei, L; Pizzorusso, T				Putignano, Elena; Lonetti, Giuseppina; Cancedda, Laura; Ratto, Gianmichele; Costa, Mario; Maffei, Larnberto; Pizzorusso, Tommaso			Developmental Downregulation of histone posttranslational modifications regulates visual cortical plasticity	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; EXPERIENCE-DEPENDENT PLASTICITY; STRESS-INDUCED PHOSPHORYLATION; CRITICAL PERIOD PLASTICITY; MAMMALIAN CIRCADIAN CLOCK; MEDIATED GENE-EXPRESSION; GROWTH-FACTOR; TRANSCRIPTIONAL REGULATION; BINDING PROTEIN; MAP KINASE	The action of visual experience on visual cortical circuits is maximal during a critical period of postnatal development. The long-term effects of this experience are likely mediated by signaling cascades regulating experiencedependent gene transcription. Developmental modifications of these pathways could explain the difference in plasticity between the young and adult cortex. We studied the pathways linking experience-dependent activation of ERK to CREB-mediated gene expression in vivo. In juvenile mice, visual stimulation that activates CREB-mediated gene transcription also induced ERK-dependent MSK and histone H3 phosphorylation and H3-H4 acetylation, an epigenetic mechanism of gene transcription activation. In adult animals, ERK and MSK were still inducible; however, visual stimulation induced weak CREB-mediated gene expression and H3-H4 posttranslational modifications. Stimulation of histone acetylation in adult animals by means of trichostatin promoted ocular dominance plasticity. Thus, differing, experiencedependent activations of signaling molecules might be at the basis of the differences in experience-dependent plasticity between juvenile and adult cortex.	CNR, Area Ric, Ist Neurosci, I-56125 Pisa, Italy; Univ Florence, Dept Psychol, I-50125 Florence, Italy; Scuola Normale Super Pisa, CNRS, Area Ric, Neurobiol Lab, I-56125 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Florence; Scuola Normale Superiore di Pisa	Pizzorusso, T (corresponding author), CNR, Area Ric, Ist Neurosci, Via Moruzzi,1, I-56125 Pisa, Italy.	tommaso@in.cnr.it	Costa, Mario/AAC-2362-2022; Ratto, Gian Michele/AAX-8514-2020; Ratto, Gian Michele/AAB-8719-2021; Pizzorusso, Tommaso/D-1399-2013	Ratto, Gian Michele/0000-0001-9632-7769; Pizzorusso, Tommaso/0000-0001-5614-0668; COSTA, Mario/0000-0001-5821-9871; Putignano, Elena/0000-0002-4313-408X; Cancedda, Laura/0000-0003-0566-057X				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Berardi N, 2000, CURR OPIN NEUROBIOL, V10, P138, DOI 10.1016/S0959-4388(99)00047-1; BODE AM, 2005, SCI STKE, DOI DOI 10.1126/ST5E.2812005RE4; Brami-Cherrier K, 2005, J NEUROSCI, V25, P11444, DOI 10.1523/JNEUROSCI.1711-05.2005; Bruning JC, 2000, P NATL ACAD SCI USA, V97, P2462, DOI 10.1073/pnas.97.6.2462; Butcher GQ, 2004, EUR J NEUROSCI, V19, P907, DOI 10.1111/j.0953-816X.2004.03155.x; Cancedda L, 2003, J NEUROSCI, V23, P7012, DOI 10.1523/JNEUROSCI.23-18-07012.2003; Chang JH, 2006, J NEUROCHEM, V99, P1517, DOI 10.1111/j.1471-4159.2006.04196.x; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Colvis CM, 2005, J NEUROSCI, V25, P10379, DOI 10.1523/JNEUROSCI.4119-05.2005; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; Crosio C, 2003, J CELL SCI, V116, P4905, DOI 10.1242/jcs.00804; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Cristo G, 2001, SCIENCE, V292, P2337, DOI 10.1126/science.1059075; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; Gordon JA, 1996, J NEUROSCI, V16, P3274; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Janknecht R, 1996, BIOCHEM BIOPH RES CO, V228, P831, DOI 10.1006/bbrc.1996.1740; Kaminska B, 1999, MOL CELL NEUROSCI, V13, P405, DOI 10.1006/mcne.1999.0757; Karmarkar UR, 2006, NEURON, V52, P577, DOI 10.1016/j.neuron.2006.11.001; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lachance PED, 2004, J NEUROCHEM, V88, P1455, DOI 10.1046/j.1471-4159.2003.02274.x; Levenson JM, 2005, NAT REV NEUROSCI, V6, P108, DOI 10.1038/nrn1604; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Majdan M, 2006, NAT NEUROSCI, V9, P650, DOI 10.1038/nn1674; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meaney MJ, 2005, TRENDS NEUROSCI, V28, P456, DOI 10.1016/j.tins.2005.07.006; Mower AF, 2002, J NEUROSCI, V22, P2237, DOI 10.1523/JNEUROSCI.22-06-02237.2002; Neely KE, 2002, MOL GENET METAB, V76, P1, DOI 10.1016/S1096-7192(02)00014-8; Ossipow V, 2004, MOL CELL NEUROSCI, V27, P70, DOI 10.1016/j.mcn.2004.05.003; Peterson CL, 2004, CURR BIOL, V14, pR546, DOI 10.1016/j.cub.2004.07.007; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Prasad SS, 2002, NEUROSCIENCE, V111, P35, DOI 10.1016/S0306-4522(01)00570-X; Prusky GT, 2000, EUR J NEUROSCI, V12, P3781, DOI 10.1046/j.1460-9568.2000.00236.x; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Sananbenesi F, 2002, MOL CELL NEUROSCI, V21, P463, DOI 10.1006/mcne.2002.1188; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schuett S, 2002, J NEUROSCI, V22, P6549; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Suzuki S, 2004, J COMP NEUROL, V479, P70, DOI 10.1002/cne.20310; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Taha S, 2002, NEURON, V34, P425, DOI 10.1016/S0896-6273(02)00673-6; Thomas GM, 2005, P NATL ACAD SCI USA, V102, P15006, DOI 10.1073/pnas.0507476102; Thomson S, 1999, EMBO J, V18, P4779, DOI 10.1093/emboj/18.17.4779; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; Tropea D, 2006, NAT NEUROSCI, V9, P660, DOI 10.1038/nn1689; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wood MA, 2006, LEARN MEMORY, V13, P241, DOI 10.1101/lm.278206; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	75	154	161	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					747	759		10.1016/j.neuron.2007.02.007	http://dx.doi.org/10.1016/j.neuron.2007.02.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329213	Bronze			2022-12-28	WOS:000245127100014
J	Karmarkar, UR; Buonomano, DV				Karmarkar, Urna R.; Buonomano, Dean V.			Timing in the absence of clocks: Encoding time in neural network states	NEURON			English	Article							TEMPORAL INFORMATION; WORKING-MEMORY; REPRESENTATION; DISCRIMINATION; INTERVAL; MECHANISMS; CORTEX; AREA; PERCEPTION; ACTIVATION	Decisions based on the timing of sensory events are fundamental to sensory processing. However, the mechanisms by which the brain measures time over ranges of milliseconds to seconds remain unclear. The dominant model of temporal processing proposes that an oscillator emits events that are integrated to provide a linear metric of time. We examine an alternate model in which cortical networks are inherently able to tell time as a result of time-dependent changes in network state. Using computer simulations we show that within this framework, there is no linear metric of time, and that a given interval is encoded in the context of preceding events. Human psychophysical studies were used to examine the predictions of the model. Our results provide theoretical and experimental evidence that, for short intervals, there is no linear metric of time, and that time may be encoded in the high-dimensional state of local neural networks.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Brain Res, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Buonomano, DV (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA.	dbuono@ucla.edu			NIMH NIH HHS [R01 MH060163, MH60163] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060163] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALLAN LG, 1979, PERCEPT PSYCHOPHYS, V26, P340, DOI 10.3758/BF03204158; Brody CD, 2002, PHILOS T R SOC B, V357, P1843, DOI 10.1098/rstb.2002.1167; Brody CD, 2003, CEREB CORTEX, V13, P1196, DOI 10.1093/cercor/bhg100; Brown SW, 1997, PERCEPT PSYCHOPHYS, V59, P1118, DOI 10.3758/BF03205526; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2005, J NEUROPHYSIOL, V94, P2275, DOI 10.1152/jn.01250.2004; Buonomano DV, 2002, NEUROSCIENTIST, V8, P42, DOI 10.1177/107385840200800109; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; CARR CE, 1993, ANNU REV NEUROSCI, V16, P223, DOI 10.1146/annurev.ne.16.030193.001255; CHURCH RM, 1984, PROPERTIES INTERNAL, V423, P556; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; CREELMAN CD, 1962, J ACOUST SOC AM, V34, P582, DOI 10.1121/1.1918172; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Gibbon J, 1997, CURR OPIN NEUROBIOL, V7, P170, DOI 10.1016/S0959-4388(97)80005-0; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Grondin S, 2003, Q J EXP PSYCHOL-A, V56, P731, DOI 10.1080/02724980244000611; GRONDIN S, 1991, PERCEPT PSYCHOPHYS, V49, P245, DOI 10.3758/BF03214309; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; HICKS RE, 1976, AM J PSYCHOL, V89, P719, DOI 10.2307/1421469; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; Ivry RB, 2004, CURR OPIN NEUROBIOL, V14, P225, DOI 10.1016/j.conb.2004.03.013; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Karmarkar UR, 2003, LEARN MEMORY, V10, P141, DOI 10.1101/lm.55503; Kilgard MP, 2002, P NATL ACAD SCI USA, V99, P3205, DOI 10.1073/pnas.261705198; KRUSEL P, 2004, NEURAL COMPUT, V16, P2079; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Lewis PA, 2003, CURR OPIN NEUROBIOL, V13, P250, DOI 10.1016/S0959-4388(03)00036-9; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; MACAR F, 1994, MEM COGNITION, V22, P673, DOI 10.3758/BF03209252; Macar F, 2002, EXP BRAIN RES, V142, P475, DOI 10.1007/s00221-001-0953-0; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matell MS, 2004, COGNITIVE BRAIN RES, V21, P139, DOI 10.1016/j.cogbrainres.2004.06.012; MAUK MD, 1992, BEHAV NEUROSCI, V106, P666, DOI 10.1037/0735-7044.106.4.666; Mauk MD, 2004, ANNU REV NEUROSCI, V27, P307, DOI 10.1146/annurev.neuro.27.070203.144247; MECK WH, 1984, ANN NY ACAD SCI, V423, P528, DOI 10.1111/j.1749-6632.1984.tb23457.x; Meck WH, 1996, COGNITIVE BRAIN RES, V3, P227, DOI 10.1016/0926-6410(96)00009-2; Medina JF, 2000, NAT NEUROSCI, V3, P1205, DOI 10.1038/81486; Medina JF, 2005, NEURON, V45, P157, DOI 10.1016/j.neuron.2004.12.017; Meegan DV, 2000, NAT NEUROSCI, V3, P860, DOI 10.1038/78757; Miall C, 1989, NEURAL COMPUT, V1, P359, DOI 10.1162/neco.1989.1.3.359; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; Rammsayer T, 2001, PSYCHON B REV, V8, P270, DOI 10.3758/BF03196161; RAMMSAYER TH, 1991, PERCEPT PSYCHOPHYS, V50, P565, DOI 10.3758/BF03207541; Rammsayer TH, 1999, Q J EXP PSYCHOL-B, V52, P273; Rao SM, 2001, NAT NEUROSCI, V4, P317, DOI 10.1038/85191; Reutimann J, 2004, J NEUROSCI, V24, P3295, DOI 10.1523/JNEUROSCI.4098-03.2004; Reyes A, 1999, J NEUROSCI, V19, P3827; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; TREISMAN M, 1963, PSYCHOL MONOGR, V77, P1, DOI 10.1037/h0093864; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; Wright BA, 1997, J NEUROSCI, V17, P3956; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004; ZAKAY D, 1989, B PSYCHONOMIC SOC, V27, P209, DOI 10.3758/BF03334586; Zhang ZW, 2004, J NEUROPHYSIOL, V91, P1171, DOI 10.1152/jn.00855.2003; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	66	352	358	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					427	438		10.1016/j.neuron.2007.01.006	http://dx.doi.org/10.1016/j.neuron.2007.01.006			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	149DI	17270738	Bronze, Green Accepted			2022-12-28	WOS:000245126800012
J	Edenfeld, G; Volohonsky, G; Krukkert, K; Naffin, E; Lammel, U; Grimm, A; Engelen, D; Reuveny, A; Volk, T; Klambt, C				Edenfeld, Gundula; Volohonsky, Gloria; Krukkert, Karin; Naffin, Elke; Lammel, Uwe; Grimm, Alexandra; Engelen, Daniel; Reuveny, Adriana; Volk, Talila; Klaembt, Christian			The splicing factor crooked neck associates with the RNA-binding protein HOW to control glial cell maturation in Drosophila	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; TRANSMEMBRANE PROTEIN; SIGNAL-TRANSDUCTION; CYCLE PROGRESSION; HNRNPA/B HOMOLOG; 2 ISOFORMS; GENE; QUAKING; SPLICEOSOME; ENCODES	In both vertebrates and invertebrates, glial cells wrap axonal processes to ensure electrical conductance. Here we report that Crooked neck (Crn), the Drosophila homolog of the yeast Clf1p splicing factor, is directing peripheral glial cell maturation. We show that crooked neck is expressed and required in glial cells to control migration and axonal wrapping. Within the cytoplasm, Crn interacts with the RNA-binding protein HOW and then translocates to the nucleus where the Crn/HOW complex controls glial differentiation by facilitating splicing of specific target genes. By using a GFP-exon trap approach, we identified some of the in vivo target genes that encode proteins localized in autocellular septate junctions. In conclusion, here we show that glial cell differentiation is controlled by a cytoplasmic assembly of splicing components, which upon translocation to the nucleus promote the splicing of genes involved in the assembly of cellular junctions.	Univ Munster, Inst Neurobiol, D-48149 Munster, Germany; Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	University of Munster; Weizmann Institute of Science	Klambt, C (corresponding author), Univ Munster, Inst Neurobiol, D-48149 Munster, Germany.	klaembt@uni-muenster.de						AULD VJ, 1995, CELL, V81, P757, DOI 10.1016/0092-8674(95)90537-5; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Banerjee S, 2006, J NEUROSCI, V26, P3319, DOI 10.1523/JNEUROSCI.5383-05.2006; Ben-Yehuda S, 2000, GENETICS, V156, P1503; Ben-Yehuda S, 2000, GENETICS, V154, P61; Bogdan S, 2005, NAT CELL BIOL, V7, P977, DOI 10.1038/ncb1305; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodu V, 2004, DEV CELL, V7, P885, DOI 10.1016/j.devcel.2004.10.016; Burnette JM, 1999, GENETICS, V151, P1517; Carlson SD, 2000, ANNU REV ENTOMOL, V45, P151, DOI 10.1146/annurev.ento.45.1.151; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chung SY, 1999, RNA, V5, P1042, DOI 10.1017/S1355838299990635; Chung SY, 2002, BBA-GENE STRUCT EXPR, V1576, P287, DOI 10.1016/S0167-4781(02)00368-8; Cox RD, 1999, GENOMICS, V57, P333, DOI 10.1006/geno.1999.5804; Davis AD, 1999, NATURE, V398, P571, DOI 10.1038/19212; Ebersole TA, 1996, NAT GENET, V12, P260, DOI 10.1038/ng0396-260; EDENFELD E, 2006, IN PRESS DEVC BIOL; Edenfeld G, 2005, CURR OPIN NEUROBIOL, V15, P34, DOI 10.1016/j.conb.2005.01.007; Freeman MR, 2006, TRENDS NEUROSCI, V29, P82, DOI 10.1016/j.tins.2005.12.002; Gasch A, 2006, J BIOL CHEM, V281, P356, DOI 10.1074/jbc.M508047200; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; GRANDERATH S, 1999, GLIAL CELL DEVEL, P245; Hardy RJ, 1998, J NEUROSCI RES, V51, P417, DOI 10.1002/(SICI)1097-4547(19980215)51:4<417::AID-JNR1>3.0.CO;2-F; Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004; Hummel T, 1999, DEVELOPMENT, V126, P771; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; ITO K, 1995, ROUX ARCH DEV BIOL, V204, P284, DOI 10.1007/BF02179499; Jones BW, 2005, DEV BIOL, V278, P265, DOI 10.1016/j.ydbio.2004.11.022; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; Lemke G, 2001, ANNU REV NEUROSCI, V24, P87, DOI 10.1146/annurev.neuro.24.1.87; Lenz PH, 2000, J COMP PHYSIOL A, V186, P337, DOI 10.1007/s003590050434; Lo PCH, 1997, DEV BIOL, V190, P241, DOI 10.1006/dbio.1997.8699; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matter N, 2002, NATURE, V420, P691, DOI 10.1038/nature01153; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nabel-Rosen H, 2005, CURR BIOL, V15, P295, DOI 10.1016/j.cub.2005.01.045; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Ohi MD, 2002, RNA, V8, P798, DOI 10.1017/S1355838202025050; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Pielage J, 2004, DEV BIOL, V275, P245, DOI 10.1016/j.ydbio.2004.07.039; POZZOLI U, 2005, CELL MOL LIFE SCI, P62; Raisin-Tani S, 2002, BIOCHEM BIOPH RES CO, V296, P288, DOI 10.1016/S0006-291X(02)00863-X; Russell CS, 2000, RNA, V6, P1565, DOI 10.1017/S1355838200000984; Schwabe T, 2005, CELL, V123, P133, DOI 10.1016/j.cell.2005.08.037; Sepp KJ, 2003, J NEUROSCI, V23, P8221; Sepp KJ, 2000, GLIA, V30, P122, DOI 10.1002/(SICI)1098-1136(200004)30:2<122::AID-GLIA2>3.0.CO;2-B; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; SIDMAN RL, 1964, SCIENCE, V144, P309, DOI 10.1126/science.144.3616.309; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Stollewerk A, 1996, MICROSC RES TECHNIQ, V35, P294, DOI 10.1002/(SICI)1097-0029(19961015)35:3&lt;294::AID-JEMT8&gt;3.0.CO;2-N; Stollewerk A, 1997, DEV GENES EVOL, V207, P402, DOI 10.1007/s004270050129; TEPASS U, 1994, DEVELOPMENT, V120, P579; Van de Bor V, 2002, CURR OPIN GENET DEV, V12, P465, DOI 10.1016/S0959-437X(02)00327-1; Vernet C, 1997, TRENDS GENET, V13, P479, DOI 10.1016/S0168-9525(97)01269-9; VOLOHONSKY G, 2007, IN PRESS DEVELOPMENT; Wang Q, 2003, J BIOL CHEM, V278, P7875, DOI 10.1074/jbc.M210839200; Weatherby TM, 2000, J COMP PHYSIOL A, V186, P347, DOI 10.1007/s003590050435; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Yano T, 2004, DEV CELL, V6, P637, DOI 10.1016/S1534-5807(04)00132-7; Zaffran S, 1997, DEVELOPMENT, V124, P2087; ZHANG K, 1991, GENE DEV, V5, P1080, DOI 10.1101/gad.5.6.1080; Zhu WG, 2002, GENETICS, V160, P1319	71	49	50	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					969	980		10.1016/j.neuron.2006.10.029	http://dx.doi.org/10.1016/j.neuron.2006.10.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178401	Bronze			2022-12-28	WOS:000243115100006
J	Priel, A; Selak, S; Lerma, J; Stern-Bach, Y				Priel, Avi; Selak, Sanja; Lerma, Juan; Stern-Bach, Yael			Block of kainate receptor desensitization uncovers a key trafficking checkpoint	NEURON			English	Article							LIGAND-BINDING CORE; AMINO-ACID-RESIDUES; GLUTAMATE-RECEPTOR; ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; CRYSTAL-STRUCTURES; REDUCES DESENSITIZATION; MOLECULAR-MECHANISMS; SURFACE EXPRESSION; AMPA RECEPTORS	A prominent feature of ionotropic glutamate receptors from the AMPA and kainate subtypes is their profound desensitization in response to glutamate-a process thought to protect the neuron from overexcitation. In AMPA receptors, it is well established that desensitization results from rearrangements of the interface formed between agonist-binding domains of adjacent subunits; however, it is unclear how this mechanism applies to kainate receptors. Here we show that stabilization of the binding domain dimer by the generation of intermolecular disulfide bonds apparently blocked desensitization of the kainate receptor GluR6. This result establishes a common desensitization mechanism in both AMPA and kainate receptors. Surprisingly, however, surface expression of these nondesensitizing mutants was drastically reduced and did not depend on channel activity. Therefore, in addition to its role at the synapse, we now propose an intracellular role for desensitization in controlling maturation and trafficking of glutamate receptors.	Hebrew Univ Jerusalem, Hadassah Dent Sch, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel; UMH, CSIC, Inst Neurosci Alicante, Alacant 03550, Spain	Hebrew University of Jerusalem; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche	Stern-Bach, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Dent Sch, Inst Basic Dent Sci, IL-91120 Jerusalem, Israel.	yaelb@cc.huji.ac.il	Priel, Avi/ABB-1721-2020; Lerma, Juan/G-7907-2015	Priel, Avi/0000-0002-6105-5035; Lerma, Juan/0000-0001-7838-5199				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Erreger Kevin, 2004, Critical Reviews in Neurobiology, V16, P187; Fleck MW, 2003, J NEUROSCI, V23, P1219; Frandsen A, 2003, NEUROCHEM RES, V28, P1495, DOI 10.1023/A:1025666207754; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Holm MM, 2005, J BIOL CHEM, V280, P35469, DOI 10.1074/jbc.M507800200; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; Jin RS, 2005, J NEUROSCI, V25, P9027, DOI 10.1523/JNEUROSCI.2567-05.2005; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Lerma J, 2006, CURR OPIN PHARMACOL, V6, P89, DOI 10.1016/j.coph.2005.08.004; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; MAYER ML, 1989, P NATL ACAD SCI USA, V86, P1411, DOI 10.1073/pnas.86.4.1411; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; Nanao MH, 2005, P NATL ACAD SCI USA, V102, P1708, DOI 10.1073/pnas.0409573102; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Ratnam J, 2005, J NEUROCHEM, V92, P878, DOI 10.1111/j.1471-4159.2004.02936.x; Ren Z, 2003, J NEUROSCI, V23, P6608; Robert A, 2002, NEUROSCIENCE, V115, P1199, DOI 10.1016/S0306-4522(02)00534-1; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Selak S, 2006, NEUROSCIENCE, V143, P953, DOI 10.1016/j.neuroscience.2006.10.014; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; Trombetta ES, 2003, ANNU REV CELL DEV BI, V19, P649, DOI 10.1146/annurev.cellbio.19.110701.153949; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vandenberghe W, 2004, CURR OPIN CELL BIOL, V16, P134, DOI 10.1016/j.ceb.2004.01.003; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Yan S, 2004, J NEUROSCI, V24, P679, DOI 10.1523/JNEUROSCI.4985-03.2004; Zhang YH, 2006, J NEUROSCI, V26, P10033, DOI 10.1523/JNEUROSCI.2750-06.2006	48	51	52	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1037	1046		10.1016/j.neuron.2006.12.006	http://dx.doi.org/10.1016/j.neuron.2006.12.006			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178406	Bronze			2022-12-28	WOS:000243115100011
J	Park, M; Salgado, JM; Ostroff, L; Helton, TD; Robinson, CG; Harris, KM; Ehlers, MD				Park, Mikyoung; Salgado, Jennifer M.; Ostroff, Linnaea; Helton, Thomas D.; Robinson, Camenzind G.; Harris, Kristen M.; Ehlers, Michael D.			Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes	NEURON			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTORS; MEMBRANE; DYNAMICS; MORPHOGENESIS; LTP; ORGANIZATION; MODULATION; ACTIVATION; INDUCTION	Dendritic spines are micron-sized membrane protrusions receiving most excitatory synaptic inputs in the mammalian brain. Spines form and grow during long-term potentiation (LTP) of synaptic strength. However, the source of membrane for spine formation and enlargement is unknown. Here we report that membrane trafficking from recycling endosomes is required for the growth and maintenance of spines. Using live-cell imaging and serial section electron microscopy, we demonstrate that LTP-inducing stimuli promote the mobilization of recycling endosomes and vesicles into spines. Preventing recycling endosomal transport abolishes LTP-induced spine formation. Using a pH-sensitive recycling cargo, we show that exocytosis from recycling endosomes occurs locally in spines, is triggered by activation of synaptic NMDA receptors, and occurs concurrently with spine enlargement. Thus, recycling endosomes provide membrane for activity-dependent spine growth and remodeling, defining a novel membrane trafficking mechanism for spine morphological plasticity and providing a mechanistic link between structural and functional plasticity during LTP.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Med Coll Georgia, Dept Neurol, Synapses & Cognit Neurosci Ctr, Augusta, GA 30912 USA; Univ Texas, Neurobiol Sect, Ctr Learning & Memory, Austin, TX 78712 USA	Duke University; Duke University; Howard Hughes Medical Institute; University System of Georgia; Augusta University; University of Texas System; University of Texas Austin	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	Robinson, Camenzind G/O-5097-2018	Robinson, Camenzind G/0000-0002-7277-692X; Harris, Kristen/0000-0002-1943-4744; Ostroff, Linnaea/0000-0002-3348-342X	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002170] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021184, R37NS021184, R01NS047574, R01NS033574, R23NS021184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024492] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG024492, R01 AG024492-03, AG024492, R01 AG024492-02, R01 AG024492-01] Funding Source: Medline; NIBIB NIH HHS [R01 EB002170, EB002170] Funding Source: Medline; NIMH NIH HHS [R01 MH064748, R01 MH064748-05, R01 MH064748-01, R01 MH064748-03, R01 MH064748-04, R01 MH064748-02, MH064748] Funding Source: Medline; NINDS NIH HHS [R01 NS021184, R37 NS021184, NS33574, R01 NS047574-01A2, R01 NS047574, NS21184, R01 NS033574] Funding Source: Medline	NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bivona TG, 2003, CURR OPIN CELL BIOL, V15, P136, DOI 10.1016/S0955-0674(03)00016-4; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Calabrese B, 2005, NEURON, V48, P77, DOI 10.1016/j.neuron.2005.08.027; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HOPKINS CR, 1994, J CELL BIOL, V125, P1265, DOI 10.1083/jcb.125.6.1265; Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005; Karcher RL, 2001, SCIENCE, V293, P1317, DOI 10.1126/science.1061086; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Khvotchev MV, 2003, J NEUROSCI, V23, P10531; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin SX, 2001, NAT CELL BIOL, V3, P567, DOI 10.1038/35078543; LISMAN JE, 1993, TRENDS NEUROSCI, V16, P141, DOI 10.1016/0166-2236(93)90122-3; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6803; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Merrifield CJ, 2005, CELL, V121, P593, DOI 10.1016/j.cell.2005.03.015; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Osterweil E, 2005, J CELL BIOL, V168, P329, DOI 10.1083/jcb.200410091; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Prekeris R, 1999, J NEUROSCI, V19, P10324; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Skop AR, 2001, CURR BIOL, V11, P735, DOI 10.1016/S0960-9822(01)00231-7; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Sun W, 2003, J CELL BIOL, V162, P125, DOI 10.1083/jcb.200302083; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Terry-Lorenzo RT, 2005, MOL BIOL CELL, V16, P2349, DOI 10.1091/mbc.E04-12-1054; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2001, J NEUROSCI, V21, P6245, DOI 10.1523/JNEUROSCI.21-16-06245.2001; Triller A, 2005, TRENDS NEUROSCI, V28, P133, DOI 10.1016/j.tins.2005.01.001; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541	48	369	380	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					817	830		10.1016/j.neuron.2006.09.040	http://dx.doi.org/10.1016/j.neuron.2006.09.040			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145503	Green Accepted, Bronze			2022-12-28	WOS:000242856400010
J	Cota, D; Barrera, JG; Seeley, RJ				Cota, Daniela; Barrera, Jason G.; Seeley, Randy J.			Leptin in energy balance and reward: Two faces of the same coin?	NEURON			English	Editorial Material							DOPAMINE; BEHAVIOR; OBESITY; INSULIN; MICE; CNS		Univ Cincinnati, Dept Psychiat, Cincinnati, OH 45237 USA	University System of Ohio; University of Cincinnati	Cota, D (corresponding author), Univ Cincinnati, Dept Psychiat, 2170 E Galbraith Rd, Cincinnati, OH 45237 USA.			Seeley, Randy/0000-0002-3721-5625; Cota, Daniela/0000-0002-6909-2156				Cota D, 2006, BRAIN RES REV, V51, P85, DOI 10.1016/j.brainresrev.2005.10.004; Davis C, 2004, APPETITE, V42, P131, DOI 10.1016/j.appet.2003.07.004; Figlewicz DP, 2003, BRAIN RES, V964, P107, DOI 10.1016/S0006-8993(02)04087-8; Figlewicz DP, 2003, AM J PHYSIOL-REG I, V284, pR882, DOI 10.1152/ajpregu.00602.2002; Fulton S, 2000, SCIENCE, V287, P125, DOI 10.1126/science.287.5450.125; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Hommel JD, 2006, NEURON, V51, P801, DOI 10.1016/j.neuron.2006.08.023; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Kelley AE, 2004, NEUROSCI BIOBEHAV R, V27, P765, DOI 10.1016/j.neubiorev.2003.11.015; Saper CB, 2002, NEURON, V36, P199, DOI 10.1016/S0896-6273(02)00969-8; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Szczypka MS, 2000, NAT GENET, V25, P102, DOI 10.1038/75484; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; Volkow ND, 2005, NAT NEUROSCI, V8, P555, DOI 10.1038/nn1452; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6	16	36	37	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					678	680		10.1016/j.neuron.2006.09.009	http://dx.doi.org/10.1016/j.neuron.2006.09.009			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982412	Bronze			2022-12-28	WOS:000240997900005
J	Alger, BE				Alger, Bradley E.			Not too excited? Thank your endocannabinoids	NEURON			English	Editorial Material							ENDOGENOUS CANNABINOIDS; SYNAPSES; SYSTEM; CELLS	Endocannabinoids can mediate neuroprotection, but it is not known how. In this issue of Neuron, Monory et al. use mutant mice and localized viral targeting to produce conditional knockouts of the cannabinoid CB1 receptor. They show that protection against kainic acid-induced seizures and cell death is conferred by CB1Rs on hippocampal glutamatergic nerve terminals.	Univ Maryland, Sch Med, Neurosci Program, Dept Physiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Neurosci Program, Dept Psychiat, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Alger, BE (corresponding author), Univ Maryland, Sch Med, Neurosci Program, Dept Physiol, 655 W Baltimore St, Baltimore, MD 21201 USA.							Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Edwards DA, 2006, J NEUROPHYSIOL, V95, P67, DOI 10.1152/jn.00813.2005; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Katona I, 2006, J NEUROSCI, V26, P5628, DOI 10.1523/JNEUROSCI.0309-06.2006; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mechoulam R, 2003, SCIENCE, V302, P65, DOI 10.1126/science.1091256; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Ohno-Shosaku T, 2002, J NEUROSCI, V22, P3864, DOI 10.1523/JNEUROSCI.22-10-03864.2002; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Ratzliff ADH, 2002, TRENDS NEUROSCI, V25, P140, DOI 10.1016/S0166-2236(00)02122-6; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015	12	9	27	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 17	2006	51	4					393	395		10.1016/j.neuron.2006.08.003	http://dx.doi.org/10.1016/j.neuron.2006.08.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908404	Bronze			2022-12-28	WOS:000240504700002
J	Frenkel, MY; Sawtell, NB; Diogo, ACM; Yoon, BJ; Neve, RL; Bear, MF				Frenkel, Mikhail Y.; Sawtell, Nathaniel B.; Diogo, Antonia Cinira M.; Yoon, Bongjune; Neve, Rachael L.; Bear, Mark F.			Instructive effect of visual experience in mouse visual cortex	NEURON			English	Article							OCULAR DOMINANCE PLASTICITY; DRIVING AMPA RECEPTORS; LONG-TERM POTENTIATION; ORIENTATION SELECTIVITY; MONOCULAR DEPRIVATION; OBLIQUE CONTOURS; SYNAPSES; NEURONS; REPRESENTATION; TRANSMISSION	We describe a form of experience-dependent response enhancement in the visual cortex of awake mice. Repeated presentations of grating stimuli of a single orientation result in a persistent enhancement of responses evoked by the test stimulus. Response potentiation is specific to the orientation of the test stimulus, develops gradually over the course of several training sessions, and occurs in both juvenile and adult mice. The stimulus-selective response potentiation (SRP) can mask deprivation-induced response depression in adult mice. SRP requires NMDA receptor activation and is prevented by viral delivery of a peptide that interferes with AMPA receptor trafficking. SRP may reveal the mechanisms involved in certain forms of perceptual learning.	MIT, Picower Inst Learning & Mem, Cambridge, MA 02139 USA; Oregon Hlth Sci Univ, Inst Neurol Sci, Beaverton, OR 97006 USA; Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; McLean Hosp, Belmont, MA 02478 USA	Massachusetts Institute of Technology (MIT); Oregon Health & Science University; Universidade Federal do Rio de Janeiro; Harvard University; McLean Hospital	Bear, MF (corresponding author), MIT, Picower Inst Learning & Mem, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbear@mit.edu	Yoon, Bong June/L-7126-2017	Bear, Mark/0000-0002-9903-2541				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; Carlezon WA, 2003, METH MOLEC MED, V79, P331; Chapman B, 1999, J NEUROBIOL, V41, P18, DOI 10.1002/(SICI)1097-4695(199910)41:1<18::AID-NEU4>3.0.CO;2-V; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Davis S, 1997, J NEUROSCI METH, V75, P75, DOI 10.1016/S0165-0270(97)00053-8; DRAGER UC, 1975, J COMP NEUROL, V160, P269, DOI 10.1002/cne.901600302; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2004, CURR OPIN NEUROBIOL, V14, P513, DOI 10.1016/j.conb.2004.07.003; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Karni A, 1997, CURR OPIN NEUROBIOL, V7, P530, DOI 10.1016/S0959-4388(97)80033-5; Logothetis NK, 2003, J NEUROSCI, V23, P3963; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MITZDORF U, 1985, PHYSIOL REV, V65, P37, DOI 10.1152/physrev.1985.65.1.37; Porciatti V, 1999, VISUAL NEUROSCI, V16, P721, DOI 10.1017/S0952523899164113; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; RUDERMAN DL, 1994, NETWORK-COMP NEURAL, V5, P517, DOI 10.1088/0954-898X/5/4/006; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SHERK H, 1976, J NEUROPHYSIOL, V39, P63, DOI 10.1152/jn.1976.39.1.63; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Wang G, 2003, NEUROSCI LETT, V338, P77, DOI 10.1016/S0304-3940(02)01355-1; WIESEL TN, 1974, J COMP NEUROL, V158, P307, DOI 10.1002/cne.901580306	39	197	201	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					339	349		10.1016/j.neuron.2006.06.026	http://dx.doi.org/10.1016/j.neuron.2006.06.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880128	Bronze			2022-12-28	WOS:000239908800009
J	Morris, RGM; Inglis, J; Ainge, JA; Olverman, HJ; Tulloch, J; Dudai, Y; Kelly, PAT				Morris, Richard G. M.; Inglis, Jennifer; Ainge, James A.; Olverman, Henry J.; Tulloch, Jane; Dudai, Yadin; Kelly, Paul A. T.			Memory reconsolidation: Sensitivity of spatial memory to inhibition of protein synthesis in dorsal hippocampus during encoding and retrieval	NEURON			English	Article							TASTE-AVERSION; CONSOLIDATION; EXTINCTION; TRACE; NEUROBIOLOGY; INFORMATION; MECHANISMS; REMINDER; REQUIRE	Reconsolidation is a putative neuronal process in which the retrieval of a previously consolidated memory returns it to a labile state that is once again subject to stabilization. This study explored the idea that reconsolidation occurs in spatial memory when animals retrieve memory under circumstances in which new memory encoding is likely to occur. Control studies confirmed that intrahippocampal infusions of anisomycin inhibited protein synthesis locally and that the spatial training protocols we used are subject to overnight protein synthesis-dependent consolidation. We then compared the impact of anisomycin in two conditions: when memory retrieval occurred in a reference memory task after performance had reached asymptote over several days; and after a comparable extent of training of a delayed matching-to-place task in which new memory encoding was required each day. Sensitivity to intrahippocampal anisomycin was observed only in the protocol involving new memory encoding at the time of retrieval.	Univ Edinburgh, Labs Cognit Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Univ Edinburgh, Cerebral Neuropharmacol Ctr Cognit & Neural Syst, Edinburgh EH8 9JZ, Midlothian, Scotland; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	University of Edinburgh; University of Edinburgh; Weizmann Institute of Science	Morris, RGM (corresponding author), Univ Edinburgh, Labs Cognit Neurosci, 1 George Sq, Edinburgh EH8 9JZ, Midlothian, Scotland.	r.g.m.morris@ed.ac.uk	Ainge, James A/D-5831-2012; Morris, Richard G M/C-9982-2013; Kelly, Paul AT/A-1663-2008	Ainge, James A/0000-0002-0007-1533; MORRIS, Richard G M/0000-0001-8661-1520	MRC [G9200370] Funding Source: UKRI; Medical Research Council [G9200370] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Anokhin KV, 2002, EUR J NEUROSCI, V15, P1759, DOI 10.1046/j.1460-9568.2002.02023.x; Bahar A, 2004, EUR J NEUROSCI, V19, P1115, DOI 10.1111/j.0953-816X.2004.03215.x; Berman DE, 2003, LEARN MEMORY, V10, P16, DOI 10.1101/lm.53703; de Hoz L, 2005, EUR J NEUROSCI, V22, P745, DOI 10.1111/j.1460-9568.2005.04255.x; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Lattal KM, 2004, P NATL ACAD SCI USA, V101, P4667, DOI 10.1073/pnas.0306546101; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Litvin O O, 2000, Neurosci Behav Physiol, V30, P671, DOI 10.1023/A:1026698700139; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Nader K, 2005, TRENDS NEUROSCI, V28, P346, DOI 10.1016/j.tins.2005.04.011; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; PANAKHOVA E, 1984, INT J PSYCHOPHYSIOL, V2, P5, DOI 10.1016/0167-8760(84)90066-7; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rodriguez-Ortiz CJ, 2005, LEARN MEMORY, V12, P533, DOI 10.1101/lm.94505; Runyan JD, 2005, HIPPOCAMPUS, V15, P333, DOI 10.1002/hipo.20055; Sara SJ, 2000, NAT REV NEUROSCI, V1, P212, DOI 10.1038/35044575; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; SMITH CB, 1991, NEUROCHEM RES, V16, P1037, DOI 10.1007/BF00965848; Spooner R I, 1994, Learn Mem, V1, P203; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Tronel S, 2005, PLOS BIOL, V3, P1630, DOI 10.1371/journal.pbio.0030293; von Hertzen LSJ, 2005, J NEUROSCI, V25, P1935, DOI 10.1523/JNEUROSCI.4707-04.2005	46	258	261	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					479	489		10.1016/j.neuron.2006.04.012	http://dx.doi.org/10.1016/j.neuron.2006.04.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	045FA	16675401	Bronze			2022-12-28	WOS:000237726800016
J	Turrigiano, G				Turrigiano, G			Maintaining your youthful spontaneity: Microcircuit homeostasis in the embryonic spinal cord	NEURON			English	Editorial Material							REFINEMENT	Many developing networks generate spontaneous network activity (SNA) that plays an important role in setting up functional circuitry, but how the proper level and pattern of SNA is itself maintained has not been clear. In this issue of Neuron, Gonzalez-Islas and Wenner show that SNA in the intact embryo regulates itself through a set of adaptive homeostatic plasticity mechanisms.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Ctr Behav Genom, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Turrigiano, G (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.							Cang JH, 2005, NEURON, V48, P797, DOI 10.1016/j.neuron.2005.09.015; Chub N, 1998, J NEUROSCI, V18, P294; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Marder E, 2005, CURR OPIN NEUROBIOL, V15, P86, DOI 10.1016/j.conb.2005.01.011; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Soto-Trevino C, 2001, NAT NEUROSCI, V4, P297, DOI 10.1038/85147; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002	13	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					481	483		10.1016/j.neuron.2006.01.029	http://dx.doi.org/10.1016/j.neuron.2006.01.029			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476657	Bronze			2022-12-28	WOS:000235643800001
J	Lerchner, W; Xiao, C; Nashmi, R; Slimko, EM; van Trigt, L; Lester, HA; Anderson, DJ				Lerchner, Walter; Xiao, Cheng; Nashmi, Raad; Slimko, Eric M.; van Trigt, Laurent; Lester, Henry A.; Anderson, David J.			Reversible silencing of neuronal excitability in behaving mice by a genetically targeted, ivermectin-gated Cl- channel	NEURON			English	Article							MAMMALIAN NEURONS; IN-VIVO; STRIATAL NEURONS; EXPRESSION; RAT; SYSTEM; DROSOPHILA; RECEPTOR; INACTIVATION; SUPPRESSION	Several genetic strategies for inhibiting neuronal function in mice have been described, but no system that directly suppresses membrane excitability and is triggered by a systemically administered drug, has been validated in awake behaving animals. We expressed unilaterally in mouse striatum a modified heteromeric ivermectin (IVM)-gated chloride channel from C. elegans (GluCl alpha beta), systemically administered IVM, and then assessed amphetamine-induced rotational behavior. Rotation was observed as early as 4 hr after a single intraperitoneal IVM injection (10 mg/kg), reached maximal levels by 12 hr, and was almost fully reversed by 4 days. Multiple cycles of silencing and recovery could be performed in a single animal. In striatal slice preparations from GluCl alpha beta-expressing animals, IVM rapidly suppressed spiking. The two-subunit GluCl/IVM system permits "intersectional" strategies designed to increase the cellular specificity of silencing in transgenic animals.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	wuwei@caltech.edu	Xiao, Cheng/O-5696-2015	Xiao, Cheng/0000-0001-9649-7450; Nashmi, Raad/0000-0001-6596-2620; Lerchner, Walter/0000-0003-0842-4409	NIMH NIH HHS [MH-67867] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH067867] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; Berke JD, 2004, NEURON, V43, P883, DOI 10.1016/j.neuron.2004.08.035; Burdett EC, 1997, CONTEMP TOP LAB ANIM, V36, P73; Callaway EM, 2005, TRENDS NEUROSCI, V28, P196, DOI 10.1016/j.tins.2005.01.007; CHABALA JC, 1980, J MED CHEM, V23, P1134, DOI 10.1021/jm00184a014; Conole J, 2003, CONTEMP TOP LAB ANIM, V42, P42; Davis JA, 1999, LAB ANIM SCI, V49, P288; Dawson GR, 2000, J PHARMACOL EXP THER, V295, P1051; Deisseroth K, 2006, J NEUROSCI, V26, P10380, DOI 10.1523/JNEUROSCI.3863-06.2006; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Heintz N, 2004, NAT NEUROSCI, V7, P483, DOI 10.1038/nn0504-483; Ibanez-Tallon I, 2004, NEURON, V43, P305, DOI 10.1016/j.neuron.2004.07.015; JIANG ZG, 1991, J PHYSIOL-LONDON, V443, P533, DOI 10.1113/jphysiol.1991.sp018850; Johns DC, 1999, J NEUROSCI, V19, P1691; Karpova AY, 2005, NEURON, V48, P727, DOI 10.1016/j.neuron.2005.11.015; Kirik D, 1998, EXP NEUROL, V152, P259, DOI 10.1006/exnr.1998.6848; Lechner HAE, 2002, J NEUROSCI, V22, P5287; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; OBERLANDER C, 1983, J PHARMACOL-PARIS, V14, P401; Olds ME, 2006, SYNAPSE, V59, P532, DOI 10.1002/syn.20270; Roder Joseph D., 1998, Veterinary and Human Toxicology, V40, P369; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Schinkel AH, 1996, J CLIN INVEST, V97, P2517, DOI 10.1172/JCI118699; SCHWARCZ R, 1979, BRAIN RES, V170, P485, DOI 10.1016/0006-8993(79)90966-1; Slimko EM, 2003, J NEUROSCI METH, V124, P75, DOI 10.1016/S0165-0270(02)00362-X; Slimko EM, 2002, J NEUROSCI, V22, P7373; Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018; Thum AS, 2006, J COMP NEUROL, V498, P194, DOI 10.1002/cne.21022; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P69; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Willis GL, 2004, REV NEUROSCIENCE, V15, P75; Wilson C.J., 1998, SYNAPTIC ORG BRAIN, P329; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Ye JH, 2006, J NEUROSCI METH, V158, P251, DOI 10.1016/j.jneumeth.2006.06.006; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zhang X, 2001, HISTOCHEM CELL BIOL, V115, P455	42	132	137	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					35	49		10.1016/j.neuron.2007.02.030	http://dx.doi.org/10.1016/j.neuron.2007.02.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408576	Bronze			2022-12-28	WOS:000245848400008
J	Gabrieli, JDE; Whitfield-Gabrieli, S				Gabrieli, John D. E.; Whitfield-Gabrieli, Susan			Attention to neglect	NEURON			English	Editorial Material							UNILATERAL NEGLECT	Patients with spatial neglect fail to attend to stimuli in the contralesional visual world. He et al. used fMRI to reveal how disrupted functional connectivity, independent of task-evoked activation, in ventral and dorsal attentional networks may explain behavioral impairment in neglect and recovery from acute neglect.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Gabrieli, JDE (corresponding author), MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.	gabrieli@mit.edu	Gabrieli, John/AAJ-2869-2020					BEHRMANN M, 1994, ATTENTION PERFORM, V15, P351; BISIACH E, 1978, CORTEX, V14, P129, DOI 10.1016/S0010-9452(78)80016-1; Corbetta M, 2005, NAT NEUROSCI, V8, P1603, DOI 10.1038/nn1574; Fox MD, 2006, P NATL ACAD SCI USA, V103, P10046, DOI 10.1073/pnas.0604187103; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Karnath HO, 2001, NATURE, V411, P950, DOI 10.1038/35082075; POSNER MI, 1984, J NEUROSCI, V4, P1863; Vuilleumier P, 2001, P NATL ACAD SCI USA, V98, P3495, DOI 10.1073/pnas.051436898	8	4	5	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 15	2007	53	6					776	777		10.1016/j.neuron.2007.03.002	http://dx.doi.org/10.1016/j.neuron.2007.03.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359913	Bronze			2022-12-28	WOS:000245292800003
J	Jiang, X; Bradley, E; Rini, RA; Zeffiro, T; VanMeter, J; Riesenhuber, M				Jiang, Xiong; Bradley, Evan; Rini, Regina A.; Zeffiro, Thomas; VanMeter, John; Riesenhuber, Maximilian			Categorization training results in shape- and category-selective human neural plasticity	NEURON			English	Article							EVENT-RELATED FMRI; VISUAL CATEGORIZATION; TASK-DIFFICULTY; ATTENTION; AREA; DISCRIMINATION; REPRESENTATION; MECHANISMS; EXPERIENCE; NEURONS	Object category learning is a fundamental ability, requiring the combination of "bottom-up" stimulus-driven with "top-down" task-specific information. It therefore may be a fruitful domain for study of the general neural mechanisms underlying cortical plasticity. A simple model predicts that category learning involves the formation of a task-independent shape-selective representation that provides input to circuits learning the categorization task, with the computationally appealing prediction of facilitated learning of additional, novel tasks over the same stimuli. Using fMRI rapid-adaptation techniques, we find that categorization training (on morphed "cars") induced a significant release from adaptation for small shape changes in lateral occipital cortex irrespective of category membership, compatible with the sharpening of a representation coding for physical appearance. In contrast, an area in lateral prefrontal cortex, selectively activated during categorization, showed sensitivity posttraining to explicit changes in category membership. Further supporting the model, categorization training also improved discrimination performance on the trained stimuli.	Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; Massachusetts Gen Hosp, Neural Syst Grp, Charlestown, MA 02129 USA; Georgetown Univ, Med Ctr, Ctr Funct & Mol Imaging, Washington, DC 20007 USA	Georgetown University; Harvard University; Massachusetts General Hospital; Georgetown University	Riesenhuber, M (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	mr287@georgetown.edu	Zeffiro, Thomas/AAE-3441-2019; Bradley, Evan D/H-9037-2012; VanMeter, John W/D-2589-2018	Zeffiro, Thomas/0000-0002-0846-4577; Bradley, Evan D/0000-0001-6887-671X; VanMeter, John W/0000-0002-7012-5197; Riesenhuber, Maximilian/0000-0002-5744-0408	NCRR NIH HHS [M01 RR020359] Funding Source: Medline; NICHD NIH HHS [P30 HD40677, P30 HD040677] Funding Source: Medline; NIMH NIH HHS [R01 MH076281, P20 MH066239-04, R01 MH076281-02, R01MH076281, P20 MH066239, P20MH66239] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD040677] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR020359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076281, P20MH066239] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aizenstein HJ, 2000, J COGNITIVE NEUROSCI, V12, P977, DOI 10.1162/08989290051137512; Ashby F Gregory, 2004, Behav Cogn Neurosci Rev, V3, P101, DOI 10.1177/1534582304270782; Buracas GT, 2002, NEUROIMAGE, V16, P801, DOI 10.1006/nimg.2002.1116; Fang F, 2007, CEREB CORTEX, V17, P1402, DOI 10.1093/cercor/bhl053; Freedman DJ, 2006, CEREB CORTEX, V16, P1631, DOI 10.1093/cercor/bhj100; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Freedman DJ, 2003, J NEUROSCI, V23, P5235; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Gerlach C, 1999, BRAIN, V122, P2159, DOI 10.1093/brain/122.11.2159; Gilaie-Dotan S, 2007, CEREB CORTEX, V17, P325, DOI 10.1093/cercor/bhj150; Grady CL, 1996, HUM BRAIN MAPP, V4, P227, DOI 10.1002/(SICI)1097-0193(1996)4:4<227::AID-HBM1>3.0.CO;2-5; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2003, CURR OPIN NEUROBIOL, V13, P159, DOI 10.1016/S0959-4388(03)00040-0; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kourtzi Z, 2005, PLOS BIOL, V3, P1317, DOI 10.1371/journal.pbio.0030204; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Little DM, 2006, BRAIN COGNITION, V60, P244, DOI 10.1016/j.bandc.2005.09.016; Little DM, 2005, COGNITIVE BRAIN RES, V25, P33, DOI 10.1016/j.cogbrainres.2005.04.015; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miyashita Y, 1998, CR ACAD SCI III-VIE, V321, P185, DOI 10.1016/S0764-4469(97)89820-4; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Murray SO, 2004, NAT NEUROSCI, V7, P70, DOI 10.1038/nn1161; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; Op de Beeck H, 2001, NAT NEUROSCI, V4, P1244, DOI 10.1038/nn767; Op de Beeck HP, 2006, J NEUROSCI, V26, P13025, DOI 10.1523/JNEUROSCI.2481-06.2006; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pollmann S, 2005, NAT NEUROSCI, V8, P1494, DOI 10.1038/nn1552; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; Rhodes G, 2004, J COGNITIVE NEUROSCI, V16, P189, DOI 10.1162/089892904322984508; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Shelton CR, 2000, INT J COMPUT VISION, V38, P75, DOI 10.1023/A:1008170818506; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sigala N, 2004, BEHAV BRAIN RES, V149, P1, DOI 10.1016/S0166-4328(03)00224-9; Sunaert S, 2000, NEUROIMAGE, V11, P612, DOI 10.1006/nimg.2000.0587; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; Thomas E, 2001, J COGNITIVE NEUROSCI, V13, P190, DOI 10.1162/089892901564252; Vogels R, 2002, NEUROIMAGE, V16, P401, DOI 10.1006/nimg.2002.1109; Yue XM, 2006, VISION RES, V46, P3802, DOI 10.1016/j.visres.2006.06.017	48	196	200	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					891	903		10.1016/j.neuron.2007.02.015	http://dx.doi.org/10.1016/j.neuron.2007.02.015			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	151LV	17359923	Bronze, Green Accepted			2022-12-28	WOS:000245292800013
J	Schlack, A; Albright, TD				Schlack, Anja; Albright, Thomas D.			Remembering visual motion: Neural correlates of associative plasticity and motion recall in cortical area MT	NEURON			English	Article							LONG-TERM-MEMORY; PSYCHOPHYSICAL EVIDENCE; STIMULUS ASSOCIATIONS; PERCEPTION; IMAGERY; MACAQUE; REPRESENTATION; NEURONS; OBJECTS; CORTEX	The pictorial content of visual memories recalled by association is embodied by neuronal activity at the highest processing stages of primate visual cortex. This activity is elicited by top-down signals from the frontal lobe and recapitulates the bottom-up pattern normally obtained by the recalled stimulus. To explore the generality and mechanisms of this phenomenon, we recorded motion-sensitive neurons at an early stage of cortical processing. After monkeys learned to associate directions of motion with static shapes, these neurons exhibited unprecedented selectivity for the shapes. This emergent shape selectivity reflects activation of neurons representing the motion stimuli recalled by association, and it suggests that recall-related activity may be a general feature of neurons in visual cortex.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Schlack, A (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA.	anja@salk.edu; tom@salk.edu						Albright T D, 1993, Rev Oculomot Res, V5, P177; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BALL K, 1980, PSYCHOL REV, V87, P435, DOI 10.1037/0033-295X.87.5.435; BARLOW H, 1990, VISION RES, V30, P1561, DOI 10.1016/0042-6989(90)90144-A; BARTLESON CJ, 1960, J OPT SOC AM, V50, P73, DOI 10.1364/JOSA.50.000073; Batschelet E., 1981, CIRCULAR STAT BIOL; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BRNSWIK E, 1956, PERCEPTION REPRESENT; BRUNER JS, 1951, AM J PSYCHOL, V64, P216, DOI 10.2307/1418668; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; DAVIES P, 1982, PERCEPTION, V11, P663, DOI 10.1068/p110663; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Erickson CA, 1999, J NEUROSCI, V19, P10404; FARAH MJ, 1985, J EXP PSYCHOL GEN, V114, P91, DOI 10.1037/0096-3445.114.1.91; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FREYD JJ, 1987, PSYCHOL REV, V94, P427, DOI 10.1037/0033-295X.94.4.427; GAFFAN D, 1983, Q J EXP PSYCHOL-B, V35, P149, DOI 10.1080/14640748308400901; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HEBB DO, 1968, PSYCHOL REV, V75, P466, DOI 10.1037/h0026771; HERING E, 1978, LEHRE LICHTSINNE; HURLBERT AC, 2005, J VIS, V5, pA787; Ishai A, 1997, J COGNITIVE NEUROSCI, V9, P734, DOI 10.1162/jocn.1997.9.6.734; ISHAI A, 1995, SCIENCE, V268, P1772, DOI 10.1126/science.7792605; Ishai A, 1997, J COGNITIVE NEUROSCI, V9, P476, DOI 10.1162/jocn.1997.9.4.476; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; James W., 1910, PRINCIPLES PSYCHOL; Kersten D, 2004, ANNU REV PSYCHOL, V55, P271, DOI 10.1146/annurev.psych.55.090902.142005; Knill DC, 1996, PERCEPTION BAYESIAN; Kosslyn S. M., 1994, IMAGE BRAIN; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Krauzlis RJ, 1996, J NEUROPHYSIOL, V76, P2822, DOI 10.1152/jn.1996.76.5.2822; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Mast FW, 2001, PERCEPTION, V30, P945, DOI 10.1068/p3088; Messinger A, 2005, NEURON, V48, P359, DOI 10.1016/j.neuron.2005.08.035; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1993, ANNU REV NEUROSCI, V16, P245, DOI 10.1146/annurev.ne.16.030193.001333; NEWSOME WT, 1988, J NEUROPHYSIOL, V60, P604, DOI 10.1152/jn.1988.60.2.604; Qi HJ, 2006, P NATL ACAD SCI USA, V103, P483, DOI 10.1073/pnas.0506728103; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P281, DOI 10.1016/0166-2236(94)90057-4; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shulman GL, 1999, J NEUROSCI, V19, P9480; SIPLE P, 1983, PERCEPT PSYCHOPHYS, V34, P363, DOI 10.3758/BF03203049; Thiele A, 1999, J NEUROSCI, V19, P6571; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Van Wezel RJA, 2002, NEUROSCIENCE, V111, P739, DOI 10.1016/S0306-4522(02)00036-2; von Helmholtz H., 1924, HELMHOLTZS TREATISE	49	69	69	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					881	890		10.1016/j.neuron.2007.02.028	http://dx.doi.org/10.1016/j.neuron.2007.02.028			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	151LV	17359922	Bronze			2022-12-28	WOS:000245292800012
J	Ihara, M; Yamasaki, N; Hagiwara, A; Tanigaki, A; Kitano, A; Hikawa, R; Tomimoto, H; Noda, M; Masashi, T; Mori, H; Hattori, N; Miyakawa, T; Kinoshita, M				Ihara, Masafumi; Yamasaki, Nobuyuki; Hagiwara, Akari; Tanigaki, Ai; Kitano, Ayumi; Hikawa, Rie; Tomimoto, Hidekazu; Noda, Makoto; Takanashi, Masashi; Mori, Hideo; Hattori, Nobutaka; Miyakawa, Tsuyoshi; Kinoshita, Makoto			Sept4, a component of presynaptic scaffold and Lewy bodies, is required for the suppression of alpha-synuclein neurotoxicity	NEURON			English	Article							PARKINSONS-DISEASE; NEUROTRANSMITTER RELEASE; MAMMALIAN SEPTIN; MICE LACKING; DOPAMINE; CDCREL-1; PROTEIN; NEURODEGENERATION; BINDING; BRAIN	In Parkinson disease (PID), alpha-synuclein aggregates called Lewy bodies often involve and sequester Septin4 (Sept4), a polymerizing scaffold protein. However, the pathophysiological significance of this phenomenon is unclear. Here, we show the physiological association of Sept4 with alpha-synuclein, the dopamine transporter, and other presynaptic proteins in dopaminergic neurons; mice lacking Sept4 exhibit diminished dopaminergic neurotransmission due to scarcity of these presynaptic proteins. These data demonstrate an important role for septin scaffolds in the brain. In transgenic mice that express human alpha-synuclein(A53T) (a mutant protein responsible for familial PD), loss of Sept4 significantly enhances neuropathology and locomotor deterioration. In this PID model, insoluble deposits of Ser(129)-phosphorylated alpha-synuclein(A53T) are negatively correlated with the dosage of Sept4. In vitro, direct association with Sept4 protects alpha-synuclein against self-aggregation and Ser(129) phosphorylation. Taken together, these data show that Sept4 may be involved in PID as a dual susceptibility factor, as its insufficiency can diminish dopaminergic neurotransmission and enhance alpha-synuclein neurotoxicity.	Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, HMRO, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Genet Engn & Funct Genom Unit, HMRO, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Neurol, HMRO, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Med, Dept Mol Oncol, HMRO, Kyoto 6068501, Japan; Juntendo Univ, Sch Med, Dept Neurol, Tokyo 1138431, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Juntendo University; Japan Science & Technology Agency (JST)	Ihara, M (corresponding author), Kyoto Univ, Grad Sch Med, Biochem & Cell Biol Unit, HMRO, Kyoto 6068501, Japan.	ihara@kuhp.kyoto-u.ac.jp; mkinoshita@hmro.med.kyoto-u.ac.jp	Hattori, Nobutaka/ACR-0069-2022; Ihara, Masafumi/O-5020-2019; Miyakawa, Tsuyoshi/A-7741-2008	Ihara, Masafumi/0000-0002-7102-4048; Miyakawa, Tsuyoshi/0000-0003-0137-8200; KINOSHITA, MAKOTO/0000-0002-7592-2400				Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Dong ZZ, 2003, P NATL ACAD SCI USA, V100, P12438, DOI 10.1073/pnas.2132992100; Field CM, 1999, TRENDS CELL BIOL, V9, P387, DOI 10.1016/S0962-8924(99)01632-3; FUJISHIMA K, 2007, IN PRESS J NEUROCHEM; Fujiwara H, 2002, NAT CELL BIOL, V4, P160, DOI 10.1038/ncb748; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Hall PA, 2005, J PATHOL, V206, P269, DOI 10.1002/path.1789; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Ihara M, 2005, DEV CELL, V8, P343, DOI 10.1016/j.devcel.2004.12.005; Ihara M, 2003, J BIOL CHEM, V278, P24095, DOI 10.1074/jbc.M301352200; Kahle PJ, 2001, AM J PATHOL, V159, P2215, DOI 10.1016/S0002-9440(10)63072-6; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2002, DEV CELL, V3, P791, DOI 10.1016/S1534-5807(02)00366-0; Kinoshita M, 1997, GENE DEV, V11, P1535, DOI 10.1101/gad.11.12.1535; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; Lee FJS, 2001, FASEB J, V15, P916, DOI 10.1096/fj.00-0334com; Lee KH, 2004, NEUROCHEM RES, V29, P1405, DOI 10.1023/B:NERE.0000026404.08779.43; Masuda M, 2006, FEBS LETT, V580, P1775, DOI 10.1016/j.febslet.2006.02.032; Miyakawa T, 2001, J NEUROSCI, V21, P5239, DOI 10.1523/JNEUROSCI.21-14-05239.2001; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Peng XR, 2002, MOL CELL BIOL, V22, P378, DOI 10.1128/MCB.22.1.378-387.2002; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Son JH, 2005, J NEUROCHEM, V94, P1040, DOI 10.1111/j.1471-4159.2005.03257.x; Spiliotis ET, 2005, SCIENCE, V307, P1781, DOI 10.1126/science.1106823; STARKE K, 1989, PHYSIOL REV, V69, P864, DOI 10.1152/physrev.1989.69.3.864; Surka MC, 2002, MOL BIOL CELL, V13, P3532, DOI 10.1091/mbc.E02-01-0042; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Zhang JH, 2000, PSYCHOPHARMACOLOGY, V149, P181, DOI 10.1007/s002130000369; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797	43	130	137	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					519	533		10.1016/j.neuron.2007.01.019	http://dx.doi.org/10.1016/j.neuron.2007.01.019			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296554	Bronze			2022-12-28	WOS:000245126900011
J	Huesmann, GR; Clayton, DF				Huesmann, Graham R.; Clayton, David F.			Dynamic role of postsynaptic caspase-3 and BIRC4 in zebra finch song-response habituation	NEURON			English	Article							SYNAPTIC PLASTICITY; LINKED INHIBITOR; GENE-EXPRESSION; MOUSE-BRAIN; ACTIVATION; MEMORY; APOPTOSIS; PATHWAYS; CLEAVAGE; CALPAIN	Activation of the protease caspase-3 is commonly thought to cause apoptotic cell death. Here, we show that caspase-3 activity is regulated at postsynaptic sites in brain following stimuli associated with memory (neural activation and subsequent response habituation) instead of cell death. In the zebra finch auditory forebrain, the concentration of caspase-3 active sites increases briefly within minutes after exposure to tape-recorded birdsong. With confocal and immuno-electron microscopy, we localize the activated enzyme to dendritic spines. The activated caspase-3 protein is present even in unstimulated brain but bound to an endogenous inhibitor, BIRC4 (xIAP), suggesting a mechanism for rapid release and sequestering at specific synaptic sites. Caspase-3 activity is necessary to consolidate a persistent physiological trace of the song stimulus, as demonstrated using pharmacological interference and the zenk gene habituation assay. Thus, the brain appears to have adapted a core component of cell death machinery to serve a unique role in learning and memory.	Univ Illinois, Dept Cell & Dev Biol, Neurosci Program, Urbana, IL 61801 USA; Univ Illinois, Beckman Inst, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Clayton, DF (corresponding author), Univ Illinois, Dept Cell & Dev Biol, Neurosci Program, 405 N Mathews Ave, Urbana, IL 61801 USA.	dclayton@uiuc.edu	Clayton, David/B-2190-2008; Huesmann, Graham/L-6819-2019	Clayton, David/0000-0002-6395-3488; 	NIMH NIH HHS [R01 MH052086, R01 MH52086] Funding Source: Medline; NINDS NIH HHS [R01 NS045264, 1 F30 NS45379-01A2, F30 NS045379, R01 NS051820] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051820, F30NS045379, R01NS045264] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Afford S, 2000, J CLIN PATHOL-MOL PA, V53, P55, DOI 10.1136/mp.53.2.55; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; Boehning D, 2003, NAT CELL BIOL, V5, P1051, DOI 10.1038/ncb1063; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chang HY, 2000, MICROBIOL MOL BIOL R, V64, P821, DOI 10.1128/MMBR.64.4.821-846.2000; Chen J, 1998, J NEUROSCI, V18, P4914; Cheng HY, 2004, J NEUROSCI, V24, P7503, DOI 10.1523/JNEUROSCI.1405-04.2004; CHEW SJ, 1995, P NATL ACAD SCI USA, V92, P3406, DOI 10.1073/pnas.92.8.3406; Chew SJ, 1996, P NATL ACAD SCI USA, V93, P1950, DOI 10.1073/pnas.93.5.1950; Clayton DF, 2000, NEUROBIOL LEARN MEM, V74, P185, DOI 10.1006/nlme.2000.3967; CLAYTON DF, 2006, IN PRESS HDB NEUROCH, V21; Dash PK, 2000, NEUROREPORT, V11, P2811, DOI 10.1097/00001756-200008210-00040; Davoli MA, 2002, NEUROSCIENCE, V115, P125, DOI 10.1016/S0306-4522(02)00376-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Faleiro L, 1997, EMBO J, V16, P2271, DOI 10.1093/emboj/16.9.2271; Ferrer I, 2003, J NEUROPATH EXP NEUR, V62, P329, DOI 10.1093/jnen/62.4.329; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Gemma C, 2005, EUR J NEUROSCI, V22, P1751, DOI 10.1111/j.1460-9568.2005.04334.x; Glazner GW, 2000, J NEUROSCI, V20, P3641, DOI 10.1523/JNEUROSCI.20-10-03641.2000; Gulyaeva NV, 2003, J NEUROSCI RES, V73, P853, DOI 10.1002/jnr.10730; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Huang YH, 2003, J BIOL CHEM, V278, P49517, DOI 10.1074/jbc.M310061200; Keane RW, 1997, J NEUROSCI RES, V48, P168, DOI 10.1002/(SICI)1097-4547(19970415)48:2<168::AID-JNR9>3.0.CO;2-A; Korhonen L, 2004, EXP CELL RES, V295, P290, DOI 10.1016/j.yexcr.2003.12.026; Kruse AA, 2000, NEUROBIOL LEARN MEM, V74, P179, DOI 10.1006/nlme.2000.3968; Kruse AA, 2004, NEUROBIOL LEARN MEM, V82, P99, DOI 10.1016/j.nlm.2004.05.001; Kudryashov I E, 2004, Neurosci Behav Physiol, V34, P877, DOI 10.1023/B:NEAB.0000042571.86110.28; Lu CB, 2002, NEUROMOL MED, V1, P69; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Mattson MP, 1999, J NEUROSCI RES, V58, P152, DOI 10.1002/(SICI)1097-4547(19991001)58:1<152::AID-JNR15>3.0.CO;2-V; Mattson MP, 2003, NAT CELL BIOL, V5, P1041, DOI 10.1038/ncb1203-1041; Mattson MP, 2001, APOPTOSIS, V6, P69, DOI 10.1023/A:1009676112184; Mattson MP, 1998, EXP NEUROL, V153, P35, DOI 10.1006/exnr.1998.6863; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 2002, J COMP PHYSIOL A, V188, P943, DOI 10.1007/s00359-002-0347-1; Mello CV, 1998, J COMP NEUROL, V393, P426, DOI 10.1002/(SICI)1096-9861(19980420)393:4<426::AID-CNE3>3.0.CO;2-2; MELLO CV, 1994, J NEUROSCI, V14, P6652; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Millin PM, 2001, NAT REV NEUROSCI, V2, P68, DOI 10.1038/35049075; Namura S, 1998, J NEUROSCI, V18, P3659; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Saito A, 2003, J CEREBR BLOOD F MET, V23, P1010, DOI 10.1097/01.WCB.0000080702.47016.FF; Slagsvold HH, 2003, BRAIN RES, V984, P111, DOI 10.1016/S0006-8993(03)03119-6; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; Stepanichev MY, 2005, NEUROSCIENCE, V136, P579, DOI 10.1016/j.neuroscience.2005.08.010; Stoddard Philip Kraft, 1996, P356; Stripling R, 2003, NEUROBIOL LEARN MEM, V79, P41, DOI 10.1016/S1074-7427(02)00005-9; Stripling R, 1997, J NEUROSCI, V17, P3883; Stripling R, 2001, J NEUROBIOL, V48, P163, DOI 10.1002/neu.1049; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Wain HM, 2004, NUCLEIC ACIDS RES, V32, pD255, DOI 10.1093/nar/gkh072; Wain HM, 2002, NUCLEIC ACIDS RES, V30, P169, DOI 10.1093/nar/30.1.169; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Zhuang SG, 1999, EXP CELL RES, V250, P203, DOI 10.1006/excr.1999.4501	60	94	100	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1061	1072		10.1016/j.neuron.2006.10.033	http://dx.doi.org/10.1016/j.neuron.2006.10.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178408	Green Accepted, Bronze			2022-12-28	WOS:000243115100013
J	Sarkisian, MR; Bartley, CM; Chi, H; Nakamura, F; Hashimoto-Torii, K; Torii, M; Flavell, RA; Rakic, P				Sarkisian, Matthew R.; Bartley, Christopher M.; Chi, Hongbo; Nakamura, Fumihiko; Hashimoto-Torii, Kazue; Torii, Masaaki; Flavell, Richard A.; Rakic, Pasko			MEKK4 signaling regulates filamin expression and neuronal migration	NEURON			English	Article							PERIVENTRICULAR NODULAR HETEROTOPIA; KINASE KINASE KINASE; STRESS-INDUCED ACTIVATION; CELL-MIGRATION; RADIAL MIGRATION; MOUSE EMBRYO; RNA INTERFERENCE; CEREBRAL-CORTEX; JNK PATHWAY; ANNEXIN-II	Periventricular heterotopia (PVH) is a congenital malformation of human cerebral cortex frequently associated with Filamin-A (FLN-A) mutations but the pathogenetic mechanisms remain unclear. Here, we show that the MEKK4 (MAP3K4) pathway is involved in Fln-A regulation and PVH formation. MEKK4(-/-)mice developed PVH associated with breaches in the neuroependymal lining which were largely comprised of neurons that failed to reach the cortical plate. RNA interference (RNAi) targeting MEKK4 also impaired neuronal migration. Expression of Fin was elevated in MEKK4(-/-) forebrain, most notably near sites of failed neuronal migration. Importantly, recombinant MKK4 protein precipitated a complex containing MEKK4 and Fln-A, and MKK4 mediated signaling between MEKK4 and Fln-A, suggesting that MKK4 may bridge these molecules during development. Finally, we showed that wild-type FLN-A overexpression inhibited neuronal migration. Collectively, our results demonstrate a link between MEKK4 and Fln-A that impacts neuronal migration initiation and provides insight into the pathogenesis of human PVH.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA; Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med,Hematol Div, Boston, MA 02115 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA.	pasko.rakic@yale.edu	Chi, Hongbo/M-9397-2018; Bartley, Christopher/G-4226-2012; Nakamura, Fumihiko/N-5476-2016	Chi, Hongbo/0000-0002-9997-2496; Nakamura, Fumihiko/0000-0002-6872-4246; Bartley, Christopher/0000-0002-1391-4130	NEI NIH HHS [R01 EY002593] Funding Source: Medline; NIA NIH HHS [R01 AG019394] Funding Source: Medline; NIGMS NIH HHS [T32 GM007205] Funding Source: Medline; NINDS NIH HHS [R01 NS038296, R01 NS014841] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002593] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038296, R01NS014841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019394] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abell AN, 2005, MOL CELL BIOL, V25, P8948, DOI 10.1128/MCB.25.20.8948-8959.2005; Bachmann AS, 2006, CANCER SCI, V97, P1359, DOI 10.1111/j.1349-7006.2006.00327.x; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Bielas S, 2004, ANNU REV CELL DEV BI, V20, P593, DOI 10.1146/annurev.cellbio.20.082503.103047; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chan-Hui PY, 1998, BIOCHEM J, V336, P599, DOI 10.1042/bj3360599; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chi HB, 2005, P NATL ACAD SCI USA, V102, P3846, DOI 10.1073/pnas.0500026102; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; D'Addario M, 2002, J BIOL CHEM, V277, P47541, DOI 10.1074/jbc.M207681200; Derbyshire ZE, 2005, MOL CELL BIOCHEM, V271, P77, DOI 10.1007/s11010-005-5386-9; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Feng YY, 2001, NAT REV NEUROSCI, V2, P408, DOI 10.1038/35077559; Fox JW, 1998, NEURON, V21, P1315, DOI 10.1016/S0896-6273(00)80651-0; Garcia E, 2006, ARCH BIOCHEM BIOPHYS, V446, P140, DOI 10.1016/j.abb.2005.12.006; Gdalyahu A, 2004, EMBO J, V23, P823, DOI 10.1038/sj.emboj.7600079; Gerwins P, 1997, J BIOL CHEM, V272, P8288, DOI 10.1074/jbc.272.13.8288; Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5; Gloster A, 1999, J COMP NEUROL, V405, P45, DOI 10.1002/(SICI)1096-9861(19990301)405:1<45::AID-CNE4>3.0.CO;2-M; Goetsch SC, 2005, STEM CELLS DEV, V14, P181, DOI 10.1089/scd.2005.14.181; Halfter UM, 2005, BIOCHEM J, V388, P17, DOI 10.1042/BJ20041236; Hart AW, 2006, HUM MOL GENET, V15, P2457, DOI 10.1093/hmg/ddl168; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Hirai S, 2005, GENE EXPR PATTERNS, V5, P517, DOI 10.1016/j.modgep.2004.12.002; Hirai S, 2002, DEVELOPMENT, V129, P4483; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Johnson GL, 2005, CURR OPIN CHEM BIOL, V9, P325, DOI 10.1016/j.cbpa.2005.04.004; Kakita A, 2002, ACTA NEUROPATHOL, V104, P649, DOI 10.1007/s00401-002-0594-9; Kaufman MH, 1995, ATLAS MOUSE DEV; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kuan CY, 2000, TRENDS NEUROSCI, V23, P291, DOI 10.1016/S0166-2236(00)01581-2; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Lu J, 2006, J COMP NEUROL, V494, P476, DOI 10.1002/cne.20806; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Marti A, 1997, J BIOL CHEM, V272, P2620, DOI 10.1074/jbc.272.5.2620; Moore SA, 2002, NATURE, V418, P422, DOI 10.1038/nature00838; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Nagano T, 2004, J NEUROSCI, V24, P9648, DOI 10.1523/JNEUROSCI.2363-04.2004; Nagano T, 2002, NAT CELL BIOL, V4, P495, DOI 10.1038/ncb808; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Niewmierzycka A, 2005, J NEUROSCI, V25, P7022, DOI 10.1523/JNEUROSCI.1695-05.2005; Powell SK, 1997, INT J BIOCHEM CELL B, V29, P401, DOI 10.1016/S1357-2725(96)00110-0; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1988, PROG BRAIN RES, V73, P15; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Robertson SP, 2003, NAT GENET, V33, P487, DOI 10.1038/ng1119; Sato Makoto, 2005, Anatomical Science International, V80, P19; Schmid RS, 2004, DEVELOPMENT, V131, P6023, DOI 10.1242/dev.01532; Scott MGH, 2006, MOL CELL BIOL, V26, P3432, DOI 10.1128/MCB.26.9.3432-3445.2006; Sheen VL, 2005, NEUROLOGY, V64, P254, DOI 10.1212/01.WNL.0000149512.79621.DF; Sheen VL, 2003, NEUROLOGY, V60, P1108, DOI 10.1212/01.WNL.0000055898.00349.02; Sheen VL, 2001, HUM MOL GENET, V10, P1775, DOI 10.1093/hmg/10.17.1775; Sheen VL, 2004, BRAIN DEV-JPN, V26, P326, DOI 10.1016/j.braindev.2003.09.004; Sheen VL, 2003, NEUROLOGY, V60, P1033, DOI 10.1212/01.WNL.0000052689.03214.61; Sheen VL, 2002, HUM MOL GENET, V11, P2845, DOI 10.1093/hmg/11.23.2845; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Takekawa M, 1997, EMBO J, V16, P4973, DOI 10.1093/emboj/16.16.4973; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Woo MS, 2004, MOL CELL BIOL, V24, P3025, DOI 10.1128/MCB.24.7.3025-3035.2004; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yuzyuk T, 2003, MOL BIOL CELL, V14, P3013, DOI 10.1091/mbc.E02-11-0747; Zenker M, 2004, AM J HUM GENET, V74, P731, DOI 10.1086/383094; Zhou CJ, 2004, J NEUROSCI, V24, P121, DOI 10.1523/JNEUROSCI.4071-03.2004	70	95	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					789	801		10.1016/j.neuron.2006.10.024	http://dx.doi.org/10.1016/j.neuron.2006.10.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145501	Bronze, Green Accepted			2022-12-28	WOS:000242856400008
J	Wu, GY; Li, PY; Tao, HZW; Zhang, LI				Wu, Guangying K.; Li, Pingyang; Tao, Huizhong W.; Zhang, Li I.			Nonmonotonic synaptic excitation and imbalanced inhibition underlying cortical intensity tuning	NEURON			English	Article							PRIMARY AUDITORY-CORTEX; MEDIAL GENICULATE-BODY; INFERIOR COLLICULUS; POSTERIOR FIELD; SINGLE NEURONS; RESPONSE PROPERTIES; TONAL STIMULATION; PYRAMIDAL NEURONS; RECEPTIVE-FIELDS; COCHLEAR NUCLEUS	Intensity-tuned neurons, characterized by their nonmonotonic response-level function, may play important roles in the encoding of sound intensity-related information. The synaptic mechanisms underlying intensity tuning remain unclear. Here, in vivo whole-cell recordings in rat auditory cortex revealed that intensity-tuned neurons, mostly clustered in a posterior zone, receive imbalanced tone-evoked excitatory and inhibitory synaptic inputs. Excitatory inputs exhibit nonmonotonic intensity tuning, whereas with tone intensity increments, the temporally delayed inhibitory inputs increase monotonically in strength. In addition, this delay reduces with the increase of intensity, resulting in an enhanced suppression of excitation at high intensities and a significant sharpening of intensity tuning. In contrast, non-intensity-tuned neurons exhibit covaried excitatory and inhibitory inputs, and the relative time interval between them is stable with intensity increments, resulting in monotonic response-level function. Thus, cortical intensity tuning is primarily determined by excitatory inputs and shaped by cortical inhibition through a dynamic control of excitatory and inhibitory timing.	Univ So Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA; Univ So Calif, Dept Physiol & Biophys, Keck Sch Med, Los Angeles, CA 90033 USA; Univ So Calif, Dept Ophthalmol, Keck Sch Med, Los Angeles, CA 90033 USA; Univ So Calif, Grad Program Neurosci, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Zhang, LI (corresponding author), Univ So Calif, Zilkha Neurogenet Inst, Keck Sch Med, Los Angeles, CA 90033 USA.	liizhang@usc.edu	Wu, Guangying/E-8117-2010; Tao, Huizhong W/HDM-9767-2022; Li, Ping/GYV-4914-2022	Wu, Guangying/0000-0002-7243-5412	NIDCD NIH HHS [R01 DC008983, R03 DC006814] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC006814, R01DC008983] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		AITKIN L, 1991, J NEUROPHYSIOL, V65, P383, DOI 10.1152/jn.1991.65.2.383; AITKIN LM, 1972, J NEUROPHYSIOL, V35, P365, DOI 10.1152/jn.1972.35.3.365; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Bao SW, 2003, J NEUROSCI, V23, P10765; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Brudzynski SM, 2002, J COMP PSYCHOL, V116, P73, DOI 10.1037//0735-7036.116.1.73; BRUDZYNSKI SM, 1993, PHYSIOL BEHAV, V54, P215, DOI 10.1016/0031-9384(93)90102-L; BRUGGE JF, 1969, J NEUROPHYSIOL, V32, P1005, DOI 10.1152/jn.1969.32.6.1005; CALFORD MB, 1995, J NEUROPHYSIOL, V73, P1876, DOI 10.1152/jn.1995.73.5.1876; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; ERULKAR SD, 1956, B JOHNS HOPKINS HOSP, V99, P55; EVANS EF, 1964, J PHYSIOL-LONDON, V171, P476, DOI 10.1113/jphysiol.1964.sp007391; FAINGOLD CL, 1991, HEARING RES, V52, P201, DOI 10.1016/0378-5955(91)90200-S; GREENWOOD DD, 1965, J NEUROPHYSIOL, V28, P863, DOI 10.1152/jn.1965.28.5.863; Hashimoto H, 2004, EXP ANIM TOKYO, V53, P409, DOI 10.1538/expanim.53.409; Heil P, 1998, CEREB CORTEX, V8, P125, DOI 10.1093/cercor/8.2.125; HEIL P, 1994, HEARING RES, V76, P188, DOI 10.1016/0378-5955(94)90099-X; Heil P, 2004, CURR OPIN NEUROBIOL, V14, P461, DOI 10.1016/j.conb.2004.07.002; Kalatsky VA, 2005, P NATL ACAD SCI USA, V102, P13325, DOI 10.1073/pnas.0505592102; KALTWASSER MT, 1990, J COMP PSYCHOL, V104, P227, DOI 10.1037/0735-7036.104.3.227; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kiang NYS, 1965, DISCHARGE PATTERNS S; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kitzes LM, 1996, HEARING RES, V100, P120, DOI 10.1016/0378-5955(96)00103-7; KUWABARA N, 1993, J NEUROPHYSIOL, V69, P1713, DOI 10.1152/jn.1993.69.5.1713; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Miller KD, 2001, CURR OPIN NEUROBIOL, V11, P488, DOI 10.1016/S0959-4388(00)00239-7; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; PHILLIPS DP, 1989, HEARING RES, V37, P269, DOI 10.1016/0378-5955(89)90027-0; PHILLIPS DP, 1995, J NEUROPHYSIOL, V73, P674, DOI 10.1152/jn.1995.73.2.674; PHILLIPS DP, 1984, J NEUROPHYSIOL, V51, P147, DOI 10.1152/jn.1984.51.1.147; POLLAK GD, 1993, HEARING RES, V65, P99, DOI 10.1016/0378-5955(93)90205-F; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Read HL, 2002, CURR OPIN NEUROBIOL, V12, P433, DOI 10.1016/S0959-4388(02)00342-2; ROUILLER E, 1983, HEARING RES, V11, P235, DOI 10.1016/0378-5955(83)90081-3; Sales GD, 1974, ULTRASONIC COMMUNICA; SCHREINER CE, 1992, EXP BRAIN RES, V92, P105; SHAMMA SA, 1985, J ACOUST SOC AM, V78, P1622, DOI 10.1121/1.392800; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Sivaramakrishnan S, 2004, J NEUROSCI, V24, P5031, DOI 10.1523/JNEUROSCI.0357-04.2004; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; Sutter ML, 2003, J NEUROPHYSIOL, V90, P2629, DOI 10.1152/jn.00722.2002; SUTTER ML, 1995, J NEUROPHYSIOL, V73, P190, DOI 10.1152/jn.1995.73.1.190; TAN AY, 2006, ARXIVQBIONC0607036; Tan AYY, 2004, J NEUROPHYSIOL, V92, P630, DOI 10.1152/jn.01020.2003; Wang JA, 2002, BRAIN RES, V944, P219, DOI 10.1016/S0006-8993(02)02926-8; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; YOUNG ED, 1976, J NEUROPHYSIOL, V39, P282, DOI 10.1152/jn.1976.39.2.282; Zhang LI, 2001, NAT NEUROSCI, V4, P1123, DOI 10.1038/nn745; Zhang LI, 2003, NATURE, V424, P201, DOI 10.1038/nature01796; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	58	112	117	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					705	715		10.1016/j.neuron.2006.10.009	http://dx.doi.org/10.1016/j.neuron.2006.10.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114053	Bronze, Green Accepted			2022-12-28	WOS:000242413100016
J	Blake, DT; Heiser, MA; Caywood, M; Merzenich, MM				Blake, David T.; Heiser, Marc A.; Caywood, Matthew; Merzenich, Michael M.			Experience-dependent adult cortical plasticity requires cognitive association between sensation and reward	NEURON			English	Article							PRIMARY AUDITORY-CORTEX; OWL MONKEYS; CEREBRAL-CORTEX; AREA 3B; SOMATOSENSORY CORTEX; DISCRIMINATION TASK; HAND REPRESENTATION; TACTILE STIMULATION; RESPONSE PROPERTIES; MAP REORGANIZATION	We tested the involvement of cognition in adult experience-dependent neuroplasticity using primate cortical implants. In a prior study, learning an operant sensory discrimination increased cortical excitability and target selectivity. Here, the prior task was separated into three behavioral phases. First, naive animals were exposed to stimulus-reward pairings from the prior study. These yoked animals did not have to discriminate to be rewarded and did not learn the discrimination. The plasticity observed in the prior study did not occur. Second, the animals were classically conditioned to discriminate the same stimuli in a simplified format. Learning was accompanied by increased sensory response strength and an increased range of sensory inputs eliciting responses. The third study recreated the original operant discrimination, and selectivity for task targets increased. These studies demonstrate that cognitive association between sensory stimuli and reinforcers accompanies adult experience-dependent cortical plasticity and suggest that selectivity in representation and action are linked.	Med Coll Georgia, Dept Neurol, Ctr Synapses & Cognit Neurosci, Augusta, GA 30912 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, Dept Otolaryngol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University System of Georgia; Augusta University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blake, DT (corresponding author), Med Coll Georgia, Dept Neurol, Ctr Synapses & Cognit Neurosci, Augusta, GA 30912 USA.	dblake@mcg.edu			NIDCD NIH HHS [R03 DC005708-01A1, 5R03DC005708, R03 DC005708, R03 DC005708-03, R03 DC005708-02] Funding Source: Medline; NINDS NIH HHS [5R01NS010413] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC005708] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ALLARD T, 1991, J NEUROPHYSIOL, V66, P1048, DOI 10.1152/jn.1991.66.3.1048; ASTONJONES G, 1994, J NEUROSCI, V14, P4467; Bakin JS, 1996, BEHAV NEUROSCI, V110, P905, DOI 10.1037/0735-7044.110.5.905; Bakin JS, 1996, P NATL ACAD SCI USA, V93, P11219, DOI 10.1073/pnas.93.20.11219; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Beitel RE, 2003, P NATL ACAD SCI USA, V100, P11070, DOI 10.1073/pnas.1334187100; Blake DT, 2005, J NEUROPHYSIOL, V94, P2239, DOI 10.1152/jn.00172.2005; Blake DT, 2002, J NEUROPHYSIOL, V88, P3409, DOI 10.1152/jn.00233.2002; Blake DT, 2002, P NATL ACAD SCI USA, V99, P10114, DOI 10.1073/pnas.092278099; Blake DT, 2002, BEHAV BRAIN RES, V135, P179, DOI 10.1016/S0166-4328(02)00163-8; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Efron B, 1998, INTRO BOOTSTRAP; Fritz JB, 2005, J NEUROSCI, V25, P7623, DOI 10.1523/JNEUROSCI.1318-05.2005; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Galvan VV, 2002, NEUROBIOL LEARN MEM, V77, P78, DOI 10.1006/nlme.2001.4044; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Hernandez A, 2000, P NATL ACAD SCI USA, V97, P6191, DOI 10.1073/pnas.120018597; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; IMIG TJ, 1977, J COMP NEUROL, V171, P111, DOI 10.1002/cne.901710108; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; McDonough R. N., 2004, DETECTION SIGNALS NO; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; MOUNTCASTLE VB, 1966, TOUCH HEAT PAIN, P325; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; Polley DB, 2004, P NATL ACAD SCI USA, V101, P16351, DOI 10.1073/pnas.0407586101; Polley DB, 2006, J NEUROSCI, V26, P4970, DOI 10.1523/JNEUROSCI.3771-05.2006; Raiguel S, 2006, J NEUROSCI, V26, P6589, DOI 10.1523/JNEUROSCI.0457-06.2006; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1071, DOI 10.1152/jn.1992.67.5.1071; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2315, DOI 10.1152/jn.2000.83.4.2315; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Reynolds JH, 1999, NEURON, V24, P19, DOI 10.1016/S0896-6273(00)80819-3; Richardson R T, 1991, Adv Exp Med Biol, V295, P233; Rutkowski RG, 2005, P NATL ACAD SCI USA, V102, P13664, DOI 10.1073/pnas.0506838102; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Suga N, 2003, NAT REV NEUROSCI, V4, P783, DOI 10.1038/nrn1222; TALBOT WH, 1968, J NEUROPHYSIOL, V31, P301, DOI 10.1152/jn.1968.31.2.301; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WANG XQ, 1995, NATURE, V378, P71, DOI 10.1038/378071a0; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264; XERRI C, 1994, J NEUROSCI, V14, P1710, DOI 10.1523/JNEUROSCI.14-03-01710.1994; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	46	105	106	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					371	381		10.1016/j.neuron.2006.08.009	http://dx.doi.org/10.1016/j.neuron.2006.08.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046698	Green Accepted, Bronze			2022-12-28	WOS:000241799900016
J	Lee, I; Griffin, AL; Zilli, EA; Eichenbaum, H; Hasselmo, ME				Lee, Inah; Griffin, Amy L.; Zilli, Eric A.; Eichenbaum, Howard; Hasselmo, Michael E.			Gradual translocation of spatial correlates of neuronal firing in the hippocampus toward prospective reward locations	NEURON			English	Article							COMPLEX-SPIKE CELLS; PLACE CELLS; ENTORHINAL CORTEX; UNIT-ACTIVITY; MEMORY; EXPERIENCE; SEQUENCES; TASK; RAT; CA1	In a continuous T-maze alternation task, CA1 complex-spike neurons in the hippocampus differentially fire as the rat traverses overlapping segments of the maze (i.e., the stem) repeatedly via alternate routes. The temporal dynamics of this phenomenon were further investigated in the current study. Rats learned the alternation task from the first day of acquisition and the differential firing pattern in the stem was observed accordingly. More importantly, we report a phenomenon in which spatial correlates of CA1 neuronal ensembles gradually changed from their original firing locations, shifting toward prospective goal locations in the continuous T-maze alternation task. The relative locations of simultaneously recorded firing fields, however, were preserved within the ensemble spatial representation during this shifting. The within-session shifts in preferred firing locations in the absence of any changes in the environment suggest that certain cognitive factors can significantly alter the location-bound coding scheme of hippocampal neurons.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Lee, I (corresponding author), Univ Iowa, Dept Psychol, E11 Seashore Hall, Iowa City, IA 52242 USA.	inah-lee@uiowa.edu; hasselmo@bu.edu		Griffin, Amy/0000-0002-4524-2156; Hasselmo, Michael/0000-0002-9925-6377	NIDA NIH HHS [DA 16454] Funding Source: Medline; NIMH NIH HHS [MH 60013, 5F32 MH 070184-02, MH 51570, MH 61492] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051570, R01MH061492, F32MH070184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anderson MI, 2003, J NEUROSCI, V23, P8827; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; Bower MR, 2005, J NEUROSCI, V25, P1313, DOI 10.1523/JNEUROSCI.2901-04.2005; BREESE CR, 1989, J NEUROSCI, V9, P1097; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; EICHENBAUM H, 1987, J NEUROSCI, V7, P716; Ekstrom AD, 2001, NEURON, V31, P631, DOI 10.1016/S0896-6273(01)00401-9; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2002, J NEUROSCI, V22, P3817; Fyhn M, 2002, NEURON, V35, P555, DOI 10.1016/S0896-6273(02)00784-5; Gothard KM, 1996, J NEUROSCI, V16, P823; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Kobayashi T, 1997, J NEUROPHYSIOL, V78, P597, DOI 10.1152/jn.1997.78.2.597; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Lenck-Santini PP, 2001, HIPPOCAMPUS, V11, P377, DOI 10.1002/hipo.1052; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; Lever C, 2002, NATURE, V416, P90, DOI 10.1038/416090a; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McClelland JL, 1998, ANN NY ACAD SCI, V843, P153, DOI 10.1111/j.1749-6632.1998.tb08212.x; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MULLER RU, 1987, J NEUROSCI, V7, P1951; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Rosenzweig ES, 2003, NAT NEUROSCI, V6, P609, DOI 10.1038/nn1053; SCHULTZ W, 1997, SCIENCE, V275, P1594; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Tanila H, 1997, HIPPOCAMPUS, V7, P613, DOI 10.1002/(SICI)1098-1063(1997)7:6<613::AID-HIPO4>3.0.CO;2-F; THOMPSON LT, 1990, BRAIN RES, V509, P299, DOI 10.1016/0006-8993(90)90555-P; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; WILSON M, 1994, SCIENCE, V261, P1055; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	44	114	117	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					639	650		10.1016/j.neuron.2006.06.033	http://dx.doi.org/10.1016/j.neuron.2006.06.033			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950161	Bronze			2022-12-28	WOS:000240623400012
J	Lee, AK; Manns, ID; Sakmann, B; Brecht, M				Lee, Albert K.; Manns, Ian D.; Sakmann, Bert; Brecht, Michael			Whole-cell recordings in freely moving rats	NEURON			English	Article							IN-VIVO; PYRAMIDAL CELLS; ELECTROPHYSIOLOGICAL CHARACTERIZATION; RECEPTIVE-FIELDS; MOTOR CORTEX; NEURONS; AWAKE; SUBTHRESHOLD; POTENTIALS; RESPONSES	Intracellular recording, which allows direct measurement of the membrane potential and currents of individual neurons, requires a very mechanically stable preparation and has thus been limited to in vitro and head-immobilized in vivo experiments. This restriction constitutes a major obstacle for linking cellular and synaptic physiology with animal behavior. To overcome this limitation we have developed a method for performing whole-cell recordings in freely moving rats. We constructed a miniature head-mountable recording device, with mechanical stabilization achieved by anchoring the recording pipette rigidly in place after the whole-cell configuration is established. We obtain long-duration recordings (mean of similar to 20 min, maximum 60 min) in freely moving animals that are remarkably insensitive to mechanical disturbances, then reconstruct the anatomy of the recorded cells. This head-anchored whole-cell recording technique will enable a wide range of new studies involving detailed measurement and manipulation of the physiological properties of identified cells during natural behaviors.	Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands; Max Planck Inst Med Res, Dept Cell Physiol, D-69120 Heidelberg, Germany	Erasmus University Rotterdam; Erasmus MC; Max Planck Society	Lee, AK (corresponding author), Erasmus MC, Dept Neurosci, Dr Molewaterolein 50, NL-3015 GE Rotterdam, Netherlands.	a.lee@erasmusmc.nl; m.brecht@erasmusmc.nl		Brecht, Michael/0000-0002-5387-0953				Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1850, DOI 10.1152/jn.1993.69.6.1850; BARANYI A, 1993, J NEUROPHYSIOL, V69, P1865, DOI 10.1152/jn.1993.69.6.1865; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Brecht M, 2002, J PHYSIOL-LONDON, V543, P49, DOI 10.1113/jphysiol.2002.018465; Brecht M, 2003, J PHYSIOL-LONDON, V553, P243, DOI 10.1113/jphysiol.2003.044222; Brecht Michael, 2005, P1; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; Covey E, 1996, J NEUROSCI, V16, P3009; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; FERSTER D, 1992, J NEUROSCI, V12, P1262; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Manns ID, 2004, J PHYSIOL-LONDON, V556, P601, DOI 10.1113/jphysiol.2003.053132; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Matsumura M, 1996, J NEUROSCI, V16, P7757; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TAUBE JS, 1990, J NEUROSCI, V10, P420; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; XING P, 1991, NEUROREPORT, V2, P485; YOKOTA T, 1970, J NEUROPHYSIOL, V33, P96, DOI 10.1152/jn.1970.33.1.96; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171	35	184	192	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					399	407		10.1016/j.neuron.2006.07.004	http://dx.doi.org/10.1016/j.neuron.2006.07.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908406	Bronze, Green Submitted			2022-12-28	WOS:000240504700004
J	Kuo, CT; Zhu, SJ; Younger, S; Jan, LY; Jan, YN				Kuo, Chay T.; Zhu, Sijun; Younger, Susan; Jan, Lily Y.; Jan, Yuh Nung			Identification of E2/E3 ubiquitinating enzymes and caspase activity regulating Drosophila sensory neuron dendrite pruning	NEURON			English	Article							WALLERIAN DEGENERATION; PROTEASOME SYSTEM; CELL-DEATH; AXON; DRONC; DIAP1; METAMORPHOSIS; APOPTOSIS; HID; DEGRADATION	Ubiquitin-proteasome system (UPS) is a multistep protein degradation machinery implicated in many diseases. In the nervous system, UPS regulates remodeling and degradation of neuronal processes and is linked to Wallerian axonal degeneration, though the ubiquitin ligases that confer substrate specificity remain unknown. Having shown previously that class IV dendritic arborization (C4da) sensory neurons in Drosophila undergo UPS-mediated dendritic pruning during metamorphosis, we conducted an E2/E3 ubiquitinating enzyme mutant screen, revealing that mutation in ubcD1, an E2 ubiquitin-conjugating enzyme, resulted in retention of C4da neuron dendrites during metamorphosis. Further, we found that UPS activation likely leads to UbcD1-mediated degradation of DIAP1, a caspase-antagonizing E3 ligase. This allows for local activation of the Dronc caspase, thereby preserving C4da neurons while severing their dendrites. Thus, in addition to uncovering E2/E3 ubiquitinating enzymes for dendrite pruning, this study provides a mechanistic link between UPS and the apoptotic machinery in regulating neuronal process remodeling.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040929] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS40929] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arama E, 2003, DEV CELL, V4, P687, DOI 10.1016/S1534-5807(03)00120-5; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Dorstyn L, 1999, P NATL ACAD SCI USA, V96, P4307, DOI 10.1073/pnas.96.8.4307; Ehlers MD, 2004, TRENDS NEUROSCI, V27, P3, DOI 10.1016/j.tins.2003.10.015; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Finn JT, 2000, J NEUROSCI, V20, P1333; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Griffin John W., 1995, P375; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2004, CURR OPIN NEUROBIOL, V14, P74, DOI 10.1016/j.conb.2004.01.001; Hawkins CJ, 2000, J BIOL CHEM, V275, P27084; Hay BA, 2004, NAT REV GENET, V5, P911, DOI 10.1038/nrg1491; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Huh JR, 2004, PLOS BIOL, V2, P43, DOI 10.1371/journal.pbio.0020015; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; Jiang YH, 2004, CURR OPIN PEDIATR, V16, P419, DOI 10.1097/01.mop.0000133634.79661.cd; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Martin SJ, 2002, CELL, V109, P793, DOI 10.1016/S0092-8674(02)00802-4; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Muro I, 2002, J BIOL CHEM, V277, P49644, DOI 10.1074/jbc.M203464200; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Pesah Y, 2004, DEVELOPMENT, V131, P2183, DOI 10.1242/dev.01095; Ryoo HD, 2002, NAT CELL BIOL, V4, P432, DOI 10.1038/ncb795; Setou M, 2004, J NEUROBIOL, V58, P201, DOI 10.1002/neu.10324; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; TREIER M, 1992, EMBO J, V11, P367, DOI 10.1002/j.1460-2075.1992.tb05059.x; Waldhuber M, 2005, MECH DEVELOP, V122, P914, DOI 10.1016/j.mod.2005.04.003; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799; Yin VP, 2004, P NATL ACAD SCI USA, V101, P8022, DOI 10.1073/pnas.0402647101; Yu SY, 2002, DEVELOPMENT, V129, P3269; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	48	203	206	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					283	290		10.1016/j.neuron.2006.07.014	http://dx.doi.org/10.1016/j.neuron.2006.07.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880123	Bronze			2022-12-28	WOS:000239908800004
J	Chih, B; Gollan, L; Scheiffele, P				Chih, Ben; Gollan, Leora; Scheiffele, Peter			Alternative splicing controls selective trans-synaptic interactions of the neuroligin-neurexin complex	NEURON			English	Article							INHIBITORY SYNAPSE FORMATION; CELL-ADHESION; VESICLE EXOCYTOSIS; ALPHA-NEUREXINS; BETA-NEUREXINS; PSD-95; MOLECULES; BINDING	Formation of synapses requires specific cellular interactions that organize pre- and postsynaptic compartments. The neuroligin-neurexin complex mediates heterophilic adhesion and can trigger assembly of glutamatergic and GABAergic synapses in cultured hippocampal neurons. Both neuroligins and neurexins are encoded by multiple genes. Alternative splicing generates large numbers of isoforms, which may engage in selective axo-dendritic interactions. We explored whether alternative splicing of the postsynaptic neuroligins modifies their activity toward glutamatergic and GABAergic axons. We find that small extracellular splice insertions restrict the function of neuroligin-1 and -2 to glutamatergic and GABAergic contacts and alter interaction with presynaptic neurexins. The neuroligin isoforms associated with GABAergic contacts bind to neurexin-1 alpha and a subset of neurexin-1 beta s. In turn, these neurexin isoforms induce GABAergic but not glutamatergic postsynaptic differentiation. Our findings suggest that alternative splicing plays a central role in regulating selective extracellular interactions through the neuroligin-neurexin complex at glutamatergic and GABAergic synapses.	Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Physiol & Cellular Biophys,Ctr Neurobiol & B, New York, NY 10032 USA	Columbia University	Scheiffele, P (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, Dept Physiol & Cellular Biophys,Ctr Neurobiol & B, P&S 11-511,630 W 168th St, New York, NY 10032 USA.	ps2018@columbia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045014] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS045014] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Bolliger MF, 2001, BIOCHEM J, V356, P581, DOI 10.1042/0264-6021:3560581; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Comoletti D, 2003, J BIOL CHEM, V278, P50497, DOI 10.1074/jbc.M306803200; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Gebski BL, 2003, HUM MOL GENET, V12, P1801, DOI 10.1093/hmg/ddg196; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006; Hoffman RC, 2004, BIOCHEMISTRY-US, V43, P1496, DOI 10.1021/bi035278t; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Missler M, 1998, J NEUROCHEM, V71, P1339; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schmajuk G, 1999, J BIOL CHEM, V274, P21783, DOI 10.1074/jbc.274.31.21783; Schmucker D, 2004, NEURON, V44, P219, DOI 10.1016/j.neuron.2004.10.004; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; ULLRICH B, 1995, NEURON, V14, P497, DOI 10.1016/0896-6273(95)90306-2; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8	34	278	286	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2006	51	2					171	178		10.1016/j.neuron.2006.06.005	http://dx.doi.org/10.1016/j.neuron.2006.06.005			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846852	Bronze			2022-12-28	WOS:000239535100005
J	Daniels, RW; DiAntonio, A				Daniels, Richard W.; DiAntonio, Aaron			Fast flies take a quantum leap	NEURON			English	Editorial Material							VESICLE SIZE	Presynaptic regulation of quantal size is an appealing mechanism for changing synapse strength. In this issue of Neuron, Steinert et al. describe an activity-dependent increase in synapse strength mediated by the formation and release of large synaptic vesicles at the Drosophila neuromuscular junction.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	Daniels, RW (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.			DiAntonio, Aaron/0000-0002-7262-0968				Colliver TL, 2000, J NEUROSCI, V20, P5276, DOI 10.1523/JNEUROSCI.20-14-05276.2000; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Liu GS, 2003, CURR OPIN NEUROBIOL, V13, P324, DOI 10.1016/S0959-4388(03)00078-3; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	10	0	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					667	669		10.1016/j.neuron.2006.05.011	http://dx.doi.org/10.1016/j.neuron.2006.05.011			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731505	Bronze			2022-12-28	WOS:000238165000002
J	Huang, ZJ				Huang, ZJ			GABA(B) receptor isoforms caught in action at the scene	NEURON			English	Editorial Material								The metabotropic GABA(B) receptors mediate slow synaptic inhibition and consist of heterodimers of GABA(B1) and GABA(B2) subunits. The only known molecular diversity of the GABAB receptors arises from the two GABA(B1) isoforms, but its functional significance has been unclear. Two studies in this issue of Neuron now demonstrate that GABA(B1)., and GABA(B1b) show strategically distinct subcellular localization and physiological action.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.			Huang, Z. Josh/0000-0003-0592-028X				Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; Brauner-Osborne H, 1999, BRIT J PHARMACOL, V128, P1370, DOI 10.1038/sj.bjp.0702914; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; KERR DIB, 1995, PHARMACOL THERAPEUT, V67, P187, DOI 10.1016/0163-7258(95)00016-A; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Mohler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; Tamas G, 2003, SCIENCE, V299, P1902, DOI 10.1126/science.1082053	9	20	21	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 18	2006	50	4					521	524		10.1016/j.neuron.2006.05.005	http://dx.doi.org/10.1016/j.neuron.2006.05.005			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701201	Bronze			2022-12-28	WOS:000237875200002
J	Inoue, E; Mochida, S; Takagi, H; Higa, S; Deguchi-Tawarada, M; Takao-Rikitsu, E; Inoue, M; Yao, I; Takeuchi, K; Kitajima, I; Setou, M; Ohtsuka, T; Takai, Y				Inoue, E; Mochida, S; Takagi, H; Higa, S; Deguchi-Tawarada, M; Takao-Rikitsu, E; Inoue, M; Yao, I; Takeuchi, K; Kitajima, I; Setou, M; Ohtsuka, T; Takai, Y			SAD: A presynaptic kinase associated with synaptic vesicles and the active zone cytomatrix that regulates neurotransmitter release	NEURON			English	Article							PROTEIN-INTERACTION SITE; FUNCTIONAL INTERACTION; SYNAPSES; FAMILY; RIM1-ALPHA; BASSOON; RIM1; CAST; DEPRESSION; MUNC13-1	A serine/threonine kinase SAD-1 in C. elegans regulates synapse development. We report here the isolation and characterization of mammalian orthologs of SAD-1, named SAD-A and SAD-B, which are specifically expressed in the brain. SAD-B is associated with synaptic vesicles and, like the active zone proteins CAST and Bassoon, is tightly associated with the presynaptic cytomatrix in nerve terminals. A short conserved region (SCR) in the COOH-terminus is required for the synaptic localization of SAD-B. Overexpression of SAD-B in cultured rat hippocampal neurons significantly increases the frequency of miniature excitatory postsynaptic current but not its amplitude. Introduction of SCR into presynaptic superior cervical ganglion neurons in culture significantly inhibits evoked synaptic transmission. Moreover, SCR decreases the size of the readily releasable pool measured by applying hypertonic sucrose. Furthermore, SAD-B phosphorylates the active zone protein RIM1 but not Munc13-1. These results suggest that mammalian SAD kinase presynaptically regulates neurotransmitter release.	KAN Res Inst, Kyoto 6008815, Japan; Tokyo Med Univ, Dept Physiol, Shinjuku Ku, Tokyo 1608402, Japan; Mitsubishi Kagaku Inst Life Sci, Setou Grp, Lab Mol Gerontol, Machida, Tokyo 1948511, Japan; Toyama Univ, Fac Med, Grad Sch Med, Dept Clin & Mol Pathol, Toyama 9300194, Japan; Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan; Japan Sci & Technol Agcy, PRESTO, Kawaguchi 3320012, Japan; Natl Inst Physiol Sci, Lab Nanostruct Physiol, Okazaki, Aichi 4448787, Japan; Osaka Univ, Grad Sch Med, Fac Med, Dept Biochem & Mol Biol, Suita, Osaka 5650871, Japan	KAN Research Institute; Tokyo Medical University; Mitsubishi Kagaku Institute of Life Sciences (MITILS); University of Toyama; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Osaka University	Ohtsuka, T (corresponding author), KAN Res Inst, Kyoto 6008815, Japan.	tohtsuka@med.u-toyama.ac.jp	Takeuchi, Kosei/AAV-3577-2021	Takeuchi, Kosei/0000-0001-6397-2243				Altrock WD, 2003, NEURON, V37, P787, DOI 10.1016/S0896-6273(03)00088-6; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BIRKS R, 1961, CAN J BIOCHEM PHYS, V39, P787, DOI 10.1139/o61-081; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chen G, 2004, P NATL ACAD SCI USA, V101, P1063, DOI 10.1073/pnas.0307149101; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Deguchi-Tawarada M, 2006, J COMP NEUROL, V495, P480, DOI 10.1002/cne.20893; Deguchi-Tawarada M, 2004, GENES CELLS, V9, P15, DOI 10.1111/j.1356-9597.2004.00697.x; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dresbach T, 2003, MOL CELL NEUROSCI, V23, P279, DOI 10.1016/S1044-7431(03)00015-0; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hennou S, 2003, EUR J NEUROSCI, V18, P811, DOI 10.1046/j.1460-9568.2003.02812.x; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; KISTNER U, 1993, J BIOL CHEM, V268, P4580; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Langnaese K, 1996, MOL BRAIN RES, V42, P118, DOI 10.1016/S0169-328X(96)00147-7; Lonart G, 2003, CELL, V115, P49, DOI 10.1016/S0092-8674(03)00727-X; MIZOGUCHI A, 1989, MOL BRAIN RES, V5, P31, DOI 10.1016/0169-328X(89)90015-6; MOCHIDA S, 1995, NEUROSCIENCE, V65, P905, DOI 10.1016/0306-4522(94)00508-3; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Mochida S, 1998, P NATL ACAD SCI USA, V95, P14523, DOI 10.1073/pnas.95.24.14523; Mochida S, 1998, P NATL ACAD SCI USA, V95, P11418, DOI 10.1073/pnas.95.19.11418; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohtsuka T, 2002, J CELL BIOL, V158, P577, DOI 10.1083/jcb.200202083; Phillips GR, 2001, NEURON, V32, P63, DOI 10.1016/S0896-6273(01)00450-0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Takao-Rikitsu E, 2004, J CELL BIOL, V164, P301, DOI 10.1083/jcb.200307101; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2002, P NATL ACAD SCI USA, V99, P14464, DOI 10.1073/pnas.182532999; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6	48	85	94	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					261	275		10.1016/j.neuron.2006.03.018	http://dx.doi.org/10.1016/j.neuron.2006.03.018			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630837	Bronze			2022-12-28	WOS:000237176700013
J	Ko, JW; Kim, SH; Chung, HS; Kim, K; Han, KH; Kim, H; Jun, HJ; Kaang, BK; Kim, EJ				Ko, JW; Kim, SH; Chung, HS; Kim, K; Han, KH; Kim, H; Jun, HJ; Kaang, BK; Kim, EJ			SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses	NEURON			English	Article							INHIBITORY SYNAPSES; LIPRIN-ALPHA; PROTEIN; FAMILY; NEUROLIGIN; PSD-95; BINDING; ASSOCIATION; RECEPTORS; DOMAIN	Synaptic cell adhesion molecules (CAMs) are known to play key roles in various aspects of synaptic structures and functions, including early differentiation, maintenance, and plasticity. We herein report the identification of a family of cell adhesion-like molecules termed SALM that interacts with the abundant postsynaptic density (PSD) protein PSD-95. SALM2, a SALM isoform, distributes to excitatory, but not inhibitory, synaptic sites. Overexpression of SALM2 increases the number of excitatory synapses and dendritic spines. Mislocalized expression of SALM2 disrupts excitatory synapses and dendritic spines. Bead-induced direct aggregation of SALM2 results in coclustering of PSD-95 and other postsynaptic proteins, including GKAP and AMPA receptors. Knockdown of SALM2 by RNA interference reduces the number of excitatory synapses and dendritic spines and the frequency, but not amplitude, of miniature excitatory postsynaptic currents. These results suggest that SALM2 is an important regulator of the differentiation of excitatory synapses.	Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; Korea Univ, Dept Anat, Seoul 136705, South Korea; Korea Univ, Div Brain Korea 21 Biomed Sci, Coll Med, Seoul 136705, South Korea; Seoul Natl Univ, Coll Nat Sci, Natl Res Lab, Inst Mol Biol & Genet,Sch Biol Sci, Seoul 151742, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea University; Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Kim, EJ (corresponding author), Korea Adv Inst Sci & Technol, Natl Creat Res Initiat Ctr Synaptogenesis, Taejon 305701, South Korea.	kime@kaist.ac.kr	Han, Kihoon/AAE-8919-2019; Kim, Karam/K-1412-2018; Kim, Eunjoon/C-1566-2011; Chun, Heejung/B-3454-2014	Han, Kihoon/0000-0002-5925-2152; Kim, Karam/0000-0002-1886-5163; Chun, Heejung/0000-0002-6451-1542; Kim, Hyun/0000-0002-7210-5798				Bao JX, 2004, NAT NEUROSCI, V7, P1250, DOI 10.1038/nn1342; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dean C, 2006, TRENDS NEUROSCI, V29, P21, DOI 10.1016/j.tins.2005.11.003; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J BIOL CHEM, V275, P23904, DOI 10.1074/jbc.M909919199; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; Kim D, 2003, NEUROREPORT, V14, P679, DOI 10.1097/00001756-200304150-00004; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2003, J NEUROSCI, V23, P1667; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Kuja-Panula J, 2003, J CELL BIOL, V160, P963, DOI 10.1083/jcb.200209074; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lin JC, 2003, NAT NEUROSCI, V6, P1270, DOI 10.1038/nn1148; Mok H, 2002, J NEUROSCI, V22, P5253; MULLER BM, 1995, J NEUROSCI, V15, P2354, DOI 10.1523/JNEUROSCI.15-03-02354.1995; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Sara Y, 2005, J NEUROSCI, V25, P260, DOI 10.1523/JNEUROSCI.3165-04.2005; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi SH, 2004, P NATL ACAD SCI USA, V101, P13346, DOI 10.1073/pnas.0405371101; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Wang CY, 2006, J NEUROSCI, V26, P2174, DOI 10.1523/JNEUROSCI.3799-05.2006; Washbourne P, 2004, J NEUROSCI, V24, P9244, DOI 10.1523/JNEUROSCI.3339-04.2004; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yap AS, 2003, J CELL BIOL, V160, P11, DOI 10.1083/jcb.200208156; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300	58	119	145	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					233	245		10.1016/j.neuron.2006.04.005	http://dx.doi.org/10.1016/j.neuron.2006.04.005			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630835	Bronze			2022-12-28	WOS:000237176700011
J	Cheung, ZH; Fu, AKY; Ip, NY				Cheung, ZH; Fu, AKY; Ip, NY			Synaptic roles of Cdk5: Implications in higher cognitive functions and neurodegenerative diseases	NEURON			English	Review							DEPENDENT KINASE-5 PHOSPHORYLATES; NEUROMUSCULAR-JUNCTION; TYROSINE-HYDROXYLASE; MEMORY; TRANSCRIPTION; HIPPOCAMPUS; EXPRESSION; PLASTICITY; NEURONS; SIGNAL	Accumulating evidence indicates that cyclin dependent kinase 5 (Cdk5), through phosphorylating a plethora of pre- and postsynaptic proteins, functions as an essential modulator of synaptic transmission. Recent advances in the field of Cdk5 research have not only consolidated the in vivo importance of Cdk5 in neurotransmission but also suggest a pivotal role of Cdk5 in the regulation of higher cognitive functions and neurodegenerative diseases. In this review, we will discuss the recent findings on the emanating role of Cdk5 as a regulator of synaptic functions and plasticity.	Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Dept Biochem, Biotechnol Res Inst, Hong Kong, Hong Kong, Peoples R China.	boip@ust.hk	Cheung, Zelda Hiu Yee/C-1402-2012	Fu, Kit Yu/0000-0003-4085-6201; Ip, Nancy Yuk-Yu/0000-0002-2763-8907				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Bibb JA, 2003, NEUROSIGNALS, V12, P191, DOI 10.1159/000074620; Cheng K, 2003, NEUROSIGNALS, V12, P180, DOI 10.1159/000074619; Chergui K, 2004, P NATL ACAD SCI USA, V101, P2191, DOI 10.1073/pnas.0308652100; Cheung ZH, 2004, NEUROSCI LETT, V361, P47, DOI 10.1016/j.neulet.2003.12.117; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2003, NEUROSIGNALS, V12, P200, DOI 10.1159/000074621; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fu AKY, 2005, P NATL ACAD SCI USA, V102, P15224, DOI 10.1073/pnas.0507678102; Fu AKY, 2004, P NATL ACAD SCI USA, V101, P6728, DOI 10.1073/pnas.0307606100; Fu AKY, 2001, NAT NEUROSCI, V4, P374, DOI 10.1038/86019; Kansy JW, 2004, J NEUROCHEM, V91, P374, DOI 10.1111/j.1471-4159.2004.02723.x; Kesavapany S, 2004, J NEUROSCI, V24, P4421, DOI 10.1523/JNEUROSCI.0690-04.2004; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003; Ledda F, 2002, NEURON, V36, P387, DOI 10.1016/S0896-6273(02)01002-4; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Li Z, 2004, J BIOL CHEM, V279, P54438, DOI 10.1074/jbc.M411002200; Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002; LIU Y, 2006, IN PRESS J BIOL CHEM; Morabito MA, 2004, J NEUROSCI, V24, P865, DOI 10.1523/JNEUROSCI.4582-03.2004; Morgan JR, 2004, J CELL BIOL, V167, P43, DOI 10.1083/jcb.200406020; Moy LY, 2004, J BIOL CHEM, V279, P54487, DOI 10.1074/jbc.M406636200; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Patel LS, 2004, J NEUROSCI, V24, P9005, DOI 10.1523/JNEUROSCI.2943-04.2004; Qi RZ, 2004, FEBS LETT, V561, P177, DOI 10.1016/S0014-5793(04)00174-7; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Smith PD, 2006, J NEUROSCI, V26, P440, DOI 10.1523/JNEUROSCI.2875-05.2006; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Takahashi S, 2005, P NATL ACAD SCI USA, V102, P1737, DOI 10.1073/pnas.0409456102; Tan TC, 2003, NAT CELL BIOL, V5, P701, DOI 10.1038/ncb1020; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Wei FY, 2005, J NEUROCHEM, V93, P502, DOI 10.1111/j.1471-4159.2005.03058.x; Xie F, 2004, J NEUROCHEM, V90, P1521, DOI 10.1111/j.1471-4159.2004.02685.x	37	139	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					13	18		10.1016/j.neuron.2006.02.024	http://dx.doi.org/10.1016/j.neuron.2006.02.024			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600851	Bronze			2022-12-28	WOS:000236811300006
J	Schoppa, NE				Schoppa, NE			A novel local circuit in the olfactory bulb involving an old short-axon cell	NEURON			English	Editorial Material							INHIBITION	Many local circuit interactions in the olfactory bulb involve atypical dendrodendritic synapses. In this issue of Neuron, Pressler and Strowbridge report a functional analysis of a class of short-axon interneurons in the bulb called Blanes cells. Blanes cells make GABAergic axonal contacts onto granule cells and may mediate a form of local feedforward disinhibition.	Univ Colorado, Dept Physiol & Biophys, Aurora, CO 80045 USA; Hlth Sci Ctr, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Schoppa, NE (corresponding author), Univ Colorado, Dept Physiol & Biophys, Aurora, CO 80045 USA.							Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Blanes T., 1898, REV TRIM MICROG, V3, P99; Egger V, 2003, J NEUROSCI, V23, P7551; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Pressler RT, 2006, NEURON, V49, P889, DOI 10.1016/j.neuron.2006.02.019; PRICE JL, 1970, J CELL SCI, V7, P631; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Shepherd G.M., 2004, SYNAPTIC ORG BRAIN, P159; YAMAMOTO C, 1963, J NEUROPHYSIOL, V26, P403, DOI 10.1152/jn.1963.26.3.403	12	4	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					783	784		10.1016/j.neuron.2006.03.005	http://dx.doi.org/10.1016/j.neuron.2006.03.005			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543124	Bronze			2022-12-28	WOS:000236227500004
J	Murad, A; Emery-Le, M; Emery, P				Murad, Alejandro; Emery-Le, Myai; Emery, Patrick			A subset of dorsal neurons modulates circadian behavior and light responses in Drosophila	NEURON			English	Article							CLOCK PROTEINS PERIOD; PACEMAKER NEURONS; CRYPTOCHROME; TIMELESS; BRAIN; RHYTHMS; PDF; PHOTORECEPTOR; MELANOGASTER; MUTATION	A fundamental property of circadian rhythms is their ability to persist under constant conditions. In Drosophila, the ventral Lateral Neurons (LNvs) are the pacemaker neurons driving circadian behavior under constant darkness. Wildtype flies are arrhythmic under constant illumination, but flies defective for the circadian photoreceptor CRY remain rhythmic. We found that flies overexpressing the pacemaker gene per or the morgue gene are also behaviorally rhythmic under constant light. Unexpectedly, the LNvs do not drive these rhythms: they are molecularly arrhythmic, and PDF-the neuropepticle they secrete to synchronize behavioral rhythms under constant darkness-is dispensable for rhythmicity in constant light. Molecular circadian rhythms are only found in a group of Dorsal Neurons: the DN1s. Thus, a subset of Dorsal Neurons shares with the LNvs the ability to function as pacemakers for circadian behavior, and its importance is promoted by light.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Neurosci Program, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Emery, P (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 365 Plantat St, Worcester, MA 01605 USA.	patrick.emery@umassmed.edu			NIGMS NIH HHS [5R01GM066777, R01 GM066777] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066777] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Cyran SA, 2003, CELL, V112, P329, DOI 10.1016/S0092-8674(03)00074-6; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Egan ES, 1999, J NEUROSCI, V19, P3665; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; Grima B, 2002, NATURE, V420, P178, DOI 10.1038/nature01122; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 1998, CHRONOBIOL INT, V15, P567, DOI 10.3109/07420529808993195; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hyun S, 2005, NEURON, V48, P267, DOI 10.1016/j.neuron.2005.08.025; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Ko HW, 2002, NATURE, V420, P673, DOI 10.1038/nature01272; Koh K, 2006, SCIENCE, V312, P1809, DOI 10.1126/science.1124951; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Lear BC, 2005, NEURON, V48, P221, DOI 10.1016/j.neuron.2005.09.008; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Lin Y, 2004, J NEUROSCI, V24, P7951, DOI 10.1523/JNEUROSCI.2370-04.2004; Mertens I, 2005, NEURON, V48, P213, DOI 10.1016/j.neuron.2005.09.009; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Peng Y, 2003, PLOS BIOL, V1, P32, DOI 10.1371/journal.pbio.0000013; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2003, J BIOL RHYTHM, V18, P377, DOI 10.1177/0748730403256997; Rorth P, 1998, DEVELOPMENT, V125, P1049; Shafer OT, 2006, J COMP NEUROL, V498, P180, DOI 10.1002/cne.21021; Shafer OT, 2002, J NEUROSCI, V22, P5946; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; STOLERU D, 2007, IN PRESS CELL; Veleri S, 2003, CURR BIOL, V13, P1758, DOI 10.1016/j.cub.2003.09.030; Wing JP, 2002, NAT CELL BIOL, V4, P451, DOI 10.1038/ncb800; Yoshii T, 2005, EUR J NEUROSCI, V22, P1176, DOI 10.1111/j.1460-9568.2005.04295.x	42	97	99	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					689	701		10.1016/j.neuron.2007.01.034	http://dx.doi.org/10.1016/j.neuron.2007.01.034			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329209	Green Accepted, Bronze			2022-12-28	WOS:000245127100010
J	Demas, J; Cline, HT				Demas, Jay; Cline, Hollis T.			The blu blur: Mutation of a vesicular glutamate transporter reduces the resolution of zebrafish vision	NEURON			English	Editorial Material							LARVAL ZEBRAFISH; TECTUM	Vesicular transporters mediate the packaging of neurotransmitters into synaptic vesicles and can therefore control the amount of neurotransmitter released into the synaptic cleft. In this issue of Neuron, Smear et al. demonstrate that mutation of a vesicular glutamate transporter (Vglut) found in the retinal ganglion cells; (RGCs) of zebrafish alters both the synaptic transmission and connectivity between RGCs and their targets, limiting the transfer of visually evoked activity from RGCs and degrading behaviors that depend on high-acuity vision.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, Beckman Bldg,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	htcline@gmail.com		Demas, Jay/0000-0001-7678-1905				Baier H, 1996, DEVELOPMENT, V123, P415; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Roeser T, 2003, J NEUROSCI, V23, P3726; Ruthazer ES, 2006, J NEUROSCI, V26, P3594, DOI 10.1523/JNEUROSCI.0069-06.2006; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046	9	1	1	2	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					4	6		10.1016/j.neuron.2006.12.019	http://dx.doi.org/10.1016/j.neuron.2006.12.019			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196524	Bronze			2022-12-28	WOS:000245126500002
J	Yu, DH; Akalal, DBG; Davis, RL				Yu, Dinghui; Akalal, David-Benjamin G.; Davis, Ronald L.			Drosophila alpha/beta mushroom body neurons form a branch-specific, long-term cellular memory trace after spaced olfactory conditioning	NEURON			English	Article							CONSOLIDATED MEMORY; MUTANT DROSOPHILA; MOLECULAR-BIOLOGY; PROTEIN; RESCUE; NEUROSCIENCE; PATHWAY; BRAIN	Functional optical imaging showed that odor or electric shock stimuli presented to the fly causes transient calcium influx into the two major axon branches of alpha/beta mushroom body (MB) neurons. One pairing of odor and electric shock stimuli or multiple, massed pairings did not alter odor-evoked calcium influx. In contrast, animals that received multiple, spaced pairings exhibited a robust increase in calcium influx into the MB axons when tested at 9 or 24 hr after training, but not at 3 hr. This modification occurred only in the alpha branch of the neurons and was blocked by mutation of the amnesiac gene, inhibition of protein synthesis, or the expression of a protein blocker of the transcription factor Creb. Thus, behavioral long-term olfactory memory appears to be encoded as a branch-specific modification of calcium influx into the alpha/beta MB neurons that occurs after spaced training in a protein synthesis-, Creb-, and amnesiac-dependent way.	Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; Baylor Coll Med, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019904, R37NS019904, R01NS052351] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS052351-02, R37 NS019904, R01 NS019904, R01 NS052351-03, NS19904, R01 NS052351-05, R01 NS052351, NS52352, R01 NS052351-04] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Beck CDO, 2000, J NEUROSCI, V20, P2944; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Perazzona B, 2004, J NEUROSCI, V24, P8823, DOI 10.1523/JNEUROSCI.4542-03.2004; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Roman G, 1999, BIOTECHNIQUES, V27, P54, DOI 10.2144/99271bm09; Roman G, 2001, BIOESSAYS, V23, P571, DOI 10.1002/bies.1083; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037	27	201	203	0	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					845	855		10.1016/j.neuron.2006.10.030	http://dx.doi.org/10.1016/j.neuron.2006.10.030			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145505	Bronze, Green Accepted			2022-12-28	WOS:000242856400012
J	Gentner, R; Classen, J				Gentner, Reinhard; Classen, Joseph			Modular organization of finger movements by the human central nervous system	NEURON			English	Article							HUMAN MOTOR CORTEX; MUSCLE SYNERGIES; SPINAL-CORD; HAND AREA; PRECENTRAL CORTEX; FORCE-FIELDS; STIMULATION; MICROSTIMULATION; REPRESENTATIONS; COMBINATIONS	The motor system may generate automated movements, such as walking, by combining modular spinal motor synergies. However, it remains unknown whether a modular neuronal architecture is sufficient to generate the unique flexibility of human finger movements, which rely on cortical structures. Here we show that finger movements evoked by transcranial magnetic stimulation (TMS) of the primary motor cortex reproduced distinctive features of the spatial representation of voluntary movements as identified in previous neurolmaging studies, consistent with naturalistic activation of neuronal elements. Principal component analysis revealed that the dimensionality of TMS-evoked movements was low. Principal components extracted from TMS-induced finger movements resembled those derived from end-postures of voluntary movements performed to grasp imagined objects, and a small subset of them was sufficient to reconstruct these movements with remarkable fidelity. The motor system may coordinate even the most dexterous movements by using a modular architecture involving cortical components.	Univ Wurzburg, Huma Cort Physiol & Motor Control Lab, Dept Neurol, D-97080 Wurzburg, Germany; Tech Univ Munich, Inst Measurement Syst & Sensor Technol, D-80333 Munich, Germany	University of Wurzburg; Technical University of Munich	Classen, J (corresponding author), Univ Wurzburg, Huma Cort Physiol & Motor Control Lab, Dept Neurol, D-97080 Wurzburg, Germany.	classen_j@klinik.uni-wuerzburg.de		Classen, Joseph/0000-0001-7182-6967				Aflalo TN, 2006, P NATL ACAD SCI USA, V103, P2909, DOI 10.1073/pnas.0511139103; Aoyagi Y, 2004, IEEE T NEUR SYS REH, V12, P12, DOI 10.1109/TNSRE.2003.823265; Barker AT, 2002, HDB TRANSCRANIAL MAG, P3; Beisteiner R, 2001, NEUROIMAGE, V13, P1016, DOI 10.1006/nimg.2000.0737; Bernstein N, 1967, COORDINATION REGULAT; BIZZI E, 1991, SCIENCE, V253, P287, DOI 10.1126/science.1857964; Brochier T, 2004, J NEUROPHYSIOL, V92, P1770, DOI 10.1152/jn.00976.2003; Cheung VCK, 2005, J NEUROSCI, V25, P6419, DOI 10.1523/JNEUROSCI.4904-04.2005; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; d'Avella A, 2003, NAT NEUROSCI, V6, P300, DOI 10.1038/nn1010; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; d'Avella A, 2006, J NEUROSCI, V26, P7791, DOI 10.1523/JNEUROSCI.0830-06.2006; Deuschl G, 2001, MUSCLE NERVE, V24, P716, DOI 10.1002/mus.1063; Di Lazzaro V, 2004, CLIN NEUROPHYSIOL, V115, P255, DOI 10.1016/j.clinph.2003.10.009; Ethier C, 2006, J NEUROSCI, V26, P5574, DOI 10.1523/JNEUROSCI.5332-05.2006; Fetz EE, 2002, ADV EXP MED BIOL, V508, P265; Flash T, 2005, CURR OPIN NEUROBIOL, V15, P660, DOI 10.1016/j.conb.2005.10.011; GISZTER SF, 1993, J NEUROSCI, V13, P467; Golub G., 2012, J HOPKINS STUDIES MA, V3rd; Graziano MSA, 2005, J NEUROPHYSIOL, V94, P4209, DOI 10.1152/jn.01303.2004; Graziano MSA, 2004, J NEUROPHYSIOL, V92, P395, DOI 10.1152/jn.01241.2003; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Hlustik P, 2001, CEREB CORTEX, V11, P312, DOI 10.1093/cercor/11.4.312; HOMMEL G, 1994, 4 INT SCI C WWDU94 M; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ivanenko YP, 2004, J PHYSIOL-LONDON, V556, P267, DOI 10.1113/jphysiol.2003.057174; Ivanenko YP, 2005, J NEUROSCI, V25, P7238, DOI 10.1523/JNEUROSCI.1327-05.2005; Jerde TE, 2003, IEEE T BIO-MED ENG, V50, P265, DOI 10.1109/TBME.2002.807640; Kleinschmidt A, 1997, EUR J NEUROSCI, V9, P2178, DOI 10.1111/j.1460-9568.1997.tb01384.x; KWAN HC, 1978, J NEUROPHYSIOL, V41, P1120, DOI 10.1152/jn.1978.41.5.1120; Lang CE, 2004, J NEUROPHYSIOL, V92, P2802, DOI 10.1152/jn.00480.2004; LAWRENCE DG, 1968, BRAIN, V91, P15, DOI 10.1093/brain/91.1.15; Mason CR, 2001, J NEUROPHYSIOL, V86, P2896, DOI 10.1152/jn.2001.86.6.2896; Mushahwar VK, 2004, CAN J PHYSIOL PHARM, V82, P702, DOI 10.1139/Y04-079; MUSSAIVALDI FA, 1994, P NATL ACAD SCI USA, V91, P7534, DOI 10.1073/pnas.91.16.7534; Nicolelis MAL, 2003, NAT REV NEUROSCI, V4, P417, DOI 10.1038/nrn1105; Poliakov AV, 1999, J NEUROPHYSIOL, V82, P3488, DOI 10.1152/jn.1999.82.6.3488; PORTER R, 1995, CORTICOSPINAL FUNCTI, V45; Rathelot JA, 2006, P NATL ACAD SCI USA, V103, P8257, DOI 10.1073/pnas.0602933103; Rothwell JC, 1997, J NEUROSCI METH, V74, P113, DOI 10.1016/S0165-0270(97)02242-5; Saltiel P, 1998, J NEUROPHYSIOL, V80, P2323, DOI 10.1152/jn.1998.80.5.2323; SANES JN, 1995, SCIENCE, V268, P1775, DOI 10.1126/science.7792606; Santello M, 2002, J NEUROSCI, V22, P1426, DOI 10.1523/JNEUROSCI.22-04-01426.2002; Santello M, 1998, J NEUROSCI, V18, P10105; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; SCHIEBER MH, 1993, SCIENCE, V261, P489, DOI 10.1126/science.8332915; Soechting JF, 1997, J COMPUT NEUROSCI, V4, P29, DOI 10.1023/A:1008812426305; SPORNS O, 1993, CHILD DEV, V64, P960, DOI 10.2307/1131321; STRICK PL, 1982, J NEUROPHYSIOL, V48, P139, DOI 10.1152/jn.1982.48.1.139; Strick PL, 2002, NAT NEUROSCI, V5, P714, DOI 10.1038/nn0802-714; Tresch MC, 1999, NAT NEUROSCI, V2, P162, DOI 10.1038/5721; Tresch MC, 1999, EXP BRAIN RES, V129, P401, DOI 10.1007/s002210050908	54	108	109	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					731	742		10.1016/j.neuron.2006.09.038	http://dx.doi.org/10.1016/j.neuron.2006.09.038			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114055	Bronze			2022-12-28	WOS:000242413100018
J	Tzingounis, AV; Nicoll, RA				Tzingounis, Anastassios V.; Nicoll, Roger A.			Arc/Arg3.1: Linking gene expression to synaptic plasticity and memory	NEURON			English	Review							IMMEDIATE-EARLY GENE; LONG-TERM POTENTIATION; NMDA RECEPTOR ACTIVATION; AMPA RECEPTORS; MESSENGER-RNA; NEURAL ACTIVITY; NERVOUS-SYSTEM; VISUAL-CORTEX; ARC PROTEIN; KINASE-II	Arc/Arg3.1 is an effector immediate-early gene implicated in the consolidation of memories. Although cloned a decade ago, the physiological role of Arc/Arg3.1 in the brain has remained elusive. Four papers in this issue of Neuron address this function. These studies show that Arc/Arg3.1 regulates endophilin 3 and dynamin 2, two components of the endocytosis machinery. Genetic ablation of Arc/Arg3.1 in mice or overexpression in culture suggest that Arc/Arg3.1 regulates AMPA receptor trafficking and synaptic plasticity. Finally, Arc/Arg3.1 knockout mice show memory retention deficits. These recent developments provide new insights into the function of this popular activity-dependent neuronal marker.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tzingounis, AV (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	tzingoun@cmpmail.ucsf.edu; nicoll@cmp.ucsf.edu						Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hinshaw JE, 2000, ANNU REV CELL DEV BI, V16, P483, DOI 10.1146/annurev.cellbio.16.1.483; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kelly MP, 2003, J NEUROSCI, V23, P6443; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McIntyre CK, 2005, P NATL ACAD SCI USA, V102, P10718, DOI 10.1073/pnas.0504436102; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 2001, P NATL ACAD SCI USA, V98, P7062, DOI 10.1073/pnas.131146398; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Temple MD, 2003, J NEUROSCI, V23, P2779; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wallace CS, 1998, J NEUROSCI, V18, P26; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	47	196	206	2	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					403	407		10.1016/j.neuron.2006.10.016	http://dx.doi.org/10.1016/j.neuron.2006.10.016			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088207	Bronze			2022-12-28	WOS:000242269700004
J	Verde, EMR; Lee-Osbourne, J; Worley, PF; Malinow, R; Cline, HT				Verde, Emiliano M. Rial; Lee-Osbourne, Jane; Worley, Paul F.; Malinow, Roberto; Cline, Hollis T.			Increased expression of the immediate-early gene Arc/Arg3.1 reduces AMPA receptor-mediated synaptic transmission	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL ORGANOTYPIC CULTURES; CYTOSKELETON-ASSOCIATED PROTEIN; ARC MESSENGER-RNA; VISUAL-CORTEX; EXCITATORY SYNAPSES; RAT-BRAIN; C-FOS; PYRAMIDAL CELLS; AREA CA1	Arc/Arg3.1 is an immediate-early gene whose expression levels are increased by strong synaptic activation, including synapse-strengthening activity patterns. Arc/Arg3.1 mRNA is transported to activated dendritic regions, conferring the distribution of Arc/Arg3.1 protein both temporal correlation with the inducing stimulus and spatial specificity. Here, we investigate the effect of increased Arc/Arg3.1 levels on synaptic transmission. Surprisingly, Arc/Arg3.1 reduces the amplitude of synaptic currents mediated by AMPA-type glutamate receptors (AMPARs). This effect is prevented by RNA! knockdown of Arc/Arg3.1, by deleting a region of Arc/Arg3.1 known to interact with endophilin 3 or by blocking clathrin-coated endocytosis of AMPARs. In the hippocampal slice, Arc/Arg3.1 results in removal of AMPARs composed of GluR2 and GluR3 subunits (GluR2/3). Finally, Arc/Arg3.1 expression occludes NMDAR-dependent long-term depression. Our results demonstrate that Arc/Arg3.1 reduces the number of GluR2/3 receptors leading to a decrease in AMPAR-mediated synaptic currents, consistent with a role in the homeostatic regulation of synaptic strength.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Neurobiol & Behav, Moscow 117901, Russia; Johns Hopkins Med Sch, Baltimore, MD 21205 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Johns Hopkins University; Johns Hopkins Medicine; Cold Spring Harbor Laboratory	Cline, HT (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, POB 100, Cold Spring Harbor, NY 11724 USA.	cline@cshl.edu			NATIONAL EYE INSTITUTE [R01EY012102] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049159] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY012102] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NIMH NIH HHS [R01 MH049159] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Berger UV, 2003, J NEUROCHEM, V86, P896, DOI 10.1046/j.1471-4159.2003.01891.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; CASTREN E, 1993, NEUROREPORT, V4, P895, DOI 10.1097/00001756-199307000-00014; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; El-Hussein AE, 2000, SCIENCE, V290, P1364; FOSNAUGH JS, 1995, J NEUROCHEM, V64, P2377; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Kelly MP, 2003, J NEUROSCI, V23, P6443; Kelly MP, 2002, NEUROSCIENCE, V110, P617, DOI 10.1016/S0306-4522(01)00605-4; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; KURIZUKA H, 1999, NEUROREPORT, V10, P1717; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1999, IMAGING NEURONS LAB; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuo R, 2000, J NEUROCHEM, V74, P2239, DOI 10.1046/j.1471-4159.2000.0742239.x; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Montag-Sallaz M, 1999, J NEUROBIOL, V38, P234, DOI 10.1002/(SICI)1097-4695(19990205)38:2<234::AID-NEU6>3.0.CO;2-G; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLER D, 1993, DEV BRAIN RES, V71, P93, DOI 10.1016/0165-3806(93)90109-N; Musleh W, 1997, P NATL ACAD SCI USA, V94, P9451, DOI 10.1073/pnas.94.17.9451; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Ons S, 2004, J NEUROCHEM, V89, P1111, DOI 10.1111/j.1471-4159.2004.02396.x; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Rabinowitch I, 2006, J NEUROPHYSIOL, V96, P276, DOI 10.1152/jn.00074.2006; Rivera C, 2004, J NEUROSCI, V24, P4683, DOI 10.1523/JNEUROSCI.5265-03.2004; Sala C, 2003, J NEUROSCI, V23, P6327; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Wallace CS, 1998, J NEUROSCI, V18, P26; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	67	303	306	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					461	474		10.1016/j.neuron.2006.09.031	http://dx.doi.org/10.1016/j.neuron.2006.09.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088212	Green Accepted, Bronze			2022-12-28	WOS:000242269700009
J	del Rio, T; Feller, MB				del Rio, Tony; Feller, Maria B.			Early retinal activity and visual circuit development	NEURON			English	Editorial Material								Does spontaneous retinal activity prior to vision play a role in the establishment of visual maps? In this issue of Neuron, two separate papers by Huberman et al. and Hooks and Chen demonstrate a role for early spontaneous retinal activity in the establishment of ocular dominance columns and synaptic refinement at retinogeniculate synapses.	Univ Calif San Diego, Div Biol Sci, Neurobiol Sect 0357, La Jolla, CA 92093 USA	University of California System; University of California San Diego	del Rio, T (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect 0357, 3125A Pacific Hall, 9500 Gilman Dr, La Jolla, CA 92093 USA.							Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Demas J, 2003, J NEUROSCI, V23, P2851; Hanganu IL, 2006, J NEUROSCI, V26, P6728, DOI 10.1523/JNEUROSCI.0752-06.2006; Hensch TK, 2005, PROG BRAIN RES, V147, P115, DOI 10.1016/S0079-6123(04)47009-5; Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007; HUBERMAN AD, 2002, J NEUROSCI, V8, P1013; Huberman AD, 2006, NEURON, V52, P247, DOI 10.1016/j.neuron.2006.07.028; Kanold PO, 2006, NEURON, V51, P627, DOI 10.1016/j.neuron.2006.07.008; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Katz LC, 2002, NAT REV NEUROSCI, V3, P34, DOI 10.1038/nrn703; MOONEY R, 1993, NEURON, V10, P815, DOI 10.1016/0896-6273(93)90198-Z; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Torborg CL, 2005, PROG NEUROBIOL, V76, P213, DOI 10.1016/j.pneurobio.2005.09.002	13	13	13	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					221	222		10.1016/j.neuron.2006.10.001	http://dx.doi.org/10.1016/j.neuron.2006.10.001			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046683	Bronze			2022-12-28	WOS:000241799900001
J	Prado, VF; Martins-Silva, C; de Castro, BM; Lima, RF; Barros, DM; Amaral, E; Ramsey, AJ; Sotnikova, TD; Ramirez, MR; Kim, HG; Rossato, JI; Koenen, J; Hui, Q; Cota, VR; Moraes, MFD; Gomez, MV; Guatimosim, C; Wetsel, WC; Kushmerick, C; Pereira, GS; Gainetdinov, RR; Izquierdo, I; Caron, MG; Prado, MAM				Prado, Vania F.; Martins-Silva, Cristina; de Castro, Braulio M.; Lima, Ricardo F.; Barros, Daniela M.; Amaral, Ernani; Ramsey, Amy J.; Sotnikova, Tatyana D.; Ramirez, Maria R.; Kim, Hyung-Gun; Rossato, Janine I.; Koenen, Janaina; Hui Quan; Cota, Vinicius R.; Moraes, Marcio F. D.; Gomez, Marcus V.; Guatimosim, Cristina; Wetsel, William C.; Kushmerick, Christopher; Pereira, Grace S.; Gainetdinov, Raul R.; Izquierdo, Ivan; Caron, Marc G.; Prado, Marco A. M.			Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition	NEURON			English	Article							CHOLINERGIC GENE LOCUS; KNOCKOUT MICE; ALZHEIMERS-DISEASE; NEUROMUSCULAR-TRANSMISSION; SYNAPTIC VESICLES; MEMORY DEFICITS; ACETYLTRANSFERASE; RECEPTOR; LACKING; RATS	An important step for cholinergic transmission involves the vesicular storage of acetylcholine (ACh), a process mediated by the vesicular acetylcholine transporter (VAChT). In order to understand the physiological roles of the VAChT, we developed a genetically altered strain of mice with reduced expression of this transporter. Heterozygous and homozygous VAChT knockdown mice have a 45% and 65% decrease in VAChT protein expression, respectively. VAChT deficiency alters synaptic vesicle filling and affects ACh release. Whereas VAChT homozygous mutant mice demonstrate major neuromuscular deficits, VAChT heterozygous mice appear normal in that respect and could be used for analysis of central cholinergic function. Behavioral analyses revealed that aversive learning and memory are not altered in mutant mice; however, performance in cognitive tasks involving object and social recognition is severely impaired. These observations suggest a critical role of VAChT in the regulation of ACh release and physiological functions in the peripheral and central nervous system.	Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27710 USA; Univ Fed Minas Gerais, Dept Bioquim Imunol, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Farmacol, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Fisiol Biofis, BR-31270901 Belo Horizonte, MG, Brazil; Univ Fed Minas Gerais, Dept Morphol, Inst Ciencias Biol, BR-31270901 Belo Horizonte, MG, Brazil; Pontificia Univ Catolica Rio Grande do Sul, Hosp Sao Lucas, Inst Pesquisas Biomed, Ctr Memoria, BR-90610000 Porto Alegre, RS, Brazil	Duke University; Duke University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Pontificia Universidade Catolica Do Rio Grande Do Sul	Caron, MG (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	m.caron@cellbio.duke.edu; mprado@icb.ufmg.br	Lima, Ricardo/G-2946-2013; Pereira, Grace Schenatto/O-6860-2019; Pereira, Grace S/B-9698-2013; Rossato, Janine/E-9543-2014; Prado, Marco Antonio Maximo/K-7638-2013; Cota, Vinícius Rosa/F-1752-2018; Amaral, Ernani/GSN-9499-2022; Gomez, Marcus Vinicius/I-4081-2012; Prado, Vania Ferreira/K-7630-2013; Rossato, Janine Inez/AHD-3513-2022; Sotnikova, Tatyana D/T-9992-2017; Moraes, Marcio FD/D-5285-2014; Kushmerick, Christopher/G-3578-2012; Gainetdinov, Raul R/G-5875-2011; de Freitas Lima, Ricardo/T-7825-2017; Martins-Silva, Cristina/F-8053-2016	Pereira, Grace Schenatto/0000-0003-4371-7020; Pereira, Grace S/0000-0003-4371-7020; Prado, Marco Antonio Maximo/0000-0002-3028-5778; Cota, Vinícius Rosa/0000-0002-2338-5949; Amaral, Ernani/0000-0001-8314-9393; Gomez, Marcus Vinicius/0000-0002-6082-930X; Prado, Vania Ferreira/0000-0003-4994-6393; Rossato, Janine Inez/0000-0002-7980-5842; Moraes, Marcio FD/0000-0002-2034-1836; Gainetdinov, Raul R/0000-0003-2951-6038; de Freitas Lima, Ricardo/0000-0003-0250-5945; Izquierdo, Ivan/0000-0002-7208-0869; Ramsey, Amy/0000-0002-2717-5279	FOGARTY INTERNATIONAL CENTER [R03TW007025] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA013551] Funding Source: NIH RePORTER; FIC NIH HHS [R03 TW 007025-01A1] Funding Source: Medline; NIDA NIH HHS [DA 13551] Funding Source: Medline; NIMH NIH HHS [MH 60451] Funding Source: Medline; NINDS NIH HHS [NS 19576] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barros DM, 2002, BEHAV PHARMACOL, V13, P163, DOI 10.1097/00008877-200203000-00008; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; BEJANIN S, 1994, J BIOL CHEM, V269, P21944; Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Bielsky IF, 2004, PEPTIDES, V25, P1565, DOI 10.1016/j.peptides.2004.05.019; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Brandon EP, 1998, J NEUROSCI, V18, P3639; Cho GW, 2000, J BIOL CHEM, V275, P19942, DOI 10.1074/jbc.M902174199; Choleris E, 2003, P NATL ACAD SCI USA, V100, P6192, DOI 10.1073/pnas.0631699100; COLLIER B, 1986, J NEUROCHEM, V46, P822, DOI 10.1111/j.1471-4159.1986.tb13046.x; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Csernansky JG, 2005, NEUROPSYCHOPHARMACOL, V30, P2135, DOI 10.1038/sj.npp.1300761; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; de Lima MNM, 2005, EXP NEUROL, V196, P177, DOI 10.1016/j.expneurol.2005.07.017; Dewachter I, 2002, J NEUROSCI, V22, P3445; Eiden LE, 1998, J NEUROCHEM, V70, P2227; ELMQVIST D, 1965, J PHYSIOL-LONDON, V177, P463, DOI 10.1113/jphysiol.1965.sp007605; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson SM, 2004, P NATL ACAD SCI USA, V101, P8762, DOI 10.1073/pnas.0401667101; Fowler SC, 2002, INT J DEV NEUROSCI, V20, P309, DOI 10.1016/S0736-5748(02)00009-6; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Izquierdo I, 1997, NEUROBIOL LEARN MEM, V68, P285, DOI 10.1006/nlme.1997.3799; Izquierdo I, 2002, TRENDS NEUROSCI, V25, P77, DOI 10.1016/S0166-2236(02)02090-8; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Lorenzini CA, 1996, BRAIN RES, V730, P32, DOI 10.1016/0006-8993(96)00427-1; Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Parent MB, 2004, LEARN MEMORY, V11, P9, DOI 10.1101/lm.69104; PARSONS SM, 1993, INT REV NEUROBIOL, V35, P279, DOI 10.1016/S0074-7742(08)60572-3; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; PATON WDM, 1967, J PHYSIOL-LONDON, V191, P59, DOI 10.1113/jphysiol.1967.sp008237; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Prado MAM, 2002, NEUROCHEM INT, V41, P291, DOI 10.1016/S0197-0186(02)00044-X; Prediger RDS, 2006, EUR J PHARMACOL, V531, P176, DOI 10.1016/j.ejphar.2005.12.032; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; Ribeiro FM, 2006, J NEUROCHEM, V97, P1, DOI 10.1111/j.1471-4159.2006.03695.x; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; ROGHANI A, 1994, P NATL ACAD SCI USA, V91, P10620, DOI 10.1073/pnas.91.22.10620; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Van der Kloot W, 2003, PROG NEUROBIOL, V71, P269, DOI 10.1016/j.pneurobio.2003.10.003; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; WAUD DR, 1975, AM J PHYSIOL, V229, P1632, DOI 10.1152/ajplegacy.1975.229.6.1632; WINSLOW JT, 1995, PSYCHOPHARMACOLOGY, V121, P164, DOI 10.1007/BF02245626; Winslow JT, 2004, CURR OPIN NEUROBIOL, V14, P248, DOI 10.1016/j.conb.2004.03.009	53	185	187	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					601	612		10.1016/j.neuron.2006.08.005	http://dx.doi.org/10.1016/j.neuron.2006.08.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950158	Bronze			2022-12-28	WOS:000240623400009
J	Bender, VA; Feldman, DE				Bender, Vanessa A.; Feldman, Daniel E.			A dynamic spatial gradient of Hebbian learning in dendrites	NEURON			English	Editorial Material							SYNAPTIC PLASTICITY		Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Bender, VA (corresponding author), Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA.							Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Johnston D, 2003, PHILOS T ROY SOC B, V358, P667, DOI 10.1098/rstb.2002.1248; Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422	10	5	5	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					153	155		10.1016/j.neuron.2006.07.003	http://dx.doi.org/10.1016/j.neuron.2006.07.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846850	Bronze			2022-12-28	WOS:000239535100003
J	Fiebach, CJ; Rissman, J; D'Esposito, M				Fiebach, Christian J.; Rissman, Jesse; D'Esposito, Mark			Modulation of inferotemporal cortex activation during verbal working memory maintenance	NEURON			English	Article							EVENT-RELATED FMRI; SHORT-TERM-MEMORY; WORD FORM AREA; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; SYSTEM; DISSOCIATION; SIMILARITY; REHEARSAL; COMPONENT	Regions of the left inferotemporal cortex are involved in visual word recognition and semantics. We utilized functional magnetic resonance imaging to localize an inferotemporal language area and to demonstrate that this area is involved in the active maintenance of visually presented words in working memory. Maintenance activity in this inferotemporal area showed an effect of memory load for words, but not pseudowords. In the absence of visual input, the selective modulation of this language-related inferotemporal area for the maintenance of words is accompanied by an increased functional connectivity with left prefrontal cortex. These results demonstrate an involvement of inferotemporal cortex in verbal working memory and provide neurophysiological support for the notion that nonphonological language representations can be recruited in the service of verbal working memory. More generally, they suggest that verbal working memory should be conceptualized as the frontally guided, sustained activation of pre-existing cortical language representations.	Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Henry H Wheeler Jr Brain Imaging Ctr, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Fiebach, CJ (corresponding author), Univ Calif Berkeley, Dept Psychol, 132 Barker Hall, Berkeley, CA 94720 USA.	fiebach@uni-heidelberg.de	Rissman, Jesse/ABH-2217-2021; Fiebach, Christian/D-9540-2012	Rissman, Jesse/0000-0001-8889-5539; Fiebach, Christian/0000-0003-0827-1721	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS053323] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH063901, MH63901] Funding Source: Medline; NINDS NIH HHS [F31 NS053323-01, F31 NS053323, F31 NS053323-02] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andrews S, 1997, PSYCHON B REV, V4, P439, DOI 10.3758/BF03214334; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Baddeley A.D., 1999, MODELS WORKING MEMOR, P28, DOI DOI 10.1017/CBO9781139174909.005; BESNER D, 1982, CAN J PSYCHOL, V36, P701, DOI 10.1037/h0080665; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Bookheimer SY, 1995, HUM BRAIN MAPP, V3, P93, DOI 10.1002/hbm.460030206; BOURASSA DC, 1994, PSYCHON B REV, V1, P122, DOI 10.3758/BF03200768; Buchsbaum BR, 2005, NEURON, V48, P687, DOI 10.1016/j.neuron.2005.09.029; Cameron KA, 2005, PSYCHOPHYSIOLOGY, V42, P643, DOI 10.1111/j.1469-8986.2005.00357.x; Chao LL, 1998, J COGNITIVE NEUROSCI, V10, P167, DOI 10.1162/089892998562636; Chein JM, 2001, CEREB CORTEX, V11, P1003, DOI 10.1093/cercor/11.11.1003; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V23, P1256, DOI 10.1016/j.neuroimage.2004.07.052; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; COLTHEART M, 1981, Q J EXP PSYCHOL-A, V33, P497, DOI 10.1080/14640748108400805; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Cowan Nelson, 1999, MODELS WORKING MEMOR, P62, DOI [10.1017/CBO9781139174909.006, DOI 10.1017/CBO9781139174909.006]; CROWDER RG, 1993, MEM COGNITION, V21, P142, DOI 10.3758/BF03202725; Curtis CE, 2003, TRENDS COGN SCI, V7, P415, DOI 10.1016/S1364-6613(03)00197-9; Dehaene S, 2002, NEUROREPORT, V13, P321, DOI 10.1097/00001756-200203040-00015; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Druzgal TJ, 2001, COGNITIVE BRAIN RES, V10, P355, DOI 10.1016/S0926-6410(00)00056-2; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; Fiebach CJ, 2004, NEUROPSYCHOLOGIA, V42, P62, DOI 10.1016/S0028-3932(03)00145-3; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; FUSTER JM, 1981, SCIENCE, V212, P952, DOI 10.1126/science.7233192; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gazzaley Adam, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P580, DOI 10.3758/CABN.4.4.580; HULME C, 1991, J MEM LANG, V30, P685, DOI 10.1016/0749-596X(91)90032-F; Ishitobi M, 2000, NEUROREPORT, V11, P2997, DOI 10.1097/00001756-200009110-00034; Jonides J, 1998, J NEUROSCI, V18, P5026; Krauss GL, 1996, EPILEPSIA, V37, P476, DOI 10.1111/j.1528-1157.1996.tb00594.x; Kucera H., 1967, COMPUTATIONAL ANAL P; Logie RH, 2000, Q J EXP PSYCHOL-A, V53, P626, DOI 10.1080/027249800410463; Logothetis NK, 2003, J NEUROSCI, V23, P3963; LUDERS H, 1991, BRAIN, V114, P743, DOI 10.1093/brain/114.2.743; Malach R, 2002, TRENDS COGN SCI, V6, P176, DOI 10.1016/S1364-6613(02)01870-3; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Pessoa L, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P919; PETRIDES M, 2002, PRINCIPLES FRONTAL L, P31, DOI DOI 10.1093/ACPROF:OSO/9780195134971.003.0003; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; Ranganath C, 2004, COGNITIVE BRAIN RES, V20, P37, DOI 10.1016/j.cogbrainres.2003.11.017; Rissman J, 2004, NEUROIMAGE, V23, P752, DOI 10.1016/j.neuroimage.2004.06.035; Ruchkin DS, 2003, BEHAV BRAIN SCI, V26, P709, DOI 10.1017/S0140525X03000165; Schaffler L, 1996, EPILEPSIA, V37, P463, DOI 10.1111/j.1528-1157.1996.tb00593.x; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Turkeltaub PE, 2003, NAT NEUROSCI, V6, P767, DOI 10.1038/nn1065; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	60	85	88	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2006	51	2					251	261		10.1016/j.neuron.2006.06.007	http://dx.doi.org/10.1016/j.neuron.2006.06.007			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846859	Green Accepted, Bronze			2022-12-28	WOS:000239535100012
J	Voglmaier, SM; Kam, K; Yang, H; Fortin, DL; Hua, ZL; Nicoll, RA; Edwards, RH				Voglmaier, Susan M.; Kam, Kaiwen; Yang, Hua; Fortin, Doris L.; Hua, Zhaolin; Nicoll, Roger A.; Edwards, Robert H.			Distinct endocytic pathways control the rate and extent of synaptic vesicle protein recycling	NEURON			English	Article							VESICULAR GLUTAMATE TRANSPORTER; KISS-AND-RUN; TRANSMITTER RELEASE; SYNAPTOTAGMIN-I; C2B DOMAIN; ENDOPHILIN; MEMBRANE; CLATHRIN; SYNAPSES; ADAPTER	Synaptic vesicles have been proposed to form through two mechanisms: one directly from the plasma membrane involving clathrin-dependent endocytosis and the adaptor protein AP2, and the other from an endosomal intermediate mediated by the adaptor AP3. However, the relative role of these two mechanisms in synaptic vesicle recycling has remained unclear. We now find that vesicular glutamate transporter VGLUT1 interacts directly with endophilin, a component of the clathrin-dependent endocytic machinery. In the absence of its interaction with endophilin, VGLUT1 recycles more slowly during prolonged, high-frequency stimulation. Inhibition of the AP3 pathway with brefeldin A rescues the rate of recycling, suggesting a competition between AP2 and -3 pathways, with endophilin recruiting VGLUT1 toward the faster AP2 pathway. After stimulation, however, inhibition of the AP3 pathway prevents the full recovery of VGLUT1 by endocytosis, implicating the AP3 pathway specifically in compensatory endocytosis.	UCSF, Sch Med, Dept Neurol & Physiol, San Francisco, CA 94143 USA; UCSF, Sch Med, Dept Psychiat, San Francisco, CA 94143 USA; UCSF, Sch Med, Grad Program Cell Biol, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; UCSF, Sch Med, Grad Program Neurosci, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; UCSF, Sch Med, Grad Program Biomed Sci, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Edwards, RH (corresponding author), UCSF, Sch Med, Dept Neurol & Physiol, 600 16th St, San Francisco, CA 94143 USA.	robert.edwards@ucsf.edu		Hua, Zhaolin/0000-0001-9242-1387; Fortin, Doris/0000-0002-2729-7890	NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH060482, K08MH071626] Funding Source: NIH RePORTER; NIMH NIH HHS [K08 MH071626] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bonazzi M, 2005, NAT CELL BIOL, V7, P570, DOI 10.1038/ncb1260; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; de Lange RPJ, 2003, J NEUROSCI, V23, P10164; Deak F, 2004, NAT CELL BIOL, V6, P1102, DOI 10.1038/ncb1185; DEGOIS S, 2006, IN PRESS CELL MOL NE; DESNOS C, 1995, J CELL BIOL, V130, P1041, DOI 10.1083/jcb.130.5.1041; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Diril MK, 2006, DEV CELL, V10, P233, DOI 10.1016/j.devcel.2005.12.011; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gallop JL, 2005, NATURE, V438, P675, DOI 10.1038/nature04136; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Grass I, 2004, J BIOL CHEM, V279, P54872, DOI 10.1074/jbc.M409995200; GROTE E, 1995, CELL, V81, P581, DOI 10.1016/0092-8674(95)90079-9; Grote E, 1996, J CELL BIOL, V132, P537, DOI 10.1083/jcb.132.4.537; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holt M, 2003, J NEUROSCI, V23, P1329, DOI 10.1523/JNEUROSCI.23-04-01329.2003; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Li HY, 2005, NEURON, V48, P619, DOI 10.1016/j.neuron.2005.09.033; Micheva KD, 1997, FEBS LETT, V414, P308, DOI 10.1016/S0014-5793(97)01016-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nakatsu F, 2004, J CELL BIOL, V167, P293, DOI 10.1083/jcb.200405032; Nicholson-Tomishima K, 2004, P NATL ACAD SCI USA, V101, P16648, DOI 10.1073/pnas.0406968101; Paillart C, 2003, J NEUROSCI, V23, P4092; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Poskanzer KE, 2006, NEURON, V50, P49, DOI 10.1016/j.neuron.2006.02.021; Richards DA, 2003, NEURON, V39, P529, DOI 10.1016/S0896-6273(03)00405-7; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Salazar G, 2005, J CELL SCI, V118, P1911, DOI 10.1242/jcs.02319; Salazar G, 2004, MOL BIOL CELL, V15, P575, DOI 10.1091/mbc.E03-06-0401; Salem N, 1998, NAT NEUROSCI, V1, P551, DOI 10.1038/2787; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Seong E, 2005, MOL BIOL CELL, V16, P128, DOI 10.1091/mbc.E04-10-0892; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Staal RGW, 2004, NAT NEUROSCI, V7, P341, DOI 10.1038/nn1205; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tan PK, 1998, J BIOL CHEM, V273, P17351, DOI 10.1074/jbc.273.28.17351; Tang YT, 1999, P NATL ACAD SCI USA, V96, P12559, DOI 10.1073/pnas.96.22.12559; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	76	281	287	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					71	84		10.1016/j.neuron.2006.05.027	http://dx.doi.org/10.1016/j.neuron.2006.05.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815333	Bronze			2022-12-28	WOS:000239037700011
J	Samson, AL; Medcalf, RL				Samson, Andre L.; Medcalf, Robert L.			Tissue-type plasminogen activator: A multifaceted modulator of neurotransmission and synaptic plasticity	NEURON			English	Review							LONG-TERM POTENTIATION; PROTEOLYTIC ACTIVITY; INDUCED INCREASE; NMDA RECEPTORS; MESSENGER-RNA; LATE-PHASE; MICE; NEURONS; BRAIN; NEUROSERPIN	For over a decade, tissue-type plasminogen activator (t-PA), a serine protease classically known for its profibrinolytic role in the vasculature, has been implicated in numerous aspects of the synaptic plasticity process. But despite being the most intensively studied protease of the CNS, the mechanisms and molecular mediators behind the action of t-PA on synaptic efficacy remain largely undefined. Rather than examine the role of t-PA in proteolytic remodeling of the synaptic extracellular matrix, this review will focus on the evidence that defines t-PA as a direct modulator of neurotransmission and synaptic plasticity by impacting on glutamatergic and dopaminergic pathways.	Monash Univ, Australian Ctr Blood Dis, Alfred Med Res & Educ Project, Prahran, Vic 3181, Australia	Monash University	Medcalf, RL (corresponding author), Monash Univ, Australian Ctr Blood Dis, Alfred Med Res & Educ Project, Level 6 Burnet Bldg,89 Commercial Rd, Prahran, Vic 3181, Australia.	robert.medcalf@med.monash.edu.au	Medcalf, Robert L/E-9632-2011; Samson, Andre L/I-3432-2012	Samson, Andre L/0000-0003-4825-1645; Samson, Andre/0000-0002-0637-2716				Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Berardi N, 2004, NEURON, V44, P905, DOI 10.1016/S0896-6273(04)00796-2; Calabresi P, 2000, EUR J NEUROSCI, V12, P1002, DOI 10.1046/j.1460-9568.2000.00991.x; Centonze D, 2002, EUR J NEUROSCI, V16, P713, DOI 10.1046/j.1460-9568.2002.02106.x; Fernandez-Monreal M, 2004, J BIOL CHEM, V279, P50850, DOI 10.1074/jbc.M407069200; Hashimoto T, 1998, EUR J NEUROSCI, V10, P3387, DOI 10.1046/j.1460-9568.1998.00343.x; Huang YY, 1996, P NATL ACAD SCI USA, V93, P8699, DOI 10.1073/pnas.93.16.8699; INOUE K, 1994, NEUROSCI LETT, V179, P87, DOI 10.1016/0304-3940(94)90941-5; Kvajo M, 2004, J NEUROSCI, V24, P9734, DOI 10.1523/JNEUROSCI.3306-04.2004; LIOT G, 2000, J CEREB BLOOD FLOW M, V24, P1153; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; Madani R, 1999, EMBO J, V18, P3007, DOI 10.1093/emboj/18.11.3007; Makarova A, 2003, J BIOL CHEM, V278, P50250, DOI 10.1074/jbc.M309150200; Mars WM, 2005, BIOCHEM J, V390, P311, DOI 10.1042/BJ20042028; Matys T, 2003, NAT MED, V9, P371, DOI 10.1038/nm0403-371; May P, 2004, MOL CELL BIOL, V24, P8872, DOI 10.1128/MCB.24.20.8872-8883.2004; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Nagai T, 2004, P NATL ACAD SCI USA, V101, P3650, DOI 10.1073/pnas.0306587101; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Pawlak R, 2002, NEUROSCIENCE, V113, P995, DOI 10.1016/S0306-4522(02)00166-5; Pawlak R, 2003, NAT NEUROSCI, V6, P168, DOI 10.1038/nn998; Pawlak R, 2005, P NATL ACAD SCI USA, V102, P443, DOI 10.1073/pnas.0406454102; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; Shin CY, 2004, J NEUROSCI, V24, P9425, DOI 10.1523/JNEUROSCI.2457-04.2004; Strickland S, 2001, THROMB HAEMOSTASIS, V86, P138; Traynelis SF, 2001, NAT MED, V7, P17, DOI 10.1038/83289; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Yepes M, 2002, J CLIN INVEST, V109, P1571, DOI 10.1172/JCI200214308; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	30	161	168	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 1	2006	50	5					673	678		10.1016/j.neuron.2006.04.013	http://dx.doi.org/10.1016/j.neuron.2006.04.013			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731507	Bronze			2022-12-28	WOS:000238165000004
J	Choi, WY; Guitton, D				Choi, Woo Young; Guitton, Daniel			Responses of collicular fixation neurons to gaze shift perturbations in head-unrestrained monkey reveal gaze feedback control	NEURON			English	Article							STEM OMNIPAUSE NEURONS; SUPERIOR COLLICULUS; TECTORETICULOSPINAL SYSTEM; VESTIBULOOCULAR REFLEX; FREE CAT; EYE; SACCADES; CELLS; COORDINATION; STIMULATION	A prominent hypothesis in motor control is that endpoint errors are minimized because motor commands are updated in real time via internal feedback loops. We investigated in monkey whether orienting saccadic gaze shifts made in the dark with coordinated eye-head movements are controlled by feedback. We recorded from superior colliculus fixation neurons (SCFNs) that fired tonically during fixation and were silent during gaze shifts. When we briefly (<= 700 ms) interrupted gaze shifts by transiently braking head movements, SCFNs fired steadily during brake-induced gaze immobility, and their mean frequency was inversely related to the remaining distance between current gaze position and the target. After head release, a corrective gaze saccade brought gaze on the unseen goal, and SCFN firing frequency peaked. The results support gaze feedback control and show that the SC is part of a network that encodes, during orientation, the distance between eye and target, irrespective of gaze trajectory characteristics.	Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal, PQ H3A 2B4, Canada	McGill University; McGill University	Guitton, D (corresponding author), Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada.	daniel.guitton@mcgill.ca						Bergeron A, 2002, J NEUROPHYSIOL, V88, P1726, DOI 10.1152/jn.2002.88.4.1726; Bergeron A, 2003, NAT NEUROSCI, V6, P404, DOI 10.1038/nn1027; Bergeron A, 2000, NAT NEUROSCI, V3, P932, DOI 10.1038/78847; Buttner-Ennever JA, 1999, J COMP NEUROL, V413, P55, DOI 10.1002/(SICI)1096-9861(19991011)413:1<55::AID-CNE3>3.0.CO;2-K; Coimbra AJF, 2000, J NEUROPHYSIOL, V83, P1103, DOI 10.1152/jn.2000.83.2.1103; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Freedman EG, 2001, BIOL CYBERN, V84, P453, DOI 10.1007/PL00007989; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; GALIANA HL, 1992, ANN NY ACAD SCI, V656, P452; Gandhi NJ, 1999, J NEUROPHYSIOL, V82, P3236, DOI 10.1152/jn.1999.82.6.3236; Goossens HHLM, 2000, J NEUROPHYSIOL, V83, P3430, DOI 10.1152/jn.2000.83.6.3430; Guitton D, 2004, METH NE FRO NEUROSCI, P241; GUITTON D, 1987, J NEUROPHYSIOL, V58, P427, DOI 10.1152/jn.1987.58.3.427; GUITTON D, 1984, J NEUROPHYSIOL, V52, P1030, DOI 10.1152/jn.1984.52.6.1030; Keller EL, 2004, METH NE FRO NEUROSCI, P277; KELLER EL, 1994, J NEUROPHYSIOL, V72, P2754, DOI 10.1152/jn.1994.72.6.2754; Klier EM, 2001, NAT NEUROSCI, V4, P627, DOI 10.1038/88450; Krauzlis RJ, 1997, SCIENCE, V276, P1693, DOI 10.1126/science.276.5319.1693; LAURUTIS VP, 1986, J PHYSIOL-LONDON, V373, P209, DOI 10.1113/jphysiol.1986.sp016043; Lefevre P, 1998, NEURAL NETWORKS, V11, P1175, DOI 10.1016/S0893-6080(98)00071-9; Matsuo S, 2004, J NEUROSCI, V24, P2760, DOI 10.1523/JNEUROSCI.5120-03.2004; Moschovakis AK, 1996, PROG NEUROBIOL, V50, P133, DOI 10.1016/S0301-0082(96)00034-2; Munoz DP, 1998, J NEUROPHYSIOL, V79, P1193, DOI 10.1152/jn.1998.79.3.1193; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; Pare M, 1998, J NEUROPHYSIOL, V79, P3060, DOI 10.1152/jn.1998.79.6.3060; PELISSON D, 1995, EXP BRAIN RES, V106, P196; Phillips JO, 1999, J NEUROPHYSIOL, V81, P1284, DOI 10.1152/jn.1999.81.3.1284; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999; Roy JE, 1998, NAT NEUROSCI, V1, P404, DOI 10.1038/1619; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Soetedjo R, 2002, J NEUROPHYSIOL, V87, P679, DOI 10.1152/jn.00886.2000; Sparks DL, 2004, METH NE FRO NEUROSCI, P303; Sparks DL, 1999, CURR OPIN NEUROBIOL, V9, P698, DOI 10.1016/S0959-4388(99)00039-2; Stanford TR, 1996, J NEUROPHYSIOL, V76, P3360, DOI 10.1152/jn.1996.76.5.3360; Takahashi M, 2005, J NEUROPHYSIOL, V94, P1707, DOI 10.1152/jn.00347.2005; TOMLINSON RD, 1990, J NEUROPHYSIOL, V64, P1873, DOI 10.1152/jn.1990.64.6.1873; Waitzman DM, 2002, ANN NY ACAD SCI, V956, P111, DOI 10.1111/j.1749-6632.2002.tb02813.x; WAITZMAN DM, 1991, J NEUROPHYSIOL, V66, P1716, DOI 10.1152/jn.1991.66.5.1716; Yoshida K, 2001, J NEUROPHYSIOL, V85, P2639, DOI 10.1152/jn.2001.85.6.2639	45	31	32	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					491	505		10.1016/j.neuron.2006.03.032	http://dx.doi.org/10.1016/j.neuron.2006.03.032			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675402	Bronze			2022-12-28	WOS:000237726800017
J	Hanley, JG; Henley, JM				Hanley, JG; Henley, JM			Picking out the details of cerebellar LTD	NEURON			English	Editorial Material							LONG-TERM DEPRESSION; AMPA-RECEPTOR TRAFFICKING; GLUR2/3; DOMAINS	Cerebellar long-term depression is thought to underlie motor learning and is mediated by internalization of AMPA receptors from the neuronal plasma membrane. In this issue of Neuron, Steinberg et al. provide firm evidence that PICK1 and the C terminus of GluR2 are central to this process by analyzing three different transgenic mice.	Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Univ Walk, Bristol BS8 1TD, Avon, England.		Jack, Anthony Ian/AAJ-7153-2021; Henley, Jeremy M/A-2776-2009	Jack, Anthony Ian/0000-0001-9613-3964; Henley, Jeremy/0000-0003-3589-8335; Hanley, Jonathan/0000-0003-1704-4707	Medical Research Council [G9629038] Funding Source: Medline; MRC [G9629038] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Greger IH, 2002, NEURON, V34, P759, DOI 10.1016/S0896-6273(02)00693-1; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Jin WY, 2006, J NEUROSCI, V26, P2380, DOI 10.1523/JNEUROSCI.3503-05.2006; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Leitges M, 2004, NEURON, V44, P585, DOI 10.1016/j.neuron.2004.10.024; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	11	3	3	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					778	780		10.1016/j.neuron.2006.03.003	http://dx.doi.org/10.1016/j.neuron.2006.03.003			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543122	Green Accepted, Bronze			2022-12-28	WOS:000236227500002
J	Johnson, KG; Tenney, AP; Ghose, A; Duckworth, AM; Higashi, ME; Parfitt, K; Marcu, O; Heslip, TR; Marsh, JL; Schwarz, TL; Flanagan, JG; Van Vactor, D				Johnson, KG; Tenney, AP; Ghose, A; Duckworth, AM; Higashi, ME; Parfitt, K; Marcu, O; Heslip, TR; Marsh, JL; Schwarz, TL; Flanagan, JG; Van Vactor, D			The HSPGs syndecan and dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN-TYROSINE PHOSPHATASES; AXON GUIDANCE; NERVOUS-SYSTEM; II RECEPTOR; GROWTH; DLAR; IDENTIFICATION; ORGANIZATION; CASK/LIN-2	The formation and plasticity of synaptic connections rely on regulatory interactions between pre- and postsynaptic cells. We show that the Drosophila heparan sulfate proteoglycans (HSPGs) Syndecan (Sdc) and Dallylike (Dlp) are synaptic proteins necessary to control distinct aspects of synaptic biology. Sdc promotes the growth of presynaptic terminals, whereas Dip regulates active zone form and function. Both Sdc and Dlp bind at high affinity to the protein tyrosine phosphatase LAR, a conserved receptor that controls both NMJ growth and active zone morphogenesis. These data and double mutant assays showing a requirement of LAR for actions of both HSPGs lead to a model in which presynaptic LAR is under complex control, with Sdc promoting and Dip inhibiting LAR in order to control synapse morphogenesis and function.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Childrens Hosp, Program Neurobiol, Boston, MA 02115 USA; Pomona Coll, Dept Biol, Claremont, CA 91711 USA; Pomona Coll, Program Neurosci, Claremont, CA 91711 USA; Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92697 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Claremont Colleges; Pomona College; Claremont Colleges; Pomona College; University of California System; University of California Irvine; University of California System; University of California Irvine	Van Vactor, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.	davie@hms.harvard.edu	Flanagan, John/AAM-2995-2020	Van Vactor, Jr., David L./0000-0001-8156-9482; Johnson, Karl/0000-0003-3931-5985	NICHD NIH HHS [HD36081, HD36049] Funding Source: Medline; NINDS NIH HHS [NS40043, NS41062] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036049, R01HD036081] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS040043, R01NS041062] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Cheng HJ, 2000, METH MOL B, V124, P313; Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Flanagan JG, 2000, METHOD ENZYMOL, V327, P19, DOI 10.1016/S0076-6879(00)27264-9; Fox AN, 2005, CURR BIOL, V15, P1701, DOI 10.1016/j.cub.2005.08.035; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Han C, 2004, DEVELOPMENT, V131, P601, DOI 10.1242/dev.00958; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Krueger NX, 2003, MOL CELL BIOL, V23, P6909, DOI 10.1128/MCB.23.19.6909-6921.2003; Lauri SE, 1999, J NEUROSCI, V19, P1226; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Sajnani G, 2005, J NEUROBIOL, V65, P59, DOI 10.1002/neu.20175; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; Van Vactor D, 2006, CURR OPIN NEUROBIOL, V16, P40, DOI 10.1016/j.conb.2006.01.011; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Veraksa A, 2005, DEV DYNAM, V232, P827, DOI 10.1002/dvdy.20272; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Worby C A, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.95.pl1; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Yamaguchi Y, 2001, SEMIN CELL DEV BIOL, V12, P99, DOI 10.1006/scdb.2000.0238; Zhai RG, 2004, PHYSIOLOGY, V19, P262, DOI 10.1152/physiol.00014.2004; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	45	185	188	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					517	531		10.1016/j.neuron.2006.01.026	http://dx.doi.org/10.1016/j.neuron.2006.01.026			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476662	Bronze, Green Submitted			2022-12-28	WOS:000235643800006
J	Palfreyman, M; Jorgensen, EM				Palfreyman, Mark; Jorgensen, Erik M.			PKC defends crown against Munc13	NEURON			English	Editorial Material							PROTEIN-KINASE-C; PHORBOL ESTER RECEPTOR; CAENORHABDITIS-ELEGANS; TRANSMITTER RELEASE; UNC-13 GENE; PHOSPHORYLATION; BINDING; BETA	Protein kinase C has long been thought to mediate DAG signaling at the synapse. Recently PKC has been supplanted by members of the Unc13 family as the predominant effectors of DAG signaling. Thanks to a study by Wierda and colleagues in this issue of Neuron, PKC returns to reclaim part of the kingdom: both pathways must be active to activate presynaptic potentiation.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu						AHMED S, 1992, BIOCHEM J, V287, P995, DOI 10.1042/bj2870995; Basu J, 2007, J NEUROSCI, V27, P1200, DOI 10.1523/JNEUROSCI.4908-06.2007; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Feng H, 2006, J BIOL CHEM, V281, P17801, DOI 10.1074/jbc.M511899200; KIKKAWA U, 1984, ADV CYCLIC NUCL PROT, V17, P437; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Majewski H, 1997, CLIN EXP PHARMACOL P, V24, P619, DOI 10.1111/j.1440-1681.1997.tb02102.x; MALENKA RC, 1986, J NEUROSCI, V6, P475; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; ONO Y, 1989, P NATL ACAD SCI USA, V86, P3099, DOI 10.1073/pnas.86.9.3099; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Sassa T, 1999, J NEUROSCI, V19, P4772; Sieburth D, 2007, NAT NEUROSCI, V10, P49, DOI 10.1038/nn1810; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Wierda KDB, 2007, NEURON, V54, P275, DOI 10.1016/j.neuron.2007.04.001	15	3	4	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 19	2007	54	2					179	180		10.1016/j.neuron.2007.04.002	http://dx.doi.org/10.1016/j.neuron.2007.04.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	163VF	17442237	Bronze			2022-12-28	WOS:000246190600001
J	Baxter, MG; Browning, PGF				Baxter, Mark G.; Browning, Philip G. F.			Two wrongs make a right: Deficits in reversal learning after orbitofrontal damage are improved by amygdala ablation	NEURON			English	Editorial Material							PREFRONTAL CORTEX; LESIONS; MEMORY	Impaired cognitive flexibility after orbitofrontal damage has informed theories of orbitofrontal function and prefrontal cortex function generally. In this issue of Neuron, Stalnaker et al. demonstrate that reversal learning deficits after orbitofrontal damage in rats are eliminated by additional lesions of the basolateral amygdala. The involvement of orbitofrontal cortex in cognitive flexibility is via its interaction with the amygdala, and perhaps other brain areas, rather than an intrinsic property of this cortical region.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Baxter, MG (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.		Browning, Philip/M-8917-2015	Browning, Philip/0000-0002-8327-2946				Gaffan D, 2005, SCIENCE, V309, P2172, DOI 10.1126/science.1119445; Gallagher M, 1999, J NEUROSCI, V19, P6610; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kim JJ, 2001, TRENDS NEUROSCI, V24, P324, DOI 10.1016/S0166-2236(00)01818-X; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; RUSHWORTH MF, 2007, IN PRESS TRENDS COGN; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Stalnaker TA, 2007, NEURON, V54, P51, DOI 10.1016/j.neuron.2007.02.014; VONBONIN G, 1960, CEREBRAL CORTEX	12	6	6	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					1	3		10.1016/j.neuron.2007.03.008	http://dx.doi.org/10.1016/j.neuron.2007.03.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408569	Bronze			2022-12-28	WOS:000245848400001
J	Iadecola, C				Iadecola, Costantino			Astrocytes take center stage in salt sensing	NEURON			English	Editorial Material							NEURONS; SODIUM; BRAIN; ANGIOTENSIN; GLUCOSE; CHANNEL	Salt sensing is essential for maintaining sodium and water balance. Shimizu et al. in this issue of Neuron provide evidence that subfornical organ astrocytes act as "salt sensors" and, using lactate as a signal, control the activity of local neurons that initiate neural, hormonal, and behavioral responses underlying sodium homeostasis.	Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA	Cornell University	Iadecola, C (corresponding author), Cornell Univ, Dept Neurol & Neurosci, Weill Med Coll, New York, NY 10021 USA.	coi2001@med.cornell.edu	Iadecola, c/ABB-8377-2020	Iadecola, Costantino/0000-0001-9797-073X				Burdakov D, 2005, PHILOS T R SOC B, V360, P2227, DOI 10.1098/rstb.2005.1763; Davisson RL, 2003, AM J PHYSIOL-REG I, V285, pR498, DOI 10.1152/ajpregu.00190.2003; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; Noda M, 2006, NEUROSCIENTIST, V12, P80, DOI 10.1177/1073858405279683; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; Shimizu H, 2007, NEURON, V54, P59, DOI 10.1016/j.neuron.2007.03.014; Skott O, 2003, AM J PHYSIOL-REG I, V285, pR14, DOI 10.1152/ajpregu.00100.2003; Song Z, 2005, DIABETES, V54, P15, DOI 10.2337/diabetes.54.1.15; Watanabe E, 2000, J NEUROSCI, V20, P7743	12	8	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					3	5		10.1016/j.neuron.2007.03.013	http://dx.doi.org/10.1016/j.neuron.2007.03.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408570	Bronze			2022-12-28	WOS:000245848400002
J	Bats, C; Groc, L; Choquet, D				Bats, Cecile; Groc, Laurent; Choquet, Daniel			The interaction between stargazin and PSD-95 regulates AMPA receptor surface trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; EXCITATORY SYNAPSES; GLUTAMATE RECEPTORS; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; MOLECULAR-MECHANISMS; DEPENDENT REGULATION; DIFFUSION DYNAMICS; LATERAL MOVEMENTS	Accumulation of AMPA receptors at synapses is a fundamental feature of glutamatergic synaptic transmission. Stargazin, a member of the TARP family, is an AMPAR auxiliary subunit allowing interaction of the receptor with scaffold proteins of the postsynaptic density, such as PSD-95. How PSD-95 and Stargazin regulate AMPAR number in synaptic membranes remains elusive. We show, using single quantum dot and FRAP imaging in live hippocampal neurons, that exchange of AMPAR by lateral diffusion between extrasynaptic and synaptic sites mostly depends on the interaction of Stargazin with PSD-95 and not upon the GluR2 AMPAR subunit C terminus. Disruption of interactions between Stargazin and PSD-95 strongly increases AMPAR surface diffusion, preventing AMPAR accumulation at postsynaptic sites. Furthermore, AMPARs and Stargazin diffuse as complexes in and out synapses. These results propose a model in which the StargazinPSD-95 interaction plays a key role to trap and transiently stabilize diffusing AMPARs in the postsynaptic density.	Univ Bordeaux, Inst Francois Magendie, CNRS, UMR 5091, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Choquet, D (corresponding author), Univ Bordeaux, Inst Francois Magendie, CNRS, UMR 5091, F-33077 Bordeaux, France.	dchoquet@u-bordeaux2.fr	Choquet, Daniel/GOJ-8825-2022; Choquet, Daniel/K-7893-2018; Choquet, Daniel/E-4203-2013	Choquet, Daniel/0000-0003-4726-9763; Choquet, Daniel/0000-0003-4726-9763; Bats, Cecile/0000-0002-2246-7248				Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; AEL DE, 2002, CELL, V108, P849; Andrasfalvy BK, 2004, J PHYSIOL-LONDON, V559, P543, DOI 10.1113/jphysiol.2004.065219; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BAUDE A, 1995, NEUROSCIENCE, V69, P1031, DOI 10.1016/0306-4522(95)00350-R; Beique JC, 2003, J PHYSIOL-LONDON, V546, P859, DOI 10.1113/jphysiol.2002.031369; Beique JC, 2006, P NATL ACAD SCI USA, V103, P19535, DOI 10.1073/pnas.0608492103; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Braithwaite SP, 2000, NEUROPHARMACOLOGY, V39, P919, DOI 10.1016/S0028-3908(99)00171-9; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choquet D, 2003, NAT REV NEUROSCI, V4, P251, DOI 10.1038/nrn1077; Christopherson KS, 2003, J CELL SCI, V116, P3213, DOI 10.1242/jcs.00617; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cognet L., 2006, SCI STKE, V2006, ppe13, DOI DOI 10.1126/STKE.3272006PE13; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; DeSouza S, 2002, J NEUROSCI, V22, P3493; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehrlich I, 2004, J NEUROSCI, V24, P916, DOI 10.1523/JNEUROSCI.4733-03.2004; El-Hussein AE, 2000, SCIENCE, V290, P1364; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Falk J, 2004, MOL BIOL CELL, V15, P4695, DOI 10.1091/mbc.E04-03-0171; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Meier J, 2001, NAT NEUROSCI, V4, P253, DOI 10.1038/85099; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; Okabe S, 2001, J NEUROSCI, V21, P9561, DOI 10.1523/JNEUROSCI.21-24-09561.2001; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perez JL, 2001, J NEUROSCI, V21, P5417, DOI 10.1523/JNEUROSCI.21-15-05417.2001; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Rao A, 1998, J NEUROSCI, V18, P1217; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Serge A, 2002, J NEUROSCI, V22, P3910, DOI 10.1523/JNEUROSCI.22-10-03910.2002; Sharma K, 2006, MOL CELL NEUROSCI, V31, P702, DOI 10.1016/j.mcn.2006.01.010; Sheng M, 2001, P NATL ACAD SCI USA, V98, P7058, DOI 10.1073/pnas.111146298; Song I, 2002, TRENDS NEUROSCI, V25, P578, DOI 10.1016/S0166-2236(02)02270-1; Stein V, 2003, J NEUROSCI, V23, P5503; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Triller A, 2003, BIOL CELL, V95, P465, DOI 10.1016/j.biolcel.2003.07.001; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X	75	405	418	0	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					719	734		10.1016/j.neuron.2007.01.030	http://dx.doi.org/10.1016/j.neuron.2007.01.030			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329211	Bronze			2022-12-28	WOS:000245127100012
J	Herz, J				Herz, Joachim			Overview: The long and winding road to understanding Alzheimer's disease	NEURON			English	Letter							AMYLOID PRECURSOR PROTEIN; APP; GENE; TIP60; FE65		Univ Texas SW, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Herz, J (corresponding author), Univ Texas SW, Dept Mol Genet, Dallas, TX 75390 USA.	joachim.herz@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL063762] Funding Source: NIH RePORTER; NHLBI NIH HHS [R37 HL063762] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Guenette S, 2006, EMBO J, V25, P420, DOI 10.1038/sj.emboj.7600926; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a	16	6	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					477	479		10.1016/j.neuron.2007.02.001	http://dx.doi.org/10.1016/j.neuron.2007.02.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296548	Bronze			2022-12-28	WOS:000245126900005
J	Kempermann, G				Kempermann, Gerd			They are not too excited: The possible role of adult-born neurons in epilepsy	NEURON			English	Editorial Material							SEIZURE-INDUCED NEUROGENESIS; HIPPOCAMPAL PROGENITOR CELLS; TEMPORAL-LOBE EPILEPSY; DENTATE GYRUS; GRANULE CELLS; PROLIFERATION; DISPERSION	In a new study in this issue of Neuron, Jakubs and colleagues report that adult-generated hippocampal granule cells develop particular functional properties when their birth is induced by epileptic seizures. The new neurons showed reduced excitatory synaptic input and decreased excitability. Their functional integration was thus adjusted to the prevailing functional state in the network. By this means, adult neurogenesis might contribute to network homeostasis in the epileptic temporal lobe.	Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kempermann, G (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.		Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Bengzon J, 1997, P NATL ACAD SCI USA, V94, P10432, DOI 10.1073/pnas.94.19.10432; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; GOULD E, 1994, ANN NY ACAD SCI, V743, P73, DOI 10.1111/j.1749-6632.1994.tb55788.x; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Jakubs K, 2006, NEURON, V52, P1047, DOI 10.1016/j.neuron.2006.11.004; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Parent JM, 2006, ANN NEUROL, V59, P81, DOI 10.1002/ana.20699; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, EPILEPSY RES, V50, P179, DOI 10.1016/S0920-1211(02)00078-5; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; Scharfman HE, 2000, J NEUROSCI, V20, P6144, DOI 10.1523/JNEUROSCI.20-16-06144.2000; Shapiro LA, 2005, NEUROSCIENCE, V136, P823, DOI 10.1016/j.neuroscience.2005.03.059; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558	17	19	19	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					935	937		10.1016/j.neuron.2006.12.004	http://dx.doi.org/10.1016/j.neuron.2006.12.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178397	Bronze			2022-12-28	WOS:000243115100002
J	Han, SK; Mancino, V; Simon, MI				Han, Sang-Kyou; Mancino, Valeria; Simon, Melvin I.			Phospholipase C beta 3 mediates the scratching response activated by the histamine H1 receptor on C-fiber nociceptive neurons	NEURON			English	Article							DORSAL-ROOT-GANGLIA; SENSORY NEURONS; MESSENGER-RNA; MAST-CELLS; CALCIUM HOMEOSTASIS; MOLECULAR-CLONING; NERVE-FIBERS; SUBSTANCE-P; EXPRESSION; PROTEIN	Phospholipase C beta (PLC beta) isozymes represent a family of molecules that link G protein-coupled receptors (GPCRs) to an intracellular signaling network. Here, we investigated the function of PLC beta isozymes in sensory neurons by using mutant mice deficient for specific PLC beta family members. Expression analysis indicated that PLC beta 3, one of the four isoforms, is predominantly expressed in a subpopulation of C-fiber nociceptors. A subset of these neurons expressed the histamine H1 receptor. Ca2+ imaging studies revealed that PLC beta 3 specifically mediates histamineinduced calcium responses through the histamine H1 receptor in cultured sensory neurons. In line with this, we found that PLC beta 3(-/-) mice showed significant defects in scratching behavior induced by histamine; histamine-trifluoromethyl-toluidine(HTMT), a selective H1 agonist; and compound 48/80, a mast cell activator. These results demonstrate that PLC beta 3 is required to mediate "itch" sensation in response to histamine acting on the histamine H1 receptor in C-fiber nociceptive neurons.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Simon, MI (corresponding author), CALTECH, Div Biol, 147-75, Pasadena, CA 91125 USA.	simonm@caltech.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499] Funding Source: NIH RePORTER; NINDS NIH HHS [NS048499] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bachert C, 2002, ALLERGY, V57, P287, DOI 10.1034/j.1398-9995.2002.1r3542.x; Bell JK, 2004, BRIT J PHARMACOL, V142, P374, DOI 10.1038/sj.bjp.0705754; Botchkarev VA, 1997, ARCH DERMATOL RES, V289, P292, DOI 10.1007/s004030050195; Braz JM, 2005, NEURON, V47, P787, DOI 10.1016/j.neuron.2005.08.015; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chopra B, 2000, EUR J NEUROSCI, V12, P911, DOI 10.1046/j.1460-9568.2000.00979.x; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; FJAELLBRANDT N, 1961, J PHYSIOL-LONDON, V156, P578, DOI 10.1113/jphysiol.1961.sp006694; GRAHAM DT, 1951, J CLIN INVEST, V30, P37, DOI 10.1172/JCI102414; Guo Q, 2001, BRAIN RES, V903, P13, DOI 10.1016/S0006-8993(01)02304-6; HAAKSMA EEJ, 1990, PHARMACOL THERAPEUT, V47, P73, DOI 10.1016/0163-7258(90)90046-5; HAGERMARK O, 1979, ACTA DERM-VENEREOL, V59, P297; Hagforsen E, 2000, ARCH DERMATOL RES, V292, P269, DOI 10.1007/s004030000132; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; HANDWERKER HO, 1991, J NEUROPHYSIOL, V66, P307, DOI 10.1152/jn.1991.66.1.307; HANDWERKER HO, 1987, FINE EFFERENT NERVE; Hunt SP, 2001, NAT REV NEUROSCI, V2, P83, DOI 10.1038/35053509; Inagaki N, 2002, EUR J PHARMACOL, V448, P175, DOI 10.1016/S0014-2999(02)01933-7; Inagaki N, 2001, SKIN PHARMACOL APPL, V14, P87, DOI 10.1159/000056338; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kasai M, 1998, NEUROSCI RES, V32, P231, DOI 10.1016/S0168-0102(98)00092-3; Kashiba H, 1999, MOL BRAIN RES, V66, P24, DOI 10.1016/S0169-328X(98)00346-5; Keller JN, 1997, NEUROSCIENCE, V80, P685, DOI 10.1016/S0306-4522(97)00065-1; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; LAWSON SN, 1991, J PHYSIOL-LONDON, V435, P41, DOI 10.1113/jphysiol.1991.sp018497; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QP, 2000, NEUROREPORT, V11, P4003, DOI 10.1097/00001756-200012180-00020; MAGERL W, 1991, ALLERGOLOGIE, V14, P395; MAGERL W, 1990, J INVEST DERMATOL, V94, P347, DOI 10.1111/1523-1747.ep12874474; Matsubara M, 2005, BIOCHEM PHARMACOL, V69, P433, DOI 10.1016/j.bcp.2004.10.006; MCMAHON SB, 1992, TRENDS NEUROSCI, V15, P497, DOI 10.1016/0166-2236(92)90102-E; Miyasaka H, 2003, LIMNOLOGY, V4, P1, DOI 10.1007/s10201-002-0088-4; Miyata M, 2001, EUR J NEUROSCI, V13, P1945, DOI 10.1046/j.0953-816x.2001.01570.x; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Molliver DC, 2002, EUR J NEUROSCI, V16, P1850, DOI 10.1046/j.1460-9568.2002.02253.x; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; Nakayama Y, 2002, METHOD FIND EXP CLIN, V24, P267, DOI 10.1358/mf.2002.24.5.802303; Nicolson TA, 2002, NEUROSCIENCE, V110, P329, DOI 10.1016/S0306-4522(01)00561-9; Oda T, 2000, J BIOL CHEM, V275, P36781, DOI 10.1074/jbc.M006480200; OHKUBO T, 1995, EUR J PHARMACOL, V273, P83, DOI 10.1016/0014-2999(94)00668-W; Perez SE, 1999, DEVELOPMENT, V126, P1715; Ranganathan R, 1997, CURR BIOL, V7, pR770, DOI 10.1016/S0960-9822(06)00401-5; Rees JL, 1999, CLIN EXP DERMATOL, V24, P490; Rubio JP, 1999, GENOMICS, V57, P84, DOI 10.1006/geno.1999.5758; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Schmelz M, 2001, NAT NEUROSCI, V4, P9, DOI 10.1038/82956; Seabrook GR, 1997, NEUROPHARMACOLOGY, V36, P1009, DOI 10.1016/S0028-3908(97)00065-8; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stucky CL, 2004, PAIN, V109, P36, DOI 10.1016/j.pain.2004.01.007; Sugimoto Y, 1998, EUR J PHARMACOL, V351, P1, DOI 10.1016/S0014-2999(98)00288-X; THAYER SA, 1988, J NEUROSCI, V8, P4089; TUCKETT RP, 1987, BRAIN RES, V413, P95, DOI 10.1016/0006-8993(87)90157-0; Ueno S, 1999, BRIT J PHARMACOL, V126, P429, DOI 10.1038/sj.bjp.0702319; Wallengren Joanna, 2005, Dermatol Ther, V18, P292; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Xie W, 1999, P NATL ACAD SCI USA, V96, P10385, DOI 10.1073/pnas.96.18.10385; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhou YX, 2005, BIOCHEM J, V391, P667, DOI 10.1042/BJ20050839; Zhu Y, 2001, MOL PHARMACOL, V59, P434, DOI 10.1124/mol.59.3.434; Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	66	129	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					691	703		10.1016/j.neuron.2006.09.036	http://dx.doi.org/10.1016/j.neuron.2006.09.036			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114052	Bronze			2022-12-28	WOS:000242413100015
J	Soler-Llavina, GJ; Chang, TH; Swartz, KJ				Soler-Llavina, Gilberto J.; Chang, Tsg-Hui; Swartz, Kenton J.			Functional interactions at the interface between voltage-sensing and pore domains in the shaker K-v channel	NEURON			English	Article							GATED POTASSIUM CHANNELS; GATING CURRENTS; OPEN-STATE; HELICAL STRUCTURE; CHARGE MOVEMENT; ACTIVATION GATE; ION CHANNELS; S4 SEGMENT; SENSOR; PROTEIN	Voltage-activated potassium (K-v) channels contain a central pore domain that is partially surrounded by four voltage-sensing domains. Recent X-ray structures suggest that the two domains lack extensive protein-protein contacts within presumed transmembrane regions, but whether this is the case for functional channels embedded in lipid membranes remains to be tested. We investigated domain interactions in the Shaker Kv channel by systematically mutating the pore domain and assessing tolerance by examining channel maturation, S4 gating charge movement, and channel opening. When mapped onto the X-ray structure of the K(v)1.2 channel the large number of permissive mutations support the notion of relatively independent domains, consistent with crystallographic studies. Inspection of the maps also identifies portions of the interface where residues are sensitive to mutation, an external cluster where mutations hinder voltage sensor activation, and an internal cluster where domain interactions between S4 and S5 helices from adjacent subunits appear crucial for the concerted opening transition.	NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	swartzk@ninds.nih.gov			Intramural NIH HHS [ZIA NS002945-13] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002945] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; ARMSTRONG CM, 1973, NATURE, V242, P459, DOI 10.1038/242459a0; Bezanilla F, 1998, METHOD ENZYMOL, V293, P331; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; del Camino D, 2005, J GEN PHYSIOL, V126, P419, DOI 10.1085/jgp.200509385; Ding SH, 2001, BIOCHEMISTRY-US, V40, P10707, DOI 10.1021/bi010709y; GARCIA ML, 1994, BIOCHEMISTRY-US, V33, P6834, DOI 10.1021/bi00188a012; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Horn R, 2000, J GEN PHYSIOL, V116, P461, DOI 10.1085/jgp.116.3.461; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jan LY, 1997, J PHYSIOL-LONDON, V505, P267, DOI 10.1111/j.1469-7793.1997.267bb.x; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Kanevsky M, 1999, J GEN PHYSIOL, V114, P215, DOI 10.1085/jgp.114.2.215; Kitaguchi T, 2004, J GEN PHYSIOL, V124, P319, DOI 10.1085/jgp.200409098; Kobertz WR, 2000, BIOCHEMISTRY-US, V39, P10347, DOI 10.1021/bi001292j; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Li-Smerin Y, 1998, P NATL ACAD SCI USA, V95, P8585, DOI 10.1073/pnas.95.15.8585; Li-Smerin Y, 2001, J GEN PHYSIOL, V117, P205, DOI 10.1085/jgp.117.3.205; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Lu Z, 2002, J GEN PHYSIOL, V120, P663, DOI 10.1085/jgp.20028696; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pathak M, 2005, J GEN PHYSIOL, V125, P57, DOI 10.1085/jgp.200409197; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; Piper David R., 2005, V266, P46; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; SANTACRUZTOLOZA L, 1994, BIOCHEMISTRY-US, V33, P5607, DOI 10.1021/bi00184a033; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schoppa NE, 1998, J GEN PHYSIOL, V111, P295, DOI 10.1085/jgp.111.2.295; SCHULTEIS CT, 1995, BIOCHEMISTRY-US, V34, P1725, DOI 10.1021/bi00005a029; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Starkus JG, 1998, J GEN PHYSIOL, V112, P85, DOI 10.1085/jgp.112.1.85; STEFANI E, 1994, BIOPHYS J, V66, P996, DOI 10.1016/S0006-3495(94)80881-1; Sukhareva M, 2003, J GEN PHYSIOL, V122, P541, DOI 10.1085/jgp.200308905; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	66	81	81	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					623	634		10.1016/j.neuron.2006.10.005	http://dx.doi.org/10.1016/j.neuron.2006.10.005			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114047	Bronze			2022-12-28	WOS:000242413100010
J	de Araujo, IE; Gutierrez, R; Oliveira-Maia, AJ; Pereira, A; Nicolelis, MAL; Simon, SA				de Araujo, Ivan E.; Gutierrez, Ranier; Oliveira-Maia, Albino J.; Pereira, Antonio, Jr.; Nicolelis, Miguel A. L.; Simon, Sidney A.			Neural ensemble coding of satiety states	NEURON			English	Article							CONTROLLING FOOD-INTAKE; HYPOTHALAMIC FUNCTION; ORBITOFRONTAL CORTEX; GLUCOSE; RESPONSES; NEURONS; LEPTIN; HUNGER; MONKEY; PALATABILITY	The motivation to start or terminate a meal involves the continual updating of information on current body status by central gustatory and reward systems. Previous electrophysiological and neuroimaging investigations revealed region-specific decreases in activity as the subject's state transitions from hunger to satiety. By implanting bundles of microelectrodes in the lateral hypothalamus, orbitofrontal cortex, insular cortex, and amygdala of hungry rats that voluntarily eat to satiety, we have measured the behavior of neuronal populations through the different phases of a complete feeding cycle (hunger-satiety-hunger). Our data show that while most satiety-sensitive units preferentially responded to a unique hunger phase within a cycle, neuronal populations integrated single-unit information in order to reflect the animal's motivational state across the entire cycle, with higher activity levels during the hunger phases. This distributed population code might constitute a neural mechanism underlying meal initiation under different metabolic states.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Anesthesiol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr Neuroimaging, Durham, NC 27710 USA; Univ Porto, Inst Histol & Embriol, Fac Med, P-4200319 Oporto, Portugal; Univ Porto, Inst Biol Mol & Celular, P-4200319 Oporto, Portugal	Duke University; Duke University; Duke University; Duke University; Universidade do Porto; Universidade do Porto	de Araujo, IE (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	araujo@neuro.duke.edu	Oliveira-Maia, AJ/B-7976-2009; Gutierrez, Ranier/B-8130-2011; Pereira, Antonio/AAY-4372-2020	Oliveira-Maia, AJ/0000-0001-5071-3007; Gutierrez, Ranier/0000-0002-9688-0289; Pereira, Antonio/0000-0002-0808-1058; De Araujo, Ivan/0000-0003-3081-3339	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001065] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-01065] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; BURTON MJ, 1976, EXP NEUROL, V51, P668, DOI 10.1016/0014-4886(76)90189-8; Chapelot D, 2000, AM J CLIN NUTR, V72, P421; Cummings DE, 2004, AM J PHYSIOL-ENDOC M, V287, pE297, DOI 10.1152/ajpendo.00582.2003; de Araujo IET, 2003, J NEUROPHYSIOL, V90, P1865, DOI 10.1152/jn.00297.2003; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Elmquist JK, 2005, J COMP NEUROL, V493, P63, DOI 10.1002/cne.20786; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Gutierrez R, 2006, J NEUROPHYSIOL, V95, P119, DOI 10.1152/jn.00467.2005; HANSSON AC, 2006, IN PRESS GENETIC IMP, DOI DOI 10.1038/SJ.NPP.1301034; Hinton EC, 2004, EUR J NEUROSCI, V20, P1411, DOI 10.1111/j.1460-9568.2004.03589.x; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Kissileff HR, 2003, AM J PHYSIOL-REG I, V285, pR992, DOI 10.1152/ajpregu.00272.2003; Liu YJ, 2000, NATURE, V405, P1058, DOI 10.1038/35016590; Mahankali S, 2000, MAGNET RESON MED, V43, P155, DOI 10.1002/(SICI)1522-2594(200001)43:1<155::AID-MRM20>3.0.CO;2-5; Matsuda M, 1999, DIABETES, V48, P1801, DOI 10.2337/diabetes.48.9.1801; NAKANO Y, 1986, BRAIN RES, V399, P167, DOI 10.1016/0006-8993(86)90613-X; NAKANO Y, 1984, BRAIN RES BULL, V12, P381, DOI 10.1016/0361-9230(84)90109-6; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; Nicolelis MAL, 1998, NAT NEUROSCI, V1, P621, DOI 10.1038/2855; O'Doherty J, 2000, NEUROREPORT, V11, P399, DOI 10.1097/00001756-200002070-00035; OOMURA Y, 1974, NATURE, V247, P284, DOI 10.1038/247284a0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Petrovich GD, 2002, J NEUROSCI, V22, P8748; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; ROLLS ET, 1981, AMYGDALOID COMPLEX, P383; SCLAFANI A, 1976, PHYSIOL BEHAV, V17, P461, DOI 10.1016/0031-9384(76)90109-8; SCLAFANI A, 1976, PHYSIOL BEHAV, V16, P355, DOI 10.1016/0031-9384(76)90144-X; Sclafani A, 1996, AM J PHYSIOL-REG I, V270, pR1197, DOI 10.1152/ajpregu.1996.270.6.R1197; Shiraishi T, 1999, NUTRITION, V15, P576, DOI 10.1016/S0899-9007(99)00088-X; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Smeets PAM, 2005, NEUROIMAGE, V24, P363, DOI 10.1016/j.neuroimage.2004.07.073; Strader AD, 2005, GASTROENTEROLOGY, V128, P175, DOI 10.1053/j.gastro.2004.10.043; TEITELBAUM P, 1954, SCIENCE, V120, P894, DOI 10.1126/science.120.3126.894; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; YAMAMOTO T, 1984, BRAIN RES BULL, V12, P441, DOI 10.1016/0361-9230(84)90117-5; Zheng HY, 2005, J COMP NEUROL, V485, P127, DOI 10.1002/cne.20515	39	98	100	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					483	494		10.1016/j.neuron.2006.07.009	http://dx.doi.org/10.1016/j.neuron.2006.07.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908413	Bronze			2022-12-28	WOS:000240504700011
J	Schnupp, J				Schnupp, Jan			Auditory filters, features, and redundant representations	NEURON			English	Editorial Material							CORTEX; SYSTEM	Responses in auditory cortex tend to be weaker, more phasic, and noisier than those of auditory brainstem and midbrain nuclei. Is the activity in cortex therefore merely a "degraded echo" of lower-level neural representations? In this issue of Neuron, Chechik and colleagues show that, while cortical responses indeed convey less sensory information than auditory midbrain neurons, their responses are also much less redundant.	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Schnupp, J (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg, Oxford OX1 3PT, England.		schnupp, jan/A-3006-2012	schnupp, jan w h/0000-0002-2604-0057				[Anonymous], 1998, NEURAL NETWORKS BRAI; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Elliffe MCM, 2002, BIOL CYBERN, V86, P59, DOI 10.1007/s004220100284; Escabi MA, 2003, J NEUROSCI, V23, P11489; Garcia-Lazaro JA, 2006, CURR BIOL, V16, P264, DOI 10.1016/j.cub.2005.12.013; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; ROLLS ET, 1995, BEHAV BRAIN RES, V66, P177, DOI 10.1016/0166-4328(94)00138-6; Schnupp JWH, 2006, J NEUROSCI, V26, P4785, DOI 10.1523/JNEUROSCI.4330-05.2006; Wang XQ, 2001, J NEUROPHYSIOL, V86, P2616, DOI 10.1152/jn.2001.86.5.2616	11	6	6	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					278	280		10.1016/j.neuron.2006.07.016	http://dx.doi.org/10.1016/j.neuron.2006.07.016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880121	Bronze			2022-12-28	WOS:000239908800002
J	van Ooyen, A; Roelfsema, PR				van Ooyen, A; Roelfsema, PR			Envisioning the reward	NEURON			English	Editorial Material								The primary visual cortex (area V1) is for vision. At least, that is what most researchers believe. However, in a recent issue of Science, Shuler and Bear demonstrate a correlate of reward timing in area V1. This surprising result indicates that brain circuits for reward processing are more extensive than expected and that area V1 has more functionality than previously thought.	Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; Netherlands Inst Neurosci, Dept Vis & Cognit, NL-1105 BA Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	van Ooyen, A (corresponding author), Vrije Univ Amsterdam, Dept Expt Neurophysiol, Ctr Neurogenom & Cognit Res, Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.		Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034				Glimcher PW, 2003, ANNU REV NEUROSCI, V26, P133, DOI 10.1146/annurev.neuro.26.010302.081134; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Pennartz CMA, 1995, BRAIN RES REV, V21, P219, DOI 10.1016/0165-0173(95)00014-3; Roelfsema PR, 2005, NEURAL COMPUT, V17, P2176, DOI 10.1162/0899766054615699; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schwartz S, 2002, P NATL ACAD SCI USA, V99, P17137, DOI 10.1073/pnas.242414599; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444	14	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					188	190		10.1016/j.neuron.2006.04.008	http://dx.doi.org/10.1016/j.neuron.2006.04.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630831	Bronze			2022-12-28	WOS:000237176700007
J	Vislay-Meltzer, R; Kampff, AR; Engert, F				Vislay-Meltzer, R; Kampff, AR; Engert, F			Spatiotemporal specificity of neuronal activity directs the modification of receptive fields in the developing retinotectal system	NEURON			English	Article							LONG-TERM POTENTIATION; TIMING-DEPENDENT PLASTICITY; VISUAL-CORTEX; STROBOSCOPIC ILLUMINATION; SYNAPTIC MODIFICATIONS; INPUT SPECIFICITY; PYRAMIDAL CELLS; STRIATE CORTEX; BARREL CORTEX; INDUCTION	The precise temporal relation between pre- and postsynaptic activity modulates the strength of synaptic connections. Despite its extensive characterization in vivo and in vitro, the degree to which spike timing-dependent plasticity can shape receptive field properties is unclear. We use in vivo patch-clamp recordings of tectal neurons in developing Xenopus tadpoles to control the precise timing of action potentials with respect to the arrival of a subset of visual inputs evoked by local light stimulation on the retina. The pattern of visual inputs onto a tectal neuron was tracked over time by rapid reverse correlation mapping of receptive fields. Spike timing-dependent potentiation or depression of a subset of synapses reliably shifts the spatial receptive fields toward or away from the trained subregion of visual space, respectively. These results demonstrate that natural patterns of activity evoked by sensory stimuli play an instructive role in the developing nervous system.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Vislay-Meltzer, R (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	vislay@mcb.harvard.edu; florian@mcb.harvard.edu		Kampff, Adam/0000-0003-3079-019X	NEI NIH HHS [R01 EY0144429-01A2] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1996, CEREB CORTEX, V6, P498, DOI 10.1093/cercor/6.3.498; Bell CC, 1997, J NEUROSCI, V17, P6409; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Celikel T, 2004, NAT NEUROSCI, V7, P534, DOI 10.1038/nn1222; CYNADER M, 1973, P NATL ACAD SCI USA, V70, P1353, DOI 10.1073/pnas.70.5.1353; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBOER E, 1968, IEEE T BIO-MED ENG, VBM15, P169, DOI 10.1109/TBME.1968.4502561; Debski EA, 2002, CURR OPIN NEUROBIOL, V12, P93, DOI 10.1016/S0959-4388(02)00295-7; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Fregnac Y, 1999, J NEUROBIOL, V41, P69; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Linkenhoker BA, 2002, NATURE, V419, P293, DOI 10.1038/nature01002; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Murphy GG, 1997, SCIENCE, V278, P467, DOI 10.1126/science.278.5337.467; NIEUWKOOP PD, 1967, NORMAL TABLE XENOPOU; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Rao RPN, 2001, NEURAL COMPUT, V13, P2221, DOI 10.1162/089976601750541787; SCHMIDT JT, 1985, NEUROSCIENCE, V14, P535, DOI 10.1016/0306-4522(85)90308-2; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sin WC, 2002, NATURE, V419, P475, DOI 10.1038/nature00987; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Tao HW, 2005, NEURON, V45, P829, DOI 10.1016/j.neuron.2005.01.046; Tao HZW, 2001, NEURON, V31, P569, DOI 10.1016/S0896-6273(01)00393-2; Touryan J, 2002, J NEUROSCI, V22, P10811; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	51	48	51	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					101	114		10.1016/j.neuron.2006.02.016	http://dx.doi.org/10.1016/j.neuron.2006.02.016			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600859	Bronze			2022-12-28	WOS:000236811300014
J	Stettler, DD; Yamahachi, H; Li, W; Denk, W; Gilbert, CD				Stettler, DD; Yamahachi, H; Li, W; Denk, W; Gilbert, CD			Axons and synaptic boutons are highly dynamic in adult visual cortex	NEURON			English	Article							DENDRITIC SPINE STABILITY; IN-VIVO; CORTICAL REORGANIZATION; HORIZONTAL CONNECTIONS; INTRINSIC CONNECTIONS; NEUROMUSCULAR-JUNCTIONS; TRANSGENE EXPRESSION; BRANCH DYNAMICS; PYRAMIDAL CELL; STRIATE CORTEX	While recent studies of synaptic stability in adult cerebral cortex have focused on dendrites, how much axons change is unknown. We have used advances in axon labeling by viruses and in vivo two-photon microscopy to investigate axon branching and bouton dynamics in primary visual cortex (V1) of adult Macaque monkeys. A nonreplicative adeno-associated virus bearing the gene for enhanced green fluorescent protein (AAV.EGFP) provided persistent labeling of axons, and a custom-designed two-photon microscope enabled repeated imaging of the intact brain over several weeks. We found that large-scale branching patterns were stable but that a subset of small branches associated with terminaux boutons, as well as a subset of en passant boutons, appeared and disappeared every week. Bouton losses and gains were both similar to 7% of the total population per week, with no net change in the overall density. These results suggest ongoing processes of synaptogenesis and elimination in adult V1.	Rockefeller Univ, New York, NY 10021 USA; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Rockefeller University; Max Planck Society	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.	gilbert@rockefeller.edu	denk, winfried/I-6627-2012; Li, Wu/G-9415-2011; Li, Wu/AHA-4320-2022	Li, Wu/0000-0002-2175-4579; 	NEI NIH HHS [EY 012896] Funding Source: Medline; NATIONAL EYE INSTITUTE [R24EY012896] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmed B, 1997, J COMP NEUROL, V380, P230; Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; AMIR Y, 1993, J COMP NEUROL, V334, P19, DOI 10.1002/cne.903340103; Anderson JC, 2005, J COMP NEUROL, V488, P320, DOI 10.1002/cne.20580; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; Anderson JC, 2001, NAT NEUROSCI, V4, P1166, DOI 10.1038/nn772; Anderson JC, 1998, J NEUROSCI, V18, P10525; ANTONINI A, 1993, J NEUROSCI, V13, P3549; Arckens L, 2000, EUR J NEUROSCI, V12, P4222, DOI 10.1046/j.0953-816X.2000.01328.x; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; BLASDEL GG, 1985, J NEUROSCI, V5, P3350; BRAITENBERG V, 1998, CORTEX STT GEOMETRY; Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; CALFORD MB, 1988, NATURE, V332, P446, DOI 10.1038/332446a0; Calford MB, 2003, J NEUROSCI, V23, P6434; CALLAWAY EM, 1990, J NEUROSCI, V10, P1134; Chamberlin NL, 1998, BRAIN RES, V793, P169, DOI 10.1016/S0006-8993(98)00169-3; CHINO YM, 1991, J NEUROPHYSIOL, V65, P841, DOI 10.1152/jn.1991.65.4.841; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Foa L, 2001, NAT NEUROSCI, V4, P499, DOI 10.1038/87447; FRIEDLANDER MJ, 1991, J NEUROSCI, V11, P3268; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; GILBERT CD, 1983, J NEUROSCI, V3, P1116; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Javaherian A, 2005, NEURON, V45, P505, DOI 10.1016/j.neuron.2004.12.051; Johnson FA, 1999, J COMP NEUROL, V406, P548, DOI 10.1002/(SICI)1096-9861(19990419)406:4<548::AID-CNE8>3.0.CO;2-3; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kasthuri N, 2003, NATURE, V424, P426, DOI 10.1038/nature01836; Kerschensteiner M, 2005, NAT MED, V11, P572, DOI 10.1038/nm1229; Kincaid AE, 1998, J NEUROSCI, V18, P4722, DOI 10.1523/jneurosci.18-12-04722.1998; KISVARDAY ZF, 1986, EXP BRAIN RES, V64, P541, DOI 10.1007/BF00340492; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; Lubke J, 2003, CEREB CORTEX, V13, P1051, DOI 10.1093/cercor/13.10.1051; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Nguyen QT, 2002, NAT NEUROSCI, V5, P861, DOI 10.1038/nn905; Pan YA, 2003, J NEUROSCI, V23, P11479; PETERS A, 1980, J NEUROCYTOL, V9, P163, DOI 10.1007/BF01205156; Peters A., 1991, FINE STRUCTURE NERVO; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; PONS TP, 1991, SCIENCE, V252, P1857, DOI 10.1126/science.1843843; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schmid LM, 1996, CEREB CORTEX, V6, P388, DOI 10.1093/cercor/6.3.388; Schmidt JT, 2004, J NEUROBIOL, V58, P328, DOI 10.1002/neu.10286; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; SCHUZ A, 1985, NEUROSCIENCE, V15, P33, DOI 10.1016/0306-4522(85)90120-4; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; SOMOGYI P, 1978, NEUROSCIENCE, V3, P167, DOI 10.1016/0306-4522(78)90099-4; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; Surace EM, 2003, J VIROL, V77, P7957, DOI 10.1128/JVI.77.14.7957-7963.2003; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Walsh MK, 2003, NEURON, V37, P67, DOI 10.1016/S0896-6273(02)01142-X; WINFIELD DA, 1981, NEUROSCIENCE, V6, P1217, DOI 10.1016/0306-4522(81)90183-4; Xiao WD, 1999, J VIROL, V73, P3994, DOI 10.1128/JVI.73.5.3994-4003.1999; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	97	184	192	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					877	887		10.1016/j.neuron.2006.02.018	http://dx.doi.org/10.1016/j.neuron.2006.02.018			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543135	Bronze			2022-12-28	WOS:000236227500015
J	Nitz, DA				Nitz, DA			Tracking route progression in the posterior parietal cortex	NEURON			English	Article							HIPPOCAMPAL-NEURONS; ASSOCIATION CORTEX; DIRECTION CELLS; UNIT-ACTIVITY; VISUAL SPACE; SPATIAL MAP; PLACE CELLS; MOTION; MEMORY; REPRESENTATION	Quick and efficient traversal of learned routes is critical to the survival of many animals. Routes can be defined by both the ordering of navigational epochs, such as continued forward motion or execution of a turn, and the distances separating them. The neural substrates conferring the ability to fluidly traverse complex routes are not well understood, but likely entail interactions between frontal, parietal, and rhinal cortices and the hippocampus. This paper demonstrates that posterior parietal cortical neurons map both individual and multiple navigational epochs with respect to their order in a route. In direct contrast to spatial firing patterns of hippocampal neurons, parietal neurons discharged in a place- and direction-independent fashion. Parietal route maps were scalable and versatile in that they were independent of the size and spatial configuration of navigational epochs. The results provide a framework in which to consider parietal function in spatial cognition.	Inst Neurosci, San Diego, CA 92121 USA		Nitz, DA (corresponding author), Inst Neurosci, San Diego, CA 92121 USA.	nitz@nsi.edu						ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Averbeck BB, 2002, P NATL ACAD SCI USA, V99, P13172, DOI 10.1073/pnas.162485599; Baeg EH, 2003, NEURON, V40, P177, DOI 10.1016/S0896-6273(03)00597-X; Berthoz A, 1997, PHILOS T R SOC B, V352, P1437, DOI 10.1098/rstb.1997.0130; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Cacucci F, 2004, J NEUROSCI, V24, P8265, DOI 10.1523/JNEUROSCI.2635-04.2004; CHEN LL, 1994, EXP BRAIN RES, V101, P24, DOI 10.1007/BF00243213; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Crowe DA, 2004, CEREB CORTEX, V14, P23, DOI 10.1093/cercor/bhg088; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; FERRERA VP, 1994, J NEUROSCI, V14, P6171; Fisher NI, 1995, STAT ANAL CIRCULAR D; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; FOSTER TC, 1989, SCIENCE, V244, P1580, DOI 10.1126/science.2740902; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Froehler MT, 2002, SCIENCE, V295, P2462, DOI 10.1126/science.1067426; Fukushima K, 1997, EXP BRAIN RES, V117, P1, DOI 10.1007/PL00005786; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Ilg UJ, 2004, NEURON, V43, P145, DOI 10.1016/j.neuron.2004.06.006; Jarosiewicz B, 2004, J NEUROSCI, V24, P5070, DOI 10.1523/JNEUROSCI.5650-03.2004; KAWANO K, 1980, NEUROSCI LETT, V17, P55, DOI 10.1016/0304-3940(80)90061-0; Kesner RP, 1991, CEREB CORTEX, V1, P367, DOI 10.1093/cercor/1.5.367; Klam F, 2003, ANN NY ACAD SCI, V1004, P271, DOI 10.1196/annals.1303.024; KOLB B, 1987, BEHAV BRAIN RES, V23, P127, DOI 10.1016/0166-4328(87)90050-7; Li CSR, 2001, EXP BRAIN RES, V137, P45, DOI 10.1007/s002210000546; MCNAUGHTON BL, 1994, CEREB CORTEX, V4, P27, DOI 10.1093/cercor/4.1.27; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; NEWSOME WT, 1988, J NEUROSCI, V8, P2201; Nitz D, 2004, J NEUROPHYSIOL, V91, P863, DOI 10.1152/jn.00614.2003; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; REEP RL, 1994, EXP BRAIN RES, V100, P67; SAVE E, 1992, BEHAV NEUROSCI, V106, P447, DOI 10.1037/0735-7044.106.3.447; Save E, 1996, BEHAV NEUROSCI, V110, P74; Sharp PE, 1999, BEHAV NEUROSCI, V113, P643, DOI 10.1037/0735-7044.113.4.643; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; STEINMETZ MA, 1987, J NEUROSCI, V7, P177; TANJI J, 1994, NATURE, V371, P413, DOI 10.1038/371413a0; WITTER MP, 1993, HIPPOCAMPUS, V3, P33; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4	48	120	121	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					747	756		10.1016/j.neuron.2006.01.037	http://dx.doi.org/10.1016/j.neuron.2006.01.037			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504949	Bronze			2022-12-28	WOS:000236070600015
J	Borgland, SL; Taha, SA; Sarti, F; Fields, HL; Bonci, A				Borgland, SL; Taha, SA; Sarti, F; Fields, HL; Bonci, A			Orexin A in the VTA is critical for the induction of synaptic plasticity and Behavioral Sensitization to cocaine	NEURON			English	Article							VENTRAL TEGMENTAL AREA; METHYL-D-ASPARTATE; PROTEIN-KINASE-C; LONG-TERM POTENTIATION; NMDA RECEPTORS; RAT-BRAIN; HYPOTHALAMIC NEUROPEPTIDES; DOPAMINERGIC-NEURONS; NUCLEUS-ACCUMBENS; EXPRESSION	Dopamine neurons in the ventral tegmental area (VTA) represent a critical site of synaptic plasticity induced by addictive drugs. Orexin/hypocretin-containing neurons in the lateral hypothalamus project to the VTA, and behavioral studies have suggested that orexin neurons play an important role in motivation, feeding, and adaptive behaviors. However, the role of orexin signaling in neural plasticity is poorly understood. The present study shows that in vitro application of orexin A induces potentiation of N-methyl-D-aspartate receptor (NMDAR)-mediated neurotransmission via a PLC/PKC-dependent insertion of NMDARs in VTA dopamine neuron synapses. Furthermore, in vivo administration of an orexin 1 receptor antagonist blocks locomotor sensitization to cocaine and occludes cocaine-induced potentiation of excitatory currents in VTA dopamine neurons. These results provide in vitro and in vivo evidence for a critical role of orexin signaling in the VTA in neural plasticity relevant to addiction.	Univ Calif San Francisco, Ernest Gallo Clin, San Francisco, CA 94110 USA; Univ Calif San Francisco, Res Ctr, Dept Neurol, San Francisco, CA 94110 USA; Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bonci, A (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin, San Francisco, CA 94110 USA.	bonci@itsa.ucsf.edu	Fields, Howard/ABG-9073-2020; Borgland, Stephanie/M-2936-2016; Borgland, Stephanie/GPC-5260-2022	Borgland, Stephanie/0000-0001-7546-5687; Borgland, Stephanie/0000-0001-7546-5687	NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015096] Funding Source: NIH RePORTER; NIDA NIH HHS [1R01 DA15096-01] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Bernardis LL, 1996, NEUROSCI BIOBEHAV R, V20, P189, DOI 10.1016/0149-7634(95)00015-1; Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Carlezon WA, 2002, TRENDS NEUROSCI, V25, P610, DOI 10.1016/S0166-2236(02)02289-0; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; DiLeone RJ, 2003, LIFE SCI, V73, P759, DOI 10.1016/S0024-3205(03)00408-9; Dunah AW, 1996, J NEUROCHEM, V67, P2335; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Fadel J, 2002, NEUROSCIENCE, V111, P379, DOI 10.1016/S0306-4522(02)00017-9; Feng BH, 2004, BRIT J PHARMACOL, V141, P508, DOI 10.1038/sj.bjp.0705644; Fitzgerald LW, 1996, J NEUROSCI, V16, P274; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Georgescu D, 2003, J NEUROSCI, V23, P3106; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; JOHNSON SW, 1992, SCIENCE, V258, P665, DOI 10.1126/science.1329209; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 2005, J PHYSIOL-LONDON, V569, P209, DOI 10.1113/jphysiol.2005.095554; Kauer JA, 2004, ANNU REV PHYSIOL, V66, P447, DOI 10.1146/annurev.physiol.66.032102.112534; Kim JA, 2004, P NATL ACAD SCI USA, V101, P5664, DOI 10.1073/pnas.0401373101; Komendantov AO, 2004, J NEUROPHYSIOL, V91, P346, DOI 10.1152/jn.00062.2003; Korotkova TM, 2003, J NEUROSCI, V23, P7; LACEY MG, 1990, BRIT J PHARMACOL, V99, P731, DOI 10.1111/j.1476-5381.1990.tb12998.x; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LEVITT DR, 1975, P NATL ACAD SCI USA, V72, P2819, DOI 10.1073/pnas.72.7.2819; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Margolis EB, 2003, J NEUROSCI, V23, P9981; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; OVERTON P, 1992, SYNAPSE, V10, P131, DOI 10.1002/syn.890100208; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Overton PG, 1999, NEUROREPORT, V10, P221, DOI 10.1097/00001756-199902050-00004; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paxinos G., 1998, RAT BRAIN STEROTAXIC; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; ROUTTENBERG A, 1965, J COMP PHYSIOL PSYCH, V60, P158, DOI 10.1037/h0022365; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHIPPENBERG TS, 1995, J PHARMACOL EXP THER, V273, P808; STANDAERT DG, 1994, J COMP NEUROL, V343, P1, DOI 10.1002/cne.903430102; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Tovar KR, 2002, NEURON, V34, P253; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Uramura K, 2001, NEUROREPORT, V12, P1885, DOI 10.1097/00001756-200107030-00024; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Wayner MJ, 2004, PEPTIDES, V25, P991, DOI 10.1016/j.peptides.2004.03.018; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Wise RA, 1996, ANNU REV NEUROSCI, V19, P319, DOI 10.1146/annurev.ne.19.030196.001535; Wisor JP, 2001, J NEUROSCI, V21, P1787, DOI 10.1523/JNEUROSCI.21-05-01787.2001; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	67	570	603	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					589	601		10.1016/j.neuron.2006.01.016	http://dx.doi.org/10.1016/j.neuron.2006.01.016			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476667	Bronze			2022-12-28	WOS:000235643800011
J	Stalnaker, TA; Franz, TM; Singh, T; Schoenbaum, G				Stalnaker, Thomas A.; Franz, Theresa M.; Singh, Teghpal; Schoenbaum, Geoffrey			Basolateral amygdala lesions abolish orbitofrontal-dependent reversal impairments	NEURON			English	Article							ORBITAL PREFRONTAL CORTEX; NEURONAL-ACTIVITY; REWARD VALUE; BEHAVIORAL FLEXIBILITY; HIPPOCAMPAL-LESIONS; OUTCOME EXPECTANCY; ANTERIOR CINGULATE; DORSAL STRIATUM; FRONTAL-CORTEX; STIMULUS	Damage to orbitofrontal cortex (OFC) has long been associated with deficits in reversal learning. OFC damage also causes inflexible associative encoding in basolateral amygdala (ABL) during reversal learning. Here we provide a critical test of the hypothesis that the reversal deficit in OFC-lesioned rats is caused by this inflexible encoding in ABL. Rats with bilateral neurotoxic lesions of OFC, ABL, or both areas were tested on a series of two-odor go/no-go discrimination problems, followed by two serial reversals of the final problem. As expected, all groups acquired the initial problems at the same rate, and rats with OFC lesions were slower to acquire the reversals than sham controls. This impairment was abolished by accompanying ABL lesions, while ABL lesions alone had no effect on reversal learning. These results are consistent with the hypothesis that OFC facilitates cognitive flexibility by promoting updating of associative encoding in downstream brain areas.	Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Program Neurosci, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Dept Psychiat, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Psychol, Catonsville, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Stalnaker, TA (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	tstal002@umaryland.edu			NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000054] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015718] Funding Source: NIH RePORTER; NIDA NIH HHS [R01-DA015718] Funding Source: Medline; NIDCD NIH HHS [T32-DC00054] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Atallah HE, 2007, NAT NEUROSCI, V10, P126, DOI 10.1038/nn1817; Balleine BW, 2006, TRENDS NEUROSCI, V29, P272, DOI 10.1016/j.tins.2006.03.002; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Birrell JM, 2000, J NEUROSCI, V20, P4320; Blair K, 2006, J NEUROSCI, V26, P11379, DOI 10.1523/JNEUROSCI.1640-06.2006; Bohn I, 2003, BEHAV BRAIN RES, V143, P49, DOI 10.1016/S0166-4328(03)00008-1; Chudasama Y, 2003, J NEUROSCI, V23, P8771; CINELLI AR, 1987, BRAIN RES BULL, V19, P651, DOI 10.1016/0361-9230(87)90051-7; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dias R, 1997, J NEUROSCI, V17, P9285; Featherstone RE, 2004, BEHAV BRAIN RES, V150, P15, DOI 10.1016/S0166-4328(03)00218-3; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; GALLAGHER M, 1994, P NATL ACAD SCI USA, V91, P11771, DOI 10.1073/pnas.91.25.11771; Gallagher M, 1999, J NEUROSCI, V19, P6610; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; Hikosaka K, 2004, EUR J NEUROSCI, V19, P1046, DOI 10.1111/j.0953-816X.2004.03120.x; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; IVERSEN SD, 1970, EXP BRAIN RES, V11, P376; Izquierdo A, 2005, EUR J NEUROSCI, V22, P2341, DOI 10.1111/j.1460-9568.2005.04434.x; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; Izquierdo A, 2004, J NEUROPHYSIOL, V91, P2023, DOI 10.1152/jn.00968.2003; Izquierdo A, 2007, J NEUROSCI, V27, P1054, DOI 10.1523/JNEUROSCI.3616-06.2007; JONES B, 1972, EXP NEUROL, V36, P362, DOI 10.1016/0014-4886(72)90030-1; Kim J, 2005, NEUROBIOL LEARN MEM, V83, P125, DOI 10.1016/j.nlm.2004.10.003; KITA H, 1990, J COMP NEUROL, V298, P40, DOI 10.1002/cne.902980104; KOSAR E, 1986, BRAIN RES, V379, P329, DOI 10.1016/0006-8993(86)90787-0; KRETTEK JE, 1977, J COMP NEUROL, V172, P225; KRUSHEL LA, 1988, J COMP NEUROL, V270, P39, DOI 10.1002/cne.902700105; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; McDannald MA, 2005, J NEUROSCI, V25, P4626, DOI 10.1523/JNEUROSCI.5301-04.2005; Meunier M, 1997, NEUROPSYCHOLOGIA, V35, P999, DOI 10.1016/S0028-3932(97)00027-4; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; Mishkin M., 1964, FRONTAL GRANULAR COR, P219; Murray EA, 1998, BEHAV NEUROSCI, V112, P1291, DOI 10.1037/0735-7044.112.6.1291; Nobre AC, 1999, NAT NEUROSCI, V2, P11, DOI 10.1038/4513; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pickens CL, 2003, J NEUROSCI, V23, P11078; PRICE JL, 1991, OLFACTION, P101; Ragozzino ME, 1999, J NEUROSCI, V19, P4585; Ragozzino ME, 2002, BEHAV NEUROSCI, V116, P105, DOI 10.1037/0735-7044.116.1.105; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Roesch MR, 2005, J NEUROPHYSIOL, V94, P2457, DOI 10.1152/jn.00373.2005; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Saddoris MP, 2005, NEURON, V46, P321, DOI 10.1016/j.neuron.2005.02.018; Sage JR, 2000, BEHAV NEUROSCI, V114, P295, DOI 10.1037/0735-7044.114.2.295; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Schoenbaum G, 2006, TRENDS NEUROSCI, V29, P116, DOI 10.1016/j.tins.2005.12.006; Schoenbaum G, 2006, J NEUROPHYSIOL, V95, P1509, DOI 10.1152/jn.01052.2005; Schoenbaum G, 2005, NEURON, V47, P633, DOI 10.1016/j.neuron.2005.07.018; Schoenbaum G, 2003, J NEUROSCI, V23, P9833; Schoenbaum G, 2003, NEURON, V39, P855, DOI 10.1016/S0896-6273(03)00474-4; Schoenbaum G, 2003, LEARN MEMORY, V10, P129, DOI 10.1101/lm.55203; Schoenbaum G, 2002, NEUROREPORT, V13, P885, DOI 10.1097/00001756-200205070-00030; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Shi CJ, 1998, J COMP NEUROL, V399, P440, DOI 10.1002/(SICI)1096-9861(19981005)399:4<440::AID-CNE2>3.0.CO;2-1; Stalnaker TA, 2006, EUR J NEUROSCI, V24, P2643, DOI 10.1111/j.1460-9568.2006.05128.x; TEITELBAUM H, 1964, EXP NEUROL, V9, P452, DOI 10.1016/0014-4886(64)90053-6; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x	69	148	151	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					51	58		10.1016/j.neuron.2007.02.014	http://dx.doi.org/10.1016/j.neuron.2007.02.014			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408577	Bronze			2022-12-28	WOS:000245848400009
J	Yoshiyama, Y; Higuchi, M; Zhang, B; Huang, SM; Iwata, N; Saido, TC; Maeda, J; Suhara, T; Trojanowski, JQ; Lee, VMY				Yoshiyama, Yasumasa; Higuchi, Makoto; Zhang, Bin; Huang, Shu-Ming; Iwata, Nobuhisa; Saido, Takaomi C.; Maeda, Jun; Suhara, Tetsuya; Trojanowski, John Q.; Lee, Virginia M. -Y.			Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model	NEURON			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; TRANSGENIC MICE; NEUROFIBRILLARY TANGLES; AXONAL-TRANSPORT; MICROTUBULE-BINDING; SENILE PLAQUES; GENE MUTATION	Filamentous tau inclusions are hallmarks of Alzheimer's disease (AD) and related tauopathies, but earlier pathologies may herald disease onset. To investigate this, we studied wild-type and P301S mutant human tau transgenic (Tg) mice. Filamentous tau lesions developed in P301 S Tg mice at 6 months of age, and progressively accumulated in association with striking neuron loss as well as hippocampal and entorhinal cortical atrophy by 9-12 months of age. Remarkably, hippocampal synapse loss and impaired synaptic function were detected in 3 month old P301S Tg mice before fibrillary tau tangles emerged. Prominent microglial activation also preceded tangle formation. Importantly, immunosuppression of young P301 S Tg mice with FK506 attenuated tau pathology and increased lifespan, thereby linking neuro-inflammation to early progression of tauopathies. Thus, hippocampal synaptic pathology and microgliosis may be the earliest manifestations of neurodegenerative tauopathies, and abrogation of tau-induced microglial activation could retard progression of these disorders.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Inst Aging, Philadelphia, PA 19104 USA; Chiba E Natl Hosp, Clin Res Ctr, Chiba 2609712, Japan; Natl Inst Radiol Sci, Mol Imaging Ctr, Chiba 2638555, Japan; RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; National Institutes for Quantum Science & Technology; RIKEN	Lee, VMY (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu	Sado, Takaomi/AAN-2759-2021; Saido, Takaomi C/N-5472-2015	Sado, Takaomi/0000-0003-1970-6903; Saido, Takaomi C/0000-0003-1970-6903; Yoshiyama, Yasumasa/0000-0002-7992-7436				Akiyama H, 2000, ALZ DIS ASSOC DIS, V14, pS47, DOI 10.1097/00002093-200000001-00008; Allen B, 2002, J NEUROSCI, V22, P9340; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Bellucci A, 2004, AM J PATHOL, V165, P1643, DOI 10.1016/S0002-9440(10)63421-9; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81, DOI 10.1001/archneur.1995.00540250089017; Bigio EH, 2001, J NEUROPATH EXP NEUR, V60, P403, DOI 10.1093/jnen/60.5.403; BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; BRAMBLETT GT, 1992, LAB INVEST, V66, P212; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Bussiere T, 2003, NEUROSCIENCE, V117, P577, DOI 10.1016/S0306-4522(02)00942-9; D'Souza I, 1999, P NATL ACAD SCI USA, V96, P5598, DOI 10.1073/pnas.96.10.5598; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; Forman MS, 2004, NAT MED, V10, P1055, DOI 10.1038/nm1113; Fukutani Y, 2000, PSYCHIAT CLIN NEUROS, V54, P523, DOI 10.1046/j.1440-1819.2000.00747.x; Giasson BI, 2000, J NEUROSCI RES, V59, P528, DOI 10.1002/(SICI)1097-4547(20000215)59:4<528::AID-JNR8>3.0.CO;2-0; GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; HARPIN ML, 1990, J NEUROSCI RES, V27, P587, DOI 10.1002/jnr.490270420; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Huang SM, 2006, J BIOL CHEM, V281, P17941, DOI 10.1074/jbc.M601372200; Ikeda M, 2005, AM J PATHOL, V166, P521, DOI 10.1016/S0002-9440(10)62274-2; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; KOSIK KS, 1988, NEURON, V1, P817, DOI 10.1016/0896-6273(88)90129-8; Kril JJ, 2002, ACTA NEUROPATHOL, V103, P370, DOI 10.1007/s00401-001-0477-5; Lee VMY, 2005, BBA-MOL BASIS DIS, V1739, P251, DOI 10.1016/j.bbadis.2004.06.014; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li YK, 2003, J NEUROSCI, V23, P1605; Lipton AM, 2001, ARCH NEUROL-CHICAGO, V58, P1233, DOI 10.1001/archneur.58.8.1233; Lossos A, 2003, J NEUROL, V250, P733, DOI 10.1007/s00415-003-1074-4; Maeda J, 2004, SYNAPSE, V52, P283, DOI 10.1002/syn.20027; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; MAWALDEWAN M, 1994, J BIOL CHEM, V269, P30981; Morris HR, 2001, ARCH NEUROL-CHICAGO, V58, P1813, DOI 10.1001/archneur.58.11.1813; Muramori F, 1998, PSYCHIAT CLIN NEUROS, V52, P593, DOI 10.1111/j.1440-1819.1998.tb02706.x; Murrell JR, 1999, J NEUROPATH EXP NEUR, V58, P1207, DOI 10.1097/00005072-199912000-00002; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Ramsden M, 2005, J NEUROSCI, V25, P10637, DOI 10.1523/JNEUROSCI.3279-05.2005; Rizzini C, 2000, J NEUROPATH EXP NEUR, V59, P990, DOI 10.1093/jnen/59.11.990; Rizzu P, 1999, AM J HUM GENET, V64, P414, DOI 10.1086/302256; RODRIGUEZ EM, 1984, HISTOCHEMISTRY, V81, P253, DOI 10.1007/BF00495636; Roy S, 2005, ACTA NEUROPATHOL, V109, P5, DOI 10.1007/s00401-004-0952-x; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Su JH, 1997, NEUROBIOL DIS, V4, P365, DOI 10.1006/nbdi.1997.0164; Suzuki M, 2002, NEUROLOGY, V58, P1013, DOI 10.1212/WNL.58.7.1013; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Togo T, 2002, ACTA NEUROPATHOL, V104, P398, DOI 10.1007/s00401-002-0569-x; TU PH, 1995, J CELL BIOL, V129, P1629, DOI 10.1083/jcb.129.6.1629; Werber E, 2003, MOVEMENT DISORD, V18, P595, DOI 10.1002/mds.10401; Yasuda M, 2000, NEUROLOGY, V55, P1224, DOI 10.1212/WNL.55.8.1224; Yoshiyama Y, 2000, NEUROSCI LETT, V290, P125, DOI 10.1016/S0304-3940(00)01326-4; Zhang B, 2005, P NATL ACAD SCI USA, V102, P227, DOI 10.1073/pnas.0406361102; Zhang B, 2004, J NEUROSCI, V24, P4657, DOI 10.1523/JNEUROSCI.0797-04.2004; Zhang MR, 2003, NUCL MED BIOL, V30, P513, DOI 10.1016/S0969-8051(03)00016-7	62	1238	1294	6	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					337	351		10.1016/j.neuron.2007.01.010	http://dx.doi.org/10.1016/j.neuron.2007.01.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270732	Bronze			2022-12-28	WOS:000245126800006
J	Dux, PE; Ivanoff, J; Asplund, CL; Marois, R				Dux, Paul E.; Ivanoff, Jason; Asplund, Christopher L.; Marois, Rene			Isolation of a central bottleneck of information processing with time-resolved fMRI	NEURON			English	Article							DUAL-TASK INTERFERENCE; PSYCHOLOGICAL REFRACTORY-PERIOD; PREFRONTAL CORTEX; RESPONSE SELECTION; COGNITIVE CONTROL; WORKING-MEMORY; FUNCTIONAL MRI; MENTAL CHRONOMETRY; ANTERIOR CINGULATE; NEURAL MECHANISMS	When humans attempt to perform two tasks at once, execution of the first task usually leads to postponement of the second one. This task delay is thought to result from a bottleneck occurring at a central, amodal stage of information processing that precludes two response selection or decision-making operations from being concurrently executed. Using time-resolved functional magnetic resonance imaging (fMRI), here we present a neural basis for such dual-task limitations, e.g. the inability of the posterior lateral prefrontal cortex, and possibly the superior medial frontal cortex, to process two decision-making operations at once. These results suggest that a neural network of frontal lobe areas acts as a central bottleneck of information processing that severely limits our ability to multitask.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA	Vanderbilt University	Marois, R (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Ctr Integrat & Cognit Neurosci, Nashville, TN 37203 USA.	rene.marois@vanderbilt.edu	Dux, Paul/I-1098-2014	Dux, Paul/0000-0002-4270-2583; Asplund, Christopher/0000-0001-5708-6966	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070776] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH70776, R01 MH070776-03, R01 MH070776-01, R01 MH070776-02, R01 MH070776] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Beede KE, 2006, ACCIDENT ANAL PREV, V38, P415, DOI 10.1016/j.aap.2005.10.015; Birn RM, 2004, NEUROIMAGE, V23, P1046, DOI 10.1016/j.neuroimage.2004.07.039; Birn RM, 1999, HUM BRAIN MAPP, V7, P106, DOI 10.1002/(SICI)1097-0193(1999)7:2<106::AID-HBM4>3.0.CO;2-O; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Boxer AL, 2006, J NEUROSCI, V26, P6354, DOI 10.1523/JNEUROSCI.0549-06.2006; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brass M, 2005, TRENDS COGN SCI, V9, P314, DOI 10.1016/j.tics.2005.05.001; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; CARRIER LM, 1995, J EXP PSYCHOL LEARN, V21, P1339, DOI 10.1037/0278-7393.21.5.1339; Chun M. M., 2001, LIMITS ATTENTION TEM, P20, DOI [10.1093/acprof:oso/9780198505150.003.0002, DOI 10.1093/ACPROF:OSO/9780198505150.003.0002]; Cohen MS, 1996, BRAIN, V119, P89, DOI 10.1093/brain/119.1.89; Derrfuss J, 2004, NEUROIMAGE, V23, P604, DOI 10.1016/j.neuroimage.2004.06.007; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Diamond A, 2006, TRENDS COGN SCI, V10, P212, DOI 10.1016/j.tics.2006.03.003; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Dosenbach NUF, 2006, NEURON, V50, P799, DOI 10.1016/j.neuron.2006.04.031; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Erickson KI, 2005, NEUROIMAGE, V28, P967, DOI 10.1016/j.neuroimage.2005.06.047; Formisano E, 2003, CURR OPIN NEUROBIOL, V13, P174, DOI 10.1016/S0959-4388(03)00044-8; Fuster J.M., 1989, PREFRONTAL CORTEX; Gernsbacher MA, 2003, ANNU REV PSYCHOL, V54, P91, DOI 10.1146/annurev.psych.54.101601.145128; Henson RNA, 2002, NEUROIMAGE, V15, P83, DOI 10.1006/nimg.2001.0940; Herath P, 2001, CEREB CORTEX, V11, P796, DOI 10.1093/cercor/11.9.796; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Ivry RB, 1998, J EXP PSYCHOL HUMAN, V24, P463, DOI 10.1037/0096-1523.24.2.463; Jiang YH, 2004, PSYCHOL SCI, V15, P390, DOI 10.1111/j.0956-7976.2004.00690.x; Jiang YH, 2004, NEUROIMAGE, V22, P748, DOI 10.1016/j.neuroimage.2004.01.043; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; KARLIN L, 1968, Q J EXP PSYCHOL, V20, P167, DOI 10.1080/14640746808400145; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 2006, NEURON, V50, P963, DOI 10.1016/j.neuron.2006.05.017; Kurata K, 2000, J NEUROPHYSIOL, V84, P1667, DOI 10.1152/jn.2000.84.3.1667; Levy J, 2001, J EXP PSYCHOL HUMAN, V27, P862, DOI 10.1037//0096-1523.27.4.862; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Luck SJ, 1998, PSYCHOL SCI, V9, P223, DOI 10.1111/1467-9280.00043; Marois R, 2005, TRENDS COGN SCI, V9, P296, DOI 10.1016/j.tics.2005.04.010; Menon RS, 1998, P NATL ACAD SCI USA, V95, P10902, DOI 10.1073/pnas.95.18.10902; Meyer DE, 1997, PSYCHOL REV, V104, P749, DOI 10.1037/0033-295X.104.4.749; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORALS R, 2005, PSYCHOL RES, V11, P1; Navon D, 2002, COGNITIVE PSYCHOL, V44, P193, DOI 10.1006/cogp.2001.0767; OSMAN A, 1993, J EXP PSYCHOL HUMAN, V19, P1292, DOI 10.1037/0096-1523.19.6.1292; PASHLER H, 1994, NEUROREPORT, V5, P2381, DOI 10.1097/00001756-199411000-00042; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; PASHLER H, 1994, J EXP PSYCHOL HUMAN, V20, P330, DOI 10.1037/0096-1523.20.2.330; Pashler HE, 1998, PSYCHOL ATTENTION; Passingham D, 2004, CURR OPIN NEUROBIOL, V14, P163, DOI 10.1016/j.conb.2004.03.003; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Ruge H, 2003, J MAGN RESON IMAGING, V18, P599, DOI 10.1002/jmri.10397; Rushworth MFS, 1998, NEUROPSYCHOLOGIA, V36, P11, DOI 10.1016/S0028-3932(97)00101-2; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; RUTHRUFF E, 1995, J EXP PSYCHOL HUMAN, V21, P552, DOI 10.1037/0096-1523.21.3.552; Ruthruff E, 2003, PERCEPT PSYCHOPHYS, V65, P801, DOI 10.3758/BF03194816; Ruthruff E, 2001, PSYCHON B REV, V8, P73, DOI 10.3758/BF03196141; Schluter ND, 2001, NEUROPSYCHOLOGIA, V39, P105, DOI 10.1016/S0028-3932(00)00105-6; Schubert T, 2003, COGNITIVE BRAIN RES, V17, P733, DOI 10.1016/S0926-6410(03)00198-8; Schumacher EH, 2003, J COGNITIVE NEUROSCI, V15, P1111, DOI 10.1162/089892903322598085; Serences JT, 2004, NEUROIMAGE, V21, P1690, DOI 10.1016/j.neuroimage.2003.12.021; Sigman M, 2005, PLOS BIOL, V3, P334, DOI 10.1371/journal.pbio.0030037; Strayer DL, 2004, HUM FACTORS, V46, P640, DOI 10.1518/hfes.46.4.640.56806; Szameitat AJ, 2002, J COGNITIVE NEUROSCI, V14, P1184, DOI 10.1162/089892902760807195; Talairach J., 1988, COPLANAR STEREOTAXIC; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; Tombu M, 2003, J EXP PSYCHOL HUMAN, V29, P3, DOI 10.1037/0096-1523.29.1.3; van Eimeren T, 2006, NEUROIMAGE, V29, P286, DOI 10.1016/j.neuroimage.2005.07.014; VanSelst M, 1997, COGNITIVE PSYCHOL, V33, P266, DOI 10.1006/cogp.1997.0662; Welford AT, 1952, B J PSYCHOL-GEN SECT, V43, P2, DOI 10.1111/j.2044-8295.1952.tb00322.x; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006	79	250	252	1	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1109	1120		10.1016/j.neuron.2006.11.009	http://dx.doi.org/10.1016/j.neuron.2006.11.009			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	120VS	17178412	Green Accepted, Bronze			2022-12-28	WOS:000243115100017
J	Karmarkar, UR; Dan, Y				Karmarkar, Uma R.; Dan, Yang			Experience-dependent plasticity in adult visual cortex	NEURON			English	Review							OCULAR DOMINANCE PLASTICITY; NR2A SUBUNIT EXPRESSION; LONG-TERM POTENTIATION; MONOCULAR DEPRIVATION; SYNAPTIC PLASTICITY; STRIATE CORTEX; TOPOGRAPHIC REORGANIZATION; HOMEOSTATIC PLASTICITY; CORTICAL EPIGENESIS; MAP REORGANIZATION	Experience-dependent plasticity is a prominent feature of the mammalian visual cortex. Although such neural changes are most evident during development, adult cortical circuits can be modified by a variety of manipulations, such as perceptual learning and visual deprivation. Elucidating the underlying mechanisms at the cellular and synaptic levels is an essential step in understanding neural plasticity in the mature animal. Although developmental and adult plasticity share many common features, notable differences may be attributed to developmental cortical changes at multiple levels. These range from shifts in the molecular profiles of cortical neurons to changes in the spatiotemporal dynamics of network activity. In this review, we will discuss recent progress and remaining challenges in understanding adult visual plasticity, focusing on the primary visual cortex.	Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Div Neurobiol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	ydan@berkeley.edu		Dan, Yang/0000-0002-3818-877X	NEI NIH HHS [F32EY016645, R01EY15180] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY016645, R01EY015180] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahissar M, 1997, NATURE, V387, P401, DOI 10.1038/387401a0; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; Bao SW, 2001, NATURE, V412, P79, DOI 10.1038/35083586; Bergan JF, 2005, J NEUROSCI, V25, P9816, DOI 10.1523/JNEUROSCI.2533-05.2005; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Calford MB, 2003, J NEUROSCI, V23, P6434; Calford MB, 2005, NATURE, V438, pE3, DOI 10.1038/nature04359; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CHINO YM, 1995, J NEUROSCI, V15, P2417, DOI 10.1523/JNEUROSCI.15-03-02417.1995; CLOTHIAUX EE, 1991, J NEUROPHYSIOL, V66, P1785, DOI 10.1152/jn.1991.66.5.1785; Crist RE, 2001, NAT NEUROSCI, V4, P519, DOI 10.1038/87470; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; DRINGENBERG HC, 2006, IN PRESS CEREB CORTE, DOI DOI 10.1093/CERCORBHK038; Dudek SM, 1996, NEURON, V16, P1097, DOI 10.1016/S0896-6273(00)80136-1; Eysel UT, 1998, NEUROREPORT, V9, P949, DOI 10.1097/00001756-199803300-00034; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Fahle M, 2002, PERCEPTUAL LEARNING; FIORENTINI A, 1980, NATURE, V287, P43, DOI 10.1038/287043a0; Fischer QS, 2004, J NEUROSCI, V24, P9049, DOI 10.1523/JNEUROSCI.2409-04.2004; Flint AC, 1997, J NEUROSCI, V17, P2469; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Frenkel MY, 2006, NEURON, V51, P339, DOI 10.1016/j.neuron.2006.06.026; Frenkel MY, 2004, NEURON, V44, P917, DOI 10.1016/j.neuron.2004.12.003; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Fu YX, 2002, SCIENCE, V296, P1999, DOI 10.1126/science.1070521; Furmanski CS, 2004, CURR BIOL, V14, P573, DOI 10.1016/j.cub.2004.03.032; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Hensch TK, 1998, J NEUROSCI, V18, P2108; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Hofer SB, 2006, NAT NEUROSCI, V9, P127, DOI 10.1038/nn1610; Hofer SB, 2006, CURR OPIN NEUROBIOL, V16, P451, DOI 10.1016/j.conb.2006.06.007; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Karmarkar UR, 2006, EUR J NEUROSCI, V23, P1575, DOI 10.1111/j.1460-9568.2006.04692.x; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Linkenhoker BA, 2005, NAT NEUROSCI, V8, P93, DOI 10.1038/nn1367; Maertens M, 2005, J COGNITIVE NEUROSCI, V17, P1553, DOI 10.1162/089892905774597209; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mataga N, 2004, NEURON, V44, P1031, DOI 10.1016/j.neuron.2004.11.028; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; Mody I, 2005, J PHYSIOL-LONDON, V562, P37, DOI 10.1113/jphysiol.2004.077362; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Morales B, 2002, J NEUROSCI, V22, P8084; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Neary K, 2005, EXP BRAIN RES, V162, P23, DOI 10.1007/s00221-004-2117-5; Oray S, 2004, NEURON, V44, P1021, DOI 10.1016/j.neuron.2004.12.001; Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; Renger JJ, 2002, P NATL ACAD SCI USA, V99, P1041, DOI 10.1073/pnas.022618799; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4; Schoups A, 2001, NATURE, V412, P549, DOI 10.1038/35087601; Schuett S, 2001, NEURON, V32, P325, DOI 10.1016/S0896-6273(01)00472-X; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; SHULZ D, 1992, J NEUROSCI, V12, P1301; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Smirnakis SM, 2005, NATURE, V435, P300, DOI 10.1038/nature03495; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Teyler TJ, 2005, EUR J NEUROSCI, V21, P2045, DOI 10.1111/j.1460-9568.2005.04007.x; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Yoshimura Y, 2003, J NEUROSCI, V23, P6557; Zheng WM, 1999, SCIENCE, V284, P962, DOI 10.1126/science.284.5416.962	96	138	138	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					577	585		10.1016/j.neuron.2006.11.001	http://dx.doi.org/10.1016/j.neuron.2006.11.001			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114043	Bronze			2022-12-28	WOS:000242413100006
J	Benda, J; Longtin, A; Maler, L				Benda, Jan; Longtin, Andre; Maler, Leonard			A synchronization-desynchronization code for natural communication signals	NEURON			English	Article							WEAKLY ELECTRIC FISH; LATERAL-LINE LOBE; AFFERENT NERVE-FIBERS; COINCIDENCE DETECTION; NEURONAL SYNCHRONY; GYMNOTIFORM FISH; APTERONOTUS-LEPTORHYNCHUS; ORGAN DISCHARGE; ELECTRORECEPTORS; OSCILLATIONS	Synchronous spiking of neural populations is hypothesized to play important computational roles in forming neural assemblies and solving the binding problem. Although the opposite phenomenon of desynchronization is well known from EEG studies, it is largely neglected on the neuronal level. We here provide an example of in vivo recordings from weakly electric fish demonstrating that, depending on the social context, different types of natural communication signals elicit transient desynchronization as well as synchronization of the electroreceptor population without changing the mean firing rate. We conclude that, in general, both positive and negative changes in the degree of synchrony can be the relevant signals for neural information processing.	Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; Univ Ottawa, Dept Phys, Ottawa, ON K1N 6N5, Canada; Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany	University of Ottawa; University of Ottawa; Humboldt University of Berlin	Benda, J (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 51 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	j.benda@biologie.hu-berlin.de	Longtin, Andre/D-2443-2009					Ackert JM, 2006, J NEUROSCI, V26, P4206, DOI 10.1523/JNEUROSCI.0496-06.2006; Aertsen A, 1996, J PHYSIOLOGY-PARIS, V90, P243, DOI 10.1016/S0928-4257(97)81432-5; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Azouz R, 2003, NEURON, V37, P513, DOI 10.1016/S0896-6273(02)01186-8; Bar-Yosef O, 2002, J NEUROSCI, V22, P8619; Bastian J, 2001, J EXP BIOL, V204, P1909; BASTIAN J, 1981, J COMP PHYSIOL, V144, P465, DOI 10.1007/BF01326832; Benda J, 2005, J NEUROSCI, V25, P2312, DOI 10.1523/JNEUROSCI.4795-04.2005; Benda J, 2003, NEURAL COMPUT, V15, P2523, DOI 10.1162/089976603322385063; Berman NJ, 1999, J EXP BIOL, V202, P1243; Berman NJ, 1998, J NEUROPHYSIOL, V80, P3173, DOI 10.1152/jn.1998.80.6.3173; BERNANDER O, 1994, NEURAL COMPUT, V6, P622, DOI 10.1162/neco.1994.6.4.622; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; CARR CE, 1982, J COMP NEUROL, V211, P139, DOI 10.1002/cne.902110204; Chacron MJ, 2005, J NEUROSCI, V25, P5521, DOI 10.1523/JNEUROSCI.0445-05.2005; Chacron MJ, 2005, NAT NEUROSCI, V8, P673, DOI 10.1038/nn1433; Chacron MJ, 2003, NATURE, V423, P77, DOI 10.1038/nature01590; Chacron MJ, 2001, J NEUROSCI, V21, P5328, DOI 10.1523/JNEUROSCI.21-14-05328.2001; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; Doiron B, 2003, NATURE, V421, P539, DOI 10.1038/nature01360; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Engler G, 2000, J COMP PHYSIOL A, V186, P645, DOI 10.1007/s003590000118; ERMNTROUT B, 1996, NEURAL COMPUT, V8, P979; Friedrich RW, 2004, NAT NEUROSCI, V7, P862, DOI 10.1038/nn1292; Galan RF, 2006, J NEUROSCI, V26, P3646, DOI 10.1523/JNEUROSCI.4605-05.2006; Galarreta M, 2001, SCIENCE, V292, P2295, DOI 10.1126/science.1061395; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; HAGIWARA S, 1965, J NEUROPHYSIOL, V28, P784, DOI 10.1152/jn.1965.28.5.784; Harris KD, 2005, NAT REV NEUROSCI, V6, P399, DOI 10.1038/nrn1669; HEILIGENBERG W, 1981, J COMP PHYSIOL, V142, P295, DOI 10.1007/BF00605443; HEILIGENBERG W, 1991, J COMP PHYSIOL A, V169, P151, DOI 10.1007/BF00215862; Hirabayashi T, 2005, J NEUROSCI, V25, P10299, DOI 10.1523/JNEUROSCI.3036-05.2005; HOPKINS CD, 1976, J COMP PHYSIOL, V111, P171, DOI 10.1007/BF00605531; Ishikane H, 2005, NAT NEUROSCI, V8, P1087, DOI 10.1038/nn1497; Krahe R, 2002, J NEUROSCI, V22, P2374, DOI 10.1523/JNEUROSCI.22-06-02374.2002; Kramer B, 1999, J EXP BIOL, V202, P1387; Lamme VAF, 1998, NATURE, V396, P362, DOI 10.1038/24608; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Lindner B, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.061919; MALER L, 1981, J COMP NEUROL, V195, P87, DOI 10.1002/cne.901950107; MALER L, 1974, J COMP NEUROL, V158, P363, DOI 10.1002/cne.901580402; METZNER W, 1991, J COMP PHYSIOL A, V169, P135, DOI 10.1007/BF00215861; MEYER JH, 1987, J COMP PHYSIOL A, V160, P385, DOI 10.1007/BF00613028; Munk MHJ, 1996, SCIENCE, V272, P271, DOI 10.1126/science.272.5259.271; Nelson ME, 1999, J EXP BIOL, V202, P1195; Nelson ME, 1997, J COMP PHYSIOL A, V181, P532, DOI 10.1007/s003590050137; Oestreich J, 2006, NEURON, V49, P577, DOI 10.1016/j.neuron.2006.01.027; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Ratnam R, 2000, J NEUROSCI, V20, P6672, DOI 10.1523/JNEUROSCI.20-17-06672.2000; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; SCHEICH H, 1973, J NEUROPHYSIOL, V36, P39, DOI 10.1152/jn.1973.36.1.39; Schreiber S, 2003, NEUROCOMPUTING, V52-4, P925, DOI 10.1016/S0925-2312(02)00838-X; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; Triefenbach F, 2003, ANIM BEHAV, V65, P19, DOI 10.1006/anbe.2002.2019; van der Togt C, 2006, CEREB CORTEX, V16, P136, DOI 10.1093/cercor/bhi093; VIJN PCM, 1991, BRAIN RES, V550, P49, DOI 10.1016/0006-8993(91)90403-I; Volgushev M, 1998, NEUROSCIENCE, V83, P15, DOI 10.1016/S0306-4522(97)00380-1; Woertz M, 2004, COGNITIVE BRAIN RES, V20, P256, DOI 10.1016/j.cogbrainres.2004.03.014; Xu Z, 1996, J NEUROPHYSIOL, V76, P2020, DOI 10.1152/jn.1996.76.3.2020; Zakon H, 2002, J PHYSIOL-PARIS, V96, P451, DOI 10.1016/S0928-4257(03)00012-3; ZUPANC GKH, 1993, CAN J ZOOL, V71, P2301, DOI 10.1139/z93-323; Zupanc GKH, 2006, J COMP PHYSIOL A, V192, P159, DOI 10.1007/s00359-005-0058-5; Zupanc GKH, 2002, J PHYSIOLOGY-PARIS, V96, P459, DOI 10.1016/S0928-4257(03)00002-0	69	76	76	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					347	358		10.1016/j.neuron.2006.08.008	http://dx.doi.org/10.1016/j.neuron.2006.08.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046696	Bronze			2022-12-28	WOS:000241799900014
J	Lee, VMY; Trojanowski, JQ				Lee, Virginia M. -Y.; Trojanowski, John Q.			Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: New targets for drug discovery	NEURON			English	Review							CEREBROSPINAL-FLUID; LEWY BODIES; DISORDERS; NEURODEGENERATION; FIBRILLIZATION; BIOMARKERS; DIAGNOSIS; DOPAMINE; MUTATION; MODELS	Classic Parkinson's disease (PD) is characterized by fibrillar alpha-synuclein inclusions known as Lewy bodies in the substantia nigra, which are associated with nigrostriatal degeneration. However, alpha-synuclein pathologies accumulate throughout the CNS in areas that also undergo progressive neurodegeneration, leading to dementia and other behavioral impairments in addition to parkinsonism. Although mutations in the alpha-synuclein gene only cause Lewy body PD in rare families, and although there are multiple other, albeit rare, genetic causes of familial parkinsonism, sporadic Lewy body PD is the most common movement disorder, and insights into mechanisms underlying alpha-synuclein-mediated neurodegeneration provide novel targets for the discovery of disease-modifying therapies for PD and related neurodegenerative alpha-synucleinopathies.	Univ Penn, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Inst Aging, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Lee, VMY (corresponding author), Univ Penn, Dept Pathol & Lab Med, Ctr Neurodegenerat Dis Res, Inst Aging, Maloney Bldg,3rd Floor 36th & Spurce St, Philadelphia, PA 19104 USA.	vmylee@mail.med.upenn.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS044233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014382, P01AG011542, P30AG010124, P01AG009215, P01AG014449, P01AG017586] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG11542, P01 AG09215, P01 AG17586, P01 AG14449, P30 AG10124, P01 AG14382] Funding Source: Medline; NINDS NIH HHS [NS044233] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdi F, 2006, J ALZHEIMERS DIS, V9, P293; Alzheimers Assoc, 1998, NEUROBIOL AGING, V19, P109; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Cooper AA, 2006, SCIENCE, V313, P324, DOI 10.1126/science.1129462; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; FAN Y, 2006, IN PRESS HUM MOL GEN; Feany MB, 2004, NEW ENGL J MED, V351, P1937, DOI 10.1056/NEJMp048263; Forman MS, 2005, NEURON, V47, P479, DOI 10.1016/j.neuron.2005.07.021; Giasson BI, 2004, CLIN NEUROSCI RES, V3, P427, DOI 10.1016/j.cnr.2004.04.008; GIASSON BI, 2004, NEUROPATHOLOGY DEMEN, P353; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Hashimoto M, 2001, NEURON, V32, P213, DOI 10.1016/S0896-6273(01)00462-7; Katzenschlager R, 2004, J NEUROL NEUROSUR PS, V75, P1672, DOI 10.1136/jnnp.2003.028761; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; MANYAM BV, 1990, MOVEMENT DISORD, V5, P47, DOI 10.1002/mds.870050112; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Norris EH, 2005, J BIOL CHEM, V280, P21212, DOI 10.1074/jbc.M412621200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Savitt JM, 2006, J CLIN INVEST, V116, P1744, DOI 10.1172/JCI29178; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thal LJ, 2006, ALZ DIS ASSOC DIS, V20, P6, DOI 10.1097/01.wad.0000191420.61260.a8; Tofaris GK, 2006, J NEUROSCI, V26, P3942, DOI 10.1523/JNEUROSCI.4965-05.2006; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	31	347	370	3	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					33	38		10.1016/j.neuron.2006.09.026	http://dx.doi.org/10.1016/j.neuron.2006.09.026			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015225	Bronze			2022-12-28	WOS:000241408100003
J	Kanold, PO; Shatz, CJ				Kanold, Patrick O.; Shatz, Carla J.			Subplate neurons regulate maturation of cortical inhibition and outcome of ocular dominance plasticity	NEURON			English	Article							CAT VISUAL-CORTEX; DEPENDENT SYNAPTIC MODIFICATIONS; GABA(A) RECEPTOR SUBUNIT; CRITICAL-PERIOD; STRIATE CORTEX; COTRANSPORTER KCC2; BARREL CORTEX; RESPONSES; COLUMNS; EXPRESSION	Synaptic plasticity during critical periods of development requires intact inhibitory circuitry. We report that subplate neurons are needed both for maturation of inhibition and for the proper sign of ocular dominance (OD) plasticity. Removal of subplate neurons prevents the developmental upregulation of genes involved in mature, fast GABAergic transmission in cortical layer 4, including GABA receptor subunits and KCC2, and thus prevents the switch to a hyperpolarizing effect of GABA. To understand the implications of these changes, a realistic circuit model was formulated. Simulations predicted that without subplate neurons, monocular deprivation (MD) paradoxically favors LGN axons representing the deprived (less active) eye, exactly what was then observed experimentally. Simulations also account for published results showing that CID plasticity requires mature inhibition. Thus, subplate neurons regulate molecular machinery required to establish an adult balance of excitation and inhibition in layer 4, and thereby influence the outcome of CD plasticity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu		Kanold, Patrick/0000-0002-7529-5435	NEI NIH HHS [F32 EY 1352, F32 EY013526-01, F32 EY013526, R01 EY 02858] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002858, F32EY013526] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; BAUMFALK U, 1987, NEUROSCI LETT, V75, P187, DOI 10.1016/0304-3940(87)90295-3; BEAR MF, 1990, J NEUROSCI, V10, P909; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Chen L, 2001, MOL BRAIN RES, V88, P135, DOI 10.1016/S0169-328X(01)00042-0; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Dan Y, 1996, J NEUROSCI, V16, P3351; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finney EM, 1998, J COMP NEUROL, V398, P105; FRIAUF E, 1990, J NEUROSCI, V10, P2601; FRIAUF E, 1991, J NEUROPHYSIOL, V66, P2059, DOI 10.1152/jn.1991.66.6.2059; Froemke RC, 2002, NATURE, V416, P433, DOI 10.1038/416433a; Galuske RAW, 2000, EUR J NEUROSCI, V12, P3315, DOI 10.1046/j.1460-9568.2000.00213.x; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GHOSH A, 1994, J NEUROSCI, V14, P3862; Golshani P, 1997, J COMP NEUROL, V383, P199, DOI 10.1002/(SICI)1096-9861(19970630)383:2<199::AID-CNE7>3.0.CO;2-W; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hata Y, 1999, NEURON, V22, P375, DOI 10.1016/S0896-6273(00)81097-1; HATA Y, 1994, SCIENCE, V265, P1732, DOI 10.1126/science.8085163; Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HERRMANN K, 1994, EUR J NEUROSCI, V6, P1729, DOI 10.1111/j.1460-9568.1994.tb00565.x; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Huntsman MM, 1999, NEUROSCIENCE, V91, P1223, DOI 10.1016/S0306-4522(98)00713-1; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Lee H, 2005, EUR J NEUROSCI, V21, P2593, DOI 10.1111/j.1460-9568.2005.04084.x; Lein ES, 1999, P NATL ACAD SCI USA, V96, P13491, DOI 10.1073/pnas.96.23.13491; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Mathern GW, 2000, EPILEPSIA, V41, pS162, DOI 10.1111/j.1528-1157.2000.tb01575.x; McQuillen PS, 2003, J NEUROSCI, V23, P3308; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; Owens DF, 1996, J NEUROSCI, V16, P6414; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Volpe JJ, 1996, PEDIATRICS, V97, P112; Weliky M, 2000, NEURON, V27, P427, DOI 10.1016/S0896-6273(00)00053-2; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; Yao HS, 2001, NEURON, V32, P315, DOI 10.1016/S0896-6273(01)00460-3; Zhou Q, 2003, SCIENCE, V300, P1953, DOI 10.1126/science.1082212	61	156	159	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					627	638		10.1016/j.neuron.2006.07.008	http://dx.doi.org/10.1016/j.neuron.2006.07.008			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950160	Bronze			2022-12-28	WOS:000240623400011
J	Zald, DH				Zald, David H.			The rodent orbitofrontal cortex gets time and direction	NEURON			English	Editorial Material							ORBITAL PREFRONTAL CORTEX; REWARD PREFERENCE; RATS; AMYGDALA; LESIONS	The orbitofrontal cortex (OFC) helps direct decision making through its flexible coding of reward and economic value. In this issue of Neuron, papers by Roesch et al. and Feierstein et al. demonstrate the importance of temporal and spatial features to processing in the rodent OFC.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Zald, DH (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA.		Zald, David H/A-1448-2011					Baxter MG, 2000, J NEUROSCI, V20, P4311; CORWIN JV, 1994, BEHAV BRAIN RES, V61, P79, DOI 10.1016/0166-4328(94)90010-8; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Izquierdo A, 2004, J NEUROSCI, V24, P7540, DOI 10.1523/JNEUROSCI.1921-04.2004; KING V, 1989, EXP NEUROL, V105, P287, DOI 10.1016/0014-4886(89)90132-5; KRETTEK JE, 1977, J COMP NEUROL, V171, P157, DOI 10.1002/cne.901710204; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Price JL, 2006, ORBITOFRONTAL CORTEX, P3, DOI DOI 10.1093/ACPROF:OSO/9780198565741.003.0001; Reep RL, 1996, EXP BRAIN RES, V111, P215; Roesch M., 2006, ORBITOFRONTAL CORTEX, DOI [10.1093/acprof:oso/9780198565741.003.0008, DOI 10.1093/ACPROF:OSO/9780198565741.003.0008]; Roesch MR, 2006, NEURON, V51, P509, DOI 10.1016/j.neuron.2006.06.027; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Winstanley CA, 2004, J NEUROSCI, V24, P4718, DOI 10.1523/JNEUROSCI.5606-03.2004	15	7	7	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 17	2006	51	4					395	397		10.1016/j.neuron.2006.08.001	http://dx.doi.org/10.1016/j.neuron.2006.08.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908405	Bronze			2022-12-28	WOS:000240504700003
J	VanHoven, MK; Huang, SLB; Albin, SD; Bargmann, CI				VanHoven, Miri K.; Huang, Sarah L. Bauer; Albin, Stephanie D.; Bargmann, Cornelia I.			The claudin superfamily protein NSY-4 biases lateral signaling to generate left-right asymmetry in C-elegans olfactory neurons	NEURON			English	Article							ODORANT RECEPTOR EXPRESSION; CELL FATE DECISION; E/DAUGHTERLESS ORTHOLOG HLH-2; GATED CALCIUM-CHANNEL; LIM HOMEOBOX GENE; CAENORHABDITIS-ELEGANS; NEGATIVE FEEDBACK; TRANSCRIPTION FACTOR; GAMMA-SUBUNIT; LOCALIZATION	Early in C. elegans development, signaling between bilaterally symmetric AWC olfactory neurons causes them to express different odorant receptor genes. AWC left-right asymmetry is stochastic: in each animal, either the left or the right neuron randomly becomes AWC(ON), and the other neuron becomes AWC(OFF). Here we show that the nsy-4 gene coordinates the lateral signaling that diversifies AWC(ON) and AWC(OFF) neurons. nsy-4 mutants generate 2 AWC(OFF) neurons, as expected if communication between the AWC neurons is lost, whereas overexpression of nsy-4 results in 2 AWC(ON) neurons. nsy-4 encodes a transmembrane protein related to the gamma subunits of voltage-activated calcium channels and the claudin superfamily; it interacts genetically with calcium channels and antagonizes a calcium-to-MAP kinase cascade in the neuron that becomes AWC(ON). Genetic mosaic analysis indicates that nsy-4 functions both cell-autonomously and nonaultonomously in signaling between AWC neurons, providing evidence for lateral signaling and feedback that coordinate asymmetric receptor choice.	Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Rockefeller Univ, HHMI, New York, NY 10025 USA; Rockefeller Univ, Lab Neural Circuits & Behav, New York, NY 10025 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Bargmann, CI (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	cori@rockefeller.edu		Bargmann, Cornelia/0000-0002-8484-0618; VanHoven, Miri/0000-0001-7714-1555; Albin, Stephanie/0000-0003-4070-7433	NIDCD NIH HHS [DC004089] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004089] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson JM, 2004, CURR OPIN CELL BIOL, V16, P140, DOI 10.1016/j.ceb.2004.01.005; Anderson P, 1995, METHOD CELL BIOL, V48, P31; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; BRENNER S, 1974, GENETICS, V77, P71; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chu PJ, 2001, GENE, V280, P37, DOI 10.1016/S0378-1119(01)00738-7; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Glodowski DR, 2005, MOL BIOL CELL, V16, P1417, DOI 10.1091/mbc.E04-10-0885; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; HAN M, 2005, GENETICS; Heiskala M, 2001, TRAFFIC, V2, P92, DOI 10.1034/j.1600-0854.2001.020203.x; Heitzler P, 1996, DEVELOPMENT, V122, P161; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hirokawa N, 2006, CELL, V125, P33, DOI 10.1016/j.cell.2006.03.002; Hobert O, 1999, DEVELOPMENT, V126, P1547; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Johnston RJ, 2005, DEVELOPMENT, V132, P5451, DOI 10.1242/dev.02163; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kang MG, 2003, J BIOL CHEM, V278, P21315, DOI 10.1074/jbc.R300004200; Karp X, 2003, GENE DEV, V17, P3100, DOI 10.1101/gad.1160803; Karp X, 2004, DEV BIOL, V272, P460, DOI 10.1016/j.ydbio.2004.05.015; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kimble J, 1997, ANNU REV CELL DEV BI, V13, P333, DOI 10.1146/annurev.cellbio.13.1.333; Kious BM, 2002, DEV BIOL, V243, P249, DOI 10.1006/dbio.2001.0570; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Kollmar R, 2001, P NATL ACAD SCI USA, V98, P10196, DOI 10.1073/pnas.171325898; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mathews EA, 2003, J NEUROSCI, V23, P6537; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511; Moss FJ, 2002, EMBO J, V21, P1514, DOI 10.1093/emboj/21.7.1514; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Price MG, 2005, J BIOL CHEM, V280, P19711, DOI 10.1074/jbc.M500623200; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Schafer WR, 1996, GENETICS, V143, P1219; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; Simard A, 2005, GENE EXPR PATTERNS, V5, P553, DOI 10.1016/j.modgep.2004.10.099; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Tanaka-Hino M, 2002, EMBO REP, V3, P56, DOI 10.1093/embo-reports/kvf001; Tepass U, 2002, BIOESSAYS, V24, P690, DOI 10.1002/bies.10129; Tomita S, 2001, J CELL BIOL, V153, pF19, DOI 10.1083/jcb.153.5.F19; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; WILKINSON HA, 1994, CELL, V79, P1187, DOI 10.1016/0092-8674(94)90010-8; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zallen JA, 1999, DEVELOPMENT, V126, P3679	70	38	46	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					291	302		10.1016/j.neuron.2006.06.029	http://dx.doi.org/10.1016/j.neuron.2006.06.029			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880124	Bronze			2022-12-28	WOS:000239908800005
J	Bagnall, MW; du Lac, S				Bagnall, Martha W.; du Lac, Sascha			A new locus for synaptic plasticity in cerebellar circuits	NEURON			English	Editorial Material							VESTIBULAR NUCLEI; PURKINJE-CELL; MEMORY; CONSOLIDATION; RAT	Experimental and computational analyses of cerebellar function indicate that excitatory synapses onto deep nucleus neurons are likely to be a critical site of plasticity during motor learning. In this issue of Neuron, Pugh and Raman report that unconventional stimulus protocols can drive synaptic plasticity in the deep cerebellar nuclei.	UCSD, Neurosci Grad Program, Salk Inst, La Jolla, CA 92037 USA; UCSD, Neurosci Grad Program, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Bagnall, MW (corresponding author), UCSD, Neurosci Grad Program, Salk Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Bagnall, Martha/0000-0003-2102-6165	NATIONAL EYE INSTITUTE [R01EY011027] Funding Source: NIH RePORTER; NEI NIH HHS [EY11027] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Aizenman CD, 2000, PROG BRAIN RES, V124, P257; Anchisi D, 2001, J NEUROPHYSIOL, V85, P323, DOI 10.1152/jn.2001.85.1.323; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; DEZEEUW CI, 1995, EUR J NEUROSCI, V7, P2322; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; Grassi S, 2001, PROG NEUROBIOL, V64, P527, DOI 10.1016/S0301-0082(00)00070-8; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Shutoh F, 2006, NEUROSCIENCE, V139, P767, DOI 10.1016/j.neuroscience.2005.12.035; Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X; Zhang W, 2006, J NEUROSCI, V26, P6935, DOI 10.1523/JNEUROSCI.0784-06.2006; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006	15	7	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 6	2006	51	1					5	7		10.1016/j.neuron.2006.06.014	http://dx.doi.org/10.1016/j.neuron.2006.06.014			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815325	Bronze			2022-12-28	WOS:000239037700003
J	Pugh, JR; Raman, IM				Pugh, Jason R.; Raman, Indira M.			Potentiation of mossy fiber EPSCs in the cerebellar nuclei by NMDA receptor activation followed by postinhibitory rebound current	NEURON			English	Article							LONG-TERM DEPRESSION; HIPPOCAMPAL-NEURONS; CALCIUM CURRENTS; PURKINJE-CELLS; INFERIOR OLIVE; PLASTICITY; RESPONSES; STIMULATION; EXPRESSION; CORTEX	Behavioral and computational studies predict that synaptic plasticity of excitatory mossy fiber inputs to cerebellar nuclear neurons is required for associative learning, but standard tetanization protocols fail to potentiate nuclear cell EPSCs in mouse cerebellar slices. Nuclear neurons fire action potentials spontaneously unless strongly inhibited by Purkinje neurons, raising the possibility that plasticity-triggering signals in these cells differ from those at classical Hebbian synapses. Based on predictions of neuronal activity during delay eyelid conditioning, we developed quasi-physiological induction protocols consisting of high-frequency mossy fiber stimulation and postsynaptic hyperpolarization. Robust, NMDA receptor-dependent potentiation of nuclear cell EPSCs occurred with protocols including a 150-250 ms hyperpolarization in which mossy fiber stimulation preceded a postinhibitory rebound depolarization. Mossy fiber stimulation potentiated EPSCs even when postsynaptic spiking was prevented by voltage-clamp, as long as rebound current was evoked. These data suggest that Purkinje cell inhibition guides the strengthening of excitatory synapses in the cerebellar nuclei.	NW Univ, Inst Neurosci, Evanston, IL 60208 USA; NW Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Raman, IM (corresponding author), NW Univ, Inst Neurosci, Evanston, IL 60208 USA.	i-raman@northwestern.edu	Pugh, Jason/V-9090-2019	Pugh, Jason/0000-0001-9042-7849	NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH067564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039395] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067564] Funding Source: Medline; NINDS NIH HHS [NS39395] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Aizenman CD, 2000, NAT NEUROSCI, V3, P109, DOI 10.1038/72049; Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; AKAZAWA C, 1994, J COMP NEUROL, V347, P150, DOI 10.1002/cne.903470112; Anchisi D, 2001, J NEUROPHYSIOL, V85, P323, DOI 10.1152/jn.2001.85.1.323; AUDINAT E, 1990, J PHYSIOL-LONDON, V430, P297, DOI 10.1113/jphysiol.1990.sp018292; Bao SW, 2002, P NATL ACAD SCI USA, V99, P1592, DOI 10.1073/pnas.032655399; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; Chan-Palay V, 1977, CEREBELLAR DENTATE N; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; Cull-Candy SG, 1998, NEUROPHARMACOLOGY, V37, P1369, DOI 10.1016/S0028-3908(98)00119-1; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017, DOI 10.1152/jn.2001.85.5.2017; Garcia KS, 1998, NEUROPHARMACOLOGY, V37, P471, DOI 10.1016/S0028-3908(98)00055-0; Garcia KS, 1999, J NEUROSCI, V19, P10940, DOI 10.1523/JNEUROSCI.19-24-10940.1999; Gauck V, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-15-j0004.2001; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hesslow G, 1999, NEURON, V24, P179, DOI 10.1016/S0896-6273(00)80831-4; HESSLOW G, 1994, J PHYSIOL-LONDON, V476, P245, DOI 10.1113/jphysiol.1994.sp020127; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P149, DOI 10.1113/jphysiol.1986.sp016002; JAHR CE, 1993, P NATL ACAD SCI USA, V90, P11573, DOI 10.1073/pnas.90.24.11573; Kim JJ, 1997, TRENDS NEUROSCI, V20, P177, DOI 10.1016/S0166-2236(96)10081-3; Kleim JA, 2002, P NATL ACAD SCI USA, V99, P13228, DOI 10.1073/pnas.202483399; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kuner T, 1996, J NEUROSCI, V16, P3549; Lavond DG, 2002, ANN NY ACAD SCI, V978, P93, DOI 10.1111/j.1749-6632.2002.tb07558.x; Linden D J, 1994, Learn Mem, V1, P121; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1991, MOL NEUROBIOL, V5, P289, DOI 10.1007/BF02935552; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MAUK MD, 1986, P NATL ACAD SCI USA, V83, P5349, DOI 10.1073/pnas.83.14.5349; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; Medina JF, 2002, NATURE, V416, P330, DOI 10.1038/416330a; Medina JF, 2001, J NEUROSCI, V21, P4081, DOI 10.1523/JNEUROSCI.21-11-04081.2001; Medina JF, 2002, NAT REV NEUROSCI, V3, P122, DOI 10.1038/nrn728; Medina JF, 2000, CURR OPIN NEUROBIOL, V10, P717, DOI 10.1016/S0959-4388(00)00154-9; Medina JF, 1999, J NEUROSCI, V19, P7140, DOI 10.1523/JNEUROSCI.19-16-07140.1999; MILES FA, 1981, ANNU REV NEUROSCI, V4, P273, DOI 10.1146/annurev.ne.04.030181.001421; Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103; Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Nelson AB, 2003, NEURON, V40, P609, DOI 10.1016/S0896-6273(03)00641-X; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; Ohyama T, 2003, LEARN MEMORY, V10, P346, DOI 10.1101/lm.67103; Ohyama T, 2001, J NEUROSCI, V21, P682, DOI 10.1523/JNEUROSCI.21-02-00682.2001; Raman IM, 2000, J NEUROSCI, V20, P9004; Shibuki K, 1996, NEURON, V16, P587, DOI 10.1016/S0896-6273(00)80078-1; STEINMETZ JE, 1989, SYNAPSE, V3, P225, DOI 10.1002/syn.890030308; Telgkamp P, 2002, J NEUROSCI, V22, P8447; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; ZHANG W, 2005, J PHYSL, V561, P703	65	172	173	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					113	123		10.1016/j.neuron.2006.05.021	http://dx.doi.org/10.1016/j.neuron.2006.05.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815336	Bronze			2022-12-28	WOS:000239037700014
J	Yu, FW; Kuo, CT; Jan, YN				Yu, Fengwei; Kuo, Chay T.; Jan, Yuh Nung			Drosophila neuroblast asymmetric cell division: Recent advances and implications for stem cell biology	NEURON			English	Review							REGULATES SPINDLE ORIENTATION; G-ALPHA-I; G-PROTEIN; MITOTIC SPINDLE; CORTICAL LOCALIZATION; PLANAR POLARITY; SELF-RENEWAL; BRAIN-TUMOR; COMPLEX; PINS	Asymmetric cell division is an evolutionarily conserved mechanism widely used to generate cellular diversity during development. Drosophila neuroblasts have been a useful model system for studying the molecular mechanisms of asymmetric cell division. In this minireview, we focus on recent progress in understanding the role of heterotrimeric G proteins and their regulators in asymmetric spindle geometry, as well as the role of an Inscuteable-independent microtubule pathway in asymmetric localization of proteins in neuroblasts. We also discuss issues of progenitor proliferation and differentiation associated with asymmetric cell division and their broader implications for stem cell biology.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol Biochem & Biophys, San Francisco, CA 94143 USA; Natl Univ Singapore, Dept Biol Sci, Singapore 117604, Singapore; Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National University of Singapore; National University of Singapore	Jan, YN (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Rock Hall,1550 4th St, San Francisco, CA 94143 USA.	yuhnung.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299				Afshar K, 2005, DEVELOPMENT, V132, P4449, DOI 10.1242/dev.02039; Afshar K, 2004, CELL, V119, P219, DOI 10.1016/j.cell.2004.09.026; Barros CS, 2003, DEV CELL, V5, P829, DOI 10.1016/S1534-5807(03)00359-9; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bonaccorsi S, 2000, NAT CELL BIOL, V2, P54, DOI 10.1038/71378; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cai Y, 2003, CELL, V112, P51, DOI 10.1016/S0092-8674(02)01170-4; Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632; Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X; David NB, 2005, NAT CELL BIOL, V7, P1083, DOI 10.1038/ncb1319; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fuse N, 2003, CURR BIOL, V13, P947, DOI 10.1016/S0960-9822(03)00334-8; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Hampoelz B, 2005, NAT CELL BIOL, V7, P1099, DOI 10.1038/ncb1318; Izumi Y, 2004, J CELL BIOL, V164, P729, DOI 10.1083/jcb.200309162; Izumi Y, 2006, NAT CELL BIOL, V8, P586, DOI 10.1038/ncb1409; Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516; Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7, DOI 10.1038/71323; Katoh M, 2003, INT J MOL MED, V11, P111; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lu BW, 1999, CURR BIOL, V9, P1247, DOI 10.1016/S0960-9822(99)80505-3; Mayer B, 2005, CURR BIOL, V15, P1847, DOI 10.1016/j.cub.2005.08.067; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; Ohshiro T, 2000, NATURE, V408, P593, DOI 10.1038/35046087; Parmentier ML, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-14-j0003.2000; Peng CY, 2000, NATURE, V408, P596, DOI 10.1038/35046094; Petritsch C, 2003, DEV CELL, V4, P273, DOI 10.1016/S1534-5807(03)00020-0; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Sanada K, 2005, CELL, V122, P119, DOI 10.1016/j.cell.2005.05.009; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Schneider M, 2006, INT J ONCOL, V28, P883; Schober M, 1999, NATURE, V402, P548, DOI 10.1038/990135; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siegrist SE, 2006, DEVELOPMENT, V133, P529, DOI 10.1242/dev.02211; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Somers WG, 2005, DEV CELL, V9, P312, DOI 10.1016/j.devcel.2005.08.007; Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801; Srinivasan DG, 2003, GENE DEV, V17, P1225, DOI 10.1101/gad.1081203; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; van Diepen MT, 2005, MOL CELL NEUROSCI, V29, P74, DOI 10.1016/j.mcn.2005.01.005; Wang H, 2003, CURR OPIN CELL BIOL, V15, P82, DOI 10.1016/S0955-0674(02)00006-6; Wang HY, 2005, NAT CELL BIOL, V7, P1091, DOI 10.1038/ncb1317; Wei SY, 2005, DEV CELL, V8, P493, DOI 10.1016/j.devcel.2005.03.015; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5; Yu FW, 2003, J CELL BIOL, V162, P623, DOI 10.1083/jcb.200303174; Zigman M, 2005, NEURON, V48, P539, DOI 10.1016/j.neuron.2005.09.030	59	131	133	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					13	20		10.1016/j.neuron.2006.06.016	http://dx.doi.org/10.1016/j.neuron.2006.06.016			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815328	Bronze			2022-12-28	WOS:000239037700006
J	Lin, DY; Shea, SD; Katz, LC				Lin, Da Yu; Shea, Stephen D.; Katz, Lawrence C.			Representation of natural stimuli in the rodent main olfactory bulb	NEURON			English	Article							RECEPTOR NEURON INPUT; ODORANT REPRESENTATIONS; INHIBITION; RESPONSES; MAPS; EXPRESSION; ORGANIZATION; TOPOGRAPHY; MIXTURES; DYNAMICS	Natural odorants are complex mixtures of diverse chemical compounds. Monomolecular odorants are represented in the main olfactory bulb by distinct spatial patterns of activated glomeruli. However, it remains unclear how individual compounds contribute to population representations of natural stimuli, which appear to be unexpectedly sparse. We combined gas chromatography and intrinsic signal imaging to visualize glomerular responses to natural stimuli and their fractionated components. While whole stimuli activated up to 20 visible glomeruli, each fractionated component activated only one or few glomeruli, and most glomeruli were activated by only one component. Thus, responses to complex mixtures reflected activation by multiple components, with each contributing only a small part of the overall representation. We conclude that the population response to a complex stimulus is largely the sum of the responses to its individual components, and activation of an individual glomerulus independently signals the presence of a specific component.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Lin, DY (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3209, Durham, NC 27710 USA.	dayulin@neuro.duke.edu		Lin, Dayu/0000-0003-2006-0791; Shea, Stephen/0000-0001-6927-0189	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005671] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC005671] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; Grosch W, 2001, CHEM SENSES, V26, P533, DOI 10.1093/chemse/26.5.533; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Igarashi KM, 2005, J NEUROPHYSIOL, V93, P1007, DOI 10.1152/jn.00873.2004; Jinks A, 2001, PHYSIOL BEHAV, V72, P51, DOI 10.1016/S0031-9384(00)00407-8; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; KOIZUMI Y, 1987, NIPPON SHOKUHIN KOGY, V34, P244; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leland J.V., 2001, GAS CHROMATOGRAPHY O; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Luo M, 2001, NEURON, V32, P1165, DOI 10.1016/S0896-6273(01)00537-2; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Olshausen BA, 2004, CURR OPIN NEUROBIOL, V14, P481, DOI 10.1016/j.conb.2004.07.007; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Roberts DD, 2000, J AGR FOOD CHEM, V48, P2430, DOI 10.1021/jf991116l; ROYET JP, 1988, J COMP NEUROL, V270, P559, DOI 10.1002/cne.902700409; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Tabor R, 2004, J NEUROSCI, V24, P6611, DOI 10.1523/JNEUROSCI.1834-04.2004; Takahashi YK, 2004, J NEUROSCI, V24, P8690, DOI 10.1523/JNEUROSCI.2510-04.2004; Takahashi YK, 2004, J NEUROPHYSIOL, V92, P2413, DOI 10.1152/jn.00236.2004; TASSAN CG, 1975, J FOOD SCI, V40, P1185, DOI 10.1111/j.1365-2621.1975.tb01048.x; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Urban NN, 2002, PHYSIOL BEHAV, V77, P607, DOI 10.1016/S0031-9384(02)00895-8; van Ruth SM, 2001, BIOMOL ENG, V17, P121, DOI 10.1016/S1389-0344(01)00070-3; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; WILSON DA, 1987, BRAIN RES, V417, P175, DOI 10.1016/0006-8993(87)90196-X; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371	45	111	111	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					937	949		10.1016/j.neuron.2006.03.021	http://dx.doi.org/10.1016/j.neuron.2006.03.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772174	Bronze			2022-12-28	WOS:000238589500013
J	Armstrong, KM; Fitzgerald, JK; Moore, T				Armstrong, Katherine M.; Fitzgerald, Jamie K.; Moore, Tirin			Changes in visual receptive fields with microstimulation of frontal cortex	NEURON			English	Article							COVERT SPATIAL ATTENTION; EYE-MOVEMENTS; SUPERIOR COLLICULUS; SELECTIVE ATTENTION; EXTRASTRIATE CORTEX; NEURAL MECHANISMS; MACAQUE; V4; RESPONSES; ORGANIZATION	The influence of attention on visual cortical neurons has been described in terms of its effect on the structure of receptive fields (RFs), where multiple stimuli compete to drive neural responses and ultimately behavior. We stimulated the frontal eye field (FEF) of passively fixating monkeys and produced changes in V4 responses similar to known effects of voluntary attention. Subthreshold FEF stimulation enhanced visual responses at particular locations within the RF and altered the interaction between pairs of RF stimuli to favor those aligned with the activated FEF site. Thus, we could influence which stimulus drove the responses of individual V4 neurons. These results suggest that spatial signals involved in saccade preparation are used to covertly select among multiple stimuli appearing within the RFs of visual cortical neurons.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA	Stanford University	Moore, T (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	tirin@stanford.edu			NEI NIH HHS [EY14924] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY014924, R56EY014924] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Bair W, 1998, VISUAL NEUROSCI, V15, P779, DOI 10.1017/S0952523898154160; BARBAS H, 1981, J COMP NEUROL, V200, P407, DOI 10.1002/cne.902000309; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1990, NEUROSCI IN, P261; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Chelazzi L, 2001, CEREB CORTEX, V11, P761, DOI 10.1093/cercor/11.8.761; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; DETZ EE, 1971, SCINECE, V174, P431; Ferraina S, 2002, J NEUROPHYSIOL, V87, P845, DOI 10.1152/jn.00317.2001; GATTASS R, 1988, J NEUROSCI, V8, P1831; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kastner S, 1998, SCIENCE, V282, P108, DOI 10.1126/science.282.5386.108; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Leopold DA, 1998, EXP BRAIN RES, V123, P341, DOI 10.1007/s002210050577; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; LYNCH JC, 1994, EXP BRAIN RES, V100, P181; McPeek RM, 2004, NAT NEUROSCI, V7, P757, DOI 10.1038/nn1269; MILLER EK, 1993, BRAIN RES, V616, P25, DOI 10.1016/0006-8993(93)90187-R; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Nowak LG, 1997, CEREBR CORT, V12, P205; PETERSEN SE, 1987, NEUROPSYCHOLOGIA, V25, P97, DOI 10.1016/0028-3932(87)90046-7; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Reynolds JH, 2003, NEURON, V37, P853, DOI 10.1016/S0896-6273(03)00097-7; Reynolds JH, 1999, J NEUROSCI, V19, P1736; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Shipp S, 2004, TRENDS COGN SCI, V8, P223, DOI 10.1016/j.tics.2004.03.004; Sommer MA, 1997, EXP BRAIN RES, V116, P229, DOI 10.1007/PL00005752; Sommer MA, 2000, J NEUROPHYSIOL, V83, P1979, DOI 10.1152/jn.2000.83.4.1979; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; WELCH K, 1958, BRAIN, V81, P341, DOI 10.1093/brain/81.3.341; Zoccolan D, 2005, J NEUROSCI, V25, P8150, DOI 10.1523/JNEUROSCI.2058-05.2005	42	167	169	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					791	798		10.1016/j.neuron.2006.05.010	http://dx.doi.org/10.1016/j.neuron.2006.05.010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731516	Bronze			2022-12-28	WOS:000238165000013
J	Atasoy, D; Kavalali, ET				Atasoy, D; Kavalali, ET			Presynaptic unsilencing: Searching for a mechanism	NEURON			English	Editorial Material							LONG-TERM POTENTIATION; MATURATION; SYNAPSES; VESICLE	Nascent synaptic networks have a high incidence of silent synapses. In this issue of Neuron, Shen et al. show that a brief burst of action potentials rapidly awaken silent synapses by increasing the availability of synaptic vesicles for fusion through BDNF-triggered presynaptic actin remodeling mediated by the small GTPase Cdc42.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Atasoy, D (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA.		Atasoy, Deniz/B-3414-2018; Atasoy, Deniz/AAR-7917-2020	Atasoy, Deniz/0000-0002-3325-8820				Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001	10	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 4	2006	50	3					345	346		10.1016/j.neuron.2006.04.018	http://dx.doi.org/10.1016/j.neuron.2006.04.018			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675387	Bronze			2022-12-28	WOS:000237726800002
J	Manookin, MB; Demb, JB				Manookin, Michael B.; Demb, Jonathan B.			Presynaptic mechanism for slow contrast adaptation in mammalian retinal ganglion cells	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LATERAL GENICULATE-NUCLEUS; VISUAL CORTICAL-NEURONS; BIPOLAR CELLS; TEMPORAL CONTRAST; PYRAMIDAL NEURONS; MACAQUE MONKEYS; RIBBON SYNAPSE; PRIMATE RETINA; CAT	Visual neurons, from retina to cortex, adapt slowly to stimulus contrast. Following a switch from high to low contrast, a neuron rapidly decreases its responsiveness and recovers over 5-20 s. Cortical adaptation arises from an intrinsic cellular mechanism: a sodium-dependent potassium conductance that causes prolonged hyperpolarization. Spiking can drive this mechanism, raising the possibility that the same mechanism exists in retinal ganglion cells. We found that adaptation in ganglion cells corresponds to a slowly recovering after hyperpolarization (AHP), but, unlike in cortical cells, this AHP is not primarily driven by an intrinsic cellular property: spiking was not sufficient to generate adaptation. Adaptation was strongest following spatial stimuli tuned to presynaptic bipolar cells rather than the ganglion cell; it was driven by a reduced excitatory conductance, and it persisted while blocking GABA and glycine receptors, K-(Ca) channels or mGluRs. Thus, slow adaptation arises from reduced glutamate release from presynaptic (nonspiking) bipolar cells.	Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Demb, JB (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48105 USA.	jdemb@umich.edu		Manookin, Michael/0000-0001-8116-7619; Demb, Jonathan/0000-0003-2227-9041	NATIONAL EYE INSTITUTE [T32EY013934, P30EY007003, R01EY014454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005341] Funding Source: NIH RePORTER; NEI NIH HHS [EY07003, T32 EY013934, T32-EY13934, EY14454] Funding Source: Medline; NIDCD NIH HHS [T32 DC005341, T32-DC005341] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Baccus SA, 2004, NEURON, V42, P5, DOI 10.1016/S0896-6273(04)00187-4; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown SP, 2001, NAT NEUROSCI, V4, P44, DOI 10.1038/82888; Calkins D.J., 1999, COLOR VISION GENES P, P163; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chichilnisky EJ, 2001, NETWORK-COMP NEURAL, V12, P199, DOI 10.1088/0954-898X/12/2/306; Cohen E D, 2001, Prog Brain Res, V131, P215; Cohen ED, 2000, J NEUROPHYSIOL, V83, P3217, DOI 10.1152/jn.2000.83.6.3217; Colbert CM, 1997, J NEUROSCI, V17, P6512; CONNORS BW, 1982, J PHARMACOL EXP THER, V220, P476; CRONER LJ, 1995, VISION RES, V35, P7, DOI 10.1016/0042-6989(94)E0066-T; Dacey D, 2000, VISION RES, V40, P1801, DOI 10.1016/S0042-6989(00)00039-0; Demb JB, 2004, J NEUROPHYSIOL, V92, P2510, DOI 10.1152/jn.00108.2004; Demb JB, 2002, NEURON, V36, P781, DOI 10.1016/S0896-6273(02)01100-5; Demb JB, 2001, NEURON, V32, P711, DOI 10.1016/S0896-6273(01)00484-6; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; ENROTHCUGELL C, 1987, J PHYSIOL-LONDON, V384, P49, DOI 10.1113/jphysiol.1987.sp016443; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; KAPLAN E, 1982, J PHYSIOL-LONDON, V330, P125, DOI 10.1113/jphysiol.1982.sp014333; KIER CK, 1995, J NEUROSCI, V15, P7673; Kim KJ, 2003, J NEUROSCI, V23, P1506, DOI 10.1523/JNEUROSCI.23-04-01506.2003; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; Kohn A, 2003, NEURON, V39, P681, DOI 10.1016/S0896-6273(03)00438-0; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Levitt JB, 2001, J NEUROPHYSIOL, V85, P2111, DOI 10.1152/jn.2001.85.5.2111; LLINAS R, 1988, J NEUROPHYSIOL, V60, P869, DOI 10.1152/jn.1988.60.3.869; MAFFEI L, 1973, SCIENCE, V182, P1036, DOI 10.1126/science.182.4116.1036; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; O'Brien BJ, 2002, J PHYSIOL-LONDON, V538, P787, DOI 10.1113/jphysiol.2001.013009; PAIMER MJ, 2003, J NEUROSCI, V23, P11332; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERRY VH, 1984, NEUROSCIENCE, V12, P1101, DOI 10.1016/0306-4522(84)90006-X; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Rieke F, 2001, J NEUROSCI, V21, P9445, DOI 10.1523/JNEUROSCI.21-23-09445.2001; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; SAKAI HM, 1995, J GEN PHYSIOL, V105, P815, DOI 10.1085/jgp.105.6.815; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Singer JH, 2006, J NEUROPHYSIOL, V95, P3191, DOI 10.1152/jn.01309.2005; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; SMIMAKIS SM, 1997, NATURE, V386, P69; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; TROY JB, 1993, EXP BRAIN RES, V93, P383; VIDYASAGAR TR, 1990, NEUROSCIENCE, V36, P175, DOI 10.1016/0306-4522(90)90360-G; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Walraven J, 1990, VISUAL PERCEPTION NE, P53; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Zaghloul KA, 2005, J NEUROSCI, V25, P860, DOI 10.1523/JNEUROSCI.2782-04.2005; Zaghloul KA, 2003, J NEUROSCI, V23, P2645	59	87	90	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					453	464		10.1016/j.neuron.2006.03.039	http://dx.doi.org/10.1016/j.neuron.2006.03.039			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675399	Bronze			2022-12-28	WOS:000237726800014
J	Gaillard, R; Naccache, L; Pinel, P; Clemenceau, S; Volle, E; Hasboun, D; Dupont, S; Baulac, M; Dehaene, S; Adam, C; Cohen, L				Gaillard, R; Naccache, L; Pinel, P; Clemenceau, S; Volle, E; Hasboun, D; Dupont, S; Baulac, M; Dehaene, S; Adam, C; Cohen, L			Direct intracranial, fMRI, and lesion evidence for the causal role of left inferoternporal cortex in reading	NEURON			English	Article							WORD FORM AREA; VISUAL-CORTEX; OCCIPITOTEMPORAL CORTEX; TEMPORAL CORTEX; MASKED WORDS; RECOGNITION; OBJECT; MASKING; FACE; PERCEPTION	Models of the "visual word form system" postulate that a left occipitotemporal region implements the automatic visual word recognition required for efficient reading. This theory was assessed in a patient in whom reading was explored with behavioral measures, fMRI, and intracranial local field potentials. Prior to surgery, when reading was normal, fMRI revealed a normal mosaic of ventral visual selectivity for words, faces, houses, and tools. Intracranial recordings demonstrated that the left occipitotemporal cortex responded with a short latency to conscious but also to subliminal words. Surgery removed a small portion of word-responsive occipitotemporal cortex overlapping with the word-specific fMRI activation. The patient developed a marked reading deficit, while recognition of other visual categories remained intact. Furthermore, in the post-surgery fMRI map of visual cortex, only word-specific activations disappeared. Altogether, these results provide direct evidence for the causal role of the left occipitotemporal cortex in the recognition of visual words.	CEA, DSV, IFR 49, INSERM U562, Orsay, France; Hop La Pitie Salpetriere, AP HP, IFR 70, Dept Neurol, Paris, France; Hop La Pitie Salpetriere, AP HP, IFR 70, Dept Clin Neurophysiol, Paris, France; Hop La Pitie Salpetriere, AP HP, IFR 70, Dept Neurosurg, Paris, France; Hop La Pitie Salpetriere, AP HP, IFR 70, Dept Neuroradiol, Paris, France; Univ Paris 06, Fac Pitie Salpetriere, Paris, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Cohen, L (corresponding author), CEA, DSV, IFR 49, INSERM U562, Orsay, France.	laurent.cohen@psl.aphp.fr	pinel, philippe/AAJ-3768-2020; Volle, Emmanuelle/J-4164-2017; Gaillard, Raphael/J-6527-2015	pinel, philippe/0000-0001-6945-1369; Volle, Emmanuelle/0000-0001-8420-4155; cohen, laurent/0000-0002-5010-9085; naccache, lionel/0000-0002-2874-1009; Gaillard, Raphael/0000-0002-1297-4369				Aghababian V, 2000, J EXP CHILD PSYCHOL, V76, P123, DOI 10.1006/jecp.1999.2540; Allison T, 1999, CEREB CORTEX, V9, P415, DOI 10.1093/cercor/9.5.415; Allison T., 1994, CEREB CORTEX, V5, P544; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Chao LL, 1999, NAT NEUROSCI, V2, P913, DOI 10.1038/13217; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2004, NEUROIMAGE, V22, P466, DOI 10.1016/j.neuroimage.2003.12.049; Cohen L, 2003, CEREB CORTEX, V13, P1313, DOI 10.1093/cercor/bhg079; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Cohen L, 2004, NEUROPSYCHOLOGIA, V42, P1768, DOI 10.1016/j.neuropsychologia.2004.04.018; Dehaene S, 2001, NAT NEUROSCI, V4, P752, DOI 10.1038/89551; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2004, PSYCHOL SCI, V15, P307, DOI 10.1111/j.0956-7976.2004.00674.x; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Forster KI, 1998, J PSYCHOLINGUIST RES, V27, P203, DOI 10.1023/A:1023202116609; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Hasson U, 2002, NEURON, V34, P479, DOI 10.1016/S0896-6273(02)00662-1; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Henry C, 2005, NEUROPSYCHOLOGIA, V43, P1983, DOI 10.1016/j.neuropsychologia.2005.04.007; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Jobard G, 2003, NEUROIMAGE, V20, P693, DOI 10.1016/S1053-8119(03)00343-4; Kiefer M, 2002, COGNITIVE BRAIN RES, V13, P27, DOI 10.1016/S0926-6410(01)00085-4; KOVACS G, 1995, P NATL ACAD SCI USA, V92, P5587, DOI 10.1073/pnas.92.12.5587; Kronbichler M, 2004, NEUROIMAGE, V21, P946, DOI 10.1016/j.neuroimage.2003.10.021; Lamme VAF, 2002, J COGNITIVE NEUROSCI, V14, P1044, DOI 10.1162/089892902320474490; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Lavidor M, 2002, BRAIN LANG, V80, P45, DOI 10.1006/brln.2001.2583; LUDERS H, 1991, BRAIN, V114, P743, DOI 10.1093/brain/114.2.743; Marinkovic K, 2003, NEURON, V38, P487, DOI 10.1016/S0896-6273(03)00197-1; Mayall K, 1997, J EXP PSYCHOL LEARN, V23, P1275, DOI 10.1037/0278-7393.23.5.1275; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mechelli A, 2005, J COGNITIVE NEUROSCI, V17, P1753, DOI 10.1162/089892905774589190; Naccache L, 2005, P NATL ACAD SCI USA, V102, P7713, DOI 10.1073/pnas.0500542102; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Pammer K, 2004, NEUROIMAGE, V22, P1819, DOI 10.1016/j.neuroimage.2004.05.004; Posner MI, 1999, NEUROREPORT, V10, pR12; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Puce A, 1996, J NEUROSCI, V16, P5205; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; Salmelin R, 1996, ANN NEUROL, V40, P157, DOI 10.1002/ana.410400206; Simos PG, 2002, CEREB CORTEX, V12, P297, DOI 10.1093/cercor/12.3.297; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tanji K, 2005, J NEUROSCI, V25, P3287, DOI 10.1523/JNEUROSCI.4948-04.2005; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Thompson KG, 1999, NAT NEUROSCI, V2, P283, DOI 10.1038/6398; Usui K, 2003, BRAIN, V126, P632, DOI 10.1093/brain/awg057; Weekes BS, 1997, Q J EXP PSYCHOL-A, V50, P439, DOI 10.1080/027249897392170	52	272	279	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					191	204		10.1016/j.neuron.2006.03.031	http://dx.doi.org/10.1016/j.neuron.2006.03.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630832	Bronze			2022-12-28	WOS:000237176700008
J	Maroof, AM; Anderson, SA				Maroof, AM; Anderson, SA			Off on a tangent: Thalamocortical axons traverse a permissive corridor across the basal telencephalon	NEURON			English	Editorial Material								The forebrain is one of most complex cellular structures known. Two phenomena that enable this complexity are tangential migrations that mix neurons from distinct progenitor fields, and axon guidance across intervening, noninnervated fields. A new paper in Cell by Lopez-Bendito et al. has discovered the convergence of these phenonema in the critical thalama-cortical system.	Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA	Cornell University	Maroof, AM (corresponding author), Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10021 USA.							Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Glantz LA, 2001, ARCH GEN PSYCHIAT, V58, P203, DOI 10.1001/archpsyc.58.2.203; HARRISON PJ, 2006, IN PRESS BIOL PSYCHI; Hevner RF, 2002, J COMP NEUROL, V447, P8, DOI 10.1002/cne.10219; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Marin O, 1998, TRENDS NEUROSCI, V21, P487, DOI 10.1016/S0166-2236(98)01297-1; Metin C, 1996, J NEUROSCI, V16, P3219; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; SILBERBERG G, 2006, GENET, V141, P142; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110	14	6	7	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 20	2006	50	2					185	188		10.1016/j.neuron.2006.04.001	http://dx.doi.org/10.1016/j.neuron.2006.04.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630830	Bronze			2022-12-28	WOS:000237176700006
J	Duclukovic, NM; Wagner, AD				Duclukovic, NM; Wagner, AD			Attending to remember and remembering to attend	NEURON			English	Editorial Material							MEMORY; REPETITION; IMPLICIT	Attention and memory are intimately linked. Two functional imaging studies in this issue of Neuron provide novel evidence for this powerful, reciprocal relationship. Turk-Browne and colleagues report that attention simultaneously facilitates the formation of both implicit and explicit memories, while Summerfield and colleagues demonstrate that memory for the past can guide the allocation of attention in the present. Together, these elegant studies reveal bidirectional interactions between attention and memory.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Duclukovic, NM (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.			Wagner, Anthony/0000-0003-0624-4543				Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; Gazzaley A, 2005, J COGNITIVE NEUROSCI, V17, P507, DOI 10.1162/0898929053279522; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Manns JR, 2001, HIPPOCAMPUS, V11, P776, DOI 10.1002/hipo.1093; Mehta MR, 2001, NEUROSCIENTIST, V7, P490, DOI 10.1177/107385840100700605; Moores E, 2003, NAT NEUROSCI, V6, P182, DOI 10.1038/nn996; Mulligan NW, 1998, J EXP PSYCHOL LEARN, V24, P27, DOI 10.1037/0278-7393.24.1.27; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Ryan JD, 2004, J EXP PSYCHOL HUMAN, V30, P988, DOI 10.1037/0096-1523.30.5.988; Summerfield JJ, 2006, NEURON, V49, P905, DOI 10.1016/j.neuron.2006.01.021; Turk-Browne NB, 2006, NEURON, V49, P917, DOI 10.1016/j.neuron.2006.01.030; Yi DJ, 2005, J NEUROSCI, V25, P3593, DOI 10.1523/JNEUROSCI.4677-04.2005	13	4	5	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 16	2006	49	6					784	787		10.1016/j.neuron.2006.03.008	http://dx.doi.org/10.1016/j.neuron.2006.03.008			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543125	Bronze			2022-12-28	WOS:000236227500005
J	Spiegel, I; Peles, E				Spiegel, I; Peles, E			A new player in CNS myelination	NEURON			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; ASTROCYTES	The formation of the myelin sheath in the CNS is the endpoint of a defined developmental program along which oligodendrocytes progress. However, the molecular signals required for the initiation of myelination are largely unknown. Ishibashi et al. report in this issue of Neuron that ATP released by axons as a result of electrical stimulation serves as an important myelination signal. Surprisingly, they found that ATP does not act directly on oligodendrocytes but rather on astrocytes, causing the release of leukemia inhibitory factor (LIF), which in turns affects promyelinating oligodendrocytes. These findings uncover a novel role for astrocytes in mediating the intricate communication between axons and myelinating glial cells.	Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Spiegel, I (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.		Spiegel, Ivo/O-4025-2014	Spiegel, Ivo/0000-0003-0979-1358; Peles, Elior/0000-0002-3325-0597				Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Coman L, 2005, J NEUROL SCI, V233, P67, DOI 10.1016/j.jns.2005.03.029; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Fields RD, 2005, NEUROSCIENTIST, V11, P528, DOI 10.1177/1073858405282304; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Park SK, 2001, DEV NEUROSCI-BASEL, V23, P327, DOI 10.1159/000048716; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Spiegel I, 2006, NEURON GLIA BIOL, V2, P27, DOI 10.1017/S1740925X0600007X; Stankoff B, 2002, J NEUROSCI, V22, P9221; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Yamakuni H, 2002, J NEUROIMMUNOL, V129, P43, DOI 10.1016/S0165-5728(02)00179-0	13	13	13	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					777	778		10.1016/j.neuron.2006.03.001	http://dx.doi.org/10.1016/j.neuron.2006.03.001			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543121	Bronze			2022-12-28	WOS:000236227500001
J	Kittler, JT				Kittler, JT			Censoring the editor transient forebrain ischemia	NEURON			English	Editorial Material							CELL-DEATH; NEURONAL DEATH; AMPA RECEPTORS; CHANNELS; MECHANISMS; BLOCKADE; BRAIN	A molecular explanation for why some neurons are more vulnerable than others to ischemic injury has long remained elusive. In this issue of Neuron, Peng et al. propose that CREB-dependent downregulation of the RNA editing enzyme ADAR2, resulting in defective Q/R editing of AMPA receptor GluR2 subunits and increased availability of calcium and zinc-permeable death-promoting AMPA receptors, underlies the vulnerability of some neuronal populations to ischemia.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Kittler, JT (corresponding author), UCL, Dept Physiol, London WC1E 6BT, England.		Kittler, Josef/N-7589-2019; Kittler, Josef T/E-9113-2010	Kittler, Josef/0000-0002-3437-9456; Kittler, Josef T/0000-0002-3437-9456	MRC [G120/972] Funding Source: UKRI; Medical Research Council [G120/972] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Kawahara Y, 2004, NATURE, V427, P801, DOI 10.1038/427801a; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Seeburg PH, 2003, CURR OPIN NEUROBIOL, V13, P279, DOI 10.1016/S0959-4388(03)00062-X; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SZATKOWSKI M, 1994, TRENDS NEUROSCI, V17, P359, DOI 10.1016/0166-2236(94)90040-X; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	16	2	2	1	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	MAR 2	2006	49	5					646	648		10.1016/j.neuron.2006.02.013	http://dx.doi.org/10.1016/j.neuron.2006.02.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504939	Bronze			2022-12-28	WOS:000236070600004
J	Davidson, BL; Boudreau, RL				Davidson, Beverly L.; Boudreau, Ryan L.			RNA interference: A tool for querying nervous system function and an emerging therapy	NEURON			English	Review							DOUBLE-STRANDED-RNA; SILENCING IN-VITRO; HUNTINGTONS-DISEASE; GENE-EXPRESSION; MICRORNA EXPRESSION; NUCLEAR EXPORT; PROTEIN-KINASE; SIRNA; MOUSE; MIRNA	RNA interference (RNAi), a mediator of gene silencing, has swiftly become one of the most exciting and applicable biological discoveries. There has been rapid progress in identifying RNAi pathway components and elucidating the mechanisms of microRNA (miRNA) biogenesis and gene suppression. As a result, RNAi technologies have been successfully employed in a variety of systems as biological tools, and studies are underway to test the therapeutic utility of RNAi. In the span of several years, significant advances in the delivery of inhibitory RNAs in the nervous system have been made. We have glimpses into how endogenous miRNAs interface with neuronal development and function; in addition, RNAi has shown therapeutic efficacy in several mouse models of human neurological conditions. In this review, we summarize the current state-of-the-art of RNAi and its utility to neuroscientists.	Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; Univ Iowa, Dept Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa	Davidson, BL (corresponding author), Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA.	beverly-davidson@uiowa.edu		Boudreau, Ryan/0000-0002-9800-5349; Davidson, Beverly/0000-0002-3715-6290				Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Boda B, 2004, J NEUROSCI, V24, P10816, DOI 10.1523/JNEUROSCI.2931-04.2004; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Borchert GM, 2006, NAT STRUCT MOL BIOL, V13, P1097, DOI 10.1038/nsmb1167; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brown KM, 2005, NAT STRUCT MOL BIOL, V12, P469, DOI 10.1038/nsmb931; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Chang HS, 2004, AM J PATHOL, V165, P1535, DOI 10.1016/S0002-9440(10)63411-6; Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chi JT, 2003, P NATL ACAD SCI USA, V100, P6343, DOI 10.1073/pnas.1037853100; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Dorn G, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh044; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Fedorov Y, 2006, RNA, V12, P1188, DOI 10.1261/rna.28106; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fish RJ, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-9; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Gonzalez-Alegre P, 2005, J NEUROSCI, V25, P10502, DOI 10.1523/JNEUROSCI.3016-05.2005; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Gupta S, 2004, P NATL ACAD SCI USA, V101, P1927, DOI 10.1073/pnas.0306111101; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Harper SQ, 2006, J VIROL, V80, P9371, DOI 10.1128/JVI.00958-06; Harper SQ, 2005, P NATL ACAD SCI USA, V102, P5820, DOI 10.1073/pnas.0501507102; Hengst U, 2006, J NEUROSCI, V26, P5727, DOI 10.1523/JNEUROSCI.5229-05.2006; Hommel JD, 2003, NAT MED, V9, P1539, DOI 10.1038/nm964; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Hosono T, 2004, HUM GENE THER, V15, P813, DOI 10.1089/1043034041648462; Ivanov AI, 2004, P NATL ACAD SCI USA, V101, P16216, DOI 10.1073/pnas.0407188101; Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2005, NAT BIOTECHNOL, V23, P222, DOI 10.1038/nbt1051; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang RQ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni019; Lin Shi-Lung, 2006, V342, P295, DOI 10.1385/1-59745-123-1:295; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Makimura H, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-18; MANCHE L, 1992, MOL CELL BIOL, V12, P5238, DOI 10.1128/MCB.12.11.5238; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; Marques JT, 2005, NAT BIOTECHNOL, V23, P1399, DOI 10.1038/nbt1161; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453; MINKS MA, 1979, J BIOL CHEM, V254, P180; Morrissey DV, 2005, NAT BIOTECHNOL, V23, P1002, DOI 10.1038/nbt1122; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703; Naito Y, 2004, NUCLEIC ACIDS RES, V32, pW124, DOI 10.1093/nar/gkh442; Nakamoto M, 2005, HUM MOL GENET, V14, P3813, DOI 10.1093/hmg/ddi397; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Nelson PT, 2004, NAT METHODS, V1, P155, DOI 10.1038/NMETH717; Overhoff M, 2005, J MOL BIOL, V348, P871, DOI 10.1016/j.jmb.2005.03.012; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Pebernard S, 2004, DIFFERENTIATION, V72, P103, DOI 10.1111/j.1432-0436.2004.07202001.x; Provost P, 2002, EMBO J, V21, P5864, DOI 10.1093/emboj/cdf578; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Raoul C, 2005, NAT MED, V11, P423, DOI 10.1038/nm1207; Rodriguez-Lebron E, 2005, MOL THER, V12, P618, DOI 10.1016/j.ymthe.2005.05.006; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Salahpour A, 2007, BIOL PSYCHIAT, V61, P65, DOI 10.1016/j.biopsych.2006.03.020; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Semizarov D, 2003, P NATL ACAD SCI USA, V100, P6347, DOI 10.1073/pnas.1131959100; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Shima Y, 2004, DEV CELL, V7, P205, DOI 10.1016/j.devcel.2004.07.007; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101; Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wang J, 2005, METHOD ENZYMOL, V392, P36, DOI 10.1016/S0076-6879(04)92003-4; Wang YL, 2005, NEUROSCI RES, V53, P241, DOI 10.1016/j.neures.2005.06.021; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Yamada T, 2005, BIOINFORMATICS, V21, P1316, DOI 10.1093/bioinformatics/bti155; Yeom KH, 2006, NUCLEIC ACIDS RES, V34, P4622, DOI 10.1093/nar/gkl458; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	115	40	49	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					781	788		10.1016/j.neuron.2007.02.020	http://dx.doi.org/10.1016/j.neuron.2007.02.020			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359914	Bronze			2022-12-28	WOS:000245292800004
J	Silberberg, G; Markram, H				Silberberg, Gilad; Markram, Henry			Disynaptic inhibition between neocortical pyramidal cells mediated by martinotti cells	NEURON			English	Article							ACTION-POTENTIAL INITIATION; DENDRITIC CALCIUM SPIKES; SOMATOSENSORY CORTEX; SYNAPTIC CONNECTIONS; INTRACELLULAR-RECORDINGS; GABAERGIC INTERNEURONS; VISUAL-CORTEX; BARREL CORTEX; RAT NEOCORTEX; ADULT-RAT	Reliable activation of inhibitory pathways is essential for maintaining the balance between excitation and inhibition during cortical activity. Little is known, however, about the activation of these pathways at the level of the local neocortical microcircuit. We report a disynaptic inhibitory pathway among neocortical pyramidal cells (PCs). Inhibitory responses were evoked in layer 5 PCs following stimulation of individual neighboring PCs with trains of action potentials. The probability for inhibition between PCs was more than twice that of direct excitation, and inhibitory responses increased as a function of rate and duration of presynaptic discharge. Simultaneous somatic and dendritic recordings indicated that inhibition originated from PC apical and tuft dendrites. Multineuron whole-cell recordings from PCs and interneurons combined with morphological reconstructions revealed the mediating interneurons as Martinotti cells. Martinotti cells received facilitating synapses from PCs and formed reliable inhibitory synapses onto dendrites of neighboring PCs. We describe this feedback pathway and propose it as a central mechanism for regulation of cortical activity.	Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, SE-17177 Stockholm, Sweden	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Karolinska Institutet	Silberberg, G (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	gilad.silberberg@ki.se	Silberberg, Gilad/A-1048-2012	Silberberg, Gilad/0000-0001-9964-505X				Ali AB, 1998, J PHYSIOL-LONDON, V507, P185, DOI 10.1111/j.1469-7793.1998.185bu.x; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buckmaster PS, 1999, J NEUROSCI, V19, P9519; Carnevale N. T., 1995, Advances in Neural Information Processing Systems 7, P69; Cauller L, 1995, BEHAV BRAIN RES, V71, P163, DOI 10.1016/0166-4328(95)00032-1; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cossart R, 2001, NAT NEUROSCI, V4, P52, DOI 10.1038/82900; Douglas R. J., 1990, SYNAPTIC ORG BRAIN, P389; Fairen A., 1984, CELLULAR COMPONENTS; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Galarreta M, 1998, NAT NEUROSCI, V1, P587, DOI 10.1038/2822; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; Goldberg JH, 2004, J PHYSIOL-LONDON, V558, P465, DOI 10.1113/jphysiol.2004.064519; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Homanics GE, 1997, P NATL ACAD SCI USA, V94, P4143, DOI 10.1073/pnas.94.8.4143; Kaiser KMM, 2004, J NEUROSCI, V24, P1319, DOI 10.1523/JNEUROSCI.2852-03.2004; Kalisman N, 2005, P NATL ACAD SCI USA, V102, P880, DOI 10.1073/pnas.0407088102; Karube F, 2004, J NEUROSCI, V24, P2853, DOI 10.1523/JNEUROSCI.4814-03.2004; Kawaguchi Y, 2006, CEREB CORTEX, V16, P696, DOI 10.1093/cercor/bhj015; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; KILLACKEY HP, 1989, J COMP NEUROL, V282, P428, DOI 10.1002/cne.902820309; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Le Be JV, 2007, CEREB CORTEX, V17, P2204, DOI 10.1093/cercor/bhl127; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MILES R, 1990, J PHYSIOL-LONDON, V428, P61, DOI 10.1113/jphysiol.1990.sp018200; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Monier C, 2003, NEURON, V37, P663, DOI 10.1016/S0896-6273(03)00064-3; Oakley JC, 2001, J NEUROPHYSIOL, V86, P514, DOI 10.1152/jn.2001.86.1.514; Oda S, 2004, NEUROSCI LETT, V367, P394, DOI 10.1016/j.neulet.2004.06.042; Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019; Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Ramon y Cajal S, 1891, CELLULE, V7, P3; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; RINALDI T, 2005, AUTISM DISORDER HYPE; ROCKLAND KS, 1979, BRAIN RES, V179, P3, DOI 10.1016/0006-8993(79)90485-2; Shu YS, 2003, NATURE, V423, P288, DOI 10.1038/nature01616; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Silver RA, 2003, SCIENCE, V302, P1981, DOI 10.1126/science.1087160; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; SPRUSTON N, 1993, J NEUROPHYSIOL, V70, P781, DOI 10.1152/jn.1993.70.2.781; Stuart G, 1997, J PHYSIOL-LONDON, V505, P617, DOI 10.1111/j.1469-7793.1997.617ba.x; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; Tamas G, 2004, EUR J NEUROSCI, V20, P2681, DOI 10.1111/j.1460-9568.2004.03719.x; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Tamas G, 1998, J NEUROSCI, V18, P4255; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395; Wang Y, 2004, J PHYSIOL-LONDON, V561, P65, DOI 10.1113/jphysiol.2004.073353; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Williams SR, 2003, J NEUROSCI, V23, P7358	63	493	499	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					735	746		10.1016/j.neuron.2007.02.012	http://dx.doi.org/10.1016/j.neuron.2007.02.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329212	Bronze			2022-12-28	WOS:000245127100013
J	Bashaw, GJ				Bashaw, Greg J.			Semaphorin directs axon traffic in the fly olfactory system	NEURON			English	Editorial Material							DROSOPHILA; GLOMERULI	The convergence of olfactory sensory axons that express the same receptor onto specific glomeruli is a common organizing principle in animal olfactory systems. In this issue of Neuron, two beautiful studies in Drosophila by Lattemann et al. and Sweeney et al. show that Semaphorin repulsion regulates interactions between olfactory receptor neurons to help axons find their correct targets.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Bashaw, GJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 1113 BRB2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	gbashaw@mail.med.upenn.edu						BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Sweeney LB, 2007, NEURON, V53, P185, DOI 10.1016/j.neuron.2006.12.022	14	3	3	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					157	159		10.1016/j.neuron.2007.01.002	http://dx.doi.org/10.1016/j.neuron.2007.01.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224397	Bronze			2022-12-28	WOS:000245126600001
J	Bloodgood, BL; Sabatini, BL				Bloodgood, Brenda L.; Sabatini, Bernardo L.			Nonlinear regulation of unitary synaptic signals by CaV2.3 voltage-sensitive calcium channels located in dendritic spines	NEURON			English	Article							HIPPOCAMPAL PYRAMIDAL NEURONS; CA2+-ACTIVATED K+ CHANNELS; LONG-TERM POTENTIATION; CA2+ CHANNELS; T-TYPE; ACTIVATION; NMDA; COMPARTMENTALIZATION; INHIBITION; PLASTICITY	The roles of voltage-sensitive sodium (Na) and calcium (Ca) channels located on dendrites and spines in regulating synaptic signals are largely unknown. Here we use 2-photon glutamate uncaging to stimulate individual spines while monitoring uncaging-evoked excitatory postsynaptic potentials (uEPSPs) and Ca transients. We find that, in CA1 pyramidal neurons in acute mouse hippocampal slices, CaV2.3 voltage-sensitive Ca channels (VSCCs) are found selectively on spines and act locally to dampen uncaging-evoked Ca transients and somatic potentials. These effects are mediated by a regulatory loop that requires opening of CaV2.3 channels, voltage-gated Na channels, small conductance Ca-activated potassium (SK) channels, and NMDA receptors. Ca influx through CaV2.3 VSCCS selectively activates SK channels, revealing the presence of functional Ca microdomains within the spine. Our results suggest that synaptic strength can be modulated by mechanisms that regulate voltage-gated conductances within the spine but do not alter the properties or numbers of synaptic glutamate receptors.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Sabatini, BL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu		Bloodgood, Brenda/0000-0002-4797-9119	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046579] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS046579, R01 NS046579-01A] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Brenowitz SD, 2006, J NEUROSCI, V26, P6841, DOI 10.1523/JNEUROSCI.1280-06.2006; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; JOHNSTON D, 1992, ANNU REV PHYSIOL, V54, P489; KOCH C, 1993, J NEUROSCI, V13, P413; LEGENDRE P, 1990, J PHYSIOL-LONDON, V429, P429, DOI 10.1113/jphysiol.1990.sp018266; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Magee J, 1998, ANNU REV PHYSIOL, V60, P327, DOI 10.1146/annurev.physiol.60.1.327; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Majewska A, 2000, J NEUROSCI, V20, P1722; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; MILLS LR, 1994, J NEUROSCI, V14, P6815; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; REGEHR WG, 1995, BIOPHYS J, V68, P2156, DOI 10.1016/S0006-3495(95)80398-X; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SEGEV I, 1988, J NEUROPHYSIOL, V60, P499, DOI 10.1152/jn.1988.60.2.499; Stackman RW, 2002, J NEUROSCI, V22, P10163; Stocker M, 1999, P NATL ACAD SCI USA, V96, P4662, DOI 10.1073/pnas.96.8.4662; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	38	206	209	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					249	260		10.1016/j.neuron.2006.12.017	http://dx.doi.org/10.1016/j.neuron.2006.12.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224406	Bronze			2022-12-28	WOS:000245126600010
J	Sweeney, LB; Couto, A; Chou, YH; Berdnik, D; Dickson, BJ; Luo, LQ; Komiyama, T				Sweeney, Lora B.; Couto, Africa; Chou, Ya-Hui; Berdnik, Daniela; Dickson, Barry J.; Luo, Liqun; Komiyama, Takaki			Temporal target restriction of olfactory receptor neurons by Semaphorin-1a/PlexinA-mediated axon-axon interactions	NEURON			English	Article							DROSOPHILA VISUAL-SYSTEM; WIRING SPECIFICITY; GROWTH CONES; SEMAPHORIN RECEPTOR; PROJECTION NEURONS; ANTENNAL LOBE; N-CADHERIN; GUIDANCE; FASCICULATION; PLEXIN	Axon-axon interactions have been implicated in neural circuit assembly, but the underlying mechanisms are poorly understood. Here, we show that in the Drosophila antennal lobe, early-arriving axons of olfactory receptor neurons (ORNs) from the antenna are required for the proper targeting of late-arriving ORN axons; from the maxillary palp (MP). Semaphorin-1 a is required for targeting of all MP but only half of the antennal ORN classes examined. Sema-1 a acts nonautonomously to control ORN axon-axon interactions, in contrast to its cell-autonomous function in olfactory projection neurons. Phenotypic and genetic interaction analyses implicate PlexinA as the Sema-1 a receptor in ORN targeting. Sema-la on antennal ORN axons is required for correct targeting of MP axons within the antennal lobe, while interactions amongst MP axons facilitate their entry into the antennal lobe. We propose that Sema-1a/PlexinA-mediated repulsion provides a mechanism by which early-arriving ORN axons constrain the target choices of late-arriving axons.	Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA; Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	Howard Hughes Medical Institute; Stanford University; Stanford University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Luo, LQ (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol Sci, Stanford, CA 94305 USA.	lluo@stanford.edu	Dickson, Barry/AAE-7632-2019; Chou, Ya-Hui/F-3775-2014	Dickson, Barry/0000-0003-0715-892X; Chou, Ya-Hui/0000-0001-6552-8728; Komiyama, Takaki/0000-0001-9609-4600; Couto, Africa/0000-0002-3868-5637; Sweeney, Lora/0000-0001-9242-5601; Luo, Liqun/0000-0001-5467-9264	NIDCD NIH HHS [R01-DC005982] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005982] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Ayoob JC, 2006, DEVELOPMENT, V133, P2125, DOI 10.1242/dev.02380; BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; Chen Y, 1998, DEVELOPMENT, V125, P4943; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Cloutier JF, 2002, NEURON, V33, P877, DOI 10.1016/S0896-6273(02)00635-9; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311; Ebrahimi FAW, 2000, CURR BIOL, V10, P219, DOI 10.1016/S0960-9822(00)00342-0; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Jhaveri D, 2000, MECH DEVELOP, V99, P101, DOI 10.1016/S0925-4773(00)00487-1; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8; KOMIYAMA T, 2007, IN PRESS CELL; Kreher SA, 2005, NEURON, V46, P445, DOI 10.1016/j.neuron.2005.04.007; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; LIN DM, 1995, NEURON, V14, P707, DOI 10.1016/0896-6273(95)90215-5; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; RAPER JA, 1983, J NEUROSCI, V3, P31; Renzi MJ, 2000, NEURON, V28, P437, DOI 10.1016/S0896-6273(00)00123-9; Robinson IM, 2002, NATURE, V418, P336, DOI 10.1038/nature00915; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwarting GA, 2004, EUR J NEUROSCI, V19, P1800, DOI 10.1111/j.1460-9568.2004.03304.x; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Walz A, 2002, J NEUROSCI, V22, P4025, DOI 10.1523/JNEUROSCI.22-10-04025.2002; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	56	110	110	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					185	200		10.1016/j.neuron.2006.12.022	http://dx.doi.org/10.1016/j.neuron.2006.12.022			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224402	Bronze			2022-12-28	WOS:000245126600006
J	Knutson, B; Rick, S; Wirnmer, GE; Prelec, D; Loewenstein, G				Knutson, Brian; Rick, Scott; Wirnmer, G. Elliott; Prelec, Drazen; Loewenstein, George			Neural predictors of purchases	NEURON			English	Article							DECISION-MAKING; ACTIVATION; UNCERTAINTY; PREFERENCE; OUTCOMES; FMRI	Microeconomic theory maintains that purchases are driven by a combination of consumer preference and price. Using eventrelated flVlRl, we investigated how people weigh these factors to make purchasing decisions. Consistent with neuroinnaging evidence suggesting that distinct circuits anticipate gain and loss, product preference activated the nucleus accumbens (NAcc), while excessive prices activated the insula and deactivated the mesial prefrontal cortex (MPFC) prior to the purchase decision. Activity from each of these regions independently predicted immediately subsequent purchases above and beyond self-report variables. These findings suggest that activation of distinct neural circuits related to anticipatory affect precedes and supports consumers' purchasing decisions.	Stanford Univ, Stanford, CA 94305 USA; Carnegie Mellon Univ, Pittsburgh, PA 15213 USA; MIT, MIT Sloan Sch Management, Cambridge, MA 02139 USA	Stanford University; Carnegie Mellon University; Massachusetts Institute of Technology (MIT)	Knutson, B (corresponding author), Stanford Univ, Bldg 420,Jordan Hall, Stanford, CA 94305 USA.	knutson@psych.stanford.edu	Loewenstein, George/G-7616-2014; Rick, Scott/A-6296-2011; Wimmer, G. Elliott/AAJ-8537-2020	Loewenstein, George/0000-0003-2790-0474; Rick, Scott/0000-0002-0306-2376; Wimmer, G. Elliott/0000-0002-2227-119X; Knutson, Brian/0000-0002-7669-426X	NIA NIH HHS [P30 AG024957, AG024957-02] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P30AG024957] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA020615] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Deaton A., 1980, EC CONSUMER BEHAV, DOI DOI 10.1017/CBO9780511805653; Deppe M, 2005, J NEUROIMAGING, V15, P171, DOI 10.1177/1051228405275074; Erk S, 2002, NEUROREPORT, V13, P2499, DOI 10.1097/00001756-200212200-00024; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; McClure SM, 2004, NEURON, V44, P379, DOI 10.1016/j.neuron.2004.09.019; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Paulus MP, 2003, NEUROREPORT, V14, P1311, DOI 10.1097/01.wnr.0000078543.07662.02; Paulus MP, 2003, NEUROIMAGE, V19, P1439, DOI 10.1016/S1053-8119(03)00251-9; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Prelec D, 1998, MARKET SCI, V17, P4, DOI 10.1287/mksc.17.1.4; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Slovic P, 2002, HEURISTICS BIASES PS, P397, DOI [DOI 10.1017/CBO9780511808098.025, 10.1017/CBO9780511808098.025]; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Volz KG, 2005, BRAIN RES BULL, V67, P403, DOI 10.1016/j.brainresbull.2005.06.011	35	663	693	7	165	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					147	156		10.1016/j.neuron.2006.11.010	http://dx.doi.org/10.1016/j.neuron.2006.11.010			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196537	Bronze, Green Accepted			2022-12-28	WOS:000245126500015
J	Montell, C				Montell, Craig			An exciting release on TRPM7	NEURON			English	Editorial Material							CHANNEL; POTENTIATION; CONTRIBUTES; PROTEIN; KINASE	Following fusion, synaptic vesicles do not always release all of their neurotransmitter. According to one model, neurotransmitters bind to a charged matrix within secretory vesicles, and release requires entry of counterions. In the current issue of Neuron, Krapi-vinsky et al. demonstrate that TRPM7 is localized to synaptic vesicles and is required for release of the positively charged neurotransmitter acetylcholine. The results raise the possibility that TRPM7 is the enigmatic channel that supplies counterions for neurotransmitter release.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482				Jiang JM, 2005, J GEN PHYSIOL, V126, P137, DOI 10.1085/jgp.200409185; Krapivinsky G, 2006, NEURON, V52, P485, DOI 10.1016/j.neuron.2006.09.033; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Munsch T, 2003, P NATL ACAD SCI USA, V100, P16065, DOI 10.1073/pnas.2535311100; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Reigada D, 2003, P NATL ACAD SCI USA, V100, P3485, DOI 10.1073/pnas.0336914100; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010	10	9	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					395	397		10.1016/j.neuron.2006.10.012	http://dx.doi.org/10.1016/j.neuron.2006.10.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088204	Bronze			2022-12-28	WOS:000242269700001
J	Small, SA; Gandy, S				Small, Scott A.; Gandy, Sam			Sorting through the cell biology of Alzheimer's disease: Intracellular pathways to pathogenesis	NEURON			English	Review							AMYLOID PRECURSOR PROTEIN; TRANS-GOLGI NETWORK; GAMMA-SECRETASE ACTIVITY; BETA-SECRETASE; IN-VIVO; RETROGRADE TRANSPORT; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; APOLIPOPROTEIN-E; PLASMA-MEMBRANE	During the first 100 years of Alzheimer's disease research, this devastating and intractable disorder has been characterized at the clinical, histological, and molecular levels. Nevertheless, many key mechanistic questions remain unanswered. Here we will emphasize the importance of the cell biology of Alzheimer's disease, reviewing the relevant literature that has expanded our mechanistic understanding, with a particular focus on pathways regulating protein sorting. Accumulated evidence indicates that sorting pathways may be uniquely vulnerable to disease pathogenesis, and recent studies have begun to reveal disease-related defects in the regulation of protein sorting.	Columbia Univ Coll Phys & Surg, Dept Neurol, Taub Inst Res Alzheimers Dis Aging Brain, New York, NY 10032 USA; Thomas Jefferson Univ, Farber Inst Neurosci, Philadelphia, PA 19107 USA	Columbia University; Jefferson University	Small, SA (corresponding author), Columbia Univ Coll Phys & Surg, Dept Neurol, Taub Inst Res Alzheimers Dis Aging Brain, New York, NY 10032 USA.	sas68@columbia.edu; samgandy@earthlink.net			NIA NIH HHS [R01 AG025161, P01 AG10491, P50 AG008702, R01 AG023611, P01 AG010491-14, P01 AG010491, P50 AG08702] Funding Source: Medline; NINDS NIH HHS [R01 NS41017, R01 NS041017] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041017] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG008702, R01AG025161, R01AG023611, P01AG010491] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Ahn J, 1996, J BIOL CHEM, V271, P6917, DOI 10.1074/jbc.271.12.6917; Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; AMADUCCI LA, 1986, NEUROLOGY, V36, P1497, DOI 10.1212/WNL.36.11.1497; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; BEACH TG, 1992, ACTA NEUROPATHOL, V83, P292, DOI 10.1007/BF00296792; Bertram L, 2005, J CLIN INVEST, V115, P1449, DOI 10.1172/JCI24761; Bhardwaj N, 2005, BIOINFORMATICS, V21, P2730, DOI 10.1093/bioinformatics/bti398; Boman AL, 2001, J CELL SCI, V114, P3413; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; BURDICK D, 1992, J BIOL CHEM, V267, P546; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Capell A, 2002, J BIOL CHEM, V277, P5637, DOI 10.1074/jbc.M109119200; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P2252, DOI 10.1073/pnas.89.6.2252; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; CHEN WJ, 1990, J BIOL CHEM, V265, P3116; Chyung ASC, 1997, J CELL BIOL, V138, P671, DOI 10.1083/jcb.138.3.671; Chyung JH, 2003, J BIOL CHEM, V278, P51035, DOI 10.1074/jbc.M304989200; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Clague MJ, 2001, J CELL SCI, V114, P3075; Clee SM, 2006, NAT GENET, V38, P688, DOI 10.1038/ng1796; Cobbold C, 2003, TRENDS CELL BIOL, V13, P639, DOI 10.1016/j.tcb.2003.10.008; Cook DG, 1997, NAT MED, V3, P1021, DOI 10.1038/nm0997-1021; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Duilio A, 1998, BIOCHEM J, V330, P513, DOI 10.1042/bj3300513; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Edgar AJ, 2000, BIOCHEM BIOPH RES CO, V277, P622, DOI 10.1006/bbrc.2000.3727; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; Fagan AM, 2004, AM J PATHOL, V165, P1413, DOI 10.1016/S0002-9440(10)63399-8; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Fukumori A, 2006, BIOCHEMISTRY-US, V45, P4907, DOI 10.1021/bi052412w; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; GABUZDA D, 1993, J NEUROCHEM, V61, P2326, DOI 10.1111/j.1471-4159.1993.tb07479.x; GANDY S, 1988, P NATL ACAD SCI USA, V85, P6218, DOI 10.1073/pnas.85.16.6218; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; GANDY SE, 1992, NEUROBIOL AGING, V13, P601, DOI 10.1016/0197-4580(92)90063-4; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GILLESPIE SL, 1992, BIOCHEM BIOPH RES CO, V187, P1285, DOI 10.1016/0006-291X(92)90442-N; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Guenette SY, 1996, P NATL ACAD SCI USA, V93, P10832, DOI 10.1073/pnas.93.20.10832; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; HAASS C, 1994, P NATL ACAD SCI USA, V91, P1564, DOI 10.1073/pnas.91.4.1564; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HARNPE W, 2001, HUM GENET, V108, P529; Harter C, 2000, Subcell Biochem, V34, P1; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; Hill K, 2003, J BIOL CHEM, V278, P36032, DOI 10.1074/jbc.M301632200; Hirst J, 1998, BBA-MOL CELL RES, V1404, P173, DOI 10.1016/S0167-4889(98)00056-1; Ho CS, 2002, J BIOL CHEM, V277, P27021, DOI 10.1074/jbc.M201823200; Holsinger RMD, 2002, ANN NEUROL, V51, P783, DOI 10.1002/ana.10208; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; HUNG AY, 1993, J BIOL CHEM, V268, P22959; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Ikin AF, 1996, J BIOL CHEM, V271, P31783, DOI 10.1074/jbc.271.50.31783; INORNATA H, 2003, J BIOL CHEM, V278, P22946; JACOBSEN JS, 1994, J BIOL CHEM, V269, P8376; JAFFE AB, 1994, J BIOL CHEM, V269, P13065; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johnston JA, 2005, BIOCHEM SOC T, V33, P1096, DOI 10.1042/BST0331096; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; KAHN RA, 1993, CELL, V75, P1045, DOI 10.1016/0092-8674(93)90314-G; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KATZMAN R, 1986, NEW ENGL J MED, V314, P964, DOI 10.1056/NEJM198604103141506; Kerr MC, 2005, TRAFFIC, V6, P991, DOI 10.1111/j.1600-0854.2005.00328.x; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Kojro E, 2005, SUB CELL BIOCHEM, V38, P105; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; KREIS TE, 1994, CURR OPIN CELL BIOL, V6, P533, DOI 10.1016/0955-0674(94)90073-6; Lah JJ, 2000, MOL CELL NEUROSCI, V16, P111, DOI 10.1006/mcne.2000.0861; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lazarov O, 2002, J NEUROSCI, V22, P9785; Le Borgne R, 1998, BBA-MOL CELL RES, V1404, P195, DOI 10.1016/S0167-4889(98)00057-3; Lee EB, 2005, J CELL BIOL, V168, P291, DOI 10.1083/jcb.200407070; Lee MK, 1997, NAT MED, V3, P756, DOI 10.1038/nm0797-756; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; LEVYLAHAD E, 1995, SCIENCE, V269, P970, DOI 10.1126/science.7638621; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lewandowski NM, 2005, J NEUROSCI, V25, P10341, DOI 10.1523/JNEUROSCI.4006-05.2005; Li R, 2004, P NATL ACAD SCI USA, V101, P3632, DOI 10.1073/pnas.0205689101; LI R, 2004, P NATL ACAD SCI USA, V405, P689; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; MarquezSterling NR, 1997, J NEUROSCI, V17, P140, DOI 10.1523/JNEUROSCI.17-01-00140.1997; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Matsuda S, 2001, J NEUROSCI, V21, P6597; Mayeux R, 2003, ANNU REV NEUROSCI, V26, P81, DOI 10.1146/annurev.neuro.26.043002.094919; McLoughlin DM, 1999, EUR J NEUROSCI, V11, P1988, DOI 10.1046/j.1460-9568.1999.00610.x; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nguyen C, 2003, J CELL BIOL, V163, P697, DOI 10.1083/jcb.200310038; Niimura M, 2005, J BIOL CHEM, V280, P12967, DOI 10.1074/jbc.M409829200; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Nothwehr SF, 2000, J CELL BIOL, V151, P297, DOI 10.1083/jcb.151.2.297; Novick P, 1997, CURR OPIN CELL BIOL, V9, P496, DOI 10.1016/S0955-0674(97)80025-7; Noviello C, 2003, J BIOL CHEM, V278, P31843, DOI 10.1074/jbc.M304133200; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Olkkonen VM, 2000, NEW ENGL J MED, V343, P1095, DOI 10.1056/NEJM200010123431507; Ono Y, 1997, J BIOCHEM-TOKYO, V121, P585; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Petanceska SS, 2000, J NEUROCHEM, V74, P1878, DOI 10.1046/j.1471-4159.2000.0741878.x; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pfeffer SR, 2001, CURR BIOL, V11, pR109, DOI 10.1016/S0960-9822(01)00042-2; Ponnambalam S, 2003, MOL MEMBR BIOL, V20, P129, DOI 10.1080/0968768031000084172; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Prekeris R, 1999, J NEUROSCI, V19, P10324; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rechards M, 2006, TRAFFIC, V7, P354, DOI 10.1111/j.1600-0854.2006.00388.x; Reddy JV, 2001, MOL BIOL CELL, V12, P3242, DOI 10.1091/mbc.12.10.3242; Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422; Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; RIEMENSCHNEIDER M, 2006, IN PRESS NEUROBIOL A, DOI DOI 10.1016/J.NEUROBIOLAGING.2006.07.016; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; Robertson SE, 2006, MOL BIOL CELL, V17, P645, DOI 10.1091/mbc.E05-07-0662; Rodriguez-Boulan E, 2005, BBA-MOL CELL RES, V1744, P455, DOI 10.1016/j.bbamcr.2005.04.007; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; ROGERS J, 1985, J NEUROSCI, V5, P2801; Rossner S, 2004, J BIOL CHEM, V279, P27841, DOI 10.1074/jbc.C400122200; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Sabo SL, 1999, J BIOL CHEM, V274, P7952, DOI 10.1074/jbc.274.12.7952; SANO Y, IN PRESS PLOS 1, V1; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SCHORER CE, 1985, INT J AGING HUM DEV, V21, P235, DOI 10.2190/GNQ1-GDUX-EPTL-0F2L; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034; Seaman MNJ, 2002, MOL BIOL CELL, V13, P2826, DOI 10.1091/mbc.02-05-0064; Selkoe DJ, 2006, NAT MED, V12, P758, DOI 10.1038/nm0706-758; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Sheng JG, 2002, J NEUROSCI, V22, P9794; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; SILVA OABDE, 1993, NEUROSCIENCE, V57, P873, DOI 10.1016/0306-4522(93)90031-A; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Skovronsky DM, 2000, BIOCHEMISTRY-US, V39, P810, DOI 10.1021/bi991728z; Smale S., 2000, MATHEMATICSFRONTIERS, P271; Small S.A., 2003, ANN M SOC NEUR NEW O; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; SMALL SA, 2003, Patent No. 60518250; Sodhi CP, 2004, MOL BRAIN RES, V128, P201, DOI 10.1016/j.molbrainres.2004.06.012; Soriano S, 1999, J BIOL CHEM, V274, P32295, DOI 10.1074/jbc.274.45.32295; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Stack JH, 1995, ANNU REV CELL DEV BI, V11, P1; Stelzma R. A., 1995, CLIN ANAT, V8, P429, DOI [10.1002/ca.980080612, DOI 10.1002/CA.980080612]; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tanahashi H, 1999, NEUROSCI LETT, V261, P143, DOI 10.1016/S0304-3940(98)00995-1; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita S, 1999, J BIOL CHEM, V274, P2243, DOI 10.1074/jbc.274.4.2243; Tomizawa K, 2003, J CELL BIOL, V163, P813, DOI 10.1083/jcb.200308110; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Traub LM, 2005, BBA-MOL CELL RES, V1744, P415, DOI 10.1016/j.bbamcr.2005.04.005; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; van Vliet C, 2003, PROG BIOPHYS MOL BIO, V83, P1, DOI 10.1016/S0079-6107(03)00019-1; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Watanabe T, 1999, J NEUROCHEM, V72, P549, DOI 10.1046/j.1471-4159.1999.0720549.x; WISNIEWSKI K, 1978, BIOL PSYCHIAT, V13, P619; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Wood DR, 2005, J BIOL CHEM, V280, P6663, DOI 10.1074/jbc.M410332200; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; XU HX, 1995, J BIOL CHEM, V270, P23243, DOI 10.1074/jbc.270.40.23243; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Zambrano N, 1997, J BIOL CHEM, V272, P6399, DOI 10.1074/jbc.272.10.6399; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200	236	254	258	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					15	31		10.1016/j.neuron.2006.09.001	http://dx.doi.org/10.1016/j.neuron.2006.09.001			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015224	Green Accepted, Bronze			2022-12-28	WOS:000241408100002
J	Hodge, JJL; Mullasseril, P; Griffith, LC				Hodge, James J. L.; Mullasseril, Praseeda; Griffith, Leslie C.			Activity-dependent Gating of CaMKII autonomous activity by Drosophila CASK	NEURON			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; AUTOPHOSPHORYLATION SITES; CA-2+ CALMODULIN; MEMORY FORMATION; PHOSPHORYLATION; MELANOGASTER; CIRCUIT; STABILIZATION	The ability of CaMKII to act as a molecular switch, becoming Ca2+ independent after activation and autophosphorylation at T287, is critical for experience-dependent plasticity. Here, we show that the Drosophila homolog of CASK, also known as Camguk, can act as a gain controller on the transition to calcium-independence in vivo. Genetic loss of dCASK significantly increases synapse-specific, activity-dependent autophosphorylation of CaMKII T287. In wild-type adult animals, simple and complex sensory stimuli cause region-specific increases in pT287. dCASK-deficient adults have a reduced dynamic range for activity-dependent T287 phosphorylation and have circuit-level defects that result in inappropriate activation of the kinase. dCASK control of the CaMKII switch occurs via its ability to induce autophosphorylation of T306 in the kinase's CaM binding domain. Phosphorylation of T306 blocks Ca2+/CaM binding, lowering the probability of intersubunit T287 phosphorylation, which requires CaM binding to both the substrate and catalytic subunits. dCASK is the first CaMKII-interacting protein other than CaM found to regulate this plasticity-controlling molecular switch.	Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA USA	Brandeis University; Brandeis University	Griffith, LC (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02254 USA.	griffith@brandeis.edu		Hodge, James/0000-0003-4741-2363; Griffith, Leslie/0000-0003-3164-9876	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054408] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045713] Funding Source: NIH RePORTER; NCRR NIH HHS [S10 RR16780] Funding Source: Medline; NIGMS NIH HHS [R01 GM054408-10, GM54408, R01 GM054408] Funding Source: Medline; NINDS NIH HHS [930 NS045713] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barth M, 1997, LEARN MEMORY, V4, P219, DOI 10.1101/lm.4.2.219; Bejar R, 2002, J NEUROSCI, V22, P5719; Biederer T, 2001, J BIOL CHEM, V276, P47869, DOI 10.1074/jbc.M105287200; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; COLBRAN RJ, 1990, J BIOL CHEM, V265, P11213; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FUKUNAGA K, 1993, J BIOL CHEM, V268, P7863; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Griffith LC, 2004, J NEUROSCI, V24, P8391, DOI 10.1523/JNEUROSCI.2888-04.2004; GRIFFITH LC, 1993, J NEUROCHEM, V61, P1534, DOI 10.1111/j.1471-4159.1993.tb13650.x; GRIFFITH LC, 1994, P NATL ACAD SCI USA, V91, P10044, DOI 10.1073/pnas.91.21.10044; Griffith Leslie C, 2003, Mol Interv, V3, P386, DOI 10.1124/mi.3.7.386; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Hardingham N, 2003, J NEUROSCI, V23, P4428; HEISENBERG M, 1994, P INT S HON HCMF HUB, P61; Hodge JJL, 2005, J NEUROBIOL, V63, P235, DOI 10.1002/neu.20126; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner MLA, 1997, J NEUROSCI, V17, P9384; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Lie ALA, 2005, EPILEPSY RES, V67, P13, DOI 10.1016/j.eplepsyres.2005.06.009; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lopes C, 2001, BIOCHEM BIOPH RES CO, V284, P1004, DOI 10.1006/bbrc.2001.5050; LOU LL, 1989, J NEUROSCI, V9, P2020; Lu CS, 2003, NEURON, V40, P1185, DOI 10.1016/S0896-6273(03)00786-4; Macleod GT, 2002, J NEUROPHYSIOL, V88, P2659, DOI 10.1152/jn.00515.2002; Marble DD, 2005, J NEUROSCI, V25, P4898, DOI 10.1523/JNEUROSCI.4566-04.2005; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; Martin JR, 1996, EMBO J, V15, P1865, DOI 10.1002/j.1460-2075.1996.tb00537.x; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Mehren JE, 2004, J NEUROSCI, V24, P10584, DOI 10.1523/JNEUROSCI.3560-04.2004; Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003; MILLARD P, 1988, PLANT CELL ENVIRON, V11, P1, DOI 10.1111/j.1365-3040.1988.tb01769.x; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Nitabach MN, 2002, CELL, V109, P485, DOI 10.1016/S0092-8674(02)00737-7; Nix SL, 2000, J BIOL CHEM, V275, P41192, DOI 10.1074/jbc.M002078200; PATTON BL, 1990, J BIOL CHEM, V265, P11204; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Ritzenthaler S, 2000, NAT NEUROSCI, V3, P1012, DOI 10.1038/79833; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHWORER CM, 1988, J BIOL CHEM, V263, P13486; Singh TD, 2005, J NEUROBIOL, V65, P179, DOI 10.1002/neu.20198; Takamatsu Y, 2003, BRAIN RES, V974, P99, DOI 10.1016/S0006-8993(03)02562-9; THIEL G, 1988, P NATL ACAD SCI USA, V85, P6337, DOI 10.1073/pnas.85.17.6337; WANG J, 1994, NEURON, V13, P1373, DOI 10.1016/0896-6273(94)90422-7; Wang Z, 1998, J NEUROCHEM, V71, P378; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; Zhao WQ, 1999, J NEUROSCI RES, V55, P557, DOI 10.1002/(SICI)1097-4547(19990301)55:5<557::AID-JNR3>3.3.CO;2-G	53	36	38	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					327	337		10.1016/j.neuron.2006.06.020	http://dx.doi.org/10.1016/j.neuron.2006.06.020			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880127	Bronze			2022-12-28	WOS:000239908800008
J	Schneider, VA; Granato, M				Schneider, Valerie A.; Granato, Michael			The myotomal diwanka (lh3) glycosyltransferase and type XVIII collagen are critical for motor growth cone migration	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; LYSYL HYDROXYLASE ISOFORMS; PERIPHERAL NERVOUS-SYSTEM; MIDLINE AXON GUIDANCE; EXTRACELLULAR-MATRIX; IV COLLAGEN; LYSYL-HYDROXYLASE-3 LH3; EMBRYONIC ZEBRAFISH; FLOOR PLATE; NC1 DOMAIN	The initial migration of motor growth cones from the spinal cord into the periphery requires extrinsic cues, yet their identities are largely unknown. In zebrafish diwanka mutants, motor growth cones are motile but fail to pioneer into the periphery. Here, we report on the positional cloning of diwanka and show that it encodes LH3, a myotomally expressed multifunctional enzyme with lysyl hydroxylase and glycosyltransferase domains. Cloning, expression analysis, and ubiquitous overexpression of other LH family members reveals that only diwanka (lh3) possesses a critical role in growth cone migration. We show that this unique role depends critically on the LH3 glycosyltransferase domain, and provide compelling evidence that diwanka (W) acts through myotomal type XVIII collagen, a ligand for neural-receptor protein tyrosine phosphatases that guide motor axons. Together, our results provide the first genetic evidence that glycosyltransferase modifications of the ECM playa critical role during vertebrate motor axon migration.	Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Granato, M (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu		Schneider, Valerie/0000-0002-3442-1888	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037975] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD037975-10, R01 HD037975, R01 HD037975-09] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ackley BD, 2001, J CELL BIOL, V152, P1219, DOI 10.1083/jcb.152.6.1219; Allan DW, 1998, J COMP NEUROL, V391, P275, DOI 10.1002/(SICI)1096-9861(19980216)391:3<275::AID-CNE1>3.0.CO;2-Z; Aricescu AR, 2002, MOL CELL BIOL, V22, P1881, DOI 10.1128/MCB.22.6.1881-1892.2002; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; Bernhardt RR, 1998, DEV DYNAM, V213, P334, DOI 10.1002/(SICI)1097-0177(199811)213:3<334::AID-AJA9>3.0.CO;2-4; Bhatt RS, 2000, GENE DEV, V14, P2216, DOI 10.1101/gad.821600; Bruses JL, 2001, BIOCHIMIE, V83, P635, DOI 10.1016/S0300-9084(01)01293-7; Bulow HE, 2004, NEURON, V41, P723, DOI 10.1016/S0896-6273(04)00084-4; Cerda J, 2002, DEV DYNAM, V224, P200, DOI 10.1002/dvdy.10101; DAVIES JA, 1990, NEURON, V4, P11, DOI 10.1016/0896-6273(90)90439-M; Devoto SH, 2006, EVOL DEV, V8, P101, DOI 10.1111/j.1525-142X.2006.05079.x; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Downes GB, 2002, GENESIS, V34, P196, DOI 10.1002/gene.10120; EISEN JS, 1993, DEV BIOL, V159, P50, DOI 10.1006/dbio.1993.1220; Elamaa H, 2002, MECH DEVELOP, V114, P109, DOI 10.1016/S0925-4773(02)00014-X; Ensslen-Craig SE, 2004, DEV BIOL, V275, P12, DOI 10.1016/j.ydbio.2004.08.009; Ethell IM, 2001, NEURON, V31, P1001, DOI 10.1016/S0896-6273(01)00440-8; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; GREENSPOON S, 1995, J NEUROSCI, V15, P5956; Haftek Z, 2003, GENE EXPR PATTERNS, V3, P351, DOI 10.1016/S1567-133X(03)00027-9; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; HATTA K, 1992, NEURON, V9, P629, DOI 10.1016/0896-6273(92)90027-B; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; Heino J, 2000, MATRIX BIOL, V19, P319, DOI 10.1016/S0945-053X(00)00076-7; Henion TR, 2005, J NEUROSCI, V25, P1894, DOI 10.1523/JNEUROSCI.4654-04.2005; Holt CE, 2005, NEURON, V46, P169, DOI 10.1016/j.neuron.2005.03.021; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; HYLAND J, 1992, NAT GENET, V2, P228, DOI 10.1038/ng1192-228; Iglesias M, 1996, NEUROSCI LETT, V207, P81, DOI 10.1016/0304-3940(96)12506-4; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kantor DB, 2004, NEURON, V44, P961, DOI 10.1016/j.neuron.2004.12.002; Kivirikko KI, 1998, ADV ENZYMOL RAMB, V72, P325; Krull CE, 2000, BRAIN RES BULL, V53, P479, DOI 10.1016/S0361-9230(00)00381-6; Lee JS, 2004, NAT REV GENET, V5, P923, DOI 10.1038/nrg1490; Lee JS, 2004, NEURON, V44, P947, DOI 10.1016/j.neuron.2004.11.029; LEIN PJ, 1991, J CELL BIOL, V113, P417, DOI 10.1083/jcb.113.2.417; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; MorinKensicki EM, 1997, DEVELOPMENT, V124, P159; MORRISONGRAHAM K, 1990, DEV BIOL, V139, P308, DOI 10.1016/0012-1606(90)90300-8; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Norman KR, 2000, DEV BIOL, V227, P690, DOI 10.1006/dbio.2000.9897; OAKLEY RA, 1991, DEV BIOL, V147, P187, DOI 10.1016/S0012-1606(05)80017-X; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Sajnani-Perez G, 2003, MOL CELL NEUROSCI, V22, P37, DOI 10.1016/S1044-7431(02)00026-X; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Schneider VA, 2003, DEV BIOL, V263, P1, DOI 10.1016/S0012-1606(03)00329-4; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Suokas M, 2003, BIOCHEM J, V370, P913, DOI 10.1042/BJ20021533; Tai MH, 2002, J NEUROCYTOL, V31, P743, DOI 10.1023/A:1025756015281; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2000, DNA CELL BIOL, V19, P71, DOI 10.1089/104454900314582; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748; Zeller J, 1999, DEVELOPMENT, V126, P3461; Zeller J, 2002, DEV BIOL, V252, P241, DOI 10.1006/dbio.2002.0852	65	71	72	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					683	695		10.1016/j.neuron.2006.04.024	http://dx.doi.org/10.1016/j.neuron.2006.04.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731508	Bronze			2022-12-28	WOS:000238165000005
J	Vigot, R; Barbieri, S; Brauner-Osborne, H; Turecek, R; Shigemoto, R; Zhang, YP; Lujan, R; Jacobson, LH; Biermann, B; Fritschy, JM; Vacher, CM; Muller, M; Sansig, G; Guetg, N; Cryan, JF; Kaupmann, K; Gassmann, M; Oertner, TG; Bettler, B				Vigot, Rejan; Barbieri, Samuel; Brauner-Osborne, Hans; Turecek, Rostislav; Shigemoto, Ryuichi; Zhang, Yan-Ping; Lujan, Rafael; Jacobson, Laura H.; Biermann, Barbara; Fritschy, Jean-Marc; Vacher, Claire-Marie; Mueller, Matthias; Sansig, Gilles; Guetg, Nicole; Cryan, John F.; Kaupmann, Klemens; Gassmann, Martin; Oertner, Thomas G.; Bettler, Bernhard			Differential compartmentalization and distinct functions of GABA(B) receptor variants	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL PYRAMIDAL CELLS; SILENT SYNAPSES; RAT HIPPOCAMPUS; SYNAPTIC-TRANSMISSION; INHIBITORY SYNAPSES; GLUTAMATE RELEASE; K+ CHANNELS; CA1 REGION; PROTEIN	GABA(B) receptors are the G protein-coupled receptors for the main inhibitory neurotransmitter in the brain, gamma-aminobutyric acid (GABA). Molecular diversity in the GABA(B) system arises from the GABA(B1a) and GABA(B1b) subunit isoforms that solely differ in their ectodomains by a pair of sushi repeats that is unique to GABA(B1a). Using a combined genetic, physiological, and morphological approach, we now demonstrate that GABA(B1) isoforms localize to distinct synaptic sites and convey separate functions in vivo. At hippocampal CA3-to-CA1 synapses, GABA(B1a) assembles heteroreceptors inhibiting glutamate release, while predominantly GABA(B1b) mediates postsynaptic inhibition. Electron microscopy reveals a synaptic distribution of GABA(B1) isoforms that agrees with the observed functional differences. Transfected CA3 neurons selectively express GABA(B1a) in distal axons, suggesting that the sushi repeats, a conserved protein interaction motif, specify heteroreceptor localization. The constitutive absence of GABA(B1a) but not GABA(B1b) results in impaired synaptic plasticity and hippocampus-dependent memory, emphasizing molecular differences in synaptic GABA(B) functions.	Univ Basel, Inst Physiol, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland; Danish Univ Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark; Acad Sci Czech Republ, Inst Expt Med, Prague 14220, Czech Republic; Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan; Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Castilla La Mancha, Dept Ciencias Med, Fac Med, CRIB, Albacete 02006, Spain; Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Basel; University of Copenhagen; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Japan Science & Technology Agency (JST); Friedrich Miescher Institute for Biomedical Research; Universidad de Castilla-La Mancha; Novartis; University of Zurich	Bettler, B (corresponding author), Univ Basel, Inst Physiol, Dept Clin Biol Sci, Pharmazentrum, CH-4056 Basel, Switzerland.	bernhard.bettler@unibas.ch	Bräuner-Osborne, Hans/D-7260-2011; Jacobson, Laura/A-3363-2013; Turecek, Rostislav/H-2706-2014; Cryan, John F./A-6950-2013; jacobson, laura/AAI-7429-2021; Turecek, Rostislav/AAL-3523-2020; bettler, bernhard/AAO-8018-2020; Shigemoto, Ryuichi/E-3628-2013; Oertner, Thomas/F-2214-2010; Lujan, Rafael/G-2555-2015	Bräuner-Osborne, Hans/0000-0001-9495-7388; Cryan, John F./0000-0001-5887-2723; jacobson, laura/0000-0003-2910-8659; Turecek, Rostislav/0000-0003-4978-7556; Shigemoto, Ryuichi/0000-0001-8761-9444; Oertner, Thomas/0000-0002-2312-7528; Bettler, Bernhard/0000-0003-0842-8207; Gassmann, Martin/0000-0001-6201-3032; Lujan Miras, Rafael/0000-0003-2001-9545; Kaupmann, Klemens/0000-0001-8903-2508; Vacher, Claire-Marie/0000-0002-2966-8149; Zhang, Yan-Ping/0000-0001-7602-4453; Fritschy, Jean-Marc/0000-0002-8552-3702	NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH069062] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BARNES CA, 1994, J NEUROSCI, V14, P5793; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bischoff S, 1999, J COMP NEUROL, V412, P1; Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200; BONANNO G, 1993, TRENDS PHARMACOL SCI, V14, P259, DOI 10.1016/0165-6147(93)90124-3; Bonanno G, 1997, BRIT J PHARMACOL, V120, P60, DOI 10.1038/sj.bjp.0700852; Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Cryan JF, 2005, TRENDS PHARMACOL SCI, V26, P36, DOI 10.1016/j.tips.2004.11.004; Cunningham MD, 1996, BRAIN RES, V720, P220, DOI 10.1016/0006-8993(96)00120-5; Davies CH, 1996, J PHYSIOL-LONDON, V496, P451, DOI 10.1113/jphysiol.1996.sp021698; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Dinkel A, 1999, J IMMUNOL METHODS, V223, P255, DOI 10.1016/S0022-1759(99)00005-8; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Fritschy JM, 2004, J COMP NEUROL, V477, P235, DOI 10.1002/cne.20188; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004; GEMIGNANI A, 1994, MOL PHARMACOL, V46, P558; Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006; Kulik A, 2003, J NEUROSCI, V23, P11026; Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017; Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Luthi A, 2001, NAT NEUROSCI, V4, P1102, DOI 10.1038/nn744; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Martin SC, 2001, GENE, V278, P63, DOI 10.1016/S0378-1119(01)00678-3; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; Mohler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; MORRISETT RA, 1991, J NEUROSCI, V11, P203; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Pineda VV, 2004, NEURON, V41, P153, DOI 10.1016/S0896-6273(03)00813-4; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Pozza MF, 1999, BRIT J PHARMACOL, V127, P211, DOI 10.1038/sj.bjp.0702498; Prosser HM, 2001, MOL CELL NEUROSCI, V17, P1059, DOI 10.1006/mcne.2001.0995; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8; Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7; Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	61	240	255	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					589	601		10.1016/j.neuron.2006.04.014	http://dx.doi.org/10.1016/j.neuron.2006.04.014			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701209	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000237875200010
J	Lauri, SE; Vesikansa, A; Segerstale, M; Collingridge, GL; Isaac, JTR; Taira, T				Lauri, Sari E.; Vesikansa, Aino; Segerstale, Mikael; Collingridge, Graham L.; Isaac, John T. R.; Taira, Tomi			Functional maturation of CA1 synapses involves activity-dependent loss of tonic kainate receptor-mediated inhibition of glutamate release	NEURON			English	Article							MOSSY FIBER SYNAPSES; LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC-TRANSMISSION; RAT HIPPOCAMPUS; SILENT SYNAPSES; AREA CA1; METABOTROPIC FUNCTION; AMPA; ACTIVATION; PLASTICITY	Early in development, excitatory synapses transmit with low efficacy, one mechanism for which is a low probability of transmitter release (Pr). However, little is known about the developmental mechanisms that control activity-dependent maturation of the presynaptic release. Here, we show that during early development, transmission at CA3-CA1 synapses is regulated by a high-affinity, G protein-dependent kainate receptor (KAR), which is endogenously activated by ambient glutamate. By tonically depressing glutamate release, this mechanism sets the dynamic properties of neonatal inputs to favor transmission during high frequency bursts of activity, typical for developing neuronal networks. In response to induction of LTP, the tonic activation of KAR is rapidly down regulated, causing an increase in Pr and profoundly changing the dynamic properties of transmission. Early development of the glutamatergic connectivity thus involves an activity-dependent loss of presynaptic KAR function producing maturation in the mode of excitatory transmission from CA3 to CA1.	Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Bio & Environm Sci, FIN-00014 Helsinki, Finland; Univ Bristol, Sch Med, MRC, Ctr Synapt Plast,Dept Anat, Bristol BS8 1TD, Avon, England; NINDS, NIH, Bethesda, MD 20892 USA	University of Helsinki; University of Helsinki; University of Bristol; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Taira, T (corresponding author), Univ Helsinki, Ctr Neurosci, POB 65 Viikinkaari 1, FIN-00014 Helsinki, Finland.	tomi.taira@helsinki.fi	collingridge, graham/AAI-8362-2020; Collingridge, Graham L/C-4605-2015; Lauri, Sari/AAD-6417-2021	Collingridge, Graham L/0000-0002-9572-5359; Lauri, Sari/0000-0002-5895-1357	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003011, Z01NS003011] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BAHN S, 1994, J NEUROSCI, V14, P5525; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clarke VRJ, 2002, NEUROPHARMACOLOGY, V42, P889, DOI 10.1016/S0028-3908(02)00039-4; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; Delaney AJ, 2002, NEURON, V36, P475, DOI 10.1016/S0896-6273(02)01008-5; Diamond JS, 2005, J NEUROSCI, V25, P2906, DOI 10.1523/JNEUROSCI.5125-04.2005; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Hanse E, 2001, J PHYSIOL-LONDON, V537, P141, DOI 10.1111/j.1469-7793.2001.0141k.x; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Isaac JTR, 2004, PHARMACOL THERAPEUT, V104, P163, DOI 10.1016/j.pharmthera.2004.08.006; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Kamiya H, 1998, J PHYSIOL-LONDON, V509, P833, DOI 10.1111/j.1469-7793.1998.833bm.x; Kidd FL, 2002, NEURON, V34, P635, DOI 10.1016/S0896-6273(02)00699-2; Kullmann DM, 2001, NEURON, V32, P561, DOI 10.1016/S0896-6273(01)00507-4; Lahtinen H, 2002, J NEUROPHYSIOL, V88, P1469, DOI 10.1152/jn.2002.88.3.1469; Lamsa K, 2000, J NEUROPHYSIOL, V83, P359, DOI 10.1152/jn.2000.83.1.359; Lauri SE, 2003, MOL CELL NEUROSCI, V22, P107, DOI 10.1016/S1044-7431(02)00012-X; Lauri SE, 2001, NEUROPHARMACOLOGY, V41, P907, DOI 10.1016/S0028-3908(01)00152-6; Lauri SE, 2001, NEURON, V32, P697, DOI 10.1016/S0896-6273(01)00511-6; LAURI SE, 2005, IN PRESS J NEUROSCI; LAURI SE, 2004, MOL NEUROPHARMACOLOG, P27; Lee CJ, 2001, J NEUROSCI, V21, P4572, DOI 10.1523/JNEUROSCI.21-13-04572.2001; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Maggi L, 2004, J PHYSIOL-LONDON, V559, P863, DOI 10.1113/jphysiol.2004.067041; Melyan Z, 2002, NEURON, V34, P107, DOI 10.1016/S0896-6273(02)00624-4; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Overstreet LS, 1997, NEUROPHARMACOLOGY, V36, P831, DOI 10.1016/S0028-3908(97)00031-2; Palmer MJ, 2004, J NEUROSCI, V24, P4903, DOI 10.1523/JNEUROSCI.0170-04.2004; Palva JM, 2000, J NEUROSCI, V20, P1170, DOI 10.1523/JNEUROSCI.20-03-01170.2000; Paulsen O, 1998, TRENDS NEUROSCI, V21, P273, DOI 10.1016/S0166-2236(97)01205-8; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Ritter LM, 2002, DEV BRAIN RES, V139, P227, DOI 10.1016/S0165-3806(02)00572-2; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Rozas JL, 2003, NEURON, V39, P543, DOI 10.1016/S0896-6273(03)00436-7; Ruiz A, 2005, J NEUROSCI, V25, P11710, DOI 10.1523/JNEUROSCI.4041-05.2005; Safiulina VF, 2005, J NEUROPHYSIOL, V94, P2797, DOI 10.1152/jn.00445.2005; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; Sykova E, 2000, PROG BRAIN RES, V125, P155; Tyzio R, 1999, J NEUROSCI, V19, P10372; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Wasling P, 2004, J NEUROPHYSIOL, V92, P2714, DOI 10.1152/jn.00464.2004; Xiao MY, 2004, NAT NEUROSCI, V7, P236, DOI 10.1038/nn1196; Zakharenko SS, 2002, NEURON, V35, P1099, DOI 10.1016/S0896-6273(02)00898-X; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7	59	101	103	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					415	429		10.1016/j.neuron.2006.03.020	http://dx.doi.org/10.1016/j.neuron.2006.03.020			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675396	Bronze			2022-12-28	WOS:000237726800011
J	Molnar, Z; Molnar, E				Molnar, Z; Molnar, E			Calcium and NeuroD2 control the development of thalamocortical communication	NEURON			English	Editorial Material							BARRELS	Donald Hebb postulated the existence of a mechanism of activity-dependent transcription and synaptic modification almost 60 years ago. While the details of this process are still unclear, a new study by Ince-Dunn et al. in this issue of Neuron indicates that NeuroD2, a calcium-regulated transcription factor, plays a central role in thalamocortical synaptic maturation.	Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; Univ Bristol, Sch Med Sci, MRC, Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Oxford; University of Bristol	Molnar, Z (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Le Gros Clark Bldg, Oxford OX1 3QX, England.		Molnar, Zoltan/J-7281-2012; Molnár, Elek/D-1427-2019	Molnar, Zoltan/0000-0002-6852-6004; Molnár, Elek/0000-0002-3525-4671	Medical Research Council [G0300200] Funding Source: Medline; MRC [G0300200] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Erzurumlu RS, 2001, TRENDS NEUROSCI, V24, P589, DOI 10.1016/S0166-2236(00)01958-5; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Ince-Dunn G, 2006, NEURON, V49, P683, DOI 10.1016/j.neuron.2006.01.031; Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Lopez-Bendito G, 2003, NAT REV NEUROSCI, V4, P276, DOI 10.1038/nrn1075; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Molnar Elek, 2002, ScientificWorldJournal, V2, P27; Olson JM, 2001, DEV BIOL, V234, P174, DOI 10.1006/dbio.2001.0245; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395	12	3	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 2	2006	49	5					639	642		10.1016/j.neuron.2006.02.012	http://dx.doi.org/10.1016/j.neuron.2006.02.012			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504936	Bronze			2022-12-28	WOS:000236070600001
J	Lattemann, M; Zierau, A; Schulte, C; Seidl, S; Kuhlmann, B; Hummel, T				Lattemann, Marc; Zierau, Ariane; Schulte, Claus; Seidl, Sascha; Kuhlmann, Britta; Hummel, Thomas			Semaphorin-1a controls receptor neuron-specific axonal convergence in the primary olfactory center of Drosophila	NEURON			English	Article							GROWTH CONE GUIDANCE; ANTENNAL LOBE; ODORANT RECEPTORS; SENSORY MAP; EXPRESSION PATTERNS; WIRING SPECIFICITY; VOMERONASAL AXONS; TARGET SELECTION; TOPOGRAPHIC MAP; MUSHROOM BODIES	In the olfactory system of Drosophila, 50 functional classes of sensory receptor neurons (ORNs) project in a highly organized fashion into the CNS, where they sort out from one another and converge into distinct synaptic glomeruli. We identified the transmembrane molecule Semaphorin-la (Sema-la) as an essential component to ensure glomerulus-specific axon segregation. Removal of sema-la in ORNs does not affect the pathfinding toward their target area but disrupts local axonal convergence into a single glomerulus, resulting in two distinct targeting phenotypes: axons either intermingle with adjacent ORN classes or segregate according to their odorant receptor identity into ectopic sites. Differential Sema-1 a expression can be detected among neighboring glomeruli, and mosaic analyses show that sema-la functions nonautonomously in ORN axon sorting. These findings provide insights into the mechanism by which afferent interactions lead to synaptic specificity in the olfactory system.	Univ Munster, Inst Neurobiol, D-48149 Munster, Germany	University of Munster	Hummel, T (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, D-48149 Munster, Germany.	hummel@uni-muenster.de						Alenius M, 2003, DEVELOPMENT, V130, P917, DOI 10.1242/dev.00317; Ang LH, 2003, DEVELOPMENT, V130, P1307, DOI 10.1242/dev.00356; Bozza T, 2004, NEURON, V42, P9, DOI 10.1016/S0896-6273(04)00144-8; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cafferty P, 2006, J NEUROSCI, V26, P3999, DOI 10.1523/JNEUROSCI.3845-05.2006; Cloutier JF, 2004, J NEUROSCI, V24, P9087, DOI 10.1523/JNEUROSCI.2786-04.2004; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cutforth T, 2003, CELL, V114, P311, DOI 10.1016/S0092-8674(03)00568-3; de Castro F, 1999, J NEUROSCI, V19, P4428; Elmore T, 2003, J NEUROSCI, V23, P9906; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Hummel T, 2004, NEURON, V42, P77, DOI 10.1016/S0896-6273(04)00158-8; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Jhaveri D, 2004, DEVELOPMENT, V131, P1903, DOI 10.1242/dev.01083; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Khare N, 2000, MECH DEVELOP, V91, P393, DOI 10.1016/S0925-4773(99)00297-X; Knoll B, 2003, DEVELOPMENT, V130, P5073, DOI 10.1242/dev.00726; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Legg AT, 2003, J HISTOCHEM CYTOCHEM, V51, P445, DOI 10.1177/002215540305100406; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2001, NAT NEUROSCI, V4, P1192, DOI 10.1038/nn751; Negishi M, 2005, CELL MOL LIFE SCI, V62, P1363, DOI 10.1007/s00018-005-5018-2; Newsome TP, 2000, DEVELOPMENT, V127, P851; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Pasterkamp RJ, 2003, CURR OPIN NEUROBIOL, V13, P79, DOI 10.1016/S0959-4388(03)00003-5; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Raper JA, 2000, CURR OPIN NEUROBIOL, V10, P88, DOI 10.1016/S0959-4388(99)00057-4; Schwarting GA, 2000, J NEUROSCI, V20, P7691; Schwarting GA, 2004, EUR J NEUROSCI, V19, P1800, DOI 10.1111/j.1460-9568.2004.03304.x; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(01)00263-X; Sepp KJ, 1999, GENETICS, V151, P1093; St John JA, 2002, INT J DEV BIOL, V46, P639; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stocker RF, 2001, MICROSC RES TECHNIQ, V55, P284, DOI 10.1002/jemt.1178; STORTKUHL KF, 1994, CELL TISSUE RES, V275, P27, DOI 10.1007/BF00305373; Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; VASSAR R, 1993, CELL, V74, P309, DOI 10.1016/0092-8674(93)90422-M; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; XU T, 1993, DEVELOPMENT, V117, P1223; YANG MY, 1995, NEURON, V15, P45; Yoshihara Y, 1997, J NEUROSCI, V17, P5830; Yu HH, 1999, NEURON, V22, P11, DOI 10.1016/S0896-6273(00)80672-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Yu HH, 2000, GENETICS, V156, P723; Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652; Zhu HT, 2004, NEURON, V42, P63, DOI 10.1016/S0896-6273(04)00142-4	72	43	43	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					169	184		10.1016/j.neuron.2006.12.024	http://dx.doi.org/10.1016/j.neuron.2006.12.024			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224401	Bronze			2022-12-28	WOS:000245126600005
J	Biederlack, J; Castelo-Branco, M; Neuenschwander, S; Wheeler, DW; Singer, W; Nikolic, D				Biederlack, Julia; Castelo-Branco, Miguel; Neuenschwander, Sergio; Wheeler, Diek W.; Singer, Wolf; Nikolic, Danko			Brightness induction: Rate enhancement and neuronal synchronization as complementary codes	NEURON			English	Article							RECEPTIVE-FIELD PROPERTIES; CAT VISUAL-CORTEX; CORTICAL NEURON; OSCILLATORY RESPONSES; LATERAL INHIBITION; APPARENT CONTRAST; CELLS; ORGANIZATION; SUPPRESSION; INTEGRATOR	In cat visual cortex, we investigated with parallel recordings from multiple units the neuronal correlates of perceived brightness. The perceived brightness of a center grating was changed by varying the orientation or the relative spatial phase of a surrounding grating. Brightness enhancement by orientation contrast is associated with an increase of discharge rates of responses to the center grating but not with changes in spike synchronization. In contrast, if brightness enhancement is induced by phase offset, discharge rates are unchanged but synchronization increases between neurons responding to the center grating. The changes in synchronization correlate well with changes in perceived brightness that were assessed in parallel in human subjects using the same stimuli. These results indicate that in cerebral cortex the modulation of synchronicity of responses is used as a mechanism complementary to rate changes to enhance the saliency of neuronal responses.	Max Planck Inst Brain Res, D-60528 Frankfurt, Germany; Miberg Inst Media, D-50677 Cologne, Germany; Ctr Oftalmol, IBILI, Coimbra, Portugal; Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, Frankfurt, Germany	Max Planck Society; Universidade de Coimbra; Goethe University Frankfurt	Nikolic, D (corresponding author), Max Planck Inst Brain Res, Deutschordenstr 46, D-60528 Frankfurt, Germany.	danko@mpih-frankfurt.mpg.de	Singer, Wolf/D-6874-2012; Castelo-Branco, Miguel/E-5689-2010; Castelo-Branco, Miguel/F-3866-2019; Wheeler, Diek/AAZ-8810-2021; Nikolic, Danko/GZG-9635-2022	Castelo-Branco, Miguel/0000-0003-4364-6373; Wheeler, Diek/0000-0001-8635-0033; Nikolic, Danko/0000-0002-9317-8494; NEUENSCHWANDER, Sergio/0000-0001-7493-121X				ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Agostini T, 2002, PSYCHOL SCI, V13, P89, DOI 10.1111/1467-9280.00417; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; Brody CD, 1999, NEURAL COMPUT, V11, P1537, DOI 10.1162/089976699300016133; CANNON MW, 1991, VISION RES, V31, P1985, DOI 10.1016/0042-6989(91)90193-9; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; EJIMA Y, 1985, VISION RES, V25, P1223, DOI 10.1016/0042-6989(85)90036-7; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; Fries P, 1997, P NATL ACAD SCI USA, V94, P12699, DOI 10.1073/pnas.94.23.12699; Gail A, 2000, CEREB CORTEX, V10, P840, DOI 10.1093/cercor/10.9.840; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Huang X, 2002, J NEUROSCI, V22, P9618; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KONIG P, 1995, P NATL ACAD SCI USA, V92, P290, DOI 10.1073/pnas.92.1.290; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; KONIG P, 1994, J NEUROSCI METH, V54, P31, DOI 10.1016/0165-0270(94)90157-0; NELSON JI, 1978, BRAIN RES, V139, P359, DOI 10.1016/0006-8993(78)90937-X; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Rossi AF, 1999, J NEUROSCI, V19, P6145, DOI 10.1523/JNEUROSCI.19-14-06145.1999; SCHILLEN TB, 1994, BIOL CYBERN, V70, P397, DOI 10.1007/BF00203232; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Sillito AM, 1996, J PHYSIOL-PARIS, V90, P205, DOI 10.1016/S0928-4257(97)81424-6; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOLOMON JA, 1993, VISION RES, V33, P2671, DOI 10.1016/0042-6989(93)90227-N; TANAKA K, 1987, EXP BRAIN RES, V65, P549; Traub RD, 2001, J NEUROSCI, V21, P9478, DOI 10.1523/JNEUROSCI.21-23-09478.2001; Usrey WM, 1998, NATURE, V395, P384, DOI 10.1038/26487; VONDERHEYDT R, 1984, SCIENCE, V224, P1260, DOI 10.1126/science.6539501; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Williams AL, 2003, J NEUROPHYSIOL, V89, P525, DOI 10.1152/jn.00048.2002; Xu WF, 2005, CEREB CORTEX, V15, P1697, DOI 10.1093/cercor/bhi046; Yu C, 2001, J VISION, V1, P18, DOI 10.1167/1.1.3	40	71	70	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					1073	1083		10.1016/j.neuron.2006.11.012	http://dx.doi.org/10.1016/j.neuron.2006.11.012			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178409	Bronze			2022-12-28	WOS:000243115100014
J	Varoqueaux, F; Aramuni, G; Rawson, RL; Mohrmann, R; Missler, M; Gottmann, K; Zhang, WQ; Sudhof, TC; Brose, N				Varoqueaux, Frederique; Aramuni, Gayane; Rawson, Randi L.; Mohrmann, Ralf; Missler, Markus; Gottmann, Kurt; Zhang, Weiqi; Suedhof, Thomas C.; Brose, Nils			Neuroligins determine synapse maturation and function	NEURON			English	Article							ALPHA-NEUREXINS; EXCITATORY SYNAPSES; INHIBITORY SYNAPSES; BETA-NEUREXINS; CA2+ CHANNELS; AUTISM; PSD-95; BINDING; PROTEIN; RECEPTORS	Synaptogenesis, the generation and maturation of functional synapses between nerve cells, is an essential step in the development of neuronal networks in the brain. It is thought to be triggered by members of the neuroligin family of postsynaptic cell adhesion proteins, which may form transsynaptic contacts with presynaptic alpha- and beta-neurexins and have been implicated in the etiology of autism. We show that deletion mutant mice lacking neuroligin expression die shortly after birth due to respiratory failure. This respiratory failure is a consequence of reduced GABAergic/glycinergic and glutamatergic synaptic transmission and network activity in brainstem centers that control respiration. However, the density of synaptic contacts is not altered in neuroligin-deficient brains and cultured neurons. Our data show that neuroligins are required for proper synapse maturation and brain function, but not for the initial formation of synaptic contacts.	Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany; Max Planck Inst Expt Med, Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; Univ Gottingen, Ctr Physiol & Pathophysiol, D-37073 Gottingen, Germany; Univ Gottingen, Ctr Mol Physiol Brain, D-37073 Gottingen, Germany; Ruhr Univ Bochum, Dept Cell Physiol ND4, D-44780 Bochum, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Ctr Basic Neurosci,Dept Mol Genet, Dallas, TX 75390 USA; Univ Magdeburg, Dept Genet & Mol Neurobiol, D-39106 Magdeburg, Germany; Univ Dusseldorf, Inst Neurophysiol & Sensory Physiol, D-40225 Dusseldorf, Germany	Max Planck Society; Max Planck Society; University of Gottingen; University of Gottingen; Ruhr University Bochum; Max Planck Society; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Otto von Guericke University; Heinrich Heine University Dusseldorf	Sudhof, TC (corresponding author), Max Planck Inst Expt Med, Dept Mol Neurobiol, D-37075 Gottingen, Germany.	thomas.sudhof@utsouthwestern.edu; brose@em.mpg.de	Varoqueaux, Frederique/AAC-1834-2021	Varoqueaux, Frederique/0000-0002-3614-3121; Missler, Markus/0000-0001-8008-984X; Rawson, Randi/0000-0002-5409-7077	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH052804, R37MH052804] Funding Source: NIH RePORTER; NIMH NIH HHS [MH52804-08] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Chih B, 2004, HUM MOL GENET, V13, P1471, DOI 10.1093/hmg/ddh158; Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074; Dresbach T, 2004, MOL CELL NEUROSCI, V27, P227, DOI 10.1016/j.mcn.2004.06.013; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Fukata Y, 2005, J CELL BIOL, V169, P399, DOI 10.1083/jcb.200501121; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Hata Y, 1996, J NEUROSCI, V16, P2488; Herbert MR, 2005, NEUROSCIENTIST, V11, P417, DOI 10.1177/0091270005278866; Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105; Ichtchenko K, 1996, J BIOL CHEM, V271, P2676, DOI 10.1074/jbc.271.5.2676; ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mohrmann R, 1999, J NEUROSCI, V19, P10004; Montgomery JM, 2004, CELL MOL LIFE SCI, V61, P911, DOI 10.1007/s00018-003-3364-5; Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; RITTER B, 2000, ANNU REV NEUROSCI, V26, P485; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SPERRY RW, 1963, P NATL ACAD SCI USA, V50, P703, DOI 10.1073/pnas.50.4.703; Talebizadeh Z, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.036897; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Yamagata M, 2003, CURR OPIN CELL BIOL, V15, P621, DOI 10.1016/S0955-0674(03)00107-8; Zhang WQ, 2005, J NEUROSCI, V25, P4330, DOI 10.1523/JNEUROSCI.0497-05.2005	50	567	591	0	66	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					741	754		10.1016/j.neuron.2006.09.003	http://dx.doi.org/10.1016/j.neuron.2006.09.003			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982420	Bronze			2022-12-28	WOS:000240997900013
J	Cagniard, B; Beeler, JA; Britt, JP; McGehee, DS; Marinelli, M; Zhuang, XX				Cagniard, Barbara; Beeler, Jeff A.; Britt, Jonathan P.; McGehee, Daniel S.; Marinelli, Michela; Zhuang, Xiaoxi			Dopamine scales performance in the absence of new learning	NEURON			English	Article							MICE LACKING; FOOD REWARD; NEURONS; AMPHETAMINE; REINFORCEMENT; HALOPERIDOL; PIMOZIDE; BEHAVIOR; AUTORECEPTORS; INHIBITION	Learning and motivation are integral in shaping an organism's adaptive behavior. The dopamine system has been implicated in both processes; however, dissociating the two, both experimentally and conceptually, has posed significant challenges. We have developed an animal model that dissociates expression or scaling of a learned behavior from learning itself. An inducible dopamine transporter (DAT) knockdown mouse line has been generated, which exhibits significantly slower reuptake of released dopamine and increased tonic firing of dopamine neurons without altering phasic burst firing. Mice were trained in experimental tasks prior to inducing a hyperdopaminergic tone and then retested. Elevated dopamine enhanced performance in goal-directed operant responses. These data demonstrate that alterations in dopaminergic tone can scale the performance of a previously learned behavior in the absence of new learning.	Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; Rosalind Franklin Univ Med & Sci, Dept Mol & Cellular Pharmacol, N Chicago, IL 60064 USA; Univ Chicago, Dept Anesthesia & Crit Care, Chicago, IL 60637 USA	University of Chicago; Rosalind Franklin University Medical & Science; University of Chicago	Zhuang, XX (corresponding author), Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA.	xzhuang@bsd.uchicago.edu	Britt, jonathan/D-8877-2011; Marinelli, Michela/P-7645-2018	Britt, jonathan/0000-0003-3044-9565; Marinelli, Michela/0000-0002-1903-1937; Beeler, Jeff/0000-0002-1344-1337	NIDA NIH HHS [DA 015918, T32 DA 07255-13, F32 DA 020427-01] Funding Source: Medline; NIMH NIH HHS [MH 66216] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA020427, R01DA015918, T32DA007255] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; BINDRA D, 1974, PSYCHOL REV, V81, P199, DOI 10.1037/h0036330; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Cannon CM, 2003, J NEUROSCI, V23, P10827; Caul WF, 2001, PHARMACOL BIOCHEM BE, V68, P53, DOI 10.1016/S0091-3057(00)00431-7; Choi WY, 2005, J NEUROSCI, V25, P6729, DOI 10.1523/JNEUROSCI.1498-05.2005; COUSINS MS, 1994, PHARMACOL BIOCHEM BE, V49, P85, DOI 10.1016/0091-3057(94)90460-X; Dickinson A, 2002, STEVENS HDB EXPT PSY, P497, DOI DOI 10.1002/0471214426.PAS0312; ETTENBERG A, 1990, PHARMACOL BIOCHEM BE, V37, P465, DOI 10.1016/0091-3057(90)90014-9; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Gainetdinov RR, 1998, BRAIN RES REV, V26, P148, DOI 10.1016/S0165-0173(97)00063-5; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRACE AA, 1984, J NEUROSCI, V4, P2866; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hnasko TS, 2005, NATURE, V438, P854, DOI 10.1038/nature04172; HODOS W, 1961, SCIENCE, V134, P943, DOI 10.1126/science.134.3483.943; HORVITZ JC, 1988, PHARMACOL BIOCHEM BE, V31, P861, DOI 10.1016/0091-3057(88)90396-6; Jones SR, 1999, NAT NEUROSCI, V2, P649, DOI 10.1038/10204; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; LUCAS JJ, 1995, TRENDS PHARMACOL SCI, V16, P246, DOI 10.1016/S0165-6147(00)89034-3; Marinelli M., 2006, CNS & Neurological Disorders-Drug Targets, V5, P79, DOI 10.2174/187152706784111542; Mathon DS, 2005, EUR J NEUROSCI, V21, P2883, DOI 10.1111/j.1460-9568.2005.04123.x; Mayorga AJ, 2000, BEHAV BRAIN RES, V109, P59, DOI 10.1016/S0166-4328(99)00165-5; McClure SM, 2003, TRENDS NEUROSCI, V26, P423, DOI 10.1016/S0166-2236(03)00177-2; McFarland K, 1995, PSYCHOPHARMACOLOGY, V122, P346, DOI 10.1007/BF02246264; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P47, DOI 10.1007/s002130000486; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; NIV Y, 2005, NIPS, V18, P1019; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; WALL SC, 1995, MOL PHARMACOL, V47, P544; WHITE FJ, 1984, LIFE SCI, V34, P1161, DOI 10.1016/0024-3205(84)90088-2; Wiley JL, 2004, PSYCHOPHARMACOLOGY, V177, P170, DOI 10.1007/s00213-004-1936-1; WISE RA, 1978, CAN J PSYCHOL, V32, P77, DOI 10.1037/h0081678; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; WISE RA, 1981, PHARMACOL BIOCHEM BE, V15, P655, DOI 10.1016/0091-3057(81)90225-2; Yin HH, 2004, EUR J NEUROSCI, V19, P181, DOI 10.1111/j.1460-9568.2004.03095.x; Zhuang XX, 2001, P NATL ACAD SCI USA, V98, P1982, DOI 10.1073/pnas.98.4.1982	47	92	93	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					541	547		10.1016/j.neuron.2006.07.026	http://dx.doi.org/10.1016/j.neuron.2006.07.026			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950153	Bronze			2022-12-28	WOS:000240623400004
J	Han, J; Mark, MD; Li, X; Xie, M; Waka, S; Rettig, J; Herlitze, S				Han, Jing; Mark, Melanie D.; Li, Xiang; Xie, Mian; Waka, Sayumi; Rettig, Jens; Herlitze, Stefan			RGS2 determines short-term synaptic plasticity in hippocampal neurons by regulating G(i/o)-mediated inhibition of presynaptic Ca2+ channels	NEURON			English	Article							BETA-GAMMA-SUBUNITS; RECTIFYING POTASSIUM CHANNELS; POLYMERASE CHAIN-REACTION; CALCIUM-CHANNELS; TRANSMITTER RELEASE; GABA(B) RECEPTOR; MODULATION; PROTEINS; FACILITATION; ACTIVATION	RGS2, one of the small members of the regulator of G protein signaling (RGS) family, is highly expressed in brain and regulates G(i/o) as well as G(q)-coupled receptor pathways. RGS2 modulates anxiety, aggression, and blood pressure in mice, suggesting that RGS2 regulates synaptic circuits underlying animal physiology and behavior. How RGS2 in brain influences synaptic activity is unknown. We therefore analyzed the synaptic function of RGS2 in hippocampal neurons by comparing electrophysiological recordings from RGS2 knockout and wild-type mice. Our study provides a general mechanism of the action of the RGS family containing RGS2 by demonstrating that RGS2 increases synaptic vesicle release by downregulating the G(i/o)-mediated presynaptic Ca2+ channel inhibition and therefore provides an explanation of how regulation of RGS2 expression can modulate the function of neuronal circuits underlying behavior.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA; Univ Saarland, Dept Physiol, D-66421 Homburg, Germany	Case Western Reserve University; Saarland University	Herlitze, S (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Room E 604,10900 Euclid Ave, Cleveland, OH 44106 USA.	sxh106@cwru.edu	Mark, Melanie/ABF-9102-2020; Rettig, Jens/K-5103-2013	Mark, Melanie/0000-0002-2788-6003; Rettig, Jens/0000-0001-6160-3954	NINDS NIH HHS [NS 42523, NS 044775 2] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blackmer T, 2001, SCIENCE, V292, P293, DOI 10.1126/science.1058803; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Burchett SA, 2005, NEUROMOL MED, V7, P101, DOI 10.1385/NMM:7:1-2:101; Burchett SA, 1998, J NEUROCHEM, V70, P2216; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Ding J, 2006, NAT NEUROSCI, V9, P832, DOI 10.1038/nn1700; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Fisher SA, 1997, TRENDS NEUROSCI, V20, P170, DOI 10.1016/S0166-2236(96)01001-6; Gerachshenko T, 2005, NAT NEUROSCI, V8, P597, DOI 10.1038/nn1439; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; HERLITZE S, 1990, GENE, V91, P143, DOI 10.1016/0378-1119(90)90177-S; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Herlitze X, 1999, J PHYSIOL-LONDON, V517, P341, DOI 10.1111/j.1469-7793.1999.0341t.x; Heximer SP, 1999, J BIOL CHEM, V274, P34253, DOI 10.1074/jbc.274.48.34253; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Ingi T, 1998, J NEUROSCI, V18, P7178; Jarvis SE, 2001, TRENDS PHARMACOL SCI, V22, P519, DOI 10.1016/S0165-6147(00)01800-9; Kajikawa Y, 2001, P NATL ACAD SCI USA, V98, P8054, DOI 10.1073/pnas.141031298; Kehrl JH, 2002, INT J BIOCHEM CELL B, V34, P432, DOI 10.1016/S1357-2725(01)00141-8; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mark MD, 2000, J PHYSIOL-LONDON, V528, P65, DOI 10.1111/j.1469-7793.2000.00065.x; Mark MD, 2000, NEUROPHARMACOLOGY, V39, P2360, DOI 10.1016/S0028-3908(00)00080-0; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Mosbacher J, 1998, FEBS LETT, V436, P104, DOI 10.1016/S0014-5793(98)01066-7; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; Oliveira-dos-Santos AJ, 2000, P NATL ACAD SCI USA, V97, P12272, DOI 10.1073/pnas.220414397; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Posner BA, 1999, BIOCHEMISTRY-US, V38, P7773, DOI 10.1021/bi9906367; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Saugstad JA, 1996, J NEUROSCI, V16, P5979; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stevens CF, 2004, CURR OPIN NEUROBIOL, V14, P341, DOI 10.1016/j.conb.2004.04.004; Takasaki J, 2004, J BIOL CHEM, V279, P47438, DOI 10.1074/jbc.M408846200; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; Wang XH, 2004, J BIOL CHEM, V279, P133, DOI 10.1074/jbc.M310040200; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Young SM, 2005, P NATL ACAD SCI USA, V102, P2614, DOI 10.1073/pnas.0409656102; Zamponi GW, 1998, P NATL ACAD SCI USA, V95, P4035, DOI 10.1073/pnas.95.7.4035; Zerangue N, 1998, CURR BIOL, V8, pR313, DOI 10.1016/S0960-9822(98)70196-4; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	54	60	63	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					575	586		10.1016/j.neuron.2006.07.012	http://dx.doi.org/10.1016/j.neuron.2006.07.012			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950156	Bronze			2022-12-28	WOS:000240623400007
J	Tomioka, M; Adachi, T; Suzuki, H; Kunitomo, H; Schafer, WR; Iino, Y				Tomioka, Masahiro; Adachi, Takeshi; Suzuki, Hiroshi; Kunitomo, Hirofumi; Schafer, William R.; Iino, Yuichi			The insulin/PI 3-kinase pathway regulates salt chemotaxis learning in Caenorhabditis elegans	NEURON			English	Article							C-ELEGANS; SYNAPTIC-TRANSMISSION; OLFACTORY ADAPTATION; SIGNALING PATHWAY; LIFE-SPAN; RECEPTOR; NEURONS; PLASTICITY; PROTEIN; DAF-2	The insulin-like signaling pathway is known to regulate fat metabolism, dauer formation, and longevity in Caenorhabditis elegans. Here, we report that this pathway is also involved in salt chemotaxis learning, in which animals previously exposed to a chemoattractive salt under starvation conditions start to show salt avoidance behavior. Mutants of ins-1, daf-2, age-1, pdk-1, and akt-1, which encode the homologs of insulin, insulin/IGF-I receptor, PI 3-kinase, phosphoinositide-dependent kinase, and Akt/PKB, respectively, show severe defects in salt chemotaxis learning. daf-2 and age-1 act in the ASER salt-sensing neuron, and the activity level of the DAF-2/AGE-1 pathway in this neuron determines the extent and orientation of salt chemotaxis. On the other hand, ins-1 acts in AIA interneurons, which receive direct synaptic inputs from sensory neurons and also send synaptic outputs to ASER. These results suggest that INS-1 secreted from AIA interneurons provides feedback to ASER to generate plasticity of chemotaxis.	Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Grad Program Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of Tokyo; University of Tokyo; University of California System; University of California San Diego	Iino, Y (corresponding author), Univ Tokyo, Grad Sch Sci, Mol Genet Res Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	iino@gen.s.u-tokyo.ac.jp	IINO, YUICHI/G-4962-2014; TOMIOKA, MASAHIRO/G-4890-2014; KUNITOMO, HIROFUMI/G-4963-2014	TOMIOKA, MASAHIRO/0000-0002-7537-714X; KUNITOMO, HIROFUMI/0000-0001-7312-7051; Schafer, William/0000-0002-6676-8034	MRC [MC_U105185857] Funding Source: UKRI; Medical Research Council [MC_U105185857] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbott MA, 1999, J NEUROSCI, V19, P7300, DOI 10.1523/JNEUROSCI.19-17-07300.1999; Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Apfeld J, 1998, CELL, V95, P199, DOI 10.1016/S0092-8674(00)81751-1; Bargmann C. I., 1997, C ELEGANS, P717; BRENNER S, 1974, GENETICS, V77, P71; Chang C, 2006, CURR BIOL, V16, P854, DOI 10.1016/j.cub.2006.03.083; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chuang CF, 2005, GENE DEV, V19, P270, DOI 10.1101/gad.1276505; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Colbert HA, 1997, J NEUROSCI, V17, P8259; DEVASKAR SU, 1994, J BIOL CHEM, V269, P8445; Faumont S, 2005, J NEUROBIOL, V65, P171, DOI 10.1002/neu.20196; Hawasli AH, 2004, GENETICS, V168, P831, DOI 10.1534/genetics.104.030502; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hirotsu T, 2000, NATURE, V404, P289, DOI 10.1038/35005101; Hobert O, 2003, J NEUROBIOL, V54, P203, DOI 10.1002/neu.10168; Hukema RK, 2006, EMBO J, V25, P312, DOI 10.1038/sj.emboj.7600940; Ishihara T, 2002, CELL, V109, P639, DOI 10.1016/S0092-8674(02)00748-1; Jansen G, 2002, EMBO J, V21, P986, DOI 10.1093/emboj/21.5.986; Jonas EA, 1997, NATURE, V385, P343, DOI 10.1038/385343a0; KABA H, 1994, SCIENCE, V265, P262, DOI 10.1126/science.8023145; Kass J, 2001, J NEUROSCI, V21, P9265, DOI 10.1523/JNEUROSCI.21-23-09265.2001; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; L'Etoile ND, 2002, NEURON, V36, P1079, DOI 10.1016/S0896-6273(02)01066-8; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin CH, 2001, NEURON, V31, P841, DOI 10.1016/S0896-6273(01)00433-0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Miller AC, 2005, J NEUROSCI, V25, P3369, DOI 10.1523/JNEUROSCI.5133-04.2005; Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Murakami H, 2005, J NEUROSCI, V25, P10894, DOI 10.1523/JNEUROSCI.3600-04.2005; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nonet ML, 1998, J NEUROSCI, V18, P70; Paradis S, 1999, GENE DEV, V13, P1438, DOI 10.1101/gad.13.11.1438; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Riddle DL, 1997, C ELEGANS, P739; Saeki S, 2001, J EXP BIOL, V204, P1757; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Skeberdis VA, 2001, P NATL ACAD SCI USA, V98, P3561, DOI 10.1073/pnas.051634698; Solari F, 2005, ONCOGENE, V24, P20, DOI 10.1038/sj.onc.1207978; Spanswick D, 2000, NAT NEUROSCI, V3, P757, DOI 10.1038/77660; Spehr M, 2002, NEURON, V33, P731, DOI 10.1016/S0896-6273(02)00610-4; Suzuki H, 2003, NEURON, V39, P1005, DOI 10.1016/j.neuron.2003.08.015; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; WEI L, 1990, J NEUROCHEM, V54, P1661, DOI 10.1111/j.1471-4159.1990.tb01219.x; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Zahn TR, 2004, TRAFFIC, V5, P544, DOI 10.1111/j.1600-0854.2004.00195.x; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	57	202	231	2	35	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					613	625		10.1016/j.neuron.2006.07.024	http://dx.doi.org/10.1016/j.neuron.2006.07.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950159	Bronze			2022-12-28	WOS:000240623400010
J	Broome, BM; Jayaraman, V; Laurent, G				Broome, Bede M.; Jayaraman, Vivek; Laurent, Gilles			Encoding and decoding of overlapping odor sequences	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; LOCUST ANTENNAL LOBE; OLFACTORY NETWORK; AUDITORY-CORTEX; VISUAL MASKING; MUSHROOM BODY; REPRESENTATIONS; NEURONS; MIXTURES; DYNAMICS	Odors evoke complex responses in locust antennal lobe projection neurons (PNs)-the mitral cell analogs. These patterns evolve over hundreds of milliseconds and contain information about odor identity and concentration. In nature, animals often encounter many odorants in short temporal succession. We explored the effects of such conditions by presenting two different odors with variable intervening delays. PN ensemble representations tracked stimulus changes and, in some delay conditions, reached states that corresponded neither to the representation of either odor alone nor to the static mixture of the two. We then recorded from Kenyon cells (KCs), the PNs' targets. Their responses were consistent with the PN population's behavior: in some conditions, KCs were recruited that did not fire during single-odor or mixture stimuli. Thus, PN population dynamics are history dependent, and responses of individual KCs are consistent with piecewise temporal decoding of PN output over large sections of the PN population.	CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA	California Institute of Technology	Laurent, G (corresponding author), CALTECH, Div Biol, Computat & Neural Syst Program, Pasadena, CA 91125 USA.	laurentg@caltech.edu	Laurent, Gilles/A-4583-2012	Laurent, Gilles/0000-0002-2296-114X	NCRR NIH HHS [P41RR09754] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR009754] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Aksay E, 2003, CEREB CORTEX, V13, P1173, DOI 10.1093/cercor/bhg099; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; DRAKE KL, 1988, IEEE T BIO-MED ENG, V35, P719, DOI 10.1109/10.7273; Duda R.O., 2000, PATTERN CLASSIFICATI; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; HOPFIELD JF, 1989, BEHAV NEUROSCI, V103, P329, DOI 10.1037/0735-7044.103.2.329; Jinks A, 1999, PERCEPTION, V28, P395, DOI 10.1068/p2898; KAHNEMAN D, 1968, PSYCHOL BULL, V70, P404, DOI 10.1037/h0026731; Knusel P, 2004, NEURAL COMPUT, V16, P2079, DOI 10.1162/0899766041732459; Koehl MAR, 2001, SCIENCE, V294, P1948, DOI 10.1126/science.1063724; Kurahashi T, 1997, NATURE, V385, P725, DOI 10.1038/385725a0; LAING DG, 1989, PHYSIOL BEHAV, V46, P809, DOI 10.1016/0031-9384(89)90041-3; LAING DG, 1989, PHYSIOL BEHAV, V45, P689, DOI 10.1016/0031-9384(89)90280-1; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leitch B, 1996, J COMP NEUROL, V372, P487; LINDA Y, 2005, NATURE, V434, P470; Maass W, 2002, NEURAL COMPUT, V14, P2531, DOI 10.1162/089976602760407955; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Mustaparta H, 1996, CHEM SENSES, V21, P269, DOI 10.1093/chemse/21.2.269; Perez-Orive J, 2004, J NEUROSCI, V24, P6037, DOI 10.1523/JNEUROSCI.1084-04.2004; Perez-Orive J, 2002, SCIENCE, V297, P359, DOI 10.1126/science.1070502; Pouzat C, 2002, J NEUROSCI METH, V122, P43, DOI 10.1016/S0165-0270(02)00276-5; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; ROUBY C, 1995, PERCEPTION, V24, P1083, DOI 10.1068/p241083; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; Stevens JC, 1997, CHEM SENSES, V22, P529, DOI 10.1093/chemse/22.5.529; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Vickers NJ, 1998, J COMP NEUROL, V400, P35; VOGT MB, 1994, J NEUROPHYSIOL, V71, P1373, DOI 10.1152/jn.1994.71.4.1373; Wegel RL, 1924, PHYS REV, V23, P266, DOI 10.1103/PhysRev.23.266; Wehr M, 2005, NEURON, V47, P437, DOI 10.1016/j.neuron.2005.06.009; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Zufall F, 1998, ANN NY ACAD SCI, V855, P199, DOI 10.1111/j.1749-6632.1998.tb10566.x	46	121	121	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 17	2006	51	4					467	482		10.1016/j.neuron.2006.07.018	http://dx.doi.org/10.1016/j.neuron.2006.07.018			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908412	Bronze			2022-12-28	WOS:000240504700010
J	Sjostrom, PJ; Hausser, M				Sjostrom, Per Jesper; Hausser, Michael			A cooperative switch determines the sign of synaptic plasticity in distal dendrites of neocortical pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; RAT VISUAL-CORTEX; EXCITATORY POSTSYNAPTIC POTENTIALS; PROPAGATING ACTION-POTENTIALS; IN-VIVO; APICAL DENDRITES; K+ CHANNELS; TIME-COURSE; SPIKE; BACKPROPAGATION	Pyramidal neurons in the cerebral cortex span multiple cortical layers. How the excitable properties of pyramidal neuron dendrites allow these neurons to both integrate activity and store associations between different layers is not well understood, but is thought to rely in part on dendritic backpropagation of action potentials. Here we demonstrate that the sign of synaptic plasticity in neocortical pyramidal neurons is regulated by the spread of the backpropagating action potential to the synapse. This creates a progressive gradient between LTP and LTD as the distance of the synaptic contacts from the soma increases. At distal synapses, cooperative synaptic input or dendritic depolarization can switch plasticity between LTD and LTP by boosting backpropagation of action potentials. This activity-dependent switch provides a mechanism for associative learning across different neocortical layers that process distinct types of information.	UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Sjostrom, PJ (corresponding author), UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England.	j.sjostrom@ucl.ac.uk	Hausser, Michael/AAW-6827-2020; Sjöström, Per Jesper/B-9696-2019	Hausser, Michael/0000-0002-2673-8957; Sjöström, Per Jesper/0000-0001-7085-2223	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Bernard C, 2003, J NEUROPHYSIOL, V90, P1807, DOI 10.1152/jn.00286.2003; Broser PJ, 2004, J BIOMED OPT, V9, P1253, DOI 10.1117/1.1806832; COOGAN TA, 1990, EXP BRAIN RES, V80, P49; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Goldberg J, 2002, TRENDS NEUROSCI, V25, P433, DOI 10.1016/S0166-2236(02)02200-2; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hansel C, 1997, EUR J NEUROSCI, V9, P2309, DOI 10.1111/j.1460-9568.1997.tb01648.x; Hausser M, 1997, J NEUROSCI, V17, P7606; Hebb Donald O., 1949, ORG BEHAV; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Hoffman DA, 1999, J NEUROPHYSIOL, V81, P408, DOI 10.1152/jn.1999.81.1.408; HOLMES WR, 1989, BRAIN RES, V478, P127, DOI 10.1016/0006-8993(89)91484-4; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Larkum ME, 1999, P NATL ACAD SCI USA, V96, P14600, DOI 10.1073/pnas.96.25.14600; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Linden DJ, 1999, NEURON, V22, P661, DOI 10.1016/S0896-6273(00)80726-6; Lisman J, 2005, NAT NEUROSCI, V8, P839, DOI 10.1038/nn0705-839; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Pologruto T. A, 2003, BIOMED ENG; RALL W, 1967, J NEUROPHYSIOL, V30, P1138, DOI 10.1152/jn.1967.30.5.1138; REDMAN S, 1983, J PHYSIOL-LONDON, V343, P117, DOI 10.1113/jphysiol.1983.sp014884; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rumsey CC, 2004, J NEUROPHYSIOL, V91, P2273, DOI 10.1152/jn.00900.2003; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; SHELTON DP, 1985, NEUROSCIENCE, V14, P111, DOI 10.1016/0306-4522(85)90168-X; Sjostrom PJ, 2003, NEURON, V39, P641, DOI 10.1016/S0896-6273(03)00476-8; Sjostrom PJ, 2004, J NEUROPHYSIOL, V92, P3338, DOI 10.1152/jn.00376.2004; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Sourdet V, 1999, LEARN MEMORY, V6, P422, DOI 10.1101/lm.6.5.422; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Thomson AM, 1998, NEUROSCIENCE, V84, P669, DOI 10.1016/S0306-4522(97)00557-5; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Waters J, 2004, J NEUROSCI, V24, P11127, DOI 10.1523/JNEUROSCI.2933-04.2004; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3; Williams SR, 2002, SCIENCE, V295, P1907, DOI 10.1126/science.1067903; Williams SR, 2000, J NEUROSCI, V20, P8238, DOI 10.1523/JNEUROSCI.20-22-08238.2000; YASUDA R, 2004, SCI STKE; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	59	261	263	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					227	238		10.1016/j.neuron.2006.06.017	http://dx.doi.org/10.1016/j.neuron.2006.06.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846857	Bronze			2022-12-28	WOS:000239535100010
J	MacDonald, JM; Beach, MG; Porpiglia, E; Sheehan, AE; Watts, RJ; Freeman, MR				MacDonald, Jennifer M.; Beach, Margaret G.; Porpiglia, Ermelinda; Sheehan, Amy E.; Watts, Ryan J.; Freeman, Marc R.			The Drosophila cell corpse engulfment receptor draper mediates glial clearance of severed axons	NEURON			English	Article							PERIPHERAL-NERVE INJURY; DEAFFERENTATION-INDUCED ALTERATIONS; LEUKEMIA INHIBITORY FACTOR; RAT DORSAL HORN; WALLERIAN DEGENERATION; OLFACTORY SYSTEM; BASIC INSIGHTS; SCIATIC-NERVE; IN-VITRO; REGENERATION	Neuron-glia communication is central to all nervous system responses to trauma, yet neural injury signaling pathways remain poorly understood. Here we explore cellular and molecular aspects of neural injury signaling in Drosophila. We show that transected Drosophila axons undergo injury-induced degeneration that is morphologically similar to Wallerlan degeneration in mammals and can be suppressed by the neuroprotective mouse Wld(s) protein. Axonal injury elicits potent morphological and molecular responses from Drosophila glia: glia upregulate expression of the engulfment receptor Draper, undergo dramatic changes in morphology, and rapidly recruit cellular processes toward severed axons. In draper mutants, glia fall to respond morphologically to axon injury, and severed axons are not cleared from the CNS. Thus Draper appears to act as a glial receptor for severed axon-derived molecular cues that drive recruitment of glial processes to injured axons for engulfment.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of Massachusetts System; University of Massachusetts Worcester; Stanford University	Freeman, MR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	marc.freeman@umassmed.edu	MacDonald, Jennifer/ABB-1560-2020	Freeman, Marc/0000-0003-3481-3715; Porpiglia, Ermelinda/0000-0003-2652-899X				Aldskogius H, 1998, PROG NEUROBIOL, V55, P1, DOI 10.1016/S0301-0082(97)00093-2; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Awasaki T, 2006, NEURON, V50, P855, DOI 10.1016/j.neuron.2006.04.027; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; CAMPBELL G, 1994, DEVELOPMENT, V120, P2957; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; CURTIS R, 1994, NEURON, V12, P191, DOI 10.1016/0896-6273(94)90163-5; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Finn JT, 2000, J NEUROSCI, V20, P1333; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Fujiki M, 1996, J COMP NEUROL, V371, P469; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Grieder NC, 2000, DEVELOPMENT, V127, P4253; GUPTA SK, 1988, MOL BRAIN RES, V4, P133, DOI 10.1016/0169-328X(88)90005-8; Hall S, 2005, J BONE JOINT SURG BR, V87B, P1309, DOI 10.1302/0301-620X.87B10.16700; Hoopfer ED, 2006, NEURON, V50, P883, DOI 10.1016/j.neuron.2006.05.013; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; KAPADIA SE, 1987, J COMP NEUROL, V266, P183, DOI 10.1002/cne.902660205; Kurek JB, 1996, NEUROMUSCULAR DISORD, V6, P105, DOI 10.1016/0960-8966(95)00029-1; LAMOTTE CC, 1987, J COMP NEUROL, V266, P198, DOI 10.1002/cne.902660206; LIU HM, 1995, J NEUROPATH EXP NEUR, V54, P487, DOI 10.1097/00005072-199507000-00002; Liu L, 1998, GLIA, V23, P221, DOI 10.1002/(SICI)1098-1136(199807)23:3<221::AID-GLIA5>3.3.CO;2-Z; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; McGee AW, 2003, TRENDS NEUROSCI, V26, P193, DOI 10.1016/S0166-2236(03)00062-6; Muller HW, 1998, CURR OPIN NEUROL, V11, P557; MURRAY M, 1990, EXP NEUROL, V110, P248, DOI 10.1016/0014-4886(90)90036-R; Nagase T, 2001, DNA RES, V8, P85, DOI 10.1093/dnares/8.2.85; Nedergaard M, 2005, GLIA, V50, P281, DOI 10.1002/glia.20205; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Pittier R, 2005, J NEUROBIOL, V63, P1, DOI 10.1002/neu.20116; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; SINGH RN, 1985, INT J INSECT MORPHOL, V14, P291; Stoll G, 1999, BRAIN PATHOL, V9, P313; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; Teismann P, 2004, CELL TISSUE RES, V318, P149, DOI 10.1007/s00441-004-0944-0; Tham S, 1997, J NEUROSCI RES, V47, P208, DOI 10.1002/(SICI)1097-4547(19970115)47:2<208::AID-JNR9>3.0.CO;2-J; TRAPP BD, 1988, J NEUROSCI, V8, P3515; Vilhardt F, 2005, INT J BIOCHEM CELL B, V37, P17, DOI 10.1016/j.biocel.2004.06.010; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Waller A., 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	56	337	341	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					869	881		10.1016/j.neuron.2006.04.028	http://dx.doi.org/10.1016/j.neuron.2006.04.028			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772169	Bronze			2022-12-28	WOS:000238589500008
J	Nguyen-Ba-Charvet, KT; Chedotal, A				Nguyen-Ba-Charvet, Kim T.; Chedotal, Alain			Under the eye of Nr-CAM	NEURON			English	Editorial Material							MOLECULAR-MECHANISMS; AXON; LATERALITY	Binocular vision relies upon the existence of contralateral and ispilateral projections from retinal ganglion cells. Contacts between visual axons and optic chiasm cells are critical for the sorting of crossed and uncrossed projections during development. In this issue of Neuron, a study by Williams et al. shows that the cell adhesion molecule Nr-CAM facilitates/promotes the decussation of contralateral axons across the chiasm.	CNRS, UMR 7102, F-75005 Paris, France; Univ Paris 06, UMR 7102, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite	Nguyen-Ba-Charvet, KT (corresponding author), CNRS, UMR 7102, F-75005 Paris, France.		Chedotal, Alain/F-2750-2017; Nguyen-Ba-Charvet, Kim/J-3507-2017	Chedotal, Alain/0000-0001-7577-3794; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872				Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Eshed Y, 2005, NEURON, V47, P215, DOI 10.1016/j.neuron.2005.06.026; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Stoeckli ET, 1998, PROG BRAIN RES, V117, P105; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934	11	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					519	521		10.1016/j.neuron.2006.05.002	http://dx.doi.org/10.1016/j.neuron.2006.05.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701200	Bronze			2022-12-28	WOS:000237875200001
J	Williams, SE; Grumet, M; Colman, DR; Henkemeyer, M; Mason, CA; Sakurai, T				Williams, Scott E.; Grumet, Martin; Colman, David R.; Henkemeyer, Mark; Mason, Carol A.; Sakurai, Takeshi			A role for Nr-CAM in the patterning of binocular visual pathways	NEURON			English	Article							CELL-ADHESION MOLECULES; RETINAL AXON DIVERGENCE; GROWTH CONE BEHAVIOR; OPTIC CHIASM; NEURITE OUTGROWTH; VENTRAL MIDLINE; GANGLION-CELLS; MOUSE EMBRYOS; GUIDANCE; NEURONS	Retinal ganglion cell (RGC) axons diverge within the optic chiasm to project to opposite sides of the brain. In mouse, contralateral RGCs are distributed throughout the retina, whereas ipsilateral RGCs are restricted to the ventrotemporal crescent (VTC). While repulsive guidance mechanisms play a major role in the formation of the ipsilateral projection, little is known about the contribution of growth-promoting interactions to the formation of binocular visual projections. Here, we show that the cell adhesion molecule Nr-CAM is expressed by RGCs that project contralaterally and is critical for the guidance of late-born RGCs within the VTC. Blocking Nr-CAM function causes an increase in the size of the ipsilateral projection and reduces neurite outgrowth on chiasm cells in an age- and region-specific manner. Finally, we demonstrate that EphB1/ephrin-B2-mediated repulsion and Nr-CAM-mediated attraction comprise distinct molecular programs that each contributes to the proper formation of binocular visual pathways.	Mt Sinai Sch Med, Dept Pharmacol & Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Biol Chem, New York, NY 10029 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada; Univ Texas, SW Med Ctr, Ctr Dev Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Columbia University; Columbia University; Rutgers State University New Brunswick; McGill University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sakurai, T (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Psychiat, New York, NY 10029 USA.	takeshi.sakurai@mssm.edu	grumet, martin/ABC-6462-2020	Williams, Scott/0000-0001-9975-7334; Henkemeyer, Mark/0000-0002-7525-1061	NEI NIH HHS [R01 EY012736, EY012736, R01 EY015290, T32 EY013933] Funding Source: Medline; NINDS NIH HHS [NS040560] Funding Source: Medline; CSR NIH HHS [RG3217-A-8] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012736, R01EY015290, T32EY013933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040560] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAKER GE, 1993, J COMP NEUROL, V330, P95, DOI 10.1002/cne.903300108; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BRUMMENDORF T, 1995, PROTEIN PROFILE, V2, P963; Buchstaller A, 1996, J CELL BIOL, V135, P1593, DOI 10.1083/jcb.135.6.1593; Castellani V, 2000, NEURON, V27, P237, DOI 10.1016/S0896-6273(00)00033-7; CHAN SO, 1993, J NEUROSCI, V13, P5277, DOI 10.1523/JNEUROSCI.13-12-05277.1993; Chan SO, 1999, J COMP NEUROL, V406, P251, DOI 10.1002/(SICI)1096-9861(19990405)406:2<251::AID-CNE8>3.0.CO;2-E; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; Deiner MS, 1999, J NEUROSCI, V19, P9900; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Falk J, 2005, NEURON, V48, P63, DOI 10.1016/j.neuron.2005.08.033; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; GODEMENT P, 1994, J NEUROSCI, V14, P7024; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; GUILLERY RW, 1995, J NEUROSCI, V15, P4727; Herrera E, 2004, DEVELOPMENT, V131, P5727, DOI 10.1242/dev.01431; Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6; Hutson LD, 2002, NEURON, V33, P205, DOI 10.1016/S0896-6273(01)00579-7; Kaprielian Z, 2001, DEV DYNAM, V221, P154, DOI 10.1002/dvdy.1143; LAGENAUR C, 1987, P NATL ACAD SCI USA, V84, P7753, DOI 10.1073/pnas.84.21.7753; Lambot MA, 2005, J NEUROSCI, V25, P7232, DOI 10.1523/JNEUROSCI.0802-05.2005; Lin L, 2005, DEV BRAIN RES, V158, P1, DOI 10.1016/j.devbrainres.2005.05.001; Lin L, 2003, EUR J NEUROSCI, V17, P2299, DOI 10.1046/j.1460-9568.2003.02686.x; Long H, 2004, NEURON, V42, P213, DOI 10.1016/S0896-6273(04)00179-5; Lustig M, 1999, DEV BIOL, V209, P340, DOI 10.1006/dbio.1999.9250; Lustig M, 2001, CURR BIOL, V11, P1864, DOI 10.1016/S0960-9822(01)00586-3; Lustig M, 2001, J COMP NEUROL, V434, P13, DOI 10.1002/cne.1161; MORALES G, 1993, NEURON, V11, P1113, DOI 10.1016/0896-6273(93)90224-F; More MI, 2001, J CELL BIOL, V154, P187, DOI 10.1083/jcb.200104038; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Pekarik V, 2003, NAT BIOTECHNOL, V21, P93, DOI 10.1038/nbt770; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Pratt T, 2004, DEVELOPMENT, V131, P3773, DOI 10.1242/dev.01246; REESE BE, 1992, NEUROSCIENCE, V46, P419, DOI 10.1016/0306-4522(92)90062-7; REESE BE, 1992, J COMP NEUROL, V324, P336, DOI 10.1002/cne.903240304; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Sakurai T, 2001, J CELL BIOL, V154, P1259, DOI 10.1083/jcb.200104122; Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907; Seth A, 2006, DEVELOPMENT, V133, P725, DOI 10.1242/dev.02244; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1995, SCIENCE, V269, P98, DOI 10.1126/science.7541558; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Wang LC, 1995, NEURON, V15, P1349, DOI 10.1016/0896-6273(95)90013-6; Williams SE, 2003, NEURON, V39, P919, DOI 10.1016/j.neuron.2003.08.017; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; Zelina P, 2005, DEVELOPMENT, V132, P3609, DOI 10.1242/dev.01934; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	53	70	70	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					535	547		10.1016/j.neuron.2006.03.037	http://dx.doi.org/10.1016/j.neuron.2006.03.037			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701205	Bronze			2022-12-28	WOS:000237875200006
J	Stegmuller, J; Konishi, Y; Huynh, MA; Yuan, ZQ; DiBacco, S; Bonni, A				Stegmuller, Judith; Konishi, Yoshiyuki; Huynh, Mai Anh; Yuan, Zengqiang; DiBacco, Sara; Bonni, Azad			Cell-intrinsic regulation of axonal morphogenesis by the Cdh1-APC target SnoN	NEURON			English	Article							ANAPHASE-PROMOTING COMPLEX; TRANSFORMING-GROWTH-FACTOR; SKI ONCOPROTEIN; SMAD PROTEINS; CO-REPRESSOR; GUIDANCE; RECEPTOR; DESTRUCTION; DEGRADATION; TRANSPORT	Axonal growth is fundamental to the establishment of neuronal connectivity in the brain. However, the cell-intrinsic mechanisms that govern axonal morphogenesis remain to be elucidated. The ubiquitin ligase Cdh1-anaphase-promoting complex (Cdh1-APC) suppresses the growth of axons in postmitotic neurons. Here, we report that Cdh1-APC operates in the nucleus to inhibit axonal growth. We also identify the transcriptional corepressor SnoN as a key target of neuronal Cdh1-APC that promotes axonal growth. Cdh1 forms a physical complex with SnoN and stimulates the ubiquitin-dependent proteasomal degradation of SnoN in neurons. Knockdown of SnoN in neurons significantly reduces axonal growth and suppresses Cdh1 RNAi enhancement of axonal growth. In addition, SnoN knockdown in vivo suggests an essential function for SnoN in the development of granule neuron parallel fibers in the cerebellar cortex. These findings define Cdh1-APC and SnoN as components of a cell-intrinsic pathway that orchestrates axonal morphogenesis in a transcription-dependent manner in the mammalian brain.	Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02116 USA	Harvard University; Harvard Medical School	Bonni, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02116 USA.	azad_bonni@hms.harvard.edu	Yuan, Zengqiang/G-5245-2017	Yuan, Zengqiang/0000-0001-5739-2867	NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bayer, 1997, RELATION ITS EVOLUTI; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; COLMENARES C, 1991, J VIROL, V65, P4929, DOI 10.1128/JVI.65.9.4929-4935.1991; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Goldberg JL, 2004, CURR OPIN NEUROBIOL, V14, P551, DOI 10.1016/j.conb.2004.08.012; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Juo P, 2004, CURR BIOL, V14, P2057, DOI 10.1016/j.cub.2004.11.010; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Luo KX, 1999, GENE DEV, V13, P2196, DOI 10.1101/gad.13.17.2196; Luo LQ, 1997, CURR OPIN NEUROBIOL, V7, P81, DOI 10.1016/S0959-4388(97)80124-9; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Page AM, 1999, ANNU REV BIOCHEM, V68, P583, DOI 10.1146/annurev.biochem.68.1.583; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2000, GENE DEV, V14, P655; Reed JA, 2001, CANCER RES, V61, P8074; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Shalizi A, 2003, J NEUROSCI, V23, P7326; Stegmuller J, 2005, TRENDS NEUROSCI, V28, P596, DOI 10.1016/j.tins.2005.09.003; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Roessel P, 2004, CELL, V119, P707, DOI 10.1016/j.cell.2004.11.028; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang SW, 2002, DEVELOPMENT, V129, P467; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; Xu WD, 2000, P NATL ACAD SCI USA, V97, P5924, DOI 10.1073/pnas.090097797; Yoneda Y, 1999, CELL STRUCT FUNCT, V24, P425, DOI 10.1247/csf.24.425; Zhang F, 2003, CANCER RES, V63, P5005	43	136	147	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					389	400		10.1016/j.neuron.2006.03.034	http://dx.doi.org/10.1016/j.neuron.2006.03.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675394	Bronze			2022-12-28	WOS:000237726800009
J	Ganel, T				Ganel, T			The objects of face perception	NEURON			English	Editorial Material							RECOGNITION; REPETITION; IDENTITY; BRAIN	In a comprehensive series of experiments that combine neural modeling, behavioral data, and fMRI, Jiang et al. (this issue of Neuron) advance a general object and face classification model, based on a feedforward shape-detector architecture. The model accounts for configural face processing as well as for shape-based fMRI activation in the fusiform face area (FFA).	Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel	Ben Gurion University	Ganel, T (corresponding author), Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel.		Ganel, Tzvi/B-9344-2011	Ganel, Tzvi/0000-0003-0658-0598				BEALE JM, 1995, COGNITION, V57, P217, DOI 10.1016/0010-0277(95)00669-X; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Goshen-Gottstein Y, 2000, J EXP PSYCHOL LEARN, V26, P1198, DOI 10.1037//0278-7393.26.5.1198; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Jiang X, 2006, NEURON, V50, P159, DOI 10.1016/j.neuron.2006.03.012; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Riesenhuber M, 2004, P ROY SOC B-BIOL SCI, V271, pS448, DOI 10.1098/rsbl.2004.0216; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Rotshtein P, 2005, NAT NEUROSCI, V8, P107, DOI 10.1038/nn1370; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	12	2	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					7	10		10.1016/j.neuron.2006.03.025	http://dx.doi.org/10.1016/j.neuron.2006.03.025			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600849	Bronze			2022-12-28	WOS:000236811300004
J	Caccamo, A; Oddo, S; Billings, LM; Green, KN; Martinez-Coria, H; Fisher, A; LaFerla, FM				Caccamo, A; Oddo, S; Billings, LM; Green, KN; Martinez-Coria, H; Fisher, A; LaFerla, FM			M1 receptors play a central role in modulating AD-like pathology in transgenic mice	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; MUSCARINIC ACETYLCHOLINE-RECEPTORS; EXACERBATES TAU PATHOLOGY; ALPHA-SECRETASE CLEAVAGE; ALZHEIMERS-DISEASE; MOUSE MODEL; CONVERTING-ENZYME; FRONTAL-CORTEX; BINDING-SITES; KINASE-C	We investigated the therapeutic efficacy of the selective M1 muscarinic agonist AF267B in the 3xTg-AD model of Alzheimer disease. AF267B administration rescued the cognitive deficits in a spatial task but not contextual fear conditioning. The effect of AF267B on cognition predicted the neuropathological outcome, as both the A beta and tau pathologies were reduced in the hippocampus and cortex, but not in the amygdala. The mechanism underlying the effect on the A beta pathology was caused by the selective activation of ADAM17, thereby shifting APP processing toward the nonamyloidogenic pathway, whereas the reduction in tau pathology is mediated by decreased GSK3 beta activity. We further demonstrate that administration of dicyclomine, an M1 antagonist, exacerbates the AD and tau pathologies. In conclusion, AF267B represents a peripherally administered low molecular weight compound to attenuate the major hallmarks of AD and to reverse deficits in cognition. Therefore, selective M1 agonists may be efficacious for the treatment of AD.	Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Israel Inst Biol Res, IL-74100 Ness Ziona, Israel	University of California System; University of California Irvine	LaFerla, FM (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA.	laferla@uci.edu		Oddo, Salvatore/0000-0001-7304-7430; Martinez-Coria, Hilda/0000-0002-0335-8564	NIA NIH HHS [AG0212982] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allinson TMJ, 2003, J NEUROSCI RES, V74, P342, DOI 10.1002/jnr.10737; Bigl V, 2003, CURR MED CHEM, V10, P871, DOI 10.2174/0929867033457692; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; BUXBAUM JD, 1992, P NATL ACAD SCI USA, V89, P10075, DOI 10.1073/pnas.89.21.10075; Cuajungco MP, 2000, ANN NY ACAD SCI, V920, P292; DAVIES P, 1976, LANCET, V2, P1403; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Eglen RM, 2001, TRENDS PHARMACOL SCI, V22, P409, DOI 10.1016/S0165-6147(00)01737-5; Forlenza OV, 2000, J NEURAL TRANSM, V107, P1201, DOI 10.1007/s007020070034; GIACHETTI A, 1986, BRIT J PHARMACOL, V89, P83, DOI 10.1111/j.1476-5381.1986.tb11123.x; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Haring R, 1998, J NEUROCHEM, V71, P2094; Ibach B, 2004, CURR PHARM DESIGN, V10, P231, DOI 10.2174/1381612043386509; Jankowsky Joanna L, 2002, Curr Neurol Neurosci Rep, V2, P457, DOI 10.1007/s11910-002-0073-7; Janus C, 2001, Curr Neurol Neurosci Rep, V1, P451, DOI 10.1007/s11910-001-0105-8; Karkkainen I, 2000, MOL CELL NEUROSCI, V15, P547, DOI 10.1006/mcne.2000.0848; Kitazawa M, 2005, J NEUROSCI, V25, P8843, DOI 10.1523/JNEUROSCI.2868-05.2005; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; LEVEY AI, 1991, J NEUROSCI, V11, P3218; McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082; Muir JL, 1997, PHARMACOL BIOCHEM BE, V56, P687, DOI 10.1016/S0091-3057(96)00431-5; NITSCH RM, 1992, SCIENCE, V258, P304, DOI 10.1126/science.1411529; NITSCH RM, 1993, ANN NY ACAD SCI, V695, P122, DOI 10.1111/j.1749-6632.1993.tb23039.x; Nordberg A, 2002, J NEUROCHEM, V81, P655, DOI 10.1046/j.1471-4159.2002.00874.x; NORDBERG A, 1992, J NEUROSCI RES, V31, P103, DOI 10.1002/jnr.490310115; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Riekkinen P, 1998, ANN MED, V30, P566, DOI 10.3109/07853899809002606; Rosenblum K, 2000, J NEUROSCI, V20, P977, DOI 10.1523/JNEUROSCI.20-03-00977.2000; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Skovronsky DM, 2001, J NEUROBIOL, V49, P40, DOI 10.1002/neu.1064; SPENCER DG, 1986, BRAIN RES, V380, P59, DOI 10.1016/0006-8993(86)91429-0; SUGAYA K, 1990, J NEUROSCI RES, V27, P349, DOI 10.1002/jnr.490270314; Sugden PH, 1997, CELL SIGNAL, V9, P337, DOI 10.1016/S0898-6568(96)00191-X; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; WEI J, 1994, J NEUROCHEM, V63, P815; WHITEHOUSE PJ, 1986, BRAIN RES, V371, P146, DOI 10.1016/0006-8993(86)90819-X; Woolf NJ, 1996, NEUROBIOL LEARN MEM, V66, P258, DOI 10.1006/nlme.1996.0068	44	345	364	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					671	682		10.1016/j.neuron.2006.01.020	http://dx.doi.org/10.1016/j.neuron.2006.01.020			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504943	Bronze			2022-12-28	WOS:000236070600009
J	Kim, H; Lee, SH; Han, JH; Lee, JA; Cheang, YH; Chang, DJ; Lee, YS; Kaang, BK				Kim, H; Lee, SH; Han, JH; Lee, JA; Cheang, YH; Chang, DJ; Lee, YS; Kaang, BK			A nucleolar protein ApLLP induces ApC/EBP expression required for long-term synaptic facilitation in Aplysia neurons	NEURON			English	Article							EARLY GENE ZIF268; TRANSCRIPTION FACTOR; CELL-CULTURE; SEROTONERGIC MODULATION; INTERSTIMULUS-INTERVAL; SENSORIMOTOR SYNAPSES; WITHDRAWAL REFLEX; NERVE INJURY; MEMORY; IDENTIFICATION	In Aplysia, long-term synaptic plasticity is induced by serotonin (5-HT) or neural activity and requires gene expression. Here, we demonstrate that ApLLP, a novel nucleolus protein, is critically involved in both long-term facilitation (LTF) and behavioral sensitization. Membrane depolarization induced ApLLP expression, which activated ApC/EBP expression through a direct binding to CRE. LTF was produced by a single pulse of 5-HT 30 min after the membrane depolarization. This LTF was blocked when either ApLLP or ApC/EBP were blocked by specific antibodies. In contrast, ApLLP overexpression induced LTF in response to a single 5-HT treatment. Simultaneously, a siphon noxious stimulus (SNS) to intact Aplysia induced ApLLP and ApC/EBP expression, and single tail shock 30 min after SNS transformed short-term sensitization to long-term sensitization of siphon withdrawal reflex. These results suggest that ApLLP is an activity-dependent transcriptional activator that switches short-term facilitation to long-term facilitation.	Seoul Natl Univ, Natl Res Lab, Inst Mol Biol & Genet, Sch Biol Sci,Coll Nat Sci, Seoul 151742, South Korea	Seoul National University (SNU)	Kaang, BK (corresponding author), Seoul Natl Univ, Natl Res Lab, Inst Mol Biol & Genet, Sch Biol Sci,Coll Nat Sci, San 56-1 Silim Dong, Seoul 151742, South Korea.	kaang@snu.ac.kr	Han, Jin-Hee/C-2069-2011; Lee, Yong Seok/J-5587-2012; Lee, Sue-Hyun/F-5490-2015	Lee, Sue-Hyun/0000-0002-5318-5657; Han, Jin-Hee/0000-0002-2139-5596				Abramson L.Y., 1991, PSYCHOL INQ, V2, P11; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Bartsch D, 2000, CELL, V103, P595, DOI 10.1016/S0092-8674(00)00163-X; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; BERRY RW, 1981, BRAIN RES, V215, P115, DOI 10.1016/0006-8993(81)90495-9; Bozon B, 2003, NEURON, V40, P695, DOI 10.1016/S0896-6273(03)00674-3; Chen DY, 2001, J CELL BIOL, V153, P169, DOI 10.1083/jcb.153.1.169; Chen HK, 1999, MOL CELL BIOL, V19, P8536; Chiu CM, 2002, J BIOL CHEM, V277, P39102, DOI 10.1074/jbc.M205915200; Colombo PJ, 2004, NEUROBIOL LEARN MEM, V82, P268, DOI 10.1016/j.nlm.2004.07.005; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; ELIOT LS, 1994, J NEUROSCI, V14, P368; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Gass P, 2004, MOL BRAIN RES, V130, P16, DOI 10.1016/j.molbrainres.2004.07.004; Ginisty H, 1999, J CELL SCI, V112, P761; Giustetto M, 2003, P NATL ACAD SCI USA, V100, P13680, DOI 10.1073/pnas.1835674100; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Hall J, 2001, J NEUROSCI, V21, P2186, DOI 10.1523/JNEUROSCI.21-06-02186.2001; HAWKINS RD, 1986, J NEUROSCI, V6, P1695; Hiscox JA, 2001, J VIROL, V75, P506, DOI 10.1128/JVI.75.1.506-512.2001; Jacklet J, 2004, ACTA BIOL HUNG, V55, P201, DOI 10.1556/ABiol.55.2004.1-4.25; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; Kim H, 2003, NEUROSCI LETT, V343, P134, DOI 10.1016/S0304-3940(03)00269-6; Lee JA, 2001, LEARN MEMORY, V8, P220, DOI 10.1101/lm.40201; Leung AKL, 2003, BIOCHEM J, V376, P553, DOI 10.1042/BJ20031169; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Lin H, 2003, J NEUROBIOL, V57, P204, DOI 10.1002/neu.10275; Lin XY, 1997, J NEUROPHYSIOL, V77, P667, DOI 10.1152/jn.1997.77.2.667; Marinesco S, 2004, J NEUROPHYSIOL, V92, P2468, DOI 10.1152/jn.00209.2004; Marinesco S, 2004, J NEUROPHYSIOL, V92, P2487, DOI 10.1152/jn.00210.2004; Miau LH, 1997, MOL CELL BIOL, V17, P230, DOI 10.1128/MCB.17.1.230; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Nakaya T, 2001, GENES CELLS, V6, P43, DOI 10.1046/j.1365-2443.2001.00397.x; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; SCHACHER S, 1983, J NEUROSCI, V3, P2403; SHORS TJ, 1992, SCIENCE, V257, P537, DOI 10.1126/science.1636089; Sun ZY, 1998, J NEUROSCI, V18, P3991; Sutton MA, 2001, NEURON, V31, P143, DOI 10.1016/S0896-6273(01)00342-7; Weragoda RMS, 2004, J NEUROSCI, V24, P10393, DOI 10.1523/JNEUROSCI.2329-04.2004; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Zimber A, 2004, CELL SIGNAL, V16, P1085, DOI 10.1016/j.cellsig.2004.03.020	45	17	18	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					707	718		10.1016/j.neuron.2006.01.035	http://dx.doi.org/10.1016/j.neuron.2006.01.035			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504946	Bronze			2022-12-28	WOS:000236070600012
J	Gerrow, K; Romorini, S; Nabi, SM; Colicos, MA; Sala, C; El-Husseini, A				Gerrow, K; Romorini, S; Nabi, SM; Colicos, MA; Sala, C; El-Husseini, A			A preformed complex of postsynaptic proteins is involved in excitatory synapse development	NEURON			English	Article							PRESYNAPTIC ACTIVE ZONES; INHIBITORY SYNAPSES; MOLECULAR-MECHANISMS; RECEPTOR TRAFFICKING; TRANSPORT PACKETS; NEUROLIGIN; PSD-95; SYNAPTOGENESIS; DOMAIN; RECRUITMENT	Nonsynaptic clusters of postsynaptic proteins have been documented; however, their role remains elusive. We monitored the trafficking of several candidate proteins implicated in synaptogenesis, when nonsynaptic clusters of scaffold proteins are most abundant. We find a protein complex consisting of two populations that differ in their content, mobility, and involvement in synapse formation. One subpopulation is mobile and relies on actin transport for delivery to nascent and existing synapses. These mobile clusters contain the scaffolding proteins PSD-95, GKAP, and Shank. A proportion of mobile clusters that exhibits slow movement and travels short distances contains neuroligin-1. The second group consists of stationary nonsynaptic scaffold complexes that mainly contain neuroligin-1, can recruit synaptophysin-containing axonal transport vesicles, and are readily transformed to functional presynaptic contacts that recycle the vital dye FM 4-64. These results postulate a mechanism whereby preformed scaffold protein complexes serve as predetermined postsynaptic hotspots for establishment of new functional excitatory synapses.	Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 1Z3, Canada; Univ Calgary, Hotchkiss Brain Inst, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada; Univ Milan, Dept Pharmacol, CNR Inst Neurosci, Milan, Italy	University of British Columbia; University of British Columbia; University of Calgary; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR); University of Milan	El-Husseini, A (corresponding author), Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z3, Canada.	alaa@interchange.ubc.ca	Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523				Ahmari SE, 2002, NEURON, V34, P333, DOI 10.1016/S0896-6273(02)00685-2; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Bresler T, 2004, J NEUROSCI, V24, P1507, DOI 10.1523/JNEUROSCI.3819-03.2004; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; El-Hussein AE, 2000, SCIENCE, V290, P1364; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003; Garner CC, 2002, TRENDS NEUROSCI, V25, P243, DOI 10.1016/S0166-2236(02)02152-5; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HINDS JW, 1976, J COMP NEUROL, V169, P15, DOI 10.1002/cne.901690103; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Liu XB, 1998, J COMP NEUROL, V395, P450, DOI 10.1002/(SICI)1096-9861(19980615)395:4<450::AID-CNE3>3.0.CO;2-0; Marrs GS, 2001, NAT NEUROSCI, V4, P1006, DOI 10.1038/nn717; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nakagawa T, 2004, NEURON, V44, P453, DOI 10.1016/j.neuron.2004.10.012; Okabe S, 2001, J NEUROSCI, V21, P6105, DOI 10.1523/JNEUROSCI.21-16-06105.2001; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Prange O, 1999, J NEUROSCI, V19, P6427; Prange O, 2001, J NEUROSCI, V21, P9325, DOI 10.1523/JNEUROSCI.21-23-09325.2001; Prange O, 2004, P NATL ACAD SCI USA, V101, P13915, DOI 10.1073/pnas.0405939101; Rao A, 1998, J NEUROSCI, V18, P1217; Romorini S, 2004, J NEUROSCI, V24, P9391, DOI 10.1523/JNEUROSCI.3314-04.2004; Sabo SL, 2003, NAT NEUROSCI, V6, P1264, DOI 10.1038/nn1149; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Sans N, 2003, NAT CELL BIOL, V5, P520, DOI 10.1038/ncb990; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; STEWARD O, 1986, J NEUROSCI, V6, P412; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Washbourne P, 2002, NAT NEUROSCI, V5, P751, DOI 10.1038/nn883; Washbourne P, 2004, J NEUROSCI, V24, P8253, DOI 10.1523/JNEUROSCI.2555-04.2004; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	48	159	166	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					547	562		10.1016/j.neuron.2006.01.015	http://dx.doi.org/10.1016/j.neuron.2006.01.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476664	Bronze			2022-12-28	WOS:000235643800008
J	Ziff, EB				Ziff, Edward B.			TARPs and the AMPA receptor trafficking paradox	NEURON			English	Editorial Material							MUTANT MOUSE; STARGAZIN; PHOSPHORYLATION; PROTEINS; PLASTICITY; PSD-95; LOCALIZATION; MATURATION; CHANNELS; DEFINE	AMPA receptors (AMPARs) conduct fast, excitatory currents that depolarize neurons and trigger action potentials. AMPARs took on new importance when it was shown that AMPAR transport can increase or decrease the number of AMPARs at synapses and give rise to synapse plasticity, including long-term potentiation (LTP) and long-term depression (LTD). This review considers how transmembrane AMPAR regulatory proteins (TARPs), a novel family of AMPAR auxiliary subunits, have changed our view of AMPAR transport and raised some perplexing questions.	NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	New York University	Ziff, EB (corresponding author), NYU, Sch Med, Dept Biochem, 550 1St Ave, New York, NY 10016 USA.	edward.ziff@med.nyu.edu		Ziff, Edward/0000-0001-7389-8649				Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chen L, 1999, P NATL ACAD SCI USA, V96, P12132, DOI 10.1073/pnas.96.21.12132; Chetkovich DM, 2002, J NEUROSCI, V22, P5791; Choi J, 2002, J BIOL CHEM, V277, P12359, DOI 10.1074/jbc.M200528200; Chung HJ, 2000, J NEUROSCI, V20, P7258; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Cuadra AE, 2004, J NEUROSCI, V24, P7491, DOI 10.1523/JNEUROSCI.1255-04.2004; Dakoji S, 2003, NEUROPHARMACOLOGY, V45, P849, DOI 10.1016/S0028-3908(03)00267-3; Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006; Elias GM, 2006, NEURON, V52, P307, DOI 10.1016/j.neuron.2006.09.012; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gouaux E, 2004, J PHYSIOL-LONDON, V554, P249, DOI 10.1113/jphysiol.2003.054320; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Hashimoto K, 1999, J NEUROSCI, V19, P6027, DOI 10.1523/JNEUROSCI.19-14-06027.1999; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Ives JH, 2004, J BIOL CHEM, V279, P31002, DOI 10.1074/jbc.M402214200; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; Letts Verity A, 2005, Epilepsy Curr, V5, P161, DOI 10.1111/j.1535-7511.2005.00051.x; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Lu W, 2005, NEURON, V47, P407, DOI 10.1016/j.neuron.2005.07.006; Mi RF, 2004, NEURON, V44, P335, DOI 10.1016/j.neuron.2004.09.029; Moss FJ, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-23; Nakagawa T, 2006, BIOL CHEM, V387, P179, DOI 10.1515/BC.2006.024; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Oh MC, 2006, J BIOL CHEM, V281, P752, DOI 10.1074/jbc.M509677200; Osten P, 2006, CURR OPIN NEUROBIOL, V16, P275, DOI 10.1016/j.conb.2006.04.002; Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Sharp AH, 2001, NEUROSCIENCE, V105, P599, DOI 10.1016/S0306-4522(01)00220-2; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Tsui J, 2006, J BIOL CHEM, V281, P13794, DOI 10.1074/jbc.M600966200; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, J NEUROSCI, V25, P1095, DOI 10.1523/JNEUROSCI.3568-04.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Walker CS, 2006, P NATL ACAD SCI USA, V103, P10781, DOI 10.1073/pnas.0604482103; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	57	102	109	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					627	633		10.1016/j.neuron.2007.02.006	http://dx.doi.org/10.1016/j.neuron.2007.02.006			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329203	Bronze			2022-12-28	WOS:000245127100004
J	Philpot, BD; Cho, KKA; Bear, MF				Philpot, Benjamin D.; Cho, Kathleen K. A.; Bear, Mark F.			Obligatory role of NR2A for metaplasticity in visual cortex	NEURON			English	Article							LONG-TERM-POTENTIATION; D-ASPARTATE RECEPTORS; SYNAPTIC NMDA RECEPTORS; SUBUNIT COMPOSITION; CRITICAL PERIOD; THALAMOCORTICAL SYNAPSES; FUNCTIONAL-PROPERTIES; DEPENDENT REGULATION; HIPPOCAMPAL LTP; EXON 5	Light deprivation lowers the threshold for long-term depression (LTD) and long-term potentiation (LTP) in visual cortex by a process termed metaplasticity, but the mechanism is unknown. The decreased LTD/P threshold correlates with a decrease in the ratio of NR2A to NR2B subunits of cortical NMDA receptors (NMDARs) and a slowing of NMDAR-mediated excitatory postsynaptic currents (EPSCs). However, whether and how changes in NR2 subunit expression contribute to LTD and LTP have been controversial. In the present study, we used an NR2A knockout (KO) mouse to examine the role of this subunit in the experience-dependent modulation of NMDAR properties, LTD, and LTP. We found that deletion of NR2A abrogates the effects of visual experience on NMDAR EPSCs and prevents metaplasticity of LTP and LTD. These data support the hypothesis that experience-dependent changes in NR2A/B are functionally significant and yield a mechanism for an adjustable synaptic modification threshold in visual cortex.	MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, Cambridge, MA 02139 USA; Univ N Carolina, Ctr Neurosci, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Northwell Health; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Bear, MF (corresponding author), MIT, Picower Inst Learning & Memory, Howard Hughes Med Inst, 77 Massachusetts Ave,46-3301, Cambridge, MA 02139 USA.	mbear@mit.edu	Cho, Kathleen/AAX-2327-2020	Cho, Kathleen/0000-0003-0215-8779; Bear, Mark/0000-0002-9903-2541	Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [R01 EY012309] Funding Source: Medline; NIMH NIH HHS [P50 MH058880] Funding Source: Medline; NINDS NIH HHS [P01 NS039321] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH058880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; CZEPITA D, 1994, J NEUROPHYSIOL, V72, P1220, DOI 10.1152/jn.1994.72.3.1220; Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100; Flint AC, 1997, J NEUROSCI, V17, P2469; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; FOX K, 1992, J NEUROSCI, V12, P2672; Fu ZY, 2005, J PHYSIOL-LONDON, V563, P867, DOI 10.1113/jphysiol.2004.079467; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; HOLLINGSWORTH EB, 1985, J NEUROSCI, V5, P2240; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Kadotani H, 1996, J NEUROSCI, V16, P7859; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Krupp JJ, 2002, NEUROPHARMACOLOGY, V42, P593, DOI 10.1016/S0028-3908(02)00031-X; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morikawa E, 1998, J NEUROSCI, V18, P9727; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Perez-Otano I, 2001, J NEUROSCI, V21, P1228; Philpot BD, 2003, J NEUROSCI, V23, P5583; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; PRIESTLEY T, 1995, MOL PHARMACOL, V48, P841; Prybylowski K, 2000, J NEUROCHEM, V75, P1140, DOI 10.1046/j.1471-4159.2000.0751140.x; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rumbaugh G, 2000, J NEUROPHYSIOL, V83, P1300, DOI 10.1152/jn.2000.83.3.1300; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Vissel B, 2002, MOL PHARMACOL, V61, P595, DOI 10.1124/mol.61.3.595; WATANABE M, 1993, ANN NY ACAD SCI, V707, P463, DOI 10.1111/j.1749-6632.1993.tb38099.x; Weitlauf C, 2005, J NEUROSCI, V25, P8386, DOI 10.1523/JNEUROSCI.2388-05.2005; Yoshii A, 2003, P NATL ACAD SCI USA, V100, P1334, DOI 10.1073/pnas.0335785100; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	60	145	153	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					495	502		10.1016/j.neuron.2007.01.027	http://dx.doi.org/10.1016/j.neuron.2007.01.027			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296552	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000245126900009
J	Kadosh, RC; Kadosh, KC; Kaas, A; Henik, A; Goebel, R				Kadosh, Roi Cohen; Kadosh, Kathrin Cohen; Kaas, Amanda; Henik, Avishai; Goebel, Rainer			Notation-dependent and -independent representations of numbers in the parietal lobes	NEURON			English	Article							RESPONSE-SELECTION; ADAPTATION; MECHANISMS; BRAIN; DEGENERACY; ACTIVATION; GENERALITY; NUMEROSITY; REPETITION; MAGNITUDE	It is a commonly held view that numbers are represented in an abstract way in both parietal lobes. This view is based on failures to find differences between various notational representations. Here we show that by using relatively smaller voxels together with an adaptation paradigm and analyzing subjects on an individual basis it is possible to detect specialized numerical representations. The current results reveal a left/right asymmetry in parietal lobe function. In contrast to an abstract representation in the left parietal lobe, the numerical representation in the right parietal lobe is notation dependent and thus includes nonabstract representations. Our results challenge the commonly held belief that numbers are represented solely in an abstract way in the human brain.	Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Birkbeck Coll, Sch Psychol, Ctr Brain & Cognit Dev, London, England; Maastricht Univ, Dept Cognit Neurosci, Maastricht, Netherlands; Max Planck Inst Brain Res, Dept Neurophysiol, Frankfurt, Germany	Ben Gurion University; Ben Gurion University; University of London; Birkbeck University London; Maastricht University; Max Planck Society	Kadosh, RC (corresponding author), Ben Gurion Univ Negev, Dept Behav Sci, IL-84105 Beer Sheva, Israel.	r.cohenkadosh@ucl.ac.uk	HENIK, AVISHAI/F-1176-2012; Kaas, Amanda/K-8565-2012; Cohen Kadosh, Roi/F-7346-2012	Cohen Kadosh, Roi/0000-0002-5564-5469; Kaas, Amanda/0000-0002-2847-8167; Goebel, Rainer/0000-0003-1780-2467; Henik, Avishai/0000-0002-5665-6004				Ansari D, 2006, BRAIN RES, V1067, P181, DOI 10.1016/j.brainres.2005.10.083; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beauchamp MS, 2004, NAT NEUROSCI, V7, P1190, DOI 10.1038/nn1333; Bledowski C, 2006, J NEUROSCI, V26, P821, DOI 10.1523/JNEUROSCI.3542-05.2006; Bunge SA, 2002, NEUROIMAGE, V17, P1562, DOI 10.1006/nimg.2002.1252; CAMPBELL JID, 1994, COGNITION, V53, P1, DOI 10.1016/0010-0277(94)90075-2; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1992, COGNITION, V43, P1, DOI 10.1016/0010-0277(92)90030-L; DEHAENE S, 1995, J EXP PSYCHOL LEARN, V21, P314, DOI 10.1037/0278-7393.21.2.314; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1995, MATH COGNITION, P83, DOI DOI 10.1155/2014/461647; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Edelman GM, 2001, P NATL ACAD SCI USA, V98, P13763, DOI 10.1073/pnas.231499798; Eger E, 2003, NEURON, V37, P719, DOI 10.1016/S0896-6273(03)00036-9; Fias W, 2003, J COGNITIVE NEUROSCI, V15, P47, DOI 10.1162/089892903321107819; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; Goebel R, 2006, HUM BRAIN MAPP, V27, P392, DOI 10.1002/hbm.20249; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Grill-Spector K, 2006, NEURON, V49, P170, DOI 10.1016/j.neuron.2006.01.004; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 2006, NAT NEUROSCI, V9, P1177, DOI 10.1038/nn1745; Jiang YH, 2003, J COGNITIVE NEUROSCI, V15, P1080, DOI 10.1162/089892903322598067; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; KADOSH RC, 2007, IN PRESS J COGN NEUR; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Lemer C, 2003, NEUROPSYCHOLOGIA, V41, P1942, DOI 10.1016/S0028-3932(03)00123-4; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Naccache L, 2001, CEREB CORTEX, V11, P966, DOI 10.1093/cercor/11.10.966; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Price CJ, 2005, COGN NEUROPSYCHOL, V22, P262, DOI 10.1080/02643290442000095; Price CJ, 2002, TRENDS COGN SCI, V6, P416, DOI 10.1016/S1364-6613(02)01976-9; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Sawamura H, 2006, NEURON, V49, P307, DOI 10.1016/j.neuron.2005.11.028; Schwarz W, 2000, J EXP PSYCHOL HUMAN, V26, P1606, DOI 10.1037//0096-1523.26.5.1606; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008; Talairach J., 1988, COPLANAR STEREOTAXIC; TZELGOV J, 1992, J EXP PSYCHOL LEARN, V18, P166, DOI 10.1037/0278-7393.18.1.166; Venkatraman V, 2005, NEUROPSYCHOLOGIA, V43, P744, DOI 10.1016/j.neuropsychologia.2004.08.005; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wilkinson D, 2004, NAT REV NEUROSCI, V5, P67, DOI 10.1038/nrn1302; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zilles Karl, 2003, Adv Neurol, V93, P1	51	185	188	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					307	314		10.1016/j.neuron.2006.12.025	http://dx.doi.org/10.1016/j.neuron.2006.12.025			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224410	Bronze, Green Submitted			2022-12-28	WOS:000245126600014
J	Smear, MC; Tao, HZW; Staub, W; Orger, MB; Gosse, NJ; Liu, Y; Takahashi, K; Poo, MM; Baier, H				Smear, Matthew C.; Tao, Huizhong W.; Staub, Wendy; Orger, Michael B.; Gosse, Nathan J.; Liu, Yan; Takahashi, Koji; Poo, Mu-Ming; Baier, Herwig			Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish	NEURON			English	Article							RETINAL GANGLION-CELLS; LARVAL ZEBRAFISH; RETINOTECTAL PROJECTION; IN-VIVO; PHOSPHATE TRANSPORTER; POSTNATAL-DEVELOPMENT; CONTRAST SENSITIVITY; SYSTEM DEVELOPMENT; SPATIAL VISION; PREY CAPTURE	The neural circuitry that constrains visual acuity in the CNS has not been experimentally identified. We show here that zebrafish blumenkohl (blu) mutants are impaired in resolving rapid movements and fine spatial detail. The blu gene encodes a vesicular glutamate transporter expressed by retinal ganglion cells. Mutant retinotectal synapses release less glutamate, per vesicle and per terminal, and fatigue more quickly than wild-type in response to high-frequency stimulation. In addition, mutant axons arborize more extensively, thus increasing the number of synaptic terminals and effectively normalizing the combined input to postsynaptic cells in the tectum. This presumably homeostatic response results in larger receptive fields of tectal cells and a degradation of the retinotopic map. As predicted, mutants have a selective deficit in the capture of small prey objects, a behavior dependent on the tecturn. Our studies successfully link the disruption of a synaptic protein to complex changes in neural circuitry and behavior.	Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94143 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of Southern California; University of Southern California; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Program Neurosci, 1550 4th St, San Francisco, CA 94143 USA.	herwig.baier@ucsf.edu	Tao, Huizhong W/HDM-9767-2022	Orger, Michael/0000-0002-9763-8902	NATIONAL EYE INSTITUTE [R21EY018718, R01EY013855, R01EY014979, R01EY012406] Funding Source: NIH RePORTER; NEI NIH HHS [R21 EY018718, R01 EY013855, R01 EY012406, R01 EY014979, EY014979, EY12406, R21 EY018718-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; BANKS MS, 1991, J OPT SOC AM A, V8, P1775, DOI 10.1364/JOSAA.8.001775; BARLOW HB, 1975, NATURE, V258, P199, DOI 10.1038/258199a0; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; BILOTTA J, 1989, J GEN PHYSIOL, V93, P1147, DOI 10.1085/jgp.93.6.1147; Borla MA, 2002, BRAIN BEHAV EVOLUT, V60, P207, DOI 10.1159/000066699; Brown SP, 2000, NEURON, V27, P371, DOI 10.1016/S0896-6273(00)00044-1; Burrows PE, 2003, NEUROIMAG CLIN N AM, V13, P13, DOI 10.1016/S1052-5149(02)00061-8; CHICHILNISKY EJ, 1993, VISION RES, V33, P2113, DOI 10.1016/0042-6989(93)90010-T; CLELAND BG, 1979, SCIENCE, V205, P1015, DOI 10.1126/science.472720; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Easter SS, 1996, DEV BIOL, V180, P646; Engert F, 2002, NATURE, V419, P470, DOI 10.1038/nature00988; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Gasnier B, 2000, BIOCHIMIE, V82, P327, DOI 10.1016/S0300-9084(00)00221-2; GEISLER WS, 1984, J OPT SOC AM A, V1, P775, DOI 10.1364/JOSAA.1.000775; Gnuegge L, 2001, J NEUROSCI, V21, P3542, DOI 10.1523/JNEUROSCI.21-10-03542.2001; Haas K, 2002, DIFFERENTIATION, V70, P148, DOI 10.1046/j.1432-0436.2002.700404.x; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; HIRSCH J, 1984, VISION RES, V24, P347, DOI 10.1016/0042-6989(84)90060-9; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P237, DOI 10.1113/jphysiol.1976.sp011594; Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409; Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218; JACOBS DS, 1988, VISION RES, V28, P947, DOI 10.1016/0042-6989(88)90104-6; JOHNSONKG, 2000, RESULTS PROBL CELL D, V31, P157; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Keegan BR, 2002, DEVELOPMENT, V129, P1623; KIORPES L, 2003, VISUAL NEUROSCIENCES, P234; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; McLaughlin T, 2003, CURR OPIN NEUROBIOL, V13, P57, DOI 10.1016/S0959-4388(03)00014-X; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Neuhauss SCF, 2003, J NEUROBIOL, V54, P148, DOI 10.1002/neu.10165; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orger MB, 2005, VISUAL NEUROSCI, V22, P275, DOI 10.1017/S0952523805223039; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Rinner O, 2005, INVEST OPHTH VIS SCI, V46, P137, DOI 10.1167/iovs.04-0682; Roeser T, 2003, J NEUROSCI, V23, P3726; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schmidt JT, 2000, J NEUROBIOL, V42, P303, DOI 10.1002/(SICI)1097-4695(20000215)42:3<303::AID-NEU2>3.3.CO;2-1; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; Takamori S, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-22-j0002.2001; Tokuoka H, 2002, J NEUROSCI, V22, P10324; Trowe T, 1996, DEVELOPMENT, V123, P439; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Watkins J C, 1990, Adv Exp Med Biol, V268, P49; WILLIAMS DR, 1987, J OPT SOC AM A, V4, P1514, DOI 10.1364/JOSAA.4.001514; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	60	71	73	2	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					65	77		10.1016/j.neuron.2006.12.013	http://dx.doi.org/10.1016/j.neuron.2006.12.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196531	Green Accepted, Bronze			2022-12-28	WOS:000245126500009
J	Churchland, MM; Afshar, A; Shenoy, KV				Churchland, Mark M.; Afshar, Afsheen; Shenoy, Krishna V.			A central source of movement variability	NEURON			English	Article							SIGNAL-DEPENDENT NOISE; MOTOR CORTEX NEURONS; PREMOTOR CORTEX; SENSORIMOTOR CONTROL; REACHING MOVEMENTS; INTENDED MOVEMENT; PRIOR INFORMATION; RHESUS-MONKEYS; CELL-ACTIVITY; DIRECTION	Movements are universally, sometimes frustratingly, variable. When such variability causes error, we typically assume that something went wrong during the movement. The same assumption is made by recent and influential models of motor control. These posit that the principal limit on repeatable performance is neuromuscular noise that corrupts movement as it occurs. An alternative hypothesis is that movement variability arises before movements begin, during motor preparation. We examined this possibility directly by recording the preparatory activity of single cortical neurons during a highly practiced reach task. Small variations in preparatory neural activity were predictive of small variations in the upcoming reach. Effect magnitudes were such that at least half of the observed movement variability likely had its source during motor preparation. Thus, even for a highly practiced task, the ability to repeatedly plan the same movement limits our ability to repeatedly execute the same movement.	Stanford Univ, Program Neurosci, Stanford, CA 94305 USA; Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; Stanford Univ, Med Scientist Training Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Shenoy, KV (corresponding author), Stanford Univ, Program Neurosci, Stanford, CA 94305 USA.	shenoy@stanford.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007158] Funding Source: NIH RePORTER; NINDS NIH HHS [T32 NS007158] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Churchland MM, 2006, J NEUROSCI, V26, P3697, DOI 10.1523/JNEUROSCI.3762-05.2006; Cisek P, 2006, J NEUROPHYSIOL, V96, P2842, DOI 10.1152/jn.00857.2006; Crammond DJ, 2000, J NEUROPHYSIOL, V84, P986, DOI 10.1152/jn.2000.84.2.986; GODSCHALK M, 1985, BEHAV BRAIN RES, V18, P143, DOI 10.1016/0166-4328(85)90070-1; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Hamilton AFD, 2002, J NEUROPHYSIOL, V87, P2434, DOI 10.1152/jn.00875.2001; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Harris CM, 2004, MATH BIOSCI, V188, P99, DOI 10.1016/j.mbs.2003.08.011; Haruno M, 2005, J NEUROPHYSIOL, V94, P4244, DOI 10.1152/jn.00404.2005; HOCHERMAN S, 1991, EXP BRAIN RES, V83, P285; Iguchi N, 2005, BIOL CYBERN, V92, P219, DOI 10.1007/s00422-005-0541-7; Johnson MTV, 1999, J NEUROPHYSIOL, V81, P875, DOI 10.1152/jn.1999.81.2.875; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; KAWATO M, 2004, ADV COMP MOT CONTR 3; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; Lebedev MA, 2001, EUR J NEUROSCI, V13, P1002, DOI 10.1046/j.0953-816x.2001.01457.x; LECAS JC, 1986, J NEUROPHYSIOL, V56, P1680, DOI 10.1152/jn.1986.56.6.1680; McIntyre J, 1997, J NEUROPHYSIOL, V78, P1601, DOI 10.1152/jn.1997.78.3.1601; Messier J, 2000, J NEUROPHYSIOL, V84, P152, DOI 10.1152/jn.2000.84.1.152; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; RIEHLE A, 1989, J NEUROPHYSIOL, V61, P534, DOI 10.1152/jn.1989.61.3.534; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Simmons G, 2006, BIOL CYBERN, V94, P393, DOI 10.1007/s00422-006-0053-0; SOECHTING JF, 1989, J NEUROPHYSIOL, V62, P595, DOI 10.1152/jn.1989.62.2.595; SOSNOFF JJ, 2005, NEUROSCI LETT, V392, P165, DOI DOI 10.1016/J.NE16ET.2005.09.010; TANJI J, 1976, J NEUROPHYSIOL, V39, P1062, DOI 10.1152/jn.1976.39.5.1062; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Todorov E, 2002, NEURAL COMPUT, V14, P1233, DOI 10.1162/089976602753712918; Todorov E, 2002, NAT NEUROSCI, V5, P1226, DOI 10.1038/nn963; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; WEINRICH M, 1984, BRAIN, V107, P385, DOI 10.1093/brain/107.2.385; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	39	253	253	1	27	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					1085	1096		10.1016/j.neuron.2006.10.034	http://dx.doi.org/10.1016/j.neuron.2006.10.034			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178410	Bronze, Green Accepted			2022-12-28	WOS:000243115100015
J	Fertleman, CR; Baker, MD; Parker, KA; Moffatt, S; Elmslie, FV; Abrahamsen, B; Ostman, J; Klugbauer, N; Wood, JN; Gardiner, RM; Rees, M				Fertleman, Caroline R.; Baker, Mark D.; Parker, Keith A.; Moffatt, Sarah; Elmslie, Frances V.; Abrahamsen, Bjarke; Ostman, Johan; Klugbauer, Norbert; Wood, John N.; Gardiner, R. Mark; Rees, Michele			SCN9A mutations in paroxysmal extreme pain disorder: Allelic variants underlie distinct channel defects and phenotypes	NEURON			English	Article							FAMILIAL RECTAL PAIN; ALPHA-SUBUNIT; SODIUM-CHANNELS; INACTIVATION; ERYTHERMALGIA; IDENTIFICATION; LINKER; LOOP; PN1	Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, or OMIM 167400), is an inherited condition characterized by paroxysms of rectal, ocular, or submandibular pain with flushing. A genome-wide linkage search followed by mutational analysis of the candidate gene SCN9A, which encodes hNaV(1.7) identified eight missense mutations in 11 families and 2 sporadic cases. Functional analysis in vitro of three of these mutant Na(V)1.7 channels revealed a reduction in fast inactivation, leading to persistent sodium current. Other mutations in SCN9A associated with more negative activation thresholds are known to cause primary erythermalgia (PE). Carbamazepine, a drug that is effective in PEPD, but not PE, showed selective block of persistent current associated with PEPD mutants, but did not affect the negative activation threshold of a PE mutant. PEPD and PE are allelic variants with distinct underlying biophysical mechanisms and represent a separate class of peripheral neuronal sodium channelopathy.	Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, London WC1E 6JJ, England; UCL, Dept Biol, London WC1E 6BT, England; Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; Barts & London Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England	University of London; University College London; University of London; University College London; University of Freiburg; University of London; Queen Mary University London	Gardiner, RM (corresponding author), Royal Free & Univ Coll Med Sch, Dept Paediat & Child Hlth, 5 Univ St, London WC1E 6JJ, England.	mark.gardiner@ucl.ac.uk	Abrahamsen, Bjarke/ABD-5874-2020	Abrahamsen, Bjarke/0000-0002-6128-8269	Medical Research Council [G9706148, G9717869] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G9717869, G9706148] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashcroft FM, 2000, ION CHANNELS DIS; Backonja MM, 2002, NEUROLOGY, V59, pS14, DOI 10.1212/WNL.59.5_suppl_2.S14; Breton H, 2005, J CHROMATOGR B, V828, P80, DOI 10.1016/j.jchromb.2005.09.019; Cannon SC, 2000, KIDNEY INT, V57, P772, DOI 10.1046/j.1523-1755.2000.00914.x; Carr RW, 2002, J GEN PHYSIOL, V120, P395, DOI 10.1085/jgp.20028628; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Dib-Hajj SD, 2005, BRAIN, V128, P1847, DOI 10.1093/brain/awh514; Drenth JPH, 2005, J INVEST DERMATOL, V124, P1333, DOI 10.1111/j.0022-202X.2005.23737.x; Elmslie FV, 1996, J ROY SOC MED, V89, pP290, DOI 10.1177/014107689608900525; Fertleman CR, 2006, J NEUROL NEUROSUR PS, V77, P1294, DOI 10.1136/jnnp.2006.089664; Filatov GN, 1998, J GEN PHYSIOL, V111, P703, DOI 10.1085/jgp.111.6.703; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; HAYDEN R, 1959, AMA J DIS CHILD, V97, P479, DOI 10.1001/archpedi.1959.02070010481013; Kellenberger S, 1997, J GEN PHYSIOL, V109, P589, DOI 10.1085/jgp.109.5.589; KLUGBAUER N, 1995, EMBO J, V14, P1084, DOI 10.1002/j.1460-2075.1995.tb07091.x; Legroux-Crespel E, 2003, ANN DERMATOL VENER, V130, P429; Lerche H, 1997, J PHYSIOL-LONDON, V505, P345, DOI 10.1111/j.1469-7793.1997.345bb.x; MANN TP, 1972, LANCET, V1, P1016; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Michiels JJ, 2005, ARCH NEUROL-CHICAGO, V62, P1587, DOI 10.1001/archneur.62.10.1587; MOHAMMADI B, 2005, GENOMICS, V15, P235; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; PTACEK LJ, 1991, CELL, V67, P1021; Renganathan M, 2001, J NEUROPHYSIOL, V86, P629, DOI 10.1152/jn.2001.86.2.629; ROJAS CV, 1991, NATURE, V354, P387, DOI 10.1038/354387a0; Sangameswaran L, 1997, J BIOL CHEM, V272, P14805, DOI 10.1074/jbc.272.23.14805; SCHUBERT R, 1992, ANN NEUROL, V32, P824, DOI 10.1002/ana.410320620; Smith MR, 1997, BIOPHYS J, V73, P1885, DOI 10.1016/S0006-3495(97)78219-5; Strassman AM, 1999, J NEUROPHYSIOL, V81, P413, DOI 10.1152/jn.1999.81.2.413; Tang LH, 1996, J GEN PHYSIOL, V108, P89, DOI 10.1085/jgp.108.2.89; ToledoAral JJ, 1997, P NATL ACAD SCI USA, V94, P1527, DOI 10.1073/pnas.94.4.1527; Waxman SG, 2005, ANN NEUROL, V57, P785, DOI 10.1002/ana.20511; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wu FF, 2005, J PHYSIOL-LONDON, V565, P371, DOI 10.1113/jphysiol.2005.082909; Yang Y, 2004, J MED GENET, V41, P171, DOI 10.1136/jmg.2003.012153	36	537	592	1	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					767	774		10.1016/j.neuron.2006.10.006	http://dx.doi.org/10.1016/j.neuron.2006.10.006			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145499	Bronze			2022-12-28	WOS:000242856400006
J	Chowdhury, S; Shepherd, JD; Okuno, H; Lyford, G; Petralia, RS; Plath, N; Kuhl, D; Huganir, RL; Worley, PF				Chowdhury, Shoaib; Shepherd, Jason D.; Okuno, Hiroyuki; Lyford, Gregory; Petralia, Ronald S.; Plath, Niels; Kuhl, Dietmar; Huganir, Richard L.; Worley, Paul F.			Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking	NEURON			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; CLATHRIN-MEDIATED ENDOCYTOSIS; SYNAPTIC VESICLE ENDOCYTOSIS; METABOTROPIC GLUTAMATE RECEPTORS; DOMAIN-CONTAINING PROTEIN; SH3 DOMAIN; DEPENDENT ENDOCYTOSIS; HIPPOCAMPAL-NEURONS; CULTURED NEURONS	Arc/Arg3.1 is an immediate-early gene whose mRNA is rapidly transcribed and targeted to dendrites of neurons as they engage in information processing and storage. Moreover, Arc/Arg3.1 is known to be required for durable forms of synaptic plasticity and learning. Despite these intriguing links to plasticity, Arc/Arg3.1's molecular function remains enigmatic. Here, we demonstrate that Arc/Arg3.1 protein interacts with dynamin and specific isoforms of endophilin to enhance receptor endocytosis. Arc/Arg3.1 selectively modulates trafficking of AMPA-type glutamate receptors (AMPARs) in neurons by accelerating endocytosis and reducing surface expression. The Arc/Arg3.1-endocytosis pathway appears to regulate basal AMPAR levels since Arc/Arg3.1 KO neurons exhibit markedly reduced endocytosis and increased steady-state surface levels. These findings reveal a novel molecular pathway that is regulated by Arc/Arg3.1 and likely contributes to late-phase synaptic plasticity and memory consolidation.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Cellular & Mol Med Grad Program, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Free Univ Berlin, Dept Biol Chem Pharm, D-14195 Berlin, Germany	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Free University of Berlin	Worley, PF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA.	pworley@jhmi.edu	Kuhl, Dietmar/A-4689-2009; Shepherd, Jason/N-8555-2018	Kuhl, Dietmar/0000-0002-4772-6701; Shepherd, Jason/0000-0001-7384-8289; OKUNO, HIROYUKI/0000-0001-6237-6503	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH068830, R01MH053608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NIMH NIH HHS [R01 MH053608, P50 MH068830] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Barik Sailen, 2002, Methods Mol Biol, V192, P189, DOI 10.1385/1-59259-177-9:189; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bock J, 2005, NEUROSCIENCE, V133, P625, DOI 10.1016/j.neuroscience.2005.02.048; Boehm J, 2005, BIOCHEM SOC T, V33, P1354, DOI 10.1042/BST0331354; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Burke SN, 2005, NEURON, V45, P667, DOI 10.1016/j.neuron.2005.01.042; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Chen Y, 2003, CELL, V115, P37, DOI 10.1016/S0092-8674(03)00726-8; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Darstein M, 2003, J NEUROSCI, V23, P8013; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Fonseca R, 2004, NEURON, V44, P1011, DOI 10.1016/j.neuron.2004.10.033; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuoka M, 2003, BRAIN RES, V975, P189, DOI 10.1016/S0006-8993(03)02634-9; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Okamoto PM, 2001, J BIOL CHEM, V276, P48458, DOI 10.1074/jbc.M104927200; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; POODRY CA, 1973, DEV BIOL, V32, P373, DOI 10.1016/0012-1606(73)90248-0; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Qualmann B, 1999, MOL BIOL CELL, V10, P501, DOI 10.1091/mbc.10.2.501; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Rao VR, 2006, NAT NEUROSCI, V9, P887, DOI 10.1038/nn1708; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Rumbaugh G, 2003, J NEUROSCI, V23, P4567; Schuske KR, 2003, NEURON, V40, P749, DOI 10.1016/S0896-6273(03)00667-6; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Steward O, 2002, NEUROBIOL LEARN MEM, V78, P508, DOI 10.1006/nlme.2002.4102; Tagawa Y, 2005, NAT NEUROSCI, V8, P380, DOI 10.1038/nn1410; Tsui CC, 1996, J NEUROSCI, V16, P2463; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Verstreken P, 2002, CELL, V109, P101, DOI 10.1016/S0092-8674(02)00688-8; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zou ZH, 2006, SCIENCE, V311, P1477, DOI 10.1126/science.1124755	78	540	564	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					445	459		10.1016/j.neuron.2006.08.033	http://dx.doi.org/10.1016/j.neuron.2006.08.033			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088211	Green Accepted, Bronze			2022-12-28	WOS:000242269700008
J	Littleton, JT				Littleton, J. Troy			Mixing and matching during synaptic vesicle endocytosis	NEURON			English	Editorial Material							FROG NEUROMUSCULAR JUNCTION; TRANSMITTER; KINETICS; REUSE; POOL		MIT, Dept Biol, Cambridge, MA 02139 USA; MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health	Littleton, JT (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.			Littleton, J. Troy/0000-0001-5576-2887	NINDS NIH HHS [R01 NS040296, R01 NS040296-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040296] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravanis AM, 2003, NATURE, V423, P643, DOI 10.1038/nature01686; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; Harata NC, 2006, NEURON, V49, P243, DOI 10.1016/j.neuron.2005.12.018; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Kavalali ET, 2006, NEUROSCIENTIST, V12, P57, DOI 10.1177/1073858405281852; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592	10	7	7	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					149	151		10.1016/j.neuron.2006.07.002	http://dx.doi.org/10.1016/j.neuron.2006.07.002			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846848	Bronze			2022-12-28	WOS:000239535100001
J	Tsuruda, PR; Julius, D; Minor, DL				Tsuruda, Pamela R.; Julius, David; Minor, Daniel L., Jr.			Coiled coils direct assembly of a cold-activated TRP channel	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; DROSOPHILA PHOTORECEPTOR CELLS; PDZ DOMAIN PROTEIN; TETRAMERIZATION DOMAIN; CRYSTAL-STRUCTURE; K+ CHANNEL; SIGNALING COMPLEX; TERMINAL DOMAIN; ION-CHANNEL; VANILLOID RECEPTOR	Transient receptor potential (TRP) channels mediate numerous sensory transduction processes and are thought to function as tetramers. TRP channel physiology is well studied; however, comparatively little is understood regarding TRP channel assembly. Here, we identify an autonomously folded assembly domain from the cold- and menthol-gated channel TRPM8. We show that the TRPM8 cytoplasmic C-terminal domain contains a coiled coil that is necessary for channel assembly and sufficient for tetramer formation. Cell biological experiments indicate that coiled-coil formation is required for proper channel maturation and trafficking and that the coiled-coil domain alone can act as a dominant-negative inhibitor of functional channel expression. Our data define an authentic TRP modular assembly domain, establish a clear role for coiled coils in ion channel assembly, demonstrate that coiled-coil assembly domains are a general feature of TRPM channels, and delineate a new tool that should be of general use in dissecting TRPM channel function.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Minor, DL (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA USA.	daniel.minor@ucsf.edu			NIDCD NIH HHS [R01 DC007664-02, R01 DC007664] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007664] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BABILA T, 1994, NEURON, V12, P615, DOI 10.1016/0896-6273(94)90217-8; BECKTEL WJ, 1987, BIOPOLYMERS, V26, P1859, DOI 10.1002/bip.360261104; BEROVA N, 2005, CIRCULAR DICHROISM P; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Clapham DE, 2003, PHARMACOL REV, V55, P591, DOI 10.1124/pr.55.4.6; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Clapham DE, 2001, NAT REV NEUROSCI, V2, P387, DOI 10.1038/35077544; CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Dempski RE, 2002, CURR OPIN CHEM BIOL, V6, P844, DOI 10.1016/S1367-5931(02)00390-3; Deutsch C, 2002, ANNU REV PHYSIOL, V64, P19, DOI 10.1146/annurev.physiol.64.081501.155934; DUNPHY WG, 1985, CELL, V42, P13, DOI 10.1016/S0092-8674(85)80097-0; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Engelke M, 2002, FEBS LETT, V523, P193, DOI 10.1016/S0014-5793(02)02971-X; Erler I, 2004, J BIOL CHEM, V279, P34456, DOI 10.1074/jbc.M404778200; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Gillo B, 1996, P NATL ACAD SCI USA, V93, P14146, DOI 10.1073/pnas.93.24.14146; HARBURY PB, 1994, NATURE, V371, P80, DOI 10.1038/371080a0; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; HILLE B, 2001, IONH CHANNELS EXCITA; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; Howard J, 2004, CURR BIOL, V14, pR224, DOI 10.1016/j.cub.2004.02.050; Jencks W. P., 1987, CATALYSIS CHEM ENZYM; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; Laue TM, 1995, METHOD ENZYMOL, V259, P427; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Minor DL, 2000, CELL, V102, P657, DOI 10.1016/S0092-8674(00)00088-X; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schulteis CT, 1998, J BIOL CHEM, V273, P26210, DOI 10.1074/jbc.273.40.26210; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Strubing C, 2003, J BIOL CHEM, V278, P39014, DOI 10.1074/jbc.M306705200; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Thiyagarajan MM, 2002, BIOCHEMISTRY-US, V41, P9470, DOI 10.1021/bi025533u; Tsunoda S, 1999, CELL CALCIUM, V26, P165, DOI 10.1054/ceca.1999.0070; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhang L, 2004, CANCER RES, V64, P8365, DOI 10.1158/0008-5472.CAN-04-2146; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhong HN, 2003, P NATL ACAD SCI USA, V100, P5509, DOI 10.1073/pnas.0931279100	72	115	116	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					201	212		10.1016/j.neuron.2006.06.023	http://dx.doi.org/10.1016/j.neuron.2006.06.023			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846855	Bronze, Green Accepted			2022-12-28	WOS:000239535100008
J	Ungless, MA; Cragg, SJ				Ungless, MA; Cragg, SJ			A choreography of nicotinic receptors directs the dopamine neuron routine	NEURON			English	Editorial Material							ACETYLCHOLINE-RECEPTORS; SYNAPTIC MECHANISMS; ADDICTION; SUBUNIT; BETA-2; REWARD	Modulation of the mesocorticolimbic dopamine system by nicotinic acetylcholine receptors (nAChRs) is thought to play an important role in both health and addiction. However, a clear understanding of how these receptors regulate in vivo firing activity has been elusive. In this issue of Neuron, Mameli-Engvall and colleagues report an impressive and thought-provoking series of in vivo experiments combining single-unit recordings from dopamine neurons with nAChR subunit deletions and region-specific lentiviral subunit re-expression.	Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England	University of Oxford; University of Oxford	Ungless, MA (corresponding author), Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, Fac Med, Hammersmith Hosp Campus,Cane Rd, London W12 0NN, England.	mark.ungless@csc.mrc.ac.uk	Ungless, Mark/A-1985-2009	Cragg, Stephanie/0000-0001-9677-2256; Ungless, Mark/0000-0002-1730-3353				Garzon M, 1999, J COMP NEUROL, V410, P197, DOI 10.1002/(SICI)1096-9861(19990726)410:2<197::AID-CNE3>3.0.CO;2-D; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Pidoplichko VI, 2004, LEARN MEMORY, V11, P60, DOI 10.1101/lm.70004; Rice ME, 2004, NAT NEUROSCI, V7, P583, DOI 10.1038/nn1244; Schilstrom B, 2003, INT J NEUROPSYCHOPH, V6, P1, DOI 10.1017/S1461145702003188; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Walters CL, 2006, PSYCHOPHARMACOLOGY, V184, P339, DOI 10.1007/s00213-005-0295-x; Zhang H, 2004, NAT NEUROSCI, V7, P581, DOI 10.1038/nn1243	13	7	7	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 15	2006	50	6					815	816		10.1016/j.neuron.2006.05.024	http://dx.doi.org/10.1016/j.neuron.2006.05.024			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772163	Bronze			2022-12-28	WOS:000238589500002
J	Steinert, JR; Kuromi, H; Hellwig, A; Knirr, M; Wyatt, AW; Kidokoro, Y; Schuster, CM				Steinert, Joern R.; Kuromi, Hiroshi; Hellwig, Andrea; Knirr, Matthias; Wyatt, Amanda W.; Kidokoro, Yoshiaki; Schuster, Christoph M.			Experience-dependent formation and recruitment of large vesicles from reserve pool	NEURON			English	Article							GLUTAMATE-RECEPTOR SUBUNIT; QUANTAL SIZE; SYNAPTIC VESICLES; DROSOPHILA MUTANT; DISTINCT POOLS; MESSENGER-RNA; RELEASE; GABA; EXPRESSION; SYNAPSES	The sizes and contents of transmitter-filled vesicles have been shown to vary depending on experimental manipulations resulting in altered quantal sizes. However, whether such a presynaptic regulation of quantal size can be induced under physiological conditions as a potential alternative mechanism to alter the strength of synaptic transmission is unknown. Here we show that presynaptic vesicles of glutamatergic synapses of Drosophila neuromuscular junctions increase in size as a result of high natural crawling activities of larvae, leading to larger quantal sizes and enhanced evoked synaptic transmission. We further show that these larger vesicles are formed during a period of enhanced replenishment of the reserve pool of vesicles, from which they are recruited via a PKA- and actin-dependent mechanism. Our results demonstrate that natural behavior can induce the formation, recruitment, and release of larger vesicles in an experience-dependent manner and hence provide evidence for an additional mechanism of synaptic potentiation.	Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, D-69120 Heidelberg, Germany; Gunma Univ, Sch Med, Inst Behav Sci, Maebashi, Gumma 3718511, Japan	Ruprecht Karls University Heidelberg; Gunma University	Schuster, CM (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neurobiol, D-69120 Heidelberg, Germany.	christoph.schuster@urz.uni-heidelberg.de	Steinert, Joern R/AAI-2742-2020; Steinert, Joern/A-6678-2008; Steinert, Joern/ABB-4561-2020	Steinert, Joern R/0000-0003-1640-0845; Steinert, Joern/0000-0003-1640-0845; 	MRC [MC_U132681855] Funding Source: UKRI; Medical Research Council [MC_U132681855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; Burgoyne RD, 2002, TRENDS NEUROSCI, V25, P176, DOI 10.1016/S0166-2236(00)02126-3; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Elhamdani A, 2001, NEURON, V31, P819, DOI 10.1016/S0896-6273(01)00418-4; Engel D, 2000, EPILEPSY RES, V40, P99, DOI 10.1016/S0920-1211(00)00112-1; Esclapez M, 1999, J COMP NEUROL, V412, P488; FATT P, 1952, J PHYSIOL-LONDON, V117, P109; Featherstone DE, 2005, J NEUROSCI, V25, P3199, DOI 10.1523/JNEUROSCI.4201-04.2005; Feeney CJ, 1998, J COMP NEUROL, V402, P197, DOI 10.1002/(SICI)1096-9861(19981214)402:2&lt;197::AID-CNE5&gt;3.0.CO;2-Q; FELDBLUM S, 1990, NEURON, V5, P361, DOI 10.1016/0896-6273(90)90172-C; Frazer A, 1999, INT J NEUROPSYCHOPH, V2, P305, DOI 10.1017/S1461145799001625; GARRAGHTY PE, 1991, SOMATOSENS MOT RES, V8, P347, DOI 10.3109/08990229109144757; Gierdalski M, 1999, MOL BRAIN RES, V71, P111, DOI 10.1016/S0169-328X(99)00153-9; Gong LW, 2003, J NEUROSCI, V23, P7917; GRAM L, 1988, EPILEPSY RES, V2, P87, DOI 10.1016/0920-1211(88)90024-1; Hartman KN, 2006, NAT NEUROSCI, V9, P642, DOI 10.1038/nn1677; IKEDA K, 1988, J PHYSIOL-LONDON, V406, P215, DOI 10.1113/jphysiol.1988.sp017377; Johnston TH, 2006, CURR OPIN INVEST DR, V7, P25; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Kuromi H, 2004, NEURON, V41, P101, DOI 10.1016/S0896-6273(03)00815-8; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; Kuromi H, 2002, NEURON, V35, P333, DOI 10.1016/S0896-6273(02)00777-8; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; LOSCHER W, 1989, EUR J PHARMACOL, V163, P1, DOI 10.1016/0014-2999(89)90389-0; LUPA MT, 1988, BRAIN RES, V461, P118, DOI 10.1016/0006-8993(88)90730-5; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Neco P, 2003, J NEUROCHEM, V85, P329, DOI 10.1046/j.1471-4159.2003.01682.x; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Pothos EN, 2002, BEHAV BRAIN RES, V130, P203, DOI 10.1016/S0166-4328(01)00419-3; Pothos EN, 2002, J PHYSIOL-LONDON, V542, P453, DOI 10.1113/jphysiol.2002.018630; Pothos EN, 2000, J NEUROSCI, V20, P7297; Qin G, 2005, J NEUROSCI, V25, P3209, DOI 10.1523/JNEUROSCI.4194-04.2005; Schneider N, 2000, BIOL CELL, V92, P495, DOI 10.1016/S0248-4900(00)01102-3; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; SEARL T, 1990, NEUROSCIENCE, V35, P145, DOI 10.1016/0306-4522(90)90129-R; Sigrist SJ, 2003, J NEUROSCI, V23, P6546; Sigrist SJ, 2002, J NEUROSCI, V22, P7362; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Trommershauser J, 2003, BIOPHYS J, V84, P1563, DOI 10.1016/S0006-3495(03)74967-4; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; VANDERKLOOT W, 1985, EXPERIENTIA, V41, P47; VANDERKLOOT W, 1986, BRAIN RES, V376, P378, DOI 10.1016/0006-8993(86)90203-9; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Verstreken P, 2005, NEURON, V47, P365, DOI 10.1016/j.neuron.2005.06.018; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wojcik SM, 2004, P NATL ACAD SCI USA, V101, P7158, DOI 10.1073/pnas.0401764101; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9	57	38	40	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					723	733		10.1016/j.neuron.2006.04.025	http://dx.doi.org/10.1016/j.neuron.2006.04.025			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731511	Bronze			2022-12-28	WOS:000238165000008
J	Farago, AF; Awatramani, RB; Dymecki, SM				Farago, AF; Awatramani, RB; Dymecki, SM			Assembly of the brainstem cochlear nuclear complex is revealed by intersectional and subtractive genetic fate maps	NEURON			English	Article							QUAIL-CHICK CHIMERAS; RHOMBIC-LIP; AUDITORY-SYSTEM; EXPRESSION PATTERN; MEDULLA-OBLONGATA; MOUSE; MICE; CEREBELLUM; HINDBRAIN; MIGRATION	The cochlear nuclear complex (CN) is the entry point for central auditory processing. Although constituent neurons have been studied physiologically, their embryological origins and molecular profiles remain obscure. Applying intersectional and subtractive genetic fate mapping approaches, we show that this complex develops modularly from genetically separable progenitor populations arrayed as rostrocaudal microdomains within and outside the hindbrain (lower) rhombic lip (LRL). The dorsal CN subdivision, structurally and topographically similar to the cerebellum, arises from microdomains unexpectedly caudal and noncontiguous to cerebellar primordium; ventral CN subdivisions arise from more rostral LRL. Magnocellular regions receive contributions from LRL and coaxial non-lip progenitors; contrastingly, ensheathing granule cells derive principally from LRL. Also LRL-derived and molecularly similar to CN granule cells are precerebellar mossy fiber neurons; surprisingly, these ostensibly intertwined populations have separable origins and adjacent but segregated migratory streams. Together, these findings provide new platforms for investigating the development and evolution of auditory and cerebellar systems.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Northwestern Univ, Feinberg Med Sch, Ctr Genet Med, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Med Sch, Dept Neurol, Chicago, IL 60611 USA	Harvard University; Harvard Medical School; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Dymecki, SM (corresponding author), Harvard Univ, Sch Med, Dept Genet, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dymecki@genetics.med.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD051936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD051936, P01 HD036379] Funding Source: Medline; NIDDK NIH HHS [R21 DK618021, R01 DK067826] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline; PHS HHS [T32 GMO7753-26] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALTMAN J, 1980, J COMP NEUROL, V194, P877, DOI 10.1002/cne.901940410; ALTMAN J, 1996, RELATION ITS EVOULTI; Awatramani R, 2003, NAT GENET, V35, P70, DOI 10.1038/ng1228; BERREBI AS, 1990, J NEUROCYTOL, V19, P643, DOI 10.1007/BF01188033; BOORD RL, 1963, J COMP NEUROL, V120, P463, DOI 10.1002/cne.901200305; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Cambronero F, 2000, J COMP NEUROL, V427, P522, DOI 10.1002/1096-9861(20001127)427:4<522::AID-CNE3>3.0.CO;2-Y; Cant NB, 1992, MAMMALIAN AUDITORY P, P66; Carr CE, 2002, BRAIN BEHAV EVOLUT, V59, P294, DOI 10.1159/000063565; Chai Y, 2000, DEVELOPMENT, V127, P1671; Clark JA, 1997, BRAIN BEHAV EVOLUT, V50, P198, DOI 10.1159/000113334; CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7; Cramer KS, 2000, DEV BIOL, V224, P138, DOI 10.1006/dbio.2000.9779; Dymecki SM, 1996, GENE, V171, P197, DOI 10.1016/0378-1119(96)00035-2; Eddison M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-14; Eichmann A, 1997, MECH DEVELOP, V65, P111, DOI 10.1016/S0925-4773(97)00063-4; Essick CR, 1912, AM J ANAT, V13, P25, DOI 10.1002/aja.1000130103; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; HARKMARK W, 1954, J COMP NEUROL, V100, P115, DOI 10.1002/cne.901000107; HIS W, 1891, MAT PHYS KI, V29, P1; Ivanova A, 1998, DEV NEUROSCI-BASEL, V20, P495, DOI 10.1159/000017350; JHAVERI S, 1982, NEUROSCIENCE, V7, P809, DOI 10.1016/0306-4522(82)90045-8; Jiang W, 1998, BIOTECHNIQUES, V24, P349; Landsberg RL, 2005, NEURON, V48, P933, DOI 10.1016/j.neuron.2005.11.031; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Machold R, 2005, NEURON, V48, P17, DOI 10.1016/j.neuron.2005.08.028; MARIN F, 1995, EUR J NEUROSCI, V7, P1714, DOI 10.1111/j.1460-9568.1995.tb00693.x; MARTIN MR, 1981, J COMP NEUROL, V197, P169, DOI 10.1002/cne.901970113; Matei V, 2005, DEV DYNAM, V234, P633, DOI 10.1002/dvdy.20551; Nichols DH, 2006, DEV DYNAM, V235, P285, DOI 10.1002/dvdy.20611; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Oertel D, 2004, TRENDS NEUROSCI, V27, P104, DOI 10.1016/j.tins.2003.12.001; OSEN KK, 1969, J COMP NEUROL, V136, P453, DOI 10.1002/cne.901360407; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; RYUGO DK, 1985, J COMP NEUROL, V242, P381, DOI 10.1002/cne.902420307; Ryugo DK, 2003, BRAIN RES BULL, V60, P435, DOI 10.1016/S0361-9230(03)00049-2; Sgaier SK, 2005, NEURON, V45, P27, DOI 10.1016/S0896-6273(04)00802-5; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; TABERPIERCE E, 1967, J COMP NEUROL, V131, P27; TABERPIERCE E, 1966, J COMP NEUROL, V126, P219; TAN K, 1991, ANAT EMBRYOL, V183, P321; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Wingate RJT, 1999, DEVELOPMENT, V126, P4395; Wingate RJT, 1996, DEVELOPMENT, V122, P2143; Wingate RJT, 2001, CURR OPIN NEUROBIOL, V11, P82, DOI 10.1016/S0959-4388(00)00177-X; Yoshihara Y, 1999, NEURON, V22, P33, DOI 10.1016/S0896-6273(00)80676-5; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	54	173	174	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					205	218		10.1016/j.neuron.2006.03.014	http://dx.doi.org/10.1016/j.neuron.2006.03.014			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630833	Bronze			2022-12-28	WOS:000237176700009
J	Losonczy, A; Magee, JC				Losonczy, A; Magee, JC			Integrative properties of radial oblique Dendrites in hippocampal CA1 pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; VOLTAGE ATTENUATION; RAT HIPPOCAMPUS; BASAL DENDRITES; SPINE-NECK; SPIKES; INITIATION; MECHANISM; SUMMATION; CHANNELS	Although radial oblique dendrites are a major synaptic input site in CA1 pyramidal neurons, little is known about their integrative properties. We have used multisite two-photon glutamate uncaging to deliver different spatiotemporal input patterns to single branches while simultaneously recording the uncaging-evoked excitatory postsynaptic potentials and local Ca2+ signals. Asynchronous input patterns sum linearly in spite of the spatial clustering and produce Ca2+ signals that are mediated by NMDA receptors (NMDARs). Appropriately timed and sized input patterns (similar to 20 inputs within similar to 6 ms) produce a supralinear summation due to the initiation of a dendritic spike. The Ca2+ signals associated with synchronous input were larger and mediated by influx through both NMDARs and voltage-gated Ca2+ channels (VGCCs). The oblique spike is a fast Na+ spike whose duration is shaped by the coincident activation of NMDAR, VGCCs, and transient K+ currents. Our results suggest that individual branches can function as single integrative compartments.	Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Losonczy, A (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Ctr Neurosci, New Orleans, LA 70112 USA.	aloson@lsuhsc.edu			NINDS NIH HHS [NS39458, R01 NS035865-08, R01 NS035865] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039458, R01NS035865] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ariav G, 2003, J NEUROSCI, V23, P7750; BANNISTER NJ, 1995, J COMP NEUROL, V360, P150, DOI 10.1002/cne.903600111; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Chevaleyre V, 2004, NEURON, V43, P871, DOI 10.1016/j.neuron.2004.08.036; Cook EP, 1999, J NEUROPHYSIOL, V81, P535, DOI 10.1152/jn.1999.81.2.535; Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 1999, J NEUROSCI, V19, P8789, DOI 10.1523/JNEUROSCI.19-20-08789.1999; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Holthoff K, 2004, J PHYSIOL-LONDON, V560, P27, DOI 10.1113/jphysiol.2004.072678; Johnston D, 1999, CURR OPIN NEUROBIOL, V9, P288, DOI 10.1016/S0959-4388(99)80042-7; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2002, J NEUROSCI, V22, P6991; Larkum ME, 2001, J PHYSIOL-LONDON, V533, P447, DOI 10.1111/j.1469-7793.2001.0447a.x; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 2005, CURR OPIN NEUROBIOL, V15, P334, DOI 10.1016/j.conb.2005.05.013; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Majewska A, 2000, J NEUROSCI, V20, P1722; Marchetti C, 2003, MOL BRAIN RES, V117, P139, DOI 10.1016/S0169-328X(03)00293-6; McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; Stuart G, 1998, J NEUROSCI, V18, P3501; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Xu J, 2005, J NEUROSCI, V25, P1750, DOI 10.1523/JNEUROSCI.4217-04.2005; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x	39	400	406	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					291	307		10.1016/j.neuron.2006.03.016	http://dx.doi.org/10.1016/j.neuron.2006.03.016			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630839	Bronze			2022-12-28	WOS:000237176700015
J	Waclaw, RR; Allen, ZJ; Bell, SM; Erdelyi, F; Szabo, G; Potter, SS; Campbell, K				Waclaw, RR; Allen, ZJ; Bell, SM; Erdelyi, F; Szabo, G; Potter, SS; Campbell, K			The zinc finger transcription factor Sp8 regulates the generation and diversity of olfactory bulb interneurons	NEURON			English	Article							ADULT MAMMALIAN BRAIN; LATERAL GANGLIONIC EMINENCE; NEURONAL MIGRATION; MOUSE TELENCEPHALON; SUBVENTRICULAR ZONE; LIMB OUTGROWTH; HOMEOBOX GENE; PAX6; EXPRESSION; GSH2	The molecular mechanisms that regulate the production and diversity of olfactory bulb interneurons remain poorly understood. With the exception of the GABAergic/dopaminergic subtype in the glomerular layer, no information exists concerning the generation of the other subtypes. Here we show that the recently identified zinc finger transcription factor Sp8 is expressed in neurogenic regions, which give rise to olfactory bulb interneurons at embryonic and postnatal time points and remains expressed in the calretinin-expressing and GABAergic/nondopaminergic interneurons of the glomerular layer. Conditional inactivation of Sp8 in the embryonic ventral telencephalon reveals a requirement for the normal generation of these interneuron subtypes. Sp8 conditional mutants exhibit an increase in cell death within the lateral ganglionic eminence and rostral migratory stream. Moreover, mutant neuroblasts/interneurons are misspecified and display abnormal migration patterns in the olfactory bulb, indicating that Sp8 contributes to olfactory bulb interneuron diversity by regulating the survival, migration, and molecular specification of neuroblasts/interneurons.	Univ Cincinnati, Childrens Hosp, Coll Med, Med Ctr,Dept Pediat,Div Dev Biol, Cincinnati, OH 45229 USA; Hungarian Acad Sci, Inst Expt Med, Dept Gene Technol & Dev Neurobiol, Budapest, Hungary	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine	Campbell, K (corresponding author), Univ Cincinnati, Childrens Hosp, Coll Med, Med Ctr,Dept Pediat,Div Dev Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	kenneth.campbell@cchmc.org	Szabo, Gabor/A-5087-2008; Campbell, Kenneth/ABC-3570-2021	Szabo, Gabor/0000-0001-5438-5151; Bell, Sheila/0000-0002-1946-0969	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH069643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044080, R56NS044080] Funding Source: NIH RePORTER; NIEHS NIH HHS [ES07051] Funding Source: Medline; NIMH NIH HHS [R01 MH069643, MH069643, R01 MH069643-02] Funding Source: Medline; NINDS NIH HHS [R01 NS044080, R01 NS044080-04, NS044080] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; Corbin JG, 2000, DEVELOPMENT, V127, P5007; De Marchis S, 2004, EUR J NEUROSCI, V20, P1307, DOI 10.1111/j.1460-9568.2004.03584.x; Dellovade TL, 1998, J COMP NEUROL, V402, P402; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HINDS JW, 1968, J COMP NEUROL, V134, P287, DOI 10.1002/cne.901340304; Kawakami Y, 2004, DEVELOPMENT, V131, P4763, DOI 10.1242/dev.01331; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; KOSAKA K, 1995, NEUROSCI RES, V23, P73, DOI 10.1016/0168-0102(95)00930-R; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Menezes JRL, 1995, MOL CELL NEUROSCI, V6, P496, DOI 10.1006/mcne.1995.0002; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Penberthy WT, 2004, DEV BIOL, V275, P225, DOI 10.1016/j.ydbio.2004.08.007; Pencea V, 2003, J COMP NEUROL, V463, P402, DOI 10.1002/cne.10746; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Stenman J, 2003, DEVELOPMENT, V130, P1113, DOI 10.1242/dev.00328; Stenman J, 2003, J NEUROSCI, V23, P167; Stenman JM, 2003, J NEUROSCI, V23, P10568; Stoykova A, 2000, J NEUROSCI, V20, P8042; Szucsik JC, 1997, DEV BIOL, V191, P230, DOI 10.1006/dbio.1997.8733; Toresson H, 2000, MECH DEVELOP, V94, P183, DOI 10.1016/S0925-4773(00)00324-5; Toresson H, 2001, DEVELOPMENT, V128, P4769; Toresson H, 2000, DEVELOPMENT, V127, P4361; Toresson H, 1999, DEVELOPMENT, V126, P1317; Treichel D, 2003, GENE DEV, V17, P2630, DOI 10.1101/gad.274103; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yun K, 2001, DEVELOPMENT, V128, P193; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201	39	187	195	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					503	516		10.1016/j.neuron.2006.01.018	http://dx.doi.org/10.1016/j.neuron.2006.01.018			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476661	Bronze			2022-12-28	WOS:000235643800005
J	Miller, CA; Sweatt, JD				Miller, Courtney A.; Sweatt, J. David			Covalent modification of DNA regulates memory formation	NEURON			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; GENE-EXPRESSION; ACETYLTRANSFERASE ACTIVITY; TRANSCRIPTIONAL REPRESSOR; HISTONE ACETYLTRANSFERASE; METHYLTRANSFERASE GENE; QUANTITATIVE PCR; METHYLATION; BINDING; MECP2	DNA methylation is a covalent chemical modification of DNA catalyzed by DNA methyltransferases (DNMTs). DNA methylation is associated with transcriptional silencing and has been studied extensively as a lifelong molecular information storage mechanism put in place during development. Here we report that DNMT gene expression is upregulated in the adult rat hippocampus following contextual fear conditioning and that DNMT inhibition blocks memory formation. In addition, fear conditioning is associated with rapid methylation and transcriptional silencing of the memory suppressor gene PP1 and demethylation and transcriptional activation of the synaptic plasticity gene reelin, indicating both methyltransferase and demethylase activity during consolidation. DNMT inhibition prevents the PP1 methylation increase, resulting in aberrant transcription of the gene during the memory-consolidation period. These results demonstrate that DNA methylation is dynamically regulated in the adult nervous system and that this cellular mechanism is a crucial step in memory formation.	Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Sweatt, JD (corresponding author), Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA.	dsweatt@nrc.uab.edu	Miller, Courtney A/E-8651-2010	Miller, Courtney A/0000-0001-8628-4902; Sweatt, J. David/0000-0003-3567-485X	NIDA NIH HHS [R00 DA024761] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R00DA024761] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Battaglioli E, 2002, J BIOL CHEM, V277, P41038, DOI 10.1074/jbc.M205691200; BECKER PB, 1987, CELL, V51, P435, DOI 10.1016/0092-8674(87)90639-8; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Brooks PJ, 1996, J NEUROSCI, V16, P939; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chen Y, 2002, NUCLEIC ACIDS RES, V30, P2930, DOI 10.1093/nar/gkf401; Chwang WB, 2006, LEARN MEMORY, V13, P322, DOI 10.1101/lm.152906; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; Cross SH, 1997, NAT GENET, V16, P256, DOI 10.1038/ng0797-256; Deng J, 1999, MOL BRAIN RES, V71, P23, DOI 10.1016/S0169-328X(99)00147-3; Detich N, 2002, J BIOL CHEM, V277, P35791, DOI 10.1074/jbc.C200408200; Endres M, 2001, NEUROREPORT, V12, P3763, DOI 10.1097/00001756-200112040-00032; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GOTO K, 1994, DIFFERENTIATION, V56, P39, DOI 10.1046/j.1432-0436.1994.56120039.x; Grayson DR, 2006, PHARMACOL THERAPEUT, V111, P272, DOI 10.1016/j.pharmthera.2005.01.007; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Holliday R, 1999, J THEOR BIOL, V200, P339, DOI 10.1006/jtbi.1999.0995; Huang YF, 2002, J NEUROSCI, V22, P8422; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jouvenceau A, 2006, EUR J NEUROSCI, V24, P564, DOI 10.1111/j.1460-9568.2006.04938.x; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Levenson JM, 2004, J NEUROSCI, V24, P3933, DOI 10.1523/JNEUROSCI.5646-03.2004; Levenson JM, 2006, J BIOL CHEM, V281, P15763, DOI 10.1074/jbc.M511767200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luczak MW, 2006, FOLIA HISTOCHEM CYTO, V44, P143; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Maciejak P, 2003, BRAIN RES BULL, V62, P39, DOI 10.1016/j.brainresbull.2003.08.003; Marquez VE, 2005, ANN NY ACAD SCI, V1058, P246, DOI 10.1196/annals.1359.037; Melia KR, 1996, NEUROSCIENCE, V74, P313, DOI 10.1016/0306-4522(96)00138-8; MONK M, 1987, DEVELOPMENT, V99, P371; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Roberson ED, 1999, J NEUROSCI, V19, P4337; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Santos KF, 2005, BRAZ J MED BIOL RES, V38, P1531, DOI 10.1590/S0100-879X2005001000010; Scarano MI, 2005, J CELL PHYSIOL, V204, P21, DOI 10.1002/jcp.20280; Siedlecki P, 2006, ACTA BIOCHIM POL, V53, P245; SINGERSAM J, 1990, NUCLEIC ACIDS RES, V18, P1255, DOI 10.1093/nar/18.5.1255; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Swank MW, 2001, J NEUROSCI, V21, P3383, DOI 10.1523/JNEUROSCI.21-10-03383.2001; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; SZYF M, 1985, J BIOL CHEM, V260, P8653; SZYF M, 1991, J BIOL CHEM, V266, P10027; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; Varga-Weisz PD, 1998, CURR OPIN CELL BIOL, V10, P346, DOI 10.1016/S0955-0674(98)80010-0; Veldic M, 2004, P NATL ACAD SCI USA, V101, P348, DOI 10.1073/pnas.2637013100; Weeber Edwin J, 2002, Mol Interv, V2, P376, DOI 10.1124/mi.2.6.376; Weeber EJ, 2002, J BIOL CHEM, V277, P39944, DOI 10.1074/jbc.M205147200; Weisenberger DJ, 2004, MOL CANCER RES, V2, P62; Wood MA, 2005, LEARN MEMORY, V12, P111, DOI 10.1101/lm.86605	66	862	909	1	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					857	869		10.1016/j.neuron.2007.02.022	http://dx.doi.org/10.1016/j.neuron.2007.02.022			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359920	Bronze			2022-12-28	WOS:000245292800010
J	Bekinschtein, P; Cammarota, M; Igaz, LM; Bevilaqua, LRM; Izquierdo, I; Medina, JH				Bekinschtein, Pedro; Cammarota, Martin; Igaz, Lionel Muller; Bevilaqua, Lia R. M.; Izquierdo, Ivan; Medina, Jorge H.			Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus	NEURON			English	Review							MEDIAL PREFRONTAL CORTEX; ELEMENT-BINDING PROTEIN; CONTEXTUAL FEAR MEMORY; 2 CRITICAL PERIODS; NEUROTROPHIC FACTOR; SPATIAL MEMORY; NMDA RECEPTOR; SYNAPTIC PLASTICITY; RETROGRADE-AMNESIA; RAT HIPPOCAMPUS	Persistence is the most characteristic attribute of long-term memory (LTM). To understand LTM, we must understand how memory traces persist over time despite the short-lived nature and rapid turnover of their molecular substrates. It is widely accepted that LTM formation is dependent upon hippocampal de novo protein synthesis and Brain-Derived Neurotrophic Factor (BDNF) signaling during or early after acquisition. Here we show that 12 hr after acquisition of a one-trial associative learning task, there is a novel protein synthesis and BDNF-dependent phase in the rat hippocampus that is critical for the persistence of LTM storage. Our findings indicate that a delayed stabilization phase is specifically required for maintenance, but not formation, of the memory trace. We propose that memory formation and memory persistence share some of the same molecular mechanisms and that recurrent rounds of consolidation-like events take place in the hippocampus for maintenance of the memory trace.	UBA, Fac Med, Inst Biol Celular & Neurociencias, Buenos Aires, DF, Argentina; UBA, Fac Med, Dept Fisiol, Buenos Aires, DF, Argentina; Pontificia Univ Catolica Rio Grande do Sul, Inst Pesquisas Biomed, Ctr Memoria, BR-90610000 Porto Alegre, RS, Brazil	University of Buenos Aires; University of Buenos Aires; Pontificia Universidade Catolica Do Rio Grande Do Sul	Medina, JH (corresponding author), UBA, Fac Med, Inst Biol Celular & Neurociencias, Paraguay 2155 30 Piso,C1121ABG, Buenos Aires, DF, Argentina.	jmedina@fmed.uba.ar	Cammarota, Martin/AAC-7478-2021; Igaz, Lionel/AAP-3059-2020	Cammarota, Martin/0000-0001-9741-5074; Izquierdo, Ivan/0000-0002-7208-0869; Igaz, Lionel Muller/0000-0001-9988-3242; Bevilaqua, Lia/0000-0001-8537-1289; Bekinschtein, Pedro/0000-0002-0004-9619				Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alder J, 2003, J NEUROSCI, V23, P10800; Alonso M, 2002, HIPPOCAMPUS, V12, P551, DOI 10.1002/hipo.10035; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Barco A, 2006, J NEUROCHEM, V97, P1520, DOI 10.1111/j.1471-4159.2006.03870.x; Barrientos RM, 2002, BEHAV BRAIN RES, V134, P299, DOI 10.1016/S0166-4328(02)00045-1; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bilang-Bleuel A, 2002, EUR J NEUROSCI, V15, P1048, DOI 10.1046/j.1460-9568.2002.01934.x; Bontempi B, 1999, NATURE, V400, P671, DOI 10.1038/23270; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; Bozon B, 2003, PHILOS T R SOC B, V358, P805, DOI 10.1098/rstb.2002.1224; Brown AS, 2002, PSYCHON B REV, V9, P403, DOI 10.3758/BF03196300; Bruel-Jungerman E, 2006, J NEUROSCI, V26, P5888, DOI 10.1523/JNEUROSCI.0782-06.2006; Burwell RD, 2004, J NEUROSCI, V24, P11023, DOI 10.1523/JNEUROSCI.3781-04.2004; Cammarota M, 2000, MOL BRAIN RES, V76, P36, DOI 10.1016/S0169-328X(99)00329-0; Countryman RA, 2005, NEUROBIOL LEARN MEM, V84, P175, DOI 10.1016/j.nlm.2005.07.005; Cui ZZ, 2004, NEURON, V41, P781, DOI 10.1016/S0896-6273(04)00072-8; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS HP, 1976, PHARMACOL BIOCHEM BE, V4, P13, DOI 10.1016/0091-3057(76)90168-4; Dudai Y, 2004, NEURON, V44, P93, DOI 10.1016/j.neuron.2004.09.003; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Dudai Y, 2002, CURR OPIN NEUROBIOL, V12, P211, DOI 10.1016/S0959-4388(02)00305-7; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Duvarci S, 2006, EUR J NEUROSCI, V24, P249, DOI 10.1111/j.1460-9568.2006.04907.x; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; Fischer A, 2004, J NEUROSCI, V24, P1962, DOI 10.1523/JNEUROSCI.5112-03.2004; Fleischmann A, 2003, J NEUROSCI, V23, P9116; FLOOD JF, 1975, PHYSIOL BEHAV, V14, P177, DOI 10.1016/0031-9384(75)90163-8; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Glorioso C, 2006, MOL PSYCHIATR, V11, P633, DOI 10.1038/sj.mp.4001835; Govindarajan A, 2006, P NATL ACAD SCI USA, V103, P13208, DOI 10.1073/pnas.0605180103; GRECKSCH G, 1980, PHARMACOL BIOCHEM BE, V12, P663, DOI 10.1016/0091-3057(80)90145-8; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; He J, 2002, NEUROPSYCHOPHARMACOL, V26, P259, DOI 10.1016/S0893-133X(01)00332-3; Howells DW, 2000, EXP NEUROL, V166, P127, DOI 10.1006/exnr.2000.7483; Igaz LM, 2002, J NEUROSCI, V22, P6781; Igaz LM, 2004, MOL BRAIN RES, V132, P1, DOI 10.1016/j.molbrainres.2004.08.016; Izquierdo I, 1998, TRENDS NEUROSCI, V21, P423, DOI 10.1016/S0166-2236(98)01279-X; Izquierdo I, 1999, EUR J NEUROSCI, V11, P3323, DOI 10.1046/j.1460-9568.1999.00742.x; Izquierdo I, 2006, TRENDS NEUROSCI, V29, P496, DOI 10.1016/j.tins.2006.07.005; Johnston ANB, 1999, NEUROSCIENCE, V88, P1033, DOI 10.1016/S0306-4522(98)00362-5; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Liu IYC, 2004, J NEUROSCI, V24, P7958, DOI 10.1523/JNEUROSCI.1948-04.2004; Malkani S, 2004, LEARN MEMORY, V11, P617, DOI 10.1101/lm.73104; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martinez A, 1998, J NEUROSCI, V18, P7336; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MCGAUGH JL, 1966, SCIENCE, V153, P1351, DOI 10.1126/science.153.3742.1351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Merhav M, 2006, LEARN MEMORY, V13, P571, DOI 10.1101/lm.282406; MINIACI MC, 2005, SOC NEUROSCIENCE PRO; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Morrow BA, 1999, J NEUROSCI, V19, P5666; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Ou LC, 2006, NEUROPSYCHOPHARMACOL, V31, P287, DOI 10.1038/sj.npp.1300830; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Power AE, 2006, LEARN MEMORY, V13, P27, DOI 10.1101/lm.91206; Qiao XX, 1998, J NEUROSCI, V18, P6990; Rattiner LM, 2004, J NEUROSCI, V24, P4796, DOI 10.1523/JNEUROSCI.5654-03.2004; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Ring RH, 2006, J NEUROBIOL, V66, P361, DOI 10.1002/neu.20223; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Rossato JI, 2006, LEARN MEMORY, V13, P431, DOI 10.1101/lm.315206; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Sangha S, 2005, BEHAV NEUROSCI, V119, P787, DOI 10.1037/0735-7044.119.3.787; Santini E, 2004, J NEUROSCI, V24, P5704, DOI 10.1523/JNEUROSCI.0786-04.2004; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Scharf MT, 2002, J NEUROPHYSIOL, V87, P2770, DOI 10.1152/jn.2002.87.6.2770; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Segal M, 2005, NAT REV NEUROSCI, V6, P277, DOI 10.1038/nrn1649; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Squire L R, 1987, Int J Neurol, V21-22, P218; SQUIRE LR, 1975, SCIENCE, V187, P77, DOI 10.1126/science.1109228; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takei N, 2004, J NEUROSCI, V24, P9760, DOI 10.1523/JNEUROSCI.1427-04.2004; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tiunova AA, 1998, LEARN MEMORY, V4, P401, DOI 10.1101/lm.4.5.401; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Trifilieff P, 2006, LEARN MEMORY, V13, P349, DOI 10.1101/lm.80206; Tronel S, 2005, PLOS BIOL, V3, P1630, DOI 10.1371/journal.pbio.0030293; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Valjent E, 2006, J NEUROSCI, V26, P4956, DOI 10.1523/JNEUROSCI.4601-05.2006; Villarreal DM, 2002, NAT NEUROSCI, V5, P48, DOI 10.1038/nn776; Viola HE, 2000, J NEUROSCI, V20; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783; Yasoshima Y, 2006, P NATL ACAD SCI USA, V103, P7106, DOI 10.1073/pnas.0600869103; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534; Zuccato C, 2001, SCIENCE, V293, P493, DOI 10.1126/science.1059581	126	458	466	3	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					261	277		10.1016/j.neuron.2006.11.025	http://dx.doi.org/10.1016/j.neuron.2006.11.025			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224407	Bronze			2022-12-28	WOS:000245126600011
J	Barker, PA				Barker, Philip A.			High affinity not in the vicinity?	NEURON			English	Editorial Material							P75 NEUROTROPHIN RECEPTOR; SYMPATHETIC NEURONS; FUNCTIONAL INTERACTIONS; NGF BINDING; TRKA; INTERNALIZATION; KINASE; CELLS	Functional interactions between the p75 neurotrophin receptor (p75NTR) and the Trk receptors were demonstrated several years ago, but their mechanistic basis remains uncertain. In this issue of Neuron, Wehrman et al. provide a three-dimensional structure of the full TrkA ectodomain complexed to NGF and examine the possibility of a ternary p75NTR-NGF-TrkA complex.	McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada	McGill University	Barker, PA (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, 3801 Univ St, Montreal, PQ H3A 2B4, Canada.	phil.barker@mcgill.ca						BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Brennan C, 1999, NAT NEUROSCI, V2, P699, DOI 10.1038/11158; CLARY DO, 1994, P NATL ACAD SCI USA, V91, P11133, DOI 10.1073/pnas.91.23.11133; Dechant G, 1997, J NEUROSCI, V17, P5281; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Ivanisevic L, 2003, ONCOGENE, V22, P5677, DOI 10.1038/sj.onc.1206864; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Lachyankar MB, 2003, J NEUROSCI RES, V71, P157, DOI 10.1002/jnr.10480; LEE KF, 1994, DEVELOPMENT, V120, P1027; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034	16	62	63	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					1	4		10.1016/j.neuron.2006.12.018	http://dx.doi.org/10.1016/j.neuron.2006.12.018			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196523	Bronze			2022-12-28	WOS:000245126500001
J	Dagher, A				Dagher, Alain			Shopping centers in the brain	NEURON			English	Editorial Material							MEDIAL PREFRONTAL CORTEX; NEURAL BASIS; DECISION-MAKING; RESPONSES; ANXIETY; FMRI	Knutson et al. performed functional MRI on individuals while the subjects were deciding whether or not to purchase various items. Their results, reported in this issue of Neuron, support the theory that the decision to purchase involves the integration of emotional signals related to the anticipation of both obtaining the desired product and suffering the financial loss of paying for it.	Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	McGill University	Dagher, A (corresponding author), Montreal Neurol Inst, 3801 Univ Ave, Montreal, PQ H3A 2B4, Canada.	alain@bic.mni.mcgill.ca						ALEXANDER GE, 1997, NEURON, V19, P591; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cools R, 2002, J NEUROSCI, V22, P4563, DOI 10.1523/JNEUROSCI.22-11-04563.2002; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Logothetis NK, 2004, MAGN RESON IMAGING, V22, P1517, DOI 10.1016/j.mri.2004.10.018; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; Paulus MP, 2006, BIOL PSYCHIAT, V60, P383, DOI 10.1016/j.biopsych.2006.03.042; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Sanfey AG, 2003, SCIENCE, V300, P1755, DOI 10.1126/science.1082976; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Simpson JR, 2001, P NATL ACAD SCI USA, V98, P688, DOI 10.1073/pnas.98.2.688; Small DM, 2003, NEUROIMAGE, V18, P633, DOI 10.1016/S1053-8119(02)00012-5; Zink CF, 2003, J NEUROSCI, V23, P8092	16	8	8	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					7	8		10.1016/j.neuron.2006.12.014	http://dx.doi.org/10.1016/j.neuron.2006.12.014			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196525	Bronze			2022-12-28	WOS:000245126500003
J	Deneen, B; Ho, R; Lukaszewicz, A; Hochstim, CJ; Gronostajski, RM; Anderson, DJ				Deneen, Benjamin; Ho, Ritchie; Lukaszewicz, Agnes; Hochstim, Christian J.; Gronostajski, Richard M.; Anderson, David J.			The transcription factor NFIA controls the onset of gliogenesis in the developing spinal cord	NEURON			English	Article							RADIAL GLIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; OLIGODENDROCYTE LINEAGE; MOTOR-NEURON; ASTROCYTE LINEAGE; DNA METHYLATION; SONIC HEDGEHOG; NOTCH ACTIVITY	The mechanisms controlling the transition from neurogenesis to gliogenesis in the vertebrate CNS are incompletely understood. We identified a family of transcription factors, called NFI genes, which are induced throughout the spinal cord ventricular zone (VZ) concomitantly with the induction of GLAST, an early marker of gliogenesis. NFIA is both necessary and sufficient for GLAST induction in the VZ. Unexpectedly, NFIA is also essential for the continued inhibition of neurogenesis in VZ progenitors. This function is mediated by the requirement of NFIA for the expression of HES5, a Notch effector. However, Notch effectors are unable to promote glial-fate specification in the absence of NFIA. Thus, NFIA links the abrogation of neurogenesis to a generic program of gliogenesis, in both astrocyte and oligodendrocyte VZ progenitors. At later stages, NFIA promotes migration and differentiation of astrocyte precursors, a function that is antagonized in oligodendrocyte precursors by Olig2.	CALTECH, Div Biol, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; SUNY Buffalo, Neurosci Program, Buffalo, NY 14214 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Anderson, DJ (corresponding author), CALTECH, Div Biol, 216-76,1201 E Calif Blvd, Pasadena, CA 91125 USA.	wuwei@caltech.edu		Deneen, Benjmain/0000-0002-6335-1081; Ho, Ritchie/0000-0003-1496-4436; Gronostajski, Richard/0000-0003-4264-208X	NINDS NIH HHS [R01-NS23476, 1F32NS048666] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS048666, R01NS023476] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Agius E, 2004, DEV BIOL, V270, P308, DOI 10.1016/j.ydbio.2004.02.015; Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Araki T, 2000, CELL DEATH DIFFER, V7, P485, DOI 10.1038/sj.cdd.4400674; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BANDYOPADHYAY S, 1994, J BIOL CHEM, V269, P29949; Bisgrove DA, 1999, DEV DYNAM, V214, P195, DOI 10.1002/(SICI)1097-0177(199903)214:3<195::AID-AJA3>3.0.CO;2-8; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Cebolla B, 2006, J NEUROCHEM, V97, P1057, DOI 10.1111/j.1471-4159.2006.03804.x; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fan GP, 2005, DEVELOPMENT, V132, P3345, DOI 10.1242/dev.01912; Fior R, 2005, DEV BIOL, V281, P318, DOI 10.1016/j.ydbio.2005.03.017; Fukuda S, 2004, CELL DEATH DIFFER, V11, P196, DOI 10.1038/sj.cdd.4401332; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kahn MA, 1997, J NEUROCHEM, V68, P1413; Kessaris N, 2001, NEURON, V31, P677, DOI 10.1016/S0896-6273(01)00430-5; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mason HA, 2006, DEV NEUROSCI-BASEL, V28, P49, DOI 10.1159/000090752; MEISTERERNST M, 1988, NUCLEIC ACIDS RES, V16, P4419, DOI 10.1093/nar/16.10.4419; Miller LK, 1997, J CELL PHYSIOL, V173, P178, DOI 10.1002/(SICI)1097-4652(199711)173:2<178::AID-JCP17>3.3.CO;2-Z; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Mukouyama Y, 2006, P NATL ACAD SCI USA, V103, P1551, DOI 10.1073/pnas.0510658103; Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Ogawa Y, 2005, DEV NEUROSCI-BASEL, V27, P364, DOI 10.1159/000088452; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Park HC, 2002, DEV BIOL, V248, P356, DOI 10.1006/dbio.2002.0738; Pringle NP, 2003, DEVELOPMENT, V130, P93, DOI 10.1242/dev.00184; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Satow T, 2001, J NEUROSCI, V21, P1265; Shibata T, 1997, J NEUROSCI, V17, P9212; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takizawa T, 2001, DEV CELL, V1, P749, DOI 10.1016/S1534-5807(01)00101-0; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Villa P, 1997, TRENDS BIOCHEM SCI, V22, P388, DOI 10.1016/S0968-0004(97)01107-9; Vincent S, 1996, DEVELOPMENT, V122, P131; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Yan Y, 2004, DEV DYNAM, V231, P248, DOI 10.1002/dvdy.20126; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	76	316	326	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					953	968		10.1016/j.neuron.2006.11.019	http://dx.doi.org/10.1016/j.neuron.2006.11.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178400	Bronze			2022-12-28	WOS:000243115100005
J	Kim, WY; Zhou, FQ; Zhou, J; Yokota, Y; Wang, YM; Yoshimura, T; Kaibuchi, K; Woodgett, JR; Anton, ES; Snider, WD				Kim, Woo-Yang; Zhou, Feng-Quan; Zhou, Jiang; Yokota, Yukako; Wang, Yan-Min; Yoshimura, Takeshi; Kaibuchi, Kozo; Woodgett, James R.; Anton, E. S.; Snider, William D.			Essential roles for GSK-3s and GSK-3-primed substrates in neurotrophin-induced and hippocampal axon growth	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3; NEURONAL POLARITY; PHARMACOLOGICAL INHIBITORS; SENSORY NEURONS; GSK-3-BETA; PROTEIN; PHOSPHORYLATION; GSK3-BETA; BINDING; CONES	Glycogen synthase kinase-3 beta (GSK-3 beta) is thought to mediate morphological responses to a variety of extracellular signals. Surprisingly, we found no gross morphological deficits in nervous system development in GSK-3 beta null mice. We therefore designed an shRNA that targeted both GSK-3 isoforms. Strong knockdown of both GSK-3 alpha and beta markedly reduced axon growth in dissociated cultures and slice preparations. We then assessed the role of different GSK-3 substrates in regulating axon morphology. Elimination of activity toward primed substrates only using the GSK-3 R96A mutant was associated with a defect in axon polarity (axon branching) compared to an overall reduction in axon growth induced by a kinase-dead mutant. Consistent with this finding, moderate reduction of GSK-3 activity by pharmacological inhibitors induced axon branching and was associated primarily with effects on primed substrates. Our results suggest that GSK-3 is a downstream convergent point for many axon growth regulatory pathways and that differential regulation of primed versus all GSK-3 substrates is associated with a specific morphological outcome.	Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Showa Ku, Nagoya, Aichi 4668550, Japan; Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; Johns Hopkins Univ, Sch Med, Dept Orthoped Surg, Baltimore, MD 21287 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Nagoya University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Johns Hopkins University; Johns Hopkins University	Snider, WD (corresponding author), Univ N Carolina, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.	wsnider@med.unc.edu	Woodgett, Jim/F-1087-2010; Zhou, Fengquan/X-5782-2019; Yoshimura, Takeshi/F-3817-2012	Woodgett, Jim/0000-0003-3731-5797; Zhou, Fengquan/0000-0002-1525-9969; Yoshimura, Takeshi/0000-0002-0316-8082	NINDS NIH HHS [R01NS050968, R01 NS050968] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050968] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Chadborn NH, 2006, J CELL SCI, V119, P951, DOI 10.1242/jcs.02801; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Eickholt BJ, 2002, J CELL BIOL, V157, P211, DOI 10.1083/jcb.200201098; Fischer PM, 2003, CHEM BIOL, V10, P1144, DOI 10.1016/j.chembiol.2003.12.009; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Goold RG, 2005, MOL CELL NEUROSCI, V28, P524, DOI 10.1016/j.mcn.2004.11.005; Goold RG, 2004, BIOCHEM SOC T, V32, P809, DOI 10.1042/BST0320809; Goold RG, 1999, J CELL SCI, V112, P3373; Goslin K., 1998, CULTURING NERVE CELL, P339; HE X, 1995, NATURE, V374, P617, DOI 10.1038/374617a0; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Knockaert M, 2002, TRENDS PHARMACOL SCI, V23, P417, DOI 10.1016/S0165-6147(02)02071-0; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lucas FR, 1998, J CELL SCI, V111, P1351; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neumann S, 1999, NEURON, V23, P83, DOI 10.1016/S0896-6273(00)80755-2; Owen R, 2003, MOL CELL NEUROSCI, V23, P626, DOI 10.1016/S1044-7431(03)00095-2; Plotkin B, 2003, J PHARMACOL EXP THER, V305, P974, DOI 10.1124/jpet.102.047381; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Smith DS, 1997, J NEUROSCI, V17, P646; Stankunas K, 2003, MOL CELL, V12, P1615, DOI 10.1016/S1097-2765(03)00491-X; TWORNEY C, 2006, FEBS LETT, V580, P4015; Valerio A, 2006, J BIOL CHEM, V281, P12950, DOI 10.1074/jbc.M508691200; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yu JY, 2003, MOL THER, V7, P228, DOI 10.1016/S1525-0016(02)00037-0; Zhou FQ, 2006, J CELL SCI, V119, P2787, DOI 10.1242/jcs.03016; Zhou FQ, 2005, SCIENCE, V308, P211, DOI 10.1126/science.1110301; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	44	190	196	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					981	996		10.1016/j.neuron.2006.10.031	http://dx.doi.org/10.1016/j.neuron.2006.10.031			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178402	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000243115100007
J	Alais, D; Parker, A				Alais, David; Parker, Amanda			Independent binocular rivalry processes for motion and form	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; HUMAN EXTRASTRIATE CORTEX; FUSIFORM FACE AREA; VISUAL-CORTEX; SUPPRESSION; PERCEPTION; DEPTH; STIMULI; PSYCHOPHYSICS; NEURONS	During binocular rivalry, conflicting monocular images undergo alternating suppression. This study explores rivalry suppression by probing visual sensitivity during rivalry with various probe stimuli. When two faces engage in rivalry, sensitivity to face probes is reduced 4-fold during suppression. Rivaling global motions also rivaled very deeply when probed with a global motion. However, in a surprising finding, sensitivity to face probes is completely unimpaired during global motion rivalry, and motion sensitivity is unimpaired during face rivalry. This suggests that rivalry suppression is localized to the neurons representing the image conflict, which means that probes of a different kind suffer no suppression. Sensibly, this would leave visual processes not involved in rivalry free to function normally.	Univ Sydney, Dept Physiol, Sch Med Sci, Sydney, NSW 2006, Australia; Univ Sydney, Inst Biomed Res, Sch Med Sci, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Alais, D (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	davida@psych.usyd.edu.au						Aguirre GK, 1998, NEURON, V21, P373, DOI 10.1016/S0896-6273(00)80546-2; Alais, 2005, BINOCULAR RIVALRY, DOI 10.7551/mitpress/1605.001.0001; Alais D, 2000, PERCEPTION, V29, P1437, DOI 10.1068/p3017; Alais D, 1998, VISION RES, V38, P637, DOI 10.1016/S0042-6989(97)00190-9; ALAIS D, 2006, IN PRESS VISION RES; Andrews TJ, 1999, NAT NEUROSCI, V2, P405, DOI 10.1038/8068; BLAKE R, 1980, PERCEPTION, V9, P223, DOI 10.1068/p090223; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1979, J EXP PSYCHOL HUMAN, V5, P315, DOI 10.1037/0096-1523.5.2.315; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BLAKE R, 1974, VISION RES, V14, P687, DOI 10.1016/0042-6989(74)90065-0; BLAKE R, 1985, PERCEPT PSYCHOPHYS, V37, P114, DOI 10.3758/BF03202845; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Carlson TA, 2000, CURR BIOL, V10, P1055, DOI 10.1016/S0960-9822(00)00672-2; Carlson TA, 2004, NEURON, V43, P907, DOI 10.1016/j.neuron.2004.08.039; CARNEY T, 1987, NATURE, V328, P647, DOI 10.1038/328647a0; Creed RS, 1935, J PHYSIOL-LONDON, V84, P381, DOI 10.1113/jphysiol.1935.sp003288; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; FOX R, 1972, J EXP PSYCHOL, V93, P283, DOI 10.1037/h0032455; GRAZIANO MSA, 1994, J NEUROSCI, V14, P54; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; He S., 2005, BINOCULAR RIVALRY, P81; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2004, VISION RES, V44, P983, DOI 10.1016/j.visres.2003.12.007; Lee SH, 1999, VISION RES, V39, P1447, DOI 10.1016/S0042-6989(98)00269-7; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Logothetis NK, 1998, PHILOS T R SOC B, V353, P1801, DOI 10.1098/rstb.1998.0333; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; MAKOUS W, 1978, VISUAL PSYCHOPHYSICS; Nguyen VA, 2001, PERCEPT PSYCHOPHYS, V63, P348, DOI 10.3758/BF03194475; Nguyen VA, 2003, VISION RES, V43, P2003, DOI 10.1016/S0042-6989(03)00314-6; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polonsky A, 2000, NAT NEUROSCI, V3, P1153, DOI 10.1038/80676; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; TANAKA K, 1989, J NEUROPHYSIOL, V62, P642, DOI 10.1152/jn.1989.62.3.642; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TREISMAN A, 1962, Q J EXP PSYCHOL, V14, P23, DOI 10.1080/17470216208416507; WALES R, 1970, PERCEPT PSYCHOPHYS, V8, P90, DOI 10.3758/BF03210180; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Watson TL, 2004, CURR BIOL, V14, P1670, DOI 10.1016/j.cub.2004.08.064; Wunderlich K, 2005, NAT NEUROSCI, V8, P1595, DOI 10.1038/nn1554	45	51	51	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					911	920		10.1016/j.neuron.2006.10.027	http://dx.doi.org/10.1016/j.neuron.2006.10.027			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145510	Bronze			2022-12-28	WOS:000242856400017
J	Catterall, WA; Yu, FH				Catterall, William A.; Yu, Frank H.			Painful channels	NEURON			English	Editorial Material							MECHANISMS	Paroxysmal extreme pain disorder (PEPD), previously known as familial rectal pain (FRP, OMIM 167400), is an inherited disease causing intense burning rectal, ocular, and submandibular pain and flushing. Fertleman et al. (this issue of Neuron) show that mutations in SCN9A, the gene encoding the sodium channel Na(V)1.7 channels, are responsible for this syndrome. Together with earlier work implicating a distinct class of functional mutations in SCN9A in a distinct inherited pain syndrome, these results point to Na(V)1.7 channels as key players in signaling nociceptive information and as a potential target for drug therapy of chronic pain.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.			Yu, Frank/0000-0001-9306-1731				Ashcroft FM, 2000, ION CHANNELS DIS; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Fertleman CR, 2006, NEURON, V52, P767, DOI 10.1016/j.neuron.2006.10.006; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639; Waxman SG, 2005, TRENDS MOL MED, V11, P555, DOI 10.1016/j.molmed.2005.10.004; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103	9	13	13	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					743	744		10.1016/j.neuron.2006.11.017	http://dx.doi.org/10.1016/j.neuron.2006.11.017			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145494	Bronze			2022-12-28	WOS:000242856400001
J	Tononi, G; Massimini, M; Riedner, BA				Tononi, Giulio; Massimini, Marcello; Riedner, Brady A.			Sleepy dialogues between cortex and hippocampus: Who talks to whom?	NEURON			English	Editorial Material							SLOW-WAVE SLEEP; PHASE-LOCKING; OSCILLATIONS; EXPERIENCE; MEMORY	During NREM sleep, neocortical neurons undergo near-synchronous transitions, every second or so, between UP states, during which they are depolarized and fire actively, and DOWN states, during which they are hyperpolarized and completely silent. In this issue of Neuron, Isomura et al. report that slow oscillations of membrane potential occur near-synchronously not only in neocortex but also in entorhinal cortex and subiculum. Within the hippocampus proper, pyramidal neurons lack the bistability of UP and DOWN states, but their firing is strongly modulated by cortical activity during the UP state. Intriguingly, many hippocampal neurons fire during the cortical DOWN state. Thus, during sleep UP states, the cortex can talk to the hippocampus, but it is unclear whether the hippocampus talks back.	Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA	University of Wisconsin System; University of Wisconsin Madison	Tononi, G (corresponding author), Univ Wisconsin, Dept Psychiat, Madison, WI 53719 USA.		Tononi, Giulio/B-8387-2009; Massimini, Marcello/T-8115-2017	Massimini, Marcello/0000-0003-2271-957X				Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Colgin LL, 2004, J PHYSIOL-LONDON, V558, P953, DOI 10.1113/jphysiol.2004.068080; CZARNECKI A, 2006, IN PRESS J PHYSL; Hahn TTG, 2006, NAT NEUROSCI, V9, P1359, DOI 10.1038/nn1788; Isomura Y, 2006, NEURON, V52, P871, DOI 10.1016/j.neuron.2006.10.023; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Molle M, 2006, J NEUROPHYSIOL, V96, P62, DOI 10.1152/jn.00014.2006; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002	12	23	24	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					748	749		10.1016/j.neuron.2006.11.014	http://dx.doi.org/10.1016/j.neuron.2006.11.014			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145497	Bronze			2022-12-28	WOS:000242856400004
J	Roux, B				Roux, Benoit			Dissecting the coupling between the voltage sensor and pore domains	NEURON			English	Editorial Material							POTASSIUM CHANNEL ACTIVATION; K+ CHANNEL; S4; COOPERATIVITY	The gating mechanism of K. channels is not known. In this issue of Neuron, Soler-Llavina et al. present fascinating results that support the concept of relatively independent voltage-sensing modules. However, they also find that its interactions with the pore domain are rather complex, with specific S4-S5 intersubunit contacts underlying the concerted transition leading to the channel opening.	Univ Chicago, Gordon Ctr Integrat Sci, Inst Mol Pediat Sci, Chicago, IL 60637 USA; Univ Chicago, Gordon Ctr Integrat Sci, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Roux, B (corresponding author), Univ Chicago, Gordon Ctr Integrat Sci, Inst Mol Pediat Sci, 929 E 57th St, Chicago, IL 60637 USA.							Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P421, DOI 10.1085/jgp.111.3.421; Soler-Llavina GJ, 2006, NEURON, V52, P623, DOI 10.1016/j.neuron.2006.10.005; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321	15	6	6	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					568	569		10.1016/j.neuron.2006.11.002	http://dx.doi.org/10.1016/j.neuron.2006.11.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114039	Bronze			2022-12-28	WOS:000242413100002
J	Baccus, SA				Baccus, Stephen A.			From a whisper to a roar: Adaptation to the mean and variance of naturalistic sounds	NEURON			English	Editorial Material							CELLS		Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA	Stanford University	Baccus, SA (corresponding author), Stanford Univ, Dept Neurobiol, Sch Med, Stanford, CA 94305 USA.							Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; ENROTHCU.C, 1973, J PHYSIOL-LONDON, V233, P271, DOI 10.1113/jphysiol.1973.sp010308; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Fettiplace R, 2003, CURR OPIN NEUROBIOL, V13, P446, DOI 10.1016/S0959-4388(03)00094-1; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Nagel KI, 2006, NEURON, V51, P845, DOI 10.1016/j.neuron.2006.08.030; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Solomon SG, 2004, NEURON, V42, P155, DOI 10.1016/S0896-6273(04)00178-3; VANHATEREN JH, 1993, VISION RES, V33, P257, DOI 10.1016/0042-6989(93)90163-Q	10	8	8	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					682	684		10.1016/j.neuron.2006.09.007	http://dx.doi.org/10.1016/j.neuron.2006.09.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982414	Bronze			2022-12-28	WOS:000240997900007
J	Kobayashi, S; Nomoto, K; Watanabe, M; Hikosaka, O; Schultz, W; Sakagami, M				Kobayashi, Shunsuke; Nomoto, Kensaku; Watanabe, Masataka; Hikosaka, Okihide; Schultz, Wolfram; Sakagami, Masamichi			Influences of rewarding and aversive outcomes on activity in macaque lateral prefrontal cortex	NEURON			English	Article							SINGLE NEURON RESPONSES; ORBITOFRONTAL CORTEX; EXPECTED REWARD; MONKEY; ATTENTION; STIMULI; AMYGDALA; ENCODE; MECHANISMS; AVOIDANCE	Both appetitive and aversive outcomes can reinforce animal behavior. It is not clear, however, whether the opposing kinds of reinforcers are processed by specific or common neural mechanisms. To investigate this issue, we studied macaque monkeys that performed a memory-guided saccade task for three different outcomes, namely delivery of liquid reward, avoidance of air puff, and feedback sound only. Animals performed the task best in rewarded trials, intermediately in aversive trials, and worst in sound-only trials. Most task-related activity in lateral prefrontal cortex was differentially influenced by the reinforcers. Aversive avoidance had clear effects on some prefrontal neurons, although the effects of rewards were more common. We also observed neurons modulated by both positive and negative reinforcers, reflecting reinforcement or attentional processes. Our results demonstrate that information about positive and negative reinforcers is processed differentially in prefrontal cortex, which could contribute to the role of this structure in goal-directed behavior.	Tamagawa Univ, Res Inst, Brain Sci Res Ctr, Tokyo 1940041, Japan; Tokyo Metropolitan Inst Neurosci, Dept Psychol, Tokyo 1838526, Japan; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Univ Tokyo, Sch Med, Dept Psychiat, Tokyo 1138655, Japan	Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University of Cambridge; University of Tokyo	Kobayashi, S (corresponding author), Tamagawa Univ, Res Inst, Brain Sci Res Ctr, Tokyo 1940041, Japan.	skoba-tky@umin.ac.jp	Kobayashi, Shunsuke/C-2551-2008; schultz, wolfram/H-8958-2016	Kobayashi, Shunsuke/0000-0002-6868-9313; Nomoto, Kensaku/0000-0003-2953-4594; schultz, wolfram/0000-0002-8530-4518	Medical Research Council [G0001354] Funding Source: Medline; Wellcome Trust [095495] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000415, Z01EY000415] Funding Source: NIH RePORTER; Medical Research Council [G0001354B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Bendiksby MS, 2006, NEUROPSYCHOLOGIA, V44, P2411, DOI 10.1016/j.neuropsychologia.2006.04.011; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; CAHILL L, 1990, BEHAV NEUROSCI, V104, P532, DOI 10.1037/0735-7044.104.4.532; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fanselow M.S., 1997, LEARNING MOTIVATION, P321; Gottfried JA, 2002, J NEUROSCI, V22, P10829; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kobayashi S, 2002, J NEUROPHYSIOL, V87, P1488, DOI 10.1152/jn.00472.2001; Koyama T, 2001, NEUROSCI RES, V39, P421, DOI 10.1016/S0168-0102(01)00197-3; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; LEWIS DA, 1987, J NEUROSCI, V7, P279; Liu Z, 2000, J NEUROPHYSIOL, V83, P1677, DOI 10.1152/jn.2000.83.3.1677; Luck SJ, 1995, BEHAV BRAIN RES, V71, P113, DOI 10.1016/0166-4328(95)00041-0; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MUIR JL, 1994, J NEUROSCI, V14, P2313; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Nishijo H, 1997, NEUROSCI LETT, V227, P79, DOI 10.1016/S0304-3940(97)00310-8; NISHIJO H, 1988, J NEUROSCI, V8, P3570; Paton JJ, 2006, NATURE, V439, P865, DOI 10.1038/nature04490; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Ravel S, 2003, J NEUROSCI, V23, P8489; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roesch MR, 2003, J NEUROPHYSIOL, V90, P1766, DOI 10.1152/jn.00019.2003; Roesch MR, 2004, SCIENCE, V304, P307, DOI 10.1126/science.1093223; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; SAWAGUCHI T, 1990, J NEUROPHYSIOL, V63, P1401, DOI 10.1152/jn.1990.63.6.1401; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Small DM, 2003, NEURON, V39, P701, DOI 10.1016/S0896-6273(03)00467-7; Solomon RL, 1953, PSYCHOL MONOGR-GEN A, V67, P1, DOI 10.1037/h0093649; SOLOMON RL, 1954, PSYCHOL REV, V61, P353, DOI 10.1037/h0054540; STERIADE H, 1990, BRAIN CHOLINERGIC SY, P3; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; Zald DH, 2002, J NEUROPHYSIOL, V87, P1068, DOI 10.1152/jn.00358.2001	41	79	84	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					861	870		10.1016/j.neuron.2006.08.031	http://dx.doi.org/10.1016/j.neuron.2006.08.031			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982429	Bronze			2022-12-28	WOS:000240997900022
J	Li, Y; Wu, YY; Zhou, Y				Li, Yong; Wu, Yuying; Zhou, Yi			Modulation of inactivation properties of Ca(v)2.2 channels by 14-3-3 proteins	NEURON			English	Article							GATED CA2+ CHANNELS; VOLTAGE-DEPENDENT INACTIVATION; PRESYNAPTIC CALCIUM CURRENT; N-TYPE; MOLECULAR DETERMINANTS; HIPPOCAMPAL-NEURONS; POTASSIUM CHANNEL; STRUCTURAL BASIS; BETA-SUBUNITS; IN-VIVO	Inactivation of presynaptic Ca(v)2.2 channels may play a role in regulating short-term synaptic plasticity. Here, we report a direct modulation of Ca(v)2.2 channel inactivation properties by 14-3-3, a family of signaling proteins involved in a wide range of biological processes. The structural elements critical for 14-3-3 binding and channel modulation lie in the carboxyl tail of the pore-forming alpha(1B) subunit, where we have identified two putative 14-3-3 interaction sites, including a phosphoserine-containing motif that directly binds to 14-3-3 and a second region near the EF hand and 10 domain. In transfected tsA 201 cells, 14-3-3 coexpression dramatically slows open-state inactivation and reduces cumulative inactivation of Ca(v)2.2 channels. In hippocampal neurons, interference with 14-3-3 binding accelerates Ca(v)2.2 channel inactivation and enhances short-term synaptic depression. These results demonstrate that 14-3-3 proteins are important regulators of Ca(v)2.2 channel activities and through this mechanism may contribute to their regulation of synaptic transmission and plasticity.	Univ Alabama, Dept Neurobiol, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; Univ Alabama, Sch Med, Civitan Int Res Ctr, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Zhou, Y (corresponding author), Univ Alabama, Dept Neurobiol, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA.	yizhou@uab.edu	Li, Yong/ABB-5588-2021					Baxter J, 2002, GENDER EDUC, V14, P5, DOI 10.1080/09540250120098843; Beguin P, 2006, J MOL BIOL, V355, P34, DOI 10.1016/j.jmb.2005.10.013; Beguin P, 2005, J CELL SCI, V118, P1923, DOI 10.1242/jcs.02321; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Budde T, 2002, NAT REV NEUROSCI, V3, P873, DOI 10.1038/nrn959; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Degtiar VE, 2000, J NEUROSCI, V20, P4355, DOI 10.1523/JNEUROSCI.20-12-04355.2000; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Jarvis SE, 2001, J NEUROSCI, V21, P2939, DOI 10.1523/JNEUROSCI.21-09-02939.2001; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Jones SW, 2003, J BIOENERG BIOMEMBR, V35, P461, DOI 10.1023/B:JOBB.0000008020.86004.28; Kaplan MP, 2003, SYNAPSE, V50, P41, DOI 10.1002/syn.10244; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Luk SCW, 1999, J CELL BIOCHEM, V73, P31, DOI 10.1002/(SICI)1097-4644(19990401)73:1<31::AID-JCB4>3.0.CO;2-X; Maeno-Hikichi Y, 2003, NAT NEUROSCI, V6, P468, DOI 10.1038/nn1041; Mao H, 2005, J NEUROSCI, V25, P7934, DOI 10.1523/JNEUROSCI.0635-05.2005; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Moore BE, 1967, PHYSL BIOCH ASPECTS, P343; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Nooney JM, 1997, TRENDS PHARMACOL SCI, V18, P363, DOI 10.1016/S0165-6147(97)01110-3; OPRIAN DD, 1991, BIOCHEMISTRY-US, V30, P11367, DOI 10.1021/bi00112a002; Park D, 1998, J NEUROSCI, V18, P6757; Patil PG, 1998, NEURON, V20, P1027, DOI 10.1016/S0896-6273(00)80483-3; PLUMMER MR, 1991, NATURE, V351, P657, DOI 10.1038/351657a0; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Scott VES, 1996, J BIOL CHEM, V271, P3207, DOI 10.1074/jbc.271.6.3207; Simsek-Duran F, 2004, NAT NEUROSCI, V7, P1296, DOI 10.1038/nn1348; Skoulakis EMC, 1996, NEURON, V17, P931, DOI 10.1016/S0896-6273(00)80224-X; Stotz SC, 2004, J PHYSIOL-LONDON, V554, P263, DOI 10.1113/jphysiol.2003.047068; SUDHOF TC, 1991, NEURON, V6, P665, DOI 10.1016/0896-6273(91)90165-V; Thaler C, 2004, P NATL ACAD SCI USA, V101, P5675, DOI 10.1073/pnas.0303402101; Toyooka K, 2002, MOL BRAIN RES, V100, P13, DOI 10.1016/S0169-328X(02)00129-8; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wittemann S, 2000, J BIOL CHEM, V275, P37807, DOI 10.1074/jbc.M004653200; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; ZHANG JF, 1994, NATURE, V372, P97, DOI 10.1038/372097a0; Zhong HJ, 2001, P NATL ACAD SCI USA, V98, P4705, DOI 10.1073/pnas.051629098; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	52	39	41	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					755	771		10.1016/j.neuron.2006.08.014	http://dx.doi.org/10.1016/j.neuron.2006.08.014			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982421	Bronze			2022-12-28	WOS:000240997900014
J	Jackson, EL; Garcia-Verdugo, JM; Gil-Perotin, S; Roy, M; Quinones-Hinojosa, A; VandenBerg, S; Alvarez-Buylla, A				Jackson, Erica L.; Garcia-Verdugo, Jose Manuel; Gil-Perotin, Sara; Roy, Monica; Quinones-Hinojosa, Alfredo; VandenBerg, Scott; Alvarez-Buylla, Arturo			PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling	NEURON			English	Article							SUBVENTRICULAR ZONE; PROGENITOR CELLS; FACTOR RECEPTOR; BRAIN; OLIGODENDROCYTES; IDENTIFICATION; ASTROCYTE; EXPRESSION; OLIG2; CNS	Neurons and oligodendrocytes are produced in the adult brain subventricular zone (SVZ) from neural stem cells (B cells), which express GFAP and have morphological properties of astrocytes. We report here on the identification B cells expressing the PDGFR alpha in the adult SVZ. Specifically labeled PDGFR alpha expressing B cells in vivo generate neurons and oligodendrocytes. Conditional ablation of PDGFR alpha in a subpopulation of postnatal stem cells showed that this receptor is required for oligodendrogenesis, but not neurogenesis. Infusion of PDGF alone was sufficient to arrest neuroblast production and induce SVZ B cell proliferation contributing to the generation of large hyperplasias with some features of gliomas. The work demonstrates that PDGFR alpha signaling occurs early in the adult stem cell lineage and may help regulate the balance between oligodendrocyte and neuron production. Excessive PDGF activation in the SVZ in stem cells is sufficient to induce hallmarks associated with early stages of tumor formation.	Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; Univ Valencia, Burjassot 4610, Valencia, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Valencia	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	Gil-Perotin, Sara/AAK-9942-2021; Gil-Perotin, Sara/I-2467-2015; García-Verdugo, José Manuel/L-8421-2017	Gil-Perotin, Sara/0000-0003-3793-0116; Gil-Perotin, Sara/0000-0003-3793-0116; García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-32116] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andrae J, 2001, MOL CELL NEUROSCI, V17, P1001, DOI 10.1006/mcne.2001.0989; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; BONFANTI L, 1994, NEUROSCIENCE, V62, P291, DOI 10.1016/0306-4522(94)90333-6; BUICK RN, 1979, BLOOD, V54, P95; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Di Pasquale G, 2003, NAT MED, V9, P1306, DOI 10.1038/nm929; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; ELLISON JA, 1994, J NEUROSCI RES, V37, P116, DOI 10.1002/jnr.490370116; Erlandsson A, 2001, J NEUROSCI, V21, P3483, DOI 10.1523/JNEUROSCI.21-10-03483.2001; FFRENCHCONSTANT C, 1986, J CELL BIOL, V102, P844, DOI 10.1083/jcb.102.3.844; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Globus J.H., 1944, J NEUROPATH EXP NEUR, V3, P1; GRINSPAN JB, 1995, J NEUROSCI RES, V41, P540, DOI 10.1002/jnr.490410414; GUHA A, 1995, INT J CANCER, V60, P168, DOI 10.1002/ijc.2910600206; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hall A, 1996, DEVELOPMENT, V122, P4085; HART IK, 1989, J CELL BIOL, V109, P3411, DOI 10.1083/jcb.109.6.3411; He WL, 2001, J NEUROSCI, V21, P8854, DOI 10.1523/JNEUROSCI.21-22-08854.2001; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Holland EC, 1998, P NATL ACAD SCI USA, V95, P1218, DOI 10.1073/pnas.95.3.1218; Holland EC, 1998, GENE DEV, V12, P3675, DOI 10.1101/gad.12.23.3675; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Lim DA, 2001, CONT NEUROS, P71; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lotery AJ, 2003, HUM GENE THER, V14, P1663, DOI 10.1089/104303403322542301; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Lu QR, 2001, P NATL ACAD SCI USA, V98, P10851, DOI 10.1073/pnas.181340798; LUSKIN MB, 1994, CHEM SENSES, V19, P695, DOI 10.1093/chemse/19.6.695; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; MCCARTHY GF, 1988, J COMP NEUROL, V271, P589, DOI 10.1002/cne.902710409; MENN B, IN PRESS J NEUROSCI; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MORRIS RJ, 1994, CELL PROLIFERAT, V27, P279, DOI 10.1111/j.1365-2184.1994.tb01425.x; Morshead CM, 2003, EUR J NEUROSCI, V18, P76, DOI 10.1046/j.1460-9568.2003.02727.x; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Recht L, 2003, J CELL BIOCHEM, V88, P11, DOI 10.1002/jcb.10208; Redwine JM, 1997, J NEUROSCI RES, V50, P229; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SMITS A, 1991, P NATL ACAD SCI USA, V88, P8159, DOI 10.1073/pnas.88.18.8159; Sonoda Y, 2001, CANCER RES, V61, P4956; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uhrbom L, 1998, CANCER RES, V58, P5275; Varela M, 2004, J SURG ONCOL, V86, P34, DOI 10.1002/jso.20036; Wang JJ, 2000, P NATL ACAD SCI USA, V97, P3497, DOI 10.1073/pnas.97.7.3497; Williams BP, 1997, NEURON, V18, P553, DOI 10.1016/S0896-6273(00)80297-4; WOLSWIJK G, 1989, DEVELOPMENT, V105, P387; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	70	404	423	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 20	2006	51	2					187	199		10.1016/j.neuron.2006.06.012	http://dx.doi.org/10.1016/j.neuron.2006.06.012			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846854	Bronze			2022-12-28	WOS:000239535100007
J	Pesaran, B; Nelson, MJ; Andersen, RA				Pesaran, Bijan; Nelson, Matthew J.; Andersen, Richard A.			Dorsal premotor neurons encode the relative position of the hand, eye, and goal during reach planning	NEURON			English	Article							ARM MOVEMENTS; VISUAL SPACE; PARIETAL; CORTEX; AREA; REPRESENTATION; TRANSFORMATIONS; MODULATION; DISCHARGE; DIRECTION	When reaching to grasp an object, we often move our arm and orient our gaze together. How are these movements coordinated? To investigate this question, we studied neuronal activity in the dorsal premotor area (PMd) and the medial intraparietal area (area MIP) of two monkeys while systematically varying the starting position of the hand and eye during reaching. PMd neurons encoded the relative position of the target, hand, and eye. MIP neurons encoded target location with respect to the eye only. These results indicate that whereas MIP encodes target locations in an eye-centered reference frame, PMd uses a relative position code that specifies the differences in locations between all three variables. Such a relative position code may play an important role in coordinating hand and eye movements by computing their relative position.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Pesaran, B (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	bijan@vis.caltech.edu	Nelson, Matthew/K-6635-2018	Nelson, Matthew/0000-0002-2325-4578; Pesaran, Bijan/0000-0003-4116-0038	NEI NIH HHS [R01 EY005522-21, R01 EY005522, EY05522-21] Funding Source: Medline; NIMH NIH HHS [R01 MH062528, MH62528-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062528] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BARASH S, 1991, J NEUROPHYSIOL, V66, P1109, DOI 10.1152/jn.1991.66.3.1109; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Boussaoud D, 1998, J NEUROPHYSIOL, V80, P1132, DOI 10.1152/jn.1998.80.3.1132; Buneo CA, 2002, NATURE, V416, P632, DOI 10.1038/416632a; Buneo CA, 2006, NEUROPSYCHOLOGIA, V44, P2594, DOI 10.1016/j.neuropsychologia.2005.10.011; Calton JL, 2002, NAT NEUROSCI, V5, P580, DOI 10.1038/nn862; CAMINITI R, 1990, EXP BRAIN RES, V83, P228; CAMINITI R, 1991, J NEUROSCI, V11, P1182; Cisek P, 2002, J NEUROPHYSIOL, V88, P1064, DOI 10.1152/jn.00995.2001; CRAMMOND DJ, 1994, J NEUROPHYSIOL, V71, P1281, DOI 10.1152/jn.1994.71.3.1281; Crawford JD, 2004, J NEUROPHYSIOL, V92, P10, DOI 10.1152/jn.00117.2004; CSORBA M, 1997, SPIE; DeSouza JFX, 2000, J NEUROSCI, V20, P5835, DOI 10.1523/JNEUROSCI.20-15-05835.2000; Dissanayake MWMG, 2001, IEEE T ROBOTIC AUTOM, V17, P229, DOI 10.1109/70.938381; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; FOGASSI L, 1992, EXP BRAIN RES, V89, P686, DOI 10.1007/BF00229894; FU QG, 1993, J NEUROPHYSIOL, V70, P2097, DOI 10.1152/jn.1993.70.5.2097; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Johnson PB, 1996, CEREB CORTEX, V6, P102, DOI 10.1093/cercor/6.2.102; Kakei S, 2001, NAT NEUROSCI, V4, P1020, DOI 10.1038/nn726; Kalaska JF, 1997, CURR OPIN NEUROBIOL, V7, P849, DOI 10.1016/S0959-4388(97)80146-8; Khan AZ, 2005, CEREB CORTEX, V15, P1547, DOI 10.1093/cercor/bhi033; Matelli M, 1998, J COMP NEUROL, V402, P327; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Medendorp WP, 2003, J NEUROSCI, V23, P6209; Merriam EP, 2003, NEURON, V39, P361, DOI 10.1016/S0896-6273(03)00393-3; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Newman P., 1999, THESIS U SYDNEY SYDN; OLFATI R, 2002, P 15 IFAC C; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; SHADMEHR, 2005, COMPUTATIONAL NEUROB; Shen LM, 1997, J NEUROPHYSIOL, V77, P1195, DOI 10.1152/jn.1997.77.3.1195; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; SOECHTING JF, 1995, J NEUROSCI, V15, P6271; Sugrue LP, 2004, SCIENCE, V304, P1782, DOI 10.1126/science.1094765; Swinnen SP, 2002, NAT REV NEUROSCI, V3, P350, DOI 10.1038/nrn807; TWEED D, 1987, J NEUROPHYSIOL, V58, P832, DOI 10.1152/jn.1987.58.4.832; van Donkelaar P, 2002, HUM MOVEMENT SCI, V21, P377, DOI 10.1016/S0167-9457(02)00121-5	45	252	261	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					125	134		10.1016/j.neuron.2006.05.025	http://dx.doi.org/10.1016/j.neuron.2006.05.025			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815337	Bronze, Green Accepted			2022-12-28	WOS:000239037700015
J	Collins, B; Blau, J				Collins, B; Blau, J			Keeping time without a Clock	NEURON			English	Editorial Material							RESTORES CIRCADIAN RHYTHMICITY; DROSOPHILA-CLOCK; MUTANT; DISRUPTION	The accepted dogma in circadian biology is that the transcription factor CLOCK lies at the heart of the molecular clock that drives behavioral and molecular rhythms. In this issue of Neuron, the generation of CLOCK-deficient mice with only subtle clock defects by DeBruyne et al. shakes up this view of the mammalian clock.	NYU, Dept Biol, New York, NY 10003 USA	New York University	Collins, B (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.				NIGMS NIH HHS [R01 GM063911] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063911] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allada R, 2003, EMBO J, V22, P3367, DOI 10.1093/emboj/cdg318; Collins BH, 2005, P NATL ACAD SCI USA, V102, P19021, DOI 10.1073/pnas.0505392102; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; King DP, 1997, GENETICS, V146, P1049; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Oster H, 2002, GENE DEV, V16, P2633, DOI 10.1101/gad.233702; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zhao J, 2003, CELL, V113, P755, DOI 10.1016/S0092-8674(03)00400-8	12	9	10	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 4	2006	50	3					348	350		10.1016/j.neuron.2006.04.022	http://dx.doi.org/10.1016/j.neuron.2006.04.022			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675389	Bronze			2022-12-28	WOS:000237726800004
J	Greer, JM; Wynshaw-Boris, A				Greer, JM; Wynshaw-Boris, A			Pten and the brain: Sizing up social interaction	NEURON			English	Editorial Material							AUTISM SPECTRUM DISORDERS	In a comprehensive set of experiments in this issue of Neuron, Kwon et al. demonstrate that conditional inactivation of Pten leads to behavioral abnormalities and neuropathological changes. Pten mutants displayed reduced social interaction and heightened responses to sensory stimuli. Additionally, neuronal hypertrophy, as well as macrocephaly was observed. Based on rare human mutations in PTEN and the PI3K pathway, the authors suggest they have produced a potential animal model of autism with macrocephaly.	Univ Calif San Diego, Dept Pediat, Sch Med, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Greer, JM (corresponding author), Univ Calif San Diego, Dept Pediat, Sch Med, La Jolla, CA 92093 USA.							Bauman ML, 2005, INT J DEV NEUROSCI, V23, P183, DOI 10.1016/j.ijdevneu.2004.09.006; Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; Hagerman RJ, 2006, J DEV BEHAV PEDIATR, V27, P63, DOI 10.1097/00004703-200602000-00012; Kwon CH, 2001, NAT GENET, V29, P404, DOI 10.1038/ng781; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; LaSalle JM, 2005, INT REV NEUROBIOL, V71, P131, DOI 10.1016/S0074-7742(05)71006-0; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Marui T, 2004, AM J MED GENET B, V131B, P43, DOI 10.1002/ajmg.b.20119; Moy SS, 2006, AM J MED GENET C, V142C, P40, DOI 10.1002/ajmg.c.30081; Penn HE, 2006, CHILD NEUROPSYCHOL, V12, P57, DOI 10.1080/09297040500253546; Wiznitzer M, 2004, J CHILD NEUROL, V19, P675, DOI 10.1177/08830738040190090701	12	12	15	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 4	2006	50	3					343	345		10.1016/j.neuron.2006.04.021	http://dx.doi.org/10.1016/j.neuron.2006.04.021			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675386	Bronze			2022-12-28	WOS:000237726800001
J	Nicholson, DA; Trana, R; Katz, Y; Kath, WL; Spruston, N; Geinisman, Y				Nicholson, Daniel A.; Trana, Rachel; Katz, Yael; Kath, William L.; Spruston, Nelson; Geinisman, Yuri			Distance-dependent differences in synapse number and AMPA receptor expression in hippocampal CA1 pyramidal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; NMDA RECEPTORS; POSTSYNAPTIC DENSITY; STRATUM-RADIATUM; RAT HIPPOCAMPUS; SPIKES; CELLS; LOCATION; RELEASE	The ability of synapses throughout the dendritic tree to influence neuronal output is crucial for information processing in the brain. Synaptic potentials attenuate dramatically, however, as they propagate along dendrites toward the soma. To examine whether excitatory axospinous synapses on CA1 pyramidal neurons compensate for their distance from the soma to counteract such dendritic filtering, we evaluated axospinous synapse number and receptor expression in three progressively distal regions: proximal and distal stratum radiatum (SR), and stratum lacunosum-moleculare (SLM). We found that the proportion of perforated synapses increases as a function of distance from the soma and that their AMPAR, but not NMDAR, expression is highest in distal SR and lowest in SLM. Computational models of pyramidal neurons derived from these results suggest that they arise from the compartment-specific use of conductance scaling in SR and dendritic spikes in SLM to minimize the influence of distance on synaptic efficacy.	Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University	Geinisman, Y (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.	yurig@northwestern.edu	Kath, William/B-6771-2009	Kath, William/0000-0003-3867-4783; Nicholson, Dan/0000-0002-1963-0569; Spruston, Nelson/0000-0003-3118-1636	NIA NIH HHS [AG20506, AG17139] Funding Source: Medline; NINDS NIH HHS [NS35180, NS46064] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035180, R01NS046064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG017139, R01AG017139, T32AG020506] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMARAL DG, 1995, RAT NERVOUS SYSTEM, P91; Andrasfalvy BK, 2001, J NEUROSCI, V21, P9151, DOI 10.1523/JNEUROSCI.21-23-09151.2001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Conti R, 2003, P NATL ACAD SCI USA, V100, P4885, DOI 10.1073/pnas.0630290100; Desmond NL, 1998, NEUROREPORT, V9, P857, DOI 10.1097/00001756-199803300-00017; Ehlers MD, 2002, TRENDS NEUROSCI, V25, P64, DOI 10.1016/S0166-2236(02)02061-1; Ganeshina O, 2004, NEUROSCIENCE, V125, P615, DOI 10.1016/j.neuroscience.2004.02.025; Ganeshina O, 2004, J COMP NEUROL, V468, P86, DOI 10.1002/cne.10950; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gasparini S, 2004, J NEUROSCI, V24, P11046, DOI 10.1523/JNEUROSCI.2520-04.2004; Geinisman Y, 2000, CEREB CORTEX, V10, P952, DOI 10.1093/cercor/10.10.952; Geinisman Y, 2004, NEUROBIOL AGING, V25, P407, DOI 10.1016/j.neurobiolaging.2003.12.001; Golding NL, 2005, J PHYSIOL-LONDON, V568, P69, DOI 10.1113/jphysiol.2005.086793; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; GREENOUGH WT, 1988, TRENDS NEUROSCI, V11, P142, DOI 10.1016/0166-2236(88)90139-7; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; ISHIZUKA N, 1995, J COMP NEUROL, V362, P17, DOI 10.1002/cne.903620103; Jarsky T, 2005, NAT NEUROSCI, V8, P1667, DOI 10.1038/nn1599; JONES DG, 1995, REV NEUROSCIENCE, V6, P177; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Li KW, 2004, J BIOL CHEM, V279, P987, DOI 10.1074/jbc.M303116200; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mackinnon P, 2000, AUSTRALAS J AGEING, V19, P3; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6; Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Nusser Z, 2000, CURR OPIN NEUROBIOL, V10, P337, DOI 10.1016/S0959-4388(00)00086-6; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Otmakhova NA, 2002, J NEUROSCI, V22, P1199, DOI 10.1523/JNEUROSCI.22-04-01199.2002; Ottersen OP, 1997, EUR J NEUROSCI, V9, P2219, DOI 10.1111/j.1460-9568.1997.tb01640.x; Peng JM, 2004, J BIOL CHEM, V279, P21003, DOI 10.1074/jbc.M400103200; PETERS A, 1969, Z ZELLFORSCH MIK ANA, V100, P487, DOI 10.1007/BF00344370; Petralia RS, 1999, METH MOL B, V128, P73; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Racca C, 2000, J NEUROSCI, V20, P2512; Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004; RALL W, 1977, HDB PHYSL NERVOUS SY, P3; Schiller J, 2001, CURR OPIN NEUROBIOL, V11, P343, DOI 10.1016/S0959-4388(00)00217-8; SMITH MA, 2003, J PHYSL, V528, P245; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Williams SR, 2003, TRENDS NEUROSCI, V26, P147, DOI 10.1016/S0166-2236(03)00035-3	59	139	139	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					431	442		10.1016/j.neuron.2006.03.022	http://dx.doi.org/10.1016/j.neuron.2006.03.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675397	Bronze			2022-12-28	WOS:000237726800012
J	Shen, WH; Wu, B; Zhang, ZJ; Dou, Y; Rao, ZR; Chen, YR; Duan, SM				Shen, Wanhua; Wu, Be; Zhang, Zhijun; Dou, Ying; Rao, Zhi-ren; Chen, Yi-ren; Duan, Shumin			Activity-induced rapid synaptic maturation mediated by presynaptic Cdc42 signaling	NEURON			English	Article							LONG-TERM-POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; BRAIN MYOSIN-V; NEUROTROPHIC FACTOR; ACTIN CYTOSKELETON; SILENT SYNAPSES; NEUROTRANSMITTER RELEASE; INHIBITORY SYNAPSES; RHO GTPASES; PLASTICITY	Maturation of presynaptic transmitter secretion machinery is a critical step in synaptogenesis. Here we report that a brief train of presynaptic action potentials rapidly converts early nonfunctional contacts between cultured hippocampal neurons into functional synapses by enhancing presynaptic glutamate release. The enhanced release was confirmed by a marked increase in the number of depolarization-induced FM4-64 puncta in the presynaptic axon. This rapid presynaptic maturation can be abolished by treatments that interfered with presynaptic BDNF and Cdc42 signaling or actin polymerization. Activation of Cdc42 by applying BDNF or bradykinin mimicked the effect of electrical activity in promoting synaptic maturation. Furthermore, activity-induced increase in presynaptic actin polymerization, as revealed by increased concentration of actin-YFP at axon boutons, was abolished by inhibiting BDNF and Cdc42 signaling. Thus, rapid presynaptic maturation induced by neuronal activity is mediated by presynaptic activation of the Cdc42 signaling pathway.	Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China; Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Neurobiol, Shanghai 200031, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai 200031, Peoples R China; Fourth Mil Med Univ, Inst Neurosci, Xian 710032, Peoples R China; Nantong Univ, Neurosci Res Inst, Nantong, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Air Force Military Medical University; Nantong University	Duan, SM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai 200031, Peoples R China.	shumin@ion.ac.cn	Wu, Bei/F-6659-2012; Shen, Wanhua/B-5554-2011	Shen, Wanhua/0000-0002-5178-9561				Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Antonova I, 2001, SCIENCE, V294, P1547, DOI 10.1126/science.1066273; Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Berninger B, 1999, LEARN MEMORY, V6, P232; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Casamayor A, 2002, CURR OPIN MICROBIOL, V5, P179, DOI 10.1016/S1369-5274(02)00300-4; Cerione RA, 2004, TRENDS CELL BIOL, V14, P127, DOI 10.1016/j.tcb.2004.01.008; Choi S, 2003, PHILOS T ROY SOC B, V358, P695, DOI 10.1098/rstb.2002.1249; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Doussau F, 2000, J BIOL CHEM, V275, P7764, DOI 10.1074/jbc.275.11.7764; Doussau F, 2000, BIOCHIMIE, V82, P353, DOI 10.1016/S0300-9084(00)00217-0; Du JL, 2004, NATURE, V429, P878, DOI 10.1038/nature02618; Duguid IC, 2004, NAT NEUROSCI, V7, P525, DOI 10.1038/nn1227; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Evans LL, 1998, J CELL SCI, V111, P2055; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Humeau Y, 2002, J NEUROSCI, V22, P7968; Itami C, 2003, P NATL ACAD SCI USA, V100, P13069, DOI 10.1073/pnas.2131948100; Kanai Y, 2003, EUR J PHARMACOL, V479, P237, DOI 10.1016/j.ejphar.2003.08.073; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Krueger SR, 2003, NEURON, V40, P945, DOI 10.1016/S0896-6273(03)00729-3; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Lee SH, 2000, CURR OPIN NEUROBIOL, V10, P125, DOI 10.1016/S0959-4388(99)00046-X; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Micheva KD, 2003, NAT NEUROSCI, V6, P925, DOI 10.1038/nn1114; Mozhayeva MG, 2002, J NEUROSCI, V22, P654, DOI 10.1523/JNEUROSCI.22-03-00654.2002; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Sankaranarayanan S, 2003, NAT NEUROSCI, V6, P127, DOI 10.1038/nn1002; Shapira M, 2003, NEURON, V38, P237, DOI 10.1016/S0896-6273(03)00207-1; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Udo H, 2005, NEURON, V45, P887, DOI 10.1016/j.neuron.2005.01.044; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Yuan XB, 2003, NAT CELL BIOL, V5, P38, DOI 10.1038/ncb895; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; Zhang HY, 2005, J NEUROSCI, V25, P3379, DOI 10.1523/JNEUROSCI.3553-04.2005; Zhang JM, 2003, NEURON, V40, P971, DOI 10.1016/S0896-6273(03)00717-7; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	57	99	105	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					401	414		10.1016/j.neuron.2006.03.017	http://dx.doi.org/10.1016/j.neuron.2006.03.017			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675395	Bronze			2022-12-28	WOS:000237726800010
J	Dragoi, G; Buzsaki, G				Dragoi, G; Buzsaki, G			Temporal encoding of place sequences by hippocampal cell assemblies	NEURON			English	Article							THETA-PHASE PRECESSION; NEURAL-NETWORK MODEL; PATH-INTEGRATION; PYRAMIDAL CELLS; ENTORHINAL CORTEX; MEMORY RETRIEVAL; MEDIAL SEPTUM; BEHAVING RAT; FREE-RECALL; EEG-THETA	Both episodic memory and spatial navigation require temporal encoding of the relationships between events or locations. In a linear maze, ordered spatial distances between sequential locations were represented by the temporal relations of hippocampal place cell pairs within cycles of theta oscillation in a compressed manner. Such correlations could arise due to spike "phase precession" of independent neurons driven by common theta pacemaker or as a result of temporal coordination among specific hippocampal cell assemblies. We found that temporal correlation between place cell pairs was stronger than predicted by a pacemaker drive of independent neurons, indicating a critical role for synaptic interactions and precise timing within and across cell assemblies in place sequence representation. CA1 and CA3 ensembles, identifying spatial locations, were active preferentially on opposite phases of theta cycles. These observations suggest that interleaving CA3 neuronal sequences bind CA1 assemblies representing overlapping past, present, and future locations into single episodes.	State Univ New Jersey, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT); Northwell Health	Dragoi, G (corresponding author), State Univ New Jersey, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	gdragoi@mit.edu; buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800				AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Ang CW, 2005, J NEUROSCI, V25, P9567, DOI 10.1523/JNEUROSCI.2992-05.2005; Bi GQ, 1999, NATURE, V401, P792, DOI 10.1038/44573; Brun VH, 2002, SCIENCE, V296, P2243, DOI 10.1126/science.1071089; Buzsaki G, 2005, HIPPOCAMPUS, V15, P827, DOI 10.1002/hipo.20113; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dragoi G, 1999, J NEUROSCI, V19, P6191, DOI 10.1523/JNEUROSCI.19-14-06191.1999; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fenton AA, 1998, P NATL ACAD SCI USA, V95, P3182, DOI 10.1073/pnas.95.6.3182; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fortin NJ, 2004, NATURE, V431, P188, DOI 10.1038/nature02853; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Gulyas AI, 2003, EUR J NEUROSCI, V17, P1861, DOI 10.1046/j.1460-9568.2003.02630.x; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Harris KD, 2002, NATURE, V417, P738, DOI 10.1038/nature00808; Hasselmo ME, 2002, NEURAL COMPUT, V14, P793, DOI 10.1162/089976602317318965; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jensen O, 2000, J NEUROPHYSIOL, V83, P2602, DOI 10.1152/jn.2000.83.5.2602; Kahana MJ, 1996, MEM COGNITION, V24, P103, DOI 10.3758/BF03197276; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kanerva P., 1988, SPARSE DISTRIBUTED M; Kocsis B, 1999, J NEUROSCI, V19, P6200, DOI 10.1523/JNEUROSCI.19-14-06200.1999; KONOPACKI J, 1988, BRAIN RES, V451, P33, DOI 10.1016/0006-8993(88)90746-9; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Lee I, 2004, NEURON, V42, P803, DOI 10.1016/j.neuron.2004.05.010; Leutgeb S, 2004, SCIENCE, V305, P1295, DOI 10.1126/science.1100265; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Nadasdy Z, 1999, J NEUROSCI, V19, P9497; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Redish AD, 1997, HIPPOCAMPUS, V7, P15; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Samsonovich AV, 2005, LEARN MEMORY, V12, P193, DOI 10.1101/lm.85205; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsodyks M, 1999, HIPPOCAMPUS, V9, P481, DOI 10.1002/(SICI)1098-1063(1999)9:4<481::AID-HIPO14>3.0.CO;2-S; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; TULVING E, 1969, SCIENCE, V164, P88, DOI 10.1126/science.164.3875.88; Tulving E., 1972, ORG MEMORY, P382, DOI DOI 10.1007/978-1-4419-0463-8_37; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wang XJ, 2002, J NEUROPHYSIOL, V87, P889, DOI 10.1152/jn.00135.2001; WILLIAMS TL, 1990, J NEUROPHYSIOL, V64, P862, DOI 10.1152/jn.1990.64.3.862; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yamaguchi Y, 2002, J NEUROPHYSIOL, V87, P2629, DOI 10.1152/jn.2002.87.6.2629; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	67	436	443	3	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					145	157		10.1016/j.neuron.2006.02.023	http://dx.doi.org/10.1016/j.neuron.2006.02.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600862	Bronze			2022-12-28	WOS:000236811300017
J	Tobler, PN; Fletcher, PC; Bullmore, ET; Schultz, W				Tobler, Philippe N.; Fletcher, Paul C.; Bullmore, Edward T.; Schultz, Wolfram			Learning-related human brain activations reflecting individual finances	NEURON			English	Article							ORBITOFRONTAL CORTEX; TEMPORAL PREDICTION; NEURONAL-ACTIVITY; REWARD; STRIATUM; IQ; REINFORCEMENT; MAGNITUDE; WEALTH; ERROR	A basic tenet of microeconomics suggests that the subjective value of financial gains decreases with increasing assets of individuals ("marginal utility"). Using concepts from learning theory and microeconomics, we assessed the capacity of financial rewards to elicit behavioral and neuronal changes during reward-predictive learning in participants with different financial backgrounds. Behavioral learning speed during both acquisition and extinction correlated negatively with the assets of the participants, irrespective of education and age. Correspondingly, response changes in midbrain and striatum measured with functional magnetic resonance imaging were slower during both acquisition and extinction with increasing assets and income of the participants. By contrast, asymptotic magnitudes of behavioral and neuronal responses after learning were unrelated to personal finances. The inverse relationship of behavioral and neuronal learning speed with personal finances is compatible with the general concept of decreasing marginal utility with increasing wealth.	Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3DY, England; Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Tobler, PN (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3DY, England.	pnt21@cam.ac.uk	Bullmore, Ed/C-1706-2012; Fletcher, Paul/F-5380-2011	Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Tobler, Philippe/0000-0002-4915-9448	Medical Research Council [G0001354B] Funding Source: researchfish; Medical Research Council [G0001354] Funding Source: Medline; Wellcome Trust [095495, 064351] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; BRUNER JS, 1947, J ABNORM SOC PSYCH, V42, P33, DOI 10.1037/h0058484; CAMPBELL PE, 1972, J COMP PHYSIOL PSYCH, V81, P360, DOI 10.1037/h0033530; Corlett PR, 2006, ARCH GEN PSYCHIAT, V63, P611, DOI 10.1001/archpsyc.63.6.611; Corlett PR, 2004, NEURON, V44, P877, DOI 10.1016/j.neuron.2004.11.022; Dickerson RE, 2006, INTELLIGENCE, V34, P291, DOI 10.1016/j.intell.2005.09.006; Fitzgerald F. Scott, 1926, ALL SAD YOUNG MEN; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; FURNHAM A, 1985, J SOC PSYCHOL, V125, P571, DOI 10.1080/00224545.1985.9712030; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kanazawa S, 2006, INTELLIGENCE, V34, P593, DOI 10.1016/j.intell.2006.04.003; KINTSCH W, 1962, J COMP PHYSIOL PSYCH, V55, P882, DOI 10.1037/h0043377; Kreps D. M, 1990, COURSE MICROECONOMIC; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McClure SM, 2003, NEURON, V38, P339, DOI 10.1016/S0896-6273(03)00154-5; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Pavlov IP, 1927, CONDITIONAL REFLEXES; Rescorla R.A., 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rescorla RA, 2002, J EXP PSYCHOL ANIM B, V28, P369, DOI 10.1037//0097-7403.28.4.369; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; TAMBS K, 1989, BEHAV GENET, V19, P209, DOI 10.1007/BF01065905; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1877, DOI 10.1152/jn.2000.83.4.1877; Tremblay L, 1998, J NEUROPHYSIOL, V80, P964, DOI 10.1152/jn.1998.80.2.964; WAGNER AR, 1964, J COMP PHYSIOL PSYCH, V58, P354, DOI 10.1037/h0048721	31	56	56	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					167	175		10.1016/j.neuron.2007.03.004	http://dx.doi.org/10.1016/j.neuron.2007.03.004			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	159EO	17408585	Bronze			2022-12-28	WOS:000245848400017
J	Panda, S				Panda, Satchidananda			Multiple photopigments entrain the mammalian circadian oscillator	NEURON			English	Editorial Material							GANGLION-CELLS; MELANOPSIN; RESPONSES; LIGHT; SENSITIVITY; RETINA; SYSTEM; COLOR; MOUSE; MICE	Circadian rhythms are entrained to the natural day:night cycle. Melanopsin expressed in retinal ganglion cells partially accounts for circadian photoentrainment. Dkhissi-Benyahya et al. demonstrate that medium wavelength opsin (MW-opsin) also plays an important role in the process. Furthermore, they develop a model explaining wavelength-dependent photoentrainment by melanopsin and MW-opsin.	Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Panda, S (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	satchin@salk.edu	Panda, Satchidananda/J-6891-2012					Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Doyle SE, 2006, P NATL ACAD SCI USA, V103, P10432, DOI 10.1073/pnas.0600934103; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Nathans J, 1999, NEURON, V24, P299, DOI 10.1016/S0896-6273(00)80845-4; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Ruby NF, 2002, SCIENCE, V298, P2211, DOI 10.1126/science.1076701; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0	15	21	27	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					619	621		10.1016/j.neuron.2007.02.017	http://dx.doi.org/10.1016/j.neuron.2007.02.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329200	Bronze			2022-12-28	WOS:000245127100001
J	Pouget, A; Bavelier, D				Pouget, Alexandre; Bavelier, Daphne			Paying attention to neurons with discriminating taste	NEURON			English	Editorial Material							VISUAL-SEARCH	Traditional theories of attention rely on the idea that when we search for a target in a visual display the brain boosts the activity of neurons optimally tuned for the target features. In this issue of Neuron, Navalpakkam and Itti take a computational approach to show that this strategy is actually very inefficient when the target is surrounded by distractors with similar features. Instead, the optimal strategy is to boost the activity of neurons that best discriminate between target and distractors, while essentially ignoring the neurons that respond best to the target.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Bavelier, Daphne/0000-0002-5904-1240; Pouget, Alexandre/0000-0003-3054-6365				COLTHEART M, 1971, PSYCHOL REV, V78, P114, DOI 10.1037/h0030639; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; Heinke D, 2005, STUD COGN, P273; Li ZP, 1999, P NATL ACAD SCI USA, V96, P10530, DOI 10.1073/pnas.96.18.10530; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Navalpakkam V, 2007, NEURON, V53, P605, DOI 10.1016/j.neuron.2007.01.018; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; Santhi N, 2004, VISION RES, V44, P1235, DOI 10.1016/j.visres.2003.11.011; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Wolfe JM, 2003, J EXP PSYCHOL HUMAN, V29, P483, DOI 10.1037/0096-1523.29.2.483	11	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					473	475		10.1016/j.neuron.2007.02.004	http://dx.doi.org/10.1016/j.neuron.2007.02.004			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296547	Bronze			2022-12-28	WOS:000245126900004
J	Federoff, HJ; Mhyre, TR				Federoff, Howard J.; Mhyre, Timothy R.			Reversal of misfolding: Prion disease behavioral and physiological impairments recover following postnatal neuronal deletion of the PrP gene	NEURON			English	Editorial Material							PROTEIN; PROPAGATION; SUPPRESSION	The prionoses are fatal neurodegenerative diseases caused by a pathogenic protein, PrP scrapie, that derives from misfolding of a normal form, PrPc. These diseases progress through stages. A new study by Mallucci et al. in this issue of Neuron shows that prion disease may be reversed in mice by selective removal of the gene in neurons after early physiological, cognitive, and pathological features have developed.	Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Aging & Dev Biol,Aab Inst Biomed Res, Rochester, NY 14642 USA; Univ Rochester, Sch Med & Dent, Dept Pathol & Lab Med, Ctr Aging & Dev Biol,Aab Inst Biomed Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Federoff, HJ (corresponding author), Univ Rochester, Sch Med & Dent, Dept Neurol, Ctr Aging & Dev Biol,Aab Inst Biomed Res, Box 645,601 Elmwood Ave, Rochester, NY 14642 USA.	howard_federoff@urmc.rochester.edu						Chiti Z, 2006, NEUROBIOL DIS, V22, P363, DOI 10.1016/j.nbd.2005.12.002; Donofrio G, 2005, J VIROL, V79, P8330, DOI 10.1128/JVI.79.13.8330-8338.2005; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; Golding MC, 2006, P NATL ACAD SCI USA, V103, P5285, DOI 10.1073/pnas.0600813103; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Pfeifer A, 2006, J CLIN INVEST, V116, P3204, DOI 10.1172/JCI29236; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457	10	3	3	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					315	317		10.1016/j.neuron.2007.01.013	http://dx.doi.org/10.1016/j.neuron.2007.01.013			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270727	Bronze			2022-12-28	WOS:000245126800001
J	Leiser, SC; Moxon, KA				Leiser, Steven C.; Moxon, Karen A.			Responses of trigeminal ganglion neurons during natural whisking behaviors in the awake rat	NEURON			English	Article							SIMULTANEOUSLY RECORDED NEURONS; 1ST-ORDER VIBRISSA AFFERENTS; CORTICAL REPRESENTATION; SOMATOSENSORY SYSTEM; ENSEMBLE ACTIVITY; RODENT WHISKING; RECEPTIVE-FIELD; SENSORY INPUT; MOTOR CORTEX; ACTIVE TOUCH	Rats use their whiskers to locate and discriminate tactile features of their environment. Mechanoreceptors surrounding each whisker encode and transmit sensory information from the environment to the brain via afferents whose cell bodies lie in the trigerninal ganglion (Vg). These afferents are classified as rapidly (RA) or slowly (SA) adapting by their response to stimulation. The activity of these cells in the awake behaving rat is yet unknown. Therefore, we developed a method to chronically record Vg neurons during natural whisking behaviors and found that all cells exhibited (1) no neuronal activity when the whiskers were not in motion, (2) increased activity when the rat whisked, with activity correlated to whisk frequency, and (3) robust increases in activity when the whiskers contacted an object. Moreover, we observed distinct differences in the firing rates between RA and SA cells, suggesting that they encode distinct aspects of stimuli in the awake rat.	Drexel Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA; Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University; Drexel University	Moxon, KA (corresponding author), Drexel Univ, Dept Neurobiol & Anat, Philadelphia, PA 19129 USA.	km57@drexel.edu	Moxon, Karen/K-7407-2012	Moxon, Karen/0000-0002-5790-097X; Leiser, Steven/0000-0002-4680-2012				Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4; Albarracin AL, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-42; Arabzadeh E, 2005, PLOS BIOL, V3, P155, DOI 10.1371/journal.pbio.0030017; Berg RW, 2003, J NEUROPHYSIOL, V90, P2950, DOI 10.1152/jn.00511.2003; Berg RW, 2003, J NEUROPHYSIOL, V89, P104, DOI 10.1152/jn.00600.2002; Bermejo R, 2005, SOMATOSENS MOT RES, V22, P213, DOI 10.1080/08990220500262505; Bermejo R, 2002, SOMATOSENS MOT RES, V19, P341, DOI 10.1080/0899022021000037809; Berryman LJ, 2006, J NEUROPHYSIOL, V96, P27, DOI 10.1152/jn.01190.2005; Blake DT, 1997, J NEUROPHYSIOL, V78, P2503, DOI 10.1152/jn.1997.78.5.2503; Blake DT, 1997, J NEUROSCI, V17, P7480; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Cahusac PMB, 2006, SYNAPSE, V59, P235, DOI 10.1002/syn.20236; CARVELL GE, 1995, SOMATOSENS MOT RES, V12, P1, DOI 10.3109/08990229509063138; CARVELL GE, 1990, J NEUROSCI, V10, P2638; Chapin JK, 1999, J NEUROSCI METH, V94, P121, DOI 10.1016/S0165-0270(99)00130-2; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; Derdikman Dori, 2006, Novartis Found Symp, V270, P4; Devilbiss DM, 2002, J NEUROSCI METH, V121, P181, DOI 10.1016/S0165-0270(02)00263-7; Diamond J, 1988, Prog Brain Res, V74, P51; Ebara S, 2002, J COMP NEUROL, V449, P103, DOI 10.1002/cne.10277; Fanselow EE, 2001, P NATL ACAD SCI USA, V98, P15330, DOI 10.1073/pnas.261273898; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Foffani G, 2004, J NEUROSCI, V24, P7266, DOI 10.1523/JNEUROSCI.2523-04.2004; Foffani G, 2004, J NEUROSCI METH, V135, P107, DOI 10.1016/j.jneumeth.2003.12.011; Friedman RM, 2002, J NEUROSCI, V22, P9556; Gamzu E, 2001, J NEUROSCI, V21, P7416, DOI 10.1523/JNEUROSCI.21-18-07416.2001; Gao PH, 2001, J NEUROSCI, V21, P5374, DOI 10.1523/JNEUROSCI.21-14-05374.2001; Garabedian CE, 2003, J NEUROPHYSIOL, V90, P1379, DOI 10.1152/jn.01158.2002; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; GIBSON JM, 1983, SOMATOSENS RES, V1, P95, DOI 10.3109/07367228309144543; GIBSON JM, 1983, SOMATOSENS RES, V1, P51, DOI 10.3109/07367228309144540; Goodwin AW, 2004, ANNU REV NEUROSCI, V27, P53, DOI 10.1146/annurev.neuro.26.041002.131032; GOTTSCHALDT KM, 1981, SCIENCE, V214, P183, DOI 10.1126/science.7280690; Haeberle H, 2004, P NATL ACAD SCI USA, V101, P14503, DOI 10.1073/pnas.0406308101; Hartmann MJ, 2003, J NEUROSCI, V23, P6510; Harvey MA, 2001, SOMATOSENS MOT RES, V18, P211; Hipp J, 2006, J NEUROPHYSIOL, V95, P1792, DOI 10.1152/jn.01104.2005; Hitchcock IS, 2004, NEUROSCI LETT, V362, P196, DOI 10.1016/j.neulet.2004.02.071; HUBEL DH, 1957, SCIENCE, V125, P549, DOI 10.1126/science.125.3247.549; Johnson KO, 2000, NEURON, V26, P563, DOI 10.1016/S0896-6273(00)81193-9; Johnson KO, 2001, CURR OPIN NEUROBIOL, V11, P455, DOI 10.1016/S0959-4388(00)00234-8; Jones LM, 2004, J NEUROPHYSIOL, V92, P665, DOI 10.1152/jn.00031.2004; Jones LM, 2004, SCIENCE, V304, P1986, DOI 10.1126/science.1097779; Kao T, 2006, BRAIN RES, V1112, P159, DOI 10.1016/j.brainres.2006.07.020; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Knutsen PM, 2006, J NEUROSCI, V26, P8451, DOI 10.1523/JNEUROSCI.1516-06.2006; Knutsen PM, 2005, J NEUROPHYSIOL, V93, P2294, DOI 10.1152/jn.00718.2004; KYRIAZI HT, 1994, J NEUROPHYSIOL, V72, P392, DOI 10.1152/jn.1994.72.1.392; Leiser SC, 2006, J NEUROPHYSIOL, V95, P3129, DOI 10.1152/jn.00157.2005; LICHTENSTEIN SH, 1990, SOMATOSENS MOT RES, V7, P47, DOI 10.3109/08990229009144697; Mehta SB, 2004, NEURON, V41, P181, DOI 10.1016/S0896-6273(04)00002-9; Minnery BS, 2003, J NEUROPHYSIOL, V89, P40, DOI 10.1152/jn.00272.2002; MOSCONI TM, 1993, J COMP NEUROL, V328, P222; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; MOXON KA, 2000, NEURAL PROSTHESES RE; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; NICOLELIS MAL, 1995, SCIENCE, V268, P1353, DOI 10.1126/science.7761855; Rajan R, 2006, J NEUROSCI METH, V157, P103, DOI 10.1016/j.jneumeth.2006.04.008; RICE FL, 1986, J COMP NEUROL, V252, P157; Sachdev RNS, 2002, J NEUROPHYSIOL, V87, P1440, DOI 10.1152/jn.00539.2001; Sachdev RNS, 2001, SOMATOSENS MOT RES, V18, P91; SEMBA K, 1986, J COMP NEUROL, V247, P144, DOI 10.1002/cne.902470203; Shetty P, 2003, SOMATOSENS MOT RES, V20, P233, DOI 10.1080/08990220310001622951; Shoykhet M, 2000, SOMATOSENS MOT RES, V17, P171; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; Szwed M, 2006, J NEUROPHYSIOL, V95, P791, DOI 10.1152/jn.00571.2005; Szwed M, 2003, NEURON, V40, P621, DOI 10.1016/S0896-6273(03)00671-8; Tachibana T, 2005, ARCH HISTOL CYTOL, V68, P383, DOI 10.1679/aohc.68.383; WAITE PME, 1992, J COMP NEUROL, V322, P233, DOI 10.1002/cne.903220209; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; ZUCKER E, 1969, BRAIN RES, V12, P138, DOI 10.1016/0006-8993(69)90061-4	73	93	93	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					117	133		10.1016/j.neuron.2006.10.036	http://dx.doi.org/10.1016/j.neuron.2006.10.036			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196535	Bronze			2022-12-28	WOS:000245126500013
J	Hsieh, H; Boehm, J; Sato, C; Iwatsubo, T; Tomita, T; Sisodia, S; Malinow, R				Hsieh, Helen; Boehm, Jannic; Sato, Chihiro; Iwatsubo, Takeshi; Tomita, Taisuke; Sisodia, Sangram; Malinow, Roberto			AMPAR removal underlies A beta-induced synaptic depression and dendritic spine loss	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; LONG-TERM DEPRESSION; ALZHEIMERS-DISEASE; RECEPTOR TRAFFICKING; TRANSGENIC MICE; GLUTAMATE RECEPTORS; IN-VIVO; RAPID REDISTRIBUTION; MOLECULAR-MECHANISMS; HIPPOCAMPAL SLICES	Beta amyloid (A beta), a peptide generated from the amyloid precursor protein (APP) by neurons, is widely believed to underlie the pathophysiology of Alzheimer's disease. Recent studies indicate that this peptide can drive loss of surface AMPA and NMDA type glutamate receptors. We now show that A beta employs signaling pathways of long-term depression (LTD) to drive endocytosis of synaptic AMPA receptors. Synaptic removal of AMPA receptors is necessary and sufficient to produce loss of dendritic spines and synaptic NIVIDA responses. Our studies indicate the central role played by AMPA receptor trafficking in A beta-induced modification of synaptic structure and function.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol, Stony Brook, NY 11794 USA; SUNY Stony Brook, Behav Grad Program, Stony Brook, NY 11794 USA; Univ Tokyo, Dept Neuropathol & Neurosci, Grad Sch Pharmaceut Sci, Tokyo, Japan; Univ Chicago, Ctr Mol Neurobiol, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Tokyo; University of Chicago	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Boehm, Jannic/AAK-8882-2020; Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Sato, Chihiro/0000-0002-7639-8727	NIA NIH HHS [R01 AG032132-15, AG021494, R01 AG021494, R01 AG032132, R01 AG032132-14] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NIMH NIH HHS [R01 MH049159-09, R01 MH049159, R37 MH049159] Funding Source: Medline; NINDS NIH HHS [R01 NS032827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH049159, R01MH049159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032132, R01AG021494] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carter TL, 2004, EXP NEUROL, V187, P299, DOI 10.1016/j.expneurol.2003.12.010; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cirrito JR, 2005, NEURON, V48, P913, DOI 10.1016/j.neuron.2005.10.028; CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; EINSTEIN G, 1994, J NEUROSCI, V14, P5077; Freir DB, 2001, J NEUROPHYSIOL, V85, P708, DOI 10.1152/jn.2001.85.2.708; Giacchino J, 2000, BRAIN RES, V876, P185, DOI 10.1016/S0006-8993(00)02615-9; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Kim JH, 2001, J NEUROSCI, V21, P1327; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Larson J, 1999, BRAIN RES, V840, P23, DOI 10.1016/S0006-8993(99)01698-4; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Rodrigues SM, 2004, NEURON, V44, P75, DOI 10.1016/j.neuron.2004.09.014; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Rush AM, 2002, J NEUROSCI, V22, P6121; Schnell E, 2002, P NATL ACAD SCI USA, V99, P13902, DOI 10.1073/pnas.172511199; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder EM, 2001, NAT NEUROSCI, V4, P1079, DOI 10.1038/nn746; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thorns V, 1997, ACTA NEUROPATHOL, V94, P539, DOI 10.1007/s004010050748; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tyszkiewicz JP, 2005, J NEUROPHYSIOL, V93, P3102, DOI 10.1152/jn.00939.2004; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; Whitmarsh AJ, 1997, MOL CELL BIOL, V17, P2360, DOI 10.1128/MCB.17.5.2360; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xiao MY, 2001, NEUROPHARMACOLOGY, V41, P664, DOI 10.1016/S0028-3908(01)00134-4; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	83	794	835	0	71	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					831	843		10.1016/j.neuron.2006.10.035	http://dx.doi.org/10.1016/j.neuron.2006.10.035			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145504	Green Accepted, Bronze			2022-12-28	WOS:000242856400011
J	Blumenfeld, B; Preminger, S; Sagi, D; Tsodyks, M				Blumenfeld, Barak; Preminger, Son; Sagi, Dov; Tsodyks, Misha			Dynamics of memory representations in networks with novelty-facilitated synaptic plasticity	NEURON			English	Article							NEURAL-NETWORKS; HIPPOCAMPAL-FORMATION; NEURONAL CORRELATE; TERM-MEMORY; INFORMATION; SYSTEMS; CORTEX; MODEL; TRANSMISSION; MODULATION	The ability to associate some stimuli while differentiating between others is an essential characteristic of biological memory. Theoretical models identify memories as attractors of neural network activity, with learning based on Hebb-like synaptic modifications. Our analysis shows that when network inputs are correlated, this mechanism results in overassociations, even up to several memories "merging" into one. To counteract this tendency, we introduce a learning mechanism that involves novelty-facilitated modifications, accentuating synaptic changes proportionally to the difference between network input and stored memories. This mechanism introduces a dependency of synaptic modifications on previously acquired memories, enabling a wide spectrum of memory associations, ranging from absolute discrimination to complete merging. The model predicts that memory representations should be sensitive to learning order, consistent with recent psychophysical studies of face recognition and electrophysiological experiments on hippocampal place cells. The proposed mechanism is compatible with a recent biological model of novelty-facilitated learning in hippocampal circuitry.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Tsodyks, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	misha@weizmann.ac.il	tsodyks, misha/J-4430-2013; Sagi, Dov/A-5454-2008	Sagi, Dov/0000-0002-8446-9230; Tsodyks, Misha/0000-0002-5661-4349				Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; AMIT DJ, 1985, PHYS REV A, V32, P1007, DOI 10.1103/PhysRevA.32.1007; AMIT DJ, 1985, PHYS REV LETT, V55, P1530, DOI 10.1103/PhysRevLett.55.1530; AMIT DJ, 1995, BEHAV BRAIN SCI, V18, P617, DOI 10.1017/S0140525X00040164; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Blumenfeld B, 2006, J COMPUT NEUROSCI, V20, P219, DOI 10.1007/s10827-006-6307-y; Brunel N., 2005, METHODS MODELS NEURO, VLXXX, P407; Carpenter G.A., 2003, HDB BRAIN THEORY NEU, P87, DOI DOI 10.1016/J.NEUNET.2012.09.017]; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; Erickson CA, 1999, J NEUROSCI, V19, P10404; Ermentrout B, 1998, REP PROG PHYS, V61, P353, DOI 10.1088/0034-4885/61/4/002; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; FUSTER JM, 1971, NEURON, V14, P477; Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X; HASSELMO ME, 1995, J NEUROSCI, V15, P5249; HASSELMO ME, 1994, J NEUROSCI, V14, P3898; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hinton GE, 2002, NEURAL COMPUT, V14, P1771, DOI 10.1162/089976602760128018; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Movellan J. R, 1991, P 1990 CONN MOD SUMM, P10; Nyberg L, 2005, CURR OPIN NEUROL, V18, P424, DOI 10.1097/01.wco.0000168080.99730.1c; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Preminger S, 2005, PERCEPTION, V34, P14; Ranganath C, 2003, NAT REV NEUROSCI, V4, P193, DOI 10.1038/nrn1052; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Seung HS, 1996, P NATL ACAD SCI USA, V93, P13339, DOI 10.1073/pnas.93.23.13339; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; TREVES A, 1990, PHYS REV A, V42, P2418, DOI 10.1103/PhysRevA.42.2418; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; TSODYKS MV, 1988, EUROPHYS LETT, V6, P101, DOI 10.1209/0295-5075/6/2/002; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905	46	63	63	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					383	394		10.1016/j.neuron.2006.08.016	http://dx.doi.org/10.1016/j.neuron.2006.08.016			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046699	Green Submitted, Bronze			2022-12-28	WOS:000241799900017
J	Uhhaas, PJ; Singer, W				Uhhaas, Peter J.; Singer, Wolf			Neural synchrony in brain disorders: Relevance for cognitive dysfunctions and pathophysiology	NEURON			English	Review							HIGH-FREQUENCY OSCILLATIONS; HIGH-FUNCTIONING AUTISM; HIPPOCAMPUS IN-VITRO; WHITE-MATTER CHANGES; WORKING-MEMORY TASK; CAT VISUAL-CORTEX; ALZHEIMERS-DISEASE; EEG SYNCHRONIZATION; GAMMA ACTIVITY; GAP-JUNCTIONS	Following the discovery of context-dependent synchronization of oscillatory neuronal responses in the visual system, novel methods of time series analysis have been developed for the examination of task- and performance-related oscillatory activity and its synchronization. Studies employing these advanced techniques revealed that synchronization of oscillatory responses in the beta- and gamma-band is involved in a variety of cognitive functions, such as perceptual grouping, attention-dependent stimulus selection, routing of signals across distributed cortical networks, sensory-motor integration, working memory, and perceptual awareness. Here, we review evidence that certain brain disorders, such as schizophrenia, epilepsy, autism, Alzheimer's disease, and Parkinson's are associated with abnormal neural synchronization. The data suggest close correlations between abnormalities in neuronal synchronization and cognitive dysfunctions, emphasizing the importance of temporal coordination. Thus, focused search for abnormalities in temporal patterning may be of considerable clinical relevance.	Max Planck Inst Brain Res, Dept Neurophysiol, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Psychiat, Lab Neurophysiol & Neuroimaging, D-60528 Frankfurt, Germany; Goethe Univ Frankfurt, Frankfurt Inst Adv Studies, D-60438 Frankfurt, Germany	Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt	Uhhaas, PJ (corresponding author), Max Planck Inst Brain Res, Dept Neurophysiol, Deutschordenstr 46, D-60528 Frankfurt, Germany.	uhlhaas@mpih-frankfurt.mpg.de	Uhlhaas, Peter/G-4310-2018; Uhlhaas, Peter/C-4496-2012; Singer, Wolf/D-6874-2012	Uhlhaas, Peter/0000-0002-0892-2224; 				ABELES A, 1991, CORTICONICS NEURAL C; ALLEN PJ, 1992, ELECTROEN CLIN NEURO, V82, P155, DOI 10.1016/0013-4694(92)90160-J; Andrew C, 1996, ELECTROEN CLIN NEURO, V98, P144, DOI 10.1016/0013-4694(95)00228-6; APA, 2000, DIAGN STAT MAN MENT; Babiloni C, 2004, EUR J NEUROSCI, V19, P2583, DOI 10.1111/j.0953-816X.2004.03333.x; Belmonte MK, 2004, J NEUROSCI, V24, P9228, DOI 10.1523/JNEUROSCI.3340-04.2004; BERTRAND O, 1994, IEEE T BIO-MED ENG, V41, P77, DOI 10.1109/10.277274; Bokde ALW, 2006, BRAIN, V129, P1113, DOI 10.1093/brain/awl051; BOROUD T, 2005, BASAL GANGLIA, V8, P3; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bragin A, 1999, EPILEPSIA, V40, P127, DOI 10.1111/j.1528-1157.1999.tb02065.x; BRESSLER SL, 1993, NATURE, V366, P153, DOI 10.1038/366153a0; Brock J, 2002, DEV PSYCHOPATHOL, V14, P209, DOI 10.1017/S0954579402002018; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Brown P, 2001, J NEUROSCI, V21, P1033, DOI 10.1523/JNEUROSCI.21-03-01033.2001; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Carlen PL, 2000, BRAIN RES REV, V32, P235, DOI 10.1016/S0165-0173(99)00084-3; Carlsson ML, 1998, J NEURAL TRANSM, V105, P525, DOI 10.1007/s007020050076; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Cover KS, 2006, NEUROIMAGE, V29, P783, DOI 10.1016/j.neuroimage.2005.08.048; de la Roque AD, 2005, EUR RADIOL, V15, P279, DOI 10.1007/s00330-004-2578-8; Delbeuck X, 2003, NEUROPSYCHOL REV, V13, P79, DOI 10.1023/A:1023832305702; DiCicco-Bloom E, 2006, J NEUROSCI, V26, P6897, DOI 10.1523/JNEUROSCI.1712-06.2006; Dierks T, 1999, NEURON, V22, P615, DOI 10.1016/S0896-6273(00)80715-1; Dominguez LG, 2005, J NEUROSCI, V25, P8077, DOI 10.1523/JNEUROSCI.1046-05.2005; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Ebert U, 1998, EUR J CLIN INVEST, V28, P944; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; FISHER RS, 1992, J CLIN NEUROPHYSIOL, V9, P441; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fries P, 2001, SCIENCE, V291, P1560, DOI 10.1126/science.1055465; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 1999, ACTA PSYCHIAT SCAND, V99, P68, DOI 10.1111/j.1600-0447.1999.tb05985.x; FRITH U, 1994, COGNITION, V50, P115, DOI 10.1016/0010-0277(94)90024-8; Fukuda T, 2006, J NEUROSCI, V26, P3434, DOI 10.1523/JNEUROSCI.4076-05.2006; Gajda Z, 2003, EPILEPSIA, V44, P1596, DOI 10.1111/j.0013-9580.2003.25803.x; Gallinat J, 2004, CLIN NEUROPHYSIOL, V115, P1863, DOI 10.1016/j.clinph.2004.03.013; Grady CL, 2001, BRAIN, V124, P739, DOI 10.1093/brain/124.4.739; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Green MF, 2003, BIOL PSYCHIAT, V53, P1113, DOI 10.1016/S0006-3223(02)01813-9; Green MF, 1996, AM J PSYCHIAT, V153, P321; Grice SJ, 2001, NEUROREPORT, V12, P2697, DOI 10.1097/00001756-200108280-00021; Haig AR, 2000, CLIN NEUROPHYSIOL, V111, P1461, DOI 10.1016/S1388-2457(00)00347-3; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Herrmann CS, 2004, TRENDS COGN SCI, V8, P347, DOI 10.1016/j.tics.2004.06.006; Hill EL, 2003, PHILOS T R SOC B, V358, P281, DOI 10.1098/rstb.2002.1209; HOF PR, 1999, ALZHEIMER DIS, P197; Honey GD, 2005, BRAIN, V128, P2597, DOI 10.1093/brain/awh632; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; Hubl D, 2004, ARCH GEN PSYCHIAT, V61, P658, DOI 10.1001/archpsyc.61.7.658; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; Hussman JP, 2001, J AUTISM DEV DISORD, V31, P247, DOI 10.1023/A:1010715619091; Hutchison WD, 2004, J NEUROSCI, V24, P9240, DOI 10.1523/JNEUROSCI.3366-04.2004; Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8; Jeong JS, 2004, CLIN NEUROPHYSIOL, V115, P1490, DOI 10.1016/j.clinph.2004.01.001; Jirsch JD, 2006, BRAIN, V129, P1593, DOI 10.1093/brain/awl085; JOHN ER, 1988, SCIENCE, V239, P162, DOI 10.1126/science.3336779; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; JUST MA, 2006, IN PRESS CEREB CORTE; Khalilov I, 2005, NEURON, V48, P787, DOI 10.1016/j.neuron.2005.09.026; Koenig T, 2005, NEUROBIOL AGING, V26, P165, DOI 10.1016/j.neurobiolaging.2004.03.008; Kopell N, 2000, P NATL ACAD SCI USA, V97, P1867, DOI 10.1073/pnas.97.4.1867; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Krishnan GP, 2005, CLIN NEUROPHYSIOL, V116, P614, DOI 10.1016/j.clinph.2004.09.016; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; KUBICKI M, 2006, IN PRESS J PSYCHIAT; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Lee SH, 2006, SCHIZOPHR RES, V83, P111, DOI 10.1016/j.schres.2005.11.025; Levitt P, 2005, EPILEPSIA, V46, P22, DOI 10.1111/j.1528-1167.2005.00305.x; Levy R, 2000, J NEUROSCI, V20, P7766; Lewis DA, 2005, NAT REV NEUROSCI, V6, P312, DOI 10.1038/nrn1648; Llinas RR, 2006, J NEUROPHYSIOL, V95, P3297, DOI 10.1152/jn.00166.2006; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Marrosu F, 2006, EPILEPSIA, V47, P489, DOI 10.1111/j.1528-1167.2006.00456.x; McCaffery P, 2005, PROG NEUROBIOL, V77, P38, DOI 10.1016/j.pneurobio.2005.10.005; MCCORMICK DA, 1989, P NATL ACAD SCI USA, V86, P8098, DOI 10.1073/pnas.86.20.8098; Medina D, 2006, NEUROBIOL AGING, V27, P663, DOI 10.1016/j.neurobiolaging.2005.03.026; Medvedev AV, 2002, BRAIN RES BULL, V58, P115, DOI 10.1016/S0361-9230(02)00768-2; Meeren HKM, 2002, J NEUROSCI, V22, P1480, DOI 10.1523/JNEUROSCI.22-04-01480.2002; Meyer-Lindenberg AS, 2005, ARCH GEN PSYCHIAT, V62, P379, DOI 10.1001/archpsyc.62.4.379; Minshew N J, 1997, J Int Neuropsychol Soc, V3, P303; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; MITZDORF U, 1979, J COMP NEUROL, V187, P71, DOI 10.1002/cne.901870105; Moghaddam B, 2003, NEURON, V40, P881, DOI 10.1016/S0896-6273(03)00757-8; Motamedi G, 2003, EPILEPSY BEHAV, V4, pS25, DOI 10.1016/j.yebeh.2003.07.004; MURPHY VN, 1996, J NEUROPHYSIOL, V76, P3949; Naggara O, 2006, PSYCHIAT RES-NEUROIM, V146, P243, DOI 10.1016/j.pscychresns.2006.01.005; Nase G, 2003, J NEUROPHYSIOL, V90, P1115, DOI 10.1152/jn.00480.2002; Netoff TI, 2002, J NEUROSCI, V22, P7297; NIEDERMEYER E, 2005, ELECTROENCEPHALOGRAP, P508; Niessing J, 2005, SCIENCE, V309, P948, DOI 10.1126/science.1110948; Nilsen KE, 2006, EPILEPSIA, V47, P1169, DOI 10.1111/j.1528-1167.2006.00540.x; Pantel J, 2004, NEUROSCI LETT, V361, P17, DOI 10.1016/j.neulet.2003.12.072; PEARSON RCA, 1985, P NATL ACAD SCI USA, V82, P4531, DOI 10.1073/pnas.82.13.4531; Penfield W, 1954, EPILEPSY FUNCTIONAL; Phillips WA, 2003, BEHAV BRAIN SCI, V26, P65, DOI 10.1017/S0140525X03000025; Pijnenburg YAL, 2004, CLIN NEUROPHYSIOL, V115, P1332, DOI 10.1016/j.clinph.2003.12.029; Polleux F, 2004, MENT RETARD DEV D R, V10, P303, DOI 10.1002/mrdd.20044; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; RAMPP S, 2006, IN PRESS CLIN NEUROP; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Rodriguez R, 2004, J NEUROSCI, V24, P10369, DOI 10.1523/JNEUROSCI.1839-04.2004; Roelfsema PR, 1997, NATURE, V385, P157, DOI 10.1038/385157a0; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sarter M, 2005, SCHIZOPHRENIA BULL, V31, P117, DOI 10.1093/schbul/sbi006; Schlosser R, 2003, NEUROIMAGE, V19, P751, DOI 10.1016/S1053-8119(03)00106-X; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Schoffelen JM, 2005, SCIENCE, V308, P111, DOI 10.1126/science.1107027; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Sharott A, 2005, EUR J NEUROSCI, V21, P1413, DOI 10.1111/j.1460-9568.2005.03973.x; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Slewa-Younan S, 2004, AM J PSYCHIAT, V161, P1595, DOI 10.1176/appi.ajp.161.9.1595; SNEAD OC, 1992, EUR J PHARMACOL, V213, P343, DOI 10.1016/0014-2999(92)90623-C; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Spencer KM, 2004, P NATL ACAD SCI USA, V101, P17288, DOI 10.1073/pnas.0406074101; Spencer KM, 2003, J NEUROSCI, V23, P7407; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P708, DOI 10.1016/j.clinph.2004.09.022; Stam CJ, 2003, ACTA NEUROL SCAND, V108, P90, DOI 10.1034/j.1600-0404.2003.02067.x; STAM CJ, 2006, IN PRESS CEREB CORTE; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; STERIADE M, 1991, P NATL ACAD SCI USA, V88, P4396, DOI 10.1073/pnas.88.10.4396; Steriade M, 2005, ELECTROENCEPHALOGRAP, P505; Steriade M., 2003, NEURONAL SUBSTRATES; Sterman MB, 2006, APPL PSYCHOPHYS BIOF, V31, P21, DOI 10.1007/s10484-006-9002-x; Stern EA, 2004, J NEUROSCI, V24, P4535, DOI 10.1523/JNEUROSCI.0462-04.2004; Symond MB, 2005, AM J PSYCHIAT, V162, P459, DOI 10.1176/appi.ajp.162.3.459; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Timmermann L, 2003, BRAIN, V126, P199, DOI 10.1093/brain/awg022; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Uhlhaas PJ, 2006, J NEUROSCI, V26, P8168, DOI 10.1523/JNEUROSCI.2002-06.2006; Uhlhaas PJ, 2005, PSYCHOL BULL, V131, P618, DOI 10.1037/0033-2909.131.4.618; Ulrich D, 1996, P NATL ACAD SCI USA, V93, P13245, DOI 10.1073/pnas.93.23.13245; van Putten MJAM, 2003, J CLIN NEUROPHYSIOL, V20, P320, DOI 10.1097/00004691-200309000-00004; Van Quyen ML, 2003, EPILEPSIA, V44, P30; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Waites AB, 2006, ANN NEUROL, V59, P335, DOI 10.1002/ana.20733; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wespatat V, 2004, J NEUROSCI, V24, P9067, DOI 10.1523/JNEUROSCI.2221-04.2004; WILSON TW, 2006, IN PRESS BIOL PSYCHI; Wynn JK, 2005, AM J PSYCHIAT, V162, P2330, DOI 10.1176/appi.ajp.162.12.2330; Zeitler M, 2006, NEURAL COMPUT, V18, P2256, DOI 10.1162/neco.2006.18.9.2256	155	1380	1406	13	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					155	168		10.1016/j.neuron.2006.09.020	http://dx.doi.org/10.1016/j.neuron.2006.09.020			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	096WS	17015233	Bronze			2022-12-28	WOS:000241408100011
J	Riven, I; Iwanir, S; Reuveny, E				Riven, Inbal; Iwanir, Shachar; Reuveny, Eitan			GIRK channel activation involves a local rearrangement of a preformed G protein channel complex	NEURON			English	Article							BETA-GAMMA-SUBUNITS; RECTIFYING K+ CHANNELS; HETEROTRIMERIC G-PROTEINS; RECTIFIER POTASSIUM CHANNELS; C-TERMINAL DOMAIN; LIVING CELLS; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; PLASMA-MEMBRANE; ENERGY-TRANSFER	G protein-coupled signaling is one of the major mechanisms for controlling cellular excitability. One of the main targets for this control at postsynaptic membranes is the G protein-coupled potassium channels (GIRK/Kir3), which generate slow inhibitory postsynaptic potentials following the activation of Pertussis toxin-sensitive G protein-coupled receptors. Using total internal reflection fluorescence (TIRF) microscopy combined with fluorescence resonance energy transfer (FRET), in intact cells, we provide evidence for the existence of a trimeric G protein-channel complex at rest. We show that activation of the channel via the receptor induces a local conformational switch of the G protein to induce channel opening. The presence of such a complex thus provides the means for a precise temporal and highly selective activation of the channel, which is required for fine tuning of neuronal excitability.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il						AXELROD D, 1989, METHOD CELL BIOL, V30, P245; Bauer PH, 1998, J BIOL CHEM, V273, P9465, DOI 10.1074/jbc.273.16.9465; BAUER PH, 1992, NATURE, V358, P73, DOI 10.1038/358073a0; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Benians A, 2005, J BIOL CHEM, V280, P13383, DOI 10.1074/jbc.M410163200; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Clancy SM, 2005, MOL CELL NEUROSCI, V28, P375, DOI 10.1016/j.mcn.2004.10.009; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; Dowal L, 2001, BIOCHEMISTRY-US, V40, P414, DOI 10.1021/bi001923+; Finley M, 2004, J PHYSIOL-LONDON, V555, P643, DOI 10.1113/jphysiol.2003.056101; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fu HW, 1999, RECENT PROG HORM RES, V54, P315; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gaudet R, 1999, MOL CELL, V3, P649, DOI 10.1016/S1097-2765(00)80358-5; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hepler JR, 1999, TRENDS PHARMACOL SCI, V20, P376, DOI 10.1016/S0165-6147(99)01369-3; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Ivanina T, 2004, J BIOL CHEM, V279, P17260, DOI 10.1074/jbc.M313425200; Ivanina T, 2003, J BIOL CHEM, V278, P29174, DOI 10.1074/jbc.M304518200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lei QB, 2003, MOL CELLS, V15, P1; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; Leifert WR, 2006, ANAL BIOCHEM, V355, P201, DOI 10.1016/j.ab.2006.04.042; LIU J, 1995, P NATL ACAD SCI USA, V92, P11642, DOI 10.1073/pnas.92.25.11642; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Mirshahi T, 2002, J BIOL CHEM, V277, P36345, DOI 10.1074/jbc.M205359200; Mirshahi T, 2002, J BIOL CHEM, V277, P7348, DOI 10.1074/jbc.M109999200; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Mullner C, 2000, J GEN PHYSIOL, V115, P547, DOI 10.1085/jgp.115.5.547; Nishida M, 2002, CELL, V111, P957, DOI 10.1016/S0092-8674(02)01227-8; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Rebois RV, 2006, J CELL SCI, V119, P2807, DOI 10.1242/jcs.03021; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Rishal I, 2005, J BIOL CHEM, V280, P16685, DOI 10.1074/jbc.M412196200; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Roy AA, 2003, MOL PHARMACOL, V64, P587, DOI 10.1124/mol.64.3.587; Sadja R, 2003, NEURON, V39, P9, DOI 10.1016/S0896-6273(03)00402-1; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sodickson DL, 1996, J NEUROSCI, V16, P6374; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; Takida S, 2003, J BIOL CHEM, V278, P17284, DOI 10.1074/jbc.M213239200; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Zhang QL, 2002, J PHYSIOL-LONDON, V545, P355, DOI 10.1113/jphysiol.2002.032151; Zhang Y, 1999, TUMOR TARGET, V4, P158; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085	68	87	90	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 7	2006	51	5					561	573		10.1016/j.neuron.2006.08.017	http://dx.doi.org/10.1016/j.neuron.2006.08.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950155	Bronze			2022-12-28	WOS:000240623400006
J	Awasaki, T; Tatsumi, R; Takahashi, K; Arai, K; Nakanishi, Y; Ueda, R; Ito, K				Awasaki, T; Tatsumi, R; Takahashi, K; Arai, K; Nakanishi, Y; Ueda, R; Ito, K			Essential role of the apoptotic cell engulfment genes draper and ced-6 in programmed axon pruning during Drosophila metamorphosis	NEURON			English	Article							UBIQUITIN-PROTEASOME SYSTEM; C-ELEGANS; CAENORHABDITIS-ELEGANS; WALLERIAN DEGENERATION; MUSHROOM BODIES; CORPSE ENGULFMENT; PERIPHERAL GLIA; DEATH; PHAGOCYTOSIS; PROTEIN	Axon pruning is a common phenomenon in neural circuit development. Previous studies demonstrate that the engulfing action of glial cells is essential in this process. The underlying molecular mechanisms, however, remain unknown. We show that draper(drpr) and ced-6, which are essential for the clearance of apoptotic cells in C. elegans, function in the glial engulfment of larval axons during Drosophila metamorphosis. The drpr mutation and glia-specific knockdown of drpr and ced-6 by RNA interference suppress glial engulfment, resulting in the inhibition of axon pruning. drpr and ced-6 interact genetically in the glial action. Disruption of the microtubule cytoskeleton in the axons to be pruned occurs via ecdysone signaling, independent of glial engulfment. These findings suggest that glial cells engulf degenerating axons through drpr and ced-6. We propose that apoptotic cells and degenerating axons of living neurons are removed by a similar molecular mechanism.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, Kawaguchi 3320012, Japan; Japan Sci & Technol Corp, Inst Bioinformat Res & Dev, Tokyo 1020081, Japan; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; Kanazawa Univ, Grad Sch Med Sci, Kanazawa, Ishikawa 9201192, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kanazawa University; Kanazawa University	Awasaki, T (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	takeshi.awasaki@umassmed.edu	AWASAKI, Takeshi/AAO-7579-2021; Nakanishi, Yoshinobu/D-4602-2014	AWASAKI, Takeshi/0000-0003-2662-6389; Nakanishi, Yoshinobu/0000-0002-8767-3587				Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Brown S, 2002, NATURE, V418, P200, DOI 10.1038/nature00811; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; ELLIS RE, 1991, GENETICS, V129, P79; FADOK VA, 1992, J IMMUNOL, V148, P2207; Fadok VA, 1998, CELL DEATH DIFFER, V5, P551, DOI 10.1038/sj.cdd.4400404; Finn JT, 2000, J NEUROSCI, V20, P1333; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Hoeppner DJ, 2001, NATURE, V412, P202, DOI 10.1038/35084103; Ito K, 2003, MICROSC RES TECHNIQ, V62, P170, DOI 10.1002/jemt.10369; Ito K, 1998, LEARN MEMORY, V5, P52; Kantor DB, 2003, NEURON, V38, P849, DOI 10.1016/S0896-6273(03)00364-7; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kinchen JM, 2005, NATURE, V434, P93, DOI 10.1038/nature03263; LANG RA, 1993, CELL, V74, P453, DOI 10.1016/0092-8674(93)80047-I; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; LITTLE GH, 1993, COMP BIOCHEM PHYS A, V105, P79, DOI 10.1016/0300-9629(93)90176-5; Liu QA, 1998, CELL, V93, P961, DOI 10.1016/S0092-8674(00)81202-7; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Manaka J, 2004, J BIOL CHEM, V279, P48466, DOI 10.1074/jbc.M408597200; NAKAMURA H, 1989, J NEUROSCI, V9, P3776; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Reddien PW, 2001, NATURE, V412, P198, DOI 10.1038/35084096; Reddien PW, 2000, NAT CELL BIOL, V2, P131, DOI 10.1038/35004000; Rosen A, 1999, CELL DEATH DIFFER, V6, P6, DOI 10.1038/sj.cdd.4400460; Savill J, 2000, NATURE, V407, P784, DOI 10.1038/35037722; Sepp KJ, 2003, DEVELOPMENT, V130, P1825, DOI 10.1242/dev.00413; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Smits E, 1999, CURR BIOL, V9, P1351, DOI 10.1016/S0960-9822(00)80062-7; Su HP, 2002, J BIOL CHEM, V277, P11772, DOI 10.1074/jbc.M109336200; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Watts RJ, 2004, CURR BIOL, V14, P678, DOI 10.1016/j.cub.2004.03.035; Whitmore AV, 2003, CELL DEATH DIFFER, V10, P260, DOI 10.1038/sj.cdd.4401147; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Wu YC, 1998, CELL, V93, P951, DOI 10.1016/S0092-8674(00)81201-5; YANG MY, 1995, NEURON, V15, P45; Yu SY, 2002, DEVELOPMENT, V129, P3269; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	58	199	205	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 15	2006	50	6					855	867		10.1016/j.neuron.2006.04.027	http://dx.doi.org/10.1016/j.neuron.2006.04.027			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772168	Bronze			2022-12-28	WOS:000238589500007
J	DeVries, SH; Li, W; Saszik, S				DeVries, Steven H.; Li, Wei; Saszik, Shannon			Parallel processing in two transmitter microenvironments at the cone photoreceptor synapse	NEURON			English	Article							GLUTAMATE-RECEPTOR SUBUNITS; GROUND-SQUIRREL RETINA; BIPOLAR CELLS; AMPA RECEPTORS; KAINATE RECEPTORS; MULTIVESICULAR RELEASE; ELECTRON-MICROSCOPY; PLEXIFORM LAYER; GANGLION-CELLS; PRIMATE RETINA	A cone photoreceptor releases glutamate at ribbons located atop narrow membrane invaginations that empty onto a terminal base. The unique shape of the cone terminal suggests that there are two transmitter microenvironments: within invaginations, where concentrations are high and exposures are brief; and at the base, where concentrations are low and exposure is smoothed by diffusion. Using multicell voltage-clamp recording, we show that different subtypes of Off bipolar cells sample transmitter in two microenvironments. The dendrites of an AMPA receptor-containing cell insert into invaginations and sense rapid fluctuations in glutamate concentration that can lead to transient responses. The dendrites of kainate receptor-containing cells make basal contacts and respond to a smoothed flow of glutamate that produces sustained responses. Signaling at the cone to Off bipolar cell synapse illustrates how transmitter spillover and synapse architecture can combine to produce distinct signals in postsynaptic neurons.	Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA; Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	DeVries, SH (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Ophthalmol, Chicago, IL 60611 USA.	s-devries@northwestern.edu		Li, Wei/0000-0002-2897-649X	NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER; NEI NIH HHS [EY12141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Cadetti L, 2005, J PHYSIOL-LONDON, V569, P773, DOI 10.1113/jphysiol.2005.096545; Calkins DJ, 1996, VISION RES, V36, P3373, DOI 10.1016/0042-6989(95)00333-9; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; Colquhoun David, 1995, P589; Cossart R, 2002, NEURON, V35, P147, DOI 10.1016/S0896-6273(02)00753-5; Cuenca N, 2002, J NEUROCYTOL, V31, P649, DOI 10.1023/A:1025791512555; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Diamond JS, 1997, J NEUROSCI, V17, P4672; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; DVORAK CA, 1980, NATURE, V283, P860, DOI 10.1038/283860a0; ELIASOF S, 1993, J NEUROSCI, V13, P402; FAIN GL, 1977, NATURE, V265, P181, DOI 10.1038/265181a0; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Fan JS, 1998, PFLUG ARCH EUR J PHY, V436, P1021, DOI 10.1007/PL00008086; Frerking M, 2002, J NEUROSCI, V22, P7434; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; Haverkamp S, 2001, J COMP NEUROL, V436, P471, DOI 10.1002/cne.1081; Haverkamp S, 2001, J NEUROSCI, V21, P2488, DOI 10.1523/JNEUROSCI.21-07-02488.2001; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Hopkins JM, 1997, J NEUROCYTOL, V26, P313, DOI 10.1023/A:1018504718282; HOPKINS JM, 1992, VISUAL NEUROSCI, V8, P379, DOI 10.1017/S0952523800005125; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jacoby RA, 2000, J COMP NEUROL, V416, P6, DOI 10.1002/(SICI)1096-9861(20000103)416:1<6::AID-CNE2>3.0.CO;2-X; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; KOLB H, 1979, J NEUROCYTOL, V8, P295, DOI 10.1007/BF01236124; KOLB H, 1970, PHILOS T R SOC B, V258, P261, DOI 10.1098/rstb.1970.0036; LASANSKY A, 1973, PHILOS T ROY SOC B, V265, P471, DOI 10.1098/rstb.1973.0033; Lerma J, 1999, HANDB EXP PHARM, V141, P275; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Li W, 2006, NAT NEUROSCI, V9, P669, DOI 10.1038/nn1686; Linberg KA, 1996, J COMP NEUROL, V365, P173, DOI 10.1002/(SICI)1096-9861(19960205)365:2<173::AID-CNE1>3.0.CO;2-2; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; Matsui K, 2003, NEURON, V40, P1173, DOI 10.1016/S0896-6273(03)00788-8; MCGUIRE BA, 1984, J NEUROSCI, V4, P2920; Missotten L, 1965, ULTRASTRUCTURE HUMAN; Morigiwa K, 1999, J COMP NEUROL, V405, P173, DOI 10.1002/(SICI)1096-9861(19990308)405:2<173::AID-CNE3>3.0.CO;2-L; NELSON R, 1983, VISION RES, V23, P1183, DOI 10.1016/0042-6989(83)90032-9; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Pourcho RG, 2002, J COMP NEUROL, V454, P341, DOI 10.1002/cne.10457; Qin P, 1999, VISUAL NEUROSCI, V16, P169, DOI 10.1017/S0952523899161121; Qin P, 2001, BRAIN RES, V890, P211, DOI 10.1016/S0006-8993(00)03162-0; RAO MR, 1995, NEURON, V14, P561; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Singer JH, 2004, NAT NEUROSCI, V7, P826, DOI 10.1038/nn1280; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; WEST RW, 1976, J COMP NEUROL, V168, P355, DOI 10.1002/cne.901680304; WEST RW, 1975, J COMP NEUROL, V159, P439, DOI 10.1002/cne.901590402; Zenisek D, 2003, J NEUROSCI, V23, P2538	62	125	126	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					735	748		10.1016/j.neuron.2006.04.034	http://dx.doi.org/10.1016/j.neuron.2006.04.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731512	Bronze			2022-12-28	WOS:000238165000009
J	Dosenbach, NUF; Visscher, KM; Palmer, ED; Miezin, FM; Wenger, KK; Kang, HSC; Burgund, ED; Grimes, AL; Schlaggar, BL; Petersen, SE				Dosenbach, Nico U. F.; Visscher, Kristina M.; Palmer, Erica D.; Miezin, Francis M.; Wenger, Kristin K.; Kang, Hyunseon C.; Burgund, E. Darcy; Grimes, Ansley L.; Schlaggar, Bradley L.; Petersen, Steven E.			A core system for the implementation of task sets	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; BLOOD-FLOW CHANGES; PREFRONTAL CORTEX; COGNITIVE CONTROL; BRAIN ACTIVITY; VISUAL TASKS; CONFLICT; ATTENTION; FMRI; TRANSIENT	When performing tasks, humans are thought to adopt task sets that configure moment-to-moment data processing. Recently developed mixed blocked/eventrelated designs allow task set-related signals to be extracted in fMRI experiments, including activity related to cues that signal the beginning of a task block, "set-maintenance" activity sustained for the duration of a task block, and event-related signals for different trial types. Data were conjointly analyzed from mixed design experiments using ten different tasks and 183 subjects. Dorsal anterior cingulate cortex/medial superior frontal cortex (dACC/msFC) and bilateral anterior insula/frontal operculum (al/fO) showed reliable start-cue and sustained activations across all or nearly all tasks. These regions also carried the most reliable error-related signals in a subset of tasks, suggesting that the regions form a "core" task-set system. Prefrontal regions commonly related to task control carried task-set signals in a smaller subset of tasks and lacked convergence across signal types.	Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurobiol & Anat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; San Diego State Univ, Dept Psychol, San Diego, CA 92120 USA; Rice Univ, Dept Psychol, Houston, TX 77251 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brandeis University; California State University System; San Diego State University; Rice University	Dosenbach, NUF (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	ndosenbach@wustl.edu; sep@npg.wustl.edu	Petersen, Steve/ABF-1368-2020; Schlaggar, Bradley/AAZ-4153-2020	Visscher, Kristina/0000-0003-0737-4024; Kang, Hyunseon/0000-0001-5313-3526	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS041255, R01NS046424] Funding Source: NIH RePORTER; NINDS NIH HHS [NS46424, NS41255, R21 NS041255, R01 NS046424] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARRIS RW, 1953, NEUROLOGY, V3, P44, DOI 10.1212/WNL.3.1.44; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; BROADBENT DE, 1982, ACTA PSYCHOL, V50, P253, DOI 10.1016/0001-6918(82)90043-9; Brown JW, 2005, SCIENCE, V307, P1118, DOI 10.1126/science.1105783; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Cohen RA, 1999, J NEUROPSYCH CLIN N, V11, P444, DOI 10.1176/jnp.11.4.444; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dehaene S, 2003, P NATL ACAD SCI USA, V100, P8520, DOI 10.1073/pnas.1332574100; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Donaldson DI, 2004, TRENDS NEUROSCI, V27, P442, DOI 10.1016/j.tins.2004.06.001; Donaldson DI, 2001, NEUROIMAGE, V13, P129, DOI 10.1006/nimg.2000.0664; Dougherty DD, 2002, AM J PSYCHIAT, V159, P269, DOI 10.1176/appi.ajp.159.2.269; Duncan J, 2001, NAT REV NEUROSCI, V2, P820, DOI 10.1038/35097575; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; Egner T, 2005, NAT NEUROSCI, V8, P1784, DOI 10.1038/nn1594; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Fiez JA, 1996, NEURON, V16, P13, DOI 10.1016/S0896-6273(00)80018-5; FIEZ JA, 1992, BRAIN, V115, P155, DOI 10.1093/brain/115.1.155; Fox MD, 2005, NEUROIMAGE, V28, P956, DOI 10.1016/j.neuroimage.2005.06.025; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Holroyd CB, 2004, NAT NEUROSCI, V7, P497, DOI 10.1038/nn1238; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Konishi S, 2005, P NATL ACAD SCI USA, V102, P12584, DOI 10.1073/pnas.0500585102; Konishi S, 2001, NEUROIMAGE, V13, P364, DOI 10.1006/nimg.2000.0691; Logan GD, 2001, PSYCHOL REV, V108, P393, DOI 10.1037//0033-295X.108.2.393; Luria A. R., 2012, HIGHER CORTICAL FUNC; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Manes F, 1999, J NERV MENT DIS, V187, P707, DOI 10.1097/00005053-199912000-00001; Meiran N, 1996, J EXP PSYCHOL LEARN, V22, P1423, DOI 10.1037/0278-7393.22.6.1423; Meyer DE, 1997, PSYCHOL REV, V104, P3, DOI 10.1037/0033-295X.104.1.3; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; Norman D. A., 1986, CONSCIOUSNESS SELF R, V4, P1; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Ollinger JM, 2001, NEUROIMAGE, V13, P218, DOI 10.1006/nimg.2000.0711; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PARDO JV, 1991, NATURE, V349, P61, DOI 10.1038/349061a0; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Posner M., 1975, INFORM PROCESSING CO; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; POSNER MI, 1994, TRENDS NEUROSCI, V17, P75, DOI 10.1016/0166-2236(94)90078-7; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Sakai K, 2003, NAT NEUROSCI, V6, P75, DOI 10.1038/nn987; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P624, DOI 10.1162/jocn.1997.9.5.624; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Snyder AZ., 1996, QUANTIFICATION BRAIN, P131, DOI DOI 10.1016/B978-012389760-2/50028-1; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; van Schie HT, 2004, NAT NEUROSCI, V7, P549, DOI 10.1038/nn1239; Visscher KM, 2003, NEUROIMAGE, V19, P1694, DOI 10.1016/S1053-8119(03)00178-2; Weissman DH, 2005, CEREB CORTEX, V15, P229, DOI 10.1093/cercor/bhh125; Wenger KK, 2004, NEUROIMAGE, V22, P975, DOI 10.1016/j.neuroimage.2004.02.028; Williams ZM, 2004, NAT NEUROSCI, V7, P1370, DOI 10.1038/nn1354; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279	81	1230	1241	4	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					799	812		10.1016/j.neuron.2006.04.031	http://dx.doi.org/10.1016/j.neuron.2006.04.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	051MK	16731517	Bronze, Green Accepted			2022-12-28	WOS:000238165000014
J	Eichenbaum, H				Eichenbaum, H			The secret life of memories	NEURON			English	Editorial Material							PROTEIN-SYNTHESIS; RECONSOLIDATION; CONSOLIDATION; REACTIVATION; HIPPOCAMPUS; EXTINCTION; SYSTEMS; CORTEX	Recent evidence has challenged the view that memories are made permanent by a consolidation process that happens just once and instead have suggested that memories are "reconsolidated" after reminders. The current findings of Morris et al. in this issue of Neuron suggest that reconsolidation may involve a complex interaction between synaptic and system processing of recent as well as remote experiences.	Boston Univ, Ctr Memory & Brain, Boston, MA 02215 USA	Boston University	Eichenbaum, H (corresponding author), Boston Univ, Ctr Memory & Brain, 2 Cummington St, Boston, MA 02215 USA.							Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Morris RGM, 2006, NEURON, V50, P479, DOI 10.1016/j.neuron.2006.04.012; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Przybyslawski J, 1997, BEHAV BRAIN RES, V84, P241, DOI 10.1016/S0166-4328(96)00153-2; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; ROSS RS, 2006, IN PRESS J NEUROSCI; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Winocur G, 2005, NAT NEUROSCI, V8, P273, DOI 10.1038/nn1401	15	12	12	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 4	2006	50	3					350	352		10.1016/j.neuron.2006.04.017	http://dx.doi.org/10.1016/j.neuron.2006.04.017			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675390	Bronze			2022-12-28	WOS:000237726800005
J	Kwan, KY; Allchorne, AJ; Vollrath, MA; Christensen, AP; Zhang, DS; Woolf, CJ; Corey, DP				Kwan, KY; Allchorne, AJ; Vollrath, MA; Christensen, AP; Zhang, DS; Woolf, CJ; Corey, DP			TRPA1 contributes to cold, mechanical, and chemical Nociception but is not essential for hair-cell transduction	NEURON			English	Article							PRIMARY SENSORY NEURONS; SPARED NERVE INJURY; ION-CHANNEL TRPA1; NEUROPATHIC PAIN; THERMOTRP CHANNELS; SEX-DIFFERENCES; TRK RECEPTORS; GROWTH-FACTOR; TIP LINKS; RAT	TRPA1, a member of the transient receptor potential (TRP) family of ion channels, is expressed by dorsal root ganglion neurons and by cells of the inner ear, where it has proposed roles in sensing sound, painful cold, and irritating chemicals. To test the in vivo roles of TRPA1, we generated a mouse in which the essential exons required for proper function of the Trpa1 gene were deleted. Knockout mice display behavioral deficits in response to mustard oil, to cold (similar to 0 degrees C), and to punctate mechanical stimuli. These mice have a normal startle reflex to loud noise, a normal sense of balance, a normal auditory brainstem response, and normal transduction currents in vestibular hair cells. TRPA1 is apparently not essential for hair-cell transduction but contributes to the transduction of mechanical, cold, and chemical stimuli in nociceptor sensory neurons.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; Massachusetts Gen Hosp, Neural Plast Res Grp, Dept Anesthesia & Crit Care, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School	Kwan, KY (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	kelvin_kwan@hms.harvard.edu	Woolf, Clifford/A-9784-2010	Kwan, Kelvin/0000-0002-8617-5543; Corey, David/0000-0003-4497-6016	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R37NS039518, R01NS039518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000304] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-00304] Funding Source: Medline; NINDS NIH HHS [NS-039518, NS-038253] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allchorne AJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-36; Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CARLTON SM, 1994, PAIN, V56, P155, DOI 10.1016/0304-3959(94)90090-6; CHOI Y, 1994, PAIN, V59, P369, DOI 10.1016/0304-3959(94)90023-X; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; COREY DP, 1980, J NEUROSCI METH, V3, P183, DOI 10.1016/0165-0270(80)90025-4; Craft RM, 2004, EUR J PAIN, V8, P397, DOI 10.1016/j.ejpain.2004.01.003; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Denk W, 1995, NEURON, V15, P1311, DOI 10.1016/0896-6273(95)90010-1; Fillingim RB, 2000, NEUROSCI BIOBEHAV R, V24, P485, DOI 10.1016/S0149-7634(00)00017-8; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; HANDWERKER HO, 1991, J PHYSIOL-LONDON, V435, P229, DOI 10.1113/jphysiol.1991.sp018507; Hu J, 2006, PAIN, V120, P3, DOI 10.1016/j.pain.2005.11.002; Jaquemar D, 1999, J BIOL CHEM, V274, P7325, DOI 10.1074/jbc.274.11.7325; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kachar B, 2000, P NATL ACAD SCI USA, V97, P13336, DOI 10.1073/pnas.97.24.13336; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; KOLTZENBURG M, 1992, PAIN, V51, P207, DOI 10.1016/0304-3959(92)90262-A; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; MCMAHON SB, 1994, NEURON, V12, P1161, DOI 10.1016/0896-6273(94)90323-9; Meyers JR, 2003, J NEUROSCI, V23, P4054; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Morin C, 1998, PAIN, V74, P67, DOI 10.1016/S0304-3959(97)00152-8; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; REEH PW, 1986, BRAIN RES, V384, P42, DOI 10.1016/0006-8993(86)91217-5; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Rosenzweig M, 2005, GENE DEV, V19, P419, DOI 10.1101/gad.1278205; Rusch A, 1996, J NEUROPHYSIOL, V76, P995, DOI 10.1152/jn.1996.76.2.995; Simpson EM, 1997, NAT GENET, V16, P19, DOI 10.1038/ng0597-19; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Suter MR, 2003, ANESTHESIOLOGY, V99, P1402, DOI 10.1097/00000542-200312000-00025; Tracey WD, 2003, CELL, V113, P261, DOI 10.1016/S0092-8674(03)00272-1; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Vollrath MA, 2003, J NEUROPHYSIOL, V90, P2676, DOI 10.1152/jn.00893.2002; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	939	984	0	69	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 20	2006	50	2					277	289		10.1016/j.neuron.2006.03.042	http://dx.doi.org/10.1016/j.neuron.2006.03.042			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630838	Bronze			2022-12-28	WOS:000237176700014
J	Etkin, A; Alarcon, JM; Weisberg, SP; Touzani, K; Huang, YY; Nordheim, A; Kandel, ER				Etkin, A; Alarcon, JM; Weisberg, SP; Touzani, K; Huang, YY; Nordheim, A; Kandel, ER			A role in learning for SRF: Deletion in the adult forebrain disrupts LTD and the formation of an immediate memory of a novel context	NEURON			English	Article							LONG-TERM DEPRESSION; SERUM RESPONSE FACTOR; INCREASED EXPLORATORY ACTIVITY; SYNAPTIC PLASTICITY; CALCIUM STORES; REGION CA1; EXPRESSION; HIPPOCAMPUS; TRANSCRIPTION; HABITUATION	Whereas significant insight exists as to how LTP-related changes can contribute to the formation of long-term memory, little is known about the role of hippocampal LTD-like changes in learning and memory storage. We describe a mouse lacking the transcription factor SRF in the adult forebrain. This mouse could not acquire a hippocampus-based immediate memory for a novel context even across a few minute timespan, which led to a profound but selective deficit in explicit spatial memory. These animals were also impaired in the induction of LTD, including LTD triggered by a cholinergic agonist. Moreover, genes regulating two processes essential for LTD-calcium release from intracellular stores and phosphatase activation-were abnormally expressed in knockouts. These findings suggest that for the hippocampus to form associative spatial memories through LTP-like processes, it must first undergo learning of the context per se through exploration and the learning of familiarity, which requires LTD-like processes.	Columbia Univ, Ctr Med, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Ctr Med, Kavli Inst Brain Sci, New York, NY 10032 USA; Columbia Univ, Ctr Med, Div Mol Genet, New York, NY 10032 USA; Columbia Univ, Ctr Med, Dept Pediat, New York, NY 10032 USA; Columbia Univ, Ctr Med, Howard Hughes Med Inst, New York, NY 10032 USA; CUNY, Brooklyn Coll, Dept Psychol, Brooklyn, NY 11210 USA; Univ Tubingen, Abt Molekularbiol, Interfak Inst Zellbiol, Tubingen, Germany	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; City University of New York (CUNY) System; Brooklyn College (CUNY); Eberhard Karls University of Tubingen	Kandel, ER (corresponding author), Columbia Univ, Ctr Med, Ctr Neurobiol & Behav, 1051 Riverside Dr, New York, NY 10032 USA.	erk5@columbia.edu	Etkin, Amit/ABD-5761-2021	Weisberg, Stuart/0000-0002-8698-5976	NICHD NIH HHS [HD 07430] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Acquas E, 1996, J NEUROSCI, V16, P3089; Adrover MF, 2003, GENES BRAIN BEHAV, V2, P103, DOI 10.1034/j.1601-183X.2003.00015.x; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Anagnostaras SG, 2003, NAT NEUROSCI, V6, P51, DOI 10.1038/nn992; ARAI A, 1994, HIPPOCAMPUS, V4, P1, DOI 10.1002/hipo.450040103; BANKER G, 1998, CULTURING NERVE CELL; Bast T, 2003, PROG NEUROBIOL, V70, P319, DOI 10.1016/S0301-0082(03)00112-6; Belaguli NS, 1997, J BIOL CHEM, V272, P18222, DOI 10.1074/jbc.272.29.18222; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; Bibbb JA, 2001, J BIOL CHEM, V276, P14490, DOI 10.1074/jbc.M007197200; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; Buchwalter G, 2004, GENE, V324, P1, DOI 10.1016/j.gene.2003.09.028; CASTROALAMANCOS MA, 1995, J NEUROSCI, V15, P5324; CHEAL M, 1982, J COMP PHYSIOL PSYCH, V96, P47, DOI 10.1037/h0077854; CHRISTY B, 1989, MOL CELL BIOL, V9, P4889, DOI 10.1128/MCB.9.11.4889; Clarke N, 1998, MOL CELL BIOL, V18, P1065, DOI 10.1128/MCB.18.2.1065; CORMAN CD, 1968, PSYCHON SCI, V13, P55, DOI 10.3758/BF03342406; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Grailhe R, 1999, NEURON, V22, P581, DOI 10.1016/S0896-6273(00)80712-6; GRAY JA, 1983, NEUROSCI BIOBEHAV R, V7, P119, DOI 10.1016/0149-7634(83)90014-3; Herdegen T, 1997, NEUROSCIENCE, V81, P199, DOI 10.1016/S0306-4522(97)00170-X; Huang Y Y, 1994, Learn Mem, V1, P74; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Hyman JM, 2003, J NEUROSCI, V23, P11725; Kaut KP, 2003, BEHAV NEUROSCI, V117, P304, DOI 10.1037/0735-7044.117.2.304; KELLY PH, 1993, CAN J PHYSIOL PHARM, V71, P352, DOI 10.1139/y93-055; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kew JNC, 2000, J NEUROSCI, V20, P4037; Kirkwood A, 1999, J NEUROSCI, V19, P1599; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Lamprea MR, 2000, BEHAV BRAIN RES, V117, P97, DOI 10.1016/S0166-4328(00)00294-1; Lamprea MR, 2003, BRAZ J MED BIOL RES, V36, P233, DOI 10.1590/S0100-879X2003000200011; Liu T, 2000, J MOL EVOL, V50, P22, DOI 10.1007/s002399910003; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Martin SJ, 2002, HIPPOCAMPUS, V12, P609, DOI 10.1002/hipo.10107; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MCCUTCHEN ME, 2004, SOC NEUR SAN DIEG CA; Moody TD, 1998, BRAIN RES, V794, P75, DOI 10.1016/S0006-8993(98)00217-0; Morishita W, 2005, NAT NEUROSCI, V8, P1043, DOI 10.1038/nn1506; Morishita W, 2001, NEURON, V32, P1133, DOI 10.1016/S0896-6273(01)00554-2; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; Nakano M, 2004, EUR J NEUROSCI, V19, P2881, DOI 10.1111/j.0953-816X.2004.03390.x; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nicoll RA, 1998, NEUROBIOL LEARN MEM, V70, P62, DOI 10.1006/nlme.1998.3838; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; Ohshima T, 2005, J NEUROCHEM, V94, P917, DOI 10.1111/j.1471-4159.2005.03233.x; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Patterson SL, 2001, NEURON, V32, P123, DOI 10.1016/S0896-6273(01)00443-3; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Pavlidis P, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-10-research0042; Petrulis A, 2003, NEUROSCIENCE, V122, P599, DOI 10.1016/j.neuroscience.2003.08.009; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Reyes M, 1996, J NEUROSCI, V16, P5951; ROBERTS WW, 1962, J COMP PHYSIOL PSYCH, V55, P695, DOI 10.1037/h0045168; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; STAUBLI U, 1994, BRAIN RES, V643, P10, DOI 10.1016/0006-8993(94)90003-5; Stringer JL, 2002, DEV BRAIN RES, V138, P81, DOI 10.1016/S0165-3806(02)00467-4; SWONGER AK, 1972, J COMP PHYSIOL PSYCH, V81, P509, DOI 10.1037/h0033690; THINUSBLANC C, 1987, J EXP PSYCHOL ANIM B, V13, P418, DOI 10.1037/0097-7403.13.4.418; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Touzani K, 1997, BEHAV BRAIN RES, V88, P133, DOI 10.1016/S0166-4328(96)02273-5; Vianna MRM, 2000, LEARN MEMORY, V7, P333, DOI 10.1101/lm.34600; VINOGRADOVA OS, 1995, PROG NEUROBIOL, V45, P523, DOI 10.1016/0301-0082(94)00051-I; Wiebel FF, 2002, GENESIS, V32, P124, DOI 10.1002/gene.10049; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004; Zakharenko SS, 2003, NEURON, V39, P975, DOI 10.1016/S0896-6273(03)00543-9; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	83	177	179	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					127	143		10.1016/j.neuron.2006.03.013	http://dx.doi.org/10.1016/j.neuron.2006.03.013			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600861	Bronze			2022-12-28	WOS:000236811300016
J	McCormack, SG; Stornetta, RL; Zhu, JJ				McCormack, SG; Stornetta, RL; Zhu, JJ			Synaptic AMPA receptor exchange maintains bidirectional plasticity	NEURON			English	Article							ETHYLMALEIMIDE-SENSITIVE FACTOR; ACTIVATED PROTEIN-KINASE; NMDA RECEPTOR; TRAFFICKING; GLUR2; PHOSPHORYLATION; TRANSMISSION; RESPONSES; REQUIREMENT; SYNAPSES	Activity-dependent synaptic delivery of GluR1-, GluR2L-, and GluR4-containing AMPA receptors (-Rs) and removal of GluR2-containing AMPA-Rs mediate synaptic potentiation and depression, respectively. The obvious puzzle is how synapses maintain the capacity for bidirectional plasticity if different AMPA-Rs are utilized for potentiation and depression. Here, we show that synaptic AMPA-R exchange is essential for maintaining the capacity for bidirectional plasticity. The exchange process consists of activity-independent synaptic removal of GluR1-, GluR2L-, or GluR4-containing AMPA-Rs and refilling with GluR2-containing AMPA-Rs at hippocampal and cortical synapses in vitro and in intact brains. In GluR1 and GiuR2 knockout mice, initiation or completion of synaptic AMPA-R exchange is compromised, respectively. The complementary AMPA-R removal and refilling events in the exchange process ultimately maintain synaptic strength unchanged, but their long rate time constants (similar to 15-18 hr) render transmission temporarily depressed in the middle of the exchange. These results suggest that the previously hypothesized "slot" proteins, rather than AMPA-Rs, code and maintain transmission efficacy at central synapses.	Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA; Univ Virginia, Sch Med, Neurosci Grad Program, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Virginia	Zhu, JJ (corresponding author), Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA.	jjzhu@virginia.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051241, R01NS053570] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS053570, R01 NS051241, R01 NS051241-01A1] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Bagal AA, 2005, P NATL ACAD SCI USA, V102, P14434, DOI 10.1073/pnas.0501956102; Bear MF, 2001, SYNAPSES, P455; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Brown TC, 2005, NEURON, V45, P81, DOI 10.1016/j.neuron.2004.12.023; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Larkum ME, 2002, J NEUROSCI, V22, P6991; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2003, PHILOS T ROY SOC B, V358, P707, DOI 10.1098/rstb.2002.1233; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Meng YH, 2003, NEURON, V39, P163, DOI 10.1016/S0896-6273(03)00368-4; Murray HJ, 2003, NEUROPHARMACOLOGY, V44, P374, DOI 10.1016/S0028-3908(02)00375-1; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Oug WY, 1996, EXP BRAIN RES, V110, P367; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; PETRALIA RS, 1992, J COMP NEUROL, V318, P329, DOI 10.1002/cne.903180309; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Steinberg JP, 2004, P NATL ACAD SCI USA, V101, P18212, DOI 10.1073/pnas.0408278102; Takahashi T, 2003, SCIENCE, V299, P1585, DOI 10.1126/science.1079886; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Zhou Q, 2004, TRENDS NEUROSCI, V27, P378, DOI 10.1016/j.tins.2004.05.006; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Zhu YH, 2005, NEURON, V46, P905, DOI 10.1016/j.neuron.2005.04.037; Zhu YH, 2004, J NEUROSCI, V24, P5101, DOI 10.1523/JNEUROSCI.0544-04.2004	50	70	73	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					75	88		10.1016/j.neuron.2006.02.027	http://dx.doi.org/10.1016/j.neuron.2006.02.027			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600857	Bronze			2022-12-28	WOS:000236811300012
J	Fransen, E; Tahvildari, B; Egorov, AV; Hasselmo, ME; Alonso, AA				Fransen, E; Tahvildari, B; Egorov, AV; Hasselmo, ME; Alonso, AA			Mechanism of graded persistent cellular activity of entorhinal cortex layer V neurons	NEURON			English	Article							PARAMETRIC WORKING-MEMORY; HEAD-DIRECTION CELLS; PREFRONTAL CORTEX; RECURRENT NETWORK; SPATIAL NAVIGATION; NEURAL INTEGRATOR; CATION CURRENT; MODEL NEURON; EYE POSITION; II NEURONS	Working memory is an emergent property of neuronal networks, but its cellular basis remains elusive. Recent data show that principal neurons of the entorhinal cortex display persistent firing at graded firing rates that can be shifted up or down in response to brief excitatory or inhibitory stimuli. Here, we present a model of a potential mechanism for graded firing. Our multicompartmental model provides stable plateau firing generated by a nonspecific calcium-sensitive cationic (CAN) current. Sustained firing is insensitive to small variations in Ca2+ concentration in a neutral zone. However, both high and low Ca2+ levels alter firing rates. Specifically, increases in persistent firing rate are triggered only during high levels of calcium, while decreases in rate occur in the presence of low levels of calcium. The model is consistent with detailed experimental observations and provides a mechanism for maintenance of memory-related activity in individual neurons.	Royal Inst Technol, Sch Comp Sci & Commun, SE-10044 Stockholm, Sweden; Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; McGill Univ, Montreal, PQ H3A 2B4, Canada; Univ Heidelberg, IZN, Dept Neuroanat, D-69120 Heidelberg, Germany; Boston Univ, Dept Psychol, Ctr Mem & Brain, Boston, MA 02215 USA	Royal Institute of Technology; McGill University; McGill University; Ruprecht Karls University Heidelberg; Boston University	Fransen, E (corresponding author), Royal Inst Technol, Sch Comp Sci & Commun, SE-10044 Stockholm, Sweden.	erikf@nada.kth.se		Egorov, Alexei/0000-0003-4899-8407; Hasselmo, Michael/0000-0002-9925-6377	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016454] Funding Source: NIH RePORTER; NIDA NIH HHS [DA16454] Funding Source: Medline; NIMH NIH HHS [MH60013, MH61492] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Bower J.M., 1995, BOOK GENESIS EXPLORI; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; CANNON SC, 1983, BIOL CYBERN, V49, P127, DOI 10.1007/BF00320393; Cho K, 2001, J PHYSIOL-LONDON, V532, P459, DOI 10.1111/j.1469-7793.2001.0459f.x; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Connors BW, 2002, NATURE, V420, P133, DOI 10.1038/420133a; Durstewitz D, 2003, J NEUROSCI, V23, P5342; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Frank LM, 2003, TRENDS NEUROSCI, V26, P400, DOI 10.1016/S0166-2236(03)00176-0; Fransen E, 2002, J NEUROSCI, V22, P1081, DOI 10.1523/JNEUROSCI.22-03-01081.2002; Fransen E, 1998, NETWORK-COMP NEURAL, V9, P235, DOI 10.1088/0954-898X/9/2/006; FRANSEN E, 1995, NETWORK-COMP NEURAL, V6, P271, DOI 10.1088/0954-898X/6/2/008; Fuhs MC, 2005, J NEUROPHYSIOL, V94, P2603, DOI 10.1152/jn.00132.2005; Georges-Francois P, 1999, CEREB CORTEX, V9, P197, DOI 10.1093/cercor/9.3.197; Gloveli T, 1999, EUR J NEUROSCI, V11, P3626, DOI 10.1046/j.1460-9568.1999.00785.x; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Heckman CJ, 2003, TRENDS NEUROSCI, V26, P688, DOI 10.1016/j.tins.2003.10.002; HINES M, 1984, INT J BIOMED COMPUT, V15, P69, DOI 10.1016/0020-7101(84)90008-4; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; INOUE R, 1994, BIOCHEM BIOPH RES CO, V203, P1392, DOI 10.1006/bbrc.1994.2339; Klink R, 1997, J NEUROPHYSIOL, V77, P1829, DOI 10.1152/jn.1997.77.4.1829; Koene RA, 2003, NEURAL NETWORKS, V16, P577, DOI 10.1016/S0893-6080(03)00106-0; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LISMAN JE, 1995, SCIENCE, V267, P1512, DOI 10.1126/science.7878473; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Major G, 2004, CURR OPIN NEUROBIOL, V14, P675, DOI 10.1016/j.conb.2004.10.017; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; Miller P, 2003, CEREB CORTEX, V13, P1208, DOI 10.1093/cercor/bhg101; OKAMOTO H, 1994, PHYS REV E, V50, P1704, DOI 10.1103/PhysRevE.50.1704; ROBINSON DA, 1972, INVEST OPHTH VISUAL, V11, P497; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Runyan JD, 2005, LEARN MEMORY, V12, P103, DOI 10.1101/lm.89405; Schon K, 2005, J NEUROSCI, V25, P9112, DOI 10.1523/JNEUROSCI.1982-05.2005; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Seung HS, 2000, NEURON, V26, P259, DOI 10.1016/S0896-6273(00)81155-1; Shalinsky MH, 2002, J NEUROPHYSIOL, V88, P1197, DOI 10.1152/jn.2002.88.3.1197; Stern CE, 2001, HIPPOCAMPUS, V11, P337; Taube JS, 2003, CEREB CORTEX, V13, P1162, DOI 10.1093/cercor/bhg102; TAUBE JS, 1990, J NEUROSCI, V10, P420; Teramae JN, 2005, J COMPUT NEUROSCI, V18, P105, DOI 10.1007/s10827-005-5474-6; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; Van Haeften T, 2000, ANN NY ACAD SCI, V911, P471; Walters RJ, 1998, VISUAL NEUROSCI, V15, P257, DOI 10.1017/S0952523898152057; Wang SSH, 2003, NAT NEUROSCI, V6, P906, DOI 10.1038/nn0903-906; Yamada WM, 1989, METHODS NEURONAL MOD, P97	51	199	201	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					735	746		10.1016/j.neuron.2006.01.036	http://dx.doi.org/10.1016/j.neuron.2006.01.036			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504948	Bronze			2022-12-28	WOS:000236070600014
J	Mejia-Gervacio, S; Collin, T; Pouzat, C; Tan, YP; Llano, I; Marty, A				Mejia-Gervacio, Sheyla; Collin, Thibault; Pouzat, Christophe; Tan, Yusuf P.; Llano, Isabel; Marty, Alain			Axonal speeding: Shaping synaptic potentials in small neurons by the axonal membrane compartment	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; PYRAMIDAL CELLS; CURRENTS; STELLATE; INTEGRATION; INITIATION; SYNAPSES; AMPLIFICATION; PROBABILITY; MODULATION	The role of the axonal membrane compartment in synaptic integration is usually neglected. We show here that in interneurons of the cerebellar molecular layer, where dendrites are so short that the somatodendritic domain can be considered isopotential, the axonal membrane contributes a significant part of the cell input capacitance. We examine the impact of axonal membrane on synaptic integration by cutting the axon with two-photon illumination. We find that the axonal compartment acts as a sink for signals generated at fast conductance synapses, thus increasing the initial decay rate of corresponding synaptic potentials over the value predicted from the resistance-capacitance (RC) product of the cell membrane; signals generated at slower synapses are much less affected. This mechanism sharpens the spike firing precision of fast glutamatergic inputs without resorting to multisynaptic pathways.	Univ Paris 05, Lab Physiol Cerebrale, UFR Biomed, F-75006 Paris, France	UDICE-French Research Universities; Universite Paris Cite	Marty, A (corresponding author), Univ Paris 05, Lab Physiol Cerebrale, UFR Biomed, 45 Rue St Peres, F-75006 Paris, France.	alain.marty@univ-paris5.fr	Pouzat, Christophe/HHM-2545-2022	Pouzat, Christophe/0000-0002-2844-8099				Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Auger C, 1998, J NEUROSCI, V18, P4532; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Carter AG, 2002, NAT NEUROSCI, V5, P1309, DOI 10.1038/nn970; Chavas J, 2003, J NEUROSCI, V23, P2019; Clark BA, 2002, J NEUROSCI, V22, P4428, DOI 10.1523/JNEUROSCI.22-11-04428.2002; Clark BA, 2005, NAT NEUROSCI, V8, P137, DOI 10.1038/nn1390; Colbert CM, 1996, J NEUROSCI, V16, P6676; Collin T, 2005, J NEUROSCI, V25, P96, DOI 10.1523/JNEUROSCI.3748-04.2005; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198, DOI 10.1113/jphysiol.1957.sp005887; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DURAND D, 1984, BIOPHYS J, V46, P645, DOI 10.1016/S0006-3495(84)84063-1; FETZ EE, 1983, J PHYSIOL-LONDON, V341, P387, DOI 10.1113/jphysiol.1983.sp014812; Fricker D, 2000, NEURON, V28, P559, DOI 10.1016/S0896-6273(00)00133-1; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Geiger JRP, 1997, NEURON, V18, P1009, DOI 10.1016/S0896-6273(00)80339-6; Glitsch M, 1999, J NEUROSCI, V19, P511; Gulledge AT, 2005, J NEUROBIOL, V64, P75, DOI 10.1002/neu.20144; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; JACKSON MB, 1993, J NEUROPHYSIOL, V69, P692, DOI 10.1152/jn.1993.69.3.692; JACKSON MB, 1992, BIOPHYS J, V61, P756, DOI 10.1016/S0006-3495(92)81880-5; Johnston D, 1996, ANNU REV NEUROSCI, V19, P165, DOI 10.1146/annurev.ne.19.030196.001121; JOHNSTON D, 2000, J PHYSL, V524, P75; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, J NEUROSCI, V26, P11786, DOI 10.1523/JNEUROSCI.2939-06.2006; KIRKWOOD PA, 1982, J PHYSIOL-LONDON, V322, P315, DOI 10.1113/jphysiol.1982.sp014039; Koch C, 1996, CEREB CORTEX, V6, P93, DOI 10.1093/cercor/6.2.93; LLANO I, 1993, J PHYSIOL-LONDON, V468, P177, DOI 10.1113/jphysiol.1993.sp019766; Llano I, 1997, J PHYSIOL-LONDON, V502, P509, DOI 10.1111/j.1469-7793.1997.509bj.x; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MAJOR G, 1994, J NEUROSCI, V14, P4613; Mann-Metzer P, 2002, J NEUROPHYSIOL, V87, P149, DOI 10.1152/jn.00310.2001; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mejia-Gervacio S, 2006, J PHYSIOL-LONDON, V571, P43, DOI 10.1113/jphysiol.2005.101675; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Pouzat C, 1999, J NEUROSCI, V19, P1675; Pouzat C, 1997, J NEUROSCI, V17, P9104; Protti DA, 1998, J NEUROSCI, V18, P3715; *R DEV COR TEAM, 2005, R LANG ENV STAT COMP; RALL W, 1967, J NEUROPHYSIOL, V30, P1169, DOI 10.1152/jn.1967.30.5.1169; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; RALL W, 1985, VOLTAGE PATCH CLAMPI, P191; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; Stuart G, 1998, J NEUROSCI, V18, P3501; Sultan F, 1998, J COMP NEUROL, V393, P353; Suter KJ, 2004, NEUROSCIENCE, V124, P305, DOI 10.1016/j.neuroscience.2003.11.015; Tan YP, 1999, J PHYSIOL-LONDON, V520, P65, DOI 10.1111/j.1469-7793.1999.00065.x; Tan YP, 1999, J NEUROSCI METH, V92, P123, DOI 10.1016/S0165-0270(99)00103-X; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a	55	25	25	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 15	2007	53	6					843	855		10.1016/j.neuron.2007.02.023	http://dx.doi.org/10.1016/j.neuron.2007.02.023			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	151LV	17359919	Bronze			2022-12-28	WOS:000245292800009
J	Peineau, S; Taghibiglou, C; Bradley, C; Wong, TP; Liu, LD; Lu, J; Lo, E; Wu, DC; Saule, E; Bouschet, T; Matthews, P; Isaac, JTR; Bortolotto, ZA; Wang, YT; Collingridge, GL				Peineau, Stephane; Taghibiglou, Changiz; Bradley, Clarrisa; Wong, Tak Pan; Liu, Lidong; Lu, Jie; Lo, Edmond; Wu, Dongchuan; Saule, Emilia; Bouschet, Tristan; Matthews, Paul; Isaac, John T. R.; Bortolotto, Zuner A.; Wang, Yu Tian; Collingridge, Graham L.			UP inhibits LTD in the hippocampus via regulation of GSK3 beta	NEURON			English	Article							GLYCOGEN-SYNTHASE KINASE-3; LONG-TERM DEPRESSION; PROTEIN-KINASE; TAU-PROTEIN; RECEPTOR TRAFFICKING; NMDA RECEPTORS; AREA CA1; EXPRESSION; INDUCTION; PHOSPHORYLATION	Glycogen synthase kinase-3 (GSK3) has been implicated in major neurological disorders, but its role in normal neuronal function is largely unknown. Here we show that GSK3 beta mediates an interaction between two major forms of synaptic plasticity in the brain, N-methyl-D-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) and NMDA receptor-dependent long-term depression (LTD). In rat hippocampal slices, GSK3 beta inhibitors block the induction of LTD. Furthermore, the activity of GSK3 beta is enhanced during LTD via activation of PP1. Conversely, following the induction of LTP, there is inhibition of GSK3 beta activity. This regulation of GSK3 beta during LTP involves activation of NMDA receptors and the PI3K-Akt pathway and disrupts the ability of synapses to undergo LTD for up to 1 hr. We conclude that the regulation of GSK3 beta activity provides a powerful mechanism to preserve information encoded during LTP from erasure by subsequent LTD, perhaps thereby permitting the initial consolidation of learnt information.	MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Bristol BS8 1TD, Avon, England; Univ British Columbia, Brain Res Ctr, UBC Hosp, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Dept Med, UBC Hosp, Vancouver, BC V6T 1Z3, Canada; NINDS, NIH, Bethesda, MD 20892 USA	University of Bristol; University of British Columbia; University of British Columbia; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Collingridge, GL (corresponding author), MRC, Ctr Synapt Plast, Dept Anat, Sch Med Sci, Univ Walk, Bristol BS8 1TD, Avon, England.	g.l.collingridge@bristol.ac.uk	collingridge, graham/AAI-8362-2020; Wang, Yu Tian/A-4729-2008; Collingridge, Graham L/C-4605-2015; Wu, Dong Chuan/O-3909-2015; Wang, Yu Tian/J-8255-2015; Bouschet, Tristan/C-8265-2019; Taghibiglou, Changiz/H-4590-2019	Collingridge, Graham L/0000-0002-9572-5359; Bouschet, Tristan/0000-0002-7858-6115; Matthews, Paul M/0000-0002-1619-8328; WU, DONG CHUAN/0000-0002-9539-5935; Liu, Lidong/0000-0002-7026-690X; Peineau, Stephane/0000-0002-4721-6795; Wong, Tak Pan/0000-0001-8611-4911	Medical Research Council [G9532377] Funding Source: Medline; MRC [G9532377] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x; Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; Anderton BH, 1999, CURR BIOL, V9, pR106, DOI 10.1016/S0960-9822(99)80062-1; Atkins CM, 2005, J NEUROSCI, V25, P5604, DOI 10.1523/JNEUROSCI.5051-04.2005; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beasley C, 2001, NEUROSCI LETT, V302, P117, DOI 10.1016/S0304-3940(01)01688-3; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Coghlan MP, 2000, CHEM BIOL, V7, P793, DOI 10.1016/S1074-5521(00)00025-9; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Daw MI, 2002, NAT NEUROSCI, V5, P835, DOI 10.1038/nn903; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Franco B, 2004, J NEUROSCI, V24, P6573, DOI 10.1523/JNEUROSCI.1580-04.2004; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Hernandez F, 2002, J NEUROCHEM, V83, P1529, DOI 10.1046/j.1471-4159.2002.01269.x; Hill MM, 1999, MOL CELL BIOL, V19, P7771; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Hou LF, 2004, J NEUROSCI, V24, P6352, DOI 10.1523/JNEUROSCI.0995-04.2004; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaidanovich-Beilin O, 2004, BIOL PSYCHIAT, V55, P781, DOI 10.1016/j.biopsych.2004.01.008; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kirschenbaum F, 2001, J BIOL CHEM, V276, P30701, DOI 10.1074/jbc.M102849200; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Kozlovsky N, 2002, EUR NEUROPSYCHOPHARM, V12, P13, DOI 10.1016/S0924-977X(01)00131-6; Lee YI, 2005, J BIOL CHEM, V280, P22044, DOI 10.1074/jbc.M413987200; Leost M, 2000, EUR J BIOCHEM, V267, P5983, DOI 10.1046/j.1432-1327.2000.01673.x; Leroy K, 1999, J CHEM NEUROANAT, V16, P279, DOI 10.1016/S0891-0618(99)00012-5; Li BL, 2003, J CELL BIOCHEM, V90, P1224, DOI 10.1002/jcb.10674; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Montgomery JM, 2002, NEURON, V33, P765, DOI 10.1016/S0896-6273(02)00606-2; Morfini G, 2004, EMBO J, V23, P2235, DOI 10.1038/sj.emboj.7600237; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Szatmari E, 2005, J BIOL CHEM, V280, P37526, DOI 10.1074/jbc.M502699200; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Takahashi M, 2000, BRAIN RES, V857, P193, DOI 10.1016/S0006-8993(99)02424-5; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; WOODGETT JR, 1990, EMBO J, V9, P2431, DOI 10.1002/j.1460-2075.1990.tb07419.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012	65	542	559	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					703	717		10.1016/j.neuron.2007.01.029	http://dx.doi.org/10.1016/j.neuron.2007.01.029			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329210	Green Submitted, Bronze			2022-12-28	WOS:000245127100011
J	Wickersham, IR; Lyon, DC; Barnard, RJO; Mori, T; Finke, S; Conzelmann, KK; Young, JAT; Callaway, EM				Wickersham, Ian R.; Lyon, David C.; Barnard, Richard J. O.; Mori, Takuma; Finke, Stefan; Conzelmann, Karl-Klaus; Young, John A. T.; Callaway, Edward M.			Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; HERPES-SIMPLEX-VIRUS; A AVIAN-LEUKOSIS; RABIES VIRUS; VISUAL-CORTEX; IN-VIVO; TRANSNEURONAL TRACER; TRANSGENIC MICE; RETROVIRAL VECTORS; NEURAL ACTIVITY	There has never been a wholesale way of identifying neurons that are monosynaptically connected either to some other cell group or, especially, to a single cell. The best available tools, transsynaptic tracers, are unable to distinguish weak direct connections from strong indirect ones. Furthermore, no tracer has proven potent enough to label any connected neurons whatsoever when starting from a single cell. Here we present a transsynaptic tracer that crosses only one synaptic step, unambiguously identifying cells directly presynaptic to the starting population. Based on rabies virus, it is genetically targetable, allows high-level expression of any gene of interest in the synaptically coupled neurons, and robustly labels connections made to single cells. This technology should enable afar more detailed understanding of neural connectivity than has previously been possible.	Salk Inst Biol Studies, Infect Dis Labs, La Jolla, CA 92037 USA; Univ Munich, Max Von Pettenkofer Inst, D-81377 Munich, Germany; Univ Munich, Gene Ctr, D-81377 Munich, Germany	Salk Institute; University of Munich; University of Munich	Wickersham, IR (corresponding author), Salk Inst Biol Studies, Infect Dis Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	iwickersham@salk.edu	Conzelmann, Karl-Klaus/L-7239-2013; Callaway, Edward/D-4336-2011; Mori, Takuma/AFS-0267-2022; Mori, Takuma/GMX-3581-2022	Callaway, Edward/0000-0002-6366-5267; Mori, Takuma/0000-0002-4195-2804; Mori, Takuma/0000-0002-4195-2804; Finke, Stefan/0000-0001-8716-2341; Conzelmann, Karl-Klaus/0000-0002-8614-3656; Young, John/0000-0003-1824-2561; Lyon, David C./0000-0002-4367-5636	NATIONAL CANCER INSTITUTE [R01CA070810] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA070810, CA70810] Funding Source: Medline; NEI NIH HHS [R01 EY010742, R01 EY010742-16, EY10742] Funding Source: Medline; NIMH NIH HHS [R01 MH063912, R01 MH063912-08, MH63912] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barnard RJO, 2006, VIROLOGY, V344, P25, DOI 10.1016/j.virol.2005.09.021; BATES P, 1993, CELL, V74, P1043, DOI 10.1016/0092-8674(93)90726-7; Boerger AL, 1999, P NATL ACAD SCI USA, V96, P9867, DOI 10.1073/pnas.96.17.9867; Borrell V, 2005, J NEUROSCI METH, V143, P151, DOI 10.1016/j.jneumeth.2004.09.027; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Braz JM, 2002, P NATL ACAD SCI USA, V99, P15148, DOI 10.1073/pnas.222546999; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Card JP, 1999, J COMP NEUROL, V407, P438, DOI 10.1002/(SICI)1096-9861(19990510)407:3<438::AID-CNE11>3.0.CO;2-2; Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558; CRICK FHC, 1979, SCI AM, V241, P219, DOI 10.1038/scientificamerican0979-219; Dantzker JL, 1998, J NEUROSCI, V18, P4145; Davis JRE, 2001, ENDOCRINOLOGY, V142, P795, DOI 10.1210/en.142.2.795; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Etessami R, 2000, J GEN VIROL, V81, P2147, DOI 10.1099/0022-1317-81-9-2147; FEDERSPIEL MJ, 1994, P NATL ACAD SCI USA, V91, P11241, DOI 10.1073/pnas.91.23.11241; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gou D, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh129; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Hoshi E, 2005, NAT NEUROSCI, V8, P1491, DOI 10.1038/nn1544; Ito N, 2001, J VIROL, V75, P9121, DOI 10.1128/JVI.75.19.9121-9128.2001; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; LAFAY F, 1991, VIROLOGY, V183, P320, DOI 10.1016/0042-6822(91)90145-2; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Maskos U, 2002, P NATL ACAD SCI USA, V99, P10120, DOI 10.1073/pnas.152266799; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McGettigan JP, 2003, J VIROL, V77, P10889, DOI 10.1128/JVI.77.20.10889-10899.2003; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; Melikyan GB, 2004, J VIROL, V78, P3753, DOI 10.1128/JVI.78.7.3753-3762.2004; Mercer A, 2005, CEREB CORTEX, V15, P1485, DOI 10.1093/cercor/bhi027; Narayan S, 2003, J VIROL, V77, P1977, DOI 10.1128/JVI.77.3.1977-1983.2003; Nassi JJ, 2006, NEURON, V50, P319, DOI 10.1016/j.neuron.2006.03.019; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Norgren RB, 1998, NEUROSCI BIOBEHAV R, V22, P695, DOI 10.1016/S0149-7634(98)00008-6; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Rinaman L, 2004, J NEUROSCI, V24, P2782, DOI 10.1523/JNEUROSCI.5329-03.2004; Sena-Esteves M, 2004, J VIROL METHODS, V122, P131, DOI 10.1016/j.jviromet.2004.08.017; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 2002, PHILOS T R SOC B, V357, P1781, DOI 10.1098/rstb.2002.1163; Timofeeva E, 2005, J NEUROSCI, V25, P9135, DOI 10.1523/JNEUROSCI.3073-05.2005; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; UGOLINI G, 1987, BRAIN RES, V422, P242, DOI 10.1016/0006-8993(87)90931-0; UGOLINI G, 1989, SCIENCE, V243, P89, DOI 10.1126/science.2536188; UGOLINI G, 1995, VIRAL VECTORS TOOLS; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Vercelli A, 2000, BRAIN RES BULL, V51, P11, DOI 10.1016/S0361-9230(99)00229-4; Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; YOUNG JAT, 1993, J VIROL, V67, P1811, DOI 10.1128/JVI.67.4.1811-1816.1993; Zarrinpar A, 2006, J NEUROPHYSIOL, V95, P1751, DOI 10.1152/jn.00974.2005; ZEMANICK MC, 1991, P NATL ACAD SCI USA, V88, P8048, DOI 10.1073/pnas.88.18.8048; Zou ZH, 2001, NATURE, V414, P173, DOI 10.1038/35102506	59	767	786	6	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					639	647		10.1016/j.neuron.2007.01.033	http://dx.doi.org/10.1016/j.neuron.2007.01.033			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329205	Bronze, Green Accepted			2022-12-28	WOS:000245127100006
J	Ansari, D				Ansari, Daniel			Does the parietal cortex distinguish between "10," "ten," and ten dots?	NEURON			English	Editorial Material							NUMERICAL COGNITION; NUMBER; BRAIN; REPRESENTATIONS; ACTIVATION; NUMEROSITY; JUDGMENTS; MAGNITUDE; FMRI	It is well established that the intraparietal sulcus (IPS) plays an important role in the processing and representation of numerical magnitude. Two recent studies by Piazza et al. and Cohen Kadosh et al. published in this issue of Neuron used fMRI adaptation to explore the extent to which parietal number processing is dependent upon or independent of a numbers' surface format. Their results, while slightly different, converge to suggest that the answer may be neither, but rather that it depends on the hemisphere.	Univ Western Ontario, Dept Psychol, Numer Cognit Lab, London, ON N6A 5B8, Canada	Western University (University of Western Ontario)	Ansari, D (corresponding author), Univ Western Ontario, Dept Psychol, Numer Cognit Lab, London, ON N6A 5B8, Canada.	daniel.ansari@uwo.ca	Ansari, Daniel/B-2832-2009	Ansari, Daniel/0000-0002-7625-618X				CAMPBELL JID, 1994, COGNITION, V53, P1, DOI 10.1016/0010-0277(94)90075-2; Cantlon JF, 2006, PLOS BIOL, V4, P844, DOI 10.1371/journal.pbio.0040125; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Dehaene S, 1996, J COGNITIVE NEUROSCI, V8, P47, DOI 10.1162/jocn.1996.8.1.47; Gobel SM, 2004, J COGNITIVE NEUROSCI, V16, P1536, DOI 10.1162/0898929042568442; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Kadosh RC, 2005, NEUROPSYCHOLOGIA, V43, P1238, DOI 10.1016/j.neuropsychologia.2004.12.017; Kadosh RC, 2007, NEURON, V53, P307, DOI 10.1016/j.neuron.2006.12.025; MCCLOSKEY M, 1992, COGNITION, V44, P107, DOI 10.1016/0010-0277(92)90052-J; Nieder A, 2006, SCIENCE, V313, P1431, DOI 10.1126/science.1130308; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Rivera SM, 2005, CEREB CORTEX, V15, P1779, DOI 10.1093/cercor/bhi055; Seron X, 2006, CORTEX, V42, P406, DOI 10.1016/S0010-9452(08)70370-8; Shuman M, 2004, NEURON, V44, P557, DOI 10.1016/j.neuron.2004.10.008	19	57	58	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					165	167		10.1016/j.neuron.2007.01.001	http://dx.doi.org/10.1016/j.neuron.2007.01.001			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224400	Bronze			2022-12-28	WOS:000245126600004
J	Krashes, MJ; Keene, AC; Leung, B; Armstrong, JD; Waddell, S				Krashes, Michael J.; Keene, Alex C.; Leung, Benjamin; Armstrong, J. Douglas; Waddell, Scott			Sequential use of mushroom body neuron subsets during Drosophila odor memory processing	NEURON			English	Article							SHORT-TERM-MEMORY; CONSOLIDATED MEMORY; COURTSHIP BEHAVIOR; MUTANT DROSOPHILA; OLFACTORY MEMORY; BODIES; MELANOGASTER; GENE; BRAIN; REPRESENTATIONS	Drosophila mushroom bodies (MB) are bilaterally symmetric multilobed brain structures required for olfactory memory. Previous studies suggested that neurotransmission from MB neurons is only required for memory retrieval. Our unexpected observation that Dorsal Paired Medial (DPM) neurons, which project only to MB neurons, are required during memory storage but not during acquisition or retrieval, led us to revisit the role of MB neurons in memory processing. We show that neurotransmission from the alpha'beta' subset of MB neurons is required to acquire and stabilize aversive and appetitive odor memory, but is dispensable during memory retrieval. In contrast, neurotransmission from MB alpha beta neurons is only required for memory retrieval. These data suggest a dynamic requirement for the different subsets of MB, neurons in memory and are consistent with the notion that recurrent activity in an MB alpha'beta' neuron-DPM neuron loop is required to stabilize memories formed in the MB alpha beta neurons.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; Univ Edinburgh, Sch Informat, Inst Adapt & Neural Computat, Edinburgh EH1 2QL, Midlothian, Scotland	University of Massachusetts System; University of Massachusetts Worcester; University of Edinburgh	Waddell, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	scott.waddell@umassmed.edu	Krashes, Michael/P-7677-2019	Armstrong, Douglas/0000-0002-5397-3864; Waddell, Scott/0000-0003-4503-6229	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH073311, F31MH009883, R01MH069883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007366] Funding Source: NIH RePORTER; NIMH NIH HHS [MH073311, R01 MH069883, F31 MH073311, F31 MH073311-02, MH09883] Funding Source: Medline; NINDS NIH HHS [NS007366, T32 NS007366] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akalal DBG, 2006, LEARN MEMORY, V13, P659, DOI 10.1101/lm.221206; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Daly KC, 2004, P NATL ACAD SCI USA, V101, P10476, DOI 10.1073/pnas.0401902101; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dubnau J, 2001, NATURE, V411, P476, DOI 10.1038/35078077; Dudai Y, 2004, ANNU REV PSYCHOL, V55, P51, DOI 10.1146/annurev.psych.55.090902.142050; Durstewitz D, 2000, NAT NEUROSCI, V3, P1184, DOI 10.1038/81460; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FOLKERS E, 1993, P NATL ACAD SCI USA, V90, P8123, DOI 10.1073/pnas.90.17.8123; Glanzman DL, 2006, BIOL BULL-US, V210, P271, DOI 10.2307/4134563; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Hammer M, 1998, LEARN MEMORY, V5, P146; Hawkins RD, 2006, BIOL BULL-US, V210, P174, DOI 10.2307/4134556; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Lukowiak K, 2003, J EXP BIOL, V206, P2097, DOI 10.1242/jeb.00374; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Mao ZM, 2004, P NATL ACAD SCI USA, V101, P198, DOI 10.1073/pnas.0306128101; Martin JR, 1998, LEARN MEMORY, V5, P179; Martini SR, 2005, J NEUROBIOL, V64, P133, DOI 10.1002/neu.20130; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire SE, 2001, SCIENCE, V293, P1330, DOI 10.1126/science.1062622; Menzel R, 2006, CELL, V124, P237, DOI 10.1016/j.cell.2006.01.011; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Riemensperger T, 2005, CURR BIOL, V15, P1953, DOI 10.1016/j.cub.2005.09.042; Schwaerzel M, 2002, NEURON, V35, P951, DOI 10.1016/S0896-6273(02)00832-2; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Tang SM, 2001, SCIENCE, V294, P1543, DOI 10.1126/science.1058237; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672	51	289	289	0	28	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					103	115		10.1016/j.neuron.2006.11.021	http://dx.doi.org/10.1016/j.neuron.2006.11.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196534	Green Accepted, Bronze			2022-12-28	WOS:000245126500012
J	Wehrman, T; He, XL; Raab, B; Dukipatti, A; Blau, H; Garcia, KC				Wehrman, Tom; He, Xiaolin; Raab, Bill; Dukipatti, Abhiram; Blau, Helen; Garcia, K. Christopher			Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors	NEURON			English	Article							AFFINITY NGF RECEPTOR; NF-KAPPA-B; LEUCINE-RICH MOTIF; NEUROTROPHIN RECEPTOR; FUNCTIONAL INTERACTIONS; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; LIGAND-BINDING; TYROSINE KINASE; SCATCHARD PLOTS	Nerve growth factor engages two structurally distinct transmembrane receptors, TrkA and p75, which have been proposed to create a "high-affinity" NGF binding site through formation of a ternary TrkA/NGF/p75 complex. To define a structural basis for the high-affinity site, we have determined the three-dimensional structure of a complete extracellular domain of TrkA complexed with NGF. The complex reveals a crab-shaped homodimeric TrkA structure, but a mechanism for p75 coordination is not obvious. We investigated the heterodimerization of membrane-bound TrkA and p75, on intact mammalian cells, using a beta-gal proteinprotein interaction system. We find that NGF dimerizes TrkA and that p75 exists on the cell surface as a preformed oligomer that is not dissociated by NGF. We find no evidence for a direct TrkA/p75 interaction. We propose that TrkA and p75 likely communicate through convergence of downstream signaling pathways and/or shared adaptor molecules, rather than through direct extracellular interactions.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Baxter Lab Genet Pharmacol, Dept Microbiol & Immunol,Stem Cell Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Dukkipati, Abhiram/0000-0001-7267-7131	NIA NIH HHS [AG009521, AG024987, AG020961] Funding Source: Medline; NIBIB NIH HHS [EB005011] Funding Source: Medline; NICHD NIH HHS [HD018179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005011] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG020961, R01AG009521, R01AG024987] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arevalo JC, 2000, MOL CELL BIOL, V20, P5908, DOI 10.1128/MCB.20.16.5908-5916.2000; Arevalo JC, 2001, ONCOGENE, V20, P1229, DOI 10.1038/sj.onc.1204215; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; BARKER PA, 1994, NEURON, V13, P203, DOI 10.1016/0896-6273(94)90470-7; BATTLEMAN DS, 1993, J NEUROSCI, V13, P941; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Bilderback TR, 2001, J NEUROCHEM, V76, P1540, DOI 10.1046/j.1471-4159.2001.00171.x; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burke MA, 2003, J NEUROBIOL, V55, P191, DOI 10.1002/neu.10174; Carter BD, 1996, SCIENCE, V272, P542, DOI 10.1126/science.272.5261.542; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; COHEN S, 1959, J BIOL CHEM, V234, P1129; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Frade JM, 1996, NATURE, V383, P166; GROB PM, 1983, P NATL ACAD SCI-BIOL, V80, P6819, DOI 10.1073/pnas.80.22.6819; Hamanoue M, 1999, MOL CELL NEUROSCI, V14, P28, DOI 10.1006/mcne.1999.0770; HANTZOPOULOS PA, 1994, NEURON, V13, P187, DOI 10.1016/0896-6273(94)90469-3; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HEMPSTEAD BL, 1990, J BIOL CHEM, V265, P9595; Howe CL, 2005, CURR OPIN NEUROBIOL, V15, P40, DOI 10.1016/j.conb.2005.01.010; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; IBANEZ CF, 1992, CELL, V69, P329, DOI 10.1016/0092-8674(92)90413-7; JING SQ, 1992, NEURON, V9, P1067, DOI 10.1016/0896-6273(92)90066-M; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Kalb R, 2005, TRENDS NEUROSCI, V28, P5, DOI 10.1016/j.tins.2004.11.003; KAPLAN DR, 1991, SCIENCE, V252, P554, DOI 10.1126/science.1850549; Karchewski LA, 1999, J COMP NEUROL, V413, P327, DOI 10.1002/(SICI)1096-9861(19991018)413:2<327::AID-CNE11>3.0.CO;2-3; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KLOTZ IM, 1984, J BIOL CHEM, V259, P60; KOBE B, 1994, TRENDS BIOCHEM SCI, V19, P415, DOI 10.1016/0968-0004(94)90090-6; Lachyankar MB, 2003, J NEUROSCI RES, V71, P157, DOI 10.1002/jnr.10480; Lad SP, 2003, J BIOL CHEM, V278, P24808, DOI 10.1074/jbc.M212270200; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; MacDonald JIS, 1996, MOL CELL NEUROSCI, V7, P371, DOI 10.1006/mcne.1996.0027; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Majdan M, 1997, J NEUROSCI, V17, P6988; Mischel PS, 2001, J BIOL CHEM, V276, P11294, DOI 10.1074/jbc.M005132200; Nekhai SA, 1997, BIOCHEM J, V325, P401, DOI 10.1042/bj3250401; NICOSIA S, 1988, PHARMACOL RES, V20, P733, DOI 10.1016/S0031-6989(88)80713-6; Nykjaer A, 2005, CURR OPIN NEUROBIOL, V15, P49, DOI 10.1016/j.conb.2005.01.004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEREZ P, 1995, MOL CELL NEUROSCI, V6, P97, DOI 10.1006/mcne.1995.1010; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; Roux PP, 2002, PROG NEUROBIOL, V67, P203, DOI 10.1016/S0301-0082(02)00016-3; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Teng KK, 2004, CELL MOL LIFE SCI, V61, P35, DOI 10.1007/s00018-003-3099-3; Urfer R, 1998, J BIOL CHEM, V273, P5829, DOI 10.1074/jbc.273.10.5829; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730; Wang JJL, 2000, J NEUROSCI RES, V60, P587, DOI 10.1002/(SICI)1097-4547(20000601)60:5<587::AID-JNR3>3.0.CO;2-1; Wang X, 2001, J BIOL CHEM, V276, P33812, DOI 10.1074/jbc.M010548200; Watson FL, 1999, J NEUROBIOL, V39, P323, DOI 10.1002/(SICI)1097-4695(199905)39:2<323::AID-NEU15>3.0.CO;2-4; Wehrman TS, 2006, P NATL ACAD SCI USA, V103, P19063, DOI 10.1073/pnas.0605218103; Wehrman TS, 2005, NAT METHODS, V2, P521, DOI 10.1038/NMETH771; Wiesmann C, 2001, CELL MOL LIFE SCI, V58, P748, DOI 10.1007/PL00000898; Wiesmann C, 1999, NATURE, V401, P184, DOI 10.1038/43705; WINDISCH JM, 1995, FEBS LETT, V374, P125, DOI 10.1016/0014-5793(95)01047-I; WINDISCH JM, 1995, BIOCHEMISTRY-US, V34, P11256, DOI 10.1021/bi00035a035; WRIGHT DE, 1995, J COMP NEUROL, V351, P329, DOI 10.1002/cne.903510302; Yano H, 2000, Pharm Acta Helv, V74, P253, DOI 10.1016/S0031-6865(99)00036-9; Ye X, 1999, J BIOL CHEM, V274, P30202, DOI 10.1074/jbc.274.42.30202; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Zaccaro MC, 2001, J BIOL CHEM, V276, P31023, DOI 10.1074/jbc.M104630200; ZIERLER K, 1989, TRENDS BIOCHEM SCI, V14, P314, DOI 10.1016/0968-0004(89)90157-6	75	220	236	1	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 4	2007	53	1					25	38		10.1016/j.neuron.2006.09.034	http://dx.doi.org/10.1016/j.neuron.2006.09.034			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196528	Bronze			2022-12-28	WOS:000245126500006
J	Narayanan, NS; Laubach, M				Narayanan, Nandakumar S.; Laubach, Mark			Top-down control of motor cortex ensembles by dorsomedial prefrontal cortex	NEURON			English	Article							CINGULATE UNIT-ACTIVITY; MEDIAL FRONTAL-CORTEX; SUBTHALAMIC NUCLEUS; EFFECTIVE CONNECTIVITY; DISCRIMINANT-ANALYSIS; RESPONSE-INHIBITION; NEURONAL-ACTIVITY; LOCUS-COERULEUS; SPIKE TRAINS; ELAPSED TIME	Dorsomedial prefrontal cortex is critical for the temporal control of behavior. Dorsomedial prefrontal cortex might alter neuronal activity in areas such as motor cortex to inhibit temporally inappropriate responses. We tested this hypothesis by recording from neuronal ensembles in rodent dorsomedial prefrontal cortex during a delayed-response task. One-third of dorsomedial prefrontal neurons were significantly modulated during the delay period. The activity of many of these neurons was predictive of premature responding. We then reversibly inactivated dorsomedial prefrontal cortex while recording ensemble activity in motor cortex. Inactivation of dorsomedial prefrontal cortex reduced delay-related firing, but not response-related firing, in motor cortex. Finally, we made simultaneous recordings in dorsomedial prefrontal cortex and motor cortex and found strong delay-related temporal correlations between neurons in the two cortical areas. These data suggest that functional interactions between dorsomedial prefrontal cortex and motor cortex might serve as a top-down control signal that inhibits inappropriate responding.	John B Pierce Fdn Lab, New Haven, CT 06519 USA; Yale Univ, Interdept Neurosci Program, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University; The John B Pierce Laboratory, Inc; Yale University; Yale University	Laubach, M (corresponding author), John B Pierce Fdn Lab, New Haven, CT 06519 USA.	mark.laubach@yale.edu		Narayanan, Nandakumar/0000-0002-0427-0003; Laubach, Mark/0000-0002-2403-4497	NIGMS NIH HHS [T32 GM007205] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Barkley RA., 1997, ADHD NATURE SELF CON; Baunez C, 1997, EUR J NEUROSCI, V9, P2086, DOI 10.1111/j.1460-9568.1997.tb01376.x; Broersen LM, 1999, NEUROSCIENCE, V94, P47, DOI 10.1016/S0306-4522(99)00312-7; Brunia CHM, 1999, ACTA PSYCHOL, V101, P213, DOI 10.1016/S0001-6918(99)00006-2; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Chafee MV, 2000, J NEUROPHYSIOL, V83, P1550, DOI 10.1152/jn.2000.83.3.1550; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407; Divac I, 1993, Acta Neurobiol Exp (Wars), V53, P425; DONOGHUE JP, 1982, J COMP NEUROL, V212, P76, DOI 10.1002/cne.902120106; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Fuster JM, 2000, BRAIN RES BULL, V52, P331, DOI 10.1016/S0361-9230(99)00258-0; Gabbott PLA, 2005, J COMP NEUROL, V492, P145, DOI 10.1002/cne.20738; Genovesio A, 2006, J NEUROPHYSIOL, V95, P3281, DOI 10.1152/jn.01011.2005; Genovesio A, 2005, NEURON, V47, P307, DOI 10.1016/j.neuron.2005.06.006; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Jacobsen C, 1936, COMP PSYCHOL MONOGR, V13, P1, DOI DOI 10.1001/ARCHNEURPSYC.1935.02250150108009; Janssen P, 2005, NAT NEUROSCI, V8, P234, DOI 10.1038/nn1386; KOLB B, 1984, BRAIN RES REV, V8, P65, DOI 10.1016/0165-0173(84)90018-3; Kyuhou S, 2002, BRAIN RES, V929, P101, DOI 10.1016/S0006-8993(01)03383-2; Laubach M, 2004, J NEUROSCI METH, V134, P159, DOI 10.1016/j.jneumeth.2003.11.007; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Lee HS, 2005, J COMP NEUROL, V481, P179, DOI 10.1002/cne.20365; LEGENDY CR, 1985, J NEUROPHYSIOL, V53, P926, DOI 10.1152/jn.1985.53.4.926; Leon MI, 2003, NEURON, V38, P317, DOI 10.1016/S0896-6273(03)00185-5; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Los SA, 2001, ACTA PSYCHOL, V106, P121, DOI 10.1016/S0001-6918(00)00029-9; LOUGHLIN SE, 1982, BRAIN RES BULL, V9, P287, DOI 10.1016/0361-9230(82)90142-3; Maimon G, 2006, NAT NEUROSCI, V9, P948, DOI 10.1038/nn1716; Martin JH, 1999, J NEUROSCI METH, V86, P145, DOI 10.1016/S0165-0270(98)00163-0; Milad MR, 2004, BEHAV NEUROSCI, V118, P389, DOI 10.1037/0735-7044.118.2.389; Miller BT, 2005, NEURON, V48, P535, DOI 10.1016/j.neuron.2005.11.002; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moore T, 2004, J NEUROPHYSIOL, V91, P152, DOI 10.1152/jn.00741.2002; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Mulder AB, 2003, BEHAV BRAIN RES, V146, P77, DOI 10.1016/j.bbr.2003.09.016; Naito E, 2000, J NEUROPHYSIOL, V83, P1701, DOI 10.1152/jn.2000.83.3.1701; Narayanan NS, 2006, NEUROSCIENCE, V139, P865, DOI 10.1016/j.neuroscience.2005.11.072; Narayanan NS, 2005, J NEUROSCI, V25, P4207, DOI 10.1523/JNEUROSCI.4697-04.2005; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; NEAFSEY EJ, 1982, BRAIN RES, V232, P151, DOI 10.1016/0006-8993(82)90617-5; NIKI H, 1979, BRAIN RES, V171, P213, DOI 10.1016/0006-8993(79)90328-7; NIKI H, 1976, BRAIN RES, V110, P381, DOI 10.1016/0006-8993(76)90412-1; OLLMAN RT, 1972, COGNITIVE PSYCHOL, V3, P311, DOI 10.1016/0010-0285(72)90010-2; PREUSS TM, 1995, J COGNITIVE NEUROSCI, V7, P1, DOI 10.1162/jocn.1995.7.1.1; REEP RL, 1987, BRAIN RES BULL, V19, P203, DOI 10.1016/0361-9230(87)90086-4; Risterucci C, 2003, EUR J NEUROSCI, V17, P1498, DOI 10.1046/j.1460-9568.2003.02541.x; ROUILLER EM, 1993, SOMATOSENS MOT RES, V10, P269, DOI 10.3109/08990229309028837; Rowe JB, 2005, CEREB CORTEX, V15, P85, DOI 10.1093/cercor/bhh111; RYAN LJ, 1991, EXP BRAIN RES, V86, P641; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Stuss DT, 2005, NEUROPSYCHOLOGIA, V43, P396, DOI 10.1016/j.neuropsychologia.2004.06.010; Swanson LW, 1999, BRAIN MAPS STRUCTURE; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Uylings HBM, 2003, BEHAV BRAIN RES, V146, P3, DOI 10.1016/j.bbr.2003.09.028; VAADIA E, 1995, P ROY SOC B-BIOL SCI, V261, P407, DOI 10.1098/rspb.1995.0167; VANEDEN CG, 1992, EUR J NEUROSCI, V4, P77; Vertes RP, 2004, SYNAPSE, V51, P32, DOI 10.1002/syn.10279; WATERHOUSE BD, 1986, J COMP NEUROL, V249, P460, DOI 10.1002/cne.902490403; WHISHAW IQ, 1992, BEHAV BRAIN RES, V50, P93, DOI 10.1016/S0166-4328(05)80291-8; WICHMANN T, 1994, J NEUROPHYSIOL, V72, P521, DOI 10.1152/jn.1994.72.2.521; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411	67	228	229	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					921	931		10.1016/j.neuron.2006.10.021	http://dx.doi.org/10.1016/j.neuron.2006.10.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145511	Green Accepted, Bronze			2022-12-28	WOS:000242856400018
J	Jaeger, T; Mecklinger, A; Kipp, KH				Jaeger, Theodor; Mecklinger, Axel; Kipp, Kerstin H.			Intra- and inter-item associations doubly dissociate the electrophysiological correlates of familiarity and recollection	NEURON			English	Article							RECOGNITION MEMORY; EPISODIC MEMORY; NEOCORTICAL CONTRIBUTIONS; COGNITIVE NEUROSCIENCE; MILD HYPOXIA; HIPPOCAMPAL; BRAIN; RETRIEVAL; ITEM; EXPERIENCE	Single-process models of recognition memory posit that recognizing is based on a unidimensional value of global memory strength. By contrast, dual-process models propose the existence of two independent processes subserving the explicit recognition of previously encountered episodes, namely "familiarity" and "recollection." Familiarity represents a noncontextual form of recognition that may only support the retrieval of associative information when the to-be-associated information can be unitized, such as when two photographs depicting the same person are memorized (intra-item associations). Conversely, recollection enables retrieving associations between arbitrarily linked information, such as associations between photographs of different persons (inter-item associations). By measuring event-related brain potentials (ERPs), we obtained a double dissociation of familiarity and recollection that strongly favors dual-process accounts of recognition memory: the electrophysiological correlate of familiarity was significantly larger for intra- than for inter-item associations. Conversely, the electrophysiological correlate of recollection was significantly larger for inter- than for intra-item associations.	Univ Saarland, Dept Psychol, Expt Neuropsychol Unit, D-66123 Saarbrucken, Germany	Saarland University	Mecklinger, A (corresponding author), Univ Saarland, Dept Psychol, Expt Neuropsychol Unit, D-66123 Saarbrucken, Germany.	mecklinger@mx.uni-saarland.de						Achim AM, 2005, J COGNITIVE NEUROSCI, V17, P652, DOI 10.1162/0898929053467578; Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aggleton JP, 1996, NEUROPSYCHOLOGIA, V34, P51, DOI 10.1016/0028-3932(95)00150-6; Brown MW, 2002, PHILOS T R SOC B, V357, P1083, DOI 10.1098/rstb.2002.1097; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; Buckley MJ, 2006, TRENDS COGN SCI, V10, P100, DOI 10.1016/j.tics.2006.01.008; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Curran T., 2006, BINDING HUMAN MEMORY, P467, DOI DOI 10.1093/ACPROF:OSO/9780198529675.003.0018; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; Donaldson DI, 1999, COGNITIVE BRAIN RES, V8, P1, DOI 10.1016/S0926-6410(98)00051-2; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Donaldson W, 1996, MEM COGNITION, V24, P523, DOI 10.3758/BF03200940; Duarte A, 2004, COGNITIVE BRAIN RES, V18, P255, DOI 10.1016/j.cogbrainres.2003.10.010; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; EICHENBAUM H, 1995, CURR DIR PSYCHOL SCI, V4, P19, DOI 10.1111/1467-8721.ep10770954; Eichenbaum H, 1997, ANNU REV PSYCHOL, V48, P547, DOI 10.1146/annurev.psych.48.1.547; Finnigan S, 2002, NEUROPSYCHOLOGIA, V40, P2288, DOI 10.1016/S0028-3932(02)00113-6; Friedman D, 2000, NEUROPSYCHOLOGIA, V38, P542, DOI 10.1016/S0028-3932(99)00122-0; Friedman D, 2000, MICROSC RES TECHNIQ, V51, P6, DOI 10.1002/1097-0029(20001001)51:1<6::AID-JEMT2>3.0.CO;2-R; GILLUND G, 1984, PSYCHOL REV, V91, P1, DOI 10.1037/0033-295X.91.1.1; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henson RNA, 2003, HIPPOCAMPUS, V13, P301, DOI 10.1002/hipo.10117; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 2005, J COGNITIVE NEUROSCI, V17, P1058, DOI 10.1162/0898929054475208; JACOBY LL, 1991, J MEM LANG, V30, P513, DOI 10.1016/0749-596X(91)90025-F; JAGER T, 2005, PSYDOC ONLINE; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; Mangels JA, 2001, COGNITIVE BRAIN RES, V11, P77, DOI 10.1016/S0926-6410(00)00066-5; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; Mayes AR, 2004, HIPPOCAMPUS, V14, P763, DOI 10.1002/hipo.10211; Mecklinger A, 1996, J COGNITIVE NEUROSCI, V8, P453, DOI 10.1162/jocn.1996.8.5.453; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2002, TRENDS COGN SCI, V6, P505, DOI 10.1016/S1364-6613(02)02005-3; OPITZ B, 2006, J COGNITIVE NEUROSCI, V8, P453; Otten LJ, 2002, TRENDS NEUROSCI, V25, P279, DOI 10.1016/S0166-2236(02)02176-8; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Quamme JR, 2004, NEUROPSYCHOLOGIA, V42, P672, DOI 10.1016/j.neuropsychologia.2003.09.008; QUAMME JR, 2004, THESIS U CALIFORNIA; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Rugg MD, 2003, TRENDS COGN SCI, V7, P313, DOI 10.1016/S1364-6613(03)00131-1; Schacter DL, 1998, ANNU REV PSYCHOL, V49, P289, DOI 10.1146/annurev.psych.49.1.289; SMITH ME, 1993, J COGNITIVE NEUROSCI, V5, P1, DOI 10.1162/jocn.1993.5.1.1; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Tsivilis D, 2001, NEURON, V31, P497, DOI 10.1016/S0896-6273(01)00376-2; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Voss JL, 2006, J NEUROSCI, V26, P926, DOI 10.1523/JNEUROSCI.3931-05.2006; Wagner AD, 1999, PHILOS T R SOC B, V354, P1307, DOI 10.1098/rstb.1999.0481; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; Wais PE, 2006, NEURON, V49, P459, DOI 10.1016/j.neuron.2005.12.020; Woodruff CC, 2006, BRAIN RES, V1100, P125, DOI 10.1016/j.brainres.2006.05.019; Yonelinas AP, 2002, J MEM LANG, V46, P441, DOI 10.1006/jmla.2002.2864; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961; Yonelinas AP, 2001, NEUROREPORT, V12, P359, DOI 10.1097/00001756-200102120-00035; Yonelinas AP, 1999, PSYCHON B REV, V6, P654, DOI 10.3758/BF03212975; Yonelinas AP, 2005, J NEUROSCI, V25, P3002, DOI 10.1523/JNEUROSCI.5295-04.2005; Yovel G, 2004, NEUROIMAGE, V21, P789, DOI 10.1016/j.neuroimage.2003.09.034	59	97	100	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					535	545		10.1016/j.neuron.2006.09.013	http://dx.doi.org/10.1016/j.neuron.2006.09.013			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	108WK	17088218	Bronze			2022-12-28	WOS:000242269700015
J	Hansel, C; de Jeu, M; Belmeguenai, A; Houtman, SH; Buitendijk, GHS; Andreev, D; De Zeeuw, CI; Elgersma, Y				Hansel, Christian; de Jeu, Marcel; Belmeguenai, Amor; Houtman, Simone H.; Buitendijk, Gabrielle H. S.; Andreev, Dmitri; De Zeeuw, Chris I.; Elgersma, Ype			alpha CaMKII is essential for cerebellar LTD and motor learning	NEURON			English	Article							LONG-TERM DEPRESSION; AMPA RECEPTOR TRAFFICKING; CALMODULIN KINASE-II; RAT PURKINJE-CELLS; PROTEIN-KINASE; MUTANT MICE; VESTIBULOOCULAR REFLEX; C INHIBITOR; PLASTICITY; POTENTIATION	Activation of postsynaptic alpha-calclum/calmodulin-dependent protein kinase II (alpha CaMKII) by calcium influx is a prerequisite for the induction of long-term potentiation (LTP) at most excitatory synapses in the hippocampus and cortex. Here we show that postsynaptic UP is unaffected at parallel fiber-Purkinje cell synapses in the cerebellum of alpha CaMKII-/- mice. In contrast, a long-term depression (LTD) protocol resulted in only transient depression in juvenile alpha CaMKII-/- mutants and in robust potentiation in adult mutants. This suggests that the function of alpha CaMKII in parallel fiber-Purkinje cell plasticity is opposite to its function at excitatory hippocampal and cortical synapses. Furthermore, alpha CaMKII-/- mice showed impaired gain-increase adaptation of both the vestibular ocular reflex and optokinetic reflex. Since Purkinje cells are the only cells in the cerebellum that express alpha CaMKII, our data suggest that an impairment of parallel fiber LTD, while leaving UP intact, is sufficient to disrupt this form of cerebellar learning.	Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	De Zeeuw, CI (corresponding author), Erasmus MC, Dept Neurosci, POB 2040, NL-3000 CA Rotterdam, Netherlands.	c.dezeeuw@erasmusmo.nl; y.elgersma@erasmusmc.nl	Elgersma, Ype/F-5164-2013	Elgersma, Ype/0000-0002-3758-1297				Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Belmeguenai A, 2005, J NEUROSCI, V25, P10768, DOI 10.1523/JNEUROSCI.2876-05.2005; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; De Zeeuw CI, 2005, CURR OPIN NEUROBIOL, V15, P667, DOI 10.1016/j.conb.2005.10.008; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DEZEEUW CI, 1989, J COMP NEUROL, V284, P12, DOI 10.1002/cne.902840103; Elgersma Y, 2004, J NEUROSCI, V24, P8410, DOI 10.1523/JNEUROSCI.3622-04.2004; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Faulstich BM, 2004, VISION RES, V44, P3419, DOI 10.1016/j.visres.2004.09.006; Feil R, 2003, J CELL BIOL, V163, P295, DOI 10.1083/jcb.200306148; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Glazewski S, 1996, SCIENCE, V272, P421, DOI 10.1126/science.272.5260.421; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; Hoebeek FE, 2005, NEURON, V45, P953, DOI 10.1016/j.neuron.2005.02.012; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; Jaarsma D, 2001, ACTA NEUROPATHOL, V102, P293; Kakegawa W, 2005, P NATL ACAD SCI USA, V102, P17846, DOI 10.1073/pnas.0508910102; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; KARACHOT L, 1994, NEUROSCI RES, V21, P161, DOI 10.1016/0168-0102(94)90158-9; Kasahara J, 1998, NEUROSCI LETT, V247, P139, DOI 10.1016/S0304-3940(98)00299-7; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399; LINDEN DJ, 1991, SCIENCE, V254, P1656, DOI 10.1126/science.1721243; Linden DJ, 2001, P NATL ACAD SCI USA, V98, P14066, DOI 10.1073/pnas.241384598; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Poncer JC, 2002, J NEUROSCI, V22, P4406, DOI 10.1523/JNEUROSCI.22-11-04406.2002; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Silva AJ, 1996, CURR BIOL, V6, P1509, DOI 10.1016/S0960-9822(96)00756-7; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stahl JS, 2000, J NEUROSCI METH, V99, P101, DOI 10.1016/S0165-0270(00)00218-1; SURNI M, 1991, BIOCHEM BIOPH RES CO, V181, P968; van Alphen AM, 2002, EUR J NEUROSCI, V16, P486, DOI 10.1046/j.1460-9568.2002.02094.x; WALAAS SI, 1988, MOL BRAIN RES, V4, P233, DOI 10.1016/0169-328X(88)90029-0; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1	49	165	167	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					835	843		10.1016/j.neuron.2006.08.013	http://dx.doi.org/10.1016/j.neuron.2006.08.013			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982427	Bronze			2022-12-28	WOS:000240997900020
J	Seburn, KL; Nangle, LA; Cox, GA; Schimmel, P; Burgess, RW				Seburn, Kevin L.; Nangle, Leslie A.; Cox, Gregory A.; Schimmel, Paul; Burgess, Robert W.			An active dominant mutation of Glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; DISEASE TYPE 2D; ATROPHY TYPE-V; SCHWANN-CELLS; HEREDITARY MOTOR; GENE MUTATION; MICE; TRANSLATION; MECHANISMS; CMT2D	the many inherited Charcot-Marie-Tooth peripheral neuropathies, type 2D (CMT2D) is caused by dominant point mutations in the gene GARS, encoding glycyl tRNA synthetase (GlyRS). Here we report a dominant mutation in Gars that causes neuropathy in the mouse. Importantly, both sensory and motor axons are affected, and the dominant phenotype is not caused by a loss of the GlyRS aminoacylation function. Mutant mice have abnormal neuromuscular junction morphology and impaired transmission, reduced nerve conduction velocities, and a loss of large-diameter peripheral axons, without defects in myelination. The mutant GlyRS enzyme retains aminoacylation activity, and a loss-of-function allele, generated by a gene-trap insertion, shows no dominant phenotype in mice. These results indicate that the CMT2D phenotype is caused not by reduction of the canonical GlyRS activity and insufficiencies in protein synthesis, but instead by novel pathogenic roles for the mutant GlyRS that specifically affect peripheral neurons.	Jackson Lab, Bar Harbor, ME 04609 USA; Scripps Res Inst, La Jolla, CA 92037 USA	Jackson Laboratory; Scripps Research Institute	Burgess, RW (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	robert.burgess@jax.org		Burgess, Robert/0000-0002-9229-3407	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015539, R01GM015539, R01GM023562] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054154, U01NS041215] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM23562, GM15539] Funding Source: Medline; NINDS NIH HHS [NS054154, U01-NS041215] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGUAYO AJ, 1977, NATURE, V265, P73, DOI 10.1038/265073a0; Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Berger P, 2002, NEUROGENETICS, V4, P1, DOI 10.1007/s10048-002-0130-z; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Court FA, 2004, NATURE, V431, P191, DOI 10.1038/nature02841; Del Bo R, 2006, NEUROLOGY, V66, P752, DOI 10.1212/01.wnl.0000201275.18875.ac; Dubourg O, 2006, NEUROLOGY, V66, P1721, DOI 10.1212/01.wnl.0000218304.02715.04; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; Ionasescu V, 1996, HUM MOL GENET, V5, P1373, DOI 10.1093/hmg/5.9.1373; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Jordanova A, 2003, BRAIN, V126, P590, DOI 10.1093/brain/awg059; Kunst CB, 1997, NAT GENET, V15, P91, DOI 10.1038/ng0197-91; Lang IM, 1996, J BIOL CHEM, V271, P30126, DOI 10.1074/jbc.271.47.30126; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Mudge SJ, 1998, GENE, V209, P45, DOI 10.1016/S0378-1119(98)00007-9; Occhi S, 2005, J NEUROSCI, V25, P9418, DOI 10.1523/JNEUROSCI.2068-05.2005; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; Sambuughin N, 1998, J NEUROL SCI, V161, P23, DOI 10.1016/S0022-510X(98)00264-0; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Scherer SS, 2005, J NEUROSCI, V25, P1550, DOI 10.1523/JNEUROSCI.3082-04.2005; SCHREIER AA, 1972, BIOCHEMISTRY-US, V11, P1582, DOI 10.1021/bi00759a006; SEBURN KL, 1995, J APPL PHYSIOL, V78, P1673, DOI 10.1152/jappl.1995.78.5.1673; SHIBA K, 1994, J BIOL CHEM, V269, P30049; Shy ME, 2002, LANCET NEUROL, V1, P110, DOI 10.1016/S1474-4422(02)00042-X; Sivakumar K, 2005, BRAIN, V128, P2304, DOI 10.1093/brain/awh590; SKARNES WC, 1995, P NATL ACAD SCI USA, V92, P6592, DOI 10.1073/pnas.92.14.6592; SKRE H, 1974, CLIN GENET, V6, P98; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147	39	154	179	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					715	726		10.1016/j.neuron.2006.08.027	http://dx.doi.org/10.1016/j.neuron.2006.08.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982418	Bronze			2022-12-28	WOS:000240997900011
J	Tan, JMM; Dawson, TM				Tan, JMM; Dawson, TM			Parkin blushed by PINK1	NEURON			English	Editorial Material							DISEASE; DROSOPHILA; MODELS	Mutations in the PTEN-induced putative kinase 1 (PINK1) are a common cause of autosomal recessive Parkinson's disease. In a recent issue of Nature, two independent reports by Park et al. (2006) and Clark et al. (2006) show that loss of Drosophila PINK1 leads to defects in mitochondrial function resulting in male sterility, apoptotic muscle degeneration, and minor loss of dopamine neurons that is rescued by overexpression of the ubiquitin E3 ligase, parkin. Thus, PINK1 and parkin appear to function in a common pathway suggesting a convergence of the two genes most commonly associated with autosomal recessive PD.	Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Tan, JMM (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Dept Neurol, Baltimore, MD 21205 USA.							Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Cha GH, 2005, P NATL ACAD SCI USA, V102, P10345, DOI 10.1073/pnas.0500346102; CLARK IE, 2006, IN PRESS NATURE 0503; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dauer W, 2002, P NATL ACAD SCI USA, V99, P14524, DOI 10.1073/pnas.172514599; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; MOORE DJ, 2006, SCI AGING KNOWLEDGE, pPE2; PARK J, 2006, IN PRESS NATURE 0503; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Whitworth AJ, 2006, DRUG DISCOV TODAY, V11, P119, DOI 10.1016/S1359-6446(05)03693-7; Yamamoto A, 2005, J BIOL CHEM, V280, P3390, DOI 10.1074/jbc.M407724200	11	31	31	2	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY 18	2006	50	4					526	529		10.1016/j.neuron.2006.05.003	http://dx.doi.org/10.1016/j.neuron.2006.05.003			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701203	Bronze			2022-12-28	WOS:000237875200004
J	DeBruyne, JP; Noton, E; Lambert, CM; Maywood, ES; Weaver, DR; Reppert, SM				DeBruyne, Jason P.; Noton, Elizabeth; Lambert, Christopher M.; Maywood, Elizabeth S.; Weaver, David R.; Reppert, Steven M.			A clock shock: Mouse CLOCK is not required for circadian oscillator function	NEURON			English	Article							GENE-EXPRESSION; MUTANT MICE; CRE RECOMBINASE; TRANSCRIPTION; COMPONENT; DNA; MUTAGENESIS; MECHANISM; PACEMAKER; PROTEINS	The circadian clock mechanism in the mouse is composed of interlocking transcriptional feedback loops. Two transcription factors, CLOCK and BMAL1, are believed to be essential components of the circadian clock. We have used the Cre-LoxP system to generate whole-animal knockouts of CLOCK and evaluated the resultant circadian phenotypes. Surprisingly, CLOCK-deficient mice continue to express robust circadian rhythms in locomotor activity, although they do have altered responses to light. At the molecular and biochemical levels, clock gene mRNA and protein levels in both the master clock in the suprachiasmatic nuclei and a peripheral clock in the liver show alterations in the CLOCK-deficient animals, although the molecular feedback loops continue to function. Our data challenge a central feature of the current mammalian circadian clock model regarding the necessity of CLOCK:BMAL1 heterodimers for clock function.	Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England	University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology	Weaver, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	david.weaver@umassmed.edu		DeBruyne, Jason/0000-0001-9803-9568; Weaver, David/0000-0001-7941-6719	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074277] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS051458, R01NS047141] Funding Source: NIH RePORTER; MRC [MC_U105170643] Funding Source: UKRI; Medical Research Council [MC_U105170643] Funding Source: Medline; NIDDK NIH HHS [DK32520] Funding Source: Medline; NIGMS NIH HHS [F32 GM074277] Funding Source: Medline; NINDS NIH HHS [R21 NS051458, RR01NS047141] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; ALBUIN A, 1996, MOL CELL BIOL, V16, P1851; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Duffield GE, 2003, J NEUROENDOCRINOL, V15, P991, DOI 10.1046/j.1365-2826.2003.01082.x; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2004, NEURON, V43, P443, DOI 10.1016/j.neuron.2004.08.009; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hastings M.H., 1999, J NEUROSCI, V11, P1; Hogenesch JB, 1997, J BIOL CHEM, V272, P8581, DOI 10.1074/jbc.272.13.8581; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kennaway DJ, 2003, AM J PHYSIOL-REG I, V284, pR1231, DOI 10.1152/ajpregu.00697.2002; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 1997, GENETICS, V146, P1049; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Morozov A, 2003, BIOL PSYCHIAT, V54, P1125, DOI 10.1016/S0006-3223(03)00467-0; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Ochi M, 2003, NEUROSCI LETT, V347, P163, DOI 10.1016/S0304-3940(03)00688-8; Oishi K, 2002, BIOCHEM BIOPH RES CO, V298, P198, DOI 10.1016/S0006-291X(02)02427-0; Oishi K, 2000, BIOCHEM BIOPH RES CO, V268, P164, DOI 10.1006/bbrc.1999.2054; Onishi H, 2002, J NEUROSCI RES, V68, P551, DOI 10.1002/jnr.10226; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Redlin U, 2005, J COMP PHYSIOL A, V191, P51, DOI 10.1007/s00359-004-0570-z; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JA, 2000, GENE DEV, V14, P679; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SAUER B, 1987, P NATL ACAD SCI USA, V84, P9108, DOI 10.1073/pnas.84.24.9108; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; WINFREE AT, 1970, J THEOR BIOL, V28, P327, DOI 10.1016/0022-5193(70)90075-5; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	55	323	328	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 4	2006	50	3					465	477		10.1016/j.neuron.2006.03.041	http://dx.doi.org/10.1016/j.neuron.2006.03.041			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	045FA	16675400	Bronze			2022-12-28	WOS:000237726800015
J	Kenchappa, RS; Zampieri, N; Chao, MV; Barker, PA; Teng, HK; Hempstead, BL; Carter, BD				Kenchappa, RS; Zampieri, N; Chao, MV; Barker, PA; Teng, HK; Hempstead, BL; Carter, BD			Ligand-dependent cleavage of the P75 neurotrophin receptor is necessary for NRIF nuclear translocation and apoptosis in sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; REGULATED INTRAMEMBRANE PROTEOLYSIS; AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE CLEAVAGE; NECROSIS-FACTOR-ALPHA; ZINC-FINGER PROTEIN; CELL-DEATH; P75-MEDIATED DEATH; NOGO RECEPTOR; IN-VITRO	The p75 neurotrophin receptor regulates neuronal survival, promoting it in some contexts yet activating apoptosis in others. The mechanism by which the receptor elicits these differential effects is poorly understood. Here, we demonstrate that p75 is cleaved by gamma-secretase in sympathetic neurons, specifically in response to proapoptotic ligands. This cleavage resulted in ubiquitination and subsequent nuclear translocation of NRIF, a DNA binding protein essential for p75-mediated apoptosis. Inhibition of gamma-secretase or expression of a mutant p75 resistant to this protease prevented receptor proteolysis, blocked NRIF nuclear entry, and prevented apoptosis. In contrast, overexpression of the p75 ICD resulted in NRIF nuclear accumulation and apoptosis. The receptor proteolysis and NRIF nuclear localization were also observed in vivo during naturally occurring cell death in the superior cervical ganglia. These results indicate that p75-mediated apoptosis requires gamma-secretase dependent release of its ICD, which facilitates nuclear translocation of NRIF.	Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37232 USA; Vanderbilt Univ, Sch Med, Ctr Mol Neurosci, Nashville, TN 37232 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; McGill Univ, Inst Neurol, Montreal, PQ H3A 2B4, Canada; Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Vanderbilt University; Vanderbilt University; New York University; New York University; McGill University; Cornell University	Carter, BD (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37232 USA.	bruce.carter@vanderbilt.edu		Zampieri, Niccolo/0000-0002-2228-9453; Chao, Moses/0000-0002-6969-3744	NICHD NIH HHS [HD23315] Funding Source: Medline; NINDS NIH HHS [NS21072, NS38220, NS30658] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R01NS038220] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bamji SX, 1998, J CELL BIOL, V140, P911, DOI 10.1083/jcb.140.4.911; Barde YA, 2004, P NATL ACAD SCI USA, V101, P5703, DOI 10.1073/pnas.0401374101; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Becker EBE, 2004, J NEUROSCI, V24, P8762, DOI 10.1523/JNEUROSCI.2953-04.2004; Berezovska O, 2000, ANN NY ACAD SCI, V920, P223; Bhakar AL, 2003, J NEUROSCI, V23, P11373; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; Chang Y, 2003, J BIOL CHEM, V278, P51100, DOI 10.1074/jbc.M309561200; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chittka A, 2004, J CELL BIOL, V164, P985, DOI 10.1083/jcb.200301106; Chittka A, 1999, P NATL ACAD SCI USA, V96, P10705, DOI 10.1073/pnas.96.19.10705; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DISTEFANO PS, 1993, J NEUROSCI, V13, P2405, DOI 10.1523/JNEUROSCI.13-06-02405.1993; DISTEFANO PS, 1990, BRAIN RES, V534, P340, DOI 10.1016/0006-8993(90)90154-4; Domeniconi M, 2005, NEURON, V46, P849, DOI 10.1016/j.neuron.2005.05.029; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Fortini ME, 2002, NAT REV MOL CELL BIO, V3, P673, DOI 10.1038/nrm910; Frade JM, 2005, J NEUROSCI, V25, P1407, DOI 10.1523/JNEUROSCI.3798-04.2005; Frade JM, 1999, DEVELOPMENT, V126, P683; Frade JM, 1998, NEURON, V20, P35, DOI 10.1016/S0896-6273(00)80432-8; Frade JM, 1996, NATURE, V383, P166; Frankowski H, 2002, NEUROMOL MED, V1, P153; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gentry JJ, 2004, J BIOL CHEM, V279, P16646, DOI 10.1074/jbc.M309209200; Gentry JJ, 2004, PROG BRAIN RES, V146, P25, DOI 10.1016/S0079-6123(03)46002-0; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Khursigara G, 1999, J BIOL CHEM, V274, P2597, DOI 10.1074/jbc.274.5.2597; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Liao YF, 2004, J BIOL CHEM, V279, P49523, DOI 10.1074/jbc.M402034200; Linggi MS, 2005, J BIOL CHEM, V280, P13801, DOI 10.1074/jbc.M410435200; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Mukai J, 2000, J BIOL CHEM, V275, P17566, DOI 10.1074/jbc.C000140200; Naito A, 1999, GENES CELLS, V4, P353, DOI 10.1046/j.1365-2443.1999.00265.x; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Palmada M, 2002, J CELL BIOL, V158, P453, DOI 10.1083/jcb.200112129; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Roux PP, 2001, J BIOL CHEM, V276, P23097, DOI 10.1074/jbc.M011520200; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; Seiffert D, 2000, J BIOL CHEM, V275, P34086, DOI 10.1074/jbc.M005430200; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Tcherpakov M, 2002, J BIOL CHEM, V277, P49101, DOI 10.1074/jbc.C200533200; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Wong ST, 2002, NAT NEUROSCI, V5, P1302, DOI 10.1038/nn975; Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zampieri N, 2005, J BIOL CHEM, V280, P14563, DOI 10.1074/jbc.M412957200	68	140	143	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					219	232		10.1016/j.neuron.2006.03.011	http://dx.doi.org/10.1016/j.neuron.2006.03.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630834	Bronze			2022-12-28	WOS:000237176700010
J	Bi, AD; Cui, JJ; Ma, YP; Olshevskaya, E; Pu, ML; Dizhoor, AM; Pan, ZH				Bi, AD; Cui, JJ; Ma, YP; Olshevskaya, E; Pu, ML; Dizhoor, AM; Pan, ZH			Ectopic expression of a microbial-type rhodopsin restores visual responses in mice with photoreceptor degeneration	NEURON			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; RETINAL GANGLION-CELLS; RETINITIS-PIGMENTOSA; GENE-THERAPY; GREEN-ALGAE; TRANSGENE EXPRESSION; BIPOLAR CELLS; BETA-SUBUNIT; MODEL; LIGHT	The death of photoreceptor cells caused by retinal degenerative diseases often results in a complete loss of retinal responses to light. We explore the feasibility of converting inner retinal neurons to photosensitive cells as a possible strategy for imparting light sensitivity to retinas lacking rods and cones. Using delivery by an adeno-associated viral vector, here, we show that long-term expression of a microbial-type rhodopsin, channelrhodopsin-2 (ChR2), can be achieved in rodent inner retinal neurons in vivo. Furthermore, we demonstrate that expression of ChR2 in surviving inner retinal neurons of a mouse with photoreceptor degeneration can restore the ability of the retina to encode light signals and transmit the light signals to the visual cortex. Thus, expression of microbial-type channelrhodopsins, such as ChR2, in surviving inner retinal neurons is a potential strategy for the restoration of vision after rod and cone degeneration.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Penn Coll Optometry, Elkins Pk, PA 19027 USA; Peking Univ, Sch Basic Med Sci, Dept Anat & Embryol, Beijing 100083, Peoples R China	Wayne State University; Peking University	Pan, ZH (corresponding author), Jiangsu Univ, Sch Med, Dept Pharmacol, Jinagsu 212013, Peoples R China.	zhpan@med.wayne.edu		Dizhoor, Alexander/0000-0001-6770-9186	NEI NIH HHS [R03 EY016087, EY11522, R01 EY012180, EY04068, R01 EY011522, P30 EY004068, EY16087, EY12180] Funding Source: Medline; NATIONAL EYE INSTITUTE [R03EY016087, P30EY004068, R01EY012180, R01EY011522] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Ali RR, 2000, NAT GENET, V25, P306, DOI 10.1038/77068; Auricchio A, 2001, HUM MOL GENET, V10, P3075, DOI 10.1093/hmg/10.26.3075; Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356; Barlow H B, 1971, Vision Res, VSuppl 3, P87; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Bennett J, 1999, P NATL ACAD SCI USA, V96, P9920, DOI 10.1073/pnas.96.17.9920; BOK D, 1993, INVEST OPHTH VIS SCI, V34, P473; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chang B, 2002, VISION RES, V42, P517, DOI 10.1016/S0042-6989(01)00146-8; Cui JJ, 2003, J PHYSIOL-LONDON, V553, P895, DOI 10.1113/jphysiol.2003.052092; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Flotte TR, 2004, GENE THER, V11, P805, DOI 10.1038/sj.gt.3302233; Harvey AR, 2002, MOL CELL NEUROSCI, V21, P141, DOI 10.1006/mcne.2002.1168; HUMPHRIES P, 1992, SCIENCE, V256, P804, DOI 10.1126/science.1589761; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Jones BW, 2003, J COMP NEUROL, V464, P1, DOI 10.1002/cne.10703; KANEKO A, 1970, J PHYSIOL-LONDON, V207, P623, DOI 10.1113/jphysiol.1970.sp009084; Kateriya S, 2004, NEWS PHYSIOL SCI, V19, P133, DOI 10.1152/nips.01517.2004; KIM CI, 1992, ARCH BIOCHEM BIOPHYS, V294, P388, DOI 10.1016/0003-9861(92)90700-7; Li X, 2005, P NATL ACAD SCI USA, V102, P17816, DOI 10.1073/pnas.0509030102; Lund RD, 2001, PROG RETIN EYE RES, V20, P415, DOI 10.1016/S1350-9462(01)00003-9; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Nagel G, 2002, SCIENCE, V296, P2395, DOI 10.1126/science.1072068; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; Olshevskaya EV, 2004, J NEUROSCI, V24, P6078, DOI 10.1523/JNEUROSCI.0963-04.2004; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; PARTRIDGE JC, 1991, VISION RES, V31, P619, DOI 10.1016/0042-6989(91)90002-M; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Santos A, 1997, ARCH OPHTHALMOL-CHIC, V115, P511, DOI 10.1001/archopht.1997.01100150513011; SCHILLER PH, 1986, NATURE, V322, P824, DOI 10.1038/322824a0; Sineshchekov OA, 2002, P NATL ACAD SCI USA, V99, P8689, DOI 10.1073/pnas.122243399; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; STRYER L, 1991, J BIOL CHEM, V266, P10711; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; Suzuki T, 2003, BIOCHEM BIOPH RES CO, V301, P711, DOI 10.1016/S0006-291X(02)03079-6; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tu DC, 2005, NEURON, V48, P987, DOI 10.1016/j.neuron.2005.09.031; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WELEBER RG, 1994, RETINA, P335; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8; Zrenner E, 2002, SCIENCE, V295, P1022, DOI 10.1126/science.1067996	57	500	581	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					23	33		10.1016/j.neuron.2006.02.026	http://dx.doi.org/10.1016/j.neuron.2006.02.026			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600853	Green Accepted, Bronze			2022-12-28	WOS:000236811300008
J	Rutishauser, U; Mamelak, AN; Schuman, EM				Rutishauser, U; Mamelak, AN; Schuman, EM			Single-trial learning of novel stimuli by individual neurons of the human hippocampus-amygdala complex	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; LONG-TERM POTENTIATION; RECOGNITION MEMORY; MONKEY HIPPOCAMPUS; PREFRONTAL CORTEX; NOVELTY DETECTION; VISUAL RESPONSES; TASTE-AVERSION; DENTATE GYRUS; FAMILIARITY	The ability to distinguish novel from familiar stimuli allows nervous systems to rapidly encode significant events following even a single exposure to a stimulus. This detection of novelty is necessary for many types of learning. Neurons in the medial temporal lobe (MTL) are critically involved in the acquisition of long-term declarative memories. During a learning task, we recorded from individual MTL neurons in vivo using microwire electrodes implanted in human epilepsy surgery patients. We report here the discovery of two classes of neurons in the hippocampus and amygdala that exhibit single-trial learning: novelty and familiarity detectors, which show a selective increase in firing for new and old stimuli, respectively. The neurons retain memory for the stimulus for 24 hr. Thus, neurons in the MTL contain information sufficient for reliable novelty-familiarity discrimination and also show rapid plasticity as a result of single-trial learning.	CALTECH, Computat & Neurol Syst Div, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Huntington Mem Hosp, Epilepsy & Brain Mapping Unit, Pasadena, CA 91105 USA; Cedars Sinai Med Ctr, Maxine Dunitz Neurosurg Inst, Los Angeles, CA 90048 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of Southern California; Huntington Memorial Hospital; Cedars Sinai Medical Center	Schuman, EM (corresponding author), CALTECH, Computat & Neurol Syst Div, Pasadena, CA 91125 USA.	schumane@caltech.edu	Mamelak, Adam/H-8347-2014; Schuman, Erin M/D-6204-2011; Rutishauser, Ueli/AAH-8348-2021; Rutishauser, Ueli/E-5721-2011	Mamelak, Adam/0000-0002-4245-6431; Rutishauser, Ueli/0000-0002-9207-7069; 				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; BERGER TW, 1976, SCIENCE, V192, P483, DOI 10.1126/science.1257783; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Clayton NS, 2001, PHILOS T R SOC B, V356, P1483, DOI 10.1098/rstb.2001.0947; Davis CD, 2004, J NEUROSCI, V24, P6497, DOI 10.1523/JNEUROSCI.4970-03.2004; Efron B., 1994, MONOGRAPHS STAT APPL; FAHY FL, 1993, EXP BRAIN RES, V96, P457; FREY U, 1990, BRAIN RES, V522, P69, DOI 10.1016/0006-8993(90)91578-5; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Fried I, 2002, CEREB CORTEX, V12, P575, DOI 10.1093/cercor/12.6.575; GALLO M, 1995, NEUROSCI LETT, V186, P1, DOI 10.1016/0304-3940(94)11265-K; HEIT G, 1990, BRAIN, V113, P1093, DOI 10.1093/brain/113.4.1093; Johnson R.A., 2002, APPL MULTIVARIATE ST; Kishiyama MM, 2004, J COGNITIVE NEUROSCI, V16, P15, DOI 10.1162/089892904322755511; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kohonen T., 1981, PARALLEL MODELS ASS, P105; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Kreiman G, 2002, P NATL ACAD SCI USA, V99, P8378, DOI 10.1073/pnas.072194099; LI L, 1993, J NEUROPHYSIOL, V69, P1918, DOI 10.1152/jn.1993.69.6.1918; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Manns JR, 2003, NEURON, V37, P171, DOI 10.1016/S0896-6273(02)01147-9; MCCARTHY G, 1989, J NEUROSCI, V9, P4253; NEUMAN RS, 1983, BRAIN RES, V273, P162, DOI 10.1016/0006-8993(83)91106-X; NOTON D, 1971, SCIENCE, V171, P308, DOI 10.1126/science.171.3968.308; Pouget A, 2003, ANNU REV NEUROSCI, V26, P381, DOI 10.1146/annurev.neuro.26.041002.131112; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; RUTISHAUSER U, 2006, IN PRESS J NEUROSCI; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; STANDING L, 1970, PSYCHON SCI, V19, P73, DOI 10.3758/BF03337426; Stark CEL, 2000, J NEUROSCI, V20, P7776; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; SUTTON S, 1965, SCIENCE, V150, P1187, DOI 10.1126/science.150.3700.1187; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; WILLIAMS S, 1988, SCIENCE, V242, P84, DOI 10.1126/science.2845578; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004; Yanike M, 2004, NEURON, V42, P477, DOI 10.1016/S0896-6273(04)00193-X; Yonelinas AP, 2002, NAT NEUROSCI, V5, P1236, DOI 10.1038/nn961	47	195	195	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					805	813		10.1016/j.neuron.2006.02.015	http://dx.doi.org/10.1016/j.neuron.2006.02.015			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543129	Bronze			2022-12-28	WOS:000236227500009
J	Fuchs, EC; Zivkovic, AR; Cunningham, MO; Middleton, S; LeBeau, FEN; Bannerman, DM; Rozov, A; Whittington, MA; Traub, RD; Rawlins, JNP; Monyer, H				Fuchs, Elke C.; Zivkovic, Aleksandar R.; Cunningham, Mark O.; Middleton, Steven; LeBeau, Fiona E. N.; Bannerman, David M.; Rozov, Andrei; Whittington, Miles A.; Traub, Roger D.; Rawlins, J. Nicholas P.; Monyer, Hannah			Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; BINDING PROTEIN PARVALBUMIN; AMPA RECEPTOR SUBUNITS; RAT HIPPOCAMPUS; NETWORK OSCILLATIONS; GAMMA OSCILLATIONS; GABAERGIC NEURONS; CA2+ PERMEABILITY; WORKING-MEMORY; GRANULE CELLS	Perisomatic inhibition provided by a subgroup of GABAergic interneurons plays a critical role in timing the output of pyramidal cells. To test their contribution at the network and the behavioral level, we generated genetically modified mice in which the excitatory drive was selectively reduced either by the knockout of the GluR-D or by conditional ablation of the GluR-A subunit in parvalbumin-positive cells. Comparable cell type-specific reductions of AMPA-mediated currents were obtained. Kainate-induced gamma oscillations exhibited reduced power in hippocampal slices from GluR-D-/- and GluR-A(PVCre-/-) mice. Experimental and modeling data indicated that this alteration could be accounted for by imprecise spike timing of fast-spiking cells (FS) caused by smaller interneuronal EPSPs. GWR-D-/- and GluR-A(PVCre-/-) mice exhibited similar impairments in hippocampus-dependent tasks. These findings directly show the effects of insufficient recruitment of fast-spiking cells at the network and behavioral level and demonstrate the role of this subpopulation for working and episodic-like memory.	Univ Hosp Neurol, Dept Clin Neurobiol, IZN, D-69120 Heidelberg, Germany; Newcastle Univ, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA	Ruprecht Karls University Heidelberg; Newcastle University - UK; University of Oxford; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Monyer, H (corresponding author), Univ Hosp Neurol, Dept Clin Neurobiol, IZN, Neuenheimer Feld 364, D-69120 Heidelberg, Germany.	monyer@urz.uni-hd.de	Rozov, Andrei/C-1997-2015	Cunningham, Mark/0000-0002-7389-9569; Zivkovic, Aleksandar/0000-0003-0757-8895; Monyer, Hannah/0000-0002-9332-5749; Bannerman, David/0000-0002-3024-7595; LeBeau, Fiona/0000-0003-1453-4022; Whittington, Miles Adrian/0000-0002-0247-1362; Middleton, Steven/0000-0001-8875-8956	Wellcome Trust [087736] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Angulo MC, 1997, J NEUROSCI, V17, P6685; BRAGIN A, 1995, J NEUROSCI, V15, P47; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X; CATANIA MV, 1995, J NEUROSCI, V15, P7046; Catania MV, 1998, EUR J NEUROSCI, V10, P3479, DOI 10.1046/j.1460-9568.1998.00356.x; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; CELIO MR, 1988, CELL CALCIUM, V9, P81, DOI 10.1016/0143-4160(88)90027-9; Chrobak JJ, 1998, NEUROSCI BIOBEHAV R, V22, P303, DOI 10.1016/S0149-7634(97)00016-X; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Csicsvari J, 2003, NEURON, V37, P311, DOI 10.1016/S0896-6273(02)01169-8; DeCoteau WE, 1998, BEHAV NEUROSCI, V112, P68, DOI 10.1037/0735-7044.112.1.68; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gilbert PE, 2004, NEUROBIOL LEARN MEM, V81, P39, DOI 10.1016/S1074-7427(03)00069-8; Gloveli T, 2005, J PHYSIOL-LONDON, V562, P131, DOI 10.1113/jphysiol.2004.073007; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Gray JA, 1982, NEUROPSYCHOLOGY ANXI, DOI 10.1002/9780470720394.ch2; Honey RC, 1998, J NEUROSCI, V18, P2226; Howard MW, 2003, CEREB CORTEX, V13, P1369, DOI 10.1093/cercor/bhg084; Joho RH, 1999, J NEUROPHYSIOL, V82, P1855, DOI 10.1152/jn.1999.82.4.1855; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KATSUMARU H, 1988, EXP BRAIN RES, V72, P347; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Klausberger T, 2002, J NEUROSCI, V22, P2513, DOI 10.1523/JNEUROSCI.22-07-02513.2002; Kondo M, 1997, J NEUROSCI, V17, P1570; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; Lambolez B, 1996, P NATL ACAD SCI USA, V93, P1797, DOI 10.1073/pnas.93.5.1797; Leranth C, 1996, NEUROSCIENCE, V70, P631, DOI 10.1016/S0306-4522(96)83003-X; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Mann EO, 2005, NEURON, V45, P105, DOI 10.1016/j.neuron.2004.12.016; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; McBain CJ, 2001, NAT REV NEUROSCI, V2, P11, DOI 10.1038/35049047; Meyer AH, 2002, J NEUROSCI, V22, P7055; MONYER H, 1991, NEURON, V6, P799, DOI 10.1016/0896-6273(91)90176-Z; Morris RGM, 2003, PHILOS T R SOC B, V358, P773, DOI 10.1098/rstb.2002.1264; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mumby DG, 2002, LEARN MEMORY, V9, P49, DOI 10.1101/lm.41302; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A, 1998, CURR BIOL, V8, P661, DOI 10.1016/S0960-9822(98)70254-4; Nakazawa K, 2002, SCIENCE, V297, P211, DOI 10.1126/science.1071795; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Pawelzik H, 2002, J COMP NEUROL, V443, P346, DOI 10.1002/cne.10118; Pesaran B, 2002, NAT NEUROSCI, V5, P805, DOI 10.1038/nn890; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Racca C, 1996, EUR J NEUROSCI, V8, P1580, DOI 10.1111/j.1460-9568.1996.tb01303.x; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RAWLINS JNP, 1982, BEHAV BRAIN RES, V5, P331, DOI 10.1016/0166-4328(82)90039-0; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; RIBAK CE, 1990, J COMP NEUROL, V300, P449, DOI 10.1002/cne.903000402; SIK A, 1995, J NEUROSCI, V15, P6651; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; SORIANO E, 1992, NEUROSCI LETT, V142, P147, DOI 10.1016/0304-3940(92)90360-J; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tallon-Baudry C, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-20-j0008.2001; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Tansey EP, 2002, HIPPOCAMPUS, V12, P137, DOI 10.1002/hipo.1104; Traub RD, 1996, J PHYSIOL-LONDON, V493, P471, DOI 10.1113/jphysiol.1996.sp021397; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; VINOGRADOVA OS, 1977, ZH VYSSH NERV DEYAT+, V27, P1165; Vreugdenhil M, 2003, J NEUROPHYSIOL, V89, P1414, DOI 10.1152/jn.00576.2002; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YLINEN A, 1995, HIPPOCAMPUS, V5, P78, DOI 10.1002/hipo.450050110; YLINEN A, 1995, J NEUROSCI, V15, P30; Yuste R, 2005, NEURON, V48, P524, DOI 10.1016/j.neuron.2005.11.012; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805	75	373	378	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					591	604		10.1016/j.neuron.2007.01.031	http://dx.doi.org/10.1016/j.neuron.2007.01.031			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296559	Bronze			2022-12-28	WOS:000245126900016
J	Abe, K; Takeichi, M				Abe, Kentaro; Takeichi, Masatoshi			NMDA-receptor activation induces calpain-mediated beta-catenin cleavages for triggering gene expression	NEURON			English	Article							CELL-ADHESION MOLECULES; WNT SIGNALING PATHWAY; SYNAPTIC PLASTICITY; N-CADHERIN; DENDRITIC SPINES; MULTIPLE ROLES; HIPPOCAMPAL; TARGET; TRANSCRIPTION; BRAIN	The canonical Wnt-beta-catenin signaling pathway is important for a variety of developmental phenomena as well as for carcinogenesis. Here, we show that, in hippocampal neurons, NMDA-receptor-dependent activation of calpain induced the cleavage of beta-catenin at the N terminus, generating stable, truncated forms. These beta-catenin fragments accumulated in the nucleus and induced Tcf/Lef-dependent gene transcription. We identified Fosl1, one of the immediateearly genes, as a target of this signaling pathway. In addition, exploratory behavior by mice resulted in a similar cleavage of beta-catenin, as well as activation of the Tcf signaling pathway, in hippocampal neurons. Both beta-catenin cleavage and Tcf-dependent gene transcription were suppressed by calpain inhibitors. These findings reveal another pathway for beta-catenindependent signaling, in addition to the canonical Wnt-beta-catenin pathway, and suggest that this other pathway could play an important role in activity-dependent gene expression.	Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Takeichi, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012; Abe, Kentaro/A-6197-2008; Abe, Kentaro/T-2247-2019	Takeichi, Masatoshi/0000-0002-9931-3378; Abe, Kentaro/0000-0002-3923-6323				Abe K, 2004, NAT NEUROSCI, V7, P357, DOI 10.1038/nn1212; Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Chan SL, 1999, J NEUROSCI RES, V58, P167, DOI 10.1002/(SICI)1097-4547(19991001)58:1<167::AID-JNR16>3.0.CO;2-K; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Chong ZZ, 2005, BRAIN RES REV, V49, P1, DOI 10.1016/j.brainresrev.2004.11.005; DasGupta R, 1999, DEVELOPMENT, V126, P4557; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Faure A, 2006, BRAIN RES BULL, V68, P233, DOI 10.1016/j.brainresbull.2005.08.017; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Gould TD, 2005, NEUROPSYCHOPHARMACOL, V30, P1223, DOI 10.1038/sj.npp.1300731; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Guttmann RP, 2001, J NEUROCHEM, V78, P1083, DOI 10.1046/j.1471-4159.2001.00493.x; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Huntley GW, 2002, NEUROSCIENTIST, V8, P221, DOI 10.1177/1073858402008003008; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kerokoski P, 2004, NEUROSCI LETT, V368, P181, DOI 10.1016/j.neulet.2004.07.007; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu XY, 2000, NEUROSCI LETT, V286, P149, DOI 10.1016/S0304-3940(00)01101-0; LYNCH G, 1987, BRAIN RES BULL, V18, P809, DOI 10.1016/0361-9230(87)90220-6; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Mann B, 1999, P NATL ACAD SCI USA, V96, P1603, DOI 10.1073/pnas.96.4.1603; Marambaud P, 2003, CELL, V114, P635, DOI 10.1016/j.cell.2003.08.008; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Murase S, 1999, CURR OPIN CELL BIOL, V11, P549, DOI 10.1016/S0955-0674(99)00019-8; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Neumar RW, 1998, J CEREBR BLOOD F MET, V18, P876, DOI 10.1097/00004647-199808000-00007; NUSSE R, 2006, WNT HOMEPAGE; Okamura K, 2004, J CELL BIOL, V167, P961, DOI 10.1083/jcb.200406030; Polakis P, 2000, GENE DEV, V14, P1837; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Rios-Doria J, 2004, CANCER RES, V64, P7237, DOI 10.1158/0008-5472.CAN-04-1048; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sakai D, 2005, DEV GROWTH DIFFER, V47, P471, DOI 10.1111/j.1440-169X.2005.00821.x; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Shibamoto S, 1998, GENES CELLS, V3, P659; STAUBLI U, 1988, BRAIN RES, V444, P153, DOI 10.1016/0006-8993(88)90922-5; Takeichi M, 2005, TRENDS CELL BIOL, V15, P216, DOI 10.1016/j.tcb.2005.02.002; Uemura K, 2006, NEUROSCI LETT, V402, P278, DOI 10.1016/j.neulet.2006.04.018; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; West AE, 2002, NAT REV NEUROSCI, V3, P921, DOI 10.1038/nrn987; Zatz M, 2005, NEW ENGL J MED, V352, P2413, DOI 10.1056/NEJMra043361	53	113	114	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					387	397		10.1016/j.neuron.2007.01.016	http://dx.doi.org/10.1016/j.neuron.2007.01.016			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270735	Bronze			2022-12-28	WOS:000245126800009
J	Campbell, JN; Meyer, RA				Campbell, James N.; Meyer, Richard A.			Mechanisms of neuropathic pain	NEURON			English	Review							PERIPHERAL-NERVE INJURY; DORSAL-ROOT GANGLION; NECROSIS-FACTOR-ALPHA; INDUCED SECONDARY HYPERALGESIA; LEUKEMIA INHIBITORY FACTOR; SPINAL-CORD; UP-REGULATION; TACTILE ALLODYNIA; SODIUM-CHANNELS; NEUROGENIC HYPERALGESIA	Neuropathic pain refers to pain that originates from pathology of the nervous system. Diabetes, infection (herpes zoster), nerve compression, nervetrauma, "channelopathies," and autoimmune disease are examples of diseases that may cause neuropathic pain. The development of both animal models and newer pharmacological strategies has led to an explosion of interest in the underlying mechanisms. Neuropathic pain reflects both peripheral and central sensitization mechanisms. Abnormal signals arise riot only from injured axons but also from the intact nociceptors that share the innervation territory of the injured nerve. This review focuses; on how both human studies and animal models are helping to elucidate the mechanisms underlying these surprisingly common disorders. The rapid gain in knowledge about abnormal signaling promises breakthroughs in the treatment of these often debilitating disorders.	Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University	Campbell, JN (corresponding author), Johns Hopkins Univ, Sch Med, 600 N Wolfe St, Baltimore, MD 21287 USA.	jcampbel@jhmi.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041269, R01NS014447] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS014447-27A2, R01 NS014447, R01 NS014447-26, NS-041269, NS-014447, R01 NS041269] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbadie C, 2003, P NATL ACAD SCI USA, V100, P7947, DOI 10.1073/pnas.1331358100; AHLGREN SC, 1993, NEUROSCIENCE, V52, P1049, DOI 10.1016/0306-4522(93)90551-P; Alessandri-Haber N, 2004, J NEUROSCI, V24, P4444, DOI 10.1523/JNEUROSCI.0242-04.2004; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; Ali Z, 2000, PAIN, V88, P161, DOI 10.1016/S0304-3959(00)00327-4; Allen BJ, 1999, J NEUROPHYSIOL, V81, P1379, DOI 10.1152/jn.1999.81.3.1379; ARNER S, 1990, PAIN, V43, P287, DOI 10.1016/0304-3959(90)90026-A; Baron R, 1999, NEUROLOGY, V53, P548, DOI 10.1212/WNL.53.3.548; Basbaum AI, 1999, P NATL ACAD SCI USA, V96, P7739, DOI 10.1073/pnas.96.14.7739; Basbaum AI, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P361; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Bian D, 1998, NEUROSCI LETT, V241, P79, DOI 10.1016/S0304-3940(98)00051-2; Bian F, 2006, BRAIN RES, V1075, P68, DOI 10.1016/j.brainres.2005.12.084; Black JA, 1999, J NEUROPHYSIOL, V82, P2776, DOI 10.1152/jn.1999.82.5.2776; BLUMBERG H, 1984, PAIN, V20, P335, DOI 10.1016/0304-3959(84)90111-8; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; Boivie J, 2003, WALL MELZACKS TXB PA, P1057; Borsook D, 2004, J NEUROBIOL, V61, P107, DOI 10.1002/neu.20085; Boucher T J, 2001, Curr Opin Pharmacol, V1, P66, DOI 10.1016/S1471-4892(01)00010-8; Boucher TJ, 2000, SCIENCE, V290, P124, DOI 10.1126/science.290.5489.124; BULLITT E, 1990, J COMP NEUROL, V296, P517, DOI 10.1002/cne.902960402; BURCHIEL KJ, 1993, J NEUROSURG, V78, P714, DOI 10.3171/jns.1993.78.5.0714; Burgess SE, 2002, J NEUROSCI, V22, P5129, DOI 10.1523/JNEUROSCI.22-12-05129.2002; Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143; CAMPBELL JN, 1988, PAIN, V32, P89, DOI 10.1016/0304-3959(88)90027-9; CARLTON SM, 1994, PAIN, V56, P155, DOI 10.1016/0304-3959(94)90090-6; Colburn RW, 1999, EXP NEUROL, V157, P289, DOI 10.1006/exnr.1999.7065; COOK AW, 1965, ARCH NEUROL-CHICAGO, V12, P72, DOI 10.1001/archneur.1965.00460250076009; Cortright DN, 2004, EUR J BIOCHEM, V271, P1814, DOI 10.1111/j.1432-1033.2004.04082.x; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Decosterd I, 2000, PAIN, V87, P149, DOI 10.1016/S0304-3959(00)00276-1; Devor M, 2006, J PAIN, V7, pS3, DOI 10.1016/j.jpain.2005.09.006; DEVOR M, 1991, PAIN, V45, P109, DOI 10.1016/0304-3959(91)90174-V; Devor M, 2006, WALL MELZACKS TXB PA, P905; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Djouhri L, 2004, NEUROREPORT, V15, P457, DOI 10.1097/00001756-200403010-00015; Djouhri L, 2004, BRAIN RES REV, V46, P131, DOI 10.1016/j.brainresrev.2004.07.015; Dogrul A, 2000, NEUROSCI LETT, V292, P115, DOI 10.1016/S0304-3940(00)01458-0; Dogrul A, 2003, PAIN, V105, P159, DOI 10.1016/S0304-3959(03)00177-5; DOUGHERTY PM, 1993, BRAIN RES REV, V18, P227, DOI 10.1016/0165-0173(93)90003-I; Duggan AW, 1995, PROG BRAIN RES, V104, P197; Dyck PJ, 2000, DIABETES CARE, V23, P510, DOI 10.2337/diacare.23.4.510; Elias WJ, 2002, CLIN J PAIN, V18, P35, DOI 10.1097/00002508-200201000-00006; Eschenfelder S, 2000, PAIN, V87, P213, DOI 10.1016/S0304-3959(00)00285-2; Flatters SJL, 2004, PAIN, V109, P150, DOI 10.1016/j.pain.2004.01.029; Freynhagen R, 2005, PAIN, V115, P254, DOI 10.1016/j.pain.2005.02.032; Fukuoka T, 1998, PAIN, V78, P13, DOI 10.1016/S0304-3959(98)00111-0; Fukuoka T, 2001, J NEUROSCI, V21, P4891, DOI 10.1523/JNEUROSCI.21-13-04891.2001; Fukuoka T, 2000, PROG PAIN RES MANAG, V16, P137; Gardell LR, 2003, NAT MED, V9, P1383, DOI 10.1038/nm944; GRACELY RH, 1992, PAIN, V51, P175, DOI 10.1016/0304-3959(92)90259-E; Griffin JW, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P271; Gu JG, 1996, NATURE, V381, P793, DOI 10.1038/381793a0; Harris JA, 1996, NEUROSCIENCE, V74, P7, DOI 10.1016/0306-4522(96)00196-0; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Ibrahim MM, 2003, P NATL ACAD SCI USA, V100, P10529, DOI 10.1073/pnas.1834309100; Inoue K, 2006, PHARMACOL THERAPEUT, V109, P210, DOI 10.1016/j.pharmthera.2005.07.001; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Kanaan SA, 1998, J NEUROIMMUNOL, V86, P142, DOI 10.1016/S0165-5728(98)00027-7; Katsura H, 2006, EXP NEUROL, V200, P112, DOI 10.1016/j.expneurol.2006.01.031; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; KIM SH, 1992, PAIN, V50, P355, DOI 10.1016/0304-3959(92)90041-9; Klede M, 2003, J NEUROPHYSIOL, V90, P353, DOI 10.1152/jn.01136.2002; Kleinschnitz C, 2004, J NEUROIMMUNOL, V149, P77, DOI 10.1016/j.jneuroim.2003.12.013; Kohno T, 2005, PAIN, V117, P77, DOI 10.1016/j.pain.2005.05.035; KOLTZENBURG M, 1994, BRAIN, V117, P579, DOI 10.1093/brain/117.3.579; LaBuda CJ, 2005, J NEUROSCI METH, V144, P175, DOI 10.1016/j.jneumeth.2004.11.008; LAMOTTE RH, 1991, J NEUROPHYSIOL, V66, P190, DOI 10.1152/jn.1991.66.1.190; Lau FH, 2004, J HAND SURG-AM, V29A, P181, DOI 10.1016/j.jhsa.2003.08.016; Li CY, 2004, J NEUROSCI, V24, P8494, DOI 10.1523/JNEUROSCI.2982-04.2004; Li YB, 2000, PAIN, V85, P493, DOI 10.1016/S0304-3959(00)00250-5; Liu CN, 2000, PAIN, V85, P503, DOI 10.1016/S0304-3959(00)00251-7; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; Lyu YS, 2000, BRAIN RES, V871, P98, DOI 10.1016/S0006-8993(00)02451-3; Magerl W, 1998, PAIN, V74, P257, DOI 10.1016/S0304-3959(97)00177-2; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Maihofner C, 2006, NEUROLOGY, V66, P711, DOI 10.1212/01.wnl.0000200961.49114.39; Maihofner C, 2004, EUR J NEUROSCI, V19, P3211, DOI 10.1111/j.1460-9568.2004.03437.x; Malcangio M, 2000, EUR J NEUROSCI, V12, P397, DOI 10.1046/j.1460-9568.2000.00946.x; Manning DC, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P161; Marchand F, 2005, NAT REV NEUROSCI, V6, P521, DOI 10.1038/nrn1700; Marcil J, 2006, BRIT J ANAESTH, V96, P761, DOI 10.1093/bja/ael096; MAVES TJ, 1993, PAIN, V54, P57, DOI 10.1016/0304-3959(93)90100-4; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Michaelis M, 2000, J NEUROSCI, V20, P2742; Milligan E, 2005, EUR J NEUROSCI, V22, P2775, DOI 10.1111/j.1460-9568.2005.04470.x; Moalem G, 2004, NEUROSCIENCE, V129, P767, DOI 10.1016/j.neuroscience.2004.08.035; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; NOGUCHI K, 1994, J NEUROSCI RES, V37, P596, DOI 10.1002/jnr.490370506; Okamoto K, 2001, EXP NEUROL, V169, P386, DOI 10.1006/exnr.2001.7677; Opree A, 2000, J NEUROSCI, V20, P6289, DOI 10.1523/JNEUROSCI.20-16-06289.2000; Orozco OE, 2001, EUR J NEUROSCI, V13, P2177, DOI 10.1046/j.0953-816x.2001.01596.x; Ossipov MH, 2002, J NEUROSCI, V22, P9858; Pertin M, 2005, J NEUROSCI, V25, P10970, DOI 10.1523/JNEUROSCI.3066-05.2005; Pertovaara A, 2001, EUR J PHARMACOL, V429, P139, DOI 10.1016/S0014-2999(01)01315-2; Porreca F, 1999, P NATL ACAD SCI USA, V96, P7640, DOI 10.1073/pnas.96.14.7640; Porreca F, 2001, J NEUROSCI, V21, P5281, DOI 10.1523/JNEUROSCI.21-14-05281.2001; PROSKE U, 1995, EXP BRAIN RES, V104, P89; Raghavendra V, 2003, PAIN, V104, P655, DOI 10.1016/S0304-3959(03)00138-6; RAJA SN, 1991, ANESTHESIOLOGY, V74, P691, DOI 10.1097/00000542-199104000-00012; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; Ringkamp M, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P87; Rush AM, 2006, P NATL ACAD SCI USA, V103, P8245, DOI 10.1073/pnas.0602813103; Salter MW, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P193; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Scadding JW, 2006, WALL MELZACKS TXB PA, P973; Schafers M, 2003, J NEUROSCI, V23, P3028; Scholz J, 2005, J NEUROSCI, V25, P7317, DOI 10.1523/JNEUROSCI.1526-05.2005; Schweinhardt P, 2006, NEUROIMAGE, V32, P256, DOI 10.1016/j.neuroimage.2006.03.024; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Sheth RN, 2002, PAIN, V96, P63, DOI 10.1016/S0304-3959(01)00429-8; Shim B, 2005, NEUROSCIENCE, V132, P193, DOI 10.1016/j.neuroscience.2004.12.036; SIMONE DA, 1991, J NEUROPHYSIOL, V66, P228, DOI 10.1152/jn.1991.66.1.228; Sommer C, 2001, BRAIN RES, V913, P86, DOI 10.1016/S0006-8993(01)02743-3; Sorkin LS, 1997, NEUROSCIENCE, V81, P255, DOI 10.1016/S0306-4522(97)00147-4; South SM, 2003, J NEUROSCI, V23, P5031; STANTONHICKS M, 1995, PAIN, V63, P127, DOI 10.1016/0304-3959(95)00110-E; Sugiura S, 2000, EUR J NEUROSCI, V12, P457, DOI 10.1046/j.1460-9568.2000.00922.x; Sukhotinsky I, 2004, EUR J PAIN, V8, P135, DOI 10.1016/S1090-3801(03)00086-7; Sun H, 2001, PAIN, V90, P105, DOI 10.1016/S0304-3959(00)00392-4; Suzuki R, 2005, PAIN, V117, P292, DOI 10.1016/j.pain.2005.06.015; Tanga FY, 2005, P NATL ACAD SCI USA, V102, P5856, DOI 10.1073/pnas.0501634102; Tofaris GK, 2002, J NEUROSCI, V22, P6696; Tomiyama M, 2005, MOL BRAIN RES, V136, P275, DOI 10.1016/j.molbrainres.2005.02.003; TOREBJORK HE, 1992, J PHYSIOL-LONDON, V448, P765, DOI 10.1113/jphysiol.1992.sp019069; Treede RD, 1998, J NEUROPHYSIOL, V80, P1082, DOI 10.1152/jn.1998.80.3.1082; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Tremont-Lukats IW, 2006, CLIN J PAIN, V22, P266, DOI 10.1097/01.ajp.0000169673.57062.40; Tsuda M, 2005, TRENDS NEUROSCI, V28, P101, DOI 10.1016/j.tins.2004.12.002; Tsuzuki K, 2001, PAIN, V91, P351, DOI 10.1016/S0304-3959(00)00456-5; Vierck CJ, 1999, PAIN, V83, P447, DOI 10.1016/S0304-3959(99)00129-3; Vierck CJ, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P475; Wagner R, 1996, NEUROREPORT, V7, P2897, DOI 10.1097/00001756-199611250-00018; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; Waxman SG, 2005, TRENDS MOL MED, V11, P555, DOI 10.1016/j.molmed.2005.10.004; Willis WD, 2006, EMERGING STRATEGIES FOR THE TREATMENT OF NEUROPATHIC PAIN, P105; Wolf G, 2006, PAIN, V120, P315, DOI 10.1016/j.pain.2005.11.011; WOOLF CJ, 1988, J PHYSIOL-PARIS, V83, P255; Wu G, 2002, J NEUROSCI, V22, P7746; Wu G, 2001, J NEUROSCI, V21; Xu JT, 2006, PAIN, V123, P306, DOI 10.1016/j.pain.2006.03.011; Yen LD, 2006, J COMP NEUROL, V495, P679, DOI 10.1002/cne.20899; Yoshimura M, 2006, NEUROSCI RES, V56, P21, DOI 10.1016/j.neures.2006.04.015	146	842	913	2	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					77	92		10.1016/j.neuron.2006.09.021	http://dx.doi.org/10.1016/j.neuron.2006.09.021			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015228	Bronze, Green Accepted			2022-12-28	WOS:000241408100006
J	Lee, S; Zhou, ZJ				Lee, Seunghoon; Zhou, Z. Jimmy			The synaptic mechanism of direction selectivity in distal processes of starburst amacrine cells	NEURON			English	Article							RETINAL GANGLION-CELLS; TRANSMITTER RELEASE; CHOLINERGIC NEURONS; RABBIT RETINA; IMAGE MOTION; INHIBITION; COMPUTATION; RECEPTORS; DENDRITES; NETWORK	Patch-clamp recordings revealed that distal processes of starburst amacrine cells (SACs) received largely excitatory synaptic input from the receptive field center and nearly purely inhibitory inputs from the surround during both stationary and moving light stimulations. The direct surround inhibition was mediated mainly by reciprocal GABA(A) synapses between opposing SACs, which provided leading and prolonged inhibition during centripetal stimulus motion. Simultaneous Ca2+ imaging and current-clamp recording during apparent-motion stimulation further demonstrated the contributions of both centrifugal excitation and GABA(A/C)-receptor-mediated centripetal inhibition to the direction-selective Ca2+ responses in SAC distal processes. Thus, by placing GABA release sites in electrotonically semi-isolated distal processes and endowing these sites with reciprocal GABAA synapses, SACs use a radial-symmetric center-surround receptive field structure to build a polarasymmetric circuitry. This circuitry may integrate at least three levels of interactions-center excitation, surround inhibition, and reciprocal inhibitions that amplify the center-surround antagonism-to generate robust direction selectivity in the distal processes.	Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Zhou, ZJ (corresponding author), Univ Arkansas Med Sci, Dept Physiol & Biophys, Little Rock, AR 72205 USA.	zhoujimmy@uams.edu			NEI NIH HHS [EY017353, R01 EY017353, R01 EY010894, EY10894] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010894, R01EY017353] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Eggers ED, 2006, J PHYSIOL-LONDON, V572, P215, DOI 10.1113/jphysiol.2005.103648; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; FAMIGLIETTI EV, 1983, BRAIN RES, V261, P138, DOI 10.1016/0006-8993(83)91293-3; FAMIGLIETTI EV, 1985, J NEUROSCI, V5, P562; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gavrikov KE, 2003, P NATL ACAD SCI USA, V100, P16047, DOI 10.1073/pnas.2637041100; HUGHES A, 1972, VISION RES, V12, P123, DOI 10.1016/0042-6989(72)90143-5; MASLAND RH, 1984, PROC R SOC SER B-BIO, V223, P79, DOI 10.1098/rspb.1984.0084; Munch TA, 2006, J NEUROPHYSIOL, V96, P471, DOI 10.1152/jn.00628.2005; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Ozaita A, 2004, J NEUROSCI, V24, P7335, DOI 10.1523/JNEUROSCI.1275-04.2004; Peters BN, 1996, J NEUROPHYSIOL, V75, P469, DOI 10.1152/jn.1996.75.1.469; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Shields CR, 2000, J NEUROSCI, V20, P2673; TAUCHI M, 1985, J NEUROSCI, V5, P2494; TAUCHI M, 1984, PROC R SOC SER B-BIO, V223, P101, DOI 10.1098/rspb.1984.0085; TAYLOR WR, 1995, EUR J NEUROSCI, V7, P2308, DOI 10.1111/j.1460-9568.1995.tb00652.x; Taylor WR, 2002, J NEUROSCI, V22, P7712; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Tukker JJ, 2004, VISUAL NEUROSCI, V21, P611, DOI 10.1017/S0952523804214109; VANEY DI, 1984, PROC R SOC SER B-BIO, V220, P501, DOI 10.1098/rspb.1984.0016; Vigh J, 2005, NEURON, V46, P469, DOI 10.1016/j.neuron.2005.03.027; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015; ZHOU ZJ, 1995, J NEUROSCI, V15, P5334; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	38	133	133	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					787	799		10.1016/j.neuron.2006.08.007	http://dx.doi.org/10.1016/j.neuron.2006.08.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982423	Green Accepted, Bronze			2022-12-28	WOS:000240997900016
J	Nagel, KI; Doupe, AJ				Nagel, Katherine I.; Doupe, Allison J.			Temporal processing and adaptation in the songbird auditory forebrain	NEURON			English	Article							MALE ZEBRA FINCHES; SPECTROTEMPORAL RECEPTIVE-FIELDS; DORSAL COCHLEAR NUCLEUS; NATURAL SOUNDS; INFERIOR COLLICULUS; INFORMATION-TRANSMISSION; FUNCTIONAL-ORGANIZATION; CONTRAST ADAPTATION; DYNAMIC SPECTRA; UNIT RESPONSES	Songbird auditory neurons must encode the dynamics of natural sounds at many volumes. We investigated how neural coding depends on the distribution of stimulus intensities. Using reverse-correlation, we modeled responses to amplitude-modulated sounds as the output of a linear filter and a nonlinear gain function, then asked how filters and nonlinearities depend on the stimulus mean and variance. Filter shape depended strongly on mean amplitude (volume): at low mean, most neurons integrated sound over many milliseconds, while at high mean, neurons responded more to local changes in amplitude. Increasing the variance (contrast) of amplitude modulations had less effect on filter shape but decreased the gain of firing in most cells. Both filter and gain changes occurred rapidly after a change in statistics, suggesting that they represent nonlinearities in processing. These changes may permit neurons to signal effectively over a wider dynamic range and are reminiscent of findings in other sensory systems.	Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Nagel, KI (corresponding author), Univ Calif San Francisco, Dept Physiol, Keck Ctr Integrat Neurosci, Box 0444, San Francisco, CA 94143 USA.	knagel@phy.ucsf.edu; ajd@phy.ucsf.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; NIMH NIH HHS [MH55987] Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aticky JJ, 2011, NETWORK-COMP NEURAL, V22, P4, DOI [10.1088/0954-898X/3/2/009, 10.3109/0954898X.2011.638888]; ATTIAS H, 1998, ADV NEURAL INFORM PR, V10; Barbour DL, 2003, J NEUROSCI, V23, P7194, DOI 10.1523/JNEUROSCI.23-18-07194.2003; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Borst A, 2005, P NATL ACAD SCI USA, V102, P6172, DOI 10.1073/pnas.0500491102; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Calhoun BM, 1998, EUR J NEUROSCI, V10, P926, DOI 10.1046/j.1460-9568.1998.00102.x; Chi T, 2005, J ACOUST SOC AM, V118, P887, DOI 10.1121/1.1945807; Dean I, 2005, NAT NEUROSCI, V8, P1684, DOI 10.1038/nn1541; Depireux DA, 2001, J NEUROPHYSIOL, V85, P1220, DOI 10.1152/jn.2001.85.3.1220; Drew PJ, 2003, J NEUROPHYSIOL, V89, P2697, DOI 10.1152/jn.00801.2002; EGGERMONT JJ, 1993, HEARING RES, V66, P177, DOI 10.1016/0378-5955(93)90139-R; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; Elhilali M, 2004, J NEUROSCI, V24, P1159, DOI 10.1523/JNEUROSCI.3825-03.2004; ENROTHCUGELL C, 1975, J PHYSIOL-LONDON, V247, P551, DOI 10.1113/jphysiol.1975.sp010947; EPPING WJM, 1986, HEARING RES, V24, P55, DOI 10.1016/0378-5955(86)90005-5; Escabi MA, 2003, J NEUROSCI, V23, P11489; Escabi MA, 2002, J NEUROSCI, V22, P4114, DOI 10.1523/JNEUROSCI.22-10-04114.2002; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; FORTUNE ES, 1992, J COMP NEUROL, V325, P388, DOI 10.1002/cne.903250306; FORTUNE ES, 1995, J COMP NEUROL, V360, P413, DOI 10.1002/cne.903600305; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Gehr DD, 1999, NEUROREPORT, V10, P375, DOI 10.1097/00001756-199902050-00030; Gentner TQ, 2003, NATURE, V424, P669, DOI 10.1038/nature01731; Gill P, 2006, J COMPUT NEUROSCI, V21, P5, DOI 10.1007/s10872-006-7059-4; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; Hausberger M, 2000, BEHAV BRAIN RES, V114, P89, DOI 10.1016/S0166-4328(00)00191-1; HEIL P, 1985, EXP BRAIN RES, V58, P532; Hessler NA, 1999, J NEUROSCI, V19, P10461; HOSE B, 1987, BRAIN RES, V422, P367, DOI 10.1016/0006-8993(87)90946-2; Kim KJ, 2001, J NEUROSCI, V21, P287, DOI 10.1523/JNEUROSCI.21-01-00287.2001; KIM PJ, 1994, J ACOUST SOC AM, V95, P410, DOI 10.1121/1.408335; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3524, DOI 10.1152/jn.1996.76.5.3524; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255, DOI 10.1152/jn.2000.84.1.255; Kvale MN, 2004, J NEUROPHYSIOL, V91, P604, DOI 10.1152/jn.00484.2003; LeMasurier M, 2005, NEURON, V48, P403, DOI 10.1016/j.neuron.2005.10.017; LEWICKI MS, 1995, P NATL ACAD SCI USA, V92, P5582, DOI 10.1073/pnas.92.12.5582; Lewicki MS, 1996, J NEUROSCI, V16, P6987; Liang L, 2002, J NEUROPHYSIOL, V87, P2237, DOI 10.1152/jn.2002.87.5.2237; Lohr B, 2003, ANIM BEHAV, V65, P763, DOI 10.1006/anbe.2003.2093; Mante V, 2005, NAT NEUROSCI, V8, P1690, DOI 10.1038/nn1556; MARGOLIASH D, 1992, J NEUROSCI, V12, P4309; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Miller LM, 2002, J NEUROPHYSIOL, V87, P516, DOI 10.1152/jn.00395.2001; MULLER CM, 1985, EXP BRAIN RES, V59, P587; Narayan R, 2005, J NEUROPHYSIOL, V94, P2970, DOI 10.1152/jn.00144.2005; Nelken I, 1997, J NEUROPHYSIOL, V78, P800, DOI 10.1152/jn.1997.78.2.800; NELKEN I, 1994, J NEUROPHYSIOL, V71, P2446, DOI 10.1152/jn.1994.71.6.2446; Nowak LG, 2003, J NEUROPHYSIOL, V89, P1541, DOI 10.1152/jn.00580.2002; PHILLIPS DP, 1987, EXP BRAIN RES, V67, P479; PHILLIPS DP, 1994, EXP BRAIN RES, V102, P210; REES A, 1987, HEARING RES, V27, P129, DOI 10.1016/0378-5955(87)90014-1; SACHS MB, 1980, J ACOUST SOC AM, V68, P858, DOI 10.1121/1.384825; SCHEICH H, 1979, CELL TISSUE RES, V204, P17; Sen K, 2001, J NEUROPHYSIOL, V86, P1445, DOI 10.1152/jn.2001.86.3.1445; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Singh NC, 2003, J ACOUST SOC AM, V114, P3394, DOI 10.1121/1.1624067; Theunissen FE, 2000, J NEUROSCI, V20, P2315; Theunissen FE, 1998, J NEUROSCI, V18, P3786; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WILD JM, 1993, J COMP NEUROL, V337, P32; Woolley SMN, 2005, NAT NEUROSCI, V8, P1371, DOI 10.1038/nn1536; YOUNG ED, 1982, HEARING RES, V6, P153, DOI 10.1016/0378-5955(82)90051-X; Yu JJ, 2000, P NATL ACAD SCI USA, V97, P11780, DOI 10.1073/pnas.97.22.11780	69	124	126	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 21	2006	51	6					845	859		10.1016/j.neuron.2006.08.030	http://dx.doi.org/10.1016/j.neuron.2006.08.030			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982428	Bronze			2022-12-28	WOS:000240997900021
J	Kay, LM; Beshel, J; Martin, C				Kay, Leslie M.; Beshel, Jennifer; Martin, Claire			When good enough is best	NEURON			English	Editorial Material							ODOR DISCRIMINATION; OLFACTORY-BULB; SPEED; ACCURACY; DYNAMICS	In this issue of Neuron, Rinberg et al. show that mice use a speed-accuracy tradeoff in odor discrimination. Shorter sampling results in high performance for easy problems, and enforced longer sampling results in higher accuracy for difficult problems, but mice freely choose intermediate sampling durations and accuracy varies with difficulty. Reward value and task requirements may determine sampling time choice and performance levels.	Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; Univ Chicago, Inst Mind & Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kay, LM (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.		Martin, Claire/T-1360-2019	Martin, Claire/0000-0001-5340-8323; Kay, Leslie/0000-0003-3049-477X				Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Friedrich RW, 2006, TRENDS NEUROSCI, V29, P40, DOI 10.1016/j.tins.2005.10.004; Kay LM, 1998, BEHAV NEUROSCI, V112, P541, DOI 10.1037/0735-7044.112.3.541; KAY LM, 2006, IN PRESS SEMIN CELL; Khan RM, 2004, NEURON, V44, P744, DOI 10.1016/j.neuron.2004.11.024; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Martin C, 2006, EUR J NEUROSCI, V23, P1801, DOI 10.1111/j.1460-9568.2006.04711.x; Rinberg D, 2006, NEURON, V51, P351, DOI 10.1016/j.neuron.2006.07.013; SHIPLEY MT, 1984, BRAIN RES BULL, V12, P669, DOI 10.1016/0361-9230(84)90148-5; Sobel N, 1998, NATURE, V392, P282, DOI 10.1038/32654; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142	12	16	16	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					277	278		10.1016/j.neuron.2006.07.015	http://dx.doi.org/10.1016/j.neuron.2006.07.015			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880120	Bronze			2022-12-28	WOS:000239908800001
J	Fernandez-Alfonso, T; Kwan, R; Ryan, TA				Fernandez-Alfonso, Tomas; Kwan, Ricky; Ryan, Timothy A.			Synaptic vesicles interchange their membrane proteins with a large surface reservoir during recycling	NEURON			English	Article							FROG NEUROMUSCULAR JUNCTION; NERVE-TERMINALS; HIPPOCAMPAL SYNAPSES; PLASMA-MEMBRANE; POOL; EXOCYTOSIS; MOBILIZATION; TRANSMITTER; ENDOCYTOSIS; RELEASE	During recycling of synaptic vesicles (SVs), the retrieval machinery faces the challenge of recapturing SV proteins in a timely and precise manner. The significant dilution factor that would result from equilibration of vesicle proteins with the much larger cell surface would make recapture by diffusional encounter with the endocytic retrieval machinery unlikely. If SV proteins exchanged with counterparts residing at steady state on the cell surface, the dilution problem would be largely avoided. In this scenario, during electrical activity, endocytosis would be driven by the concentration of a pre-existing pool of SVs residing on the axonal or synaptic surface rather than the heavily diluted postfusion vesicular pool. Using both live cell imaging of endogenous synaptotagmin la (sytla) as well as pHluorin-tagged sytla and VAMP-2, we show here that synaptic vesicle proteins interchange with a large pool on the cell axonal surface whose concentration is similar to 10-fold lower than that in SVs.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA	Cornell University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Fernandez Alfonso, Tomas/0000-0002-9339-6678; Ryan, Timothy/0000-0003-2533-9548	NINDS NIH HHS [R01 NS036942] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036942] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; FERNANDEZALFONS.T, 2006, IN PRESS TRENDS CELL; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gandhi SP, 2003, NATURE, V423, P607, DOI 10.1038/nature01677; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Li ZY, 2005, P NATL ACAD SCI USA, V102, P6131, DOI 10.1073/pnas.0501145102; Li ZY, 2001, NEURON, V31, P593, DOI 10.1016/S0896-6273(01)00398-1; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Mitchell SJ, 2004, J NEUROSCI, V24, P4884, DOI 10.1523/JNEUROSCI.0174-04.2004; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; Pennuto M, 2003, MOL BIOL CELL, V14, P4909, DOI 10.1091/mbc.E03-06-0380; Poskanzer KE, 2004, NEUROPHARMACOLOGY, V47, P714, DOI 10.1016/j.neuropharm.2004.07.026; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Taubenblatt P, 1999, J CELL SCI, V112, P3559; Willig KI, 2006, NATURE, V440, P935, DOI 10.1038/nature04592; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6	24	146	148	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					179	186		10.1016/j.neuron.2006.06.008	http://dx.doi.org/10.1016/j.neuron.2006.06.008			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846853	Bronze			2022-12-28	WOS:000239535100006
J	Collins, CA; Wairkar, YP; Johnson, SL; DiAntonio, A				Collins, Catherine A.; Wairkar, Yogesh P.; Johnson, Sylvia L.; DiAntonio, Aaron			Highwire restrains synaptic growth by attenuating a MAP kinase signal	NEURON			English	Article							ZIPPER-BEARING KINASE; ACTIVATED PROTEIN-KINASE; MOLECULAR-CLONING; II RECEPTOR; DROSOPHILA; GENE; EXPRESSION; IDENTIFICATION; ORTHOLOG; RPM-1	Highwire is an extremely large, evolutionarily conserved E3 ubiquitin ligase that negatively regulates synaptic growth at the Drosophila NMJ. Highwire has been proposed to restrain synaptic growth by downregulating a synaptogenic signal. Here we identify such a downstream signaling pathway. A screen for suppressors of the highwire synaptic overgrowth phenotype yielded mutations in wallenda, a MAP kinase kinase kinase (MAPKKK) homologous to vertebrate DLK and LZK. wallenda is both necessary for highwire synaptic overgrowth and sufficient to promote synaptic overgrowth, and synaptic levels of Wallenda protein are controlled by Highwire and ubiquitin hydrolases. highwire synaptic overgrowth requires the MAP kinase JNK and the transcription factor Fos. These results suggest that Highwire controls structural plasticity of the synapse by regulating gene expression through a MAP kinase signaling pathway. In addition to controlling synaptic growth, Highwire promotes synaptic function through a separate pathway that does not require wallenda.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL)	DiAntonio, A (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.	dianton@molecool.wustl.edu		DiAntonio, Aaron/0000-0002-7262-0968; Collins, Catherine/0000-0002-1608-6692	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051453, R01NS043171] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS051453, R01 NS043171] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; Adachi-Yamada T, 1999, MOL CELL BIOL, V19, P2322; BRAND AH, 1993, DEVELOPMENT, V118, P401; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Burgess RW, 2004, MOL CELL BIOL, V24, P1096, DOI 10.1128/MCB.24.3.1096-1105.2004; Chen B, 1998, GENETICS, V149, P157; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; D'Souza J, 2005, DEVELOPMENT, V132, P247, DOI 10.1242/dev.01578; Daniels RW, 2004, J NEUROSCI, V24, P10466, DOI 10.1523/JNEUROSCI.3001-04.2004; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; FISCHERVIZE JA, 1992, DEVELOPMENT, V116, P985; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Guo QB, 1998, P NATL ACAD SCI USA, V95, P9172, DOI 10.1073/pnas.95.16.9172; HARRISON SD, 1995, GENETICS, V139, P1701; Hirai S, 2005, GENE EXPR PATTERNS, V5, P517, DOI 10.1016/j.modgep.2004.12.002; Hirai S, 2002, DEVELOPMENT, V129, P4483; HOLZMAN LB, 1994, J BIOL CHEM, V269, P30808; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; KULKARNI SJ, 1994, MOL GEN GENET, V243, P555, DOI 10.1007/BF00284204; LAINE A, 2005, SCI STKE; Le Guyader S, 2005, DEV BIOL, V277, P378, DOI 10.1016/j.ydbio.2004.09.029; Liao EH, 2004, NATURE, V430, P345, DOI 10.1038/nature02647; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Marrus SB, 2004, CURR BIOL, V14, P924, DOI 10.1016/j.cub.2004.05.047; Mata M, 1996, J BIOL CHEM, V271, P16888, DOI 10.1074/jbc.271.28.16888; McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X; Murthy V, 2004, J BIOL CHEM, V279, P1351, DOI 10.1074/jbc.M310208200; Nakata K, 2005, CELL, V120, P407, DOI 10.1016/j.cell.2004.12.017; PIERARD E, 2004, RES DATA CTR INFORMA, V1, P23; Riese J, 1997, DEVELOPMENT, V124, P3353; RiesgoEscovar JR, 1997, SCIENCE, V278, P669, DOI 10.1126/science.278.5338.669; Robitaille H, 2005, J BIOL CHEM, V280, P12732, DOI 10.1074/jbc.M411619200; Rorth P, 1998, DEVELOPMENT, V125, P1049; Sakuma H, 1997, J BIOL CHEM, V272, P28622, DOI 10.1074/jbc.272.45.28622; Sanyal S, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-20; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; SchultzEhrenburg U, 1996, PHLEBOLOGY, V11, P17; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Weber U, 2000, DEVELOPMENT, V127, P3619; Wu CL, 2005, J NEUROSCI, V25, P9557, DOI 10.1523/JNEUROSCI.2532-05.2005; Xu ZH, 2001, MOL CELL BIOL, V21, P4713, DOI 10.1128/MCB.21.14.4713-4724.2001; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; YAO KM, 1994, J NEUROCHEM, V63, P41; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8	52	244	251	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					57	69		10.1016/j.neuron.2006.05.026	http://dx.doi.org/10.1016/j.neuron.2006.05.026			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815332	Bronze			2022-12-28	WOS:000239037700010
J	Shirasaki, R; Lewcock, JW; Lettieri, K; Pfaff, SL				Shirasaki, Ryuichi; Lewcock, Joseph W.; Lettieri, Karen; Pfaff, Samuel L.			FGF as a target-derived chemoattractant for developing motor axons genetically programmed by the LIM code	NEURON			English	Article							PATTERNED NEURITE OUTGROWTH; GROWTH-FACTOR RECEPTOR-1; SPINAL-CORD; TRANSCRIPTIONAL CODES; EMBRYONIC ZEBRAFISH; COMMISSURAL AXONS; PATHWAY SELECTION; LUMBOSACRAL LEVEL; PROXIMAL TISSUES; VERTEBRATE LIMB	LIM transcription factors confer developing axons with specific navigational properties, but the downstream guidance receptors and ligands are not well defined. The dermomyotome, a transient structure from which axial muscles arise, is the source of a secreted long-range chemoattractant specific for medial-class spinal motor neuron axons (MMCm axons). We show that fibroblast growth factors (FGFs) produced by the dermomyotome selectively attract MMCm axons in vitro. FGF receptor 1 (FGFR1) expression is restricted to MMCm neurons, and conditional deletion of FGFR1 causes motor axon guidance defects. Furthermore, reprogramming the identity of limb-innervating motor neurons to that of dermomyotome-innervating MMCm cells using the LIM factor Lhx3 induces FGFR1 expression and shifts an increased number of motor axons to an FGF-responsive state. These results point to a role for FGF signaling in axon guidance and further unravel how downstream effectors of LIM codes direct wiring of the developing nervous system.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Salk Institute	Pfaff, SL (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pfaff@salk.edu		Shirasaki, Ryuichi/0000-0001-8561-7023				Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; Aurelio O, 2003, DEVELOPMENT, V130, P599, DOI 10.1242/dev.00277; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X; Certel SJ, 2004, DEVELOPMENT, V131, P5429, DOI 10.1242/dev.01418; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; Colvin JS, 1999, DEV DYNAM, V216, P72; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Diez del Corral R, 2004, BIOESSAYS, V26, P857, DOI 10.1002/bies.20080; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Eberhart J, 2004, J NEUROSCI, V24, P1070, DOI 10.1523/JNEUROSCI.4719-03.2004; Eberhart J, 2002, DEV BIOL, V247, P89, DOI 10.1006/dbio.2002.0695; EISEN JS, 1991, NEURON, V6, P767, DOI 10.1016/0896-6273(91)90173-W; Fujisawa H, 2004, J NEUROBIOL, V59, P24, DOI 10.1002/neu.10337; GUTHRIE S, 1995, NEURON, V14, P1117, DOI 10.1016/0896-6273(95)90260-0; Helmbacher F, 2000, DEVELOPMENT, V127, P3313; Huber AB, 2005, NEURON, V48, P949, DOI 10.1016/j.neuron.2005.12.003; Irving C, 2002, DEVELOPMENT, V129, P5389, DOI 10.1242/dev.00117; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kablar B, 1999, DEV BIOL, V208, P93, DOI 10.1006/dbio.1998.9184; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; LANDMESSER LT, 1992, GROWTH CONE GUIDANCE; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Lin HY, 1996, J NEUROSCI, V16, P4579; Loo BM, 2002, J BIOL CHEM, V277, P32616, DOI 10.1074/jbc.M204961200; LUMSDEN AGS, 1983, NATURE, V306, P786, DOI 10.1038/306786a0; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MCCAIG CD, 1986, J PHYSIOL-LONDON, V375, P39, DOI 10.1113/jphysiol.1986.sp016104; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; Miyashita T, 2004, DEVELOPMENT, V131, P3705, DOI 10.1242/dev.01228; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; NAKAO T, 1994, ANAT EMBRYOL, V189, P115; NISWANDER L, 1992, DEVELOPMENT, V114, P755; O'Connor R, 1999, NEURON, V24, P165, DOI 10.1016/S0896-6273(00)80830-2; Ohkubo Y, 2004, J NEUROSCI, V24, P6057, DOI 10.1523/JNEUROSCI.1140-04.2004; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Pak W, 2004, CELL, V119, P567, DOI 10.1016/j.cell.2004.10.026; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; Raffioni S, 1999, P NATL ACAD SCI USA, V96, P7178, DOI 10.1073/pnas.96.13.7178; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Segawa H, 2001, NEURON, V30, P423, DOI 10.1016/S0896-6273(01)00283-5; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Sharma K, 2000, NATURE, V406, P515, DOI 10.1038/35020078; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916; Szebenyi G, 2001, J NEUROSCI, V21, P3932, DOI 10.1523/JNEUROSCI.21-11-03932.2001; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TOSNEY KW, 1987, DEV BIOL, V122, P540, DOI 10.1016/0012-1606(87)90318-6; TOSNEY KW, 1985, DEV BIOL, V109, P193, DOI 10.1016/0012-1606(85)90360-4; TOSNEY KW, 1988, DEV BIOL, V127, P266, DOI 10.1016/0012-1606(88)90314-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Tzarfati-Majar V, 2001, P NATL ACAD SCI USA, V98, P4722, DOI 10.1073/pnas.081062398; Uemura O, 2005, DEV BIOL, V278, P587, DOI 10.1016/j.ydbio.2004.11.031; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; West AG, 2002, GENE DEV, V16, P271, DOI 10.1101/gad.954702; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102	69	95	96	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					841	853		10.1016/j.neuron.2006.04.030	http://dx.doi.org/10.1016/j.neuron.2006.04.030			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772167	Bronze			2022-12-28	WOS:000238589500006
J	Liston, C; Matalon, S; Hare, TA; Davidson, MC; Casey, BJ				Liston, Conor; Matalon, Shanna; Hare, Todd A.; Davidson, Matthew C.; Casey, B. J.			Anterior cingulate and posterior parietal cortices are sensitive to dissociable forms of conflict in a task-switching paradigm	NEURON			English	Article							COGNITIVE CONTROL MECHANISMS; MEDIAL FRONTAL-CORTEX; PREFRONTAL CORTEX; ATTENTIONAL SET; FUNCTIONAL-ANATOMY; RESPONSE CONFLICT; RHESUS-MONKEY; FMRI; PERFORMANCE; COMPUTATIONS	The conflict-monitoring hypothesis posits that anterior cingulate cortex (ACC) monitors conflict in information processing and recruits dorsolateral prefrontal cortex (DLPFC) to resolve competition as needed. We used fMRI to test this prediction directly in the context of a task-switching paradigm, in which subjects responded to the color or the motion of a visual stimulus. Conflict was indexed in terms of the product of activities in areas specialized for color or motion processing on a trial-by-trial basis. Here, we report that ACC and posterior parietal cortex (PPC) were sensitive to distinct forms of conflict, at the level of the response and the stimulus representation, respectively. Activity in PPC preceded increased activity in DLPFC and predicted enhanced behavioral performance on subsequent trials. These findings suggest that ACC and PPC may act in concert to detect dissociable forms of conflict and signal to DLPFC the need for increased control.	Cornell Univ, Weill Med Coll, Sackler Inst Dev Psychobiol, New York, NY 10021 USA	Cornell University	Liston, C (corresponding author), Cornell Univ, Weill Med Coll, Sackler Inst Dev Psychobiol, 1300 York Ave,Box 40, New York, NY 10021 USA.	col2004@med.cornell.edu	Hare, Todd A/E-7091-2017; , Conor Liston/GQH-8931-2022; Hare, Todd/AAE-8574-2019	Hare, Todd A/0000-0002-0260-2772; Hare, Todd/0000-0002-0260-2772	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063255, P50MH062196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015882] Funding Source: NIH RePORTER; NIDA NIH HHS [R21 DA15882] Funding Source: Medline; NIGMS NIH HHS [GM 07739] Funding Source: Medline; NIMH NIH HHS [R01 MH63255, P01 MH62196] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen RA, 2002, ANNU REV NEUROSCI, V25, P189, DOI 10.1146/annurev.neuro.25.112701.142922; Badre D, 2004, NEURON, V41, P473, DOI 10.1016/S0896-6273(03)00851-1; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; BATES JF, 1993, J COMP NEUROL, V336, P211, DOI 10.1002/cne.903360205; Birrell JM, 2000, J NEUROSCI, V20, P4320; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Burgess PW, 2000, NEUROPSYCHOLOGIA, V38, P848, DOI 10.1016/S0028-3932(99)00134-7; CAMPBELL FW, 1981, VISION RES, V21, P713, DOI 10.1016/0042-6989(81)90080-8; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; Casey BJ, 2002, DEV PSYCHOBIOL, V40, P237, DOI 10.1002/dev.10030; COHEN JD, 1992, PSYCHOL REV, V99, P47; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dias R, 1996, NATURE, V380, P69, DOI 10.1038/380069a0; Dreher JC, 2003, CEREB CORTEX, V13, P329, DOI 10.1093/cercor/13.4.329; Dreher JC, 2002, P NATL ACAD SCI USA, V99, P14595, DOI 10.1073/pnas.222193299; Durston S, 2002, NEUROIMAGE, V16, P449, DOI 10.1006/nimg.2002.1074; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Fox MT, 2003, J NEUROSCI, V23, P676, DOI 10.1523/JNEUROSCI.23-02-00676.2003; Glover GH, 2004, MAGN RESON MED, V51, P863, DOI 10.1002/mrm.20016; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Luks TL, 2002, NEUROIMAGE, V17, P792, DOI 10.1006/nimg.2002.1210; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McAlonan K, 2003, BEHAV BRAIN RES, V146, P97, DOI 10.1016/j.bbr.2003.09.019; MENT XL, 1992, PSYCHOL BULL, V111, P172; Milham MP, 2005, HUM BRAIN MAPP, V25, P328, DOI 10.1002/hbm.20110; Milham MP, 2003, NEUROIMAGE, V18, P483, DOI 10.1016/S1053-8119(02)00050-2; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; O'Reilly RC, 2002, CEREB CORTEX, V12, P246, DOI 10.1093/cercor/12.3.246; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rushworth MFS, 2002, J NEUROPHYSIOL, V87, P2577, DOI 10.1152/jn.2002.87.5.2577; Rushworth MFS, 2003, J COGNITIVE NEUROSCI, V15, P338, DOI 10.1162/089892903321593072; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; van Veen V, 2001, NEUROIMAGE, V14, P1302, DOI 10.1006/nimg.2001.0923; van Veen V, 2005, NEUROIMAGE, V27, P497, DOI 10.1016/j.neuroimage.2005.04.042; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Wise SP, 1997, ANNU REV NEUROSCI, V20, P25, DOI 10.1146/annurev.neuro.20.1.25	52	181	183	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					643	653		10.1016/j.neuron.2006.04.015	http://dx.doi.org/10.1016/j.neuron.2006.04.015			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701213	Bronze			2022-12-28	WOS:000237875200014
J	Peelen, MV; Wiggett, AJ; Downing, PE				Peelen, MV; Wiggett, AJ; Downing, PE			Patterns of fMRI activity dissociate overlapping functional brain areas that respond to biological motion	NEURON			English	Article							VISUAL-PERCEPTION; FACE; BODY; RECOGNITION; SPECIFICITY; SELECTIVITY; SYSTEMS; OBJECTS; CORTEX	Accurate perception of the actions and intentions of other people is essential for successful interactions in asocial environment. Several cortical areas that support this process respond selectively in fMRI to static and dynamic displays of human bodies and faces. Here we apply pattern-analysis techniques to arrive at a new understanding of the neural response to biological motion. Functionally defined body-, face-, and motion-selective visual areas all responded significantly to "point-light" human motion. Strikingly, however, only body selectivity was correlated, on a voxel-by-voxel basis, with biological motion selectivity. We conclude that (1) biological motion, through the process of structure-from-motion, engages areas involved in the analysis of the static human form; (2) body-selective regions in posterior fusiform gyrus and posterior inferior temporal sulcus overlap with, but are distinct from, face- and motion-selective regions; (3) the interpretation of region-of-interest findings may be substantially altered when multiple patterns of selectivity are considered.	Univ Coll N Wales, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales	Bangor University	Peelen, MV (corresponding author), Univ Coll N Wales, Sch Psychol, Bangor LL57 2AS, Gwynedd, Wales.	pspe40@bangor.ac.uk; p.downing@bangor.ac.uk	Peelen, Marius V/D-1780-2010	Peelen, Marius V/0000-0002-4026-7303; Downing, Paul/0000-0002-5046-2858	Biotechnology and Biological Sciences Research Council [BB/C502530/1] Funding Source: Medline; FDA HHS [BB/C502530/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); FDA HHS		Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Beauchamp MS, 2002, NEURON, V34, P149, DOI 10.1016/S0896-6273(02)00642-6; Bonda E, 1996, J NEUROSCI, V16, P3737; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; DOWNING PE, 2005, IN PRESS CEREB CORTE, DOI DOI 10.1093/CANCOR/BHJ086; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Giese MA, 2003, NAT REV NEUROSCI, V4, P179, DOI 10.1038/nrn1057; Grezes J, 2001, NEUROIMAGE, V13, P775, DOI 10.1006/nimg.2000.0740; Grossman E, 2000, J COGNITIVE NEUROSCI, V12, P711, DOI 10.1162/089892900562417; Grossman ED, 2004, J COGNITIVE NEUROSCI, V16, P1669, DOI 10.1162/0898929042568569; Grossman ED, 2002, NEURON, V35, P1167, DOI 10.1016/S0896-6273(02)00897-8; Grossman ED, 2001, VISION RES, V41, P1475, DOI 10.1016/S0042-6989(00)00317-5; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Haxby JV, 2002, BIOL PSYCHIAT, V51, P59, DOI 10.1016/S0006-3223(01)01330-0; Haynes JD, 2005, CURR BIOL, V15, P1301, DOI 10.1016/j.cub.2005.06.026; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; LOFTUS GR, 1994, PSYCHON B REV, V1, P476, DOI 10.3758/BF03210951; Michels L, 2005, NEUROREPORT, V16, P1037, DOI 10.1097/00001756-200507130-00002; Peelen MV, 2005, NAT NEUROSCI, V8, P125, DOI 10.1038/nn0205-125a; Peelen MV, 2005, HUM BRAIN MAPP, V25, P402, DOI 10.1002/hbm.20116; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pelphrey KA, 2005, CEREB CORTEX, V15, P1866, DOI 10.1093/cercor/bhi064; Peuskens H, 2005, EUR J NEUROSCI, V21, P2864, DOI 10.1111/j.1460-9568.2005.04106.x; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Santi A, 2003, J COGNITIVE NEUROSCI, V15, P800, DOI 10.1162/089892903322370726; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Swallow KM, 2003, NEUROIMAGE, V20, P1561, DOI 10.1016/S1053-8119(03)00436-1; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarr MJ, 2000, NAT NEUROSCI, V3, P764, DOI 10.1038/77666; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Vaina LM, 2001, P NATL ACAD SCI USA, V98, P11656, DOI 10.1073/pnas.191374198	36	289	293	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					815	822		10.1016/j.neuron.2006.02.004	http://dx.doi.org/10.1016/j.neuron.2006.02.004			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543130	Bronze			2022-12-28	WOS:000236227500010
J	Kuramoto, N; Wilkins, ME; Fairfax, BP; Revilla-Sanchez, R; Terunuma, M; Tamaki, K; Iemata, M; Warren, N; Couve, A; Calver, A; Horvath, Z; Freeman, K; Carling, D; Huang, L; Gonzales, C; Cooper, E; Smart, TG; Pangalos, MN; Moss, SJ				Kuramoto, Nobuyuki; Wilkins, Megan E.; Fairfax, Benjamin P.; Revilla-Sanchez, Raquel; Terunuma, Miho; Tamaki, Keisuke; Iemata, Mika; Warren, Noel; Couve, Andres; Calver, Andrew; Horvath, Zsolt; Freeman, Katie; Carling, David; Huang, Lan; Gonzales, Cathleen; Cooper, Edward; Smart, Trevor G.; Pangalos, Menelas N.; Moss, Stephen J.			Phospho-dependent functional modulation of GABA(B) receptors by the metabolic sensor AMP-dependent protein kinase	NEURON			English	Article							CEREBRAL-ARTERY OCCLUSION; INTRALUMINAL SUTURE; UPSTREAM KINASE; PHOSPHORYLATION; TRAFFICKING; ISCHEMIA; CASCADE; RAT; EXCITOTOXICITY; ASSOCIATION	GABA(B) receptors are heterodimeric G protein-coupled receptors composed of R1 and R2 subunits that mediate slow synaptic inhibition in the brain by activating inwardly rectifying K+ channels (GIRKs) and inhibiting Ca2+, channels. We demonstrate here that GABAB receptors are intimately associated with 5'AMP-dependent protein kinase (AMPK). AMPK acts as a metabolic sensor that is potently activated by increases in 5'AMP concentration that are caused by enhanced metabolic activity, anoxia, or ischemia. AMPK binds the R1 subunit and directly phosphorylates S783 in the R2 subunit to enhance GABAB receptor activation of GIRKs. Phosphorylation of S783 is evident in many brain regions, and is increased dramatically after ischemic injury. Finally, we also reveal that S783 plays a critical role in enhancing neuronal survival after ischemia. Together our results provide evidence of a neuroprotective mechanism, which, under conditions of metabolic stress or after ischemia, increases GABAB receptor function to reduce excitotoxicity and thereby promotes neuronal survival.	Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA; UCL, Dept Pharmacol, London WC1E 6BT, England; GlaxoSmithKline Inc, Neurol & GI CEDD, Harlow CM19 5AW, Essex, England; Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; GlaxoSmithKline Inc, Dept Comparat Genom Genet Res, Collegeville, PA 19426 USA; Hammersmith Hosp, MRC, Ctr Clin Sci, London W12 0NN, England; Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Cellular & Dev Biol, Irvine, CA 92697 USA; Wyeth Res, Princeton, NJ 08543 USA	University of Pennsylvania; University of London; University College London; GlaxoSmithKline; University of Pennsylvania; GlaxoSmithKline; Imperial College London; University of California System; University of California Irvine; University of California System; University of California Irvine; Pfizer	Moss, SJ (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.	sjmoss@mail.med.upenn.edu	Carling, David/F-1943-2014; couve, andres/I-2249-2013; Huang, Lan/C-3618-2011	Carling, David/0000-0002-2316-1830; couve, andres/0000-0003-4216-8672; Takarada-Iemata, Mika/0000-0002-2113-0707; Wilkins, Megan/0000-0003-0150-4457; Fairfax, Benjamin/0000-0001-7413-5002; Terunuma, Miho/0000-0003-1876-9726	MRC [G0601529] Funding Source: UKRI; Medical Research Council [MC_U120027537, G0601529] Funding Source: Medline; NINDS NIH HHS [R01 NS051195, R01 NS047478-01A2, NS 048045, R01 NS046478, NS051195, R01 NS081986, R21 NS080064, R21NS42100, R01 NS048045, R01 NS047478, NS 046478, R01 NS047478-02, R01 NS048045-01A2, R01 NS051195-01A1, R01 NS048045-02] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047478, R01NS051195, R21NS042100, R01NS048045, R01NS046478, R21NS080064, R01NS081986] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bowery NG, 2006, CURR OPIN PHARMACOL, V6, P37, DOI 10.1016/j.coph.2005.10.002; Brandon NJ, 1999, J NEUROSCI, V19, P9228; Brandon NJ, 1999, BIOCHEM SOC T, V27, P527, DOI 10.1042/bst0270527; Calver AR, 2001, J NEUROSCI, V21, P1203; Carling D, 2005, BIOCHIMIE, V87, P87, DOI 10.1016/j.biochi.2004.10.017; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H; Choi D, 1998, MT SINAI J MED, V65, P133; Couve A, 2004, J BIOL CHEM, V279, P13934, DOI 10.1074/jbc.M311737200; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Dave KR, 2005, J NEUROSCI RES, V82, P665, DOI 10.1002/jnr.20674; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Huang L, 2001, J BIOL CHEM, V276, P28327, DOI 10.1074/jbc.M008342200; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Imura T, 1999, J NEUROSCI, V19, P9768; JacksonFriedman C, 1997, EXP NEUROL, V147, P346, DOI 10.1006/exnr.1997.6637; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kittler JT, 2004, P NATL ACAD SCI USA, V101, P12736, DOI 10.1073/pnas.0401860101; Kulinskii VI, 2000, B EXP BIOL MED+, V130, P772, DOI 10.1007/BF02766091; Kume T, 2002, EUR J PHARMACOL, V455, P91, DOI 10.1016/S0014-2999(02)02582-7; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Ramamurthy S, 2006, J PHYSIOL-LONDON, V574, P85, DOI 10.1113/jphysiol.2006.110122; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Woollhead AM, 2005, J PHYSIOL-LONDON, V566, P781, DOI 10.1113/jphysiol.2005.088674	40	150	155	2	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					233	247		10.1016/j.neuron.2006.12.015	http://dx.doi.org/10.1016/j.neuron.2006.12.015			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224405	Bronze, Green Accepted			2022-12-28	WOS:000245126600009
J	Lakatos, P; Chen, CM; O'Connell, MN; Mills, A; Schroeder, CE				Lakatos, Peter; Chen, Chi-Ming; O'Connell, Monica N.; Mills, Aimee; Schroeder, Charles E.			Neuronal oscillations and multisensory interaction in primary auditory cortex	NEURON			English	Article							SOURCE-DENSITY ANALYSIS; MACAQUE MONKEYS; ASSOCIATION CORTEX; EVOKED-POTENTIALS; LAMINAR PROFILE; LOW-LEVEL; CONNECTIONS; RESPONSES; INTEGRATION; DYNAMICS	Recent anatomical, physiological, and neuroimaging findings indicate multisensory convergence at early, putatively unisensory stages of cortical processing. The objective of this study was to confirm somatosensory-auditory interaction in Al and to define both its physiological mechanisms and its consequences for auditory information processing. Laminar current source density and multiunit activity sampled during multielectrode penetrations of primary auditory area Al in awake macaques revealed clear somatosensory-auditory interactions, with a novel mechanism: somatosensory inputs appear to reset the phase of ongoing neuronal oscillations, so that accompanying auditory inputs arrive during an ideal, high-excitability phase, and produce amplified neuronal responses. In contrast, responses to auditory inputs arriving during the opposing low-excitability phase tend to be suppressed. Our findings underscore the instrumental role of neuronal oscillations in cortical operations. The timing and laminar profile of the multisensory interactions in Al indicate that nonspecific thalamic systems may play a key role in the effect.	Nathan S Kline Inst Psychiat Res, Cognit Neurosci Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA; Hungarian Acad Sci, Inst Psychol, H-1394 Budapest, Hungary; Columbia Univ Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA	Nathan Kline Institute for Psychiatric Research; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Columbia University	Schroeder, CE (corresponding author), Nathan S Kline Inst Psychiat Res, Cognit Neurosci Neurosci & Schizophrenia Program, Orangeburg, NY 10962 USA.	schrod@nki.rfmh.org	Chen, Chi-Ming/G-1321-2010	Chen, Chi-Ming/0000-0003-4419-1593; Lakatos, Peter/0000-0003-0221-4021	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061989] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH061989, MH61989] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; ATTEVELDT N, 2004, NEURON, V43, P271; BLUM PS, 1979, EXP BRAIN RES, V34, P1; Brosch M, 2005, J NEUROSCI, V25, P6797, DOI 10.1523/JNEUROSCI.1571-05.2005; Callan DE, 2001, COGNITIVE BRAIN RES, V10, P349, DOI 10.1016/S0926-6410(00)00054-9; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Cappe C, 2005, EUR J NEUROSCI, V22, P2886, DOI 10.1111/j.1460-9568.2005.04462.x; de la Mothe LA, 2006, J COMP NEUROL, V496, P72, DOI 10.1002/cne.20924; Falchier A, 2002, J NEUROSCI, V22, P5749; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Fiser J, 2004, NATURE, V431, P573, DOI 10.1038/nature02907; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foxe JJ, 2000, COGNITIVE BRAIN RES, V10, P77, DOI 10.1016/S0926-6410(00)00024-0; Foxe JJ, 2002, J NEUROPHYSIOL, V88, P540, DOI 10.1152/jn.2002.88.1.540; Fries P, 2001, NAT NEUROSCI, V4, P194, DOI 10.1038/84032; Fu KMG, 2004, J NEUROPHYSIOL, V92, P3522, DOI 10.1152/jn.01228.2003; Fu KMG, 2003, J NEUROSCI, V23, P7510; GALAMBOS R, 1981, P NATL ACAD SCI-BIOL, V78, P2643, DOI 10.1073/pnas.78.4.2643; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2006, TRENDS COGN SCI, V10, P278, DOI 10.1016/j.tics.2006.04.008; Hackett TA, 1998, J COMP NEUROL, V394, P475, DOI 10.1002/(SICI)1096-9861(19980518)394:4<475::AID-CNE6>3.0.CO;2-Z; Hackett TA, 1998, J COMP NEUROL, V400, P271, DOI 10.1002/(SICI)1096-9861(19981019)400:2<271::AID-CNE8>3.0.CO;2-6; Jones EG, 1998, NEUROSCIENCE, V85, P331, DOI 10.1016/S0306-4522(97)00581-2; Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6; Jousmaki V, 1998, CURR BIOL, V8, pR190, DOI 10.1016/S0960-9822(98)70120-4; Kaiser J, 2005, CEREB CORTEX, V15, P646, DOI 10.1093/cercor/bhh166; Kayser C, 2005, NEURON, V48, P373, DOI 10.1016/j.neuron.2005.09.018; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Lakatos P, 2005, NEUROREPORT, V16, P933, DOI 10.1097/00001756-200506210-00011; Lipton ML, 2006, J NEUROSCI, V26, P180, DOI 10.1523/JNEUROSCI.1073-05.2006; Makeig S, 2004, TRENDS COGN SCI, V8, P204, DOI 10.1016/j.tics.2004.03.008; MOLINARI M, 1995, J COMP NEUROL, V362, P171, DOI 10.1002/cne.903620203; MOREL A, 1992, J COMP NEUROL, V318, P27, DOI 10.1002/cne.903180104; Murray MM, 2005, CEREB CORTEX, V15, P963, DOI 10.1093/cercor/bhh197; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; PETERSON NN, 1995, EVOKED POTENTIAL, V96, P248, DOI 10.1016/0168-5597(95)00006-E; POGGIO GF, 1960, B JOHNS HOPKINS HOSP, V106, P266; Recanzone GH, 1998, P NATL ACAD SCI USA, V95, P869, DOI 10.1073/pnas.95.3.869; Rizzuto DS, 2006, NEUROIMAGE, V31, P1352, DOI 10.1016/j.neuroimage.2006.01.009; Rockland KS, 2003, INT J PSYCHOPHYSIOL, V50, P19, DOI 10.1016/S0167-8760(03)00121-1; Sakowitz OW, 2005, COGNITIVE BRAIN RES, V23, P316, DOI 10.1016/j.cogbrainres.2004.10.012; Sakowitz OW, 2001, COGNITIVE BRAIN RES, V11, P267, DOI 10.1016/S0926-6410(00)00081-1; Sanabria D, 2005, EXP BRAIN RES, V165, P505, DOI 10.1007/s00221-005-2327-5; Schroeder CE, 1995, EEG CL N SU, P55; Schroeder CE, 2002, COGNITIVE BRAIN RES, V14, P187, DOI 10.1016/S0926-6410(02)00073-3; Schroeder CE, 2003, INT J PSYCHOPHYSIOL, V50, P5, DOI 10.1016/S0167-8760(03)00120-X; Schroeder CE, 1998, CEREB CORTEX, V8, P575, DOI 10.1093/cercor/8.7.575; Schroeder CE, 2005, CURR OPIN NEUROBIOL, V15, P454, DOI 10.1016/j.conb.2005.06.008; Schroeder CE, 2001, J NEUROPHYSIOL, V85, P1322, DOI 10.1152/jn.2001.85.3.1322; Schurmann M, 2004, J ACOUST SOC AM, V115, P830, DOI 10.1121/1.1639909; Senkowski D, 2007, NEUROPSYCHOLOGIA, V45, P561, DOI 10.1016/j.neuropsychologia.2006.01.013; Senkowski D, 2006, CEREB CORTEX, V16, P1556, DOI 10.1093/cercor/bhj091; Shah AS, 2004, CEREB CORTEX, V14, P476, DOI 10.1093/cercor/bhh009; Stein BE., 1993, MERGING SENSES; STEINSCHNEIDER M, 1995, BRAIN RES, V674, P147, DOI 10.1016/0006-8993(95)00008-E; Stone JV, 2001, P ROY SOC B-BIOL SCI, V268, P31, DOI 10.1098/rspb.2000.1326; SUMBY WH, 1954, J ACOUST SOC AM, V26, P212, DOI 10.1121/1.1907309; Werner-Reiss U, 2003, CURR BIOL, V13, P554, DOI 10.1016/S0960-9822(03)00168-4	59	675	683	2	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 18	2007	53	2					279	292		10.1016/j.neuron.2006.12.011	http://dx.doi.org/10.1016/j.neuron.2006.12.011			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224408	Green Accepted, Bronze			2022-12-28	WOS:000245126600012
J	Oka, Y; Katada, S; Omura, M; Suwa, M; Yoshihara, Y; Touhara, K				Oka, Yuki; Katada, Sayako; Omura, Masayo; Suwa, Makiko; Yoshihara, Yoshihiro; Touhara, Kazushige			Odorant receptor map in the mouse olfactory bulb: In vivo sensitivity and specificity of receptor-defined glomeruli	NEURON			English	Article							NEURON INPUT; MICE DEFICIENT; FUNCTIONAL MRI; EXPRESSION; REPRESENTATIONS; DISCRIMINATION; LIGANDS; SYSTEM; IDENTIFICATION; RECONSTITUTION	Odorant identity is represented in the olfactory bulb (OB) by the glomerular activity pattern, which reflects a combination of activated odorant receptors (ORs) in the olfactory epithelium. To elucidate this neuronal circuit at the molecular level, we established a functional OR identification strategy based on glomerular activity by combining in vivo Ca2+, imaging, retrograde dye labeling, and single-cell RT-PCR. Spatial and functional mapping of OR-defined glomeruli revealed that the glomerular positional relationship varied considerably between individual animals, resulting in different OR maps in the OB. Notably, OR-defined glomeruli exhibited different ligand spectra and far higher sensitivity compared to the in vitro pharmacological properties of corresponding ORs. Moreover, we found that the olfactory mucus was an important factor in the regulation of in vivo odorant responsiveness. Our results provide a methodology to examine in vivo glomerular responses at the receptor level and further help address the long-standing issues of olfactory sensitivity and specificity under physiological conditions.	Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan; Natl Inst Adv Ind Sci & Technol AIST, CBRC, Tokyo 1350064, Japan; RIKEN Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan; Japan Sci & Technol Agcy, Osaka 5600082, Japan	University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); RIKEN; Japan Science & Technology Agency (JST)	Touhara, K (corresponding author), Univ Tokyo, Dept Integrated Biosci, Chiba 2778562, Japan.	touhara@k.u-tokyo.ac.jp	Oka, Yoshitaka/G-4952-2014; Yoshihara, Yoshihiro/N-6481-2015; Suwa, Makiko/M-5056-2018	Oka, Yoshitaka/0000-0002-3482-3051; Yoshihara, Yoshihiro/0000-0002-0319-7166; Oka, Yuki/0000-0003-2686-0677; Suwa, Makiko/0000-0001-8812-1023; Katada, Sayako/0000-0002-0466-0466				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Belluscio L, 2002, NATURE, V419, P296, DOI 10.1038/nature01001; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Bozza TC, 1998, J NEUROSCI, V18, P4560; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 2004, NUTR REV, V62, pS184, DOI 10.1111/j.1753-4887.2004.tb00097.x; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Firestein Stuart, 2004, Sci STKE, V2004, ppe15; Fried HU, 2002, P NATL ACAD SCI USA, V99, P3222, DOI 10.1073/pnas.052658399; GUTHRIE KM, 1995, CHEM SENSES, V20, P271, DOI 10.1093/chemse/20.2.271; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Katada S, 2003, BIOCHEM BIOPH RES CO, V305, P964, DOI 10.1016/S0006-291X(03)00863-5; Kurtz DB, 2004, CHEM SENSES, V29, P763, DOI 10.1093/chemse/bjh079; Lin WH, 2004, J NEUROSCI, V24, P3703, DOI 10.1523/JNEUROSCI.0188-04.2004; Luu P, 2004, J NEUROSCI, V24, P10128, DOI 10.1523/JNEUROSCI.3117-04.2004; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Miyamichi K, 2005, J NEUROSCI, V25, P3586, DOI 10.1523/JNEUROSCI.0324-05.2005; Mizrahi A, 2004, NEUROPHARMACOLOGY, V47, P661, DOI 10.1016/j.neuropharm.2004.07.020; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mori K, 2006, PHYSIOL REV, V86, P409, DOI 10.1152/physrev.00021.2005; Oka Y, 2004, CHEM SENSES, V29, P815, DOI 10.1093/chemse/bjh247; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; Touhara K, 2002, MICROSC RES TECHNIQ, V58, P135, DOI 10.1002/jemt.10131; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2001, NEURON, V32, P723, DOI 10.1016/S0896-6273(01)00506-2; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Weiler E, 2006, CHEM SENSES, V31, P641, DOI 10.1093/chemse/bjl004; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; Xu FQ, 2003, P NATL ACAD SCI USA, V100, P11029, DOI 10.1073/pnas.1832864100; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X	48	132	133	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 7	2006	52	5					857	869		10.1016/j.neuron.2006.10.019	http://dx.doi.org/10.1016/j.neuron.2006.10.019			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145506	Bronze			2022-12-28	WOS:000242856400013
J	Shin, RM; Tsvetkov, E; Bolshakov, VY				Shin, Ryong-Moon; Tsvetkov, Evgeny; Bolshakov, Vadim Y.			Spatiotemporal asymmetry of associative synaptic plasticity in fear conditioning pathways	NEURON			English	Article							LONG-TERM POTENTIATION; LATERAL AMYGDALA; POSTSYNAPTIC INDUCTION; SUBUNIT COMPOSITION; NMDA RECEPTORS; LTP; INPUTS; INTERNEURONS; TRANSMISSION; EXPRESSION	Input-specific long-term potentiation (LTP) in afferent inputs to the amygdala serves an essential function in the acquisition of fear memory. Factors underlying input specificity of synaptic modifications implicated in information transfer in fear conditioning pathways remain unclear. Here we show that the strength of naive synapses in two auditory inputs converging on a single neuron in the lateral nucleus of the amygdala (LA) is only modified when a postsynaptic action potential closely follows a synaptic response. The stronger inhibitory drive in thalamic pathway, as compared with cortical input, hampers the induction of LTP at thalamo-amygdala synapses, contributing to the spatial specificity of LTP in convergent inputs. These results indicate that spike timing-dependent synaptic plasticity in afferent projections to the LA is both temporarily and spatially asymmetric, thus providing a mechanism for the conditioned stimulus discrimination during fear behavior.	Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA	Harvard University	Bolshakov, VY (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	vadimb@mclean.harvard.edu	Tsvetkov, Evgeny/C-1085-2016; Tsvetkov, Evgeny A/B-6573-2016	Tsvetkov, Evgeny/0000-0001-9339-1677; Tsvetkov, Evgeny A/0000-0002-6784-0907	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045625, R01NS044185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA015098] Funding Source: NIH RePORTER; NIDA NIH HHS [DA15098, R03 DA015098] Funding Source: Medline; NINDS NIH HHS [NS44185, R01 NS044185, R01 NS045625, NS045625] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bauer EP, 2002, J NEUROSCI, V22, P5239, DOI 10.1523/JNEUROSCI.22-12-05239.2002; Bauer EP, 2001, NAT NEUROSCI, V4, P687, DOI 10.1038/89465; Bi GQ, 2005, TRENDS NEUROSCI, V28, P222, DOI 10.1016/j.tins.2005.02.002; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bissiere S, 2003, NAT NEUROSCI, V6, P587, DOI 10.1038/nn1058; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; de Armentia ML, 2003, J NEUROSCI, V23, P6876; Doyere V, 2003, EUR J NEUROSCI, V17, P2703, DOI 10.1046/j.1460-9568.2003.02707.x; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Goosens KA, 2003, NEURON, V40, P1013, DOI 10.1016/S0896-6273(03)00728-1; Han VZ, 2000, NEURON, V27, P611, DOI 10.1016/S0896-6273(00)00070-2; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Humeau Y, 2005, NEURON, V45, P119, DOI 10.1016/j.neuron.2004.12.019; Karmarkar UR, 2002, BIOL CYBERN, V87, P373, DOI 10.1007/s00422-002-0351-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Neyton J, 2006, J NEUROSCI, V26, P1331, DOI 10.1523/JNEUROSCI.5242-05.2006; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; Steele PM, 1999, J NEUROPHYSIOL, V81, P1559, DOI 10.1152/jn.1999.81.4.1559; Szinyei C, 2000, J NEUROSCI, V20, P8909; Tsvetkov E, 2004, NEURON, V41, P139, DOI 10.1016/S0896-6273(03)00800-6; Tsvetkov E, 2002, NEURON, V34, P289, DOI 10.1016/S0896-6273(02)00645-1; Tzounopoulos T, 2004, NAT NEUROSCI, V7, P719, DOI 10.1038/nn1272; Wang HX, 2005, NAT NEUROSCI, V8, P187, DOI 10.1038/nn1387; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000	42	65	66	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					883	896		10.1016/j.neuron.2006.10.010	http://dx.doi.org/10.1016/j.neuron.2006.10.010			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145508	Green Accepted, Bronze			2022-12-28	WOS:000242856400015
J	Howarth, C; Attwell, D				Howarth, Clare; Attwell, David			Transports of delight	NEURON			English	Editorial Material							INTRINSIC OPTICAL SIGNALS; FUNCTIONAL ARCHITECTURE; OLFACTORY-BULB; BRAIN; MICROCIRCULATION; GLUTAMATE; CORTEX	Intrinsic optical signals, evoked by neural activity, provide an essentially noninvasive means of monitoring the organization of brain circuitry. A new study by Gurden et al. in this issue of Neuron reveals a surprising role of astrocyte glutamate transporters in generating these signals.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Howarth, C (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.		Attwell, David/ABE-6750-2020	Howarth, Clare/0000-0002-6660-9770				Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Gurden H, 2006, NEURON, V52, P335, DOI 10.1016/j.neuron.2006.07.022; Meister M, 2001, J NEUROSCI, V21, P1351; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Utsumi M, 2001, MOL BRAIN RES, V92, P1, DOI 10.1016/S0169-328X(01)00098-5; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	11	1	1	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					224	225		10.1016/j.neuron.2006.09.002	http://dx.doi.org/10.1016/j.neuron.2006.09.002			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046685	Bronze			2022-12-28	WOS:000241799900003
J	Bunzeck, N; Duzel, E				Bunzeck, Nico; Duzel, Emrah			Absolute coding of stimulus novelty in the human substantia nigra/VTA	NEURON			English	Article							LONG-TERM POTENTIATION; EVENT-RELATED FMRI; MEMORY FORMATION; DOPAMINERGIC MIDBRAIN; RECOGNITION MEMORY; HUMAN HIPPOCAMPAL; VISUAL-STIMULI; DENTATE GYRUS; SHORT-LATENCY; REWARD	Novelty exploration can enhance hippocampal plasticity in animals through dopaminergic neuromodulation arising in the substantia nigra/ventral tegmental area (SN/VTA). This enhancement can outlast the exploration phase by several minutes. Currently, little is known about dopaminergic novelty processing and its relationship to hippocampal function in humans. In two functional magnetic resonance imaging (fMRI) studies, SN/VTA activations in humans were indeed driven by stimulus novelty rather than other forms of stimulus salience such as rareness, negative emotional valence, or targetness of familiar stimuli, whereas hippocampal responses were less selective. SN/VTA novelty responses were scaled according to absolute rather than relative novelty in a given context, unlike adaptive SN/VTA responses recently reported for reward outcome in animal studies. Finally, novelty enhanced learning and perirhinal/parahippocampal processing of familiar items presented in the same context. Thus, the human SN/VTA can code absolute stimulus novelty and might contribute to enhancing learning in the context of novelty.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; Otto Von Guericke Univ, Dept Neurol 2, D-39120 Magdeburg, Germany; Otto Von Guericke Univ, Ctr Adv Imaging, D-39120 Magdeburg, Germany	University of London; University College London; Otto von Guericke University; Otto von Guericke University	Duzel, E (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	e.duzel@ucl.ac.uk	Duzel, Emrah/A-1794-2010	Bunzeck, Nico/0000-0001-8834-450X; Duzel, Emrah/0000-0002-0139-5388				Adcock RA, 2006, NEURON, V50, P507, DOI 10.1016/j.neuron.2006.03.036; [Anonymous], 2001, A5 U FLOR CTR RES PS; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bouret S, 2003, J NEUROSCI, V23, P3491; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Crottaz-Herbette S, 2005, HIPPOCAMPUS, V15, P132, DOI 10.1002/hipo.20039; Davis CD, 2004, J NEUROSCI, V24, P6497, DOI 10.1523/JNEUROSCI.4970-03.2004; Dommett E, 2005, SCIENCE, V307, P1476, DOI 10.1126/science.1107026; Duzel E, 2003, J NEUROSCI, V23, P9439; Duzel E, 2001, P NATL ACAD SCI USA, V98, P8101, DOI 10.1073/pnas.131205798; Eckert T, 2004, NEUROIMAGE, V21, P229, DOI 10.1016/j.neuroimage.2003.08.028; Ekman P., 1976, PICTURES FACIAL AFFE; Frey U, 1998, TRENDS NEUROSCI, V21, P181, DOI 10.1016/S0166-2236(97)01189-2; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; HOLLAND PC, 1977, J EXP PSYCHOL ANIM B, V3, P77, DOI 10.1037/0097-7403.3.1.77; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Houk J C, 1991, Curr Opin Neurobiol, V1, P610, DOI 10.1016/S0959-4388(05)80037-6; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Knecht S, 2004, ANN NEUROL, V56, P20, DOI 10.1002/ana.20125; Lee HJJ, 2005, J NEUROSCI, V25, P3881, DOI 10.1523/JNEUROSCI.0416-05.2005; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu Z, 2004, P NATL ACAD SCI USA, V101, P12336, DOI 10.1073/pnas.0403639101; McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157; Mishkin M, 1998, HIPPOCAMPUS, V8, P212; Pitkanen A., 2000, AMYGDALA FUNCTIONAL, V2; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Reed P, 1996, ANIM LEARN BEHAV, V24, P38, DOI 10.3758/BF03198952; Schott BH, 2006, J NEUROSCI, V26, P1407, DOI 10.1523/JNEUROSCI.3463-05.2006; Schott BH, 2004, LEARN MEMORY, V11, P383, DOI 10.1101/lm.75004; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shanks DR, 2003, J EXP PSYCHOL LEARN, V29, P248, DOI 10.1037/0278-7393.29.2.248; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Strange BA, 2001, HIPPOCAMPUS, V11, P690, DOI 10.1002/hipo.1084; Straube T, 2003, J PHYSIOL-LONDON, V552, P953, DOI 10.1113/jphysiol.2003.049452; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Ungless MA, 2004, TRENDS NEUROSCI, V27, P702, DOI 10.1016/j.tins.2004.10.001; Wittmann BC, 2005, NEURON, V45, P459, DOI 10.1016/j.neuron.2005.01.010; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Yamaguchi S, 2004, J NEUROSCI, V24, P5356, DOI 10.1523/JNEUROSCI.4587-03.2004; Zink CF, 2003, J NEUROSCI, V23, P8092	46	304	306	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					369	379		10.1016/j.neuron.2006.06.021	http://dx.doi.org/10.1016/j.neuron.2006.06.021			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880131	Bronze			2022-12-28	WOS:000239908800012
J	McEwen, JM; Madison, JM; Dybbs, M; Kaplan, JM				McEwen, Jason M.; Madison, Jon M.; Dybbs, Michael; Kaplan, Joshua M.			Antagonistic regulation of synaptic vesicle priming by tomosyn and UNC-13	NEURON			English	Article							GLR-1 GLUTAMATE RECEPTORS; C-ELEGANS; CAENORHABDITIS-ELEGANS; TRANSMITTER RELEASE; DROSOPHILA UNC-13; AXONAL-TRANSPORT; EXOCYTOSIS; SYNTAXIN; PROTEIN; FUSION	Priming of synaptic vesicles (SVs) is essential for synaptic transmission. UNC-13 proteins are required for priming. Current models propose that UNC-13 stabilizes the open conformation of Syntaxin, in which the SNARE helix is available for interactions with Synaptobrevin and SNAP-25. Here we show that Tomosyn inhibits SV priming. Tomosyn contains a SNARE motif, which forms an inhibitory SNARE complex with Syntaxin and SNAP-25. Mutants lacking Tomosyn have increased synaptic transmission, an increased pool of primed vesicles, and increased abundance of UNC-13 at synapses. Behavioral, imaging, and electrophysiological studies suggest that SV priming was reconstituted in unc-13 mutants by expressing a constitutively open mutant Syntaxin, or by mutations eliminating Tomosyn. Thus, priming is modulated by the balance between Tomosyn and UNC-13, perhaps by regulating the availability of open-Syntaxin. Even when priming was restored, synaptic transmission remained defective in unc-13 mutants, suggesting that UNC-13 is also required for other aspects of secretion.	Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Kaplan, JM (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Simches Res Bldg,7th Floor,185 Cambridge St, Boston, MA 02114 USA.	kaplan@molbio.mgh.harvard.edu			NIGMS NIH HHS [GM54728] Funding Source: Medline; NINDS NIH HHS [1F32NS10310] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010310] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Aravamudan B, 2003, J NEUROBIOL, V54, P417, DOI 10.1002/neu.10142; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Baba T, 2005, J CELL BIOL, V170, P1113, DOI 10.1083/jcb.200504055; Basu J, 2005, NAT STRUCT MOL BIOL, V12, P1017, DOI 10.1038/nsmb1001; Betz A, 1997, J BIOL CHEM, V272, P2520; BRENNER S, 1974, GENETICS, V77, P71; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Burbea M, 2002, NEURON, V35, P107, DOI 10.1016/S0896-6273(02)00749-3; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; DITTMAN JS, 2006, IN PRESS P NATL ACAD; Dreier L, 2005, NEURON, V46, P51, DOI 10.1016/j.neuron.2004.12.058; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Fernandez-Alfonso T, 2004, NEURON, V41, P943, DOI 10.1016/S0896-6273(04)00113-8; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gerst JE, 2003, BBA-MOL CELL RES, V1641, P99, DOI 10.1016/S0167-4889(03)00096-X; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Junge HJ, 2004, CELL, V118, P389, DOI 10.1016/j.cell.2004.06.029; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Koushika SP, 2001, NAT NEUROSCI, V4, P997, DOI 10.1038/nn732; Lehman K, 1999, J CELL BIOL, V146, P125, DOI 10.1083/jcb.146.1.125; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Madison JM, 2005, CURR BIOL, V15, P2236, DOI 10.1016/j.cub.2005.10.049; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P791, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Stevens DR, 2005, CURR BIOL, V15, P2243, DOI 10.1016/j.cub.2005.10.055; Varoqueaux F, 2005, MOL CELL BIOL, V25, P5973, DOI 10.1128/MCB.25.14.5973-5984.2005; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Widberg CH, 2003, J BIOL CHEM, V278, P35093, DOI 10.1074/jbc.M304261200; Yizhar O, 2004, P NATL ACAD SCI USA, V101, P2578, DOI 10.1073/pnas.0308700100; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	43	100	112	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 3	2006	51	3					303	315		10.1016/j.neuron.2006.06.025	http://dx.doi.org/10.1016/j.neuron.2006.06.025			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	075TT	16880125	Bronze			2022-12-28	WOS:000239908800006
J	Kleinschmidt, A				Kleinschmidt, Andreas			Cognitive control signals in visual cortex: Flashes meet spotlights	NEURON			English	Editorial Material							ATTENTION; AREAS; MODULATION; STRIATE; MONKEY	At the intersection of two intensely belabored fields, primary visual cortex (V1) function and neural mechanisms of cognitive control, Jack et al. (in this issue of Neuron) report a neural signal that is neither related to stimulus representation nor spatial attention. Instead, this endogenous signal correlates with task structure and raises new questions.	INSERM, U562, Serv Hosp, Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Kleinschmidt, A (corresponding author), INSERM, U562, Serv Hosp, 4,Pl Gen Leclerc, Orsay, France.							Casagrande Vivien A., 1994, Cerebral Cortex, V10, P201; Jack AI, 2006, NEURON, V51, P135, DOI 10.1016/j.neuron.2006.06.003; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; McAlonan K, 2006, J NEUROSCI, V26, P4444, DOI 10.1523/JNEUROSCI.5602-05.2006; MINCIACCHI D, 1995, J COMP NEUROL, V362, P46, DOI 10.1002/cne.903620104; Muller NG, 2004, NEUROREPORT, V15, P977, DOI 10.1097/01.wnr.000012504766941.17; Muller NG, 2003, J NEUROSCI, V23, P9812; PERKEL DJ, 1986, J COMP NEUROL, V253, P374, DOI 10.1002/cne.902530307; Posner MI, 1999, P NATL ACAD SCI USA, V96, P2585, DOI 10.1073/pnas.96.6.2585; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Thiel CM, 2004, NEUROIMAGE, V21, P318, DOI 10.1016/j.neuroimage.2003.08.044; Watanabe J, 1996, BRAIN RES BULL, V40, P143, DOI 10.1016/0361-9230(95)02147-7	12	2	2	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 6	2006	51	1					9	11		10.1016/j.neuron.2006.06.010	http://dx.doi.org/10.1016/j.neuron.2006.06.010			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815327	Bronze			2022-12-28	WOS:000239037700005
J	Arevalo, JC; Waite, J; Rajagopal, R; Beyna, M; Chen, ZY; Lee, FS; Chao, MV				Arevalo, Juan Carlos; Waite, Janelle; Rajagopal, Rithwick; Beyna, Mercedes; Chen, Zhe-Yu; Lee, Francis S.; Chao, Moses V.			Cell survival through Trk neurotrophin receptors is differentially regulated by ubiquitination	NEURON			English	Article							RETROGRADE SURVIVAL; DROSOPHILA NEDD4; LIGASE ITCH; PHOSPHORYLATION; FAMILY; ENDOCYTOSIS; PATHWAY; MOTIFS; ACTIVATION; EXPRESSION	Specificity of neurotrophin factor signaling is dictated through the action of Trk receptor tyrosine kinases. Once activated, Trk receptors are internalized and targeted for degradation. However, the mechanisms implicated in this process are incompletely understood. Here we report that the Trk receptors are multimonoubiquitinated in response to neurotrophins. We have identified an E3 ubiquitin ligase, Nedd4-2, that associates with the TrkA receptor and is phosphorylated upon NGF binding. The binding of Nedd4-2 to TrkA through a PPXY motif leads to the ubiquitination and downregulation of TrkA. Activated TrkA receptor levels and the survival of NGF-dependent sensory neurons, but not BDNF-dependent sensory neurons, are directly influenced by Nedd4-2 expression. Unexpectedly, Nedd4-2 does not bind or ubiquitinate related TrkB receptors, due to the lack of a consensus PPXY motif. Our results indicate that Trk neurotrophin receptors are differentially regulated by ubiquitination to modulate the survival of neurons.	NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Physiol, New York, NY 10016 USA; NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Neurosci, New York, NY 10016 USA; Cornell Univ, Dept Psychiat, Weill Med Coll, New York, NY 10021 USA	New York University; New York University; New York University; Cornell University	Arevalo, JC (corresponding author), NYU, Sch Med, Mol Neurobiol Program, Skirball Inst Biomol Med,Dept Cell Biol, 540 1st Ave, New York, NY 10016 USA.	arevalo@saturn.med.nyu.edu; chao@saturn.med.nyu.edu	Arévalo, Juan Carlos/J-8154-2014	Arévalo, Juan Carlos/0000-0003-1994-3095; Chao, Moses/0000-0002-6969-3744; Beyna, Mercedes/0000-0003-0603-3981	NICHD NIH HHS [HD023315] Funding Source: Medline; NIMH NIH HHS [MH068850] Funding Source: Medline; NINDS NIH HHS [NS21072] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD023315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH068850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021072, R56NS021072] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arevalo JC, 2004, EMBO J, V23, P2358, DOI 10.1038/sj.emboj.7600253; Bai YL, 2004, MOL CELL, V15, P825, DOI 10.1016/j.molcel.2004.07.021; Bhalla V, 2005, MOL ENDOCRINOL, V19, P3073, DOI 10.1210/me.2005-0193; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Harvey KF, 1999, TRENDS CELL BIOL, V9, P166, DOI 10.1016/S0962-8924(99)01541-X; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 1997, GENOMICS, V40, P435, DOI 10.1006/geno.1996.4582; Kuratomi G, 2005, BIOCHEM J, V386, P461, DOI 10.1042/BJ20040738; Kuruvilla R, 2004, CELL, V118, P243, DOI 10.1016/j.cell.2004.06.021; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Makkerh JPS, 2005, EMBO REP, V6, P936, DOI 10.1038/sj.embor.7400503; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390; Martin-Serrano J, 2005, J CELL BIOL, V168, P89, DOI 10.1083/jcb.200408155; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; OBERMEIER A, 1993, EMBO J, V12, P933, DOI 10.1002/j.1460-2075.1993.tb05734.x; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Rajagopal R, 2004, J NEUROSCI, V24, P6650, DOI 10.1523/JNEUROSCI.0010-04.2004; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 2004, J BIOL CHEM, V279, P45753, DOI 10.1074/jbc.M407858200; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Zhou RF, 2005, J BIOL CHEM, V280, P4518, DOI 10.1074/jbc.M411053200	48	151	152	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					549	559		10.1016/j.neuron.2006.03.044	http://dx.doi.org/10.1016/j.neuron.2006.03.044			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701206	Bronze			2022-12-28	WOS:000237875200007
J	Story, GM; Gereau, RW				Story, GM; Gereau, RW			Numbing the senses: Role of TRPA1 in mechanical and cold sensation	NEURON			English	Editorial Material							CHANNEL	In this issue of Neuron, Kwan et al. demonstrate that TRPA1 is critical for the transduction of noxious cold and mechanical stimuli, as well as in mediating the activation of nociceptors by endogenous and natural irritants. Differences between the present report and a previous study indicate that further study is needed to reach a consensus on the role of TRPA1 in the transduction of mechanical and noxious cold stimuli.	Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Story, GM (corresponding author), Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA.							Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Corey DP, 2004, NATURE, V432, P723, DOI 10.1038/nature03066; Gillespie PG, 2005, CURR OPIN NEUROBIOL, V15, P389, DOI 10.1016/j.conb.2005.06.007; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Mogil JS, 2005, PAIN, V117, P1, DOI 10.1016/j.pain.2005.06.020; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2	12	32	34	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					177	180		10.1016/j.neuron.2006.04.009	http://dx.doi.org/10.1016/j.neuron.2006.04.009			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630827	Bronze			2022-12-28	WOS:000237176700003
J	Clem, RL; Barth, A				Clem, RL; Barth, A			Pathway-specific trafficking of native AMPARs by in vivo experience	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM DEPRESSION; RECEPTOR TRAFFICKING; SYNAPTIC POTENTIATION; GLUTAMATE RECEPTORS; SENSORY DEPRIVATION; PYRAMIDAL NEURONS; NMDA RECEPTORS; MAP PLASTICITY; VISUAL-CORTEX	An accumulating body of evidence supports the notion that trafficking of AMPA receptors (AMPARs) underlies strengthening of glutamatergic synapses and, in turn, learning and memory in the behaving animal. However, without exception, these experiments have been performed using artificial stimulation protocols, cultured neurons, or viral-overexpression systems that can significantly alter the normal function of AMPARs. Using a single-whisker experience protocol that significantly enhances neuronal responses in vivo, we have targeted neurons in and around the spared whisker column of fosGFP transgenic mice for whole-cell recording. Here we show that in vivo experience induces the pathway-specific strengthening of neocortical excitatory synapses. By assaying AMPARs for rectification and sensitivity to joro spider toxin, we find that in vivo experience induces the delivery of native GluR2-lacking receptors at spared, but not deprived, inputs. These data demonstrate that pathway-specific trafficking of GluR2-lacking AMPARs is a normal feature of synaptic strengthening that underlies experience-dependent plasticity in the behaving animal.	Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA; Carnegie Mellon Univ, Ctr Neural Basis Cognit, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barth, A (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA.	barth@cmu.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017188] Funding Source: NIH RePORTER; NIDA NIH HHS [DA017188-01] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Aizenman CD, 2002, NEURON, V34, P623, DOI 10.1016/S0896-6273(02)00674-8; Allen CB, 2003, NAT NEUROSCI, V6, P291, DOI 10.1038/nn1012; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Barth AL, 2000, J NEUROSCI, V20, P4206; Bisler S, 2002, J CHEM NEUROANAT, V23, P187, DOI 10.1016/S0891-0618(01)00155-7; Dai WM, 2001, BRIT J PHARMACOL, V132, P1859, DOI 10.1038/sj.bjp.0703993; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Feldman DE, 2005, SCIENCE, V310, P810, DOI 10.1126/science.1115807; Feldmeyer D, 2002, J PHYSIOL-LONDON, V538, P803, DOI 10.1113/jphysiol.2001.012959; Finnerty GT, 2000, P NATL ACAD SCI USA, V97, P12864, DOI 10.1073/pnas.230175697; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100; Joshi I, 2004, J NEUROSCI, V24, P183, DOI 10.1523/JNEUROSCI.1074-03.2004; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; Kumar SS, 2002, J NEUROSCI, V22, P3005, DOI 10.1523/JNEUROSCI.22-08-03005.2002; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Ogoshi F, 2003, J NEUROSCI, V23, P10521; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rumpel S, 2005, SCIENCE, V308, P83, DOI 10.1126/science.1103944; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thomas MJ, 2001, NAT NEUROSCI, V4, P1217, DOI 10.1038/nn757; Wall MJ, 2002, EUR J NEUROSCI, V15, P785, DOI 10.1046/j.1460-9568.2002.01910.x; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1; Zhao ML, 2005, J NEUROSCI, V25, P7032, DOI 10.1523/JNEUROSCI.1579-05.2005; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	39	173	180	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					663	670		10.1016/j.neuron.2006.01.019	http://dx.doi.org/10.1016/j.neuron.2006.01.019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504942	Bronze			2022-12-28	WOS:000236070600008
J	Allada, R				Allada, Ravi			Two oscillators are better than one: A circadian pacemaker escapes from the light	NEURON			English	Editorial Material							DROSOPHILA; CLOCK; BRAIN; PHOTORECEPTION; MUTATION; NEURONS; RHYTHM	Continuous light exposure can suppress circadian rhythms. In this issue of Neuron, Murad et al. demonstrate that, under certain genetic conditions, a novel cluster of pacemaker neurons can drive rhythmic behavior in constant light. Surprisingly, these neurons are distinct from those thought to drive rhythms in constant darkness.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Allada, R (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 Sheridan Rd, Evanston, IL 60208 USA.	r-allada@northwestern.edu						Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Klarsfeld A, 2004, J NEUROSCI, V24, P1468, DOI 10.1523/JNEUROSCI.3661-03.2004; Murad A, 2007, NEURON, V53, P689, DOI 10.1016/j.neuron.2007.01.034; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Stoleru D, 2005, NATURE, V438, P238, DOI 10.1038/nature04192; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Yoshii T, 2004, J INSECT PHYSIOL, V50, P479, DOI 10.1016/j.jinsphys.2004.02.011	12	0	0	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					621	623		10.1016/j.neuron.2007.02.016	http://dx.doi.org/10.1016/j.neuron.2007.02.016			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329201	Bronze			2022-12-28	WOS:000245127100002
J	Rainer, G				Rainer, Gregor			Behavioral flexibility and the frontal lobe	NEURON			English	Editorial Material							PREFRONTAL CORTEX; PERFORMANCE; TASK	Brain areas in the frontal lobe have been implicated in behavioral flexibility and control. The study by Johnston et al. in this issue of Neuron provides novel insights into the roles of the prefrontal and anterior cingulate cortices in controlling behavior.	Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	Max Planck Society	Rainer, G (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.	gregor.rainer@tuebingen.mpg.de	Rainer, Gregor/B-5876-2012	Rainer, Gregor/0000-0002-5805-2220				Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Bouret S, 2005, TRENDS NEUROSCI, V28, P574, DOI 10.1016/j.tins.2005.09.002; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Johnston K, 2007, NEURON, V53, P453, DOI 10.1016/j.neuron.2006.12.023; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; Nakamura K, 2005, J NEUROPHYSIOL, V93, P884, DOI 10.1152/jn.00305.2004; Nielsen KJ, 2006, J NEUROSCI, V26, P9639, DOI 10.1523/JNEUROSCI.2273-06.2006; Pasupathy A, 2005, NATURE, V433, P873, DOI 10.1038/nature03287; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335	11	8	9	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					321	323		10.1016/j.neuron.2007.01.015	http://dx.doi.org/10.1016/j.neuron.2007.01.015			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270730	Bronze			2022-12-28	WOS:000245126800004
J	Zhang, YL; Guo, HF; Kwan, H; Wang, JW; Kosek, J; Lu, BW				Zhang, Yali; Guo, Huifu; Kwan, Helen; Wang, Ji-Wu; Kosek, Jon; Lu, Bingwei			PAR-1 kinase phosphorylates Dlg and regulates its postsynaptic targeting at the Drosophila neuromuscular junction	NEURON			English	Article							TUMOR-SUPPRESSOR GENE; C-ELEGANS EMBRYOS; DISCS-LARGE; ALZHEIMERS-DISEASE; SYNAPTIC GROWTH; FASCICLIN-II; INTRAMOLECULAR INTERACTION; CELL POLARITY; PROTEIN; LOCALIZATION	Targeting of synaptic molecules to their proper location is essential for synaptic differentiation and plasticity. PSD-95/Dig proteins have been established as key components of the post-synapse. However, the molecular mechanisms regulating the synaptic targeting, assembly, and disassembly of PSD-95/Dlg are not well understood. Here we show that PAR-1 kinase, a conserved cell polarity regulator, is critically involved in controlling the postsynaptic localization of Dig. PAR-1 is prominently localized at the Drosophila neuromuscular junction (NMJ). Loss of PAR-1 function leads to increased synapse formation and synaptic transmission, whereas overexpression of PAR-1 has the opposite effects. PAR-1 directly phosphorylates Dig at a conserved site and negatively regulates its mobility and targeting to the postsynapse. The ability of a nonphosphorylatable Dig to largely rescue PAR-1-induced synaptic defects supports the idea that Dig is a major synaptic substrate of PAR-1. Control of Dig synaptic targeting by PAR-1-mediated phosphorylation thus constitutes a critical event in synaptogenesis.	Stanford Univ, Sch Med, Dept Pathol, GRECC,VAPAHCS, Palo Alto, CA 94304 USA; Stanford Univ, Sch Med, Dept Pathol, Pathol Serv,VAPAHCS, Palo Alto, CA 94304 USA; Blanchette Rockefeller Neurosci Inst, Rockville, MD 20852 USA	Geriatric Research Education & Clinical Center; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Lu, BW (corresponding author), Stanford Univ, Sch Med, Dept Pathol, GRECC,VAPAHCS, Palo Alto, CA 94304 USA.	bingwei@stanford.edu		Wang, Jiwu/0000-0002-9516-3384; Lu, Bingwei/0000-0002-5807-7014	NIMH NIH HHS [R01 MH080378] Funding Source: Medline; NINDS NIH HHS [NS043167, R01 NS043167] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043167] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Biernat J, 2002, MOL BIOL CELL, V13, P4013, DOI 10.1091/mbc.02-03-0046; Brenman JE, 1998, J NEUROSCI, V18, P8805; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen KY, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-1; Chetkovich DM, 2002, J NEUROSCI, V22, P6415; Collins CA, 2006, NEURON, V51, P57, DOI 10.1016/j.neuron.2006.05.026; Craven SE, 1999, NEURON, V22, P497, DOI 10.1016/S0896-6273(00)80705-9; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Doerflinger H, 2006, CURR BIOL, V16, P1090, DOI 10.1016/j.cub.2006.04.001; Drewes G, 2004, TRENDS BIOCHEM SCI, V29, P548, DOI 10.1016/j.tibs.2004.08.001; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Guo HF, 2006, J NEUROSCI, V26, P4004, DOI 10.1523/JNEUROSCI.3616-05.2006; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; JAN LY, 1976, J PHYSIOL-LONDON, V262, P215, DOI 10.1113/jphysiol.1976.sp011593; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Koh YH, 2000, MICROSC RES TECHNIQ, V49, P14, DOI 10.1002/(SICI)1097-0029(20000401)49:1<14::AID-JEMT3>3.3.CO;2-7; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; McGee AW, 1999, J BIOL CHEM, V274, P17431, DOI 10.1074/jbc.274.25.17431; Mendoza C, 2003, J NEUROSCI, V23, P2093; Moran LB, 2004, NEUROGENETICS, V5, P95, DOI 10.1007/s10048-004-0172-5; Nishimura I, 2004, CELL, V116, P671, DOI 10.1016/S0092-8674(04)00170-9; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shin HW, 2000, J NEUROSCI, V20, P3580, DOI 10.1523/JNEUROSCI.20-10-03580.2000; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Sun TQ, 2001, NAT CELL BIOL, V3, P628, DOI 10.1038/35083016; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Tomancak P, 2000, NAT CELL BIOL, V2, P458, DOI 10.1038/35017101; Woods DF, 1996, J CELL BIOL, V134, P1469, DOI 10.1083/jcb.134.6.1469; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	52	66	66	1	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					201	215		10.1016/j.neuron.2006.12.016	http://dx.doi.org/10.1016/j.neuron.2006.12.016			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224403	Green Accepted, Bronze			2022-12-28	WOS:000245126600007
J	Salecker, I				Salecker, Iris			HOW to wrap Axons with crooked neck	NEURON			English	Editorial Material							RNA-BINDING PROTEIN; DROSOPHILA; FAMILY; GENE	How can RNA processing direct specific aspects of nervous system development? In this issue of Neuron, Edenfeld et al. identified a novel function for two regulators of mRNA splicing in Drosophila: peripheral glial cells require Crooked neck (Crn) and Held out wings (HOW) to mediate migration and ensheathment of peripheral axons.	Natl Inst Med Res, MRC, Div Mol Neurobiol, London NW7 1AA, England	MRC National Institute for Medical Research	Salecker, I (corresponding author), Natl Inst Med Res, MRC, Div Mol Neurobiol, Ridgeway, London NW7 1AA, England.		Salecker, Iris/V-1228-2018	Salecker, Iris/0000-0003-3775-7763	Medical Research Council [MC_U117581332] Funding Source: Medline; MRC [MC_U117581332] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Park JW, 2004, P NATL ACAD SCI USA, V101, P15974, DOI 10.1073/pnas.0407004101; Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012; Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691; Raisin-Tani S, 2002, BIOCHEM BIOPH RES CO, V296, P288, DOI 10.1016/S0006-291X(02)00863-X; Wang Q, 2003, J BIOL CHEM, V278, P7875, DOI 10.1074/jbc.M210839200; Wu JI, 2002, P NATL ACAD SCI USA, V99, P4233, DOI 10.1073/pnas.072090399; Zaffran S, 1997, DEVELOPMENT, V124, P2087; ZHANG K, 1991, GENE DEV, V5, P1080, DOI 10.1101/gad.5.6.1080	11	0	0	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					933	935		10.1016/j.neuron.2006.12.007	http://dx.doi.org/10.1016/j.neuron.2006.12.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178396	Bronze			2022-12-28	WOS:000243115100001
J	Grillner, S				Grillner, Sten			Biological pattern generation: The cellular and computational logic of networks in motion	NEURON			English	Review							LAMPREY SPINAL-CORD; BRAIN-STEM CONTROL; RHYTHMIC MOTOR PATTERNS; PHASIC GAIN-CONTROL; LOCOMOTOR NETWORK; INTERSEGMENTAL COORDINATION; FICTIVE LOCOMOTION; ION CHANNELS; GENETIC IDENTIFICATION; PRESYNAPTIC MODULATION	In 1900, Ramon y Cajal advanced the neuron doctrine, defining the neuron as the fundamental signaling unit of the nervous system. Over a century later, neurobiologists address the circuit doctrine: the logic of the core units of neuronal circuitry that control animal behavior. These are circuits that can be called into action for perceptual, conceptual, and motor tasks, and we now need to understand whether there are coherent and overriding principles that govern the design and function of these modules. The discovery of central motor programs has provided crucial insight into the logic of one prototypic set of neural circuits: those that generate motor patterns. In this review, I discuss the mode of operation of these pattern generator networks and consider the neural mechanisms through which they are selected and activated. In addition, I will outline the utility of computational models in analysis of the dynamic actions of these motor networks.	Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, SE-17177 Stockholm, Sweden	Karolinska Institutet	Grillner, S (corresponding author), Karolinska Inst, Dept Neurosci, Nobel Inst Neurophysiol, SE-17177 Stockholm, Sweden.	sten.grillner@ki.se						ALFORD S, 1991, EUR J NEUROSCI, V3, P107, DOI 10.1111/j.1460-9568.1991.tb00071.x; ANDERSSON B, 1978, PHYSIOL REV, V58, P582, DOI 10.1152/physrev.1978.58.3.582; ANDERSSON O, 1978, BRAIN RES, V149, P503, DOI 10.1016/0006-8993(78)90493-6; Behrman AL, 2005, PHYS THER, V85, P1356, DOI 10.1093/ptj/85.12.1356; Beloozerova IN, 2003, J NEUROSCI, V23, P1087; Bem T, 2003, BIOL CYBERN, V88, P79, DOI 10.1007/s00422-002-0340-3; Biro Z, 2006, J NEUROPHYSIOL, V96, P931, DOI 10.1152/jn.00309.2006; BJURSTEN LM, 1976, EXP BRAIN RES, V25, P115; Bosco G, 2001, PHYSIOL REV, V81, P539, DOI 10.1152/physrev.2001.81.2.539; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Buchanan JT, 1999, J NEUROPHYSIOL, V81, P2037, DOI 10.1152/jn.1999.81.5.2037; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; Butera RJ, 1999, J NEUROPHYSIOL, V82, P398, DOI 10.1152/jn.1999.82.1.398; Butt SJB, 2005, P NATL ACAD SCI USA, V102, P14098, DOI 10.1073/pnas.0503317102; Cangiano L, 2005, J NEUROSCI, V25, P923, DOI 10.1523/JNEUROSCI.2301-04.2005; Cangiano L, 2003, J NEUROPHYSIOL, V89, P2931, DOI 10.1152/jn.01100.2002; Cattaert D, 2001, J NEUROSCI, V21, P1007, DOI 10.1523/JNEUROSCI.21-03-01007.2001; CHEVALIER S, 2006, IN PRESS BRAIN RES B; CHRISTENSON J, 1991, ADV NEUROSC, V1, P159; Combes D, 2004, J PHYSIOL-LONDON, V559, P17, DOI 10.1113/jphysiol.2004.069542; d'Avella A, 2005, P NATL ACAD SCI USA, V102, P3076, DOI 10.1073/pnas.0500199102; Darwin Charles, 1998, EXPRESS EMOT MAN, V3rd, DOI [10.1037/h0076058, DOI 10.1037/10001-000]; DIPRISCO GV, 1990, BRAIN RES, V530, P161; Drew T, 2004, PROG BRAIN RES, V143, P251, DOI 10.1016/S0079-6123(03)43025-2; Dum RP, 2002, PHYSIOL BEHAV, V77, P677, DOI 10.1016/S0031-9384(02)00929-0; DUYSENS J, 1980, BRAIN RES, V187, P321, DOI 10.1016/0006-8993(80)90206-1; Ekeberg O, 1999, PHILOS T ROY SOC B, V354, P895, DOI 10.1098/rstb.1999.0441; Ekman P., 2006, DARWIN FACIAL EXPRES, P169, DOI DOI 10.1371/J0URNAL.P0NE.0014679; El Manira A, 2000, NEWS PHYSIOL SCI, V15, P186; El Manira A, 2002, BRAIN RES REV, V40, P9, DOI 10.1016/S0165-0173(02)00184-4; ElManira A, 1997, EUR J NEUROSCI, V9, P696, DOI 10.1111/j.1460-9568.1997.tb01418.x; ELMANIRA A, 1994, J NEUROPHYSIOL, V72, P1852, DOI 10.1152/jn.1994.72.4.1852; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; FORSSBERG H, 1977, BRAIN RES, V132, P121, DOI 10.1016/0006-8993(77)90710-7; Fransen E, 2006, NEURON, V49, P735, DOI 10.1016/j.neuron.2006.01.036; FUKSON OI, 1980, SCIENCE, V209, P1261, DOI 10.1126/science.7403886; GEORGOPOULOS AP, 1989, SCIENCE, V245, P1209, DOI 10.1126/science.2675307; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; GRILLNER S, 1978, BRAIN RES, V146, P269, DOI 10.1016/0006-8993(78)90973-3; GRILLNER S, 1985, SCIENCE, V228, P143, DOI 10.1126/science.3975635; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S, 2005, TRENDS NEUROSCI, V28, P525, DOI 10.1016/j.tins.2005.08.003; Grillner S, 2005, CURR OPIN NEUROBIOL, V15, P614, DOI 10.1016/j.conb.2005.08.017; GRILLNER S, 1976, BRAIN RES, V109, P255, DOI 10.1016/0006-8993(76)90529-1; GRILLNER S, 1974, EXP BRAIN RES, V20, P459; GRILLNER S, 1975, BRAIN RES, V88, P367, DOI 10.1016/0006-8993(75)90401-1; GRILLNER S, 1978, BRAIN RES, V144, P411, DOI 10.1016/0006-8993(78)90169-5; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; Grillner S., 1973, CONTROL POSTURE LOCO, P515; Grillner S., 1981, HDB PHYSL NERVOUS SY, P1179, DOI DOI 10.1002/CPHY.CP010226; Grillner S., 2006, MICROCIRCUITS INTERF; Hajos N, 2004, J NEUROSCI, V24, P9127, DOI 10.1523/JNEUROSCI.2113-04.2004; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; HELLGREN J, 1992, BIOL CYBERN, V68, P1, DOI 10.1007/BF00203132; Hess WR, 1949, ZWISCHENHIRN; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hill AAV, 2003, J NEUROPHYSIOL, V90, P531, DOI 10.1152/jn.00338.2003; Hill RH, 2003, EUR J NEUROSCI, V18, P2919, DOI 10.1111/j.1460-9568.2003.03051.x; Hinsey JC, 1930, ARCH NEURO PSYCHIATR, V23, P1; Isa T, 2002, CURR OPIN NEUROBIOL, V12, P668, DOI 10.1016/S0959-4388(02)00387-2; Islam SS, 2006, J NEUROPHYSIOL, V96, P451, DOI 10.1152/jn.01277.2005; Jackson A, 2006, J PHYSIOL-LONDON, V573, P107, DOI 10.1113/jphysiol.2005.100537; Jacobs BL, 1997, CURR OPIN NEUROBIOL, V7, P820, DOI 10.1016/S0959-4388(97)80141-9; Jankowska E, 2001, J PHYSIOL-LONDON, V533, P31, DOI 10.1111/j.1469-7793.2001.0031b.x; Jean A, 2001, PHYSIOL REV, V81, P929, DOI 10.1152/physrev.2001.81.2.929; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jing J, 2005, CURR BIOL, V15, P1712, DOI 10.1016/j.cub.2005.08.051; Kandel E R, 1979, Harvey Lect, V73, P19; Kettunen P, 2005, NEURON, V45, P95, DOI 10.1016/j.neuron.2004.12.022; Kiehn O, 2004, NEURON, V41, P317, DOI 10.1016/S0896-6273(04)00042-X; Kiehn O, 2003, PROG NEUROBIOL, V70, P347, DOI 10.1016/S0301-0082(03)00091-1; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kotaleski JH, 1999, BIOL CYBERN, V81, P317, DOI 10.1007/s004220050565; Kristan WB, 2005, PROG NEUROBIOL, V76, P279, DOI 10.1016/j.pneurobio.2005.09.004; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lechner HAE, 2002, J NEUROSCI, V22, P5287; LeDoux J.E., 1996, EMOTIONAL BRAIN MYST; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; LUNDBERG A, 1962, ACTA PHYSIOL SCAND, V56, P220, DOI 10.1111/j.1748-1716.1962.tb02498.x; Lundberg A, 1979, Prog Brain Res, V50, P11; Marder E, 2005, CURR BIOL, V15, pR685, DOI 10.1016/j.cub.2005.08.022; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; MATSUSHIMA T, 1992, J NEUROPHYSIOL, V67, P373, DOI 10.1152/jn.1992.67.2.373; McCrea DA, 2001, J PHYSIOL-LONDON, V533, P41, DOI 10.1111/j.1469-7793.2001.0041b.x; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1378, DOI 10.1152/jn.1982.48.6.1378; Nusbaum MP, 2002, NATURE, V417, P343, DOI 10.1038/417343a; Orlovsky G., 1999, NEURONAL CONTROL LOC; Parker D, 1999, J NEUROSCI, V19, P1647; Parker D, 1998, J NEUROSCI, V18, P4800; Pfaff D. W., 1999, DRIVE NEURAL MOL MEC; Poggio T, 2004, NATURE, V431, P768, DOI 10.1038/nature03014; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009; Selverston AI, 2005, CELL MOL NEUROBIOL, V25, P223, DOI 10.1007/s10571-005-3154-8; SMITH JC, 1995, LUNG BIOL HEALTH DIS, V82, P463; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stein PSG, 2002, J NEUROSCI, V22, P6800; Tegner J, 1997, J NEUROPHYSIOL, V77, P1795, DOI 10.1152/jn.1997.77.4.1795; Tunstall MJ, 2002, J COMPUT NEUROSCI, V13, P143, DOI 10.1023/A:1020114324350; von Holst E, 1935, PFLUG ARCH GES PHYS, V236, P149; VONEULER C, 1981, CAN J PHYSIOL PHARM, V59, P700, DOI 10.1139/y81-106; Wadden T, 1997, BIOL CYBERN, V76, P1, DOI 10.1007/s004220050316; WALLEN P, 1984, J PHYSIOL-LONDON, V347, P225, DOI 10.1113/jphysiol.1984.sp015063; WALLEN P, 1989, J NEUROPHYSIOL, V61, P759, DOI 10.1152/jn.1989.61.4.759; WALLEN P, 1987, J NEUROSCI, V7, P2745; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; Wilson D. M., 1966, Symposia of the Society for Experimental Biology, V20, P199; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005	112	581	590	0	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 7	2006	52	5					751	766		10.1016/j.neuron.2006.11.008	http://dx.doi.org/10.1016/j.neuron.2006.11.008			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	117EU	17145498	Bronze			2022-12-28	WOS:000242856400005
J	Gurden, H; Uchida, N; Mainen, ZF				Gurden, Hirac; Uchida, Naoshige; Mainen, Zachary F.			Sensory-evoked intrinsic optical signals in the olfactory bulb are coupled to glutamate release and uptake	NEURON			English	Article							CEREBRAL-BLOOD-FLOW; ACTIVITY-DEPENDENT INCREASES; RECEPTOR NEURON INPUT; CAT VISUAL-CORTEX; MITRAL CELLS; PRESYNAPTIC INHIBITION; ODORANT REPRESENTATIONS; FUNCTIONAL-ORGANIZATION; DOPAMINERGIC MODULATION; OXIDATIVE-METABOLISM	Functional imaging signals arise from metabolic and hemodynamic activity, but how these processes are related to the synaptic and electrical activity of neurons is not well understood. To provide insight into this issue, we used in vivo imaging and simultaneous local pharmacology to study how sensory-evoked neural activity leads to intrinsic optical signals (IOS) in the well-defined circuitry of the olfactory glomerulus. Odorevoked IOS were tightly coupled to release of glutamate and were strongly modulated by activation of presynaptic dopamine and GABA-B receptors. Surprisingly, IOS were independent of postsynaptic transmission through ionotropic or metabotropic glutamate receptors, but instead were inhibited when uptake by astrocytic glutamate transporters was blocked. These data suggest that presynaptic glutamate release and uptake by astrocytes form a critical pathway through which neural activity is linked to metabolic processing and hence to functional imaging signals.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Mainen, ZF (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	mainen@cshi.edu		Uchida, Naoshige/0000-0002-5755-9409; Mainen, Zachary/0000-0001-7913-9109	NIDCD NIH HHS [5 RO1 DC006104-03] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006104] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aitken PG, 1999, METHODS, V18, P91, DOI 10.1006/meth.1999.0762; Araque A, 2001, ANNU REV PHYSIOL, V63, P795, DOI 10.1146/annurev.physiol.63.1.795; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; AroniadouAnderjaska V, 1997, NEUROSCIENCE, V79, P425, DOI 10.1016/S0306-4522(96)00706-3; Attwell D, 2002, TRENDS NEUROSCI, V25, P621, DOI 10.1016/S0166-2236(02)02264-6; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; BAILEY MS, 1993, J COMP NEUROL, V328, P501, DOI 10.1002/cne.903280405; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Berkowicz DA, 2000, BRAIN RES, V855, P90, DOI 10.1016/S0006-8993(99)02342-2; BERKOWICZ DA, 1994, J NEUROPHYSIOL, V71, P2557, DOI 10.1152/jn.1994.71.6.2557; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bonhoeffer Tobias, 1996, P55; Bonino M, 1999, NEUROSCI LETT, V274, P195, DOI 10.1016/S0304-3940(99)00697-7; Bonvento G, 2002, TRENDS NEUROSCI, V25, P359, DOI 10.1016/S0166-2236(02)02168-9; Bouzier-Sore AK, 2003, J CEREBR BLOOD F MET, V23, P1298, DOI 10.1097/01.WCB.0000091761.61714.25; Buchheim K, 2005, EUR J NEUROSCI, V22, P125, DOI 10.1111/j.1460-9568.2005.04203.x; Caesar K, 2003, P NATL ACAD SCI USA, V100, P4239, DOI 10.1073/pnas.0635075100; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chao TI, 1997, J COMP NEUROL, V388, P191; Cholet N, 2001, J CEREBR BLOOD F MET, V21, P404, DOI 10.1097/00004647-200104000-00009; COOPERSMITH R, 1995, BRAIN RES, V674, P230, DOI 10.1016/0006-8993(94)01445-N; Coronas V, 1997, J CHEM NEUROANAT, V12, P243, DOI 10.1016/S0891-0618(97)00215-9; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Duchamp-Viret P, 2000, NEUROSCIENCE, V97, P771, DOI 10.1016/S0306-4522(00)00055-5; DuchampViret P, 1997, NEUROSCIENCE, V79, P203, DOI 10.1016/S0306-4522(96)00646-X; Ennis M, 2006, J NEUROPHYSIOL, V95, P2233, DOI 10.1152/jn.01150.2005; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; Ennis M, 1996, NEUROREPORT, V7, P989, DOI 10.1097/00001756-199604100-00007; Fayuk D, 2002, J NEUROPHYSIOL, V87, P1924, DOI 10.1152/jn.00231.2001; FOX PT, 1986, P NATL ACAD SCI USA, V83, P1140, DOI 10.1073/pnas.83.4.1140; GALL CM, 1987, J COMP NEUROL, V266, P307, DOI 10.1002/cne.902660302; Gutierrez-Mecinas M, 2005, EUR J NEUROSCI, V22, P1357, DOI 10.1111/j.1460-9568.2005.04328.x; Heeger DJ, 2002, NAT REV NEUROSCI, V3, P142, DOI 10.1038/nrn730; Heinbockel T, 2004, J NEUROPHYSIOL, V92, P3085, DOI 10.1152/jn.00349.2004; Higashi K, 2001, AM J PHYSIOL-CELL PH, V281, pC922, DOI 10.1152/ajpcell.2001.281.3.C922; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; Iserhot C, 2004, BRAIN RES, V1027, P151, DOI 10.1016/j.brainres.2004.08.052; JAN DD, 2005, J NEUROSCI, V25, P2917, DOI DOI 10.1523/JNEUR0SCI.5042-04.2005; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kayser C, 2004, CEREB CORTEX, V14, P881, DOI 10.1093/cercor/bhh047; Keller A, 1998, J NEUROSCI, V18, P2602; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koster NL, 1999, J COMP NEUROL, V411, P666, DOI 10.1002/(SICI)1096-9861(19990906)411:4<666::AID-CNE10>3.0.CO;2-S; Laughlin SB, 2003, SCIENCE, V301, P1870, DOI 10.1126/science.1089662; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Macaulay N, 2004, NEUROSCIENCE, V129, P1031, DOI 10.1016/j.neuroscience.2004.06.045; MACVICAR BA, 1991, J NEUROSCI, V11, P1458; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Magistretti PJ, 1999, SCIENCE, V283, P496, DOI 10.1126/science.283.5401.496; Mathiesen C, 1998, J PHYSIOL-LONDON, V512, P555, DOI 10.1111/j.1469-7793.1998.555be.x; Mayhew JEW, 1996, NEUROIMAGE, V4, P183, DOI 10.1006/nimg.1996.0069; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; MCLEAN JH, 1988, J NEUROSCI, V8, P3658; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; NICKELL WT, 1994, BRAIN RES BULL, V35, P119, DOI 10.1016/0361-9230(94)90091-4; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Palouzier-Paulignan B, 2002, NEUROSCIENCE, V111, P241, DOI 10.1016/S0306-4522(02)00003-9; Pellerin L, 2004, NEUROSCIENTIST, V10, P53, DOI 10.1177/1073858403260159; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Raichle ME, 2003, J NEUROSCI, V23, P3959; RAICHLE ME, 1999, ANNU REV NEUROSCI, V23, P499; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; SALLAZ M, 1992, NEUROREPORT, V3, P833, DOI 10.1097/00001756-199210000-00003; SCHNEIDER GH, 1992, CAN J PHYSIOL PHARM, V70, pS334, DOI 10.1139/y92-280; Schoppa NE, 1997, J NEUROPHYSIOL, V78, P1468, DOI 10.1152/jn.1997.78.3.1468; Schoppa NE, 2001, NEURON, V31, P639, DOI 10.1016/S0896-6273(01)00389-0; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Shulman RG, 1998, P NATL ACAD SCI USA, V95, P11993, DOI 10.1073/pnas.95.20.11993; Sibson NR, 1998, P NATL ACAD SCI USA, V95, P316, DOI 10.1073/pnas.95.1.316; Simard M, 2003, J NEUROSCI, V23, P9254; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Thomsen K, 2004, J PHYSIOL-LONDON, V560, P181, DOI 10.1113/jphysiol.2004.068072; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Uchida N, 2003, NAT NEUROSCI, V6, P1224, DOI 10.1038/nn1142; Utsumi M, 2001, MOL BRAIN RES, V92, P1, DOI 10.1016/S0169-328X(01)00098-5; VANDENPOL AN, 1995, J COMP NEUROL, V359, P253, DOI 10.1002/cne.903590206; Voutsinos-Porche B, 2003, CEREB CORTEX, V13, P1110, DOI 10.1093/cercor/13.10.1110; Vucinic D, 2006, J NEUROPHYSIOL, V95, P1881, DOI 10.1152/jn.00918.2005; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2003, J NEUROPHYSIOL, V89, P1623, DOI 10.1152/jn.00747.2002; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Yuan Q, 2006, J NEUROPHYSIOL, V95, P3097, DOI 10.1152/jn.00001.2006; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980	92	93	96	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 19	2006	52	2					335	345		10.1016/j.neuron.2006.07.022	http://dx.doi.org/10.1016/j.neuron.2006.07.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046695	Bronze			2022-12-28	WOS:000241799900013
J	Schwartz, AB; Cui, XT; Weber, DJ; Moran, DW				Schwartz, Andrew B.; Cui, X. Tracy; Weber, Douglas J.; Moran, Daniel W.			Brain-controlled interfaces: Movement restoration with neural prosthetics	NEURON			English	Review							PERIPHERAL-NERVE FIBERS; PRIMATE MOTOR CORTEX; REAL-TIME CONTROL; COMPUTER INTERFACE; SURFACE MODIFICATION; ACTION-POTENTIALS; CORTICAL-NEURONS; SENSORY FEEDBACK; ELECTRODE ARRAY; CELL DISCHARGE	Brain-controlled interfaces are devices that capture brain transmissions involved in a subject's intention to act, with the potential to restore communication and movement to those who are immobilized. Current devices record electrical activity from the scalp, on the surface of the brain, and within the cerebral cortex. These signals are being translated to command signals driving prosthetic limbs and computer displays. Somatosensory feedback is being added to this control as generated behaviors become more complex. New technology to engineer the tissue-electrode interface, electrode design, and extraction algorithms to transform the recorded signal to movement will help translate exciting laboratory demonstrations to patient practice in the near future.	Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Neural Basis Cognit, Dept Neurobiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Neural Basis Cognit, Dept Bioengn, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15213 USA; Washington Univ, Dept Biomech Engn, St Louis, MO 63130 USA; Washington Univ, Dept Neurobiol, St Louis, MO 63130 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL)	Schwartz, AB (corresponding author), Univ Pittsburgh, McGowan Inst Regenerat Med, Ctr Neural Basis Cognit, Dept Neurobiol, Pittsburgh, PA 15213 USA.	abs21@pitt.edu	Cui, Tracy/GRF-5659-2022; Weber, Douglas/E-7554-2011	Cui, Xinyan/0000-0002-0470-2005				Andersen RA, 2004, CURR OPIN NEUROBIOL, V14, P720, DOI 10.1016/j.conb.2004.10.005; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Bogey RA, 2005, IEEE T NEUR SYS REH, V13, P302, DOI 10.1109/TNSRE.2005.851768; Borisoff JF, 2006, IEEE T BIO-MED ENG, V53, P1715, DOI 10.1109/TBME.2006.877800; Brockwell AE, 2004, J NEUROPHYSIOL, V91, P1899, DOI 10.1152/jn.00438.2003; BROOKS RA, 1991, ARTIF INTELL, V47, P139, DOI 10.1016/0004-3702(91)90053-M; Brown EN, 2004, NAT NEUROSCI, V7, P456, DOI 10.1038/nn1228; Buchko CJ, 2000, J MATER RES, V15, P231, DOI 10.1557/JMR.2000.0038; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; CAMPBELL PK, 1991, IEEE T BIO-MED ENG, V38, P758, DOI 10.1109/10.83588; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; CHARLEY EA, 2005, IMPROVING BRAIN TISS; COOPER R, 1965, ELECTROEN CLIN NEURO, V18, P217, DOI 10.1016/0013-4694(65)90088-X; Crago P E, 1998, IEEE Trans Rehabil Eng, V6, P1, DOI 10.1109/86.662614; Cui XY, 2003, SENSOR ACTUAT B-CHEM, V89, P92, DOI 10.1016/S0925-4005(02)00448-3; Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I; Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5; Dario P, 1998, IEEE Trans Rehabil Eng, V6, P353, DOI 10.1109/86.736149; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Dhillon GS, 2005, IEEE T NEUR SYS REH, V13, P468, DOI 10.1109/TNSRE.2005.856072; Dhillon GS, 2004, J HAND SURG-AM, V29A, P605, DOI 10.1016/j.jhsa.2004.02.006; Donchin E, 2000, IEEE T REHABIL ENG, V8, P174, DOI 10.1109/86.847808; DONCHIN E, 1970, ELECTROEN CLIN NEURO, V29, P201, DOI 10.1016/0013-4694(70)90124-0; DONOGHUE JP, 1989, J NERUOPHYSIOL, V79, P159; DONOGHUE JP, 2006, NEUR INT WORKSH AUG; Ebersole JS, 1997, J CLIN NEUROPHYSIOL, V14, P470, DOI 10.1097/00004691-199711000-00003; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; EDELMAN GM, 1985, HOW WE CAN SEE, P1; ELBERT T, 1980, ELECTROEN CLIN NEURO, V48, P293, DOI 10.1016/0013-4694(80)90265-5; Emerich DF, 1999, CELL TRANSPLANT, V8, P47, DOI 10.1177/096368979900800114; Fetz EE, 1999, NAT NEUROSCI, V2, P583, DOI 10.1038/10131; Freeman WJ, 2003, CLIN NEUROPHYSIOL, V114, P1053, DOI 10.1016/S1388-2457(03)00045-2; Georgopoulos AP, 2005, EXP BRAIN RES, V167, P132, DOI 10.1007/s00221-005-0028-8; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; GEORGOPOULOS AP, 1983, EXP BRAIN RES, V49, P327; Ghovanloo M, 2004, IEEE J SOLID-ST CIRC, V39, P2457, DOI 10.1109/JSSC.2004.837026; Grill J H, 1998, IEEE Trans Rehabil Eng, V6, P190, DOI 10.1109/86.681185; Haugland M, 1999, Technol Health Care, V7, P393; He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021; HELDMAN A, 2004, LOCAL FIELD POTENTIA; Heldman DA, 2006, IEEE T NEUR SYS REH, V14, P180, DOI 10.1109/TNSRE.2006.875549; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HOFFER JA, 2005, INITIAL RESULTS FULL; HOLLERBACH JM, 1982, BIOL CYBERN, V44, P67, DOI 10.1007/BF00353957; Isaacs RE, 2000, IEEE T REHABIL ENG, V8, P196, DOI 10.1109/86.847814; James CD, 2000, IEEE T BIO-MED ENG, V47, P17, DOI 10.1109/10.817614; JI J, 1991, IEEE T BIO-MED ENG, V38, P75, DOI 10.1109/10.68212; Johnson MD, 2004, P ANN INT IEEE EMBS, V26, P4103; KACZMAREK KA, 1991, IEEE T BIO-MED ENG, V38, P1, DOI 10.1109/10.68204; Kang T, 2005, EXP BRAIN RES, V167, P352, DOI 10.1007/s00221-005-0039-5; Kass RE, 2005, J NEUROPHYSIOL, V94, P8, DOI 10.1152/jn.00648.2004; Kemere C, 2004, IEEE T BIO-MED ENG, V51, P925, DOI 10.1109/TBME.2004.826675; KENNEDY PR, 1992, NEUROSCI LETT, V142, P89, DOI 10.1016/0304-3940(92)90627-J; Kennedy PR, 2000, IEEE T REHABIL ENG, V8, P198, DOI 10.1109/86.847815; Kennedy PR, 2004, IEEE T NEUR SYS REH, V12, P339, DOI 10.1109/TNSRE.2004.834629; Kim DH, 2006, BIOMATERIALS, V27, P3031, DOI 10.1016/j.biomaterials.2005.12.021; Kim SP, 2006, J NEURAL ENG, V3, P145, DOI 10.1088/1741-2560/3/2/009; Kim YT, 2004, BIOMATERIALS, V25, P2229, DOI 10.1016/j.biomaterials.2003.09.010; Kirsch RF, 2001, J REHABIL RES DEV, V38, P619; KOVACS GTA, 1992, IEEE T BIO-MED ENG, V39, P893, DOI 10.1109/10.256422; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kuiken Todd, 2006, Phys Med Rehabil Clin N Am, V17, P1, DOI 10.1016/j.pmr.2005.10.001; Kurosawa K, 2005, IEEE T NEUR SYS REH, V13, P359, DOI 10.1109/TNSRE.2005.847355; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lebedev MA, 2005, J NEUROSCI, V25, P4681, DOI 10.1523/JNEUROSCI.4088-04.2005; LEBEDEV MA, 2006, IN PRESS TRENDS NEUR; Leuthardt EC, 2006, NEUROSURGERY, V59, P1, DOI 10.1227/01.NEU.0000221506.06947.AC; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Lin G, 2005, CYTOM PART A, V66A, P9, DOI 10.1002/cyto.a.20149; Lin SM, 1997, NEURAL COMPUT, V9, P607, DOI 10.1162/neco.1997.9.3.607; Liu X, 1999, IEEE Trans Rehabil Eng, V7, P315, DOI 10.1109/86.788468; Loeb GE, 2005, IEEE ENG MED BIOL, V24, P45, DOI 10.1109/MEMB.2005.1511499; LOEB GE, 1977, SCIENCE, V197, P1192, DOI 10.1126/science.897663; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Macefield VG, 2005, CLIN EXP PHARMACOL P, V32, P135, DOI 10.1111/j.1440-1681.2005.04143.x; MALAGODI MS, 1989, ANN BIOMED ENG, V17, P397, DOI 10.1007/BF02368058; MANNARD A, 1974, SCIENCE, V183, P547, DOI 10.1126/science.183.4124.547; Margalit E, 2003, J NEUROSCI METH, V123, P129, DOI 10.1016/S0165-0270(02)00345-X; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Meilander NJ, 2001, J CONTROL RELEASE, V71, P141, DOI 10.1016/S0168-3659(01)00214-0; MENEI P, 1994, J BIOMED MATER RES, V28, P1079, DOI 10.1002/jbm.820280913; Mensinger AF, 2000, J NEUROPHYSIOL, V83, P611, DOI 10.1152/jn.2000.83.1.611; Mofid MM, 1997, PLAST RECONSTR SURG, V100, P14, DOI 10.1097/00006534-199707000-00003; Mohseni P, 2005, IEEE T NEUR SYS REH, V13, P263, DOI 10.1109/TNSRE.2005.853625; Mokry J, 2000, BIOTECHNOL PROGR, V16, P897, DOI 10.1021/bp000113m; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P881, DOI 10.1109/TBME.2004.827465; Moxon KA, 2004, IEEE T BIO-MED ENG, V51, P647, DOI 10.1109/TBME.2003.821037; NAJAFI K, 1985, IEEE T ELECTRON DEV, V32, P1206, DOI 10.1109/T-ED.1985.22102; Neihart NM, 2005, IEEE T BIO-MED ENG, V52, P1950, DOI 10.1109/TBME.2005.856247; Nicolelis MAL, 2003, P NATL ACAD SCI USA, V100, P11041, DOI 10.1073/pnas.1934665100; Niedermeyer E., 1999, ELECTROENCEPHALOGRAP; Nunez PL, 2005, ELECT FIELDS BRAIN N, DOI 10.1093/acprof:oso/9780195050387.001.0001; Obeid I, 2004, J NEUROSCI METH, V133, P27, DOI 10.1016/j.jneumeth.2003.09.024; Obeid I, 2003, IEEE T BIO-MED ENG, V50, P255, DOI 10.1109/TBME.2002.807643; Paninski L, 2004, J NEUROPHYSIOL, V91, P515, DOI 10.1152/jn.00587.2002; Pfurtscheller G, 2003, CLIN NEUROPHYSIOL, V114, P1226, DOI 10.1016/S1388-2457(03)00067-1; Pfurtscheller G, 1997, NEUROSCI LETT, V239, P65, DOI 10.1016/S0304-3940(97)00889-6; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Pouget A, 1998, NEURAL COMPUT, V10, P373, DOI 10.1162/089976698300017809; PROCHAZKA A, 1976, J NEUROPHYSIOL, V39, P1090, DOI 10.1152/jn.1976.39.5.1090; REIER PJ, 1983, SPINAL CORD RECONSTR, P163; Retterer ST, 2004, IEEE T BIO-MED ENG, V51, P2063, DOI 10.1109/TBME.2004.834288; RICHARDSONBURNS S, 2005, NIH NEUR INT WORKSH; Rickert J, 2005, J NEUROSCI, V25, P8815, DOI 10.1523/JNEUROSCI.0816-05.2005; ROJAS AL, 2005, IMPROVED MODELS ANAL, V815; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Rubinstein Jay T, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P444, DOI 10.1097/01.moo.0000134452.24819.c0; SALCMAN M, 1973, IEEE T BIO-MED ENG, VBM20, P253, DOI 10.1109/TBME.1973.324189; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; SANES JN, 1993, P NATL ACAD SCI USA, V90, P4470, DOI 10.1073/pnas.90.10.4470; Santiesteban FMM, 2006, IEEE T BIO-MED ENG, V53, P547, DOI 10.1109/TBME.2005.864497; SCHALK G, 2004, 2 DIMENSIONAL CURSOS; Scherberger H, 2005, NEURON, V46, P347, DOI 10.1016/j.neuron.2005.03.004; Schmidt E. M., 1999, CRC METH NEUROSCI S; SCHMIDT EM, 1976, EXP NEUROL, V52, P496, DOI 10.1016/0014-4886(76)90220-X; Schwartz AB, 2000, EUR J NEUROSCI, V12, P1851, DOI 10.1046/j.1460-9568.2000.00097.x; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Schwartz AB, 2004, ANNU REV NEUROSCI, V27, P487, DOI 10.1146/annurev.neuro.27.070203.144233; Schwartz AB, 2001, CURR OPIN NEUROBIOL, V11, P701, DOI 10.1016/S0959-4388(01)00272-0; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Shain W, 2003, IEEE T NEUR SYS REH, V11, P186, DOI 10.1109/TNSRE.2003.814800; SOECHTING JF, 1984, NEUROSCIENCE, V13, P595, DOI 10.1016/0306-4522(84)90252-5; SOECHTING JF, 1983, KINEMATICS DYNAMICS, P1; Spataro L, 2005, EXP NEUROL, V194, P289, DOI 10.1016/j.expneurol.2004.08.037; Stein R B, 1975, Can J Neurol Sci, V2, P235; Stein RB, 2004, CAN J PHYSIOL PHARM, V82, P757, DOI 10.1139/Y04-075; STENSAAS SS, 1978, ACTA NEUROPATHOL, V41, P145, DOI 10.1007/BF00689766; STENSAAS SS, 1976, ACTA NEUROPATHOL, V35, P187; Strange K D, 1999, IEEE Trans Rehabil Eng, V7, P289, DOI 10.1109/86.788466; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Taylor DM, 2003, IEEE T NEUR SYS REH, V11, P195, DOI 10.1109/TNSRE.2003.814451; TOREBJORK HE, 1987, BRAIN, V110, P1509, DOI 10.1093/brain/110.6.1509; Turner JN, 1999, EXP NEUROL, V156, P33, DOI 10.1006/exnr.1998.6983; VALLBO AB, 1981, BRAIN RES, V215, P359, DOI 10.1016/0006-8993(81)90517-5; Vetter RJ, 2004, IEEE T BIO-MED ENG, V51, P896, DOI 10.1109/TBME.2004.826680; Voges J, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.081232; Wadhwa R, 2006, J CONTROL RELEASE, V110, P531, DOI 10.1016/j.jconrel.2005.10.027; WADHWA R, 2006, J NEURAL ENG, V3, P162; WADHWA R, 2006, ANN M SOC BIOM PITTS; Webb K, 2001, BIOMATERIALS, V22, P1017, DOI 10.1016/S0142-9612(00)00353-7; Weber DJ, 2006, IEEE T NEUR SYS REH, V14, P240, DOI 10.1109/TNSRE.2006.875575; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Williams JC, 1999, NEUROCOMPUTING, V26-7, P1069, DOI 10.1016/S0925-2312(99)00106-X; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; WILLIAMS JC, 2001, THESIS ARIZONA STATE; Wilson JA, 2006, IEEE T NEUR SYS REH, V14, P246, DOI 10.1109/TNSRE.2006.875570; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585; Wu W, 2004, IEEE T BIO-MED ENG, V51, P933, DOI 10.1109/TBME.2004.826666; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; YOSHIDA K, 1993, IEEE T BIO-MED ENG, V40, P492, DOI 10.1109/10.243412; YUEN TGH, 1995, BIOMATERIALS, V16, P951, DOI 10.1016/0142-9612(95)93121-S; Zhong YH, 2001, J REHABIL RES DEV, V38, P627	164	531	557	5	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					205	220		10.1016/j.neuron.2006.09.019	http://dx.doi.org/10.1016/j.neuron.2006.09.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015237	Bronze			2022-12-28	WOS:000241408100015
J	Watabe-Uchida, M; John, KA; Janas, JA; Newey, SE; Van Aelst, L				Watabe-Uchida, Mitsuko; John, Keisha A.; Janas, Justyna A.; Newey, Sarah E.; Van Aelst, Linda			The Rac activator DOCK7 regulates neuronal polarity through local phosphorylation of stathmin/Op18	NEURON			English	Article							HIPPOCAMPAL-NEURONS; PHOSPHOPROTEIN FAMILY; AXON SPECIFICATION; CELL-CYCLE; MICROTUBULE; PROTEIN; GROWTH; RHO; GSK-3-BETA; TUBULIN	The polarization of a neuron generally results in the formation of one axon and multiple dendrites, allowing for the establishment of neuronal circuitry. The molecular mechanisms involved in priming one neurite to become the axon, particularly those regulating the microtubule network, remain elusive. Here we report the identification of DOCK7, a member of the DOCK180-related protein superfamily, as a Rac GTPase activator that is asymmetrically distributed in unpolarized hippocampal neurons and selectively expressed in the axon. Knockdown of DOCK7 expression prevents axon formation, whereas overexpression induces formation of multiple axons. We further demonstrate that DOCK7 and Rac activation lead to phosphorylation and inactivation of the microtubule destabilizing protein stathmIn/Op18 in the nascent axon and that this event is important for axon development. Our findings unveil a pathway linking the Rac activator DOCK7 to a microtubule regulatory protein and highlight the contribution of microtubule network regulation to axon development.	Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Van Aelst, L (corresponding author), Cold Spring Harbor Lab, Watson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	vanaelst@cshl.edu		Janas, Justyna A/0000-0001-9840-9928	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082808] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH082808] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arimura N, 2005, NEURON, V48, P881, DOI 10.1016/j.neuron.2005.11.007; Baas PW, 2002, NAT CELL BIOL, V4, pE194, DOI 10.1038/ncb0802-e194; BANKER G, 1998, CULTURING NERVE CELL; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; Daub H, 2001, J BIOL CHEM, V276, P1677, DOI 10.1074/jbc.C000635200; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Esch T, 1999, J NEUROSCI, V19, P6417; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Gavet O, 1998, J CELL SCI, V111, P3333; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Gumienny TL, 2001, CELL, V107, P27, DOI 10.1016/S0092-8674(01)00520-7; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Janas J, 2006, METHOD ENZYMOL, V406, P593, DOI 10.1016/S0076-6879(06)06046-0; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kim MD, 2003, DEV BIOL, V262, P282, DOI 10.1016/S0012-1606(03)00393-2; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174; Meller N, 2002, NAT CELL BIOL, V4, P639, DOI 10.1038/ncb835; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Nakahira E, 2005, J COMP NEUROL, V483, P329, DOI 10.1002/cne.20441; Namekata K, 2004, J BIOL CHEM, V279, P14331, DOI 10.1074/jbc.M311275200; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; Nishimura T, 2005, NAT CELL BIOL, V7, P270, DOI 10.1038/ncb1227; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Nolan KM, 1998, GENE DEV, V12, P3337, DOI 10.1101/gad.12.21.3337; Ozon S, 2002, MOL BIOL CELL, V13, P698, DOI 10.1091/mbc.01-07-0362; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Ruusala A, 2004, FEBS LETT, V572, P159, DOI 10.1016/j.febslet.2004.06.095; Sanui T, 2003, IMMUNITY, V19, P119, DOI 10.1016/S1074-7613(03)00169-9; Schubart UK, 1996, J BIOL CHEM, V271, P14062, DOI 10.1074/jbc.271.24.14062; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Van Aelst L, 1998, METH MOL B, V84, P201; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wiggin GR, 2005, DEV CELL, V8, P803, DOI 10.1016/j.devcel.2005.05.007; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wittmann T, 2003, J CELL BIOL, V161, P845, DOI 10.1083/jcb.200303082; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; YU WQ, 1994, J NEUROSCI, V14, P2818; Yu WQ, 2001, J NEUROCYTOL, V30, P861, DOI 10.1023/A:1020622530831; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	56	157	168	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 21	2006	51	6					727	739		10.1016/j.neuron.2006.07.020	http://dx.doi.org/10.1016/j.neuron.2006.07.020			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	091AM	16982419	Bronze			2022-12-28	WOS:000240997900012
J	Krispel, CM; Chen, D; Melling, N; Chen, YJ; Martemyanov, KA; Quillinan, N; Arshavsky, VY; Wensel, TG; Chen, CK; Burns, ME				Krispel, Claudia M.; Chen, Desheng; Melling, Nathan; Chen, Yu-Jiun; Martemyanov, Kirill A.; Quillinan, Nidia; Arshavsky, Vadim Y.; Wensel, Theodore G.; Chen, Ching-Kang; Burns, Marie E.			RGS expression rate-limits recovery of rod photoresponses	NEURON			English	Article							GTPASE ACCELERATING PROTEIN; RETINAL RODS; MICE LACKING; RHODOPSIN; PHOTOTRANSDUCTION; LIGHT; RESPONSES; KINETICS; ACTIVATION; R9AP	Signaling through G protein-coupled receptors (GPCRs) underlies many cellular processes, yet it is not known which molecules determine the duration of signaling in intact cells. Two candidates are G protein-coupled receptor kinases (GRKs) and Regulators of G protein signaling (RGSs), deactivation enzymes for GPCRs and G proteins, respectively. Here we investigate whether GRK or RGS governs the overall rate of recovery of the light response in mammalian rod photoreceptors, a model system for studying GPCR signaling. We show that overexpression of rhodopsin kinase (GRK1) increases phosphorylation of the GPCR rhodopsin but has no effect on photoresponse recovery. In contrast, overexpression of the photoreceptor FIGS complex (RGS9-1(.)G beta 5L(.)R9AP) dramatically accelerates response recovery. Our results show that G protein deactivation is normally at feast 2.5 times slower than rhodopsin deactivation, resolving a long-standing controversy concerning the mechanism underlying the recovery of rod visual transduction.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; Univ Calif Davis, Dept Psychiat & Behav Sci, Davis, CA 95616 USA; Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA; Harvard Univ, Howe Lab Ophthalmol, Sch Med, Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Baylor Coll Med, Dept Biochem, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA	University of California System; University of California Davis; University of California System; University of California Davis; Virginia Commonwealth University; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Baylor College of Medicine; Baylor College of Medicine	Chen, CK (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.	cjchen@vcu.edu; meburns@ucdavis.edu		Wensel, Theodore/0000-0003-3518-9352	NATIONAL EYE INSTITUTE [R01EY013811, R01EY014047, R01EY011900, R56EY013811, P30EY012576, R01EY012859] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY014047, R01 EY014047-05, EY013811, EY12576, EY011900, EY012859, EY014047] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; Burns ME, 2006, J NEUROSCI, V26, P1036, DOI 10.1523/JNEUROSCI.3301-05.2006; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; Chen CK, 2003, P NATL ACAD SCI USA, V100, P6604, DOI 10.1073/pnas.0631825100; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; Cowan CW, 1998, P NATL ACAD SCI USA, V95, P5351, DOI 10.1073/pnas.95.9.5351; Gold SJ, 2002, J NEUROCHEM, V82, P828, DOI 10.1046/j.1471-4159.2002.01002.x; Hamer RD, 2003, J GEN PHYSIOL, V122, P419, DOI 10.1085/jgp.200308832; Hamer RD, 2000, MOL VIS, V6, P265; He W, 1998, NEURON, V20, P95, DOI 10.1016/S0896-6273(00)80437-7; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Ingi T, 1998, J NEUROSCI, V18, P7178; KAWAMURA S, 1993, NATURE, V362, P855, DOI 10.1038/362855a0; Kennedy MJ, 2003, INVEST OPHTH VIS SCI, V44, P1016, DOI 10.1167/iovs.02-0692; Keresztes G, 2004, J BIOL CHEM, V279, P1581, DOI 10.1074/jbc.C300456200; KLENCHIN VA, 1995, J BIOL CHEM, V270, P16147, DOI 10.1074/jbc.270.27.16147; Krispel CM, 2003, J GEN PHYSIOL, V122, P703, DOI 10.1085/jgp.200308938; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Li S, 2005, GENESIS, V41, P73, DOI 10.1002/gene.20097; Lyubarsky A, 1996, J GEN PHYSIOL, V107, P19, DOI 10.1085/jgp.107.1.19; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Makino CL, 2003, CURR OPIN NEUROBIOL, V13, P404, DOI 10.1016/S0959-4388(03)00091-6; Makino ER, 1999, P NATL ACAD SCI USA, V96, P1947, DOI 10.1073/pnas.96.5.1947; Matthews HR, 1997, J GEN PHYSIOL, V109, P141, DOI 10.1085/jgp.109.2.141; MATTHEWS HR, 1995, J PHYSIOL-LONDON, V484, P267, DOI 10.1113/jphysiol.1995.sp020664; Mirnics K, 2001, MOL PSYCHIATR, V6, P293, DOI 10.1038/sj.mp.4000866; Murnick JG, 1996, J PHYSIOL-LONDON, V495, P1; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; Nikonov S, 1998, J GEN PHYSIOL, V111, P7, DOI 10.1085/jgp.111.1.7; Nishiguchi KM, 2004, NATURE, V427, P75, DOI 10.1038/nature02170; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Rieke F, 1998, BIOPHYS J, V75, P1836, DOI 10.1016/S0006-3495(98)77625-8; Sagoo MS, 1997, NATURE, V389, P392, DOI 10.1038/38750; Tekumalla PK, 2001, BIOL PSYCHIAT, V50, P813, DOI 10.1016/S0006-3223(01)01234-3; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Wang ZY, 2005, J BIOL CHEM, V280, P24293, DOI 10.1074/jbc.M502588200; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Whitlock GG, 1999, NEURON, V23, P337, DOI 10.1016/S0896-6273(00)80784-9; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Zhang X, 2003, J NEUROSCI, V23, P1287, DOI 10.1523/JNEUROSCI.23-04-01287.2003	43	197	205	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 17	2006	51	4					409	416		10.1016/j.neuron.2006.07.010	http://dx.doi.org/10.1016/j.neuron.2006.07.010			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	084AU	16908407	Bronze			2022-12-28	WOS:000240504700005
J	Boehm, J; Kang, MG; Johnson, RC; Esteban, J; Huganir, RL; Malinow, R				Boehm, Jannic; Kang, Myoung-Goo; Johnson, Richard C.; Esteban, Jose; Huganir, Richard L.; Malinow, Roberto			Synaptic incorporation of AMPA receptors during LTP is controlled by a PKC phosphorylation site on GluR1	NEURON			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; CULTURED HIPPOCAMPAL-NEURONS; POLYMERASE CHAIN-REACTION; GLUTAMATE RECEPTORS; EXCITATORY SYNAPSES; OVERLAP EXTENSION; IN-VIVO; CAM-KII; PLASTICITY	Incorporation of GluR1-containing AMPA receptors into synapses is essential to several forms of neural plasticity, including long-term potentiation (LTP). Numerous signaling pathways that trigger this process have been identified, but the direct modifications of GluR1 that control its incorporation into synapses are unclear. Here, we show that phosphorylation of GluR1 by PKC at a highly conserved serine 818 residue is increased during LTP and critical for LTP expression. GluR1 is phosphorylated by PKC at this site in vitro and in vivo. In addition, acute phosphorylation at GluR1 S818 by PKC, as well as a phosphomimetic mutation, promotes GluR1 synaptic incorporation. Conversely, preventing GluR1 S818 phosphorylation reduces LTP and blocks PKC-driven synaptic incorporation of GluR1. We conclude that the phosphorylation of GluR1 S818 by PKC is a critical event in the plasticity-driven synaptic incorporation of AMPA receptors.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Johns Hopkins University; University of Michigan System; University of Michigan	Malinow, R (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	malinow@cshi.edu	Boehm, Jannic/AAK-8882-2020; Esteban, Jose/L-4944-2014	Esteban, Jose/0000-0002-3759-3300; Kang, Myoung-Goo/0000-0003-2649-219X				Alier KA, 2005, BBA-MOL CELL RES, V1745, P342, DOI 10.1016/j.bbamcr.2005.04.003; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Barry MF, 2002, CURR OPIN NEUROBIOL, V12, P279, DOI 10.1016/S0959-4388(02)00329-X; BAUDIER J, 1989, J BIOL CHEM, V264, P1824; Blom N, 1998, NUCLEIC ACIDS RES, V26, P382, DOI 10.1093/nar/26.1.382; Bortolotto ZA, 2000, EUR J NEUROSCI, V12, P4055, DOI 10.1046/j.1460-9568.2000.00291.x; Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8; Broutman G, 2001, J NEUROSCI, V21, P27, DOI 10.1523/JNEUROSCI.21-01-00027.2001; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2000, J NEUROSCI, V20, P7258; COLLINGRIDGE GL, 1990, TRENDS PHARMACOL SCI, V11, P290, DOI 10.1016/0165-6147(90)90011-V; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HORTON RM, 1990, BIOTECHNIQUES, V8, P528; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Hussain RJ, 2005, CELL MOL NEUROBIOL, V25, P649, DOI 10.1007/s10571-005-4045-8; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Kim CH, 2005, NAT NEUROSCI, V8, P985, DOI 10.1038/nn1432; KLANN E, 1993, P NATL ACAD SCI USA, V90, P8337, DOI 10.1073/pnas.90.18.8337; KLANN E, 1992, J NEUROCHEM, V58, P1576, DOI 10.1111/j.1471-4159.1992.tb11382.x; Kolleker A, 2003, NEURON, V40, P1199, DOI 10.1016/S0896-6273(03)00722-0; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luthi A, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-44; MALENKA RC, 1986, NATURE, V321, P175, DOI 10.1038/321175a0; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Maren S, 2005, NEURON, V47, P783, DOI 10.1016/j.neuron.2005.08.009; MAREN S, 1993, P NATL ACAD SCI USA, V90, P9654, DOI 10.1073/pnas.90.20.9654; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Qin Y, 2005, GENE DEV, V19, P2000, DOI 10.1101/gad.342205; Ramakers GMJ, 1999, J NEUROCHEM, V73, P2175; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; SACKTOR TC, 1993, P NATL ACAD SCI USA, V90, P8342, DOI 10.1073/pnas.90.18.8342; Sanna PP, 2002, J NEUROSCI, V22, P3359; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Shen L, 2000, J NEUROSCI, V20, P7932; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SILVA A, 1995, NEUROPHARMACOLOGY, V34, P1559, DOI 10.1016/0028-3908(95)00128-S; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; WANG JH, 1995, NEURON, V15, P443, DOI 10.1016/0896-6273(95)90048-9; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wisden W, 1993, Curr Opin Neurobiol, V3, P291, DOI 10.1016/0959-4388(93)90120-N; Yasuda H, 2003, NAT NEUROSCI, V6, P15, DOI 10.1038/nn985; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	64	282	292	1	38	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 20	2006	51	2					213	225		10.1016/j.neuron.2006.06.013	http://dx.doi.org/10.1016/j.neuron.2006.06.013			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	070PK	16846856	Bronze			2022-12-28	WOS:000239535100009
J	Koechlin, E; Jubault, T				Koechlin, Etienne; Jubault, Thomas			Broca's area and the hierarchical organization of human behavior	NEURON			English	Article							ANTERIOR PREFRONTAL CORTEX; NEURAL MECHANISMS; COGNITIVE CONTROL; ACTION SEQUENCES; HUMAN BRAIN; LANGUAGE; INVOLVEMENT; ACTIVATION; TRANSIENT; NEURONS	The prefrontal cortex subserves executive control, i.e., the organization of action or thought in relation to internal goals. This brain region hosts a system of executive processes extending from premotor to the most anterior prefrontal regions that governs the temporal organization of behavior. Little is known, however, about the prefrontal executive system involved in the hierarchical organization of behavior. Here, we show using magnetic resonance imaging in humans that the posterior portion of the prefrontal cortex, including Broca's area and its homolog in the right hemisphere, contains a system of executive processes that control start and end states and the nesting of functional segments that combine in hierarchically organized action plans. Our results indicate that Broca's area and its right homolog process hierarchically structured behaviors regardless of their temporal organization, suggesting a fundamental segregation between prefrontal executive systems involved in the hierarchical and temporal organization of goal-directed behaviors.	Univ Paris 06, Inst Natl Rech Sci Sante, F-75005 Paris, France; Ecole Normale Super, Dept Etud Cognit, F-75005 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Koechlin, E (corresponding author), Univ Paris 06, Inst Natl Rech Sci Sante, 9 Quai St Bernard, F-75005 Paris, France.	koechlin@ccr.jussieu.fr	Koechlin, Etienne/E-5061-2016; Koechlin, Etienne/AAF-5717-2021	Koechlin, Etienne/0000-0002-6514-9311; Koechlin, Etienne/0000-0002-6514-9311				Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Bor D, 2003, NEURON, V37, P361, DOI 10.1016/S0896-6273(02)01171-6; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; Dominey PF, 2003, BRAIN LANG, V86, P207, DOI 10.1016/S0093-934X(02)00529-1; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Fujii N, 2003, SCIENCE, V301, P1246, DOI 10.1126/science.1086872; Fuster J.M., 1989, PREFRONTAL CORTEX; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Gelfand JR, 2003, NEURON, V38, P831, DOI 10.1016/S0896-6273(03)00285-X; Gough PM, 2005, J NEUROSCI, V25, P8010, DOI 10.1523/JNEUROSCI.2307-05.2005; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Kennerley SW, 2004, J NEUROPHYSIOL, V91, P978, DOI 10.1152/jn.00651.2003; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2002, NEURON, V35, P371, DOI 10.1016/S0896-6273(02)00742-0; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Koechlin E, 1999, NATURE, V399, P148, DOI 10.1038/20178; Koeneke S, 2004, NEUROIMAGE, V22, P1336, DOI 10.1016/j.neuroimage.2004.03.012; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; Martin RC, 2003, ANNU REV PSYCHOL, V54, P55, DOI 10.1146/annurev.psych.54.101601.145201; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Petrides M, 2005, NATURE, V435, P1235, DOI 10.1038/nature03628; Petrides M, 2002, EUR J NEUROSCI, V16, P291, DOI 10.1046/j.1460-9568.2001.02090.x; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; ROGERS RD, 1995, J EXP PSYCHOL GEN, V124, P207, DOI 10.1037/0096-3445.124.2.207; Rogers RD, 1998, BRAIN, V121, P815, DOI 10.1093/brain/121.5.815; Sakai K, 2002, NAT NEUROSCI, V5, P479, DOI 10.1038/nn846; Sakai K, 1998, J NEUROSCI, V18, P1827; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanji J, 2001, ANNU REV NEUROSCI, V24, P631, DOI 10.1146/annurev.neuro.24.1.631; Thompson-Schill SL, 2005, CURR OPIN NEUROBIOL, V15, P219, DOI 10.1016/j.conb.2005.03.006	41	342	348	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					963	974		10.1016/j.neuron.2006.05.017	http://dx.doi.org/10.1016/j.neuron.2006.05.017			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772176	Bronze			2022-12-28	WOS:000238589500015
J	Yoshida, W; Ishii, S				Yoshida, Wako; Ishii, Shin			Resolution of uncertainty in prefrontal cortex	NEURON			English	Article							ANTERIOR CINGULATE; BASAL GANGLIA; INFORMATION; SELECTION; CONFLICT; SYSTEMS	Making optimal decisions in the face of uncertain or incomplete information arises as a common problem in everyday behavior, but the neural processes underlying this ability remain poorly understood. A typical case is navigation, in which a subject has to search for a known goal from an unknown location. Navigating under uncertain conditions requires making decisions on the basis of the current belief about location and updating that belief based on incoming information. Here, we use functional magnetic resonance imaging during a maze navigation task to study neural activity relating to the resolution of uncertainty as subjects make sequential decisions to reach a goal. We show that distinct regions of prefrontal cortex are engaged in specific computational functions that are well described by a Bayesian model of decision making. This permits efficient goal-oriented navigation and provides new insights into decision making by humans.	Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara 6300192, Japan	Nara Institute of Science & Technology	Ishii, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Informat Sci, 8916-5 Takayama, Nara 6300192, Japan.	ishii@is.naist.jp		Ishii, Shin/0000-0001-9385-8230				ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ASTROM KJ, 1965, J MATH ANAL APPL, V10, P174, DOI 10.1016/0022-247X(65)90154-X; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Christoff K, 2003, BEHAV NEUROSCI, V117, P1161, DOI 10.1037/0735-7044.117.6.1161; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Daw ND, 2005, NAT NEUROSCI, V8, P1704, DOI 10.1038/nn1560; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Ishii S, 2002, NEURAL NETWORKS, V15, P665, DOI 10.1016/S0893-6080(02)00056-4; Kaelbling LP, 1998, ARTIF INTELL, V101, P99, DOI 10.1016/S0004-3702(98)00023-X; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Knutson B, 2001, NEUROREPORT, V12, P3683, DOI 10.1097/00001756-200112040-00016; Koechlin E, 2000, P NATL ACAD SCI USA, V97, P7651, DOI 10.1073/pnas.130177397; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; MacDonald IL., 1997, HIDDEN MARKOV OTHER, V110; MacKay D. J. C., 2003, INFORM THEORY INFERE; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Middleton FA, 2000, BRAIN COGNITION, V42, P183, DOI 10.1006/brcg.1999.1099; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; O'Doherty J, 2004, SCIENCE, V304, P452, DOI 10.1126/science.1094285; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Seymour B, 2004, NATURE, V429, P664, DOI 10.1038/nature02581; Shidara M, 2002, SCIENCE, V296, P1709, DOI 10.1126/science.1069504; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; STANKIEWICZ BJ, 2006, IN PRESS J EXP PSYCH; Strange BA, 2005, NEURAL NETWORKS, V18, P225, DOI 10.1016/j.neunet.2004.12.004; Strange BA, 2001, CEREB CORTEX, V11, P1040, DOI 10.1093/cercor/11.11.1040; Sugrue LP, 2005, NAT REV NEUROSCI, V6, P363, DOI 10.1038/nrn1666; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tsutsui KI, 2002, SCIENCE, V298, P409, DOI 10.1126/science.1074128; Wood JN, 2003, NAT REV NEUROSCI, V4, P139, DOI 10.1038/nrn1033	34	145	146	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 1	2006	50	5					781	789		10.1016/j.neuron.2006.05.006	http://dx.doi.org/10.1016/j.neuron.2006.05.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731515	Bronze			2022-12-28	WOS:000238165000012
J	Nassi, JJ; Lyon, DC; Callaway, EM				Nassi, JJ; Lyon, DC; Callaway, EM			The parvocellular LGN provides a robust disynaptic input to the visual motion area MT	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; MACAQUE STRIATE CORTEX; CENTRAL-NERVOUS-SYSTEM; TRANSNEURONAL TRACER; SUPERIOR COLLICULUS; RESPONSE PROPERTIES; MEYNERT CELLS; RABIES VIRUS; MONKEY; ORGANIZATION	Dorsal visual cortical areas are thought to be dominated by input from the magnocellular (M) visual pathway, with little or no parvocellular (P) contribution. These relationships are supported by a close correlation between the functional properties of these areas and the M pathway and by a lack of anatomical evidence for P input. Here we use rabies virus as a retrograde transynaptic tracer to show that the dorsal area MT receives strong input, via a single relay, from both M and P cells of the lateral geniculate nucleus. This surprising P input, likely relayed via layer 6 Meynert cells in primary visual cortex, can provide MT with sensitivity to a more complete range of spatial, temporal, and chromatic cues than the M pathway alone. These observations provide definitive evidence for P pathway input to MT and show that convergence of parallel visual pathways occurs in the dorsal stream.	Salk Inst Biol Studies, Syst Neurobiol Labs, La Jolla, CA 92037 USA	Salk Institute	Callaway, EM (corresponding author), Salk Inst Biol Studies, Syst Neurobiol Labs, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	callaway@salk.edu	Callaway, Edward/D-4336-2011	Callaway, Edward/0000-0002-6366-5267; Lyon, David C./0000-0002-4367-5636; Nassi, Jonathan/0000-0002-3144-3846	NEI NIH HHS [R01 EY010742] Funding Source: Medline; NIA NIH HHS [T32 AG000216] Funding Source: Medline; NIMH NIH HHS [T32 MH020002] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000216] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALLMAN JM, 1971, BRAIN RES, V31, P85, DOI 10.1016/0006-8993(71)90635-4; ANDERSON SJ, 1995, P ROY SOC B-BIOL SCI, V261, P129, DOI 10.1098/rspb.1995.0127; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BULLIER J, 1983, EXP BRAIN RES, V53, P168; BURKHALTER A, 1986, VISION RES, V26, P63, DOI 10.1016/0042-6989(86)90071-4; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; CASAGRANDE VA, 1994, CEREB CORTEX, P201; De Valois RL, 2000, VISION RES, V40, P3685, DOI 10.1016/S0042-6989(00)00210-8; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; Erwin E, 1999, J COMP NEUROL, V407, P92; FITZPATRICK D, 1985, J NEUROSCI, V5, P3329; FRIES W, 1985, EXP BRAIN RES, V58, P613; GEGENFURTNER KR, 1994, VISUAL NEUROSCI, V11, P455, DOI 10.1017/S095252380000239X; HENDRICKSON AE, 1978, J COMP NEUROL, V182, P123, DOI 10.1002/cne.901820108; JONES EG, 1989, EUR J NEUROSCI, V1, P222, DOI 10.1111/j.1460-9568.1989.tb00791.x; Kaas J.H., 1988, P327; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kelly RM, 2003, J NEUROSCI, V23, P8432; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Lyon DC, 2002, NEURON, V33, P453, DOI 10.1016/S0896-6273(02)00580-9; LYSAKOWSKI A, 1988, EXP BRAIN RES, V69, P651; MALPELI JG, 1975, J COMP NEUROL, V161, P569, DOI 10.1002/cne.901610407; MALPELI JG, 1981, J NEUROPHYSIOL, V46, P1102, DOI 10.1152/jn.1981.46.5.1102; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; MERIGAN WH, 1991, J NEUROSCI, V11, P3422; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; Morimoto K, 1998, P NATL ACAD SCI USA, V95, P3152, DOI 10.1073/pnas.95.6.3152; Movshon JA, 1996, J NEUROSCI, V16, P7733; Saul AB, 2005, J NEUROPHYSIOL, V94, P282, DOI 10.1152/jn.00868.2004; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; SHIPP S, 1989, EUR J NEUROSCI, V1, P309, DOI 10.1111/j.1460-9568.1989.tb00798.x; SHIPP S, 1989, EUR J NEUROSCI, V1, P333, DOI 10.1111/j.1460-9568.1989.tb00799.x; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Sincich LC, 2005, ANNU REV NEUROSCI, V28, P303, DOI 10.1146/annurev.neuro.28.061604.135731; Sincich LC, 2003, J NEUROSCI, V23, P5684; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; TOOTELL RBH, 1985, J NEUROSCI, V5, P2786; UGOLINI G, 1995, J COMP NEUROL, V356, P457, DOI 10.1002/cne.903560312; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302; WELLER RE, 1983, J COMP NEUROL, V220, P253, DOI 10.1002/cne.902200302; WINFIELD DA, 1983, PROC R SOC SER B-BIO, V217, P129, DOI 10.1098/rspb.1983.0002; Yabuta NH, 2001, SCIENCE, V292, P297, DOI 10.1126/science.1057916; ZEKI S, 1988, NATURE, V335, P311, DOI 10.1038/335311a0; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	48	99	103	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					319	327		10.1016/j.neuron.2006.03.019	http://dx.doi.org/10.1016/j.neuron.2006.03.019			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630841	Green Accepted, Bronze			2022-12-28	WOS:000237176700017
J	Hu, HJ; Carrasquillo, Y; Karim, F; Jung, WE; Nerbonne, JM; Schwarz, TL; Gereau, RW				Hu, HJ; Carrasquillo, Y; Karim, F; Jung, WE; Nerbonne, JM; Schwarz, TL; Gereau, RW			The Kv4.2 potassium channel subunit is required for pain plasticity	NEURON			English	Article							DORSAL-HORN NEURONS; LONG-TERM POTENTIATION; DENDRITIC K+ CHANNELS; ERK INTEGRATES PKA; PROTEIN-KINASE-C; RAT SPINAL-CORD; INFLAMMATORY PAIN; NOXIOUS-STIMULATION; CENTRAL SENSITIZATION; PYRAMIDAL NEURONS	A-type potassium currents are important determinants of neuronal excitability. In spinal cord dorsal horn neurons, A-type currents are modulated by extracellular signal-regulated kinases (ERKs), which mediate central sensitization during inflammatory pain. Here, we report that Kv4.2 mediates the majority of A-type current in dorsal horn neurons and is a critical site for modulation of neuronal excitability and nociceptive behaviors. Genetic elimination of Kv4.2 reduces A-type currents and increases excitability of dorsal horn neurons, resulting in enhanced sensitivity to tactile and thermal stimuli. Furthermore, ERK-mediated modulation of excitability in dorsal horn neurons and ERK-dependent forms of pain hypersensitivity are absent in Kv4.2(-/-) mice compared to wild-type littermates. Finally, mutational analysis of Kv4.2 indicates that S616 is the functionally relevant ERK phosphorylation site for modulation of Kv4.2-mediated currents in neurons. These results show that Kv4.2 is a downstream target of ERK in spinal cord and plays a crucial role in pain plasticity.	Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Boston Children's Hospital; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL)	Gereau, RW (corresponding author), Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA.	gereaur@wustl.edu		Hu, Huijuan/0000-0003-2306-2514				Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Adwanikar H, 2004, PAIN, V111, P125, DOI 10.1016/j.pain.2004.06.009; Barry DM, 1998, CIRC RES, V83, P560, DOI 10.1161/01.RES.83.5.560; BASBAUM AI, 1996, SCI MED          NOV, P22; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Ciruela A, 2003, BRIT J PHARMACOL, V138, P751, DOI 10.1038/sj.bjp.0705103; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Fu KY, 2001, J PAIN, V2, P2, DOI 10.1054/jpai.2001.9804; Fu KY, 2000, NEUROSCIENCE, V101, P1127, DOI 10.1016/S0306-4522(00)00376-6; Galan A, 2002, NEUROSCI LETT, V322, P37, DOI 10.1016/S0304-3940(02)00078-2; Gereau RW, 1998, NEURON, V20, P143, DOI 10.1016/S0896-6273(00)80442-0; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1671, DOI 10.1152/jn.00340.2003; Hu HJ, 2003, J NEUROPHYSIOL, V90, P1680, DOI 10.1152/jn.00341.2003; Hugel S, 2000, J NEUROSCI, V20, P2121; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Ji RR, 1999, NAT NEUROSCI, V2, P1114, DOI 10.1038/16040; Ji RR, 2002, J NEUROSCI, V22, P478, DOI 10.1523/JNEUROSCI.22-02-00478.2002; Ji RR, 1997, J NEUROSCI, V17, P1776; Ji RR, 2003, TRENDS NEUROSCI, V26, P696, DOI 10.1016/j.tins.2003.09.017; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Karim F, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-2; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Kominato Y, 2003, BRAIN RES, V967, P89, DOI 10.1016/S0006-8993(02)04229-4; Lever IJ, 2003, MOL CELL NEUROSCI, V24, P259, DOI 10.1016/S1044-7431(03)00200-8; Malin SA, 2001, J NEUROSCI, V21, P8004, DOI 10.1523/JNEUROSCI.21-20-08004.2001; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; Nassar MA, 2004, P NATL ACAD SCI USA, V101, P12706, DOI 10.1073/pnas.0404915101; Pezet S, 2002, MOL CELL NEUROSCI, V21, P684, DOI 10.1006/mcne.2002.1205; Pongs O, 1999, FEBS LETT, V452, P31, DOI 10.1016/S0014-5793(99)00535-9; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Ramakers GMJ, 2002, P NATL ACAD SCI USA, V99, P10144, DOI 10.1073/pnas.152620399; Ruscheweyh R, 2002, J PHYSIOL-LONDON, V541, P231, DOI 10.1113/jphysiol.2002.017756; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; Schrader LA, 2006, AM J PHYSIOL-CELL PH, V290, pC852, DOI 10.1152/ajpcell.00358.2005; Song WJ, 2002, NEUROSCI RES, V42, P7, DOI 10.1016/S0168-0102(01)00305-4; Song XS, 2005, ACTA PHARMACOL SIN, V26, P789, DOI 10.1111/j.1745-7254.2005.00123.x; Watanabe S, 2002, P NATL ACAD SCI USA, V99, P8366, DOI 10.1073/pnas.122210599; Willis WD, 2002, BRAIN RES REV, V40, P202, DOI 10.1016/S0165-0173(02)00202-3; Woolf CJ, 1999, P NATL ACAD SCI USA, V96, P7723, DOI 10.1073/pnas.96.14.7723; Yang GP, 2003, WOUND REPAIR REGEN, V11, P411, DOI 10.1046/j.1524-475X.2003.11604.x; Yuan LL, 2002, J NEUROSCI, V22, P4860, DOI 10.1523/JNEUROSCI.22-12-04860.2002; Zeitz KP, 2004, NEUROSCIENCE, V128, P889, DOI 10.1016/j.neuroscience.2004.07.029	46	197	202	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 6	2006	50	1					89	100		10.1016/j.neuron.2006.03.010	http://dx.doi.org/10.1016/j.neuron.2006.03.010			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600858	Bronze			2022-12-28	WOS:000236811300013
J	De Paola, V; Holtmaat, A; Knott, G; Song, S; Wilbrecht, L; Caroni, P; Svoboda, K				De Paola, V; Holtmaat, A; Knott, G; Song, S; Wilbrecht, L; Caroni, P; Svoboda, K			Cell type-specific structural plasticity of axonal branches and boutons in the adult neocortex	NEURON			English	Article							PRIMARY SOMATOSENSORY CORTEX; DENDRITIC SPINE STABILITY; BARREL FIELD; DEPENDENT PLASTICITY; PYRAMIDAL NEURONS; VISUAL-CORTEX; SINGLE-CELL; RAT; PROJECTIONS; REORGANIZATION	We imaged axons in layer (L) 1 of the mouse barrel cortex in vivo. Axons from thalamus and L2/3/5, or L6 pyramidal cells were identified based on their distinct morphologies. Their branching patterns and sizes were stable over times of months. However, axonal branches and boutons displayed cell type-specific rearrangements. Structural plasticity in thalamocortical afferents was mostly due to elongation and retraction of branches (range, 1-150 mu m over 4 days; similar to 5% of total axonal length), while the majority of boutons persisted for up to 9 months (persistence over 1 month similar to 85%). In contrast, L6 axon terminaux boutons were highly plastic (persistence over 1 month similar to 40 %), and other intracortical axon boutons showed intermediate levels of plasticity. Retrospective electron microscopy revealed that new boutons make synapses. Our data suggest that structural plasticity of axonal branches and boutons contributes to the remodeling of specific functional circuits.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Univ Lausanne, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; Friedrich Miescher Inst, CH-4058 Basel, Switzerland	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Lausanne; Friedrich Miescher Institute for Biomedical Research	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.edu	Wilbrecht, Linda/J-7988-2013; de paola, vincenzo/B-4900-2016	de paola, vincenzo/0000-0001-9987-8291; Holtmaat, Anthony/0000-0002-7577-0769; Knott, Graham W/0000-0002-2956-9052				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Anderson JC, 2002, J NEUROCYTOL, V31, P211, DOI 10.1023/A:1024113707630; Anderson JC, 2001, NAT NEUROSCI, V4, P1166, DOI 10.1038/nn772; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; BOURASSA J, 1995, EUR J NEUROSCI, V7, P19, DOI 10.1111/j.1460-9568.1995.tb01016.x; Braitenberg V., 1991, ANATOMY CORTEX, V18; Chen R, 2002, NEUROSCIENCE, V111, P761, DOI 10.1016/S0306-4522(02)00025-8; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Chklovskii DB, 2004, NEURON, V43, P609, DOI 10.1016/j.neuron.2004.08.012; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Cover TM, 1991, ELEMENTS INFORM THEO; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Diamond ME, 1995, CEREBR CORT, V11, P189; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fawcett JW, 1998, TRENDS NEUROSCI, V21, P179, DOI 10.1016/S0166-2236(98)01241-7; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Florence SL, 1998, SCIENCE, V282, P1117, DOI 10.1126/science.282.5391.1117; Fox K, 2000, CURR OPIN NEUROBIOL, V10, P494, DOI 10.1016/S0959-4388(00)00112-4; Gan WB, 2003, NAT NEUROSCI, V6, P956, DOI 10.1038/nn1115; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; HERKENHAM M, 1980, SCIENCE, V207, P532, DOI 10.1126/science.7352263; HOLTMAAT AJ, 2004, LONG TERM HIGH RESOL; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Hur EE, 2005, J COMP NEUROL, V483, P351, DOI 10.1002/cne.20444; Jones EG, 2000, ANNU REV NEUROSCI, V23, P1, DOI 10.1146/annurev.neuro.23.1.1; Kolb B, 1998, ANNU REV PSYCHOL, V49, P43, DOI 10.1146/annurev.psych.49.1.43; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Lubke J, 1996, J NEUROSCI, V16, P3209; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Nikonenko I, 2003, J NEUROSCI, V23, P8498; Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Portera-Cailliau C, 2005, PLOS BIOL, V3, P1473, DOI 10.1371/journal.pbio.0030272; PURVES D, 1985, NATURE, V315, P404, DOI 10.1038/315404a0; Robinson TE, 1997, J NEUROSCI, V17, P8491; Rockland KS, 1996, J COMP NEUROL, V368, P57, DOI 10.1002/(SICI)1096-9861(19960422)368:1<57::AID-CNE5>3.0.CO;2-J; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schikorski T, 1997, J NEUROSCI, V17, P5858; SETTLER DD, 2006, NEURON, V49, P877; Shepherd GMG, 2005, NAT NEUROSCI, V8, P782, DOI 10.1038/nn1447; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sherman S., 2000, EXPLORING THALAMUS; Staiger JF, 1996, ANAT EMBRYOL, V194, P533; Stepanyants A, 2002, NEURON, V34, P275, DOI 10.1016/S0896-6273(02)00652-9; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013; SUTULA T, 1988, SCIENCE, V239, P1147, DOI 10.1126/science.2449733; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Van der Werf YD, 2002, BRAIN RES REV, V39, P107, DOI 10.1016/S0165-0173(02)00181-9; Veinante P, 2003, J COMP NEUROL, V464, P98, DOI 10.1002/cne.10769; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; White EL, 2004, J COMP NEUROL, V479, P56, DOI 10.1002/cne.20300; Zhang ZW, 1998, CEREB CORTEX, V8, P428, DOI 10.1093/cercor/8.5.428; Zhang ZW, 1997, J NEUROSCI, V17, P6365; Zhu YH, 2004, J NEUROSCI, V24, P1272, DOI 10.1523/JNEUROSCI.4805-03.2004; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	72	321	324	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					861	875		10.1016/j.neuron.2006.02.017	http://dx.doi.org/10.1016/j.neuron.2006.02.017			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543134	Bronze			2022-12-28	WOS:000236227500014
J	Schulte, U; Thumfart, JO; Klocker, N; Sailer, CA; Blidl, W; Biniossek, M; Dehn, D; Deller, T; Eble, S; Abbass, K; Wangler, T; Knaus, HG; Fakler, B				Schulte, U; Thumfart, JO; Klocker, N; Sailer, CA; Blidl, W; Biniossek, M; Dehn, D; Deller, T; Eble, S; Abbass, K; Wangler, T; Knaus, HG; Fakler, B			The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kv beta 1	NEURON			English	Article							DOMINANT PARTIAL EPILEPSY; CA2+-ACTIVATED K+ CHANNELS; EPISODIC ATAXIA TYPE-1; BETA-SUBUNIT; AUDITORY FEATURES; RAT-BRAIN; MAMMALIAN BRAIN; ALPHA-SUBUNITS; GENE; MUTATIONS	The voltage-gated potassium (Kv) channel subunit Kv1.1 is a major constituent of presynaptic A-type channels that modulate synaptic transmission in CNS neurons. Here, we show that Kv1.1-containing channels are complexed with Lgi1, the functionally unassigned product of the leucine-rich glioma inactivated gene 1 (LGI1), which is causative for an autosomal dominant form of lateral temporal lobe epilepsy (ADILTE). In the hippocampal formation, both Kv1.1 and Lgi1 are coassembled with Kv1.4 and Kv beta 1 in axonal terminals. In A-type channels composed of these subunits, Lgi1 selectively prevents N-type inactivation mediated by the Kv beta 1 subunit. In contrast, defective Lgi1 molecules identified in ADILTE patients fall to exert this effect resulting in channels with rapid inactivation kinetics. The results establish Lgi1 as a novel subunit of Kv1.1-associated protein complexes and suggest that changes in inactivation gating of presynaptic A-type channels may promote epileptic activity.	Univ Freiburg, Inst Physiol, D-79104 Freiburg, Germany; Logopharm GmbH, D-79104 Freiburg, Germany; Med Univ Innsbruck, Div Mol & Cellular Pharmacol, A-6020 Innsbruck, Austria; Univ Frankfurt, Inst Clin Neuroanat, D-60590 Frankfurt, Germany; Univ Freiburg, Inst Mol Med & Cell Res, D-79104 Freiburg, Germany	University of Freiburg; Medical University of Innsbruck; Goethe University Frankfurt; University of Freiburg	Fakler, B (corresponding author), Univ Freiburg, Inst Physiol, Hermann Herder Str 7, D-79104 Freiburg, Germany.	bernd.fakler@physiologie.uni-freiburg.de	Thumfart, Joerg O/F-9741-2013	Thumfart, Joerg O/0000-0001-7647-9888				Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033; Brodtkorb E, 2003, EPILEPSY RES, V56, P205, DOI 10.1016/j.eplepsyres.2003.09.006; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Campomanes CR, 2002, J BIOL CHEM, V277, P8298, DOI 10.1074/jbc.M110276200; Chernova OB, 1998, ONCOGENE, V17, P2873, DOI 10.1038/sj.onc.1202481; Chrobak JJ, 1998, J NEUROSCI, V18, P388; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; DELLER T, 1995, J NEUROSCI, V15, P6868; Dodson PD, 2004, TRENDS NEUROSCI, V27, P210, DOI 10.1016/j.tins.2004.02.012; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; GOMEZLAGUNAS F, 1995, BIOPHYS J, V68, P89, DOI 10.1016/S0006-3495(95)80162-1; Gu W, 2005, NEUROGENETICS, V6, P59, DOI 10.1007/s10048-005-0216-5; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kobayashi E, 2003, ARCH NEUROL-CHICAGO, V60, P1546, DOI 10.1001/archneur.60.11.1546; KOBE B, 1995, CURR OPIN STRUC BIOL, V5, P409, DOI 10.1016/0959-440X(95)80105-7; Krex D, 2002, ACTA NEUROPATHOL, V103, P255, DOI 10.1007/s004010100463; Kunapuli P, 2003, ONCOGENE, V22, P3985, DOI 10.1038/sj.onc.1206584; Ma MH, 1996, J NEUROSCI, V16, P4089; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; McNamara JO, 1999, NATURE, V399, pA15, DOI 10.1038/399a015; Monaghan MM, 2001, J NEUROSCI, V21, P5973, DOI 10.1523/JNEUROSCI.21-16-05973.2001; Morante-Redolat JM, 2002, HUM MOL GENET, V11, P1119, DOI 10.1093/hmg/11.9.1119; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Ottman R, 2004, NEUROLOGY, V62, P1120, DOI 10.1212/01.WNL.0000120098.39231.6E; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Roeper J, 1998, NATURE, V391, P390, DOI 10.1038/34916; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Sailer CA, 2004, MOL CELL NEUROSCI, V26, P458, DOI 10.1016/j.mcn.2004.03.002; Sailer CA, 2002, J NEUROSCI, V22, P9698; Sewing S, 1996, NEURON, V16, P455, DOI 10.1016/S0896-6273(00)80063-X; Shamotienko O, 1999, BIOCHEMISTRY-US, V38, P16766, DOI 10.1021/bi991039n; Shamotienko OG, 1997, BIOCHEMISTRY-US, V36, P8195, DOI 10.1021/bi970237g; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; Smart SL, 1998, NEURON, V20, P809, DOI 10.1016/S0896-6273(00)81018-1; Steinlein OK, 2004, NAT REV NEUROSCI, V5, P400, DOI 10.1038/nrn1388; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Wang FC, 1999, EUR J BIOCHEM, V263, P230, DOI 10.1046/j.1432-1327.1999.00493.x; Winawer MR, 2000, NEUROLOGY, V54, P2173, DOI 10.1212/WNL.54.11.2173; Winawer MR, 2002, NEUROLOGIST, V8, P133, DOI 10.1097/00127893-200205000-00001; Zuberi SM, 1999, BRAIN, V122, P817, DOI 10.1093/brain/122.5.817	50	227	239	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 2	2006	49	5					697	706		10.1016/j.neuron.2006.01.033	http://dx.doi.org/10.1016/j.neuron.2006.01.033			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504945	Bronze			2022-12-28	WOS:000236070600011
J	Oestreich, J; Dembrow, NC; George, AA; Zakon, HH				Oestreich, J; Dembrow, NC; George, AA; Zakon, HH			A "Sample-and-Hold" pulse-counting integrator as a mechanism for graded memory underlying sensorimotor adaptation	NEURON			English	Article							WEAKLY ELECTRIC FISH; JAMMING AVOIDANCE-RESPONSE; CAPACITATIVE CA2+ ENTRY; CENTRAL-NERVOUS-SYSTEM; APTERONOTUS-LEPTORHYNCHUS; PACEMAKER NUCLEUS; CATION CHANNEL; ELECTROSENSORY SYSTEM; NEURONAL OSCILLATOR; NMDA RECEPTORS	The mechanisms behind the induction of cellular correlates of memory by sensory input and their contribution to meaningful behavioral changes are largely unknown. We previously reported a graded memory in the form of sensorimotor adaptation in the electromotor output of electric fish. Here we show that the mechanism for this adaptation is a synaptically induced long-lasting shift in intrinsic neuronal excitability. This mechanism rapidly integrates hundreds of spikes in a second, or gradually integrates the same number of spikes delivered over tens of minutes. Thus, this mechanism appears immune to frequency-dependent fluctuations in input and operates as a simple pulse counter over a wide range of time scales, enabling it to transduce graded sensory information into a graded memory and a corresponding change in the behavioral output. This adaptation is based on an NMDA receptor-mediated change in intrinsic excitability of the postsynaptic neurons involving the Ca2+-dependent activation of TRP channels.	Univ Texas, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Oestreich, J (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	joerg_oestreich@hms.harvard.edu			NIMH NIH HHS [R01 MH56535] Funding Source: Medline; NINDS NIH HHS [F32 NS046949] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS046949] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baba A, 2003, J NEUROSCI, V23, P7737; Bottai D, 1998, J NEUROSCI, V18, P5191, DOI 10.1523/JNEUROSCI.18-14-05191.1998; Bottai D, 1997, J COMP NEUROL, V389, P65, DOI 10.1002/(SICI)1096-9861(19971208)389:1<65::AID-CNE5>3.0.CO;2-C; BULLOCK TH, 1972, J COMP PHYSIOL, V77, P23, DOI 10.1007/BF00696518; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; DAW NW, 1993, ANNU REV NEUROSCI, V16, P207, DOI 10.1146/annurev.ne.16.030193.001231; DULKA JG, 1994, J COMP PHYSIOL A, V174, P331; DYE J, 1989, P NATL ACAD SCI USA, V86, P8993, DOI 10.1073/pnas.86.22.8993; DYE J, 1988, J COMP PHYSIOL A, V163, P445, DOI 10.1007/BF00604899; DYE J, 1987, J COMP PHYSIOL A, V161, P175, DOI 10.1007/BF00615239; DYE J, 1987, J COMP PHYSIOL A, V161, P187, DOI 10.1007/BF00615240; Eder C, 1998, J NEUROSCI, V18, P7127; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; Feng BH, 2005, NEUROPHARMACOLOGY, V48, P354, DOI 10.1016/j.neuropharm.2004.11.004; HAGEDORN M, 1985, ANIM BEHAV, V33, P254, DOI 10.1016/S0003-3472(85)80139-1; Harks EGA, 2001, J PHARMACOL EXP THER, V298, P1033; Harvey-Girard E, 2003, J NEUROPHYSIOL, V89, P822, DOI 10.1152/jn.00629.2002; Heiligenberg W, 1996, J COMP PHYSIOL A, V179, P653, DOI 10.1007/BF00216130; Heiligenberg W., 1991, NEURAL NETS ELECT FI; HELD R, 1963, SCIENCE, V142, P455, DOI 10.1126/science.142.3591.455; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Juranek J, 1998, J NEUROSCI, V18, P9010; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lee YM, 2003, AM J PHYSIOL-GASTR L, V284, pG604, DOI 10.1152/ajpgi.00069.2002; Luo SQ, 1998, J NEUROSCI, V18, P8571; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P971, DOI 10.1152/jn.2000.83.2.971; Moortgat KT, 2000, J NEUROPHYSIOL, V83, P984, DOI 10.1152/jn.2000.83.2.984; Oestreich J, 2005, J COMP PHYSIOL A, V191, P845, DOI 10.1007/s00359-005-0006-4; Oestreich J, 2002, J NEUROSCI, V22, P8287; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; PARTRIDGE LD, 1994, BRAIN RES REV, V19, P319, DOI 10.1016/0165-0173(94)90017-5; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Smith GT, 2000, J COMP NEUROL, V423, P427; Smith GT, 2000, J NEUROBIOL, V42, P270, DOI 10.1002/(SICI)1097-4695(20000205)42:2<270::AID-NEU10>3.0.CO;2-V; SPIRO JE, 1994, J NEUROSCI, V14, P6289; Srinivas M, 2003, MOL PHARMACOL, V63, P1389, DOI 10.1124/mol.63.6.1389; Tabata T, 1996, NEUROPHARMACOLOGY, V35, P633, DOI 10.1016/0028-3908(96)84634-X; Tallarovic SK, 2002, J COMP PHYSIOL A, V188, P649, DOI 10.1007/s00359-002-0344-4; Tesfai Y, 2001, BIOCHEM J, V358, P717, DOI 10.1042/0264-6021:3580717; Tozzi A, 2003, EUR J NEUROSCI, V18, P2133, DOI 10.1046/j.1460-9568.2003.02936.x; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; van Rossum DB, 2000, J BIOL CHEM, V275, P28562, DOI 10.1074/jbc.M003147200; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zhu ZT, 2005, NEUROPHARMACOLOGY, V49, P317, DOI 10.1016/j.neuropharm.2005.03.018	47	18	18	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 16	2006	49	4					577	588		10.1016/j.neuron.2006.01.027	http://dx.doi.org/10.1016/j.neuron.2006.01.027			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476666	Bronze			2022-12-28	WOS:000235643800010
J	Couey, JJ; Meredith, RM; Spijker, S; Poorthuis, RB; Smit, AB; Brussaard, AB; Mansvelder, HD				Couey, Jonathan J.; Meredith, Rhiannon M.; Spijker, Sabine; Poorthuis, Rogier B.; Smit, August B.; Brussaard, Arjen B.; Mansvelder, Huibert D.			Distributed network actions by nicotine increase the threshold for spike-timing-dependent plasticity in prefrontal cortex	NEURON			English	Article							LONG-TERM POTENTIATION; EXCITATORY SYNAPTIC-TRANSMISSION; ACETYLCHOLINE-RECEPTORS; PYRAMIDAL CELLS; GLUTAMATE RELEASE; HIPPOCAMPAL CA1; WORKING-MEMORY; RAT; NEURONS; CALCIUM	Nicotine enhances attention and working memory by activating nicotinic acetylcholine receptors (nAChRs). The prefrontal cortex (PFC) is critical for these cognitive functions and is also rich in nAChR expression. Specific cellular and synaptic mechanisms underlying nicotine's effects on cognition remain elusive. Here we show that nicotine exposure increases the threshold for synaptic spike-timing-dependent potentiation (STDP) in layer V pyramidal neurons of the mouse PFC. During coincident presynaptic and postsynaptic activity, nicotine reduces dendritic calcium signals associated with action potential propagation by enhancing GABAergic transmission. This results from a series of presynaptic actions involving different PFC interneurons and multiple nAChR subtypes. Pharmacological block of nAChRs or GABA(A) receptors prevented nicotine's actions and restored STDP, as did increasing dendritic calcium signals with stronger postsynaptic activity. Thus, by activating nAChRs distributed throughout the PFC neuronal network, nicotine affects PFC information processing and storage by increasing the amount of postsynaptic activity necessary to induce STDP.	Vrije Univ Amsterdam, Dept Expt & Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands; Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Mansvelder, HD (corresponding author), Vrije Univ Amsterdam, Dept Expt & Neurophysiol, Ctr Neurogenom & Cognit Res, NL-1081 HV Amsterdam, Netherlands.	huib@cncr.vu.nl	Smit, August B/E-8410-2011; Couey, Jonathan/GXG-6340-2022; Meredith, Rhiannon/A-4657-2010; Spijker, Sabine/F-2300-2011; Mansvelder, Huibert/N-6138-2018	Mansvelder, Huibert/0000-0003-1365-5340; Spijker, Sabine/0000-0002-6814-2019; Meredith, Rhiannon/0000-0003-0228-4169; Couey, Jonathan/0000-0003-2658-692X				Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alkondon M, 2001, J NEUROPHYSIOL, V86, P3043, DOI 10.1152/jn.2001.86.6.3043; Alkondon M, 2004, PROG BRAIN RES, V145, P109, DOI 10.1016/S0079-6123(03)45007-3; BERENDSE HW, 1991, NEUROSCIENCE, V42, P73, DOI 10.1016/0306-4522(91)90151-D; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Cauli B, 2000, P NATL ACAD SCI USA, V97, P6144, DOI 10.1073/pnas.97.11.6144; Dalley JW, 2004, NEUROSCI BIOBEHAV R, V28, P771, DOI 10.1016/j.neubiorev.2004.09.006; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; DAY M, 2006, IN PRESS BIOCH PHARM; Froemke RC, 2005, NATURE, V434, P221, DOI 10.1038/nature03366; Gabbott PLA, 1997, J COMP NEUROL, V377, P465, DOI 10.1002/(SICI)1096-9861(19970127)377:4<465::AID-CNE1>3.0.CO;2-0; Ge SY, 2005, J NEUROSCI, V25, P6084, DOI 10.1523/JNEUROSCI.0542-05.2005; Gioanni Y, 1999, EUR J NEUROSCI, V11, P18, DOI 10.1046/j.1460-9568.1999.00403.x; GRANON S, 1995, PSYCHOPHARMACOLOGY, V119, P139, DOI 10.1007/BF02246154; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Gulledge AT, 2007, J NEUROPHYSIOL, V97, P2215, DOI 10.1152/jn.00493.2006; Gulledge AT, 2003, J NEUROSCI, V23, P11363; Heidbreder CA, 2003, NEUROSCI BIOBEHAV R, V27, P555, DOI 10.1016/j.neubiorev.2003.09.003; Helmchen F, 2002, TRENDS NEUROSCI, V25, P438, DOI 10.1016/S0166-2236(02)02232-4; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; JAY TM, 1991, J COMP NEUROL, V313, P574, DOI 10.1002/cne.903130404; JAY TM, 1995, EUR J NEUROSCI, V7, P247, DOI 10.1111/j.1460-9568.1995.tb01060.x; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; KAWAGUCHI Y, 1993, J NEUROPHYSIOL, V69, P416, DOI 10.1152/jn.1993.69.2.416; Kawaguchi Y, 2002, J NEUROCYTOL, V31, P277, DOI 10.1023/A:1024126110356; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Lambe EK, 2003, NEUROPSYCHOPHARMACOL, V28, P216, DOI 10.1038/sj.npp.1300032; LAROCHE S, 1990, NEUROSCI LETT, V114, P184, DOI 10.1016/0304-3940(90)90069-L; Laroche S, 2000, HIPPOCAMPUS, V10, P438; LEVIN ED, 1992, PSYCHOPHARMACOLOGY, V108, P417, DOI 10.1007/BF02247415; Levin ED, 2005, PSYCHOPHARMACOLOGY B, V184, P523, DOI DOI 10.1007/S00213-005-0164-7; Liss B, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf088; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Mansvelder HD, 2006, PSYCHOPHARMACOLOGY, V184, P292, DOI 10.1007/s00213-005-0070-z; Mansvelder HD, 2002, NEURON, V33, P905, DOI 10.1016/S0896-6273(02)00625-6; Mansvelder HD, 2002, J NEUROBIOL, V53, P606, DOI 10.1002/neu.10148; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; McGehee DS, 1996, CURR OPIN NEUROBIOL, V6, P342, DOI 10.1016/S0959-4388(96)80118-8; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Meredith RM, 2003, J NEUROSCI, V23, P11142, DOI 10.1523/jneurosci.23-35-11142.2003; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Mirza NR, 1998, PSYCHOPHARMACOLOGY, V138, P266, DOI 10.1007/s002130050671; MUIR JL, 1995, PSYCHOPHARMACOLOGY, V118, P82; Newhouse P, 2004, CURR TOP MED CHEM, V4, P267, DOI 10.2174/1568026043451401; Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Picciotto MR, 2002, J NEUROBIOL, V53, P641, DOI 10.1002/neu.10102; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Sjostrom PJ, 2002, CURR OPIN NEUROBIOL, V12, P305, DOI 10.1016/S0959-4388(02)00325-2; Stuart G, 1997, TRENDS NEUROSCI, V20, P125, DOI 10.1016/S0166-2236(96)10075-8; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; VIDAL C, 1993, NEUROSCIENCE, V56, P23, DOI 10.1016/0306-4522(93)90558-W; VIDAL C, 1989, NEUROSCIENCE, V29, P261, DOI 10.1016/0306-4522(89)90056-0; Wonnacott S, 2000, EUR J PHARMACOL, V393, P51, DOI 10.1016/S0014-2999(00)00005-4; Wonnacott S, 2005, CURR OPIN PHARMACOL, V5, P53, DOI 10.1016/j.coph.2004.12.002; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; Yang CR, 1996, J NEUROSCI, V16, P1904; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	66	181	183	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					73	87		10.1016/j.neuron.2007.03.006	http://dx.doi.org/10.1016/j.neuron.2007.03.006			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408579	Bronze			2022-12-28	WOS:000245848400011
J	Thiele, A				Thiele, Alexander			Reconstructing the world: Switching from segmentation to integration allows neurons in area MT to make "sense" of the visual scene	NEURON			English	Editorial Material							CORTEX; RESPONSES; ATTENTION	Huang et al. in this issue of Neuron show that primate area MT neurons exploit contextual cues to adequately interpret motion information. MT neurons switch from segmentation to integration when motion arises from single rather than multiple objects. This switching may help solve the aperture problem and bind distant object components into a perceptual whole.	Univ Newcastle Upon Tyne, Sch Biol & Psychol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Thiele, A (corresponding author), Univ Newcastle Upon Tyne, Sch Biol & Psychol, Framlington Pl,Henry Wellcome Bldg, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	alex.thiele@ncl.ac.uk		Thiele, Alexander/0000-0003-4894-0213				Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Bakin JS, 2000, J NEUROSCI, V20, P8188; Huang X, 2007, NEURON, V53, P761, DOI 10.1016/j.neuron.2007.01.032; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Muller NG, 2003, J NEUROSCI, V23, P9812; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Roberts MJ, 2005, J NEUROPHYSIOL, V93, P2062, DOI 10.1152/jn.00911.2004; Sugita Y, 1999, NATURE, V401, P269, DOI 10.1038/45785; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; Zinke W, 2006, EUR J NEUROSCI, V24, P314, DOI 10.1111/j.1460-9568.2006.04882.x	12	5	5	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					623	625		10.1016/j.neuron.2007.02.008	http://dx.doi.org/10.1016/j.neuron.2007.02.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329202	Bronze			2022-12-28	WOS:000245127100003
J	Mokeichev, A; Okun, M; Barak, O; Katz, Y; Ben-Shahar, O; Lampl, I				Mokeichev, Alik; Okun, Michael; Barak, Omri; Katz, Yonatan; Ben-Shahar, Ohad; Lampl, Ilan			Stochastic emergence of repeating cortical motifs in spontaneous membrane potential fluctuations in vivo	NEURON			English	Article							PRECISELY REPLICATING PATTERNS; NEURONAL AVALANCHES; STIMULUS DEPENDENCE; FAVORED PATTERNS; FRONTAL-CORTEX; VISUAL-CORTEX; SPIKE TRAINS; DYNAMICS; MODULATION; NETWORK	It was recently discovered that subthreshold membrane potential fluctuations of cortical neurons can precisely repeat during spontaneous activity, seconds to minutes apart, both in brain slices and in anesthetized animals. These repeats, also called cortical motifs, were suggested to reflect a replay of sequential neuronal firing patterns. We searched for motifs in spontaneous activity, recorded from the rat barrel cortex and from the cat striate cortex of anesthetized animals, and found numerous repeating patterns of high similarity and repetition rates. To test their significance, various statistics were compared between physiological data and three different types of stochastic surrogate data that preserve dynamical characteristics of the recorded data. We found no evidence for the existence of deterministically generated cortical motifs. Rather, the stochastic properties of cortical motifs suggest that they appear by chance, as a result of the constraints imposed by the coarse dynamics of subthreshold ongoing activity.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; Hebrew Univ Jerusalem, Dept Comp Sci, IL-91904 Jerusalem, Israel	Weizmann Institute of Science; Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem	Lampl, I (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	ilan.lampl@weizmann.ac.il	Ben-Shahar, Ohad/F-8918-2015	Katz, Yonatan/0000-0003-1674-0508; Barak, Omri/0000-0002-7894-6344; Katz, Yonatan/0000-0002-1256-9515; Okun, Michael/0000-0002-7795-5513; Okun, Michael/0000-0002-6247-9358; Ben-Shahar, Ohad/0000-0001-5346-152X; Lampl, Ilan/0000-0002-9380-0730				ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; Beggs JM, 2004, J NEUROSCI, V24, P5216, DOI 10.1523/JNEUROSCI.0540-04.2004; Beggs JM, 2003, J NEUROSCI, V23, P11167; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Burgess N, 1996, HIPPOCAMPUS, V6, P749; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cowan AI, 2004, J NEUROPHYSIOL, V92, P2137, DOI 10.1152/jn.01262.2003; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; Dan Y, 1998, NAT NEUROSCI, V1, P501, DOI 10.1038/2217; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1334, DOI 10.1152/jn.1983.49.6.1334; DAYHOFF JE, 1983, J NEUROPHYSIOL, V49, P1349, DOI 10.1152/jn.1983.49.6.1349; DeWeese MR, 2006, J NEUROSCI, V26, P12206, DOI 10.1523/JNEUROSCI.2813-06.2006; ECKHORN R, 1994, PROG BRAIN RES, V102, P405; ENGEL AK, 1992, TRENDS NEUROSCI, V15, P218, DOI 10.1016/0166-2236(92)90039-B; Friedberg MH, 1999, J NEUROPHYSIOL, V81, P2243, DOI 10.1152/jn.1999.81.5.2243; GRAY CM, 1992, VISUAL NEUROSCI, V8, P337, DOI 10.1017/S0952523800005071; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Katz Y, 2006, J NEUROSCI, V26, P13363, DOI 10.1523/JNEUROSCI.4056-06.2006; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; Leger JF, 2005, J NEUROPHYSIOL, V93, P281, DOI 10.1152/jn.00067.2003; Lestienne R, 1998, NEUROSCIENCE, V82, P315; LESTIENNE R, 1987, BRAIN RES, V437, P214, DOI 10.1016/0006-8993(87)91638-6; MacLean JN, 2005, NEURON, V48, P811, DOI 10.1016/j.neuron.2005.09.035; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; Mazurek ME, 2002, NAT NEUROSCI, V5, P463, DOI 10.1038/nn836; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Richard V, 1990, Rev Med Brux, V11, P64; Richmond BJ, 1999, NEURAL PLAST, V6, P133, DOI 10.1155/NP.1999.133; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rudolph M, 2004, J NEUROPHYSIOL, V91, P2884, DOI 10.1152/jn.01223.2003; Sachdev RNS, 2004, J NEUROPHYSIOL, V92, P3511, DOI 10.1152/jn.00347.2004; Schreiber T, 1996, PHYS REV LETT, V77, P635, DOI 10.1103/PhysRevLett.77.635; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Victor JD, 1998, J NEUROPHYSIOL, V80, P554, DOI 10.1152/jn.1998.80.2.554; Wilson CJ, 1996, J NEUROSCI, V16, P2397	47	71	74	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 1	2007	53	3					413	425		10.1016/j.neuron.2007.01.017	http://dx.doi.org/10.1016/j.neuron.2007.01.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270737	Bronze			2022-12-28	WOS:000245126800011
J	Ray, A; van Naters, WVG; Shiraiwa, T; Carlson, JR				Ray, Anandasankar; van Naters, Wynand van der Goes; Shiraiwa, Takashi; Carlson, John R.			Mechanisms of odor receptor gene choice in Drosophila	NEURON			English	Article							OLFACTORY SENSORY NEURONS; TASTE RECEPTORS; MAXILLARY PALP; PRONEURAL GENE; AXON GUIDANCE; CELL FATES; ANTENNA; SYSTEM; EXPRESSION; LOZENGE	A remarkable problem in neurobiology is how olfactory receptor neurons (ORNs) select, from among a large odor receptor repertoire, which receptors to express. We use computational algorithms and mutational analysis to define positive and negative regulatory elements that are required for selection of odor receptor (Or) genes in the proper olfactory organ of Drosophila, and we identify an element that is essential for selection in one ORN class. Two odor receptors are coexpressed by virtue of the alternative splicing of a single gene, and we identify dicistronic m1RNAs that each encode two receptors. Systematic analysis reveals no evidence for negative feedback regulation, but provides evidence that the choices made by neighboring ORNs of a sensillum are coordinated via the asymmetric segregation of regulatory factors from a common progenitor. We show that receptor gene choice in Drosophila also depends on a combinatorial code of transcription factors to generate the receptor-to-neuron map.	Yale Univ, Dept Mol Cellular & Anim Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Anim Biol, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	Ray, Anandasankar/0000-0003-4133-2581; van der Goes van Naters, Wynand/0000-0002-6808-0161	NIDCD NIH HHS [R01 DC004729-03, R01 DC004729, R01 DC002174, R01 DC002174-20, R01 DC002174-21, R01 DC004729-07, DC04729, R01 DC004729-04, R01 DC002174-19, R01 DC002174-22, R01 DC002174-18A1, R01 DC004729-05, R01 DC004729-06, DC02174] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174, R01DC004729] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BERGMAN C, 2002, GENOME BIOL, V3; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Dahanukar A, 2001, NAT NEUROSCI, V4, P1182, DOI 10.1038/nn765; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Fishilevich E, 2005, CURR BIOL, V15, P2086, DOI 10.1016/j.cub.2005.11.016; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Goulding SE, 2000, NEURON, V25, P69, DOI 10.1016/S0896-6273(00)80872-7; Gupta BP, 1998, DEV BIOL, V203, P400, DOI 10.1006/dbio.1998.9064; Gupta BP, 1997, GENES CELLS, V2, P225, DOI 10.1046/j.1365-2443.1997.d01-312.x; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, TRENDS GENET, V20, P453, DOI 10.1016/j.tig.2004.06.015; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Helms W, 1999, DEV BIOL, V215, P358, DOI 10.1006/dbio.1999.9477; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896; Komiyama T, 2004, NAT NEUROSCI, V7, P819, DOI 10.1038/nn1284; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lewcock JW, 2004, P NATL ACAD SCI USA, V101, P1069, DOI 10.1073/pnas.0307986100; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Maier D, 2002, P NATL ACAD SCI USA, V99, P15480, DOI 10.1073/pnas.242596699; Melkman T, 2004, DEV BIOL, V265, P302, DOI 10.1016/j.ydbio.2003.07.005; MISRA S, 2002, GENOME BIOL, V3; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P143, DOI 10.1007/s003590050035; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Rothman A, 2005, MOL CELL NEUROSCI, V28, P535, DOI 10.1016/j.mcn.2004.11.006; Schuldt AJ, 1999, DEV BIOL, V205, P287, DOI 10.1006/dbio.1998.9014; Sen A, 2003, DEV BIOL, V254, P79, DOI 10.1016/S0012-1606(02)00021-0; Serizawa S, 2003, SCIENCE, V302, P2088, DOI 10.1126/science.1089122; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; Shykind BM, 2004, CELL, V117, P801, DOI 10.1016/j.cell.2004.05.015; STOCKER RF, 1993, J NEUROGENET, V9, P29, DOI 10.3109/01677069309167274; van Heiden J, 2000, NUCLEIC ACIDS RES, V28, P1808, DOI 10.1093/nar/28.8.1808; van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947; Vassalli A, 2002, NEURON, V35, P681, DOI 10.1016/S0896-6273(02)00793-6; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yao CA, 2005, J NEUROSCI, V25, P8359, DOI 10.1523/JNEUROSCI.2432-05.2005; Yedvobnick B, 2004, GENETICS, V166, P1281, DOI 10.1534/genetics.166.3.1281	53	83	86	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 1	2007	53	3					353	369		10.1016/j.neuron.2006.12.010	http://dx.doi.org/10.1016/j.neuron.2006.12.010			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DI	17270733	Green Accepted, Bronze			2022-12-28	WOS:000245126800007
J	Grabner, C; Zenisek, D				Grabner, Chad; Zenisek, David			Rustling synaptic vesicle cargo after exocytosis	NEURON			English	Editorial Material							TRANSMISSION; ENDOSOMES; PROTEINS; COMPLEX; AP-3	In this issue of Neuron, Voglmaier et al. provide new evidence that the retrieval of synaptic vesicle transporters after exocytosis proceeds along at least two different endocytic pathways. This work provides new insight into the mechanisms of sorting synaptic vesicle cargo at the cell surface.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA	Yale University	Grabner, C (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.		Zenisek, David/C-6555-2011					Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; De Gois S, 2006, CELL MOL NEUROBIOL, V26, P679, DOI 10.1007/s10571-006-9054-8; Dieck ST, 2005, J CELL BIOL, V168, P825, DOI 10.1083/jcb.200408157; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fremeau RT, 2004, SCIENCE, V304, P1815, DOI 10.1126/science.1097468; Guichet A, 2002, EMBO J, V21, P1661, DOI 10.1093/emboj/21.7.1661; Kantheti P, 1998, NEURON, V21, P111, DOI 10.1016/S0896-6273(00)80519-X; Liu YJ, 1999, TRENDS CELL BIOL, V9, P356, DOI 10.1016/S0962-8924(99)01605-0; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Murthy VN, 2003, ANNU REV NEUROSCI, V26, P701, DOI 10.1146/annurev.neuro.26.041002.131445; Nie ZZ, 2003, DEV CELL, V5, P513, DOI 10.1016/S1534-5807(03)00234-X; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Takamori S, 2006, NEUROSCI RES, V55, P343, DOI 10.1016/j.neures.2006.04.016; Vinatier J, 2006, J NEUROCHEM, V97, P1111, DOI 10.1111/j.1471-4159.2006.03821.x; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027	15	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					3	5		10.1016/j.neuron.2006.06.015	http://dx.doi.org/10.1016/j.neuron.2006.06.015			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815324	Bronze			2022-12-28	WOS:000239037700002
J	Salehi, A; Delcroix, JD; Belichenko, PV; Zhan, K; Wu, CB; Valletta, JS; Takimoto-Kimura, R; Kleschevnikov, AM; Sambamurti, K; Chung, PP; Xia, WM; Villar, A; Campbell, WA; Kulnane, LS; Nixon, RA; Lamb, BT; Epstein, CJ; Stokin, GB; Goldstein, LSB; Mobley, WC				Salehi, Ahmad; Delcroix, Jean-Dominique; Belichenko, Pavel V.; Zhan, Ke; Wu, Chengbiao; Valletta, Janice S.; Takimoto-Kimura, Ryoko; Kleschevnikov, Alexander M.; Sambamurti, Kumar; Chung, Peter P.; Xia, Weiming; Villar, Angela; Campbell, William A.; Kulnane, Laura Shapiro; Nixon, Ralph A.; Lamb, Bruce T.; Epstein, Charles J.; Stokin, Gorazd B.; Goldstein, Lawrence S. B.; Mobley, William C.			Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration	NEURON			English	Article							NERVE GROWTH-FACTOR; AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; RAT BASAL FOREBRAIN; TRANSGENIC MICE; SIGNALING ENDOSOME; TRKA EXPRESSION; NUCLEUS BASALIS; MESSENGER-RNAS; BETA-PEPTIDES	Degeneration of basal forebrain cholinergic neurons (BFCNs) contributes to cognitive dysfunction in Alzheimer's disease (AD) and Down's syndrome (DS). We used Ts65Dn and Ts1Cje mouse models of DS to show that the increased dose of the amyloid precursor protein gene, App, acts to markedly decrease NGF retrograde transport and cause degeneration of BFCNs. NGF transport was also decreased in mice expressing wild-type human APP or a familial AD-linked mutant APP; while significant, the decreases were less marked and there was no evident degeneration of BFCNs. Because of evidence suggesting that the NGF transport defect was intra-axonal, we explored within cholinergic axons the status of early endosomes (EEs). NGF-containing EEs were enlarged in Ts65Dn mice and their App content was increased. Our study thus provides evidence for a pathogenic mechanism for DS in which increased expression of App, in the context of trisomy, causes abnormal transport of NGF and cholinergic neurodegeneration.	Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Med Univ S Carolina, Ctr Aging, Charleston, SC 29425 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Case Western Reserve Univ, Dept Genet, Cleveland, OH 44195 USA; Nathan S Kline Inst Psychiat Res, Ctr Dementia Res, Orangeburg, NY 10962 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Stanford Univ, Sch Med, Neurosci Inst, Stanford, CA 94305 USA	Stanford University; Medical University of South Carolina; Harvard University; Harvard Medical School; University of California System; University of California San Francisco; Case Western Reserve University; Nathan Kline Institute for Psychiatric Research; University of California System; University of California San Diego; Stanford University	Salehi, A (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	asalehi@stanford.edu	xia, weiming/E-5465-2016; Sambamurti, Kumar/A-1620-2012; Stokin, Gorazd Bernard/D-9480-2015; Salehi, Ahmad/H-2746-2019; Salehi, Ahmad/A-1148-2007; Kleschevnikov, Alexander/R-6926-2016	xia, weiming/0000-0002-7463-3295; Sambamurti, Kumar/0000-0001-9507-9214; Stokin, Gorazd Bernard/0000-0001-8430-8755; Salehi, Ahmad/0000-0001-8257-3280; Salehi, Ahmad/0000-0001-8257-3280; Kleschevnikov, Alexander/0000-0002-1562-6706	NIA NIH HHS [AG16999] Funding Source: Medline; NINDS NIH HHS [NS38869] Funding Source: Medline; PHS HHS [31498] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016999] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Auld DS, 2002, PROG NEUROBIOL, V68, P209, DOI 10.1016/S0301-0082(02)00079-5; Belichenko PV, 2004, J COMP NEUROL, V480, P281, DOI 10.1002/cne.20337; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Cataldo AM, 2003, J NEUROSCI, V23, P6788; Chen KS, 1997, J NEUROSCI, V17, P7288; Cobb SR, 1999, J PHYSIOL-LONDON, V518, P131, DOI 10.1111/j.1469-7793.1999.0131r.x; COOPER JD, 1994, NEUROSCIENCE, V62, P625, DOI 10.1016/0306-4522(94)90462-6; Cooper JD, 2001, P NATL ACAD SCI USA, V98, P10439, DOI 10.1073/pnas.181219298; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; DAVISSON MT, 1990, PROG CLIN BIOL RES, V360, P263; Delcroix JD, 2004, PROG BRAIN RES, V146, P3, DOI 10.1016/S0079-6123(03)46001-69; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; GAGE FH, 1989, NEURON, V2, P1177, DOI 10.1016/0896-6273(89)90184-0; Gardiner K, 2003, GENE, V318, P137, DOI 10.1016/S0378-1119(03)00769-8; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1990, NEURON, V4, P253, DOI 10.1016/0896-6273(90)90100-T; Goldstein LSB, 2003, NEURON, V40, P415, DOI 10.1016/S0896-6273(03)00630-5; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; Hodes ME, 2000, AM J HUM GENET, V67, P14, DOI 10.1086/302965; Hof PR., 2000, COMP CYTOARCHITECTON; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Howe CL, 2004, J NEUROBIOL, V58, P207, DOI 10.1002/neu.10323; Jaffar S, 2000, EXP NEUROL, V170, P227, DOI 10.1006/exnr.2001.7710; Jankowsky JL, 2004, NEUROBIOL AGING, V25, P885, DOI 10.1016/j.neurobiolaging.2003.09.008; KISS J, 1993, NEUROSCIENCE, V57, P297, DOI 10.1016/0306-4522(93)90063-L; Kleschevnikov AM, 2004, J NEUROSCI, V24, P8153, DOI 10.1523/JNEUROSCI.1766-04.2004; KOH SY, 1989, J NEUROSCI, V9, P2999; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; LAI F, 1989, ARCH NEUROL-CHICAGO, V46, P849, DOI 10.1001/archneur.1989.00520440031017; LAMB BT, 1993, NAT GENET, V5, P22, DOI 10.1038/ng0993-22; Lamb BT, 1997, HUM MOL GENET, V6, P1535, DOI 10.1093/hmg/6.9.1535; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MANN DMA, 1985, J MENT DEFIC RES, V29, P125; Petanceska SS, 2000, NEUROLOGY, V54, P2212, DOI 10.1212/WNL.54.12.2212; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sago H, 1998, P NATL ACAD SCI USA, V95, P6256, DOI 10.1073/pnas.95.11.6256; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; SALEHI A, 1994, NEUROSCIENCE, V59, P871, DOI 10.1016/0306-4522(94)90291-7; SAMBAMURTI K, 1992, J NEUROSCI RES, V33, P319, DOI 10.1002/jnr.490330216; Seet LF, 2001, J BIOL CHEM, V276, P42445, DOI 10.1074/jbc.M105917200; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Seo HY, 2005, EXP NEUROL, V193, P469, DOI 10.1016/j.expneurol.2004.11.017; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; SOFRONIEW MV, 1993, J NEUROSCI, V13, P5263, DOI 10.1523/JNEUROSCI.13-12-05263.1993; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; WESSENDORF MW, 1991, BRAIN RES, V553, P135, DOI 10.1016/0006-8993(91)90241-M; WHITEHOUSE PJ, 1981, ANN NEUROL, V10, P122, DOI 10.1002/ana.410100203; WISNIEWSKI KE, 1985, NEUROLOGY, V35, P957, DOI 10.1212/WNL.35.7.957; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; YAMADA T, 1989, BIOCHEM BIOPH RES CO, V158, P906, DOI 10.1016/0006-291X(89)92808-8; Ye HH, 2003, NEURON, V39, P57, DOI 10.1016/S0896-6273(03)00266-6; Yeo TT, 1997, J NEUROSCI, V17, P7594; Zheng H, 1996, ANN NY ACAD SCI, V777, P421, DOI 10.1111/j.1749-6632.1996.tb34456.x; Zweifel LS, 2005, NAT REV NEUROSCI, V6, P615, DOI 10.1038/nrn1727	67	393	406	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 6	2006	51	1					29	42		10.1016/j.neuron.2006.05.022	http://dx.doi.org/10.1016/j.neuron.2006.05.022			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815330	Bronze			2022-12-28	WOS:000239037700008
J	Svoboda, K; Yasuda, R				Svoboda, Karel; Yasuda, Ryohei			Principles of two-photon excitation microscopy and its applications to neuroscience	NEURON			English	Review							GREEN FLUORESCENT PROTEIN; NANOJOULE FEMTOSECOND PULSES; DENDRITIC SPINE STABILITY; ACTION-POTENTIALS; ENERGY-TRANSFER; TRANSMITTER RELEASE; CALCIUM TRANSIENTS; NEURAL ACTIVITY; CROSS-SECTIONS; MONOMERIC RED	The brain is complex and dynamic. The spatial scales of interest to the neurobiologist range from individual synapses (similar to 1 mu m) to neural circuits (centimeters); the timescales range from the flickering of channels (less than a millisecond) to long-term memory (years). Remarkably, fluorescence microscopy has the potential to revolutionize research on all of these spatial and temporal scales. Two-photon excitation (2PE) laser scanning microscopy allows high-resolution and high-sensitivity fluorescence microscopy in intact neural tissue, which is hostile to traditional forms of microscopy. Over the last 10 years, applications of 2PE, including microscopy and photostimulation, have contributed to our understanding of a broad array of neurobiological phenomena, including the dynamics of single channels in individual synapses and the functional organization of cortical maps. Here we review the principles of 2PE microscopy, highlight recent applications, discuss its limitations, and point to areas for future research and development.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Cold Spring Harbor Laboratory; Duke University	Svoboda, K (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	svoboda@cshi.edu; yasuda@neuro.duke.edu	Yasuda, Ryohei/E-7726-2011	Yasuda, Ryohei/0000-0001-6263-9297				Albota M, 1998, SCIENCE, V281, P1653, DOI 10.1126/science.281.5383.1653; Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Andrasfalvy BK, 2003, J PHYSIOL-LONDON, V552, P35, DOI 10.1113/jphysiol.2003.045575; Andresen V, 2001, OPT LETT, V26, P75, DOI 10.1364/OL.26.000075; Backskai BJ, 2001, NAT MED, V7, P369, DOI 10.1038/85525; Baker BJ, 2005, CELL MOL NEUROBIOL, V25, P245, DOI 10.1007/s10571-005-3059-6; Beaurepaire E, 2001, OPT COMMUN, V188, P25, DOI 10.1016/S0030-4018(00)01156-1; Becker W, 2001, PROC SPIE, V4262, P414, DOI 10.1117/12.424584; Bestvater F, 2002, J MICROSC-OXFORD, V208, P108, DOI 10.1046/j.1365-2818.2002.01074.x; Bewersdorf J, 1998, OPT LETT, V23, P655, DOI 10.1364/OL.23.000655; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Brown EB, 1999, BIOPHYS J, V76, P489, DOI 10.1016/S0006-3495(99)77217-6; Campagnola PJ, 1999, BIOPHYS J, V77, P3341, DOI 10.1016/S0006-3495(99)77165-1; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Centonze VE, 1998, BIOPHYS J, V75, P2015, DOI 10.1016/S0006-3495(98)77643-X; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chen IH, 2002, OPT QUANT ELECTRON, V34, P1251, DOI 10.1023/A:1021303426482; Chen TS, 2002, BIOCHEM BIOPH RES CO, V291, P1272, DOI 10.1006/bbrc.2002.6587; Christie RH, 2001, J NEUROSCI, V21, P858, DOI 10.1523/JNEUROSCI.21-03-00858.2001; Chudakov DM, 2003, NAT BIOTECHNOL, V21, P191, DOI 10.1038/nbt778; Chudakov DM, 2004, NAT BIOTECHNOL, V22, P1435, DOI 10.1038/nbt1025; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Cossart R, 2005, CELL CALCIUM, V37, P451, DOI 10.1016/j.ceca.2005.01.013; Cox CL, 2000, P NATL ACAD SCI USA, V97, P9724, DOI 10.1073/pnas.170278697; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; De Paola V, 2006, NEURON, V49, P861, DOI 10.1016/j.neuron.2006.02.017; Deguil N, 2004, MICROSC RES TECHNIQ, V63, P23, DOI 10.1002/jemt.10419; Dela Cruz JM, 2004, P NATL ACAD SCI USA, V101, P16996, DOI 10.1073/pnas.0407733101; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DelPrincipe F, 1999, CELL CALCIUM, V25, P85, DOI 10.1054/ceca.1998.0009; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DENK W, 1994, J NEUROSCI METH, V54, P151, DOI 10.1016/0165-0270(94)90189-9; DENK W, 1995, P NATL ACAD SCI USA, V92, P8279, DOI 10.1073/pnas.92.18.8279; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk Winfried, 1995, P445; Diez-Garcia J, 2005, EUR J NEUROSCI, V22, P627, DOI 10.1111/j.1460-9568.2005.04250.x; Dombeck DA, 2004, J NEUROSCI, V24, P999, DOI 10.1523/JNEUROSCI.4840-03.2004; Dudovich N, 2001, PHYS REV LETT, V86, P47, DOI 10.1103/PhysRevLett.86.47; Eggeling C, 2005, CHEMPHYSCHEM, V6, P791, DOI 10.1002/cphc.200400509; Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005; EIGEN M, 1994, P NATL ACAD SCI USA, V91, P5740, DOI 10.1073/pnas.91.13.5740; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Feierabend M, 2004, OPT LETT, V29, P2255, DOI 10.1364/OL.29.002255; Felmy F, 2003, P NATL ACAD SCI USA, V100, P15200, DOI 10.1073/pnas.2433276100; Felmy F, 2003, NEURON, V37, P801, DOI 10.1016/S0896-6273(03)00085-0; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fisher JAN, 2005, J NEUROSCI METH, V148, P94, DOI 10.1016/j.jneumeth.2005.06.027; Flusberg BA, 2005, NAT METHODS, V2, P941, DOI 10.1038/NMETH820; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Fu AH, 2005, CURR OPIN NEUROBIOL, V15, P568, DOI 10.1016/j.conb.2005.08.004; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; GANNAWAY JN, 1978, OPT QUANT ELECTRON, V10, P435, DOI 10.1007/BF00620308; Gasparini S, 2006, J NEUROSCI, V26, P2088, DOI 10.1523/JNEUROSCI.4428-05.2006; Gobel W, 2004, OPT LETT, V29, P1285, DOI 10.1364/OL.29.001285; Goldberg JH, 2003, NEURON, V40, P807, DOI 10.1016/S0896-6273(03)00714-1; Goldberg JH, 2004, J PHYSIOL-LONDON, V558, P465, DOI 10.1113/jphysiol.2004.064519; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; GOSNELL TR, 1991, SELECTED PAPERS ULTR; Gratton E, 2003, J BIOMED OPT, V8, P381, DOI 10.1117/1.1586704; Grinvald A, 2004, NAT REV NEUROSCI, V5, P874, DOI 10.1038/nrn1536; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Guerrero G, 2005, NAT NEUROSCI, V8, P1188, DOI 10.1038/nn1526; Guild JB, 1997, APPL OPTICS, V36, P397, DOI 10.1364/AO.36.000397; Gurskaya NG, 2006, NAT BIOTECHNOL, V24, P461, DOI 10.1038/nbt1191; Habuchi S, 2005, P NATL ACAD SCI USA, V102, P9511, DOI 10.1073/pnas.0500489102; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; HAUGLAND RP, 1996, HDB BIOL FLUORESCENT; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Helmchen F, 2002, CURR OPIN NEUROBIOL, V12, P593, DOI 10.1016/S0959-4388(02)00362-8; Helmchen F, 2001, NEURON, V31, P903, DOI 10.1016/S0896-6273(01)00421-4; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hirase H, 2002, J NEUROBIOL, V51, P237, DOI 10.1002/neu.10056; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; HOLTMAAT AJ, 2004, IMAGING NEURONS, P627; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Honninger C, 1998, OPT LETT, V23, P126, DOI 10.1364/OL.23.000126; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; Iyer V, 2006, J NEUROPHYSIOL, V95, P535, DOI 10.1152/jn.00865.2005; Iyer V, 2003, J BIOMED OPT, V8, P460, DOI 10.1117/1.1580827; Jakobs S, 2000, FEBS LETT, V479, P131, DOI 10.1016/S0014-5793(00)01896-2; Jung JC, 2004, J NEUROPHYSIOL, V92, P3121, DOI 10.1152/jn.00234.2004; Kantevari S, 2006, CHEMBIOCHEM, V7, P174, DOI 10.1002/cbic.200500345; Kaplan A, 2001, OPT LETT, V26, P1078, DOI 10.1364/OL.26.001078; Kasischke KA, 2004, SCIENCE, V305, P99, DOI 10.1126/science.1096485; Kawano H, 2003, BIOCHEM BIOPH RES CO, V311, P592, DOI 10.1016/j.bbrc.2003.09.236; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kim KH, 1999, APPL OPTICS, V38, P6004, DOI 10.1364/AO.38.006004; Kiskin NI, 2002, EUR BIOPHYS J BIOPHY, V30, P588, DOI 10.1007/s00249-001-0187-x; Klein RC, 2005, J PHYSIOL-LONDON, V568, P881, DOI 10.1113/jphysiol.2005.096081; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Konig K, 1999, OPT LETT, V24, P113, DOI 10.1364/OL.24.000113; Kurtz R, 2006, J NEUROSCI METH, V151, P276, DOI 10.1016/j.jneumeth.2005.12.003; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; Lechleiter JD, 2002, BIOPHYS J, V83, P2292, DOI 10.1016/S0006-3495(02)73989-1; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Levene MJ, 2004, J NEUROPHYSIOL, V91, P1908, DOI 10.1152/jn.01007.2003; Lichtman JW, 2005, NAT METHODS, V2, P910, DOI 10.1038/NMETH817; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lukyanov KA, 2005, NAT REV MOL CELL BIO, V6, P885, DOI 10.1038/nrm1741; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Maiti S, 1997, SCIENCE, V275, P530, DOI 10.1126/science.275.5299.530; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Mertz J, 2004, CURR OPIN NEUROBIOL, V14, P610, DOI 10.1016/j.conb.2004.08.013; Meshulach D, 1998, NATURE, V396, P239, DOI 10.1038/24329; Miyawaki A, 2005, NEURON, V48, P189, DOI 10.1016/j.neuron.2005.10.003; Miyawaki A, 2003, DEV CELL, V4, P295, DOI 10.1016/S1534-5807(03)00060-1; Mizrahi A, 2004, J NEUROSCI, V24, P3147, DOI 10.1523/JNEUROSCI.5218-03.2004; Mizrahi A, 2003, NAT NEUROSCI, V6, P1201, DOI 10.1038/nn1133; Momotake A, 2006, NAT METHODS, V3, P35, DOI 10.1038/NMETH821; Moreaux L, 2000, OPT LETT, V25, P320, DOI 10.1364/OL.25.000320; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Neil MAA, 2000, J MICROSC-OXFORD, V200, P105, DOI 10.1046/j.1365-2818.2000.00770.x; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Nevian T, 2004, J NEUROSCI, V24, P1689, DOI 10.1523/JNEUROSCI.3332-03.2004; Ngoi BKA, 2001, OPT EXPRESS, V9, P200, DOI 10.1364/OE.9.000200; Nguyen QT, 2001, CELL CALCIUM, V30, P383, DOI 10.1054/ceca.2001.0246; NGUYEN QT, 2006, IN PRESS J NEUROSCI; Niell CM, 2005, NEURON, V45, P941, DOI 10.1016/j.neuron.2005.01.047; Nikolenko V, 2005, CHEM COMMUN, P1752, DOI 10.1039/b418572b; Nikolenko V, 2003, METHODS, V30, P3, DOI 10.1016/S1046-2023(03)00003-3; Nimchinsky EA, 2004, J NEUROSCI, V24, P2054, DOI 10.1523/JNEUROSCI.5066-03.2004; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; NIU L, 1993, BIOCHEMISTRY-US, V32, P3833; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Oesch N, 2005, NEURON, V47, P739, DOI 10.1016/j.neuron.2005.06.036; Oheim M, 2001, J NEUROSCI METH, V111, P29, DOI 10.1016/S0165-0270(01)00438-1; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Oron D, 2005, OPT EXPRESS, V13, P9903, DOI 10.1364/OPEX.13.009903; Ouzounov DG, 2002, OPT LETT, V27, P1513, DOI 10.1364/OL.27.001513; Pakhomov AA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P901, DOI 10.1023/B:BIRY.0000040223.09641.29; PALMER AE, 2006, IN PRESS CHEM BIOL; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Patterson GH, 2000, BIOPHYS J, V78, P2159, DOI 10.1016/S0006-3495(00)76762-2; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Philip J, 2003, J OPT SOC AM A, V20, P368, DOI 10.1364/JOSAA.20.000368; PISTON DW, 1992, TIME RESOLVED LASER, V3, P379; Pologruto TA, 2004, J NEUROSCI, V24, P9572, DOI 10.1523/JNEUROSCI.2854-04.2004; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Porres L, 2004, J NONLINEAR OPT PHYS, V13, P451, DOI 10.1142/S0218863504002109; Ramon y Cajal S, 1995, HISTOLOGY NERVOUS SY; Raymond CR, 2006, J PHYSIOL-LONDON, V570, P97, DOI 10.1113/jphysiol.2005.098947; Reddy GD, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2141504; Reiff DF, 2005, J NEUROSCI, V25, P4766, DOI 10.1523/JNEUROSCI.4900-04.2005; Ridsdale A, 2004, APPL OPTICS, V43, P1669, DOI 10.1364/AO.43.001669; Roorda RD, 2004, J NEUROPHYSIOL, V92, P609, DOI 10.1152/jn.00087.2004; Rozsa B, 2004, J NEUROSCI, V24, P661, DOI 10.1523/JNEUROSCI.3906-03.2004; Rusakov DA, 2004, CEREB CORTEX, V14, P748, DOI 10.1093/cercor/bhh035; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneider M, 2005, BIOPHYS J, V89, P1346, DOI 10.1529/biophysj.104.054502; Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shear JB, 1997, PHOTOCHEM PHOTOBIOL, V65, P931, DOI 10.1111/j.1751-1097.1997.tb07950.x; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Smith MA, 2003, J PHYSIOL-LONDON, V548, P245, DOI 10.1113/jphysiol.2002.036376; So P. T. C., 1995, Bioimaging, V3, P49, DOI 10.1002/1361-6374(199506)3:2<49::AID-BIO1>3.3.CO;2-5; So PTC, 2000, ANNU REV BIOMED ENG, V2, P399, DOI 10.1146/annurev.bioeng.2.1.399; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Soler-Llavina GJ, 2006, NAT NEUROSCI, V9, P798, DOI 10.1038/nn1698; Spiess E, 2005, J MICROSC-OXFORD, V217, P200, DOI 10.1111/j.1365-2818.2005.01437.x; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Squire A, 2000, J MICROSC-OXFORD, V197, P136, DOI 10.1046/j.1365-2818.2000.00651.x; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Straub M, 1998, APPL PHYS LETT, V73, P1769, DOI 10.1063/1.122276; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Takano T, 2006, NAT NEUROSCI, V9, P260, DOI 10.1038/nn1623; Theer P, 2003, OPT LETT, V28, P1022, DOI 10.1364/OL.28.001022; Tirlapur UK, 2002, NATURE, V418, P290, DOI 10.1038/418290a; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Tsai PS, 2003, NEURON, V39, P27, DOI 10.1016/S0896-6273(03)00370-2; Tsai PS, 2002, METH NE FRO NEUROSCI, P113; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; USTER PS, 1986, J CELL BIOL, V103, P1221, DOI 10.1083/jcb.103.4.1221; Verkhusha VV, 2005, CHEM BIOL, V12, P279, DOI 10.1016/j.chembiol.2005.01.005; Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang TD, 2004, J BIOMED OPT, V9, P735, DOI 10.1117/1.1760760; Wang YL, 2004, J NEUROSCI, V24, P6507, DOI 10.1523/JNEUROSCI.3727-03.2004; Waters J, 2004, J NEUROSCI, V24, P11127, DOI 10.1523/JNEUROSCI.2933-04.2004; Welch MD, 1998, METHOD ENZYMOL, V298, P52, DOI 10.1016/S0076-6879(98)98008-9; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wilson T., 1984, THEORY PRACTICE SCAN; Wokosin DL, 2004, BIOPHYS J, V86, P1726, DOI 10.1016/S0006-3495(04)74241-1; Xu C, 1996, P NATL ACAD SCI USA, V93, P10763, DOI 10.1073/pnas.93.20.10763; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yasuda R, 2003, NAT NEUROSCI, V6, P948, DOI 10.1038/nn1112; Yasuda R, 2003, P NATL ACAD SCI USA, V100, P9314, DOI 10.1073/pnas.1637860100; Yasuda Ryohei, 2004, Sci STKE, V2004, ppl5, DOI 10.1126/stke.2192004pl5; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; ZACHARIAS DA, 2003, METHOD BIOCHEM ANAL, V47, P83; Zhu GH, 2005, OPT EXPRESS, V13, P2153, DOI 10.1364/OPEX.13.002153; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899; Zito K, 2004, NEURON, V44, P321, DOI 10.1016/j.neuron.2004.09.022; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	241	657	675	9	258	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					823	839		10.1016/j.neuron.2006.05.019	http://dx.doi.org/10.1016/j.neuron.2006.05.019			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772166	Bronze			2022-12-28	WOS:000238589500005
J	Wayman, GA; Impey, S; Marks, D; Saneyoshi, T; Grant, WF; Derkach, V; Soderling, TR				Wayman, Gary A.; Impey, Soren; Marks, Daniel; Saneyoshi, Takeo; Grant, Wilmon F.; Derkach, Victor; Soderling, Thomas R.			Activity-dependent dendritic arborization mediated by CaM-Kinase I activation and enhanced CREB-dependent transcription of Wnt-2	NEURON			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; SYNAPTIC PLASTICITY; BETA-CATENIN; HIPPOCAMPAL-NEURONS; SIGNALING PATHWAYS; DEFICIENT MICE; RETINOIC ACID; PHOSPHORYLATION; RAT; GROWTH	Members of the Wnt signaling family are important mediators of numerous developmental events, including activity-dependent dendrite development, but the pathways regulating expression and secretion of Wnt in response to neuronal activity are poorly defined. Here, we identify an NMDA receptor-mediated, Ca2+-dependent signaling pathway that couples neuronal activity to dendritic arborization through enhanced Wnt synthesis and secretion. Activity-dependent dendritic outgrowth and branching in cultured hippocampal neurons and slices is mediated through activation by CaM-dependent protein kinase kinase (CaMKK) of the membrane-associated gamma isoform of CaMKI. Downstream effectors of CaMKII include the MAP-kinase pathway of Ras/MEK/ERK and the transcription factor CREB. A serial analysis of chromatin occupancy screen identified Wnt-2 as an activity-dependent CREB-responsive gene. Neuronal activity enhances CREB-dependent transcription of Wnt-2, and expression of Wnt-2 stimulates dendritic arborization. This novel signaling pathway contributes to dynamic remodeling of the dendritic architecture in response to neuronal activity during development.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97239 USA; Oregon Hlth Sci Univ, Ctr Study Weight Regulat, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Soderling, TR (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	soderlit@ohsu.edu	Marks, Daniel/C-3712-2009; Saneyoshi, Takeo/AAF-5170-2019		NIGMS NIH HHS [R01 GM041292] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041292] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; Bamji SX, 2005, NEURON, V47, P175, DOI 10.1016/j.neuron.2005.06.024; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; BECKER LE, 1986, ANN NEUROL, V20, P520, DOI 10.1002/ana.410200413; Benavides-Piccione R, 2004, PROG NEUROBIOL, V74, P111, DOI 10.1016/j.pneurobio.2004.08.001; Brewer GJ, 1997, J NEUROSCI METH, V71, P143, DOI 10.1016/S0165-0270(96)00136-7; CAESER M, 1991, J COMP NEUROL, V307, P87, DOI 10.1002/cne.903070109; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; ENSLEN H, 1995, BIOCHEM BIOPH RES CO, V207, P1038, DOI 10.1006/bbrc.1995.1289; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Han C, 2005, MOL CELL, V17, P321, DOI 10.1016/j.molcel.2005.01.009; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Impey S, 2002, NEURON, V34, P235, DOI 10.1016/S0896-6273(02)00654-2; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Katoh M, 2002, INT J MOL MED, V10, P683; Konur S, 2005, NEURON, V46, P401, DOI 10.1016/j.neuron.2005.04.022; Lee B, 2005, J NEUROSCI, V25, P1137, DOI 10.1523/JNEUROSCI.4288-04.2005; Libersat F, 2004, MOL NEUROBIOL, V29, P303, DOI 10.1385/MN:29:3:303; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Madsen TM, 2003, BIOL PSYCHIAT, V54, P1006, DOI 10.1016/S0006-3223(03)00700-5; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; Miller FD, 2003, CURR OPIN NEUROBIOL, V13, P391, DOI 10.1016/s0959-4388(03)00072-2; MOCHIZUKI H, 1993, J BIOL CHEM, V268, P9143; NAIRN AC, 1987, J BIOL CHEM, V262, P7273; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nishimura T, 2006, MOL BIOL CELL, V17, P1273, DOI 10.1091/mbc.E05-07-0700; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; PICCIOTTO MR, 1995, SYNAPSE, V20, P75, DOI 10.1002/syn.890200111; POKORNY J, 1981, BRAIN RES BULL, V7, P113, DOI 10.1016/0361-9230(81)90075-7; Qin H, 2003, J BIOL CHEM, V278, P48570, DOI 10.1074/jbc.M308781200; Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Schmitt JM, 2005, J NEUROSCI, V25, P1281, DOI 10.1523/JNEUROSCI.4086-04.2005; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Suizu F, 2002, BIOCHEM J, V367, P335, DOI 10.1042/BJ20020536; Takemoto-Kimura S, 2003, J BIOL CHEM, V278, P18597, DOI 10.1074/jbc.M300578200; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Tokumitsu H, 2005, J BIOL CHEM, V280, P35108, DOI 10.1074/jbc.M503912200; Tokumitsu H, 2003, J BIOL CHEM, V278, P10908, DOI 10.1074/jbc.M213183200; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; TUCKER RP, 1988, DEV BIOL, V130, P423, DOI 10.1016/0012-1606(88)90338-7; Vaillant AR, 2002, NEURON, V34, P985, DOI 10.1016/S0896-6273(02)00717-1; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; VOLKMAR FR, 1972, SCIENCE, V176, P1445, DOI 10.1126/science.176.4042.1445; Wayman GA, 2004, J NEUROSCI, V24, P3786, DOI 10.1523/JNEUROSCI.3294-03.2004; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	73	358	370	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN 15	2006	50	6					897	909		10.1016/j.neuron.2006.05.008	http://dx.doi.org/10.1016/j.neuron.2006.05.008			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	057IM	16772171	Bronze			2022-12-28	WOS:000238589500010
J	Yasuda, M; Mayford, MR				Yasuda, M; Mayford, MR			CaMKII activation in the entorhinal cortex disrupts previously encoded spatial memory	NEURON			English	Article							LONG-TERM POTENTIATION; IMPAIRED RECOGNITION MEMORY; II MUTANT MICE; SYNAPTIC PLASTICITY; RETROGRADE-AMNESIA; CONTEXTUAL FEAR; HIPPOCAMPUS; RAT; ORGANIZATION; CONSOLIDATION	To investigate the role of the entorhinal cortex in memory at a molecular level, we developed transgenic mice in which transgene expression was inducible and limited to the superficial layers of the medial entorhinal cortex, pre- and parasubiculum. We found that expression of a constitutively active mutant form of CaMKII in these structures disrupted spatial memory formation. Immediate post-training activation of the transgene disrupted previously established memory while transgene activation 3 weeks following the training was ineffective. These results demonstrate that, similar to the hippocampus, the entorhinal cortex plays a time-limited role in spatial memory formation but is not a final cortical repository of long-term memory. Moreover, these results suggest that the indiscriminate activation of CaMKII is able to disrupt preexisting memories, possibly by altering the pattern of synaptic weight changes that are thought to form the basis of the memory trace.	Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Mayford, MR (corresponding author), Scripps Res Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mmayford@scripps.edu		Mayford, Mark/0000-0002-9001-5024	NIMH NIH HHS [MH57368] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bejar R, 2002, J NEUROSCI, V22, P5719; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brun VH, 2001, J NEUROSCI, V21, P356, DOI 10.1523/JNEUROSCI.21-01-00356.2001; Burwell RD, 2004, J NEUROSCI, V24, P3826, DOI 10.1523/JNEUROSCI.0410-04.2004; CHEN ZL, 1995, J NEUROSCI, V15, P5088; Clark RE, 2000, J NEUROSCI, V20, P8853; deToledo-Morrell L, 2004, NEUROBIOL AGING, V25, P1197, DOI 10.1016/j.neurobiolaging.2003.12.007; Dolorfo CL, 1998, J COMP NEUROL, V398, P25; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Glazewski S, 2001, NEUROPHARMACOLOGY, V41, P771, DOI 10.1016/S0028-3908(01)00097-1; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Honda Y, 2004, J COMP NEUROL, V473, P463, DOI 10.1002/cne.20093; KIM JJ, 1993, BEHAV NEUROSCI, V107, P1093, DOI 10.1037/0735-7044.107.6.1093; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; KOHLER C, 1985, J COMP NEUROL, V236, P504, DOI 10.1002/cne.902360407; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; MAYFORD M, 1995, CELL, V81, P891, DOI 10.1016/0092-8674(95)90009-8; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nakazawa K, 2003, NEURON, V38, P305, DOI 10.1016/S0896-6273(03)00165-X; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Reed JM, 1998, J NEUROSCI, V18, P3943; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Schacter D., 1994, MEMORY SYSTEMS; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Spooner R I, 1994, Learn Mem, V1, P203; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; van Groen T, 2001, HIPPOCAMPUS, V11, P397, DOI 10.1002/hipo.1054; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; Wang H, 2003, P NATL ACAD SCI USA, V100, P4287, DOI 10.1073/pnas.0636870100; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yang XDW, 1997, NAT BIOTECHNOL, V15, P859, DOI 10.1038/nbt0997-859; Zola SM, 2000, J NEUROSCI, V20, P451, DOI 10.1523/JNEUROSCI.20-01-00451.2000	44	78	82	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 20	2006	50	2					309	318		10.1016/j.neuron.2006.03.035	http://dx.doi.org/10.1016/j.neuron.2006.03.035			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630840	Bronze			2022-12-28	WOS:000237176700016
J	Pressler, RT; Strowbridge, BW				Pressler, RT; Strowbridge, BW			Blanes cells mediate persistent feedforward inhibition onto granule cells in the olfactory bulb	NEURON			English	Article							SHORT-AXON CELLS; RAT SUPRAOPTIC NUCLEUS; DENDRODENDRITIC INHIBITION; PREFRONTAL CORTEX; NEURONS; MECHANISMS; PARVALBUMIN; POTENTIALS; IMMUNOREACTIVITY; INTERNEURONS	Inhibitory local circuits in the olfactory bulb play a critical role in determining the firing patterns of output neurons. However, little is known about the circuitry in the major plexiform layers of the olfactory bulb that regulate this output. Here we report the first electrophysiological recordings from Blanes cells, large stellate-shaped interneurons located in the granule cell layer. We find that Blanes cells are GABAergic and generate large I-CAN-mediated afterdepolarizations following bursts of action potentials. Using paired two-photon guided intracellular recordings, we show that Blanes cells have a presumptive axon and monosynaptically inhibit granule cells. Sensory axon stimulation evokes barrages of EPSPs in Blanes cells that trigger long epochs of persistent spiking; this firing mode was reset by hyperpolarizing membrane potential steps. Persistent firing in Blanes cells may represent a novel mechanism for encoding short-term olfactory information through modulation of tonic inhibitory synaptic input onto bulbar neurons.	Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Strowbridge, BW (corresponding author), Case Western Reserve Univ, Dept Neurosci, Cleveland, OH 44106 USA.	bens@case.edu			NIA NIH HHS [AG00271] Funding Source: Medline; NIDCD NIH HHS [DC04285] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004285] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alonso JR, 2001, J COMP NEUROL, V432, P389, DOI 10.1002/cne.1110; Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Balu R, 2004, J NEUROPHYSIOL, V92, P743, DOI 10.1152/jn.00016.2004; Blanes T., 1898, REV TRIM MICROG, V3, P99; BOURQUE CW, 1986, NEUROSCI LETT, V70, P204, DOI 10.1016/0304-3940(86)90464-7; Cang JH, 2003, J NEUROSCI, V23, P4108; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Egger V, 2003, J NEUROSCI, V23, P7551; Egorov AV, 2002, NATURE, V420, P173, DOI 10.1038/nature01171; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Friedman D, 2003, J NEUROPHYSIOL, V89, P2601, DOI 10.1152/jn.00887.2002; Ghamari-Langroudi M, 2002, J PHYSIOL-LONDON, V545, P537, DOI 10.1113/jphysiol.2002.033589; Gracia-Llanes FJ, 2003, EUR J NEUROSCI, V18, P1751, DOI 10.1046/j.1460-9568.2003.02895.x; Haj-Dahmane S, 1998, J NEUROPHYSIOL, V80, P1197, DOI 10.1152/jn.1998.80.3.1197; Haj-Dahmane S, 1999, EUR J NEUROSCI, V11, P1973, DOI 10.1046/j.1460-9568.1999.00612.x; Halabisky B, 2003, J NEUROPHYSIOL, V90, P644, DOI 10.1152/jn.00212.2003; Hall BJ, 2002, J PHYSIOL-LONDON, V543, P819, DOI 10.1113/jphysiol.2002.024638; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Kakuta S, 1998, BRAIN BEHAV EVOLUT, V52, P285, DOI 10.1159/000006573; Li ZH, 1997, J PHYSIOL-LONDON, V505, P95, DOI 10.1111/j.1469-7793.1997.095bc.x; LOPEZMASCARAQUE L, 1986, J COMP NEUROL, V253, P135, DOI 10.1002/cne.902530202; Margrie TW, 2003, J PHYSIOL-LONDON, V546, P363, DOI 10.1113/jphysiol.2002.031245; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Nakajima T, 1996, J VET MED SCI, V58, P903, DOI 10.1292/jvms.58.903; OHM TG, 1990, J COMP NEUROL, V291, P1, DOI 10.1002/cne.902910102; Partridge LD, 2000, BRAIN RES, V867, P143, DOI 10.1016/S0006-8993(00)02275-7; PARTRIDGE LD, 1994, BRAIN RES REV, V19, P319, DOI 10.1016/0165-0173(94)90017-5; PRICE JL, 1970, J CELL SCI, V7, P631; PRICE JL, 1970, J CELL SCI, V7, P125; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Roper P, 2004, J NEUROSCI, V24, P4818, DOI 10.1523/JNEUROSCI.4203-03.2004; Roper P, 2003, J COMPUT NEUROSCI, V15, P367, DOI 10.1023/A:1027424128972; Sanchez-Vives MV, 2000, NAT NEUROSCI, V3, P1027, DOI 10.1038/79848; SCHNEIDER SP, 1978, BRAIN RES BULL, V3, P73, DOI 10.1016/0361-9230(78)90063-1; Schoppa NE, 1998, J NEUROSCI, V18, P6790; SCOTT JW, 1987, J COMP NEUROL, V260, P378, DOI 10.1002/cne.902600305; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Stepanyants A, 2004, NEURON, V43, P251, DOI 10.1016/j.neuron.2004.06.013	43	117	120	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 16	2006	49	6					889	904		10.1016/j.neuron.2006.02.019	http://dx.doi.org/10.1016/j.neuron.2006.02.019			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	024WQ	16543136	Bronze			2022-12-28	WOS:000236227500016
J	Kumaran, D; Maguire, EA				Kumaran, D; Maguire, EA			The dynamics of hippocampal activation during encoding of overlapping sequences	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; AMNESIC PATIENTS; EPISODIC MEMORY; EVENTS; CORTEX; ORDER; REPRESENTATIONS; DISAMBIGUATION; RECOGNITION; ASSOCIATOR	Sequence disambiguation, the process by which overlapping sequences are kept separate, has been proposed to underlie a wide range of memory capacities supported by the hippocampus, including episodic memory and spatial navigation. We used functional magnetic resonance imaging (fMRI) to explore the dynamic pattern of hippocampal activation during the encoding of sequences of faces. Activation in right posterior hippocampus, only during the encoding of overlapping sequences but not nonoverlapping sequences, was found to correlate robustly with a subject-specific behavioral index of sequence learning. Moreover, our data indicate that hippocampal activation in response to elements common to both sequences in the overlapping sequence pair, may be particularly important for accurate sequence encoding and retrieval. Together, these findings support the conclusion that the human hippocampus is involved in the earliest stage of sequence disambiguation, when memory representations are in the process of being created, and provide empirical support for contemporary computational models of hippocampal function.	UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England	University of London; University College London	Kumaran, D (corresponding author), UCL, Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Square, London WC1N 3BG, England.	d.kumaran@fil.ion.ucl.ac.uk			Wellcome Trust [071173] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Agster KL, 2002, J NEUROSCI, V22, P5760; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Curran T, 1997, J COGNITIVE NEUROSCI, V9, P522, DOI 10.1162/jocn.1997.9.4.522; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Fletcher PC, 2005, CEREB CORTEX, V15, P1002, DOI 10.1093/cercor/bhh201; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Golby AJ, 2001, BRAIN, V124, P1841, DOI 10.1093/brain/124.9.1841; GRAFTON ST, 1995, J COGNITIVE NEUROSCI, V7, P497, DOI 10.1162/jocn.1995.7.4.497; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hazeltine E, 1997, BRAIN, V120, P123, DOI 10.1093/brain/120.1.123; Holdstock JS, 2005, HIPPOCAMPUS, V15, P203, DOI 10.1002/hipo.20046; Hopkins RO, 2004, NEUROPSYCHOLOGIA, V42, P1877, DOI 10.1016/j.neuropsychologia.2004.05.008; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KESNER RP, 1982, SCIENCE, V218, P173, DOI 10.1126/science.7123228; Kesner RP, 2002, BEHAV NEUROSCI, V116, P286, DOI 10.1037//0735-7044.116.2.286; Kumaran D, 2005, J NEUROSCI, V25, P7254, DOI 10.1523/JNEUROSCI.1103-05.2005; Levy WB, 2005, BIOL CYBERN, V92, P409, DOI 10.1007/s00422-005-0568-9; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Maguire EA, 2003, NAT NEUROSCI, V6, P90, DOI 10.1038/nn988; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; RAWLINS JNP, 1985, BEHAV BRAIN SCI, V8, P479, DOI 10.1017/S0140525X00001291; Schendan HE, 2003, NEURON, V37, P1013, DOI 10.1016/S0896-6273(03)00123-5; SHIMAMURA AP, 1990, NEUROPSYCHOLOGIA, V28, P803, DOI 10.1016/0028-3932(90)90004-8; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; Small SA, 2001, NAT NEUROSCI, V4, P442, DOI 10.1038/86115; Sohal VS, 1998, HIPPOCAMPUS, V8, P171, DOI 10.1002/(SICI)1098-1063(1998)8:2<171::AID-HIPO9>3.0.CO;2-O; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Strange BA, 2005, NEUROIMAGE, V25, P51, DOI 10.1016/j.neuroimage.2004.12.014; Strange BA, 1999, P NATL ACAD SCI USA, V96, P4034, DOI 10.1073/pnas.96.7.4034; Treves A, 2004, HIPPOCAMPUS, V14, P539, DOI 10.1002/hipo.10187; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Willingham DB, 2002, J NEUROPHYSIOL, V88, P1451, DOI 10.1152/jn.2002.88.3.1451; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775	46	88	89	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 16	2006	49	4					617	629		10.1016/j.neuron.2005.12.024	http://dx.doi.org/10.1016/j.neuron.2005.12.024			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476669	Bronze			2022-12-28	WOS:000235643800013
J	Carandini, M				Carandini, Matteo			Melting the iceberg: Contrast invariance in visual cortex	NEURON			English	Editorial Material							SIMPLE CELLS; ORIENTATION SELECTIVITY; INPUT; INHIBITION; RESPONSES	Neurons in visual cortex maintain their selectivity for stimulus orientation despite wide variations in stimulus contrast. Achieving this invariance is a challenge because of the iceberg effect: subthreshold responses are broader in selectivity than firing responses, and increasing contrast would bring them above threshold. An article in this issue of Neuron by Finn et al. explains how neurons solve this problem using simple mechanisms: contrast-gain control, additive noise, and firing threshold.	Smith Kettlewell Eye Res Inst, San Francisco, CA 94115 USA	The Smith-Kettlewell Eye Research Institute	Carandini, M (corresponding author), Smith Kettlewell Eye Res Inst, 2232 Webster St, San Francisco, CA 94115 USA.	matteo@ski.org	Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682				Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Carandini M, 2004, PLOS BIOL, V2, P1483, DOI 10.1371/journal.pbio.0020264; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Carandini M, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P313; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; Finn IM, 2007, NEURON, V54, P137, DOI 10.1016/j.neuron.2007.02.029; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Lauritzen TZ, 2003, J NEUROSCI, V23, P10201; ROSE D, 1974, NATURE, V249, P375, DOI 10.1038/249375a0; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Troyer TW, 2002, J NEUROPHYSIOL, V87, P2741, DOI 10.1152/jn.2002.87.6.2741; Troyer TW, 1998, J NEUROSCI, V18, P5908	16	19	19	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					11	13		10.1016/j.neuron.2007.03.019	http://dx.doi.org/10.1016/j.neuron.2007.03.019			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408573	Bronze			2022-12-28	WOS:000245848400005
J	Davis, RL				Davis, Ronald L.			The scent of Drosophila sex	NEURON			English	Editorial Material							PHEROMONE; ORGANIZATION; RESPONSES; NEURONS; BRAIN	Three recent studies report on the olfactory mechanisms used for gender identification in Drosophila and on the olfactory receptors stimulated by the pheromone 11-cis-vaccenyl acetate. This pheromone activates specific olfactory receptors that suppress the courtship of males with other males, promote the sexual receptivity of females, and participate in the formation of memories about prior courtship experiences.	Baylor Coll Med, Dept Mol & Cellular Biol, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA	Baylor College of Medicine	Davis, RL (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Menninger Dept Psychiat & Behav Sci, Houston, TX 77030 USA.	rdavis@bcm.tmc.edu	Davis, Ronald/J-4998-2013	Davis, Ronald/0000-0002-5986-7608				Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ejima A, 2005, CURR BIOL, V15, P194, DOI 10.1016/j.cub.2005.01.035; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; Kondoh Y, 2003, P ROY SOC B-BIOL SCI, V270, P1005, DOI 10.1098/rspb.2003.2331; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031	11	5	5	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					14	16		10.1016/j.neuron.2007.03.012	http://dx.doi.org/10.1016/j.neuron.2007.03.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408574	Bronze			2022-12-28	WOS:000245848400006
J	Olsen, SR; Bhandawat, V; Wilson, RI				Olsen, Shawn R.; Bhandawat, Vikas; Wilson, Rachel I.			Excitatory interactions between olfactory processing channels in the Drosophila antennal lobe	NEURON			English	Article							PRESYNAPTIC INHIBITION; PERIPLANETA-AMERICANA; BULB GLOMERULI; NEURONS; SYSTEM; MELANOGASTER; MECHANISMS; GABA; FLY; REPRESENTATIONS	Each odorant receptor gene defines a unique type of olfactory receptor neuron (ORN) and a corresponding type of second-order neuron. Because each odor can activate multiple ORN types, information must ultimately be integrated across these processing channels to form a unified percept. Here, we show that, in Drosophila, integration begins at the level of second-order projection neurons (PNs). We genetically silence all the ORNs that normally express a particular odorant receptor and find that PNs postsynaptic to the silent glomerulus receive substantial lateral excitatory input from other glomeruli. Genetically confining odor-evoked ORN input to just one glomerulus reveals that most PNs postsynaptic to other glomeruli receive indirect excitatory input from the single ORN type that is active. Lateral connections between identified glomeruli vary in strength, and this pattern of connections is stereotyped across flies. Thus, a dense network of lateral connections distributes odor-evoked excitation between channels in the first brain region of the olfactory processing stream.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Wilson, RI (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	rachel_wilson@hms.harvard.edu	Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266; Olsen, Shawn/0000-0002-9568-7057	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008174] Funding Source: NIH RePORTER; NIDCD NIH HHS [1R01DC008174-01, R01 DC008174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Aungst JL, 2003, NATURE, V426, P623, DOI 10.1038/nature02185; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Berdnik D, 2006, J NEUROSCI, V26, P3367, DOI 10.1523/JNEUROSCI.4941-05.2006; BUCK LB, 1996, NEUROSCIENCE, V19, P517; Christensen TA, 1998, J NEUROSCI, V18, P5999; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dobritsa AA, 2003, NEURON, V37, P827, DOI 10.1016/S0896-6273(03)00094-1; Elmore T, 2003, J NEUROSCI, V23, P9906; Ennis M, 2001, J NEUROPHYSIOL, V86, P2986, DOI 10.1152/jn.2001.86.6.2986; ERNST KD, 1983, CELL TISSUE RES, V229, P1, DOI 10.1007/BF00217877; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Goldman AL, 2005, NEURON, V45, P661, DOI 10.1016/j.neuron.2005.01.025; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; HOSKINS SG, 1986, CELL TISSUE RES, V244, P243; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Laissue PP, 1999, J COMP NEUROL, V405, P543; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laurent G, 2002, NAT REV NEUROSCI, V3, P884, DOI 10.1038/nrn964; Leitch B, 1996, J COMP NEUROL, V372, P487; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MALUN D, 1991, HISTOCHEMISTRY, V96, P197, DOI 10.1007/BF00271538; McGann JP, 2005, NEURON, V48, P1039, DOI 10.1016/j.neuron.2005.10.031; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Murphy GJ, 2005, NAT NEUROSCI, V8, P354, DOI 10.1038/nn1403; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Python F, 2002, J COMP NEUROL, V453, P157, DOI 10.1002/cne.10383; Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Urban NN, 2002, J PHYSIOL-LONDON, V542, P355, DOI 10.1113/jphysiol.2001.013491; Wachowiak M, 2005, J NEUROPHYSIOL, V94, P2700, DOI 10.1152/jn.00286.2005; Wachowiak M, 2002, MICROSC RES TECHNIQ, V58, P365, DOI 10.1002/jemt.10144; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005; Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	42	198	202	1	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 5	2007	54	1					89	103		10.1016/j.neuron.2007.03.010	http://dx.doi.org/10.1016/j.neuron.2007.03.010			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408580	Green Accepted, Bronze			2022-12-28	WOS:000245848400012
J	Steuber, V; Mittmann, W; Hoebeek, FE; Silver, RA; De Zeeuw, CI; Hausser, M; De Schutter, E				Steuber, Volker; Mittmann, Wolfgang; Hoebeek, Freek E.; Silver, R. Angus; De Zeeuw, Chris I.; Hausser, Michael; De Schutter, Erik			Cerebellar LTD and pattern recognition by Purkinje cells	NEURON			English	Article							LONG-TERM DEPRESSION; ACTIVE MEMBRANE MODEL; KINASE-C INHIBITOR; PARALLEL FIBER LTD; BIDIRECTIONAL PLASTICITY; SYNAPTIC CURRENTS; GRANULE CELL; SIMPLE SPIKE; RAT; NEURONS	Many theories of cerebellar function assume that long-term depression (LTD) of parallel fiber (PF) synapses enables Purkinje cells to learn to recognize PF activity patterns. We have studied the LTD-based recognition of PF patterns in a biophysically realistic Purkinje-cell model. With simple-spike firing as observed in vivo, the presentation of a pattern resulted in a burst of spikes followed by a pause. Surprisingly, the best criterion to distinguish learned patterns was the duration of this pause. Moreover, our simulations predicted that learned patterns elicited shorter pauses, thus increasing Purkinje-cell output. We tested this prediction in Purkinje-cell recordings both in vitro and in vivo. In vitro, we found a shortening of pauses when decreasing the number of active PFs or after inducing LTD. In vivo, we observed longer pauses in LTD-deficient mice. Our results suggest a novel form of neural coding in the cerebellar cortex.	Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium; UCL, Dept Physiol, London WC1E 6BT, England; UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; Erasmus MC, Dept Neurosci, NL-3000 DR Rotterdam, Netherlands; Royal Acad Sci, KNAW, NIN, NL-1105 BA Amsterdam, Netherlands; Okinawa Inst Sci & Technol, Computat Neurosci Unit, Okinawa 9040411, Japan	University of Antwerp; University of London; University College London; University of London; University College London; Erasmus University Rotterdam; Erasmus MC; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); Okinawa Institute of Science & Technology Graduate University	Steuber, V (corresponding author), Univ Antwerp, Lab Theoret Neurobiol, B-2610 Antwerp, Belgium.	v.steuber@herts.ca.uk	Hausser, Michael/AAW-6827-2020; De Schutter, Erik/G-8460-2011	Hausser, Michael/0000-0002-2673-8957; De Schutter, Erik/0000-0001-8618-5138; Steuber, Volker/0000-0003-0186-3580; Silver, Robin/0000-0002-5480-6638	MRC [G0400598] Funding Source: UKRI; Medical Research Council [G0400598] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aizenman CD, 1999, J NEUROPHYSIOL, V82, P1697, DOI 10.1152/jn.1999.82.4.1697; Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; ARMSTRONG DM, 1979, J PHYSIOL-LONDON, V289, P425, DOI 10.1113/jphysiol.1979.sp012745; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BOWER JM, 1983, J NEUROPHYSIOL, V49, P745, DOI 10.1152/jn.1983.49.3.745; Bower JM, 1998, BOOK GENESIS EXPLORI; Boyden ES, 2006, NEURON, V51, P823, DOI 10.1016/j.neuron.2006.08.026; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/S0896-6273(04)00528-8; Cingolani LA, 2002, J NEUROSCI, V22, P4456, DOI 10.1523/JNEUROSCI.22-11-04456.2002; Cohen D, 2000, J NEUROPHYSIOL, V83, P1932, DOI 10.1152/jn.2000.83.4.1932; Czubayko U, 2001, J NEUROPHYSIOL, V85, P2017, DOI 10.1152/jn.2001.85.5.2017; DAYAN P, 1991, BIOL CYBERN, V65, P253, DOI 10.1007/BF00206223; De Zeeuw CI, 1998, NEURON, V20, P495, DOI 10.1016/S0896-6273(00)80990-3; DESCHUTTER E, 1994, P NATL ACAD SCI USA, V91, P4736, DOI 10.1073/pnas.91.11.4736; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P401, DOI 10.1152/jn.1994.71.1.401; DESCHUTTER E, 1994, J NEUROPHYSIOL, V71, P375, DOI 10.1152/jn.1994.71.1.375; Eccles J.C., 1967, CEREBELLUM NEURONAL, DOI [10.1016/0013-4694(69)90099-6, DOI 10.1016/0013-4694(69)90099-6]; EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0; Etzion Y, 1998, EXP BRAIN RES, V122, P283, DOI 10.1007/s002210050516; FOX EA, 1993, NEUROSCI LETT, V149, P103, DOI 10.1016/0304-3940(93)90358-R; GARDETTE R, 1985, DEV BRAIN RES, V19, P47, DOI 10.1016/0165-3806(85)90230-5; GILBERT PFC, 1974, BRAIN RES, V70, P1, DOI 10.1016/0006-8993(74)90208-X; Goossens HHLM, 2004, EUR J NEUROSCI, V19, P687, DOI 10.1111/j.0953-816X.2003.03173.x; Goossens J, 2001, J NEUROSCI, V21, P5813, DOI 10.1523/JNEUROSCI.21-15-05813.2001; Graham BP, 2001, NETWORK-COMP NEURAL, V12, P473, DOI 10.1088/0954-898X/12/4/304; HAMANN M, 1988, BRAIN RES, V442, P287, DOI 10.1016/0006-8993(88)91514-4; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HARVEY RJ, 1991, PROG NEUROBIOL, V36, P437, DOI 10.1016/0301-0082(91)90012-P; Hausser M, 1997, NEURON, V19, P665, DOI 10.1016/S0896-6273(00)80379-7; Isope P, 2002, J NEUROSCI, V22, P9668; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Ito M, 1984, CEREBELLUM NEURAL CO; ITO M, 1982, J PHYSL, V324, P133; Jaeger D, 1997, J NEUROSCI, V17, P91, DOI 10.1523/JNEUROSCI.17-01-00091.1997; JAHNSEN H, 1986, J PHYSIOL-LONDON, V372, P129, DOI 10.1113/jphysiol.1986.sp016001; Jorntell H, 2003, J NEUROSCI, V23, P9620; Jorntell H, 2002, NEURON, V34, P797, DOI 10.1016/S0896-6273(02)00713-4; Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032; Kahlon M, 2000, J NEUROPHYSIOL, V84, P2945, DOI 10.1152/jn.2000.84.6.2945; Koekkoek SKE, 2005, NEURON, V47, P339, DOI 10.1016/j.neuron.2005.07.005; Koekkoek SKE, 2003, SCIENCE, V301, P1736, DOI 10.1126/science.1088383; Kreitzer AC, 2000, J NEUROSCI, V20, P1348; Lev-Ram V, 2003, P NATL ACAD SCI USA, V100, P15989, DOI 10.1073/pnas.2636935100; LLINAS R, 1988, J PHYSIOL-LONDON, V404, P241, DOI 10.1113/jphysiol.1988.sp017288; Loewenstein Y, 2005, NAT NEUROSCI, V8, P202, DOI 10.1038/nn1393; Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; Medina JF, 2000, J NEUROSCI, V20, P5516, DOI 10.1523/JNEUROSCI.20-14-05516.2000; Mittmann W, 2005, J PHYSIOL-LONDON, V563, P369, DOI 10.1113/jphysiol.2004.075028; Monsivais P, 2005, J NEUROSCI, V25, P464, DOI 10.1523/JNEUROSCI.3871-04.2005; MOUGINOT D, 1995, NEUROSCIENCE, V64, P699, DOI 10.1016/0306-4522(94)00456-F; MURI R, 1994, J NEUROPHYSIOL, V71, P420, DOI 10.1152/jn.1994.71.1.420; MURPHY JT, 1970, BRAIN RES, V17, P515, DOI 10.1016/0006-8993(70)90259-3; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Ohyama T, 2003, TRENDS NEUROSCI, V26, P222, DOI 10.1016/S0166-2236(03)00054-7; Poirazi P, 2001, NEURON, V29, P779, DOI 10.1016/S0896-6273(01)00252-5; Rancillac A, 2004, J PHYSIOL-LONDON, V554, P707, DOI 10.1113/jphysiol.2003.055871; SAKURAI M, 1987, J PHYSIOL-LONDON, V394, P463, DOI 10.1113/jphysiol.1987.sp016881; Schonewille M, 2006, NAT NEUROSCI, V9, P459, DOI 10.1038/nn0406-459; Schweighofer N, 2000, P NATL ACAD SCI USA, V97, P10661, DOI 10.1073/pnas.97.19.10661; Shin SL, 2007, EUR J NEUROSCI, V25, P785, DOI 10.1111/j.1460-9568.2007.05308.x; Shin SL, 2006, J NEUROPHYSIOL, V96, P3485, DOI 10.1152/jn.00570.2006; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005; Smith SL, 2005, P NATL ACAD SCI USA, V102, P14901, DOI 10.1073/pnas.0505028102; Solinas SMG, 2006, EUR J NEUROSCI, V23, P1207, DOI 10.1111/j.1460-9568.2005.04564.x; Steuber V, 2001, NEUROCOMPUTING, V38, P383, DOI 10.1016/S0925-2312(01)00458-1; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949; Sultan F, 1998, J COMP NEUROL, V393, P353; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Wall MJ, 1998, NAT NEUROSCI, V1, P675, DOI 10.1038/3677; Walter JT, 2006, J NEUROSCI, V26, P12861, DOI 10.1523/JNEUROSCI.4507-05.2006; Walter JT, 2006, NAT NEUROSCI, V9, P389, DOI 10.1038/nn1648; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Womack MD, 2003, J NEUROSCI, V23, P2600; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8	81	115	118	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 5	2007	54	1					121	136		10.1016/j.neuron.2007.03.015	http://dx.doi.org/10.1016/j.neuron.2007.03.015			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	159EO	17408582	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000245848400014
J	Fry, EJ; Ho, C; David, S				Fry, Elizabeth J.; Ho, Carole; David, Samuel			A role for Nogo receptor in macrophage clearance from injured peripheral nerve	NEURON			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; NECROSIS-FACTOR-ALPHA; WALLERIAN DEGENERATION; AXONAL REGENERATION; NEURITE OUTGROWTH; SCIATIC-NERVE; FAMILY-MEMBER; SPINAL-CORD; IN-VIVO; RHO	We report a role for Nogo receptors (NgRs) in macrophage efflux from sites of inflammation in peripheral nerve. Increasing numbers of macrophages in crushed rat sciatic nerves express NgR1 and NgR2 on the cell surface in the first week after injury. These macrophages show reduced binding to myelin and MAG in vitro, which is reversed by NgR siRNA knockdown and by inhibiting Rho-associated kinase. Fourteen days after sciatic nerve crush, regenerating nerves with newly synthesized myelin have fewer macrophages than cut/ligated nerves that lack axons and myelin. Almost all macrophages in the cut/ligated nerves lie within the Schwann cell basal lamina, while in the crushed regenerating nerves the majority migrate out. Furthermore, crush-injured nerves of NgR1 and MAG-deficient mice and Y-27632-treated rats show impaired macrophage efflux from Schwann cell basal lamina containing myelinated axons. These data have implications for the resolution of inflammation in peripheral nerve and CNS pathologies.	McGill Univ, Ctr Hlth, Neurosci Res Ctr, Montreal, PQ, Canada; Stanford Univ, Med Ctr, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; Genentech Inc, Div Res, San Francisco, CA 94080 USA	McGill University; Stanford University; Roche Holding; Genentech	David, S (corresponding author), McGill Univ, Ctr Hlth, Neurosci Res Ctr, 1650 Cedar Ave, Montreal, PQ, Canada.	sam.david@mcgill.ca			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048058] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 048058] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aepfelbacher M, 1996, J IMMUNOL, V157, P5070; Bendszus M, 2003, J NEUROSCI, V23, P10892; BRAY GM, 1972, BRAIN RES, V42, P297, DOI 10.1016/0006-8993(72)90532-X; Bruck W, 1997, BRAIN PATHOL, V7, P741, DOI 10.1111/j.1750-3639.1997.tb01060.x; Coleman MP, 2002, TRENDS NEUROSCI, V25, P532, DOI 10.1016/S0166-2236(02)02255-5; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Feroze-Merzoug F, 2002, BIOTECHNIQUES, V32, P776, DOI 10.2144/02324st03; Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195; Fournier AE, 2001, CURR OPIN NEUROBIOL, V11, P89, DOI 10.1016/S0959-4388(00)00178-1; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; George A, 2004, EXP NEUROL, V188, P187, DOI 10.1016/j.expneurol.2004.02.011; GEORGE EB, 1995, J NEUROSCI, V15, P6445; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6; Huang JK, 2005, SCIENCE, V310, P1813, DOI 10.1126/science.1118313; Jeong SY, 2003, J BIOL CHEM, V278, P27144, DOI 10.1074/jbc.M301988200; Kiefer R, 2001, PROG NEUROBIOL, V64, P109, DOI 10.1016/S0301-0082(00)00060-5; Kuhlmann T, 1999, NEUROSCI LETT, V275, P191, DOI 10.1016/S0304-3940(99)00782-X; Kuhlmann T, 2001, J NEUROSCI, V21, P3401, DOI 10.1523/JNEUROSCI.21-10-03401.2001; LEBLANC AC, 1990, J NEUROSCI RES, V26, P317, DOI 10.1002/jnr.490260308; Leskovar A, 2000, J EXP BIOL, V203, P1783; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Liao H, 2004, J NEUROCHEM, V90, P1156, DOI 10.1111/j.1471-4159.2004.02573.x; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; McKerracher L, 2004, NAT MED, V10, P1052, DOI 10.1038/nm1004-1052; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Melendez-Vasquez CV, 2004, J NEUROSCI, V24, P3953, DOI 10.1523/JNEUROSCI.4920-03.2004; Mueller M, 2003, LAB INVEST, V83, P175, DOI 10.1097/01.LAB.0000056993.28149.BF; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Perrin FE, 2005, BRAIN, V128, P854, DOI 10.1093/brain/awh407; PERRY VH, 1987, J EXP MED, V165, P1218, DOI 10.1084/jem.165.4.1218; Pomorski P, 2004, CELL MOTIL CYTOSKEL, V57, P143, DOI 10.1002/cm.10159; PRINEAS JW, 1976, J NEUROL SCI, V27, P427, DOI 10.1016/0022-510X(76)90213-6; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; ROTSHENKER S, 1992, J NEUROIMMUNOL, V39, P75, DOI 10.1016/0165-5728(92)90176-L; ROTSHENKER S, 2001, GLIAL INTERFACES NER, P3; Saada A, 1996, J CELL BIOL, V133, P159, DOI 10.1083/jcb.133.1.159; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Shamash S, 2002, J NEUROSCI, V22, P3052, DOI 10.1523/JNEUROSCI.22-08-03052.2002; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Siebert H, 2000, J NEUROIMMUNOL, V110, P177, DOI 10.1016/S0165-5728(00)00343-X; Siebert H, 2003, BRAIN RES, V960, P152, DOI 10.1016/S0006-8993(02)03806-4; Siebert H, 2001, J NEUROPATH EXP NEUR, V60, P85, DOI 10.1093/jnen/60.1.85; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; STOLL G, 1993, J NEUROIMMUNOL, V45, P175, DOI 10.1016/0165-5728(93)90178-2; Stoll G, 1999, PROG NEUROBIOL, V58, P233, DOI 10.1016/S0301-0082(98)00083-5; Trigueros SDA, 2003, MOL CELL NEUROSCI, V24, P753, DOI 10.1016/S1044-7431(03)00241-0; Venkatesh K, 2005, J NEUROSCI, V25, P808, DOI 10.1523/JNEUROSCI.4464-04.2005; Winton MJ, 2002, J BIOL CHEM, V277, P32820, DOI 10.1074/jbc.M201195200; Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yamauchi J, 2004, P NATL ACAD SCI USA, V101, P8774, DOI 10.1073/pnas.0402795101; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	55	86	89	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR 1	2007	53	5					649	662		10.1016/j.neuron.2007.02.009	http://dx.doi.org/10.1016/j.neuron.2007.02.009			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329206	Bronze			2022-12-28	WOS:000245127100007
J	Wadel, K; Neher, E; Sakaba, T				Wadel, Kristian; Neher, Erwin; Sakaba, Takeshi			The coupling between synaptic vesicles and Ca2+ channels determines fast neurotransmitter release	NEURON			English	Article							SHORT-TERM PLASTICITY; TRANSMITTER RELEASE; CLIMBING FIBER; CALCIUM-DEPENDENCE; PRINCIPAL NEURON; CALYX; POOL; MODULATION; DEPRESSION; TRANSMISSION	In order to release neurotransmitter synchronously in response to a presynaptic action potential, synaptic vesicles must be both release competent and located close to presynaptic Ca2+ channels. It has not been shown, however, which of the two is the more decisive factor. We tested this issue at the calyx of Held synapse by combining Ca2+ uncaging and electrophysiological measurements of postsynaptic responses. After depletion of the synaptic vesicles that are responsible for synchronous release during action potentials, uniform elevation of intracellular Ca2+ by Ca2+ uncaging could still elicit rapid release. The Ca2+ sensitivity of remaining vesicles was reduced no more than 2-fold, which is insufficient to explain the slow-down of the kinetics of release (10-fold) observed during a depolarizing pulse. We conclude that recruitment of synaptic vesicles to sites where Ca2+ channels cluster, rather than fusion competence, is a limiting step for rapid neurotransmitter release in response to presynaptic action potentials.	Max Planck Inst Biophys Chem, Res Grp Biophys Synapt Transmiss, D-37077 Gottingen, Germany; Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Sakaba, T (corresponding author), Max Planck Inst Biophys Chem, Res Grp Biophys Synapt Transmiss, D-37077 Gottingen, Germany.	tsakaba@gwdg.de	Neher, Erwin/A-2109-2013; Oka, Yoshitaka/C-9670-2010	Oka, Yoshitaka/0000-0002-3482-3051; Sakaba, Takeshi/0000-0003-0688-7717				ADLER EM, 1991, J NEUROSCI, V11, P1496; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Bollmann JH, 2005, NAT NEUROSCI, V8, P426, DOI 10.1038/nn1417; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; CALAKOS N, 1994, J BIOL CHEM, V269, P24534; Cao YQ, 2004, NEURON, V43, P387, DOI 10.1016/j.neuron.2004.07.014; CORNILLE F, 1995, J BIOL CHEM, V270, P16826, DOI 10.1074/jbc.270.28.16826; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; Escobar AL, 1997, PFLUG ARCH EUR J PHY, V434, P615, DOI 10.1007/s004240050444; Fedchyshyn MJ, 2005, J NEUROSCI, V25, P4131, DOI 10.1523/JNEUROSCI.0350-05.2005; Felmy F, 2004, EUR J NEUROSCI, V20, P1473, DOI 10.1111/j.1460-9568.2004.03604.x; Foster KA, 2004, NEURON, V43, P119, DOI 10.1016/j.neuron.2004.06.022; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hallermann S, 2003, P NATL ACAD SCI USA, V100, P8975, DOI 10.1073/pnas.1432836100; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Hsu SF, 1996, NEURON, V17, P501, DOI 10.1016/S0896-6273(00)80182-8; Ishikawa T, 2002, NEURON, V34, P613, DOI 10.1016/S0896-6273(02)00692-X; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Katz B., 1969, RELEASE NEURAL TRANS; Kittel RJ, 2006, SCIENCE, V312, P1051, DOI 10.1126/science.1126308; Koike-Tani M, 2005, J NEUROSCI, V25, P199, DOI 10.1523/JNEUROSCI.3861-04.2005; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Lou XL, 2005, NATURE, V435, P497, DOI 10.1038/nature03568; Lu T, 2000, NEURON, V26, P683, DOI 10.1016/S0896-6273(00)81204-0; McMahon HT, 1996, P NATL ACAD SCI USA, V93, P4760, DOI 10.1073/pnas.93.10.4760; Meinrenken CJ, 2002, J NEUROSCI, V22, P1648, DOI 10.1523/JNEUROSCI.22-05-01648.2002; Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Moulder KL, 2005, J NEUROSCI, V25, P3842, DOI 10.1523/JNEUROSCI.5231-04.2005; Neher E, 2001, J NEUROSCI, V21, P9638, DOI 10.1523/JNEUROSCI.21-24-09638.2001; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Rettig J, 1997, J NEUROSCI, V17, P6647; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2005, SCIENCE, V309, P491, DOI 10.1126/science.1112645; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Satzler K, 2002, J NEUROSCI, V22, P10567; Scheuss V, 2002, J NEUROSCI, V22, P728, DOI 10.1523/JNEUROSCI.22-03-00728.2002; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R., 2005, IMAGING NEUROSCIENCE, P415; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; von Gersdorff H, 2002, NAT REV NEUROSCI, V3, P53, DOI 10.1038/nrn705; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu-Friedman MA, 2000, J NEUROSCI, V20, P4414, DOI 10.1523/JNEUROSCI.20-12-04414.2000; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	63	176	179	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 15	2007	53	4					563	575		10.1016/j.neuron.2007.01.021	http://dx.doi.org/10.1016/j.neuron.2007.01.021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296557	Bronze, Green Submitted			2022-12-28	WOS:000245126900014
J	Bhatt, DH; McLean, DL; Hale, ME; Fetcho, JR				Bhatt, Dimple H.; McLean, David L.; Hale, Melina E.; Fetcho, Joseph R.			Grading movement strength by changes in firing intensity versus recruitment of spinal interneurons	NEURON			English	Article							LARVAL ZEBRAFISH; MOTOR PATTERNS; RETICULOSPINAL NEURONS; LOCOMOTOR NETWORK; XENOPUS-EMBRYOS; LAMPREY; ESCAPE; MOTONEURONS; CORD; CELL	Animals can produce movements of widely varying speed and strength by changing the recruitment of motoneurons according to the well-known size principle. Much less is known about patterns of recruitment in the spinal interneurons that control motoneurons because of the difficulties of monitoring activity simultaneously in multiple interneurons of an identified class. Here we use electrophysiology in combination with in vivo calcium imaging of groups of identified excitatory spinal interneurons in larval zebrafish to explore how they are recruited during different forms of the escape response that fish use to avoid predators. Our evidence indicates that escape movements are graded largely by differences in the level of activity within an active pool of interneurons rather than by the recruitment of an inactive subset.	Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Chicago	Fetcho, JR (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA.	jrf49@cornell.edu	; McLean, Dianne/H-2449-2012	Bhatt, D/0000-0002-7646-0981; McLean, Dianne/0000-0002-0306-8348	NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NINDS NIH HHS [NS 26539, R01 NS026539, NS043977,, R01 NS026539-25] Funding Source: Medline; PHS HHS [NRSA 44728] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS026539, R01NS026539, R29NS026539, R01NS043977] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Berkowitz A, 2006, J NEUROPHYSIOL, V95, P2821, DOI 10.1152/jn.01246.2005; BERKOWITZ A, 1994, J NEUROSCI, V14, P5089; Bhatt DH, 2004, SCIENCE, V305, P254, DOI 10.1126/science.1098439; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P948, DOI 10.1152/jn.1982.47.5.948; Cangiano L, 2005, J NEUROSCI, V25, P923, DOI 10.1523/JNEUROSCI.2301-04.2005; Cope TC, 1999, J PHYSIOL-PARIS, V93, P81, DOI 10.1016/S0928-4257(99)80138-7; Deliagina TG, 2000, J NEUROPHYSIOL, V83, P853, DOI 10.1152/jn.2000.83.2.853; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; EATON RC, 1991, J EXP BIOL, V161, P469; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FETCHO JR, 1992, J NEUROPHYSIOL, V67, P1574, DOI 10.1152/jn.1992.67.6.1574; FETCHO JR, 1995, J NEUROPHYSIOL, V73, P399, DOI 10.1152/jn.1995.73.1.399; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Green CS, 1996, J COMP PHYSIOL A, V178, P279; Hale ME, 2004, J NEUROSCI, V24, P3070, DOI 10.1523/JNEUROSCI.5624-03.2004; Hale ME, 2001, J COMP NEUROL, V437, P1, DOI 10.1002/cne.1266; HENNEMAN E, 1957, SCIENCE, V126, P1345, DOI 10.1126/science.126.3287.1345; Higashijima S, 2004, J COMP NEUROL, V480, P19, DOI 10.1002/cne.20279; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; Higashijima S, 2004, J NEUROSCI, V24, P5827, DOI 10.1523/JNEUROSCI.5342-03.2004; Kimura Y, 2006, J NEUROSCI, V26, P5684, DOI 10.1523/JNEUROSCI.4993-05.2006; KOCH M, 1992, NEUROSCIENCE, V49, P617, DOI 10.1016/0306-4522(92)90231-P; Li WC, 2004, J NEUROSCI, V24, P5840, DOI 10.1523/JNEUROSCI.1633-04.2004; LIU DW, 1988, J PHYSIOL-LONDON, V403, P73, DOI 10.1113/jphysiol.1988.sp017239; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Ritter DA, 2001, J NEUROSCI, V21, P8956, DOI 10.1523/JNEUROSCI.21-22-08956.2001; Saint-Amant L, 2001, NEURON, V31, P1035, DOI 10.1016/S0896-6273(01)00416-0; SILLAR KT, 1993, J PHYSIOL-LONDON, V472, P557, DOI 10.1113/jphysiol.1993.sp019962; SOFFE SR, 1993, J NEUROSCI, V13, P4456; Zelenin PV, 2003, J NEUROPHYSIOL, V90, P3161, DOI 10.1152/jn.00555.2003	32	68	68	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 4	2007	53	1					91	102		10.1016/j.neuron.2006.11.011	http://dx.doi.org/10.1016/j.neuron.2006.11.011			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DF	17196533	Bronze			2022-12-28	WOS:000245126500011
J	Macleod, GT; Zinsmaier, KE				Macleod, Gregory T.; Zinsmaier, Konrad E.			Synaptic homeostasis on the fast track	NEURON			English	Editorial Material							PRESYNAPTIC TRANSMITTER RELEASE; GLUTAMATE RECEPTORS; RETROGRADE SIGNAL; DROSOPHILA; NEURONS; INACTIVITY; REVEALS	Synaptic homeostasis is a phenomenon that prevents the nervous system from descending into chaos. In this issue of Neuron, Frank et al. overturn the notion that synaptic homeostasis at Drosophila NMJs is a slow developmental process. They report that postsynaptic changes are offset within minutes by a homeostatic increase in neurotransmitter release that requires the presynaptic Ca2+ channel Cacophony.	Univ Texas, Hlth Sci Ctr, Dept Physiol, San Antonio, TX 78229 USA; Univ Arizona, Arizona Res Labs, Div Neurobiol, Tucson, AZ 85721 USA	University of Texas System; University of Texas Health San Antonio; University of Arizona	Macleod, GT (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Physiol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.			Macleod, Gregory/0000-0003-3782-6968				Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Frank CA, 2006, NEURON, V52, P663, DOI 10.1016/j.neuron.2006.09.029; Haghighi AP, 2003, NEURON, V39, P255, DOI 10.1016/S0896-6273(03)00427-6; Marques G, 2005, J NEUROBIOL, V64, P417, DOI 10.1002/neu.20165; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wildemann B, 1999, J NEUROBIOL, V39, P337, DOI 10.1002/(SICI)1097-4695(19990605)39:3<337::AID-NEU1>3.0.CO;2-9	13	8	8	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 22	2006	52	4					569	571		10.1016/j.neuron.2006.11.006	http://dx.doi.org/10.1016/j.neuron.2006.11.006			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114040	Bronze			2022-12-28	WOS:000242413100003
J	Wintermantel, TM; Campbell, RE; Porteous, R; Bock, D; Grone, HJ; Todman, MG; Korach, KS; Greiner, E; Perez, CA; Schutz, G; Herbison, AE				Wintermantel, Tim M.; Campbell, Rebecca E.; Porteous, Robert; Bock, Dagmar; Groene, Hermann-Josef; Todman, Martin G.; Korach, Kenneth S.; Greiner, Erich; Perez, Cristian A.; Schuetz, Guenther; Herbison, Allan E.			Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; LUTEINIZING-HORMONE; PREOPTIC AREA; RAT-BRAIN; PSEUDORABIES VIRUS; NERVOUS-SYSTEM; LHRH NEURONS; FEMALE RAT; SURGE; ALPHA	The mechanisms through which estrogen regulates gonadotropin-releasing hormone (GnRH) neurons to control mammalian ovulation are unknown. We found that estrogen positive feedback to generate the preovulatory gonadotropin surge was normal in estrogen receptor beta knockout (ER beta) mutant mice, but absent in ER alpha mutant mice. An ER alpha-selective compound was sufficient to generate positive feedback in wild-type mice. As GnRH neurons do not express ER alpha, estrogen positive feedback upon GnRH neurons must be indirect in nature. To establish the cell type responsible, we generated a neuron-specific ERa mutant mouse line. These mice failed to exhibit estrogen positive feedback, demonstrating that neurons expressing ER alpha are critical. We then used a GnRH neuron-specific Pseudorabies virus (PRV) tracing approach to show that the ER alpha-expressing neurons innervating GnRH neurons are located within rostral periventricular regions of the hypothalamus. These studies demonstrate that ovulation is driven by estrogen actions upon ER alpha-expressing neuronal afferents to GnRH neurons.	German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Otago, Sch Med Sci, Ctr Neuroendocrinol, Dunedin 9001, New Zealand; Univ Otago, Sch Med Sci, Dept Physiol, Dunedin 9001, New Zealand; NIEHS, Receptor Biol Sect, Reprod & Dev Toxicol Lab, Res Triangle Pk, NC 27709 USA; Rockefeller Univ, Mol Genet Lab, New York, NY 10021 USA	Helmholtz Association; German Cancer Research Center (DKFZ); University of Otago; University of Otago; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Rockefeller University	Schutz, G (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	g.schuetz@dkfz.de; allan.herbison@stonebow.otago.ac.nz	Perez, Cristian A./A-2341-2008; Oka, Yoshitaka/C-9670-2010; Campbell, Rebecca E/F-6430-2010	Oka, Yoshitaka/0000-0002-3482-3051; Campbell, Rebecca E/0000-0002-0309-532X; Korach, Kenneth/0000-0002-7765-418X; Herbison, Allan/0000-0002-9615-3022	Wellcome Trust [063216] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Abraham IM, 2003, J NEUROSCI, V23, P5771; BRONSON FH, 1981, ENDOCRINOLOGY, V108, P506, DOI 10.1210/endo-108-2-506; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CARD JP, 1995, CRIT REV NEUROBIOL, V9, P137; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Couse JF, 1999, ENDOCRINOLOGY, V140, P5855, DOI 10.1210/en.140.12.5855; Couse JF, 1999, ENDOCR REV, V20, P358, DOI 10.1210/er.20.3.358; DELFALCO J, 2001, SCIENCE, V291, P2608; Dupont S, 2000, DEVELOPMENT, V127, P4277; Evans NP, 1997, ENDOCRINOLOGY, V138, P5408, DOI 10.1210/en.138.12.5408; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gu GB, 1997, J COMP NEUROL, V384, P142; Hegele-Hartung C, 2004, P NATL ACAD SCI USA, V101, P5129, DOI 10.1073/pnas.0306720101; Herbison AE, 1998, ENDOCR REV, V19, P302, DOI 10.1210/edrv.19.3.0332; Herbison AE, 2001, FRONT NEUROENDOCRIN, V22, P292, DOI 10.1006/frne.2001.0219; HERBISON AE, 1995, J NEUROENDOCRINOL, V7, P377, DOI 10.1111/j.1365-2826.1995.tb00772.x; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; HOFFMAN GE, 1993, FRONT NEUROENDOCRIN, V14, P173, DOI 10.1006/frne.1993.1006; Horvath S, 2002, EUR J NEUROSCI, V15, P937, DOI 10.1046/j.1460-9568.2002.01923.x; HORVATH TL, 1993, J NEUROENDOCRINOL, V5, P71, DOI 10.1111/j.1365-2826.1993.tb00365.x; Hrabovszky E, 2001, ENDOCRINOLOGY, V142, P3261, DOI 10.1210/en.142.7.3261; Karsch FJ, 1997, BIOL REPROD, V56, P303, DOI 10.1095/biolreprod56.2.303; Le WW, 1999, ENDOCRINOLOGY, V140, P510, DOI 10.1210/en.140.1.510; LEE WS, 1990, P NATL ACAD SCI USA, V87, P5163, DOI 10.1073/pnas.87.13.5163; LEGAN SJ, 1975, ENDOCRINOLOGY, V96, P50, DOI 10.1210/endo-96-1-50; Levine JE, 1997, BIOL REPROD, V56, P293, DOI 10.1095/biolreprod56.2.293; Li C, 1999, BRAIN RES, V824, P267, DOI 10.1016/S0006-8993(99)01217-2; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; OUIMET CC, 1984, P NATL ACAD SCI-BIOL, V81, P5604, DOI 10.1073/pnas.81.17.5604; PETERSEN SL, 1989, BRAIN RES, V484, P279, DOI 10.1016/0006-8993(89)90371-5; Petersen SL, 2003, BIOL REPROD, V69, P1771, DOI 10.1095/biolreprod.103.019745; Prevot V, 2002, J NEUROENDOCRINOL, V14, P247, DOI 10.1046/j.0007-1331.2001.00772.x; Rage F, 1997, J NEUROSCI, V17, P9145; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Shughrue PJ, 1997, ENDOCRINOLOGY, V138, P5476, DOI 10.1210/en.138.12.5476; Shupnik MA, 1996, TRENDS ENDOCRIN MET, V7, P272, DOI 10.1016/S1043-2760(96)00124-5; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Simonian SX, 1999, J COMP NEUROL, V411, P346, DOI 10.1002/(SICI)1096-9861(19990823)411:2<346::AID-CNE13>3.0.CO;2-S; Skinner DC, 2005, J NEUROENDOCRINOL, V17, P29, DOI 10.1111/j.1365-2826.2005.01271.x; Skynner MJ, 1999, ENDOCRINOLOGY, V140, P5195, DOI 10.1210/en.140.11.5195; Skynner MJ, 1999, J NEUROSCI, V19, P5955, DOI 10.1523/JNEUROSCI.19-14-05955.1999; Smith MJ, 2001, REPRODUCTION, V122, P1, DOI 10.1530/rep.0.1220001; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Vente A, 1999, NAT GENET, V22, P22, DOI 10.1038/8734; WIEGAND SJ, 1982, NEUROENDOCRINOLOGY, V34, P395, DOI 10.1159/000123335; XIA L, 1992, ENDOCRINOLOGY, V131, P2812, DOI 10.1210/en.131.6.2812; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	50	430	438	0	33	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 19	2006	52	2					271	280		10.1016/j.neuron.2006.07.023	http://dx.doi.org/10.1016/j.neuron.2006.07.023			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	102GV	17046690	Bronze, Green Accepted			2022-12-28	WOS:000241799900008
J	Lee, JA; Lupski, JR				Lee, Jennifer A.; Lupski, James R.			Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders	NEURON			English	Review							SMITH-MAGENIS-SYNDROME; PELIZAEUS-MERZBACHER-DISEASE; MARIE-TOOTH-DISEASE; BIPOLAR AFFECTIVE-DISORDER; 22Q11.2 DELETION SYNDROME; SPINAL MUSCULAR-ATROPHY; CARDIO-FACIAL SYNDROME; GENOTYPE-PHENOTYPE CORRELATION; FAMILIAL PARKINSONS-DISEASE; NF1 MICRODELETION PATIENTS	Genomic disorders are a group of human genetic diseases caused by genomic rearrangements resulting in copy-number variation (CNV) affecting a dosage-sensitive gene or genes critical for normal development or maintenance. These disorders represent a wide range of clinically distinct entities but include many diseases affecting nervous system function. Herein, we review selected neurodevelopmental, neurodegenerative, and psychiatric disorders either known or suggested to be caused by genomic rearrangement and CNV. Further, we emphasize the cause-and-effect relationship between gene CNV and complex disease traits. We also discuss the prevalence and heritability of CNV, the correlation between CNV and higher-order genome architecture, and the heritability of personality, behavioral, and psychiatric traits. We speculate that CNV could underlie a significant proportion of normal human variation including differences in cognitive, behavioral, and psychological features.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu						Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amos-Landgraf JM, 1999, AM J HUM GENET, V65, P370, DOI 10.1086/302510; Anderlid BM, 2002, HUM GENET, V110, P439, DOI 10.1007/s00439-002-0713-7; Andersson PB, 2000, NEUROLOGY, V54, P40, DOI 10.1212/WNL.54.1.40; Avramopoulos D, 2004, MOL PSYCHIATR, V9, P191, DOI 10.1038/sj.mp.4001388; AXTON M, 2006, NAT GENET, V38, P959; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Barber JCK, 1998, J MED GENET, V35, P491, DOI 10.1136/jmg.35.6.491; Battaglia A, 2005, BRAIN DEV-JPN, V27, P365, DOI 10.1016/j.braindev.2004.08.006; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Bearden CE, 2001, J CLIN EXP NEUROPSYC, V23, P447, DOI 10.1076/jcen.23.4.447.1228; BI W, 2006, INBORN ERRORS DEV; BI W, 2006, IN PRESS AM J MED A; Bi WM, 2005, HUM MOL GENET, V14, P983, DOI 10.1093/hmg/ddi085; Bi WM, 2004, HUM GENET, V115, P515, DOI 10.1007/s00439-004-1187-6; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bittel Douglas C., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405009531; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; BOUCHARD TJ, 1994, SCIENCE, V264, P1700, DOI 10.1126/science.8209250; BRITTEN RJ, 1976, P NATL ACAD SCI USA, V73, P415, DOI 10.1073/pnas.73.2.415; Browne CE, 1997, AM J HUM GENET, V61, P1342, DOI 10.1086/301624; Bruder CEG, 2001, HUM MOL GENET, V10, P271, DOI 10.1093/hmg/10.3.271; Burghes AHM, 1997, AM J HUM GENET, V61, P9, DOI 10.1086/513913; CABREJO L, 2006, IN PRESS BRAIN; Cardoso C, 2003, AM J HUM GENET, V72, P918, DOI 10.1086/374320; Casaubon LK, 1996, AM J HUM GENET, V58, P28; Cassidy SB, 2000, AM J MED GENET, V97, P136, DOI 10.1002/1096-8628(200022)97:2<136::AID-AJMG5>3.0.CO;2-V; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chance PF, 1998, NEUROLOGY, V51, P664, DOI 10.1212/WNL.51.3.664; Chapman CA, 1996, J CHILD NEUROL, V11, P63, DOI 10.1177/088307389601100116; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chen K-S, 1996, MENTAL RETARD DEV DI, V2, P122; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; CHIPUER HM, 1990, INTELLIGENCE, V14, P11, DOI 10.1016/0160-2896(90)90011-H; Cichon S, 2001, HUM MOL GENET, V10, P2933, DOI 10.1093/hmg/10.25.2933; Cnossen MH, 1997, HUM MUTAT, V9, P458, DOI 10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; DELGUADIO D, 2006, IN PRESS GENET MED; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Dorschner MO, 2000, HUM MOL GENET, V9, P35, DOI 10.1093/hmg/9.1.35; Dykens EM, 1998, J INTELL DISABIL RES, V42, P481, DOI 10.1046/j.1365-2788.1998.4260481.x; EARL CJ, 1964, Q J MED, V33, P481; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Eichler EE, 1999, GENOME RES, V9, P1048, DOI 10.1101/gr.9.11.1048; El Tahir MO, 2004, J INTELL DISABIL RES, V48, P695, DOI 10.1111/j.1365-2788.2003.00563.x; Emanuel BS, 2001, NAT REV GENET, V2, P791, DOI 10.1038/35093500; Engelen JJM, 2000, AM J MED GENET, V91, P18, DOI 10.1002/(SICI)1096-8628(20000306)91:1<18::AID-AJMG3>3.3.CO;2-V; Ensenauer RE, 2003, AM J HUM GENET, V73, P1027, DOI 10.1086/378818; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Estivill X, 2002, HUM MOL GENET, V11, P1987, DOI 10.1093/hmg/11.17.1987; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FINUCANE BM, 1994, DEV MED CHILD NEUROL, V36, P78; Flint J, 2003, CURR OPIN GENET DEV, V13, P310, DOI 10.1016/S0959-437X(03)00049-2; Forbes SH, 2004, GENE CHROMOSOME CANC, V41, P12, DOI 10.1002/gcc.20065; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Fullerton J, 2003, AM J HUM GENET, V72, P879, DOI 10.1086/374178; Galaburda AM, 2002, ARCH NEUROL-CHICAGO, V59, P1461, DOI 10.1001/archneur.59.9.1461; Garbern J, 1999, ARCH NEUROL-CHICAGO, V56, P1210, DOI 10.1001/archneur.56.10.1210; GARCIA CA, 1995, CHARCOT MARIE TOOTH, P5; GENCIC S, 1989, AM J HUM GENET, V45, P435; Giglio S, 2002, AM J HUM GENET, V71, P276, DOI 10.1086/341610; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Girirajan S, 2005, J MED GENET, V42, P820, DOI 10.1136/jmg.2005.031211; Goldman AM, 2006, J CHILD NEUROL, V21, P93, DOI 10.1177/08830738060210021201; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gratacos M, 2001, CELL, V106, P367, DOI 10.1016/S0092-8674(01)00447-0; GREENBERG F, 1991, AM J HUM GENET, V49, P1207; Greenberg F, 1996, AM J MED GENET, V62, P247, DOI 10.1002/(SICI)1096-8628(19960329)62:3<247::AID-AJMG9>3.3.CO;2-9; Gropman AL, 2006, PEDIATR NEUROL, V34, P337, DOI 10.1016/j.pediatrneurol.2005.08.018; Hanemann CO, 1998, GLIA, V23, P89, DOI 10.1002/(SICI)1098-1136(199806)23:2<89::AID-GLIA1>3.0.CO;2-Z; Henrichsen CN, 2004, AM J MED GENET B, V128B, P80, DOI 10.1002/ajmg.b.30037; Hollox EJ, 2003, EUR J HUM GENET, V11, P911, DOI 10.1038/sj.ejhg.5201074; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; IMAI Y, 1995, MOL BRAIN RES, V31, P1, DOI 10.1016/0169-328X(95)00020-S; Inoue K, 2003, CURR OPIN GENET DEV, V13, P303, DOI 10.1016/S0959-437X(03)00057-1; Inoue K, 2002, AM J HUM GENET, V71, P838, DOI 10.1086/342728; Jenne DE, 2001, AM J HUM GENET, V69, P516, DOI 10.1086/323043; JERNIGAN TL, 1990, ARCH NEUROL-CHICAGO, V47, P529, DOI 10.1001/archneur.1990.00530050049011; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; JOHNSTON AW, 1962, AM J HUM GENET, V14, P83; KAKU DA, 1993, NEUROLOGY, V43, P1806, DOI 10.1212/WNL.43.9.1806; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kehrer-Sawatzki H, 2004, AM J HUM GENET, V75, P410, DOI 10.1086/423624; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kriek M, 2006, EUR J HUM GENET, V14, P180, DOI 10.1038/sj.ejhg.5201540; LAUMONNIER F, 2002, AM J HUM GENET, V71, P1540; Lee C, 1997, HUM GENET, V100, P291, DOI 10.1007/s004390050508; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Lee JA, 2005, PRENATAL DIAG, V25, P1188, DOI 10.1002/pd.1308; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Leppig KA, 1997, AM J MED GENET, V73, P197, DOI 10.1002/(SICI)1096-8628(1997)73:2<197::AID-AJMG17>3.0.CO;2-P; Leyfer OT, 2006, AM J MED GENET B, V141B, P615, DOI 10.1002/ajmg.b.30344; Li J, 2004, MUSCLE NERVE, V29, P205, DOI 10.1002/mus.10521; LINDENBAUM RH, 1991, AM J HUM GENET S285, V49, P1582; LINDSAY SJ, 2006, IN PRESS AM J HUM GE; Liu CM, 2001, AM J MED GENET, V105, P658, DOI 10.1002/ajmg.1547; Liu J, 2003, MOL PSYCHIATR, V8, P333, DOI 10.1038/sj.mp.4001254; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Luciani JJ, 2003, J MED GENET, V40, P690, DOI 10.1136/jmg.40.9.690; Lupski J.R., 2006, GENOMIC DISORDERS TH; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-242; LUPSKI JR, 1992, NAT GENET, V1, P29, DOI 10.1038/ng0492-29; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; LYNCH DR, 1995, J MED GENET, V32, P561, DOI 10.1136/jmg.32.7.561; Macayran JF, 2006, BIPOLAR DISORD, V8, P294, DOI 10.1111/j.1399-5618.2006.00306.x; Madduri N, 2006, J DEV BEHAV PEDIATR, V27, P188, DOI 10.1097/00004703-200606000-00002; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Marler JA, 2005, AM J MED GENET A, V138A, P318, DOI 10.1002/ajmg.a.30970; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mazzei R, 2004, ACTA NEUROL SCAND, V109, P151, DOI 10.1034/j.1600-0404.2003.00181.x; McCrae RR, 2005, J PERS SOC PSYCHOL, V89, P407, DOI 10.1037/0022-3514.89.3.407; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McDermid HE, 2002, AM J HUM GENET, V70, P1077, DOI 10.1086/340363; McGue M, 1998, ANNU REV NEUROSCI, V21, P1, DOI 10.1146/annurev.neuro.21.1.1; McInnis MG, 2003, MOL PSYCHIATR, V8, P288, DOI 10.1038/sj.mp.4001277; McQueen MB, 2005, AM J HUM GENET, V77, P582, DOI 10.1086/491603; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Mercuri E, 1997, Eur J Paediatr Neurol, V1, P177; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Mervis CB, 2000, BRAIN COGNITION, V44, P604, DOI 10.1006/brcg.2000.1232; Middleton FA, 2006, AM J MED GENET B, V141B, P28, DOI 10.1002/ajmg.b.30250; Middleton FA, 2004, AM J HUM GENET, V74, P886, DOI 10.1086/420775; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Millar JK, 2000, HUM MOL GENET, V9, P1415, DOI 10.1093/hmg/9.9.1415; Ming JRE, 2006, HUM MUTAT, V27, P467, DOI 10.1002/humu.20322; Morris CA, 2003, AM J MED GENET A, V123A, P45, DOI 10.1002/ajmg.a.20496; Moss EM, 1999, J PEDIATR-US, V134, P193, DOI 10.1016/S0022-3476(99)70415-4; Muncke N, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019141; Murphy KC, 2002, LANCET, V359, P426, DOI 10.1016/S0140-6736(02)07604-3; Murphy KC, 2001, BRIT J PSYCHIAT, V179, P397, DOI 10.1192/bjp.179.5.397; Nadeau JH, 2006, NATURE, V439, P798, DOI 10.1038/439798a; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; North KN, 1997, NEUROLOGY, V48, P1121, DOI 10.1212/WNL.48.4.1121; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; PADLATH QS, 2006, IN PRESS NAT GENET; Pareyson D, 1998, MUSCLE NERVE, V21, P1686, DOI 10.1002/(SICI)1097-4598(199812)21:12<1686::AID-MUS10>3.0.CO;2-Z; Park SS, 2002, GENOME RES, V12, P729, DOI 10.1101/gr.82802; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; PENTAO L, 1992, NAT GENET, V2, P292, DOI 10.1038/ng1292-292; Peoples R, 2000, AM J HUM GENET, V66, P47, DOI 10.1086/302722; Phelan MC, 2001, AM J MED GENET, V101, P91, DOI 10.1002/1096-8628(20010615)101:2<91::AID-AJMG1340>3.0.CO;2-C; PLOMIN R, 1990, SCIENCE, V248, P183, DOI 10.1126/science.2183351; POBER BR, 1995, PEDIATR NEUROL, V12, P84, DOI 10.1016/0887-8994(94)00117-K; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Pujana MA, 2002, EUR J HUM GENET, V10, P26, DOI 10.1038/sj.ejhg.5200760; Pujana MA, 2001, GENOME RES, V11, P98, DOI 10.1101/gr.155601; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; Ramanathan Subhadra, 2004, BMC Med Genet, V5, P10, DOI 10.1186/1471-2350-5-10; Rasmussen SA, 1998, J MED GENET, V35, P468, DOI 10.1136/jmg.35.6.468; Rauch A, 2005, J MED GENET, V42, P871, DOI 10.1136/jmg.2004.030619; Ravn K, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9320; Reif A, 2004, EUR PSYCHIAT, V19, P179, DOI 10.1016/j.eurpsy.2004.03.001; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Reiter LT, 1997, HUM MOL GENET, V6, P1595, DOI 10.1093/hmg/6.9.1595; RENDON R, 2006, IN PRESS NATURE; Repetto GR, 1998, AM J MED GENET, V79, P82, DOI 10.1002/(SICI)1096-8628(19980901)79:2<82::AID-AJMG2>3.0.CO;2-P; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Robinson Wendy P., 1993, European Journal of Human Genetics, V1, P37; ROUSSEAU F, 1991, AM J HUM GENET, V48, P108; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; SAUGIERVEBER P, 1994, NAT GENET, V6, P257, DOI 10.1038/ng0394-257; Schmitt JE, 2001, DEV MED CHILD NEUROL, V43, P155, DOI 10.1017/S0012162201000305; Schrock E, 2006, CYTOGENET GENOME RES, V114, P199, DOI 10.1159/000094203; Schumacher J, 2003, HUM GENET, V114, P115, DOI 10.1007/s00439-003-1022-5; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Sereda MW, 2003, NAT MED, V9, P1533, DOI 10.1038/nm957; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; SHAFFER LG, 2001, METABOLIC MOL BASIS, P1291; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shashi V, 2006, CLIN GENET, V69, P234, DOI 10.1111/j.1399-0004.2006.00569.x; Shaw CJ, 2004, J MED GENET, V41, P113, DOI 10.1136/jmg.2003.012831; Shaw CJ, 2005, HUM GENET, V116, P1, DOI 10.1007/s00439-004-1204-9; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2002, AM J HUM GENET, V71, P1072, DOI 10.1086/344346; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shy ME, 2006, ANN NEUROL, V59, P358, DOI 10.1002/ana.20777; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sistermans EA, 1998, NEUROLOGY, V50, P1749, DOI 10.1212/WNL.50.6.1749; SKRE H, 1974, CLIN GENET, V6, P98; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Southwood C, 2001, MICROSC RES TECHNIQ, V52, P700, DOI 10.1002/jemt.1054; Spena S, 2004, EUR J HUM GENET, V12, P891, DOI 10.1038/sj.ejhg.5201207; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stankiewicz P, 2005, AM J MED GENET A, V138A, P11, DOI 10.1002/ajmg.a.30910; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; STEVANOVIC M, 1993, HUM MOL GENET, V3, P2013; Stober G, 2000, AM J HUM GENET, V67, P1201, DOI 10.1086/321183; Tabiner M, 2003, AM J HUM GENET, V72, P535, DOI 10.1086/367777; TELLEGEN A, 1988, J PERS SOC PSYCHOL, V54, P1031, DOI 10.1037/0022-3514.54.6.1031; Terracciano A, 2005, SCIENCE, V310, P96, DOI 10.1126/science.1117199; Theos A, 2006, ANN INTERN MED, V144, P842, DOI 10.7326/0003-4819-144-11-200606060-00010; Theuns J, 2006, AM J HUM GENET, V78, P936, DOI 10.1086/504044; Tomaiuolo F, 2002, NEUROREPORT, V13, P2281, DOI 10.1097/00001756-200212030-00022; Trask BJ, 1996, HUM GENET, V98, P710, DOI 10.1007/s004390050291; Tu PH, 1998, ANN NEUROL, V44, P415, DOI 10.1002/ana.410440324; Uddin RK, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-18; Urban Z, 1996, AM J HUM GENET, V59, P958; VALENTIJN LJ, 1992, NAT GENET, V2, P288, DOI 10.1038/ng1292-288; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Veltman JA, 2003, AM J HUM GENET, V72, P1578, DOI 10.1086/375695; Vermeulen SJ, 2004, AM J MED GENET A, V131A, P320, DOI 10.1002/ajmg.a.30343; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Walz K, 2004, HUM MOL GENET, V13, P367, DOI 10.1093/hmg/ddh044; Walz K, 2003, MOL CELL BIOL, V23, P3646, DOI 10.1128/MCB.23.10.3646-3655.2003; WALZ K, 2006, IN PRESS J CLIN INVE; Weiland Y, 2003, AM J HUM GENET, V72, P1349, DOI 10.1086/375168; WILLIAMS CA, 1995, AM J MED GENET, V56, P237, DOI 10.1002/ajmg.1320560224; Wilson GM, 2006, HUM MOL GENET, V15, P743, DOI 10.1093/hmg/ddi489; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Windebank A, 1993, PERIPHERAL NEUROPATH, V2, P1137; Wirtenberger M, 2006, AM J HUM GENET, V78, P520, DOI 10.1086/500793; Wirth B, 2006, HUM GENET, V119, P422, DOI 10.1007/s00439-006-0156-7; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Woods KS, 2005, AM J HUM GENET, V76, P833, DOI 10.1086/430134; Woodward KJ, 2005, AM J HUM GENET, V77, P966, DOI 10.1086/498048; Yobb TM, 2005, AM J HUM GENET, V76, P865, DOI 10.1086/429841; Zhu GS, 2004, EUR J HUM GENET, V12, P505, DOI 10.1038/sj.ejhg.5201181; Zoller M, 1997, ACTA NEUROL SCAND, V95, P225	245	211	221	0	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 5	2006	52	1					103	121		10.1016/j.neuron.2006.09.027	http://dx.doi.org/10.1016/j.neuron.2006.09.027			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015230	Bronze			2022-12-28	WOS:000241408100008
J	Hnasko, TS; Edwards, RH				Hnasko, Thomas S.; Edwards, Robert H.			Synaptic vesicles: Half full or half empty?	NEURON			English	Editorial Material							KNOCKOUT MICE; QUANTAL SIZE; AMPHETAMINE; TRANSPORTER; NEUROTRANSMISSION; EXPRESSION; NEURONS	The regulation of quantal size through pre- rather than postsynaptic mechanisms has recently received considerable attention as a potential mechanism for plasticity. Vesicular transporters catalyze the filling of synaptic vesicles with transmitter and are thus potential substrates for such presynaptic regulation. In this issue of Neuron, Prado et al. pursue this line of investigation and show that changes in transporter expression that alter quantal size can affect behavior.	Univ Calif San Francisco, Sch Med, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hnasko, TS (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, 600 16th St,GH-N272B, San Francisco, CA 94158 USA.			Hnasko, Thomas/0000-0001-6176-8513				COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Croft BG, 2005, MOL BIOL CELL, V16, P306, DOI 10.1091/mbc.e04-07-0559; Daniels RW, 2006, NEURON, V49, P11, DOI 10.1016/j.neuron.2005.11.032; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Paban V, 2005, NEUROSCIENCE, V132, P13, DOI 10.1016/j.neuroscience.2004.11.024; Parsons RL, 1999, J NEUROPHYSIOL, V81, P2696, DOI 10.1152/jn.1999.81.6.2696; Patel J, 2003, J NEUROCHEM, V85, P898, DOI 10.1046/j.1471-4159.2003.01732.x; Pothos EN, 2000, J NEUROSCI, V20, P7297; Prado VF, 2006, NEURON, V51, P601, DOI 10.1016/j.neuron.2006.08.005; Sara Y, 2005, NEURON, V45, P563, DOI 10.1016/j.neuron.2004.12.056; Song HJ, 1997, NEURON, V18, P815, DOI 10.1016/S0896-6273(00)80320-7; Takahashi N, 1997, P NATL ACAD SCI USA, V94, P9938, DOI 10.1073/pnas.94.18.9938; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Williams J, 1997, NEURON, V18, P683, DOI 10.1016/S0896-6273(00)80308-6; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	17	1	1	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 7	2006	51	5					523	524		10.1016/j.neuron.2006.08.019	http://dx.doi.org/10.1016/j.neuron.2006.08.019			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	085RZ	16950150	Bronze			2022-12-28	WOS:000240623400001
J	Graziano, MSA				Graziano, Michael S. A.			Progress in understanding spatial coordinate systems in the primate brain	NEURON			English	Editorial Material							PARIETAL NEURONS; CORTEX; SPACE	A new study in this issue of Neuron shows that when monkeys reach to a visual target, neurons in the dorsal premotor cortex compare the location of the target, the hand, and the point of visual fixation. The neurons therefore encode space through a combination of eye-centered and hand-centered coordinates.	Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA	Princeton University	Graziano, MSA (corresponding author), Princeton Univ, Dept Psychol, Green Hall, Princeton, NJ 08544 USA.							ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; BROTCHIE PR, 1995, NATURE, V375, P232, DOI 10.1038/375232a0; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Pesaran B, 2006, NEURON, V51, P125, DOI 10.1016/j.neuron.2006.05.025; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777	9	15	15	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 6	2006	51	1					7	9		10.1016/j.neuron.2006.06.011	http://dx.doi.org/10.1016/j.neuron.2006.06.011			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	063RQ	16815326	Bronze			2022-12-28	WOS:000239037700004
J	Wiser, O; Qian, X; Ehlers, M; Ja, WW; Roberts, RW; Reuveny, E; Jan, YN; Jan, LY				Wiser, Ofer; Qian, Xiang; Ehlers, Melissa; Ja, William W.; Roberts, Richard W.; Reuveny, Eitan; Jan, Yuh Nung; Jan, Lily Yeh			Modulation of basal and receptor-induced GIRK potassium channel activity and neuronal excitability by the mammalian PINS homolog LGN	NEURON			English	Article							G-PROTEIN SIGNALING-3; HETEROTRIMERIC G-PROTEINS; G-ALPHA SUBUNITS; K+ CHANNEL; DISSOCIATION INHIBITOR; TRANSITION-STATE; GOLOCO MOTIF; TPR DOMAIN; KEY ROLE; AGS3	G protein-activated inwardly rectifying potassium (GIRK) channels mediate slow synaptic inhibition and control neuronal excitability. It is unknown whether GIRK channels are subject to regulation by guanine dissociation inhibitor (GDI) proteins like LGN, a mammalian homolog of Drosophila Partner of Inscuteable (mPINS). Here we report that LGN increases basal GIRK current but reduces GIRK activation by metabotropic transmitter receptors coupled to Gi or Go, but not Gs. Moreover, expression of its N-terminal, TPR-containing protein interaction domains mimics the effects of LGN in mammalian cells, probably by releasing sequestered endogenous LGN. In hippocampal neurons, expression of LGN, or LGN fragments that mimic or enhance LGN activity, hyperpolarizes the resting potential due to increased basal GIRK activity and reduces excitability. Using Lenti virus for LGN RNA! to reduce endogenous LGN levels in hippocampal neurons, we further show an essential role of LGN for maintaining basal GIRK channel activity and for harnessing neuronal excitability.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem, San Francisco, CA 94143 USA; CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; California Institute of Technology; Weizmann Institute of Science	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, 1550 4th St, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; QIAN, XIANG/0000-0003-0697-2540; Ja, William/0000-0002-4003-7356	NIMH NIH HHS [MH63981] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH063981] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adhikari A, 2003, J BIOL CHEM, V278, P51825, DOI 10.1074/jbc.M306300200; Benians A, 2003, J BIOL CHEM, V278, P10851, DOI 10.1074/jbc.M212299200; Bernard ML, 2001, J BIOL CHEM, V276, P1585, DOI 10.1074/jbc.M005291200; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Blumer JB, 2003, J BIOL CHEM, V278, P23217, DOI 10.1074/jbc.C200686200; Blumer JB, 2002, J BIOL CHEM, V277, P15897, DOI 10.1074/jbc.M112185200; Bowers MS, 2004, NEURON, V42, P269, DOI 10.1016/S0896-6273(04)00159-X; Chen XX, 2005, J NEUROSCI, V25, P3787, DOI 10.1523/JNEUROSCI.5312-04.2005; Collins A, 1997, P NATL ACAD SCI USA, V94, P5456, DOI 10.1073/pnas.94.10.5456; De Vries L, 2000, P NATL ACAD SCI USA, V97, P14364, DOI 10.1073/pnas.97.26.14364; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Drake CT, 1997, P NATL ACAD SCI USA, V94, P1007, DOI 10.1073/pnas.94.3.1007; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fuja TJ, 2004, J NEUROSCI RES, V75, P782, DOI 10.1002/jnr.10874; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Huang CS, 2005, CELL, V123, P105, DOI 10.1016/j.cell.2005.07.033; Ja WW, 2005, J BIOL CHEM, V280, P32057, DOI 10.1074/jbc.C500319200; Ja WW, 2004, BIOCHEMISTRY-US, V43, P9265, DOI 10.1021/bi0498398; Karasinska JM, 2003, BRAIN RES REV, V41, P125, DOI 10.1016/S0165-0173(02)00221-7; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kelley AE, 2004, NEURON, V42, P181, DOI 10.1016/S0896-6273(04)00223-5; Kimple Randall J, 2002, Mol Interv, V2, P88, DOI 10.1124/mi.2.2.88; Kimple RJ, 2002, NATURE, V416, P878, DOI 10.1038/416878a; Kimple RJ, 2001, J BIOL CHEM, V276, P29275, DOI 10.1074/jbc.M103208200; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Ma HZ, 2003, BIOCHEMISTRY-US, V42, P8085, DOI 10.1021/bi034561p; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marty C, 2003, MOL CELL BIOL, V23, P3847, DOI 10.1128/MCB.23.11.3847-3858.2003; McCudden CR, 2005, BBA-MOL CELL RES, V1745, P254, DOI 10.1016/j.bbamcr.2005.05.002; Mittal R, 1996, SCIENCE, V273, P115, DOI 10.1126/science.273.5271.115; Mochizuki N, 1996, GENE, V181, P39, DOI 10.1016/S0378-1119(96)00456-8; Myszka DG, 2000, METHOD ENZYMOL, V323, P325; Natochin M, 2002, BIOCHEMISTRY-US, V41, P258, DOI 10.1021/bi015708k; Natochin M, 2000, J BIOL CHEM, V275, P40981, DOI 10.1074/jbc.M006478200; Natochin M, 2001, BIOCHEMISTRY-US, V40, P5322, DOI 10.1021/bi015505w; Paddison PJ, 2002, GENE DEV, V16, P948, DOI 10.1101/gad.981002; Peleg S, 2002, NEURON, V33, P87, DOI 10.1016/S0896-6273(01)00567-0; Peterson YK, 2000, J BIOL CHEM, V275, P33193, DOI 10.1074/jbc.C000509200; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325; Sato M, 2004, J BIOL CHEM, V279, P13375, DOI 10.1074/jbc.M312660200; Satoh Kiyotoshi, 1999, Medical Electron Microscopy, V32, P221; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; SCHATZ PJ, 1993, BIO-TECHNOL, V11, P1138, DOI 10.1038/nbt1093-1138; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Seeger T, 2001, J PHYSIOL-LONDON, V535, P383, DOI 10.1111/j.1469-7793.2001.00383.x; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Takigawa T, 2002, J PHYSIOL-LONDON, V539, P67, DOI 10.1113/jphysiol.2001.012883; Tall GG, 2005, P NATL ACAD SCI USA, V102, P16584, DOI 10.1073/pnas.0508306102; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tsao KL, 1996, GENE, V169, P59, DOI 10.1016/0378-1119(95)00762-8; Waldhoer M, 2004, ANNU REV BIOCHEM, V73, P953, DOI 10.1146/annurev.biochem.73.011303.073940; Willard FS, 2004, ANNU REV BIOCHEM, V73, P925, DOI 10.1146/annurev.biochem.73.011303.073756; Yao L, 2005, P NATL ACAD SCI USA, V102, P8746, DOI 10.1073/pnas.0503419102; Yu FW, 2005, GENE DEV, V19, P1341, DOI 10.1101/gad.1295505	70	51	51	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY 18	2006	50	4					561	573		10.1016/j.neuron.2006.03.046	http://dx.doi.org/10.1016/j.neuron.2006.03.046			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	047JI	16701207	Bronze			2022-12-28	WOS:000237875200008
J	Hasegawa, J; Obara, T; Tanaka, K; Tachibana, M				Hasegawa, J; Obara, T; Tanaka, K; Tachibana, M			High-density presynaptic transporters are required for glutamate removal from the first visual synapse	NEURON			English	Article							RETINAL BIPOLAR CELLS; CYCLIC-GMP CASCADE; RAT RETINA; MOUSE RETINA; CONE PHOTORECEPTORS; TRANSMITTER RELEASE; ACTIVATED CHANNELS; RECEPTOR SUBUNITS; RIBBON SYNAPSE; G-PROTEIN	Reliable synaptic transmission depends not only on the release machinery and the postsynaptic response mechanism but also on removal or degradation of transmitter from the synaptic cleft. Accumulating evidence indicates that postsynaptic and glial excitatory amino acid transporters (EAATs) contribute to glutamate removal. However, the role of presynaptic EAATs is unclear. Here, we show in the mouse retina that glutamate is removed from the synaptic cleft at the rod to rod bipolar cell (RBC) synapse by presynaptic EAATs rather than by postsynaptic or glial EAATs. The RBC currents evoked by electrical stimulation of rods decayed slowly after pharmacological blockade of EAATs. Recordings of the evoked RBC currents from EAAT subtype-deficient mice and the EAAT-coupled anion current reveal that functional EAATs are localized to rod terminals. Model simulations suggest that rod EAATs are densely packed near the release site and that rods are equipped with an almost self-sufficient glutamate recollecting system.	Univ Tokyo, Grad Sch Humanities & Sociol, Dept Psychol, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Sch Biomed Sci & Med Res Inst, Tokyo 1138510, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU)	Tachibana, M (corresponding author), Univ Tokyo, Grad Sch Humanities & Sociol, Dept Psychol, Tokyo 1130033, Japan.	ltmasao@l.u-tokyo.ac.jp						ARRIZA JL, 1997, P NATL ACAD SCI USA, V94, P4156; Barbour B, 2001, J NEUROSCI, V21, P7969, DOI 10.1523/JNEUROSCI.21-20-07969.2001; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARTOL TM, 1991, BIOPHYS J, V59, P1290, DOI 10.1016/S0006-3495(91)82344-X; BAYLOR DA, 1970, J PHYSIOL-LONDON, V207, P77, DOI 10.1113/jphysiol.1970.sp009049; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Berntson A, 2000, J PHYSIOL-LONDON, V524, P879, DOI 10.1111/j.1469-7793.2000.00879.x; Berntson A, 2004, VISUAL NEUROSCI, V21, P913, DOI 10.1017/S095252380421611X; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DELAVILLA P, 1995, J NEUROSCI, V15, P3571; Derouiche A, 1996, VISION RES, V36, P3875, DOI 10.1016/S0042-6989(96)00140-X; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Dhingra A, 2004, J NEUROSCI, V24, P5684, DOI 10.1523/JNEUROSCI.0492-04.2004; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 2002, NAT NEUROSCI, V5, P291, DOI 10.1038/nn0402-291; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; DOWLING JE, 1973, NATURE, V242, P101, DOI 10.1038/242101a0; Eskandari S, 2000, P NATL ACAD SCI USA, V97, P8641, DOI 10.1073/pnas.97.15.8641; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; Franks KM, 2002, BIOPHYS J, V83, P2333, DOI 10.1016/S0006-3495(02)75248-X; Gaal L, 1998, J NEUROPHYSIOL, V79, P190, DOI 10.1152/jn.1998.79.1.190; Glowatzki E, 2002, NAT NEUROSCI, V5, P147, DOI 10.1038/nn796; Hack I, 2001, EUR J NEUROSCI, V13, P15, DOI 10.1046/j.1460-9568.2001.01357.x; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hertz L, 1999, J NEUROSCI RES, V57, P417, DOI 10.1002/(SICI)1097-4547(19990815)57:4<417::AID-JNR1>3.3.CO;2-E; HESTRIN S, 1992, NEURON, V9, P991, DOI 10.1016/0896-6273(92)90250-H; Higgs MH, 1999, J NEUROSCI, V19, P3691; Hosoi N, 2005, J NEUROSCI, V25, P4062, DOI 10.1523/JNEUROSCI.2735-04.2005; Kamphuis W, 2003, EUR J NEUROSCI, V18, P1085, DOI 10.1046/j.1460-9568.2003.02841.x; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Matsui K, 2001, J NEUROPHYSIOL, V86, P2285, DOI 10.1152/jn.2001.86.5.2285; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Nawy S, 2004, J PHYSIOL-LONDON, V558, P137, DOI 10.1113/jphysiol.2004.064980; Nawy S, 1999, J NEUROSCI, V19, P2938; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; Nielsen TA, 2004, NEURON, V42, P757, DOI 10.1016/j.neuron.2004.04.003; Otis TS, 1998, J NEUROSCI, V18, P7099; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Palmer MJ, 2003, J NEUROSCI, V23, P4831; Peghini P, 1997, EMBO J, V16, P3822, DOI 10.1093/emboj/16.13.3822; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; RAO R, 1994, BIOPHYS J, V67, P57, DOI 10.1016/S0006-3495(94)80454-0; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; RAOMIROTZNIK R, 1995, NEURON, V14, P561, DOI 10.1016/0896-6273(95)90312-7; Rauen T, 1998, CELL TISSUE RES, V291, P19; Rauen T, 2000, AMINO ACIDS, V19, P53, DOI 10.1007/s007260070033; Rauen T, 1996, CELL TISSUE RES, V286, P325, DOI 10.1007/s004410050702; Reichelt W, 2002, J NEUROPHYSIOL, V87, P1974, DOI 10.1152/jn.00704.2001; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Shiells RA, 2000, J PHYSIOL-LONDON, V528, P327, DOI 10.1111/j.1469-7793.2000.00327.x; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tsukamoto Y, 2001, J NEUROSCI, V21, P8616, DOI 10.1523/JNEUROSCI.21-21-08616.2001; Vandenbranden CAV, 2000, J COMP NEUROL, V423, P440, DOI 10.1002/1096-9861(20000731)423:3<440::AID-CNE7>3.0.CO;2-7; Vandenbranden CAV, 1996, VISION RES, V36, P3859, DOI 10.1016/S0042-6989(96)00134-4; Vardi N, 2000, J COMP NEUROL, V423, P402, DOI 10.1002/1096-9861(20000731)423:3<402::AID-CNE4>3.0.CO;2-E; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Wiessner M, 2002, CELL TISSUE RES, V310, P31, DOI 10.1007/s00441-002-0612-1; WILSON M, 1987, BIOPHYS J, V52, P95; Winkler BS, 1999, VISUAL NEUROSCI, V16, P345, DOI 10.1017/S095252389916214X	76	77	81	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR 6	2006	50	1					63	74		10.1016/j.neuron.2006.02.022	http://dx.doi.org/10.1016/j.neuron.2006.02.022			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	032XZ	16600856	Bronze			2022-12-28	WOS:000236811300011
J	Huang, X; Albright, TD; Stoner, GR				Huang, Xin; Albright, Thomas D.; Stoner, Gene R.			Adaptive surround modulation in cortical area MT	NEURON			English	Article							TEMPORAL VISUAL AREA; MACAQUE V1 NEURONS; CLASSICAL RECEPTIVE-FIELD; OWL MONKEY; DIRECTIONAL SELECTIVITY; FUNCTIONAL-PROPERTIES; SPATIAL-DISTRIBUTION; CONTRAST DEPENDENCE; RESPONSE PROPERTIES; MOTION COHERENCE	Visual motion perception relies on two opposing operations: integration and segmentation. Integration overcomes motion ambiguity in the visual image by spatial pooling of motion signals, whereas segmentation identifies differences between adjacent moving objects. For visual motion area MT, previous investigations have reported that stimuli in the receptive field surround, which do not elicit a response when presented alone, can nevertheless modulate responses to stimuli in the receptive field center. The directional tuning of this "surround modulation" has been found to be mainly antagonistic and hence consistent with segmentation. Here, we report that surround modulation in area MT can be either antagonistic or integrative depending upon the visual stimulus. Both types of modulation were delayed relative to response onset. Our results suggest that the dominance of antagonistic modulation in previous MT studies was due to stimulus choice and that segmentation and integration are achieved, in part, via adaptive surround modulation.	Salk Inst Biol Studies, Vis Ctr Lab, La Jolla, CA 92037 USA	Salk Institute	Huang, X (corresponding author), Salk Inst Biol Studies, Vis Ctr Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	huangx@phy.ucsf.edu; gene@salk.edu			NEI NIH HHS [R01 EY012872-07, R01 EY012872-06, R01 EY012872-05, R01 EY012872-04] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012872] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Bair W, 2003, J NEUROSCI, V23, P7690; BAKER JF, 1981, J NEUROPHYSIOL, V45, P397, DOI 10.1152/jn.1981.45.3.397; Berezovskii VK, 2000, J NEUROSCI, V20, P1157, DOI 10.1523/JNEUROSCI.20-03-01157.2000; Born RT, 2000, J NEUROPHYSIOL, V84, P2658, DOI 10.1152/jn.2000.84.5.2658; Born RT, 2005, ANNU REV NEUROSCI, V28, P157, DOI 10.1146/annurev.neuro.26.041002.131052; BORN RT, 1992, NATURE, V357, P497, DOI 10.1038/357497a0; BRADDICK O, 1993, TRENDS NEUROSCI, V16, P263, DOI 10.1016/0166-2236(93)90179-P; Bradley DC, 1998, J NEUROSCI, V18, P7552; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; Duncan RO, 2000, J NEUROSCI, V20, P5885, DOI 10.1523/JNEUROSCI.20-15-05885.2000; GATTASS R, 1988, J NEUROSCI, V8, P1831; Hanada M, 2004, VISION RES, V44, P1757, DOI 10.1016/j.visres.2004.03.001; HEINEMANN EG, 1955, J EXP PSYCHOL, V50, P89, DOI 10.1037/h0040919; HELSON H, 1963, J OPT SOC AM, V53, P179, DOI 10.1364/JOSA.53.000179; Krekelberg B, 2005, J NEUROPHYSIOL, V93, P2908, DOI 10.1152/jn.00473.2004; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; MARR D, 1981, PROC R SOC SER B-BIO, V211, P151, DOI 10.1098/rspb.1981.0001; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; MAUNSELL JHR, 1992, J NEUROPHYSIOL, V68, P1332, DOI 10.1152/jn.1992.68.4.1332; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Morgan MJ, 1997, VISION RES, V37, P2737, DOI 10.1016/S0042-6989(97)00074-6; MOULDEN B, 1990, PERCEPTION, V19, P79, DOI 10.1068/p190079; MURAKAMI I, 1993, VISION RES, V33, P2091, DOI 10.1016/0042-6989(93)90008-K; NAKAYAMA K, 1974, PERCEPTION, V3, P63, DOI 10.1068/p030063; Osborne LC, 2004, J NEUROSCI, V24, P3210, DOI 10.1523/JNEUROSCI.5305-03.2004; Pack CC, 2005, J NEUROPHYSIOL, V93, P1809, DOI 10.1152/jn.00629.2004; Pack CC, 2004, J NEUROSCI, V24, P3268, DOI 10.1523/JNEUROSCI.4387-03.2004; Perge JA, 2005, EUR J NEUROSCI, V22, P2049, DOI 10.1111/j.1460-9568.2005.04363.x; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; RAIGUEL S, 1995, EUR J NEUROSCI, V7, P2064, DOI 10.1111/j.1460-9568.1995.tb00629.x; Rust NC, 2006, NAT NEUROSCI, V9, P1421, DOI 10.1038/nn1786; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; TANAKA K, 1986, J NEUROSCI, V6, P134; Thiele A, 2003, NATURE, V421, P366, DOI 10.1038/nature01285; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; WESTHEIMER G, 1986, J PHYSIOL-LONDON, V370, P619, DOI 10.1113/jphysiol.1986.sp015954; Wuerger S, 1996, PERCEPTION, V25, P1317, DOI 10.1068/p251317; XIAO DK, 1995, P NATL ACAD SCI USA, V92, P11303, DOI 10.1073/pnas.92.24.11303; Xiao DK, 1997, CEREB CORTEX, V7, P662, DOI 10.1093/cercor/7.7.662; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	51	57	57	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					761	770		10.1016/j.neuron.2007.01.032	http://dx.doi.org/10.1016/j.neuron.2007.01.032			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329214	Green Accepted, Bronze			2022-12-28	WOS:000245127100015
J	Peterlin, Z; Chesler, A; Firestein, S				Peterlin, Zita; Chesler, Alexander; Firestein, Stuart			A painful Trp can be a bonding experience	NEURON			English	Editorial Material							ION-CHANNEL TRPA1; COVALENT MODIFICATION; OLFACTORY RECEPTORS; ODORANT RECEPTOR; ACTIVATE; COLD; ANKTM1	The receptive field of the TRPA1 nociceptor is remarkably expansive when compared to other chemodetectors such as odorant receptors. The identification of a unique mechanism utilized by TRPA1 helps clarify how this protein can efficiently alert the cell to an array of reactive chemical agents, regardless of their structure.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	stuart@biology.columbia.edu	Chesler, Alexander/V-2748-2019	Chesler, Alexander/0000-0002-3131-0728				Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Gaillard I, 2002, EUR J NEUROSCI, V15, P409, DOI 10.1046/j.0953-816x.2001.01871.x; Hall SE, 2004, CHEM SENSES, V29, P595, DOI 10.1093/chemse/bjh063; Hamana H, 2003, CHEM SENSES, V28, P87, DOI 10.1093/chemse/28.2.87; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Macpherson LJ, 2006, MOL CELL NEUROSCI, V32, P335, DOI 10.1016/j.mcn.2006.05.005; Macpherson LJ, 2005, CURR BIOL, V15, P929, DOI 10.1016/j.cub.2005.04.018; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; ZURBORG S, 2007, IN PRESS NAT NEUROSC	20	23	23	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 1	2007	53	5					635	638		10.1016/j.neuron.2007.02.011	http://dx.doi.org/10.1016/j.neuron.2007.02.011			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DL	17329204	Bronze			2022-12-28	WOS:000245127100005
J	Tzingounis, AV; Kobayashi, M; Takamatsu, K; Nicoll, RA				Tzingounis, Anastassios V.; Kobayashi, Masaaki; Takamatsu, Ken; Nicoll, Roger A.			Hippocalcin gates the calcium activation of the slow afterhyperpolarization in hippocampal pyramidal cells	NEURON			English	Article							POTASSIUM CHANNELS; K+ CURRENT; PHOTOLYTIC MANIPULATION; CA2+ TRANSIENTS; ION CHANNELS; CA1 NEURONS; TIME-COURSE; RAT-BRAIN; KINETICS; CALMODULIN	In the brain, calcium influx following a train of action potentials activates potassium channels that mediate a slow afterhyperpolarization current (I-sAHP). The key steps between calcium influx and potassium channel activation remain unknown. Here we report that the key intermediate between calcium and the sAHP channels is the diffusible calcium sensor hippocalcin. Brief depolarizations sufficient to activate the IsAHP in wild-type mice do not elicit the I-sAHP in hippocalcin knockout mice. Introduction of hippocalcin in cultured hippocampal neurons leads to a pronounced IsAHP, while neurons expressing a hippocalcin mutant lacking N-terminal myristoylation exhibit a small I-sAHP that is similar to that recorded in uninfected neurons. This implies that hippocalcin must bind to the plasma membrane to mediate its effects. These findings support a model in which the calcium sensor for the sAHP channels is not preassociated with the channel complex.	Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Toho Univ, Sch Med, Dept Physiol, Ohta Ku, Tokyo 1438540, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.	nicoll@cmp.ucsf.edu			NIMH NIH HHS [R37 MH038256] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038256] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel HJ, 2004, J NEUROPHYSIOL, V91, P324, DOI 10.1152/jn.00583.2003; Adesnik H, 2005, NEURON, V48, P977, DOI 10.1016/j.neuron.2005.11.030; ALGER BE, 1994, NEUROSCI LETT, V168, P23, DOI 10.1016/0304-3940(94)90407-3; An WF, 2000, NATURE, V403, P553, DOI 10.1038/35000592; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bradley J, 2004, NAT NEUROSCI, V7, P705, DOI 10.1038/nn1266; Dargan SL, 2003, J PHYSIOL-LONDON, V553, P775, DOI 10.1113/jphysiol.2003.054247; Elliott RC, 2003, J NEUROSCI, V23, P2218; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Few AP, 2005, J NEUROSCI, V25, P7071, DOI 10.1523/JNEUROSCI.0452-05.2005; Gerlach AC, 2004, PFLUG ARCH EUR J PHY, V448, P187, DOI 10.1007/s00424-003-1237-2; Jahromi BS, 1999, NEUROSCIENCE, V88, P719, DOI 10.1016/S0306-4522(98)00203-6; KNOPFEL T, 1990, P NATL ACAD SCI USA, V87, P4083, DOI 10.1073/pnas.87.11.4083; Kobayashi M, 2005, NEUROSCIENCE, V133, P471, DOI 10.1016/j.neuroscience.2005.02.034; KOBAYASHI M, 1993, J BIOL CHEM, V268, P18898; Korhonen L, 2005, MOL CELL NEUROSCI, V28, P85, DOI 10.1016/j.mcn.2004.08.015; LANCASTER B, 1994, J PHYSIOL-LONDON, V475, P229, DOI 10.1113/jphysiol.1994.sp020064; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Levitan IB, 2006, NAT NEUROSCI, V9, P305, DOI 10.1038/nn1647; MADISON DV, 1982, NATURE, V299, P636, DOI 10.1038/299636a0; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6; NICOLL RA, 1988, SCIENCE, V241, P545, DOI 10.1126/science.2456612; O'Callaghan DW, 2003, J CELL BIOL, V163, P715, DOI 10.1083/jcb.200306042; O'Callaghan DW, 2002, J BIOL CHEM, V277, P14227, DOI 10.1074/jbc.M111750200; Palmer CL, 2005, NEURON, V47, P487, DOI 10.1016/j.neuron.2005.06.014; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Sah P, 1999, J NEUROSCI, V19, P3657; SAH P, 1992, J NEUROPHYSIOL, V68, P2237, DOI 10.1152/jn.1992.68.6.2237; Shah M, 2000, J NEUROPHYSIOL, V83, P2554, DOI 10.1152/jn.2000.83.5.2554; Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516; Vogalis F, 2003, EUR J NEUROSCI, V18, P3155, DOI 10.1111/j.1460-9568.2003.03040.x; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Zhang L, 1995, J NEUROPHYSIOL, V74, P2225, DOI 10.1152/jn.1995.74.6.2225	35	85	86	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 15	2007	53	4					487	493		10.1016/j.neuron.2007.01.011	http://dx.doi.org/10.1016/j.neuron.2007.01.011			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DJ	17296551	Bronze, Green Accepted			2022-12-28	WOS:000245126900008
J	Paradis, S; Harrar, DB; Lin, YX; Koon, AC; Hauser, JL; Griffith, EC; Zhu, L; Brass, LF; Chen, CF; Greenberg, ME				Paradis, Suzanne; Harrar, Dana B.; Lin, Yingxi; Koon, Alex C.; Hauser, Jessica L.; Griffith, Eric C.; Zhu, Li; Brass, Lawrence F.; Chen, Chinfei; Greenberg, Michael E.			An RNAi-based approach identifies molecules required for glutamatergic and GABAergic synapse development	NEURON			English	Article							DENDRITIC SPINE MORPHOGENESIS; HIPPOCAMPAL-NEURONS; GENE-EXPRESSION; NERVOUS-SYSTEM; PLASTICITY; NEUROLIGINS; RECEPTORS; REM2; DIFFERENTIATION; TRANSMISSION	We report the results of a genetic screen to identify molecules important for synapse formation and/or maintenance. siRNAs were used to decrease the expression of candidate genes in neurons, and synapse development was assessed. We surveyed 22 cadherin family members and demonstrated distinct roles for cadherin-11 and cadherin-13 in synapse development. Our screen also revealed roles for the class 4 Semaphorins Sema4B and Sema4D in the development of glutamatergic and/or GABAergic synapses. We found that Sema4D affects the formation of GABAergic, but not glutamatergic, synapses. Our screen also identified the activity-regulated small GTPase Rem2 as a regulator of synapse development. A known calcium channel modulator, Rem2 may function as part of a homeostatic mechanism that controls synapse number. These experiments establish the feasibility of RNAi screens to characterize the mechanisms that control mammalian neuronal development and to identify components of the genetic program that regulate synapse formation and/or maintenance.	Childrens Hosp, Dept Neurol, Program Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ Penn, Dept Med, Philadelphia, PA 19104 USA; Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; University of Pennsylvania	Greenberg, ME (corresponding author), Childrens Hosp, Dept Neurol, Program Neurobiol, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@childrens.harvard.edu		Harrar, Dana/0000-0001-6382-8479; Hauser Chatterjee, Jessica/0000-0002-9992-1736; /0000-0002-7002-1275; Griffith, Eric/0000-0003-0428-3215; Koon, Alex/0000-0002-4274-7052	NEI NIH HHS [R01 EY013613] Funding Source: Medline; NHLBI NIH HHS [HL81012, P50 HL081012] Funding Source: Medline; NICHD NIH HHS [P30 HD018655-25, P30 HD018655, HD18655] Funding Source: Medline; NINDS NIH HHS [NS45500, R01 NS045500, R01 NS045500-20] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013613] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL081012] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045500] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson TR, 2004, NEUROPHARMACOLOGY, V47, P694, DOI 10.1016/j.neuropharm.2004.07.023; Baron GS, 2003, J BIOL CHEM, V278, P14883, DOI 10.1074/jbc.M210840200; Beguin P, 2005, BIOCHEM J, V390, P67, DOI 10.1042/BJ20050414; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Burkhardt C, 2005, FEBS LETT, V579, P3821, DOI 10.1016/j.febslet.2005.05.079; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chen HM, 2005, J NEUROSCI, V25, P9762, DOI 10.1523/JNEUROSCI.3111-05.2005; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Elhabazi A, 2001, J IMMUNOL, V166, P4341, DOI 10.4049/jimmunol.166.7.4341; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Finlin BS, 2005, J BIOL CHEM, V280, P41864, DOI 10.1074/jbc.M414261200; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; HE Z, 2002, SCI STKE, V119, pRE1, DOI DOI 10.1126/STKE.2002.119.RE1; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Magdaleno S, 2006, PLOS BIOL, V4, P497, DOI 10.1371/journal.pbio.0040086; Manabe T, 2000, MOL CELL NEUROSCI, V15, P534, DOI 10.1006/mcne.2000.0849; McGee AW, 2003, CURR OPIN NEUROBIOL, V13, P111, DOI 10.1016/S0959-4388(03)00008-4; Myers JW, 2003, NAT BIOTECHNOL, V21, P324, DOI 10.1038/nbt792; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Novina CD, 2004, NATURE, V430, P161, DOI 10.1038/430161a; Nusser Z, 1998, J NEUROSCI, V18, P1693; Pak DTS, 2003, SCIENCE, V302, P1368, DOI 10.1126/science.1082475; Pratt KG, 2003, NEURON, V39, P269, DOI 10.1016/S0896-6273(03)00422-7; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 2000, J NEUROSCI, V20, P8344, DOI 10.1523/JNEUROSCI.20-22-08344.2000; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Sala C, 2003, J NEUROSCI, V23, P6327; Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Steward O, 2001, NEURON, V30, P227, DOI 10.1016/S0896-6273(01)00275-6; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Ziv NE, 2004, NAT REV NEUROSCI, V5, P385, DOI 10.1038/nrn1370	45	178	183	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 18	2007	53	2					217	232		10.1016/j.neuron.2006.12.012	http://dx.doi.org/10.1016/j.neuron.2006.12.012			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	149DG	17224404	Bronze, Green Accepted			2022-12-28	WOS:000245126600008
J	Chung, HJ; Jan, LY				Chung, Hee Jung; Jan, Lily Y.			Channeling to the nucleus	NEURON			English	Editorial Material							CALCIUM-CHANNELS; CLASS-C; SUBUNITS	L-type voltage-gated calcium channels (LTCs) may control neuronal gene expression by increasing nuclear Ca2+ levels or regulating Ca2+/calmoclulin-dependent transcription factors. In the November 3 issue of Cell, Gomez-Ospina et al. demonstrate another signaling mechanism, in which a C-terminal fragment of LTC translocates to the nucleus in a calcium-dependent manner and directly regulates transcription.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Chung, HJ (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.			Chung, Hee Jung/0000-0002-5555-9907; Jan, Lily/0000-0003-3938-8498				Belliveau DJ, 2006, J BIOL CHEM, V281, P20920, DOI 10.1074/jbc.M600026200; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Connors BW, 2004, ANNU REV NEUROSCI, V27, P393, DOI 10.1146/annurev.neuro.26.041002.131128; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Ebinu JO, 2002, NEURON, V34, P499, DOI 10.1016/S0896-6273(02)00704-3; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Lipscombe D, 2004, J NEUROPHYSIOL, V92, P2633, DOI 10.1152/jn.00486.2004; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6	12	5	5	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 21	2006	52	6					937	940		10.1016/j.neuron.2006.12.001	http://dx.doi.org/10.1016/j.neuron.2006.12.001			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	120VS	17178398	Bronze			2022-12-28	WOS:000243115100003
J	Friederici, AD				Friederici, Angela D.			The neural basis of language development and its impairment	NEURON			English	Review							EVENT-RELATED POTENTIALS; STRUCTURAL BRAIN ABNORMALITIES; AUDITORY CHANGE-DETECTION; ELECTROPHYSIOLOGICAL EVIDENCE; MISMATCH NEGATIVITY; SENTENCE COMPREHENSION; SEMANTIC PROCESSES; SEVERE SPEECH; PICTURE CONTEXTS; INHERITED SPEECH	The neural correlates of early language development and language impairment are described, with the adult language-related brain systems as a target model. Electrophysiological and hemodynamic studies indicate that language functions to be installed in the child's brain are similar to those of adults, with lateralization being present at birth, phonological processes during the first months, semantic processes at 12 months, and syntactic processes around 30 months. These findings support the view that the brain basis of language develops continuously over time. Discontinuities are observed in children with language impairment. Here, the observed functional abnormalities are accompanied by structural abnormalities in inferior frontal and temporal brain regions.	Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Max Planck Society	Friederici, AD (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	angelafr@cbs.mpg.de						Ahmad Z, 2003, NEUROLOGY, V60, P1598, DOI 10.1212/01.WNL.0000059865.32155.86; Alho K, 1998, PSYCHOPHYSIOLOGY, V35, P211, DOI 10.1111/1469-8986.3520211; Atchley RA, 2006, BRAIN LANG, V99, P236, DOI 10.1016/j.bandl.2005.08.005; Balsamo LM, 2006, NEUROIMAGE, V31, P1306, DOI 10.1016/j.neuroimage.2006.01.027; BaronCohen S, 1997, CHILD DEV, V68, P48; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bates E, 1999, CARN S COGN, P29; BELTON E, 2002, NEUROIMAGE, V16, P10144; BISHOP DVM, 1994, PHILOS T ROY SOC B, V346, P105, DOI 10.1098/rstb.1994.0134; BISHOP DVM, 1992, J CHILD PSYCHOL PSYC, V33, P3, DOI 10.1111/j.1469-7610.1992.tb00858.x; Bookheimer S, 2002, ANNU REV NEUROSCI, V25, P151, DOI 10.1146/annurev.neuro.25.112701.142946; Cheour M, 1998, NAT NEUROSCI, V1, P351, DOI 10.1038/1561; Cheour M, 2000, CLIN NEUROPHYSIOL, V111, P4, DOI 10.1016/S1388-2457(99)00191-1; Cheour M, 1997, DEV NEUROPSYCHOL, V13, P167, DOI 10.1080/87565649709540676; CHEOURLUHTANEN M, 1995, HEARING RES, V82, P53, DOI 10.1016/0378-5955(94)00164-L; Chou TL, 2006, NEUROIMAGE, V29, P1141, DOI 10.1016/j.neuroimage.2005.09.064; CLAHSEN H, 1989, LINGUISTICS, V27, P897, DOI 10.1515/ling.1989.27.5.897; Dehaene-Lambertz G, 1998, NEUROREPORT, V9, P1885, DOI 10.1097/00001756-199806010-00040; Dehaene-Lambertz G, 2002, SCIENCE, V298, P2013, DOI 10.1126/science.1077066; DEHAENELAMBERTZ G, 1994, NATURE, V370, P292, DOI 10.1038/370292a0; DEMONET JF, 1994, NEUROSCI LETT, V182, P25, DOI 10.1016/0304-3940(94)90196-1; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Fisher SE, 1998, NAT GENET, V18, P168, DOI 10.1038/ng0298-168; Friebe L, 2006, J MACROMOL SCI PURE, VA43, P11, DOI 10.1080/10601320500405786; Friederici AD, 2000, HUM BRAIN MAPP, V11, P1, DOI 10.1002/1097-0193(200009)11:1<1::AID-HBM10>3.0.CO;2-B; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2004, NEUROREPORT, V15, P165, DOI 10.1097/00001756-200401190-00032; Friederici AD, 2002, NEUROREPORT, V13, P1251, DOI 10.1097/00001756-200207190-00006; Friederici AD, 2002, TRENDS COGN SCI, V6, P78, DOI 10.1016/S1364-6613(00)01839-8; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Friedrich M, 2005, NEUROREPORT, V16, P1801, DOI 10.1097/01.wnr.0000185013.98821.62; Friedrich M, 2005, NEUROREPORT, V16, P653, DOI 10.1097/00001756-200504250-00028; Friedrich M, 2004, J COGNITIVE NEUROSCI, V16, P1465, DOI 10.1162/0898929042304705; Friedrich M, 2004, PSYCHOPHYSIOLOGY, V41, P772, DOI 10.1111/j.1469-8986.2004.00202.x; Gauger LM, 1997, J SPEECH LANG HEAR R, V40, P1272, DOI 10.1044/jslhr.4006.1272; GOPNIK M, 1990, NATURE, V347, P26, DOI 10.1038/347026a0; Griffiths TD, 2002, TRENDS NEUROSCI, V25, P348, DOI 10.1016/S0166-2236(02)02191-4; Grodzinsky Y, 2006, CURR OPIN NEUROBIOL, V16, P240, DOI 10.1016/j.conb.2006.03.007; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Hahne A, 2002, COGNITIVE BRAIN RES, V13, P339, DOI 10.1016/S0926-6410(01)00127-6; Hahne A, 1999, J COGNITIVE NEUROSCI, V11, P194, DOI 10.1162/089892999563328; Halgren E, 2002, NEUROIMAGE, V17, P1101, DOI 10.1006/nimg.2002.1268; Hohle B., 2001, APPROACHES BOOTSTRAP, VVol. 1, P249; HOLCOMB PJ, 1992, DEV NEUROPSYCHOL, V8, P203, DOI 10.1080/87565649209540525; Homae F, 2006, NEUROSCI RES, V54, P276, DOI 10.1016/j.neures.2005.12.006; Hugdahl K, 2004, J SPEECH LANG HEAR R, V47, P162, DOI 10.1044/1092-4388(2004/014); HURST JA, 1990, DEV MED CHILD NEUROL, V32, P352; JERNIGAN TL, 1991, ARCH NEUROL-CHICAGO, V48, P539, DOI 10.1001/archneur.1991.00530170103028; Jusczyk P., 1997, DISCOVERY SPOKEN LAN; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; KAIL R, 1994, J SPEECH HEAR RES, V37, P418, DOI 10.1044/jshr.3702.418; Kooijman V, 2005, COGNITIVE BRAIN RES, V24, P109, DOI 10.1016/j.cogbrainres.2004.12.009; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Kuhl PK, 2004, NAT REV NEUROSCI, V5, P831, DOI 10.1038/nrn1533; Kuperberg GR, 2000, J COGNITIVE NEUROSCI, V12, P321, DOI 10.1162/089892900562138; Kushnerenko E, 2001, DEV NEUROPSYCHOL, V19, P83, DOI 10.1207/S15326942DN1901_6; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1994, PSYCHOLINGUISTICS EL, P83; Lai CSL, 2003, BRAIN, V126, P2455, DOI 10.1093/brain/awg247; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Leonard CM, 2002, J COMMUN DISORD, V35, P501, DOI 10.1016/S0021-9924(02)00120-X; Leppanen PHT, 1999, NEUROREPORT, V10, P969, DOI 10.1097/00001756-199904060-00014; Levy Y., 2003, LANGUAGE COMPETENCE; Liegeois F, 2003, NAT NEUROSCI, V6, P1230, DOI 10.1038/nn1138; Maess B, 2006, BRAIN RES, V1096, P163, DOI 10.1016/j.brainres.2006.04.037; Makela AM, 2001, NEUROREPORT, V12, P249; MERZENICH MM, 1993, ANN NY ACAD SCI, V682, P1; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Miller Arnold I., 1997, Geobios Memoire Special (Villeurbanne), V20, P397; Mills DL, 2004, J COGNITIVE NEUROSCI, V16, P1452, DOI 10.1162/0898929042304697; Molholm S, 2005, CEREB CORTEX, V15, P545, DOI 10.1093/cercor/bhh155; Mummery CJ, 1999, BRAIN, V122, P61, DOI 10.1093/brain/122.1.61; Naatanen R, 2001, TRENDS NEUROSCI, V24, P283, DOI 10.1016/S0166-2236(00)01790-2; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; NEVILLE HJ, 1993, J COGNITIVE NEUROSCI, V5, P235, DOI 10.1162/jocn.1993.5.2.235; Newbury DF, 2004, AM J HUM GENET, V74, P1225, DOI 10.1086/421529; Newbury DF, 2002, AM J HUM GENET, V70, P1318, DOI 10.1086/339931; Newbury DF, 2002, AM J HUM GENET, V70, P384; Ni W, 2000, J COGNITIVE NEUROSCI, V12, P120, DOI 10.1162/08989290051137648; O'Brien EK, 2003, AM J HUM GENET, V72, P1536, DOI 10.1086/375403; Oberecker R, 2005, J COGNITIVE NEUROSCI, V17, P1667, DOI 10.1162/089892905774597236; Oberecker R, 2006, NEUROREPORT, V17, P1017, DOI 10.1097/01.wnr.0000223397.12694.9a; Opitz B, 2002, NEUROIMAGE, V15, P167, DOI 10.1006/nimg.2001.0970; OSTERHOUT L, 1992, J MEM LANG, V31, P785, DOI 10.1016/0749-596X(92)90039-Z; OSTERHOUT L, 1994, J EXP PSYCHOL LEARN, V20, P786, DOI 10.1037/0278-7393.20.4.786; Pannekamp A, 2005, J COGNITIVE NEUROSCI, V17, P407, DOI 10.1162/0898929053279450; Pannekamp A, 2006, NEUROREPORT, V17, P675, DOI 10.1097/00001756-200604240-00024; Pena M, 2003, P NATL ACAD SCI USA, V100, P11702, DOI 10.1073/pnas.1934290100; Pereyra JFS, 2005, NEUROREPORT, V16, P645, DOI 10.1097/00001756-200504250-00026; PINKO E, 1999, NEUROREPORT, V10, P901; PLANTE E, 1991, BRAIN LANG, V41, P52, DOI 10.1016/0093-934X(91)90110-M; RICE ML, 1993, J SPEECH HEAR RES, V36, P1249, DOI 10.1044/jshr.3606.1249; Rivera-Gaxiola M, 2005, NEUROREPORT, V16, P495, DOI 10.1097/00001756-200504040-00015; Rossell SL, 2001, NEUROPSYCHOLOGIA, V39, P1167, DOI 10.1016/S0028-3932(01)00049-5; Schall U, 2003, NEUROIMAGE, V20, P729, DOI 10.1016/S1053-8119(03)00398-7; Scott SK, 2003, TRENDS NEUROSCI, V26, P100, DOI 10.1016/S0166-2236(02)00037-1; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Silva-Pereyra J, 2005, COGNITIVE BRAIN RES, V23, P247, DOI 10.1016/j.cogbrainres.2004.10.015; Steinhauer K, 1999, NAT NEUROSCI, V2, P191, DOI 10.1038/5757; TALLAL P, 1993, ANN NY ACAD SCI, V682, P27, DOI 10.1111/j.1749-6632.1993.tb22957.x; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Thierry G, 2003, NEUROREPORT, V14, P2307, DOI 10.1097/00001756-200312190-00004; Ullman MT, 2005, CORTEX, V41, P399, DOI 10.1016/S0010-9452(08)70276-4; Ulualp SO, 1998, LARYNGOSCOPE, V108, P1782, DOI 10.1097/00005537-199812000-00004; Van der Lely H.K.J., 2006, 19 ANN CUNY C HUM SE; van der Lely HKJ, 1998, CURR BIOL, V8, P1253, DOI 10.1016/S0960-9822(07)00534-9; van der Lely HKJ, 2005, TRENDS COGN SCI, V9, P53, DOI 10.1016/j.tics.2004.12.002; VANDERLELY HKJ, 1994, COGNITION, V51, P29, DOI 10.1016/0010-0277(94)90008-6; Vargha-Khadem F, 1998, P NATL ACAD SCI USA, V95, P12695, DOI 10.1073/pnas.95.21.12695; VARGHAKHADEM F, 1995, P NATL ACAD SCI USA, V92, P930, DOI 10.1073/pnas.92.3.930; VOLKMANN J, 1992, BRAIN LANG, V43, P386, DOI 10.1016/0093-934X(92)90108-Q; Watkins KE, 2002, BRAIN, V125, P465, DOI 10.1093/brain/awf057; Watkins KE, 1999, AM J HUM GENET, V65, P1215, DOI 10.1086/302631; Weber C, 2005, COGNITIVE BRAIN RES, V25, P180, DOI 10.1016/j.cogbrainres.2005.05.007; Weber C, 2004, COGNITIVE BRAIN RES, V18, P149, DOI 10.1016/j.cogbrainres.2003.10.001; West WC, 2002, COGNITIVE BRAIN RES, V13, P363, DOI 10.1016/S0926-6410(01)00129-X; Wilke M, 2005, NEUROREPORT, V16, P915, DOI 10.1097/00001756-200506210-00008	118	114	115	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 21	2006	52	6					941	952		10.1016/j.neuron.2006.12.002	http://dx.doi.org/10.1016/j.neuron.2006.12.002			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	120VS	17178399	Bronze			2022-12-28	WOS:000243115100004
J	MacLeod, D; Dowman, J; Hammond, R; Leete, T; Inoue, K; Abeliovich, A				MacLeod, David; Dowman, Julia; Hammond, Rachel; Leete, Thomas; Inoue, Keiichi; Abeliovich, Asa			The familial parkinsonism gene LRRK2 regulates neurite process morphology	NEURON			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; MUTATIONS; TRANSCRIPTION; OUTGROWTH; SYNUCLEIN	Mutations in LRRK2 underlie an autosomal-dominant, inherited form of Parkinson's disease (PD) that mimics the clinical features of the common "sporadic" form of PD. The LRRK2 protein includes putative GTPase, protein kinase, WD40 repeat, and leucine-rich repeat (LRR) domains of unknown function. Here we show that PD-associated LRRK2 mutations display disinhibited kinase activity and induce a progressive reduction in neurite length and branching both in primary neuronal cultures and in the intact rodent CNS. In contrast, LRRK2 deficiency leads to increased neurite length and branching. Neurons that express PD-associated LRRK2 mutations additionally harbor prominent phospho-tau-positive inclusions with lysosomal characteristics and ultimately undergo apoptosis.	Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Taub Inst, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Abeliovich, A (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Ctr Neurobiol & Behav, 15-403 630 W 168th St, New York, NY 10032 USA.	aa900@columbia.edu		Inoue, Keiichi/0000-0002-7101-486X; Leete, Thomas/0000-0001-8655-1476				Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Arantes RME, 2006, J NEUROSCI, V26, P4630, DOI 10.1523/JNEUROSCI.0009-06.2006; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Kirik D, 2002, J NEUROSCI, V22, P2780, DOI 10.1523/JNEUROSCI.22-07-02780.2002; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Martinat C, 2006, P NATL ACAD SCI USA, V103, P2874, DOI 10.1073/pnas.0511153103; Martinez-Arca S, 2001, J NEUROSCI, V21, P3830, DOI 10.1523/JNEUROSCI.21-11-03830.2001; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Staropoli JF, 2003, NEURON, V37, P735, DOI 10.1016/S0896-6273(03)00084-9; TROY CM, 1992, J CELL BIOL, V117, P1085, DOI 10.1083/jcb.117.5.1085; Tsai JW, 2005, J CELL BIOL, V170, P935, DOI 10.1083/jcb.200505166; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wszolek ZK, 2004, NEUROLOGY, V62, P1619, DOI 10.1212/01.WNL.0000125015.06989.DB; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	17	453	470	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 22	2006	52	4					587	593		10.1016/j.neuron.2006.10.008	http://dx.doi.org/10.1016/j.neuron.2006.10.008			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	110WX	17114044	Bronze			2022-12-28	WOS:000242413100007
J	Pelkey, KA; Topolnik, L; Lacaille, JC; McBain, CJ				Pelkey, Kenneth A.; Topolnik, Lisa; Lacaille, Jean-Claude; McBain, Chris J.			Compartmentalized Ca2+ channel regulation at divergent mossy-fiber release sites underlies target cell-dependent plasticity	NEURON			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; LONG-TERM POTENTIATION; SINGLE NERVE-TERMINALS; FEEDFORWARD INHIBITION; RAT HIPPOCAMPUS; TRANSMITTER RELEASE; PYRAMIDAL CELLS; SYNAPTIC TRANSMISSION; PRESYNAPTIC CALCIUM; NEUROTRANSMITTER RELEASE	Hippocampal mossy fibers (MFs) innervate CA3 targets via anatomically distinct presynaptic elements: MF boutons (MFBs) innervate pyramidal cells (PYRs), whereas filopodial extensions (Fils) of MFBs innervate st. lucidum interneurons (SLINs). Surprisingly, the same high-frequency stimulation (HFS) protocol induces presynaptically expressed LTP and LTD at PYR and SLIN inputs, respectively. This differential distribution of plasticity indicates that neighboring, functionally divergent presynaptic elements along the same axon serve as autonomous computational elements capable of modifying release independently. Indeed we report that HFS persistently depresses voltage-gated calcium channel (VGCC) function in Fil terminals, leaving MFB VGCCs unchanged despite similar contributions of N- and P/Q-type VGCCs to transmission at each terminal. Selective Fil VGCC depression results from HFS-induced mGluR7 activation leading to persistent P/Q-type VGCC inhibition. Thus, mGluR7 localization to MF-SLIN terminals and not MFBs allows for MF-SLIN LTD expression via depressed presynaptic VGCC function, whereas MF-PYR plasticity proceeds independently of VGCC alterations.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; Univ Montreal, Dept Physiol, Ctr Rech Sci Neurol, Montreal, PQ H3C 3J7, Canada	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universite de Montreal	Pelkey, KA (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bldg 35, Bethesda, MD 20892 USA.	pelkeyk2@mail.nih.gov		Topolnik, Lisa/0000-0003-4236-5473	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Acsady L, 1998, J NEUROSCI, V18, P3386; Alle H, 2001, P NATL ACAD SCI USA, V98, P14708, DOI 10.1073/pnas.251610898; ALTIER C, 2005, NAT NEUROSCI, V9, P8; Bischofberger J, 2002, J NEUROSCI, V22, P10593; Blitz DM, 2005, NEURON, V45, P917, DOI 10.1016/j.neuron.2005.01.033; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRAGIN A, 1995, J NEUROPHYSIOL, V73, P1691, DOI 10.1152/jn.1995.73.4.1691; Breustedt J, 2003, P NATL ACAD SCI USA, V100, P12450, DOI 10.1073/pnas.2035117100; Calakos N, 2004, NEURON, V42, P889, DOI 10.1016/j.neuron.2004.05.014; Castillo PE, 2002, NATURE, V415, P327, DOI 10.1038/415327a; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Chevaleyre V, 2003, NEURON, V38, P461, DOI 10.1016/S0896-6273(03)00235-6; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Contractor A, 2002, SCIENCE, V296, P1864, DOI 10.1126/science.1069081; Corti C, 2002, NEUROSCIENCE, V110, P403, DOI 10.1016/S0306-4522(01)00591-7; Engel D, 2005, NEURON, V45, P405, DOI 10.1016/j.neuron.2004.12.048; Ferraguti F, 2005, J NEUROSCI, V25, P10520, DOI 10.1523/JNEUROSCI.2547-05.2005; Gabernet L, 2005, NEURON, V48, P315, DOI 10.1016/j.neuron.2005.09.022; Gerdeman GL, 2002, NAT NEUROSCI, V5, P446, DOI 10.1038/nn832; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 1999, J PHYSIOL-LONDON, V518, P497, DOI 10.1111/j.1469-7793.1999.0497p.x; Kamiya H, 2002, J NEUROSCI, V22, P10524; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; Koester HJ, 2005, SCIENCE, V308, P863, DOI 10.1126/science.1100815; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Lawrence JJ, 2004, J PHYSIOL-LONDON, V554, P175, DOI 10.1113/jphysiol.2003.049551; Lawrence JJ, 2003, TRENDS NEUROSCI, V26, P631, DOI 10.1016/j.tins.2003.09.007; Lei SB, 2004, J NEUROSCI, V24, P2112, DOI 10.1523/JNEUROSCI.4645-03.2004; Lei SB, 2002, NEURON, V33, P921, DOI 10.1016/S0896-6273(02)00608-6; Liang Y, 2002, J NEUROPHYSIOL, V87, P1132, DOI 10.1152/jn.00661.2001; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Millan C, 2003, J BIOL CHEM, V278, P23955, DOI 10.1074/jbc.M211471200; Millan C, 2002, J BIOL CHEM, V277, P47796, DOI 10.1074/jbc.M207531200; Millan C, 2002, J BIOL CHEM, V277, P14092, DOI 10.1074/jbc.M109044200; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Miyazaki K, 2005, NEUROSCIENCE, V136, P1003, DOI 10.1016/j.neuroscience.2005.08.049; Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854; Murphy GJ, 2004, J NEUROSCI, V24, P3023, DOI 10.1523/JNEUROSCI.5745-03.2004; Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786; Pelkey KA, 2005, NEURON, V46, P89, DOI 10.1016/j.neuron.2005.02.011; Penttonen M, 1997, HIPPOCAMPUS, V7, P437, DOI 10.1002/(SICI)1098-1063(1997)7:4<437::AID-HIPO9>3.0.CO;2-F; Perroy J, 2000, J NEUROSCI, V20, P7896; Perroy J, 2002, EMBO J, V21, P2990, DOI 10.1093/emboj/cdf313; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; REGEHR WG, 1991, NEURON, V7, P451, DOI 10.1016/0896-6273(91)90297-D; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schoch S, 2002, NATURE, V415, P321, DOI 10.1038/415321a; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Thoreson WB, 2004, NEURON, V42, P595, DOI 10.1016/S0896-6273(04)00254-5; Tokunaga T, 2004, HIPPOCAMPUS, V14, P570, DOI 10.1002/hipo.10202; Topolnik L, 2005, J NEUROSCI, V25, P990, DOI 10.1523/JNEUROSCI.4388-04.2005; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Tzounopoulos T, 1998, NEURON, V21, P837, DOI 10.1016/S0896-6273(00)80599-1; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WU LG, 1994, J NEUROSCI, V14, P5613; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; Yokoi M, 1996, SCIENCE, V273, P645, DOI 10.1126/science.273.5275.645; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	67	89	90	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 9	2006	52	3					497	510		10.1016/j.neuron.2006.08.032	http://dx.doi.org/10.1016/j.neuron.2006.08.032			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	108WK	17088215	Bronze			2022-12-28	WOS:000242269700012
J	Uncapher, MR; Otten, LJ; Rugg, MD				Uncapher, Melina R.; Otten, Leun J.; Rugg, Michael D.			Episodic encoding is more than the sum of its parts: An fMRI investigation of multifeatural contextual encoding	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; HIPPOCAMPAL CONTRIBUTIONS; PREFRONTAL CORTEX; OBJECT-LOCATION; FEATURE BINDING; BRAIN ACTIVITY; SOURCE MEMORY; ITEM; PARIETAL; INFORMATION	Episodic memories are characterized by their contextual richness, yet little is known about how the various features comprising an episode are brought together in memory. Here we employed fMRI and a multidimensional source memory procedure to investigate processes supporting the mnemonic binding of item and contextual information. Volunteers were scanned while encoding items for which the contextual features (color and location) varied independently, allowing activity elicited at the time of study to be segregated according to whether both, one, or neither feature was successfully retrieved on a later memory test. Activity uniquely associated with successful encoding of both features was identified in the intra-parietal sulcus, a region strongly implicated in the support of attentionally mediated perceptual binding. The findings suggest that the encoding of disparate features of an episode into a common memory representation requires that the features be conjoined in a common perceptual representation when the episode is initially experienced.	Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; UCL, Dept Psychol, London WC1N 3NR, England; UCL, Inst Cognit Neurosci, London WC1N 3NR, England	University of California System; University of California Irvine; University of California System; University of California Irvine; University of London; University College London; University of London; University College London	Uncapher, MR (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA.	melina.u@uci.edu	Otten, Leun/C-6036-2008		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074528] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH074528, 1R01MH074528] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; BADDELEY AD, 1982, PSYCHOL REV, V89, P708, DOI 10.1037/0033-295X.89.6.708; Baker JT, 2001, NEUROREPORT, V12, P1251, DOI 10.1097/00001756-200105080-00039; Blumenfeld RS, 2006, J NEUROSCI, V26, P916, DOI 10.1523/JNEUROSCI.2353-05.2006; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; Cansino S, 2002, CEREB CORTEX, V12, P1048, DOI 10.1093/cercor/12.10.1048; Chalfonte BL, 1996, MEM COGNITION, V24, P403, DOI 10.3758/BF03200930; Chao LL, 1999, J COGNITIVE NEUROSCI, V11, P25, DOI 10.1162/089892999563229; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Committeri G, 2004, J COGNITIVE NEUROSCI, V16, P1517, DOI 10.1162/0898929042568550; Cusack R, 2005, J COGNITIVE NEUROSCI, V17, P641, DOI 10.1162/0898929053467541; Davachi L, 2002, J NEUROPHYSIOL, V88, P982, DOI 10.1152/jn.2002.88.2.982; Davachi L, 2001, J COGNITIVE NEUROSCI, V13, P1059, DOI 10.1162/089892901753294356; Davachi L, 2003, P NATL ACAD SCI USA, V100, P2157, DOI 10.1073/pnas.0337195100; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; EICHENBAUM H, 1992, J COGNITIVE NEUROSCI, V4, P217, DOI 10.1162/jocn.1992.4.3.217; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; FRINGS L, 2006, IN PRESS EXP BRAIN R; Friston K., 1994, HUM BRAIN MAPP, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Friston KJ, 2002, NEUROIMAGE, V16, P465, DOI 10.1006/nimg.2002.1090; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gold BT, 2002, NEURON, V35, P803, DOI 10.1016/S0896-6273(02)00800-0; Gold JJ, 2006, P NATL ACAD SCI USA, V103, P9351, DOI 10.1073/pnas.0602716103; Hanna A, 1996, MEM COGNITION, V24, P322, DOI 10.3758/BF03213296; HAYMAN CAG, 1995, MEM COGNITION, V23, P95, DOI 10.3758/BF03210560; Humphreys GW, 1998, PHILOS T R SOC B, V353, P1341, DOI 10.1098/rstb.1998.0288; Johnson Marcia K., 1994, P311; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kellenbach ML, 2001, COGN AFFECT BEHAV NE, V1, P207, DOI 10.3758/CABN.1.3.207; Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006; Kohler S, 2001, MEM COGNITION, V29, P948, DOI 10.3758/BF03195757; Kucera H., 1967, COMPUTATIONAL ANAL P; LIGHT LL, 1976, J EXP PSYCHOL-HUM L, V2, P654; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; Marsh RL, 2004, MEMORY, V12, P183, DOI 10.1080/09658210344000008; Mayes AR, 2004, NEUROPSYCHOLOGY, V18, P426, DOI 10.1037/0894-4105.18.3.426; Meiser T, 2002, J EXP PSYCHOL LEARN, V28, P116, DOI 10.1037//0278-7393.28.1.116; Mitchell JP, 2004, J NEUROSCI, V24, P4912, DOI 10.1523/JNEUROSCI.0481-04.2004; MOSCOVITCH M, 1992, J COGNITIVE NEUROSCI, V4, P257, DOI 10.1162/jocn.1992.4.3.257; NAVEHBENJAMIN M, 1987, J EXP PSYCHOL LEARN, V13, P595, DOI 10.1037/0278-7393.13.4.595; Norman KA, 2003, PSYCHOL REV, V110, P611, DOI 10.1037/0033-295X.110.4.611; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Otten LJ, 2002, NAT NEUROSCI, V5, P1339, DOI 10.1038/nn967; Otten LJ, 2001, CEREB CORTEX, V11, P1150, DOI 10.1093/cercor/11.12.1150; Paller KA, 2002, TRENDS COGN SCI, V6, P93, DOI 10.1016/S1364-6613(00)01845-3; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Prince SE, 2005, J NEUROSCI, V25, P1203, DOI 10.1523/JNEUROSCI.2540-04.2005; Ranganath C, 2004, NEUROPSYCHOLOGIA, V42, P2, DOI 10.1016/j.neuropsychologia.2003.07.006; Reynolds JR, 2004, NEUROIMAGE, V21, P1472, DOI 10.1016/j.neuroimage.2003.10.033; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rolls ET, 2000, ANNU REV PSYCHOL, V51, P599, DOI 10.1146/annurev.psych.51.1.599; Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102; Shafritz KM, 2002, P NATL ACAD SCI USA, V99, P10917, DOI 10.1073/pnas.152694799; Sommer T, 2006, NEUROBIOL LEARN MEM, V85, P243, DOI 10.1016/j.nlm.2005.11.002; Sommer T, 2005, NEUROPSYCHOLOGIA, V43, P732, DOI 10.1016/j.neuropsychologia.2004.08.002; Starns JJ, 2005, J EXP PSYCHOL LEARN, V31, P1213, DOI 10.1037/0278-7393.31.6.1213; Treisman A, 1998, PHILOS T ROY SOC B, V353, P1295, DOI 10.1098/rstb.1998.0284; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Uncapher MR, 2005, J NEUROSCI, V25, P7260, DOI 10.1523/JNEUROSCI.1641-05.2005; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wolbers T, 2005, J NEUROSCI, V25, P3333, DOI 10.1523/JNEUROSCI.4705-04.2005	65	153	155	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 9	2006	52	3					547	556		10.1016/j.neuron.2006.08.011	http://dx.doi.org/10.1016/j.neuron.2006.08.011			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	108WK	17088219	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000242269700016
J	Wichmann, T; DeLong, MR				Wichmann, Thomas; DeLong, Mahlon R.			Deep brain stimulation for neurologic and neuropsychiatric disorders	NEURON			English	Review							OBSESSIVE-COMPULSIVE DISORDER; PRIMARY GENERALIZED DYSTONIA; GLOBUS-PALLIDUS INTERNUS; QUALITY-OF-LIFE; SUBTHALAMIC NUCLEUS STIMULATION; MOTOR CORTEX STIMULATION; TERM-FOLLOW-UP; PARKINSONS-DISEASE; THALAMIC-STIMULATION; ESSENTIAL TREMOR	In the 1960s, ablative stereotactic surgery was employed for a variety of movement disorders and psychiatric conditions. Although largely abandoned in the 1970s because of highly effective drugs, such as levodopa for Parkinson's disease (PD), and a reaction against psychosurgery, the field has undergone a virtual renaissance, guided by a better understanding of brain circuitry and the circuit abnormalities underlying movement disorders such as PD and neuropsychiatric conditions, such as obsessive compulsive disorder. High-frequency electrical deep brain stimulation (DBS) of specific targets, introduced in the early 1990s for tremor, has gained widespread acceptance because of its less invasive, reversible, and adjustable features and is now utilized for an increasing number of brain disorders. This review summarizes the rationale behind DBS and the use of this technique for a variety of movement disorders and neuropsychiatric diseases.	Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA	Emory University; Emory University	DeLong, MR (corresponding author), Emory Univ, Dept Neurol, Atlanta, GA 30322 USA.	medmrd@emory.edu						ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Anderson VC, 2005, ARCH NEUROL-CHICAGO, V62, P554, DOI 10.1001/archneur.62.4.554; ANDY OJ, 1987, APPL NEUROPHYSIOL, V50, P324; Aouizerate B, 2004, J NEUROSURG, V101, P682, DOI 10.3171/jns.2004.101.4.0682; Bejjani BP, 1999, NEW ENGL J MED, V340, P1476, DOI 10.1056/NEJM199905133401905; BENABID AL, 1993, ACTA NEUROCHIR, P39; Berk C, 2002, J NEUROSURG, V97, P815, DOI 10.3171/jns.2002.97.4.0815; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brown P, 2004, EXP NEUROL, V188, P480, DOI 10.1016/j.expneurol.2004.05.009; Carbon Maren, 2004, Adv Neurol, V94, P155; Ceballos-Baumann AO, 2001, NEUROLOGY, V56, P1347, DOI 10.1212/WNL.56.10.1347; Cif L, 2003, J Neurosurg Sci, V47, P52; Coubes P, 2004, J NEUROSURG, V101, P189, DOI 10.3171/jns.2004.101.2.0189; Detante O, 2004, BRAIN, V127, P1899, DOI 10.1093/brain/awh213; Deuschl G, 2006, NEW ENGL J MED, V355, P896, DOI 10.1056/NEJMoa060281; Drouot' X, 2004, NEURON, V44, P769, DOI 10.1016/j.neuron.2004.11.023; Eltahawy HA, 2004, CAN J NEUROL SCI, V31, P328, DOI 10.1017/S0317167100003401; Fields JA, 2003, J NEUROL NEUROSUR PS, V74, P305, DOI 10.1136/jnnp.74.3.305; Flaherty AW, 2005, NEUROSURGERY, V57, DOI 10.1227/01.NEU.0000176854.24694.95; Fontaine D, 2004, J NEUROSURG, V100, P1084, DOI 10.3171/jns.2004.100.6.1084; Fukuda M, 2004, NEUROIMAGE, V21, P608, DOI 10.1016/j.neuroimage.2003.09.068; GATEV P, 2006, IN PRESS MOV DISORD; Grafton ST, 2006, NEUROLOGY, V66, P1192, DOI 10.1212/01.wnl.0000214237.58321.c3; Greenberg BD, 2006, NEUROPSYCHOPHARMACOL, V31, P2384, DOI 10.1038/sj.npp.1301165; Halbig TD, 2005, J NEUROL NEUROSUR PS, V76, P1713, DOI 10.1136/jnnp.2004.057992; Hallett Mark, 2004, Adv Neurol, V94, P1; Hashimoto T, 2003, J NEUROSCI, V23, P1916; Houeto JL, 2005, J NEUROL NEUROSUR PS, V76, P992, DOI 10.1136/jnnp.2004.043273; Jimenez F, 2005, NEUROSURGERY, V57, P585, DOI 10.1227/01.NEU.0000170434.44335.19; Kitagawa M, 2000, NEUROLOGY, V55, P114, DOI 10.1212/WNL.55.1.114; Kitagawa M, 2005, NEUROSURGERY, V56, P281, DOI 10.1227/01.neu.0000148167.49105.A3; Kojima J, 1997, NEUROSCI LETT, V226, P111, DOI 10.1016/S0304-3940(97)00254-1; Krauss JK, 2002, J NEUROL NEUROSUR PS, V72, P249, DOI 10.1136/jnnp.72.2.249; Kuhn AA, 2003, NEUROLOGY, V60, P768, DOI 10.1212/01.WNL.0000044396.64752.4C; Kumar R, 2003, NEUROLOGY, V61, P1601, DOI 10.1212/01.WNL.0000096012.07360.1C; Loher TJ, 2000, J NEUROSURG, V92, P457, DOI 10.3171/jns.2000.92.3.0457; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McIntyre CC, 2004, J CLIN NEUROPHYSIOL, V21, P40, DOI 10.1097/00004691-200401000-00006; Mena-Segovia J, 2004, TRENDS NEUROSCI, V27, P585, DOI 10.1016/j.tins.2004.07.009; Mink Jonathan W, 2006, Adv Neurol, V99, P89; Moringlane Jean Richard, 2004, Mult Scler, V10, P708, DOI 10.1191/1352458504ms1102cr; Murata J, 2003, J NEUROSURG, V99, P708, DOI 10.3171/jns.2003.99.4.0708; Nandi D, 2002, J CLIN NEUROSCI, V9, P64, DOI 10.1054/jocn.2001.1012; Nandi D, 2002, J CLIN NEUROSCI, V9, P170, DOI 10.1054/jocn.2001.0943; Nuttin BJ, 2003, NEUROSURGERY, V52, P1263, DOI 10.1227/01.NEU.0000064565.49299.9A; Obeso JA, 1997, BAILLIERE CLIN NEUR, V6, P125; Ondo W, 1998, NEUROLOGY, V51, P1063, DOI 10.1212/WNL.51.4.1063; Pagni CA, 2005, ACT NEUR S, V93, P113; Pahwa R, 2006, J NEUROSURG, V104, P506, DOI 10.3171/jns.2006.104.4.506; Parsons TD, 2006, LANCET NEUROL, V5, P578, DOI 10.1016/S1474-4422(06)70475-6; Pastor-Gomez J, 2003, REV NEUROLOGIA, V37, P529, DOI 10.33588/rn.3706.2003273; Payne MS, 2005, NEUROSURGERY, V56, P868, DOI 10.1227/01.NEU.0000156492.99035.EE; Pierantozzi M, 2002, CLIN NEUROPHYSIOL, V113, P108, DOI 10.1016/S1388-2457(01)00694-0; Pillon B, 2006, NEUROLOGY, V66, P1556, DOI 10.1212/01.wnl.0000216131.41563.24; Plaha P, 2005, NEUROREPORT, V16, P1883, DOI 10.1097/01.wnr.0000187637.20771.a0; Plaha P, 2006, BRAIN, V129, P1732, DOI 10.1093/brain/awl127; Rauch SL, 2006, J NEUROSURG, V104, P558, DOI 10.3171/jns.2006.104.4.558; Rehncrona S, 2003, MOVEMENT DISORD, V18, P163, DOI 10.1002/mds.10309; Rodriguez-Oroz MC, 2004, J NEUROL NEUROSUR PS, V75, P1382, DOI 10.1136/jnnp.2003.031294; Romanelli P, 2003, J NEUROSURG, V99, P566, DOI 10.3171/jns.2003.99.3.0566; Sakas DE, 2006, MED HYPOTHESES, V66, P491, DOI 10.1016/j.mehy.2005.07.036; Schramm P, 2005, ACTA NEUROCHIR, V147, P679, DOI 10.1007/s00701-005-0508-4; Shapira NA, 2006, J NEUROL NEUROSUR PS, V77, P410, DOI 10.1136/jnnp.2005.069906; Starr PA, 2005, J NEUROPHYSIOL, V93, P3165, DOI 10.1152/jn.00971.2004; Stefurak T, 2003, MOVEMENT DISORD, V18, P1508, DOI 10.1002/mds.10593; Stover NP, 2005, ARCH NEUROL-CHICAGO, V62, P141, DOI 10.1001/archneur.62.1.141; Taha JM, 1999, J NEUROSURG, V91, P68, DOI 10.3171/jns.1999.91.1.0068; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Temel Y, 2004, MOVEMENT DISORD, V19, P3, DOI 10.1002/mds.10649; Temel Y, 2006, PARKINSONISM RELAT D, V12, P265, DOI 10.1016/j.parkreldis.2006.01.004; Troster AI, 1997, NEUROLOGY, V49, P1078, DOI 10.1212/WNL.49.4.1078; Trottenberg T, 2005, NEUROLOGY, V64, P344, DOI 10.1212/01.WNL.0000149762.80932.55; Vidailhet M, 2005, NEW ENGL J MED, V352, P459, DOI 10.1056/NEJMoa042187; Visser-Vandewalle V, 2004, ACTA NEUROL BELG, V104, P32; Weaver F, 2005, J NEUROSURG, V103, P956, DOI 10.3171/jns.2005.103.6.0956; Wishart HA, 2003, J NEUROL NEUROSUR PS, V74, P1392, DOI 10.1136/jnnp.74.10.1392; Yamamoto T, 2004, J NEUROSURG, V101, P201, DOI 10.3171/jns.2004.101.2.0201; Yelnik J, 2003, J NEUROSURG, V99, P89, DOI 10.3171/jns.2003.99.1.0089	79	219	233	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 5	2006	52	1					197	204		10.1016/j.neuron.2006.09.022	http://dx.doi.org/10.1016/j.neuron.2006.09.022			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	096WS	17015236	Bronze			2022-12-28	WOS:000241408100014
J	Preuschoff, K; Bossaerts, P; Quartz, SR				Preuschoff, Kerstin; Bossaerts, Peter; Quartz, Steven R.			Neural differentiation of expected reward and risk in human subcortical structures	NEURON			English	Article							SOMATIC MARKER HYPOTHESIS; DOPAMINE NEURONS; DECISION-MAKING; ASSET PRICES; UNCERTAINTY; RESPONSES; BRAIN; ANTICIPATION; MIDBRAIN; CORTEX	In decision-making under uncertainty, economic studies emphasize the importance of risk in addition to expected reward. Studies in neuroscience focus on expected reward and learning rather than risk. We combined functional imaging with a simple gambling task to vary expected reward and risk simultaneously and in an uncorrelated manner. Drawing on financial decision theory, we modeled expected reward as mathematical expectation of reward, and risk as reward variance. Activations in dopaminoceptive structures correlated with both mathematical parameters. These activations differentiated spatially and temporally. Temporally, the activation related to expected reward was immediate, while the activation related to risk was delayed. Analyses confirmed that our paradigm minimized confounds from learning, motivation, and salience. These results suggest that the primary task of the dopaminergic system is to convey signals of upcoming stochastic rewards, such as expected reward and risk, beyond its role in learning, motivation, and salience.	CALTECH, Computat & Neural Syst Program, Social Cognit Neurosci Lab, Pasadena, CA 91125 USA; CALTECH, Div Humanities & Social Sci, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Preuschoff, K (corresponding author), CALTECH, Computat & Neural Syst Program, Social Cognit Neurosci Lab, 1200 E California Blvd 228-77, Pasadena, CA 91125 USA.	kerstinp@caltech.edu	Preuschoff, Kerstin/AAG-4725-2019; Bossaerts, Peter/AAZ-9851-2020; Preuschoff, Kerstin/G-4710-2015; Zhang, Xiao/V-9027-2017; Bossaerts, Peter/O-9964-2015	Preuschoff, Kerstin/0000-0001-7254-833X; Bossaerts, Peter/0000-0003-2308-2603; Zhang, Xiao/0000-0002-2932-5875; 				ABEL AB, 1990, AM ECON REV, V80, P38; Aron AR, 2004, J NEUROPHYSIOL, V92, P1144, DOI 10.1152/jn.01209.2003; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; BIALEK W, 1992, TRENDS NEUROSCI, V15, P428, DOI 10.1016/0166-2236(92)90005-S; BLACK F, 1973, J POLIT ECON, V81, P637, DOI 10.1086/260062; Bossaerts P., 2004, Review of Finance, V8, P135, DOI 10.1023/B:EUFI.0000035190.24818.e5; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Cavedini P, 2002, BIOL PSYCHIAT, V51, P334, DOI 10.1016/S0006-3223(01)01227-6; Clark L, 2001, AM J PSYCHIAT, V158, P1605, DOI 10.1176/appi.ajp.158.10.1605; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAVIDSON R, 1981, ECONOMETRICA, V49, P781, DOI 10.2307/1911522; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Dreher JC, 2006, CEREB CORTEX, V16, P561, DOI 10.1093/cercor/bhj004; Dunn BD, 2006, NEUROSCI BIOBEHAV R, V30, P239, DOI 10.1016/j.neubiorev.2005.07.001; Elliott R, 2003, J NEUROSCI, V23, P303; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Ernst M, 2004, NEUROPSYCHOLOGIA, V42, P1585, DOI 10.1016/j.neuropsychologia.2004.05.011; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; Fukui H, 2005, NEUROIMAGE, V24, P253, DOI 10.1016/j.neuroimage.2004.08.028; Grinband J, 2006, NEURON, V49, P757, DOI 10.1016/j.neuron.2006.01.032; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Hsu M, 2005, SCIENCE, V310, P1680, DOI 10.1126/science.1115327; Huettel SA, 2006, NEURON, V49, P765, DOI 10.1016/j.neuron.2006.01.024; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Knutson B, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-16-j0002.2001; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; LINTNER J, 1965, REV ECON STAT, V47, P13, DOI 10.2307/1924119; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McCoy AN, 2003, NEURON, V40, P1031, DOI 10.1016/S0896-6273(03)00719-0; Minassian A, 2004, J AFFECT DISORDERS, V82, P203, DOI 10.1016/j.jad.2003.11.010; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; MONTAGUE PR, 1994, LEARN MEMORY, V1, P1; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MOSSIN J, 1966, ECONOMETRICA, V34, P768, DOI 10.2307/1910098; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; REAL LA, 1991, SCIENCE, V253, P980, DOI 10.1126/science.1887231; ROMO R, 1990, J NEUROPHYSIOL, V63, P592, DOI 10.1152/jn.1990.63.3.592; Rustichini A, 2005, GAME ECON BEHAV, V52, P257, DOI 10.1016/j.geb.2004.08.005; Samuelson W, 1988, J RISK UNCERTAINTY, V1, P7, DOI 10.1007/BF00055564; SHARPE WF, 1964, J FINANC, V19, P425, DOI 10.2307/2977928; Shurman B, 2005, SCHIZOPHR RES, V72, P215, DOI 10.1016/j.schres.2004.03.020; Sutton R. S., 1988, Machine Learning, V3, P9, DOI 10.1023/A:1022633531479; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; TOBIN J, 1957, REV ECON STUD, V25, P65; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Zink CF, 2004, NEURON, V42, P509, DOI 10.1016/S0896-6273(04)00183-7	54	457	462	0	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 3	2006	51	3					381	390		10.1016/j.neuron.2006.06.024	http://dx.doi.org/10.1016/j.neuron.2006.06.024			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	075TT	16880132	Bronze, Green Submitted			2022-12-28	WOS:000239908800013
J	Matsui, K; von Gersdorff, H				Matsui, K; von Gersdorff, H			The great escape of glutamate from the depth of presynaptic invaginations	NEURON			English	Editorial Material							AMPA RECEPTORS; SYNAPSE; SPILLOVER; DENSITY	The basal pole of a cone photoreceptor is in close contact with hundreds of bipolar cell dendrites. The function and properties of these unconventional junctions are a long-standing mystery. In this issue of Neuron, DeVries and colleagues provide compelling evidence that glutamate release from a single quanta can diffuse to distant AMPA/KA receptors on these basal junctions to generate slow mEPSCs.	Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan; Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Oregon Health & Science University	Matsui, K (corresponding author), Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan.		Matsui, Ko/AAE-3687-2019	Matsui, Ko/0000-0003-1068-9705				Diamond JS, 2002, NAT NEUROSCI, V5, P291, DOI 10.1038/nn0402-291; DiGregorio DA, 2002, NEURON, V35, P521, DOI 10.1016/S0896-6273(02)00787-0; Franks KM, 2003, J NEUROSCI, V23, P3186; Hasegawa J, 2006, NEURON, V50, P63, DOI 10.1016/j.neuron.2006.02.022; Haverkamp S, 2000, NEURON, V27, P85, DOI 10.1016/S0896-6273(00)00011-8; Matsui K, 2005, J NEUROSCI, V25, P7538, DOI 10.1523/JNEUROSCI.1927-05.2005; Rao-Mirotznik R, 1998, J NEUROPHYSIOL, V80, P3163, DOI 10.1152/jn.1998.80.6.3163; Renden R, 2005, J NEUROSCI, V25, P8482, DOI 10.1523/JNEUROSCI.1848-05.2005; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; WAGNER HJ, 1993, TRENDS NEUROSCI, V16, P201, DOI 10.1016/0166-2236(93)90155-F	11	2	2	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN 1	2006	50	5					669	671		10.1016/j.neuron.2006.05.012	http://dx.doi.org/10.1016/j.neuron.2006.05.012			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	051MK	16731506	Bronze			2022-12-28	WOS:000238165000003
J	Nakazawa, K				Nakazawa, K			Inducible and cell-type restricted manipulation in the entorhinal cortex	NEURON			English	Editorial Material							MEDIAL TEMPORAL-LOBE; REMOTE SPATIAL MEMORY; HIPPOCAMPAL-LESIONS; RETROGRADE-AMNESIA; RAT; PLACES; DAMAGE	The entorhinal cortex functions as the gateway to the hippocampal formation. However, its role in formation and consolidation of hippocampus-dependent memory remains relatively unexplored. In this issue of Neuron, Yasuda and Mayford report an elegant cell-type restricted inducible transgenic mouse overexpressing a mutant form of CaM kinase II selectively in superficial layers of medial entorhinal cortex and its upstream regions. These animals display a selective spatial memory deficit during the immediate posttraining period as well as during acquisition in the Morris water maze. Similar to the hippocampus, this time-limited involvement of entorhinal cortex in spatial memory processing suggests a crucial role for hippocampal-entorhinal circuitry in spatial memory formation.	NIMH, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Nakazawa, K (corresponding author), NIMH, Intramural Res Program, NIH, 35 Convent Dr, Bethesda, MD 20892 USA.		Nakazawa, Kazutoshi/J-6195-2015	Nakazawa, Kazutoshi/0000-0001-5699-9093	NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002824] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aggleton JP, 2000, HIPPOCAMPUS, V10, P466, DOI 10.1002/1098-1063(2000)10:4<466::AID-HIPO13>3.3.CO;2-P; Clark RE, 2005, HIPPOCAMPUS, V15, P340, DOI 10.1002/hipo.20076; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Iijima T, 1996, SCIENCE, V272, P1176, DOI 10.1126/science.272.5265.1176; Jarrard LE, 2004, HIPPOCAMPUS, V14, P434, DOI 10.1002/hipo.10194; Martin SJ, 2005, NEUROPSYCHOLOGIA, V43, P609, DOI 10.1016/j.neuropsychologia.2004.07.007; Mumby DG, 1999, BEHAV BRAIN RES, V106, P97, DOI 10.1016/S0166-4328(99)00097-2; Murray EA, 2005, Q J EXP PSYCHOL-B, V58, P378, DOI 10.1080/02724990544000077; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; SAGAR HJ, 1985, ANN NY ACAD SCI, V444, P533, DOI 10.1111/j.1749-6632.1985.tb37637.x; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Teng E, 1999, NATURE, V400, P675, DOI 10.1038/23276; Winocur G, 2005, NEUROPSYCHOLOGIA, V43, P1580, DOI 10.1016/j.neuropsychologia.2005.01.013; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; Yasuda M, 2006, NEURON, V50, P309, DOI 10.1016/j.neuron.2006.03.035	18	3	3	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR 20	2006	50	2					183	185		10.1016/j.neuron.2006.04.007	http://dx.doi.org/10.1016/j.neuron.2006.04.007			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	037VW	16630829	Bronze			2022-12-28	WOS:000237176700005
J	Eckel-Mahan, KL; Storm, DR				Eckel-Mahan, KL; Storm, DR			Rookie snail protein LAPS veteran C/EBP: Net transcriptional proceeds for long-term facilitation	NEURON			English	Editorial Material							BEHAVIORAL SENSITIZATION; MEMORY; CONSOLIDATION; APLYSIA; BETA	Long-term changes in synaptic plasticity require new protein synthesis. This preview discusses data from Kim et al. (this issues of Neuron) that demonstrate the requirement of a novel, nucleolar protein, LLP (LAPS18-like protein), for the formation of long-term facilitation in Aplysia. LLP binds to and transcriptionally activates C/EBP, thereby promoting the formation of long-term facilitation and behavioral sensitization.	Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eckel-Mahan, KL (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.			Eckel-Mahan, Kristin/0000-0001-8201-1675				ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Athos J, 2002, NAT NEUROSCI, V5, P1119, DOI 10.1038/nn951; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Kim H, 2006, NEURON, V49, P707, DOI 10.1016/j.neuron.2006.01.035; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rosen ED, 2000, GENE DEV, V14, P1293; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001	11	3	3	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR 2	2006	49	5					645	646		10.1016/j.neuron.2006.02.009	http://dx.doi.org/10.1016/j.neuron.2006.02.009			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	022QL	16504938	Bronze			2022-12-28	WOS:000236070600003
J	Garcia-Murillas, I; Pettitt, T; Macdonald, E; Okkenhaug, H; Georgiev, P; Trivedi, D; Hassan, B; Wakelam, M; Raghu, P				Garcia-Murillas, I; Pettitt, T; Macdonald, E; Okkenhaug, H; Georgiev, P; Trivedi, D; Hassan, B; Wakelam, M; Raghu, P			Iazaro encodes a lipid phosphate phosphohydrolase that regulates phosphatidylinositol turnover during Drosophila phototransduction	NEURON			English	Article							LIGHT-SENSITIVE CHANNELS; RETINAL-DEGENERATION-B; MIGRATING GERM-CELLS; DIACYLGLYCEROL KINASE; PHOSPHOLIPASE-C; TRP CHANNELS; IN-VIVO; ENDOPLASMIC-RETICULUM; 4-PHOSPHATE 5-KINASE; INSP(3) RECEPTOR	An essential step in Drosophila phototransduction is the hydrolysis of phosphatidylinositol 4,5 bisphosphate PI(4,5)P-2 by phospholipase C beta (PLC beta) to generate a second messenger that opens the light-activated channels TRP and TRPL. Although the identity of this messenger remains unknown, recent evidence has implicated diacylglycerol kinase (DGK), encoded by rdgA, as a key enzyme that regulates its levels, mediating both amplification and response termination. In this study, we demonstrate that lazaro (laza) encodes a lipid phosphate phosphohydrolase (LPP) that functions during phototransduction. We demonstrate that the synergistic activity of laza and rdgA regulates response termination during phototransduction. Analysis of retinal phospholipids revealed a reduction in phosphatidic acid (PA) levels and an associated reduction in phosphatidylinositol (PI) levels. Together our results demonstrate the contribution of PI depletion to the rdgA phenotype and provide evidence that depletion of PI and its metabolites might be a key signal for TRP channel activation in vivo.	Babraham Inst, Inositide Lab, Cambridge CB2 4AT, England; Univ Birmingham, CRUK Inst Canc Studies, Birmingham B15 2TA, W Midlands, England; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; VIB, Dept Human Genet, Neurogenet Lab, B-3000 Louvain, Belgium; Univ Louvain, Sch Med, B-3000 Louvain, Belgium	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Birmingham; University of Cambridge; Flanders Institute for Biotechnology (VIB)	Raghu, P (corresponding author), Babraham Inst, Inositide Lab, Babraham Res Campus, Cambridge CB2 4AT, England.	raghu.padinjat@bbsrc.ac.uk	Hassan, Bassem A/D-5221-2012; Padinjat, Raghu/Z-5578-2019	Hassan, Bassem A/0000-0001-9533-4908; Trivedi, Deepti/0000-0001-8105-0728; garcia-murillas, isaac/0000-0001-8183-7969; Wakelam, Michael/0000-0003-4059-9276; Okkenhaug, Hanneke/0000-0003-0669-4069				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Alderton F, 2001, J BIOL CHEM, V276, P13452, DOI 10.1074/jbc.M006582200; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Burnett C, 2003, EMBO REP, V4, P793, DOI 10.1038/sj.embor.embor900; Burnett Camilla, 2004, BMC Biochemistry, V5, P2, DOI 10.1186/1471-2091-5-2; Chyb S, 1999, NATURE, V397, P255, DOI 10.1038/16703; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Estacion M, 2001, J PHYSIOL-LONDON, V530, P1, DOI 10.1111/j.1469-7793.2001.0001m.x; FUJITA SC, 1987, BIOCHEM J, V243, P97, DOI 10.1042/bj2430097; GANI D, 1993, BIOCHIM BIOPHYS ACTA, V1177, P253, DOI 10.1016/0167-4889(93)90121-5; Georgiev P, 2005, J CELL SCI, V118, P1373, DOI 10.1242/jcs.01712; GLOOR GB, 1993, GENETICS, V135, P81; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Hardie RC, 2002, NEURON, V36, P689, DOI 10.1016/S0896-6273(02)01048-6; Hardie RC, 1998, CELL CALCIUM, V24, P153, DOI 10.1016/S0143-4160(98)90125-7; Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; Hardie RC, 2001, NEURON, V30, P149, DOI 10.1016/S0896-6273(01)00269-0; Hassan BA, 1998, GENETICS, V150, P1527; Hooks SB, 1998, FEBS LETT, V427, P188, DOI 10.1016/S0014-5793(98)00421-9; Horton R M, 1997, Methods Mol Biol, V67, P141; INOUE H, 1989, J BIOL CHEM, V264, P5996; JAMAL Z, 1991, J BIOL CHEM, V266, P2988; Jasinska R, 1999, BIOCHEM J, V340, P677, DOI 10.1042/0264-6021:3400677; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; JOPE RS, 1992, BIOL PSYCHIAT, V31, P505, DOI 10.1016/0006-3223(92)90261-W; Kai M, 1996, J BIOL CHEM, V271, P18931, DOI 10.1074/jbc.271.31.18931; Kanoh H, 2002, J BIOCHEM, V131, P629, DOI 10.1093/oxfordjournals.jbchem.a003144; Karagiosis SA, 2004, DEVELOPMENT, V131, P725, DOI 10.1242/dev.00976; KENDALL DA, 1987, J PHARMACOL EXP THER, V241, P1023; KENNEDY ED, 1990, BIOCHEM J, V267, P781, DOI 10.1042/bj2670781; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Lykidis A, 1997, J BIOL CHEM, V272, P33402, DOI 10.1074/jbc.272.52.33402; Masai I, 1997, J NEUROBIOL, V32, P695, DOI 10.1002/(SICI)1097-4695(19970620)32:7<695::AID-NEU5>3.0.CO;2-#; MASAI I, 1993, P NATL ACAD SCI USA, V90, P11157, DOI 10.1073/pnas.90.23.11157; MATSUMOTO H, 1982, SCIENCE, V217, P839, DOI 10.1126/science.7100927; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; NAPIER RM, 1992, J CELL SCI, V102, P261; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; Raghu P, 2000, NEURON, V26, P169, DOI 10.1016/S0896-6273(00)81147-2; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; Renault AD, 2004, SCIENCE, V305, P1963, DOI 10.1126/science.1102421; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Roberts R, 1998, J BIOL CHEM, V273, P22059, DOI 10.1074/jbc.273.34.22059; ROBERTSON HM, 1988, GENETICS, V118, P461; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Starz-Gaiano M, 2001, DEVELOPMENT, V128, P983; VIHTELIC TS, 1991, GENETICS, V127, P761; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; Voets T, 2003, J MEMBRANE BIOL, V192, P1, DOI 10.1007/s00232-002-1059-8; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Whatmore J, 1999, BIOCHEM J, V341, P435, DOI 10.1042/0264-6021:3410435; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; Zhang N, 1997, NATURE, V385, P64, DOI 10.1038/385064a0; Zhang QX, 2000, BIOCHEM J, V345, P181, DOI 10.1042/0264-6021:3450181	63	57	58	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					533	546		10.1016/j.neuron.2006.02.001	http://dx.doi.org/10.1016/j.neuron.2006.02.001			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476663	Bronze			2022-12-28	WOS:000235643800007
J	Gonzalez-Islas, C; Wenner, P				Gonzalez-Islas, C; Wenner, P			Spontaneous network activity in the embryonic spinal cord regulates AMPAergic and GABAergic synaptic strength	NEURON			English	Article							PATTERNED NEURAL ACTIVITY; HOMEOSTATIC PLASTICITY; NERVOUS-SYSTEM; QUANTAL SIZE; CHICK-EMBRYO; PRESYNAPTIC REGULATION; NEOCORTICAL SYNAPSES; HIPPOCAMPAL-NEURONS; VESICULAR GLUTAMATE; GABA(A) RECEPTORS	Spontaneous network activity (SNA) has been described in most developing circuits, including the spinal cord, retina, and hippocampus. Despite the widespread nature of this developmental phenomenon, its role in network maturation is poorly understood. We reduced SNA in the intact embryo and found compensatory increases in synaptic strength of spinal motoneuron inputs. AMPAergic miniature postsynaptic current (mPSC) amplitude and frequency increased following the reduction of activity. Interestingly, excitatory GABAergic mPSCs also increase in amplitude through a process of synaptic scaling. Finally, the normal modulation of GABAergic mPSC amplitude was accelerated. Together, these compensatory responses appear to increase the excitability of the cord and could act to maintain appropriate SNA levels, thus demonstrating a distinct functional role for synaptic homeostasis. Because spontaneous network activity can regulate AMPAergic and GABAergic synaptic strength during development, SNA is likely to play an important role in a coordinated maturation of excitatory and inhibitory synaptic strength.	Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA	Emory University	Wenner, P (corresponding author), Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA.	pwenner@emory.edu		Wenner, Peter/0000-0002-7072-2194	NINDS NIH HHS [NS-046510] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046510] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atwood HL, 2002, NAT REV NEUROSCI, V3, P497, DOI 10.1038/nrn876; BEKOFF A, 1975, P NATL ACAD SCI USA, V72, P1245, DOI 10.1073/pnas.72.4.1245; Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P361, DOI 10.1016/j.tins.2004.05.007; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Borodinsky LN, 2004, NATURE, V429, P523, DOI 10.1038/nature02518; Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Chub N, 1998, J NEUROSCI, V18, P294; Chub N, 2001, J NEUROPHYSIOL, V85, P2166, DOI 10.1152/jn.2001.85.5.2166; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Fedirchuk B, 1999, J NEUROSCI, V19, P2102; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FORTIN G, 1995, J PHYSIOL-LONDON, V486, P735, DOI 10.1113/jphysiol.1995.sp020849; FRERKING M, 1995, NEURON, V15, P885, DOI 10.1016/0896-6273(95)90179-5; FRITSCHY JM, 1994, J NEUROSCI, V14, P5302; Galante M, 2000, J PHYSIOL-LONDON, V523, P639, DOI 10.1111/j.1469-7793.2000.t01-1-00639.x; GUMMER AW, 1994, NEUROREPORT, V5, P685, DOI 10.1097/00001756-199402000-00006; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; HAMBURGER V, 1977, NEUROSCI RES PROG B, V15, P1; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hanson MG, 2003, J NEUROSCI, V23, P587, DOI 10.1523/JNEUROSCI.23-02-00587.2003; Hanson MG, 2004, NEURON, V43, P687, DOI 10.1016/j.neuron.2004.08.018; Harrison RG, 1904, AM J ANAT, V3, P197, DOI 10.1002/aja.1000030206; HAVERKAMP LJ, 1986, J NEUROSCI, V6, P1332; Ho SM, 1999, NEUROREPORT, V10, P659, DOI 10.1097/00001756-199902250-00039; Isaac JTR, 2003, NEUROPHARMACOLOGY, V45, P450, DOI 10.1016/S0028-3908(03)00229-6; Itaya SK, 1995, CAN J PHYSIOL PHARM, V73, P1372, DOI 10.1139/y95-192; Jarvis JC, 1996, AM J PHYSIOL-CELL PH, V270, pC306, DOI 10.1152/ajpcell.1996.270.1.C306; Karunanithi S, 2002, J NEUROSCI, V22, P10267; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilman V, 2002, J NEUROSCI, V22, P1328, DOI 10.1523/JNEUROSCI.22-04-01328.2002; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Lippe WR, 1995, BRAIN RES, V703, P205, DOI 10.1016/0006-8993(95)01096-3; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Marchetti C, 2005, J NEUROSCI, V25, P3601, DOI 10.1523/JNEUROSCI.4290-04.2005; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; MENDELSON B, 1991, J NEUROSCI, V11, P1390; Milner LD, 1999, J NEUROSCI, V19, P3007; Nicoll RA, 2003, PHILOS T R SOC B, V358, P721, DOI 10.1098/rstb.2002.1228; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; O'Donovan MJ, 1998, J NEUROBIOL, V37, P131, DOI 10.1002/(SICI)1097-4695(199810)37:1<131::AID-NEU10>3.0.CO;2-H; OPPENHEIM RW, 1986, J NEUROSCI, V6, P1338; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; PERSSON M, 1983, J ANAT, V137, P591; Preyer W., 1885, SPECIELLE PHYSL EMBR; Preyer W.T., 1937, MONOGR SOC RES CHILD, V2, P1; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Ritter A, 1999, J NEUROSCI, V19, P3457; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; ROUFA D, 1981, BIOCHEM PHARMACOL, V30, P1501, DOI 10.1016/0006-2952(81)90373-7; RUANOGIL D, 1978, ACTA ANAT, V101, P36, DOI 10.1159/000144947; Spitzer NC, 2002, J PHYSIOLOGY-PARIS, V96, P73, DOI 10.1016/S0928-4257(01)00082-1; Swanwick CC, 2006, MOL CELL NEUROSCI, V31, P481, DOI 10.1016/j.mcn.2005.11.002; Tabak J, 2000, J NEUROSCI, V20, P3041; Tabak J, 2001, J NEUROSCI, V21, P8966, DOI 10.1523/JNEUROSCI.21-22-08966.2001; Thiagarajan TC, 2005, NEURON, V47, P725, DOI 10.1016/j.neuron.2005.06.037; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; TOUTANT JP, 1979, CELL DIFFER DEV, V8, P375, DOI 10.1016/0045-6039(79)90022-8; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang XY, 2005, J NEUROSCI, V25, P343, DOI 10.1523/JNEUROSCI.3252-04.2005; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wenner P, 2001, J NEUROPHYSIOL, V86, P1481, DOI 10.1152/jn.2001.86.3.1481; Wierenga CJ, 2005, J NEUROSCI, V25, P2895, DOI 10.1523/JNEUROSCI.5217-04.2005; Wilson NR, 2005, J NEUROSCI, V25, P6221, DOI 10.1523/JNEUROSCI.3003-04.2005; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753	76	118	121	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 16	2006	49	4					563	575		10.1016/j.neuron.2006.01.017	http://dx.doi.org/10.1016/j.neuron.2006.01.017			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	016TR	16476665	Bronze			2022-12-28	WOS:000235643800009
